FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Liu, K
   Chen, D
   Marcozzi, A
   Zheng, LF
   Su, JJ
   Pesce, D
   Zajaczkowski, W
   Kolbe, A
   Pisula, W
   Mullen, K
   Clark, NA
   Herrmann, A
AF Liu, Kai
   Chen, Dong
   Marcozzi, Alessio
   Zheng, Lifei
   Su, Juanjuan
   Pesce, Diego
   Zajaczkowski, Wojciech
   Kolbe, Anke
   Pisula, Wojciech
   Muellen, Klaus
   Clark, Noel A.
   Herrmann, Andreas
TI Thermotropic liquid crystals from biomacromolecules
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; liquid crystal; smectic; lipid; surfactant
ID LIPOSOME-DNA COMPLEXES; ORDERED PHASES; CAST FILM; TEMPERATURE;
   POLYMERS; DELIVERY; LENGTH; LIPIDS
AB Complexation of biomacromolecules (e. g., nucleic acids, proteins, or viruses) with surfactants containing flexible alkyl tails, followed by dehydration, is shown to be a simple generic method for the production of thermotropic liquid crystals. The anhydrous smectic phases that result exhibit biomacromolecular sublayers intercalated between aliphatic hydrocarbon sublayers at or near room temperature. Both this and low transition temperatures to other phases enable the study and application of thermotropic liquid crystal phase behavior without thermal degradation of the biomolecular components.
C1 [Liu, Kai; Marcozzi, Alessio; Zheng, Lifei; Pesce, Diego; Kolbe, Anke; Herrmann, Andreas] Univ Groningen, Zernike Inst Adv Mat, Dept Polymer Chem, NL-9747 AG Groningen, Netherlands.
   [Su, Juanjuan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Dynam, NL-9747 AG Groningen, Netherlands.
   [Su, Juanjuan] Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands.
   [Chen, Dong; Clark, Noel A.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA.
   [Zajaczkowski, Wojciech; Pisula, Wojciech; Muellen, Klaus] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
RP Clark, NA (reprint author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.
EM noel.clark@colorado.edu; a.herrmann@rug.nl
RI Herrmann, Andreas/F-3189-2016; Zajaczkowski, Wojciech/C-1464-2016;
   Clark, Noel/E-9011-2010
OI Herrmann, Andreas/0000-0002-8886-0894; Zajaczkowski,
   Wojciech/0000-0003-0113-0985; Pesce, Diego/0000-0003-4623-3558
FU European Union; Netherlands Organization for Scientific Research
   (NWO-Vici, NWO-Echo); Zernike Institute for Advanced Materials; National
   Science Foundation under Biomolecular Materials [1270606]; Materials
   Research Science and Engineering Centers [DMR-0820579, DMR-1420736]
FX The help of Wenqiang Zou in recording the fluorescence spectra is
   gratefully acknowledged. This research was supported by the European
   Union [European Research Council Starting Grant and specific targeted
   research project (STREP): Microscale Chemically Reactive Electronic
   Agents], the Netherlands Organization for Scientific Research (NWO-Vici,
   NWO-Echo), the Zernike Institute for Advanced Materials, and the
   National Science Foundation under Biomolecular Materials Grant 1270606,
   and Materials Research Science and Engineering Centers Grants
   DMR-0820579 and DMR-1420736.
CR Bangham A. D., 1983, LIPOSOME LETT
   Bouxsein NF, 2011, J AM CHEM SOC, V133, P7585, DOI 10.1021/ja202082c
   Briman M, 2004, NANO LETT, V4, P733, DOI 10.1021/nl049961s
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Coleman DA, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.021703
   Coleman DA, 2003, SCIENCE, V301, P1204, DOI 10.1126/science.1084956
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051
   Dogic Z, 2006, CURR OPIN COLLOID IN, V11, P47, DOI 10.1016/j.cocis.2005.10.004
   Faul CFJ, 2003, ADV MATER, V15, P673, DOI 10.1002/adma.200300379
   Gajria S, 2011, WIRES NANOMED NANOBI, V3, P479, DOI 10.1002/wnan.148
   Goodby JW, 2007, CHEM SOC REV, V36, P1971, DOI 10.1039/b708458g
   Gorecka E, 2008, J MATER CHEM, V18, P3044, DOI 10.1039/b803567a
   Gray G.W, 1984, SMECTIC LIQUID CRYST
   Hamad-Schifferli K, 2002, NATURE, V415, P152, DOI 10.1038/415152a
   Hamley IW, 2010, SOFT MATTER, V6, P1863, DOI 10.1039/b923942a
   Hanski S, 2008, MACROMOLECULES, V41, P866, DOI 10.1021/ma7019495
   Hanski S, 2010, BIOMACROMOLECULES, V11, P3440, DOI 10.1021/bm100972m
   JEFFREY GA, 1986, ACCOUNTS CHEM RES, V19, P168, DOI 10.1021/ar00126a002
   Kolbe A, 2011, MACROMOL RAPID COMM, V32, P186, DOI 10.1002/marc.201000491
   Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lewis FD, 1997, SCIENCE, V277, P673, DOI 10.1126/science.277.5326.673
   LIVOLANT F, 1991, PHYSICA A, V176, P117, DOI 10.1016/0378-4371(91)90436-G
   LIVOLANT F, 1986, J PHYS-PARIS, V47, P1813, DOI 10.1051/jphys:0198600470100181300
   McBride C, 2002, J CHEM PHYS, V117, P10370, DOI 10.1063/1.1517604
   Milkereit G, 2006, J CARBOHYD CHEM, V25, P615, DOI 10.1080/07328300601082385
   Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826
   Neumann T, 2010, J AM CHEM SOC, V132, P7025, DOI 10.1021/ja909514j
   Okahata Y, 1998, J AM CHEM SOC, V120, P6165, DOI 10.1021/ja980165w
   Perriman AW, 2009, ANGEW CHEM INT EDIT, V48, P6242, DOI 10.1002/anie.200903100
   Ramamoorthy A., 2007, THERMOTROPIC LIQUID
   Sakya P, 1997, LIQ CRYST, V23, P409, DOI 10.1080/026782997208334
   Sengupta K, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031710
   STRZELECKA TE, 1988, NATURE, V331, P457, DOI 10.1038/331457a0
   Tanaka K, 1996, J AM CHEM SOC, V118, P10679, DOI 10.1021/ja9617855
   Tschierske C, 2007, CHEM SOC REV, V36, P1930, DOI 10.1039/b615517k
   Wenzel A, 1997, ADV MATER, V9, P487, DOI 10.1002/adma.19970090607
   Yamahata C, 2008, BIOPHYS J, V94, P63, DOI 10.1529/biophysj.107.115980
   Yu SJM, 1997, NATURE, V389, P167
   Zhou J, 2006, BIOPHYS J, V90, P544, DOI 10.1529/biophysj.105.071290
   Zhou SQ, 2004, BIOMACROMOLECULES, V5, P1256, DOI 10.1021/bm034524d
NR 42
TC 14
Z9 15
U1 8
U2 70
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 30
PY 2014
VL 111
IS 52
BP 18596
EP 18600
DI 10.1073/pnas.1421257111
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY2UL
UT WOS:000347444400052
PM 25512508
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Park, H
   Woo, EK
   Lee, KY
AF Park, Honghyun
   Woo, Eun Kyung
   Lee, Kuen Yong
TI Ionically cross-linkable hyaluronate-based hydrogels for injectable cell
   delivery
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Hyaluronate; Alginate; Ionic cross-linking; Cartilage regeneration;
   Tissue engineering
ID MESENCHYMAL STEM-CELLS; HUMAN GROWTH-HORMONE; SUSTAINED-RELEASE
   FORMULATION; ARTICULAR-CARTILAGE REPAIR; SODIUM HYALURONATE; ALGINATE
   HYDROGELS; BIOMEDICAL APPLICATIONS; EXTRACELLULAR-MATRIX; DRUG-DELIVERY;
   ACID HYDROGEL
AB Although hyaluronate is an attractive biomaterial for many biomedical applications, hyaluronate hydrogels are generally formed using chemical cross-linking reagents that may cause unwanted side effects, including toxicity. We thus propose to design and prepare ionically cross-linkable hyaluronate compounds that can form gels in the presence of counter-ions. This study is based on the hypothesis that introduction of alginate to hyaluronate backbones (hyaluronate-g-alginate) could allow for gel formation in the presence of calcium ions. Here, we demonstrated ease of formation of cross-linked structures with calcium ions without additional chemical cross-linking reagents in hyaluronate-g-alginate (HGA) gels. The mechanical properties of HGA gels were regulated through changes in polymer composition and calcium concentration. We also confirmed that HGA gels could be useful in regenerating cartilage in a mouse model following subcutaneous injection into the dorsal region with primary chondrocytes. This finding was supported by histological and immunohistochemical analyses, glycosaminoglycan quantification and chondrogenic marker gene expression. This approach to the design and tailoring of ionically cross-linkable biomedical polymers may be broadly applicable to the development of biomaterials, especially in the drug delivery and tissue engineering fields. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Park, Honghyun; Woo, Eun Kyung; Lee, Kuen Yong] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Lee, KY (reprint author), Hanyang Univ, Dept Bioengn, Coll Engn, Seoul 133791, South Korea.
EM leeky@hanyang.ac.kr
OI Lee, Kuen Yong/0000-0002-5759-5952
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning [NRF-2013R1A2A2A03010055]
FX This research was supported by the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT & Future Planning
   (NRF-2013R1A2A2A03010055).
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Barbucci R, 2002, BIOMATERIALS, V23, P4503, DOI 10.1016/S0142-9612(02)00194-1
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Burke SE, 2003, BIOMACROMOLECULES, V4, P1773, DOI 10.1021/bm034184w
   Chung CW, 2011, COLLOID SURFACE B, V88, P711, DOI 10.1016/j.colsurfb.2011.08.005
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   D'Arrigo G, 2012, COLLOID POLYM SCI, V290, P1575, DOI 10.1007/s00396-012-2735-6
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   FREI E, 1962, NATURE, V196, P130, DOI 10.1038/196130a0
   Giovannini S, 2010, J CELL PHYSIOL, V222, P411, DOI 10.1002/jcp.21965
   Hahn SK, 2004, PHARM RES, V21, P1374, DOI 10.1023/B:PHAM.0000036910.41224.de
   HAUG A, 1966, ACTA CHEM SCAND, V20, P183, DOI 10.3891/acta.chem.scand.20-0183
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Huang S, 1999, NAT CELL BIOL, V1, pE131
   Huebsch N, 2014, P NATL ACAD SCI USA, V111, P9762, DOI 10.1073/pnas.1405469111
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Kim MR, 2002, J CONTROL RELEASE, V80, P69, DOI 10.1016/S0168-3659(01)00557-0
   Kim SJ, 2005, J CONTROL RELEASE, V104, P323, DOI 10.1016/j.jcornel.2005.02.012
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P291, DOI 10.1016/S1381-5148(03)00019-1
   Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82
   Knudson Cheryl B., 2003, Birth Defects Research, V69, P174, DOI 10.1002/bdrc.10013
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   LOHRE JM, 1992, ARTIF ORGANS, V16, P630
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Paramonov SE, 2006, BIOMACROMOLECULES, V7, P24, DOI 10.1021/bm050798k
   Park H, 2011, CARBOHYD POLYM, V86, P1107, DOI 10.1016/j.carbpol.2011.05.032
   Park H, 2009, MACROMOL BIOSCI, V9, P895, DOI 10.1002/mabi.200800376
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   Takigawa T, 2006, J OCCUP HEALTH, V48, P75, DOI 10.1539/joh.48.75
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Wang LS, 2014, BIOMATERIALS, V35, P2207, DOI 10.1016/j.biomaterials.2013.11.070
   Wei G, 2002, J CONTROL RELEASE, V83, P65, DOI 10.1016/S0168-3659(02)00175-X
   Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200
   WOLFF DA, 1992, J ORTHOPAED RES, V10, P49, DOI 10.1002/jor.1100100106
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 54
TC 12
Z9 12
U1 3
U2 98
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD DEC 28
PY 2014
VL 196
BP 146
EP 153
DI 10.1016/j.jconrel.2014.10.008
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AW2PZ
UT WOS:000346132100017
PM 25315489
DA 2018-10-20
ER

PT J
AU Chen, YC
   Sun, TP
   Su, CT
   Wu, JT
   Lin, CY
   Yu, JS
   Huang, CW
   Chen, CJ
   Chen, HY
AF Chen, Yung-Chih
   Sun, Ting-Pi
   Su, Chiao-Tzu
   Wu, Jyun-Ting
   Lin, Chih-Yeh
   Yu, Jiashing
   Huang, Chao-Wei
   Chen, Chia-Jie
   Chen, Hsien-Yeh
TI Sustained Immobilization of Growth Factor Proteins Based on
   Functionalized Parylenes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE protein immobilization; growth factor; biomaterial; bioconjugation;
   surface modification
ID QUARTZ-CRYSTAL MICROBALANCE; CROSS-LINKING; SURFACES; PEPTIDE;
   STRATEGIES; REDUCTION; ENZYMES; DESIGN
C1 [Chen, Yung-Chih; Sun, Ting-Pi; Su, Chiao-Tzu; Wu, Jyun-Ting; Lin, Chih-Yeh; Yu, Jiashing; Chen, Hsien-Yeh] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   [Huang, Chao-Wei] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei 10617, Taiwan.
   [Chen, Chia-Jie] Natl Taiwan Univ, Dept Orthoped Surg, Taipei 10018, Taiwan.
RP Chen, HY (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM hsychen@ntu.edu.tw
OI Yu, Jiashing/0000-0002-0782-2328
FU Ministry of Science and Technology of Taiwan [NSC
   101-2628-E-002-034-MY3, NSC-DAAD 102-2911-I-002-507]
FX H.-Y.C. gratefully acknowledges support from the Ministry of Science and
   Technology of Taiwan (NSC 101-2628-E-002-034-MY3 and NSC-DAAD
   102-2911-I-002-507). We thank Dr. Chih-Hao Chang, Department of
   Orthopedic Surgery at National Taiwan University, for the discussion of
   osteogensis experiments.
CR Chen G., 2013, PLOS ONE, V8
   Chen HY, 2011, LANGMUIR, V27, P34, DOI 10.1021/la101623n
   D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102
   Han HC, 2009, BIOSENS BIOELECTRON, V24, P1543, DOI 10.1016/j.bios.2008.07.033
   Hedin J, 2007, LANGMUIR, V23, P6148, DOI 10.1021/la063406j
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Ito Y, 2013, BIOMATERIALS, V34, P7565, DOI 10.1016/j.biomaterials.2013.06.037
   Kim SE, 2011, BIOMATERIALS, V32, P366, DOI 10.1016/j.biomaterials.2010.09.008
   Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Liberelle B, 2010, BIOCONJUGATE CHEM, V21, P2257, DOI 10.1021/bc1002604
   Madler S, 2009, J MASS SPECTROM, V44, P694, DOI 10.1002/jms.1544
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1
   Rickert J, 1997, ANAL CHEM, V69, P1441, DOI 10.1021/ac960875p
   SAUERBREY G, 1959, Z PHYS, V206, P155
   Secundo F, 2013, CHEM SOC REV, V42, P6250, DOI 10.1039/c3cs35495d
   Singh R, 2002, ANAL BIOCHEM, V304, P147, DOI 10.1006/abio.2002.5624
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Sun MMC, 2005, BIOCONJUGATE CHEM, V16, P1282, DOI 10.1021/bc050201y
   Talbert JN, 2012, COLLOID SURFACE B, V93, P8, DOI 10.1016/j.colsurfb.2012.01.003
   Tsai MY, 2012, CHEM COMMUN, V48, P10969, DOI 10.1039/c2cc35892a
   Valenzuela CD, 2013, TISSUE ENG PT A, V19, P1373, DOI [10.1089/ten.tea.2012.0323, 10.1089/ten.TEA.2012.0323]
   Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   Wong LS, 2008, J AM CHEM SOC, V130, P12456, DOI 10.1021/ja8030278
   Wu JT, 2012, MACROMOL RAPID COMM, V33, P922, DOI 10.1002/marc.201200011
   Zaera F, 2012, CHEM REV, V112, P2920, DOI 10.1021/cr2002068
NR 29
TC 16
Z9 16
U1 3
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD DEC 24
PY 2014
VL 6
IS 24
BP 21906
EP 21910
DI 10.1021/am5071865
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AX8DA
UT WOS:000347139400019
PM 25434778
DA 2018-10-20
ER

PT J
AU Tan, L
   Pu, YQ
   Pattathil, S
   Avci, U
   Qian, J
   Arter, A
   Chen, LW
   Hahn, MG
   Ragauskas, AJ
   Kieliszewski, MJ
AF Tan, Li
   Pu, Yunqiao
   Pattathil, Sivakumar
   Avci, Utku
   Qian, Jin
   Arter, Allison
   Chen, Liwei
   Hahn, Michael G.
   Ragauskas, Arthur J.
   Kieliszewski, Marcia J.
TI Changes in Cell Wall Properties Coincide with Overexpression of Extensin
   Fusion Proteins in Suspension Cultured Tobacco Cells
SO PLOS ONE
LA English
DT Article
ID INTERMOLECULAR CROSS-LINK; O-GLYCOSYLATION CODES;
   ARABINOGALACTAN-PROTEINS; DI-ISODITYROSINE; EXPRESSION; GLYCOPROTEIN;
   CELLULASE; IMPROVES; TYROSINE; GROWTH
AB Extensins are one subfamily of the cell wall hydroxyproline-rich glycoproteins, containing characteristic SerHyp(4) glycosylation motifs and intermolecular cross-linking motifs such as the TyrXaaTyr sequence. Extensins are believed to form a cross-linked network in the plant cell wall through the tyrosine-derivatives isodityrosine, pulcherosine, and di-isodityrosine. Overexpression of three synthetic genes encoding different elastin-arabinogalactan protein-extensin hybrids in tobacco suspension cultured cells yielded novel cross-linking glycoproteins that shared features of the extensins, arabinogalactan proteins and elastin. The cell wall properties of the three transgenic cell lines were all changed, but in different ways. One transgenic cell line showed decreased cellulose crystallinity and increased wall xyloglucan content; the second transgenic cell line contained dramatically increased hydration capacity and notably increased cell wall biomass, increased di-isodityrosine, and increased protein content; the third transgenic cell line displayed wall phenotypes similar to wild type cells, except changed xyloglucan epitope extractability. These data indicate that overexpression of modified extensins may be a route to engineer plants for bioenergy and biomaterial production.
C1 [Tan, Li; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Hahn, Michael G.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.
   [Tan, Li; Pattathil, Sivakumar; Avci, Utku; Qian, Jin; Hahn, Michael G.] Univ Georgia, BioEnergy Sci Ctr, Athens, GA 30602 USA.
   [Hahn, Michael G.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.
   [Pu, Yunqiao; Ragauskas, Arthur J.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.
   [Arter, Allison; Chen, Liwei; Kieliszewski, Marcia J.] Ohio Univ, Dept Chem & Biochem, Athens, OH 45701 USA.
   [Chen, Liwei] Suzhou Inst Nanotech & Nanobion SINANO, Suzhou, Peoples R China.
RP Tan, L (reprint author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.
EM tan@ccrc.uga.edu
RI Ragauskas, Art/J-7486-2016
OI Ragauskas, Art/0000-0002-3536-554X; Pu, Yunqiao/0000-0003-2554-1447; ,
   Sivakumar Pattathil/0000-0003-3870-4137
FU National Science Foundation [MCB9874744]; Herman Frasch Foundation
   [526-HF02]; Department of Energy Bioenergy Research Center Award DOE
   [DE-PS02-06ER64304]; Office of Biological and Environmental Research in
   the Department of Energy Office of Science
FX This research was funded by grants to MK from the National Science
   Foundation (MCB9874744) and the Herman Frasch Foundation (526-HF02); and
   to LT, MGH, and AJR by the Department of Energy Bioenergy Research
   Center Award DOE DE-PS02-06ER64304. The BioEnergy Science Center is a
   United States Department of Energy Bioenergy Research Center supported
   by the Office of Biological and Environmental Research in the Department
   of Energy Office of Science. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abramson M, 2010, PLANT SCI, V178, P61, DOI 10.1016/j.plantsci.2009.11.003
   AN G, 1988, PLANT MOL BIOL MAN A, V3, P1
   BERGMAN T, 1986, ADV METHODS PROTEIN, P45
   Blemenkrantz N, 1973, ANAL BIOCHEM, V54, P484
   Brady JD, 1996, BIOCHEM J, V315, P323, DOI 10.1042/bj3150323
   Brady JD, 1998, PHYTOCHEMISTRY, V47, P349, DOI 10.1016/S0031-9422(97)00592-X
   Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105
   Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834
   Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108
   Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200
   Herbers K., 1995, NAT BIOTECHNOL, V13, P63, DOI DOI 10.1038/NBT0195-63
   Jung HJG, 2012, PLANT SCI, V185, P65, DOI 10.1016/j.plantsci.2011.10.014
   Kieliszewski MJ, 2001, PHYTOCHEMISTRY, V57, P319, DOI 10.1016/S0031-9422(01)00029-2
   Kieliszewski MJ, 2014, USA patent, Patent No. [US 08623812, 08623812]
   KOMALAVILAS P, 1989, CARBOHYD RES, V189, P261, DOI 10.1016/0008-6215(89)84102-3
   Lamport DTA, 2011, PLANT PHYSIOL, V156, P11, DOI 10.1104/pp.110.169011
   Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x
   Pattathil Sivakumar, 2012, Methods Mol Biol, V908, P61, DOI 10.1007/978-1-61779-956-3_6
   Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985
   Pechar M, 2007, MACROMOL BIOSCI, V7, P56, DOI 10.1002/mabi.200600196
   POPE DG, 1977, PLANT PHYSIOL, V59, P894, DOI 10.1104/pp.59.5.894
   Pu YQ, 2006, CARBOHYD RES, V341, P591, DOI 10.1016/j.carres.2005.12.012
   Reiersen H, 1998, J MOL BIOL, V283, P255, DOI 10.1006/jmbi.1998.2067
   Sage E H, 1977, Adv Exp Med Biol, V79, P291
   Schnabelrauch LS, 1996, PLANT J, V9, P477, DOI 10.1046/j.1365-313X.1996.09040477.x
   Showalter AM, 2001, CELL MOL LIFE SCI, V58, P1399, DOI 10.1007/PL00000784
   Shpak E, 1999, P NATL ACAD SCI USA, V96, P14736, DOI 10.1073/pnas.96.26.14736
   Shpak E, 2001, J BIOL CHEM, V276, P11272, DOI 10.1074/jbc.M011323200
   Tan L, 2003, PLANT PHYSIOL, V132, P1362, DOI 10.1104/pp.103.021766
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   Wang HZ, 2012, IND CROP PROD, V37, P170, DOI 10.1016/j.indcrop.2011.12.014
   Wang HZ, 2012, MOL PLANT, V5, P297, DOI 10.1093/mp/ssr098
   Xu JF, 2007, BIOTECHNOL BIOENG, V97, P997, DOI 10.1002/bit.21407
   Xu JF, 2010, TRANSGENIC RES, V19, P849, DOI 10.1007/s11248-010-9367-8
   Zhang D, 2011, BIOENERG RES, V4, P276, DOI 10.1007/s12155-011-9138-2
NR 35
TC 4
Z9 5
U1 0
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 23
PY 2014
VL 9
IS 12
AR e115906
DI 10.1371/journal.pone.0115906
PG 23
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ9UY
UT WOS:000348563300084
PM 25536327
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Duncan, GA
   Bevan, MA
AF Duncan, Gregg A.
   Bevan, Michael A.
TI Tunable Aggregation by Competing Biomolecular Interactions
SO LANGMUIR
LA English
DT Article
ID DIFFUSING COLLOIDAL PROBES; CONCANAVALIN-A; NANOPARTICLE INTERACTIONS;
   QUANTITATIVE-ANALYSIS; MEDIATED ADHESION; CARBOHYDRATE; COAGULATION;
   SURFACE; DISSOCIATION; MICROARRAYS
AB Measurements and models are reported for Concanavalin A (ConA) mediated aggregation of dextran coated colloids that is tunable via a competing ConA-glucose interaction. Video and confocal scanning laser microscopy were used to characterize ConA adsorption to dextran colloids and quasi-2D dextran coated colloid aggregation kinetics vs [ConA] and [glucose]. ConA adsorption to, and aggregation rates of, dextran coated colloids increased from negligible values to high coverage and rapid rates for increasing [ConA] in the range 0.1-10 mM and decreasing [glucose] in the range 1-100 mM, consistent with dissociation constant estimates. Analysis of colloidal aggregation kinetics indicates ConA bridge formation is the rate-limiting step controlling the transition from slow to rapid aggregation. Our findings reveal a mechanism for tuning colloidal interactions and aggregation kinetics through specific, competitive biomolecular interactions, which lends insights into aggregation phenomena in mixed synthetic-biomaterial and biological systems.
C1 [Duncan, Gregg A.; Bevan, Michael A.] Johns Hopkins Univ, Baltimore, MD 21218 USA.
RP Bevan, MA (reprint author), Johns Hopkins Univ, Baltimore, MD 21218 USA.
EM mabevan@jhu.edu
OI Duncan, Gregg/0000-0002-6811-1327
FU National Science Foundation [CBET-0834125, CBET-1066254]; National
   Science Foundation (IGERT)
FX We acknowledge financial support by the National Science Foundation
   (CBET-0834125, CBET-1066254, and an IGERT traineeship).
CR Alaniz L, 2009, CANCER LETT, V278, P9, DOI 10.1016/j.canlet.2008.12.029
   Anekal SG, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2211616
   Anekal SG, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1830012
   Barone P. W., 2006, ANGEW CHEM, V118, P8318
   BRENNER H, 1961, CHEM ENG SCI, V16, P242, DOI 10.1016/0009-2509(61)80035-3
   Castro LBR, 2006, LANGMUIR, V22, P3757, DOI 10.1021/la053080z
   Dorig P, 2013, BIOPHYS J, V105, P463, DOI 10.1016/j.bpj.2013.06.002
   Duncan GA, 2014, SOFT MATTER, V10, P8524, DOI 10.1039/c4sm01300j
   Eichmann SL, 2008, LANGMUIR, V24, P714, DOI 10.1021/la702571z
   Eichmann SL, 2013, LANGMUIR, V29, P2299, DOI 10.1021/la304355t
   Eichmann SL, 2010, LANGMUIR, V26, P14409, DOI 10.1021/la1027674
   Elender G, 1996, BIOSENS BIOELECTRON, V11, P565, DOI 10.1016/0956-5663(96)83292-1
   ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761
   Evans E, 2001, P NATL ACAD SCI USA, V98, P3784, DOI 10.1073/pnas.061324998
   Everett WN, 2010, LANGMUIR, V26, P18976, DOI 10.1021/la1038443
   Fuchs N, 1934, Z PHYS, V89, P736, DOI 10.1007/BF01341386
   GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   HARDT SL, 1979, BIOPHYS CHEM, V10, P239, DOI 10.1016/0301-4622(79)85012-7
   HOGG R, 1976, J COLLOID INTERF SCI, V56, P573, DOI 10.1016/0021-9797(76)90123-5
   HONIG EP, 1971, J COLLOID INTERF SCI, V36, P97, DOI 10.1016/0021-9797(71)90245-1
   Johansson EMV, 2008, CHEM BIOL, V15, P1249, DOI 10.1016/j.chembiol.2008.10.009
   Kim AJ, 2009, NAT MATER, V8, P52, DOI 10.1038/NMAT2338
   Kruyt H. R., 1952, COLLOID SCI, V1
   Liang F, 2005, PHOTOCHEM PHOTOBIOL, V81, P1386, DOI 10.1562/2005-02-14-RA-440
   Liang PH, 2007, J AM CHEM SOC, V129, P11177, DOI 10.1021/ja072931h
   Morse PM, 1929, PHYS REV, V34, P57, DOI 10.1103/PhysRev.34.57
   ODA Y, 1981, J BIOCHEM-TOKYO, V89, P285, DOI 10.1093/oxfordjournals.jbchem.a133192
   Rogers WB, 2011, P NATL ACAD SCI USA, V108, P15687, DOI 10.1073/pnas.1109853108
   Russel W.B, 1989, COLLOIDAL DISPERSION
   Sato Y, 2012, LANGMUIR, V28, P1846, DOI 10.1021/la2030044
   Scurr DJ, 2010, LANGMUIR, V26, P17143, DOI 10.1021/la1029933
   SHIMURA K, 1995, ANAL BIOCHEM, V227, P186, DOI 10.1006/abio.1995.1269
   Smoluchowski M., 1916, Z PHYS, V17, P557
   SPIELMAN LA, 1970, J COLLOID INTERF SCI, V33, P562, DOI 10.1016/0021-9797(70)90008-1
   STELL G, 1991, J STAT PHYS, V63, P1203, DOI 10.1007/BF01030007
   Tison CK, 2007, LANGMUIR, V23, P9728, DOI 10.1021/la700601j
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Wang X, 2010, ANAL CHEM, V82, P9082, DOI 10.1021/ac102114z
   Wu KT, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022304
   Ye T, 2014, POLYM CHEM-UK, V5, P186, DOI 10.1039/c3py00778b
NR 41
TC 5
Z9 5
U1 1
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 23
PY 2014
VL 30
IS 50
BP 15253
EP 15260
DI 10.1021/la503772g
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AX8DG
UT WOS:000347140000025
PM 25458784
DA 2018-10-20
ER

PT J
AU Wei, Y
   Thyparambil, AA
   Wu, YN
   Latour, RA
AF Wei, Yang
   Thyparambil, Aby A.
   Wu, Yonnie
   Latour, Robert A.
TI Adsorption-Induced Changes in Ribonuclease A Structure and Enzymatic
   Activity on Solid Surfaces
SO LANGMUIR
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; MASS-SPECTROMETRY; CONFORMATIONAL STABILITY;
   CHEMICAL-MODIFICATION; ADSORBED PROTEINS; ORIENTATION; LYSOZYME;
   BIOACTIVITY; FIBRINOGEN; RESIDUES
AB Ribonuclease A (RNase A) is a small globular enzyme that lyses RNA. The remarkable solution stability of its structure and enzymatic activity has led to its investigation to develop a new class of drugs for cancer chemotherapeutics. However, the successful clinical application of RNase A has been reported to be limited by insufficient stability and loss of enzymatic activity when it was coupled with a biomaterial carrier for drug delivery. The objective of this study was to characterize the structural stability and enzymatic activity of RNase A when it was adsorbed on different surface chemistries (represented by fused silica glass, high-density polyethylene, and poly(methyl-methacrylate)). Changes in protein structure were measured by circular dichroism, amino acid labeling with mass spectrometry, and in vitro assays of its enzymatic activity. Our results indicated that the process of adsorption caused RNase A to undergo a substantial degree of unfolding with significant differences in its adsorbed structure on each material surface. Adsorption caused RNase A to lose about 60% of its native-state enzymatic activity independent of the material on which it was adsorbed. These results indicate that the native-state structure of RNase A is greatly altered when it is adsorbed on a wide range of surface chemistries, especially at the catalytic site. Therefore, drug delivery systems must focus on retaining the native structure of RNase A in order to maintain a high level of enzymatic activity for applications such as antitumor chemotherapy.
C1 [Wei, Yang; Thyparambil, Aby A.; Latour, Robert A.] Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
   [Wu, Yonnie] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.
RP Latour, RA (reprint author), Clemson Univ, Dept Bioengn, Rhodes Engn Res Ctr 501, Clemson, SC 29634 USA.
EM LatourR@clemson.edu
OI Thyparambil, Aby/0000-0003-1760-1454
FU Defense Threat Reduction Agency, Joint Science and Technology Office for
   Chemical and Biological Defense [HDTRA1-10-1-0028]; NIH grant
   [5P20RR021949, 8P20GM103444]; NIBIB [EB002027]
FX This project received support from the Defense Threat Reduction Agency,
   Joint Science and Technology Office for Chemical and Biological Defense
   (grant no. HDTRA1-10-1-0028). The facilities used in this research were
   also supported by NIH grant nos. 5P20RR021949 and 8P20GM103444. We also
   would like to thank Megan Grobman, Dr. Lara Gamble, and Dr. David
   Castner of NESAC/BIO at the University of Washington for assistance with
   surface characterization with XPS under the funding support by NIBIB
   (grant no. EB002027).
CR Altman DG, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d2090
   Anand G, 2010, LANGMUIR, V26, P10803, DOI 10.1021/la1006132
   Arnold U, 2006, BIOTECHNOL LETT, V28, P1615, DOI 10.1007/s10529-006-9145-0
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BORAH B, 1985, BIOCHEMISTRY-US, V24, P2058, DOI 10.1021/bi00329a038
   Chatani E, 2001, J BIOSCI BIOENG, V92, P98, DOI 10.1263/jbb.92.98
   Daly SM, 2005, BIOTECHNOL BIOENG, V90, P856, DOI 10.1002/bit.20481
   Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101
   Fears KP, 2009, LANGMUIR, V25, P13926, DOI 10.1021/la900799m
   Fears KP, 2009, LANGMUIR, V25, P9319, DOI 10.1021/la901885d
   Hu Y.-J., 2009, BIOMACROMOLECULES, V11, P106
   Ilinskaya ON, 2005, MOL BIOL+, V39, P1, DOI 10.1007/s11008-005-0001-4
   Kastantin M, 2014, ADV COLLOID INTERFAC, V207, P240, DOI 10.1016/j.cis.2013.12.006
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Klink TA, 2000, J BIOL CHEM, V275, P17463, DOI 10.1074/jbc.M001132200
   Klink TA, 2000, EUR J BIOCHEM, V267, P566, DOI 10.1046/j.1432-1327.2000.01037.x
   Konradi R, 2012, BIOSENSORS-BASEL, V2, P341, DOI 10.3390/bios2040341
   LEE CS, 1989, P NATL ACAD SCI USA, V86, P8392, DOI 10.1073/pnas.86.21.8392
   Lee WK, 2002, J COLLOID INTERF SCI, V252, P473, DOI 10.1006/jcis.2002.8473
   Leitner A, 2007, RAPID COMMUN MASS SP, V21, P1321, DOI 10.1002/rcm.2967
   Leland PA, 2001, CHEM BIOL, V8, P405, DOI 10.1016/S1074-5521(01)00030-8
   Li CJ, 2012, J BIOTECHNOL, V162, P283, DOI 10.1016/j.jbiotec.2012.09.008
   Lins L, 2003, PROTEIN SCI, V12, P1406, DOI 10.1110/ps.0304803
   Mathe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081346
   Mendoza VL, 2009, MASS SPECTROM REV, V28, P785, DOI 10.1002/mas.20203
   Michaelis M, 2002, ANTI-CANCER DRUG, V13, P149, DOI 10.1097/00001813-200202000-00006
   Mu QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068559
   Ostuni E, 2003, LANGMUIR, V19, P1861, DOI 10.1021/la020649c
   Ovod V, 2012, J BIOMED MATER RES A, V100A, P622, DOI 10.1002/jbm.a.33285
   Pai SS, 2011, BIOCONJUGATE CHEM, V22, P2317, DOI 10.1021/bc2003583
   Poklar N, 1999, PROTEIN SCI, V8, P832
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014
   Rybak SM, 1999, EXP CELL RES, V253, P325, DOI 10.1006/excr.1999.4718
   Serra J, 2003, J NON-CRYST SOLIDS, V332, P20, DOI 10.1016/j.jnoncrysol.2003.09.013
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   Smith BD, 2005, LANGMUIR, V21, P187, DOI 10.1021/la0480686
   SUCKAU D, 1992, P NATL ACAD SCI USA, V89, P5630, DOI 10.1073/pnas.89.12.5630
   Thyparambil AA, 2014, ACTA BIOMATER, V10, P2404, DOI 10.1016/j.actbio.2014.01.027
   TOWNSEND MW, 1990, J PHARM SCI, V79, P1083, DOI 10.1002/jps.2600791209
   Wei Y, 2013, COLLOID SURFACE B, V110, P363, DOI 10.1016/j.colsurfb.2013.04.018
   XIAO Y, 2012, BIOINFORMATICS, V30, P801
   Xu JS, 2006, J AM CHEM SOC, V128, P6813, DOI 10.1021/ja054219v
   Xue XY, 2013, BIOMACROMOLECULES, V14, P331, DOI 10.1021/bm301511w
   Yi C., 2008, NANOTECHNOLOGY, V19
NR 47
TC 7
Z9 7
U1 4
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 16
PY 2014
VL 30
IS 49
BP 14849
EP 14858
DI 10.1021/la503854a
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AX1CE
UT WOS:000346685100018
PM 25420087
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Loessner, D
   Holzapfel, BM
   Clements, JA
AF Loessner, Daniela
   Holzapfel, Boris Michael
   Clements, Judith Ann
TI Engineered microenvironments provide new insights into ovarian and
   prostate cancer progression and drug responses
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Tissue engineering; Humanised; 3D culture models; Intraperitoneal
   metastasis; Bone metastasis; Preclinical drug testing
ID IN-VIVO MODEL; MATRIX-METALLOPROTEINASE ACTIVITY; COMBINED
   IMMUNODEFICIENT MICE; MARROW STROMAL FIBROBLASTS; PELVIC SEROUS
   CARCINOMA; TUMOR-CELL INVASION; HUMAN BREAST-CANCER; BONE-MARROW; MOUSE
   MODEL; EXTRACELLULAR-MATRIX
AB Tissue engineering technologies, which have originally been designed to reconstitute damaged tissue structure and function, can mimic not only tissue regeneration processes but also cancer development and progression. Bioengineered approaches allow cell biologists to develop sophisticated experimentally and physiologically relevant cancer models to recapitulate the complexity of the disease seen in patients. Tissue engineering tools enable three-dimensionality based on the design of biomaterials and scaffolds that re-create the geometry, chemistry, function and signalling milieu of the native tumour microenvironment. Three-dimensional (3D) microenvironments, including cell-derived matrices, biomaterial-based cell culture models and integrated co-cultures with engineered stromal components, are powerful tools to study dynamic processes like proteolytic functions associated with cancer progression, metastasis and resistance to therapeutics. In this review, we discuss how biomimetic strategies can reproduce a humanised niche for human cancer cells, such as peritoneal or bone-like microenvironments, addressing specific aspects of ovarian and prostate cancer progression and therapy response. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Loessner, Daniela; Holzapfel, Boris Michael; Clements, Judith Ann] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Canc & Mol Med Program, Brisbane, Qld 4059, Australia.
   [Holzapfel, Boris Michael] Univ Wurzburg, Orthopaed Ctr Musculoskeletal Res, Dept Orthopaed Surg, D-97074 Wurzburg, Germany.
   [Clements, Judith Ann] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Translat Res Inst, Brisbane, Qld 4102, Australia.
RP Loessner, D (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Canc & Mol Med Program, 60 Musk Ave, Brisbane, Qld 4059, Australia.
EM daniela.lossner@qut.edu.au; holzapfel@orthopaedic-oncology.net;
   j.clements@qut.edu.au
RI Loessner, Daniela/L-2265-2017
OI Loessner, Daniela/0000-0001-5891-3441; Clements,
   Judith/0000-0001-6026-1964
FU Australian Research Council [DP110103890]; Cancer Council Queensland
   [1034134]; National Health and Medical Research Council of Australia
   [553045]; Institute of Health and Biomedical Innovation, Queensland
   University of Technology, Australia; German Research Foundation (DFG)
   [HO 5068/1-1]
FX D.L. and J.A.C. are supported by the Australian Research Council
   (DP110103890), the Cancer Council Queensland (1034134) and National
   Health and Medical Research Council of Australia (553045). D.L. was
   awarded a Cells and Tissue Domain Collaborative Research Development
   grant from the Institute of Health and Biomedical Innovation, Queensland
   University of Technology, Australia. B.M.H. is supported by the German
   Research Foundation (DFG HO 5068/1-1). The authors would like to
   cordially thank Dr. Christina Theodoropoulos and Thi-My-Tam Nguyen for
   their technical assistance with the immunohistochemical analyses.
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Abramov Y, 2012, ONCOL REP, V28, P735, DOI 10.3892/or.2012.1810
   Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123
   Albadine R, 2009, MODERN PATHOL, V22, P1415, DOI 10.1038/modpathol.2009.121
   Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545
   Araujo A, 2014, CANCER RES, V74, P2391, DOI 10.1158/0008-5472.CAN-13-2652
   Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985
   Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8
   Auersperg Nelly, 2013, Front Biosci (Schol Ed), V5, P709
   Bainer R, 2013, SCIENCE, V341, P965, DOI 10.1126/science.1243643
   Bakondi B, 2010, BIOCHEM BIOPH RES CO, V400, P212, DOI 10.1016/j.bbrc.2010.08.040
   Banerjee S, 2007, CANCER RES, V67, P3818, DOI 10.1158/0008-5472.CAN-06-3879
   Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243
   Banzato A, 2008, CLIN CANCER RES, V14, P3598, DOI 10.1158/1078-0432.CCR-07-2019
   Barbolina MV, 2007, J BIOL CHEM, V282, P4924, DOI 10.1074/jbc.M608428200
   Barcellos-Hoff MH, 2013, NAT REV CANCER, V13, P511, DOI 10.1038/nrc3536
   Baron JA, 2012, NAT REV CANCER, V12, P368, DOI 10.1038/nrc3260
   Barry ZT, 2012, J BIOL CHEM, V287, P27723, DOI 10.1074/jbc.M111.332684
   Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644
   Batra J, 2012, BIOL CHEM, V393, P1365, DOI 10.1515/hsz-2012-0211
   Batra J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026527
   Batra J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-119
   BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L
   Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963
   Bethel CR, 2009, PROSTATE, V69, P838, DOI 10.1002/pros.20935
   Bhowmick NA, 2005, CURR OPIN GENET DEV, V15, P97, DOI 10.1016/j.gde.2004.12.003
   Bichsel CA, 2012, LAB CHIP, V12, P2313, DOI [10.1039/c2lc40130d, 10.1039/c21c40130d]
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bissell MJ, 2005, COLD SH Q B, V70, P343, DOI 10.1101/sqb.2005.70.013
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Bray F, 2010, EUR J CANCER, V46, P3040, DOI 10.1016/j.ejca.2010.09.013
   Brown RA, 2013, EXP CELL RES, V319, P2460, DOI 10.1016/j.yexcr.2013.07.001
   Brown TD, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0013-7
   Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544
   Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chen Y, 2012, BLOOD, V119, P4971, DOI 10.1182/blood-2011-11-389957
   Cho KR, 2009, ARCH PATHOL LAB MED, V133, P1775, DOI 10.1043/1543-2165-133.11.1775
   Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246
   Chou J, 2012, CANCER DISCOV, V2, P1078, DOI 10.1158/2159-8290.CD-12-0465
   Chow TFF, 2008, BIOL CHEM, V389, P731, DOI 10.1515/BC.2008.071
   Chu GCY, 2014, ENDOCR-RELAT CANCER, V21, P311, DOI 10.1530/ERC-13-0548
   Chu JH, 2009, PROSTATE, V69, P428, DOI 10.1002/pros.20897
   Clark AK, 2013, BIOMATERIALS, V34, P4777, DOI 10.1016/j.biomaterials.2013.03.005
   Connolly DC, 2009, CURR PROTOC PHARM, V45
   Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091
   Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161
   Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945
   Coward JIG, 2012, CYTOKINE GROWTH F R, V23, P333, DOI 10.1016/j.cytogfr.2012.08.005
   Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388
   Curtin P, 2012, BIOMATERIALS, V33, P1065, DOI 10.1016/j.biomaterials.2011.10.046
   David L, 2004, MATRIX BIOL, V23, P183, DOI 10.1016/j.matbio.2004.05.005
   De Marzo AM, 2003, UROLOGY, V62, P55, DOI 10.1016/j.urology.2003.09.053
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deisboeck TS, 2011, ANNU REV BIOMED ENG, V13, P127, DOI 10.1146/annurev-bioeng-071910-124729
   Deng XY, 2008, INT J CANCER, V122, P209, DOI 10.1002/ijc.23053
   Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748
   Deu E, 2012, NAT STRUCT MOL BIOL, V19, P9, DOI 10.1038/nsmb.2203
   Di Leva G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00153
   Diamandis EP, 2013, CLIN CHEM, V59, P22, DOI 10.1373/clinchem.2012.187047
   Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126
   Dong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057056
   Dorn J, 2011, ANN ONCOL, V22, P1783, DOI 10.1093/annonc/mdq701
   Dorn J, 2014, BIOL CHEM, V395, P95, DOI 10.1515/hsz-2013-0172
   Drew AF, 2004, GYNECOL ONCOL, V95, P437, DOI 10.1016/j.ygyno.2004.08.032
   DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Evensen NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082811
   Fang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075187
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Fidler I J, 2001, Surg Oncol Clin N Am, V10, P257
   Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106
   Fizazi K, 2003, CLIN CANCER RES, V9, P2587
   Florczyk SJ, 2012, ADV HEALTHC MATER, V1, P590, DOI 10.1002/adhm.201100054
   Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   FREEDMAN RS, 2004, J TRANSL MED, V2, P23, DOI DOI 10.1186/1479-5876-2-23
   Fuhrman-Luck RA, 2014, PROTEOM CLIN APPL, V8, P403, DOI 10.1002/prca.201300098
   Galasko C, 1981, BONE METASTASIS, P49
   Gan A, 2013, HUM PATHOL, V44, P1638, DOI 10.1016/j.humpath.2013.01.015
   Gao H, 2006, CANCER RES, V66, P7929, DOI 10.1158/0008-5472.CAN-06-1637
   Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI [10.1089/ten.tea.2010.0135, 10.1089/ten.TEA.2010.0135]
   Ghosh A, 2005, CANCER RES, V65, P727
   Gill JH, 2014, MOL PHARMACEUT, V11, P1294, DOI 10.1021/mp400760b
   Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108
   Godinat A, 2013, ACS CHEM BIOL, V8, P987, DOI 10.1021/cb3007314
   Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Grignon DJ, 2004, MODERN PATHOL, V17, P316, DOI 10.1038/modpathol.3800052
   Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111
   Gurski LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050075
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Harjanto D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052509
   Harjanto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024891
   Harjanto D, 2010, ANN BIOMED ENG, V38, P1815, DOI 10.1007/s10439-010-9970-0
   Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154
   Hellstrom I, 2003, CANCER RES, V63, P3695
   Hensley H, 2007, CANCER BIOL THER, V6, P1717, DOI 10.4161/cbt.6.11.4830
   Hensley HH, 2012, NEOPLASIA, V14, P451, DOI 10.1596/neo.12480
   Hesami P, 2014, CLIN EXP METASTAS, V31, P435, DOI 10.1007/s10585-014-9638-5
   Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012
   Holbeck SL, 2004, EUR J CANCER, V40, P785, DOI 10.1016/j.ejca.2003.11.022
   Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599
   Holzapfel BM, 2014, BIOMATERIALS, V35, P4108, DOI 10.1016/j.biomaterials.2014.01.062
   Holzapfel BM, 2013, CANCER METAST REV, V32, P129, DOI 10.1007/s10555-013-9437-5
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Holzapfel Boris Michael, 2013, Sarcoma, P153640, DOI 10.1155/2013/153640
   Horiguchi A, 2007, CANCER GENE THER, V14, P583, DOI 10.1038/sj.cgt.7701047
   Horino K, 2001, FASEB J, V15, P932, DOI 10.1096/fj.00-0392com
   Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0
   Howell VM, 2014, SEMIN CELL DEV BIOL, V27, P106, DOI 10.1016/j.semcdb.2014.03.019
   Hubin F, 2004, CELL TRANSPLANT, V13, P823, DOI 10.3727/000000004783983387
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x
   Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446
   Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016
   Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936
   Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010
   Jaeger AA, 2013, BIOMATERIALS, V34, P8301, DOI 10.1016/j.biomaterials.2013.07.013
   Jin J.K., 2014, ONCOGENE
   Johnson PA, 2013, NAT REV CANCER, V13, P432, DOI 10.1038/nrc3535
   Jones PM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00217
   Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618
   Kaemmerer E, 2014, ACTA BIOMATER, V10, P2551, DOI 10.1016/j.actbio.2014.02.035
   Kajiyama H, 2003, CANCER RES, V63, P2278
   Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186
   Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407
   Karlou M, 2010, NAT REV UROL, V7, P494, DOI 10.1038/nrurol.2010.134
   Karst AM, 2012, NAT PROTOC, V7, P1755, DOI 10.1038/nprot.2012.097
   Karst AM, 2010, J ONCOL, DOI 10.1155/2010/932371
   Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233
   Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775
   Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874
   Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109
   Kim MJ, 2002, CANCER RES, V62, P2999
   Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47
   King S.M., 2011, JOVE-J VIS EXP, V52, P2804, DOI DOI 10.3791/2804
   Klotz L, 2013, CURR TREAT OPTION ON, V14, P97, DOI 10.1007/s11864-012-0221-5
   Kovacic N, 2014, CALCIFIED TISSUE INT, V94, P125, DOI 10.1007/s00223-013-9794-7
   Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263
   Krausz E, 2013, J BIOMOL SCREEN, V18, P54, DOI 10.1177/1087057112456874
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178
   Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4
   Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040
   Kuperwasser C, 2005, CANCER RES, V65, P6130, DOI 10.1158/0008-5472.CAN-04-1408
   Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Kwon H, 2010, J TISSUE ENG REGEN M, V4, P590, DOI 10.1002/term.268
   Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105
   Latifi A, 2011, J CELL BIOCHEM, V112, P2850, DOI 10.1002/jcb.23199
   Lawrence MG, 2013, NAT PROTOC, V8, P836, DOI 10.1038/nprot.2013.043
   Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034
   Lawrenson K, 2009, PLOS MED, V6, P126, DOI 10.1371/journal.pmed.1000025
   Le Page C, 2004, EXPERT REV MOL DIAGN, V4, P157, DOI 10.1586/14737159.4.2.157
   Lech A, 2013, FRONT BIOSCI-LANDMRK, V18, P543, DOI 10.2741/4119
   Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lee SH, 2007, BIOMATERIALS, V28, P3163, DOI 10.1016/j.biomaterials.2007.03.004
   Leight JL, 2013, BIOMATERIALS, V34, P7344, DOI 10.1016/j.biomaterials.2013.06.023
   Leinster DA, 2012, J PATHOL, V227, P136, DOI 10.1002/path.4002
   Lengyel E., 2013, ONCOGENE
   Lescarbeau RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040372
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li CR, 2013, AM J PATHOL, V182, P363, DOI 10.1016/j.ajpath.2012.10.024
   Lin HM, 2014, BRIT J CANCER, V110, P2462, DOI 10.1038/bjc.2014.181
   Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297
   Loessner Daniela, 2013, Microarrays (Basel), V2, P208, DOI 10.3390/microarrays2030208
   Loessner D, 2013, BIOMATERIALS, V34, P7389, DOI 10.1016/j.biomaterials.2013.06.009
   Loessner D, 2013, J CELL SCI, V126, P2761, DOI 10.1242/jcs.123836
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228
   Lose F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044520
   Lose F, 2012, BIOL CHEM, V393, P403, DOI 10.1515/hsz-2011-0268
   Lu P., 2011, COLD SPRING HARB PER, V3
   Lu Z, 2010, FUTURE ONCOL, V6, P1625, DOI 10.2217/FON.10.100
   Lutolf MP, 2009, INTEGR BIOL, V1, P235, DOI 10.1039/b902243k
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002
   Mathot L, 2012, CANCER SCI, V103, P626, DOI 10.1111/j.1349-7006.2011.02195.x
   Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206
   Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089
   Moreau J, 2007, ANN NY ACAD SCI, V1117, P328, DOI 10.1196/annals.1402.003
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Mosquera JM, 2007, J PATHOL, V212, P91, DOI 10.1002/path.2154
   Mosquera JM, 2008, CLIN CANCER RES, V14, P3380, DOI 10.1158/1078-0432.CCR-07-5194
   Moss NM, 2009, CANCER RES, V69, P7121, DOI 10.1158/0008-5472.CAN-08-4151
   Mullins SR, 2012, BIOL CHEM, V393, P1405, DOI 10.1515/hsz-2012-0252
   MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212
   Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611
   Neijenhuis S, 2013, DNA REPAIR, V12, P394, DOI 10.1016/j.dnarep.2013.02.003
   Nemeth JA, 1999, CANCER RES, V59, P1987
   Ness RB, 1999, JNCI-J NATL CANCER I, V91, P1459, DOI 10.1093/jnci/91.17.1459
   Ni J, 2013, INT J BIOCHEM CELL B, V45, P2736, DOI 10.1016/j.biocel.2013.09.008
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492
   Niggemann B, 2004, EXP CELL RES, V298, P178, DOI 10.1016/j.yexcr.2004.04.001
   Nishimura M, 2013, CANCER DISCOV, V3, P1302, DOI 10.1158/2159-8290.CD-13-0159
   Norgaard M, 2010, J UROLOGY, V184, P162, DOI 10.1016/j.juro.2010.03.034
   O'Mara TA, 2011, TWIN RES HUM GENET, V14, P323, DOI 10.1375/twin.14.4.323
   Olsen CJ, 2010, BMC CANCER, V10, DOI [10.1186/1471-2407-10-444, 10.1186/71-2407-10-444]
   Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2
   Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821
   Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001
   Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pampaloni Francesco, 2009, Recent Pat Biotechnol, V3, P103
   Paraguassu-Braga FH, 2012, CELL TRANSPLANT, V21, P2677, DOI 10.3727/096368912X636993
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Payne H, 2009, ASIAN J ANDROL, V11, P81, DOI 10.1038/aja.2008.9
   Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013
   Podgorski I, 2005, NEOPLASIA, V7, P207, DOI 10.1593/neo.04349
   Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533
   Qazi H, 2013, INTEGR BIOL-UK, V5, P1334, DOI 10.1039/c3ib40057c
   Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   Reichert JC, 2010, BIOMATERIALS, V31, P7928, DOI 10.1016/j.biomaterials.2010.06.055
   Ribatti D, 2006, CLIN EXP MED, V6, P145, DOI 10.1007/s10238-006-0117-4
   Riddick ACP, 2005, BRIT J CANCER, V92, P2171, DOI 10.1038/sj.bjc.6602630
   Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795
   Rose S, 2013, CANCER DISCOV, V3, P7, DOI 10.1158/2159-8290.CD-ND2012-044
   Rosenthal SA, 2010, NAT REV UROL, V7, P31, DOI 10.1038/nrurol.2009.237
   Rosol TJ, 2003, CANCER, V97, P748, DOI 10.1002/cncr.11150
   Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019
   Sameni M., 2012, J VIS EXP, V60
   Sameni M, 2009, CLIN EXP METASTAS, V26, P299, DOI 10.1007/s10585-008-9218-7
   Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396
   Schneider A, 2003, J ORTHOPAED RES, V21, P859, DOI 10.1016/S0736-0266(03)00042-1
   Schummer M, 2012, GYNECOL ONCOL, V125, P65, DOI 10.1016/j.ygyno.2011.11.050
   Schuster J, 2006, J NEUROSURG-SPINE, V4, P388, DOI 10.3171/spi.2006.4.5.388
   Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814
   Scott CL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00295
   Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110
   Seano G, 2013, BLOOD, V121, pE129, DOI 10.1182/blood-2012-08-452292
   Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264
   Serban M.A., 2008, CURR PROTOC CELL BIO, V40
   Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008
   Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136
   Sethi N, 2011, NAT REV CANCER, V11, P735, DOI 10.1038/nrc3125
   Shapira I, 2014, BRIT J CANCER, V110, P976, DOI 10.1038/bjc.2013.795
   Sharma S, 2012, NANOMED-NANOTECHNOL, V8, P757, DOI 10.1016/j.nano.2011.09.015
   Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013
   Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810
   Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104
   Shih IM, 2009, FUTURE ONCOL, V5, P1641, DOI [10.2217/fon.09.126, 10.2217/FON.09.126]
   Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Sieh S, 2014, BONE, V63, P121, DOI 10.1016/j.bone.2014.02.001
   Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217
   Sieh S, 2010, ORGANOGENESIS, V6, P181, DOI 10.4161/org.6.3.12041
   Sieh W, 2013, LANCET ONCOL, V14, P853, DOI 10.1016/S1470-2045(13)70253-5
   Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559
   Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071
   Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812
   Sotiropoulou G, 2009, RNA, V15, P1443, DOI 10.1261/rna.1534709
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Sutcliffe S, 2013, NAT REV CANCER, V13, P208, DOI 10.1038/nrc3434
   Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247
   Swedberg JE, 2009, CHEM BIOL, V16, P633, DOI 10.1016/j.chembiol.2009.05.008
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720
   Taubenberger AV, 2013, J BONE MINER RES, V28, P1399, DOI 10.1002/jbmr.1875
   Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026
   Thulin MH, 2014, CLIN EXP METASTAS, V31, P269, DOI 10.1007/s10585-013-9626-1
   Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679
   Touboul C, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-28
   Tseng CL, 2013, J BIOMATER APPL, V27, P1055, DOI 10.1177/0885328211434089
   Uzgare AR, 2004, CANCER RES, V64, P6190, DOI 10.1158/0008-5472.CAN-04-0968
   Vaiselbuh SR, 2010, TISSUE ENG PART C-ME, V16, P1523, DOI 10.1089/ten.tec.2010.0179
   Varzavand A, 2013, CLIN EXP METASTAS, V30, P541, DOI 10.1007/s10585-012-9558-1
   Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144
   Verdoes M, 2013, J AM CHEM SOC, V135, P14726, DOI 10.1021/ja4056068
   Voeller HJ, 1997, CANCER RES, V57, P4455
   Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391
   Wang CY, 2012, NUCL MED COMMUN, V33, P379, DOI 10.1097/MNM.0b013e3283504528
   Wang E, 2005, CLIN CANCER RES, V11, P113
   Wang RX, 2005, SEMIN CANCER BIOL, V15, P353, DOI 10.1016/j.semcancer.2005.05.005
   Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537
   Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949
   Wesley UV, 2005, CANCER RES, V65, P1325, DOI 10.1158/0008-5472.CAN-04-1852
   White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634
   White NMA, 2012, BIOL CHEM, V393, P379, DOI 10.1515/hsz-2011-0246
   Wilt TJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007091
   Windus LCE, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-112
   Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
   Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2
   Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340
   Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609
   Xu X, 2012, BIOMATERIALS, V33, P9049, DOI 10.1016/j.biomaterials.2012.08.061
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang JY, 2013, J CLIN INVEST, V123, P3740, DOI 10.1172/JCI68509
   Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583
   Yonou H, 2004, PROSTATE, V58, P406, DOI 10.1002/pros.10349
   Yonou H, 2003, CANCER RES, V63, P2096
   Yonou H, 2001, CANCER RES, V61, P2177
   Yousef GM, 2009, CANCER TREAT RES, V149, P165, DOI 10.1007/978-0-387-98094-2_8
   Yousef GM, 2003, CANCER RES, V63, P2223
   Zaman MH, 2013, NAT REV CANCER, V13, P596, DOI 10.1038/nrc3564
   Zheng YY, 2007, CLIN CANCER RES, V13, P6984, DOI 10.1158/1078-0432.CCR-07-1409
NR 320
TC 28
Z9 28
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD DEC 15
PY 2014
VL 79-80
BP 193
EP 213
DI 10.1016/j.addr.2014.06.001
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AY5HX
UT WOS:000347604400017
PM 24969478
DA 2018-10-20
ER

PT J
AU Abdal-Hay, A
   Hamdy, AS
   Morsi, Y
   Khalil, KA
   Lim, JH
AF Abdal-hay, Abdalla
   Hamdy, Abdel Salam
   Morsi, Yosry
   Khalil, Khalil Abdelrazek
   Lim, Ju Hyun
TI Novel bone regeneration matrix for next-generation biomaterial using a
   vertical array of carbonated hydroxyapatite nanoplates coated onto
   electrospun nylon 6 nanofibers
SO MATERIALS LETTERS
LA English
DT Article
DE Nanostructures; Biomaterials; Nanofibers; Hydroxyapatite nanoplates;
   Bone-regeneration; Electrospun nylon 6
ID MEMBRANE; COMPOSITE
AB For the first time, a novel method for nucleation and deposition of vertically arrayed carbonated hydroxyapatite (HA) nanoplates without obvious agglomeration onto the post-electrospun nylon 6 (N6) nanofibers was successfully designed. The technique is based on a simple hydrothermal treatment of the fabricated N6 mat. The excellent bioactivity of the treated scaffold was confirmed in vitro within MC3T3-E1 osteoblastic cells by significant attachment and in-growth activity on the treated scaffold, and the ability to differentiate into osteoblastic cells with excellent osteogenic potential higher than that of plain nanofibers. Based on this study, the bioactive N6 nanofibers matrix treated with HA nanoplated is regarded as a promising next-generation biomaterial in the bone regeneration field. (c) 2014 Elsevier B.V. All rights reserved.
C1 [Abdal-hay, Abdalla] South Valley Univ, Fac Engn, Dept Engn Mat & Mech Design, Qena, Egypt.
   [Abdal-hay, Abdalla] Chonbuk Natl Univ, Coll Engn, Dept Bionano Syst Engn, Jeonju 561756, South Korea.
   [Abdal-hay, Abdalla] Univ Cuenca, Fac Engn, Dept Comp Sci, Cuenca, Ecuador.
   [Hamdy, Abdel Salam] Univ Texas Pan Amer, Coll Engn & Comp Sci, Dept Mfg Engn, Edinburg, TX 78541 USA.
   [Morsi, Yosry] Swinburne Univ Technol, Fac Sci Engn & Technol, Dept Biomech & Tissue Engn Grp, Melbourne, Vic 3122, Australia.
   [Khalil, Khalil Abdelrazek] King Saud Univ, Coll Engn, Dept Mech Engn, Riyadh 11421, Saudi Arabia.
   [Khalil, Khalil Abdelrazek] Aswan Univ, Fac Energy Engn, Dept Mech Engn, Aswan, Egypt.
   [Lim, Ju Hyun] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Urol, Kangnung, South Korea.
RP Lim, JH (reprint author), Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Urol, Kangnung, South Korea.
EM jhlim@gnah.co.kr
RI Hamdy Makhlouf, Abdel Salam/G-2319-2015
OI Hamdy Makhlouf, Abdel Salam/0000-0002-1971-9942; Abdal-hay,
   Abdalla/0000-0001-6307-6027
FU Deanship of Scientific Research at King Saud University [RG 1435-001]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for funding this
   Research Group (NO. RG 1435-001).
CR Abdal-hay A, 2014, MATER LETT, V125, P51, DOI 10.1016/j.matlet.2014.03.138
   Abdal-hay A, 2013, EUR POLYM J, V49, P1314, DOI 10.1016/j.eurpolymj.2013.02.004
   Abdal-haya A, 2013, COLLOID SURFACE B, V102, P635, DOI 10.1016/j.colsurfb.2012.09.017
   Barakat NAM, 2009, POLYMER, V50, P4389, DOI 10.1016/j.polymer.2009.07.005
   Dong H, 2008, CHEM MATER, V20, P6627, DOI 10.1021/cm801077p
   Jokic B, 2011, CERAM INT, V37, P167
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Neira I. S., 2008, CRYSTAL GROWTH DESIG, V9, P466, DOI DOI 10.1021/CG800738A
   Nejati E, 2008, COMPOS PART A-APPL S, V39, P1589, DOI 10.1016/j.compositesa.2008.05.018
   Pant HR, 2013, MATER LETT, V92, P90, DOI 10.1016/j.matlet.2012.10.047
   Ravichandran R, 2012, BIOMATERIALS, V33, P846, DOI 10.1016/j.biomaterials.2011.10.030
   Wang YJ, 2006, ADV ENG MATER, V8, P97, DOI 10.1002/adem.200500220
   Zhang Y, TISSUE ENG A
NR 13
TC 6
Z9 7
U1 5
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD DEC 15
PY 2014
VL 137
BP 378
EP 381
DI 10.1016/j.matlet.2014.09.034
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AU2TF
UT WOS:000345469700100
DA 2018-10-20
ER

PT J
AU He, JK
   Qin, T
   Liu, YX
   Li, X
   Li, DC
   Jin, ZM
AF He, Jiankang
   Qin, Ting
   Liu, Yaxiong
   Li, Xiang
   Li, Dichen
   Jin, Zhongmin
TI Electrospinning of nanofibrous scaffolds with continuous structure and
   material gradients
SO MATERIALS LETTERS
LA English
DT Article
DE Gradients; Electrospinning; Nanofibrous scaffolds; Biomaterials;
   Nanocomposites
ID TISSUE ENGINEERING APPLICATIONS; LIGAMENT-BONE INTERFACE; FIBROUS
   SCAFFOLDS; INSERTION SITE; GRADATIONS; FABRICATION; MIMICKING; FIBER
AB One of the major challenges in tissue engineering is to engineer biomaterial scaffolds with desirable gradients for the regeneration of composite tissues. Here we propose a unique electrospinning strategy to fabricate nanofibrous scaffolds with both structure and material composition gradients. The results demonstrate that the microstructural organization of nanofibers gradually changed from random to aligned patterns. Nanoparticles like nanohydroxyapatite (nano-HA) were encapsulated into these nanofibers and nano-HA content in the electrospun scaffolds gradually altered in a similar gradient manner to structural organization. This simple yet versatile method might be useful to engineer graded tissues by flexibly generating tissue-specific structure and material gradients. (c) 2014 Elsevier B.V. All rights reserved.
C1 [He, Jiankang; Qin, Ting; Liu, Yaxiong; Li, Dichen; Jin, Zhongmin] Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Peoples R China.
   [Li, Xiang] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.
RP He, JK (reprint author), Xi An Jiao Tong Univ, State Key Lab Mfg Syst Engn, Xian 710049, Peoples R China.
EM jiankanghe@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [51105298, 51422508];
   Research Fund for the Doctoral Program of Higher Education
   [20110201120027]; Fundamental Research Funds for Central Universities of
   China
FX This work was supported by the National Natural Science Foundation of
   China (51105298, 51422508), the Research Fund for the Doctoral Program
   of Higher Education (20110201120027) and the Fundamental Research Funds
   for Central Universities of China.
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Dong B, 2009, SMALL, V5, P1508, DOI 10.1002/smll.200801750
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Ladd MR, 2011, BIOMATERIALS, V32, P1549, DOI 10.1016/j.biomaterials.2010.10.038
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Ramalingam M, 2013, J BIOMATER APPL, V27, P695, DOI 10.1177/0885328211423783
   Samavedi S, 2012, BIOMATERIALS, V33, P7727, DOI 10.1016/j.biomaterials.2012.07.008
   Samavedi S, 2011, ACTA BIOMATER, V7, P4131, DOI 10.1016/j.actbio.2011.07.008
   Seidi A, 2011, ACTA BIOMATER, V7
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Sundararaghavan HG, 2011, BIOMACROMOLECULES, V12, P2344, DOI 10.1021/bm200415g
   Xie JW, 2012, MACROMOL BIOSCI, V12, P1336, DOI 10.1002/mabi.201200115
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Zhang X, 2012, LANGMUIR, V28, P10026, DOI 10.1021/la300821r
   Zou B, 2012, ACTA BIOMATER, V8, P1576, DOI 10.1016/j.actbio.2012.01.003
NR 15
TC 20
Z9 20
U1 1
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD DEC 15
PY 2014
VL 137
BP 393
EP 397
DI 10.1016/j.matlet.2014.09.045
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AU2TF
UT WOS:000345469700104
DA 2018-10-20
ER

PT J
AU Chaves, JM
   Florencio, O
   Silva, PS
   Marques, PWB
   Schneider, SG
AF Chaves, J. M.
   Florencio, O.
   Silva, P. S., Jr.
   Marques, P. W. B.
   Schneider, S. G.
TI Anelastic relaxation associated to phase transformations and
   interstitial atoms in the Ti-35Nb-7Zr alloy
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Ti alloys; Anelastic relaxation; Transformation phase; Elastic modulus;
   Interstitial atoms
ID TI-NB ALLOYS; BIOMEDICAL APPLICATIONS; MO ALLOYS; ZR ALLOYS;
   SPECTROSCOPY; TITANIUM; SUPERELASTICITY; PRECIPITATION; BIOMATERIAL;
   MARTENSITE
AB Ti-35Nb-7Zr (wt.%) alloy was analyzed by mechanical spectroscopy. The results showed a relaxation peak, involving components of phase transformations and matrix-interstitial interactions and substitutional-interstitial interactions. The phase transformation beta -> omega in the first thermal cycle was identified by increases in elastic modulus and Vickers hardness. In the subsequent thermal cycles, a fall in the strength of relaxation and stabilization of the dynamical elastic modulus were associated with variation in the fraction of omega-phase formed and nucleation of the alpha-phase, as indicated by DSC, XRD and SEM-EDX results. In addition, once the strength of relaxation was stabilized shifts of the relaxation peak to higher temperatures were observed with increasing oscillating frequency. This frequency dependence of the peak was accompanied by a change in the oscillation frequency that is characteristic of a Snoek-type relaxation. Thus, this behavior can be related to stress-induced reorientation of interstitial oxygen atoms with matrix (Ti) and substitutional (Nb) atoms in the bcc structure of the beta-phase. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Chaves, J. M.; Florencio, O.; Silva, P. S., Jr.; Marques, P. W. B.] Univ Fed Sao Carlos, Dept Phys, BR-13565905 Sao Carlos, SP, Brazil.
   [Schneider, S. G.] EEL USP, Dept Mat Engn, BR-12602810 Lorena, SP, Brazil.
RP Chaves, JM (reprint author), Univ Fed Sao Carlos, Dept Phys, CP 676, BR-13565905 Sao Carlos, SP, Brazil.
EM javier@df.ufscar.br
RI Munoz Chaves, Javier Andres/G-1518-2013; Silva Jr, Paulo/C-9395-2012;
   Schneider, Sandra/E-6087-2015; Florencio, Odila/D-3002-2012
OI Munoz Chaves, Javier Andres/0000-0002-9614-2112; Silva Jr,
   Paulo/0000-0001-9663-7142; Florencio, Odila/0000-0003-3655-4470
FU FAPESP; CAPES; CNPq
FX The authors would like to thank FAPESP, CAPES and CNPq for financial
   support.
CR Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   AHMAD MS, 1970, J PHYS CHEM SOLIDS, V31, P1799, DOI 10.1016/0022-3697(70)90170-8
   Almeida A, 2012, MAT SCI ENG C-MATER, V32, P1190, DOI 10.1016/j.msec.2012.03.007
   Almeida LH, 2009, MAT SCI ENG A-STRUCT, V521-22, P59, DOI 10.1016/j.msea.2008.09.123
   CANNELLI G, 1986, J PHYS F MET PHYS, V16, P1153, DOI 10.1088/0305-4608/16/9/006
   Cremasco A, 2011, MATER DESIGN, V32, P2387, DOI 10.1016/j.matdes.2010.11.012
   Florencio O., 1994, Journal of Alloys and Compounds, V211-212, P37, DOI 10.1016/0925-8388(94)90442-1
   Florencio O, 2009, DEFECT DIFFUS FORUM, V283-286, P84, DOI 10.4028/www.scientific.net/DDF.283-286.84
   Florencio O, 2012, MATER RES-IBERO-AM J, V15, P911, DOI [10.1590/S1516-14392012005000109, 10.1590/S1516-14392012000600012]
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Kent D, 2012, APPL PHYS A-MATER, V107, P835, DOI 10.1007/s00339-012-6778-9
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Li Q, 2012, MAT SCI ENG A-STRUCT, V536, P197, DOI 10.1016/j.msea.2011.12.103
   Li Q, 2011, METALL MATER TRANS A, V42A, P2843, DOI 10.1007/s11661-011-0713-0
   Lu H, 2012, MAT SCI ENG A-STRUCT, V541, P28, DOI 10.1016/j.msea.2012.01.113
   Lutjering G., 2003, ENG MAT PROCESSES TI
   Mantani Y, 2006, MAT SCI ENG A-STRUCT, V442, P409, DOI 10.1016/j.msea.2006.03.124
   Mantani Y, 2006, MAT SCI ENG A-STRUCT, V438, P315, DOI 10.1016/j.msea.2006.02.180
   Martins DQ, 2009, J ALLOY COMPD, V478, P111, DOI 10.1016/j.jallcom.2008.11.030
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Nowick A. S., 1972, ANELASTIC RELAXATION
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Yin FX, 2006, ADV MATER, V18, P1541, DOI 10.1002/adma.200600128
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
   Zhou ZC, 2011, J ALLOY COMPD, V509, P7356, DOI 10.1016/j.jallcom.2011.04.090
NR 32
TC 10
Z9 11
U1 1
U2 34
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD DEC 15
PY 2014
VL 616
BP 420
EP 425
DI 10.1016/j.jallcom.2014.07.159
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA AQ2XT
UT WOS:000342654000063
DA 2018-10-20
ER

PT J
AU Czenek, A
   Blanchard, R
   Dejaco, A
   Sigurjonsson, OE
   Orlygsson, G
   Gargiulo, P
   Hellmich, C
AF Czenek, Agnes
   Blanchard, Romane
   Dejaco, Alexander
   Sigurjonsson, Olafur E.
   Orlygsson, Gissur
   Gargiulo, Paolo
   Hellmich, Christian
TI Quantitative intravoxel analysis of microCT-scanned resorbing ceramic
   biomaterials - Perspectives for computer-aided biomaterial design
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID CALCIUM-PHOSPHATE SCAFFOLDS; MARROW STROMAL CELLS; ENERGY-ABSORPTION
   COEFFICIENTS; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; HYDROXYAPATITE
   BIOMATERIALS; NEUTRON-DIFFRACTION; MULTISCALE APPROACH; BONE
   REGENERATION; TISSUE
AB Driving the field of micro computed tomography toward more quantitative, rather than qualitative, approaches, we here present a new evaluation method, which uses the unique linear relationship between gray values and x-ray attenuation coefficients, together with the energy-dependence of the latter, to identify (i) the average x-ray energy used in the CT device, (ii) the x-ray attenuation coefficients, and (iii), via the x-ray attenuation average rule, the intravoxel composition, i. e., the microporosity, which, amongst others, governs the voxel-specific mechanical properties, such as stiffness and strength. The method is realized for six 3D tricalcium phosphate scaffolds, seeded with pre-osteoblastic cells and differentiated for 3, 6, and 8 weeks, respectively. The corresponding voxel-specific microporosities turn out to increase during the culturing period (resulting in reduced elastic properties, as determined from micromechanical considerations), while the overall macroporosity remains constant. The new methods are expected to further foster the development of a rationally based and computer-aided design of biomaterials and tissue engineering scaffolds.
C1 [Czenek, Agnes; Blanchard, Romane; Dejaco, Alexander; Hellmich, Christian] Vienna Univ Technol TU Wien, Inst Mech Mat & Struct, Vienna, Austria.
   [Czenek, Agnes; Sigurjonsson, Olafur E.; Gargiulo, Paolo] Reykjavik Univ, Inst Biomed & Neural Engn, Reykjavik, Iceland.
   [Czenek, Agnes; Gargiulo, Paolo] Landspitali Univ Hosp, Dept Sci, Reykjavik, Iceland.
   [Sigurjonsson, Olafur E.] Landspitali Univ Hosp, Blood Bank, REModel Lab, Reykjavik, Iceland.
   [Orlygsson, Gissur] Innovat Ctr Iceland, Dept Mat Biotechnol & Energy, Reykjavik, Iceland.
RP Hellmich, C (reprint author), Vienna Univ Technol TU Wien, Inst Mech Mat & Struct, Vienna, Austria.
EM christian.hellmich@tuwien.ac.at
OI Gargiulo, Paolo/0000-0002-5049-4817; Sigurjonsson,
   Olafur/0000-0002-4968-842X
FU ERASMUS network; European Research Council (ERC) [257023]; Reykjavik
   University; Vienna University of Technology (TU Wien)
FX The authors are grateful for the financial support through the ERASMUS
   network, and through COST Action MP1005 NAMABIO, making the cooperation
   between the Reykjavik University and the Vienna University of Technology
   (TU Wien) possible. Moreover, the Viennese researchers gratefully
   acknowledge the support from the European Research Council (ERC), in the
   course of project #257023, MICROBONE.
CR AKAO M, 1981, J MATER SCI, V16, P809, DOI 10.1007/BF02402799
   ALI MA, 1975, J MATER SCI, V10, P1920, DOI 10.1007/BF00754481
   ARITA IH, 1995, BIOMATERIALS, V16, P403, DOI 10.1016/0142-9612(95)98858-B
   Azami M, 2010, INT J ARTIF ORGANS, V33, P86
   Blanchard R, 2013, J BIOMECH, V46, P2710, DOI 10.1016/j.jbiomech.2013.06.036
   BONAR LC, 1985, J MOL BIOL, V181, P265, DOI 10.1016/0022-2836(85)90090-7
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Chen Q, 2014, J EUR CERAM SOC, V34, P2663, DOI 10.1016/j.jeurceramsoc.2013.11.041
   Cobel R., 1956, J AM CERAM SOC, V39, P377
   Colak M., 2006, MATER LETT, V60, P1977
   Cong A, 2011, MED ENG PHYS, V33, P164, DOI 10.1016/j.medengphy.2010.09.018
   Couteau B, 1998, J BIOMECH, V31, P383, DOI 10.1016/S0021-9290(98)00018-9
   Craciun F, 1998, FERROELECTRICS, V205, P49, DOI 10.1080/00150199808228387
   CRAWLEY EO, 1988, PHYS MED BIOL, V33, P1113, DOI 10.1088/0031-9155/33/10/002
   Cuy JL, 2002, ARCH ORAL BIOL, V47, P281, DOI 10.1016/S0003-9969(02)00006-7
   Dejaco A, 2012, J BIOMECH, V45, P1068, DOI 10.1016/j.jbiomech.2011.12.026
   DEWITH G, 1981, J MATER SCI, V16, P1592
   Dias MR, 2012, J BIOMECH, V45, P938, DOI 10.1016/j.jbiomech.2012.01.019
   Diaz A, 2004, J EUR CERAM SOC, V24, P413, DOI 10.1016/S0955-2219(03)00212-7
   Eberhardsteiner L, 2014, COMPUT METHOD BIOMEC, V17, P48, DOI 10.1080/10255842.2012.670227
   Fritsch A, 2006, CR MECANIQUE, V334, P151, DOI 10.1016/j.crme.2006.01.008
   Fritsch A., 2013, J APPL MECH, V80
   Fritsch A, 2010, PHILOS T R SOC A, V368, P1913, DOI 10.1098/rsta.2010.0005
   Fritsch A, 2009, J THEOR BIOL, V260, P230, DOI 10.1016/j.jtbi.2009.05.021
   Fritsch A, 2009, J BIOMED MATER RES A, V88A, P149, DOI 10.1002/jbm.a.31727
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Giuliani A, 2013, STEM CELL TRANSL MED, V2, P316, DOI 10.5966/sctm.2012-0136
   Hara T, 2002, BONE, V31, P107, DOI 10.1016/S8756-3282(02)00782-2
   Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI 10.1007/s10439-007-9393-8
   Hellmich C, 2004, BIOMECH MODEL MECHAN, V2, P219, DOI 10.1007/S10237-004-0040-0
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   HOUNSFIELD GM, 1972, Patent No. 1283915
   Huang SP, 2013, MATER LETT, V112, P43, DOI 10.1016/j.matlet.2013.08.114
   Hubbel J. H., 2004, TABLES XRAY MASS ATT
   HUBBELL JH, 1982, INT J APPL RADIAT IS, V33, P1269, DOI 10.1016/0020-708X(82)90248-4
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   KATZ EP, 1973, J MOL BIOL, V80, P1, DOI 10.1016/0022-2836(73)90230-1
   Keyak JH, 2003, MED ENG PHYS, V25, P781, DOI 10.1016/S1350-4533(03)00081-X
   Khanna R., 2012, CMES, V87
   Khanna R, 2009, J ENG MECH, V135, P468, DOI 10.1061/(ASCE)EM.1943-7889.0000002
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   LEES S, 1984, INT J BIOL MACROMOL, V6, P321, DOI 10.1016/0141-8130(84)90017-5
   Levengood SKL, 2010, ACTA BIOMATER, V6, P3283, DOI 10.1016/j.actbio.2010.02.026
   Liang L, 2010, ACTA BIOMATER, V6, P3763, DOI 10.1016/j.actbio.2010.03.033
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Luczynski KW, 2012, CMES-COMP MODEL ENG, V87, P505
   Lv Q., 2008, J BIOMED MATER RES A, V91, P679
   Lv Q, 2013, CLIN ORTHOP RELAT R, V471, P2422, DOI 10.1007/s11999-013-2859-0
   Malandrino A, 2012, MATER LETT, V78, P154, DOI 10.1016/j.matlet.2012.03.052
   MARTIN RI, 1995, J MATER SCI-MATER M, V6, P138, DOI 10.1007/BF00120289
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Mastrogiacomo M, 2004, TISSUE ENG, V10, P1767, DOI 10.1089/ten.2004.10.1767
   Medical Imaging and Technology Alliance, 2013, DICOM PS3 3 2013 INF
   MEEK KM, 1991, BIOPHYS J, V60, P467, DOI 10.1016/S0006-3495(91)82073-2
   Meille S., 2001, THESIS INSA LYON LYO
   Miller M, 2008, CEMENT CONCRETE RES, V38, P467, DOI 10.1016/j.cemconres.2007.11.014
   Morin C, 2013, J THEOR BIOL, V335, P185, DOI 10.1016/j.jtbi.2013.06.018
   Morin C, 2013, J THEOR BIOL, V317, P384, DOI 10.1016/j.jtbi.2012.09.026
   Pabst W, 2006, J EUR CERAM SOC, V26, P1085, DOI 10.1016/j.jeurceramsoc.2005.01.041
   Pabst W, 2004, CERAM-SILIKATY, V48, P165
   Peelen J. G. J., 1978, Ceramurgia International, V4, P71, DOI 10.1016/0390-5519(78)90122-9
   PHANI KK, 1986, AM CERAM SOC BULL, V65, P1584
   Radon J., 1917, SBLEIPZIG, V29, P69
   Renghini C, 2009, ACTA BIOMATER, V5, P1328, DOI 10.1016/j.actbio.2008.10.017
   Reynaud C, 2005, J EUR CERAM SOC, V25, P589, DOI 10.1016/j.jeurceramsoc.2004.02.009
   RHO JY, 1995, MED ENG PHYS, V17, P347, DOI 10.1016/1350-4533(95)97314-F
   Rougvie M.A., 1953, J AM LEATHER CHEM AS, V48, P735
   Sanahuja J, 2010, J ENG MECH, V136, P239, DOI 10.1061/(ASCE)EM.1943-7889.0000072
   Sandino C, 2011, BIOMECH MODEL MECHAN, V10, P565, DOI 10.1007/s10237-010-0256-0
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Scheiner S, 2009, BIOMATERIALS, V30, P2411, DOI 10.1016/j.biomaterials.2008.12.048
   SELTZER SM, 1993, RADIAT RES, V136, P147, DOI 10.2307/3578607
   SHAREEF MY, 1993, BIOMATERIALS, V14, P69, DOI 10.1016/0142-9612(93)90078-G
   Tazawa E, 1998, ADV CEM BASED MATER, V7, P1, DOI 10.1016/S1065-7355(97)00010-2
   Truscello S, 2012, ACTA BIOMATER, V8, P1648, DOI 10.1016/j.actbio.2011.12.021
   von Doernberg MC, 2006, BIOMATERIALS, V27, P5186, DOI 10.1016/j.biomaterials.2006.05.051
NR 79
TC 7
Z9 7
U1 0
U2 10
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0884-2914
EI 2044-5326
J9 J MATER RES
JI J. Mater. Res.
PD DEC 14
PY 2014
VL 29
IS 23
BP 2757
EP 2772
DI 10.1557/jmr.2014.326
PG 16
WC Materials Science, Multidisciplinary
SC Materials Science
GA AW7FX
UT WOS:000346431100001
DA 2018-10-20
ER

PT J
AU Ahmed, F
   Choudhury, NR
   Dutta, NK
   Zou, LD
   Zannettino, A
AF Ahmed, Furqan
   Choudhury, Namita Roy
   Dutta, Naba K.
   Zou, Linda
   Zannettino, Andrew
TI Fabrication and characterisation of an electrospun tubular 3D scaffold
   platform of poly(vinylidene fluoride-co-hexafluoropropylene) for
   small-diameter blood vessel application
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE platelets; fibres; poly(vinylidene fluoride-co-hexafluoropropylene);
   zeta potential; vascular graft; SEM; electrospinning
ID VASCULAR GRAFTS; FIBRINOGEN ADSORPTION; HYDROPHOBIC SURFACES;
   ENDOTHELIAL-CELLS; POTENTIAL MEASUREMENTS; BIOMATERIAL SURFACES;
   ADSORBED FIBRINOGEN; CHARGE; FILMS; CONFORMATION
AB In this research, nanofibrous 3D tubular (~4-mm-diameter tube) scaffolds of poly (vinylidene fluoride-co-hexafluoropropylene) were fabricated by electrospinning. The role of surface charge in the success of these scaffolds for potential small-diameter artificial vascular grafts has been investigated using streaming potential study. Prior to endothelial cell culture, surface properties such as wettability and the surface charge of these tubular scaffolds were evaluated using unmodified and fibrinogen-adsorbed surfaces to understand their interaction with surrounding environment. The tubular scaffolds constructed using electrospinning show similar mechanical properties such as tensile strength and elastic modulus as those of native vessels. Whilst endothelial cell proliferation on unmodified tubes, as analysed by scanning electron microscopy, was found to be moderate, a simple process of dynamic fibrinogen adsorption was seen to enhance the endothelialisation of these tubular grafts. The high negative zeta potential values, high strength, robustness and structural reliability of the scaffolds represent them to be promising biomaterials for vascular graft applications.
C1 [Ahmed, Furqan; Choudhury, Namita Roy; Dutta, Naba K.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA, Australia.
   [Zou, Linda] Univ S Australia, Sch Nat & Built Environm, SA Water Ctr Water Management & Reuse, Mawson Lakes, SA, Australia.
   [Zannettino, Andrew] Univ Adelaide, Sch Med Sci, Myeloma Res Lab, Adelaide, SA, Australia.
RP Choudhury, NR (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes Campus, Mawson Lakes, SA, Australia.
EM Namita.choudhury@unisa.edu.au
RI Roy Choudhury, Namita/F-8278-2011
FU ARC; NED University of Engineering & Technology Karachi, Pakistan
FX The authors are thankful to ARC for financial support of this work
   through ARC grants and to Sara Azari, Division of Information
   Technology, Engineering and the Environment, University of South
   Australia for their support in streaming potential analysis. One of the
   authors (FA) is thankful for the scholarship supported by NED University
   of Engineering & Technology Karachi, Pakistan.
CR Ahmed F, 2014, BIOMACROMOLECULES, V15, P744, DOI 10.1021/bm4015396
   Ahmed F, 2013, BIOMACROMOLECULES, V14, P3850, DOI 10.1021/bm400938n
   Armentano I, 2009, J MATER SCI, V44, P4789, DOI 10.1007/s10853-009-3721-3
   Arras MML, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/3/035008
   BAGNALL RD, 1978, J BIOMED MATER RES, V12, P203, DOI 10.1002/jbm.820120206
   Bai ZJ, 2009, SURF SCI, V603, P839, DOI 10.1016/j.susc.2009.01.040
   BERNABEU P, 1990, BIOMATERIALS, V11, P258, DOI 10.1016/0142-9612(90)90007-D
   Bhushan B, 2002, J APPL POLYM SCI, V83, P2225, DOI [10.1002/app.10194, 10.1002/app10194]
   Boland E. D., 2004, FRONT BIOSCI, V9, pC1432
   Buk H, 2010, ACTA CHIM SLOV, V57, P700
   Del Gaudio C, 2013, J MATER SCI-MATER M, V24, P523, DOI 10.1007/s10856-012-4803-3
   Garguilo JM, 2004, DIAM RELAT MATER, V13, P595, DOI 10.1016/j.diamond.2003.10.008
   Gugutkov D, 2011, J BIOACT COMPAT POL, V26, P375, DOI 10.1177/0883911511409020
   Inoguchi H, 2006, BIOMATERIALS, V27, P1470, DOI 10.1016/j.biomaterials.2005.08.029
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kalasin S, 2009, COLLOID SURFACE B, V73, P229, DOI 10.1016/j.colsurfb.2009.05.028
   Kang J, 2013, ANN VASC SURG, V27, P487, DOI 10.1016/j.avsg.2012.07.016
   Khorasani MT, 2006, COLLOID SURFACE B, V51, P112, DOI 10.1016/j.colsurfb.2006.06.002
   Khorasani MT, 2005, APPL SURF SCI, V242, P339, DOI 10.1016/j.apsusc.2004.08.035
   Lasia A., 2002, MOD ASPECT ELECTROC, V32, P143, DOI DOI 10.1007/0-306-46916-22
   Lin ZT, 2011, J MATER CHEM, V21, P19153, DOI 10.1039/c1jm13208c
   LINDON JN, 1986, BLOOD, V68, P355
   Liu DP, 2006, J BIOMED MATER RES A, V77A, P763, DOI 10.1002/jbm.a.30641
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   MALMSTEN M, 1994, J COLLOID INTERF SCI, V166, P333, DOI 10.1006/jcis.1994.1303
   Mun CH, 2012, TISSUE ENG PT A, V18, P1608, DOI [10.1089/ten.tea.2011.0695, 10.1089/ten.TEA.2011.0695]
   Nichols Michael D, 2013, J Biomed Mater Res B Appl Biomater, V101, P1367, DOI 10.1002/jbm.b.32954
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Remy M, 2013, BIOMATERIALS, V34, P9842, DOI 10.1016/j.biomaterials.2013.07.091
   SCHURZ J, 1990, J MACROMOL SCI CHEM, VA27, P1673
   Sendner C, 2009, LANGMUIR, V25, P10768, DOI 10.1021/la901314b
   Shi Q, 1998, BLOOD, V92, P362
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   SRINIVASAN S, 1970, J COLLOID INTERF SCI, V32, P456, DOI 10.1016/0021-9797(70)90131-1
   Stana-Kleinschek K, 1998, COLLOID SURFACE A, V140, P127, DOI 10.1016/S0927-7757(97)00301-4
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sun DM, 2014, J BIOMED MATER RES A, V102, P1625, DOI 10.1002/jbm.a.34806
   Tandon V, 2008, ELECTROPHORESIS, V29, P1092, DOI 10.1002/elps.200700734
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Toscano A, 2006, LANGMUIR, V22, P2588, DOI 10.1021/la051641g
   Toth A, 2014, CLIN HEMORHEOL MICRO, V56, P197, DOI 10.3233/CH-131685
   Tsai PP, 2002, J ELECTROSTAT, V54, P333, DOI 10.1016/S0304-3886(01)00160-7
   Tsang EMW, 2007, J AM CHEM SOC, V129, P15106, DOI 10.1021/ja074765j
   Veleva AN, 2009, J BIOMED MATER RES A, V91A, P1131, DOI 10.1002/jbm.a.32276
   Wang QY, 2012, DESALINATION, V297, P79, DOI 10.1016/j.desal.2012.04.020
   Wang S, 2013, INT J NANOMED, V8, P1231, DOI [10.2147/IJN, DOI 10.2147/IJN]
   Wasilewska M, 2010, LANGMUIR, V27, P686
   Webb AR, 2007, J MATER CHEM, V17, P900, DOI 10.1039/b611353b
   Weijers EM, 2010, J THROMB HAEMOST, V8, P2800, DOI 10.1111/j.1538-7836.2010.04096.x
   Werner C, 1999, COLLOID SURFACE A, V159, P519, DOI 10.1016/S0927-7757(99)00290-3
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   ZEMBALA M, 1994, COLLOID SURFACE B, V3, P119
   Zhai Wei, 2013, J Biomed Mater Res B Appl Biomater, DOI 10.1002/jbm.b.32972
   Zhang P, 2009, ELECTROCHEM COMMUN, V11, P161, DOI 10.1016/j.elecom.2008.11.002
   Zimmermann R, 2001, J PHYS CHEM B, V105, P8544, DOI 10.1021/jp004051u
NR 57
TC 3
Z9 3
U1 3
U2 59
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD DEC 12
PY 2014
VL 25
IS 18
BP 2023
EP 2041
DI 10.1080/09205063.2014.968018
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AS7YR
UT WOS:000344468400002
PM 25358334
DA 2018-10-20
ER

PT J
AU Huang, YS
   Bertrand, V
   Bozukova, D
   Pagnoulle, C
   Labrugere, C
   De Pauw, E
   De Pauw-Gillet, MC
   Durrieu, MC
AF Huang, Yi-Shiang
   Bertrand, Virginie
   Bozukova, Dimitriya
   Pagnoulle, Christophe
   Labrugere, Christine
   De Pauw, Edwin
   De Pauw-Gillet, Marie-Claire
   Durrieu, Marie-Christine
TI RGD Surface Functionalization of the Hydrophilic Acrylic Intraocular
   Lens Material to Control Posterior Capsular Opacification
SO PLOS ONE
LA English
DT Article
ID EPITHELIAL-CELL MIGRATION; POLYETHYLENE TEREPHTHALATE SURFACES;
   MESENCHYMAL STEM-CELL; INTRA OCULAR LENS; OPTIC EDGE; HYDROPHOBIC
   RECOVERY; IN-VITRO; ADHESION; TRANSITION; PEPTIDES
AB Posterior Capsular Opacification (PCO) is the capsule fibrosis developed on implanted IntraOcular Lens (IOL) by the de-differentiation of Lens Epithelial Cells (LECs) undergoing Epithelial Mesenchymal Transition (EMT). Literature has shown that the incidence of PCO is multifactorial including the patient's age or disease, surgical technique, and IOL design and material. Reports comparing hydrophilic and hydrophobic acrylic IOLs have shown that the former has more severe PCO. On the other hand, we have previously demonstrated that the adhesion of LECs is favored on hydrophobic compared to hydrophilic materials. By combining these two facts and contemporary knowledge in PCO development via the EMT pathway, we propose a biomimetically inspired strategy to promote LEC adhesion without dedifferentiation to reduce the risk of PCO development. By surface grafting of a cell adhesion molecule (RGD peptide) onto the conventional hydrophilic acrylic IOL material, the surface-functionalized IOL can be used to reconstitute a capsule-LEC-IOL sandwich structure, which has been considered to prevent PCO formation in literature. Our results show that the innovative biomaterial improves LEC adhesion, while also exhibiting similar optical (light transmittance, optical bench) and mechanical (haptic compression force, IOL injection force) properties compared to the starting material. In addition, compared to the hydrophobic IOL material, our bioactive biomaterial exhibits similar abilities in LEC adhesion, morphology maintenance, and EMT biomarker expression, which is the crucial pathway to induce PCO. The in vitro assays suggest that this biomaterial has the potential to reduce the risk factor of PCO development.
C1 [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Dept Chem, Liege, Belgium.
   [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Dept Biomed & Preclin Sci, Mass Spectrometry Lab, Liege, Belgium.
   [Huang, Yi-Shiang; Bertrand, Virginie; De Pauw, Edwin; De Pauw-Gillet, Marie-Claire] Univ Liege, Mammalian Cell Culture Lab GIGA R, Liege, Belgium.
   [Huang, Yi-Shiang; Durrieu, Marie-Christine] Univ Bordeaux, Inst Chem & Biol Membranes & Nanoobjects, CBMN UMR5248, Pessac, France.
   [Bozukova, Dimitriya; Pagnoulle, Christophe] PhysIOL SA, Dept Res & Dev, Liege, Belgium.
   [Labrugere, Christine] Univ Bordeaux, PLACAMAT, Plateforme Aquitaine Caracterisat Mat, Pessac, France.
RP De Pauw-Gillet, MC (reprint author), Univ Liege, Dept Chem, Liege, Belgium.
EM marie-claire.depauw@ulg.ac.be; marie-christine.durrieu@inserm.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; De Pauw,
   Edwin/0000-0003-3475-1315
FU project LINOLA from Walloon region, Belgium [1117465]; PhysIOL
FX This study was financed by project LINOLA (1117465) from Walloon region,
   Belgium (http://recherchetechnologie.wallonie.be/). YSH and MCG received
   the funding. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript. DB and
   CP are employees of PhysIOL. PhysIOL provided support in the form of
   salaries for authors DB and CP, as well as the materials and
   installations for performing part of the research activities (i.e.
   plasma equipment, optical bench, haptic compression force measuring
   equipment), and had additional role in the study design, data collection
   and analysis, decision to publish, and preparation of the manuscript.
   The specific roles of these authors are articulated in the 'author
   contributions' section.
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1
   Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P1141, DOI 10.1016/S0886-3350(02)01425-6
   Agarwal A, 2011, PHACOEMULSIFICATION
   Amoozgar B, 2013, J BIOACT COMPAT POL, V28, P637, DOI 10.1177/0883911513504855
   Anderson JM, 2001, ANN REV MATER RES, V31, P30
   Bartouilh de Taillac L, 2004, COMPOS SCI TECHNOL, V64, P827, DOI 10.1016/j.compscitech.2003.09.011
   Behar-Cohen F., 2001, J FR OPHTALMOL, V24, P9
   Bertrand V, 2014, J CATARACT REFR SURG, V40, P1536, DOI 10.1016/j.jcrs.2014.01.035
   Bhattacharya SD, 2012, SURGERY, V152, P449, DOI 10.1016/j.surg.2012.06.011
   Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037
   Bozukova D, 2013, J CATARACT REFR SURG, V39, P1404, DOI 10.1016/j.jcrs.2013.01.050
   Bozukova D, 2010, MAT SCI ENG R, V69, P63, DOI 10.1016/j.mser.2010.05.002
   Briggs D., 1999, SURFACE ANAL POLYM X
   Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI [10.1089/ten.tea.2010.0199, 10.1089/ten.TEA.2010.0199]
   Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30
   Celine Chollet SL, 2006, J LASER MICRO NANOEN, V1, P5
   Cheng JW, 2007, AM J OPHTHALMOL, V143, P428, DOI 10.1016/j.ajo.2006.11.045
   Cheng ZA, 2013, NANO LETT, V13, P3923, DOI 10.1021/nl4020149
   Chollet C, 2007, BIOMOL ENG, V24, P477, DOI 10.1016/j.bioeng.2007.07.012
   Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Daniele Tognetto LT, 2002, J CATARACT REFR SURG, V28, P8
   Das RK ZO, 2013, ACS NANO, V7, P11
   De Giglio E, 2011, J BIOACT COMPAT POL, V26, P420, DOI 10.1177/0883911511410460
   Dick HB, 2000, OPHTHALMOLOGY, V107, P241, DOI 10.1016/S0161-6420(99)00082-2
   Dimitriya Bozukova CP, 2007, BIOMACROMOLECULES, V8, P9
   Eisele G, 2014, J NEURO-ONCOL, V117, P141, DOI 10.1007/s11060-014-1365-x
   Fine IH, 2007, J CATARACT REFR SURG, V33, P94, DOI 10.1016/j.icrs.2006.09.016
   Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gonzalez-Chomon C, 2011, MATERIALS, V4, P1927, DOI 10.3390/ma4111927
   Guelcher S. A., 2005, INTRO BIOMATERIALS
   Hayashi K, 2005, OPHTHALMOLOGY, V112, P1550, DOI 10.1016/j.ophtha.2005.03.024
   Heatley CJ, 2005, J CATARACT REFR SURG, V31, P718, DOI 10.1016/j.jcrs.2004.08.060
   Hongling Liu GF, 2010, IN VITRO STUDY, V16, P8
   Huang X, 2013, J OCUL PHARMACOL TH, V29, P208, DOI 10.1089/jop.2012.0184
   Hyeon II Lee MKK, 2007, J KOREAN MED SCI, V22, P6
   James F., 2002, J CATARACT REFR SURG, V28, P7
   Juila M, 1999, EYE, V13, P5
   Kanokpanont S, 2013, INT J BIOL MACROMOL, V55, P88, DOI 10.1016/j.ijbiomac.2013.01.003
   Katayama Y KS, 2007, OPHTHALMIC RES, P6
   Kavoussi SC, 2011, J CATARACT REFR SURG, V37, P2194, DOI 10.1016/j.jcrs.2011.05.049
   Kiefel H, 2012, CELL ADHES MIGR, V6, P374, DOI 10.4161/cam.20832
   Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817
   Kohnen T, 2008, OPHTHALMOLOGY, V115, P1308, DOI 10.1016/j.ophtha.2008.01.002
   Latz C, 2000, GRAEF ARCH CLIN EXP, V238, P696, DOI 10.1007/s004170000153
   Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018
   Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5
   Legeais JM, 2001, J FR OPHTALMOL, V24, P309
   Lei Y ZO, 2013, SMALL, V9, P10
   Lei YF, 2012, J MATER SCI-MATER M, V23, P2761, DOI 10.1007/s10856-012-4736-x
   Lei YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041163
   Liliana Werner J-ML, 1999, J BIOMED MATER RES, V46, P8
   Lim H, 2001, J VAC SCI TECHNOL A, V19, P1490, DOI 10.1116/1.1382650
   Lingli Li LL, 2011, J CONTROL RELEASE, V152, P2
   Linnola RJ, 2003, J CATARACT REFR SURG, V29, P146, DOI 10.1016/S0886-3350(02)01422-0
   Linnola RJ, 1997, J CATARACT REFR SURG, V23, P4
   Linnola RJ WL, 2000, J CATARACT REFR SURG, V26, P12
   Linnola RJ WL, 2000, J CATARACT REFR SURG, V26, P15
   Liu HL, 2009, GRAEF ARCH CLIN EXP, V247, P801, DOI 10.1007/s00417-008-1007-0
   Luensmann D, 2009, J CATARACT REFR SURG, V35, P2000, DOI 10.1016/j.jcrs.2009.05.052
   Manju S, 2010, PHARM DEV TECHNOL, V15, P379, DOI 10.3109/10837450903262025
   Matsushima H, 2006, J CATARACT REFR SURG, V32, P1035, DOI 10.1016/j.jcrs.2006.02.042
   Morarescu D, 2010, BIOMATERIALS, V31, P2399, DOI 10.1016/j.biomaterials.2009.11.108
   Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6
   Nagamoto T, 2009, ARCH OPHTHALMOL-CHIC, V127, P471, DOI 10.1001/archophthalmol.2009.63
   Niranjan Awasthi SG, 2009, ARCH OPHTHALMOL-CHIC, V127, P8
   Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0
   Nishi O, 2012, J CATARACT REFR SURG, V38, P924, DOI 10.1016/j.jcrs.2012.03.005
   Nixon DR, 2006, AM J OPHTHALMOL, V142, P557, DOI 10.1016/j.ajo.2006.05.049
   Pagnoulle C, 2012, J CATARACT REFR SURG, V38, P1271, DOI 10.1016/j.jcrs.2012.02.041
   Peng Q, 2000, J CATARACT REFR SURG, V26, P188, DOI 10.1016/S0886-3350(99)00354-5
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Porte-Durrieu MC LC, 1999, J BIOMED MATER RES, V46, P8
   Poulin S, 2006, APPL SURF SCI, V252, P6738, DOI 10.1016/j.apsusc.2006.02.233
   POWER W, 1993, DOC OPHTHALMOL, V84, P351, DOI 10.1007/BF01215449
   Prunier C, 2005, J BIOL CHEM, V280, P17540, DOI 10.1074/jbc.M500974200
   Puleo DA, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P1, DOI 10.1007/978-0-387-98161-1
   Reardon DA, 2011, FUTURE ONCOL, V7, P339, DOI [10.2217/FON.11.8, 10.2217/fon.11.8]
   Roberts C, 1998, J AM CHEM SOC, V120, P6548, DOI 10.1021/ja972467o
   Ruoslahti E PM, 1987, SCIENCE, V238, P7
   Ryu JJ, 2013, INT J ORAL MAX IMPL, V28, P963, DOI 10.11607/jomi.2421
   Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004
   Sheardown H, 2003, CELLS PROTEINS MAT F
   Spalton D, 2012, BRIT J OPHTHALMOLOGY, V2012
   Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261
   Sun CB, 2014, COLLOID SURFACE B, V113, P33, DOI 10.1016/j.colsurfb.2013.08.024
   Susanne Krag TTA, 2003, INVEST OPHTH VIS SCI, V44, P6
   Tatsuo Arita L-RL, 1990, INVESTIGATIVE OPHTHA, V31
   Tognetto D, 2003, OPHTHALMOLOGY, V110, P1935, DOI 10.1016/S0161-6420(03)00736-X
   Wadajkar AS, 2014, ISRN DENT, V2014, P4
   Wang GQ, 2012, INT J OPHTHALMOL-CHI, V5, P84, DOI 10.3980/j.issn.2222-3959.2012.01.17
   Wang GQ, 2010, INT J OPHTHALMOL-CHI, V3, P141, DOI 10.3980/j.issn.2222-3959.2010.02.11
   Werner JP, 1999, J FR OPHTALMOL, V22, P492
   Werner L, 2008, CURR OPIN OPHTHALMOL, V19, P41, DOI 10.1097/ICU.0b013e3282f20132
   Werner L, 2010, J CATARACT REFR SURG, V36, P1398, DOI 10.1016/j.jcrs.2010.06.003
   Werner LP, 1998, J FR OPHTALMOL, V21, P515
   Wright A, 2005, CUTAN OCUL TOXICOL, V24, P53, DOI 10.1081/CUS-200046191
   Xu ZX, 2011, BIOPOLYMERS, V95, P682, DOI 10.1002/bip.21635
   Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398
   Yang CL, 2009, J MATER SCI-MATER M, V20, P2349, DOI 10.1007/s10856-009-3794-1
   Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183
   Zouani OF LY, 2013, SMALL, V9, P6
   Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
   Zuk A, 1994, DEV DYNAM, V201, P16
NR 108
TC 6
Z9 8
U1 1
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 11
PY 2014
VL 9
IS 12
AR e114973
DI 10.1371/journal.pone.0114973
PG 32
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX8FY
UT WOS:000347146700079
PM 25501012
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, CH
   Rodeo, SA
   Fortier, LA
   Lu, CY
   Erisken, C
   Mao, JJ
AF Lee, Chang H.
   Rodeo, Scott A.
   Fortier, Lisa Ann
   Lu, Chuanyong
   Erisken, Cevat
   Mao, Jeremy J.
TI Protein-releasing polymeric scaffolds induce fibrochondrocytic
   differentiation of endogenous cells for knee meniscus regeneration in
   sheep
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; BONE-MARROW; TISSUE; TRANSPLANTATION; MODEL;
   DEFECT; CARTILAGE; DELIVERY; MATRIX; REPAIR
AB Regeneration of complex tissues, such as kidney, liver, and cartilage, continues to be a scientific and translational challenge. Survival of ex vivo cultured, transplanted cells in tissue grafts is among one of the key barriers. Meniscus is a complex tissue consisting of collagen fibers and proteoglycans with gradient phenotypes of fibrocartilage and functions to provide congruence of the knee joint, without which the patient is likely to develop arthritis. Endogenous stem/progenitor cells regenerated the knee meniscus upon spatially released human connective tissue growth factor (CTGF) and transforming growth factor-beta 3 (TGF beta 3) from a three-dimensional (3D)-printed biomaterial, enabling functional knee recovery. Sequentially applied CTGF and TGF beta 3 were necessary and sufficient to propel mesenchymal stem/progenitor cells, as a heterogeneous population or as single-cell progenies, into fibrochondrocytes that concurrently synthesized procollagens I and II alpha. When released from microchannels of 3D-printed, human meniscus scaffolds, CTGF and TGF beta 3 induced endogenous stem/progenitor cells to differentiate and synthesize zone-specific type I and II collagens. We then replaced sheep meniscus with anatomically correct, 3D-printed scaffolds that incorporated spatially delivered CTGF and TGF beta 3. Endogenous cells regenerated the meniscus with zone-specific matrix phenotypes: primarily type I collagen in the outer zone, and type II collagen in the inner zone, reminiscent of the native meniscus. Spatiotemporally delivered CTGF and TGF beta 3 also restored inhomogeneous mechanical properties in the regenerated sheep meniscus. Survival and directed differentiation of endogenous cells in a tissue defect may have implications in the regeneration of complex (heterogeneous) tissues and organs.
C1 [Lee, Chang H.; Lu, Chuanyong; Erisken, Cevat; Mao, Jeremy J.] Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA.
   [Rodeo, Scott A.] Hosp Special Surg, Dept Orthopaed Surg, New York, NY 10021 USA.
   [Fortier, Lisa Ann] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.
RP Mao, JJ (reprint author), Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA.
EM jmao@columbia.edu
RI Erisken, Cevat/P-7850-2014
OI Erisken, Cevat/0000-0002-6337-8022
FU NIH [AR065023, EB009663]; Arthroscopy Association of North America;
   Harry M. Zweig Foundation; American Orthopaedic Society for Sports
   Medicine
FX NIH grants AR065023 and EB009663 to J.J.M., grants from Arthroscopy
   Association of North America and American Orthopaedic Society for Sports
   Medicine to S.A.R., and a Harry M. Zweig Foundation grant to L.A.F.
CR Abraham AC, 2011, J MECH BEHAV BIOMED, V4, P2024, DOI 10.1016/j.jmbbm.2011.06.022
   Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012
   [Anonymous], 2011, CTR DIS CONTROL PREV
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Athanasiou K. A., 2009, ENG KNEE MENISCUS
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028
   CHEUNG HS, 1987, CONNECT TISSUE RES, V16, P343, DOI 10.3109/03008208709005619
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Horie M, 2012, J BONE JOINT SURG AM, V94A, P701, DOI 10.2106/JBJS.K.00176
   Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324
   Katagiri H, 2013, BIOCHEM BIOPH RES CO, V435, P603, DOI 10.1016/j.bbrc.2013.05.026
   Kim K, 2013, J CONTROL RELEASE, V168, P166, DOI 10.1016/j.jconrel.2013.03.013
   Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.tea.2011.0572, 10.1089/ten.TEA.2011.0572]
   Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee DH, 2012, OSTEOARTHR CARTILAGE, V20, P106, DOI 10.1016/j.joca.2011.11.010
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102
   Noyes FR, 2010, J BONE JOINT SURG AM, V92A, P1012
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozeki N, 2013, ARTHRITIS RHEUM-US, V65, P2876, DOI 10.1002/art.38099
   PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Singh M, 2008, TISSUE ENG PART C-ME, V14, P299, DOI 10.1089/ten.tec.2008.0167
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777
   Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100
   Yamasaki T, 2008, ARTIF ORGANS, V32, P519, DOI 10.1111/j.1525-1594.2008.00580.x
   Zantop T, 2005, AM J SPORT MED, V33, P388, DOI 10.1177/0363546504271204
   Zhang HN, 2009, CLIN ORTHOP RELAT R, V467, P3165, DOI 10.1007/s11999-009-0921-8
NR 36
TC 81
Z9 84
U1 9
U2 99
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD DEC 10
PY 2014
VL 6
IS 266
AR 266ra171
DI 10.1126/scitranslmed.3009696
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA AW3NJ
UT WOS:000346193300003
PM 25504882
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liao, HY
   Tsai, MH
   Kao, WL
   Kuo, DY
   Shyue, JJ
AF Liao, Hua-Yang
   Tsai, Meng-Hung
   Kao, Wei-Lun
   Kuo, Ding-Yuan
   Shyue, Jing-Jong
TI Effects of the temperature and beam parameters on depth profiles in
   X-ray photoelectron spectrometry and secondary ion mass spectrometry
   under C-60(+)-Ar+ cosputtering
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE Cluster ion; C-60(+)-sputtering; X-ray photoelectron spectrometry (XPS);
   Secondary ion mass spectrometry (SIMS); Depth profiles; Temperature
   effect
ID TOF-SIMS ANALYSIS; POLY(METHYL METHACRYLATE); POLYMER SURFACES;
   MICROSCOPIC INSIGHTS; SPUTTERING YIELDS; ORGANIC MATERIALS; GA
   BOMBARDMENT; IMPACT ENERGY; CLUSTER; C-60
AB Polymethylmethacrylate (PMMA) is widely used in various fields, including the semiconductor, biomaterial and microelectronic fields. Obtaining the correct depth profiles of PMMA is essential, especially when it is used as a thin-film. There have been many studies that have used earlier generation of cluster ion (SF5+) as the sputtering source to profile PMMA films, but few reports have discussed the use of the more recently developed C-60(+) in the PMMA sputtering process. In this study, X-ray photoelectron spectroscopy (XPS) and dynamic secondary ion mass spectroscopy (D-SIMS) were used concurrently to monitor the depth profiles of PMMA under C-60(+) bombardment. Additionally, the cosputtering technique (C-60(+) sputtering with auxiliary, low-kinetic-energy Ar+) was introduced to improve the analytical results. The proper cosputtering conditions could eliminate the signal enhancement near the interface that occurred with C-60(+) sputtering and enhance the sputtering yield of the characteristic signals. Atomic force microscopy (AFM) was also used to measure the ion-induced topography. Furthermore, the effect of the specimen temperature on the PMMA depth profile was also examined. At higher temperatures (+120 degrees C), the depolymerization reaction that corresponded to main-chain scission dominated the sputtering process. At lower temperatures (-120 degrees C), the cross-linking mechanism was retarded significantly due to the immobilization of free radicals. Both the higher and lower sample temperatures were found to further improve the resulting depth profiles. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Liao, Hua-Yang; Kao, Wei-Lun; Kuo, Ding-Yuan; Shyue, Jing-Jong] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan.
   [Tsai, Meng-Hung; Shyue, Jing-Jong] Nation Taiwan Univ, Dept Mat Sci & Engn, Taipei 106, Taiwan.
RP Shyue, JJ (reprint author), Acad Sinica, Res Ctr Appl Sci, 128,Sect 2,Acad Rd, Taipei 115, Taiwan.
EM shyue@gate.sinica.edu.tw
RI Shyue, Jing-Jong/D-7222-2011
FU Academia Sinica; Taiwan Ministry of Science and Technology
   [100-2113-M-001-030-MY3, 103-2628-M-001-003-MY3, 103-2113-M-001-030-MY3]
FX The authors acknowledge support from the Academia Sinica and the Taiwan
   Ministry of Science and Technology through grant number
   100-2113-M-001-030-MY3, 103-2628-M-001-003-MY3 and
   103-2113-M-001-030-MY3.
CR Andersen HH, 1998, PHYS REV LETT, V80, P5433, DOI 10.1103/PhysRevLett.80.5433
   Chang CJ, 2012, ANAL CHIM ACTA, V718, P64, DOI 10.1016/j.aca.2011.12.064
   Davies N, 2003, APPL SURF SCI, V203, P223, DOI 10.1016/S0169-4332(02)00631-1
   Fletcher J.S., 2012, ANAL CHEM, V85, P610
   Fletcher JS, 2007, ANAL CHEM, V79, P2199, DOI 10.1021/ac061370u
   Fletcher JS, 2006, ANAL CHEM, V78, P1827, DOI 10.1021/ac051624w
   Gillen G, 1999, J VAC SCI TECHNOL A, V17, P845, DOI 10.1116/1.581657
   Gillen G, 1998, RAPID COMMUN MASS SP, V12, P1303, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1303::AID-RCM330>3.0.CO;2-7
   Gillen G, 2006, APPL SURF SCI, V252, P6521, DOI 10.1016/j.apsusc.2006.02.234
   Hager GJ, 2006, APPL SURF SCI, V252, P6558, DOI 10.1016/j.apsusc.2006.02.284
   Hill R, 2006, APPL SURF SCI, V252, P7304, DOI 10.1016/j.apsusc.2006.02.211
   Kollmer F, 2004, APPL SURF SCI, V231, P153, DOI 10.1016/j.apsusc.2004.03.101
   Kotter F, 1998, APPL SURF SCI, V133, P47, DOI 10.1016/S0169-4332(97)00515-1
   Kozole J, 2008, ANAL CHEM, V80, P5293, DOI 10.1021/ac8002962
   LEGGETT GJ, 1992, INT J MASS SPECTROM, V122, P281, DOI 10.1016/0168-1176(92)87021-6
   LEGGETT GJ, 1992, APPL SURF SCI, V55, P105, DOI 10.1016/0169-4332(92)90100-C
   Liao HY, 2013, ANAL CHEM, V85, P3781, DOI 10.1021/ac400214t
   Liao HY, 2012, ANAL CHEM, V84, P9318, DOI 10.1021/ac3020824
   Liao HY, 2012, ANAL CHEM, V84, P3355, DOI 10.1021/ac300147g
   Mahoney CM, 2007, ANAL CHEM, V79, P837, DOI 10.1021/ac061357+
   Mahoney CM, 2007, ANAL CHEM, V79, P828, DOI 10.1021/ac061356h
   Mahoney CM, 2010, J PHYS CHEM C, V114, P14510, DOI 10.1021/jp103938y
   Mahoney CM, 2010, MASS SPECTROM REV, V29, P247, DOI 10.1002/mas.20233
   Mao D, 2012, ANAL CHEM, V84, P3981, DOI 10.1021/ac2032589
   Matsuo J, 2004, NUCL INSTRUM METH B, V219, P463, DOI 10.1016/j.nimb.2004.01.103
   Matsuo J, 2008, APPL SURF SCI, V255, P1235, DOI 10.1016/j.apsusc.2008.05.057
   Miyayama T, 2008, APPL SURF SCI, V255, P951, DOI 10.1016/j.apsusc.2008.05.265
   Mollers R, 2006, APPL SURF SCI, V252, P6509, DOI 10.1016/j.apsusc.2006.02.083
   Ninomiya S, 2006, APPL SURF SCI, V252, P6550, DOI 10.1016/j.apsusc.2006.02.100
   Ninomiya S, 2006, APPL SURF SCI, V252, P7290, DOI 10.1016/j.apsusc.2006.02.138
   PATKIN AJ, 1982, ANAL CHEM, V54, P2, DOI 10.1021/ac00238a005
   Postawa Z, 2005, J PHYS CHEM B, V109, P11973, DOI 10.1021/jp050821w
   Postawa Z, 2004, J PHYS CHEM B, V108, P7831, DOI 10.1021/jp049936a
   Rabbani S, 2011, ANAL CHEM, V83, P3793, DOI 10.1021/ac200288v
   Rading D, 2011, SURF INTERFACE ANAL, V43, P198, DOI 10.1002/sia.3422
   Razo I. B., 2014, SURF INTERFACE ANAL
   Shard AG, 2007, SURF INTERFACE ANAL, V39, P294, DOI 10.1002/sia.2525
   Sjovall P, 2010, J PHYS CHEM B, V114, P769, DOI 10.1021/jp9095216
   Sjovall P., 2009, J PHYS CHEM B, V114, P769
   Stapel D, 2000, APPL SURF SCI, V158, P362, DOI 10.1016/S0169-4332(00)00034-9
   Stapel D, 2001, APPL SURF SCI, V174, P261, DOI 10.1016/S0169-4332(01)00173-8
   Su YT, 2009, NUCL INSTRUM METH B, V267, P2525, DOI 10.1016/j.nimb.2009.06.008
   Szakal C, 2004, APPL SURF SCI, V231, P183, DOI 10.1016/j.apsusc.2004.03.113
   THOMPSON DA, 1979, APPL PHYS LETT, V34, P342, DOI 10.1063/1.90781
   Toyoda N, 2008, IEEE T PLASMA SCI, V36, P1471, DOI 10.1109/TPS.2008.927266
   Wagner MS, 2005, SURF INTERFACE ANAL, V37, P42, DOI 10.1002/sia.2006
   Wagner MS, 2005, SURF INTERFACE ANAL, V37, P53, DOI 10.1002/sia.2007
   Wagner MS, 2005, SURF INTERFACE ANAL, V37, P62, DOI 10.1002/sia.2008
   Wagner MS, 2004, ANAL CHEM, V76, P1264, DOI 10.1021/ac035330r
   Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o
   Wong SCC, 2003, APPL SURF SCI, V203, P219, DOI 10.1016/S0169-4332(02)00629-3
   You YW, 2011, RAPID COMMUN MASS SP, V25, P2897, DOI 10.1002/rcm.5181
   Zhu ZH, 2009, ANAL CHEM, V81, P8272, DOI 10.1021/ac900553z
NR 53
TC 5
Z9 5
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
EI 1873-4324
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD DEC 10
PY 2014
VL 852
BP 129
EP 136
DI 10.1016/j.aca.2014.08.044
PG 8
WC Chemistry, Analytical
SC Chemistry
GA AS4HW
UT WOS:000344235900018
PM 25441889
DA 2018-10-20
ER

PT J
AU Winkler, TE
   Ben-Yoav, H
   Chocron, SE
   Kim, E
   Kelly, DL
   Payne, GF
   Ghodssi, R
AF Winkler, Thomas E.
   Ben-Yoav, Hadar
   Chocron, Sheryl E.
   Kim, Eunkyoung
   Kelly, Deanna L.
   Payne, Gregory F.
   Ghodssi, Reza
TI Electrochemical Study of the Catechol-Modified Chitosan System for
   Clozapine Treatment Monitoring
SO LANGMUIR
LA English
DT Article
ID CAPILLARY-ZONE-ELECTROPHORESIS; ANTIPSYCHOTIC-DRUGS; GLASSY-CARBON;
   ELECTRODE; OXIDATION; PLASMA; QUANTIFICATION; SCHIZOPHRENIA;
   SPECTROMETRY; METABOLITE
AB This work presents a thorough electrochemical and reliability analysis of a sensing scheme for the antipsychotic clozapine. We have previously demonstrated a novel detection approach for this redox-active drug, highly effective in schizophrenia treatment, based on a catechol-modified chitosan film. The biomaterial film enables amplification of the oxidative current generated by clozapine through redox cycling. Here, we study critical electrochemical and material aspects of the redox cycling system to overcome barriers in point-of-care monitoring in complex biological samples. Specifically, we explore the electrochemical parameter space, showing that enhanced sensing performance depends on the presence of a reducing mediator as well as the electrochemical technique applied. These factors account for up to 1.75-fold and 2.47-fold signal enhancement, respectively. Looking at potential interferents, we illustrate that the redox cycling system allows for differentiation between selected redox-active species, clozapine's structurally largely analogous metabolite norclozapine as well as the representative catecholamine dopamine. Furthermore, we investigate material stability and fouling with reuse as well as storage. We find no evidence of film fouling due to clozapine; slow overall biomaterial degradation with successive use accounts for a 2.2% absolute signal loss and can be controlled for. Storage of the redox cycling system appears feasible over weeks when kept in solution with only 0.26%/day clozapine signal degradation, while ambient air exposure of three or more days reduces performance by 58%. This study not only advances our understanding of the catechol-modified chitosan system, but also further establishes the viability of applying it toward sensing clozapine in a clinical setting. Such point-of-care monitoring will allow for broader use of clozapine by increasing convenience to patients as well as medical professionals, thus improving the lives of people affected by schizophrenia through personalized medicine.
C1 [Winkler, Thomas E.; Ben-Yoav, Hadar; Chocron, Sheryl E.; Ghodssi, Reza] Univ Maryland, Dept Elect & Comp Engn, Syst Res Inst, MEMS Sensors & Actuators Lab MSAL, College Pk, MD 20742 USA.
   [Winkler, Thomas E.; Chocron, Sheryl E.; Payne, Gregory F.; Ghodssi, Reza] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Kim, Eunkyoung; Payne, Gregory F.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA.
   [Kelly, Deanna L.] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21228 USA.
RP Ghodssi, R (reprint author), Univ Maryland, Dept Elect & Comp Engn, Syst Res Inst, MEMS Sensors & Actuators Lab MSAL, College Pk, MD 20742 USA.
EM ghodssi@umd.edu
RI Winkler, Thomas/H-3369-2011
OI Winkler, Thomas/0000-0002-2331-4833
FU Robert W. Deutsch Foundation; Maryland Innovation Initiative; Maryland
   NanoCenter; FabLab
FX The authors would like to thank the Robert W. Deutsch Foundation and the
   Maryland Innovation Initiative for financial support. The authors also
   appreciate the support of the Maryland NanoCenter and its FabLab. The
   authors wish to thank Sarah Brady and Ashlyn Lee for useful discussions.
CR Bard AJ, 2000, ELECTROCHEMICAL METH
   Bashir R, 2004, ADV DRUG DELIVER REV, V56, P1565, DOI 10.1016/j.addr.2004.03.002
   Ben-Yoav H., 2013, MRS ONLINE P LIB, V1572
   Ben-Yoav H, 2014, ELECTROCHIM ACTA, V130, P497, DOI 10.1016/j.electacta.2014.03.045
   BONDESSON U, 1988, PSYCHOPHARMACOLOGY, V95, P472
   BREIER A, 1994, AM J PSYCHIAT, V151, P20
   Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116
   BUHLER HU, 1978, J PHYSIOL-LONDON, V276, P311
   Carlstedt RA, 2010, HDB INTEGRATIVE CLIN
   CLARK WM, 1960, OXIDATION REDUCTION
   Cohen D, 2012, J CLIN PSYCHIAT, V73, P1307, DOI 10.4088/JCP.11r06977
   Conley RR, 1999, BIOL PSYCHIAT, V46, P73, DOI 10.1016/S0006-3223(99)00029-3
   Farhadi K, 2007, ANAL SCI, V23, P479, DOI 10.2116/analsci.23.479
   Freeman DJ, 1997, CLIN PHARMACOKINET, V32, P93, DOI 10.2165/00003088-199732020-00001
   Hammam E, 2004, J PHARMACEUT BIOMED, V36, P149, DOI 10.1016/j.jpba.2004.04.012
   HERNANDEZ L, 1988, ANALYST, V113, P1715, DOI 10.1039/an9881301715
   Hilaert S, 2004, J CHROMATOGR A, V1033, P357, DOI 10.1016/j.chroma.2004.01.057
   Katelhon E, 2012, REV ANAL CHEM, V31, P7, DOI 10.1515/revac-2011-0031
   KALVODA R, 1990, CONTEMPORARY ELECTROANALYTICAL CHEMISTRY, P403
   KAUFFMANN JM, 1979, ANAL LETT PT B, V12, P1217, DOI 10.1080/00032717908067911
   Kelly D., 2007, CLIN SCHIZOPHR RELAT, V1, P92
   Kim E, 2013, ANAL CHEM, V85, P2102, DOI 10.1021/ac302703y
   Kim E, 2010, ADV FUNCT MATER, V20, P2683, DOI 10.1002/adfm.200902428
   Koev ST, 2010, LAB CHIP, V10, P3026, DOI [10.1039/c0lc00047g, 10.1039/c01c00047g]
   Li DM, 1999, ANAL CHEM, V71, P687, DOI 10.1021/ac980843x
   Ma CX, 2013, ACS NANO, V7, P5483, DOI 10.1021/nn401542x
   Mashhadizadeh MH, 2013, ELECTROCHIM ACTA, V87, P816, DOI 10.1016/j.electacta.2012.09.004
   Mohammad-Shiri H, 2011, INT J ELECTROCHEM SC, V6, P317
   Neugebauer S, 2006, ELECTROANAL, V18, P1929, DOI 10.1002/elan.200603612
   Novartis, 2013, CLOZARIL PRESCR INF
   Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724
   Plasson R, 2005, ANAL CHEM, V77, P6047, DOI 10.1021/ac050783c
   Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957
   Pucci V, 1999, J CHROMATOGR A, V853, P461, DOI 10.1016/S0021-9673(99)00567-1
   Sadock B. J., 2007, KAPLAN SADOCKS SYNOP
   Spina E, 2000, PSYCHOPHARMACOLOGY, V148, P83, DOI 10.1007/s002130050028
   Stark A, 2012, AUST NZ J PSYCHIAT, V46, P816, DOI 10.1177/0004867412438871
   Tinoco I. J., 2013, PHYS CHEM PRINCIPLES
   van Leeuwen SM, 2005, ANAL BIOANAL CHEM, V382, P742, DOI 10.1007/s00216-005-3053-3
   Yu DH, 2005, ANAL LETT, V38, P1687, DOI 10.1080/00032710500205659
NR 40
TC 13
Z9 14
U1 2
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 9
PY 2014
VL 30
IS 48
BP 14686
EP 14693
DI 10.1021/la503529k
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AW5PC
UT WOS:000346325700037
PM 25383917
DA 2018-10-20
ER

PT J
AU Hemmer, B
   Calabresi, PA
AF Hemmer, Bernhard
   Calabresi, Peter A.
TI Complex antibody profiling to predict clinical outcome in childhood ADS
SO NEUROLOGY
LA English
DT Editorial Material
ID MULTIPLE-SCLEROSIS
AB Studies in children presenting with a first CNS demyelinating event are particularly valuable as a focus for investigation of the early immunologic mechanism occurring during the induction and progression of CNS autoimmune diseases.(1) According to our current view, the adaptive immune response has a central role in the pathogenesis of inflammatory demyelinating diseases of the CNS.(2) Peripheral priming of antigen-specific T cells and B cells targeting antigens in the CNS will most likely precede the first clinical event. Evolution of additional antigen-specific immune responses may occur, when the disease progresses from the monophasic to the chronic stage. The extent of inflammatory disease activity, determined by relapse rates or new MRI lesions, decreases with age and disease duration, suggesting that the most pronounced immune responses occur in children.(3,4) Moreover, the immune system in children has been less exposed to environmental factors and chronic diseases than in adults. It is therefore reasonable to assume that immunologic processes associated with the first demyelinating event possibly leading to multiple sclerosis (MS) should be easier to identify in children than in adults. Although studies in children bear many advantages, they are also challenging given the lower prevalence of MS during childhood. Antigen-specific T cells, B cells, or their released antibodies can be studied in blood or CSF, but the small amount of biomaterial available from children limits broad testing for antigen-specific immune responses to antibodies.
C1 [Hemmer, Bernhard] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany.
   [Hemmer, Bernhard] Munich Cluster Syst Neurol SyNergy, Munich, Germany.
   [Calabresi, Peter A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
RP Hemmer, B (reprint author), Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany.
EM hemmer@lrz.tu-muenchen.de
CR Chitnis Tanuja, 2013, Continuum (Minneap Minn), V19, P1023, DOI 10.1212/01.CON.0000433285.84973.43
   Gorman MP, 2009, ARCH NEUROL-CHICAGO, V66, P54, DOI 10.1001/archneurol.2008.505
   McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507
   Quintana FJ, 2014, NEUROLOGY, V83, P2219, DOI 10.1212/WNL.0000000000001066
   Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105
   Schirmer L, 2014, MULT SCLER J, V20, P271, DOI 10.1177/1352458514522104
   Tremlett H, 2008, J NEUROL NEUROSUR PS, V79, P1368, DOI 10.1136/jnnp.2008.145805
NR 7
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD DEC 9
PY 2014
VL 83
IS 24
BP 2200
EP 2201
DI 10.1212/WNL.0000000000001083
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA AW1SK
UT WOS:000346070000006
PM 25381297
DA 2018-10-20
ER

PT J
AU Monteiro, N
   Martins, A
   Reis, RL
   Neves, NM
AF Monteiro, Nelson
   Martins, Albino
   Reis, Rui L.
   Neves, Nuno M.
TI Liposomes in tissue engineering and regenerative medicine
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE liposomes; scaffolds; delivery systems; bioactive agents; stem cells
ID MESENCHYMAL STEM-CELLS; NONVIRAL GENE DELIVERY; MANNOSYLATED CATIONIC
   LIPOSOMES; FIBRIN ENCAPSULATED LIPOSOMES; CHITOSAN-COATED LIPOSOMES;
   PH-SENSITIVE LIPOSOMES; GROWTH-FACTOR DELIVERY; WATER-SOLUBLE DRUGS;
   MAGNETIC FORCE; IN-VITRO
AB Liposomes are vesicular structures made of lipids that are formed in aqueous solutions. Structurally, they resemble the lipid membrane of living cells. Therefore, they have been widely investigated, since the 1960s, as models to study the cell membrane, and as carriers for protection and/or delivery of bioactive agents. They have been used in different areas of research including vaccines, imaging, applications in cosmetics and tissue engineering. Tissue engineering is defined as a strategy for promoting the regeneration of tissues for the human body. This strategy may involve the coordinated application of defined cell types with structured biomaterial scaffolds to produce living structures. To create a new tissue, based on this strategy, a controlled stimulation of cultured cells is needed, through a systematic combination of bioactive agents and mechanical signals. In this review, we highlight the potential role of liposomes as a platform for the sustained and local delivery of bioactive agents for tissue engineering and regenerative medicine approaches.
C1 [Monteiro, Nelson; Martins, Albino; Reis, Rui L.; Neves, Nuno M.] Univ Minho, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, European Inst Excellence Tissue Engn & Regenerat, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Monteiro, Nelson; Martins, Albino; Reis, Rui L.; Neves, Nuno M.] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
RP Neves, NM (reprint author), Univ Minho, Dept Polymer Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, European Inst Excellence Tissue Engn & Regenerat, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM nuno@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Neves, Nuno/B-4685-2008; Group,
   3Bs/E-4374-2012; Martins, Albino/C-8432-2012
OI Reis, Rui L./0000-0002-4295-6129; Neves, Nuno/0000-0003-3041-0687;
   Group, 3Bs/0000-0002-5195-3456; Martins, Albino/0000-0003-3868-0251
FU Portuguese Foundation for Science and Technology [SFRH/BD/62465/2009,
   SFRH/BPD/73663/2010]; POLARIS [FP7-REGPOT-2012-2013-1]; North Portugal
   Regional Operational Programme (ON.2-O Novo Norte), under the National
   Strategic Reference Framework (NSRF), through the European Regional
   Development Fund (ERDF); OsteoGraphy project [PTDC/EME-MFE/2008];
   MaxBone project [PTDC/SAU-ENB/115179/2009]; 
   [RL3-TECT-NORTE-01-0124-FEDER-000020]
FX The authors thank the Portuguese Foundation for Science and Technology
   for the PhD grant to N.S.M. (SFRH/BD/62465/2009), the post-doctoral
   grants of A.M. (SFRH/BPD/73663/2010). This study was also partly
   supported by POLARIS (FP7-REGPOT-2012-2013-1),
   RL3-TECT-NORTE-01-0124-FEDER-000020, co-financed by the North Portugal
   Regional Operational Programme (ON.2-O Novo Norte), under the National
   Strategic Reference Framework (NSRF), through the European Regional
   Development Fund (ERDF), the OsteoGraphy (PTDC/EME-MFE/2008) and MaxBone
   (PTDC/SAU-ENB/115179/2009) projects.
CR Adler AF, 2010, NANO TODAY, V5, P553, DOI 10.1016/j.nantod.2010.10.007
   Ahl PL, 1997, BBA-BIOMEMBRANES, V1329, P370, DOI 10.1016/S0005-2736(97)00129-6
   Akbarzadeh A, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-102
   Akiyama H, 2010, BIOMATERIALS, V31, P1251, DOI 10.1016/j.biomaterials.2009.11.017
   Alexander C, 2008, NAT MATER, V7, P767, DOI 10.1038/nmat2281
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   An SY, 2009, J COLLOID INTERF SCI, V331, P98, DOI 10.1016/j.jcis.2008.11.022
   Antimisiaris SG, 2007, PHARM MANUFACTURING, P443
   Bai Xiao-feng, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P468
   Balmayor ER, 2011, J R SOC INTERFACE, V8, P896, DOI 10.1098/rsif.2010.0531
   Banerjee R, 2001, J BIOMATER APPL, V16, P3, DOI 10.1106/RA7U-1V9C-RV7C-8QXL
   BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   BANGHAM AD, 1993, CHEM PHYS LIPIDS, V64, P275, DOI 10.1016/0009-3084(93)90071-A
   Barua S, 2011, COMB CHEM HIGH T SCR, V14, P908, DOI 10.2174/138620711797537076
   BARZA M, 1987, INVEST OPHTH VIS SCI, V28, P893
   Batista Cinthia Meireles, 2007, Rev. Bras. Cienc. Farm., V43, P167, DOI 10.1590/S1516-93322007000200003
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bengali Z, 2009, BIOTECHNOL BIOENG, V102, P1679, DOI 10.1002/bit.22212
   BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0
   Bhardwaj U, 2010, INT J PHARMACEUT, V388, P181, DOI 10.1016/j.ijpharm.2010.01.003
   Boerman OC, 2000, PROG LIPID RES, V39, P461, DOI 10.1016/S0163-7827(00)00013-8
   Bolliet C, 2008, TISSUE ENG PT C-METH, V14, P207, DOI 10.1089/ten.tec.2008.0168
   BRUNNER J, 1976, BIOCHIM BIOPHYS ACTA, V455, P322, DOI 10.1016/0005-2736(76)90308-4
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Burgess P, 2010, NAT BIOTECHNOL, V28, P1267, DOI 10.1038/nbt.1725
   Buse J, 2010, NANOMEDICINE-UK, V5, P1237, DOI 10.2217/NNM.10.107
   Cabral ECM, 2004, BRAZ J CHEM ENG, V21, P137, DOI 10.1590/S0104-66322004000200002
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   CHU B, 1974, J CHEM PHYS, V61, P5132, DOI 10.1063/1.1681858
   Chung TW, 2006, INT J PHARM, V311, P122, DOI 10.1016/j.ijpharm.2005.12.038
   Collier JH, 2001, ANNU REV MATER RES, V31, P237, DOI 10.1146/annurev.matsci.31.1.237
   Dai YQ, 2012, RSC ADV, V2, P3340, DOI 10.1039/c2ra01171a
   Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   DiTizio V, 1998, BIOMATERIALS, V19, P1877, DOI 10.1016/S0142-9612(98)00096-9
   Drummond DC, 1999, PHARMACOL REV, V51, P691
   Eibl H, 1995, J LIPOS RES, V5, P131, DOI 10.3109/08982109509039914
   Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200
   Fenske DB, 2008, TOXICOL PATHOL, V36, P21, DOI 10.1177/0192623307310960
   Fonseca C, 2005, EUR J PHARM BIOPHARM, V59, P359, DOI 10.1016/j.ejpb.2004.08.012
   Franzen U, 2011, ELECTROPHORESIS, V32, P738, DOI 10.1002/elps.201000552
   Freeman S., 2011, BIOL SCI LIPIDS MEMB
   Frezard F, 2005, QUIM NOVA, V28, P511, DOI 10.1590/S0100-40422005000300025
   Frezard F, 1999, BRAZ J MED BIOL RES, V32, P181, DOI 10.1590/S0100-879X1999000200006
   FRUCHTPERRY J, 1992, CORNEA, V11, P393, DOI 10.1097/00003226-199209000-00006
   Giannoni P, 2003, BIOTECHNOL BIOENG, V83, P121, DOI 10.1002/bit.10639
   Gomes-da-Silva LC, 2012, ACCOUNTS CHEM RES, V45, P1163, DOI 10.1021/ar300048p
   Gomez-Hens A, 2005, TRAC-TREND ANAL CHEM, V24, P9, DOI 10.1016/j.trac.2004.07.017
   Goncalves MCF, 2012, J BIOMED NANOTECHNOL, V8, P240, DOI 10.1166/jbn.2012.1375
   GRIT M, 1993, CHEM PHYS LIPIDS, V64, P3, DOI 10.1016/0009-3084(93)90053-6
   Guo CA, 2007, J BIOSCI BIOENG, V103, P547, DOI 10.1263/jbb.103.547
   Haidar ZS, 2010, POLYMERS-BASEL, V2, P323, DOI 10.3390/polym2030323
   HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9
   Herbst SM, 2010, MOL PHARMACEUT, V7, P3, DOI 10.1021/mp900116r
   Hong JS, 2008, LANGMUIR, V24, P4092, DOI 10.1021/la7031219
   Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8
   Immordino ML, 2006, INT J NANOMED, V1, P297
   Ino K, 2007, J CHEM ENG JPN, V40, P51, DOI 10.1252/jcej.40.51
   Ishida T, 2005, J CONTROL RELEASE, V105, P305, DOI 10.1016/j.jconrel.2005.04.003
   Ishii M, 2011, ARTERIOSCL THROM VAS, V31, P2210, DOI 10.1161/ATVBAHA.111.231100
   Ito A, 2005, J BIOSCI BIOENG, V100, P1, DOI 10.1263/jbb.100.1
   Ito A, 2005, TISSUE ENG, V11, P1553, DOI 10.1089/ten.2005.11.1553
   Ito A, 2005, BIOMATERIALS, V26, P6185, DOI 10.1016/j.biomaterials.2005.03.039
   Ito A, 2005, TISSUE ENG, V11, P489, DOI 10.1089/ten.2005.11.489
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Joguparthi V, 2008, J PHARM SCI-US, V97, P433, DOI 10.1002/jps.21135
   Joo KI, 2013, BIOMATERIALS, V34, P3098, DOI 10.1016/j.biomaterials.2013.01.039
   Joo V, 2011, POLYMERS-BASEL, V3, P967, DOI 10.3390/polym3020967
   Kale AA, 2007, J LIPOSOME RES, V17, P197, DOI 10.1080/08982100701525035
   Kawakami S, 2000, GENE THER, V7, P292, DOI 10.1038/sj.gt.3301089
   Kawakami S, 2001, STP PHARMA SCI, V11, P117
   Kawakami S, 2008, J PHARM SCI-US, V97, P726, DOI 10.1002/jps.21024
   Kelleher CM, 2010, J R SOC INTERFACE, V7, pS717, DOI 10.1098/rsif.2010.0345.focus
   Kim YT, 2012, NANO LETT, V12, P3587, DOI 10.1021/nl301253v
   Kito T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01418
   Kleusch C, 2012, MOLECULES, V17, P1055, DOI 10.3390/molecules17011055
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9
   Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003
   Kulkarni M, 2009, BIOMACROMOLECULES, V10, P1650, DOI 10.1021/bm900248n
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Kwong FNK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2436
   Laouini A, 2012, J COLLOID SCI BIOTEC, V1, P147, DOI 10.1166/jcsb.2012.1020
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lei Lei, 2006, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V20, P134
   Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049
   Levy O, 2010, INT J BIOCHEM CELL B, V42, P1823, DOI 10.1016/j.biocel.2010.07.017
   Li N, 2012, DRUG DELIV, V19, P28, DOI 10.3109/10717544.2011.621994
   LICHTENBERG D, 1988, METHOD BIOCHEM ANAL, V33, P337
   Lindner LH, 2010, CURR OPIN DRUG DISC, V13, P111
   LIPID-MAPS, 2014, LIP GAT
   LITZINGER DC, 1994, BBA-BIOMEMBRANES, V1190, P99, DOI 10.1016/0005-2736(94)90038-8
   Liu PY, 2004, WOUND REPAIR REGEN, V12, P80, DOI 10.1111/j.1067-1927.2004.012114.x-1
   Lu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021154
   MA L, 1991, INT J PHARM, V77, P127, DOI 10.1016/0378-5173(91)90310-K
   Mader S., 2010, INQUIRY INTO LIFE, P13
   Maestrelli F, 2006, INT J PHARM, V312, P53, DOI 10.1016/j.ijpharm.2005.12.047
   Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015
   Malvern-Instrument-Company, 2013, DYN LIGHT SCATT ZET
   Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   Matsuo T, 2003, J BIOMED MATER RES A, V66A, P747, DOI 10.1002/jbm.a.10002
   Maurer N, 2001, EXPERT OPIN BIOL TH, V1, P923, DOI 10.1517/14712598.1.6.923
   MCCORMACK B, 1994, INT J PHARM, V112, P249, DOI 10.1016/0378-5173(94)90361-1
   Messersmith PB, 1998, CHEM MATER, V10, P109, DOI 10.1021/cm970251f
   Meyenburg S, 2000, J CONTROL RELEASE, V69, P159, DOI 10.1016/S0168-3659(00)00295-9
   Michlits W, 2007, WOUND REPAIR REGEN, V15, P360, DOI 10.1111/j.1524-475X.2007.00238.x
   Mickova A, 2012, BIOMACROMOLECULES, V13, P952, DOI 10.1021/bm2018118
   Mohammed AR, 2004, INT J PHARM, V285, P23, DOI 10.1016/j.ijpharm.2004.07.010
   MONSHIPOURI M, 1995, J MICROENCAPSUL, V12, P117, DOI 10.3109/02652049509015282
   Monteiro N, 2015, J TISSUE ENG REGEN M, V9, P1056, DOI 10.1002/term.1817
   Monteiro N, 2014, ACS NANO, V8, P8082, DOI 10.1021/nn5021049
   Monteiro N, 2014, BIOMATER SCI-UK, V2, P1195, DOI 10.1039/c4bm00069b
   Moura V, 2012, BREAST CANCER RES TR, V133, P61, DOI 10.1007/s10549-011-1688-7
   Mozafari MR, 2005, CELL MOL BIOL LETT, V10, P711
   Mozafari MR, 2002, TECHNOL HEALTH CARE, V10, P342
   Mozafari MR, 2004, J AEROSOL MED, V17, P100
   Murao A, 2002, PHARMACEUT RES, V19, P1808, DOI 10.1023/A:1021433206081
   Murphy WL, 2000, POLYHEDRON, V19, P357, DOI 10.1016/S0277-5387(99)00366-6
   Newland B, 2013, BIOMATER SCI-UK, V1, P556, DOI 10.1039/c3bm60030k
   Newland B, 2013, BIOMATERIALS, V34, P2130, DOI 10.1016/j.biomaterials.2012.11.049
   OLSON F, 1979, BIOCHIM BIOPHYS ACTA, V557, P9, DOI 10.1016/0005-2736(79)90085-3
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   PAPAHADJOPOULOS D, 1972, BIOCHIM BIOPHYS ACTA, V266, P561, DOI 10.1016/0005-2736(72)90354-9
   Pardridge WM, 2002, NAT REV DRUG DISCOV, V1, P131, DOI 10.1038/nrd725
   Paszko E, 2012, CURR MED CHEM, V19, P5239, DOI 10.2174/092986712803833362
   Pederson AW, 2003, BIOMATERIALS, V24, P4881, DOI 10.1016/S0142-9162(03)00369-7
   Perrie Y, 2000, BBA-GEN SUBJECTS, V1475, P125, DOI 10.1016/S0304-4165(00)00055-6
   Phillips NC, 1996, PHARM SCI, V2, P73
   Podesta JE, 2009, METHOD ENZYMOL, V464, P343, DOI 10.1016/S0076-6879(09)64017-9
   Pornpattananangkul D, 2010, ACS NANO, V4, P1935, DOI 10.1021/nn9018587
   Quaglia F, 2008, INT J PHARMACEUT, V364, P281, DOI 10.1016/j.ijpharm.2008.04.030
   Rampichova M, 2012, J MATER SCI-MATER M, V23, P555, DOI 10.1007/s10856-011-4518-x
   Randles EG, 2013, LANGMUIR, V29, P1490, DOI 10.1021/la303526k
   Rea JC, 2009, ACTA BIOMATER, V5, P903, DOI 10.1016/j.actbio.2008.10.003
   REINECCIUS GA, 1995, ACS SYM SER, V590, P113
   Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c
   Ruozi B, 2011, INT J NANOMED, V6, P557, DOI 10.2147/IJN.S14615
   Sakai H, 2008, J OLEO SCI, V57, P613, DOI 10.5650/jos.57.613
   Samal SK, 2012, CHEM SOC REV, V41, P7147, DOI 10.1039/c2cs35094g
   Samoshin AV, 2013, TETRAHEDRON LETT, V54, P5600, DOI 10.1016/j.tetlet.2013.07.156
   Sanborn TJ, 2002, BIOMATERIALS, V23, P2703, DOI 10.1016/S0142-9612(02)00002-9
   Santo VE, 2012, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, DOI 10.1089/TEN.TEB.2012.0138]
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P327, DOI [10.1089/ten.teb.2012.0727, 10.1089/ten.TEB.2012.0727]
   Santo VE, 2012, NANOMEDICINE-UK, V7, P1045, DOI [10.2217/NNM.12.78, 10.2217/nnm.12.78]
   Santos JL, 2011, CURR GENE THER, V11, P46
   Sasaki Y, 2006, J PHOTOCH PHOTOBIO A, V183, P309, DOI 10.1016/j.jphotochem.2006.05.022
   Schroeder JE, 2011, INJURY, V42, P609, DOI 10.1016/j.injury.2011.03.029
   SENIOR J, 1985, BIOCHIM BIOPHYS ACTA, V839, P1, DOI 10.1016/0304-4165(85)90174-6
   Shanmugam T, 2011, THER DELIV, V2, P1485, DOI 10.4155/TDE.11.105
   Shi NY, 2000, P NATL ACAD SCI USA, V97, P7567, DOI 10.1073/pnas.130187497
   Shimizu K, 2006, J BIOMED MATER RES B, V77B, P265, DOI 10.1002/jbm.b.30443
   Shimizu K, 2007, J BIOSCI BIOENG, V104, P171, DOI 10.1263/jbb.104.171
   Shimizu K, 2007, J BIOMED MATER RES B, V82B, P471, DOI 10.1002/jbm.b.30752
   Shimizu K, 2007, J BIOSCI BIOENG, V103, P472, DOI 10.1263/jbb.103.472
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   Singh AK, 2001, ANAL CHEM, V73, P1057, DOI 10.1021/ac001159x
   Sirc J, 2012, INT J NANOMED, V7, P5315, DOI 10.2147/IJN.S35781
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Subramaniam S, 2011, CHEM REV, V111, P6452, DOI 10.1021/cr200295k
   Sun XY, 2010, AGEING RES REV, V9, P475, DOI 10.1016/j.arr.2010.06.002
   SZOKA F, 1980, ANNU REV BIOPHYS BIO, V9, P467, DOI 10.1146/annurev.bb.09.060180.002343
   Tanaka H, 2005, J BIOMED MATER RES A, V73A, P255, DOI 10.1002/jbm.a.30187
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tehrany EA, 2012, COLLOID SURFACE B, V95, P75, DOI 10.1016/j.colsurfb.2012.02.024
   Thakur RA, 2008, INT J PHARMACEUT, V364, P87, DOI 10.1016/j.ijpharm.2008.07.033
   Toh MR, 2013, ASIAN J PHARM SCI, V8, P88, DOI 10.1016/j.ajps.2013.07.011
   Torchilin V, 2003, LIPOSOMES PRACTICAL
   Tsotas VA, 2007, DRUG DELIV, V14, P441, DOI 10.1080/10717540701603530
   Tsukanova V, 2004, J PHYS CHEM B, V108, P10754, DOI 10.1021/jp036992n
   Ulbrich W, 2010, J R SOC INTERFACE, V7, pS55, DOI 10.1098/rsif.2009.0285.focus
   Uskokovic V, 2011, ARCH ORAL BIOL, V56, P521, DOI 10.1016/j.archoralbio.2010.11.011
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83
   Vemuri S, 1995, Pharm Acta Helv, V70, P95, DOI 10.1016/0031-6865(95)00010-7
   Viallat A, 2004, BIOPHYS J, V86, P2179, DOI 10.1016/S0006-3495(04)74277-0
   Vo TN, 2012, ADV DRUG DELIVER REV, V64, P1292, DOI 10.1016/j.addr.2012.01.016
   Voinea M, 2002, J CELL MOL MED, V6, P465, DOI 10.1111/j.1582-4934.2002.tb00450.x
   von Groll A, 2006, BIOTECHNOL PROGR, V22, P1220, DOI 10.1021/bp060029s
   Wagner A, 2011, J DRUG DELIV, DOI 10.1155/2011/591325
   Wang GL, 2012, J BIOMED MATER RES A, V100A, P684, DOI 10.1002/jbm.a.34002
   Wang SS, 2008, DRUG DELIV, V15, P149, DOI [10.1080/10717540801952456, 10.1080/10717540801952456 ]
   Whittlesey KJ, 2006, BIOMATERIALS, V27, P2477, DOI 10.1016/j.biomaterials.2005.11.016
   Winn S R, 2005, Orthod Craniofac Res, V8, P183, DOI 10.1111/j.1601-6343.2005.00332.x
   Woodle MC, 2001, CURR OPIN COLLOID IN, V6, P78, DOI 10.1016/S1359-0294(00)00091-1
   WOODLE MC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P171, DOI 10.1016/0304-4157(92)90038-C
   Wu GP, 2010, ANN PLAS SURG, V65, P80, DOI 10.1097/SAP.0b013e3181b4bc5d
   Xia SQ, 2005, FOOD RES INT, V38, P289, DOI 10.1016/j.foodres.2004.04.010
   Xu XM, 2012, INT J PHARMACEUT, V423, P410, DOI 10.1016/j.ijpharm.2011.12.019
   Yamamoto Y, 2011, TISSUE ENG PT A, V17, P107, DOI [10.1089/ten.tea.2010.0312, 10.1089/ten.TEA.2010.0312]
   Yang F, 2010, P NATL ACAD SCI USA, V107, P3317, DOI 10.1073/pnas.0905432106
   Yang SY, 2012, INT J PHARMACEUT, V434, P155, DOI 10.1016/j.ijpharm.2012.05.041
   Yau WWY, 2012, BIOMATERIALS, V33, P2608, DOI 10.1016/j.biomaterials.2011.12.021
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhang J, 2011, J BONE MINER RES, V26, P1953, DOI 10.1002/jbmr.377
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
   Zhang ZY, 2002, BIOCONJUGATE CHEM, V13, P640, DOI 10.1021/bc015580j
NR 199
TC 48
Z9 48
U1 5
U2 40
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD DEC 6
PY 2014
VL 11
IS 101
AR 20140459
DI 10.1098/rsif.2014.0459
PG 24
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CC1KX
UT WOS:000350100700001
PM 25401172
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Gonte, RR
   Shelar, G
   Balasubramanian, K
AF Gonte, Renuka R.
   Shelar, Gauri
   Balasubramanian, K.
TI Polymer-agro-waste composites for removal of Congo red dye from
   wastewater: adsorption isotherms and kinetics
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Agro-waste; Congo red; SMA; Polymer composite; Physisorption
ID LOW-COST ADSORBENTS; ION-EXCHANGE-RESINS; AQUEOUS-SOLUTIONS;
   METHYLENE-BLUE; ACTIVATED CARBON; TREATMENT TECHNOLOGIES; EQUILIBRIUM;
   SORPTION; SAWDUST; BIODEGRADATION
AB Composites of sawdust and sugarcane molasses with styrene-maleic acid copolymer [(SD-SMA) and (SM-SMA)] were successfully synthesized by suspension polymerization and used as adsorbents for removal of Congo red (CR) dye from aqueous solution. The surface morphology of composite beads was observed under scanning electron microscope, which revealed highly porous surface. Maximum 20 wt.% sawdust and 10 wt.% sugarcane molasses loading were achieved in respective composite. Adsorption of CR was performed in batch process. The effect of initial solution concentration, amount of composite dose, and biomaterial content into the composite were investigated to test the adsorption efficiency and adsorption capacity of these composite beads at pH 7. Adsorption efficiency of 90 and 48% was observed in 2 h using SM-SMA and SD-SMA composites, respectively. The equilibrium data was analyzed using Langmuir, Freundlich, Temkin, and Dubinin-Radushkevich isotherm models. Adsorption onto SD-SMA composites followed the Langmuir model whereas Freundlich model was obeyed by SM-SMA composite beads. Pseudo-second-order kinetics was followed by both types of composites with good correlation coefficient values. The results indicates that SD-SMA and SM-SMA composite beads can be considered as potential adsorbent for the CR dye removal from aqueous solutions.
C1 [Gonte, Renuka R.; Balasubramanian, K.] Def Inst Adv Technol DU, Dept Mat Engn, Pune 411025, Maharashtra, India.
   [Shelar, Gauri] Fergusson Coll, Dept Chem, Pune 411004, Maharashtra, India.
RP Balasubramanian, K (reprint author), Def Inst Adv Technol DU, Dept Mat Engn, Pune 411025, Maharashtra, India.
EM balask@diat.ac.in
FU Department of Applied Chemistry, DIAT (DU) laboratory; Department of
   Applied Chemistry, DRDO laboratory
FX This work was supported by the Department of Applied Chemistry, DIAT
   (DU) and DRDO laboratories. Authors would like to thank Vice Chancellor,
   DIAT (DU) for his encouragement in this research activity. The authors
   would also like to thank Dr. Partha Ghosal, Scientist 'E', Defence
   Metallurgical Research Laboratory, Kanchanbagh, Hyderabad for the SEM
   micrographs.
CR Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1
   Al-Degs YS, 2008, DYES PIGMENTS, V77, P16, DOI 10.1016/j.dyepig.2007.03.001
   Annadurai G, 2002, J HAZARD MATER, V92, P263, DOI 10.1016/S0304-3894(02)00017-1
   Benhamou A, 2009, J HAZARD MATER, V171, P1001, DOI 10.1016/j.jhazmat.2009.06.106
   BERING BP, 1972, J COLLOID INTERF SCI, V38, P185, DOI 10.1016/0021-9797(72)90233-0
   BROWN MA, 1993, CRIT REV ENV SCI TEC, V23, P249, DOI 10.1080/10643380490434119
   Chatterjee S, 2009, BIORESOURCE TECHNOL, V100, P2803, DOI 10.1016/j.biortech.2008.12.035
   Choy KKH, 1999, RESOUR CONSERV RECY, V27, P57, DOI 10.1016/S0921-3449(98)00085-8
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Demirbas O, 2002, ADSORPTION, V8, P341, DOI 10.1023/A:1021589514766
   Djeribi R, 2008, DESALINATION, V225, P95, DOI 10.1016/j.desal.2007.04.091
   Dogan M, 2000, WATER AIR SOIL POLL, V120, P229, DOI 10.1023/A:1005297724304
   Elahmadi MF, 2009, J HAZARD MATER, V168, P1163, DOI 10.1016/j.jhazmat.2009.02.139
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Gharbani P, 2008, INT J ENVIRON SCI TE, V5, P495, DOI 10.1007/BF03326046
   Ghosh D, 2002, APPL CLAY SCI, V20, P295, DOI 10.1016/S0169-1317(01)00081-3
   Gonte R., J SAUDI CHE IN PRESS
   Gonte R, 2012, INT J POLYM MATER, V61, P919, DOI 10.1080/00914037.2011.610057
   Gopinath KP, 2009, BIORESOURCE TECHNOL, V100, P6295, DOI 10.1016/j.biortech.2009.07.043
   Gregory A R, 1981, J Appl Toxicol, V1, P308
   Gunay A, 2007, J HAZARD MATER, V146, P362, DOI 10.1016/j.jhazmat.2006.12.034
   Gupta VK, 2009, CRIT REV ENV SCI TEC, V39, P783, DOI 10.1080/10643380801977610
   Gupta VK, 2009, J ENVIRON MANAGE, V90, P2313, DOI 10.1016/j.jenvman.2008.11.017
   Gurses A, 2006, J HAZARD MATER, V131, P217, DOI 10.1016/j.jhazmat.2005.09.036
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   HALSEY GD, 1952, ADV CATAL, V4, P259, DOI 10.1016/S0360-0564(08)60616-1
   Hamdaoui O, 2007, ACTA CHIM SLOV, V54, P407
   Han RP, 2008, BIORESOURCE TECHNOL, V99, P2938, DOI 10.1016/j.biortech.2007.06.027
   Khadhraoui M, 2009, J HAZARD MATER, V161, P974, DOI 10.1016/j.jhazmat.2008.04.060
   Khan E, 2008, WATER ENVIRON RES, V80, P1654, DOI 10.2175/106143008X328770
   Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007
   Kumar P.A., 2009, CHEM ENG J, V149, P115
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Lennox JA, 2010, AFR J MICROBIOL RES, V4, P1352
   Li YH, 2005, WATER RES, V39, P605, DOI 10.1016/j.watres.2004.11.004
   Lorenc-Grabowska E, 2007, DYES PIGMENTS, V74, P34, DOI 10.1016/j.dyepig.2006.01.027
   Mall ID, 2005, CHEMOSPHERE, V61, P492, DOI 10.1016/j.chemosphere.2005.03.065
   MAVROS P, 1994, ENVIRON TECHNOL, V15, P601, DOI 10.1080/09593339409385467
   MCKAY G, 1985, WATER AIR SOIL POLL, V24, P307, DOI 10.1007/BF00161790
   Namasivayam C, 2002, DYES PIGMENTS, V54, P47, DOI 10.1016/S0143-7208(02)00025-6
   Namasivayam C, 2003, CELL CHEM TECHNOL, V37, P333
   NYHOLM N, 1992, WATER RES, V26, P339, DOI 10.1016/0043-1354(92)90031-X
   Ozacar M, 2005, PROCESS BIOCHEM, V40, P565, DOI 10.1016/j.procbio.2004.01.032
   Ozacar M, 2006, J ENVIRON MANAGE, V80, P372, DOI 10.1016/j.jenvman.2005.10.004
   Rafatullah M, 2009, J HAZARD MATER, V170, P969, DOI 10.1016/j.jhazmat.2009.05.066
   Raymundo AS, 2010, BRAZ ARCH BIOL TECHN, V53, P931, DOI 10.1590/S1516-89132010000400023
   Rengaraj S, 2004, KOREAN J CHEM ENG, V21, P187, DOI 10.1007/BF02705397
   Rengaraj S, 2007, J HAZARD MATER, V143, P469, DOI 10.1016/j.jhazmat.2006.09.064
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Sag Y, 2002, BIOCHEM ENG J, V12, P143, DOI 10.1016/S1369-703X(02)00068-2
   Sarkar M, 2003, J COLLOID INTERF SCI, V266, P28, DOI 10.1016/S0021-9797(03)00551-4
   Wahi RK, 2005, J MOL CATAL A-CHEM, V242, P48, DOI 10.1016/j.molcata.2005.07.034
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Xia CL, 2011, DESALINATION, V265, P81, DOI 10.1016/j.desal.2010.07.035
   Yu H., 2010, J HAZARD MATER, V177, P130
   Zhang Y, 2010, J HAZARD MATER, V181, P898, DOI 10.1016/j.jhazmat.2010.05.097
NR 56
TC 7
Z9 7
U1 1
U2 20
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD DEC 6
PY 2014
VL 52
IS 40-42
BP 7797
EP 7811
DI 10.1080/19443994.2013.833876
PG 15
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA AW9KM
UT WOS:000346576000035
DA 2018-10-20
ER

PT J
AU Rozman, M
   Fabris, D
   Mrla, T
   Vukelic, Z
AF Rozman, Marko
   Fabris, Dragana
   Mrla, Tomislav
   Vukelic, Zeljka
TI Database and data analysis application for structural characterization
   of gangliosides and sulfated glycosphingolipids by negative ion mass
   spectrometry
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE Database; Glycosphingolipid analysis; MS ion search; MSMS ion search
ID THIN-LAYER-CHROMATOGRAPHY; HUMAN BRAIN; ELECTROSPRAY-IONIZATION; MYELIN
   MEMBRANES; NERVOUS-SYSTEM; SPHINGOLIPIDS; TUMORS; GALACTOSYLCERAMIDE;
   OLIGODENDROCYTE; GLYCOSYNAPSES
AB Gangliosides and sulfated glycosphingolipids, as building and functional components of animal cell membranes, participate in cell-to-cell interactions and signaling, but also in changes of cell architecture due to different pathophysiological events. In order to enable higher throughput and to facilitate structural characterization of gangliosides/sulfo-glycosphingolipids (GSL) and their neutral GSL counterparts by negative ion mass spectrometry (MS) and tandem MS techniques, a database and data analysis application have been developed. In silico developed glycosphingolipid database considers a high diversity of ceramide compositions, several sialic acid types (N-acetylneuraminic acid, N-glycolylneuraminic acid and 2-keto-3-deoxynononic acid) as well as possible additional substitutions/modifications of glycosphingolipids, such as O-acetylation, de-N-acetylation, fucosylation, glucuronosylation, sulfation, attachment of repeating terminal hexose-N-acetylhexosamine- (Hex-HexNAc-)(1-6) extension, and possible lactone forms. Data analysis application, named GSL-finder, enables correlation of negative ion MS and/or low-energy tandem MS spectra with the database structures. The GSL-database construction and the GSL-finder application searching rules are explained. Validation conducted on GD1a fraction as well as on complex mixtures of native gangliosides isolated from different mammalian brain tissues (human fetal and adult brain, and calf brain tissue) demonstrated agreement with previous studies. Plain, fast, and automated routine for structural characterization of gangliosides/sulfated glycosphingolipids and their neutral GSL counterparts described here could facilitate and improve mass spectrometric analysis of complex glycosphingolipid mixtures originating from variety of normal and pathological biomaterial, where it is known that distinctive changes in glycosphingolipid composition occur. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Rozman, Marko; Mrla, Tomislav] Rudjer Boskovic Inst, Dept Phys Chem, Zagreb 10000, Croatia.
   [Fabris, Dragana; Vukelic, Zeljka] Univ Zagreb, Sch Med, Dept Chem & Biochem, Zagreb 10000, Croatia.
RP Rozman, M (reprint author), Rudjer Boskovic Inst, Dept Phys Chem, Bijenicka 54, Zagreb 10000, Croatia.
EM marko@irb.hr; dragana.fabris@mef.hr; tomislav.mrla@irb.hr;
   zvukelic@mef.hr
OI Rozman, Marko/0000-0001-5513-3386
FU Ministry of Science, Education, and Sports of Republic of Croatia
   [098-0982915-2945, 108-1081870-2415]
FX The Ministry of Science, Education, and Sports of Republic of Croatia
   supported this work (Grant Numbers: 098-0982915-2945 and
   108-1081870-2415).
CR Ariga T, 2008, NEUROSIGNALS, V16, P226, DOI 10.1159/000111565
   Boggs JA, 2008, BBA-GEN SUBJECTS, V1780, P445, DOI 10.1016/j.bbagen.2007.10.015
   Boggs JM, 2010, FEBS LETT, V584, P1771, DOI 10.1016/j.febslet.2009.11.074
   Chester MA, 1999, GLYCOCONJUGATE J, V16, P1
   Davies L., 2013, TOP CURR CHEM
   DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915
   Dreisewerd K, 2005, ANAL CHEM, V77, P4098, DOI 10.1021/ac048373w
   Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324
   Flangea C, 2013, AUST J CHEM, V66, P781, DOI 10.1071/CH13173
   Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699
   Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851
   Hoffmann-Ostenhof O., 1977, EUR J BIOCHEM, V79, P11
   Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P536, DOI 10.1016/j.jasms.2003.12.007
   JUNGALWALA FB, 1994, NEUROCHEM RES, V19, P945, DOI 10.1007/BF00968704
   Kasahara K, 2000, GLYCOCONJUGATE J, V17, P153, DOI 10.1023/A:1026576804247
   Kofeler HC, 2012, METABOLITES, V2, P19, DOI 10.3390/metabo2010019
   Kohla G, 2002, NEUROCHEM RES, V27, P583, DOI 10.1023/A:1020211714104
   KRACUN I, 1992, NEUROCHEM INT, V20, P421, DOI 10.1016/0197-0186(92)90057-X
   Liu Y., 2010, MOL CANC
   Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001
   Metelmann W, 2001, J MASS SPECTROM, V36, P21, DOI 10.1002/jms.100
   Miyagi T, 2012, GLYCOCONJUGATE J, V29, P567, DOI 10.1007/s10719-012-9394-1
   Mlinac K, 2013, CARBOHYD RES, V382, P1, DOI 10.1016/j.carres.2013.09.007
   Muthing J, 2010, MASS SPECTROM REV, V29, P425, DOI 10.1002/mas.20253
   OBRIEN JS, 1964, J LIPID RES, V5, P339
   OGAWAGOTO K, 1993, J NEUROCHEM, V61, P1398, DOI 10.1111/j.1471-4159.1993.tb13633.x
   Popa I, 2007, GLYCOBIOLOGY, V17, P367, DOI 10.1093/glycob/cwm006
   Schiopu C, 2012, ELECTROPHORESIS, V33, P1778, DOI 10.1002/elps.201200044
   Schiopu C, 2009, ANAL BIOANAL CHEM, V395, P2465, DOI 10.1007/s00216-009-3188-8
   Shida K, 2009, GLYCOBIOLOGY, V19, P1018, DOI 10.1093/glycob/cwp083
   Sonnino S, 2000, BBA-REV BIOMEMBRANES, V1469, P63, DOI 10.1016/S0005-2736(00)00210-8
   Souady J, 2010, RAPID COMMUN MASS SP, V24, P1039, DOI 10.1002/rcm.4479
   Sullards MC, 2007, METHOD ENZYMOL, V432, P83, DOI 10.1016/S0076-6879(07)32004-1
   Sullards MC, 2011, BBA-MOL CELL BIOL L, V1811, P838, DOI 10.1016/j.bbalip.2011.06.027
   SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802
   SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1
   Svennerholm L, 1980, Adv Exp Med Biol, V125, P11
   SVENNERHOLM L, 1963, J NEUROCHEM, V10, P613, DOI 10.1111/j.1471-4159.1963.tb08933.x
   Todeschini AR, 2008, BBA-GEN SUBJECTS, V1780, P421, DOI 10.1016/j.bbagen.2007.10.008
   Vukelic Z, 2005, J AM SOC MASS SPECTR, V16, P571, DOI 10.1016/j.jasms.2005.01.013
   Vukelic Z, 2001, BIOL CHEM, V382, P259, DOI 10.1515/BC.2001.033
   Vukelic Z, 2007, GLYCOBIOLOGY, V17, P504, DOI 10.1093/glycob/cwm012
   Vukelic Z, 2006, J CHROMATOGR A, V1130, P238, DOI 10.1016/j.chroma.2006.05.033
   Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033
   Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u
   Yu Robert K., 1994, Journal of Biomedical Science, V1, P167, DOI 10.1007/BF02253346
   Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537
   Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200
   Zamfir A, 2004, J AM SOC MASS SPECTR, V15, P1649, DOI 10.1016/j.jasms.2004.08.002
   Zamfir AD, 2013, ANAL BIOANAL CHEM, V405, P7321, DOI 10.1007/s00216-013-7173-x
   Zamfir AD, 2011, J AM SOC MASS SPECTR, V22, P2145, DOI 10.1007/s13361-011-0250-5
NR 51
TC 4
Z9 4
U1 2
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
EI 1873-426X
J9 CARBOHYD RES
JI Carbohydr. Res.
PD DEC 5
PY 2014
VL 400
BP 1
EP 8
DI 10.1016/j.carres.2014.06.029
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA AT4AX
UT WOS:000344880900001
PM 25299937
DA 2018-10-20
ER

PT J
AU de Almeida, LH
   Bastos, IN
   Santos, ID
   Dutra, AJB
   Nunes, CA
   Gabriel, SB
AF de Almeida, L. H.
   Bastos, I. N.
   Santos, I. D.
   Dutra, A. J. B.
   Nunes, C. A.
   Gabriel, S. B.
TI Corrosion resistance of aged Ti-Mo-Nb alloys for biomedical applications
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article; Proceedings Paper
CT International Symposium on Metastable, Amorphous and Nanostructured
   Materials (ISMANAM)
CY JUN 30-JUL 05, 2013
CL Torino, ITALY
DE Ti-Mo-Nb alloys; Electrochemical behavior; Mechanical properties;
   Biomaterial
ID MECHANICAL-PROPERTIES; NIOBIUM; BEHAVIOR; AL
AB Metastable beta-Ti alloys combine low elastic modulus, excellent mechanical strength as well as good corrosion resistance. Wherever, the presence of nontoxic elements such as Nb, Ta, Mo, and Zr is an important advantage. With such properties this type alloy has been developed for orthopedic applications. Previous studies had shown that the Ti-12Mo-13Nb and Ti-10Mo-20Nb alloys aged at 500 C presented higher hardness/elastic modulus ratio compared to commercially Ti-6Al-4V, indicating a great potential for biomedical application. However, additional studies are needed such as corrosion resistance. Therefore, the objective of this work was to analyze the electrochemical behavior of the Ti-12Mo-13Nb and Ti-10Mo-20Nb alloys aged at 500 degrees C/24 h and 500 degrees C/4 h, respectively. The electrochemical behavior was carried through by potentiodynamic polarization curves in Ringer's solutions to simulate the body fluid. The Ti-10Mo-20Nb alloy showed to be more resistant to corrosion when compared to Ti-12Mo-13Nb alloy and the commercially Ti-6Al-4V alloy. (C) 2014 Published by Elsevier B.V.
C1 [de Almeida, L. H.; Dutra, A. J. B.; Gabriel, S. B.] Univ Fed Rio de Janeiro, Dept Mat & Met Engn, BR-21945970 Rio De Janeiro, RJ, Brazil.
   [Bastos, I. N.] Univ Estado Rio de Janeiro, BR-2862557 Nova Friburgo, RJ, Brazil.
   [Nunes, C. A.] Univ Sao Paulo, Dept Mat Engn, BR-12600970 Lorena, SP, Brazil.
   [Gabriel, S. B.] Ctr Univ Volta Redonda, BR-27240560 Volta Redonda, RJ, Brazil.
   [Santos, I. D.] Vale SA, Inst Tecnol Vale, BR-30140130 Belo Horizonte, MG, Brazil.
RP de Almeida, LH (reprint author), Univ Fed Rio de Janeiro, Dept Mat & Met Engn, CP 68505, BR-21945970 Rio De Janeiro, RJ, Brazil.
EM lha@metalmat.ufrj.br
RI Dutra, Achilles/I-8848-2012
OI Nunes, Carlos/0000-0001-9100-9761; Dutra, Achilles/0000-0001-8187-7186
FU Brazilian Agencies CNPq; FAPERJ; CAPES
FX This work was supported by the Brazilian Agencies CNPq, FAPERJ and
   CAPES.
CR [Anonymous], 1977, ANN BOOK ASTM STAND
   Burke D.R., 1980, COMPOSITION FUNCTION
   Ferrandini PL, 2007, J ALLOY COMPD, V433, P207, DOI 10.1016/j.jallcom.2006.06.094
   Gabriel S.B., 2008, THESIS COPPE UFR RIO
   Gabriel S.B., 2010, MAT RES, V13, P1
   Gabriel SB, 2013, MAT SCI ENG C-MATER, V33, P3319, DOI 10.1016/j.msec.2013.04.015
   Gabriel SB, 2008, ARTIF ORGANS, V32, P299, DOI 10.1111/j.1525-1594.2008.00546.x
   Guo WY, 2009, MATER CHEM PHYS, V113, P816, DOI 10.1016/j.matchemphys.2008.08.043
   Lee DG, 2005, J MATER PROCESS TECH, V162, P342, DOI 10.1016/j.jmatprotec.2005.02.102
   Liu YZ, 2006, NUCL INSTRUM METH B, V244, P397, DOI 10.1016/j.nimb.2005.10.025
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Nam ND, 2010, CORROS SCI, V52, P3377, DOI 10.1016/j.corsci.2010.06.010
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Steinemann S., 1980, EVALUATION BIOMATERI
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
NR 15
TC 9
Z9 9
U1 0
U2 27
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD DEC 5
PY 2014
VL 615
SU 1
BP S666
EP S669
DI 10.1016/j.jallcom.2014.01.173
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA AR5GR
UT WOS:000343613600138
DA 2018-10-20
ER

PT J
AU Amdursky, N
   Simkovitch, R
   Huppert, D
AF Amdursky, Nadav
   Simkovitch, Ron
   Huppert, Dan
TI Excited-State Proton Transfer of Photoacids Adsorbed on Biomaterials
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID MESOSCOPIC HETEROGENEOUS MATRIX; MICROCRYSTALLINE CELLULOSE; AMYLOID
   FIBRILS; THIOFLAVIN-T; GEMINATE RECOMBINATION; REVERSE MICELLES; VAPOR
   SORPTION; WATER; DIFFUSION; CALORIMETRY
AB The interaction between a photoacid (8-hydroxy-1,3,6-pyrenetrisulfonate, HPTS) and the surfaces of biomaterials and the diffusion of protons along the biomaterial surfaces were examined by following the excited-state proton transfer (ESPT) from the photoacid, adsorbed on the surfaces, to water molecules next to it. We chose two different types of biomaterial surfaces, hydrophobic insulin amyloid fibrils and hydrophilic cellulose surfaces. With the help of steady-state and time-resolved fluorescence techniques, we found that the rate of ESPT from HPTS on insulin fibrils to adjacent water molecules is about (1)/(10) that in bulk water. However, the proton geminate recombination takes place with an efficiency similar to that in bulk water. ESPT from HPTS in wet cellulose to water depends on the weight percentage of water adsorbed by the cellulose. In a semidry sample (<100% weight percentage of water), the ESPT rate is rather low and thus the quantum efficiency of the ESPT is also low within the excited-state lifetime. When the water content is higher, the ESPT rate is almost that of bulk water. We explain these results by the existence of pools of water in cellulose of high water content, in which the triple-negatively charged HPTS molecules desorb from the cellulose surface to these pools. The use of HPTS has allowed us to examine the biological surface and its interaction with water molecules, while obtaining important information regarding the hydration state of the surface that otherwise could not have been obtained. The model that we propose here for the use of photoacids to follow the hydrated state of a given surface is a promising new method of examining the interaction of water molecules with biological surfaces.
C1 [Amdursky, Nadav] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Simkovitch, Ron; Huppert, Dan] Tel Aviv Univ, Sch Chem, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel.
RP Huppert, D (reprint author), Tel Aviv Univ, Sch Chem, Raymond & Beverly Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel.
EM dhuppert@post.tau.ac.il
OI Simkovitch, Ron/0000-0003-4188-225X; Amdursky, Nadav/0000-0003-1543-5333
FU James-Franck German-Israeli Program in Laser-Matter Interaction; Israel
   Science Foundation
FX This work was supported by grants from the James-Franck German-Israeli
   Program in Laser-Matter Interaction and by the Israel Science
   Foundation.
CR AGMON N, 1988, J CHEM PHYS, V88, P5631, DOI 10.1063/1.454573
   Agmon N, 2005, J PHYS CHEM A, V109, P13, DOI 10.1021/jp047465m
   Agrawal AM, 2004, J PHARM SCI-US, V93, P1766, DOI 10.1002/jps.20085
   Amdursky N, 2009, J PHYS CHEM C, V113, P19500, DOI 10.1021/jp9063388
   Amdursky N, 2012, ACCOUNTS CHEM RES, V45, P1548, DOI 10.1021/ar300053p
   Bell R.P., 1959, PROTON CHEM, V1958
   Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001
   Chattoraj M, 1996, P NATL ACAD SCI USA, V93, P8362, DOI 10.1073/pnas.93.16.8362
   Cohen B, 2002, J AM CHEM SOC, V124, P7539, DOI 10.1021/ja012646c
   COLLINS FC, 1949, J COLL SCI IMP U TOK, V4, P425, DOI 10.1016/0095-8522(49)90023-9
   Crawford RL, 1981, LIGNIN BIODEGRADATIO
   Debye P., 1942, Transactions of the Electrochemical Society, V82, P265, DOI 10.1149/1.3071413
   FIELDEN KE, 1988, J PHARM PHARMACOL, V40, P674, DOI 10.1111/j.2042-7158.1988.tb06993.x
   Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991
   GUTMAN M, 1992, BIOPHYS J, V63, P274, DOI 10.1016/S0006-3495(92)81584-9
   GUTMAN M, 1992, BIOPHYS J, V63, P281, DOI 10.1016/S0006-3495(92)81585-0
   HOLLENBECK RG, 1978, J PHARM SCI, V67, P1599, DOI 10.1002/jps.2600671125
   Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200
   HUPPERT D, 1982, J AM CHEM SOC, V104, P6949, DOI 10.1021/ja00389a011
   Hutter T, 2010, J PHYS CHEM C, V114, P2341, DOI 10.1021/jp910099j
   Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399
   KHAN F, 1987, POWDER TECHNOL, V50, P237, DOI 10.1016/0032-5910(87)80069-4
   KHAN F, 1986, POWDER TECHNOL, V48, P145, DOI 10.1016/0032-5910(86)80073-0
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Knight C., 2011, ACCOUNTS CHEM RES, V45, P101
   Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002
   Krissinel EB, 1996, J COMPUT CHEM, V17, P1085
   LeVine H, 1999, METHOD ENZYMOL, V309, P274
   Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x
   NAKAI Y, 1977, CHEM PHARM BULL, V25, P96
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   PINES E, 1988, J CHEM PHYS, V88, P5620, DOI 10.1063/1.454572
   Presiado I, 2012, J PHYS CHEM A, V116, P7353, DOI 10.1021/jp304123y
   SADEGHNEJAD G, 1985, Journal of Pharmacy and Pharmacology, V37, p110P
   Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154
   Simkovitch R, 2015, J PHYS CHEM B, V119, P2253, DOI 10.1021/jp506011e
   Solntsev KM, 2001, J PHYS CHEM A, V105, P5868, DOI 10.1021/jp004569y
   Soroka HP, 2013, J PHYS CHEM C, V117, P25786, DOI 10.1021/jp4087514
   Spry DB, 2007, J AM CHEM SOC, V129, P8122, DOI 10.1021/ja071939o
   Tielrooij KJ, 2009, CHEMPHYSCHEM, V10, P245, DOI 10.1002/cphc.200800541
   Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173
   Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539
   UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6
   ZOGRAFI G, 1984, INT J PHARM, V18, P99, DOI 10.1016/0378-5173(84)90111-X
NR 44
TC 15
Z9 15
U1 1
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD DEC 4
PY 2014
VL 118
IS 48
BP 13859
EP 13869
DI 10.1021/jp509153r
PG 11
WC Chemistry, Physical
SC Chemistry
GA AU9DJ
UT WOS:000345891500009
PM 25380297
DA 2018-10-20
ER

PT J
AU Hohne, S
   Breier, A
   Jager, M
   Hanke, T
   Worch, H
   Simon, F
AF Hoehne, Susanne
   Breier, Annette
   Jaeger, Maria
   Hanke, Thomas
   Worch, Hartmut
   Simon, Frank
TI Heterogeneous Cross-Linking and Sulphation of Chitosan
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 12th International Polymers for Advanced Technologies conference (PAT)
CY SEP 29-OCT 02, 2013
CL Berlin, GERMANY
DE biocompatibility; Chitosan; cross-linking; heterogeneous sulphation;
   textile scaffolds
ID BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; BIOMATERIALS; DERIVATIVES;
   BMP-2; REGENERATION
AB Chitosan textile scaffolds are novel promising biomaterials for application in tissue engineering. The introduction of sulphate groups in the chitosan molecule leads to a biomaterial that combines two important features. At first it's an excellent material in order to build scaffolds for tissue engineering, and at second it is able to mimic the beneficial interaction of natural occurring sulphated polysaccharides with growth factors. Known sulphating methods, developed for the sulphation of chitosan in solutions (homogeneous phase reactions), were adapted to apply them on solid chitosan surfaces (heterogeneous phase reactions). Surface reactions preventing the chitosan's dissolution were fundamentally necessary to keep the predetermined geometric structure of the scaffolds during derivatization reactions. Model studies were carried out on chitosan particles as well as chitosan textiles. Points of interests were the control of the regioselectivity of the sulphation reactions and the adjustment of the degree of sulphation. It was shown that a partial cross-linking of chitosan is a key tool to keep the geometric structure of the chitosan particles and fibres during the subsequent sulphation reaction. The modified samples were comprehensively characterized by means of X-ray photoelectron spectroscopy and elemental analysis.
C1 [Hoehne, Susanne; Breier, Annette; Simon, Frank] Leibniz Inst Polymerforsch Dresden eV, Dresden, Germany.
   [Jaeger, Maria; Hanke, Thomas; Worch, Hartmut] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany.
RP Hohne, S (reprint author), Leibniz Inst Polymerforsch Dresden eV, Dresden, Germany.
EM hoehne@ipfdd.de
RI Umlauf, Ursula/D-3356-2014
CR Batura L. I., 1981, CELL CHEM TECHNOL, V15, P487
   Baumann H, 2001, CARBOHYD RES, V331, P43, DOI 10.1016/S0008-6215(01)00009-X
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   Gamzazade A, 1997, CARBOHYD POLYM, V34, P113, DOI 10.1016/S0144-8617(97)00067-2
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2014, BIOMACROMOLECULES, V15, P3083, DOI 10.1021/bm5006855
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   Levengood SKL, 2014, J MATER CHEM B, V2, P3161, DOI 10.1039/c4tb00027g
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Peschel D, 2012, ACTA BIOMATER, V8, P183, DOI 10.1016/j.actbio.2011.08.012
   Shelke NB, 2014, POLYM ADVAN TECHNOL, V25, P448, DOI 10.1002/pat.3266
   Xing RE, 2004, CARBOHYD RES, V339, P2515, DOI 10.1016/j.carres.2004.08.013
   Zhang K, 2011, CARBOHYD POLYM, V83, P60, DOI 10.1016/j.carbpol.2010.07.021
   Zhang K, 2010, POLYMER, V51, P4698, DOI 10.1016/j.polymer.2010.08.034
   Zhao X., 2003, J OCEAN U QINGDAO, V2, P69
   Zhou HJ, 2009, BIOMATERIALS, V30, P1715, DOI 10.1016/j.biomaterials.2008.12.016
NR 18
TC 1
Z9 1
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD DEC
PY 2014
VL 346
IS 1
SI SI
BP 66
EP 72
DI 10.1002/masy.201400067
PG 7
WC Polymer Science
SC Polymer Science
GA AX2KI
UT WOS:000346772000009
DA 2018-10-20
ER

PT J
AU Rijckaert, B
   Neffe, AT
   Roch, T
   Gebauer, T
   Pierce, BF
   Gors, J
   Smink, JJ
   Gossen, M
   Lendlein, A
   Leutz, A
AF Rijckaert, Bart
   Neffe, Axel T.
   Roch, Toralf
   Gebauer, Tim
   Pierce, Benjamin F.
   Goers, Julia
   Smink, Jeske J.
   Gossen, Manfred
   Lendlein, Andreas
   Leutz, Achim
TI A High Content Screening Assay for Evaluation of Biomaterial-Mediated
   Cell Fusion Processes
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 12th International Polymers for Advanced Technologies conference (PAT)
CY SEP 29-OCT 02, 2013
CL Berlin, GERMANY
DE biocompatibility; biomaterial degradation; high content screening;
   osteoclasts
ID FACTOR C/EBP-BETA; OSTEOCLAST DIFFERENTIATION; DC-STAMP; GELATIN; BONE;
   ENDOTOXIN; RAPAMYCIN; COLLAGEN; TUMOR; LINES
AB Biomaterials are of increasing importance in regenerative medicine and entail delivery systems in somatic cell therapies, matrices for tissue engineering or tissue regeneration. The evaluation of biomaterial induced biological effects remains a key issue in clinical application. Cell-based assays for potential cytotoxic and immunological responses have been developed but are often inadequate to address cell-type specific responses to biomaterials. To quantitatively monitor attachment, survival, proliferation and fusion-controlled differentiation of osteoclasts (bone resorbing cells), a High Content Screening (HCS) assay has been developed based on osteoclast differentiation of the murine monocytic cell line RAW 264.7. This assay was applied to investigate the influence of degradation products of polymers from gelatin and lysine diisocyanate, which display tailorable mechanical properties and have potential as biomaterials. The data show that the degradation products inhibit formation of multinuclear osteoclasts and suggest a potential support of bone regeneration by suppression of bone resorption.
C1 [Rijckaert, Bart; Neffe, Axel T.; Roch, Toralf; Gebauer, Tim; Pierce, Benjamin F.; Goers, Julia; Gossen, Manfred; Lendlein, Andreas; Leutz, Achim] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Rijckaert, Bart; Pierce, Benjamin F.; Goers, Julia; Smink, Jeske J.; Gossen, Manfred; Lendlein, Andreas; Leutz, Achim] Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany.
   [Smink, Jeske J.; Leutz, Achim] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.
   [Rijckaert, Bart; Goers, Julia; Lendlein, Andreas] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.
   [Neffe, Axel T.; Gebauer, Tim; Lendlein, Andreas] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
   [Leutz, Achim] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Neffe, Axel/H-6997-2013; Leutz, Achim/K-9643-2013; Lendlein,
   Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Leutz, Achim/0000-0001-8259-927X;
   Lendlein, Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
CR Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Courtial N, 2012, FASEB J, V26, P523, DOI 10.1096/fj.11-190850
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Huppertz B, 2001, INT REV CYTOL, V205, P215, DOI 10.1016/S0074-7696(01)05005-7
   Huppertz B, 1998, HISTOCHEM CELL BIOL, V110, P495, DOI 10.1007/s004180050311
   Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437
   Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Neffe Axel T, 2007, Med Device Technol, V18, P14
   Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P484, DOI 10.1002/mabi.201100232
   Pierce BF, 2012, MACROMOL BIOSCI, V12, P312, DOI 10.1002/mabi.201100237
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223
   RALPH P, 1977, J IMMUNOL, V119, P950
   RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0
   Roch T., 2013, MATER RES SOC S P, V1569, P21
   Roch T, 2014, CLIN HEMORHEOL MICRO, V57, P203, DOI 10.3233/CH-141831
   Roch T, 2011, MACROMOL SYMP, V309-310, P182, DOI 10.1002/masy.201100048
   Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252
   Smink JJ, 2012, J MOL MED, V90, P25, DOI 10.1007/s00109-011-0823-6
   Smink JJ, 2010, J MOL MED-JMM, V88, P227, DOI 10.1007/s00109-009-0567-8
   Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127
   Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
   Zioupos P, 1999, J BIOMED MATER RES, V45, P108, DOI 10.1002/(SICI)1097-4636(199905)45:2<108::AID-JBM5>3.0.CO;2-A
NR 33
TC 0
Z9 0
U1 0
U2 7
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD DEC
PY 2014
VL 346
IS 1
SI SI
BP 91
EP 99
DI 10.1002/masy.201400147
PG 9
WC Polymer Science
SC Polymer Science
GA AX2KI
UT WOS:000346772000012
DA 2018-10-20
ER

PT J
AU Yang, JC
   Chen, H
   Yuan, Y
   Sarkar, D
   Zheng, J
AF Yang, Juichen
   Chen, Hong
   Yuan, Yuan
   Sarkar, Debanjan
   Zheng, Jie
TI Synthesis and characterization of biocompatible polyurethanes for
   controlled release of hydrophobic and hydrophilic drugs
SO FRONTIERS OF CHEMICAL SCIENCE AND ENGINEERING
LA English
DT Article
DE polyurethanes; controlled release; drug delivery; phase structure;
   degradation
ID TYROSINE-BASED POLYURETHANES; STRUCTURE-PROPERTY RELATIONSHIPS;
   BIODEGRADABLE POLYURETHANE; BIOMATERIAL APPLICATIONS; SEGMENTED
   POLYURETHANES; MECHANICAL-PROPERTIES; DELIVERY SYSTEMS; CHAIN EXTENDER;
   SOFT SEGMENTS; ELASTOMERS
AB Design of biocompatible and biodegradable polymer systems for sustained and controlled release of bioactive agents is critical for numerous biomedical applications. Here, we designed, synthesized, and characterized four polyurethane carrier systems for controlled release of model drugs. These polyurethanes are biocompatible and biodegradable because they consist of biocompatible poly(ethylene glycol) or poly(caprolactone diol) as soft segment, linear aliphatic hexamethylene diisocyanate or symmetrical aliphatic cyclic dicyclohexylmethane-4,4'-diisocyanate as hard segment, and biodegradable urethane linkage. They were characterized with Fourier transform infrared spectroscopy, atomic force microscope, and differential scanning calorimetry, whereas their degradation behaviors were investigated in both phosphate buffered saline and enzymatic solutions. By tuning polyurethane segments, different release profiles of hydrophobic and hydrophilic drugs were obtained in the absence and presence of enzymes. Such difference in release profiles was attributed to a complex interplay among structure, hydrophobicity, and degradability of polyurethanes, the size and hydrophobicity of drugs, and drug-polymer interactions. Different drug-polyurethane combinations modulated the distribution and location of the drugs in polymer matrix, thus inducing different drug release mechanisms. Our results highlight an important role of segmental structure of the polyurethane as an engineering tool to control drug release.
C1 [Yang, Juichen; Chen, Hong; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Yuan, Yuan; Sarkar, Debanjan] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
   [Sarkar, Debanjan] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
RP Sarkar, D (reprint author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.
EM debanjan@buffalo.edu; zhengj@uakron.edu
RI Chen, Hong/B-9585-2016; Zheng, Jie/B-5057-2013; Sarkar,
   Debanjan/C-6093-2017
OI Zheng, Jie/0000-0003-1547-3612; Sarkar, Debanjan/0000-0002-6666-3152
FU NSF (CAREER Award) [0952624, NSF-CBET-1158447]; University at Buffalo
   Foundation (UBF)
FX J.Z. thanks financial supports from NSF grants (CAREER Award-0952624 and
   NSF-CBET-1158447). D.S. acknowledges research support from University at
   Buffalo Foundation (UBF). This paper is also devoted to Stephanie T.
   Lopina for her consistent support and mentorship.
CR Caldorera-Moore ME, 2011, ACCOUNTS CHEM RES, V44, P1061, DOI 10.1021/ar2001777
   Christenson EM, 2006, BIOMATERIALS, V27, P3920, DOI 10.1016/j.biomaterials.2006.03.012
   Desai S, 2000, EUR POLYM J, V36, P711, DOI 10.1016/S0014-3057(99)00114-7
   EDLUND U, 2002, DEGRADABLE ALIPHATIC, V157, P67, DOI DOI 10.1007/3-540-45734-8
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Guelcher SA, 2008, BIOMATERIALS, V29, P1762, DOI 10.1016/j.biomaterials.2007.12.046
   Guo QY, 2009, J CONTROL RELEASE, V137, P224, DOI 10.1016/j.jconrel.2009.04.016
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   Hassan MK, 2006, J POLYM SCI POL CHEM, V44, P2990, DOI 10.1002/pola.21373
   HESKETH TR, 1980, POLYM ENG SCI, V20, P190, DOI 10.1002/pen.760200304
   Hong Y, 2012, BIOMACROMOLECULES, V13, P3686, DOI 10.1021/bm301158j
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hood MA, 2010, POLYMER, V51, P2191, DOI 10.1016/j.polymer.2010.03.027
   Huang X, 2005, BIOMACROMOLECULES, V6, P2131, DOI 10.1021/bm050116t
   IKEDA Y, 1990, BIOMATERIALS, V11, P553, DOI 10.1016/0142-9612(90)90077-4
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Kissel T, 2002, ADV DRUG DELIVER REV, V54, P99, DOI 10.1016/S0169-409X(01)00244-7
   Korley LTJ, 2006, MACROMOLECULES, V39, P7030, DOI 10.1021/ma061383+
   LANGER R, 1993, ACCOUNTS CHEM RES, V26, P537, DOI 10.1021/ar00034a004
   Lee DK, 2000, J APPL POLYM SCI, V75, P167, DOI 10.1002/(SICI)1097-4628(20000103)75:1<167::AID-APP19>3.0.CO;2-N
   Martin DJ, 1999, J APPL POLYM SCI, V71, P937
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Mishra A, 2010, J PHYS CHEM B, V114, P5292, DOI 10.1021/jp100599u
   Park D, 2011, BIOMATERIALS, V32, P777, DOI 10.1016/j.biomaterials.2010.09.044
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   PETROVIC ZS, 1991, PROG POLYM SCI, V16, P695, DOI 10.1016/0079-6700(91)90011-9
   Puttipipatkhachorn S, 2001, J CONTROL RELEASE, V75, P143, DOI 10.1016/S0168-3659(01)00389-3
   RATNER BD, 1988, J BIOMED MATER RES, V22, P509, DOI 10.1002/jbm.820220607
   Rueda L, 2008, POLYM ENG SCI, V48, P519
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2007, POLYM DEGRAD STABIL, V92, P1994, DOI 10.1016/j.polymdegradstab.2007.08.003
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Shen E, 2001, BIOMATERIALS, V22, P201, DOI 10.1016/S0142-9612(00)00175-7
   Shen E, 2002, J CONTROL RELEASE, V82, P115, DOI 10.1016/S0168-3659(02)00125-6
   SIEGMANN A, 1987, POLYM ENG SCI, V27, P1187, DOI 10.1002/pen.760271512
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   TAKAHARA A, 1992, J BIOMED MATER RES, V26, P801, DOI 10.1002/jbm.820260609
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   van Minnen B, 2006, J BIOMED MATER RES A, V76A, P377, DOI 10.1002/jbm.a.30531
   Waletzko RS, 2009, MACROMOLECULES, V42, P2041, DOI 10.1021/ma8022052
   Wang ZG, 2011, POLYM CHEM-UK, V2, P601, DOI 10.1039/c0py00235f
   Yamaoka T, 2000, J CONTROL RELEASE, V66, P187, DOI 10.1016/S0168-3659(99)00270-9
   Yang JC, 2012, POLYM INT, V61, P616, DOI 10.1002/pi.3220
   YUI N, 1986, MAKROMOL CHEM-RAPID, V7, P747
   YUI N, 1987, Journal of Controlled Release, V6, P329, DOI 10.1016/0168-3659(87)90086-1
   Zhou LJ, 2011, MACROMOLECULES, V44, P857, DOI 10.1021/ma102346a
NR 49
TC 5
Z9 5
U1 1
U2 19
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-0179
EI 2095-0187
J9 FRONT CHEM SCI ENG
JI Front. Chem. Sci. Eng.
PD DEC
PY 2014
VL 8
IS 4
BP 498
EP 510
DI 10.1007/s11705-014-1451-9
PG 13
WC Engineering, Chemical
SC Engineering
GA CI6WJ
UT WOS:000354904200011
DA 2018-10-20
ER

PT J
AU Liu, X
   Bai, SM
   Zhao, HJ
AF Liu, Xi
   Bai, Shumeng
   Zhao, Huijing
TI Silk Fibroin-Based Scaffold for Neural Tissue Engineering
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Review
DE Silk Fibroin; Neural Tissue Engineering; Scaffold; Central Nervous
   System; Peripheral Nervous System
ID PERIPHERAL-NERVE REGENERATION; TRAUMATIC BRAIN-INJURY; MESENCHYMAL
   STEM-CELLS; GUIDE CONDUIT MATERIAL; OSTEOBLAST IN-VITRO; SCHWANN-CELLS;
   GROWTH-FACTOR; NANOFIBROUS SCAFFOLDS; POLY(D,L-LACTIC ACID);
   CONTROLLED-RELEASE
AB Nerve regeneration is a complex biological phenomenon. Peripheral nerves can regenerate on their own or after surgical treatment, while central nervous system (CNS) regeneration is more complicated due to the growth-inhibitory environment. As one of the strategies for resolving this problem, tissue engineering has attracted extensive attention and showed increasing positive outcomes. Bioengineering strategies for the peripheral nervous system (PNS) are focused on alternatives to the nerve graft, whereas efforts for CNS are focused on creating a permissive environment for regeneration. Biomaterial scaffold, mimicking the natural extracellular matrix (ECM), has become the primary choice in such regeneration field. Silk fibroin (SF) is a promising scaffold material in neural tissue engineering due to its unique physic-chemical and biological properties. This review extensively covers the progress in SF-based neural tissue engineering and regeneration.
C1 [Liu, Xi; Bai, Shumeng; Zhao, Huijing] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Liu, X (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
FU National Nature Foundation of China [51303119, 51103092]; Natural
   Science Foundation of Jiangsu Province [BK20130309, BK2012634]; Natural
   Science Foundation of the Jiangsu Higher Education Institutions
   [13KJB430019]; National Science Foundation for Post-doctoral Scientists
   of China [2013M541724, 2014T70545]
FX This work was supported by National Nature Foundation of China
   (51303119, 51103092), Natural Science Foundation of Jiangsu Province
   (BK20130309, BK2012634), Natural Science Foundation of the Jiangsu
   Higher Education Institutions (13KJB430019), and National Science
   Foundation for Post-doctoral Scientists of China (2013M541724,
   2014T70545).
CR ABERNETHY DA, 1994, J ANAT, V184, P239
   ADAMS IW, 1977, LANCET, V2, P1216
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ayan Irfan, 2007, Hand (N Y), V2, P199, DOI 10.1007/s11552-007-9049-z
   Beris A, 2007, J NEUROTRAUM, V24, P909, DOI 10.1089/neu.2006.0165
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen XM, 2007, PROG NAT SCI, V17, P1029
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Cirillo B, 2004, INT J ARTIF ORGANS, V27, P60
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   DUCKER TB, 1970, J NEUROSURG, V32, P236, DOI 10.3171/jns.1970.32.2.0236
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581
   Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1
   Ghaznavi AM, 2011, ANN PLAS SURG, V66, P273, DOI 10.1097/SAP.0b013e3181e6cff7
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gu Y, 2014, BIOMATERIALS, V35, P2253, DOI 10.1016/j.biomaterials.2013.11.087
   Gui-Bo Y, 2010, J BIOMED MATER RES A, V93A, P158, DOI 10.1002/jbm.a.32496
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4
   Hu AJ, 2013, OTOL NEUROTOL, V34, P311, DOI 10.1097/MAO.0b013e31827b4bd4
   Ishikawa N, 2009, J BIOMED MATER RES A, V89A, P1118, DOI 10.1002/jbm.a.32389
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kim DH, 2003, J NEUROSURG, V98, P993, DOI 10.3171/jns.2003.98.5.0993
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li S, 2012, ARTIF CELL BLOOD SUB, V40, P171, DOI 10.3109/10731199.2011.637927
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lu Yan, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P603
   LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Lv QA, 2005, POLYMER, V46, P12662, DOI 10.1016/j.polymer.2005.10.137
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mao HQ, 2010, STUD MECHANOBIOL TIS, V2, P89, DOI 10.1007/8415_2010_2
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MIYAMOTO Y, 1979, PLAST RECONSTR SURG, V64, P540, DOI 10.1097/00006534-197910000-00017
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park SY, 2015, J TISSUE ENG REGEN M, V9, P66, DOI 10.1002/term.1615
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Qian Yuqiang, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P1365
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Ren YJ, 2009, INT J BIOL MACROMOL, V44, P372, DOI 10.1016/j.ijbiomac.2009.02.004
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Scott JB, 2011, BIOMATERIALS, V32, P4830, DOI 10.1016/j.biomaterials.2011.03.037
   Shen YX, 2010, CELL TRANSPLANT, V19, P147, DOI 10.3727/096368910X492616
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tan Xue-xin, 2009, Journal of China Medical University, V38, P253
   Tang X, 2012, BIOMATERIALS, V33, P3860, DOI 10.1016/j.biomaterials.2012.02.008
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011
   Wang GL, 2011, IN VITRO CELL DEV-AN, V47, P234, DOI 10.1007/s11626-010-9381-4
   Wang S, 2001, BIOMATERIALS, V22, P1157, DOI 10.1016/S0142-9612(00)00356-2
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang XM, 2012, INTERFACE FOCUS, V2, P278, DOI 10.1098/rsfs.2012.0016
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wei YJ, 2011, J MATER SCI-MATER M, V22, P1947, DOI 10.1007/s10856-011-4370-z
   Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wu Gang, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P1007
   Yan J., WET SPINNING REGENER
   Yan X, 2009, ADV STUDIES BIOL, V1, P119
   Yang Y., BIOMATERIALS, V28, P1643
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2011, TISSUE ENG PT A, V17, P2231, DOI [10.1089/ten.tea.2010.0633, 10.1089/ten.TEA.2010.0633]
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Zhang CC, 2012, BIOMACROMOLECULES, V13, P2148, DOI 10.1021/bm300541g
   Zhang KH, 2013, MACROMOL MATER ENG, V298, P565, DOI 10.1002/mame.201200038
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhu HL, 2009, J BIOMAT SCI-POLYM E, V20, P1259, DOI 10.1163/156856209X452980
NR 100
TC 7
Z9 7
U1 1
U2 43
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2014
VL 4
IS 12
SI SI
BP 1012
EP 1018
DI 10.1166/jbt.2014.1254
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA CD1ZV
UT WOS:000350874100004
DA 2018-10-20
ER

PT J
AU Sun, XD
   Yan, H
   Shan, C
   Ding, SS
   Li, C
   Dong, J
   Cheng, X
   Qian, WP
AF Sun, Xiao-Dan
   Yan, Hao
   Shan, Cheng
   Ding, Si-Sheng
   Li, Cheng
   Dong, Jian
   Cheng, Xi
   Qian, Wei-Ping
TI Biomimetic Double-Layered Scaffolds Composed of Jellyfish Collagen and
   Chitosan for Cartilage Tissue Engineering
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Cartilage Tissue Engineering; Scaffold; Double-Layered Structures;
   Columnar Arrangement; Jellyfish Collagen
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; BIOMATERIALS; MATRIX; ALIGNMENT;
   AFFINITY; DESIGN; BONE
AB In this paper, collagen extracted from jellyfish and rat tail collagen were used with chitosan to prepare scaffolds with biomimetic double-layered structures by a simple method. Properties of the collagen and scaffolds were characterised by viscosity measurement, degradation in simulated body fluid (SBF) and water absorption test respectively. Morphologies and structures of the scaffolds were observed by scanning electron microscope (SEM). Culture of rat chondrocytes on scaffolds was studied by histological examination (hematoxylin and eosin stain, HE). The preliminary results demonstrated that collagen extracted from jellyfish was more cytocompatible than collagen extracted from rat tail, which indicated an alternative way to use jellyfish as a biomaterial source. On the other hand, chondrocytes revealed a unique columnar arrangement in the long channel pores of the scaffolds with biomimetic double-layered structure, which is comparable to the orientation within native cartilage.
C1 [Sun, Xiao-Dan; Yan, Hao; Shan, Cheng; Ding, Si-Sheng] Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ China, Key Lab Adv Mat, Beijing 100084, Peoples R China.
   [Li, Cheng] Geol Univ China, State Key Lab Geol Proc & Mineral Resources, Beijing 100083, Peoples R China.
   [Dong, Jian; Cheng, Xi; Qian, Wei-Ping] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
RP Sun, XD (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ China, Key Lab Adv Mat, Beijing 100084, Peoples R China.
FU NSFC [30911120495]; Beijing Natural Science Foundation [2112017];
   Tsinghua University Initiative Scientific Research Program [20131089199]
FX The authors are grateful for the kind assistance of Professor Qiong WU
   in the Department of Biology, Tsinghua University. We thank the NSFC
   (No. 30911120495), Beijing Natural Science Foundation (No. 2112017) and
   Tsinghua University Initiative Scientific Research Program (No.
   20131089199) for support of funding.
CR Addad S, 2011, MAR DRUGS, V9, P967, DOI 10.3390/md9060967
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Exposito JY, 2010, INT J MOL SCI, V11, P407, DOI 10.3390/ijms11020407
   Fong ELS, 2012, ADV MATER, V24, P4995, DOI 10.1002/adma.201201762
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Hayashi Y, 2012, ADV FOOD NUTR RES, V65, P107, DOI 10.1016/B978-0-12-416003-3.00006-8
   Hoyer B, 2014, ACTA BIOMATER, V10, P883, DOI 10.1016/j.actbio.2013.10.022
   Hu XX, 2008, BIOMATERIALS, V29, P3128, DOI 10.1016/j.biomaterials.2008.04.010
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Jones CW, 2008, J ORTHOP RES, V26, P292, DOI 10.1002/jor.20502
   Keeney M, 2011, CURR OPIN BIOTECH, V22, P734, DOI 10.1016/j.copbio.2011.04.003
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Lee SJ, 2007, J BIOMED MATER RES B, V82B, P506, DOI 10.1002/jbm.b.30756
   Li H, 2004, FOOD CHEM, V84, P65, DOI 10.1016/S0308-8146(03)00167-5
   Lu JX, 1999, BIOMATERIALS, V20, P1937
   MIURA S, 1985, J BIOL CHEM, V260, P5352
   Montanez Eloi, 2002, Angiogenesis, V5, P167, DOI 10.1023/A:1023837821062
   Nagai T, 2000, FOOD CHEM, V70, P205, DOI 10.1016/S0308-8146(00)00081-9
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   Ogawa M, 2004, FOOD CHEM, V88, P495, DOI 10.1016/j.foodchem.2004.02.006
   Park SH, 2012, INT J PRECIS ENG MAN, V13, P2059, DOI 10.1007/s12541-012-0271-4
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Ruan YH, 2011, MACROMOL BIOSCI, V11, P419, DOI 10.1002/mabi.201000392
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Shi DH, 2005, CHINESE MED J-PEKING, V118, P1436
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zehbe R, 2005, BIO-MED MATER ENG, V15, P445
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 35
TC 4
Z9 4
U1 2
U2 28
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD DEC
PY 2014
VL 4
IS 12
SI SI
BP 1080
EP 1086
DI 10.1166/jbt.2014.1259
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA CD1ZV
UT WOS:000350874100012
DA 2018-10-20
ER

PT J
AU Slabaugh, E
   Sethaphong, L
   Xiao, CW
   Amick, J
   Anderson, CT
   Haigler, CH
   Yingling, YG
AF Slabaugh, Erin
   Sethaphong, Latsavongsakda
   Xiao, Chaowen
   Amick, Joshua
   Anderson, Charles T.
   Haigler, Candace H.
   Yingling, Yaroslava G.
TI Computational and genetic evidence that different structural
   conformations of a non-catalytic region affect the function of plant
   cellulose synthase
SO JOURNAL OF EXPERIMENTAL BOTANY
LA English
DT Article
DE Cellulose biosynthesis; CESA; genetic complementation; protein
   structural modelling; rsw1 mutant; transmembrane helix
ID ARABIDOPSIS-THALIANA; CATALYTIC SUBUNIT; PROTEIN SECONDARY;
   MEMBRANE-PROTEINS; COMPLEXES; PREDICTION; WALL; MICROTUBULES;
   CRYSTALLINITY; VISUALIZATION
AB The beta-1,4-glucan chains comprising cellulose are synthesized by cellulose synthases in the plasma membranes of diverse organisms including bacteria and plants. Understanding structure-function relationships in the plant enzymes involved in cellulose synthesis (CESAs) is important because cellulose is the most abundant component in the plant cell wall, a key renewable biomaterial. Here, we explored the structure and function of the region encompassing transmembrane helices (TMHs) 5 and 6 in CESA using computational and genetic tools. Ab initio computational structure prediction revealed novel bi-modal structural conformations of the region between TMH5 and 6 that may affect CESA function. Here we present our computational findings on this region in three CESAs of Arabidopsis thaliana (AtCESA1, 3, and 6), the Atcesa3(ixr1-2) mutant, and a novel missense mutation in AtCESA1. A newly engineered point mutation in AtCESA1 (Atcesa1(F954L)) that altered the structural conformation in silico resulted in a protein that was not fully functional in the temperature-sensitive Atcesa1(rsw1-1) mutant at the restrictive temperature. The combination of computational and genetic results provides evidence that the ability of the TMH5-6 region to adopt specific structural conformations is important for CESA function.
C1 [Slabaugh, Erin; Haigler, Candace H.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.
   [Slabaugh, Erin; Haigler, Candace H.] N Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.
   [Sethaphong, Latsavongsakda; Amick, Joshua; Yingling, Yaroslava G.] N Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC 27695 USA.
   [Xiao, Chaowen; Anderson, Charles T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA.
RP Haigler, CH (reprint author), N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA.
EM candace_haigler@ncsu.edu; yara_yingling@ncsu.edu
RI Yingling, Yaroslava/B-2901-2008
OI Yingling, Yaroslava/0000-0002-8557-9992
FU Center for LignoCellulose Structure and Formation, an Energy Frontier
   Research Center - US Department of Energy, Office of Science, Basic
   Energy Sciences [DE-SC0001090]
FX This research was supported by The Center for LignoCellulose Structure
   and Formation, an Energy Frontier Research Center funded by the US
   Department of Energy, Office of Science, Basic Energy Sciences under
   award # DE-SC0001090. We would like to thank the Somerville Lab
   (University of California Berkeley) for kindly providing us with seeds
   from the Atcesa6<SUP>prc1</SUP> Atcesa1<SUP>rsw1</SUP> YFP-CESA6 line.
   We would also like to thank Jonathan K. Davis for providing helpful
   scientific insight and discussion as well as artistic contributions to
   Figure S4.
CR Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717
   Arkun Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013275
   Berenger F, 2012, J COMPUT CHEM, V33, P471, DOI 10.1002/jcc.21988
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Charnock SJ, 1999, BIOCHEMISTRY-US, V38, P6380, DOI 10.1021/bi990270y
   Chen SL, 2010, P NATL ACAD SCI USA, V107, P17188, DOI 10.1073/pnas.1012348107
   Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x
   Crowell EF, 2009, PLANT CELL, V21, P1141, DOI 10.1105/tpc.108.065334
   Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044
   Desprez T, 2007, P NATL ACAD SCI USA, V104, P15572, DOI 10.1073/pnas.0706569104
   Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079
   Fujita M, 2013, PLANT PHYSIOL, V162, P74, DOI 10.1104/pp.112.211565
   Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886
   Harris DM, 2012, P NATL ACAD SCI USA, V109, P4098, DOI 10.1073/pnas.1200352109
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Lei L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00075
   Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100
   Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803
   Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744
   Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551
   Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637
   Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pysh L, 2012, PHYSIOL PLANTARUM, V144, P369, DOI 10.1111/j.1399-3054.2012.01575.x
   Saxena IM, 2012, BACTERIAL NANOCELLUL, P1
   Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598
   Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577
   Sethaphong L, 2013, P NATL ACAD SCI USA, V110, P7512, DOI 10.1073/pnas.1301027110
   Slabaugh E, 2014, TRENDS PLANT SCI, V19, P99, DOI 10.1016/j.tplants.2013.09.009
   Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442
   Taylor NG, 2008, NEW PHYTOL, V178, P239, DOI 10.1111/j.1469-8137.2008.02385.x
   Valla Svein, 2009, P43
   Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221
   Vinothkumar KR, 2010, Q REV BIOPHYS, V43, P65, DOI 10.1017/S0033583510000041
   Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817
   Zhang BC, 2009, PLANT MOL BIOL, V71, P509, DOI 10.1007/s11103-009-9536-4
NR 36
TC 7
Z9 7
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-0957
EI 1460-2431
J9 J EXP BOT
JI J. Exp. Bot.
PD DEC
PY 2014
VL 65
IS 22
BP 6645
EP 6653
DI 10.1093/jxb/eru383
PG 9
WC Plant Sciences
SC Plant Sciences
GA AZ3WJ
UT WOS:000348154300025
PM 25262226
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Niakan, A
   Ramesh, S
   Hamdi, M
   Jahanshahi, A
   Tan, CY
   Ching, YC
   Tolouei, R
AF Niakan, A.
   Ramesh, S.
   Hamdi, M.
   Jahanshahi, A.
   Tan, C. Y.
   Ching, Y. C.
   Tolouei, R.
TI Thermal treatment and properties of bovine hydroxyapatite
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Bone; Hydroxyapatite; Sinterability; Biomaterial; Properties
ID BONE; COMPOSITES; GLASS
AB Restoration process for damaged human bone may be performed using autograft, xenograft or allograft and alloplasts methods. Different bio-waste materials have been used as scaffolds for bone tissue engineering. Hydroxyapatite is a biomaterial that can be used as a bone graft material as it is similar to human bone and hard tissue. This work aims to characterise hydroxyapatite produced from the bovine bone at various temperatures from 400 to 700 degrees C. The microstructure and properties of a hydroxyapatite made by the sintering of bovine bone were examined by X-ray diffraction, scanning electron microscopy, energy dispersive X-ray spectroscopy and infrared spectroscopy. The analyses indicated that the white sintered bone was hydroxyapatite and did not contain any organic components of the bone. X-ray diffraction patterns affirmed the phase condition and height of crystallinity level of the bovine hydroxyapatite obtained. Furthermore, phase transformation of the resulting hydroxyapatite to other calcium phosphate phases did not occur.
C1 [Niakan, A.; Ramesh, S.; Hamdi, M.; Jahanshahi, A.; Tan, C. Y.; Ching, Y. C.] Univ Malaya, Dept Mech Engn, Fac Engn, Ctr Adv Mfg & Mat Proc AMMP, Kuala Lumpur 50603, Malaysia.
   [Tolouei, R.] Univ Laval, Fac Sci & Engn, Quebec City, PQ G1V 0A6, Canada.
RP Niakan, A (reprint author), Univ Malaya, Dept Mech Engn, Fac Engn, Ctr Adv Mfg & Mat Proc AMMP, Kuala Lumpur 50603, Malaysia.
EM ali.niakan1983@gmail.com
RI Ramesh, S./E-9947-2011; Tan, Chou Yong/J-5357-2012; shukor,
   hamdi/B-9093-2010
OI Ramesh, S./0000-0002-4425-0146; 
FU PPP grant [PG079-2013A]; UMRG grant [RP011D-13AET]
FX The authors would like to acknowledge University of Malaya for providing
   the necessary facilities and resources for this research. This research
   was supported by the PPP grant no. PG079-2013A and UMRG grant no.
   RP011D-13AET.
CR Accorsi-Mendonc T., 2008, J BRAZ ORAL, V22, P5
   BEGLEY CT, 1995, BIOMATERIALS, V16, P1181, DOI 10.1016/0142-9612(95)93584-Z
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   Greish YE, 2005, BIOMATERIALS, V26, P1, DOI 10.1016/j.biomaterials.2004.02.016
   Habal M. B., 1992, BONE GRAFTS BONE S A, V6-8
   He ZM, 2005, BIOMATERIALS, V26, P1613, DOI 10.1016/j.biomaterials.2004.05.027
   Herliansyah M., 2009, J MAT SCI ENG C, V29C, P74
   Lin FH, 1999, BIOMATERIALS, V20, P475, DOI 10.1016/S0142-9612(98)00193-8
   Martin R. B., 2000, ENG HDB
   Naser F., 2000, J PERIODONLOL, V19, P74
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Pelin I. M., 2009, J MAT SCI ENG C, V29C, P88
   Rabiei A., 2007, J MAT SCI ENG C, VC27, P29
   Strietzel FP, 2007, CLIN ORAL IMPLAN RES, V18, P743, DOI 10.1111/j.1600-0501.2007.01416.x
   Suchanek W., 1998, J BIOMATER, V17, P1715
   Tancred DC, 1998, BIOMATERIALS, V19, P1735, DOI 10.1016/S0142-9612(98)00082-9
   VALLETREGI M, 2004, J PROG SOLID STATE C, V32, P1
   YANG Z, 2005, MATER LETT, V58, P3586
NR 18
TC 1
Z9 1
U1 3
U2 9
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD DEC
PY 2014
VL 18
SU S6
BP 117
EP 120
DI 10.1179/1432891714Z.000000000941
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA CA7QP
UT WOS:000349112500025
DA 2018-10-20
ER

PT J
AU Mohammadian, R
   Salehipour, M
   Mohammadian, R
   Malekahmadi, A
   Natami, M
   Yadollahi, M
AF Mohammadian, R.
   Salehipour, M.
   Mohammadian, R.
   Malekahmadi, A.
   Natami, M.
   Yadollahi, M.
TI IS RENAL CAPSULE A FAVORABLE BIOMATERIAL FOR AUGMENTATION CYSTOPLASTY IN
   CANINE MODEL?
SO INTERNATIONAL JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
RI salehipour, mehdi/U-5423-2017
OI salehipour, mehdi/0000-0003-3882-0234
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0919-8172
EI 1442-2042
J9 INT J UROL
JI Int. J. Urol.
PD DEC
PY 2014
VL 21
SU 2
SI SI
BP A258
EP A258
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA AX4QG
UT WOS:000346916000403
DA 2018-10-20
ER

PT J
AU Rudolf, R
   Tomic, S
   Anzel, I
   Hartner, TZ
   Colic, M
AF Rudolf, Rebeka
   Tomic, Sergej
   Anzel, Ivan
   Hartner, Tjasa Zupancic
   Colic, Miodrag
TI Microstructure and biocompatibility of gold-lanthanum strips
SO GOLD BULLETIN
LA English
DT Article
DE Microalloying; Gold-Lanthanum; Rapid solidification; Biocompatibility;
   Immunomodulation
ID SHAPE-MEMORY ALLOY; NITRIC-OXIDE; IN-VITRO; DENDRITIC CELLS;
   DIFFERENTIATION; INTERLEUKIN-8; CYTOTOXICITY; MACROPHAGES; CORROSION;
   IMMUNITY
AB Microalloying of pure gold, which has the highest biocompatibility but relatively low yield strength and poor wear resistance, might improve its applicability as adornments and biomedical implants. The objective of this study was to analyse the microstructure and biocompatibility of gold-lanthanum (Au-0.5 wt% La) microstrips as a potential biomaterial in dentistry or medicine. We found that microalloying of Au with La produced very fine nanosized grains homogeneously dispersed through the entire volume of the rapidly solidified (RS) alloys. This initiates the formation of Au6La phase which increases strength and hardness of the alloy significantly. By RS, large reduction of grains and microsegregation increases the strength of the alloy additionally. Our results suggest that Au-La microstrips, although non-cytotoxic for L929 cells, rat thymocytes, rat peritoneal macrophages (PMO) and human peripheral blood mononuclear cells (PBMNCs), can activate immune cells. Namely, RS Au-La microstrips stimulated the production of nitric oxide (NO) by PMO. Using a model of phytohemaglutinine (PHA)-stimulated human PBMNCs, we found that RS Au-La strips increased the proliferation of these cells and stimulated the production of Th1, Th17 cytokines, and immunoregulatory cytokine IL-10. Our results suggest that RS Au-La microstrips are biocompatible, but they can modulate the immune response. Therefore, their use as potential implants should be considered carefully.
C1 [Rudolf, Rebeka; Anzel, Ivan] Univ Maribor, Fac Mech Engn, Maribor 2000, Slovenia.
   [Rudolf, Rebeka] Zlatarna Celje Dd, Celje, Slovenia.
   [Tomic, Sergej; Colic, Miodrag] Univ Def, Mil Med Acad, Fac Med, Belgrade 11000, Serbia.
   [Hartner, Tjasa Zupancic] Ortotip Doo, Murska Sobota, Slovenia.
   [Colic, Miodrag] Univ Nis, Fac Med, Nish 18000, Serbia.
RP Rudolf, R (reprint author), Univ Maribor, Fac Mech Engn, Maribor 2000, Slovenia.
EM rebeka.rudolf@um.si
OI Tomic, Sergej/0000-0003-2570-1295
FU EUREKA Project [E!3971 BIO-SMA]; Ministry of Science and Technological
   Development of Serbia [175102]
FX This study was supported by the EUREKA Project E!3971 BIO-SMA and the
   Project of the Ministry of Science and Technological Development of
   Serbia (Project no. 175102). The authors thank the firm Zlatarna Celje
   d.d. and collaborators from the Military Medical Academy, Belgrade (T.
   Dzopalic, A. Dragicevic, J. Dokic, I. Rajkovic, S. Vasilijic) and
   Faculty of Mechanical Engineering, Maribor (I. Orozim) for their helpful
   assistance during the experiments.
CR BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135
   Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8
   Colic M, 2009, GOLD BULL, V42, P34, DOI 10.1007/BF03214904
   Colic M, 2010, J BIOMATER APPL, V25, P269, DOI 10.1177/0885328209354613
   Colic M, 2010, ACTA BIOMATER, V6, P308, DOI 10.1016/j.actbio.2009.06.027
   Corti CW, 2002, GOLD BULL, V35, P111, DOI 10.1007/BF03214852
   Corti CW, 1999, GOLD BULL, V32, P39, DOI 10.1007/BF03214789
   Corti CW, 2005, P 2 INT C JEW PROD T
   Corti CW, 2001, GOLD TECHNOL, V33, P27
   Dokic J, 2012, J BIOMED NANOTECHNOL, V8, P528, DOI 10.1166/jbn.2012.1405
   FISHER DJ, 1980, ACTA METALL MATER, V28, P777, DOI 10.1016/0001-6160(80)90155-8
   Gabrysova L, 2009, J EXP MED, V206, P1755, DOI [10.1084/jem20082118, 10.1084/jem.20082118]
   Geurtsen W, 2002, CRIT REV ORAL BIOL M, V13, P71, DOI 10.1177/154411130201300108
   Guo Fei, 2013, Zhonghua Shao Shang Za Zhi, V29, P531
   Guo F, 2011, BIOL TRACE ELEM RES, V142, P693, DOI 10.1007/s12011-010-8792-0
   Harada A, 1996, MOL MED TODAY, V2, P482
   He ML, 2006, ASIAN AUSTRAL J ANIM, V19, P119
   Honeycombe RWK., 1975, PLASTIC DEFORMATION
   International Standards Organisation, 1997, 7404 ISO
   Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7
   Kaiko GE, 2008, IMMUNOLOGY, V123, P326, DOI 10.1111/j.1365-2567.2007.02719.x
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   KURZ W, 1981, ACTA METALL MATER, V29, P11, DOI 10.1016/0001-6160(81)90082-1
   LORSBACH RB, 1993, J BIOL CHEM, V268, P1908
   Lou Yuan-lei, 2007, Zhonghua Shao Shang Za Zhi, V23, P280
   Lukic A, 2006, ORAL MICROBIOL IMMUN, V21, P296, DOI 10.1111/j.1399-302X.2006.00293.x
   Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357
   McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Ning YT, 2005, GOLD BULL, V38, P3, DOI 10.1007/BF03215221
   Okamoto H, 2010, PHASE DIAGRAMS BINAR
   PALMER RJ, 1987, ENVIRON RES, V43, P142, DOI 10.1016/S0013-9351(87)80066-X
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Qi WH, 2013, CELL IMMUNOL, V285, P18, DOI 10.1016/j.cellimm.2013.06.001
   Rinner I, 1996, INT ARCH ALLERGY IMM, V111, P230, DOI 10.1159/000237372
   Rudolf R, 2010, J BIOMATER APPL
   Spaic S, 1996, FIZIKALNA METALURGIJ
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Tomic S, 2012, EUR CELLS MATER, V23, P58, DOI 10.22203/eCM.v023a05
   Wang X, 2009, PROG NAT SCI, V19, P331, DOI 10.1016/j.pnsc.2008.04.018
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xiao B, 1997, Zhonghua Yu Fang Yi Xue Za Zhi, V31, P228
   Xue LH, 2000, J BEIJING MED U, V3
   Zhou SJ, 2006, J RARE EARTH, V24, P385
   Zupancic-Hartner T, 2009, PRAKT MET SONDERBAND, V41, P277
NR 45
TC 0
Z9 0
U1 0
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0017-1557
J9 GOLD BULL
JI Gold Bull.
PD DEC
PY 2014
VL 47
IS 4
BP 263
EP 273
DI 10.1007/s13404-014-0150-0
PG 11
WC Chemistry, Inorganic & Nuclear; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AZ9HJ
UT WOS:000348524300006
OA Other Gold
DA 2018-10-20
ER

PT J
AU Carreon, H
   Barriuso, S
   Porro, JA
   Gonzalez-Carrasco, JL
   Ocana, JL
AF Carreon, Hector
   Barriuso, Sandra
   Antonio Porro, Juan
   Luis Gonzalez-Carrasco, Jose
   Ocana, Jose Luis
TI Characterization of laser peening-induced effects on a biomedical
   Ti6Al4V alloy by thermoelectric means
SO OPTICAL ENGINEERING
LA English
DT Article
DE laser shock peening; thermoelectric measurements; Ti-6Al-4V; biomaterial
ID MECHANICAL SURFACE TREATMENTS; POWER MEASUREMENTS; RESIDUAL-STRESS;
   STAINLESS-STEEL; TI-6AL-4V; FATIGUE; MICROSTRUCTURES; DEFORMATION;
   BEHAVIOR; COLD
AB Laser peening has recently emerged as a useful technique to overcome detrimental effects associated with other well-known surface modification processes such as shot peening or grit blasting used in the biomedical field. It is worthwhile to notice that besides the primary residual stress effect, thermally induced effects might also cause subtle surface and subsurface microstructural changes that might influence corrosion resistance and fatigue strength of structural components. In this work, plates of Ti-6Al-4V alloy of 7 mm in thick-ness were modified by laser peening without using a sacrificial outer layer. Irradiation by a Q-switched Nd-YAG laser (9.4-ns pulse length) working at the fundamental 1064-nm wavelength at 2.8 J/pulse and with water as a confining medium was used. Laser pulses with a 1.5-mm diameter at an equivalent overlapping density of 5000 cm(-2) were applied. Attempts to analyze the global-induced effects after laser peening were addressed by using the contacting and noncontacting thermoelectric power techniques. (C) 2014 Society of Photo-Optical Instrumentation Engineers (SPIE)
C1 [Carreon, Hector] UMSNH IIM, Inst Invest Met, Morelia 58000888, Michoacan, Mexico.
   [Barriuso, Sandra; Luis Gonzalez-Carrasco, Jose] CENIM CSIC, Ctr Nacl Invest Met, Madrid 28040, Spain.
   [Antonio Porro, Juan] Univ Politecn Madrid, Madrid 28040, Spain.
   [Luis Gonzalez-Carrasco, Jose] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid 28029, Spain.
RP Carreon, H (reprint author), UMSNH IIM, Inst Invest Met, Edif U CU, Morelia 58000888, Michoacan, Mexico.
EM hcarreon@umich.mx
RI OCANA, JOSE LUIS/I-7475-2012
OI OCANA, JOSE LUIS/0000-0001-9263-8404; CARREON,
   HECTOR/0000-0002-4803-0650
FU CONACYT (Mexico) [CB-80883]; MINECO (Spain) [MAT2009-14695-C04, MAT
   2012-37736-C05-01, MAT 2012-37782]; CSIC
FX The authors acknowledge financial support from CONACYT (Mexico) under
   project CB-80883, MINECO (Spain), under projects MAT2009-14695-C04, MAT
   2012-37736-C05-01 and MAT 2012-37782 and CSIC for the scholarship
   JAE-I3P of S.B.
CR Altenberger I, 1999, MAT SCI ENG A-STRUCT, V264, P1, DOI 10.1016/S0921-5093(98)01121-6
   Altenberger I, 2012, INT J FATIGUE, V44, P292, DOI 10.1016/j.ijfatigue.2012.03.008
   Caballero FG, 2004, SCRIPTA MATER, V50, P1061, DOI 10.1016/j.scriptamat.2003.12.017
   Carreon H, 2007, NONDESTRUCT TEST EVA, V22, P299, DOI 10.1080/10589750701546960
   Carreon H, 2006, NDT&E INT, V39, P22, DOI 10.1016/j.ndteint.2005.05.002
   Carreon H, 2013, MAT SCI ENG C-MATER, V33, P1417, DOI 10.1016/j.msec.2012.12.045
   Carreon H, 2002, RES NONDESTRUCT EVAL, V14, P59, DOI 10.1007/s00164-002-0001-x
   Carreon H., 2000, 7 ASME NDE TOP C, V20, P209
   Carreon H., 2012, SURF COAT TECH, V206, P2942
   Carreon H, 2007, J ALLOY COMPD, V427, P183, DOI 10.1016/j.jallcom.2006.03.004
   Dahotre N B, 2008, LASER FABRICATION MA, P477
   Drechsler A, 1998, MAT SCI ENG A-STRUCT, V243, P217, DOI 10.1016/S0921-5093(97)00804-6
   Ferrer JP, 2007, ACTA MATER, V55, P2075, DOI 10.1016/j.actamat.2006.11.010
   Hanagarth H., 1993, SHOT PEENING, P337
   Kleber X, 2008, NDT&E INT, V41, P364, DOI 10.1016/j.ndteint.2008.01.003
   Lakshminayaran B., 2003, REV PROG QUANT NDE, V22, P1523
   Martinez SA, 2003, REV PROG Q, V20, P1531
   MORGNER W, 1994, NDT&E INT, V27, P263, DOI 10.1016/0963-8695(94)90131-7
   Ocana JL, 2007, P SOC PHOTO-OPT INS, V6346, pP3461, DOI 10.1117/12.738836
   Peyre P, 1997, P SOC PHOTO-OPT INS, V3097, P558
   Yu F, 2010, NDT&E INT, V43, P182, DOI 10.1016/j.ndteint.2009.11.001
   Zinn W, 1999, J MATER ENG PERFORM, V8, P145, DOI 10.1361/105994999770346972
NR 22
TC 2
Z9 2
U1 1
U2 32
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 0091-3286
EI 1560-2303
J9 OPT ENG
JI Opt. Eng.
PD DEC
PY 2014
VL 53
IS 12
AR 122502
DI 10.1117/1.OE.53.12.122502
PG 7
WC Optics
SC Optics
GA AY7EX
UT WOS:000347725200017
OA Green Published
DA 2018-10-20
ER

PT J
AU Amigo, A
   Zambrano, J
   Martinez, S
   Amigo, V
AF Amigo, A.
   Zambrano, J.
   Martinez, S.
   Amigo, V.
TI Microstructural characterisation of Ti-Nb-(Fe-Cr) alloys obtained by
   powder metallurgy
SO POWDER METALLURGY
LA English
DT Article
ID TI-NB ALLOYS; TITANIUM-ALLOYS; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; ELASTIC-MODULUS; FABRICATION; DESIGN
AB beta alloys based on the Ti-Nb alloy system are of growing interest to the biomaterial community. The addition of small amounts of Fe and Cr further increases beta-phase stability, improving the properties of Ti-Nb alloy. However, PM materials sintered from elemental powders are inhomogeneous due to restricted solid state diffusion and mechanical alloying provides a route to enhance mixing and elemental diffusion. The microstructural characteristics and bend strength of Ti-Nb-(Fe-Cr) alloys obtained from elemental powder mixture and mechanical alloyed powders are compared. Mechanical alloying gives more homogeneous compositions and particle morphology, characterised by rounded, significantly enlarged particles. In the sintered samples a and b phase are observed. The a phase appears at the grain boundaries and in lamellae growing inward from the edge, and is depleted in Nb. The beta phase is enriched with Nb, Fe and Cr. The addition of Fe and Cr significantly increases the mechanical properties of Ti-Nb alloys, providing increased ductility.
C1 [Amigo, A.; Zambrano, J.; Martinez, S.; Amigo, V.] Univ Polytech Valencia, Inst Mat Technol ITM UPV, Valencia, Spain.
   [Zambrano, J.] Univ Carabobo, Ctr Mat Res, Naguanagu, Venezuela.
RP Amigo, A (reprint author), Univ Polytech Valencia, Inst Mat Technol ITM UPV, Valencia, Spain.
EM anamma@posgrado.upv.es
RI Amigo, Vicente/K-6893-2014
OI Amigo, Vicente/0000-0002-2107-0273; Amigo, Angelica/0000-0001-8186-5935;
   Zambrano, Jenny/0000-0002-9737-7116
FU UPV; Ministry of Science and Innovation of Spain [MAT2011-28492-C03];
   Generalitat Valenciana [ACOMP / 2014/151]
FX This paper is based on a presentation at Euro PM 2014, organised by EPMA
   in Salzburg, Austria on 21-24 September 2014. This work was funded by
   UPV by the Staff Training Program for Predoctoral Researchers dated 28
   February 2014. The Ministry of Science and Innovation of Spain by
   project research MAT2011-28492-C03 and Generalitat Valenciana by ACOMP /
   2014/151.
CR Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   Angeletti P., 2009, POWDER METALLURGY SC, P1
   [Anonymous], 2000, ISO33252000 EN
   Bidaux JE, 2013, POWDER METALL, V56, P263, DOI 10.1179/0032589913Z.000000000118
   BOYER R, 1994, MAT PROPERTIES HDB T
   Cremasco A, 2011, MAT SCI ENG C-MATER, V31, P833, DOI 10.1016/j.msec.2010.12.013
   Kim HS, 2006, SCRIPTA MATER, V54, P887, DOI 10.1016/j.scriptamat.2005.11.001
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lagos MA, 2013, INTERMETALLICS, V36, P51, DOI 10.1016/j.intermet.2013.01.006
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Liu Y, 2006, MAT SCI ENG A-STRUCT, V418, P25, DOI [10.1016/j.msea.2005.10.057, 10.1016/j.msca.2005.10.057]
   Majumdar P, 2008, MAT SCI ENG A-STRUCT, V489, P419, DOI 10.1016/j.msea.2007.12.029
   Malek J, 2013, MATER CHARACT, V84, P225, DOI 10.1016/j.matchar.2013.08.006
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Souza SA, 2010, J ALLOY COMPD, V504, P330, DOI 10.1016/j.jallcom.2010.05.134
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Terayama A, 2013, J ALLOY COMPD, V577, pS408, DOI 10.1016/j.jallcom.2011.12.166
   Wen M, 2014, MATER DESIGN, V56, P629, DOI 10.1016/j.matdes.2013.11.066
   Yang YL, 2009, MATER SCI FORUM, V618-619, P169, DOI 10.4028/www.scientific.net/MSF.618-619.169
   Zhao DP, 2014, POWDER METALL, V57, P2, DOI 10.1179/0032589914Z.000000000153
   Zhao DP, 2013, J MECH BEHAV BIOMED, V28, P171, DOI 10.1016/j.jmbbm.2013.08.013
   Zou LM, 2012, POWDER METALL, V55, P65, DOI 10.1179/1743290111Y.0000000021
NR 22
TC 0
Z9 0
U1 3
U2 21
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0032-5899
EI 1743-2901
J9 POWDER METALL
JI Powder Metall.
PD DEC
PY 2014
VL 57
IS 5
BP 316
EP 319
DI 10.1179/0032589914Z.000000000210
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA AZ1BH
UT WOS:000347974900003
DA 2018-10-20
ER

PT J
AU de Olyveira, GM
   dos Santos, ML
   Costa, LMM
   Daltro, PB
   Basmaji, P
   Daltro, GD
   Guastaldi, AC
AF de Olyveira, Gabriel Molina
   dos Santos, Marcio Luiz
   Manzine Costa, Ligia Maria
   Daltro, Paula Braga
   Basmaji, Pierre
   Daltro, Gildysio de Cerqueira
   Guastaldi, Antonio Carlos
TI Bacterial Cellulose Biocomposites for Guided Tissue Regeneration
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Bacterial Cellulose; Nanoskin (R); Nanocomposites; Scaffolds; Dental
   Materials
ID BIOMEDICAL APPLICATIONS; NANOCOMPOSITES; BIOMATERIALS
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of chondroitin sulfate and hyaluronic acid (1% w/w) to the culture medium before the bacteria is inoculated. Besides, biomimetic precipitation of calcium phosphate of biological interest from simulated body fluid on bacterial cellulose was studied. Chondroitin sulfate and hyaluronic acid influences in bacterial cellulose were analyzed using transmission infrared spectroscopy (FTIR), XRD (X-ray diffraction) and scanning electron microscopy (SEM). FTIR analysis showed interaction between bacterial cellulose nanobiocomposites and calcium phosphate and XRD demonstrated amorphous calcium phosphate and calcium chloride on bacterial cellulose nanobiocomposites. SEM images confirmed incorporation of calcium phosphate in bacterial cellulose nanobiocomposites surface with different calcium phosphate particles morphology.
C1 [de Olyveira, Gabriel Molina; dos Santos, Marcio Luiz; Daltro, Paula Braga; Guastaldi, Antonio Carlos] Univ Estadual Paulista, Dept Phys Chem, BR-14800900 Sao Paulo, Brazil.
   [Manzine Costa, Ligia Maria] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09210170 Santo Andre, SP, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
   [Daltro, Gildysio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex Prof Edgard Santos COM HUPES, BR-40110910 Salvador, BA, Brazil.
RP de Olyveira, GM (reprint author), Univ Estadual Paulista, Dept Phys Chem, BR-14800900 Sao Paulo, Brazil.
EM gabriel.ufabc@gmail.com
RI Manzine Costa, Ligia Maria/N-1780-2015; Guastaldi, Antonio/O-7379-2014;
   dos Santos, Marcio/D-9905-2014
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633; Guastaldi,
   Antonio/0000-0002-6433-3555; dos Santos, Marcio/0000-0002-3385-7516
CR Aoki H., 1999, SCI MED APPL HYDROXY, P214
   Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0
   Basmaji P, 2014, J BIOMATER TISS ENG, V4, P59, DOI 10.1166/jbt.2014.1133
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Cherian BM, 2012, RSC GREEN CHEM SER, P255, DOI 10.1039/9781849735315-00255
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Filho L. X., 2013, J NANOSCI NANOTECHNO, V13, P1
   Gois P. B. P., 2013, INT REV BIOPHYSICAL, V3, P48
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Olyveira G. M., 2011, J NANOTECH ENG MED, V2, P34001
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P665, DOI 10.1166/jbt.2013.1127
   SINACORE MS, 1989, BIO-TECHNOL, V7, P1275
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Willians D. F., 1991, CONCISE ENCY MED DEN
   Willians D. F., 1981, BIOCOMPATIBILITY CLI
   Acasigua GAX, 2014, CURR STEM CELL RES T, V9, P117, DOI 10.2174/1574888X08666131124135654
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
NR 29
TC 0
Z9 0
U1 3
U2 31
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD DEC
PY 2014
VL 6
IS 12
BP 2673
EP 2678
DI 10.1166/sam.2014.1985
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA CA2AR
UT WOS:000348711900012
DA 2018-10-20
ER

PT J
AU Pilarek, M
AF Pilarek, Maciej
TI LIQUID PERFLUOROCHEMICALS AS FLEXIBLE AND EFFICIENT GAS CARRIERS APPLIED
   IN BIOPROCESS ENGINEERING: AN UPDATED OVERVIEW AND FUTURE PROSPECTS
SO CHEMICAL AND PROCESS ENGINEERING-INZYNIERIA CHEMICZNA I PROCESOWA
LA English
DT Article
DE liquid perfluorochemical (fluorocarbon); liquid gas carrier; solubility;
   cell/tissue culture; hybrid culture system
ID ARTIFICIAL OXYGEN CARRIERS; CELL-SUSPENSION-CULTURES; MASS-TRANSFER
   CHARACTERISTICS; DEPENDENT MAMMALIAN-CELLS; SINGLE-USE SYSTEMS; BLOOD
   SUBSTITUTES; PERFLUOROCARBON EMULSIONS; FLUORINATED LIQUIDS;
   CARBON-DIOXIDE; PLURONIC F-68
AB Fully synthetic, biochemically inert and water-immiscible liquid perfluorochemicals (PFCs) are recognised as flexible liquid carriers/scavengers of gaseous compounds (respiratory gases mainly, i.e. O-2 and CO2) and increasingly applied in bioprocess engineering. A range of unmatched physicochemical properties of liquid PFCs, i.e. outstanding chemo-and thermostability, extremely low surface tension, simultaneous hydro-and lipophobicity, which result from carbon chain substitution with fluorine atoms (the most electronegative chemical element) and the presence of intramolecular C-F bonds (the strongest single bond known in organic chemistry) have been described in detail. Exceptional propensity to solubility of respiratory gases in liquid perfluorinated compounds has been widely discussed. Advantages and disadvantages of bioprocess applications of liquid PFCs in the form of a pure PFC as well as in an emulsified form have been pointed out. A liquid PFC-mediated mass transfer intensification in various types of microbial, plant cell and animal cell culture systems: from miniaturised microlitre-scale cultures, via biomaterial-based scaffolds containing culture systems, to litre-scale bioreactors, has been reviewed and elaborated on bearing in mind the benefits of bioprocesses.
C1 Warsaw Univ Technol, Fac Chem & Proc Engn, PL-00645 Warsaw, Poland.
RP Pilarek, M (reprint author), Warsaw Univ Technol, Fac Chem & Proc Engn, Ul Warynskiego 1, PL-00645 Warsaw, Poland.
EM M.Pilarek@ichip.pw.edu.pl
OI Pilarek, Maciej/0000-0002-8489-0842
CR ADLERCREUTZ P, 1982, EUR J APPL MICROBIOL, V16, P165, DOI 10.1007/BF00505826
   ANTHONY P, 1994, PLANT CELL REP, V13, P251, DOI 10.1007/BF00233314
   Audonnet-Blaise S, 2006, RESUSCITATION, V70, P124, DOI 10.1016/j.resuscitation.2005.11.014
   Bakulin MK, 2007, APPL BIOCHEM MICRO+, V43, P399, DOI 10.1134/S0003683807040072
   BALDYGA J, 1998, APPL MECH REV, V51, P121, DOI DOI 10.1115/1.3098987
   Bezinover D, 2014, J SURG RES, V188, P517, DOI 10.1016/j.jss.2014.01.045
   Bouchemal K, 2004, INT J PHARM, V280, P241, DOI 10.1016/j.ijpharm.2004.05.016
   BRZEZINSKA M, 2012, INZ AP CHEM, V51, P101
   Bucci E, 2009, BIOPHYS CHEM, V142, P1, DOI 10.1016/j.bpc.2008.12.009
   Cabrales P, 2013, ASAIO J, V59, P337, DOI 10.1097/MAT.0b013e318291fbaa
   Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x
   Centis V, 2009, FRONT BIOSCI, V14, P665, DOI 10.2741/3272
   Cesario MT, 1996, APPL MICROBIOL BIOT, V46, P497, DOI 10.1007/s002530050850
   Chen ZZ, 2010, LANGMUIR, V26, P3803, DOI 10.1021/la100502x
   CHO MH, 1988, BIOTECHNOL LETT, V10, P855, DOI 10.1007/BF01026995
   Courrier HM, 2004, INT J PHARM, V282, P131, DOI 10.1016/j.ijpharm.2004.06.011
   da Silva TL, 2006, BIOTECHNOL BIOPROC E, V11, P245, DOI 10.1007/BF02932038
   Davey MR, 2005, ACTA PHYSIOL PLANT, V27, P117, DOI 10.1007/s11738-005-0044-0
   Davey MR, 2003, ADV EXP MED BIOL, V540, P139
   Deschamps J, 2007, J CHEM THERMODYN, V39, P847, DOI 10.1016/j.jct.2006.11.012
   Dias AMA, 2004, FLUID PHASE EQUILIBR, V222, P325, DOI 10.1016/j.fluid.2004.06.037
   Douglas TEL, 2014, MATER LETT, V128, P79, DOI 10.1016/j.matlet.2014.03.173
   Dumont E, 2006, BIOCHEM ENG J, V30, P245, DOI 10.1016/j.bej.2006.05.003
   EATON DF, 1990, J AM CHEM SOC, V112, P2821, DOI 10.1021/ja00163a065
   Elibol M, 1999, PROCESS BIOCHEM, V34, P557, DOI 10.1016/S0032-9592(98)00126-5
   Elibol M, 2001, J CHEM TECHNOL BIOT, V76, P418, DOI 10.1002/jctb.389
   Elliott S, 2008, BRIT J PHARMACOL, V154, P529, DOI 10.1038/bjp.2008.89
   Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5
   Galaction AI, 2004, BIOCHEM ENG J, V20, P85, DOI 10.1016/j.bej.2004.02.005
   Garcia-Ochoa F, 2013, BIOPROC BIOSYST ENG, V36, P911, DOI 10.1007/s00449-012-0825-y
   Garcia-Ochoa F, 2010, BIOCHEM ENG J, V49, P289, DOI 10.1016/j.bej.2010.01.011
   Gardeazabal T, 2008, J APPL PHYSIOL, V105, P588, DOI 10.1152/japplphysiol.00152.2008
   Glazyrina J, 2012, NEW BIOTECHNOL, V29, P235, DOI 10.1016/j.nbt.2011.11.004
   Gogate PR, 2000, BIOCHEM ENG J, V6, P109, DOI 10.1016/S1369-703X(00)00081-4
   Gomes L., 2007, REV FACULDADE CIENCI, V4, P58
   Gomes MFC, 2004, J FLUORINE CHEM, V125, P1325, DOI 10.1016/j.jfluchem.2004.03.013
   Gotoh T, 2001, BIOCHEM ENG J, V7, P69, DOI 10.1016/S1369-703X(00)00103-0
   GOTOH T, 2001, BIOCH ENG J, V8, P165, DOI DOI 10.1016/S1369-703X(01)00110-3
   Goyal MMZA, 2005, BIOTECHNOL PROGR, V21, P70, DOI 10.1021/bp049815s
   GRUEN D, 1985, ABSTR PAP AM CHEM S, V190, P153
   Grunzel P, 2014, BIOTECHNOL J, V9, P128, DOI 10.1002/biot.201300177
   HAMAMOTO K, 1987, AGR BIOL CHEM TOKYO, V51, P3415
   Han B, 2009, APPL MICROBIOL BIOT, V83, P669, DOI 10.1007/s00253-009-1866-2
   Hill SE, 2002, J CARDIOTHOR VASC AN, V16, P555, DOI 10.1053/jcan.2002.126947
   Hillig F, 2014, ADV BIOCHEM ENG BIOT, V138, P179, DOI 10.1007/10_2013_219
   Hillig F, 2013, CHEM-ING-TECH, V85, P153, DOI 10.1002/cite.201200143
   Hondred PR, 2013, HIGH PERFORM POLYM, V25, P535, DOI 10.1177/0954008312473491
   Horvath I. T., 1995, U. S. Patent, Patent No. [5,463,082, 5463082]
   Jewitt N, 1999, ENZYME MICROB TECH, V25, P349, DOI 10.1016/S0141-0229(99)00052-6
   JU LK, 1991, BIOTECHNOL PROGR, V7, P323, DOI 10.1021/bp00010a006
   Kaisers U, 2003, BRIT J ANAESTH, V91, P143, DOI 10.1093/bja/aeg147
   KAUFMAN RJ, 1992, NATO ADV SCI I C-MAT, V363, P207
   Kaufmann BA, 2007, CURR OPIN BIOTECH, V18, P11, DOI 10.1016/j.copbio.2007.01.004
   Kim HW, 2007, BIOTECHNOL BIOPROC E, V12, P43, DOI 10.1007/BF02931802
   Kirsch P., 2004, MODERN FLUOROORGANIC
   KOLTUNIEWICZ AB, 2014, SUSTAINABLE PROCESS, P354
   Krafft MP, 2007, J POLYM SCI POL CHEM, V45, P1185, DOI 10.1002/pola.21937
   Krafft MP, 1998, BIOCHIMIE, V80, P489, DOI 10.1016/S0300-9084(00)80016-4
   Krafft MP, 2003, CURR OPIN COLLOID IN, V8, P251, DOI 10.1016/S1359-0294(03)00045-1
   Kuznetsova I.N., 2003, PHARM CHEM J, V37, P415, DOI [10.1023/A:1027355913348, DOI 10.1023/A:1027355913348]
   Lai ZW, 2012, J BIOSCI BIOENG, V114, P286, DOI 10.1016/j.jbiosc.2012.04.011
   LAMY M, 2009, SARTONIANA, V22, P113
   Lanza GM, 2001, PROG CARDIOVASC DIS, V44, P13, DOI 10.1053/pca2001.26442
   Lee YH, 2013, BIOPROC BIOSYST ENG, V36, P1071, DOI 10.1007/s00449-012-0860-8
   Lewandowski G, 2006, J HAZARD MATER, V136, P385, DOI 10.1016/j.jhazmat.2006.04.017
   Li H, 2014, ANN BIOMED ENG, V42, P1456, DOI 10.1007/s10439-013-0925-0
   Li MH, 2012, J CHEM TECHNOL BIOT, V87, P1379, DOI 10.1002/jctb.3752
   Lowe KC, 2003, IN VITRO CELL DEV-PL, V39, P557, DOI 10.1079/IVP2003469
   Lowe KC, 2002, J FLUORINE CHEM, V118, P19, DOI 10.1016/S0022-1139(02)00200-2
   Lowe KC, 2001, J FLUORINE CHEM, V109, P59, DOI 10.1016/S0022-1139(01)00374-8
   Lowe KC, 2001, ARTIF CELL BLOOD SUB, V29, P297, DOI 10.1081/BIO-100104232
   Lowe KC, 1999, BLOOD REV, V13, P171, DOI 10.1054/blre.1999.0113
   Maevsky E, 2005, KEIO U INT SYMP LIFE, V12, P221
   Maevsky E, 2005, ARTIF CELL BLOOD SUB, V33, P37, DOI 10.1081/BIO-200046654
   Maillard E, 2008, TRANSPL P, V40, P372, DOI 10.1016/j.transproceed.2008.01.006
   Martin KH, 2013, WIRES NANOMED NANOBI, V5, P329, DOI 10.1002/wnan.1219
   Martin M, 2010, CHEM ENG SCI, V65, P3814, DOI 10.1016/j.ces.2010.03.015
   MARTIN S, 1995, BIOPROCESS ENG, V13, P293
   Martin Y, 2005, BIOMATERIALS, V26, P7481, DOI 10.1016/j.biomaterials.2005.05.057
   Menge M, 2001, APPL MICROBIOL BIOT, V55, P411, DOI 10.1007/s002530100592
   MITSUNO T, 1982, ANN SURG, V195, P60, DOI 10.1097/00000658-198201001-00010
   MOORE RE, 1978, Patent No. 4105798
   Neubauer P, 2010, CURR OPIN BIOTECH, V21, P114, DOI 10.1016/j.copbio.2010.02.001
   Ntwampe SKO, 2010, AFR J BIOTECHNOL, V9, P1106
   PERCHERON G, 1995, BIOPROCESS ENG, V12, P11, DOI 10.1007/BF01112987
   PILAREK M, 2005, BIOTECHNOLOGIA, V69, P125
   PILAREK M, 2009, INZ AP CHEM, V48, P85
   PILAREK M, 2012, ENG BIOMATER, V114, P12
   PILAREK M, 2013, INZ AP CHEM, V52, P467
   Pilarek M, 2008, BIOCHEM ENG J, V41, P38, DOI 10.1016/j.bej.2008.03.004
   Pilarek M, 2006, PRZEM CHEM, V85, P1131
   Pilarek M, 2007, J BIOTECHNOL, V131, pS143, DOI 10.1016/j.jbiotec.2007.07.850
   Pilarek M, 2014, BIOPROC BIOSYST ENG, V37, P1707, DOI 10.1007/s00449-014-1143-3
   Pilarek M, 2013, BIOTECHNOL LETT, V35, P1387, DOI 10.1007/s10529-013-1218-2
   Pilarek M, 2013, BIOPROC BIOSYST ENG, V36, P1079, DOI 10.1007/s00449-012-0861-7
   Pilarek M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-50
   POHORECKI R, 1988, CHEM ENG SCI, V43, P1677, DOI 10.1016/0009-2509(88)85159-5
   Pohorecki R, 2001, BIOCHEM ENG J, V9, P147, DOI 10.1016/S1369-703X(01)00135-8
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Randsoe T, 2009, J APPL PHYSIOL, V107, P1857, DOI 10.1152/japplphysiol.00785.2009
   Rappaport C, 2003, IN VITRO CELL DEV-AN, V39, P187
   Rappaport C, 2002, BIOTECHNIQUES, V32, P142, DOI 10.2144/02321rr03
   Rappaport C, 1996, BIOTECHNIQUES, V21, P672
   Remy B, 1999, ANN FR ANESTH, V18, P211
   Richardson GF, 2002, THERIOGENOLOGY, V58, P1283, DOI 10.1016/S0093-691X(02)00955-X
   Riess J. G., 2006, BLOOD SUBSTITUTES, P259, DOI DOI 10.1016/B978-012759760-7/50000-7
   Riess J. G., 2004, HDB FLUOROUS CHEM, P521, DOI DOI 10.1002/3527603905.CH13
   Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824
   Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659
   Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c
   Riess JG, 2002, TETRAHEDRON, V58, P4113, DOI 10.1016/S0040-4020(02)00262-4
   Riess JG, 2002, J FLUORINE CHEM, V114, P119, DOI 10.1016/S0022-1139(02)00017-9
   ROLS JL, 1990, BIOTECHNOL BIOENG, V35, P427, DOI 10.1002/bit.260350410
   Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570
   RULAND O, 1987, CLIN OXYGEN PRESSURE, DOI DOI 10.1007/978-3-642-71226-5_30
   Sandford G, 2003, TETRAHEDRON, V59, P437, DOI 10.1016/S0040-4020(02)01568-5
   Shi Y, 1998, RES IMMUNOL, V149, P576, DOI 10.1016/S0923-2494(98)80009-6
   Shiba Y, 1998, BIOTECHNOL BIOENG, V57, P583, DOI 10.1002/(SICI)1097-0290(19980305)57:5<583::AID-BIT10>3.0.CO;2-D
   Shine KP, 2005, ATMOS ENVIRON, V39, P1759, DOI 10.1016/j.atmosenv.2005.01.001
   Smola M, 2008, INT J NANOMED, V3, P1
   Sobieszuk P, 2012, CHEM PROCESS ENG-INZ, V33, P595, DOI 10.2478/v10176-012-0049-3
   Spiess BD, 2009, J APPL PHYSIOL, V106, P1444, DOI 10.1152/japplphysiol.90995.2008
   Suresh S, 2009, J CHEM TECHNOL BIOT, V84, P1091, DOI 10.1002/jctb.2154
   Syklowska-Baranek K, 2014, APPL BIOCHEM BIOTECH, V172, P2618, DOI 10.1007/s12010-013-0701-5
   Tawfic Qutaiba A, 2011, Oman Med J, V26, P4, DOI 10.5001/omj.2011.02
   Terai S, 2010, J SURG RES, V162, P284, DOI 10.1016/j.jss.2009.03.082
   Turick CE, 1998, BIOTECHNOL LETT, V20, P123, DOI 10.1023/A:1005364121431
   Vasquez DM, 2013, BIOTECHNOL PROGR, V29, P796, DOI 10.1002/btpr.1724
   Wardrop J, 1996, J BIOTECHNOL, V50, P47, DOI 10.1016/0168-1656(96)01548-9
   Wasanasathian A, 2001, ARTIF CELL BLOOD SUB, V29, P47, DOI 10.1081/BIO-100001255
   WESSELER EP, 1977, J FLUORINE CHEM, V9, P137, DOI 10.1016/S0022-1139(00)82152-1
   Wijekoon A, 2013, ACTA BIOMATER, V9, P5653, DOI 10.1016/j.actbio.2012.10.034
   Yacoub A, 2014, J NEUROTRAUM, V31, P256, DOI 10.1089/neu.2013.3037
   Yue J, 2007, CHEM ENG SCI, V62, P2096, DOI 10.1016/j.ces.2006.12.057
   Zetterlund PB, 2008, CHEM REV, V108, P3747, DOI 10.1021/cr800242x
   1985, Patent No. 0164813
   2008, Patent No. 7404943
   2011, Patent No. 20060278224
   2013, Patent No. 404726
   1996, Patent No. 5531219
   2005, Patent No. 6897331
   2012, Patent No. 2402433
   1997, Patent No. 5702949
NR 143
TC 8
Z9 8
U1 5
U2 28
PU POLISH ACAD SCIENCES
PI WARSZAWA
PA PL DEFILAD 1, WARSZAWA, 00000, POLAND
SN 0208-6425
EI 2300-1925
J9 CHEM PROCESS ENG-INZ
JI Chem. Process Eng.
PD DEC
PY 2014
VL 35
IS 4
BP 463
EP 487
DI 10.2478/cpe-2014-0035
PG 25
WC Engineering, Chemical
SC Engineering
GA AZ4UN
UT WOS:000348218800006
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Xu, LC
   Bauer, JW
   Siedlecki, CA
AF Xu, Li-Chong
   Bauer, James W.
   Siedlecki, Christopher A.
TI Proteins, platelets, and blood coagulation at biomaterial interfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biomaterials; Blood compatibility; Surfaces; Biological response;
   Coagulation; Thrombosis
ID SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY;
   VON-WILLEBRAND-FACTOR; DEPENDENT FUNCTIONAL-ACTIVITY;
   MONOCLONAL-ANTIBODY BINDING; ACTIVATED HUMAN PLATELETS; HUMAN
   HAGEMAN-FACTOR; FACTOR FACTOR-XII; CONTACT ACTIVATION; FIBRINOGEN
   ADSORPTION
AB Blood coagulation and platelet adhesion remain major impediments to the use of biomaterials in implantable medical devices. There is still significant controversy and question in the field regarding the role that surfaces play in this process. This manuscript addresses this topic area and reports on state of the art in the field. Particular emphasis is placed on the subject of surface engineering and surface measurements that allow for control and observation of surface-mediated biological responses in blood and test solutions. Appropriate use of surface texturing and chemical patterning methodologies allow for reduction of both blood coagulation and platelet adhesion, and new methods of surface interrogation at high resolution allow for measurement of the relevant biological factors. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Xu, Li-Chong; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Inst Biomed Engn, Dept Surg, Hershey, PA 17033 USA.
   [Bauer, James W.; Siedlecki, Christopher A.] Penn State Univ, Coll Med, Inst Biomed Engn, Dept Bioengn, Hershey, PA 17033 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Coll Med, Inst Biomed Engn, Dept Surg, Mail Code H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
FU NIH [RO1 HL69965]; National Science Foundation [DMR-0804873]
FX These studies were supported in part by NIH RO1 HL69965, and the
   National Science Foundation (DMR-0804873). The authors would like to
   thank Dr. Keith Milner, Dr. Erwin Vogler and Dr. Avantika Goias for
   numerous discussions and technical assistance.
CR Afara N, 2012, THIN SOLID FILMS, V522, P381, DOI 10.1016/j.tsf.2012.08.025
   Agashe M, 2005, LANGMUIR, V21, P1103, DOI 10.1021/la0478364
   Agnihotri A, 2006, J BIOMAT SCI-POLYM E, V17, P227, DOI 10.1163/156856206774879036
   Agnihotri A, 2005, ULTRAMICROSCOPY, V102, P257, DOI 10.1016/j.ultramic.2004.10.006
   Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Alibeik S, 2010, COLLOID SURFACE B, V81, P389, DOI 10.1016/j.colsurfb.2010.07.024
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Amiji M.M., 1995, ENCY HDB BIOMATERIAL
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Archambault JG, 2004, COLLOID SURFACE B, V39, P9, DOI 10.1016/j.colsurfb.2004.08.009
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   ASCH E, 1990, J CLIN INVEST, V85, P1372, DOI 10.1172/JCI114581
   Aubin-Tam ME, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034001
   Ayres N, 2010, POLYM CHEM-UK, V1, P769, DOI 10.1039/b9py00246d
   Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123
   Balasubramanian V, 1999, J BIOMED MATER RES, V44, P253, DOI 10.1002/(SICI)1097-4636(19990305)44:3<253::AID-JBM3>3.0.CO;2-K
   Balasubramanian V, 2001, ASAIO J, V47, P354, DOI 10.1097/00002480-200107000-00012
   Barattin R, 2008, CHEM COMMUN, P1513, DOI 10.1039/b614328h
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   BASTIDA E, 1987, BLOOD, V70, P1437
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Berglin M, 2009, LANGMUIR, V25, P5602, DOI 10.1021/la803686m
   Bhushan B, 2011, PROG MATER SCI, V56, P1, DOI 10.1016/j.pmatsci.2010.04.003
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   Brittain WJ, 2007, J POLYM SCI POL CHEM, V45, P3505, DOI 10.1002/pola.22180
   Bultmann A, 2010, J MOL CELL CARDIOL, V49, P532, DOI 10.1016/j.yjmcc.2010.04.009
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Cha P, 2008, LANGMUIR, V24, P2553, DOI 10.1021/la703310k
   Chatterjee K, 2009, BIOMATERIALS, V30, P4915, DOI 10.1016/j.biomaterials.2009.05.076
   Chatterjee K, 2009, J BIOMED MATER RES A, V90A, P27, DOI 10.1002/jbm.a.32076
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2008, COLLOID SURFACE B, V61, P237, DOI 10.1016/j.colsurfb.2007.08.012
   Chen H, 2009, COLLOID SURFACE B, V71, P275, DOI 10.1016/j.colsurfb.2009.02.018
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   Chiumiento A, 2007, BIOMACROMOLECULES, V8, P523, DOI 10.1021/bm060664m
   Chuang WH, 2007, J BIOMED MATER RES A, V82A, P820, DOI 10.1002/jbm.a.31193
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Colman R.W., 1994, HEMOSTASIS THROMBOSI, P3
   COLMAN RW, 1987, ANN NY ACAD SCI, V516, P253, DOI 10.1111/j.1749-6632.1987.tb33046.x
   Comelles J, 2010, NANOMED-NANOTECHNOL, V6, P44, DOI 10.1016/j.nano.2009.05.006
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   dos Santos EA, 2008, J MATER SCI-MATER M, V19, P2307, DOI 10.1007/s10856-007-3347-4
   Dufrene YF, 2008, PFLUG ARCH EUR J PHY, V456, P237, DOI 10.1007/s00424-007-0413-1
   Dupres V, 2007, BIOMATERIALS, V28, P2393, DOI 10.1016/j.biomaterials.2006.11.011
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7
   Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   FARRELL DH, 1992, P NATL ACAD SCI USA, V89, P10729, DOI 10.1073/pnas.89.22.10729
   FARRELL DH, 1994, J BIOL CHEM, V269, P226
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fuchs B, 2010, THROMB RES, V125, P239, DOI 10.1016/j.thromres.2009.08.020
   Gawaz M, 1997, CIRCULATION, V96, P1809, DOI 10.1161/01.CIR.96.6.1809
   Geer CB, 2007, ACTA BIOMATER, V3, P663, DOI 10.1016/j.actbio.2007.03.004
   Golas A, 2013, BIOMATERIALS, V34, P607, DOI 10.1016/j.biomaterials.2012.09.034
   Golas A, 2010, BIOMATERIALS, V31, P1068, DOI 10.1016/j.biomaterials.2009.10.039
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   GOODMAN SL, 1989, SCANNING MICROSCOPY, P285
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   GOODMAN SL, 1993, J BIOMED MATER RES, V27, P683, DOI 10.1002/jbm.820270516
   GOODMAN SL, 1990, J COLLOID INTERF SCI, V139, P561, DOI 10.1016/0021-9797(90)90129-C
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054
   GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998
   GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P497, DOI 10.1163/156856294X00464
   Grunkemeier JM, 2000, J BIOMED MATER RES, V51, P669, DOI 10.1002/1097-4636(20000915)51:4<669::AID-JBM15>3.0.CO;2-#
   Guo Z, 2006, BIOMATERIALS, V27, P796, DOI 10.1016/j.biomaterials.2005.06.021
   Gutierrez-Gonzalez R, 2012, EUR J CLIN MICROBIOL, V31, P889, DOI 10.1007/s10096-011-1420-x
   Hantgan RR, 1994, HEMOSTASIS THROMBOSI, P277
   Hayashi T, 2012, PHYS CHEM CHEM PHYS, V14, P10196, DOI 10.1039/c2cp41236e
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Hernandez R, 2008, MACROMOLECULES, V41, P9767, DOI 10.1021/ma8014454
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   HORBETT TA, 1994, J BIOMAT SCI-POLYM E, V6, P15, DOI 10.1163/156856295X00724
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Hsu SH, 2005, MACROMOL BIOSCI, V5, P246, DOI 10.1002/mabi.200400163
   Hsu SH, 2004, MACROMOL BIOSCI, V4, P891, DOI 10.1002/mabi.200400062
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Huang QL, 2012, BIOMATERIALS, V33, P8213, DOI 10.1016/j.biomaterials.2012.08.017
   Huang SL, 2000, EUR POLYM J, V36, P285, DOI 10.1016/S0014-3057(99)00063-4
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jenny N.S., 2002, THROMBOSIS HEMORRHAG, P1
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P159, DOI 10.1016/0021-9797(91)90044-9
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jin J, 2013, LANGMUIR, V29, P6624, DOI 10.1021/la4017239
   Johnson B, 2012, J TRAUMA ACUTE CARE, V72, P1375, DOI 10.1097/TA.0b013e318245267c
   Kanyanta V, 2010, J MECH BEHAV BIOMED, V3, P51, DOI 10.1016/j.jmbbm.2009.03.005
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kidoaki S, 2002, COLLOID SURFACE B, V23, P153, DOI 10.1016/S0927-7765(01)00232-6
   Kirschner CM, 2012, ANNU REV MATER RES, V42, P211, DOI 10.1146/annurev-matsci-070511-155012
   Koc Y, 2008, LAB CHIP, V8, P582, DOI 10.1039/b716509a
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   Krishnan A, 2006, J R SOC INTERFACE, V3, P283, DOI 10.1098/rsif.2005.0087
   Krishnan A, 2006, BIOMATERIALS, V27, P3187, DOI 10.1016/j.biomaterials.2005.12.032
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Leibner ES, 2009, ACTA BIOMATER, V5, P1389, DOI 10.1016/j.actbio.2008.11.003
   Lim JY, 2005, J ROY SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Linnes JC, 2012, J BIOMED MATER RES A, V100A, P1990, DOI 10.1002/jbm.a.34036
   Liu CC, 2010, MICROFLUID NANOFLUID, V9, P923, DOI 10.1007/s10404-010-0615-2
   Lo YS, 2001, LANGMUIR, V17, P3741, DOI 10.1021/la001569g
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Luong-Van E, 2013, J MATER RES, V28, P165, DOI 10.1557/jmr.2012.398
   Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4
   MAGNANI A, 1995, J MATER CHEM, V5, P1321, DOI 10.1039/jm9950501321
   Mao YD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3167546
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754
   Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   MILLER G, 1980, BIOCHEM BIOPH RES CO, V92, P803, DOI 10.1016/0006-291X(80)90774-3
   Miller R, 2006, BIOMATERIALS, V27, P208, DOI 10.1016/j.biomaterials.2005.05.087
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Milner KR, 2005, ASAIO J, V51, P578, DOI 10.1097/01.mat.0000171594.44974.89
   Minelli C., 2006, INT C NAN NAN ICONN
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Mitropoulos KA, 1999, THROMB RES, V94, P117, DOI 10.1016/S0049-3848(98)00207-2
   NAGAOKA S, 1990, BIOMATERIALS, V11, P119, DOI 10.1016/0142-9612(90)90126-B
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pandey LM, 2013, APPL SURF SCI, V264, P832, DOI 10.1016/j.apsusc.2012.10.150
   Panyala NR, 2009, J APPL BIOMED, V7, P75
   Parhi P, 2009, BIOMATERIALS, V30, P6814, DOI 10.1016/j.biomaterials.2009.09.005
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Pokhilko AV, 1998, J THEOR BIOL, V191, P213, DOI 10.1006/jtbi.1997.0584
   Quinn A, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/56003
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Reininger AJ, 2006, BLOOD, V107, P3537, DOI 10.1182/blood-2005-02-0618
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rothstein JP, 2010, ANNU REV FLUID MECH, V42, P89, DOI 10.1146/annurev-fluid-121108-145558
   RUCKENSTEIN E, 1986, BIOMATERIALS, V7, P403, DOI 10.1016/0142-9612(86)90028-1
   Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611
   Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s
   Sapan CV, 1999, BIOTECHNOL APPL BIOC, V29, P99
   Scardino AJ, 2009, BIOFOULING, V25, P757, DOI 10.1080/08927010903165936
   Scardino AJ, 2009, BIOFOULING, V25, P83, DOI 10.1080/08927010802538480
   Scardino AJ, 2011, BIOFOULING, V27, P73, DOI 10.1080/08927014.2010.536837
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   Sit PS, 1999, THROMB HAEMOSTASIS, V82, P1053
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sivaraman B, 2009, LANGMUIR, V25, P3050, DOI 10.1021/la8036814
   SLACK SM, 1992, J BIOMED MATER RES, V26, P1633, DOI 10.1002/jbm.820261208
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Soman P, 2008, MICRON, V39, P832, DOI 10.1016/j.micron.2007.12.013
   Soman P, 2008, LANGMUIR, V24, P8801, DOI 10.1021/la801227e
   Soman P, 2011, LANGMUIR, V27, P10814, DOI 10.1021/la201111r
   Song WL, 2013, SOFT MATTER, V9, P2985, DOI 10.1039/c3sm27739a
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Su WT, 2006, MICRON, V37, P699, DOI 10.1016/j.micron.2006.03.007
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Szott LM, 2011, J BIOMED MATER RES A, V96A, P150, DOI 10.1002/jbm.a.32954
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   Tomokiyo K, 2005, BLOOD, V105, P1078, DOI 10.1182/blood-2004-05-1827
   Tsai WB, 1999, J BIOMAT SCI-POLYM E, V10, P163, DOI 10.1163/156856299X00117
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   VANDERKAMP KWHJ, 1995, J BIOMED MATER RES, V29, P1303, DOI 10.1002/jbm.820291018
   Vlachopoulou ME, 2008, J VAC SCI TECHNOL B, V26, P2543, DOI 10.1116/1.3010723
   Vogler E. A., 2001, WATER BIOMATERIALS S, P269
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   VOGLER EA, 1993, LANGMUIR, V9, P497, DOI 10.1021/la00026a023
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2011, BIOMATERIALS, V32, P6670, DOI 10.1016/j.biomaterials.2011.05.066
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wagner MS, 2001, LANGMUIR, V17, P4649, DOI 10.1021/la001209t
   Wang LF, 2005, COLLOID SURFACE B, V41, P249, DOI 10.1016/j.colsurfb.2004.12.014
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Wertz CF, 2002, LANGMUIR, V18, P706, DOI 10.1021/la011075z
   WIGGINS RC, 1979, J EXP MED, V150, P1122, DOI 10.1084/jem.150.5.1122
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Wu YP, 2004, BLOOD, V104, P1034, DOI 10.1182/blood-2003-12-4293
   Xu LC, 2007, J BIOMAT SCI-POLYM E, V18, P353, DOI 10.1163/156856207780425013
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xu LC, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035003
   Xu LC, 2012, ACTA BIOMATER, V8, P72, DOI 10.1016/j.actbio.2011.08.009
   Xu LC, 2010, ACTA BIOMATER, V6, P1938, DOI 10.1016/j.actbio.2009.11.031
   Xu LC, 2010, J BIOMED MATER RES A, V92A, P126, DOI 10.1002/jbm.a.32340
   Xu LC, 2009, BIOLOGICAL INTERACTIONS ON MATERIALS SURFACES: UNDERSTANDING AND CONTROLLING PROTEIN, CELL, AND TISSUE RESPONSES, P43, DOI 10.1007/978-0-387-98161-1_3
   Xu LC, 2009, LANGMUIR, V25, P3675, DOI 10.1021/la803258h
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754
   Yamamoto S, 2006, SURF SCI, V600, P3785, DOI 10.1016/j.susc.2006.01.085
   Ye X, 2009, APPL SURF SCI, V255, P6686, DOI 10.1016/j.apsusc.2009.02.068
   Yeh CHJ, 2012, BIOMATERIALS, V33, P9, DOI 10.1016/j.biomaterials.2011.09.034
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
   Zhuo R, 2006, BIOMATERIALS, V27, P4840, DOI 10.1016/j.biomaterials.2006.05.008
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 224
TC 53
Z9 53
U1 6
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD DEC 1
PY 2014
VL 124
SI SI
BP 49
EP 68
DI 10.1016/j.colsurfb.2014.09.040
PG 20
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AY5EP
UT WOS:000347596200006
PM 25448722
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ghaffar, A
   Younis, MN
AF Ghaffar, Abdul
   Younis, Muhammad Naeem
TI Adsorption of organic chemicals on graphene coated biochars and its
   environmental implications
SO GREEN PROCESSING AND SYNTHESIS
LA English
DT Article; Proceedings Paper
CT 4th International Congress on Green Process Engineering (GPE)
CY APR 07-JUL 10, 2014
CL Seville, SPAIN
DE adsorption; biochar; graphene; isotherm; universal adsorbent
ID HEAVY-METALS; MOLECULAR-STRUCTURE; HAZARDOUS ELEMENTS; AQUEOUS-SOLUTION;
   BLACK CARBON; SORPTION; BIOMASS; SOILS; CHARS; PLANT
AB Biochar is a stabilized carbon-rich product, and has drawn scientists' interest because of its specific properties and potential use in many environmental areas. It is emphasized that innovative technologies comprised of engineered nanoparticles in conventional biochar systems could ameliorate the functions of biochar to some extent, such as carbon sequestration, soil fertility and wastewater treatment. As a result, it enables an enhanced sorption of both inorganic and organic pollutants to their surfaces, reducing environmental fate and mobility. In this study, biochar and graphene-coated biochars were prepared by dip-coating of biomass by slow pyrolysis. Batch sorption experiments were performed on the resultant biochars to evaluate sorption ability. The graphene covering on biochar surface changes to increase the surface properties of the biochars, exhibiting the greatest surface area, pore volume and carbon content. Graphene-coated biochars had the ultimate sorption ability compared to their corresponding chars. The sorption data indicated that electrostatic attraction, pi-pi interaction between graphene sheets on the char surface and aromatic domain, was the controlling mechanism for the sorption of organic chemicals onto the chars. Graphene-coated biochars can thus be used as a stable, cheap sorbent, biomaterial for the removal of organic pollutants from aqueous media.
C1 [Ghaffar, Abdul] Kunming Univ Sci & Technol, Coll Environm Sci & Engn, Kunming 650600, Peoples R China.
   [Younis, Muhammad Naeem] King Fahd Univ Petr & Minerals, Dept Chem Engn, Dhahran 31261, Saudi Arabia.
RP Ghaffar, A (reprint author), Kunming Univ Sci & Technol, Coll Environm Sci & Engn, Kunming 650600, Peoples R China.
EM abdulghaffar_30@yahoo.com
RI Ghaffar, Abdul/M-9600-2013
OI Ghaffar, Abdul/0000-0003-0592-3456; Younis, Muhammad
   Naeem/0000-0003-0578-6973
CR Allen MJ, 2010, CHEM REV, V110, P132, DOI 10.1021/cr900070d
   Amonette JE, 2009, BIOCHAR ENV MANAGEME, P33
   Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023
   Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052
   Cao XD, 2009, ENVIRON SCI TECHNOL, V43, P3285, DOI 10.1021/es803092k
   Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109
   Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684
   Chen JS, 2011, NANOSCALE, V3, P2158, DOI 10.1039/c1nr10162e
   Chen JY, 2007, ENVIRON SCI TECHNOL, V41, P2536, DOI 10.1021/es062113+
   Choi W, 2010, CRIT REV SOLID STATE, V35, P52, DOI 10.1080/10408430903505036
   Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w
   Coates J., 2000, ENCY ANAL CHEM APPL
   Cornelissen G, 2005, ENVIRON SCI TECHNOL, V39, P6881, DOI 10.1021/es050191b
   Downie A., 2009, BIOCHAR ENV MANAGEME, P13
   Guo SJ, 2011, CHEM SOC REV, V40, P2644, DOI 10.1039/c0cs00079e
   Harvey OR, 2012, ENVIRON SCI TECHNOL, V46, P1415, DOI 10.1021/es2040398
   Hu XG, 2012, J HAZARD MATER, V213, P387, DOI 10.1016/j.jhazmat.2012.02.012
   Inyang M, 2014, CHEM ENG J, V236, P39, DOI 10.1016/j.cej.2013.09.074
   Inyang M, 2012, BIORESOURCE TECHNOL, V110, P50, DOI 10.1016/j.biortech.2012.01.072
   Ippolito JA, 2012, J ENVIRON QUAL, V41, P967, DOI 10.2134/jeq2012.0151
   Ju SA, 2011, ACS APPL MATER INTER, V3, P2904, DOI 10.1021/am200056t
   Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419
   Keiluweit M, 2009, ENVIRON SCI TECHNOL, V43, P3421, DOI 10.1021/es8033044
   Kercher AK, 2003, CARBON, V41, P15, DOI 10.1016/S0008-6223(02)00261-0
   Kookana RS, 2010, AUST J SOIL RES, V48, P627, DOI 10.1071/SR10007
   Liu WJ, 2011, BIORESOURCE TECHNOL, V102, P8247, DOI 10.1016/j.biortech.2011.06.014
   Mattevi C, 2011, J MATER CHEM, V21, P3324, DOI 10.1039/c0jm02126a
   Novak J. M., 2009, Annals of Environmental Science, V3, P195
   Oliveira MLS, 2012, SCI TOTAL ENVIRON, V430, P34, DOI 10.1016/j.scitotenv.2012.04.046
   Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006
   Quispe D, 2012, FUEL, V94, P495, DOI 10.1016/j.fuel.2011.09.034
   Ribeiro J, 2010, SCI TOTAL ENVIRON, V408, P6032, DOI 10.1016/j.scitotenv.2010.08.046
   Rochefort A, 2009, LANGMUIR, V25, P210, DOI 10.1021/la802284j
   Schoen DT, 2010, NANO LETT, V10, P3628, DOI 10.1021/nl101944e
   Silva LFO, 2012, SCI TOTAL ENVIRON, V419, P250, DOI 10.1016/j.scitotenv.2011.12.069
   Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9
   Song ZG, 2014, CHEM ENG J, V242, P36, DOI 10.1016/j.cej.2013.12.061
   Sun K, 2011, BIORESOURCE TECHNOL, V102, P9897, DOI 10.1016/j.biortech.2011.08.036
   Tsui L, 2008, BIORESOURCE TECHNOL, V99, P5673, DOI 10.1016/j.biortech.2007.10.026
   Varhegyi G, 1998, ENERG FUEL, V12, P969, DOI 10.1021/ef9800359
   Wang XL, 2006, ENVIRON SCI TECHNOL, V40, P3267, DOI 10.1021/es0521977
   Yang YN, 2003, ENVIRON SCI TECHNOL, V37, P3635, DOI 10.1021/es034006a
   Zhang M, 2013, CHEM ENG J, V226, P286, DOI 10.1016/j.cej.2013.04.077
   Zhang M, 2012, SCI TOTAL ENVIRON, V435, P567, DOI 10.1016/j.scitotenv.2012.07.038
   Zhou YM, 2013, CHEM ENG J, V231, P512, DOI 10.1016/j.cej.2013.07.036
NR 45
TC 6
Z9 6
U1 2
U2 64
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 2191-9542
EI 2191-9550
J9 GREEN PROCESS SYNTH
JI Green Process. Synth.
PD DEC
PY 2014
VL 3
IS 6
SI SI
BP 479
EP 487
DI 10.1515/gps-2014-0071
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA AZ0AB
UT WOS:000347907900012
DA 2018-10-20
ER

PT J
AU Kaya, M
   Baran, T
   Erdogan, S
   Mentes, A
   Ozusaglam, MA
   Cakmak, YS
AF Kaya, Murat
   Baran, Talat
   Erdogan, Sevil
   Mentes, Ayfer
   Ozusaglam, Meltem Asan
   Cakmak, Yavuz Selim
TI Physicochemical comparison of chitin and chitosan obtained from larvae
   and adult Colorado potato beetle (Leptinotarsa decemlineata)
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Nanofibre; Porosity; FTIR; TGA; XRD
ID MOLECULAR-WEIGHT CHITOSAN; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT
   ACTIVITIES; RESTING EGGS; BETA-CHITIN; CRAB SHELLS; DERIVATIVES;
   EXTRACTION; ANTIBACTERIAL; CANDIDA
AB Chitins and chitosans obtained from larva and adult Coloradopotato beetles (Leptinotarsa decemlineata) were physico-chemically characterized and differences between adults and larvae were identified. The dry weight chitin contents of the adult Colorado potato beetles and larvae were determined as 20% and 7%, respectively. The chitin produced chitosan yields of 72% from the adult Colorado potato beetles and 67% from the larvae. FTIR analysis showed that the isolated chitins were in the alpha form. Crystalline index values, determined by XRD, were 72% for larvae and 76% for adults. The degradation temperatures of the isolated chitin structures were measured by TGA, and this showed that the chitin from adult Colorado potato beetles had a more stable structure than that from the larvae. The surface morphologies of the isolated chitin and chitosan structures were analysed with SEM and it was revealed that these structures consisted of nanofibres. According to elemental analysis, the purity of chitin and chitosan from adults was greater than that from the larvae. The results of molecular analysis showed that the chitosans from adults (2.722 kDa) and larvae (2.676 kDa) of the Colorado potato beetle have low molecular weights. Antimicrobial and antioxidant activities of both adult and larval chitosans were determined. The adult potato beetle is more appropriate than the larvae as an alternative chitin source because of the fact that its dry weight chitin content, chitosan yield and purity of chitin are higher than those from the larvae, and its antimicrobial and antioxidant activities are also higher than those from the larvae. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kaya, Murat; Ozusaglam, Meltem Asan; Cakmak, Yavuz Selim] Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey.
   [Kaya, Murat; Baran, Talat; Erdogan, Sevil; Mentes, Ayfer; Ozusaglam, Meltem Asan; Cakmak, Yavuz Selim] Aksaray Univ, Sci & Technol Applicat & Res Ctr, TR-68100 Aksaray, Turkey.
   [Baran, Talat; Mentes, Ayfer] Aksaray Univ, Fac Sci & Letters, Dept Chem, TR-68100 Aksaray, Turkey.
   [Erdogan, Sevil] Trakya Univ, Kesan Vocat Coll, Fisheries Programme, TR-22800 Kesan, Edirne, Turkey.
RP Kaya, M (reprint author), Aksaray Univ, Fac Sci & Letters, Dept Biotechnol & Mol Biol, TR-68100 Aksaray, Turkey.
EM muratkaya3806@yahoo.com; talatbaran66@hotmail.com;
   serdogantrakya@gmail.com; amentes@aksaray.edu.tr;
   meltemozusaglam@gmail.com; yavuzselimcakmak@gmail.com
RI Mentes, Ayfer/F-8710-2011; University, Aksaray/A-1857-2018; Science and
   Arts Faculty, Aksaray University/Q-7606-2016
OI Kaya, Murat/0000-0001-6954-2703; MENTES, AYFER/0000-0003-3946-4075;
   BARAN, TALAT/0000-0003-0206-3841; CAKMAK, Yavuz
   Selim/0000-0001-8954-5485
CR Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051
   Ai H, 2008, CARBOHYD POLYM, V72, P419, DOI 10.1016/j.carbpol.2007.09.010
   Alonso MJ, 2003, J PHARM PHARMACOL, V55, P1451, DOI 10.1211/0022357022476
   Alyokhin A, 2008, AM J POTATO RES, V85, P395, DOI 10.1007/s12230-008-9052-0
   Casalinuovo I A, 2004, Eur Rev Med Pharmacol Sci, V8, P69
   Chandrasekaran M, 2004, J ETHNOPHARMACOL, V91, P105, DOI 10.1016/j.jep.2003.12.012
   Chatterjee S, 2005, PROCESS BIOCHEM, V40, P395, DOI 10.1016/j.procbio.2004.01.025
   Chien PJ, 2007, FOOD CHEM, V102, P1192, DOI 10.1016/j.foodchem.2006.07.007
   CLARK JM, 1994, ADVANCES IN POTATO PEST, P294
   Coma V, 2002, J FOOD SCI, V67, P1162, DOI 10.1111/j.1365-2621.2002.tb09470.x
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   EPPO CABI, 2006, DAT SHEETS QUAR PEST
   Felse PA, 1999, BIOPROCESS ENG, V20, P505, DOI 10.1007/s004490050622
   Fontana CR, 2008, DRUG DELIV, V15, P417, DOI [10.1080/10717540802007433, 10.1080/10717540802007433 ]
   Goy RC, 2009, POLIMEROS, V19, P241, DOI 10.1590/S0104-14282009000300013
   Hafdani F. N., 2011, WORLD ACAD SCI ENG T, V50, P252
   Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20179
   Je JY, 2004, FOOD CHEM TOXICOL, V42, P381, DOI 10.1016/j.fct.2003.10.001
   Jing YJ, 2007, ACTA BIOL HUNG, V58, P75, DOI 10.1556/ABiol.57.2007.1.7
   Jung B.O., 2002, J CHITIN CHITOSAN, V7, P231
   Jung J, 2012, BIOORGAN MED CHEM, V20, P2905, DOI 10.1016/j.bmc.2012.03.020
   Jung J, 2011, CARBOHYD RES, V346, P1876, DOI 10.1016/j.carres.2011.05.021
   Kaya M., 2014, ZOOMORPHOLOGY
   Kaya M, 2014, BIOTECHNOL BIOPROC E, V19, P58, DOI 10.1007/s12257-013-0488-9
   Kaya M, 2013, INT J BIOL MACROMOL, V61, P459, DOI 10.1016/j.ijbiomac.2013.08.016
   Koryagin AS, 2006, B EXP BIOL MED+, V142, P461, DOI 10.1007/s10517-006-0392-9
   Kucukgulmez A, 2011, FOOD CHEM, V126, P1144, DOI 10.1016/j.foodchem.2010.11.148
   LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548
   Limam Z, 2011, AFR J BIOTECHNOL, V10, P640
   Liu SF, 2012, MOLECULES, V17, P4604, DOI 10.3390/molecules17044604
   Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010
   Muzzarelli RAA, 2011, MAR DRUGS, V9, P1510, DOI 10.3390/md9091510
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nemtsev SV, 2004, APPL BIOCHEM MICRO+, V40, P39, DOI 10.1023/B:ABIM.0000010349.62620.49
   No HK, 2006, CARBOHYD POLYM, V65, P174, DOI 10.1016/j.carbpol.2005.12.036
   Park PJ, 2004, CARBOHYD POLYM, V55, P17, DOI 10.1016/j.carbpol.2003.05.002
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   PENG T, 1994, J POLYM SCI POL CHEM, V32, P591, DOI 10.1002/pola.1994.080320322
   Pfaller MA, 2006, J CLIN MICROBIOL, V44, P819, DOI 10.1128/JCM.44.3.819-826.2006
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rajalakshmi A., 2013, MIDDLE E J SCI RES, V16, P1446, DOI DOI 10.5829/ID0SI.MEJSR.2013.16.10.12033
   ROBERTS GAF, 1982, INT J BIOL MACROMOL, V4, P374, DOI 10.1016/0141-8130(82)90074-5
   Sajomsang W, 2010, MAT SCI ENG C-MATER, V30, P357, DOI 10.1016/j.msec.2009.11.014
   Sims CR, 2006, J CLIN MICROBIOL, V44, P2105, DOI 10.1128/JCM.02591-05
   Sun T, 2007, EUR FOOD RES TECHNOL, V225, P451, DOI 10.1007/s00217-006-0439-1
   Synowiecki J, 2003, CRIT REV FOOD SCI, V43, P145, DOI 10.1080/10408690390826473
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   Tikhonov VE, 2006, CARBOHYD POLYM, V64, P66, DOI 10.1016/j.carbpol.2005.10.021
   Tolaimate A, 2003, POLYMER, V44, P7939, DOI 10.1016/j.polymer.2003.10.025
   Tsai GJ, 2004, J FOOD PROTECT, V67, P396, DOI 10.4315/0362-028X-67.2.396
   Tsuchido T., 2003, BIOCONTROL SCI, V8, P25
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Vinsova J, 2011, CURR PHARM DESIGN, V17, P3596, DOI 10.2174/138161211798194468
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wang YC, 2013, CARBOHYD POLYM, V92, P90, DOI 10.1016/j.carbpol.2012.09.084
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2
   Yen MT, 2009, CARBOHYD POLYM, V75, P15, DOI 10.1016/j.carbpol.2008.06.006
   Yen MT, 2008, CARBOHYD POLYM, V74, P840, DOI 10.1016/j.carbpol.2008.05.003
   Yen MT, 2007, LWT-FOOD SCI TECHNOL, V40, P472, DOI 10.1016/j.lwt.2006.01.002
   Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3
   Zhao Y, 2010, MAR DRUGS, V8, P24, DOI 10.3390/md8010024
   Zivanovic S, 2004, J FOOD PROTECT, V67, P952, DOI 10.4315/0362-028X-67.5.952
NR 64
TC 39
Z9 39
U1 4
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2014
VL 45
BP 72
EP 81
DI 10.1016/j.msec.2014.09.004
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AY4ZE
UT WOS:000347582600010
PM 25491803
DA 2018-10-20
ER

PT J
AU Kakkar, P
   Verma, S
   Manjubala, I
   Madhan, B
AF Kakkar, Prachi
   Verma, Sudhanshu
   Manjubala, I.
   Madhan, B.
TI Development of keratin-chitosan-gelatin composite scaffold for soft
   tissue engineering
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Keratin; Biomaterial; Wound healing; Gelatin; Chitosan; Tissue
   engineering
ID ANTIBACTERIAL ACTIVITY; COLLAGEN SCAFFOLD; SHRIMP CHITOSAN;
   DRUG-DELIVERY; ACID; CHITIN; DEGRADATION; FABRICATION
AB Keratin has gained much attention in the recent past as a biomaterial for wound healing owing to its biocompatibility, biodegradability, intrinsic biological activity and presence of cellular binding motifs. In this paper, a novel biomimetic scaffold containing keratin, chitosan and gelatin was prepared by freeze drying method. The prepared keratin composite scaffold had good structural integrity. Fourier Transform Infrared (FTIR) spectroscopy showed the retention of the native structure of individual biopolymers (keratin, chitosan, and gelatin) used in the scaffold. Thermogravimetric Analysis (TGA) and Differential Scanning Calorimetry (DSC) results revealed a high thermal denaturation temperature of the scaffold (200-250 degrees C). The keratin composite scaffold exhibited tensile strength (96 kPa), compression strength (8.5 kPa) and water uptake capacity (> 1700%) comparable to that of a collagen scaffold, which was used as control.The morphology of the keratin composite scaffold observed using a Scanning Electron Microscope (SEM) exhibited good porosity and interconnectivity of pores. MTT assay using NIH 3T3 fibroblast cells demonstrated that the cell viability of the keratin composite scaffold was good. These observations suggest that the keratin-chitosan-gelatin composite scaffold is a promising alternative biomaterial for tissue engineering applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kakkar, Prachi; Madhan, B.] CSIR, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
   [Verma, Sudhanshu; Manjubala, I.] VIT Univ, Sch Bio Sci & Technol, Biomed Engn Div, Vellore 632014, Tamil Nadu, India.
RP Madhan, B (reprint author), CSIR, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
EM bmadhan76@yahoo.co.in
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452; Manjubala, I/0000-0003-4873-2377
FU Council of Scientific and Industrial Research (CSIR) [CSC 0134]
FX The author is thankful to the Council of Scientific and Industrial
   Research (CSIR) (CSC 0134) for providing support in the form of Senior
   Research Fellowship (SRF).
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   DOWLING LM, 1986, BIOCHEM J, V236, P705, DOI 10.1042/bj2360705
   Feughelmann M., 1985, ENCY POLYM SCI ENG
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Kaya M, 2014, FOOD BIOPHYS, V9, P145, DOI 10.1007/s11483-013-9327-y
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Liu Y, 2013, MAT SCI ENG C-MATER, V33, P196, DOI 10.1016/j.msec.2012.08.030
   Liu YY, 2012, MAT SCI ENG C-MATER, V32, P2361, DOI 10.1016/j.msec.2012.07.008
   Fernandez JM, 2011, J TISSUE ENG REGEN M, V5, pE126, DOI 10.1002/term.394
   MARSHALL RC, 1991, ELECTRON MICROSC REV, V4, P47, DOI 10.1016/0892-0354(91)90016-6
   Natarajan V, 2013, J BIOMED MATER RES B, V101B, P560, DOI 10.1002/jbm.b.32856
   Patel S., 2009, INT J PHARM PHARM SC, V1, P38
   Pawlak A, 2004, THERMOCHIM ACTA, V409, P95, DOI 10.1016/S0040-6031(03)00324-1
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Ribeiro MP, 2013, MAT SCI ENG C-MATER, V33, P2958, DOI 10.1016/j.msec.2013.03.025
   Sang L, 2011, MAT SCI ENG C-MATER, V31, P262, DOI 10.1016/j.msec.2010.09.008
   SPEI M, 1987, COLLOID POLYM SCI, V265, P965, DOI 10.1007/BF01412398
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   TANAKA S, 1988, J BIOL CHEM, V263, P17650
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
   Tsai GJ, 2000, J FOOD PROTECT, V63, P747, DOI 10.4315/0362-028X-63.6.747
   Tseng HJ, 2013, J TISSUE ENG REGEN M, V7, P20, DOI 10.1002/term.492
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Wang HJ, 2009, MATERIALS, V2, P613, DOI 10.3390/ma2020613
   Wojciechowska E, 1999, J MOL STRUCT, V511, P307, DOI 10.1016/S0022-2860(99)00173-8
   Xiao W, 2013, INJURY, V44, P941, DOI 10.1016/j.injury.2013.03.029
   Xu C., 2012, SCI WORLD J, V2012
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zeng MF, 2004, J MEMBRANE SCI, V230, P175, DOI 10.1016/j.memsci.2003.11.020
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 31
TC 28
Z9 28
U1 5
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2014
VL 45
BP 343
EP 347
DI 10.1016/j.msec.2014.09.021
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA AY4ZE
UT WOS:000347582600045
PM 25491838
DA 2018-10-20
ER

PT J
AU Bagnasco, DS
   Ballarin, FM
   Cymberknop, LJ
   Balay, G
   Negreira, C
   Abraham, GA
   Arrnentano, RL
AF Suarez Bagnasco, D.
   Montini Ballarin, F.
   Cymberknop, L. J.
   Balay, G.
   Negreira, C.
   Abraham, G. A.
   Arrnentano, R. L.
TI Elasticity assessment of electrospun nanofibrous vascular grafts: A
   comparison with femoral ovine arteries
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Vascular grafts; Electrospinning; PLLA; Mechanical properties;
   Pressure-diameter loop
ID CONSCIOUS DOGS; MECHANICS; BEHAVIOR; POLYCAPROLACTONE; OPTIMIZATION;
   POLYMERS; COLLAGEN; MATRIX
AB Development of successful small-diameter vascular grafts constitutes a real challenge to biomaterial engineering. In most cases these grafts fail in-vivo due to the presence of a mechanical mismatch between the native vessel and the vascular graft. Biomechanical characterization of real native vessels provides significant information for synthetic graft development. Electrospun nanofibrous vascular grafts emerge as a potential tailor made solution to this problem. PLLA-electrospun nanofibrous tubular structures were prepared and selected as model bioresorbable grafts. An experimental setup, using gold standard and high resolution ultrasound techniques, was adapted to characterize in vitro the poly(L-lactic acid) (PLLA) electrospun structures. The grafts were subjected to near physiologic pulsated pressure conditions, following the pressure-diameter loop approach and the criteria stated in the international standard for cardiovascular implants-tubular vascular prostheses. Additionally, ovine femoral arteries were subjected to a similar evaluation. Measurements of pressure and diameter variations allowed the estimation of dynamical compliance (%C, 10(-2) mm Hg) and the pressure-strain elastic modulus (E-P epsilon, 10(6) dyn cm(-2)) of the abovementioned vessels (grafts and arteries). Nanofibrous PLLA showed a decrease in %C (1.38 +/- 0.21, 0.93 +/- 0.13 and 0.76 +/- 0.15) concomitant to an increase in E-P epsilon (10.57 +/- 0.97, 14.31 +/- 1.47 and 17.63 +/- 2.61) corresponding to pressure ranges of 50 to 90 mm Hg, 80 to 120 mm Hg and 100 to 150 mm Hg, respectively. Furthermore, femoral arteries exhibited a decrease in %C (8.52 +/- 1.15 and 0.79 +/- 0.20) and an increase in E-P epsilon (1.66 +/- 0.30 and 15.76 +/- 4.78) corresponding to pressure ranges of 50-90 mm Hg (elastin zone) and 100-130 mm Hg (collagen zone). Arterial mechanics framework, extensively applied in our previous works, was successfully used to characterize PLLA vascular grafts in vitro, although its application can be directly extended to in vivo experiences, in conscious and chronically instrumented animals. The specific design and construction of the electrospun nanofibrous PLLA vascular grafts assessed in this work, showed similar mechanical properties as the ones observed in femoral arteries, at the collagen pressure range. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Suarez Bagnasco, D.; Balay, G.; Negreira, C.] Univ Republica, Inst Fis, Fac Ciencias, Lab Acust Ultrasonora, Montevideo, Uruguay.
   [Montini Ballarin, F.; Abraham, G. A.] Inst Invest Ciencia & Tecnol Mat INTEMA UNMdP CON, Mar Del Plata, Buenos Aires, Argentina.
   [Cymberknop, L. J.; Arrnentano, R. L.] Univ Tecnol Nacl, Grp Invest & Desarrollo Bioingn GIBIO, Buenos Aires, DF, Argentina.
   [Arrnentano, R. L.] Univ Republica, Ctr Univ Reg Noroeste, Grp Ingn Aplicada Proc Biol & Agr, Montevideo, Uruguay.
RP Arrnentano, RL (reprint author), Univ Tecnol Nacl, Fac Reg Buenos Aires, Dept Ingn Elect, Av Medrano 951 1 Piso,C1179AAQ CABA, Buenos Aires, DF, Argentina.
EM dsuarez@fisica.edu.uy; florenciamontini@fi.mdp.edu.ar;
   ljcymber@ieee.org; gbalay@fisica.edu.uy; negreira.carlos@gmail.com;
   gabraham@fi.mdp.edu.ar; armen@ieee.org
RI Abraham, Gustavo/E-2820-2014
OI Abraham, Gustavo/0000-0001-7094-1031
FU National Agency of Innovation and Research (ANII), Uruguay
   [FCE-1-2011-1-7172]; PEDECIBA-BIOLOGIA (Uruguay); Buenos Aires Regional
   Faculty of National Technological University [PID 25/c131]; Argentinean
   National Agency of Scientific and Technological Promotion [PICT 224];
   National Research Council [PIP 522]; National University of Mar del
   Plata [15/G359]; CONICET
FX This work was supported by the National Agency of Innovation and
   Research (ANII; grants: FCE-1-2011-1-7172; Uruguay) and
   PEDECIBA-BIOLOGIA (Uruguay), the Buenos Aires Regional Faculty of
   National Technological University (PID 25/c131), the Argentinean
   National Agency of Scientific and Technological Promotion (PICT 224
   grant), the National Research Council (PIP 522 grant), and the National
   University of Mar del Plata (15/G359 grant). F.M.B. thanks CONICET for
   the fellowship awarded.
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Agarwal S, 2013, PROG POLYM SCI, V38, P963, DOI 10.1016/j.progpolymsci.2013.02.001
   Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   [Anonymous], 719819982001R2010 AN
   ARMENTANO RL, 1994, MED PROG TECHNOL, V20, P91
   ARMENTANO RL, 1995, CIRC RES, V76, P468, DOI 10.1161/01.RES.76.3.468
   Balay G, 2010, IEEE ENG MED BIO, P2521, DOI 10.1109/IEMBS.2010.5626873
   Ballarin FM, 2014, MAT SCI ENG C-MATER, V42, P489, DOI 10.1016/j.msec.2014.05.074
   BARRA JG, 1993, CIRC RES, V73, P1040, DOI 10.1161/01.RES.73.6.1040
   Bia D, 2007, ARTIF ORGANS, V31, P809, DOI 10.1111/j.1525-1594.2007.00467.x
   Brum J, 2010, PHYSCS PROC, V3, P1095, DOI 10.1016/j.phpro.2010.01.142
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Gamero LG, 2001, EXP PHYSIOL, V86, P519, DOI 10.1113/eph8602172
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   HOW TV, 1987, J BIOMED MATER RES, V21, P1093, DOI 10.1002/jbm.820210904
   Lee H., 2010, J TISSUE ENG REGEN M, V7, P298
   McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nerem RM, 2003, BIORHEOLOGY, V40, P281
   Rachev A., 2011, J BIOMECH ENG, V133
   Raghavan P, 2012, REACT FUNCT POLYM, V72, P915, DOI 10.1016/j.reactfunctpolym.2012.08.018
   Roh JD, 2008, BIOMATERIALS, V29, P1454, DOI 10.1016/j.biomaterials.2007.11.041
   RUSHMER RF, 1956, CIRC RES, V4, P684, DOI 10.1161/01.RES.4.6.684
   Lopes MS, 2012, PROCEDIA ENGINEER, V42, P1402, DOI 10.1016/j.proeng.2012.07.534
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sin LT, 2013, PDL HANDB SER, P247, DOI 10.1016/B978-1-4377-4459-0.00007-X
   Soletti L, 2010, ACTA BIOMATER, V6, P110, DOI 10.1016/j.actbio.2009.06.026
   Sonoda H, 2001, J BIOMED MATER RES, V55, P266, DOI 10.1002/1097-4636(20010605)55:3<266::AID-JBM1014>3.0.CO;2-C
   STEWART SFC, 1988, J BIOMECH ENG-T ASME, V110, P344, DOI 10.1115/1.3108451
   Suarez-Bagnasco D., 2013, J PHYS C SER, V421
   U.N.R. Council, 1996, GUIDE CARE USE LAB A
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
NR 35
TC 11
Z9 11
U1 4
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2014
VL 45
BP 446
EP 454
DI 10.1016/j.msec.2014.09.016
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AY4ZE
UT WOS:000347582600057
PM 25491850
DA 2018-10-20
ER

PT J
AU Stylianou, A
   Yova, D
   Alexandratou, E
AF Stylianou, Andreas
   Yova, Dido
   Alexandratou, Eleni
TI Investigation of the influence of UV irradiation on collagen thin films
   by AFM imaging
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Atomic Force Microscopy (AFM); Collagen; Thin films; Ultraviolet (UV);
   Nanocharacterization; Biomaterials
ID ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; ULTRAVIOLET-RADIATION; I
   COLLAGEN; NATIVE COLLAGEN; CELL RESPONSE; SURFACE; FIBRILS; NANOSCALE;
   BIOMATERIALS
AB Collagen is the major fibrous extracellular matrix protein and due to its unique properties, it has been widely used as biomaterial, scaffold and cell-substrate. The aim of the paper was to use Atomic Force Microscopy (AFM) in order to investigate well-characterized collagen thin films after ultraviolet light (UV) irradiation. The films were also used as in vitro culturing substrates in order to investigate the UV-induced alterations to fibroblasts. A special attention was given in the alteration on collagen D-periodicity. For short irradiation times, spectroscopy (fluorescence/absorption) studies demonstrated that photodegradadon took place and AFM imaging showed alterations in surface roughness. Also, it was highlighted that UV-irradiation had different effects when it was applied on collagen solution than on films. Concerning fibroblast culturing, it was shown that fibroblast behavior was affected after LTV irradiation of both collagen solution and films. Furthermore, after a long irradiation time, collagen fibrils were deformed revealing that collagen fibrils are consisting of multiple shells and D-periodicity occurred on both outer and inner shells. The clarification of the effects of UV light on collagen and the induced modifications of cell behavior on UV-irradiated collagen-based surfaces will contribute to the better understanding of cell-matrix interactions in the nanoscale and will assist in the appropriate use of UV light for sterilizing and photo-cross-linldng applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Stylianou, Andreas; Yova, Dido; Alexandratou, Eleni] Natl Tech Univ Athens, Sch Elect & Comp Engn, Div Electromagnet Electroopt & Elect Mat, Biomed Opt & Appl Biophys Lab, Athens 15780, Greece.
RP Stylianou, A (reprint author), Natl Tech Univ Athens, Sch Elect & Comp Engn, Div Electromagnet Electroopt & Elect Mat, Biomed Opt & Appl Biophys Lab, 9 Iroon Polytech, Athens 15780, Greece.
EM styliand@mail.ntua.gr
RI Stylianou, Andreas/B-9466-2014
OI Stylianou, Andreas/0000-0002-1641-1854
FU European Union (European Social Fund - ESF); Greek national funds
   through the Operational Program "Education and Lifelong Learning" of the
   National Strategic Reference Framework (NSRF) - Research Funding
   Program: Heracleitus II. Investing in knowledge society through the
   European Social Fund
FX This research has been co-financed by the European Union (European
   Social Fund - ESF) and Greek national funds through the Operational
   Program "Education and Lifelong Learning" of the National Strategic
   Reference Framework (NSRF) - Research Funding Program: Heracleitus II.
   Investing in knowledge society through the European Social Fund.
CR Achilli M, 2010, MACROMOL BIOSCI, V10, P307, DOI 10.1002/mabi.200900248
   Alexandratou E, 2002, PHOTOCH PHOTOBIO SCI, V1, P547, DOI 10.1039/b110213n
   Anastase-Ravion S, 2002, J BIOMED MATER RES, V60, P384
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Au AY, 2012, J BIOMED MATER RES A, V100A, P342, DOI 10.1002/jbm.a.33277
   Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943
   Bertassoni LE, 2012, MICRON, V43, P1364, DOI 10.1016/j.micron.2012.03.021
   Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704
   Brouwer KM, 2011, J TISSUE ENG REGEN M, V5, P501, DOI 10.1002/term.397
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Casuso I, 2011, J MOL RECOGNIT, V24, P406, DOI 10.1002/jmr.1081
   Chakraborty I., 2013, NANOTECHNOLOGY, V24
   Chang CT, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500577
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Covani U, 2007, J BIOMED MATER RES A, V82A, P723, DOI 10.1002/jbm.a.31055
   Fathima NN, 2008, COLLOID SURFACE B, V62, P11, DOI 10.1016/j.colsurfb.2007.09.006
   Fathima NN, 2007, J APPL POLYM SCI, V104, P3642, DOI 10.1002/app.26129
   Fessel G, 2012, J ORTHOP RES, V30, P973, DOI 10.1002/jor.22014
   Francis LW, 2010, J MICROSC-OXFORD, V240, P111, DOI 10.1111/j.1365-2818.2010.03392.x
   Frankel DJ, 2006, BIOPHYS J, V90, P2404, DOI 10.1529/biophysj.105.073692
   Fratzl P., 2008, COLLAGEN STRUCTURE M
   Gaspar A, 2011, J Med Life, V4, P172
   Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4
   Grant CA, 2012, J MECH BEHAV BIOMED, V5, P165, DOI 10.1016/j.jmbbm.2011.08.020
   Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1
   Hecht E, 2011, ANAL BIOANAL CHEM, V399, P2369, DOI 10.1007/s00216-010-4407-z
   Horcas I., 2007, REV SD INSTRUM, V78
   Hou S, 2009, ANAL BIOANAL CHEM, V394, P2111, DOI 10.1007/s00216-009-2892-8
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Ionita I, 2010, ROM REP PHYS, V62, P634
   Ivanova VP, 2012, J EVOL BIOCHEM PHYS+, V48, P127, DOI 10.1134/S0022093012020016
   Jariashvili K, 2012, BIOPOLYMERS, V97, P189, DOI 10.1002/bip.21725
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Knotek P, 2013, MAT SCI ENG C-MATER, V33, P1963, DOI 10.1016/j.msec.2013.01.006
   Kontomaris S.V., 2012, 12 IEEE INT C BIOINF, P608
   Koutsopoulos S, 2012, ADV DRUG DELIVER REV, V64, P1459, DOI 10.1016/j.addr.2012.08.002
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   [路婷婷 Lu Tingting], 2012, [中国药理学通报, Chinese Pharmacological Bulletin], V28, P1655
   Markiewicz P, 1997, ULTRAMICROSCOPY, V68, P215, DOI 10.1016/S0304-3991(97)00035-1
   Menter JM, 2001, PHOTODERMATOL PHOTO, V17, P114, DOI 10.1034/j.1600-0781.2001.170302.x
   Metreveli N., 2006, INT J PHOTOENERGY, V2006
   Metreveli NO, 2010, ECOTOX ENVIRON SAFE, V73, P448, DOI 10.1016/j.ecoenv.2009.12.005
   Morris V. J., 2008, ATOMIC FORCE MICROSC
   Muller DJ, 2011, TRENDS CELL BIOL, V21, P461, DOI 10.1016/j.tcb.2011.04.008
   Nagao E, 1999, BIOPHYS J, V76, P3289, DOI 10.1016/S0006-3495(99)77481-3
   PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871
   Plant AL, 2009, BBA-MOL CELL RES, V1793, P893, DOI 10.1016/j.bbamcr.2008.10.012
   Poole K, 2005, J MOL BIOL, V349, P380, DOI 10.1016/j.jmb.2005.03.064
   Rajan N, 2008, BIOTECHNOL PROGR, V24, P884, DOI 10.1002/btpr.3
   Reungpatthanaphong P, 2003, J BIOCHEM BIOPH METH, V57, P1, DOI 10.1016/S0165-022X(03)00032-0
   Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819
   Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978
   Ryssel H, 2012, EUR J PLAST SURG, V35, P121, DOI 10.1007/s00238-008-0251-1
   Sawhney RK, 2002, J CELL BIOL, V157, P1083, DOI 10.1083/jcb.200203069
   Sherratt MJ, 2010, J PATHOL, V222, P32, DOI 10.1002/path.2730
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Silver FH, 2009, J ENG FIBER FABR, V4, P9
   Sionkowska A, 2006, POLYM DEGRAD STABIL, V91, P3026, DOI 10.1016/j.polymdegradstab.2006.08.009
   Sionkowska A, 2005, INT J BIOL MACROMOL, V35, P145, DOI 10.1016/j.ijbiomac.2005.01.009
   Sionkowska A, 2004, SURF SCI, V566, P608, DOI 10.1016/j.susc.2004.05.114
   Sionkowska A, 2004, INT J BIOL MACROMOL, V34, P9, DOI 10.1016/j.ijbiomac.2003.10.001
   Sionkowska A, 2004, POLYM DEGRAD STABIL, V83, P117, DOI 10.1016/S0141-3910(03)00232-5
   Sionkowska A, 2000, POLYM DEGRAD STABIL, V68, P147, DOI 10.1016/S0141-3910(99)00176-7
   Sionkowska A, 2008, APPL SURF SCI, V255, P2030, DOI 10.1016/j.apsusc.2008.06.200
   Sionkowska A, 2009, APPL SURF SCI, V255, P4135, DOI 10.1016/j.apsusc.2008.10.108
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Stamov DR, 2013, J STRUCT BIOL, V183, P394, DOI 10.1016/j.jsb.2013.05.022
   Strasser S, 2007, BIOCHEM BIOPH RES CO, V354, P27, DOI 10.1016/j.bbrc.2006.12.114
   Stylianou A, 2011, BIOMED SIGNAL PROCES, V6, P307, DOI 10.1016/j.bspc.2011.02.006
   Stylianou A., 2011, 5 EUR C INT FED MED, P1058, DOI [10.1007/978-3-642-23508-5_275, DOI 10.1007/978-3-642-23508-5_275]
   STYLIANOU A, 2012, 5 INT C EM TECHN NON, P415
   Stylianou A., 2014, IFMBE P, V41, P407
   Stylianou A., 2010, 12 MED C MED BIOL EN, P612, DOI [10.1007/978-3-642-13039-7_154, DOI 10.1007/978-3-642-13039-7_154]
   Stylianou A., 2009, 9 INT C INF TECHN AP
   Stylianou A., 2012, 12 IEEE INT C BIOL F, V2012, P602
   Stylianou A, 2013, J NANOPHOTONICS, V7, DOI 10.1117/1.JNP.7.073590
   Stylianou A, 2013, MAT SCI ENG C-MATER, V33, P2947, DOI 10.1016/j.msec.2013.03.029
   Suh H, 2000, MAT SCI ENG C-BIO S, V13, P65, DOI 10.1016/S0928-4931(00)00178-8
   Torikai A, 1999, J APPL POLYM SCI, V73, P1259, DOI 10.1002/(SICI)1097-4628(19990815)73:7<1259::AID-APP20>3.0.CO;2-#
   Tsai SW, 2010, J TAIWAN INST CHEM E, V41, P247, DOI 10.1016/j.jtice.2009.10.002
   Vanharanta S, 2012, CELL, V149, P1179, DOI 10.1016/j.cell.2012.05.013
   Wallace JM, 2011, J STRUCT BIOL, V173, P146, DOI 10.1016/j.jsb.2010.08.003
   Wang XN, 2005, J BIOMED MATER RES A, V74A, P263, DOI 10.1002/jbm.a.30387
   Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308
   Wu K, 2013, SPECTROCHIM ACTA A, V102, P186, DOI 10.1016/j.saa.2012.10.048
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zink C, 2012, BIOMATERIALS, V33, P8055, DOI 10.1016/j.biomaterials.2012.07.037
NR 90
TC 15
Z9 15
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD DEC 1
PY 2014
VL 45
BP 455
EP 468
DI 10.1016/j.msec.2014.09.006
PG 14
WC Materials Science, Biomaterials
SC Materials Science
GA AY4ZE
UT WOS:000347582600058
PM 25491851
DA 2018-10-20
ER

PT J
AU Struzyna, LA
   Katiyar, K
   Cullen, DK
AF Struzyna, Laura A.
   Katiyar, Kritika
   Cullen, D. Kacy
TI Living scaffolds for neuroregeneration
SO CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE
LA English
DT Review
DE Tissue engineering; Cell transplant; Biomaterials; Regeneration;
   Neurotrauma; Neurodegeneration; Axon pathfinding; Cell migration
ID PERIPHERAL-NERVE REGENERATION; NEURAL STEM-CELLS; LONG-TERM SURVIVAL;
   NEURITE OUTGROWTH; IN-VITRO; NEURONAL MIGRATION; NEUROTROPHIC FACTOR;
   GRASSHOPPER EMBRYOS; SUBSTRATE CURVATURE; FUNCTIONAL RECOVERY
AB Neural tissue engineers are exploiting key mechanisms responsible for neural cell migration and axonal pathfinding during embryonic development to create living scaffolds for neuroregeneration following injury and disease. These mechanisms involve the combined use of haptotactic, chemotactic, and mechanical cues to direct cell movement and re-growth. Living scaffolds provide these cues through the use of cells engineered in a predefined architecture, generally in combination with biomaterial strategies. Although several hurdles exist in the implementation of living regenerative scaffolds, there are considerable therapeutic advantages to using living cells in conjunction with biomaterials. The leading contemporary living scaffolds for neurorepair are utilizing aligned glial cells and neuronal/axonal tracts to direct regenerating axons across damaged tissue to appropriate targets, and in some cases to directly replace the function of lost cells. Future advances in technology, including the use of exogenous stimulation and genetically engineered stem cells, will further the potential of living scaffolds and drive a new era of personalized medicine for neuroregeneration. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Struzyna, Laura A.; Katiyar, Kritika; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.
   [Struzyna, Laura A.; Cullen, D. Kacy] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA.
   [Katiyar, Kritika] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA.
RP Cullen, DK (reprint author), 105E Hayden Hall 3320 Smith Walk, Philadelphia, PA 19104 USA.
EM lstruz@mail.med.upenn.edu; kritikak@mail.med.upenn.edu;
   dkacy@mail.med.upenn.edu
FU U.S. Army Medical Research and Materiel Command through the Armed Forces
   Institute of Regenerative Medicine [W81XWH-08-2-0034]; Congressionally
   Directed Medical Research Program [W81XWH-10-1-0941]; Axonia Medical,
   Inc.; Department of Veterans Affairs (RRD Merit Review) [B1097-I];
   National Institutes of Health/NINDS [T32-NS043126]; National Science
   Foundation (Graduate Research Fellowship) [DGE-1321851]
FX This work was made possible due to financial support provided by the
   U.S. Army Medical Research and Materiel Command through the Armed Forces
   Institute of Regenerative Medicine (#W81XWH-08-2-0034) and the
   Congressionally Directed Medical Research Program (#W81XWH-10-1-0941);
   Axonia Medical, Inc., through a sponsored research agreement; Department
   of Veterans Affairs (RR&D Merit Review #B1097-I); National Institutes of
   Health/NINDS (T32-NS043126); and the National Science Foundation
   (Graduate Research Fellowship DGE-1321851).
CR Akerud P, 2001, J NEUROSCI, V21, P8108
   Apel PJ, 2010, MUSCLE NERVE, V41, P335, DOI 10.1002/mus.21485
   Arumuganathar S, 2008, BIOMACROMOLECULES, V9, P759, DOI 10.1021/bm701322k
   Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.10.021
   Bai LH, 2013, NEUROSCI BULL, V29, P239, DOI 10.1007/s12264-013-1312-4
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Barker Roger A, 2004, NeuroRx, V1, P472, DOI 10.1007/BF03206631
   Barron V, 2003, ANN BIOMED ENG, V31, P1017, DOI 10.1114/1.1603260
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Bozkurt A, 2012, BIOMATERIALS, V33, P1363, DOI 10.1016/j.biomaterials.2011.10.069
   Bryson JB, 2014, SCIENCE, V344, P94, DOI 10.1126/science.1248523
   CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   Cullen DK, 2013, SCI AM, V308, P52, DOI 10.1038/scientificamerican0113-52
   Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.TEA.2011.0534, 10.1089/ten.tea.2011.0534]
   Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201
   Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P241
   Cullen DK, 2008, J NEURAL ENG, V5, P374, DOI 10.1088/1741-2560/5/4/002
   Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199
   Dillon GP, 1998, J BIOMAT SCI-POLYM E, V9, P1049, DOI 10.1163/156856298X00325
   East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017
   Eberli D, 2006, METHOD ENZYMOL, V420, P287, DOI 10.1016/S0076-6879(06)20013-2
   Enriquez-Barreto L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00076
   Faroni A, 2013, INT REV NEUROBIOL, V108, P121, DOI 10.1016/B978-0-12-410499-0.00005-8
   FAWCETT JW, 1989, DEV BIOL, V135, P449, DOI 10.1016/0012-1606(89)90193-0
   Fine EG, 2002, EUR J NEUROSCI, V15, P589, DOI 10.1046/j.1460-9568.2002.01892.x
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Gravvanis AI, 2005, MICROSURG, V25, P423, DOI 10.1002/micr.20141
   Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006
   Haile Y, 2007, BIOMATERIALS, V28, P1163, DOI 10.1016/j.biomaterials.2006.10.030
   HO RK, 1982, NATURE, V297, P404, DOI 10.1038/297404a0
   Honsa P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036816
   Hsu SH, 2009, ARTIF ORGANS, V33, P26, DOI 10.1111/j.1525-1594.2008.00671.x
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   JACOBS JR, 1989, J NEUROSCI, V9, P2402
   Jang MJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046019
   Jayo MJ, 2008, TOXICOL PATHOL, V36, P92, DOI 10.1177/0192623307311405
   Jensen JN, 2005, ANN PLAS SURG, V54, P420, DOI 10.1097/01.sap.0000151461.60911.c0
   Keenan TM, 2012, INTEGR BIOL-UK, V4, P1522, DOI 10.1039/c2ib20074k
   Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054
   Korecka JA, 2007, REGEN MED, V2, P425, DOI 10.2217/17460751.2.4.425
   KREWSON CE, 1994, BIOTECHNOL BIOENG, V43, P555, DOI 10.1002/bit.260430704
   Lee JS, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024103
   Lee ST, 2006, J NEUROSCI METH, V152, P250, DOI 10.1016/j.jneumeth.2005.09.013
   Liu GB, 2011, ARCH MED SCI, V7, P592, DOI 10.5114/aoms.2011.24127
   Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031675
   Lorber B, 2013, BIOFABRICATION, V6
   Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052
   Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Mason HA, 2001, J NEUROSCI, V21, P7654
   Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128
   Mortimer D, 2008, TRENDS NEUROSCI, V31, P90, DOI 10.1016/j.tins.2007.11.008
   Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931
   Nichterwitz S, 2010, NEUROSCI LETT, V484, P118, DOI 10.1016/j.neulet.2010.08.028
   O'Connor SM, 2001, NEUROSCI LETT, V304, P189, DOI 10.1016/S0304-3940(01)01769-4
   Parenteau N, 1999, SCI AM, V280, P83
   Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012
   Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004
   Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81
   Pina-Crespo JC, 2012, J NEUROSCI, V32, P15837, DOI 10.1523/JNEUROSCI.3735-12.2012
   Rajnicek AM, 2011, BIOL EFF ELECTROMAGN, P201
   RAPER JA, 1983, J NEUROSCI, V3, P31
   Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933
   Rosenstein JM, 2010, ORGANOGENESIS, V6, P107, DOI 10.4161/org.6.2.11687
   Royo-Gascon N, 2013, ANN BIOMED ENG, V41, P112, DOI 10.1007/s10439-012-0628-y
   Santosa KB, 2013, MUSCLE NERVE, V47, P213, DOI 10.1002/mus.23490
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015
   Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411
   Shi P, 2007, DEV NEUROBIOL, V67, P1765, DOI 10.1002/dneu.20553
   Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z
   Smeal RM, 2008, EXP NEUROL, V213, P281, DOI 10.1016/j.expneurol.2008.05.026
   Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4
   Thorne RG, 2001, CLIN PHARMACOKINET, V40, P907, DOI 10.2165/00003088-200140120-00003
   Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278
   Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003
   Verdu E, 2002, RESTOR NEUROL NEUROS, V20, P169
   Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002
   Weick JP, 2010, STEM CELLS, V28, P2008, DOI 10.1002/stem.514
   Weightman A, 2013, NANOMED-NANOTECHNOL, V10, P291
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Withers GS, 2006, J NEUROBIOL, V66, P1183, DOI 10.1002/neu.20298
   Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004
   Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a
   Yamada M, 2007, STEM CELLS, V25, P562, DOI 10.1634/stemcells.2006-0011
   Yan QJ, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-36
   Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006
   Zuo H, 2013, NEUROSCI BULL, V29, P165, DOI 10.1007/s12264-013-1320-4
NR 101
TC 18
Z9 20
U1 0
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-0286
EI 1879-0348
J9 CURR OPIN SOLID ST M
JI Curr. Opin. Solid State Mat. Sci.
PD DEC
PY 2014
VL 18
IS 6
BP 308
EP 318
DI 10.1016/j.cossms.2014.07.004
PG 11
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA AY3QU
UT WOS:000347498600002
PM 28736499
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Bowers, DT
   Tanes, ML
   Das, A
   Lin, Y
   Keane, NA
   Neal, RA
   Ogle, ME
   Brayman, KL
   Fraser, CL
   Botchwey, EA
AF Bowers, Daniel T.
   Tanes, Michael L.
   Das, Anusuya
   Lin, Yong
   Keane, Nicole A.
   Neal, Rebekah A.
   Ogle, Molly E.
   Brayman, Kenneth L.
   Fraser, Cassandra L.
   Botchwey, Edward A.
TI Spatiotemporal Oxygen Sensing Using Dual Emissive Boron Dye Polylactide
   Nanofibers
SO ACS NANO
LA English
DT Article
DE nanofibers; electrospinning; ratiometric; oxygen; hypoxia; scaffold;
   cell transplant
ID EMBRYONIC STEM-CELLS; ELECTROSPUN NANOFIBERS; REGENERATIVE MEDICINE;
   DIFFERENTIATION; HYPOXIA; NANOPARTICLES; SCAFFOLDS; CULTURE; MATRIX;
   TRANSPLANTATION
AB Oxygenation in tissue scaffolds continues to be a limiting factor in regenerative medicine despite efforts to induce neovascularization or to use oxygen-generating materials. Unfortunately, many established methods to measure oxygen concentration, such as using electrodes, require mechanical disturbance of the tissue structure. To address the need for scaffold-based oxygen concentration monitoring, a single-component, self-referenced oxygen sensor was made into nanofibers. Electrospinning process parameters were tuned to produce a biomaterial scaffold with specific morphological features. The ratio of an oxygen sensitive phosphorescence signal to an oxygen insensitive fluorescence signal was calculated at each image pixel to determine an oxygenation value. A single component boron dye-polymer conjugate was chosen for additional investigation due to improved resistance to degradation in aqueous media compared to a boron dye polymer blend. Standardization curves show that in fully supplemented media, the fibers are responsive to dissolved oxygen concentrations less than 15 ppm. Spatial (millimeters) and temporal (minutes) ratiometric gradients were observed in vitro radiating outward from the center of a dense adherent cell grouping on scaffolds. Sensor activation in ischemia and cell transplant models in vivo show oxygenation decreases on the scale of minutes. The nanofiber construct offers a robust approach to biomaterial scaffold oxygen sensing.
C1 [Bowers, Daniel T.; Das, Anusuya; Lin, Yong; Keane, Nicole A.; Neal, Rebekah A.; Brayman, Kenneth L.; Fraser, Cassandra L.; Botchwey, Edward A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Tanes, Michael L.; Ogle, Molly E.; Botchwey, Edward A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Tanes, Michael L.; Ogle, Molly E.; Botchwey, Edward A.] Emory Univ, Atlanta, GA 30332 USA.
   [Das, Anusuya] Univ Virginia, Charlottesville, VA 22908 USA.
   [Brayman, Kenneth L.] Univ Virginia, Dept Surg, Charlottesville, VA 22908 USA.
   [Fraser, Cassandra L.] Univ Virginia, Dept Chem, Charlottesville, VA 22908 USA.
RP Botchwey, EA (reprint author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
EM edward.botchwey@bme.gatech.edu
RI Lin, Yong/I-4505-2016
OI Lin, Yong/0000-0002-2839-5740; Neal, Rebekah/0000-0002-2566-3850
FU National Science Foundation [0933643, EFRI 0902969]; NIH [RO1CA167250,
   1R01DE019935-01, 1R01AR056445-01A2]; nanoSTAR Undergraduate Summer
   Research Fund
FX We thank the National Science Foundation (E.A.B., K.L.B.: 0933643; C.
   Laurencin, E.A.B.: EFRI 0902969) for support of this research. We also
   thank the NIH (RO1CA167250, to C.L.F. and 1R01DE019935-01,
   1R01AR056445-01A2 to E.A.B.) for funding the research. We are grateful
   for student support from nanoSTAR Undergraduate Summer Research Fund
   (M.L.T.). We thank P. Chhabra for teaching islet isolation. We thank R.
   Murray, R. Linhart, J. Samonina-Kosicka, and G. Zhang, for data
   collection assistance. We are also grateful to C. Bampoe for
   contributing murine surgical expertise.
CR Allen J, 2007, BIOMATERIALS, V28, P162, DOI 10.1016/j.biomaterials.2006.07.002
   Ardeshirylajimi A, 2013, MOL BIOL REP, V40, P4287, DOI 10.1007/s11033-013-2515-5
   Bath C, 2013, STEM CELL RES, V10, P349, DOI 10.1016/j.scr.2013.01.004
   Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5
   Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x
   Cohen-Karni T, 2012, NANO LETT, V12, P5403, DOI 10.1021/nl302810c
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015
   DULING BR, 1970, CIRC RES, V27, P669, DOI 10.1161/01.RES.27.5.669
   Escribese MM, 2012, IMMUNOBIOLOGY, V217, P1233, DOI 10.1016/j.imbio.2012.07.002
   Forristal CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062507
   Franke K, 2013, BLOOD, V122, P1122, DOI 10.1182/blood-2013-01-478065
   Gershovich JG, 2013, TISSUE ENG PT A, V19, P2565, DOI [10.1089/ten.tea.2013.0256, 10.1089/ten.TEA.2013.0256]
   Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Hong H, 2012, SPECTROCHIM ACTA A, V98, P466, DOI 10.1016/j.saa.2012.09.006
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Jiang X, 2015, J BIOMED MATER RES A, V103, P959, DOI 10.1002/jbm.a.35237
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kersey FR, 2010, ACS NANO, V4, P4989, DOI 10.1021/nn901873t
   Kingham E, 2013, ACS NANO, V7, P1867, DOI 10.1021/nn3037094
   Koo YEL, 2004, ANAL CHEM, V76, P2498, DOI 10.1021/ac035493f
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Lee S, 2012, NAT METHODS, V9, P917, DOI 10.1038/nmeth.2105
   Lin SZ, 2010, SPECTROCHIM ACTA A, V77, P885, DOI 10.1016/j.saa.2010.08.025
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Ludwig B, 2012, P NATL ACAD SCI USA, V109, P5022, DOI 10.1073/pnas.1201868109
   McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040
   McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Mosinger J, 2010, LANGMUIR, V26, P10050, DOI 10.1021/la1001607
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Murray RA, 2010, ACS SYM SER, V1054, P33
   Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022
   Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204
   Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Pfister A, 2008, ACS NANO, V2, P1252, DOI 10.1021/nn7003525
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Pietrocola F, 2013, SEMIN CANCER BIOL, V23, P310, DOI 10.1016/j.semcancer.2013.05.008
   Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470
   Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034
   Semenza GL, 2011, NEW ENGL J MED, V365, P537, DOI 10.1056/NEJMra1011165
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stacpoole SRL, 2013, STEM CELL TRANSL MED, V2, P464, DOI 10.5966/sctm.2012-0144
   Sun H, 2006, CHEM MATER, V18, P3381, DOI 10.1021/cm052750j
   Thibault RA, 2010, TISSUE ENG PT A, V16, P431, DOI [10.1089/ten.tea.2009.0583, 10.1089/ten.TEA.2009.0583]
   Wen CH, 2011, SPECTROCHIM ACTA A, V79, P1345, DOI 10.1016/j.saa.2011.04.067
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Xue RP, 2013, MAT SCI ENG C-MATER, V33, P3450, DOI 10.1016/j.msec.2013.04.030
   Yamazoe T, 2013, J CELL SCI, V126, P5391, DOI 10.1242/jcs.129767
   Yeo M, 2011, BIOMACROMOLECULES, V12, P502, DOI 10.1021/bm1013052
   Zhang GQ, 2008, ADV MATER, V20, P2099, DOI 10.1002/adma.200702681
   Zhang GQ, 2009, NAT MATER, V8, P747, DOI [10.1038/NMAT2509, 10.1038/nmat2509]
   Zhang HR, 2011, J NANOSCI NANOTECHNO, V11, P9840, DOI 10.1166/jnn.2011.5241
NR 58
TC 16
Z9 16
U1 4
U2 85
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD DEC
PY 2014
VL 8
IS 12
BP 12080
EP 12091
DI 10.1021/nn504332j
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AX8CL
UT WOS:000347138000021
PM 25426706
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Chiang, YC
   Lin, HP
   Chang, HH
   Cheng, YW
   Tang, HY
   Yen, WC
   Lin, PY
   Chang, KW
   Lin, CP
AF Chiang, Yu-Chih
   Lin, Hong-Ping
   Chang, Hao-Hueng
   Cheng, Ya-Wen
   Tang, Hsin-Yen
   Yen, Wei-Ching
   Lin, Po-Yen
   Chang, Kei-Wen
   Lin, Chun-Pin
TI A Mesoporous Silica Biomaterial for Dental Biomimetic Crystallization
SO ACS NANO
LA English
DT Article
DE biomimetics; crystal growth; dentinal tubule; mesoporous materials;
   sub-mu-CT
ID CALCIUM-PHOSPHATE PRECIPITATION; DENTINAL TUBULE OCCLUSION; DP-BIOGLASS
   PASTE; IN-VITRO; HYPERSENSITIVITY; HYDROXYAPATITE; PERMEABILITY; AGENTS
AB The loss of overlying enamel or cementum exposes dentinal tubules and increases the risk of several dental diseases, such as dentin hypersensitivity (causing sharp pain and anxiety), caries, and pulp inflammation. This paper presents a fast-reacting, more reliable and biocompatible biomaterial that effectively occludes exposed dentinal tubules by forming a biomimetic crystalline dentin barrier. To generate this biomaterial, a gelatin-templated mesoporous silica biomaterial (CaCO3@mesoporous silica, CCMS) containing nanosized calcium carbonate particles is mixed with 30% H3PO4 at a 1/1 molar ratio of Ca/P (denoted as CCMS-HP), which enables Ca2+ and PO43/HPO42 ions to permeate the dentinal tubules and form dicalcium phosphate dihydrate (DCPD), tricalcium phosphate (TCP) or hydroxyapatite (HAp) crystals at a depth of approximately 40 mu m (sub-mu-CT and nano-SEM/EDS examinations). In vitro biocompatibility tests (WST-1 and lactate dehydrogenase) and ALP assays show high cell viability and mineralization ability in a transwell dentin disc model treated with CCMS-HP (p < 0.05). The in vivo efficacy and biocompatibility analyses of the biomaterial in an animal model reveal significant crystal growth (DCPD, TCP or HAp-like) and no pulp irritation after 70 days (p < 0.05). The developed CCMS-HP holds great promise for treating exposed dentin by growing biomimetic crystals within dentinal tubules. These findings demonstrate that the mesoporous silica biomaterials presented here have great potential for serving as both a catalyst and carrier in the repair or regeneration of dental hard tissue.
C1 [Chiang, Yu-Chih; Chang, Hao-Hueng; Cheng, Ya-Wen; Tang, Hsin-Yen; Yen, Wei-Ching; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Taipei 10016, Taiwan.
   [Chiang, Yu-Chih; Chang, Hao-Hueng; Cheng, Ya-Wen; Tang, Hsin-Yen; Yen, Wei-Ching; Lin, Chun-Pin] Natl Taiwan Univ, Grad Inst Clin Dent, Taipei 10016, Taiwan.
   [Chiang, Yu-Chih; Chang, Hao-Hueng; Cheng, Ya-Wen; Tang, Hsin-Yen; Yen, Wei-Ching; Lin, Chun-Pin] Natl Taiwan Univ Hosp, Taipei 10016, Taiwan.
   [Lin, Po-Yen] Natl Yang Ming Univ, Dept Dent, Sch Dent, Taipei 112, Taiwan.
   [Lin, Hong-Ping; Chang, Kei-Wen] Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan.
RP Lin, CP (reprint author), Natl Taiwan Univ, Sch Dent, 1 Chang Te St, Taipei 10016, Taiwan.
EM pinlin@ntu.edu.tw
OI Lin, Chun-Pin/0000-0002-3498-1113; CHIANG, YU-CHIH/0000-0001-8110-3033
FU National Science Council [97-2314-B-002-105]; National Taiwan University
   Hospital [96-S653, 100-N1766]
FX This study was partly supported with funding from the National Science
   Council (97-2314-B-002-105) and the National Taiwan University Hospital
   (96-S653 &100-N1766).
CR ABSI EG, 1987, J CLIN PERIODONTOL, V14, P280, DOI 10.1111/j.1600-051X.1987.tb01533.x
   Addy M., 2000, TOOTH WEAR SENSITIVI, P339
   Ayad Farid, 2009, J Clin Dent, V20, P10
   Bergamini MR, 2014, LIFE SCI, V98, P96, DOI 10.1016/j.lfs.2014.01.004
   BRANNSTROM M, 1963, J AM DENT ASSOC, V66, P366
   Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148
   CLARK DC, 1985, J PERIODONTAL RES, V20, P212, DOI 10.1111/j.1600-0765.1985.tb00428.x
   DAMEN JJM, 1989, J DENT RES, V68, P1355, DOI 10.1177/00220345890680091301
   DAMEN JJM, 1992, J DENT RES, V71, P453, DOI 10.1177/00220345920710030601
   Featherstone JDB, 2006, MG ORAL SCI, V20, P66
   GERZINA TM, 1995, J DENT RES, V74, P369, DOI 10.1177/00220345950740011301
   GREENHILL JD, 1981, J DENT RES, V60, P686, DOI 10.1177/00220345810600030401
   He CL, 2010, ADV FUNCT MATER, V20, P3568, DOI 10.1002/adfm.201000993
   Heyeraas KJ, 2001, QUINTESSENCE INT, V32, P611
   HOPPENBROUWERS PMM, 1986, J DENT RES, V65, P955, DOI 10.1177/00220345860650071101
   Imai Y, 1990, Dent Mater J, V9, P167
   ISHIKAWA K, 1994, J DENT RES, V73, P1462, DOI 10.1177/00220345940730081101
   Kolker Justine L, 2002, J Adhes Dent, V4, P211
   Kuo TC, 2007, J ENDODONT, V33, P451, DOI 10.1016/j.joen.2006.12.014
   Lee BS, 2007, DENT MATER J, V26, P52, DOI 10.4012/dmj.26.52
   Lee BS, 2005, DENT MATER J, V24, P562, DOI 10.4012/dmj.24.562
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Li CC, 2011, CHEM COMMUN, V47, P9414, DOI 10.1039/c1cc12613j
   LI PJ, 1993, BIOMATERIALS, V14, P963, DOI 10.1016/0142-9612(93)90186-6
   Lin PY, 2013, J CLIN PERIODONTOL, V40, P53, DOI 10.1111/jcpe.12011
   Moritz A, 1998, J CLIN LASER MED SUR, V16, P211, DOI 10.1089/clm.1998.16.211
   Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321
   PASHLEY DH, 1985, J DENT RES, V64, P613, DOI 10.1177/002203458506400419
   Pashley DH, 1996, ARCH ORAL BIOL, V41, P1065, DOI 10.1016/S0003-9969(96)00059-3
   Petrou Irene, 2009, J Clin Dent, V20, P23
   Rashid F, 2003, J ENDODONT, V29, P104, DOI 10.1097/00004770-200302000-00004
   Rusin RP, 2010, DENT MATER, V26, P600, DOI 10.1016/j.dental.2010.02.010
   Sakthivel A, 2005, ADV FUNCT MATER, V15, P253, DOI 10.1002/adfm.200400038
   Sakthivel A, 2007, DALTON T, P320, DOI 10.1039/b611550k
   Schlueter N, 2009, EUR J ORAL SCI, V117, P427, DOI 10.1111/j.1600-0722.2009.00647.x
   SCHMALZ G, 1994, J ENDODONT, V20, P592, DOI 10.1016/S0099-2399(06)80083-X
   Suge T, 2002, AM J DENT, V15, P220
   Suge T, 1995, J DENT RES, V74, P1709, DOI 10.1177/00220345950740101301
   Tanase C. E., 2013, BIOMED MATER, V8, P1
   THOMAS HF, 1984, J DENT RES, V63, P1064, DOI 10.1177/00220345840630081101
   Vahid Golpayegani M, 2012, J Dent (Tehran), V9, P68
   Vieira AR, 2012, J ENDODONT, V38, P250, DOI 10.1016/j.joen.2011.10.019
   West NX, 2013, CLIN ORAL INVEST, V17, pS9, DOI 10.1007/s00784-012-0887-x
   Wu SH, 2013, CHEM SOC REV, V42, P3862, DOI 10.1039/c3cs35405a
   Yeh YQ, 2011, J COLLOID INTERF SCI, V362, P354, DOI 10.1016/j.jcis.2011.07.011
NR 45
TC 16
Z9 16
U1 5
U2 134
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD DEC
PY 2014
VL 8
IS 12
BP 12502
EP 12513
DI 10.1021/nn5053487
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AX8CL
UT WOS:000347138000063
PM 25482513
DA 2018-10-20
ER

PT J
AU Navitsky, MA
   Taylor, JO
   Smith, AB
   Slattery, MJ
   Deutsch, S
   Siedlecki, CA
   Manning, KB
AF Navitsky, Michael A.
   Taylor, Joshua O.
   Smith, Alexander B.
   Slattery, Margaret J.
   Deutsch, Steven
   Siedlecki, Christopher A.
   Manning, Keefe B.
TI Platelet Adhesion to Polyurethane Urea Under Pulsatile Flow Conditions
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Platelet adhesion; Fluid dynamics; Polyurethane; Pulsatile flow;
   Rotating disk; Shear stress
ID VENTRICULAR ASSIST DEVICE; IN-VIVO; SURFACE THROMBOSIS; BLOOD PUMPS;
   SYSTEM; VISUALIZATION
AB Platelet adhesion to a polyurethane urea surface is a precursor to thrombus formation within blood-contacting cardiovascular devices, and platelets have been found to adhere strongly to polyurethane surfaces below a shear rate of approximately 500s(-1). The aim of the current work is to determine the properties of platelet adhesion to the polyurethane urea surface as a function of time-varying shear exposure. A rotating disk system was used to study the influence of steady and pulsatile flow conditions (e.g., cardiac inflow and sawtooth waveforms) for platelet adhesion to the biomaterial surface. All experiments were conducted with the same root mean square angular rotation velocity (29.63rad/s) and waveform period. The disk was rotated in platelet-rich bovine plasma for 2h, with adhesion quantified by confocal microscopy measurements of immunofluorescently labeled bovine platelets. Platelet adhesion under pulsating flow was found to decay exponentially with increasing shear rate. Adhesion levels were found to depend upon peak platelet flux and shear rate, regardless of rotational waveform. In combination with flow measurements, these results may be useful for predicting regions susceptible to thrombus formation within ventricular assist devices.
C1 [Navitsky, Michael A.; Taylor, Joshua O.; Smith, Alexander B.; Slattery, Margaret J.; Deutsch, Steven; Siedlecki, Christopher A.; Manning, Keefe B.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA.
   [Siedlecki, Christopher A.; Manning, Keefe B.] Penn State Hershey Med Ctr, Dept Surg, Hershey, PA USA.
RP Manning, KB (reprint author), Penn State Univ, Dept Bioengn, 205 Hallowell Bldg, University Pk, PA 16802 USA.
EM kbm10@psu.edu
FU NHLBI NIH HHS [HL60276, R56 HL060276, R01 HL060276]
CR Balsasubramanian V, 2002, J BIOMAT SCI-POLYM E, V13, P543
   BENTON ER, 1966, J FLUID MECH, V24, P781, DOI 10.1017/S0022112066001009
   Dailyn JW, 1960, T ASME J BASIC ENG, V3, P217
   Deutsch S, 2006, ANNU REV FLUID MECH, V38, P65, DOI 10.1146/annurev.fluid.38.050304.092022
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hochareon P, 2004, ASAIO J, V50, P537, DOI 10.1097/01.MAT.0000145694.40637.A0
   HUBBELL JA, 1986, BIOMATERIALS, V7, P354, DOI 10.1016/0142-9612(86)90006-2
   Kahn RA, 2003, TRANSFUSION, V20, P498
   Kreider JW, 2006, ASAIO J, V52, P123, DOI 10.1097/01.mat.0000199750.89636.77
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Linneweber J, 2007, ARTIF ORGANS, V31, P345, DOI 10.1111/j.1525-1594.2007.00391.x
   Massa TM, 2005, BIOMATERIALS, V26, P7367, DOI 10.1016/j.biomaterials.2005.05.063
   Medvitz RB, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000116
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Nanna JC, 2011, ASAIO J, V57, P349, DOI 10.1097/MAT.0b013e318224e20b
   Navitsky MA, 2013, ANN BIOMED ENG, V41, P4, DOI 10.1007/s10439-012-0627-z
   Oley LA, 2005, ARTIF ORGANS, V29, P378, DOI 10.1111/j.1525-1594.2005.29064.x
   ROSENBERG G, 1981, ASAIO J, V4, P41
   Roszelle B, 2010, THESIS PENNSYLVANIA
   Roszelle BN, 2011, ANN BIOMED ENG, V39, P2046, DOI 10.1007/s10439-011-0291-8
   SCOTT EP, 1980, TRANSFUSION, V20, P489, DOI 10.1046/j.1537-2995.1980.20581034500.x
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Yamanaka H, 2006, ASAIO J, V52, P257, DOI 10.1097/01.mat.0000219067.19482.1e
   Yamanaka H, 2005, ASAIO J, V51, P567, DOI 10.1097/01.mat.0000181707.06225.a0
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 26
TC 8
Z9 8
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD DEC
PY 2014
VL 38
IS 12
BP 1046
EP 1053
DI 10.1111/aor.12296
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA AX0QI
UT WOS:000346656300009
PM 24721222
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wei, JC
   Guo-Wang, PY
   Cui, LG
   Zhang, HB
   Dai, YF
   Liu, TX
AF Wei Junchao
   Guo-Wang Peiyao
   Cui Liguo
   Zhang Haobin
   Dai Yanfeng
   Liu Tianxi
TI Novel Method to Graft Chitosan on the Surface of Hydroxyapatite
   Nanoparticles via "Click" Reaction
SO CHEMICAL RESEARCH IN CHINESE UNIVERSITIES
LA English
DT Article
DE Hydroxyapatite; Chitosan; Surface modification; Nanocomposite;
   Biomaterial
ID NANO-HYDROXYAPATITE; MECHANICAL-PROPERTIES; COMPOSITE; SCAFFOLDS;
   POLY(L-LACTIDE); BIOACTIVITY; CHEMISTRY
AB In order to tune the surface properties of hydroxyapatite(HA) nanoparticles and prevent them from aggregation, an efficient method was proposed to graft chitosan(CS) molecules on the surface of HA via "click" reaction. Thermal gravimetric analysis(TGA) shows that CS was successfully grafted on the surface of HA nanoparticles and the grafting amount was about 8.9 g of CS on per hundred grams of HA. The grafted chitosan chains can prevent HA nanoparticles from aggregation and greatly enhance the colloidal stability of HA in water. The 3-(4,5-dimethylthiazoyl-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay demonstrats that the cytotoxicity of CS modified HA(HA-CS) is negligible and thus HA-CS may find potential application in biomedical fields.
C1 [Wei Junchao; Guo-Wang Peiyao; Zhang Haobin; Dai Yanfeng; Liu Tianxi] Nanchang Univ, Dept Chem, Nanchang 330031, Peoples R China.
   [Wei Junchao; Liu Tianxi] Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Cui Liguo] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.
RP Wei, JC (reprint author), Nanchang Univ, Dept Chem, Nanchang 330031, Peoples R China.
EM weijunchao@ncu.edu.cn; txliu@fudan.edu.cn
RI Liu, Tianxi/E-6628-2011
OI Liu, Tianxi/0000-0002-5592-7386
FU National Natural Science Foundation of China [51203073, 51463013];
   Natural Science Foundation of Jiangxi Province of China
   [20142BAB203018]; Natural Science Foundation of Education Department of
   Jiangxi Province of China [GJJ13107]
FX Supported by the National Natural Science Foundation of China(Nos.
   51203073, 51463013), the Natural Science Foundation of Jiangxi Province
   of China(No. 20142BAB203018) and the Natural Science Foundation of
   Education Department of Jiangxi Province of China(No. GJJ13107).
CR Chen J, 2011, J POLYM SCI POL CHEM, V49, P4379, DOI 10.1002/pola.24878
   Ding CC, 2012, MATER LETT, V79, P72, DOI 10.1016/j.matlet.2012.03.092
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Lee HJ, 2006, CHEM MATER, V18, P5111, DOI 10.1021/cm061139x
   Liu YD, 2013, MACROMOL BIOSCI, V13, P356, DOI 10.1002/mabi.201200345
   MCCONNELL D, 1961, SCIENCE, V133, P281, DOI 10.1126/science.133.3448.281
   Pu XM, 2013, MATER LETT, V94, P169, DOI 10.1016/j.matlet.2012.12.009
   Qian JM, 2013, MATER LETT, V93, P72, DOI 10.1016/j.matlet.2012.11.046
   Schlossbauer A, 2008, J AM CHEM SOC, V130, P12558, DOI 10.1021/ja803018w
   Sun YH, 2013, COLLOID SURFACE B, V111, P107, DOI 10.1016/j.colsurfb.2013.05.037
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   Tang YF, 2014, CHINESE J POLYM SCI, V32, P805, DOI 10.1007/s10118-014-1454-5
   Wang Y, 2011, APPL SURF SCI, V257, P6233, DOI 10.1016/j.apsusc.2011.02.045
   Wang Y, 2010, APPL SURF SCI, V256, P6107, DOI 10.1016/j.apsusc.2010.03.127
   Wei JC, 2009, MACROMOL BIOSCI, V9, P1237, DOI 10.1002/mabi.200900256
   Wei JC, 2009, MACROMOL BIOSCI, V9, P631, DOI 10.1002/mabi.200800324
   Yu CC, 2013, MATER LETT, V93, P133, DOI 10.1016/j.matlet.2012.11.040
   Yu T, 2009, CHEM J CHINESE U, V30, P1439
   Zhang JZ, 2012, CHEM J CHINESE U, V33, P219
   Zhang PB, 2011, BIOMACROMOLECULES, V12, P2667, DOI 10.1021/bm2004725
NR 20
TC 4
Z9 4
U1 2
U2 67
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 1005-9040
EI 2210-3171
J9 CHEM RES CHINESE U
JI Chem. Res. Chin. Univ.
PD DEC
PY 2014
VL 30
IS 6
BP 1063
EP 1065
DI 10.1007/s40242-014-4166-z
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AX4TL
UT WOS:000346924000033
DA 2018-10-20
ER

PT J
AU Bencharit, S
   Byrd, WC
   Altarawneh, S
   Hosseini, B
   Leong, A
   Reside, G
   Morelli, T
   Offenbacher, S
AF Bencharit, Sompop
   Byrd, Warren C.
   Altarawneh, Sandra
   Hosseini, Bashir
   Leong, Austin
   Reside, Glenn
   Morelli, Thiago
   Offenbacher, Steven
TI Development and Applications of Porous Tantalum Trabecular
   Metal-Enhanced Titanium Dental Implants
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE immediate loading; implant; implant design; implant surface;
   osseointegration; surface properties
ID BONE; INGROWTH; OSSEOINTEGRATION; RECONSTRUCTION; BIOMATERIAL;
   PERFORMANCE; EDENTULISM; SURFACES; DISEASE; RISK
AB BackgroundPorous tantalum trabecular metal has recently been incorporated in titanium dental implants as a new form of implant surface enhancement. However, there is little information on the applications of this material in implant dentistry.
   PurposeThe purpose of this article is to summarize the contemporary concept on the applications of porous tantalum trabecular metal in implant dentistry.
   Materials and MethodsWe therefore review the current literature on the basic science and clinical uses of this material.
   ResultsPorous tantalum metal is used to improve the contact between osseous structure and dental implants and therefore presumably facilitate osseointegration. Success of porous tantalum metal in orthopedic implants led to the incorporation of porous tantalum metal in the design of root-form endosseous titanium implants. The porous tantalum three-dimensional enhancement of titanium dental implant surface allows for combining bone ongrowth together with bone ingrowth, or osseoincorporation. While little is known about the biological aspect of the porous tantalum in the oral cavity, there seems to be several possible advantages of this implant design. This article reviews the biological aspects of porous tantalum-enhanced titanium dental implants, in particular the effects of anatomical consideration and oral environment to implant designs.
   ConclusionsWe propose here possible clinical situations and applications for this type of dental implant. Advantages and disadvantages of the implants as well as needed future clinical studies are discussed.
C1 [Bencharit, Sompop; Leong, Austin] Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA.
   [Bencharit, Sompop] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.
   [Byrd, Warren C.] Univ N Carolina, Sch Dent, Dept Dent Res, Chapel Hill, NC 27599 USA.
   [Altarawneh, Sandra] Univ Jordan, Fac Dent, Dept Prosthodont, Amman, Jordan.
   [Hosseini, Bashir] Univ N Carolina, Sch Dent, Dept Endodont, Chapel Hill, NC 27599 USA.
   [Reside, Glenn] Univ N Carolina, Sch Dent, Dept Oral & Maxillofacial Surg, Chapel Hill, NC 27599 USA.
   [Morelli, Thiago; Offenbacher, Steven] Univ N Carolina, Sch Dent, Dept Periodontol, Chapel Hill, NC 27599 USA.
RP Bencharit, S (reprint author), Univ N Carolina, Sch Dent, Dept Prosthodont, CB 7450, Chapel Hill, NC 27599 USA.
EM sompop_bencharit@dentistry.unc.edu
FU American Academy of Implant Dentistry Research Grant; American College
   of Prosthodontists Educational Fund; National Institutes of Health (NIH)
   grant [HL092338]
FX Zimmer Dental Inc. has provided the figures of porous Ta metal and
   PTTM-enhanced dental implants. The authors would like to thank the
   members of the University of North Carolina at Chapel Hill Dental
   Faculty Practice, Graduate Prosthodontic Clinic, and the General-Oral
   Health Clinic where clinical work was done. The work of author SB was
   partly supported by the American Academy of Implant Dentistry Research
   Grant, the American College of Prosthodontists Educational Fund, and the
   National Institutes of Health (NIH) grant HL092338.
CR ADELL R, 1986, INT J ORAL MAX SURG, V15, P39, DOI 10.1016/S0300-9785(86)80010-2
   Agulyanski A, 2004, CHEM TANTALUM NIOBIU, P1
   Aycan S, 2005, J SOC SCI, V1, P238
   Bain C A, 1993, Int J Oral Maxillofac Implants, V8, P609
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bothe RT, 1940, SURG GYNECOL OBSTET, V7, P1598
   Brogniez V, 1998, INT J ORAL MAX IMPL, V13, P506
   Christie Michael J, 2002, Am J Orthop (Belle Mead NJ), V31, P219
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Colakis M, 2007, CLASSICAL MYTHOLOGY, P204
   FAIRBROTHER F, 1967, CHEM NIOBIUM TANTALU, P20
   Felton DA, 2009, J PROSTHODONT, V18, P88, DOI 10.1111/j.1532-849X.2009.00437.x
   Greenwood N, 1997, CHEM ELEMENTS, P1138
   Griffith WP, 2003, NOTES REC ROY SOC, V57, P299, DOI 10.1098/rsnr.2003.0216
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Harrison AK, 2010, CLIN ORTHOP RELAT R, V468, P2739, DOI 10.1007/s11999-009-1222-y
   Heiner AD, 2001, T ORTHOP RES SOC, V26, P480
   Henry P J, 1996, Int J Oral Maxillofac Implants, V11, P450
   HIRAI T, 1993, J PROSTHET DENT, V69, P49, DOI 10.1016/0022-3913(93)90240-O
   Hiraki A, 2008, CANCER EPIDEM BIOMAR, V17, P1222, DOI 10.1158/1055-9965.EPI-07-2761
   Javed F, 2009, J PERIODONTOL, V80, P1719, DOI 10.1902/jop.2009.090283
   Joshipura KJ, 2003, STROKE, V34, P47, DOI 10.1161/01.STR.0000052974.79428.0C
   Kaplan RB, 1994, U.S. Patent, Patent No. 5282861
   Kaplan RB, 1994, OR HLTH, Patent No. 5282861
   KOCK W, 1989, JOM-J MIN MET MAT S, V41, P33
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Loesche WJ, 1998, J AM DENT ASSOC, V129, P301, DOI 10.14219/jada.archive.1998.0204
   Medina-Solis CE, 2006, AM J PUBLIC HEALTH, V96, P1578, DOI 10.2105/AJPH.2005.071209
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mineta K, 2005, J PHYS CHEM SOLIDS, V66, P318, DOI 10.1016/j.jpcs.2004.06.060
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Moy PK, 2005, INT J ORAL MAX IMPL, V20, P569
   Roberts W E, 1992, Implant Dent, V1, P11, DOI 10.1097/00008505-199200110-00002
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schwartz-Arad D, 2002, J PERIODONTOL, V73, P153, DOI 10.1902/jop.2002.73.2.153
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   TAYLOR TD, 1993, J PROSTHET DENT, V69, P60, DOI 10.1016/0022-3913(93)90242-G
   Weeks ME, 1932, J CHEM EDUC, V9, P867
   Wollaston WH, 1809, JSTOR, V99, P246
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 46
TC 27
Z9 28
U1 1
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD DEC
PY 2014
VL 16
IS 6
BP 817
EP 826
DI 10.1111/cid.12059
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AX6NR
UT WOS:000347039400004
PM 23527899
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Han, XT
   Xing, ZG
   Si, SX
   Yao, YY
   Zhang, QY
AF Han, Xiaotong
   Xing, Zuge
   Si, Shaoxiong
   Yao, Yongyi
   Zhang, Qiyi
TI Electrospun grape seed polyphenols/gelatin composite fibers contained
   silver nanoparticles as biomaterials
SO FIBERS AND POLYMERS
LA English
DT Article
DE Nanofibers; Silver nanoparticles; Grape seed polyphenols; Gelatin;
   Electrospun; Antibacterial
ID NANOFIBERS; TOXICITY; RATS
AB GSP/gelatin composite nanofiber membranes containing silver nanoparticles were successfully fabricated as a novel biomaterial by electrospinning. The silver nanoparticles (AgNPs) were synthesized with the grape seed polyphenols (GSP) as reducing agent in aqueous solution of gelatin, and then the GSP/gelatin/AgNPs mixed solution was electrospun into nanofibers at 55 A degrees C. The scanning electron microscopy (SEM) confirmed that the composite fibers were uniform and the average fiber diameter ranged between 150 nm and 230 nm with an increase in applied potentials from 14 kV to 22 kV. And the transmission electron microscopy (TEM) showed that silver nanoparticles distributed individually in the fibers with the average particle size of about 11 nm. Furthermore, the ultraviolet visible spectrophotometer (UV-vis spectroscopy) test demonstrated that all of Ag+ converted to Ag-0 when the concentration of gelatin was 24 wt% and the mass ratio of GSP to AgNO3 was about 5:2. The antibacterial activities of the fiber membranes against E.coli and S.aureus were measured via a shake flank test and demonstrated good performance after the importation of silver nanopaticles. Cytotoxicity testing also revealed that fiber membranes contained silver nanoparticles had no cyto-toxic. All the results indicated that the GSP was effective for the formation and stabilization of silver nanoparticles in composite nanofibers mats which had the potential for applications in antimicrobial tissue engineering and wound dressing.
C1 [Han, Xiaotong; Xing, Zuge; Si, Shaoxiong; Zhang, Qiyi] Sichuan Univ, Coll Chem Engn, Chengdu 610065, Peoples R China.
   [Yao, Yongyi] Sichuan Univ, Text Inst, Chengdu 610065, Peoples R China.
RP Zhang, QY (reprint author), Sichuan Univ, Coll Chem Engn, Chengdu 610065, Peoples R China.
EM qyzhang@scu.edu.cn
FU Excellent Personnel of the New Century, Ministry of Educational of China
   [2009 SCU-NCET-09-0579]
FX This work was financially supported by the Excellent Personnel of the
   New Century, Ministry of Educational of China (Contract No. 2009
   SCU-NCET-09-0579).
CR Chedea V. S., 2013, AFRICAN J BIOTECHNOL, V33, P6276
   Chen Q., 2008, SURF COAT TECH, V22-23, P5576
   Darroudi M., 2012, MATER LETT, V1, P117
   El-Alfy AT, 2005, PHARMACOL RES, V52, P264, DOI 10.1016/j.phrs.2005.04.003
   Greiner A., 2007, CHEM INT ED, V30, P5670
   Guo C. X., 2009, J POLYM RES, V16, P295
   Guo J. L., 2011, J PHYS CHEM C, V48, P23688
   HEATH JR, 1989, PHYS REV B, V40, P9982, DOI 10.1103/PhysRevB.40.9982
   Huang X, 2010, GREEN CHEM, V12, P395, DOI 10.1039/b918176h
   Ji JH, 2007, INHAL TOXICOL, V19, P857, DOI 10.1080/08958370701432108
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Kim SJ, 2013, FIBER POLYM, V14, P1491, DOI 10.1007/s12221-013-1491-7
   Kurek A., 2011, POL J MICROBIOL, V1, P1
   Li XB, 2013, MATER LETT, V100, P119, DOI 10.1016/j.matlet.2013.02.117
   Nuraje N, 2013, J MATER CHEM A, V1, P1929, DOI 10.1039/c2ta00189f
   Rujitanaroj PO, 2008, POLYMER, V49, P4723, DOI 10.1016/j.polymer.2008.08.021
   Samantha A. J., 2004, WOUND REPAIR REGEN, V3, P288
   Sergio R., 1982, J CHEM PHYS, V7, P3406
   Son YJ, 2014, ARCH PHARM RES, V37, P69, DOI 10.1007/s12272-013-0284-2
   Wan HG, 2014, J COLLOID INTERF SCI, V417, P18, DOI 10.1016/j.jcis.2013.11.009
   Wang S. G., 2012, INT J MOL SCI, V11, P14136
   Wannatong L, 2004, POLYM INT, V53, P1851, DOI 10.1002/pi.1599
   Xiao L. L., 2008, CAN J PHYSL PHARM, V12, P841
   Xing Z. G., 2014, ACTA MATERIAE COMPOS, V31, P1203
   Xu XL, 2008, FIBER POLYM, V9, P685, DOI 10.1007/s12221-008-0108-z
   Yan LD, 2011, FIBER POLYM, V12, P207, DOI 10.1007/s12221-011-0207-0
   Zhang S., 2009, J BIO MAT RES A, V30, P671
   Zhuang X. P., 2010, CARBOHYD POLYM, V2, P524
NR 28
TC 5
Z9 5
U1 6
U2 46
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
EI 1875-0052
J9 FIBER POLYM
JI Fiber. Polym.
PD DEC
PY 2014
VL 15
IS 12
BP 2572
EP 2580
DI 10.1007/s12221-014-2572-y
PG 9
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA AX9WQ
UT WOS:000347250400016
DA 2018-10-20
ER

PT J
AU Wu, QX
   Lin, DQ
   Yao, SJ
AF Wu, Qing-Xi
   Lin, Dong-Qiang
   Yao, Shan-Jing
TI Design of Chitosan and Its Water Soluble Derivatives-Based Drug Carriers
   with Polyelectrolyte Complexes
SO MARINE DRUGS
LA English
DT Review
DE chitosan; water soluble chitosan; drug carriers; polyelectrolyte
   complexes; targeted/controlled release
ID COLON-SPECIFIC DELIVERY; IN-VITRO EVALUATION; SODIUM CELLULOSE SULFATE;
   CROSS-LINKING AGENT; ALGINATE/CHITOSAN MICROPARTICLES; MUCOADHESIVE
   PROPERTIES; RELEASE CARRIER; VIVO EVALUATION; ORAL DELIVERY;
   NANOPARTICLES
AB Chitosan, the cationic polysaccharide derived from the natural polysaccharide chitin, has been studied as a biomaterial for more than two decades. As a polycationic polymer with favorable properties, it has been widely used to form polyelectrolyte complexes with polyanions for various applications in drug delivery fields. In recent years, a growing number of studies have been focused on the preparation of polyelectrolyte complexes based on chitosan and its water soluble derivatives. They have been considered well-suited as biomaterials for a number of vital drug carriers with targeted/controlled release profiles, e.g., films, capsules, microcapsules. In this work, an overview highlights not only the favorable properties of chitosan and its water soluble derivatives but also the good performance of the polyelectrolyte complexes produced based on chitosan. Their various types of applications as drug carriers are reviewed in detail.
C1 [Wu, Qing-Xi] Anhui Univ, Sch Life Sci, Integrated Biotechnol Lab, Hefei 230601, Peoples R China.
   [Wu, Qing-Xi; Lin, Dong-Qiang; Yao, Shan-Jing] Zhejiang Univ, Coll Chem & Biol Engn, Key Lab Biomass Chem Engn, Minist Educ, Hangzhou 310027, Zhejiang, Peoples R China.
   [Lin, Dong-Qiang; Yao, Shan-Jing] Collaborat Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.
RP Yao, SJ (reprint author), Zhejiang Univ, Coll Chem & Biol Engn, Key Lab Biomass Chem Engn, Minist Educ, Hangzhou 310027, Zhejiang, Peoples R China.
EM wuqx@ahu.edu.cn; lindq@zju.edu.cn; yaosj@zju.edu.cn
RI Lin, Dong-Qiang/A-1897-2010
OI Lin, Dong-Qiang/0000-0002-0504-8391
FU Anhui University; National Natural Science Foundation of China; Doctoral
   Programs Foundation of Ministry of Education of China
FX This work was supported by the Doctoral Research Start-up Fund of Anhui
   University, the National Natural Science Foundation of China and the
   Doctoral Programs Foundation of Ministry of Education of China.
CR Anitha A, 2014, EUR J PHARM BIOPHARM, V88, P238, DOI 10.1016/j.ejpb.2014.04.017
   Arai K., 1968, B TOKAI REGIONAL FIS, V56, P88
   Argin S, 2014, FOOD HYDROCOLLOID, V40, P138, DOI 10.1016/j.foodhyd.2014.02.018
   Arora Saahil, 2011, Sci Pharm, V79, P673, DOI 10.3797/scipharm.1011-05
   Bajaj G., 2012, PLOS ONE, V7, P1
   Balabushevich NG, 2013, MACROMOL BIOSCI, V13, P1379, DOI 10.1002/mabi.201300207
   Barakat NS, 2011, DRUG DEVELOP RES, V72, P235, DOI 10.1002/ddr.20389
   Bravo-Osuna I, 2007, BIOMATERIALS, V28, P2233, DOI 10.1016/j.biomaterials.2007.01.005
   Busilacchi A, 2013, CARBOHYD POLYM, V98, P665, DOI 10.1016/j.carbpol.2013.06.044
   Calija B, 2013, COLLOID SURFACE B, V110, P395, DOI 10.1016/j.colsurfb.2013.05.016
   Chen CY, 2012, J APPL ORAL SCI, V20, P620, DOI 10.1590/S1678-77572012000600006
   Cook MT, 2011, BIOMACROMOLECULES, V12, P2834, DOI 10.1021/bm200576h
   Costa EM, 2014, CARBOHYD POLYM, V111, P385, DOI 10.1016/j.carbpol.2014.04.046
   Dang QF, 2010, J FOOD SCI, V75, pS125, DOI 10.1111/j.1750-3841.2009.01483.x
   Devi N, 2009, J MACROMOL SCI A, V46, P1114, DOI 10.1080/10601320903245524
   Dima C, 2014, INNOV FOOD SCI EMERG, V22, P203, DOI 10.1016/j.ifset.2013.12.020
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Fernandes M, 2013, INT J PHARMACEUT, V454, P116, DOI 10.1016/j.ijpharm.2013.06.068
   Fetih G, 2005, INT J PHARMACEUT, V293, P127, DOI 10.1016/j.ijpharm.2004.12.017
   Franco RA, 2011, J MATER SCI-MATER M, V22, P2207, DOI 10.1007/s10856-011-4402-8
   Fukuda M, 2006, INT J PHARM, V310, P90, DOI 10.1016/j.ijpharm.2005.11.042
   Fukui Y, 2010, COLLOID SURFACE A, V370, P28, DOI 10.1016/j.colsurfa.2010.08.039
   Ganguly K, 2011, IND ENG CHEM RES, V50, P11797, DOI 10.1021/ie201623d
   Gulbake A, 2012, EXPERT OPIN DRUG DEL, V9, P713, DOI 10.1517/17425247.2012.682148
   Guo R, 2013, J MATER SCI-MATER M, V24, P2093, DOI 10.1007/s10856-013-4977-3
   Hamman JH, 2010, MAR DRUGS, V8, P1305, DOI 10.3390/md8041305
   Hawary DL, 2011, J RADIOANAL NUCL CH, V290, P557, DOI 10.1007/s10967-011-1310-9
   Hejazi R, 2003, J CONTROL RELEASE, V89, P151, DOI 10.1016/S0168-3659(03)00126-3
   Henricus MM, 2009, MACROMOL BIOSCI, V9, P317, DOI 10.1002/mabi.200800220
   Huang BB, 2008, WORLD J GASTROENTERO, V14, P4928, DOI 10.3748/wjg.14.4928
   II'ina AV, 2005, APPL BIOCHEM MICRO+, V41, P5
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jain AK, 2011, BIOMATERIALS, V32, P503, DOI 10.1016/j.biomaterials.2010.09.037
   Kaihara S, 2011, COLLOID SURFACE B, V85, P343, DOI 10.1016/j.colsurfb.2011.03.008
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Kumar A, 2013, INT J BIOL MACROMOL, V62, P80, DOI 10.1016/j.ijbiomac.2013.08.035
   Lacerda L, 2014, MAT SCI ENG C-MATER, V39, P161, DOI 10.1016/j.msec.2014.01.054
   Li C, 2000, CANCER CHEMOTH PHARM, V46, P416, DOI 10.1007/s002800000168
   Li J, 2013, MACROMOL RES, V21, P1331, DOI 10.1007/s13233-013-1171-x
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Ma GP, 2014, NEW J CHEM, V38, P1211, DOI 10.1039/c3nj00701d
   Mahmoudzadeh M, 2013, J DRUG TARGET, V21, P693, DOI 10.3109/1061186X.2013.824455
   Meng-Lund E, 2014, INT J PHARMACEUT, V461, P280, DOI 10.1016/j.ijpharm.2013.10.047
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Muzzarelli RAA, 1997, CELL MOL LIFE SCI, V53, P131, DOI 10.1007/PL00000584
   Nunthanid J, 2008, EUR J PHARM BIOPHARM, V68, P253, DOI 10.1016/j.ejpb.2007.05.017
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Orienti I, 2002, INT J PHARM, V238, P51, DOI 10.1016/S0378-5173(02)00060-1
   Oyarzun-Ampuero FA, 2009, INT J PHARMACEUT, V381, P122, DOI 10.1016/j.ijpharm.2009.04.009
   Paliwal R, 2012, INT J PHARMACEUT, V422, P179, DOI 10.1016/j.ijpharm.2011.10.048
   Pandey S, 2013, J YOUNG PHARM, V5, P160, DOI 10.1016/j.jyp.2013.11.002
   Parodi B, 2013, DRUG DEV IND PHARM, V39, P1911, DOI 10.3109/03639045.2012.694589
   Racovita S, 2010, REV ROUM CHIM, V55, P659
   Rai G, 2005, PHARMAZIE, V60, P131
   RAMARAJ B, 1994, J APPL POLYM SCI, V51, P979, DOI 10.1002/app.1994.070510602
   Shelly, 2013, INT J BIOL MACROMOL, V61, P411, DOI 10.1016/j.ijbiomac.2013.07.022
   Sheng Y, 2014, DRUG DELIV, V21, P370, DOI 10.3109/10717544.2014.905653
   Shu SJ, 2009, CARBOHYD RES, V344, P1197, DOI 10.1016/j.carres.2009.04.018
   Shu XZ, 2002, INT J PHARM, V233, P217, DOI 10.1016/S0378-5173(01)00943-7
   Silva CL, 2008, J MEMBRANE SCI, V320, P268, DOI 10.1016/j.memsci.2008.04.011
   Simi SP, 2010, ASIAN PAC J TROP MED, V3, P374, DOI 10.1016/S1995-7645(10)60091-0
   Singh V, 2011, ASIAN J CHEM, V23, P2141
   Sinha VR, 2001, INT J PHARM, V224, P19, DOI 10.1016/S0378-5173(01)00720-7
   Sobol M, 2013, J BIOMED MATER RES A, V101, P1907, DOI 10.1002/jbm.a.34500
   Supper S, 2014, EXPERT OPIN DRUG DEL, V11, P249, DOI 10.1517/17425247.2014.867326
   Thunemann AF, 2004, ADV POLYM SCI, V166, P113, DOI 10.1007/b11350
   Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g
   Tozaki H, 2002, J CONTROL RELEASE, V82, P51, DOI 10.1016/S0168-3659(02)00084-6
   Vasiliu S, 2008, EUR POLYM J, V44, P3894, DOI 10.1016/j.eurpolymj.2008.07.040
   Wang MJ, 2010, J APPL POLYM SCI, V117, P3001, DOI 10.1002/app.32259
   Wang MJ, 2009, IND ENG CHEM RES, V48, P5276, DOI 10.1021/ie801295y
   Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44
   Wittaya-areekul S, 2006, INT J PHARM, V312, P113, DOI 10.1016/j.ijpharm.2006.01.003
   Wu QX, 2014, CELLULOSE, V21, P1897, DOI 10.1007/s10570-014-0209-3
   Wu QX, 2013, INT J PHARMACEUT, V455, P124, DOI 10.1016/j.ijpharm.2013.07.048
   Wu QX, 2013, COLLOID SURFACE B, V109, P147, DOI 10.1016/j.colsurfb.2013.03.035
   Xia WS, 2008, BIORESOURCE TECHNOL, V99, P6751, DOI 10.1016/j.biortech.2008.01.011
   Xiao CM, 2013, CARBOHYD POLYM, V98, P1366, DOI 10.1016/j.carbpol.2013.07.068
   Xie YL, 2009, LANGMUIR, V25, P8999, DOI 10.1021/la9014338
   Xiong Y, 2014, ACS APPL MATER INTER, V6, P2948, DOI 10.1021/am405544r
   Xu J, 1996, MACROMOLECULES, V29, P3436, DOI 10.1021/ma951638b
   Xu PS, 2010, BIOMACROMOLECULES, V11, P2352, DOI 10.1021/bm100481r
   Yan SF, 2013, J MATER CHEM B, V1, P1541, DOI 10.1039/c2tb00440b
   Yang YM, 2007, J MATER SCI-MATER M, V18, P2117, DOI 10.1007/s10856-007-3013-x
   Yoshizawa T, 2005, EUR J PHARM BIOPHARM, V59, P307, DOI 10.1016/j.ejpb.2004.08.002
   Yu WT, 2011, J MEMBRANE SCI, V377, P214, DOI 10.1016/j.memsci.2011.04.053
   Zakhem E, 2014, BIOMATERIALS, V35, P1882, DOI 10.1016/j.biomaterials.2013.11.049
   Zhang H, 2002, INT J PHARMACEUT, V239, P197, DOI 10.1016/S0378-5173(02)00112-6
   Zhang YQ, 2014, FOOD CHEM, V142, P269, DOI 10.1016/j.foodchem.2013.07.058
   Zhu LY, 2014, ACTA PHYS-CHIM SIN, V30, P365, DOI 10.3866/PKU.WHXB201312091
   Zhu LY, 2010, CARBOHYD POLYM, V82, P323, DOI 10.1016/j.carbpol.2010.04.062
NR 92
TC 16
Z9 16
U1 10
U2 123
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD DEC
PY 2014
VL 12
IS 12
BP 6236
EP 6253
DI 10.3390/md12126236
PG 18
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AX2TE
UT WOS:000346796500029
PM 25532565
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bezerra, RDS
   Silva, MMF
   Morais, AIS
   Osajima, JA
   Santos, MRMC
   Airoldi, C
   Silva, EC
AF Bezerra, Roosevelt D. S.
   Silva, Marcia M. F.
   Morais, Alan I. S.
   Osajima, Josy A.
   Santos, Maria R. M. C.
   Airoldi, Claudio
   Silva Filho, Edson C.
TI Phosphated Cellulose as an Efficient Biomaterial for Aqueous Drug
   Ranitidine Removal
SO MATERIALS
LA English
DT Article
DE trimetaphosphate; cellulose; phosphatation; sorption; ranitidine
ID PHOSPHORYLATED BACTERIAL CELLULOSE; PASTING PROPERTIES; ACTIVATED
   CARBON; ADSORPTION; STARCH; WATER; PHARMACEUTICALS; ADSORBENTS;
   PROTEINS; CU(II)
AB Crystalline cellulose chemically modified through a reaction with sodium trimetaphosphate (STMP) in an acidic or basic condition yielded Cel-P4 and Cel-P10. These phosphated solids were characterized by elemental analysis, X-ray diffraction (XRD), infrared (IR) spectroscopy, scanning electron microscopy (SEM), nuclear magnetic resonance (NMR) at the solid state for phosphorus nucleus and dispersive X-ray energy. The elemental results demonstrated that the phosphorylation reaction was more efficient in the basic medium, as supported by the amount of phosphorous content. The synthesized biomaterials decreased in crystallinity in comparison to the precursor cellulose, with an increase in roughness and present two distinct phosphorus environments in the formed structure. The phosphated cellulose in an alkaline condition was applied to sorb the drug ranitidine. This process was applied in varying pH, time, temperature and concentration. The best sorption kinetic model to fit the experimental data was the pseudo-second-order with a coefficient correlation of 0.8976, and the Langmuir isotherm model was the most adjusted to the variation in concentration. The efficient drug sorption has a low dependence on temperature, with maximum values of 85.0, 82.0 mg and 85.7 mg . g(-1) for Cel-P10 at 298, 308 and 318 K, respectively. The best sorption occurred at pH = 6 with a saturation time of 210 min.
C1 [Bezerra, Roosevelt D. S.] Fed Inst Educ Sci & Technol Piaui IFPI, BR-64000040 Teresina, Piaui, Brazil.
   [Silva, Marcia M. F.; Morais, Alan I. S.; Osajima, Josy A.; Santos, Maria R. M. C.; Silva Filho, Edson C.] Fed Univ Piaui UFPI, Interdisciplinary Lab Adv Mat, BR-64049550 Teresina, Piaui, Brazil.
   [Airoldi, Claudio] Univ Estadual Campinas, Inst Chem, UNICAMP, BR-13083971 Sao Paulo, Brazil.
RP Silva, EC (reprint author), Fed Univ Piaui UFPI, Interdisciplinary Lab Adv Mat, BR-64049550 Teresina, Piaui, Brazil.
EM rooseveltdsb@ifpi.edu.br; marciaf3004@yahoo.com.br; bredyalan@gmail.com;
   josyosajima@ufpi.edu.br; mrita@ufpi.edu.br; airoldi@iqm.unicamp.br;
   edsonfilho@ufpi.edu.br
RI Santos, Maria Rita/Q-3665-2016
OI Santos, Maria Rita/0000-0003-1618-7319; Morais,
   Alan/0000-0002-6974-6455; Silva Filho, Edson/0000-0003-0988-2970
FU Coordination Support in Higher Education (CAPES); National Council for
   Scientific and Technological Development (CNPq)
FX The authors thank to Coordination Support in Higher Education (CAPES)
   and National Council for Scientific and Technological Development (CNPq)
   for financial support, the Federal University of Piaui (UFPI) and
   Federal Institute of Piaui (IFPI), to provide work research conditions.
CR Babel S, 2003, J HAZARD MATER, V97, P219, DOI 10.1016/S0304-3894(02)00263-7
   Bergheim M, 2012, ENVIRON SCI POLLUT R, V19, P72, DOI 10.1007/s11356-011-0536-y
   Bezerra R.D.S., 2013, J ENV CHEM ENG, V2, P605
   Bhattacharyya KG, 2004, J HAZARD MATER, V113, P97, DOI 10.1016/j.jhazmat.2004.05.034
   Dalrymple OK, 2007, J CHEM TECHNOL BIOT, V82, P121, DOI 10.1002/jctb.1657
   Daud WRW, 2011, BIORESOURCES, V6, P1719
   Deetae P, 2008, CARBOHYD POLYM, V73, P351, DOI 10.1016/j.carbpol.2007.12.004
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Granja O.L., 2001, J APPL POLYM SCI, V82, P3341
   Granja PL, 2006, REACT FUNCT POLYM, V66, P728, DOI 10.1016/j.reactfunctpolym.2005.10.027
   Guaratini CCI, 2000, QUIM NOVA, V23, P71, DOI 10.1590/S0100-40422000000100013
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Igura M, 2010, J HAZARD MATER, V178, P686, DOI 10.1016/j.jhazmat.2010.01.142
   Kalavathy MH, 2005, J COLLOID INTERF SCI, V292, P354, DOI 10.1016/j.jcis.2005.05.087
   Kargi F, 2004, BIORESOURCE TECHNOL, V94, P285, DOI 10.1016/j.biortech.2004.01.003
   Kim SS, 1998, J BIOMED MATER RES, V40, P401, DOI 10.1002/(SICI)1097-4636(19980605)40:3<401::AID-JBM9>3.0.CO;2-J
   Kobya M, 2004, BIORESOURCE TECHNOL, V91, P317, DOI 10.1016/j.biortech.2003.07.001
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   LIM S, 1993, CEREAL CHEM, V70, P137
   Liu Z, 2011, MATER CHEM PHYS, V128, P220, DOI 10.1016/j.matchemphys.2011.02.062
   Magosso HA, 2012, CELLULOSE, V19, P913, DOI 10.1007/s10570-012-9657-9
   Mucalo MR, 2009, COLLOID SURFACE B, V71, P52, DOI 10.1016/j.colsurfb.2009.01.004
   Oshima T, 2008, REACT FUNCT POLYM, V68, P376, DOI 10.1016/j.reactfunctpolym.2007.07.046
   Oshima T, 2011, CARBOHYD POLYM, V83, P953, DOI 10.1016/j.carbpol.2010.09.005
   Ott E., 1954, CELLULOSE CELLULOSE
   Paiva D.L., 1996, INTRO SPECTROSCOPY G
   Pal A, 2010, SCI TOTAL ENVIRON, V408, P6062, DOI 10.1016/j.scitotenv.2010.09.026
   Pereira PHF, 2012, POLIMEROS, V22, P88, DOI 10.1590/S0104-14282012005000002
   Perrin D. D., 1988, PURIFICATION LAB CHE
   Pomati F, 2006, ENVIRON SCI TECHNOL, V40, P2442, DOI 10.1021/es051715a
   Purkait MK, 2005, J ENVIRON MANAGE, V76, P135, DOI 10.1016/j.jenvman.2005.01.012
   Rungrodnimitchai S, 2014, SCI WORLD J, DOI 10.1155/2014/634837
   Sang Y, 2007, CARBOHYD POLYM, V67, P201, DOI 10.1016/j.carbpol.2006.05.009
   Santana SAA, 2010, J HAZARD MATER, V174, P714, DOI 10.1016/j.jhazmat.2009.09.109
   Shen R, 2011, WATER RES, V45, P944, DOI 10.1016/j.watres.2010.09.036
   Silverstein RM, 2000, IDENTIFICACAO ESPECT
   Sulflet D.M., 2006, REACT FUNCT POLYM, V66, P1240
   Suzuki S, 2012, CELLULOSE, V19, P713, DOI 10.1007/s10570-012-9678-4
   Temkin MI, 1940, ACTA PHYSIOCHIM USSR, V12, P217
   Vieira AP, 2009, J HAZARD MATER, V166, P1272, DOI 10.1016/j.jhazmat.2008.12.043
   Wanrosli WD, 2011, CARBOHYD POLYM, V84, P262, DOI 10.1016/j.carbpol.2010.11.032
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Zheng H, 2009, J HAZARD MATER, V167, P141, DOI 10.1016/j.jhazmat.2008.12.093
NR 44
TC 11
Z9 11
U1 1
U2 32
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD DEC
PY 2014
VL 7
IS 12
BP 7907
EP 7924
DI 10.3390/ma7127907
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA AX2TG
UT WOS:000346796800020
PM 28788283
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bagda, E
   Zonuz, NA
AF Bagda, Esra
   Zonuz, Nuray Akkaya
TI Uranyl Ions Removal by Quercus macrenthera Gall's Extract-Based Cryogels
   with Extreme Characteristics
SO CLEAN-SOIL AIR WATER
LA English
DT Article
DE Adsorption; Biomaterial; Polymers; Tannin-based cryogels
ID AQUEOUS-SOLUTION; METHYLENE-BLUE; CRYSTAL VIOLET; URANIUM VI;
   ADSORPTION; BIOSORPTION; KINETICS; TANNIN; RECOVERY; SORPTION
AB In this study, one type of oak galls (galls of Quercus macrenthera, QMG) was used as tannin source for the production of tannic acid-based cryogels (CRGs). QMG-CRGs were characterized with scanning electron microscopy and attenuated total reflectance infrared. The produced CRGs have excellent characteristics such as extreme lightweightness. They look like sponges and are so elastic that they can easily absorb water and the water content can be removed easily by only compressing. These CRGs are able to swell violently immersed in aqueous solution. The prepared CRGs were used in removing uranyl ions from aqueous solutions. Some experimental parameters which affect the adsorption process as pH of the solution, initial uranyl concentration, and sorbent dosage have been investigated. The experimental data were analyzed by the Langmuir and Freundlich isotherm models and kinetic data were treated with pseudo first and second-order models. It is found that the adsorption data of uranium is equally well described by both Langmuir and Freundlich models, besides kinetic data strictly fits the pseudo-second-order rate model.
C1 [Bagda, Esra] Cumhuriyet Univ, Fac Pharm, TR-58140 Sivas, Turkey.
   [Zonuz, Nuray Akkaya] Cumhuriyet Univ, Fac Sci, TR-58140 Sivas, Turkey.
RP Bagda, E (reprint author), Cumhuriyet Univ, Fac Pharm, TR-58140 Sivas, Turkey.
EM esraer@cumhuriyet.edu.tr
FU Scientific Research Project Foundation of Cumhuriyet University
FX The laboratory equipment used in this study was taken from the budget of
   Scientific Research Project Foundation of Cumhuriyet University.
CR Bagda E, 2012, J ENVIRON PROT ECOL, V13, P517
   Bagda E, 2012, DESALIN WATER TREAT, V43, P63, DOI 10.1080/19443994.2012.672203
   Bai J, 2010, J ENVIRON RADIOACTIV, V101, P969, DOI 10.1016/j.jenvrad.2010.07.003
   Bayramoglu G, 2006, J HAZARD MATER, V136, P345, DOI 10.1016/j.jhazmat.2005.12.027
   Bereli N, 2012, MAT SCI ENG C-MATER, V32, P2052, DOI 10.1016/j.msec.2012.05.015
   Bhat SV, 2008, J HAZARD MATER, V158, P628, DOI 10.1016/j.jhazmat.2008.02.042
   Chiad K., 2011, THESIS J GUTENBERG U
   Chiem LT, 2006, J COLLOID INTERF SCI, V297, P54, DOI 10.1016/j.jcis.2005.10.037
   Daneshvar Shohreh, 2009, Advances in Environmental Biology, V3, P61
   Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155
   Donat R, 2005, J RADIOANAL NUCL CH, V265, P107, DOI 10.1007/s10967-005-0794-6
   Eroglu H, 2009, J HAZARD MATER, V163, P607, DOI 10.1016/j.jhazmat.2008.07.076
   Ersan M, 2013, COLLOID SURFACE B, V104, P75, DOI 10.1016/j.colsurfb.2012.11.034
   Fan FL, 2012, J ENVIRON RADIOACTIV, V106, P40, DOI 10.1016/j.jenvrad.2011.11.003
   Ghasemi M, 2011, J HAZARD MATER, V189, P141, DOI 10.1016/j.jhazmat.2011.02.011
   Gong RM, 2008, DESALINATION, V230, P220, DOI 10.1016/j.desal.2007.12.002
   Grishechko LI, 2013, IND CROP PROD, V41, P347, DOI 10.1016/j.indcrop.2012.04.052
   Guerra DL, 2012, INT J MINER PROCESS, V102, P25, DOI 10.1016/j.minpro.2011.09.007
   Jaikumar V., 2009, INT J CHEM, V1, P2
   Karadag E, 2004, NUCL INSTRUM METH B, V225, P489, DOI 10.1016/j.nimb.2004.06.010
   Khani MH, 2008, J HAZARD MATER, V150, P612, DOI 10.1016/j.jhazmat.2007.05.010
   Liao XP, 2004, J MEMBRANE SCI, V243, P235, DOI 10.1016/j.memsci.2004.06.025
   Liu MX, 2010, BIORESOURCE TECHNOL, V101, P8573, DOI 10.1016/j.biortech.2010.06.063
   Liu YL, 2012, J RADIOANAL NUCL CH, V292, P803, DOI 10.1007/s10967-011-1515-y
   Manis M. S., 1992, BIOL INSECT INDUCED
   Muller K, 2012, GEOCHIM COSMOCHIM AC, V76, P191, DOI 10.1016/j.gca.2011.10.004
   NAKAJIMA A, 1987, J CHEM TECHNOL BIOT, V40, P223
   Nilchi A, 2013, DESALINATION, V321, P67, DOI [10.1016/j.desal.2012.06.022, 10.1016/j.desa1.2012.06.022]
   Pang C, 2011, CHEM ENG J, V170, P1, DOI 10.1016/j.cej.2010.10.068
   Radhika M, 2006, J HAZARD MATER, V138, P116, DOI 10.1016/j.jhazmat.2006.05.045
   Sadeghi S, 2012, J HAZARD MATER, V215, P208, DOI 10.1016/j.jhazmat.2012.02.054
   SAKAGUCHI T, 1987, SEPAR SCI TECHNOL, V22, P1609, DOI 10.1080/01496398708058421
   Sariozlu NY, 2011, NUTS AND SEEDS IN HEALTH AND DISEASE PREVENTION, P505, DOI 10.1016/B978-0-12-375688-6.10060-X
   Sert S., 2012, J NUCL MATER, V406, P285
   Singh DK, 2009, ANAL CHIM ACTA, V644, P42, DOI 10.1016/j.aca.2009.04.020
   Sprynskyy M, 2011, CHEM ENG J, V171, P1185, DOI 10.1016/j.cej.2011.05.022
   Sprynskyy M, 2010, J HAZARD MATER, V181, P700, DOI 10.1016/j.jhazmat.2010.05.069
   Sun X, 2010, J HAZARD MATER, V179, P295, DOI 10.1016/j.jhazmat.2010.03.002
   Tashkhourian J, 2011, J HAZARD MATER, V187, P75, DOI 10.1016/j.jhazmat.2010.12.053
   Tseng RL, 2008, J HAZARD MATER, V155, P277, DOI 10.1016/j.jhazmat.2007.11.061
   Wang JS, 2010, J ENVIRON RADIOACTIV, V101, P504, DOI 10.1016/j.jenvrad.2010.03.002
   Xie SB, 2008, J ENVIRON RADIOACTIV, V99, P126, DOI 10.1016/j.jenvrad.2007.07.003
   Yahaya YA, 2009, J HAZARD MATER, V161, P189, DOI 10.1016/j.jhazmat.2008.03.104
   Yang JB, 1999, WATER RES, V33, P3357, DOI 10.1016/S0043-1354(99)00043-3
   Yusan S, 2011, DESALINATION, V269, P58, DOI 10.1016/j.desal.2010.10.042
NR 45
TC 4
Z9 4
U1 2
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1863-0650
EI 1863-0669
J9 CLEAN-SOIL AIR WATER
JI Clean-Soil Air Water
PD DEC
PY 2014
VL 42
IS 12
BP 1816
EP 1823
DI 10.1002/clen.201300603
PG 8
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences; Marine
   & Freshwater Biology; Water Resources
SC Science & Technology - Other Topics; Environmental Sciences & Ecology;
   Marine & Freshwater Biology; Water Resources
GA AW4UH
UT WOS:000346275300019
DA 2018-10-20
ER

PT J
AU He, M
   Zhang, ZT
   Zheng, DX
   Ding, N
   Liu, Y
AF He, Min
   Zhang, Zutai
   Zheng, Dongxiang
   Ding, Ning
   Liu, Yan
TI Effect of sandblasting on surface roughness of zirconia-based ceramics
   and shear bond strength of veneering porcelain
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Zirconia; Sandblasting; Shear strength; Veneering porcelain
ID FIXED PARTIAL DENTURES; OF-THE-LITERATURE; FLEXURAL STRENGTH; Y-TZP;
   RESIN CEMENT; TITANIUM; BIOMATERIAL; RELIABILITY; ADHESION
AB This study aims to investigate the effect of sandblasting on the surface roughness of zirconia and the shear bond strength of the veneering porcelain. Pre-sintered zirconia plates were prepared and divided into four groups. Group A were not treated at all; group B were first sandblasted under 0.2 MPa pressure and then densely sintered; group C and D were sintered first, and then sandblasted under 0.2 MPa and 0.4 MPa pressures respectively. Surface roughness was measured and 3D roughness was reconstructed for the specimens, which were also analyzed with X-ray diffractometry. Finally after veneering porcelain sintering, shear bond tests were conducted. Sandblasting zirconia before sintering significantly increased surface roughness and the shear bond strength between zirconia and veneering porcelain (p<0.05). Sandblasting zirconia before sintering is a useful method to increase surface roughness and could successfully improve the bonding strength of veneering porcelain.
C1 [He, Min; Zhang, Zutai; Zheng, Dongxiang; Ding, Ning; Liu, Yan] Capital Med Univ, Sch Stomatol, Beijing Inst Dent Res, Beijing Stomatol Hosp, Beijing 100050, Peoples R China.
RP Zhang, ZT (reprint author), Capital Med Univ, Sch Stomatol, Beijing Inst Dent Res, Beijing Stomatol Hosp, 4 Tian Tan Xi Li, Beijing 100050, Peoples R China.
EM showazhang@hotmail.com
FU National Natural Science Foundation of China [30872909, 81371175]
FX This study was supported by the National Natural Science Foundation of
   China (Grant No. 30872909 and No. 81371175).
CR Benetti P, 2010, DENT MATER, V26, P743, DOI 10.1016/j.dental.2010.03.019
   Bindl A, 2005, J ORAL REHABIL, V32, P441, DOI 10.1111/j.1365-2842.2005.01446.x
   Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50
   Chaiyabutr Y, 2008, J PROSTHET DENT, V100, P194, DOI 10.1016/S0022-3913(08)60178-X
   Comlekoglu ME, 2008, J DENT, V36, P822, DOI 10.1016/j.jdent.2008.05.019
   de Jager N, 2000, DENT MATER, V16, P381, DOI 10.1016/S0109-5641(00)00030-0
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Fischer J, 2002, BIOMATERIALS, V23, P1303, DOI 10.1016/S0142-9612(01)00248-4
   Fischer J, 2008, DENT MATER J, V27, P448, DOI 10.4012/dmj.27.448
   Fischer J, 2010, J PROSTHET DENT, V103, P267, DOI 10.1016/S0022-3913(10)60056-X
   Fushiki R, 2012, CLIN ORAL INVEST, V16, P1401, DOI 10.1007/s00784-011-0641-9
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Gemalmaz D, 2002, J PROSTHET DENT, V87, P133, DOI 10.1067/mpr.2002.120901
   GILBERT JL, 1994, DENT MATER, V10, P134, DOI 10.1016/0109-5641(94)90054-X
   Gorman CM, 2000, DENT MATER, V16, P389, DOI 10.1016/S0109-5641(00)00031-2
   Guazzato M, 2005, DENT MATER, V21, P454, DOI 10.1016/j.dental.2004.07.010
   Guess PC, 2008, DENT MATER, V24, P1556, DOI 10.1016/j.dental.2008.03.028
   Hanawa T, 1994, Dent Mater J, V13, P164
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kern M, 1998, DENT MATER, V14, P64, DOI 10.1016/S0109-5641(98)00011-6
   Kim HJ, 2011, J PROSTHET DENT, V105, P315, DOI 10.1016/S0022-3913(11)60060-7
   Chintapalli RK, 2014, J MECH BEHAV BIOMED, V29, P126, DOI 10.1016/j.jmbbm.2013.09.004
   Kosmac T, 1999, DENT MATER, V15, P426, DOI 10.1016/S0109-5641(99)00070-6
   Luthardt RG, 2002, J DENT RES, V81, P487, DOI 10.1177/154405910208100711
   Moon JE, 2011, DENT MATER, V27, P651, DOI 10.1016/j.dental.2011.03.005
   Oka K, 1996, Dent Mater J, V15, P111
   Ozcan M, 2008, DENT MATER J, V27, P99
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Qeblawi DM, 2010, J PROSTHET DENT, V103, P210, DOI 10.1016/S0022-3913(10)60033-9
   Quinn JB, 2005, DENT MATER, V21, P920, DOI 10.1016/j.dental.2005.01.006
   Sailer I, 2007, INT J PROSTHODONT, V20, P383
   Sailer I, 2006, QUINTESSENCE INT, V37, P685
   Saito A, 2010, J PROSTHET DENT, V104, P247, DOI 10.1016/S0022-3913(10)60133-3
   Schley JS, 2010, EUR J ORAL SCI, V118, P443, DOI 10.1111/j.1600-0722.2010.00767.x
   Schubert H, 2005, J EUR CERAM SOC, V25, P1597, DOI 10.1016/j.jeurceramsoc.2004.03.025
   SHIMIZU K, 1993, J BIOMED MATER RES, V27, P729, DOI 10.1002/jbm.820270605
   Thompson JY, 2011, DENT MATER, V27, P71, DOI 10.1016/j.dental.2010.10.022
   Uehara K, 2002, J MATER PROCESS TECH, V127, P178, DOI 10.1016/S0924-0136(02)00122-X
   Wei YH, 2013, DENT MATER J, V32, P564, DOI 10.4012/dmj.2013-007
   Yan M, 2007, SURF COAT TECH, V202, P288, DOI 10.1016/j.surfcoat.2007.05.056
   Zhang Y, 2004, J BIOMED MATER RES B, V71B, P381, DOI 10.1002/jbm.b.30097
   Zhang Y, 2004, J BIOMED MATER RES B, V69B, P166, DOI 10.1002/jbm.b.20039
NR 42
TC 14
Z9 14
U1 0
U2 8
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD DEC
PY 2014
VL 33
IS 6
BP 778
EP 785
DI 10.4012/dmj.2014-002
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AW4AN
UT WOS:000346224100009
PM 25311341
OA Bronze
DA 2018-10-20
ER

PT J
AU Panayotov, IV
   Collart-Dutilleul, PY
   Salehi, H
   Martin, M
   Vegh, A
   Yachouh, J
   Vladimirov, B
   Sipos, P
   Szalontai, B
   Gergely, C
   Cuisinier, FJG
AF Panayotov, Ivan V.
   Collart-Dutilleul, Pierre-Yves
   Salehi, Hamideh
   Martin, Marta
   Vegh, Attila
   Yachouh, Jacques
   Vladimirov, Boyan
   Sipos, Peter
   Szalontai, Balazs
   Gergely, Csilla
   Cuisinier, Frederic J. G.
TI Sprayed Cells and Polyelectrolyte Films for Biomaterial
   Functionalization: The Influence of Physical PLL-PGA Film Treatments on
   Dental Pulp Cell Behavior
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; cell spray deposition; dental pulp cells; polyelectrolyte
   multilayers
ID MULTILAYER FILMS; FORCE MICROSCOPY; CROSS-LINKING; STIFFNESS; ADHESION;
   BUILDUP; SPECTROSCOPY; OSTEOBLASTS; ELASTICITY; ADSORPTION
AB Further development of biomaterials is expected as advanced therapeutic products must be compliant to good manufacturing practice regulations. A spraying method for building-up polyelectrolyte films followed by the deposition of dental pulp cells by spraying is presented. Physical treatments of UV irradiation and a drying/wetting process are applied to the system. Structural changes and elasticity modifications of the obtained coatings are revealed by atomic force microscopy and by Raman spectroscopy. This procedure results in thicker, rougher and stiffer film. The initially ordered structure composed of mainly a helices is transformed into random/beta-structures. The treatment enhanced dental pulp cell adhesion and proliferation, suggesting that this system is promising for medical applications.
C1 [Panayotov, Ivan V.; Collart-Dutilleul, Pierre-Yves; Salehi, Hamideh; Yachouh, Jacques; Cuisinier, Frederic J. G.] Univ Montpellier I, Lab Biosante & Nanosci, EA4203, Montpellier, France.
   [Martin, Marta; Gergely, Csilla] Univ Montpellier 2, Lab Charles Coulomb, UMR 5221, Montpellier, France.
   [Martin, Marta; Gergely, Csilla] CNRS, Lab Charles Coulomb, UMR 5221, Montpellier, France.
   [Vegh, Attila; Szalontai, Balazs] Hungarian Acad Sci, Inst Biophys, Biol Res Ctr, Szeged, Hungary.
   [Vladimirov, Boyan] Med Univ, Dept Maxillofacial Surg, Plovdiv, Bulgaria.
   [Sipos, Peter] Univ Szeged, Dept Pharmaceut Technol, Szeged, Hungary.
RP Panayotov, IV (reprint author), Univ Montpellier I, Lab Biosante & Nanosci, EA4203, Montpellier, France.
EM ivan.panayotov@gmail.com
FU Egide (France) under RILA program; IFRO (Institut francais pour la
   recherche odontologique)
FX These studies were realized with the financial support of Egide (France)
   under the RILA program and the IFRO (Institut francais pour la recherche
   odontologique).
CR ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   Arthur A, 2009, STEM CELLS, V27, P2229, DOI 10.1002/stem.138
   Bahoric H. A. R., 1997, CAN J PLAST SURG, V5, P153
   Biazar E, 2011, INT J NANOMED, V6, P631, DOI 10.2147/IJN.S17218
   Boulmedais F, 2003, LANGMUIR, V19, P9873, DOI 10.1021/la0348259
   Boulmedais F, 2002, LANGMUIR, V18, P4523, DOI 10.1021/la0117505
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   Burke SE, 2005, BIOMACROMOLECULES, V6, P1419, DOI 10.1021/bm0492834
   Cado G, 2012, LANGMUIR, V28, P8470, DOI 10.1021/la300563s
   Cohen M, 2001, PLAST RECONSTR SURG, V107, P1208, DOI 10.1097/00006534-200104150-00018
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 2003, MULTILAYER THIN FILM, P1
   DECHER G, 1992, THIN SOLID FILMS, V210, P831
   Facca S, 2008, BIO-MED MATER ENG, V18, P231, DOI 10.3233/BME-2008-0530
   Hafez AT, 2003, J UROLOGY, V169, P2316, DOI 10.1097/01.ju.0000067485.51252.f5
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P303
   Hertz H., 1981, REINE ANGEW MATH, P156
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146
   Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520
   Kolasinska M, 2007, J COLLOID INTERF SCI, V305, P46, DOI 10.1016/j.jcis.2006.09.035
   Ladam G, 2000, BIOMACROMOLECULES, V1, P674, DOI 10.1021/bm005572q
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880
   Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056286
   Navarro FA, 2000, J BURN CARE REHABIL, V21, P513, DOI 10.1067/mbc.2000.110291
   Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667
   Picart C, 2001, LANGMUIR, V17, P7414, DOI 10.1021/la010848g
   Picart C, 2004, BIOSENS BIOELECTRON, V20, P553, DOI 10.1016/j.bios.2004.03.005
   Porcel C, 2007, LANGMUIR, V23, P1898, DOI 10.1021/la062728k
   Porcel C, 2006, LANGMUIR, V22, P4376, DOI 10.1021/la053218d
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   Richert L, 2006, CELL BIOCHEM BIOPHYS, V44, P273, DOI 10.1385/CBB:44:2:273
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Roberts A, 2005, BIOTECHNOL BIOENG, V91, P801, DOI 10.1002/bit.20549
   Rosenbluth MJ, 2006, BIOPHYS J, V90, P2994, DOI 10.1529/biophysj.105.067496
   Saab M. B., 2013, CELL BIOCH BIOPHYS, V3, P399
   Schaaf P, 2012, ADV MATER, V24, P1001, DOI 10.1002/adma.201104227
   Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Seil JT, 2011, INT J NANOMED, V6, P1095, DOI 10.2147/IJN.S18803
   Tristan F, 2009, BIOMACROMOLECULES, V10, P2275, DOI 10.1021/bm900453s
   Tritz J, 2010, SOFT MATTER, V6, P5165, DOI 10.1039/c000790k
   Vazquez CP, 2009, LANGMUIR, V25, P3556, DOI 10.1021/la803577t
NR 48
TC 4
Z9 4
U1 3
U2 23
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD DEC
PY 2014
VL 14
IS 12
BP 1771
EP 1782
DI 10.1002/mabi.201400256
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA AW1SG
UT WOS:000346069600012
PM 25212873
DA 2018-10-20
ER

PT J
AU Huang, YS
   Shaw, MA
   Mullins, ES
   Kirley, TL
   Ayres, N
AF Huang, Yongshun
   Shaw, Maureen A.
   Mullins, Eric S.
   Kirley, Terence L.
   Ayres, Neil
TI Synthesis and Anticoagulant Activity of Polyureas Containing Sulfated
   Carbohydrates
SO BIOMACROMOLECULES
LA English
DT Article
ID GLYCOSAMINOGLYCAN-MIMETIC BIOMATERIALS; HEPARIN-MIMICKING POLYMER;
   FREE-RADICAL POLYMERIZATION; MOLECULAR-WEIGHT HEPARIN; BIOMEDICAL
   APPLICATIONS; ANTITHROMBIN-III; INDUCED THROMBOCYTOPENIA; COVALENT
   IMMOBILIZATION; BLOOD COMPATIBILITY; GROWTH-FACTOR
AB Polyurea-based synthetic glycopolymers containing sulfated glucose, mannose, glucosamine, or lactose as pendant groups have been synthesized by step-growth polymerization of hexamethylene diisocyanate and corresponding secondary diamines. The obtained polymers were characterized by gel permeation chromatography, nuclear magnetic resonance spectroscopy, and Fourier transform infrared spectroscopy. The nonsulfated polymers showed similar results to the commercially available biomaterial polyurethane TECOFLEX in a platelet adhesion assay. The average degree of sulfation after reaction with SO3 was calculated from elemental analysis and found to be between three and four -OSO3 groups per saccharide. The blood-compatibility of the synthetic polymers was measured using activated partial thromboplastin time, prothrombin time, thrombin time, anti-IIa, and anti-Xa assays. Activated partial thromboplastin time, prothrombin time, and thrombin time results indicated that the mannose and lactose based polymers had the highest anticoagulant activities among all the sulfated polymers. The mechanism of action of the polymers appears to be mediated via an anti-IIa pathway rather than an anti-Xa pathway.
C1 [Huang, Yongshun; Ayres, Neil] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.
   [Ayres, Neil] Univ Cincinnati, Mat Sci & Engn Program, Cincinnati, OH 45221 USA.
   [Shaw, Maureen A.; Mullins, Eric S.] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA.
   [Kirley, Terence L.] Univ Cincinnati, Dept Pharmacol & Cell Biophys, Coll Med, Cincinnati, OH 45267 USA.
RP Ayres, N (reprint author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.
EM ayresni@ucmail.uc.edu
RI Huang, Yongshun/I-9226-2016
OI Huang, Yongshun/0000-0002-7562-1392; Kirley, Terence/0000-0002-6211-1414
FU National Heart, Lung, and Blood Institute [1K08HL105672]
FX N.A. and Y.H. thank the National Science Foundation (DMR-1206150) for
   the resources to conduct this work. E.M. acknowledges the National
   Heart, Lung, and Blood Institute for the funding contributing to this
   work (1K08HL105672). The authors thank Robert Giulitto of the Hoxworth
   Blood Center at the University of Cincinnati for human platelet rich
   plasma.
CR Akashi M, 1996, BIOCONJUGATE CHEM, V7, P393, DOI 10.1021/bc960031c
   Aucagne V, 2006, J AM CHEM SOC, V128, P1784, DOI 10.1021/ja057206q
   Ayres N, 2008, J POLYM SCI POL CHEM, V46, P7713, DOI 10.1002/pola.23075
   Bae IH, 2012, J MATER SCI-MATER M, V23, P1259, DOI 10.1007/s10856-012-4587-5
   Baskaran S, 2002, BIOCONJUGATE CHEM, V13, P1309, DOI 10.1021/bc0255485
   Baumann H, 2001, CARBOHYD RES, V331, P43, DOI 10.1016/S0008-6215(01)00009-X
   Burke A, 2004, ADV EXP MED BIOL, V553, P83
   Charef S, 1996, BIOMATERIALS, V17, P903, DOI 10.1016/0142-9612(96)83286-8
   Christman KL, 2008, J AM CHEM SOC, V130, P16585, DOI 10.1021/ja803676r
   de Kort M, 2005, DRUG DISCOV TODAY, V10, P769, DOI 10.1016/S1359-6446(05)03457-4
   DULOS E, 1988, BIOMATERIALS, V9, P405, DOI 10.1016/0142-9612(88)90004-X
   Fasl H, 2010, BIOMACROMOLECULES, V11, P377, DOI 10.1021/bm9010084
   Faucher KM, 2003, LANGMUIR, V19, P1664, DOI 10.1021/la0263864
   Gilding D., 1984, ASAIO J, V30, P571
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Grande D, 2001, MACROMOLECULES, V34, P1640, DOI 10.1021/ma001680t
   Grande D, 2000, MACROMOLECULES, V33, P1123, DOI 10.1021/ma991579s
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   Guan R, 2004, BIOCONJUGATE CHEM, V15, P145, DOI 10.1021/bc034138t
   HATANAKA K, 1987, J MED CHEM, V30, P810, DOI 10.1021/jm00388a011
   HEUCK CC, 1985, J BIOL CHEM, V260, P4598
   HIRSH J, 1992, BLOOD, V79, P1
   Hou SJ, 2004, BIOCONJUGATE CHEM, V15, P954, DOI 10.1021/bc0499275
   Huang YS, 2013, J POLYM SCI POL CHEM, V51, P5230, DOI 10.1002/pola.26953
   Isac-Garcia J, 1999, CHEM-EUR J, V5, P1512, DOI 10.1002/(SICI)1521-3765(19990503)5:5<1512::AID-CHEM1512>3.3.CO;2-1
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Kajiyama T, 1991, J Biomater Appl, V6, P42, DOI 10.1177/088532829100600103
   Kartha KPR, 1997, TETRAHEDRON, V53, P11753, DOI 10.1016/S0040-4020(97)00742-4
   Lamba N, 1997, POLYURETHANES BIOMED
   Lee YK, 2007, BIOMATERIALS, V28, P1523, DOI 10.1016/j.biomaterials.2006.11.020
   Leung Lawrence L K, 2006, Hematology Am Soc Hematol Educ Program, P457
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a
   Matsumoto NM, 2013, ACS NANO, V7, P867, DOI 10.1021/nn3053457
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Meijs GF, 1995, U. S. patent, Patent No. [5, 393 , 858 -A, 5393858]
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   MIGONNEY V, 1988, BIOMATERIALS, V9, P413, DOI 10.1016/0142-9612(88)90005-1
   Moynihan HA, 2013, CARBOHYD RES, V374, P29, DOI 10.1016/j.carres.2013.03.024
   Nguyen TH, 2013, NAT CHEM, V5, P221, DOI [10.1038/nchem.1573, 10.1038/NCHEM.1573]
   Oh YI, 2013, ANGEW CHEM INT EDIT, V52, P11796, DOI 10.1002/anie.201306968
   OKKEMA AZ, 1991, BIOMATERIALS, V12, P668, DOI 10.1016/0142-9612(91)90115-Q
   Olson ST, 2002, TRENDS CARDIOVAS MED, V12, P331, DOI 10.1016/S1050-1738(02)00183-4
   Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640
   Petitou M, 1999, NATURE, V398, P417, DOI 10.1038/18877
   Petitou M., 1989, Patent, Patent No. [4,818,816, 4818816]
   Ruff Y, 2010, J AM CHEM SOC, V132, P2573, DOI 10.1021/ja9082733
   Sangaj N, 2010, BIOMACROMOLECULES, V11, P3294, DOI 10.1021/bm101041f
   SANTERRE JP, 1992, J BIOMED MATER RES, V26, P39, DOI 10.1002/jbm.820260105
   Seifert J., 2009, U.S. Patent, Patent No. [EP1440077B1, 1440077]
   Sheng GJ, 2013, J AM CHEM SOC, V135, P10898, DOI 10.1021/ja4027727
   SILVER JH, 1992, BIOMATERIALS, V13, P339, DOI 10.1016/0142-9612(92)90037-O
   Sun XL, 2002, BIOMACROMOLECULES, V3, P1065, DOI 10.1021/bm025561s
   Sun XL, 2002, J AM CHEM SOC, V124, P7258, DOI 10.1021/ja025788v
   Taylor L, 2014, POLYM INT, V63, P127, DOI 10.1002/pi.4567
   UENO Y, 1981, CARBOHYD RES, V96, P65, DOI 10.1016/S0008-6215(00)84695-9
   Vazquez-Dorbatt V, 2012, CHEMBIOCHEM, V13, P2478, DOI 10.1002/cbic.201200480
   Vermette P., 2001, BIOMEDICAL APPL POLY
   Wang R, 1997, BIOORGAN MED CHEM, V5, P661, DOI 10.1016/S0968-0896(97)00005-9
   WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003
   Warkentin TE, 1998, THROMB HAEMOSTASIS, V79, P1
   Weitz JI, 2007, EXPERT OPIN INV DRUG, V16, P271, DOI 10.1517/13543784.16.3.271
   Wu SJ, 1998, THROMB RES, V92, P273, DOI 10.1016/S0049-3848(98)00146-7
   Xu FM, 2011, MACROMOL BIOSCI, V11, P257, DOI 10.1002/mabi.201000313
   Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478
   Yang ZL, 2011, PLASMA PROCESS POLYM, V8, P850, DOI 10.1002/ppap.201000101
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Yeganeh H, 2008, J BIOACT COMPAT POL, V23, P276, DOI 10.1177/0883911508091829
   You I, 2011, BIOCONJUGATE CHEM, V22, P1264, DOI 10.1021/bc2000534
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 70
TC 26
Z9 26
U1 1
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2014
VL 15
IS 12
BP 4455
EP 4466
DI 10.1021/bm501245v
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AW2JR
UT WOS:000346114400009
PM 25329742
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Yan, SF
   Wang, TT
   Feng, L
   Zhu, J
   Zhang, KX
   Chen, XS
   Cui, L
   Yin, JB
AF Yan, Shifeng
   Wang, Taotao
   Feng, Long
   Zhu, Jie
   Zhang, Kunxi
   Chen, Xuesi
   Cui, Lei
   Yin, Jingbo
TI Injectable In Situ Self-Cross-Linking Hydrogels Based on Poly(L-glutamic
   acid) and Alginate for Cartilage Tissue Engineering
SO BIOMACROMOLECULES
LA English
DT Article
ID HYALURONIC-ACID; STEREOCOMPLEX FORMATION; BIOMEDICAL APPLICATIONS;
   BIOMIMETIC MATERIALS; PROTEIN DELIVERY; PART 1; CHITOSAN; SCAFFOLDS;
   DEXTRAN; REGENERATION
AB Injectable hydrogels as an important biomaterial class have been widely used in regenerative medicine. A series of injectable poly(l-glutamic acid)/alginate (PLGA/ALG) hydrogels were fabricated by self-cross-linking of hydrazide-modified poly(L-glutamic acid) (PLGA-ADH) and aldehyde-modified alginate (ALG-CHO). Both the degree of PLGA modification and the oxidation degree of ALG-CHO could be adjusted by the amount of activators and sodium periodate, respectively. The effect of the solid content of the hydrogels and oxidation degree of ALG-CHO on the gelation time, equilibrium swelling, mechanical properties, microscopic morphology, and in vitro degradation of the hydrogels was examined. Encapsulation of rabbit chondrocytes within hydrogels showed viability of the entrapped cells and good biocompatibility of the injectable hydrogels. A preliminary study exhibited injectability and rapid in vivo gel formation, as well as mechanical stability, cell ingrowth, and ectopic cartilage formation. The injectable PLGA/ALG hydrogels demonstrated attractive properties for future application in a variety of pharmaceutical delivery and tissue engineering, especially in cartilage tissue engineering.
C1 [Yan, Shifeng; Wang, Taotao; Feng, Long; Zhu, Jie; Zhang, Kunxi; Yin, Jingbo] Shanghai Univ, Dept Polymer Mat, Shanghai 200444, Peoples R China.
   [Cui, Lei] Capital Med Univ, Beijing Shijitan Hosp, Med Sci & Res Ctr, Beijing 100038, Peoples R China.
   [Yan, Shifeng] Fudan Univ, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Chen, Xuesi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.
RP Yan, SF (reprint author), Shanghai Univ, Dept Polymer Mat, 333 Nanchen Rd, Shanghai 200444, Peoples R China.
EM yansf@staff.shu.edu.cn; xschen@ciac.jl.cn; cuileite@yahoo.com.cn;
   jbyin@oa.shu.edu.cn
FU National Natural Science Foundation of China [51473090, 51373094,
   51173101]; Natural Science Foundation of Shanghai City [14ZR1414600];
   Key Basic Research Project of Shanghai Municipal Science and Technology
   Commission [11JC1404200]
FX The work was supported by the National Natural Science Foundation of
   China (Nos. 51473090, 51373094, and 51173101), the Natural Science
   Foundation of Shanghai City (No. 14ZR1414600), and the Key Basic
   Research Project of Shanghai Municipal Science and Technology Commission
   (No. 11JC1404200). Mr. Yuliang Chu from Instrumental Analysis Research
   Centre (Shanghai University) is acknowledged for their help in SEM
   measurement.
CR Aliaghaie M, 2012, SOFT MATTER, V8, P7128, DOI 10.1039/c2sm25254f
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   Bos GW, 2005, BIOMATERIALS, V26, P3901, DOI 10.1016/j.biomaterials.2004.10.008
   Chau Y, 2004, BIOCONJUGATE CHEM, V15, P931, DOI 10.1021/bc0499174
   Chiu YT, 2007, J AGR FOOD CHEM, V55, P5123, DOI 10.1021/jf0700069
   Dai ZZ, 2007, POLYM INT, V56, P1122, DOI 10.1002/pi.2247
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   de Jong SJ, 2001, J CONTROL RELEASE, V72, P47, DOI 10.1016/S0168-3659(01)00261-9
   Ding CX, 2010, BIOMACROMOLECULES, V11, P1043, DOI 10.1021/bm1000179
   Doug Y. X., 2012, MACROMOL RAPID COMM, V33, P120
   Fang YP, 2005, BIOMACROMOLECULES, V6, P3202, DOI 10.1021/bm0505383
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Guan JJ, 2008, BIOMACROMOLECULES, V9, P1283, DOI 10.1021/bm701265j
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hou QX, 2008, CARBOHYD POLYM, V74, P235, DOI 10.1016/j.carbpol.2008.02.010
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021
   Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Kang HA, 2002, J CHEM TECHNOL BIOT, V77, P205, DOI 10.1002/jctb.550
   Kristiansen KA, 2011, CARBOHYD POLYM, V86, P1595, DOI 10.1016/j.carbpol.2011.06.069
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kurisawa M, 2010, J MATER CHEM, V20, P5371, DOI 10.1039/b926456f
   Lea D., 2008, CARBOHYD RES, V343, P308
   Lee SY, 2007, J CONTROL RELEASE, V119, P313, DOI 10.1016/j.jconrel.2007.03.007
   Li C, 2002, ADV DRUG DELIVER REV, V54, P695, DOI 10.1016/S0169-409X(02)00045-5
   Li XX, 2010, CARBOHYD POLYM, V79, P660, DOI 10.1016/j.carbpol.2009.09.020
   Lu SY, 2010, CHEM ENG J, V160, P779, DOI 10.1016/j.cej.2010.03.072
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Matsumura K, 2014, CARBOHYD POLYM, V113, P32, DOI 10.1016/j.carbpol.2014.06.073
   Molinos M, 2012, BIOMACROMOLECULES, V13, P517, DOI 10.1021/bm2015834
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ngoenkam J, 2010, INT J PHARMACEUT, V391, P115, DOI 10.1016/j.ijpharm.2010.02.028
   PAINTER T, 1970, ACTA CHEM SCAND, V24, P813, DOI 10.3891/acta.chem.scand.24-0813
   Park KM, 2010, BIOMACROMOLECULES, V11, P706, DOI 10.1021/bm9012875
   Pereira CL, 2012, J MATER SCI-MATER M, V23, P1583, DOI 10.1007/s10856-012-4639-x
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Robb SA, 2007, BIOMACROMOLECULES, V8, P2294, DOI 10.1021/bm070267r
   Rouillard AD, 2011, TISSUE ENG PART C-ME, V17, P173, DOI [10.1089/ten.tec.2009.0582, 10.1089/ten.TEC.2009.0582]
   Ruszymah BHI, 2007, INT J PEDIATR OTORHI, V71, P1225, DOI 10.1016/j.ijporl.2007.04.014
   Sargeant TD, 2012, ACTA BIOMATER, V8, P124, DOI 10.1016/j.actbio.2011.07.028
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Song ZJ, 2009, MACROMOL BIOSCI, V9, P268, DOI 10.1002/mabi.200800164
   Su WY, 2010, ACTA BIOMATER, V6, P3044, DOI 10.1016/j.actbio.2010.02.037
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Teng DY, 2010, POLYMER, V51, P639, DOI 10.1016/j.polymer.2009.12.003
   Yan SF, 2013, J MATER CHEM B, V1, P1541, DOI 10.1039/c2tb00440b
   Yu HQ, 2007, MACROMOL BIOSCI, V7, P1100, DOI 10.1002/mabi.200700035
   Zhang KX, 2013, ACTA BIOMATER, V9, P7276, DOI 10.1016/j.actbio.2013.03.025
NR 55
TC 62
Z9 65
U1 19
U2 232
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2014
VL 15
IS 12
BP 4495
EP 4508
DI 10.1021/bm501313t
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AW2JR
UT WOS:000346114400013
PM 25279766
DA 2018-10-20
ER

PT J
AU Taggart, JC
   Welch, EZ
   Mulqueen, MF
   Dioguardi, VB
   Cauer, AG
   Kokona, B
   Fairman, R
AF Taggart, James C.
   Welch, Elizabeth Z.
   Mulqueen, Mary F.
   Dioguardi, Vincent B.
   Cauer, Alexandra G.
   Kokona, Bashkim
   Fairman, Robert
TI Testing the Role of Charge and Structure on the Stability of
   Peptide-Porphyrin Complexes
SO BIOMACROMOLECULES
LA English
DT Article
ID AMINO-ACIDS; PHOTOCONDUCTIVITY; CHEMISTRY; NANORODS; OXIDASE; DESIGN;
   ARRAYS; ENERGY
AB This study aims to extend a structural and biophysical understanding of a coiled-coil based peptide model system that serves as a scaffold for the anionic porphyrin, TPPS4. This is part of an ongoing biomaterials effort to create photoelectronically active mesoscale fibrils for surface deposition and characterization of conductivity properties. The goals are two-fold: (1) to explore optimal basic side-chain moieties for tight binding to TPPS4 and (2) to test the binding of various metalated TPPS4 derivatives to our peptide model system. The latter goal is to control the electronic and redox properties of the fibrillar biomaterials. A soluble version of the peptide biomaterial was used in order to probe binding and to extract thermodynamically rigorous equilibrium binding constants. UVvisible spectroscopy and circular dichroism spectropolarimtery are used to measure the effects of binding on the Soret band of the porphyrin and the helical signal of the peptide, respectively. For the first study, it was found that lysine, ornithine, and arginine are equally robust at engaging TPPS4 with low micromolar binding affinity. In the case of the metalated porphyrins, submicromolar binding affinity was observed for Cu(II), Ni(II), and Pd(II). The ability of these metalated porphyrins to bind with high affinity is dependent largely on structural perturbations of the porphyrin molecule, rather than on induced electronic effects.
C1 [Taggart, James C.; Welch, Elizabeth Z.; Mulqueen, Mary F.; Dioguardi, Vincent B.; Cauer, Alexandra G.; Kokona, Bashkim; Fairman, Robert] Haverford Coll, Dept Biol, Haverford, PA 19041 USA.
RP Fairman, R (reprint author), Haverford Coll, Dept Biol, 370 Lancaster Ave, Haverford, PA 19041 USA.
EM rfairman@haverford.edu
FU NSF [CHE-0616615, MCB-0516025, MCB-1243656]; Arnold and Mabel Beckman
   Foundation; HHMI Undergraduate Science Education Program
FX We thank the Department of Biochemistry and Biophysics at the University
   of Pennsylvania for the use of their MALDI-TOF mass spectrometer. This
   research was supported by grants from NSF (CHE-0616615, MCB-0516025, and
   MCB-1243656 to R.F.) and grants to Haverford College from the Arnold and
   Mabel Beckman Foundation and the HHMI Undergraduate Science Education
   Program to support undergraduate research.
CR ALLEN LC, 1989, J AM CHEM SOC, V111, P9003, DOI 10.1021/ja00207a003
   Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b
   Biesaga M, 2000, TALANTA, V51, P209, DOI 10.1016/S0039-9140(99)00291-X
   Drain CM, 2002, P NATL ACAD SCI USA, V99, P6498, DOI 10.1073/pnas.012521899
   Drain CM, 2002, P NATL ACAD SCI USA, V99, P5178, DOI 10.1073/pnas.062635099
   Dunetz JR, 2005, ORG LETT, V7, P2559, DOI 10.1021/ol050644h
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Fry HC, 2012, J AM CHEM SOC, V134, P14646, DOI 10.1021/ja304674d
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   HARRIMAN A, 1983, J PHYS CHEM-US, V87, P4957, DOI 10.1021/j150642a038
   HERRMANN O, 1978, CAN J CHEM, V56, P1084, DOI 10.1139/v78-184
   Jurow M, 2010, COORDIN CHEM REV, V254, P2297, DOI 10.1016/j.ccr.2010.05.014
   Kang B, 2013, ORG LETT, V15, P1670, DOI 10.1021/ol4004564
   Kokona B, 2009, BIOMACROMOLECULES, V10, P1454, DOI 10.1021/bm9000553
   Kovaric BC, 2006, J AM CHEM SOC, V128, P4166, DOI 10.1021/ja056357q
   Kubat P, 1996, J PHOTOCH PHOTOBIO A, V96, P93, DOI 10.1016/1010-6030(95)04279-2
   Kuciauskas D, 2010, J PHYS CHEM B, V114, P16029, DOI 10.1021/jp.108685n
   Kuciauskas D, 2009, J PHYS CHEM B, V113, P14439, DOI 10.1021/jp905468y
   Mashiko T., 1987, PORPHYRINS HYDROPORP, V2, P813
   Milgrom LR, 1997, NATURE, V390, P136
   Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525
   Pace CN, 1998, BIOPHYS J, V75, P422
   Padmanabhan S, 1996, J MOL BIOL, V257, P726, DOI 10.1006/jmbi.1996.0197
   Pepe-Mooney BJ, 2011, BIOMACROMOLECULES, V12, P4196, DOI 10.1021/bm201354m
   Pepe-Mooney BJ, 2009, CURR OPIN STRUC BIOL, V19, P483, DOI 10.1016/j.sbi.2009.07.001
   PRENDERGAST K, 1992, J AM CHEM SOC, V114, P3793, DOI 10.1021/ja00036a031
   Riley CK, 2010, J PHYS CHEM C, V114, P19227, DOI 10.1021/jp1068494
   Rohl CA, 1998, METHOD ENZYMOL, V295, P1
   ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2
   SARMA YA, 1989, SPECTROCHIM ACTA A, V45, P649, DOI 10.1016/0584-8539(89)80173-4
   Schwab AD, 2004, NANO LETT, V4, P1261, DOI 10.1021/nl049421v
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   SHERMAN D, 1991, P NATL ACAD SCI USA, V88, P4265, DOI 10.1073/pnas.88.10.4265
   WILSON DF, 1967, BIOCHIM BIOPHYS ACTA, V143, P52, DOI 10.1016/0005-2728(67)90108-9
   Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2
   Zaytsev DV, 2010, BIOMACROMOLECULES, V11, P2602, DOI 10.1021/bm100540t
NR 36
TC 2
Z9 3
U1 0
U2 24
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC
PY 2014
VL 15
IS 12
BP 4544
EP 4550
DI 10.1021/bm5013426
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AW2JR
UT WOS:000346114400018
PM 25371967
DA 2018-10-20
ER

PT J
AU Liu, ZW
   Li, WQ
   Wang, JK
   Ma, XC
   Liang, C
   Liu, P
   Chu, Z
   Dang, YH
AF Liu, Zhong-wei
   Li, Wen-qiang
   Wang, Jun-kui
   Ma, Xian-cang
   Liang, Chen
   Liu, Peng
   Chu, Zheng
   Dang, Yong-hui
TI Zirconium oxide ceramic foam: a promising supporting biomaterial for
   massive production of glial cell line-derived neurotrophic factor
SO JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
LA English
DT Article
DE Zirconium oxide; Ceramic foam; Glial cell line-derived neurotrophic
   factor (GDNF); Parkinson's disease
ID TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; FACTOR GDNF; RAT MODEL;
   GROWTH-FACTORS; NEURONS; EXPRESSION; INFUSION; BDNF; TRANSPLANTATION
AB This study investigated the potential application of a zirconium oxide (ZrO2) ceramic foam culturing system to the production of glial cell line-derived neurotrophic factor (GDNF). Three sets of ZrO2 ceramic foams with different pore densities of 10, 20, and 30 pores per linear inch (PPI) were prepared to support a 3D culturing system. After primary astrocytes were cultured in these systems, production yields of GDNF were evaluated. The biomaterial biocompatibility, cell proliferation and activation of cellular signaling pathways in GDNF synthesis and secretion in the culturing systems were also assessed and compared with a conventional culturing system. In this study, we found that the ZrO2 ceramic foam culturing system was biocompatible, using which the GDNF yields were elevated and sustained by stimulated cell proliferation and activation of signaling pathways in astrocytes cultured in the system. In conclusion, the ZrO2 ceramic foam is promising for the development of a GDNF mass production device for Parkinson's disease treatment.
C1 [Liu, Zhong-wei; Wang, Jun-kui] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 3, Xian 710068, Peoples R China.
   [Li, Wen-qiang] Northwestern Polytech Univ, Sch Astronaut, Xian 710072, Peoples R China.
   [Ma, Xian-cang] Xi An Jiao Tong Univ, Dept Psychiat, Affiliated Hosp 1, Xian 710061, Peoples R China.
   [Liang, Chen] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian 710061, Peoples R China.
   [Liu, Peng; Chu, Zheng; Dang, Yong-hui] Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710061, Peoples R China.
   [Dang, Yong-hui] Xi An Jiao Tong Univ, Hlth Sci Ctr, Hlth Minist Forens Med, Key Lab, Xian 710061, Peoples R China.
   [Dang, Yong-hui] Xi An Jiao Tong Univ, Hlth Sci Ctr, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Peoples R China.
RP Dang, YH (reprint author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710061, Peoples R China.
EM liuzhongweicn@gmail.com; psydyh@mail.xjtu.edu.cn
OI Chu, Zheng/0000-0003-1805-3824
FU National Natural Science Foundation of China [81171262, 81371473]
FX Project supported by the National Natural Science Foundation of China
   (Nos. 81171262 and 81371473)
CR Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x
   Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039
   Burke RE, 2006, J NEURAL TRANSM-SUPP, P41
   Cho KS, 2010, BIOCHEM BIOPH RES CO, V402, P48, DOI 10.1016/j.bbrc.2010.09.099
   ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362
   Foltynie T, 2013, J NEUROL, V260, P1433, DOI 10.1007/s00415-013-6915-1
   Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850
   Golan M, 2011, INT J NEUROPSYCHOPH, V14, P1289, DOI 10.1017/S1461145710001550
   Grundstrom E, 2000, NEUROREPORT, V11, P1781, DOI 10.1097/00001756-200006050-00037
   Hebb AO, 2003, J NEUROSURG, V98, P1078, DOI 10.3171/jns.2003.98.5.1078
   Heckmann L, 2008, BIOTECHNOL APPL BIOC, V49, P185, DOI 10.1042/BA20070071
   Hidalgo-Figueroa M, 2012, J NEUROSCI, V32, P864, DOI 10.1523/JNEUROSCI.2693-11.2012
   Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019
   Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737
   Li ZH, 2014, BIOTECHNOL ADV, V32, P243, DOI 10.1016/j.biotechadv.2013.10.006
   Lo WC, 2008, J NUCL MED, V49, P1512, DOI 10.2967/jnumed.108.051896
   Matsushita Y, 2008, J NEUROSCI RES, V86, P1959, DOI 10.1002/jnr.21657
   Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528
   Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009
   Ortiz-Ortiz MA, 2011, ENVIRON TOXICOL PHAR, V31, P129, DOI 10.1016/j.etap.2010.09.013
   Parsadanian A, 2006, EXP NEUROL, V200, P26, DOI 10.1016/j.expneurol.2006.01.014
   Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374
   Sale P, 2013, EUR J PHYS REHAB MED, V49, P161
   Schenck M, 2007, UROLOGE, V46, P1262, DOI 10.1007/s00120-007-1385-7
   Shingo T, 2002, J NEUROSCI RES, V69, P946, DOI 10.1002/jnr.10375
   Sun M, 2005, BRAIN RES, V1052, P119, DOI 10.1016/j.brainres.2005.05.072
   Tanaka Y, 2008, CELL BIOL INT, V32, P505, DOI 10.1016/j.cellbi.2007.12.012
   Tokutake T, 2014, PARKINSONISM RELAT D, V20, P262, DOI 10.1016/j.parkreldis.2013.11.008
   von Frenckell C, 2012, Rev Med Liege, V67 Spec No, P22
   Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024
   Yasuhara T, 2005, J NEUROSURG, V102, P80, DOI 10.3171/jns.2005.102.1.0080
   Yasuhara T, 2007, ACTA MED OKAYAMA, V61, P51
   Zesiewicz TA, 2007, CURR NEUROL NEUROSCI, V7, P302, DOI 10.1007/s11910-007-0046-y
   Zuo Dong-qing, 2013, Zhonghua Zhong Liu Za Zhi, V35, P641
NR 34
TC 3
Z9 3
U1 0
U2 7
PU ZHEJIANG UNIV
PI HANGZHOU
PA EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA
SN 1673-1581
EI 1862-1783
J9 J ZHEJIANG UNIV-SC B
JI J. Zhejiang Univ.-SCI. B
PD DEC
PY 2014
VL 15
IS 12
BP 1013
EP 1022
DI 10.1631/jzus.B1400163
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Research & Experimental Medicine
GA AW3EJ
UT WOS:000346168300001
PM 25471830
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hsu, SK
   Hsu, HC
   Ho, WF
   Yao, CH
   Chang, PL
   Wu, SC
AF Hsu, Shih-Kuang
   Hsu, Hsueh-Chuan
   Ho, Wen-Fu
   Yao, Chun-Hsu
   Chang, Pai-Ling
   Wu, Shih-Ching
TI Biomolecular modification of zirconia surfaces for enhanced
   biocompatibility
SO THIN SOLID FILMS
LA English
DT Article
DE Zirconia; Surface modification; RGD-peptide
ID CELL-ADHESION; Y-TZP; RGD; ATTACHMENT; TITANIUM; DIFFERENTIATION;
   DEGRADATION; IMMOBILIZATION; BIOMATERIALS; GROWTH
AB Yttria-tetragonal zirconia polycrystal (Y-TZP) is a preferred biomaterial due to its good mechanical properties. In order to improve the biocompatibility of zirconia, RGD-peptide derived from extracellular matrix proteins was employed to modify the surface of Y-TZP to promote cell adhesion in this study.
   The surface of Y-TZP specimens was first modified using a hydrothermal method for different lengths of time. The topographies of modified Y-TZP specimens were analyzed by contact angle, XRD, FTIR, AFM, and FE-SEM. The mechanical properties were evaluated using Vickers hardness and three point bending strength. Then, the RGD-peptide was immobilized on the surface of the Y-TZP by chemical treatment. These RGD-peptide immobilized Y-TZP specimens were characterized by FTIR and AFM, and then were cocultured with MG-63 osteoblast cells for biocompatibility assay. The cell morphology and proliferation were evaluated by SEM, WST-1, and ALP activity assay.
   The XRD results indicated that the phase transition, from tetragonal phase to monoclinic phase, was increased with a longer incubation time of hydrothermal treatment. However, there were no significant differences in mechanical strengths after RGD-peptide was successfully grafted onto the Y-TZP surface. The SEM images showed that the MG-63 cells appeared polygonal, spindle-shaped, and attached on the RGD-peptide immobilized Y-TZP. The proliferation and cellular activities of MG-63 cells on the RGD-peptide immobilized Y-TZP were better than that on the unmodified Y-TZP.
   From the above results, the RGD-peptide can be successfully grafted onto the hydrothermal modified Y-TZP surface. The RGD-peptide immobilized Y-TZP can increase cell adhesion, and thus, improve the biocompatibility of Y-TZP. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Hsu, Shih-Kuang; Hsu, Hsueh-Chuan; Wu, Shih-Ching] Cent Taiwan Univ Sci & Technol, Dept Dent Technol & Mat Sci, Taichung 40601, Taiwan.
   [Ho, Wen-Fu] Natl Univ Kaohsiung, Dept Chem & Mat Engn, Kaohsiung, Taiwan.
   [Yao, Chun-Hsu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung 40402, Taiwan.
   [Chang, Pai-Ling] Taoyuan Gen Hosp, Taoyuan 33004, Taiwan.
RP Wu, SC (reprint author), Cent Taiwan Univ Sci & Technol, Dept Dent Technol & Mat Sci, 666 Buzih Rd, Taichung 40601, Taiwan.
EM scwu@ctust.edu.tw
FU Ministry of Science and Technology of the Republic of China, Taiwan
   [NSC102-2221-E-166-005-]; Taoyuan General Hospital [PTH10207]
FX The authors thank the Ministry of Science and Technology of the Republic
   of China, Taiwan (contract no. NSC102-2221-E-166-005-) and the Taoyuan
   General Hospital (contract no. PTH10207) for financial support.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bae MS, 2013, CARBOHYD POLYM, V92, P167, DOI 10.1016/j.carbpol.2012.09.044
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   CHRISTEL P, 1989, J BIOMED MATER RES, V23, P45, DOI 10.1002/jbm.820230105
   Davis DH, 2002, BIOMATERIALS, V23, P4019, DOI 10.1016/S0142-9612(02)00152-7
   Dehestani M, 2012, J BIOMED MATER RES B, V100B, P832, DOI 10.1002/jbm.b.32647
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Hashimoto K, 2011, DENT MATER J, V30, P935, DOI 10.4012/dmj.2011-161
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Lughi V, 2010, DENT MATER, V26, P807, DOI 10.1016/j.dental.2010.04.006
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Munoz-Tabares JA, 2012, J EUR CERAM SOC, V32, P325, DOI 10.1016/j.jeurceramsoc.2011.08.029
   Mura S, 2012, BEILSTEIN J NANOTECH, V3, P485, DOI 10.3762/bjnano.3.55
   Oya K, 2009, BIOMATERIALS, V30, P1281, DOI 10.1016/j.biomaterials.2008.11.030
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Sato T., 1985, J AM CERAM SOC, V68, P320
   Schliephake H, 2002, CLIN ORAL IMPLAN RES, V13, P312, DOI 10.1034/j.1600-0501.2002.130312.x
   Schwartz J, 2003, MAT SCI ENG C-BIO S, V23, P395, DOI 10.1016/S0928-4931(02)00310-7
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SWAB JJ, 1991, J MATER SCI, V26, P6706, DOI 10.1007/BF02402664
   Tominaga H, 1999, ANAL COMMUN, V36, P47, DOI 10.1039/a809656b
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Yang CL, 2009, J MATER SCI-MATER M, V20, P2349, DOI 10.1007/s10856-009-3794-1
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   YOSHIMURA M, 1987, J MATER SCI LETT, V6, P465, DOI 10.1007/BF01756800
NR 31
TC 7
Z9 7
U1 0
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD DEC 1
PY 2014
VL 572
BP 91
EP 98
DI 10.1016/j.tsf.2014.07.068
PG 8
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA AW1NM
UT WOS:000346056100017
DA 2018-10-20
ER

PT J
AU Zhou, L
   Tan, GX
   Ning, CY
AF Zhou, Lei
   Tan, Guo-Xin
   Ning, Cheng-Yun
TI Modification of biomaterials surface by mimetic cell membrane to improve
   biocompatibility
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE mimetic cell membrane; phosphorylcholine (PC); biocompatibility; surface
   modification; biomaterial
ID PHOSPHOLIPID POLYMER HYDROGEL; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE;
   POLY(2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE); PROTEIN ADSORPTION;
   NETWORK HYDROGELS; GENE DELIVERY; HEMOCOMPATIBILITY; RESISTANCE;
   MECHANISMS; COPOLYMER
AB Modification of biomaterials surface by mimetic cell membrane for improving biocompatibility, to imitate the excellent biological and physiological properties of the natural cell membrane, is an important research area in materials science. Numerous studies have been attempted to construct a mimetic cell membrane biointerface composed of phosphorylcholine (PC)-containing polymers or other phospholipid analogues on biomaterials surface. PC-containing biointerfaces show outstanding characteristics, especially in biological aspects such as blood compatibility and antifouling property. In this mini-review, the strategies of membrane mimetic modification of biomaterials and their antifouling applications are summarized.
C1 [Zhou, Lei; Tan, Guo-Xin] Guangdong Univ Technol, Sch Chem Engn & Light Ind, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhou, Lei; Ning, Cheng-Yun] S China Univ Technol, Coll Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Tan, GX (reprint author), Guangdong Univ Technol, Sch Chem Engn & Light Ind, Guangzhou 510006, Guangdong, Peoples R China.
EM tanguoxin@126.com; ning_lab@hotmail.com
FU National Basic Research Program of China [2012CB619100]; National
   Natural Science Foundation of China [51372087, 51232002, 51072055]
FX The authors gratefully acknowledge the financial support of the National
   Basic Research Program of China (Grant No. 2012CB619100) and the
   National Natural Science Foundation of China (Grant Nos. 51372087,
   51232002, and 51072055).
CR Aikawa T, 2013, SOFT MATTER, V9, P4628, DOI 10.1039/c3sm50394a
   Barthelemy B, 2014, ACS APPL MATER INTER, V6, P10060, DOI 10.1021/am500725d
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Choi J, 2009, BIOMATERIALS, V30, P5201, DOI 10.1016/j.biomaterials.2009.06.003
   Gao B, 2013, MAT SCI ENG C-MATER, V33, P2871, DOI 10.1016/j.msec.2013.03.007
   Gao BT, 2014, BIOMATERIALS, V35, P2181, DOI 10.1016/j.biomaterials.2013.11.060
   Goda T, 2013, CHEM COMMUN, V49, P8683, DOI 10.1039/c3cc44357d
   Gong M, 2013, SOFT MATTER, V9, P4501, DOI 10.1039/c3sm00086a
   Gong M, 2011, COLLOID SURFACE B, V85, P48, DOI 10.1016/j.colsurfb.2010.10.049
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Hoshi T, 2008, APPL SURF SCI, V255, P379, DOI 10.1016/j.apsusc.2008.06.145
   Huangfu PB, 2009, COLLOID SURFACE B, V71, P268, DOI 10.1016/j.colsurfb.2009.02.014
   Jang K, 2009, BIOMATERIALS, V30, P1413, DOI 10.1016/j.biomaterials.2008.11.013
   Kitayama Y, 2014, ANAL CHEM, V86, P5587, DOI 10.1021/ac501322x
   Konno T, 2007, BIOMATERIALS, V28, P1770, DOI 10.1016/j.biomaterials.2006.12.017
   Kyomoto M, 2013, BIOMATERIALS, V34, P7829, DOI 10.1016/j.biomaterials.2013.07.023
   Kyomoto M, 2010, BIOMATERIALS, V31, P1017, DOI 10.1016/j.biomaterials.2009.10.055
   Kyomoto M, 2010, BIOMATERIALS, V31, P658, DOI 10.1016/j.biomaterials.2009.09.083
   Liu WG, 2009, BIOMATERIALS, V30, P1551, DOI 10.1016/j.biomaterials.2008.11.022
   Liu Y, 2014, CARBON, V71, P166, DOI 10.1016/j.carbon.2014.01.025
   Long LX, 2014, MATER CHEM PHYS, V143, P929, DOI 10.1016/j.matchemphys.2013.09.041
   Lu J, 2012, MACROMOL RES, V20, P693, DOI 10.1007/s13233-012-0104-4
   Ma Q, 2012, APPL SURF SCI, V258, P9711, DOI 10.1016/j.apsusc.2012.06.017
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   Nishigochi S, 2014, IND ENG CHEM RES, V53, P2491, DOI 10.1021/ie404094t
   Oda H, 2013, BIOMATERIALS, V34, P5891, DOI 10.1016/j.biomaterials.2013.04.015
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Raigoza AF, 2013, ACS APPL MATER INTER, V5, P9249, DOI 10.1021/am4018048
   Shimizu T, 2010, BIOMATERIALS, V31, P3274, DOI 10.1016/j.biomaterials.2010.01.026
   Son S, 2011, SMALL, V7, P2991, DOI 10.1002/smll.201100232
   Sun J, 2013, POLYM CHEM-UK, V4, P5810, DOI 10.1039/c3py00752a
   UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259
   Wang JJ, 2011, POLYM ADVAN TECHNOL, V22, P2091, DOI 10.1002/pat.1726
   Wang YB, 2014, J MEMBRANE SCI, V452, P29, DOI 10.1016/j.memsci.2013.10.032
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu ZR, 2007, J BIOMED MATER RES A, V81A, P355, DOI 10.1002/jbm.a.30993
   Ye SH, 2009, COLLOID SURFACE B, V74, P96, DOI 10.1016/j.colsurfb.2009.06.032
   Yoshimoto K, 2009, MACROMOL RAPID COMM, V30, P2136, DOI 10.1002/marc.200900484
   Yuan J, 2013, COLLOID SURFACE B, V111, P432, DOI 10.1016/j.colsurfb.2013.06.009
   Zahedi P, 2009, INT J PHARMACEUT, V377, P76, DOI 10.1016/j.ijpharm.2009.05.003
NR 42
TC 4
Z9 4
U1 6
U2 92
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD DEC
PY 2014
VL 8
IS 4
BP 325
EP 331
DI 10.1007/s11706-014-0265-5
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AW1DZ
UT WOS:000346032000002
DA 2018-10-20
ER

PT J
AU Zeng, RC
   Qi, WC
   Song, YW
   He, QK
   Cui, HZ
   Han, EH
AF Zeng, Rong-Chang
   Qi, Wei-Chen
   Song, Ying-Wei
   He, Qin-Kun
   Cui, Hong-Zhi
   Han, En-Hou
TI In vitro degradation of MAO/PLA coating on Mg-1.21Li-1.12Ca-1.0Y alloy
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE magnesium alloy; micro-arc oxidation (MAO); poly(lactic acid) (PLA);
   biomaterial; degradation
ID PLASMA ELECTROLYTIC OXIDATION; CALCIUM-PHOSPHATE COATINGS; MG-CA ALLOYS;
   MAGNESIUM ALLOYS; COATED MAGNESIUM; CORROSION-RESISTANCE; VIVO
   CORROSION; HANKS SOLUTION; BIOMATERIALS; IMPLANTS
AB Magnesium and its alloys are promising biomaterials due to their biocompatibility and osteoinduction. The plasticity and corrosion resistance of commercial magnesium alloys cannot meet the requirements for degradable biomaterials completely at present. Particularly, the alkalinity in the microenvironment surrounding the implants, resulting from the degradation, arouses a major concern. Micro-arc oxidation (MAO) and poly(lactic acid) (PLA) composite (MAO/PLA) coating on biomedical Mg-1.21Li-1.12Ca-1.0Y alloy was prepared to manipulate the pH variation in an appropriate range. Surface morphologies were discerned using SEM and EMPA. And corrosion resistance was evaluated via electrochemical polarization and impedance and hydrogen volumetric method. The results demonstrated that the MAO coating predominantly consisted of MgO, Mg2SiO4 and Y2O3. The composite coating markedly improved the corrosion resistance of the alloy. The rise in solution pH for the MAO/PLA coating was tailored to a favorable range of 7.5-7.8. The neutralization caused by the alkalinity of MAO and Mg substrate and acidification of PLA was probed. The result designates that MAO/PLA composite coating on Mg-1.21Li-1.12Ca-1.0Y alloys may be a promising biomedical coating.
C1 [Zeng, Rong-Chang; Qi, Wei-Chen; He, Qin-Kun; Cui, Hong-Zhi] Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
   [Zeng, Rong-Chang; Qi, Wei-Chen] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Cofu, Qingdao 266590, Peoples R China.
   [Zeng, Rong-Chang; Qi, Wei-Chen] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China.
   [Song, Ying-Wei; Han, En-Hou] Chinese Acad Sci, Inst Met Res, Natl Engn Ctr Corros Control, Shenyang 110016, Peoples R China.
RP Zeng, RC (reprint author), Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
EM rczeng@foxmail.com
RI Zeng, Rong-Chang/H-4154-2011
OI Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [51241001]; Shandong
   Provincial Natural Science Foundation, China [ZR2011E MM004]; SDUST
   Research Fund [2014TDJH104]; Joint Innovative Center for Safe and
   Effective Mining Technology and Equipment of Coal Resources; Shandong
   Province; Taishan Scholarship Project of Shandong Province [TS20110828]
FX This research was financially supported by the National Natural Science
   Foundation of China (Grant No. 51241001), Shandong Provincial Natural
   Science Foundation, China (ZR2011E MM004), SDUST Research Fund
   (2014TDJH104), Joint Innovative Center for Safe and Effective Mining
   Technology and Equipment of Coal Resources, and Shandong Province as
   well as Taishan Scholarship Project of Shandong Province (TS20110828).
   Thanks go to Prof. Rong-Shi Chen and the members of his group at
   Institute of Metals Research, Chinese Academy of Sciences for the
   preparation of the ingots.
CR Bonilla FA, 2002, CORROS SCI, V44, P1941, DOI 10.1016/S0010-938X(02)00018-5
   Chen J, 2008, T NONFERR METAL SOC, V18, pS361, DOI 10.1016/S1003-6326(10)60232-4
   Gaurava S, 2012, RES J CHEM ENVIRON, V16, P2
   Ghasemi A, 2010, SURF COAT TECH, V204, P1469, DOI 10.1016/j.surfcoat.2009.09.069
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Guo MQ, 2011, J MATER SCI-MATER M, V22, P1735, DOI 10.1007/s10856-011-4354-z
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Lu P, 2011, J BIOMED MATER RES B, V96B, P101, DOI 10.1002/jbm.b.31744
   Narayanan TSNS, 2014, PROG MATER SCI, V60, P1, DOI 10.1016/j.pmatsci.2013.08.002
   Ostrowski NJ, 2013, J MATER SCI-MATER M, V24, P85, DOI 10.1007/s10856-012-4773-5
   Piemonte V, 2013, J POLYM ENVIRON, V21, P313, DOI 10.1007/s10924-012-0547-x
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Sreekanth D, 2013, SURF COAT TECH, V222, P31, DOI 10.1016/j.surfcoat.2013.01.056
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wang LS, 2007, SURF ENG, V23, P324, DOI 10.1179/174329407X260519
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Wu YH, 2013, J MATER SCI TECHNOL, V29, P545, DOI 10.1016/j.jmst.2013.03.004
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Zeng R C, 2012, ACTA METALLURGICA SI, V47, P1477
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang CY, 2010, T NONFERR METAL SOC, V20, pS655, DOI 10.1016/S1003-6326(10)60556-0
   Zhang CY, 2010, SURF COAT TECH, V204, P3636, DOI 10.1016/j.surfcoat.2010.04.038
   Zhang RF, 2009, APPL SURF SCI, V255, P7893, DOI 10.1016/j.apsusc.2009.04.145
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
   Zhao LC, 2010, CORROS SCI, V52, P2228, DOI 10.1016/j.corsci.2010.03.008
   Zhao X, 2013, J MATER SCI TECHNOL, V29, P781, DOI 10.1016/j.jmst.2013.05.017
NR 38
TC 23
Z9 23
U1 6
U2 55
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD DEC
PY 2014
VL 8
IS 4
BP 343
EP 353
DI 10.1007/s11706-014-0264-6
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA AW1DZ
UT WOS:000346032000004
DA 2018-10-20
ER

PT J
AU Muller-Stich, BP
   Senft, JD
   Lasitschka, F
   Shevchenko, M
   Billeter, AT
   Bruckner, T
   Kenngott, HG
   Fischer, L
   Gehrig, T
AF Mueller-Stich, B. P.
   Senft, J. D.
   Lasitschka, F.
   Shevchenko, M.
   Billeter, A. T.
   Bruckner, T.
   Kenngott, H. G.
   Fischer, L.
   Gehrig, T.
TI Polypropylene, polyester or polytetrafluoroethylene-is there an ideal
   material for mesh augmentation at the esophageal hiatus? Results from an
   experimental study in a porcine model
SO HERNIA
LA English
DT Article
DE Hiatal hernia; Surgical mesh; Polypropylene; Polyester;
   Polytetrafluoroethylene
ID PARAESOPHAGEAL HERNIA REPAIR; LAPAROSCOPIC REPAIR; BIOLOGIC PROSTHESIS;
   ADHESION FORMATION; RANDOMIZED-TRIAL; PATCH REPAIR; FOLLOW-UP;
   BIOMATERIALS; HIATOPLASTY; MULTICENTER
AB Knowledge about the influence of underlying biomaterial on behavior of surgical meshes at the esophageal hiatus is rare, but essential for safe and effective hiatal hernia surgery. This study aimed to characterize the influence of polymer material on mesh behavior at the hiatus.
   24 pigs in three groups of eight underwent implantation of either polypropylene (PP), polyester (PET) or polytetrafluoroethylene (PTFE) mesh placed circularly at the esophageal hiatus. After 8 weeks, necropsy and measurements were performed evaluating mesh deformation, adhesion formation, fixation of the esophagogastric junction and mesh position. Foreign body reaction was assessed by mononuclear cell count and immunostaining of Ki-67. Tissue integration was evaluated by immunostaining of type I and type III collagen fibers.
   Mesh shrinkage was the highest for PTFE, lower for PP and the lowest for PET (34.9 vs. 19.8 vs. 12.1 %; p = 0.002). Mesh aperture for the esophagus showed an enlargement within all groups, which was highest for PTFE compared to PP and PET (100.8 vs. 47.0 vs. 35.9 %; p = 0.001). The adhesion score was highest for PP, lower for PTFE and the lowest for PET (11.0 vs. 9.5 vs. 5.0; p = 0.001) and correlated positively with the score of esophagogastric fixation (r (s) = 0.784, p < 0.001). No mesh migration, erosion or stenosis of the esophagus occurred. Evaluation of foreign body reaction and tissue integration showed no significant differences.
   In this experimental setting, PP-meshes showed the most appropriate characteristics for augmentation at the hiatus. Due to solid fixation of the esophagogastric junction and low shrinkage tendency, PP-meshes may be effective in preventing hiatal hernia recurrence. The use of PTFE-mesh at the hiatus may be disadvantageous due to high shrinkage rates and correlating enlargement of the aperture for the esophagus.
C1 [Mueller-Stich, B. P.; Senft, J. D.; Shevchenko, M.; Billeter, A. T.; Kenngott, H. G.; Fischer, L.; Gehrig, T.] Heidelberg Univ, Dept Gen Abdominal & Transplantat Surg, Heidelberg, Germany.
   [Lasitschka, F.] Heidelberg Univ, Inst Pathol, Heidelberg, Germany.
   [Bruckner, T.] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany.
RP Muller-Stich, BP (reprint author), Heidelberg Univ, Dept Gen Abdominal & Transplantat Surg, Heidelberg, Germany.
EM beat.mueller@med.uni-heidelberg.de
OI Billeter, Adrian/0000-0001-8724-4793
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Cardarelli F, 2008, MAT HDB, P691
   Desai KM, 2006, SURG ENDOSC, V20, P1693, DOI 10.1007/s00464-006-0680-5
   Frantzides CT, 2002, ARCH SURG-CHICAGO, V137, P649, DOI 10.1001/archsurg.137.6.649
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Furnee E, 2013, SURG ENDOSC, V27, P3998, DOI 10.1007/s00464-013-3036-y
   Gouvas N, 2011, DIS ESOPHAGUS, V24, P69, DOI 10.1111/j.1442-2050.2010.01094.x
   HILL LD, 1967, ANN SURG, V166, P681, DOI 10.1097/00000658-196710000-00015
   Jacob DA, 2012, LANGENBECK ARCH SURG, V397, P283, DOI 10.1007/s00423-011-0858-8
   Jansen M, 2007, SURG ENDOSC, V21, P2298, DOI 10.1007/s00464-007-9514-3
   Junge K, 2009, SURG ENDOSC, V23, P327, DOI 10.1007/s00464-008-9923-y
   Klinge U, 1998, EUR J SURG, V164, P965
   Lee E, 2007, SURG ENDOSC, V21, P641, DOI 10.1007/s00464-006-9117-4
   Linke GR, 2014, SURG TODAY, V44, P820, DOI 10.1007/s00595-013-0609-2
   Muller-Stich BP, 2009, AM J SURG, V198, P17, DOI 10.1016/j.amjsurg.2008.07.050
   Muller-Stich BP, 2009, SURG ENDOSC, V23, P1372, DOI 10.1007/s00464-008-0185-5
   Muller-Stich BP, 2006, SURG ENDOSC, V20, P380, DOI 10.1007/s00464-004-2272-6
   Oelschlager BK, 2006, ANN SURG, V244, P481, DOI 10.1097/01.sla.0000237759.42831.03
   Oelschlager BK, 2011, J AM COLL SURGEONS, V213, P461, DOI 10.1016/j.jamcollsurg.2011.05.017
   Otto Jens, 2008, BMC Surg, V8, P7, DOI 10.1186/1471-2482-8-7
   Rauth TP, 2007, J SURG RES, V143, P43, DOI 10.1016/j.jss.2007.04.079
   Schildberg CW, 2014, ZBL CHIR, V139, P66, DOI 10.1055/s-0032-1315116
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Shankaran V, 2011, ANN SURG, V253, P16, DOI 10.1097/SLA.0b013e3181f9b6e6
   Smith GS, 2008, SURG ENDOSC, V22, P1625, DOI 10.1007/s00464-007-9669-y
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   ten Hallers EJO, 2007, J BIOMED MATER RES A, V80A, P372, DOI 10.1002/jbm.a.30887
   Wolf I, 2005, MED IMAGE ANAL, V9, P594, DOI 10.1016/j.media.2005.04.005
   Zaninotto G, 2007, WORLD J SURG, V31, P2177, DOI 10.1007/s00268-007-9212-2
NR 30
TC 7
Z9 8
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1265-4906
EI 1248-9204
J9 HERNIA
JI Hernia
PD DEC
PY 2014
VL 18
IS 6
BP 873
EP 881
DI 10.1007/s10029-014-1305-x
PG 9
WC Surgery
SC Surgery
GA AU6GO
UT WOS:000345702100015
PM 25159558
DA 2018-10-20
ER

PT J
AU Kim, SY
   Go, KC
   Song, YS
   Jeong, YS
   Kim, EJ
   Kim, BJ
AF Kim, So Young
   Go, Kyung Chan
   Song, Yi Seop
   Jeong, Yeon Su
   Kim, Eun Joo
   Kim, Beom Joon
TI Extract of the mycelium of T. matsutake inhibits elastase activity and
   TPA-induced MMP-1 expression in human fibroblasts
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE human fibroblast; aging; 12-O-tetradecanoylphorbol-13-acetate; matrix
   metalloproteinase-1; tissue inhibitor of matrix metalloproteinases-1;
   elastase; tropoelastin
ID GENE-EXPRESSION; TRICHOLOMA-MATSUTAKE; MATRIX METALLOPROTEINASE-1;
   EPIDERMAL-KERATINOCYTES; SELECTIVE-INHIBITION; EXTRACELLULAR-MATRIX;
   WRINKLE FORMATION; PROTEIN COMPLEX; I COLLAGEN; HUMAN-SKIN
AB Skin aging is induced through complex biological processes in human skin caused by proteolysis of collagen and elastin, two structural proteins of the dermal extracellular matrix (ECM). Collagen and elastin degradation can induce the expression of matrix metalloproteinases (MMPs), as well as that of a family of zinc-dependent endopeptidases that play critical roles in skin aging. Moreover, elastase is a metalloproteinase which acts on the degradation of elastin in skin aging, and is also involved in the inhibition or. the repair of wrinkle formation. Extract of the mycelium of Tricholoma matsutake (T. matsutake), or pine mushroom, is widely distributed in Asian countries. The extract is from the natural biomaterial of the mushroom which is rich in polysaccharides, including P.-glucan. This extract has shown potent bioactive antioxidant, immunomodulatory and antitumoral properties. In the present study, we investigated whether the extract of the mycelium of T. matsutake has effects on elastase activity, as well as on the expression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) and MMP-1 under basal conditions. Our results revealed that the extract of the mycelium of T. matsutake significantly decreased elastase activity in a dose-dependent manner and reduced the levels of MMP-1 and MMP-3. On the other hand, the expression of TIMP-1 and tropoelastin was increased in fibroblasts treated with the extract of the mycelium of T. matsutake. However, collagent expression was not affected. In addition, our results demonstrated that the extract of the mycelium of T. matsutake inhibited the 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced MMP-1 expression and suppressed TPA-induced p38 activity. Therefore, the inhibitory effects of the extract of the mycelium of T. matsutake on MMP-1 induction are mediated by the inhibition of p38 in human fibroblasts. Our data suggest that the extract of the mycelium of T. matsutake may prove to be an effective biomaterial for anti-wrinkle treatment, as it can obstruct the degradation of the dermal ECM.
C1 [Kim, So Young; Go, Kyung Chan; Song, Yi Seop; Kim, Beom Joon] Chung Ang Univ, Grad Sch, Dept Med, Seoul 156755, South Korea.
   [Jeong, Yeon Su; Kim, Eun Joo; Kim, Beom Joon] Chung Ang Univ, Coll Med, Dept Dermatol, Seoul 156755, South Korea.
RP Kim, BJ (reprint author), Chung Ang Univ, Coll Med, Dept Dermatol, 224-1 Heukseok Dong, Seoul 156755, South Korea.
EM beomjoon@unitel.co.kr
OI Kim, Beom Joon/0000-0003-2320-7621
FU Biomedical Science Scholarship Grants, Department of Medicine, Chung-Ang
   University
FX This study was supported by Biomedical Science Scholarship Grants,
   Department of Medicine, Chung-Ang University in 2012.
CR Amalinei Cornelia, 2007, Rom J Morphol Embryol, V48, P323
   BONNAUREMALLET M, 1995, J PERIODONTAL RES, V30, P58, DOI 10.1111/j.1600-0765.1995.tb01253.x
   Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003
   Choi JJ, 2006, BIOCHEM BIOPH RES CO, V339, P880, DOI 10.1016/j.bbrc.2005.11.109
   Ebina Takusaburo, 2003, Gan To Kagaku Ryoho, V30, P1555
   Enjoji M, 2000, IN VITRO CELL DEV-AN, V36, P71
   Fagot D, 2002, ARCH DERMATOL RES, V293, P576, DOI 10.1007/s00403-001-0271-1
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003
   Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3
   GODEAU G, 1988, PATHOL BIOL, V36, P1133
   Hoshi H, 2005, J AGR FOOD CHEM, V53, P8948, DOI 10.1021/jf0510743
   Hou YL, 2013, PHARMACOGN MAG, V9, P244, DOI 10.4103/0973-1296.113278
   HUANG TS, 1995, P NATL ACAD SCI USA, V92, P4793, DOI 10.1073/pnas.92.11.4793
   IIDA I, 1995, ERGONOMICS, V38, P1921, DOI 10.1080/00140139508925240
   IMOKAWA G, 1995, J INVEST DERMATOL, V105, P254, DOI 10.1111/1523-1747.ep12317607
   Jenkins G, 2002, MECH AGEING DEV, V123, P801, DOI 10.1016/S0047-6374(01)00425-0
   Jimenez F, 2006, J INVEST DERMATOL, V126, P1272, DOI 10.1038/sj.jid.5700285
   Kim GY, 2006, BIOSCI BIOTECH BIOCH, V70, P1218, DOI 10.1271/bbb.70.1218
   Kim JY, 2008, J MICROBIOL BIOTECHN, V18, P95
   Lim M, 1998, FEBS LETT, V441, P88, DOI 10.1016/S0014-5793(98)01474-4
   Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071
   Millward TA, 1999, TRENDS BIOCHEM SCI, V24, P186, DOI 10.1016/S0968-0004(99)01375-4
   Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Naylor EC, 2011, MATURITAS, V69, P249, DOI 10.1016/j.maturitas.2011.04.011
   Philips N, 2003, J AM AGING ASSOC, V26, P59, DOI 10.1007/s11357-003-0006-7
   Philips Neena, 2011, Enzyme Res, V2011, P427285, DOI 10.4061/2011/427285
   Reunanen N, 1998, J BIOL CHEM, V273, P5137, DOI 10.1074/jbc.273.9.5137
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Rittie L, 2002, AGEING RES REV, V1, P705, DOI 10.1016/S1568-1637(02)00024-7
   Seite S, 2006, J EUR ACAD DERMATOL, V20, P980, DOI 10.1111/j.1468-3083.2006.01706.x
   SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204
   Simon C, 2001, EXP CELL RES, V271, P344, DOI 10.1006/excr.2001.5374
   TETI A, 1992, J AM SOC NEPHROL, V2, pS83
   THORSETT ED, 1982, P NATL ACAD SCI-BIOL, V79, P2176, DOI 10.1073/pnas.79.7.2176
   Tong HB, 2013, WORLD J MICROB BIOT, V29, P775, DOI 10.1007/s11274-012-1232-x
   Tsuji N, 2001, PHOTOCHEM PHOTOBIOL, V74, P283, DOI 10.1562/0031-8655(2001)074<0283:TROESB>2.0.CO;2
   Tsukahara K, 2005, BIOL PHARM BULL, V28, P2302, DOI 10.1248/bpb.28.2302
   Tsukahara K, 2001, J INVEST DERMATOL, V117, P671, DOI 10.1046/j.0022-202x.2001.01450.x
   VERMA AK, 1986, CANCER RES, V46, P6149
   Volman JJ, 2010, MOL NUTR FOOD RES, V54, P268, DOI 10.1002/mnfr.200900009
   Wasser SP, 2002, APPL MICROBIOL BIOT, V60, P258, DOI 10.1007/s00253-002-1076-7
   Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786
   Westermarck J, 1998, MATRIX BIOL, V17, P547, DOI 10.1016/S0945-053X(98)90107-X
   Westermarck J, 1997, ONCOGENE, V14, P2651, DOI 10.1038/sj.onc.1201111
   Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001
NR 47
TC 2
Z9 3
U1 3
U2 21
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD DEC
PY 2014
VL 34
IS 6
BP 1613
EP 1621
DI 10.3892/ijmm.2014.1969
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AU9ZC
UT WOS:000345949400020
PM 25319362
OA Bronze
DA 2018-10-20
ER

PT J
AU Cardwell, RD
   Dahlgren, LA
   Goldstein, AS
AF Cardwell, Robyn D.
   Dahlgren, Linda A.
   Goldstein, Aaron S.
TI Electrospun fibre diameter, not alignment, affects mesenchymal stem cell
   differentiation into the tendon/ligament lineage
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE ligament; electrospinning; poly(esterurethane urea); scleraxis; decorin
ID ANTERIOR CRUCIATE LIGAMENT; COLLAGEN; SCAFFOLDS; TENDON; GROWTH;
   PROLIFERATION; MATRIX; GENE; RECONSTRUCTION; ORGANIZATION
AB Efforts to develop engineered tendons and ligaments have focused on the use of a biomaterial scaffold and a stem cell source. However, the ideal scaffold microenvironment to promote stem cell differentiation and development of organized extracellular matrix is unknown. Through electrospinning, fibre scaffolds can be designed with tailorable architectures to mimic the intended tissue. In this study, the effects of fibre diameter and orientation were examined by electrospinning thin mats, consisting of small (< 1 mu m), medium (1-2 mu m) or large (> 2 mu m) diameter fibres with either random or aligned fibre orientation. C3H10T1/2 model stem cells were cultured on the six different electrospun mats, as well as smooth spin-coated films, and the morphology, growth and expression of tendon/ligament genes were evaluated. The results demonstrated that fibre diameter affects cellular behaviour more significantly than fibre alignment. Initially, cell density was greater on the small fibre diameter mats, but similar cell densities were found on all mats after an additional week in culture. After 2weeks, gene expression of collagen 11 and decorin was increased on all mats compared to films. Expression of the tendon/ligament transcription factor scleraxis was suppressed on all electrospun mats relative to spin-coated films, but expression on the large-diameter fibre mats was consistently greater than on the medium-diameter fibre mats. These results suggest that larger-diameter fibres (e.g. > 2 mu m) may be more suitable for in vitro development of a tendon/ligament tissue. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Cardwell, Robyn D.] Sch Biomed Engn & Sci, Blacksburg, VA USA.
   [Cardwell, Robyn D.] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.
   [Dahlgren, Linda A.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA.
   [Goldstein, Aaron S.] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, 339 ICTAS 1, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
FU National Institutes of Health [F31AR055872]
FX This work was supported by the National Institutes of Health (Fellowship
   Grant No. F31AR055872 to RDC). The authors gratefully acknowledge Dr
   Scott Guelcher for providing the synthesized PEUUR.
CR Abes S, 1993, ARTHROSCOPY, V9, P394
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Bashur CA, 2006, BIOMATERIALS, V27, P5681, DOI 10.1016/j.biomaterials.2006.07.005
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x
   Brown CH, 1999, CLIN SPORT MED, V18, P109, DOI 10.1016/S0278-5919(05)70133-2
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   CSERJESI P, 1995, DEVELOPMENT, V121, P1099
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200
   Fithian DC, 2005, AM J SPORT MED, V33, P335, DOI 10.1177/0363546504269590
   Frank CB, 1997, J BONE JOINT SURG AM, V79A, P1556, DOI 10.2106/00004623-199710000-00014
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   HEALY KE, 1994, BIOTECHNOL BIOENG, V43, P792, DOI 10.1002/bit.260430814
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Hoffmann A, 2007, INT ORTHOP, V31, P791, DOI 10.1007/s00264-007-0395-9
   Jelinsky SA, 2010, J ORTHOP RES, V28, P289, DOI 10.1002/jor.20999
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Lees CH, 2005, BIOMATERIALS, V26, P1261
   Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200
   Lius Y, 2009, J BIOMED MATER RES A, V90, P1092
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Murray MM, 2007, J ORTHOP RES, V25, P81, DOI 10.1002/jor.20282
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nirmalanandhan VS, 2007, J BIOMECH ENG-T ASME, V129, P919, DOI 10.1115/1.2800828
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rezgui F, 2005, POLYMER, V46, P7370, DOI 10.1016/j.polymer.2005.03.116
   Shang SH, 2010, EUR CELLS MATER, V19, P180, DOI 10.22203/eCM.v019a18
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Stella JA, 2010, ACTA BIOMATER, V6, P2365, DOI 10.1016/j.actbio.2010.01.001
   Straus WM, 2001, PREPARATION GENOMIC
   Suggss LJ, 1996, PHYS PROPERTIES POLY
   Tehs TKH, 2011, TISSUE ENG PART C-ME, V17, P687
   Valeriani M, 1999, ACTA NEUROL SCAND, V99, P303, DOI 10.1111/j.1600-0404.1999.tb00680.x
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Xues Y, 2010, J BIOMED MATER RES A, V95, P1244
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yims EK, 2007, EXP CELL RES, V313, P1820
   Yins Z, 2010, BIOMATERIALS, V31, P2163
NR 52
TC 43
Z9 43
U1 5
U2 56
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD DEC
PY 2014
VL 8
IS 12
BP 937
EP 945
DI 10.1002/term.1589
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AU9MA
UT WOS:000345915800002
PM 23038413
DA 2018-10-20
ER

PT J
AU Furtado, A
   Lupoi, JS
   Hoang, NV
   Healey, A
   Singh, S
   Simmons, BA
   Henry, RJ
AF Furtado, Agnelo
   Lupoi, Jason S.
   Hoang, Nam V.
   Healey, Adam
   Singh, Seema
   Simmons, Blake A.
   Henry, Robert J.
TI Modifying plants for biofuel and biomaterial production
SO PLANT BIOTECHNOLOGY JOURNAL
LA English
DT Review
DE biomass; biofuels; biomaterials
ID CINNAMYL ALCOHOL-DEHYDROGENASE; ACIDOTHERMUS-CELLULOLYTICUS
   ENDOGLUCANASE; CELL-WALL; DOWN-REGULATION; LIGNOCELLULOSIC BIOMASS;
   LIGNIN BIOSYNTHESIS; ENZYMATIC-HYDROLYSIS; TRANSCRIPTION FACTOR;
   TRANSGENIC TOBACCO; HYBRID POPLAR
AB The productivity of plants as biofuel or biomaterial crops is established by both the yield of plant biomass per unit area of land and the efficiency of conversion of the biomass to biofuel. Higher yielding biofuel crops with increased conversion efficiencies allow production on a smaller land footprint minimizing competition with agriculture for food production and biodiversity conservation. Plants have traditionally been domesticated for food, fibre and feed applications. However, utilization for biofuels may require the breeding of novel phenotypes, or new species entirely. Genomics approaches support genetic selection strategies to deliver significant genetic improvement of plants as sources of biomass for biofuel manufacture. Genetic modification of plants provides a further range of options for improving the composition of biomass and for plant modifications to assist the fabrication of biofuels. The relative carbohydrate and lignin content influences the deconstruction of plant cell walls to biofuels. Key options for facilitating the deconstruction leading to higher monomeric sugar release from plants include increasing cellulose content, reducing cellulose crystallinity, and/or altering the amount or composition of noncellulosic polysaccharides or lignin. Modification of chemical linkages within and between these biomass components may improve the ease of deconstruction. Expression of enzymes in the plant may provide a cost-effective option for biochemical conversion to biofuel.
C1 [Furtado, Agnelo; Lupoi, Jason S.; Hoang, Nam V.; Healey, Adam; Simmons, Blake A.; Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.
   [Lupoi, Jason S.; Singh, Seema; Simmons, Blake A.] Joint BioEnergy Inst, Emeryville, CA USA.
RP Henry, RJ (reprint author), Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld, Australia.
EM robert.henry@uq.edu.au
RI Henry, Robert/B-5824-2008; Hoang, Nam V/R-8757-2018
OI Henry, Robert/0000-0002-4060-0292; Hoang, Nam V/0000-0003-0782-2835;
   Simmons, Blake/0000-0002-1332-1810; Furtado, Agnelo/0000-0001-6130-9026
FU Queensland Government; University of Queensland; US Department of
   Energy; Office of Science, Office of Biological and Environmental
   Research, of the U.S. Department of Energy [DE-AC02-05CH11231]
FX This research is supported by the Queensland Government, University of
   Queensland and US Department of Energy. The work conducted by the Joint
   BioEnergy Institute was supported by the Office of Science, Office of
   Biological and Environmental Research, of the U.S. Department of Energy
   under Contract No. DE-AC02-05CH11231.
CR Arruda P, 2012, CURR OPIN BIOTECH, V23, P315, DOI 10.1016/j.copbio.2011.10.012
   Bakker R. R., 2005, MANAGING ASH CONTENT, P4
   Barcelo AR, 2007, TRENDS PLANT SCI, V12, P486, DOI 10.1016/j.tplants.2007.09.002
   Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479
   Bhat MK, 1997, BIOTECHNOL ADV, V15, P583, DOI 10.1016/S0734-9750(97)00006-2
   Biswas GCG, 2006, PLANT SCI, V171, P617, DOI 10.1016/j.plantsci.2006.06.004
   Blanch HW, 2011, BIOTECHNOL J, V6, P1086, DOI 10.1002/biot.201000180
   Blevins LG, 2005, J ENG GAS TURB POWER, V127, P457, DOI 10.1115/1.1804540
   Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938
   Bonawitz ND, 2014, NATURE, V509, P376, DOI 10.1038/nature13084
   Borkhardt B, 2010, PLANT BIOTECHNOL J, V8, P363, DOI 10.1111/j.1467-7652.2010.00506.x
   Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001
   Browning B. L., 1963, CHEM WOOD
   Buanafina MMD, 2010, PLANT BIOTECHNOL J, V8, P316, DOI 10.1111/j.1467-7652.2009.00485.x
   Burner DM, 2009, BIOMASS BIOENERG, V33, P610, DOI 10.1016/j.biombioe.2008.10.002
   Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975
   Carere CR, 2008, INT J MOL SCI, V9, P1342, DOI 10.3390/ijms9071342
   Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125
   Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x
   Chandra RP, 2007, ADV BIOCHEM ENG BIOT, V108, P67, DOI 10.1007/10_2007_064
   Chase M. W., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P7, DOI 10.1079/9780851999043.0007
   Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316
   Chen M, 2009, BIOMASS BIOENERG, V33, P1381, DOI 10.1016/j.biombioe.2009.05.025
   Chen Y.J., 2012, MOL PLANT IMMUNITY, P251, DOI DOI 10.1002/9781118481431.CH12
   Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500
   Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746
   Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000
   Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834
   Dai ZY, 1999, APPL BIOCHEM BIOTECH, V77-9, P689, DOI 10.1385/ABAB:79:1-3:689
   Davies M, 2010, PLANT BIOTECHNOL J, V8, P243, DOI 10.1111/j.1467-7652.2009.00493.x
   Dean J. F. D., 2005, BIOTECHNOLOGY BIOPOL, P4
   Demirbas A, 2005, ENERG SOURCE, V27, P327, DOI 10.1080/00908310390266643
   desSiqueira F. S., 2013, GENOME BIOL, V14, P210
   Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004
   Doorsselaere V. J., 1995, PLANT J, V8, P855
   Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079
   Eriksson ME, 2000, NAT BIOTECHNOL, V18, P784
   Esteghlalian Ali R., 2000, GLYCOSYL HYDROLASES, V769, P100
   Eudes A, 2012, PLANT BIOTECHNOL J, V10, P609, DOI 10.1111/j.1467-7652.2012.00692.x
   Fan ZM, 2010, PLANT BIOTECHNOL J, V8, P308, DOI 10.1111/j.1467-7652.2009.00484.x
   Feldman D, 1985, WOOD CHEM ULTRASTRUC
   Franke R, 2000, PLANT J, V22, P223, DOI 10.1046/j.1365-313x.2000.00727.x
   Fu CX, 2012, PLANT BIOTECHNOL J, V10, P443, DOI 10.1111/j.1467-7652.2011.00677.x
   Fu CX, 2011, BIOENERG RES, V4, P153, DOI 10.1007/s12155-010-9109-z
   Grabber JH, 1998, J SCI FOOD AGR, V77, P193, DOI 10.1002/(SICI)1097-0010(199806)77:2<193::AID-JSFA25>3.0.CO;2-A
   Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191
   Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f
   Gressel J, 2008, PLANT SCI, V174, P246, DOI 10.1016/j.plantsci.2007.11.009
   Grima-Pettenati J, 1999, PLANT SCI, V145, P51, DOI 10.1016/S0168-9452(99)00051-5
   Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x
   Harris D, 2010, PLANT BIOTECHNOL J, V8, P244, DOI 10.1111/j.1467-7652.2009.00481.x
   Harris P. J., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P201, DOI 10.1079/9780851999043.0201
   Harrison MD, 2011, PLANT BIOTECHNOL J, V9, P884, DOI 10.1111/j.1467-7652.2011.00597.x
   Hatfield RD, 1999, CROP SCI, V39, P27, DOI 10.2135/cropsci1999.0011183X003900010005x
   Henry RJ, 1997, PLANT MOL BIOL REP, V15, P216, DOI 10.1023/A:1007498823211
   Henry RJ, 2010, PLANT RESOURCES FOOD
   Henry RJ, 2010, PLANT BIOTECHNOL J, V8, P288, DOI 10.1111/j.1467-7652.2009.00482.x
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   Hinchee M, 2009, IN VITRO CELL DEV-PL, V45, P619, DOI 10.1007/s11627-009-9235-5
   Hinchee MAW, 2010, BIOTECH AGR FOREST, V66, P155, DOI 10.1007/978-3-642-13440-1_7
   Hu WJ, 1999, NAT BIOTECHNOL, V17, P808
   Huntley SK, 2003, J AGR FOOD CHEM, V51, P6178, DOI 10.1021/jf034320o
   Jackson PA, 2011, WILD CROP RELATIVES, P97, DOI 10.1007/978-3-642-21102-7_5
   JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346
   Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956
   Jenkins BM, 1998, FUEL PROCESS TECHNOL, V54, P17, DOI 10.1016/S0378-3820(97)00059-3
   Joshi CP, 2011, MOL PLANT, V4, P331, DOI 10.1093/mp/ssq081
   Jung JH, 2012, PLANT BIOTECHNOL J, V10, P1067, DOI 10.1111/j.1467-7652.2012.00734.x
   Jung SK, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/405842
   Jung YH, 2013, BIORESOURCE TECHNOL, V129, P639, DOI 10.1016/j.biortech.2012.12.074
   Kawaoka A, 2006, SILVAE GENET, V55, P269, DOI 10.1515/sg-2006-0035
   Keating JD, 2006, BIOTECHNOL BIOENG, V93, P1196, DOI 10.1002/bit.20838
   Kerr RA, 2005, SCIENCE, V309, P101, DOI 10.1126/science.309.5731.101
   Kimura T, 2003, APPL MICROBIOL BIOT, V62, P374, DOI 10.1007/s00253-003-1301-z
   Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153
   Laureano-Perez L, 2005, APPL BIOCHEM BIOTECH, V121, P1081
   Lee CH, 2009, PLANT CELL PHYSIOL, V50, P1075, DOI 10.1093/pcp/pcp060
   Legay S, 2010, NEW PHYTOL, V188, P774, DOI 10.1111/j.1469-8137.2010.03432.x
   Leple JC, 2007, PLANT CELL, V19, P3669, DOI 10.1105/tpc.107.054148
   Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x
   Li X, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-27
   Li YH, 2003, J PLANT RES, V116, P175, DOI 10.1007/s10265-003-0087-5
   Lupoi J, 2013, BIOENERG RES, P1, DOI [10.1007/s12155-013-9352-1, DOI 10.1007/S12155-013-9352-1]
   Lynd LR, 2008, NAT BIOTECHNOL, V26, P169, DOI 10.1038/nbt0208-169
   LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318
   Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x
   Manickavasagam M, 2004, PLANT CELL REP, V23, P134, DOI 10.1007/s00299-004-0794-y
   Mansfield SD, 2009, CURR OPIN BIOTECH, V20, P286, DOI 10.1016/j.copbio.2009.05.001
   Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003
   Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995
   Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025
   Oraby H, 2007, TRANSGENIC RES, V16, P739, DOI 10.1007/s11248-006-9064-9
   Park YW, 2004, FEBS LETT, V564, P183, DOI 10.1016/S0014-5793(04)00346-1
   Perlack R. D., 2011, US BILLION TON UPDAT, P227
   Petersen PD, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-84
   Pilate G, 2002, NAT BIOTECHNOL, V20, P607, DOI 10.1038/nbt0602-607
   Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4
   Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9
   Saathoff AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016416
   Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x
   Sahoo DK, 2013, PLANT BIOTECHNOL J, V11, P362, DOI 10.1111/pbi.12024
   Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x
   SARKANEN KV, 1971, LIGNINS OCCURRENCE F, P43
   Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8
   Schubert C, 2006, NAT BIOTECHNOL, V24, P777, DOI 10.1038/nbt0706-777
   Shani Z, 2004, MOL BREEDING, V14, P321, DOI 10.1023/B:MOLB.0000049213.15952.8a
   Shapter FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082641
   Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x
   Shirley BW, 1996, TRENDS PLANT SCI, V1, P377, DOI 10.1016/S1360-1385(96)80312-8
   Simmons Blake A., 2010, CURR OPIN PLANT BIOL, V13, P312, DOI DOI 10.1016/J.PBI.2010.03.001
   Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034
   Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765
   Somerville C, 2007, CURR BIOL, V17, P115, DOI DOI 10.1016/J.CUB.2007.01.010
   Souza G. M., 2011, Tropical Plant Biology, V4, P145
   Spangenberg G, 2001, DEV PLANT BREED, V10, P1
   Stewart JJ, 2009, PLANT PHYSIOL, V150, P621, DOI 10.1104/pp.109.137059
   Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003
   Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336
   Studer M. H., 2011, P NAT ACAD SCI, V108, P1
   Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002
   Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845
   TSUTSUMI Y, 1995, HOLZFORSCHUNG, V49, P423, DOI 10.1515/hfsg.1995.49.5.423
   Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005
   Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119
   Verma D, 2010, PLANT BIOTECHNOL J, V8, P332, DOI 10.1111/j.1467-7652.2009.00486.x
   Voelker SL, 2010, PLANT PHYSIOL, V154, P874, DOI 10.1104/pp.110.159269
   Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014
   Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161
   WYMAN CE, 2005, POLYSACCHARIDES STRU
   Ximenes E, 2010, ENZYME MICROB TECH, V46, P170, DOI 10.1016/j.enzmictec.2009.11.001
   Yang F, 2013, PLANT BIOTECHNOL J, V11, P325, DOI 10.1111/pbi.12016
   Yi Zheng, 2009, International Journal of Agricultural and Biological Engineering, V2, P51, DOI 10.3965/j.issn.1934-6344.2009.03.051-068
   York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007
   Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875
   Ziegelhoffer T, 1999, MOL BREEDING, V5, P309, DOI 10.1023/A:1009646830403
NR 135
TC 29
Z9 29
U1 5
U2 76
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7644
EI 1467-7652
J9 PLANT BIOTECHNOL J
JI Plant Biotechnol. J.
PD DEC
PY 2014
VL 12
IS 9
BP 1246
EP 1258
DI 10.1111/pbi.12300
PG 13
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA AU6GS
UT WOS:000345702500009
PM 25431201
OA Other Gold
DA 2018-10-20
ER

PT J
AU Oliveira, MB
   Mano, JF
AF Oliveira, Mariana B.
   Mano, Joao F.
TI High-throughput screening for integrative biomaterials design: exploring
   advances and new trends
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
DE high-throughput; combinatorial; biomaterials; lab-on-chip testing;
   arrays
ID EMBRYONIC STEM-CELLS; LAYER-BY-LAYER; ON-CHIP; CHEMICAL GRADIENTS;
   COMBINATORIAL; ARRAYS; 3D; FATE; MICROARRAY; PROTEINS
AB With the increasing need for biomaterials and tissue engineering alternatives, more accurate, rapid, and cost-saving methods and models to study biomaterial cell interactions must be developed. We review the evolution of microarray platforms used for such studies in order to meet the criteria of complex tissue engineering biological environments. Particular aspects regarding biomaterials processing, data acquisition, and treatment are addressed. Apart from in vitro array-based strategies, we also address emerging in vivo high-throughput approaches and their associated trends, such as the role of inflammation in regeneration. The up-scaling of high-throughput methods using single cell encapsulation systems is also explored. Possible limitations related to the use of such methods, such as spot-to-spot crosstalk, are also discussed.
C1 [Oliveira, Mariana B.; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Oliveira, Mariana B.; Mano, Joao F.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Oliveira,
   Mariana/H-6933-2017; Oliveira, Mariana/A-1440-2014
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765;
   Oliveira, Mariana/0000-0002-6104-6075; Oliveira,
   Mariana/0000-0002-6104-6075
FU Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/71396/2010]; Fundo
   Europeu de Desenvolvimento Regional (FEDER) through the Competitive
   Factors Operation Program Programa Operacional Factores de
   Competitividade (COMPETE); FCT [PTDC/CTM-BIO/1814/2012]
FX Mariana B. Oliveira acknowledges the Fundacao para a Ciencia e a
   Tecnologia (FCT) for PhD grant SFRH/BD/71396/2010, Fundo Europeu de
   Desenvolvimento Regional (FEDER) through the Competitive Factors
   Operation Program Programa Operacional Factores de Competitividade
   (COMPETE) and national funds from the FCT in the scope of the project
   PTDC/CTM-BIO/1814/2012.
CR Akagi T, 2014, LANGMUIR, V30, P1669, DOI 10.1021/la404162h
   Allazetta S, 2011, CHEM COMMUN, V47, P191, DOI 10.1039/c0cc02377a
   Almodovar J, 2014, BIOMATERIALS, V35, P3975, DOI 10.1016/j.biomaterials.2014.01.012
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andreas K, 2014, TRENDS BIOTECHNOL, V32, P483, DOI 10.1016/j.tibtech.2014.06.008
   Ankam S, 2013, ORGANOGENESIS, V9, P128, DOI 10.4161/org.25425
   Ballester-Beltran J, 2011, SOFT MATTER, V7, P10803, DOI 10.1039/c1sm06102j
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106
   Castleberry SA, 2014, ACS NANO, V8, P6580, DOI 10.1021/nn501963q
   Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p
   Chatterjee K, 2011, COMB CHEM HIGH T SCR, V14, P227, DOI 1386-2073/11 $58.00+.00
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chung SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4468
   Coskun AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015955
   Cranford SW, 2013, ADV MATER, V25, P802, DOI 10.1002/adma.201202553
   Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149
   Dendukuri D, 2006, NAT MATER, V5, P365, DOI 10.1038/nmat1617
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dolatshahi-Pirouz A., 2014, SCI REP, V4
   Geyer FL, 2011, ANGEW CHEM INT EDIT, V50, P8424, DOI 10.1002/anie.201102545
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gorocs Zoltan, 2013, IEEE Rev Biomed Eng, V6, P29, DOI 10.1109/RBME.2012.2215847
   Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029
   Hancock MJ, 2011, SMALL, V7, P892, DOI 10.1002/smll.201002088
   He JK, 2011, BIOTECHNOL BIOENG, V108, P175, DOI 10.1002/bit.22901
   He JK, 2010, ADV FUNCT MATER, V20, P131, DOI 10.1002/adfm.200901311
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hook AL, 2010, BIOMATERIALS, V31, P187, DOI 10.1016/j.biomaterials.2009.09.037
   Hull R, 2002, MAT SCI ENG C-BIO S, V19, P383, DOI 10.1016/S0928-4931(01)00426-X
   Ino K, 2008, LAB CHIP, V8, P134, DOI 10.1039/b712330b
   Kang LF, 2010, J BIOMED MATER RES A, V93A, P547, DOI 10.1002/jbm.a.32557
   Khan F, 2010, BIOMATERIALS, V31, P2216, DOI 10.1016/j.biomaterials.2009.11.101
   Khetan S, 2011, SOFT MATTER, V7, P830, DOI 10.1039/c0sm00852d
   Kim K.M, 2014, PLOS ONE, V9
   Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]
   Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773
   Lagus T.P., 2013, J PHYS D, V46
   Leferink A.M., 2013, J TISSUE ENG REGEN M, V9, P1864
   Levorson EJ, 2014, ACTA BIOMATER, V10, P1824, DOI 10.1016/j.actbio.2013.12.026
   Lima A.C., 2015, NANOMEDICINE
   Lima AC, 2013, SMALL, V9, P2487, DOI 10.1002/smll.201202147
   Lima AC, 2013, TISSUE ENG PT A, V19, P1175, DOI [10.1089/ten.tea.2012.0249, 10.1089/ten.TEA.2012.0249]
   Lourenco BN, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0046-6
   Lu CH, 2013, BIOTECHNOL ADV, V31, P1695, DOI 10.1016/j.biotechadv.2013.08.015
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Nandakumar A, 2013, SMALL, V9, P3405, DOI 10.1002/smll.201300220
   Neto AI, 2014, ADV FUNCT MATER, V24, P5096, DOI 10.1002/adfm.201400503
   Neto AI, 2011, SOFT MATTER, V7, P4147, DOI 10.1039/c1sm05169e
   Okano K, 2013, LAB CHIP, V13, P4078, DOI 10.1039/c3lc50750e
   Oliveira MB, 2014, J MATER CHEM B, V2, P5627, DOI 10.1039/c4tb00437j
   Oliveira M.B, 2014, TISSUE ENG C
   Oliveira MB, 2014, ACS APPL MATER INTER, V6, P9488, DOI 10.1021/am5018607
   Oliveira MB, 2013, SMALL, V9, P768, DOI 10.1002/smll.201201436
   Oliveira MB, 2013, ANAL CHEM, V85, P2391, DOI 10.1021/ac303405x
   Oliveira NM, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.085205
   Oliveira SM, 2011, SOFT MATTER, V7, P8932, DOI 10.1039/c1sm05943b
   Range A., 2014, NAT COMMUN, V3, P4324
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Ruder WC, 2012, LAB CHIP, V12, P1775, DOI 10.1039/c2lc21117c
   Sala A, 2011, INTEGR BIOL-UK, V3, P1102, DOI 10.1039/c1ib00045d
   Salgado CL, 2012, INTEGR BIOL-UK, V4, P318, DOI 10.1039/c2ib00170e
   Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Schonbrun E, 2010, LAB CHIP, V10, P852, DOI 10.1039/b923554j
   Schurgers E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2939
   Selimovic S, 2011, ANAL CHEM, V83, P2020, DOI 10.1021/ac2001737
   Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763
   Smith Callahan L.A., 2013, BIOMACROMOLECULES, V14, P3047
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Stewart MP, 2011, NATURE, V469, P226, DOI 10.1038/nature09642
   Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109
   Suntivich R, 2014, BIOMACROMOLECULES, V15, P1428, DOI 10.1021/bm500027c
   Tumarkin E, 2011, INTEGR BIOL-UK, V3, P653, DOI 10.1039/c1ib00002k
   Tweedie CA, 2005, ADV MATER, V17, P2599, DOI 10.1002/adma.200501142
   Ueda E, 2013, ADV MATER, V25, P1234, DOI 10.1002/adma.201204120
   Ueda E, 2012, LAB CHIP, V12, P5218, DOI [10.1039/c2lc40921f, 10.1039/c2lc40921]
   Unadkat HV, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0753
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Velasco D, 2012, SMALL, V8, P1633, DOI 10.1002/smll.201102464
   Walther A, 2013, CHEM REV, V113, P5194, DOI 10.1021/cr300089t
   Wei JS, 2014, BIOMATERIALS, V35, P7724, DOI 10.1016/j.biomaterials.2014.05.060
   Wei QS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01699
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yao X, 2011, ADV MATER, V23, P719, DOI 10.1002/adma.201002689
   Yu HY, 2013, ADV HEALTHC MATER, V2, P1188, DOI 10.1002/adhm.201300053
   Yuan B, 2010, ADV FUNCT MATER, V20, P3715, DOI 10.1002/adfm.201001298
   Zhang R, 2009, BIOMATERIALS, V30, P6193, DOI 10.1016/j.biomaterials.2009.07.055
   Zhao S, 2013, LAB CHIP, V13, P2350, DOI 10.1039/c3lc50183c
   Zhou J, 2012, LAB CHIP, V12, P5025, DOI 10.1039/c2lc40309a
   Zonca MR, 2013, MACROMOL BIOSCI, V13, P177, DOI 10.1002/mabi.201200315
NR 97
TC 24
Z9 24
U1 3
U2 60
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
EI 1879-3096
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD DEC
PY 2014
VL 32
IS 12
BP 627
EP 636
DI 10.1016/j.tibtech.2014.09.009
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AU8ZA
UT WOS:000345880600006
PM 25450043
DA 2018-10-20
ER

PT J
AU Silverman, BR
   Champion, JA
AF Silverman, Bradley R.
   Champion, Julie A.
TI Presentation of fibronectin fragments using affinity protein
   interactions for enhanced retention and function
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Wound healing; Fibronectin; Engineered proteins; Affinity; Cell motility
ID CELL-ADHESION; SH3 DOMAIN; MOTILITY; BINDING; IMMOBILIZATION;
   SPECIFICITY; ADSORPTION; REPAIR
AB We present a protein immobilization system, based on the Src Homology 3 (SH3) affinity domain, allowing for a transient interaction between a fibronectin ligand and a biomaterial surface. This strategy leads to enhanced retention of the fibronectin fragment over adsorbed fibronectin, and increased cellular proliferation and motility over either covalently immobilized or adsorbed fibronectin. The results indicate that intermediate affinity protein immobilization could provide benefits for tissue engineering beyond the traditional immobilization techniques, adsorption or covalent attachment. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Silverman, Bradley R.; Champion, Julie A.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
RP Champion, JA (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
EM julie.champion@chbe.gatech.edu
OI Silverman, Bradley/0000-0002-9256-8941
FU Air Products; Georgia Tech; NSF
FX B.S. was funded by an Air Products research fellowship and a Georgia
   Tech President's Undergraduate Research Award. This work was performed
   in part at the GT Institute for Electronics and Nanotechnology, a member
   of the National Nanotechnology Infrastructure Network, which is
   supported by the NSF. The authors thank Drs Patrick Daugherty and Xia
   You for the Mona-Gads DNA sequence and Drs David Tirrell, Eileen Fong
   and Kechun Zhang for FN10 and ELP DNA sequences.
CR Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Custodio CA, 2010, J TISSUE ENG REGEN M, V4, P316, DOI 10.1002/term.248
   Fong E, 2010, ADV MATER, V22, P5271, DOI 10.1002/adma.201002448
   Ghosh K, 2006, TISSUE ENG, P12
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258
   Karatan E, 2004, CHEM BIOL, V11, P835, DOI 10.1016/j.chembiol.2004.04.009
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Poujade M, 2007, PNAS
   Sevilla CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077316
   Sharma RI, 2004, J BIOMED MATER RES A, V69A, P114, DOI 10.1002/jbm.a.20125
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Webb K, 2001, J BIOMED MATER RES, V54, P509
   Zhang Y, 2007, MAT SCI ENG C-BIO S, V27, P213, DOI 10.1016/j.msec.2006.03.013
NR 19
TC 1
Z9 1
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2014
VL 10
IS 12
BP 4956
EP 4960
DI 10.1016/j.actbio.2014.08.026
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU2SQ
UT WOS:000345468300004
PM 25173838
DA 2018-10-20
ER

PT J
AU Kang, HM
   Shih, YRV
   Hwang, Y
   Wen, C
   Rao, V
   Seo, T
   Varghese, S
AF Kang, Heemin
   Shih, Yu-Ru V.
   Hwang, Yongsung
   Wen, Cai
   Rao, Vikram
   Seo, Timothy
   Varghese, Shyni
TI Mineralized gelatin methacrylate-based matrices induce osteogenic
   differentiation of human induced pluripotent stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Human induced pluripotent stem cells; Osteogenic differentiation;
   Calcium phosphate; Bone tissue engineering; Gelatin methacrylate
ID ECTOPIC BONE-FORMATION; CALCIUM-PHOSPHATE; POROUS HYDROGELS; IN-VIVO;
   RELEASE; REGENERATION; SCAFFOLDS; COMPOSITE; NANOFIBERS; PROSPECTS
AB Human induced pluripotent stem cells (hiPSC) are a promising cell source with pluripotency and self-renewal properties. Design of simple and robust biomaterials with an innate ability to induce lineage-specificity of hiPSC is desirable to realize their application in regenerative medicine. In this study, the potential of biomaterials containing calcium phosphate minerals to induce osteogenic differentiation of hiPSC was investigated. hiPSC cultured using mineralized gelatin methacrylate-based matrices underwent osteogenic differentiation ex vivo, in both two-dimensional and three-dimensional cultures, in growth medium devoid of any osteogenic-inducing chemical components or growth factors. The findings that osteogenic differentiation of hiPSC can be achieved through biomaterial-based cues alone present new avenues for personalized regenerative medicine. Such biomaterials that could not only act as structural scaffolds, but could also provide tissue-specific functions such as directing stem cell differentiation commitment, have great potential in bone tissue engineering. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kang, Heemin; Shih, Yu-Ru V.; Hwang, Yongsung; Wen, Cai; Rao, Vikram; Seo, Timothy; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Kang, Heemin; Varghese, Shyni] Univ Calif San Diego, Mat Sci & Engn Program, La Jolla, CA 92093 USA.
   [Wen, Cai] Southeast Univ, Sch Chem & Chem Engn, Nanjing 210018, Jiangsu, Peoples R China.
   [Seo, Timothy; Varghese, Shyni] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
RP Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr,Mail Code 0412, La Jolla, CA 92093 USA.
EM svarghese@ucsd.edu
FU National Institutes of Health; California Institute of Regenerative
   Medicine (NIH) [1 R01 AR063184-01A1]; California Institute of
   Regenerative Medicine (CIRM) [RN2-00945, RT2-01889]
FX The authors gratefully acknowledge the financial support from National
   Institutes of Health and California Institute of Regenerative Medicine
   (NIH, Grant 1 R01 AR063184-01A1; CIRM, RN2-00945 and RT2-01889).
CR Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003
   Ardeshirylajimi A, 2013, CELL TISSUE RES, V354, P849, DOI 10.1007/s00441-013-1693-8
   Ardeshirylajimi A, 2013, MOL BIOL REP, V40, P4287, DOI 10.1007/s11033-013-2515-5
   Autefage H, 2009, J BIOMED MATER RES B, V91B, P706, DOI 10.1002/jbm.b.31447
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Heino J, 2007, BIOESSAYS, V29, P1001, DOI 10.1002/bies.20636
   HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Hwang YS, 2011, REGEN MED, V6, P505, DOI [10.2217/RME.11.38, 10.2217/rme.11.38]
   Hwang YS, 2010, J MATER CHEM, V20, P345, DOI 10.1039/b917142h
   Illich DJ, 2011, STEM CELLS, V29, P555, DOI 10.1002/stem.611
   Kang HM, 2014, J MATER CHEM B, V2, P5676, DOI 10.1039/c4tb00714j
   Kang R, 2014, RSC ADV, V4, P5734, DOI 10.1039/c3ra44181d
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Levi B, 2012, P NATL ACAD SCI USA, V109, P20379, DOI 10.1073/pnas.1218052109
   Liu J, 2013, BIOMATERIALS, V34, P7862, DOI 10.1016/j.biomaterials.2013.07.029
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Park KM, 2012, BIOMACROMOLECULES, V13, P604, DOI 10.1021/bm201712z
   Phadke A, 2013, EUR CELLS MATER, V25, P114, DOI 10.22203/eCM.v025a08
   Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289
   Phadke A, 2010, BIOMACROMOLECULES, V11, P2060, DOI 10.1021/bm100425p
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111
   Song GD, 2013, BIOMATERIALS, V34, P2167, DOI 10.1016/j.biomaterials.2012.12.010
   Suarez-Gonzalez D, 2012, ACTA BIOMATER, V8, P1117, DOI 10.1016/j.actbio.2011.11.028
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Talwar R, 2001, J CLIN PERIODONTOL, V28, P340, DOI 10.1034/j.1600-051x.2001.028004340.x
   Teng SS, 2014, TISSUE ENG PART B-RE, V20, P328, DOI [10.1089/ten.teb.2013.0301, 10.1089/ten.TEB.2013.0301]
   Vaquette C, 2013, BIOMATERIALS, V34, P5538, DOI 10.1016/j.biomaterials.2013.03.088
   Wen L, 2012, BIOCHEM BIOPH RES CO, V424, P439, DOI 10.1016/j.bbrc.2012.06.128
   Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zou L., 2013, SCI REP, V3
NR 46
TC 34
Z9 35
U1 1
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2014
VL 10
IS 12
BP 4961
EP 4970
DI 10.1016/j.actbio.2014.08.010
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU2SQ
UT WOS:000345468300005
PM 25153779
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Oneto, JMM
   Gupta, M
   Leach, JK
   Lee, M
   Sutcliffe, JL
AF Oneto, Jose M. Mejia
   Gupta, Munish
   Leach, J. Kent
   Lee, Mark
   Sutcliffe, Julie L.
TI Implantable biomaterial based on click chemistry for targeting small
   molecules
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Alginate; Hydrogel; Click chemistry; Drug delivery; In vivo imaging
ID IN-VIVO CHEMISTRY; PERIPROSTHETIC INFECTION; BACTERIAL-COLONIZATION;
   STAPHYLOCOCCUS-AUREUS; ALGINATE HYDROGELS; BIOFILM FORMATION;
   TITANIUM-ALLOY; HEALTH-CARE; VANCOMYCIN; ANTIBIOTICS
AB Specific and targeted delivery of medical therapies continues to be a challenge for the optimal treatment of multiple medical conditions. Technological advances permit physicians to target most sites of the body. However, after the intervention, physicians rely on systemic medications that need frequent dosing and may have noxious side effects. A novel system combining the temporal flexibility of systemic drug delivery and the spatial control of injectable biomaterials would improve the spatiotemporal control of medical therapies. Here we present an implantable biomaterial that harnesses in vivo click chemistry to enhance the delivery of suitable small molecules by an order of magnitude. The results demonstrate a simple and modular method to modify a biomaterial with small molecules in vitro and present an example of a polysaccharide modified hours after in vivo implantation. This approach provides the ability to precisely control the moment when biochemical and/or physical signals may appear in an implanted biomaterial. This is the first step towards the construction of a biomaterial that enhances the spatial location of systemic small molecules via in vivo chemical delivery. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oneto, Jose M. Mejia; Gupta, Munish; Leach, J. Kent; Lee, Mark] Univ Calif Davis, Dept Orthopaed Surg, Sacramento, CA 95817 USA.
   [Leach, J. Kent; Sutcliffe, Julie L.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Sutcliffe, Julie L.] Univ Calif Davis, Dept Internal Med, Div Hematol Oncol, Sacramento, CA 95817 USA.
   [Sutcliffe, Julie L.] Univ Calif Davis, Ctr Mol & Genom Imaging, Davis, CA 95616 USA.
RP Oneto, JMM (reprint author), Univ Calif Davis, Dept Orthopaed Surg, 4860 Y St,Suite 3800, Sacramento, CA 95817 USA.
EM jose.mejiaoneto@gmail.com
FU Department of Orthopaedic Surgery at the University of California,
   Davis; Orthopaedic Trauma Association (OTA); Orthopaedic Research &
   Educational Fund (OREF); University of California, Davis Orthopaedic
   Surgery Department, the Office of Science, United States Department of
   Energy [DE-SC0008385]
FX J.M.M.O was supported by the Denny and Jeanene Dickenson Resident
   Research Fellowship of the Department of Orthopaedic Surgery at the
   University of California, Davis. Support for this research was provided
   by the University of California, Davis Orthopaedic Surgery Department,
   the Office of Science, United States Department of Energy, DE-SC0008385,
   a grant from the Orthopaedic Trauma Association (OTA) and a Resident
   Clinician Scientist Training Grant from the Orthopaedic Research &
   Educational Fund (OREF).
CR Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, CLIN ORTHOP RELAT R, P88, DOI 10.1097/BLO.0b013e318073c2b2
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2
   Bartlett JG, 2013, CLIN INFECT DIS, V56, P1445, DOI 10.1093/cid/cit070
   Blackman ML, 2008, J AM CHEM SOC, V130, P13518, DOI 10.1021/ja8053805
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Devaraj NK, 2012, P NATL ACAD SCI USA, V109, P4762, DOI 10.1073/pnas.1113466109
   Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599
   Gurwitz JH, 2004, ARCH INTERN MED, V164, P1957, DOI 10.1001/archinte.164.18.1957
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Holman JE, 2013, J BONE JOINT SURG AM, V95A, P1075, DOI 10.2106/JBJS.L.00619
   Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Jose S, 2014, ACTA BIOMATER, V10, P1955, DOI 10.1016/j.actbio.2014.01.020
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Ketonis C, 2010, TISSUE ENG PT A, V16, P2041, DOI [10.1089/ten.tea.2009.0610, 10.1089/ten.TEA.2009.0610]
   Ketonis C, 2011, ANTIMICROB AGENTS CH, V55, P487, DOI 10.1128/AAC.00741-10
   Ketonis C, 2011, BONE, V48, P631, DOI 10.1016/j.bone.2010.10.171
   Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
   Laurencin CT, 2012, SCI TRANSL MED, V4, ped9
   Lee JH, 2013, ANGEW CHEM INT EDIT, V52, P4384, DOI 10.1002/anie.201207721
   Lee LC, 2013, INT J CARDIOL, V168, P2022, DOI 10.1016/j.ijcard.2013.01.003
   Lee RJ, 2013, CELL TRANSPLANT, V22, P529, DOI 10.3727/096368911X637461
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Mejia-Oneto JM, 2006, ORG LETT, V8, P3275, DOI 10.1021/ol061137i
   Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381
   Pashuck ET, 2012, SCI TRANSL MED, V4, psr4
   Piddock LJ, 2012, LANCET INFECT DIS, V12, P249
   Poloso NJ, 2002, MOL IMMUNOL, V38, P803, DOI 10.1016/S0161-5890(02)00005-6
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   Rossin R, 2013, J NUCL MED, V54, P1989, DOI 10.2967/jnumed.113.123745
   Rossin R, 2013, BIOCONJUGATE CHEM, V24, P1210, DOI 10.1021/bc400153y
   Rossin R, 2010, ANGEW CHEM INT EDIT, V49, P3375, DOI 10.1002/anie.200906294
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Royzen M, 2008, J AM CHEM SOC, V130, P3760, DOI 10.1021/ja8001919
   Stairs S, 2013, CHEMBIOCHEM, V14, P1063, DOI 10.1002/cbic.201300130
   Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886
   Tibbitt MW, 2012, SCI TRANSL MED, V4, pps24
   Velema WA, 2013, NAT CHEM, V5, P924, DOI [10.1038/NCHEM.1750, 10.1038/nchem.1750]
   WHO, 2014, ANT RES GLOB REP SUR
   Zeglis BM, 2013, J NUCL MED, V54, P1389, DOI 10.2967/jnumed.112.115840
NR 47
TC 5
Z9 5
U1 2
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2014
VL 10
IS 12
BP 5099
EP 5105
DI 10.1016/j.actbio.2014.08.019
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU2SQ
UT WOS:000345468300019
PM 25162537
DA 2018-10-20
ER

PT J
AU Riool, M
   de Boer, L
   Jaspers, V
   van der Loos, CM
   van Wamel, WJB
   Wu, G
   Kwakman, PHS
   Zaat, SAJ
AF Riool, Martijn
   de Boer, Leonie
   Jaspers, Valery
   van der Loos, Chris M.
   van Wamel, Willem J. B.
   Wu, Gang
   Kwakman, Paulus H. S.
   Zaat, Sebastian A. J.
TI Staphylococcus epidermidis originating from titanium implants infects
   surrounding tissue and immune cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterial-associated infection; Biofilm; Intracellular survival;
   Staphylococcus epidermidis; Titanium
ID BIOMATERIAL-ASSOCIATED INFECTION; BACTERIAL BIOFILMS; MEDICAL DEVICES;
   MICE; PATHOGENESIS; CATHETERS; AUREUS; NICHE; RECOMMENDATIONS;
   CONTAMINATION
AB Infection is a major cause of failure of inserted or implanted biomedical devices (biomaterials). During surgery, bacteria may adhere to the implant, initiating biofilm formation. Bacteria are also observed in and recultured from the tissue surrounding implants, and may even reside inside host cells. Whether these bacteria originate from biofilms is not known. Therefore, we investigated the fate of Staphylococcus epidermidis inoculated on the surface of implants as adherent planktonic cells or as a biofilm in mouse experimental biomaterial-associated infection. In order to discriminate the challenge strain from potential contaminating mouse microflora, we constructed a fully virulent green fluorescent S. epidermidis strain. S. epidermidis injected along subcutaneous titanium implants, pre-seeded on the implants or pre-grown as biofilm, were retrieved from the implants as well as the surrounding tissue in all cases after 4 days, and in histology bacteria were observed in the tissue co-localizing with macrophages. Thus, bacteria adherent to or in a biofilm on the implant are a potential source of infection of the surrounding tissue, and antimicrobial strategies should prevent both biofilm formation and tissue colonization. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Riool, Martijn; de Boer, Leonie; Jaspers, Valery; Kwakman, Paulus H. S.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   [van der Loos, Chris M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.
   [van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, NL-3015 CE Rotterdam, Netherlands.
   [Wu, Gang] Vrije Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Implantol & Prosthet Dent, NL-1081 LA Amsterdam, Netherlands.
   [Wu, Gang] Univ Amsterdam, NL-1081 LA Amsterdam, Netherlands.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Ctr Infect & Immun Amsterdam CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
RI Riool, Martijn/A-8404-2018
OI Riool, Martijn/0000-0002-5444-3179
FU Dutch Ministry of Economic Affairs
FX We thank Gerda Lamers of the Institute Biology of the University of
   Leiden for her support with the scanning electron microscopy, Niels Kamp
   and Jens Wartenberg for assisting with the animal experiments, Fritz
   Gotz for the kind gift of S. epidermidis 0-47, Wim van Est for
   photography, Ton Dirks for providing the titanium implants and Menno de
   Jong for critically reviewing the manuscript. This research forms part
   of the NANTICO project of the BioMedical Materials program, co-funded by
   the Dutch Ministry of Economic Affairs.
CR Anderson J. M., 2013, BIOMATERIALS ASS INF, P119
   Bach A, 1999, CRIT CARE MED, V27, P515, DOI 10.1097/00003246-199903000-00028
   Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004
   Boelens JJ, 2000, J INFECT DIS, V181, P1167, DOI 10.1086/315344
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, INFECT IMMUN, V68, P6924, DOI 10.1128/IAI.68.12.6924-6931.2000
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Bosse MJ, 2005, J BONE JOINT SURG AM, V87A, P1343, DOI 10.2106/JBJS.D.02649
   Boyce JM, 2002, AM J INFECT CONTROL, V30, pS1, DOI 10.1067/mic.2002.130391
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Broekhuizen CAN, 2008, CRIT CARE MED, V36, P2395, DOI 10.1097/CCM.0b013e3181818268
   Broekhuizen CAN, 2008, J BIOMED MATER RES A, V85A, P498, DOI 10.1002/jbm.a.31528
   Broekhuizen CAN, 2007, INFECT IMMUN, V75, P1129, DOI 10.1128/IAI.01262-06
   Broekhuizen CAN, 2009, BIOMATERIALS, V30, P6444, DOI 10.1016/j.biomaterials.2009.08.018
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Christensen L, 2013, CLIN INFECT DIS, V221, P1
   Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479
   Clark L, 2009, MICROBIOL-SGM, V155, P461, DOI 10.1099/mic.0.025700-0
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Daghighi S, 2012, ACTA BIOMATER, V8, P3991, DOI 10.1016/j.actbio.2012.07.017
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dobbins BM, 2002, J CLIN PATHOL, V55, P824, DOI 10.1136/jcp.55.11.824
   Elek S, 1957, BR J EXP PATHOL, P573
   Emanuel N, 2012, J CONTROL RELEASE, V160, P353, DOI 10.1016/j.jconrel.2012.03.027
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   HAAS DW, 2000, INFECT ASS INDWELLIN, P395
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Heilmann C, 1996, INFECT IMMUN, V64
   JAMES RC, 1961, BRIT J EXP PATHOL, V42, P266
   Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea
   Knodler LA, 2005, INFECT IMMUN, V73, P7027, DOI 10.1128/IAI.73.10.7027-7031.2005
   Krimmer V, 1999, J CLIN MICROBIOL, V37, P2667
   Lee J C, 1995, Methods Mol Biol, V47, P209
   Lofblom J, 2007, J APPL MICROBIOL, V102, P736, DOI 10.1111/j.1365-2672.2006.03127.x
   Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620
   Manna A, 2001, INFECT IMMUN, V69, P885, DOI 10.1128/IAI.69.2.885-896.2001
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188
   Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014
   Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x
   van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170
   van der Loos CM, 2010, J HISTOTECHNOL, V33, P31, DOI 10.1179/his.2010.33.1.31
   Veneman WJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-255
   Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X
   VIRDEN CP, 1992, AESTHET PLAST SURG, V16, P173, DOI 10.1007/BF00450610
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   Walenkamp GHIM, 2001, J CHEMOTHERAPY, V13, P66, DOI 10.1179/joc.2001.13.Supplement-2.66
   Wu G, 2010, BIOMATERIALS, V31, P7485, DOI 10.1016/j.biomaterials.2010.06.037
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zaat S. A. J., 2013, BIOMATERIALS ASS INF, P175
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 56
TC 34
Z9 34
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD DEC
PY 2014
VL 10
IS 12
BP 5202
EP 5212
DI 10.1016/j.actbio.2014.08.012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU2SQ
UT WOS:000345468300029
PM 25153780
DA 2018-10-20
ER

PT J
AU Aspenberg, P
AF Aspenberg, Per
TI Alendronate-eluting polyglucose-lignol composite (POGLICO) A new
   biomaterial for fracture fixating implants
SO ACTA ORTHOPAEDICA
LA English
DT Article
ID RANDOMIZED-TRIAL; IMPROVES; BONE
AB Background and purpose - Due to the known drawbacks of metal implants, new biomaterials for internal fracture fixation are attracting increasing interest, among them poly(lactic-coglucolic) acids (PLGAs) and the recently developed silk-tenoin derived materials (STDMs). In accordance with the new philosophy of bio-derived biomaterials (BIODERIBIOs), I describe a novel innovative technology for use in fracture fixation.
   Patients and methods - Screws (2 mm dia.) were manufactured from cylindrical bars of polyglucose-lignol composite (POGLICO) in the form of birch toothpicks from the hospital canteen, dip-coated with alendronate (1 mg/mL, n = 6) or saline (n = 6), and inserted in the proximal tibias of rats for 4 weeks. Fixation was evaluated by mechanical pullout testing. POGLICO nails were inserted in the contralateral tibia for microCT and histology.
   Results - All POGLICO implants remained fixed in the bone (p < 0.001) with a mean pullout force of 37 (SD 5.5) N. MicroCT showed that the control nails were surrounded by a thin layer of new bone, while all bisphosphonate-treated implants were surrounded by a thick layer of cancellous bone. Bisphosphonates more than doubled the bone density around the nails (p = 0.004).
   Interpretation - POGLICO is biocompatible, remains in situ, and appears to provide a higher resistance to pullout forces than bulk silk protein. The material is light, strong, and bio-derived. BIODERIBIO-POGLICO can be sterilized by autoclaving, and has a porous surface that can serve for slow release of drugs applied by simple dip-coating, as demonstrated by the effect of the alendronate treatment. As the raw material for the screws is readily available from the toothpick industry, I believe that the possibilities for commercial development of the material for fracture fixation are promising..
C1 Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.
RP Aspenberg, P (reprint author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden.
EM per.aspenberg@liu.se
CR Abtahi J, 2012, BONE, V50, P1148, DOI 10.1016/j.bone.2012.02.001
   Agholme F, 2014, J ORTHOP RES, V32, P471, DOI 10.1002/jor.22525
   Agholme F, 2011, ACTA ORTHOP, V82, P125, DOI [10.3109/17453674.2011.572252, 10.3109/17453674.2011.625539]
   Aspenberg P, 2009, ACTA ORTHOP, V80, P2, DOI 10.1080/17453670902804489
   BOSTMAN OM, 2000, CLIN ORTHOPAEDICS, V371, P216
   Hilding M, 2007, ACTA ORTHOP, V78, P795, DOI 10.1080/17453670710014572
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Rekola J, 2009, ACTA BIOMATER, V5, P1596, DOI 10.1016/j.actbio.2009.01.018
   Toksvig-Larsen S, 2013, ACTA ORTHOP, V84, P314, DOI 10.3109/17453674.2013.797315
   Wermelin K, 2008, BONE, V42, P65
NR 10
TC 2
Z9 2
U1 0
U2 11
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 1745-3674
EI 1745-3682
J9 ACTA ORTHOP
JI Acta Orthop.
PD DEC
PY 2014
VL 85
IS 6
BP 687
EP 690
DI 10.3109/17453674.2014.979724
PG 4
WC Orthopedics
SC Orthopedics
GA AU0YH
UT WOS:000345347600026
PM 25350611
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Qin, ZP
   Balasubramanian, SK
   Wolkers, WF
   Pearce, JA
   Bischof, JC
AF Qin, Zhenpeng
   Balasubramanian, Saravana Kumar
   Wolkers, Willem F.
   Pearce, John A.
   Bischof, John C.
TI Correlated Parameter Fit of Arrhenius Model for Thermal Denaturation of
   Proteins and Cells
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Thermal therapy; Kinetics; FTIR; Differential scanning calorimetry;
   Enthalpy-entropy compensation; Protein denaturation
ID DIFFERENTIAL SCANNING CALORIMETRY; PROSTATE TUMOR-CELLS; MATHEMATICAL
   ORIGINS; CANCER-TREATMENT; COMPENSATION; KINETICS; COLLAGEN; OVALBUMIN;
   PEPTIDE; DAMAGE
AB Thermal denaturation of proteins is critical to cell injury, food science and other biomaterial processing. For example protein denaturation correlates strongly with cell death by heating, and is increasingly of interest in focal thermal therapies of cancer and other diseases at temperatures which often exceed 50 A degrees C. The Arrhenius model is a simple yet widely used model for both protein denaturation and cell injury. To establish the utility of the Arrhenius model for protein denaturation at 50 A degrees C and above its sensitivities to the kinetic parameters (activation energy E (a) and frequency factor A) were carefully examined. We propose a simplified correlated parameter fit to the Arrhenius model by treating E (a), as an independent fitting parameter and allowing A to follow dependently. The utility of the correlated parameter fit is demonstrated on thermal denaturation of proteins and cells from the literature as a validation, and new experimental measurements in our lab using FTIR spectroscopy to demonstrate broad applicability of this method. Finally, we demonstrate that the end-temperature within which the denaturation is measured is important and changes the kinetics. Specifically, higher E (a) and A parameters were found at low end-temperature (50 A degrees C) and reduce as end-temperatures increase to 70 A degrees C. This trend is consistent with Arrhenius parameters for cell injury in the literature that are significantly higher for clonogenics (45-50 A degrees C) vs. membrane dye assays (60-70 A degrees C). Future opportunities to monitor cell injury by spectroscopic measurement of protein denaturation are discussed.
C1 [Qin, Zhenpeng; Balasubramanian, Saravana Kumar; Bischof, John C.] Univ Minnesota, Dept Mech Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.
   [Bischof, John C.] Univ Minnesota, Dept Urol Surg, Minneapolis, MN 55455 USA.
   [Wolkers, Willem F.] Leibniz Univ Hannover, Inst Multiphase Proc, D-30167 Hannover, Germany.
   [Pearce, John A.] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.
RP Bischof, JC (reprint author), Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA.
EM bischof@umn.edu
RI Qin, Zhenpeng/N-6036-2015
OI Qin, Zhenpeng/0000-0003-3406-3045
FU National Institute of Health (NIH) [R01-CA07528]; Deutsche
   Forschungsgemeinschaft (DFG, German Research Foundation); McKnight
   Professorship; Carl and Janet Kuhrmeyer Chair in Mechanical Engineering;
   T.L.L. Temple Foundation; O-Donnell Foundation; Transonic/Scisense Inc.
FX This project was financially supported by the National Institute of
   Health (NIH) R01-CA07528. W. F. W. performed work in Minnesota and
   Hannover for this project and was supported in part by funding from the
   Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for
   the Cluster of Excellence REBIRTH (From Regenerative Biology to
   Reconstructive Therapy). Z.Q was supported by an Interdisciplinary
   Doctoral Fellowship and Doctoral Dissertation Fellowship. J.C.B. was
   supported by McKnight Professorship and Carl and Janet Kuhrmeyer Chair
   in Mechanical Engineering. J.A.P. received partial support for his
   investigations from the T.L.L. Temple and O-Donnell Foundations, and
   from Transonic/Scisense Inc. We thank Dr. Neil Wright for his insightful
   comments.
CR Alberts B., 1998, ESSENTIAL CELL BIOL
   Aravalli RN, 2012, TECHNOL CANCER RES T, V11, P467, DOI 10.7785/tcrt.2012.500271
   Balasubramanian S. K., 2007, AMSE 2007 SUMM BIOEN, P87
   BANKS BEC, 1972, NATURE, V240, P147, DOI 10.1038/240147a0
   Barrie PJ, 2012, PHYS CHEM CHEM PHYS, V14, P318, DOI 10.1039/c1cp22666e
   Barrie PJ, 2012, PHYS CHEM CHEM PHYS, V14, P327, DOI 10.1039/c1cp22667c
   Bhowmick S, 2000, J BIOMECH ENG-T ASME, V122, P51, DOI 10.1115/1.429627
   Carpentier A, 2008, NEUROSURGERY, V63, P21, DOI [10.1227/01.neu.0000335007.07381.df, 10.1227/01.NEU.0000311254.63848.72]
   Daggett V, 2002, ACCOUNTS CHEM RES, V35, P422, DOI 10.1021/ar0100834
   Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242
   DEWEY WC, 1994, INT J HYPERTHER, V10, P457, DOI 10.3109/02656739409009351
   Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200
   Elliott AM, 2007, MED PHYS, V34, P3102, DOI 10.1118/1.2733801
   Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604
   Feng YS, 2009, ENG COMPUT-GERMANY, V25, P3, DOI 10.1007/s00366-008-0109-y
   FRENSDORFF HK, 1953, J AM CHEM SOC, V75, P5157, DOI 10.1021/ja01117a004
   He Xiaoming, 2003, Crit Rev Biomed Eng, V31, P355, DOI 10.1615/CritRevBiomedEng.v31.i56.10
   He XM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128671
   He XM, 2004, ANN BIOMED ENG, V32, P1384, DOI 10.1114/B:ABME.0000042226.97347.de
   Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6
   KRUG RR, 1976, J PHYS CHEM-US, V80, P2341, DOI 10.1021/j100562a007
   LEPOCK JR, 1992, BIOCHEMISTRY-US, V31, P12706, DOI 10.1021/bi00165a023
   LEPOCK JR, 1993, J CELL BIOL, V122, P1267, DOI 10.1083/jcb.122.6.1267
   LUMRY R, 1954, J PHYS CHEM-US, V58, P110, DOI 10.1021/j150512a005
   Lung David C., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P101, DOI 10.1080/10255840410001689376
   Maron S. H., 1974, FUNDAMENTALS PHYS CH
   Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   Miles CA, 2004, J MOL BIOL, V337, P917, DOI 10.1016/j.jmb.2004.02.012
   Miles CA, 2007, BIOPOLYMERS, V87, P51, DOI 10.1002/bip.20787
   Pearce J. A., 2009, SPIE BIOS BIOMEDICAL
   Pearce JA, 2013, INT J HYPERTHER, V29, P262, DOI 10.3109/02656736.2013.786140
   Qin ZP, 2012, CHEM SOC REV, V41, P1191, DOI 10.1039/c1cs15184c
   Relkin P, 1996, CRIT REV FOOD SCI, V36, P565, DOI 10.1080/10408399609527740
   ROSENBERG B, 1971, NATURE, V232, P471, DOI 10.1038/232471a0
   Salloum M, 2009, INT J HYPERTHER, V25, P309, DOI 10.1080/02656730902803118
   SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4
   SAPARETO SA, 1978, CANCER RES, V38, P393
   Schwaab M, 2007, CHEM ENG SCI, V62, P2750, DOI 10.1016/j.ces.2007.02.020
   Shanmugam G, 2004, BIOPHYS CHEM, V111, P73, DOI 10.1016/j.bpc.2004.04.005
   Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5
   THOMSEN S, 1989, IEEE T BIO-MED ENG, V36, P1174, DOI 10.1109/10.42111
   Thomsen S, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P487, DOI 10.1007/978-90-481-8831-4_13
   Vajpai N, 2013, P NATL ACAD SCI USA, V110, pE368, DOI 10.1073/pnas.1212222110
   Wang Y, 1998, J PHYS CHEM B, V102, P6655, DOI 10.1021/jp9816115
   Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803
   Wolkers WF, 2007, BBA-BIOMEMBRANES, V1768, P728, DOI 10.1016/j.bbamem.2006.12.007
   Wright NT, 2003, J BIOMECH ENG-T ASME, V125, P300, DOI 10.1115/1.1553974
   Wright NT, 2002, ANNU REV BIOMED ENG, V4, P109, DOI 10.1146/annurev.bioeng.4.101001.131546
   Yan CL, 2010, J MOL GRAPH MODEL, V29, P2, DOI 10.1016/j.jmgm.2010.03.011
   Yelon A, 2006, REP PROG PHYS, V69, P1145, DOI 10.1088/0034-4885/69/4/R04
   YELON A, 1992, PHYS REV B, V46, P12244, DOI 10.1103/PhysRevB.46.12244
   YELON A, 1990, PHYS REV LETT, V65, P618, DOI 10.1103/PhysRevLett.65.618
   ZAMYATNIN AA, 1984, ANNU REV BIOPHYS BIO, V13, P145, DOI 10.1146/annurev.bb.13.060184.001045
NR 54
TC 13
Z9 13
U1 1
U2 31
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD DEC
PY 2014
VL 42
IS 12
BP 2392
EP 2404
DI 10.1007/s10439-014-1100-y
PG 13
WC Engineering, Biomedical
SC Engineering
GA AU1QB
UT WOS:000345394000002
PM 25205396
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gaston, J
   Bartlett, RS
   Klemuk, SA
   Thibeault, SL
AF Gaston, Joel
   Bartlett, Rebecca S.
   Klemuk, Sarah A.
   Thibeault, Susan L.
TI Formulation and Characterization of a Porous, Elastomeric Biomaterial
   for Vocal Fold Tissue Engineering Research
SO ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY
LA English
DT Article
DE cellular therapy; vocal folds; mechanomimetic; Tecoflex; elasticity;
   rheology; polyether polyurethane
ID IN-VIVO BIOCOMPATIBILITY; EXTRACELLULAR-MATRIX; VASCULAR GRAFTS;
   POLYURETHANE; SCAFFOLDS; STIFFNESS; FREQUENCIES; BIOREACTOR; SUBSTRATE;
   CELLS
AB Objective: Biomaterials able to mimic the mechanical properties of vocal fold tissue may be particularly useful for furnishing a 3-dimensional microenvironment allowing for in vitro investigation of cell and molecular responses to vibration. Motivated by the dearth of biomaterials available for use in an in vitro model for vocal fold tissue, we investigated polyether polyurethane (PEU) matrices, which are porous, mechanically tunable biomaterials that are inexpensive and require only standard laboratory equipment for fabrication.
   Methods: Rheology, dynamic mechanical analysis, and scanning electron microscopy were performed on PEU matrices at 5%, 10%, and 20% w/v mass concentrations.
   Results: For 5%, 10%, and 20% w/v concentrations, shear storage moduli were 2 kPa, 3.4 kPa, and 6 kPa, respectively, with shear loss moduli being 0.2 kPa, 0.38 kPa, and 0.62 kPa, respectively. Storage moduli responded to applied frequency as a linear function. Mercury intrusion porosimetry revealed that all 3 mass concentrations of PEU have a similar overall percentage porosity but differ in pore architecture.
   Conclusion: Twenty-pm diameter pores are ideal for cell seeding, and a range of mechanical properties indicates that the higher mass concentration PEU formulations are best suited for mimicking the viscoelastic properties of vocal fold tissue for in vitro research.
C1 [Gaston, Joel; Thibeault, Susan L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53792 USA.
   [Gaston, Joel; Bartlett, Rebecca S.; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53792 USA.
   [Klemuk, Sarah A.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA.
RP Thibeault, SL (reprint author), Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53792 USA.
EM thibeaul@surgery.wisc.edu
FU National Institute of Deafness and Other Communication Disorders [R01
   DC009600]; David Bradley Fund; National Institutes of Health [R01
   DC4336, T32 DC009401]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors acknowledge the National Institute of Deafness and Other
   Communication Disorders (R01 DC009600) and the David Bradley Fund for
   supporting this project. They also acknowledge the National Institutes
   of Health for funding this project (R01 DC4336 and T32 DC009401).
CR Alberts B., 1994, MOL BIOL CELL, P971
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Chan KMC, 2014, ACTA BIOMATER, V10, P2563, DOI 10.1016/j.actbio.2014.02.021
   Chan RW, 2008, J ACOUST SOC AM, V124, P1207, DOI 10.1121/1.2946715
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Gaston J, 2012, PLOS ONE, V7, DOI [10.1371/joumal.pone.0030965, DOI 10.1371/JOUMAL.PONE.0030965]
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Han DK, 1997, MACROMOLECULES, V30, P6077, DOI 10.1021/ma970302u
   Karajanagi SS, 2011, ANN OTO RHINOL LARYN, V120, P175, DOI 10.1177/000348941112000306
   Klemuk SA, 2004, LARYNGOSCOPE, V114, P1597, DOI 10.1097/00005537-200409000-00018
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Mishkin GJ, 2007, CONTRIB NEPHROL, V154, P72
   Mulder MM, 1998, J BIOMAT SCI-POLYM E, V9, P731, DOI 10.1163/156856298X00118
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   SAKAS DE, 1990, J NEUROSURG, V73, P936, DOI 10.3171/jns.1990.73.6.0936
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Thomas V, 2009, J BIOMED MATER RES A, V89A, P192, DOI 10.1002/jbm.a.31937
   Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Williams RL, 2005, J MATER SCI-MATER M, V16, P1087, DOI 10.1007/s10856-005-4710-y
   Wolchok JC, 2009, BIOMATERIALS, V30, P327, DOI 10.1016/j.biomaterials.2008.08.035
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
NR 34
TC 4
Z9 4
U1 0
U2 30
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0003-4894
EI 1943-572X
J9 ANN OTO RHINOL LARYN
JI Ann. Otol. Rhinol. Laryngol.
PD DEC
PY 2014
VL 123
IS 12
BP 866
EP 874
DI 10.1177/0003489414539131
PG 9
WC Otorhinolaryngology
SC Otorhinolaryngology
GA AU0KC
UT WOS:000345310700009
PM 24944281
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Panda, N
   Biswas, A
   Sukla, LB
   Pramanik, K
AF Panda, N.
   Biswas, A.
   Sukla, L. B.
   Pramanik, K.
TI Degradation Mechanism and Control of Blended Eri and Tasar Silk
   Nanofiber
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Eri-tasar silk fibroin; Biodegradation; Hydrophilic amino acid;
   Physio-chemical property
ID LITHIUM THIOCYANATE SOLUTION; IN-VIVO DEGRADATION; FIBROIN; PROTEINS;
   WATER; BIODEGRADABILITY
AB Fabrication of nanofibers from wild varieties of silk such as eri and tasar is very promising for tissue engineering application because of the presence of RGD (arginine-glycine-aspartic acid) ligand and high content of hydrophilic amino acids. In this study, the biodegradation of silk fibroin (SF) nanofibers have been studied in protease XIV solution to analyze the degradation behavior. The present study reveals that the degradation of nanofibrous mat strongly depends on hydrophilic amino acid fragments possessing bulky groups connecting the crystalline portion in nanofibrous structure. The newly found mechanism shows that beta sheet content and percentage of crystal in nanofibers play a major role in addition to hydrophilic fragments in degradation processes. Understanding of this mechanism can optimize the preparation of nanofibers with controlled and flexible degradation behavior without affecting essential bi(o)material properties such as hydrophilicity, mechanical strength, and morphological property. This knowledge would widen the application of silk-based biomaterial for several tissues engineering application.
C1 [Panda, N.; Biswas, A.; Pramanik, K.] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India.
   [Sukla, L. B.] CSIR Inst Minerals & Mat Technol, Bhubaneswar 751013, Orissa, India.
RP Pramanik, K (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, Odisha, India.
EM suklalb@yahoo.co.in; kpr@nitrkl.ac.in
RI Sukla, Lala Behari/F-3144-2011; Biswas, Amit/O-7144-2017; Pramanik,
   Krishna/M-3729-2018
OI Sukla, Lala Behari/0000-0001-5684-3021; Pramanik,
   Krishna/0000-0002-5676-7740
CR Berlin E., 1972, Thermochimica Acta, V4, P11, DOI 10.1016/0040-6031(72)87058-8
   BHAT NV, 1983, J POLYM SCI POL CHEM, V21, P1273, DOI 10.1002/pol.1983.170210504
   Esch DC, 2004, THERMAL ANAL CONSTRU
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0
   Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Kim JH, 2012, J BIOMED MATER RES A, V100A, P3287, DOI 10.1002/jbm.a.34274
   Liu Y, 2008, POLYM INT, V57, P632, DOI 10.1002/pi.2387
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Mrevlishvili GM, 1998, THERMOCHIM ACTA, V308, P49, DOI 10.1016/S0040-6031(97)00329-8
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   PATEL K, 1990, PHARMACEUT RES, V7, P787, DOI 10.1023/A:1015999012852
   Roy S, 2012, APPL BIOCHEM BIOTECH, V168, P1076, DOI 10.1007/s12010-012-9842-1
   SAGAR AJ, 1978, INDIAN J BIOCHEM BIO, V15, P59
   Scrivener K., 2005, MATER STRUCT, V38, P659, DOI [10.1007/BF02481597, DOI 10.1007/BF02481597]
   Sen K, 2004, J APPL POLYM SCI, V92, P1080, DOI 10.1002/app.13609
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tungtasana H, 2010, J MATER SCI-MATER M, V21, P3151, DOI 10.1007/s10856-010-4159-5
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
NR 22
TC 0
Z9 0
U1 1
U2 15
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD DEC
PY 2014
VL 174
IS 7
BP 2403
EP 2412
DI 10.1007/s12010-014-1151-4
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AU0RG
UT WOS:000345331100005
PM 25227684
DA 2018-10-20
ER

PT J
AU Oosterbeek, RN
   Seal, CK
   Hyland, MM
AF Oosterbeek, Reece N.
   Seal, Christopher K.
   Hyland, Margaret M.
TI Protein arrangement on modified diamond-like carbon surfaces - An ARXPS
   study
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Diamond-like carbon; Angle resolved XPS; Protein adsorption; Protein
   arrangement; Surface graphitisation; Surface energy
ID BOVINE SERUM-ALBUMIN; RAY PHOTOELECTRON-SPECTROSCOPY; THIN-FILMS;
   ADSORPTION; XPS; ENERGY; GRAPHITE; CHROMIUM; FTIR; DLC
AB Understanding the nature of the interface between a biomaterial implant and the biological fluid is an essential step towards creating improved implant materials. This study examined a diamond-like carbon coating biomaterial, the surface energy of which was modified by Ar+ ion sputtering and laser graphitisation. The arrangement of proteins was analysed by angle resolved X-ray photoelectron spectroscopy, and the effects of the polar component of surface energy on this arrangement were observed. It was seen that polar groups (such as CN, CO) are more attracted to the coating surface due to the stronger polar interactions. This results in a segregation of these groups to the DLC-protein interface; at increasing takeoff angle (further from to DLC-protein interface) fewer of these polar groups are seen. Correspondingly, groups that interact mainly by dispersive forces (CC, CH) were found to increase in intensity as takeoff angle increased, indicating they are segregated away from the DLC-protein interface. The magnitude of the segregation was seen to increase with increasing polar surface energy, this was attributed to an increased net attraction between the solid surface and polar groups at higher polar surface energy (gamma(p)(s)). (C) 2014 Elsevier B.V. All rights reserved.
C1 [Oosterbeek, Reece N.; Hyland, Margaret M.] Univ Auckland, Dept Chem & Mat Engn, Auckland 1, New Zealand.
   [Seal, Christopher K.] Univ Auckland, Light Met Res Ctr, Auckland 1, New Zealand.
RP Oosterbeek, RN (reprint author), Univ Auckland, Dept Chem & Mat Engn, Private Bag 92019, Auckland 1, New Zealand.
EM reece.oosterbeek@auckland.ac.nz
OI Seal, Christopher/0000-0002-4850-1395; Hyland,
   Margaret/0000-0002-4505-1077; Oosterbeek, Reece/0000-0002-2412-4505
CR Ahmed MH, 2013, APPL SURF SCI, V273, P507, DOI 10.1016/j.apsusc.2013.02.070
   Baio JE, 2011, J VAC SCI TECHNOL B, V29, DOI 10.1116/1.3613919
   Briand JP, 2009, NUCL INSTRUM METH B, V267, P678, DOI 10.1016/j.nimb.2008.11.051
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   Dumitru G, 2003, DIAM RELAT MATER, V12, P1034, DOI 10.1016/S0925-9635(02)00372-2
   FENG B, 2003, MATER CHARACT, V49, P129, DOI DOI 10.1016/S1044-5803(02)00341-8
   Frateur I, 2007, ELECTROCHIM ACTA, V52, P7660, DOI 10.1016/j.electacta.2006.12.060
   Gruian C, 2012, BBA-PROTEINS PROTEOM, V1824, P873, DOI 10.1016/j.bbapap.2012.04.008
   Hedberg YS, 2012, LANGMUIR, V28, P16306, DOI 10.1021/la3039279
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   LEE SH, 1988, J COLLOID INTERF SCI, V125, P365, DOI 10.1016/0021-9797(88)90001-X
   Lifshitz Y, 1999, DIAM RELAT MATER, V8, P1659, DOI 10.1016/S0925-9635(99)00087-4
   Logothetidis S, 2007, DIAM RELAT MATER, V16, P1847, DOI 10.1016/j.diamond.2007.05.012
   Lousinian S, 2007, DIAM RELAT MATER, V16, P1868, DOI 10.1016/j.diamond.2007.08.034
   McClellan S.J., 2003, COLLOID SURFACE B, V28, P63
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Peters T., 1995, ALL ALBUMIN
   Pradier CM, 2003, J PHYS CHEM B, V107, P6766, DOI 10.1021/jp026365i
   Premathilaka S., 2008, THESIS U AUCKLAND
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Speranza G, 2006, SURF SCI, V600, P4438, DOI 10.1016/j.susc.2006.07.008
   Takabayashi S., 2007, J APPL PHYS, V101
   Tan ZY, 2006, RADIAT ENVIRON BIOPH, V45, P135, DOI 10.1007/s00411-006-0049-0
   Viljoen PE, 1996, APPL SURF SCI, V100, P612, DOI 10.1016/0169-4332(96)00349-2
   Xue Y., 2012, ISRN SPECTROSC, V2012, P6
   Yang L.Q., 2009, P ISPC 19 BOCH
NR 29
TC 2
Z9 2
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD DEC 1
PY 2014
VL 321
BP 432
EP 438
DI 10.1016/j.apsusc.2014.10.005
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AU3JE
UT WOS:000345507900059
DA 2018-10-20
ER

PT J
AU Neo, PY
   Shi, PJ
   Goh, JCH
   Toh, SL
AF Neo, Puay Yong
   Shi, Pujiang
   Goh, James Cho-Hong
   Toh, Siew Lok
TI Characterization and mechanical performance study of silk/PVA cryogels:
   towards nucleus pulposus tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE silk; polyvinyl alcohol; nucleus pulposus; tissue engineering; adipose
   derived mesenchymal stem cells
ID ADIPOSE STEM-CELLS; INTERVERTEBRAL DISC; FIBROIN CRYOGELS; BLEND FILMS;
   HYDROGELS; REPLACEMENT; SCAFFOLDS; ACID; COMPATIBILITY; BIOMATERIALS
AB Poly (vinyl) alcohol (PVA) cryogels are reported in the literature for application in nucleus pulposus (NP) replacement strategies. However, these studies are mainly limited to acellular approaches-in part due to the high hydrophilicity of PVA gels that renders cellular adhesion difficult. Silk is a versatile biomaterial with excellent biocompatibility. We hypothesize that the incorporation of silk with PVA will (i) improve the cell-hosting abilities of PVA cryogels and (ii) allow better tailoring of physical properties of the composite cryogels for an NP tissue engineering purpose. 5% (wt/vol) PVA is blended with 5% silk fibroin (wt/vol) to investigate the effect of silk : PVA ratios on the cryogels' physical properties. Results show that the addition of silk results in composite cryogels that are able to swell to more than 10 times its original dry weight and rehydrate to at least 70% of its original wet weight. Adding at least 20% silk significantly improves surface hydrophobicity and is correlated with an improvement in cell-hosting abilities. Cell-seeded cryogels also display an increment in compressive modulus and hoop stress values. In all, adding silk to PVA creates cryogels that can be potentially used as NP replacements.
C1 [Neo, Puay Yong; Shi, Pujiang; Goh, James Cho-Hong; Toh, Siew Lok] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore 117548, Singapore.
   [Goh, James Cho-Hong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117548, Singapore.
   [Toh, Siew Lok] Natl Univ Singapore, Fac Engn, Dept Mech Engn, Singapore 117548, Singapore.
RP Neo, PY (reprint author), Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore 117548, Singapore.
EM bietohsl@nus.edu.sg
RI Shi, Pujiang/P-7482-2017
OI Shi, Pujiang/0000-0002-8051-6773
FU Biomedical Research Council; Singapore National Research Foundation
FX This research was supported in part by the Biomedical Research Council
   and the Singapore National Research Foundation under its Cooperative
   Basic Research Grant, and administered by the Singapore Ministry of
   Health's National Medical Research Council. The authors thank Mr Aneel
   Kumar Maheshwari for his technical assistance with the Instron machine,
   Dr Eugene See for his input into the development of the mechanical
   testing protocol and Ms Priscilla Peh from the Tissue Modulation
   Laboratory for fruitful discussions.
CR Abdullah M., 2009, INDONESIAN J PHYS, V20, P37
   Ak F, 2013, BIOMACROMOLECULES, V14, P719, DOI 10.1021/bm3018033
   Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Bertagnoli Rudolf, 2005, Spine J, V5, P672, DOI 10.1016/j.spinee.2004.12.004
   Bonakdar S, 2010, MAT SCI ENG C-MATER, V30, P636, DOI 10.1016/j.msec.2010.02.017
   Bron JL, 2009, J ORTHOP RES, V27, P620, DOI 10.1002/jor.20789
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Carl Allen, 2004, Spine J, V4, p325S, DOI 10.1016/j.spinee.2004.07.030
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Gil ES, 2010, LANGMUIR, V26, P15614, DOI 10.1021/la102509a
   GLOVER MG, 1991, J ORTHOPAED RES, V9, P61, DOI 10.1002/jor.1100090109
   Hassan C M, 2000, BIOPOLYMERS PVA HYDR, P221
   Heini PF, 2001, EUR SPINE J, V10, P164, DOI 10.1007/s005860000204
   Hoogendoorn RJW, 2008, J CELL MOL MED, V12, P2205, DOI 10.1111/j.1582-4934.2008.00291.x
   Hudgins RG, 1998, POLYM COMPOSITE, V19, P837, DOI 10.1002/pc.10158
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Johannessen W, 2005, SPINE, V30, pE724, DOI 10.1097/01.brs.0000192236.92867.15
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Klara PM, 2002, SPINE, V27, P1374, DOI 10.1097/00007632-200206150-00022
   Ku D, 2007, Patent US, Patent No. [20070299540 A1, 20070299540]
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   Kundu B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055003
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Kwon SM, 2009, J NANOSCI NANOTECHNO, V9, P7204, DOI 10.1166/jnn.2009.1616
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Li MZ, 2001, MACROMOL MATER ENG, V286, P529
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   Lu ZF, 2007, BIOCHEM BIOPH RES CO, V359, P991, DOI 10.1016/j.bbrc.2007.06.002
   Luo Q, 2013, INT J BIOL MACROMOL, V61, P135, DOI 10.1016/j.ijbiomac.2013.06.050
   Lyons JG, 2009, J MECH BEHAV BIOMED, V2, P485, DOI 10.1016/j.jmbbm.2008.12.003
   Minoura N, 1998, MAT SCI ENG C-BIO S, V6, P275, DOI 10.1016/S0928-4931(98)00062-9
   Neo P Y, 2013, J TISSUE ENG REGEN M
   Nerurkar NL, 2010, J BIOMECH, V43, P1017, DOI 10.1016/j.jbiomech.2009.12.001
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Park SH, 2011, TISSUE ENG PT A, V17, P2999, DOI [10.1089/ten.TEA.2010.0747, 10.1089/ten.tea.2010.0747]
   Pereira DR, 2013, J TISSUE ENG REGEN M, V7, P85, DOI 10.1002/term.500
   Ray CD, 2002, EUR SPINE J, V11, pS137, DOI 10.1007/s00586-002-0425-7
   Reitmaier S, 2012, J MECH BEHAV BIOMED, V14, P67, DOI 10.1016/j.jmbbm.2012.05.010
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saltzman W M, 2013, CELL INTERACTIONS PO, P1936
   Sasson A, 2012, J MECH BEHAV BIOMED, V8, P143, DOI 10.1016/j.jmbbm.2011.12.008
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Shapiro IM, 2014, INTERVERTEBRAL DISC
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   van Dijk M, 2003, EUR SPINE J, V12, P34, DOI 10.1007/s00586-002-0458-y
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang BH, 2009, SPINE, V34, P2745, DOI 10.1097/BRS.0b013e3181b4abf5
   Wang SB, 2009, J BIOMECH, V42, P705, DOI 10.1016/j.jbiomech.2009.01.004
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Wiltsey C, 2013, J MATER SCI-MATER M, V24, P837, DOI 10.1007/s10856-013-4857-x
   Yang Z, 2011, J ORTHOP RES, V29, P1291, DOI 10.1002/jor.21336
   Yun YS, 2014, MACROMOL RES, V22, P509, DOI 10.1007/s13233-014-2071-4
   Zhang DK, 2012, J BIONIC ENG, V9, P234, DOI 10.1016/S1672-6529(11)60116-9
NR 64
TC 9
Z9 10
U1 4
U2 37
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD DEC
PY 2014
VL 9
IS 6
AR 065002
DI 10.1088/1748-6041/9/6/065002
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4ZA
UT WOS:000345615600003
PM 25329452
DA 2018-10-20
ER

PT J
AU Steffens, D
   Leonardi, D
   Soster, PRD
   Lersch, M
   Rosa, A
   Crestani, T
   Scher, C
   de Morais, MG
   Costa, JAV
   Pranke, P
AF Steffens, Daniela
   Leonardi, Dilmar
   da Luz Soster, Paula Rigon
   Lersch, Michelle
   Rosa, Annelise
   Crestani, Thayane
   Scher, Cristiane
   de Morais, Michele Greque
   Vieira Costa, Jorge Alberto
   Pranke, Patricia
TI Development of a new nanofiber scaffold for use with stem cells in a
   third degree burn animal model
SO BURNS
LA English
DT Article
DE Burn model; Stem cells; Electrospinning; Spirulina
ID TISSUE ENGINEERING APPLICATIONS; IN-VITRO CHARACTERIZATION; POLYLACTIDE
   FOAMS; SKIN SUBSTITUTES; SPIRULINA; REGENERATION; BIOGLASS(R);
   BIOMATERIAL; COMPOSITES; COLLAGEN
AB The combination of mesenchymal stem cells (MSCs) and nanotechnology to promote tissue engineering presents a strategy for the creation of new substitutes for tissues. Aiming at the utilization of the scaffolds of poly-D,L-lactic acid (PDLLA) associated or not with Spirulina biomass (PDLLA/Sp) in skin wounds, MSCs were seeded onto nanofibers produced by electrospinning. These matrices were evaluated for morphology and fiber diameter by scanning electron microscopy and their interaction with the MSCs by confocal microscopy analysis. The biomaterials were implanted in mice with burn imitating skin defects for up to 7 days and five groups were studied for healing characteristics. The scaffolds demonstrated fibrous and porous structures and, when implanted in the animals, they tolerated mechanical stress for up to two weeks. Seven days after the induction of lesions, a similar presence of ulceration, inflammation and fibrosis among all the treatments was observed. No group showed signs of re-epithelization, keratinization or presence of hair follicles on the lesion site. In conclusion, although there was no microscopical difference among all the groups, it is possible that more prolonged analysis would show different results. Moreover, the macroscopic analysis of the groups with the scaffolds showed better cicatrization in comparison with the control group. (C) 2014 Elsevier Ltd and ISBI. All rights reserved.
C1 [Steffens, Daniela; Leonardi, Dilmar; Lersch, Michelle; Rosa, Annelise; Crestani, Thayane; Scher, Cristiane; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90046900 Porto Alegre, RS, Brazil.
   [Steffens, Daniela; Rosa, Annelise; Pranke, Patricia] Univ Fed Rio Grande do Sul, Post Grad Program Physiol, BR-90046900 Porto Alegre, RS, Brazil.
   [da Luz Soster, Paula Rigon] Univ Fed Rio Grande do Sul, Dept Morphol Sci, BR-90046900 Porto Alegre, RS, Brazil.
   [de Morais, Michele Greque; Vieira Costa, Jorge Alberto] Fed Univ Rio Grande, Coll Chem & Food Engn, Biochem Engn Lab, Rio Grande, Brazil.
   [Pranke, Patricia] Stem Cell Res Inst, Sao Paulo, Brazil.
RP Steffens, D (reprint author), Univ Rio Grande do Sul, Av Ipiranga 2752,Room 304 G, BR-90610000 Porto Alegre, RS, Brazil.
EM dani_ste@hotmail.com
RI Costa, Jorge/L-3999-2013
OI Costa, Jorge/0000-0001-8042-7642; Morais, Michele/0000-0001-8920-2896
FU National Council of Technological and Scientific Development (CNPq);
   CAPES; FAPERGS; Stem Cell Research Institute, Brazil
FX We are thankful to Dr. Nance Beyer Nardi from Universidade Luterana do
   Brasil for the cytometry analysis. This work was supported by the
   National Council of Technological and Scientific Development (CNPq),
   CAPES, FAPERGS and Stem Cell Research Institute, Brazil.
CR Atiyeh BS, 2005, WORLD J SURG, V29, P131, DOI 10.1007/s00268-004-1082-2
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Brohem CA, 2011, PIGM CELL MELANOMA R, V24, P35, DOI 10.1111/j.1755-148X.2010.00786.x
   Burd Andrew, 2009, P273, DOI 10.1007/978-1-84800-167-1_12
   DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932
   de Morais MG, 2010, BIORESOURCE TECHNOL, V101, P2872, DOI 10.1016/j.biortech.2009.11.059
   Fujimori Y, 2006, ANN PLAS SURG, V57, P408, DOI 10.1097/01.sap.0000237057.49772.4f
   JAIN RK, 1987, CANCER RES, V47, P3039
   Jhong JF, 2013, ACS APPL MATER INTER, V5, P6732, DOI 10.1021/am401669q
   Jung SM, 2013, IN VITRO CELL DEV-AN, V49, P27, DOI 10.1007/s11626-012-9568-y
   Karkos PD, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1093/ECAM/NEN058NEN058
   Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188
   Khan Z, 2005, CURR PHARM BIOTECHNO, V6, P373, DOI 10.2174/138920105774370607
   Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111
   Leite F., 2001, APAGAO TRAZ RISCO QU
   Leonardi D, 2012, BURNS, V38, P1143, DOI 10.1016/j.burns.2012.07.028
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Liu H, 2013, EVID-BASED COMPL ALT, V2013
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009
   Middelkoop E, 2004, BIOMATERIALS, V25, P1559, DOI 10.1016/S0142-9612(03)00502-7
   Pereira C, 2007, J BIOMATER APPL, V22, P101, DOI 10.1177/0885328207081690
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P465, DOI 10.3109/08923979609052748
   Qureshi MA, 1996, IMMUNOPHARM IMMUNOT, V18, P457, DOI 10.3109/08923979609052747
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Steffens D, 2013, J BIOMED NANOTECHNOL, V9, P710, DOI 10.1166/jbn.2013.1571
   Supp DM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0868com
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang C, 2009, POLYMER, V50, P6100, DOI 10.1016/j.polymer.2009.10.025
   Yamaguchi R, 2007, WOUND REPAIR REGEN, V15, P87, DOI 10.1111/j.1524-475X..2006.00189.x
   Yoeruek E, 2012, ACTA OPHTHALMOL, V90, pe125, DOI 10.1111/j.1755-3768.2011.02261.x
   Zwaginga JJ, 2003, CLIN EXP PHARMACOL P, V30, P900, DOI 10.1046/j.1440-1681.2003.03931.x
NR 40
TC 16
Z9 16
U1 2
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-4179
EI 1879-1409
J9 BURNS
JI Burns
PD DEC
PY 2014
VL 40
IS 8
BP 1650
EP 1660
DI 10.1016/j.burns.2014.03.008
PG 11
WC Critical Care Medicine; Dermatology; Surgery
SC General & Internal Medicine; Dermatology; Surgery
GA AU1ER
UT WOS:000345364400035
PM 24794225
DA 2018-10-20
ER

PT J
AU Ebeid, K
   Wille, S
   Hamdy, A
   Salah, T
   El-Etreby, A
   Kern, M
AF Ebeid, Kamal
   Wille, Sebastian
   Hamdy, Amina
   Salah, Tarek
   El-Etreby, Amr
   Kern, Matthias
TI Effect of changes in sintering parameters on monolithic translucent
   zirconia
SO DENTAL MATERIALS
LA English
DT Article
DE Dental materials; Ceramics; Zirconia; Biaxial flexural strength;
   Translucency
ID BIAXIAL FLEXURAL STRENGTH; FIXED DENTAL PROSTHESES; FRACTURE-TOUGHNESS;
   GRAIN-SIZE; CERAMICS; COLOR; PERCEPTIBILITY; ACCEPTABILITY; BIOMATERIAL;
   SYSTEMS
AB Objectives. Aim of this study was to evaluate the effect of different sintering parameters on color reproduction, translucency and biaxial flexural strength of monolithic zirconia.
   Methods. Translucent zirconia discs having 15 mm diameter, 1 mm thickness, and shade A3 were milled and divided according to the sintering temperatures (1460 degrees C, 1530 degrees C, and 1600 degrees C) into three groups (n = 30). Each group was later divided into three subgroups (n = 10) according to the sintering holding time (1, 2, and 4 h). Easyshade spectrophotometer (Vita, Bad Sackingen, Germany) was used to obtain the Delta E between the specimens and the shade A3. Mean Delta E values below 3.0 were considered "clinically imperceptible", Delta E values between 3.0 and 5.0 were considered "clinically acceptable" and Delta E values above 5.0 were considered "clinically unacceptable". Contrast ratio (CR) was obtained after comparing the reflectance of light through the specimens over black and white background. Biaxial flexural strength was tested using the piston-on-three balls technique in a universal testing machine.
   Results. Mean Delta E results ranged from 4.4 to 2.2. Statistically significant decrease in the Delta E was observed as the sintering time and temperature increased. CR decreased from 0.75 to 0.68 as the sintering time and temperature increased. No significant change in the biaxial flexural strength was observed.
   Signcance. Sintering zirconia using long cycles and high temperatures will result in reduction of Delta E and CR. Biaxial flexural strength is not affected by changes in the evaluated sintering parameters. (C) 2014 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Ebeid, Kamal; Wille, Sebastian; Kern, Matthias] Univ Kiel, Sch Dent, Dept Prosthodont Propaedeut & Dent Mat, Kiel, Germany.
   [Ebeid, Kamal; Hamdy, Amina; Salah, Tarek; El-Etreby, Amr] Ain Shams Univ, Fac Dent, Dept Fixed Prosthodont, Cairo, Egypt.
RP Ebeid, K (reprint author), Univ Kiel, Sch Dent, Dept Prosthodont Propaedeut & Dent Mat, Kiel, Germany.
EM kebeid@proth.uni-kiel.de
RI Kern, Matthias/A-9445-2010; Salah, Tarek/L-7023-2015
OI Kern, Matthias/0000-0002-0378-9698; Salah, Tarek/0000-0001-6724-9458
CR Alghazali N, 2012, J DENT, V40, pE10, DOI 10.1016/j.jdent.2012.04.023
   ANUSAVICE KJ, 1993, J AM DENT ASSOC, V124, P72, DOI 10.14219/jada.archive.1993.0031
   Anusavice KJ, 1993, J AM DENT ASSOC, V124, P80
   Anusavice KJ, 1993, J AM DENT ASSOC, V174, P76
   Baldissara P, 2010, J PROSTHET DENT, V104, P6, DOI 10.1016/S0022-3913(10)60086-8
   BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201
   Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548
   Chen YM, 2008, DENT MATER, V24, P1506, DOI 10.1016/j.dental.2008.03.010
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chu FCS, 2007, J PROSTHET DENT, V98, P359, DOI 10.1016/S0022-3913(07)60120-6
   Della Bona A, 2009, DENT MATER, V25, P276, DOI 10.1016/j.dental.2008.09.006
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Douglas RD, 2007, J PROSTHET DENT, V97, P200, DOI 10.1016/j.prosdent.2007.02.012
   Heffernan MJ, 2002, J PROSTHET DENT, V88, P5
   Heydecke G, 2001, J PROSTHET DENT, V85, P551, DOI 10.1067/mpr.2001.115385
   Hjerppe J, 2008, ACTA ODONTOL SCAND, V66, P262, DOI 10.1080/00016350802247123
   Hjerppe J, 2009, DENT MATER, V25, P166, DOI 10.1016/j.dental.2008.05.011
   Jiang L, 2011, J MATER SCI-MATER M, V22, P2429, DOI 10.1007/s10856-011-4438-9
   JOHNSTON WM, 1989, J DENT RES, V68, P819, DOI 10.1177/00220345890680051301
   Khashayar G, 2014, J DENT, V42, P637, DOI 10.1016/j.jdent.2013.11.017
   Kim MJ, 2013, J ADV PROSTHODONT, V5, P161, DOI 10.4047/jap.2013.5.2.161
   Kohorst P, 2009, EUR J ORAL SCI, V117, P319, DOI 10.1111/j.1600-0722.2009.00622.x
   Luthardt RG, 2004, DENT MATER, V20, P655, DOI 10.1016/j.dental.2003.08.007
   Nogueira AD, 2013, J DENT, V41, P18
   Ozturk O, 2008, J PROSTHET DENT, V100, P99, DOI 10.1016/S0022-3913(08)60156-0
   Paravina RD, 2006, DENT MATER, V22, P299, DOI 10.1016/j.dental.2005.04.022
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pittayachawan P, 2007, DENT MATER, V23, P1018, DOI 10.1016/j.dental.2006.09.003
   Raigrodski AJ, 2012, J PROSTHET DENT, V107, P170, DOI 10.1016/S0022-3913(12)60051-1
   Sailer I, 2007, INT J PROSTHODONT, V20, P383
   Spyropoulou PE, 2011, J PROSTHET DENT, V105, P304, DOI 10.1016/S0022-3913(11)60056-5
   Stawarczyk B, 2013, CLIN ORAL INVEST, V17, P269, DOI 10.1007/s00784-012-0692-6
   Tinschert J, 2004, Int J Comput Dent, V7, P25
   Traini T, 2014, CLIN ORAL INVEST, V18, P707, DOI 10.1007/s00784-013-1018-z
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Wagner WC, 1996, J PROSTHET DENT, V76, P140, DOI 10.1016/S0022-3913(96)90297-8
   Wennerberg A, 1996, MED ENG PHYS, V18, P548, DOI 10.1016/1350-4533(95)00005-4
NR 37
TC 22
Z9 22
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD DEC
PY 2014
VL 30
IS 12
BP E419
EP E424
DI 10.1016/j.dental.2014.09.003
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AU3PI
UT WOS:000345525500014
PM 25262211
DA 2018-10-20
ER

PT J
AU Zhen, ZP
   Tang, W
   Todd, T
   Xie, J
AF Zhen, Zipeng
   Tang, Wei
   Todd, Trever
   Xie, Jin
TI Ferritins as nanoplatforms for imaging and drug delivery
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE drug delivery; ferritin; MRI; nanomedicine; reporter gene
ID PHOTODYNAMIC THERAPY; LOADED APOFERRITIN; GENE-EXPRESSION; CONTRAST
   AGENTS; CANCER-THERAPY; HUMAN LIVER; MRI; NANOPARTICLES; IRON; PROTEIN
AB Introduction: Due to unique architecture and surface properties, ferritin has emerged as an important class of biomaterial. Many studies suggest that ferritin and its derivatives hold great potential in a wide range of bio-applications.
   Areas covered: In this review, we summarize recent progress on employing ferritins as a platform to construct functional nanoparticles for applications in MRI, optical imaging, cell tracking, and drug delivery.
   Expert opinion: As a natural polymer, ferritins afford advantages such as high biocompatibility, good biodegradability, and a relatively long plasma half-life. These attributes put ferritins ahead of conventional materials in clinical translation for imaging and drug delivery purposes.
C1 [Zhen, Zipeng; Tang, Wei; Todd, Trever; Xie, Jin] Univ Georgia, Dept Chem, Athens, GA 30602 USA.
   [Xie, Jin] Univ Georgia, BIRC, Athens, GA 30602 USA.
RP Xie, J (reprint author), Univ Georgia, Dept Chem, Athens, GA 30602 USA.
EM jinxie@uga.edu
FU NCI/NIH [R00CA153772]; Elsa U. Pardee foundation; UGA
FX This work was supported by an NCI/NIH R00 grant (R00CA153772), an Elsa
   U. Pardee foundation grant, and a UGA startup grant. The authors have no
   other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript apart from those disclosed.
CR Aime S, 2002, ANGEW CHEM INT EDIT, V114, P1059
   Bartzokis G, 2000, CELL MOL BIOL, V46, P821
   Beeman SC, 2011, AM J PHYSIOL-RENAL, V300, pF1454, DOI 10.1152/ajprenal.00044.2011
   Bennett KM, 2013, AM J PHYSIOL-RENAL, V304, pF1252, DOI 10.1152/ajprenal.00714.2012
   Bennett KM, 2008, MAGN RESON MED, V60, P564, DOI 10.1002/mrm.21684
   Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014
   Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126
   Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735
   Campan M, 2011, AM J PHYSIOL-HEART C, V300, pH2238, DOI 10.1152/ajpheart.00935.2010
   Cao CQ, 2014, ADV MATER, V26, P2566, DOI 10.1002/adma.201304544
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Cohen B, 2005, NEOPLASIA, V7, P109, DOI 10.1593/neo.04436
   Cohen B, 2007, NAT MED, V13, P498, DOI 10.1038/nm1497
   Crich SG, 2006, CANCER RES, V66, P9196, DOI 10.1158/0008-5472.CAN-06-1728
   Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010
   DANON D, 1972, J ULTRA MOL STRUCT R, V38, P500, DOI 10.1016/0022-5320(72)90087-1
   De Jong WH, 2008, INT J NANOMED, V3, P133
   Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Ensign D, 2004, INORG CHEM, V43, P3441, DOI 10.1021/ic035415a
   Fan KL, 2012, NAT NANOTECHNOL, V7, P459, DOI [10.1038/NNANO.2012.90, 10.1038/nnano.2012.90]
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fisher J, 2007, AM J PHYSIOL-CELL PH, V293, pC641, DOI 10.1152/ajpcell.00599.2006
   Gossuin Y, 2005, MAGN RESON IMAGING, V23, P1001, DOI 10.1016/j.mri.2005.10.009
   Gossuin Y, 2004, NMR BIOMED, V17, P427, DOI 10.1002/nbm.903
   Green MR, 2006, ANN ONCOL, V17, P1263, DOI 10.1093/annonc/mdl104
   HAINFELD JF, 1992, P NATL ACAD SCI USA, V89, P11064, DOI 10.1073/pnas.89.22.11064
   Hosein HA, 2004, LANGMUIR, V20, P10283, DOI 10.1021/la0491100
   Hughes GA, 2005, NANOMED-NANOTECHNOL, V1, P22, DOI 10.1016/j.nano.2004.11.009
   Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139
   JAIN SK, 1985, J BIOL CHEM, V260, P1762
   Kalman FK, 2010, ANGEW CHEM INT EDIT, V49, P612, DOI 10.1002/anie.200904731
   Kim M, 2011, BIOMACROMOLECULES, V12, P1629, DOI 10.1021/bm200026v
   Lee S, 2008, ANGEW CHEM INT EDIT, V47, P2804, DOI 10.1002/anie.200705240
   Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107
   Lin X, 2011, NANO LETT, V11, P814, DOI 10.1021/nl104141g
   Lin X, 2011, ANGEW CHEM INT EDIT, V50, P1569, DOI 10.1002/anie.201006757
   MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602
   MARCHESI VT, 1972, P NATL ACAD SCI USA, V69, P1445, DOI 10.1073/pnas.69.6.1445
   Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539
   MOSS D, 1992, J INORG BIOCHEM, V47, P219, DOI 10.1016/0162-0134(92)84067-W
   MUNRO HN, 1978, PHYSIOL REV, V58, P317
   Murray-Kolb LE, 2003, AM J CLIN NUTR, V77, P180
   Okuda M, 2011, CRYST GROWTH DES, V11, P2540, DOI 10.1021/cg200299y
   Pan YH, 2009, J STRUCT BIOL, V166, P22, DOI 10.1016/j.jsb.2008.12.001
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Powell JJ, 2014, NANOMEDICINE
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sanchez P, 2009, DALTON T, P800, DOI 10.1039/b809645g
   SAYERS MH, 1973, BRIT J HAEMATOL, V24, P209, DOI 10.1111/j.1365-2141.1973.tb05741.x
   Stefanini S, 1996, ARCH BIOCHEM BIOPHYS, V325, P58, DOI 10.1006/abbi.1996.0007
   Sun CJ, 2011, J AM CHEM SOC, V133, P8617, DOI 10.1021/ja200746p
   Takahashi T, 2003, BIOPHYS J, V84, P2256, DOI 10.1016/S0006-3495(03)75031-0
   THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289
   Todd TJ, 2013, NANOMEDICINE-UK, V8, P1555, DOI [10.2217/NNM.13.141, 10.2217/nnm.13.141]
   TORTI SV, 1988, J BIOL CHEM, V263, P12638
   Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690
   Ueno T, 2009, J AM CHEM SOC, V131, P5094, DOI 10.1021/ja806688s
   Yan F, 2008, CHEM COMMUN, P4579, DOI 10.1039/b810949d
   YANG DW, 1995, BIOCHEM J, V307, P253, DOI 10.1042/bj3070253
   Zhen ZP, 2013, ACS NANO, V7, P6988, DOI 10.1021/nn402199g
   Zhen ZP, 2013, ACS NANO, V7, P4830, DOI 10.1021/nn305791q
NR 62
TC 21
Z9 21
U1 5
U2 75
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD DEC
PY 2014
VL 11
IS 12
BP 1913
EP 1922
DI 10.1517/17425247.2014.941354
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AU0XP
UT WOS:000345345800008
PM 25070839
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cao, Y
   Mei, ML
   Li, QL
   Lo, ECM
   Chu, CH
AF Cao, Ying
   Mei, May Lei
   Li, Quan-Li
   Lo, Edward Chin Man
   Chu, Chun Hung
TI Enamel prism-like tissue regeneration using enamel matrix derivative
SO JOURNAL OF DENTISTRY
LA English
DT Article
DE Enamel matrix derivative; Emdogain; Hydroxyapatite; Regeneration;
   Biomimetic mineralisation
ID OCTACALCIUM PHOSPHATE CRYSTALS; HUMAN TOOTH ENAMEL; BIOMIMETIC
   MINERALIZATION; HYDROXYAPATITE NANORODS; AMELOGENIN; GROWTH;
   REMINERALIZATION; FLUORIDE; APATITE; MICROSTRUCTURE
AB Backgrounds: Enamel matrix derivative (EMD) has been shown to promote periodontal regeneration, but its effect on biomimetic mineralisation of enamel is not reported. Objectives: This in vitro study aimed to investigate the effect of commercially available EMD on promoting biomimetic mineralisation in demineralised enamel using an agarose hydrogel model.
   Methods: Human enamel slices were demineralised with 37% phosphoric acid for 1 min. They were covered with a 2-mm-thick EMD-calcium chloride (CaCl2) agarose hydrogel. Another 2-mm-thick ion-free agarose hydrogel was added on top of the EMD-CaCl2 hydrogel. They were incubated in a phosphate solution containing fluoride at 37 degrees C for 96 h. Scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), and X-ray diffraction (XRD) were used to evaluate the crystals formed on the demineralised enamel surface. A nano-indenter was used to evaluate the elastic modulus and nanohardness on the surface of the enamel slices.
   Results: SEM observed enamel prism-like crystals formed on the enamel. They had typical apatite hexagonal structures, which corroborated the enamel's microstructure. EDX revealed that the elements were predominantly calcium, phosphorus, and fluorine. XRD confirmed that they were fluorinated hydroxyapatite. The mean elastic modulus before and after remineralisation was 59.1 GPa and 78.5 GPa (p < 0.001), respectively; the mean nanohardness was 1.1 GPa and 2.2 GPa, respectively (p < 0.001).
   Conclusions: EMD promoted in vitro biomimetic mineralisation and facilitated enamel prismlike tissue formation on demineralised human enamel.
   Clinical significance: This study is the first to report on using EMD in biomimetic mineralisation, which may serve as a biomaterial for enamel repair. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Cao, Ying; Mei, May Lei; Li, Quan-Li; Lo, Edward Chin Man; Chu, Chun Hung] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
   [Cao, Ying; Li, Quan-Li] Anhui Med Univ, Stomatol Hosp & Coll, Key Lab Oral Dis Res Anhui Prov, Hefei, Peoples R China.
RP Li, QL (reprint author), Univ Hong Kong, Fac Dent, 1B30 Prince Philip Dent Hosp,34 Hosp Rd, Hong Kong, Hong Kong, Peoples R China.
EM chchu@hku.hk
FU University of Hong Kong Seed Funding Programme for Basic Research
   [201310159015]
FX This study was supported by the University of Hong Kong Seed Funding
   Programme for Basic Research (no. 201310159015).
CR Al-Hezaimi K, 2013, AUST ENDOD J, V39, P171, DOI 10.1111/j.1747-4477.2012.00357.x
   Bouropoulos N, 2004, J DENT RES, V83, P278, DOI 10.1177/154405910408300402
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Cao Y, 2014, CLIN ORAL INVEST, V18, P873, DOI 10.1007/s00784-013-1035-y
   Cao Y, 2014, ACS APPL MATER INTER, V6, P410, DOI 10.1021/am4044823
   Cao Y, 2013, J DENT, V41, P818, DOI 10.1016/j.jdent.2013.06.008
   Cha C, 2011, BIOMATERIALS, V32, P2695, DOI 10.1016/j.biomaterials.2010.12.038
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chen HF, 2005, J COLLOID INTERF SCI, V288, P97, DOI 10.1016/j.jcis.2005.02.064
   Chen JD, 2007, BIOMATERIALS, V28, P2275, DOI 10.1016/j.biomaterials.2007.01.033
   Fan YW, 2011, ACTA BIOMATER, V7, P2293, DOI 10.1016/j.actbio.2011.01.028
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Fincham AG, 1999, J STRUCT BIOL, V126, P270, DOI 10.1006/jsbi.1999.4130
   Fletcher J, 2011, CRYSTENGCOMM, V13, P3692, DOI 10.1039/c0ce00806k
   Guentsch A, 2010, ADV ENG MATER, V12, pB571, DOI 10.1002/adem.201080008
   Habelitz S, 2004, J DENT RES, V83, P698, DOI 10.1177/154405910408300908
   Iijima M, 2005, BIOMATERIALS, V26, P1595, DOI 10.1016/j.biomaterials.2004.05.009
   Iijima M, 2002, J DENT RES, V81, P69, DOI 10.1177/154405910208100115
   Iijima M, 2010, CRYST GROWTH DES, V10, P4815, DOI 10.1021/cg100696r
   Koop R, 2012, J PERIODONTOL, V83, P707, DOI 10.1902/jop.2011.110266
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Li L, 2011, ADV MATER, V23, P4695, DOI 10.1002/adma.201102773
   Marinho VCC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002279.pub2
   Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075
   Moradian-Oldak J, 1998, BIOPOLYMERS, V46, P225, DOI 10.1002/(SICI)1097-0282(19981005)46:4<225::AID-BIP4>3.0.CO;2-R
   Moradian-Oldak J, 2012, FRONT BIOSCI-LANDMRK, V17, P1996, DOI 10.2741/4034
   Tschoppe P, 2012, ARCH ORAL BIOL, V57, P931, DOI 10.1016/j.archoralbio.2012.02.010
   Wang LJ, 2008, J PHYS CHEM C, V112, P5892, DOI 10.1021/jp077105+
   Wang XK, 2009, J NANOSCI NANOTECHNO, V9, P1361, DOI 10.1166/jnn.2009.C157
   Wen HB, 2000, J DENT RES, V79, P1902, DOI 10.1177/00220345000790111501
   Wu D, 2013, BIOMATERIALS, V34, P5036, DOI 10.1016/j.biomaterials.2013.03.053
   Xie RQ, 2011, CRYST GROWTH DES, V11, P5206, DOI 10.1021/cg101708y
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yang XD, 2011, EUR J ORAL SCI, V119, P351, DOI 10.1111/j.1600-0722.2011.00916.x
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 35
TC 4
Z9 4
U1 3
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
EI 1879-176X
J9 J DENT
JI J. Dent.
PD DEC
PY 2014
VL 42
IS 12
BP 1535
EP 1542
DI 10.1016/j.jdent.2014.08.014
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AU3KO
UT WOS:000345512200003
PM 25193522
OA Other Gold
DA 2018-10-20
ER

PT J
AU Ma, SQ
   Chen, Z
   Qiao, F
   Sun, YC
   Yang, XP
   Deng, XL
   Cen, L
   Cai, Q
   Wu, MY
   Zhang, X
   Gao, P
AF Ma, Shiqing
   Chen, Zhen
   Qiao, Feng
   Sun, Yingchun
   Yang, Xiaoping
   Deng, Xuliang
   Cen, Lian
   Cai, Qing
   Wu, Mingyao
   Zhang, Xu
   Gao, Ping
TI Guided bone regeneration with tripolyphosphate cross-linked asymmetric
   chitosan membrane
SO JOURNAL OF DENTISTRY
LA English
DT Article
DE Guided bone regeneration; Asymmetric; Chitosan membrane; Sodium
   tripolyphosphate
ID PERIODONTAL TISSUE REGENERATION; IN-VITRO; ANTIBACTERIAL ACTIVITY;
   SCAFFOLDS; LINKING; RELEASE; PH; NANOPARTICLES; KINETICS; DELIVERY
AB Objectives: The objective of this study was to prepare a novel asymmetric chitosan guided bone regeneration (GBR) membrane, which is composed of a dense layer isolating the bone defect from the invasion of surrounding connective fibrous tissue and a loose layer which can improve cell adhesion and stabilize blood clots, thus guided bone regeneration.
   Methods: The chitosan membrane was fabricated through liquid nitrogen quencher combined with lyophilization and cross-linked by sodium tripolyphosphate (TPP). The physical properties of asymmetric chitosan membrane were measured by scanning electron microscope (SEM), Fourier-transform infrared (FTIR), x-ray diffraction (XRD) and tensile test machine. MTT assay and Live/Dead cell staining for MC3T3-E1 osteoblasts cultured on the membrane were used to characterize the biocompatibility of the membrane. In animal experiments, full-thickness and critical sized skull defects were made to evaluate the effect of the membrane on bone regeneration.
   Results: The results of this study indicate that the asymmetric chitosan membrane can be built and cross-linked by TPP to enhance the tensile strength of the membrane. In vitro experiment showed that no significant numbers of dead cells were detected on the chitosan membrane, indicating that the membrane had good biocompatibility. In animal experiments, the chitosan membrane had faster new bone formation, showing the capability to enhance bone regeneration. Conclusions: The chitosan membrane prepared in this study has an asymmetric structure; its tensile strength, biodegradation and biocompatibility fulfil the requirements of guided bone regeneration. Therefore, the asymmetric chitosan membrane is a promising GBR membrane for bone regeneration.
   Clinical significance: Guided bone regeneration (GBR) is an effective method for healing bone defects caused by periodontitis and implantitis, in which GBR membrane is a key biomaterial. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ma, Shiqing; Chen, Zhen; Qiao, Feng; Sun, Yingchun; Wu, Mingyao; Zhang, Xu; Gao, Ping] Tianjin Med Univ, Sch & Hosp Stomatol, Tianjin 300070, Peoples R China.
   [Yang, Xiaoping; Cai, Qing] Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
   [Deng, Xuliang] Peking Univ, Sch & Hosp Stomatol, Dept Geriatr Dent, Beijing 100081, Peoples R China.
   [Cen, Lian] Natl Tissue Engn Ctr China, Shanghai 200241, Peoples R China.
   [Cen, Lian] E China Univ Sci & Technol, Sch Chem Engn, Shanghai 200237, Peoples R China.
RP Zhang, X (reprint author), Tianjin Med Univ, Sch & Hosp Stomatol, 12 Observ Rd, Tianjin 300070, Peoples R China.
EM zhxden@gmail.com; gptj@sina.com
FU National Science and Technology Support Project Foundation
   [2012BAI07B00]; Tianjin Research Program of Application Foundation and
   Advanced Technology [14JCYBJC29600]; National "973'' Project Foundation
   [2010CB944804]; National Training Programs of Innovation and
   Entrepreneurship for Undergraduates [201310062005]
FX This work was jointly supported by National Science and Technology
   Support Project Foundation (Grant no.: 2012BAI07B00), Tianjin Research
   Program of Application Foundation and Advanced Technology (Grant no.:
   14JCYBJC29600), National "973'' Project Foundation (Grant no.:
   2010CB944804), and National Training Programs of Innovation and
   Entrepreneurship for Undergraduates (Grant no.: 201310062005).
CR Bashutski JD, 2009, J ENDODONT, V35, P321, DOI 10.1016/j.joen.2008.11.023
   Bhumkar DR, 2006, AAPS PHARMSCITECH, V7
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Chen FM, 2010, BIOMATERIALS, V31, P7892, DOI 10.1016/j.biomaterials.2010.07.019
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Chen KY, 2009, BIOMACROMOLECULES, V10, P1642, DOI 10.1021/bm900238b
   Chen TW, 2006, J APPL POLYM SCI, V102, P4528, DOI 10.1002/app.24945
   Cho WJ, 2009, J BIOMED MATER RES A, V91A, P400, DOI 10.1002/jbm.a.32264
   Du YJ, 2009, INNOV FOOD SCI EMERG, V10, P103, DOI 10.1016/j.ifset.2008.07.004
   Fang DJ, STEM CELLS
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Gierszewska-Druzynska M, PROGR CHEM APPL CHIT
   Gierszewska-Druzynska M, 2011, PROG CHEM APPL CHITI, V16, P15
   Han CM, 2010, J ZHEJIANG UNIV-SC B, V11, P524, DOI 10.1631/jzus.B0900400
   Hong H, 2007, COMPOS PART B-ENG, V38, P311, DOI 10.1016/j.compositesb.2006.05.005
   Hu M, 2010, J AGR FOOD CHEM, V58, P1283, DOI 10.1021/jf903270y
   Ito M, 1999, J BIOMED MATER RES, V45, P204, DOI 10.1002/(SICI)1097-4636(19990605)45:3<204::AID-JBM7>3.0.CO;2-4
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Kafshgari MH, 2011, IRAN POLYM J, V20, P445
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   Lin WC, 2005, COLLOID SURFACE B, V44, P143, DOI 10.1016/j.colsurfb.2005.06.010
   Liu H, 2009, POLYM ADVAN TECHNOL, V20, P613, DOI 10.1002/pat.1306
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734
   Lou CW, 2010, ADV MATER RES-SWITZ, V123-125, P177, DOI 10.4028/vvww.scientific.net/AMR.123-125.177
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oh SH, 2006, J BIOMAT SCI-POLYM E, V17, P1375, DOI 10.1163/156856206778937253
   Owen GR, 2010, J BIOMED MATER RES A, V95A, P857, DOI 10.1002/jbm.a.32865
   Park J, 2007, BIOMATERIALS, V28, P2772, DOI 10.1016/j.biomaterials.2007.012.009
   Pierog M, 2009, PROG CHEM APPL CHITI, V14, P75
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Xu C, 2012, J BIOMED MATER RES B, V100B, P1435, DOI 10.1002/jbm.b.32662
   Yan JH, 2006, ARTIF CELL BLOOD SUB, V34, P27, DOI [10.1080/10731190500430024, 10.1080/107311090500430024]
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 45
TC 20
Z9 22
U1 5
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
EI 1879-176X
J9 J DENT
JI J. Dent.
PD DEC
PY 2014
VL 42
IS 12
BP 1603
EP 1612
DI 10.1016/j.jdent.2014.08.015
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AU3KO
UT WOS:000345512200011
PM 25193523
DA 2018-10-20
ER

PT J
AU Barui, A
   Khare, R
   Dhara, S
   Banerjee, P
   Chatterjee, J
AF Barui, Ananya
   Khare, Ritesh
   Dhara, Santanu
   Banerjee, Provas
   Chatterjee, Jyotirmoy
TI Ex vivo bio-compatibility of honey-alginate fibrous matrix for HaCaT and
   3T3 with prime molecular expressions
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; E-CADHERIN; IN-VITRO; TISSUE;
   SCAFFOLDS; BIOMATERIALS; HYDROGELS; DELIVERY; POLYMERS
AB Honey's inherent compositional diversity, bio-compatibility and time tested therapeutic efficacy, especially in tissue repair as a topical agent, attract researchers towards harnessing its biomaterial potential particularly in developing matrix for tissue engineering applications. Hence, this study fabricates fibrous mat from optimum honey-alginate formulation and alginate solution using wet spinning technology. The physical and morphological properties of the scaffolds are assessed and finally their comparative biological performances are evaluated through in vitro studies on adherence, viability and prime molecular expression of HaCaT and 3T3 cells. The honey-alginate scaffold demonstrates better performance than that of alginate in terms of cellular adherence, viability and proper expression of cell-cell adhesion molecule (E-cadherin) and prime molecules of extra cellular matrix (Collagen I and III) by HaCaT and 3T3 respectively.
C1 [Barui, Ananya; Khare, Ritesh; Dhara, Santanu; Banerjee, Provas; Chatterjee, Jyotirmoy] IIT Kharagpur, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
   [Banerjee, Provas] Banerjees Biomed Res Fdn, Sainthia 700005, India.
RP Dhara, S (reprint author), IIT Kharagpur, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.
EM sdhara@smst.iitkgp.ernet.in; jchatterjee@smst.iitkgp.ernet.in
FU ISIRD, SRIC, IIT Kharagpur [IIT/SRIC/ISIRD/2007-08]
FX Financial support from ISIRD, SRIC, IIT Kharagpur
   (IIT/SRIC/ISIRD/2007-08, 02.01.2008) for this work is gratefully
   acknowledged.
CR Bansal V, 2005, Kathmandu Univ Med J (KUMJ), V3, P305
   Bhattarai N, 2007, NANOTECHNOLOGY, V18
   Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Cuy J, 2004, BIOMATERIALS TUTORIA
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Foroughi J, 2008, SYNTHETIC MET, V158, P104, DOI 10.1016/j.synthmet.2007.12.008
   Gonzalez RC, 2002, DIGITAL IMAGE PROCES, P595
   Grace M, 2009, J ENG FIBER FABR, V4, P24
   Gun A., 2005, OUTLINE STAT THEORY
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Hunt Nicola C., 2009, Biotechnology Journal, V4, P730, DOI 10.1002/biot.200800292
   Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028
   Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   Ko HF, 2010, PHILOS T R SOC A, V368, P1981, DOI 10.1098/rsta.2010.0009
   Korossis SA, 2005, TOPICS TISSUE ENG
   Krell R., 1996, VALUE ADDED PRODUCTS
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lia Z.S., 2005, BIOMATERIALS, V26, P3919
   Lord A, 2000, NEW SCI, P32
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023
   Michael S, 2008, INT J PHARMACEUT, V364, P281
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Mohan N., 2005, TRENDS BIOMATERIALS, V18, P219
   MUMPER RJ, 1994, J CONTROL RELEASE, V30, P241, DOI 10.1016/0168-3659(94)90030-2
   Nadeem F, 1998, FEBS LETT, V435
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nawrocki B, 1998, AM J PATHOL, V153, P1521, DOI 10.1016/S0002-9440(10)65740-9
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qi Y., 2009, P CLEO PAC RIM SHANG, P1, DOI DOI 10.1145/1639622.1639627
   Riva B., 2009, EUR J PHARM BIOPHARM, V73, P50
   Ruozi B, 2009, INT J PHARMACEUT, V378, P108, DOI 10.1016/j.ijpharm.2009.05.049
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sell SA, 2010, POLYMERS-BASEL, V2, P522, DOI 10.3390/polym2040522
   SMETANA K, 1993, BIOMATERIALS, V14, P1046, DOI 10.1016/0142-9612(93)90203-E
   Soni M. L., 2010, INT J DRUG DELIV, V2, P64
   Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029
   TANG A, 1994, J CELL SCI, V107, P983
   Visavadia BG, 2008, BRIT J ORAL MAX SURG, V46, P55, DOI 10.1016/j.bjoms.2006.09.013
   Vogt S., 2002, European Cells & Materials, V4, P30
   Wang YY, 2010, POLYM DEGRAD STABIL, V95, P207, DOI 10.1016/j.polymdegradstab.2009.11.023
   Watthanaphanit A, 2010, CARBOHYD POLYM, V79, P738, DOI 10.1016/j.carbpol.2009.09.031
NR 48
TC 9
Z9 9
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2014
VL 25
IS 12
BP 2659
EP 2667
DI 10.1007/s10856-011-4456-7
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU5KA
UT WOS:000345644300006
PM 22042457
DA 2018-10-20
ER

PT J
AU Jotz, GP
   Soster, PRD
   Kunrath, SO
   Steffens, D
   Braghirolli, DI
   Zettler, CG
   Beck, CA
   Muccillo, M
   Lopes, RFF
   Mastella, B
   Pranke, P
AF Jotz, Geraldo P.
   da Luz Soster, Paula R.
   Kunrath, Seno O.
   Steffens, Daniela
   Braghirolli, Daikelly I.
   Zettler, Claudio Galleano
   Beck, Carlos A.
   Muccillo, Marcelo
   Lopes, Rui F. F.
   Mastella, Bernardo
   Pranke, Patricia
TI Mesenchymal Stem Cells and Nanofibers as Scaffolds for the Regeneration
   of Thyroid Cartilage
SO LARYNGOSCOPE
LA English
DT Article
DE Stem cells; thyroid cartilage; regeneration; scaffolds
ID STENOSIS; PULP
AB Objectives/HypothesisThe aim of this study has been to establish an alternative approach in the form of regeneration of the thyroid cartilage.
   Study DesignFour 1-month old pigs (Sus scrofa) were used (divided into 3 groups) and submitted to general anesthetic to perform cervictomy with exposure of the thyroid cartilage in a total of 12 (twelve) samples.
   MethodA resection of 4.0 cm(2) of cartilage was carried out in the right upper region and in the left upper and lower left region of the cartilage, where a scaffold with or without stem cells was implanted. In the left lower region, no biomaterial was implanted and the defect was left open (lesion control [L]).
   ResultsThe average extension of the cartilaginous neoformation of L group was 136.3 m ( 9.6) and 387.7 m ( 43.2) in the scaffold (SCA) group, presenting a significant statistical difference (P<0.01). The analysis carried out on the lesion site sections of the cartilage of the larynx of the animals from the SCA group+mesenchymal stem cells (SCA+MSC) showed an average of the extension of neocartilage of 825.4 m (+/- 122.1), showing a more extensive area of neocartilage when compared to the other groups. These results demonstrated a high significantly statistical difference (P<0.001) when compared with the L and SCA groups.
   ConclusionIn 100% of the cases for which SCA+MSCs were used, a significant success in the cartilage growth and closing of the lesion in the thyroid cartilage was obtained compared to the other two groups for which MSCs were not used.
   Level of EvidenceN/A. Laryngoscope, 124:E455-E460, 2014
C1 [Jotz, Geraldo P.; da Luz Soster, Paula R.; Kunrath, Seno O.; Lopes, Rui F. F.] Univ Fed Rio Grande do Sul, Dept Morphol Sci, BR-90550142 Porto Alegre, RS, Brazil.
   [Steffens, Daniela; Braghirolli, Daikelly I.; Pranke, Patricia] Univ Fed Rio Grande do Sul, Hematol & Stem Cells Lab, Sch Pharm, BR-90550142 Porto Alegre, RS, Brazil.
   [Steffens, Daniela; Braghirolli, Daikelly I.; Pranke, Patricia] Univ Fed Rio Grande do Sul, Post Grad Program Physiol, BR-90550142 Porto Alegre, RS, Brazil.
   [Beck, Carlos A.; Muccillo, Marcelo] Univ Fed Rio Grande do Sul, Sch Vet Med, BR-90550142 Porto Alegre, RS, Brazil.
   [Mastella, Bernardo] Univ Fed Rio Grande do Sul, Sch Med, BR-90550142 Porto Alegre, RS, Brazil.
   [Zettler, Claudio Galleano] Fed Univ Hlth Sci Porto Alegre, Porto Alegre, RS, Brazil.
   [Pranke, Patricia] Stem Cell Res Inst, Porto Alegre, RS, Brazil.
RP Jotz, GP (reprint author), Univ Fed Rio Grande do Sul, Dept Morphol Sci, Rua Dom Pedro 2 891 Room 604, BR-90550142 Porto Alegre, RS, Brazil.
EM geraldo.jotz@terra.com.br
FU National Council for Scientific and Technological Development (CNPq);
   Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS); Stem Cell
   Research Institute
FX This work was supported by the National Council for Scientific and
   Technological Development (CNPq), Fundacao de Amparo a Pesquisa do Rio
   Grande do Sul (FAPERGS), and the Stem Cell Research Institute. The
   authors have no other funding, financial relationships, or conflicts of
   interest to disclose.
CR Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705
   Gustafson LM, 2001, ANN OTO RHINOL LARYN, V110, P16, DOI 10.1177/000348940111000103
   Hartley BEJ, 2000, CLIN OTOLARYNGOL, V25, P342, DOI 10.1046/j.1365-2273.2000.00399.x
   Inanc B, 2008, TISSUE ENG PT A, V14, P955, DOI [10.1089/ten.tea.2007.0213, 10.1089/tea.2007.0213]
   Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Lee KBL, 2012, ANN ACAD MED SINGAP, V41, P511
   Luisi SB, 2007, J ENDODONT, V33, P833, DOI 10.1016/j.joen.2007.04.002
   Martinod E, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-25
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Steffens D, 2013, J BIOMED NANOTECHNOL, V9, P710, DOI 10.1166/jbn.2013.1571
NR 14
TC 1
Z9 1
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD DEC
PY 2014
VL 124
IS 12
BP E455
EP E460
DI 10.1002/lary.24805
PG 6
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA AU0WZ
UT WOS:000345344200002
PM 24965085
DA 2018-10-20
ER

PT J
AU Zhu, S
   Diamond, SL
AF Zhu, Shu
   Diamond, Scott L.
TI Contact activation of blood coagulation on a defined kaolin/collagen
   surface in a microfluidic assay
SO THROMBOSIS RESEARCH
LA English
DT Article
DE Contact pathway; Kaolin; Microfluidics
ID FACTOR-XII; THROMBUS FORMATION; TISSUE FACTOR; IN-VIVO; PLASMA
   COAGULATION; INTRINSIC PATHWAY; COLLAGEN SURFACES; PLATELET-FUNCTION;
   FIBRIN FORMATION; P2 RECEPTORS
AB Generation of active Factor XII (FXIIa) triggers blood clotting on artificial surfaces and may also enhance intravascular thrombosis. We developed a patterned kaolin (0 to 0.3 pg/mu m(2))/type 1 collagen fibril surface for controlled microfluidic clotting assays. Perfusion of whole blood (treated only with a low level of 4 mu g/mL of the XIIa inhibitor, corn trypsin inhibitor) drove platelet deposition followed by fibrin formation. At venous wall shear rate (100 s(-1)), kaolin accelerated onset of fibrin formation by similar to 100 sec when compared to collagen alone (250 sec vs. 350 sec), with little effect on platelet deposition. Even with kaolin present, arterial wall shear rate (1000 s(-1)) delayed and suppressed fibrin formation compared to venous wall shear rate. A comparison of surfaces for extrinsic activation (tissue factor TF/collagen) versus contact activation (kaolin/collagen) that each generated equal platelet deposition at 100 s(-1) revealed: (1) TF surfaces promoted much faster fibrin onset (at 100 sec) and more endpoint fibrin at 600 sec at either 100 s(-1) or 1000 s(-1), and (2) kaolin and TF surfaces had a similar sensitivity for reduced fibrin deposition at 1000 s(-1) (compared to fibrin formed at 100 s(-1)) despite differing coagulation triggers. Anti-platelet drugs inhibiting P2Y(1), P2Y(12), cyclooxygenase-1 or activating IP-receptor or guanylate cyclase reduced platelet and fibrin deposition on kaolin/collagen. Since FXIIa or FXIa inhibition may offer safe antithrombotic therapy, especially for biomaterial thrombosis, these defined collagen/kaolin surfaces may prove useful in drug screening tests or in clinical diagnostic assays of blood under flow conditions. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhu, Shu; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.
RP Diamond, SL (reprint author), Univ Penn, Vagelos Res Labs 1024, Philadelphia, PA 19104 USA.
EM sld@seas.upenn.edu
FU NIH [R01 HL103419]
FX This study was performed through support of NIH R01 HL103419 (S.L.D.).
CR ALTMAN R, 1967, THROMB DIATH HAEMOST, V18, P525, DOI 10.1055/s-0038-1655061
   Blezer R, 1998, THROMB HAEMOSTASIS, V79, P296
   Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, P1
   Cheng QF, 2010, BLOOD, V116, P3981, DOI 10.1182/blood-2010-02-270918
   Citarella F, 1996, EUR J BIOCHEM, V238, P240, DOI 10.1111/j.1432-1033.1996.0240q.x
   Colace T, 2011, ANN BIOMED ENG, V39, P922, DOI 10.1007/s10439-010-0182-4
   Colace TV, 2014, J THROMB HAEMOST, V12, P147, DOI 10.1111/jth.12457
   Colace TV, 2013, ANNU REV BIOMED ENG, V15, P283, DOI 10.1146/annurev-bioeng-071812-152406
   Colace TV, 2012, ARTERIOSCL THROM VAS, V32, P1466, DOI 10.1161/ATVBAHA.112.249789
   Colace TV, 2011, BIOCONJUGATE CHEM, V22, P2104, DOI 10.1021/bc200326v
   Diaz CA, 2013, NANOSCALE, V5, P164, DOI 10.1039/c2nr32978f
   Flamm MH, 2012, BLOOD, V120, P190, DOI 10.1182/blood-2011-10-388140
   Franco F, 2004, J COLLOID INTERF SCI, V274, P107, DOI 10.1016/j.jcis.2003.12.003
   Gachet C, 2005, PHARMACOL THERAPEUT, V108, P180, DOI 10.1016/j.pharmthera.2005.03.009
   Hechler B, 2005, SEMIN THROMB HEMOST, V31, P150, DOI 10.1055/s-2005-869520
   Johansson PI, 2008, TRANSFUSION, V48, P2377, DOI 10.1111/j.1537-2995.2008.01846.x
   KAWABATA SI, 1988, EUR J BIOCHEM, V172, P17, DOI 10.1111/j.1432-1033.1988.tb13849.x
   Kuijpers MJE, 2014, ARTERIOSCL THROM VAS, V34, P1674, DOI 10.1161/ATVBAHA.114.303315
   Larsson M, 2014, SCI TRANSL MED, V6, P1
   Maloney SF, 2009, INTEGR BIOL, V2, P183
   Matafonov A, 2014, BLOOD, V123, P1739, DOI 10.1182/blood-2013-04-499111
   Meijers JC, 2014, BLOOD, V123, P1929
   Montfoort MLV, 2013, THROMB HAEMOSTASIS, V110, P223
   Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61
   Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x
   Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250
   RADOMSKI MW, 1992, BRIT J PHARMACOL, V107, P745, DOI 10.1111/j.1476-5381.1992.tb14517.x
   Renne T, 2006, BLOOD CELL MOL DIS, V36, P148, DOI 10.1016/j.bcmd.2005.12.014
   Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664
   Schroth BK, 1997, CLAY CLAY MINER, V45, P85, DOI 10.1346/CCMN.1997.0450110
   Smith JK, 1996, HAEMOPHILIA, V2, P128, DOI 10.1111/j.1365-2516.1996.tb00155.x
   Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x
   Stavrou E, 2010, THROMB RES, V125, P210, DOI 10.1016/j.thromres.2009.11.028
   Tremoli E, 1987, PROSTACYCLIN ITS STA, P47
   van der Meijden PEJ, 2009, BLOOD, V114, P881, DOI 10.1182/blood-2008-07-171066
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   WAGNER WR, 1990, J LAB CLIN MED, V116, P636
   WALSH PN, 1981, BLOOD, V57, P106
   Welsby IJ, 2006, J CARDIOTHOR VASC AN, V20, P531, DOI 10.1053/j.jvca.2005.04.013
   Welsh JD, 2012, J THROMB HAEMOST, V10, P2344, DOI 10.1111/j.1538-7836.2012.04928.x
   Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
NR 43
TC 20
Z9 20
U1 3
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD DEC
PY 2014
VL 134
IS 6
BP 1335
EP 1343
DI 10.1016/j.thromres.2014.09.030
PG 9
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AU3GJ
UT WOS:000345500100029
PM 25303860
OA Green Accepted
DA 2018-10-20
ER

PT J
AU McAndrews, KM
   Kim, MJ
   Lam, TY
   McGrail, DJ
   Dawson, MR
AF McAndrews, Kathleen M.
   Kim, Min Jeong
   Lam, Tuyet Y.
   McGrail, Daniel J.
   Dawson, Michelle R.
TI Architectural and Mechanical Cues Direct Mesenchymal Stem Cell
   Interactions with Crosslinked Gelatin Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID IN-VITRO; DIFFERENTIATION; BONE; GLUTARALDEHYDE; LINKING; MICROSCOPY;
   GROWTH; FATE; BETA; MICE
AB Naturally derived biomaterials have emerged as modulators of cell function and tissue substitutes. Here, we developed crosslinked glutaraldehyde (GTA) scaffolds for the expansion and differentiation of mesenchymal stem cells (MSCs). The mechanical and architectural properties of the scaffolds were altered by varying the concentration of gelatin and GTA. Higher GTA concentrations were associated with an increase in more confined pores and osteogenic differentiation. In addition, myogenic potential varied with crosslinking degree, although bulk mechanical properties were unaltered. Correlation analysis revealed that ALP activity of differentiated MSCs on higher gelatin concentration scaffolds was dependent on traditional effectors, including environment elasticity and spread area. In contrast, the differentiation capacity of cells cultured on lower gelatin concentration scaffolds did not correlate with these factors, instead it was dependent on the hydrated pore structure. These results suggest that scaffold composition can determine what factors direct differentiation and may have critical implications for biomaterial design.
C1 [McAndrews, Kathleen M.; Kim, Min Jeong; McGrail, Daniel J.; Dawson, Michelle R.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
   [Lam, Tuyet Y.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [Dawson, Michelle R.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Dawson, MR (reprint author), Georgia Inst Technol, Sch Chem & Biomol Engn, 311 Ferst Dr Northwest, Atlanta, GA 30332 USA.
EM mdawson@gatech.edu
FU National Science Foundation [1032527]; Emory/Georgia Tech Regenerative
   Engineering and Medicine Center; Atlanta Clinical and Translational
   Science Institute ACTSI; NIH Cell and Tissue Engineering Biotechnology
   Training Grant [TG GM08433]
FX The authors would like to acknowledge C. Ononye, D. Ghosh, and C. Kuo
   for preliminary work on these studies. Funding for this work was
   provided by the National Science Foundation (1032527) and Emory/Georgia
   Tech Regenerative Engineering and Medicine Center and the Atlanta
   Clinical and Translational Science Institute ACTSI. K.M. was supported
   by the NIH Cell and Tissue Engineering Biotechnology Training Grant (TG
   GM08433).
CR Abete T, 2013, POLYM COMPOSITE, V34, P259, DOI 10.1002/pc.22399
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   AVRAMEAS S, 1969, IMMUNOCHEMISTRY, V6, P53, DOI 10.1016/0019-2791(69)90178-5
   Banerjee I, 2009, INT J BIOMATER, DOI 10.1155/2009/143659
   Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Choi YS, 2012, BIOMATERIALS, V33, P6943, DOI 10.1016/j.biomaterials.2012.06.057
   Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Ghosh D, 2014, STEM CELLS DEV, V23, P245, DOI 10.1089/scd.2013.0240
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGrail DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033248
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Sun YY, 2012, J ELECTRON MATER, V41, P519, DOI 10.1007/s11664-011-1800-0
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Valentine MT, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061506
NR 33
TC 3
Z9 3
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
IS 23-24
BP 3252
EP 3260
DI 10.1089/ten.tea.2013.0753
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU8EO
UT WOS:000345829500015
PM 24873687
OA Green Published
DA 2018-10-20
ER

PT J
AU Akar, B
   Somo, S
   Tichauer, K
   Brey, E
AF Akar, B.
   Somo, S.
   Tichauer, K.
   Brey, E.
TI Imaging Growth Factor Gradients in Biomaterial Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Akar, B.; Somo, S.; Tichauer, K.; Brey, E.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-473
BP S107
EP S107
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300421
DA 2018-10-20
ER

PT J
AU Bracaglia, L
   Messina, M
   Fisher, JP
AF Bracaglia, L.
   Messina, M.
   Fisher, J. P.
TI A Hybrid Biomaterial for Drug Delivery in Cardiovascular Implants
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Bracaglia, L.; Messina, M.; Fisher, J. P.] Univ Maryland, College Pk, MD 20742 USA.
NR 0
TC 1
Z9 1
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-286
BP S82
EP S82
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300321
DA 2018-10-20
ER

PT J
AU Florczyk, SJ
   Juba, D
   Cardone, A
   Sarkar, S
   Chen, D
   Baker, PJ
   Bajcsy, P
   Brady, M
   Simon, CG
AF Florczyk, S. J.
   Juba, D.
   Cardone, A.
   Sarkar, S.
   Chen, D.
   Baker, P. J.
   Bajcsy, P.
   Brady, M.
   Simon, C. G., Jr.
TI Effect of Biomaterial Scaffolds on 3D Shape of Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Florczyk, S. J.; Sarkar, S.; Chen, D.; Baker, P. J.; Simon, C. G., Jr.] NIST, Biosyst & Biomat Div, Gaithersburg, MD 20899 USA.
   [Juba, D.; Cardone, A.; Bajcsy, P.; Brady, M.] NIST, Software & Syst Div, Gaithersburg, MD 20899 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-274
BP S81
EP S81
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300316
DA 2018-10-20
ER

PT J
AU Harris, JP
   Struzyna, LA
   Murphy, PL
   Cullen, DK
AF Harris, J. P.
   Struzyna, L. A.
   Murphy, P. L.
   Cullen, D. K.
TI Restoring Brain Circuitry Using Novel Biomaterial Strategies to
   Encapsulate Micro-Tissue Engineered Neural Networks
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Harris, J. P.; Struzyna, L. A.; Murphy, P. L.; Cullen, D. K.] Univ Penn, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA O-106
BP S9
EP S9
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300027
DA 2018-10-20
ER

PT J
AU Jeon, O
   Panicker, LM
   Feldman, RA
   Elisseeff, JH
AF Jeon, O.
   Panicker, L. M.
   Feldman, R. A.
   Elisseeff, J. H.
TI Engineering Bone Substitutes To Modulate Bone Homeostasis With
   Biomaterial Using Human Induced Pluripotent Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Jeon, O.; Elisseeff, J. H.] Johns Hopkins Univ, Baltimore, MD USA.
   [Panicker, L. M.; Feldman, R. A.] Univ Maryland Sch Med, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-600
BP S123
EP S123
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300484
DA 2018-10-20
ER

PT J
AU Kim, E
   Khang, G
AF Kim, E.
   Khang, G.
TI SILK: The Possible Biomaterial as a Equilibrium for Corneal Endothelium
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Kim, E.; Khang, G.] Chonbuk Natl Univ, Jeonju, South Korea.
RI Khang, Gilson/B-2109-2013
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-125
BP S60
EP S60
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300231
DA 2018-10-20
ER

PT J
AU Ramamoorthy, S
   Jacobson, R
   Malcovitch, J
   Bertucci, C
   Saunders, G
   Thompson, D
   Karande, P
AF Ramamoorthy, S.
   Jacobson, R.
   Malcovitch, J.
   Bertucci, C.
   Saunders, G.
   Thompson, D.
   Karande, P.
TI A High Throughput Combinatorial Biomaterial Screening Platform for
   Probing Cell Responses
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Ramamoorthy, S.; Bertucci, C.; Thompson, D.; Karande, P.] Rensselaer Polytech Inst, Troy, NY USA.
   [Jacobson, R.; Malcovitch, J.; Saunders, G.] Rensselaer Polytech Inst, Ctr Automat Technol & Syst, Troy, NY USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-168
BP S67
EP S67
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300258
DA 2018-10-20
ER

PT J
AU Singh, A
   Corvelli, M
   Elisseeff, J
AF Singh, A.
   Corvelli, M.
   Elisseeff, J.
TI Biomimetic Hyaluronic Acid Delivery And Lubrication On Tissue And
   Biomaterial Surfaces
SO TISSUE ENGINEERING PART A
LA English
DT Meeting Abstract
CT TERMIS-AM Conference
CY DEC 13-16, 2014
CL Washington, DC
SP TERMIS AM
C1 [Singh, A.; Corvelli, M.; Elisseeff, J.] Johns Hopkins Univ, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD DEC 1
PY 2014
VL 20
SU 1
MA P-712
BP S128
EP S128
PG 1
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AU6AK
UT WOS:000345684300503
DA 2018-10-20
ER

PT J
AU Liu, XD
   Zhou, B
   Feng, XL
   Cao, RB
   Chen, PY
AF Liu, Xiao-Dong
   Zhou, Bin
   Feng, Xiu-Li
   Cao, Rui-Bing
   Chen, Pu-Yan
TI BP8, a novel peptide from avian immune system, modulates B cell
   developments
SO AMINO ACIDS
LA English
DT Article
DE Bursal peptide (BP8); Immunomodulatory function; B cell development
ID DIFFERENTIATING HORMONE; ANTIBODY-PRODUCTION; CHICKEN BURSA;
   BONE-MARROW; FABRICIUS; PROLIFERATION; EXPRESSION; RESPONSES; LINEAGE;
   GENES
AB The bursa of Fabricius (BF) is the key humoral immune organ unique to birds, and is critical for early B-lymphocyte proliferation and differentiation. However, the molecular basis and mechanisms through which the BF regulates B cell development are not fully understood. In this study, we isolated and identified a new bursal peptide (BP8, AGHTKKAP) by RP-HPLC and MALDI-TOF-MS. BP8 promoted colony-forming pre-B formation, bound B cell precursor, regulated B cell development in vitro as well as in vivo, upstream of the EBF-E2A-Pax5 regulatory complex and increased immunoglobulin secretion. These data revealed a bursal-derived multifunctional factor BP8 as a novel biomaterial which is essential for the development of the immune system. This study elucidates further the mechanisms involved in humoral immune system and has implications in treating human diseases.
C1 [Liu, Xiao-Dong; Zhou, Bin; Feng, Xiu-Li; Cao, Rui-Bing; Chen, Pu-Yan] Nanjing Agr Univ, Div Key Lab Anim Dis Diag & Immunol, Chinas Dept Agr, Nanjing 210095, Jiangsu, Peoples R China.
   [Liu, Xiao-Dong] Qingdao Agr Univ, Coll Anim Sci & Vet Med, Qingdao 266109, Peoples R China.
RP Chen, PY (reprint author), Nanjing Agr Univ, Div Key Lab Anim Dis Diag & Immunol, Chinas Dept Agr, Nanjing 210095, Jiangsu, Peoples R China.
EM puyanchennj@163.com
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD); National Special Research Programs for Non-profit
   Trades, Ministry of Agriculture [200803015]; international S&T
   Cooperation Program of China (ISTCP) [2014DFR30980]
FX This work was supported by the project funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   National Special Research Programs for Non-profit Trades, Ministry of
   Agriculture (No. 200803015) and international S&T Cooperation Program of
   China (ISTCP) (No. 2014DFR30980). The funders had no role in the study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript. We are grateful to the Life Sciences
   Institute of Nanjing Agricultural University for providing RP-HPLC
   facilities and to the Institute of Biochemistry and Cell Biology, SIBS,
   CAS for providing mass spectrometric analysis.
CR ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
   AUDHYA T, 1986, SCIENCE, V231, P997, DOI 10.1126/science.3484838
   BABA T, 1977, IMMUNOLOGY, V32, P271
   BRAND A, 1976, SCIENCE, V193, P319, DOI 10.1126/science.180600
   COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75
   Feng XL, 2012, AMINO ACIDS, V42, P2215, DOI 10.1007/s00726-011-0961-8
   Feng XL, 2011, PEPTIDES, V32, P1103, DOI 10.1016/j.peptides.2011.04.020
   Feng XL, 2010, PEPTIDES, V31, P1562, DOI 10.1016/j.peptides.2010.05.007
   FINE JS, 1994, EXP HEMATOL, V22, P1188
   Fred D, 2011, AVIAN IMMUNOLOGY
   Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504
   GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224
   Hagman J, 2005, TRENDS IMMUNOL, V26, P455, DOI 10.1016/j.it.2005.07.001
   Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595
   HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213
   LASSILA O, 1989, CELL IMMUNOL, V122, P319, DOI 10.1016/0008-8749(89)90080-4
   Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1
   Li DY, 2011, AMINO ACIDS, V40, P505, DOI 10.1007/s00726-010-0663-7
   LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951
   LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0
   Liu XD, 2012, PEPTIDES, V35, P107, DOI 10.1016/j.peptides.2012.03.003
   LYDYARD PM, 1976, J EXP MED, V144, P79, DOI 10.1084/jem.144.1.79
   Moore RW, 2003, COMP BIOCHEM PHYS C, V134, P291, DOI 10.1016/S1532-0456(02)00208-9
   MURTHY KK, 1992, POULTRY SCI, V71, P311, DOI 10.3382/ps.0710311
   Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319
   Oveissi S, 2010, COMP IMMUNOL MICROB, V33, P491, DOI 10.1016/j.cimid.2009.08.004
   Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498
   Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464
NR 28
TC 2
Z9 3
U1 0
U2 7
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0939-4451
EI 1438-2199
J9 AMINO ACIDS
JI Amino Acids
PD DEC
PY 2014
VL 46
IS 12
BP 2705
EP 2713
DI 10.1007/s00726-014-1824-x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AT6TW
UT WOS:000345073100007
PM 25168247
DA 2018-10-20
ER

PT J
AU Osman, RB
   Swain, MV
   Atieh, M
   Ma, SY
   Duncan, W
AF Osman, Reham B.
   Swain, Michael V.
   Atieh, Momen
   Ma, Sunyoung
   Duncan, Warwick
TI Ceramic implants (Y-TZP): are they a viable alternative to titanium
   implants for the support of overdentures? A randomized clinical trial
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE implants; mandibular overdentures; maxillary; titanium; zirconia
ID ZIRCONIA DENTAL IMPLANTS; CRYSTAL SAPPHIRE IMPLANTS;
   FINITE-ELEMENT-ANALYSIS; OSSEOINTEGRATED ORAL IMPLANTS; DIFFERENT ROUGH
   SURFACES; OF-THE-LITERATURE; LONG-TERM; MANDIBULAR OVERDENTURES;
   MAXILLARY OVERDENTURES; RETROSPECTIVE ANALYSIS
AB Objective: The objective of this study was to assess 1-year clinical success of one-piece zirconia implants compared with similar-design titanium implants, in the context of a novel protocol for implant distribution.
   Materials and Methods: Twenty-four edentulous participants were randomly allocated to one-piece titanium or zirconia implant group. Each participant received four implants in the maxilla (mid-palatal and three anterior crestal implants) and three implants in the mandible (mid-symphyseal and two bilateral distal implants). Conventional loading protocol was followed. Marginal bone remodeling and clinical success of implants were evaluated. The data were statistically analyzed, and risk predictors for implant failures were evaluated.
   Results: There was no significant difference in the survival rate between the two groups. In the mandible, the survival rate of titanium implants was 95.8% vs. 90.9% for the zirconia implants. The corresponding values in the maxilla were 71.9% and 55%, respectively. Three implants in the zirconia group fractured. Statistically significant less marginal bone loss was observed around titanium implants (0.18 mm) compared with the zirconia group (0.42 mm). The prediction model revealed a higher risk for implant failures in the maxilla (P < 0.0001).
   Conclusion: The outcome of this study indicates caution before recommendation can be made for the use of single-piece zirconia implants for overdenture support. Their use should be limited to cases with proven allergy to titanium. This is mainly due to the increased bone loss and higher fracture rate observed for zirconia implants. Future biomaterial research should focus on producing surface characteristics on zirconia implants with outcomes similar to those established for the optimum osseointegration of titanium implants.
C1 [Osman, Reham B.] Cairo Univ, Fac Dent, Cairo, Egypt.
   [Swain, Michael V.; Atieh, Momen; Ma, Sunyoung; Duncan, Warwick] Univ Otago, Sir John Walsh Res Inst, Sch Dent, Oral Implantol Res Grp, Dunedin, New Zealand.
RP Osman, RB (reprint author), Univ Otago, Sir John Walsh Res Inst, Sch Dent, 280 Great King St, Dunedin, New Zealand.
EM rehambosman@gmail.com
RI Swain, Michael/J-7266-2017; Duncan, Warwick/S-2126-2016
OI Duncan, Warwick/0000-0002-5412-0089; Atieh, Momen/0000-0003-4019-9491
CR Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   Albrektsson T, 1993, Int J Prosthodont, V6, P95
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P544
   Albrektsson T, 2004, INT J PROSTHODONT, V17, P536
   Albrektsson T, 2007, CLIN IMPLANT DENT R, V9, P65, DOI 10.1111/j.1708-8208.2007.00054.x
   Alsabeeha NHM, 2011, CLIN ORAL IMPLAN RES, V22, P330, DOI 10.1111/j.1600-0501.2010.02004.x
   Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Arvidson K, 1991, CLIN ORAL IMPLAN RES, V2, P47, DOI 10.1034/j.1600-0501.1991.020201.x
   Asscherickx K, 2010, AM J ORTHOD DENTOFAC, V137, P114, DOI 10.1016/j.ajodo.2008.02.022
   Attard NJ, 2004, INT J PROSTHODONT, V17, P425
   Berge TI, 2000, CLIN ORAL IMPLAN RES, V11, P154, DOI 10.1034/j.1600-0501.2000.011002154.x
   Borgonovo A E, 2010, Minerva Stomatol, V59, P381
   Bryant R.S., 1998, INT J PROSTHODONT, V11, P470
   Cannizzaro G, 2010, EUR J ORAL IMPLANTOL, V3, P111
   Carr A. B., 2005, MCCRACKENS REMOVABLE, P25
   Chan MFWY, 1998, INT J PROSTHODONT, V11, P7
   Cune MS, 1996, J CLIN PERIODONTOL, V23, P425, DOI 10.1111/j.1600-051X.1996.tb00569.x
   das Neves FD, 2006, INT J ORAL MAX IMPL, V21, P86
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Depprich R, 2014, CLIN IMPLANT DENT R, V16, P124, DOI 10.1111/j.1708-8208.2012.00454.x
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Drago C J, 1992, J Prosthodont, V1, P29, DOI 10.1111/j.1532-849X.1992.tb00423.x
   Ekfeldt A, 2001, CLIN ORAL IMPLAN RES, V12, P462, DOI 10.1034/j.1600-0501.2001.120505.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   FARTASH B, 1995, CLIN ORAL IMPLAN RES, V6, P181, DOI 10.1034/j.1600-0501.1995.060307.x
   Fartash B, 1996, CLIN ORAL IMPLAN RES, V7, P220, DOI 10.1034/j.1600-0501.1996.070304.x
   Fartash B, 1990, CLIN ORAL IMPLAN RES, V1, P13, DOI 10.1034/j.1600-0501.1990.010103.x
   Finne K, 2007, J PROSTHET DENT, V97, pS79, DOI 10.1016/S0022-3913(07)60011-0
   Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049
   Fugazzotto PA, 2008, INT J ORAL MAX IMPL, V23, P487
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gahlert M, 2012, CLIN ORAL IMPLAN RES, V23, P287, DOI 10.1111/j.1600-0501.2011.02206.x
   Gahlert M, 2009, CLIN ORAL IMPLAN RES, V20, P1247, DOI 10.1111/j.1600-0501.2009.01734.x
   Griffin TJ, 2004, J PROSTHET DENT, V92, P139, DOI 10.1016/j.prosdent.2004.05.010
   Hahn Jack A, 2007, J Oral Implantol, V33, P152, DOI 10.1563/1548-1336(2007)33[152:CAREOO]2.0.CO;2
   Himmlova L, 2004, J PROSTHET DENT, V91, P20, DOI 10.1016/j.prosdent.2003.08.008
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hoffmann O, 2008, INT J ORAL MAX IMPL, V23, P691
   Johns R B, 1992, Int J Oral Maxillofac Implants, V7, P513
   Jung BA, 2012, CLIN ORAL IMPLAN RES, V23, P746, DOI 10.1111/j.1600-0501.2011.02197.x
   Kohal RJ, 2008, PERIODONTOL 2000, V47, P224, DOI 10.1111/j.1600-0757.2007.00243.x
   Kohal RJ, 2012, J CLIN PERIODONTOL, V39, P590, DOI 10.1111/j.1600-051X.2012.01876.x
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Kohal RJ, 2002, INT J PROSTHODONT, V15, P189
   KOTH DL, 1988, J PROSTHET DENT, V60, P226, DOI 10.1016/0022-3913(88)90321-6
   Kotsovilis S, 2009, J PERIODONTOL, V80, P1700, DOI 10.1902/jop.2009.090107
   Lambrich M, 2008, Z ZAHNARZTLICHE IMPL, V24, P182
   Lee JH, 2005, J PROSTHET DENT, V94, P377, DOI 10.1016/j.prosdent.2005.04.018
   Lekholm U, 1998, J PROSTHET DENT, V79, P43, DOI 10.1016/S0022-3913(98)70192-1
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X
   Lindhe J, 2013, CLIN ORAL IMPLAN RES, V24, P372, DOI 10.1111/clr.12064
   Malo P, 2007, CLIN IMPLANT DENT R, V9, P15, DOI 10.1111/j.1708-8208.2006.00027.x
   MCKINNEY RV, 1982, J PROSTHET DENT, V47, P69, DOI 10.1016/0022-3913(82)90245-1
   MEIJER HJA, 1992, J PROSTHET DENT, V68, P96, DOI 10.1016/0022-3913(92)90293-J
   Mellinghoft J, 2006, Z ZAHNARZTL IMPLANTO, V22, P288
   Mertens C, 2012, INT J ORAL MAX IMPL, V27, P1501
   Misch CE, 2006, J PERIODONTOL, V77, P1340, DOI 10.1902/jop.2006.050402
   Moher David, 2003, Clin Oral Investig, V7, P2
   Moy PK, 2005, INT J ORAL MAX IMPL, V20, P569
   Neldam CA, 2012, CLIN IMPLANT DENT R, V14, P622, DOI 10.1111/j.1708-8208.2010.00303.x
   Nowzari H, 2006, CLIN IMPLANT DENT R, V8, P1, DOI 10.2310/6480.2005.00034
   Oh TJ, 2002, J PERIODONTOL, V73, P322, DOI 10.1902/jop.2002.73.3.322
   Oliva J, 2007, INT J ORAL MAX IMPL, V22, P430
   Oliva J, 2010, INT J ORAL MAX IMPL, V25, P336
   Osman RB, 2013, INT J ORAL MAX IMPL, V28, pE198, DOI 10.11607/jomi.3019
   Osman RB, 2013, INT J PROSTHODONT, V26, P277, DOI 10.11607/ijp.2903
   Osman RB, 2013, CLIN ORAL IMPLAN RES, V24, P592, DOI 10.1111/j.1600-0501.2011.02411.x
   Osman RB, 2013, INT J ORAL MAX IMPL, V28, pE1, DOI 10.11607/jomi.2303
   Ostman PO, 2007, CLIN ORAL IMPLAN RES, V18, P409, DOI 10.1111/j.1600-0501.2007.01346.x
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Payer M, 2013, CLIN ORAL IMPLAN RES, V24, P569, DOI 10.1111/j.1600-0501.2012.02425.x
   Payne AG, 2013, PROSTHODONTIC TREATM, P330
   Payne AGT, 2002, CLIN ORAL IMPLAN RES, V13, P603, DOI 10.1034/j.1600-0501.2002.130605.x
   Payne AGT, 1999, CLIN ORAL IMPLAN RES, V10, P307, DOI 10.1034/j.1600-0501.1999.100407.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pierrisnard Laurent, 2003, Clin Implant Dent Relat Res, V5, P254, DOI 10.1111/j.1708-8208.2003.tb00208.x
   Pirker W, 2009, INT J ORAL MAX SURG, V38, P1127, DOI 10.1016/j.ijom.2009.07.008
   Prithviraj DR, 2013, J PROSTHODONT, V22, P237, DOI 10.1111/j.1532-849X.2012.00928.x
   Rangert B, 1995, Int J Oral Maxillofac Implants, V10, P326
   Renouard F, 2006, CLIN ORAL IMPLAN RES, V17, P35, DOI 10.1111/j.1600-0501.2006.01349.x
   Ross J., 1997, INT J ORAL MAXILLOF, V12, P504
   Schwartz-Arad D, 2005, J PERIODONTOL, V76, P1431, DOI 10.1902/jop.2005.76.9.1431
   SENNERBY L, 1992, International Journal of Oral and Maxillofacial Implants, V7, P62
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, pS13, DOI 10.1111/j.1708-8208.2005.tb00070.x
   Sennerby L, 2008, CLIN ORAL IMPLAN RES, V19, P219, DOI 10.1111/j.1600-0501.2007.01410.x
   Siddiqi A, 2014, CLIN ORAL IMPLAN RES, V25, P101, DOI 10.1111/clr.12050
   Siepenkothen T, 2007, J PROSTHET DENT, V97, pS69, DOI 10.1016/S0022-3913(07)60010-9
   Srinivasan M, 2012, INT J ORAL MAX IMPL, V27, P1429
   Tagger Green N., 2002, IMPLANT DENT, V11, P137, DOI DOI 10.1097/00008505-200204000-00014
   Tawse-Smith A, 2001, Clin Implant Dent Relat Res, V3, P185, DOI 10.1111/j.1708-8208.2001.tb00140.x
   Truhlar RS, 1997, J ORAL MAXIL SURG, V55, P46, DOI 10.1016/S0278-2391(16)31197-1
   Van de Velde T, 2009, CLIN IMPLANT DENT R, V11, P183, DOI 10.1111/j.1708-8208.2008.00112.x
   VonRecum A., 1986, HDB BIOMATERIAL EVAL
   Wennerberg A., 2009, INT J ORAL MAXILLOF, V24, P63
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Winkler S, 2000, Ann Periodontol, V5, P22, DOI 10.1902/annals.2000.5.1.22
   Wiskott HWA, 1999, CLIN ORAL IMPLAN RES, V10, P429, DOI 10.1034/j.1600-0501.1999.100601.x
   Zarb G. A., 2013, PROSTHODONTIC TREATM
NR 101
TC 21
Z9 24
U1 3
U2 15
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD DEC
PY 2014
VL 25
IS 12
BP 1366
EP 1377
DI 10.1111/clr.12272
PG 12
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AT7ZF
UT WOS:000345152600007
PM 24118368
DA 2018-10-20
ER

PT J
AU Dewidar, M
   Adamek, G
   Jakubowicz, J
   Khalil, KA
AF Dewidar, Montasser
   Adamek, G.
   Jakubowicz, J.
   Khalil, Khalil AbdelRazik
TI Fabrication, Microstructure and Properties of Mechanically Alloyed and
   Electrochemically Etched Porous Ti-Y2O3
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Mechanical alloying; Nanocomposite; Mechanical properties; Corrosion
AB In this study the formation of porous Ti-10wt.% Y2O3 nanostructure biomaterial was described. After high-energy ball milling of a Ti-Y2O3 for 24 h, powder mixture was pressed and sintered to consolidate the granules. Mechanically alloyed Ti-Y2O3 has nanostructure with grain size in the range of 150 nm and large grain boundaries volume fraction, which essentially to improve etching process. The sintered compacts were electrochemically etched in a mixture of H3PO4 and HF electrolyte at 10 V for 25 min. The electrolyte penetrates sintered samples through the grain boundaries, resulting in effective material removing and pores formation. The pore diameter reaches up to 50 mu m, which is very attractive for strong bonding with bone. The ultra low grain size structure improves mechanical properties of the implants in comparison to commonly used microcrystalline Ti-based implants. The corrosion properties were investigated in Ringer's solution. Mechanically alloyed samples followed by electrochemical etching shows good corrosion resistance.
C1 [Dewidar, Montasser; Khalil, Khalil AbdelRazik] Aswan Univ, Fac Energy Engn, Dept Mat & Mech Design, Aswan, Egypt.
   [Adamek, G.; Jakubowicz, J.] Poznan Univ Tech, Inst Mat Sci & Engn, PL-60965 Poznan, Poland.
   [Khalil, Khalil AbdelRazik] King Saud Univ, Coll Engn, Dept Mech Engn, Riyadh 11421, Saudi Arabia.
RP Dewidar, M (reprint author), Aswan Univ, Fac Energy Engn, Dept Mat & Mech Design, Aswan, Egypt.
EM kabdelmawgoud@KSU.EDU.SA
RI Jakubowicz, Jaroslaw/F-7836-2014; Abdelmawgoud, Khalil/C-2656-2012
OI Jakubowicz, Jaroslaw/0000-0001-6339-0796; Abdelmawgoud,
   Khalil/0000-0001-7965-5779
FU Deanship of Scientific Research at King Saud University [RG 1435-001]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for its funding
   this Research Group NO. (RG 1435-001)
CR Adamek G, 2010, MATER CHEM PHYS, V124, P1198, DOI 10.1016/j.matchemphys.2010.08.057
   Adamopoulos O, 2007, J MATER SCI-MATER M, V18, P1587, DOI 10.1007/s10856-007-3041-6
   Amini R, 2009, J MATER SCI, V44, P136, DOI 10.1007/s10853-008-3117-9
   Bhattarai S.R., 2007, J BIOMEDICAL MAT R A, V86A, P289
   Danie J., 2011, ACTA MAT, V59, P640
   Dewidar M, 2010, MATER DESIGN, V31, P3964, DOI 10.1016/j.matdes.2010.03.042
   Handtrack D, 2006, MAT SCI ENG A-STRUCT, V437, P423, DOI 10.1016/j.msea.2006.07.143
   Hu RH, 2007, J MATER SCI TECHNOL, V23, P257
   Jakubowicz J, 2008, ELECTROCHEM COMMUN, V10, P735, DOI 10.1016/j.elecom.2008.02.027
   Jakubowicz J, 2009, ELECTROCHEM COMMUN, V11, P1772, DOI 10.1016/j.elecom.2009.07.014
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Narayanan R, 2007, CORROS SCI, V49, P542, DOI 10.1016/j.corsci.2006.06.021
   Niespodziana K, 2010, MATER CHEM PHYS, V123, P160, DOI 10.1016/j.matchemphys.2010.03.076
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
NR 18
TC 1
Z9 1
U1 0
U2 18
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD DEC
PY 2014
VL 9
IS 12
BP 7773
EP 7783
PG 11
WC Electrochemistry
SC Electrochemistry
GA AT9QR
UT WOS:000345261900083
DA 2018-10-20
ER

PT J
AU Guo, T
   Li, Y
   Cao, G
   Zhang, Z
   Chang, S
   Czajka-Jakubowska, A
   Nor, JE
   Clarkson, BH
   Liu, J
AF Guo, T.
   Li, Y.
   Cao, G.
   Zhang, Z.
   Chang, S.
   Czajka-Jakubowska, A.
   Noer, J. E.
   Clarkson, B. H.
   Liu, J.
TI Fluorapatite-modified Scaffold on Dental Pulp Stem Cell Mineralization
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE odontogenesis; osteogenesis; biomaterial(s); cell differentiation;
   nanofibers; tissue engineering
ID IN-VITRO; ODONTOGENIC DIFFERENTIATION; TISSUE; GROWTH; VIVO;
   MORPHOGENESIS; REGENERATION; SURFACES
AB In previous studies, fluorapatite (FA) crystal-coated surfaces have been shown to stimulate the differentiation and mineralization of human dental pulp stem cells (DPSCs) in two-dimensional cell culture. However, whether the FA surface can recapitulate these properties in three-dimensional culture is still unknown. This study examined the differences in behavior of human DPSCs cultured on electrospun polycaprolactone (PCL) NanoECM nanofibers with or without the FA crystals. Under near-physiologic conditions, the FA crystals were synthesized on the PCL nanofiber scaffolds. The FA crystals were evenly distributed on the scaffolds. DPSCs were cultured on the PCL+FA or the PCL scaffolds for up to 28 days. Scanning electron microscope images showed that DPSCs attached well to both scaffolds after the initial seeding. However, it appeared that more multicellular aggregates formed on the PCL+FA scaffolds. After 14 days, the cell proliferation on the PCL+FA was slower than that on the PCL-only scaffolds. Interestingly, even without any induction of mineralization, from day 7, the upregulation of several pro-osteogenic molecules (dmp1, dspp, runx2, ocn, spp1, col1a1) was detected in cells seeded on the PCL+FA scaffolds. A significant increase in alkaline phosphatase activity was also seen on FA-coated scaffolds compared with the PCL-only scaffolds at days 14 and 21. At the protein level, osteocalcin expression was induced only in the DPSCs on the PCL+FA surfaces at day 21 and then significantly enhanced at day 28. A similar pattern was observed in those specimens stained with Alizarin red and Von Kossa after 21 and 28 days. These data suggest that the incorporation of FA crystals within the three-dimensional PCL nanofiber scaffolds provided a favorable extracellular matrix microenvironment for the growth, differentiation, and mineralization of human DPSCs. This FA-modified PCL nanofiber scaffold shows promising potential for future bone, dental, and orthopedic regenerative applications.
C1 [Guo, T.; Li, Y.; Zhang, Z.; Chang, S.; Noer, J. E.; Clarkson, B. H.; Liu, J.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.
   [Guo, T.; Cao, G.] Nanjing Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China.
   [Li, Y.] Fourth Mil Med Univ, Sch Stomatol, State Key Lab Mil Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Shaanxi, Peoples R China.
   [Czajka-Jakubowska, A.] Poznan Univ Med Sci, Dept Maxillofacial Orthoped & Orthodont, Poznan, Poland.
RP Liu, J (reprint author), Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.
EM junlc@umich.edu
FU Department of Cariology, Restorative Sciences, and Endodontics at the
   University of Michigan, School of Dentistry
FX The authors thank Dr. Haifeng Chen (College of Engineering, Peking
   University, China) for his technical guidance on fluorapatite synthesis
   at near-physiologic conditions. This work was supported by the
   Department of Cariology, Restorative Sciences, and Endodontics at the
   University of Michigan, School of Dentistry. The authors declare no
   potential conflicts of interest with respect to the authorship and/or
   publication of this article.
CR Antebi B, 2013, TISSUE ENG PART C-ME, V19, P487, DOI [10.1089/ten.tec.2012.0452, 10.1089/ten.TEC.2012.0452]
   Chang MC, 2013, J ENDODONT, V39, P1272, DOI 10.1016/j.joen.2013.06.003
   Chen HF, 2006, CRYST GROWTH DES, V6, P1504, DOI 10.1021/cg0600086
   Clark D, 2014, J BIOMED MAT RES A
   Czajka-Jakubowska A, 2009, MED SCI MONITOR, V15, pMT84
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   Dong YX, 2009, TISSUE ENG PART B-RE, V15, P333, DOI [10.1089/ten.teb.2008.0619, 10.1089/ten.TEB.2008.0619]
   Dreesmann L, 2009, EUR J CELL BIOL, V88, P285, DOI 10.1016/j.ejcb.2009.01.001
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Iohara K, 2014, EXP GERONTOL, V52, P39, DOI 10.1016/j.exger.2014.01.020
   Kim JJ, 2014, J BIOMATER APPL, V28, P1069, DOI 10.1177/0885328213495903
   Kinney MA, 2014, ANN BIOMED ENG, V42, P352, DOI 10.1007/s10439-013-0953-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04446
   Lin LW, 2009, J BIOMED MATER RES A, V89A, P326, DOI 10.1002/jbm.a.31994
   Liu J, 2012, BIOMATERIALS, V33, P5036, DOI 10.1016/j.biomaterials.2012.03.050
   Liu J, 2010, TISSUE ENG PT A, V16, P2977, DOI [10.1089/ten.tea.2009.0632, 10.1089/ten.TEA.2009.0632]
   Polykandriotis E, 2010, J CELL MOL MED, V14, P2350, DOI 10.1111/j.1582-4934.2010.01169.x
   Qu T, 2014, TISSUE ENG A
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Wang XD, 2014, TISSUE ENG PT A, V20, P12, DOI [10.1089/ten.TEA.2013.0113, 10.1089/ten.tea.2013.0113]
   Wang XD, 2012, TISSUE ENG PART C-ME, V18, P821, DOI [10.1089/ten.tec.2011.0624, 10.1089/ten.TEC.2011.0624]
   Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535
   Yin Y, 2009, CHEM COMMUN, V39, P5892
   Zhang WB, 2008, J TISSUE ENG REGEN M, V2, P117, DOI 10.1002/term.71
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 29
TC 8
Z9 8
U1 2
U2 21
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2014
VL 93
IS 12
SI SI
BP 1290
EP 1295
DI 10.1177/0022034514547914
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AU0UN
UT WOS:000345340400016
PM 25139361
OA Green Published
DA 2018-10-20
ER

PT J
AU Park, CH
   Kim, KH
   Rios, HF
   Lee, YM
   Giannobile, WV
   Seol, YJ
AF Park, C. H.
   Kim, K. H.
   Rios, H. F.
   Lee, Y. M.
   Giannobile, W. V.
   Seol, Y. J.
TI Spatiotemporally Controlled Microchannels of Periodontal Mimic Scaffolds
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biomaterials; periodontal ligament; regenerative medicine; tissue
   engineering; freeze casting; bioengineering
ID MICRO-COMPUTED-TOMOGRAPHY; FIBER-GUIDING SCAFFOLDS; TISSUE INTERFACES;
   POLYMER SCAFFOLDS; BONE INGROWTH; STEM-CELLS; LIGAMENT; REGENERATION;
   COMPLEX; BIOMATERIALS
AB Physiologic bioengineering of the oral, dental, and craniofacial complex requires optimized geometric organizations of fibrous connective tissues. A computer-designed, fiber-guiding scaffold has been developed to promote tooth-supporting periodontal tissue regeneration and functional restoration despite limited printing resolution for the manufacture of submicron-scaled features. Here, we demonstrate the use of directional freeze-casting techniques to control pore directional angulations and create mimicked topographies to alveolar crest, horizontal, oblique, and apical fibers of natural periodontal ligaments. For the differing anatomic positions, the gelatin displayed varying patterns of ice growth, determined via internal pore architectures. Regardless of the freezing coordinates, the longitudinal pore arrangements resulted in submicron-scaled diameters (similar to 50 mu m), along with corresponding high biomaterial porosity (similar to 90%). Furthermore, the horizontal + coronal ((x) over right arrow-(y) over right arrow) freezing orientation facilitated the creation of similar structures to major fibers in the periodontal ligament interface. This periodontal tissue-mimicking microenvironment is a potential tissue platform for the generation of naturally oriented ligamentous tissues consistent with periodontal ligament neogenesis.
C1 [Park, C. H.; Kim, K. H.; Lee, Y. M.; Seol, Y. J.] Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Periodontol, Seoul, South Korea.
   [Park, C. H.] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Park, C. H.] Dankook Univ, PLUS NBM Global Res Ctr Regenerat Med BK21, Cheonan, South Korea.
   [Park, C. H.] Dankook Univ, Inst Tissue Regenerat Engn, Cheonan, South Korea.
   [Rios, H. F.; Giannobile, W. V.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
   [Giannobile, W. V.] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Seol, YJ (reprint author), Seoul Natl Univ, Sch Dent, Dent Res Inst, Dept Periodontol, Seoul, South Korea.
EM yjseol@snu.ac.kr
OI Giannobile, William/0000-0002-7102-9746
FU Ministry of Health & Welfare, Republic of Korea [HI12C0985]; Korea
   Science and Technology Foundation [2013036438]; National Institutes of
   Health/National Institute of Dental and Craniofacial Research [DE 13397]
FX This study was supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (HI12C0985)
   (Y.J.S.); by the Korea Science and Technology Foundation
   Nanobiotechnology Development Program entitled Regenomics (2013036438)
   (Y.J.S.); and by the National Institutes of Health/National Institute of
   Dental and Craniofacial Research (DE 13397) (W.V.G.). The authors
   declare no potential conflicts of interest with respect to the
   authorship and/or publication of this article.
CR Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   BERKOVITZ BKB, 1990, EUR J ORTHODONT, V12, P51, DOI 10.1093/ejo/12.1.51
   Burdick JA, 2009, NATURE, V460, P469, DOI 10.1038/460469a
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2121, DOI 10.1007/s10439-010-0033-3
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho SP, 2010, BIOMATERIALS, V31, P6635, DOI 10.1016/j.biomaterials.2010.05.024
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hughes FJ, 2010, P I MECH ENG H, V224, P1345, DOI 10.1243/09544119JEIM820
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Jones AC, 2004, J MATER SCI-MATER M, V15, P529, DOI 10.1023/B:JMSM.0000021133.48661.62
   Jones AC, 2004, BIOMATERIALS, V25, P4947, DOI 10.1016/j.biomatcrials.2004.01.047
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Li WL, 2012, INT MATER REV, V57, P37, DOI 10.1179/1743280411Y.0000000011
   Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922
   Mendes PM, 2013, CHEM SOC REV, V42, P9207, DOI 10.1039/c3cs60198f
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Pagni G, 2012, ADV DRUG DELIVER REV, V64, P1310, DOI 10.1016/j.addr.2012.03.005
   Park CH, 2014, TISSUE ENG PART C-ME, V20, P533, DOI [10.1089/ten.tec.2013.0619, 10.1089/ten.TEC.2013.0619]
   Park CH, 2012, BIOMATERIALS, V33, P137, DOI 10.1016/j.biomaterials.2011.09.057
   Park CH, 2010, BIOMATERIALS, V31, P5945, DOI 10.1016/j.biomaterials.2010.04.027
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Poiate IAVP, 2009, J PERIODONTOL, V80, P1859, DOI 10.1902/jop.2009.090220
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Vaquette C, 2012, BIOMATERIALS, V33, P5560, DOI 10.1016/j.biomaterials.2012.04.038
   Waschkies T, 2011, ACTA MATER, V59, P5135, DOI 10.1016/j.actamat.2011.04.046
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613
NR 35
TC 15
Z9 16
U1 4
U2 19
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2014
VL 93
IS 12
SI SI
BP 1304
EP 1312
DI 10.1177/0022034514550716
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AU0UN
UT WOS:000345340400018
PM 25216511
OA Green Published
DA 2018-10-20
ER

PT J
AU Calenic, B
   Paun, IA
   van Staden, RI
   Didilescu, A
   Petre, A
   Dinescu, M
   Greabu, M
AF Calenic, B.
   Paun, I. A.
   van Staden, R. I.
   Didilescu, A.
   Petre, A.
   Dinescu, M.
   Greabu, M.
TI Novel method for proliferation of oral keratinocyte stem cells
SO JOURNAL OF PERIODONTAL RESEARCH
LA English
DT Article
DE biopolymer; oral keratinocyte; stem cell; tissue engineering
ID DISORDERED NANOTOPOGRAPHY; DIFFERENTIATION; ORGANIZATION; EPITHELIUM;
   MUCOSA; CANCER; SKIN
AB Background and ObjectiveStem cell-based tissue engineering offers clear advantages over conventional normal cell approaches. Owing to their specific characteristics, oral keratinocyte stem cells represent an attractive solution for therapeutic applications. However, when cultured in vitro, these cells lose their unique properties, acquiring a limited capacity for self-renewal, and differentiate rapidly into normal functional keratinocytes. The main aim of the present study was to develop an in-vitro method for the expansion of oral keratinocyte stem cells using a biomaterial approach.
   Material and MethodsOral keratinocyte stem cells were isolated based on the identification of two surface markers - integrin 64 and CD71 - using a magnetic method. The cells were cultured on specific substrates formed from blends of polymers: poly(lactide-co-glycolide) (PLGA); poly(lactide-co-glycolide)+polyurethane (PLGA+PU); and poly(lactide-co-glycolide)+extracellular matrix (PLGA+ECM). The polymers were deposited using a laser-based technique - matrix-assisted pulsed laser evaporation. The cells were analyzed for cell size, cell proliferation, colony-forming efficiency, cell adhesion markers (such as E-cadherin and beta 1 integrin), keratinocyte stem cells and differentiation markers. The methods included ELISAs, immunofluorescence and atomic force microscopy imaging.
   ResultsAfter 14d in culture, cells seeded on PLGA+PU stained positive for p63, cd44H, cytokeratin 19 and integrin 64 and negative for involucrin, cytokeratin 14 and cytokeratin 10. The levels of adhesion molecules were significantly increased in cells grown on PLGA+PU: at 14d the E-cadherin levels were 5.40.2ng/mL (for cells grown on PLGA+PU) vs. 4.1 +/- 0.4ng/mL (for cells grown on control medium) (n=5, p<0.05 Bonferroni). Oral keratinocyte stem cells grown on PLGA+PU had the highest colony-forming efficiency and proliferation rate, together with the smallest cell size, compared with cells grown on control medium or other polymeric substrates.
   ConclusionThe present study demonstrates that by culturing oral keratinocyte stem cells on PLGA blended with PU it is possible to preserve their phenotype in vitro and to guide their short-term expansion and proliferation. Certain stem-cell characteristics are preserved and their short-term expansion may be enhanced.
C1 [Calenic, B.; Greabu, M.] Univ Med & Pharm Carol Davila, Dept Biochem, Fac Dent, Bucharest, Romania.
   [Calenic, B.; van Staden, R. I.] Natl Inst Res Electrochem & Condensed Mater, Bucharest, Romania.
   [Paun, I. A.; Dinescu, M.] Natl Inst Laser Plasma & Radiat Phys, Bucharest, Romania.
   [Paun, I. A.] Univ Politehn Bucuresti, Fac Sci Appl, Bucharest, Romania.
   [Didilescu, A.] Univ Med & Pharm Carol Davila, Dept Embryol, Fac Dent, Bucharest, Romania.
   [Petre, A.] Univ Med & Pharm Carol Davila, Dept Prosthet Dent, Fac Dent, Bucharest, Romania.
RP Calenic, B (reprint author), Univ Med & Pharm Carol Davila, Dept Biochem, Fac Dent, Blvd Ul Eroii Sanit 8, Bucharest, Romania.
EM bcalenic@yahoo.co.uk
RI Dinescu, Maria/C-4775-2011; Didilescu, Andreea/C-5732-2012
OI Dinescu, Maria/0000-0001-7327-8714; Didilescu,
   Andreea/0000-0002-2915-5124
FU Executive Agency for Higher Education, Research, Development and
   Innovation Funding, Romania [PN-II-RU-PD-2011-3-0105]; UEFISCDI through
   the ELITISS project; University of Medicine and Pharmacy Carol Davila,
   Bucharest, Romania
FX B.C is grateful for the funding received from the Executive Agency for
   Higher Education, Research, Development and Innovation Funding, Romania
   (Postdoctoral grant - PN-II-RU-PD-2011-3-0105). I. A. P. acknowledges
   the financial support of UEFISCDI through the ELITISS project. B. C.
   also acknowledges the Young Scientist Grant 2011-2013 received from the
   University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
CR Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390
   Beck B, 2012, EMBO J, V31, P2067, DOI 10.1038/emboj.2012.67
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bluteau G, 2008, EUR CELLS MATER, V16, P1
   Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027
   Calenic B, 2010, J PERIODONTAL RES, V45, P703, DOI 10.1111/j.1600-0765.2010.01284.x
   Calenic B, 2010, J PERIODONTOL, V81, P1317, DOI 10.1902/jop.2010.100080
   Chen B, 2009, J DENT RES, V88, P539, DOI 10.1177/0022034509338008
   Chen HF, 2011, STEM CELL REV REP, V7, P722, DOI 10.1007/s12015-011-9233-y
   Chen L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-471
   Curran JM, 2011, BIOMATERIALS, V32, P4753, DOI 10.1016/j.biomaterials.2011.03.045
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Fujimori Y, 2009, J DERMATOL SCI, V56, P181, DOI 10.1016/j.jdermsci.2009.09.003
   Hamilton DW, 2009, CELL MOTIL CYTOSKEL, V66, P260, DOI 10.1002/cm.20354
   Harrison J, 2004, BIOMATERIALS, V25, P4963, DOI 10.1016/j.biomaterials.2004.01.054
   Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007
   Izumi K, 2007, J DENT RES, V86, P341, DOI 10.1177/154405910708600408
   Kantawong F, 2009, J R SOC INTERFACE, V6, P1075, DOI 10.1098/rsif.2008.0447
   Kantawong F, 2009, BIOMATERIALS, V30, P4723, DOI 10.1016/j.biomaterials.2009.05.040
   Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207
   Leelahavanichkul Kantima, 2013, Methods Mol Biol, V945, P67, DOI 10.1007/978-1-62703-125-7_5
   Li ZX, 2010, J PHYS CHEM B, V114, P2894, DOI 10.1021/jp906737q
   Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z
   Lorenz K, 2009, CELLS TISSUES ORGANS, V189, P382, DOI 10.1159/000151291
   Moharamzadeh K, 2007, J DENT RES, V86, P115, DOI 10.1177/154405910708600203
   Nakamura T, 2011, BRIT J OPHTHALMOL, V95, P942, DOI 10.1136/bjo.2010.188714
   Pique A, 2011, APPL PHYS A-MATER, V105, P517, DOI 10.1007/s00339-011-6594-7
   Piwko-Czuchra A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005488
   Richard V, 2010, BBA-REV CANCER, V1806, P146, DOI 10.1016/j.bbcan.2010.06.004
   Schluter H, 2011, STEM CELLS, V29, P1256, DOI 10.1002/stem.675
   Sen S, 2011, INVEST OPHTH VIS SCI, V52, P9548, DOI 10.1167/iovs.11-7946
   Sequeira SJ, 2012, BIOMATERIALS, V33, P3175, DOI 10.1016/j.biomaterials.2012.01.010
   Takagi R, 2010, GASTROINTEST ENDOSC, V72, P1253, DOI 10.1016/j.gie.2010.08.007
   Stone Anthony R, 2008, Eur Urol, V53, P1270, DOI [10.1016/j.eururo.2008.01.063, 10.1016/j.eururo.2008.01.062]
   Xiao L, 2012, J CELL BIOCHEM, V113, P1875, DOI 10.1002/jcb.24056
NR 40
TC 4
Z9 5
U1 2
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3484
EI 1600-0765
J9 J PERIODONTAL RES
JI J. Periodont. Res.
PD DEC
PY 2014
VL 49
IS 6
BP 711
EP 718
DI 10.1111/jre.12153
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AT7ZC
UT WOS:000345152300005
PM 24329011
DA 2018-10-20
ER

PT J
AU Wang, H
   Leinwand, LA
   Anseth, KS
AF Wang, Huan
   Leinwand, Leslie A.
   Anseth, Kristi S.
TI Cardiac valve cells and their microenvironment-insights from in vitro
   studies
SO NATURE REVIEWS CARDIOLOGY
LA English
DT Review
ID VALVULAR INTERSTITIAL-CELLS; GROWTH-FACTOR-BETA; CALCIFIC
   AORTIC-STENOSIS; EXTRACELLULAR-MATRIX; MYOFIBROBLAST DIFFERENTIATION;
   ENDOTHELIAL-CELLS; LIVER FIBROSIS; TGF-BETA; TRANSFORMING
   GROWTH-FACTOR-BETA-1; PROGENITOR CELLS
AB During every heartbeat, cardiac valves open and close coordinately to control the unidirectional flow of blood. In this dynamically challenging environment, resident valve cells actively maintain homeostasis, but the signalling between cells and their microenvironment is complex. When homeostasis is disrupted and the valve opening obstructed, haemodynamic profiles can be altered and lead to impaired cardiac function. Currently, late stages of cardiac valve diseases are treated surgically, because no drug therapies exist to reverse or halt disease progression. Consequently, investigators have sought to understand the molecular and cellular mechanisms of valvular diseases using in vitro cell culture systems and biomaterial scaffolds that can mimic the extracellular microenvironment. In this Review, we describe how signals in the extracellular matrix regulate valve cell function. We propose that the cellular context is a critical factor when studying the molecular basis of valvular diseases in vitro, and one should consider how the surrounding matrix might influence cell signalling and functional outcomes in the valve. Investigators need to build a systems-level understanding of the complex signalling network involved in valve regulation, to facilitate drug target identification and promote in situ or ex vivo heart valve regeneration.
C1 [Wang, Huan; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, JSC Biotechnol Ctr, Boulder, CO 80303 USA.
   [Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, JSC Biotechnol Ctr, 3415 Colorado Ave,596 UCB, Boulder, CO 80303 USA.
EM kristi.anseth@colorado.edu
OI Wang, Huan/0000-0001-9048-2733
FU NIH [R01 GM029090]; Howard Hughes Medical Institute
FX We acknowledge K. Barthel, P. Harvey, W. Wan, and K. Mabry (University
   of Colorado, Boulder, CO, USA) for kindly reading and editing the paper,
   and W. Wan for assistance in taking images for Figure 3. The authors'
   research work is supported by NIH research grants R01 GM029090 to L.A.L
   and the Howard Hughes Medical Institute to K.S.A.
CR Alexopoulos A, 2010, INT J CARDIOL, V139, P142, DOI 10.1016/j.ijcard.2008.10.014
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Balachandran K, 2011, INT J INFLAMM, DOI 10.4061/2011/263870
   Balachandran K, 2010, AM J PATHOL, V177, P49, DOI 10.2353/ajpath.2010.090631
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Benton JA, 2009, ARTERIOSCL THROM VAS, V29, P1950, DOI 10.1161/ATVBAHA.109.195271
   Benton JA, 2008, J HEART VALVE DIS, V17, P689
   Bertazzo S, 2013, NAT MATER, V12, P576, DOI [10.1038/NMAT3627, 10.1038/nmat3627]
   Bischoff J, 2011, J CARDIOVASC TRANSL, V4, P710, DOI 10.1007/s12265-011-9312-0
   Bodas M, 2010, DISCOV MED, V9, P346
   Bonow RO, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.05.007
   Bostrom KI, 2011, CIRC RES, V109, P564, DOI 10.1161/CIRCRESAHA.110.234278
   Boudreau J, 1999, BIOCHEM J, V339, P481
   Butcher JT, 2007, PHILOS T R SOC B, V362, P1445, DOI 10.1098/rstb.2007.2127
   Butcher JT, 2006, TISSUE ENG, V12, P905, DOI 10.1089/ten.2006.12.905
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040
   Callister W. D., 2000, FUNDAMENTALS MAT SCI, P153
   Cebotari S, 2006, CIRCULATION, V114, pI132, DOI 10.1161/CIRCULATIONAHA.105.001065
   Chen JH, 2011, CIRC RES, V108, P1510, DOI 10.1161/CIRCRESAHA.110.234237
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750
   Chester Adrian H., 2005, Current Vascular Pharmacology, V3, P353, DOI 10.2174/157016105774329435
   Clark-Greuel JN, 2007, ANN THORAC SURG, V83, P946, DOI 10.1016/j.athoracsur.2006.10.026
   Cloyd KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048154
   Combs MD, 2009, CIRC RES, V105, P408, DOI 10.1161/CIRCRESAHA.109.201566
   Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876
   Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI200112455
   Cushing MC, 2005, MATRIX BIOL, V24, P428, DOI 10.1016/j.matbio.2005.06.007
   Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   Demer LL, 2014, ARTERIOSCL THROM VAS, V34, P715, DOI 10.1161/ATVBAHA.113.302070
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Duan B, 2013, ACTA BIOMATER, V9, P7640, DOI 10.1016/j.actbio.2013.04.050
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Dweck MR, 2012, J AM COLL CARDIOL, V60, P1854, DOI 10.1016/j.jacc.2012.02.093
   Eckert CE, 2013, ACTA BIOMATER, V9, P4653, DOI 10.1016/j.actbio.2012.09.031
   Egan KP, 2011, ARTERIOSCL THROM VAS, V31, P2965, DOI 10.1161/ATVBAHA.111.234724
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014
   Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738
   Gandavarapu NR, 2014, ADV MATER, V26, P2521, DOI 10.1002/adma.201304847
   Geirsson A, 2012, CIRCULATION, V126, pS189, DOI 10.1161/CIRCULATIONAHA.111.082610
   Gharacholou SM, 2011, AM J MED, V124, P103, DOI 10.1016/j.amjmed.2010.10.012
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gossl M, 2012, J AM COLL CARDIOL, V60, P1945, DOI 10.1016/j.jacc.2012.07.042
   Gooch JL, 2004, J BIOL CHEM, V279, P15561, DOI 10.1074/jbc.M308759200
   Gould S. T., J TISSUE ENG REGEN M
   Gould ST, 2014, BIOMATERIALS, V35, P3596, DOI 10.1016/j.biomaterials.2014.01.005
   Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Grande-Allen KJ, 2007, CARDIOVASC RES, V76, P19, DOI 10.1016/j.cardiores.2007.05.014
   Grinnell F, 1999, EXP CELL RES, V248, P608, DOI 10.1006/excr.1999.4440
   Gu XX, 2010, J BIOMED MATER RES A, V93A, P1620, DOI 10.1002/jbm.a.32660
   Gupta V, 2007, TISSUE ENG, V13, P41, DOI 10.1089/ten.2006.0091
   Guvendiren M, 2014, J MECH BEHAV BIOMED, V38, P198, DOI 10.1016/j.jmbbm.2013.11.008
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Guy TS, 2012, ANNU REV MED, V63, P277, DOI 10.1146/annurev-med-022811-091602
   Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242
   Hinton RB, 2006, CIRC RES, V98, P1431, DOI 10.1161/01.RES.0000224114.65109.4e
   Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145
   Hinton RB, 2010, CIRC RES, V107, P549, DOI 10.1161/CIRCRESAHA.110.221358
   Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004
   Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020
   Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001
   Hutcheson JD, 2014, NAT REV CARDIOL, V11, P218, DOI 10.1038/nrcardio.2014.1
   Hutcheson JD, 2013, ARTERIOSCL THROM VAS, V33, P114, DOI 10.1161/ATVBAHA.112.300278
   Hutcheson JD, 2012, J MOL CELL CARDIOL, V53, P707, DOI 10.1016/j.yjmcc.2012.08.012
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jenkins G, 2008, INT J BIOCHEM CELL B, V40, P1068, DOI 10.1016/j.biocel.2007.11.026
   Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6
   Kaden JJ, 2005, INT J MOL MED, V16, P869
   Kaden JJ, 2003, ATHEROSCLEROSIS, V170, P205, DOI 10.1016/S0021-9150(03)00284-3
   KAGAMI S, 1994, J CLIN INVEST, V93, P2431, DOI 10.1172/JCI117251
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4
   Kirschner CM, 2014, ADV HEALTHC MATER, V3, P649, DOI 10.1002/adhm.201300288
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200
   Krishnamurthy VK, 2011, J BIOMECH, V44, P77, DOI 10.1016/j.jbiomech.2010.08.026
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kural MH, 2014, BIOMATERIALS, V35, P1128, DOI 10.1016/j.biomaterials.2013.10.047
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737
   Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Leopold JA, 2012, CIRC-CARDIOVASC INTE, V5, P605, DOI 10.1161/CIRCINTERVENTIONS.112.971028
   Levine RA, 2005, CIRCULATION, V112, P745, DOI 10.1161/CIRCULATIONAHA.104.486720
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251
   Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082
   Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mahler G. J., 2014, BIOTECHNOL BIOENG, V4, P25291
   Mahler GJ, 2013, ARTERIOSCL THROM VAS, V33, P121, DOI 10.1161/ATVBAHA.112.300504
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361
   Miller JD, 2008, J AM COLL CARDIOL, V52, P843, DOI 10.1016/j.jacc.2008.05.043
   Miller JD, 2011, CIRC RES, V108, P1392, DOI 10.1161/CIRCRESAHA.110.234138
   Miller JD, 2010, ARTERIOSCL THROM VAS, V30, P2482, DOI 10.1161/ATVBAHA.110.211029
   Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200
   Mohler ER, 2001, CIRCULATION, V103, P1522
   Monzack EL, 2011, J HEART VALVE DIS, V20, P449
   Moraes C, 2013, INTEGR BIOL-UK, V5, P673, DOI 10.1039/c3ib20254b
   Nadlonek N, 2013, ANN THORAC SURG, V96, P155, DOI 10.1016/j.athoracsur.2013.04.013
   OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523
   Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010
   Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Paruchuri S, 2006, CIRC RES, V99, P861, DOI 10.1161/01.RES.0000245188.41002.2c
   Pho M, 2008, AM J PHYSIOL-HEART C, V294, pH1767, DOI 10.1152/ajpheart.01305.2007
   Pohle K, 2001, CIRCULATION, V104, P1927, DOI 10.1161/hc4101.097527
   Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051
   Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489
   Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767
   Rajamannan NM, 2005, CIRCULATION, V111, P3296, DOI 10.1161/CIRCULATIONAHA.104.473165
   Rajamannan NM, 2003, CIRCULATION, V107, P2181, DOI 10.1161/01.CIR.0000070591.21548.69
   Richards J, 2013, AM J PATHOL, V182, P1922, DOI 10.1016/j.ajpath.2013.01.037
   Rodriguez KJ, 2009, J BIOMED MATER RES A, V90A, P1043, DOI 10.1002/jbm.a.32187
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Rothman RB, 2000, CIRCULATION, V102, P2836
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sainger R, 2012, J CELL PHYSIOL, V227, P2595, DOI 10.1002/jcp.22999
   Santiago JJ, 2010, DEV DYNAM, V239, P1573, DOI 10.1002/dvdy.22280
   Santos E., 2011, CELL BIOMATERIAL INT
   Schmedlen KH, 2002, BIOMATERIALS, V23, P4325, DOI 10.1016/S0142-9612(02)00177-1
   Schneider DJ, 2012, FASEB J, V26, P503, DOI 10.1096/fj.11-186098
   Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911
   Schwartz M. A., 2010, COLD SPRING HARB PER, V2, P17
   Sewell-Loftin MK, 2014, BIOMATERIALS, V35, P2809, DOI 10.1016/j.biomaterials.2013.12.051
   Sewell-Loftin MK, 2012, J HEART VALVE DIS, V21, P513
   Shah DN, 2008, BIOMATERIALS, V29, P2060, DOI 10.1016/j.biomaterials.2008.01.001
   Sider K. L., 2011, INT J INFLAM, V2011, P18, DOI DOI 10.4061/2011/364310
   Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007060930
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Stella JA, 2007, J BIOMECH ENG-T ASME, V129, P757, DOI 10.1115/1.2768111
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tseng H, 2011, ACTA BIOMATER, V7, P2101, DOI 10.1016/j.actbio.2011.01.022
   Tseng H, 2014, ACTA BIOMATER, V10, P173, DOI 10.1016/j.actbio.2013.09.003
   Vesely I, 1998, J BIOMECH, V31, P115
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
   Wang H., FASEB J
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307
   Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110
   Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069667
   Weiss RM, 2013, CIRC RES, V113, P209, DOI 10.1161/CIRCRESAHA.113.300153
   Wiltz D., 2013, EXTRACELLULAR MATRIX
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Witt W., 2014, THORAC CARDIOVASC SU, V62, pSC130
   Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yang XP, 2009, J THORAC CARDIOV SUR, V138, P1008, DOI 10.1016/j.jtcvs.2009.06.024
   Yap CH, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004232
   Yip CYY, 2011, ARTERIOSCL THROM VAS, V31, P1881, DOI 10.1161/ATVBAHA.111.223974
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
   Zhang YH, 2011, MATRIX BIOL, V30, P135, DOI 10.1016/j.matbio.2010.10.008
   Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004
NR 175
TC 23
Z9 24
U1 1
U2 33
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1759-5002
EI 1759-5010
J9 NAT REV CARDIOL
JI Nat. Rev. Cardiol.
PD DEC
PY 2014
VL 11
IS 12
BP 715
EP 727
DI 10.1038/nrcardio.2014.162
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AU0DE
UT WOS:000345292800005
PM 25311230
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zhang, XJ
   Chen, XY
   Yang, T
   Zhang, NL
   Dong, L
   Ma, SY
   Liu, XM
   Zhou, M
   Li, BX
AF Zhang, Xiujie
   Chen, Xueying
   Yang, Ting
   Zhang, Naili
   Dong, Li
   Ma, Shaoying
   Liu, Xiaoming
   Zhou, Mo
   Li, Baoxing
TI The effects of different crossing-linking conditions of genipin on type
   I collagen scaffolds: an in vitro evaluation
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Cross-link; Genipin; Type I collagen; Scaffolds
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; TISSUE; BIOMATERIAL;
   DEGRADATION; IRRADIATION; CARTILAGE; FIXATION; BLENDS; AGENT
AB The purpose of this paper is to analyze the properties of fabricating rat tail type I collagen scaffolds cross-linked with genipin under different conditions. The porous genipin cross-linked scaffolds are obtained through a two step freeze-drying process. To find out the optimal cross-link condition, we used different genipin concentrations and various cross-linked temperatures to prepare the scaffolds in this study. The morphologies of the scaffolds were characterized by scanning electron microscope, and the mechanical properties of the scaffolds were evaluated under dynamic compression. Additionally, the cross-linking degree was assessed by ninhydrin assay. To investigate the swelling ratio and the in vitro degradation of the collagen scaffold, the tests were also carried out by immersion of the scaffolds in a PBS solution or digestion in a type I collagenase respectively. The morphologies of the non-cross-linked scaffolds presented a lattice-like structure while the cross-linked ones displayed a sheet-like framework. The morphology of the genipin cross-linked scaffolds could be significantly changed by either increasing genipin concentration or the temperature. The swelling ratio of each cross-linked scaffold was much lower than that of the control (non-cross-linked).The ninhydrin assay demonstrated that the higher temperature and genipin concentration could obviously increase the cross-linking efficiency. The in vitro degradation studies indicated that genipin cross-linking can effectively elevate the biostability of the scaffolds. The biocompatibility and cytotoxicity of the scaffolds was evaluated by culturing rat chondrocytes on the scaffold in vitro and by MTT. The results of MTT and the fact that the chondrocytes adhered well to the scaffolds demonstrated that genipin cross-linked scaffolds possessed an excellent biocompatibility and low cytotoxicity. Based on these results, 0.3 % genipin concentrations and 37 A degrees C cross-linked temperatures are recommended.
C1 [Zhang, Xiujie] Southern Med Univ, Guangzhou, Guangdong, Peoples R China.
   [Chen, Xueying; Yang, Ting; Zhang, Naili; Dong, Li; Ma, Shaoying; Liu, Xiaoming; Zhou, Mo; Li, Baoxing] China Inst Radiat Protect, Taiyuan 030006, Peoples R China.
RP Li, BX (reprint author), China Inst Radiat Protect, Taiyuan 030006, Peoples R China.
EM zxj_lily@sina.cn
CR Aramwit P, 2013, CELLS TISSUES ORGANS, V197, P224, DOI 10.1159/000345600
   Bedran-Russo AKB, 2011, ACTA BIOMATER, V7, P1735, DOI 10.1016/j.actbio.2010.12.013
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Castellan CS, 2010, DENT MATER, V26, P968, DOI 10.1016/j.dental.2010.06.001
   CauichRodriguez JV, 1996, BIOMATERIALS, V17, P2259, DOI 10.1016/0142-9612(96)00058-0
   Chaubaroux C, 2012, BIOMACROMOLECULES, V13, P2128, DOI 10.1021/bm300529a
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Dong CM, 2005, BIOMATERIALS, V26, P4041, DOI 10.1016/j.biomaterials.2004.10.017
   Fernandes-Silva S, 2013, MACROMOL BIOSCI, V13, P1621, DOI 10.1002/mabi.201300228
   Grant ME, 2007, INT J EXP PATHOL, V88, P203, DOI 10.1111/j.1365-2613.2007.00537.x
   Hiraishi N, 2011, J DENT, V39, P391, DOI 10.1016/j.jdent.2011.03.002
   Kato MT, 2010, J DENT RES, V89, P468, DOI 10.1177/0022034510363248
   Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025
   Koide T, 1997, Dent Mater J, V16, P1
   KON M, 1981, PLAST RECONSTR SURG, V67, P289, DOI 10.1097/00006534-198103000-00002
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kuo YC, 2006, BIOTECHNOL BIOENG, V95, P132, DOI 10.1002/bit.21007
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Lima EG, 2009, J BIOMED MATER RES A, V91A, P692, DOI 10.1002/jbm.a.32305
   Lund MN, 2008, BIOCHEM J, V410, P565, DOI 10.1042/BJ20071107
   Mathew AP, 2013, MACROMOL BIOSCI, V13, P289, DOI 10.1002/mabi.201200317
   Menter JM, 2001, PHOTODERMATOL PHOTO, V17, P114, DOI 10.1034/j.1600-0781.2001.170302.x
   Mi FL, 2001, J BIOMAT SCI-POLYM E, V12, P835, DOI 10.1163/156856201753113051
   Reich MS, 2014, J BIOMATER APPL, V28, P1336, DOI 10.1177/0885328213507799
   Reich MS, 2013, CELL TISSUE BANK, V14, P381, DOI 10.1007/s10561-012-9335-z
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yoo Jae Suk, 2011, Korean J Thorac Cardiovasc Surg, V44, P197, DOI 10.5090/kjtcs.2011.44.3.197
   Zhang J, 2005, BIOMATERIALS, V26, P3353, DOI 10.1016/j.biomaterials.2004.08.019
NR 40
TC 18
Z9 19
U1 4
U2 50
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD DEC
PY 2014
VL 15
IS 4
BP 531
EP 541
DI 10.1007/s10561-014-9423-3
PG 11
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA AT2YZ
UT WOS:000344802000006
PM 24442821
DA 2018-10-20
ER

PT J
AU Veruva, SY
   Steinbeck, MJ
   Toth, J
   Alexander, DD
   Kurtz, SM
AF Veruva, Sai Y.
   Steinbeck, Marla J.
   Toth, Jeffrey
   Alexander, Dominik D.
   Kurtz, Steven M.
TI Which Design and Biomaterial Factors Affect Clinical Wear Performance of
   Total Disc Replacements? A Systematic Review
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article
ID METAL-ON-METAL; INVESTIGATIONAL-DEVICE-EXEMPTION; SERUM FOLLOWING
   IMPLANTATION; MEDTRONIC SOFAMOR DANEK; RETRIEVAL-ANALYSIS; CERVICAL
   DISC; IN-VIVO; ARTIFICIAL DISC; CHROMIUM IONS; MAVERICK DISC
AB Background Total disc replacement was clinically introduced to reduce pain and preserve segmental motion of the lumbar and cervical spine. Previous case studies have reported on the wear and adverse local tissue reactions around artificial prostheses, but it is unclear how design and biomaterials affect clinical outcomes.
   Questions/purposes Which design and material factors are associated with differences in clinical wear performance (implant wear and periprosthetic tissue response) of (1) lumbar and (2) cervical total disc replacements?
   Methods We performed a systematic review on the topics of implant wear and periprosthetic tissue response using an advanced search in MEDLINE and Scopus electronic databases. Of the 340 references identified, 33 were retrieved for full-text evaluation, from which 16 papers met the inclusion criteria (12 on lumbar disc replacement and five on cervical disc replacement; one of the included studies reported on both lumbar and cervical disc replacement), which involved semiquantitative analysis of wear and adverse local tissue reactions along with a description of the device used. An additional three papers were located by searching bibliographies of key articles. There were seven case reports, three case series, two case-control studies, and seven analytical studies. The Methodological Index for Non-randomized Studies (MINORS) Scale was used to score case series and case-control studies, which yielded mean scores of 10.3 of 16 and 17.5 of 24, respectively. In general, the case series (three) and case-control (two) studies were of good quality.
   Results In lumbar regions, metal-on-polymer devices with mobile-bearing designs consistently generated small and large polymeric wear debris, triggering periprosthetic tissue activation of macrophages and giant cells, respectively. In the cervical regions, metal-on-polymer devices with fixed-bearing designs had similar outcomes. All metal-on-metal constructs tended to generate small metallic wear debris, which typically triggered an adaptive immune response of predominantly activated lymphocytes. There were no retrieval studies on one-piece prostheses.
   Conclusions This review provides evidence that design and biomaterials affect the type of wear and inflammation. However, clinical study design, followup, and analytical techniques differ among investigations, preventing us from drawing firm conclusions about the relationship between implant design and wear performance for both cervical and lumbar total disc replacement.
C1 [Veruva, Sai Y.; Steinbeck, Marla J.; Kurtz, Steven M.] Drexel Univ, Implant Res Ctr, Philadelphia, PA 19104 USA.
   [Toth, Jeffrey] Med Coll Wisconsin, Dept Orthopaed Surg, Milwaukee, WI 53226 USA.
   [Alexander, Dominik D.] Exponent Inc, Boulder, CO USA.
   [Kurtz, Steven M.] Exponent Inc, Philadelphia, PA USA.
RP Kurtz, SM (reprint author), Drexel Univ, Implant Res Ctr, 3401 Market St,Suite 345, Philadelphia, PA 19104 USA.
EM skurtz@drexel.edu
FU National Institutes of Health (NIAMS) [R01 AR56264]
FX Funding received (MJS, SMK) from the National Institutes of Health
   (NIAMS) R01 AR56264.
CR Anderson PA, 2004, J NEUROSURG-SPINE, V1, P202, DOI 10.3171/spi.2004.1.2.0202
   Austen Shennah, 2012, Eur Spine J, V21 Suppl 4, pS513, DOI 10.1007/s00586-011-2141-7
   Baxter Ryan M, 2013, J Bone Joint Surg Am, V95, pe751, DOI 10.2106/JBJS.K.00522
   Cavanaugh DA, 2009, SPINE, V34, pE262, DOI 10.1097/BRS.0b013e318195dd60
   Choma TJ, 2009, J SPINAL DISORD TECH, V22, P290, DOI 10.1097/BSD.0b013e31816dd2b6
   Chung SK, 2009, SPINE, V34, P1281, DOI 10.1097/BRS.0b013e3181a4ec2d
   Cunningham BW, 2003, SPINE, V28, pS118, DOI 10.1097/00007632-200310151-00005
   David T, 2005, EUR SPINE J, V14, P507, DOI 10.1007/s00586-004-0842-x
   Devin CJ, 2008, J BONE JOINT SURG AM, V90A, P2230, DOI 10.2106/JBJS.G.01712
   Fan HB, 2012, SPINE, V37, pE814, DOI 10.1097/BRS.0b013e3182477d85
   Francois J, 2007, ACTA ORTHOP BELG, V73, P122
   Gallo J, 2008, PHYSIOL RES, V57, P339
   Golish SR, 2012, SPINE J, V12, P693, DOI 10.1016/j.spinee.2011.05.008
   Gornet MF, 2013, EUR SPINE J, V22, P741, DOI 10.1007/s00586-012-2581-8
   Gornet MF, 2011, SPINE, V36, pE1600, DOI 10.1097/BRS.0b013e318217668f
   Guyer RD, 2011, SPINE, V36, pE492, DOI 10.1097/BRS.0b013e31820ea9a2
   Heuer F, 2007, J BIOMECH, V40, P271, DOI 10.1016/j.jbiomech.2006.01.007
   Hujoel Philippe, 2009, J Evid Based Dent Pract, V9, P122, DOI 10.1016/j.jebdp.2009.06.007
   Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P99, DOI 10.2106/JBJS.F.00102
   Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1
   Kurtz Steven M, 2012, Semin Spine Surg, V24, P57
   Kurtz Steven M, 2009, SAS J, V3, P161, DOI 10.1016/j.esas.2009.11.003
   Kurtz SM, 2009, SPINE, V34, P2369, DOI 10.1097/BRS.0b013e3181b20230
   Lazennec J-Y, 2013, SPINE J
   Lebl DR, 2012, SPINE, V37, P2151, DOI 10.1097/BRS.0b013e31826b3f61
   Lebl DR, 2012, SPINE, V37, pE1209, DOI 10.1097/BRS.0b013e31825ab6c1
   Lehman Ronald, 2012, Evid Based Spine Care J, V3, P31, DOI 10.1055/s-0031-1298606
   Link HD, 2003, ARTIFICIAL DISC, P33
   McAfee PC, 2005, SPINE, V30, P1576, DOI 10.1097/01.brs.0000170561.25636.1c
   McAfee PC, 2005, SPINE, V30, pE1588
   O'Leary Patrick, 2005, Spine J, V5, P590, DOI 10.1016/j.spinee.2005.06.015
   Punt I, 2011, ACTA BIOMATER, V7, P3404, DOI 10.1016/j.actbio.2011.05.010
   Punt IM, 2012, SPINE, V37, P150, DOI 10.1097/BRS.0b013e3182154c22
   Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992
   Slim K, 2003, ANZ J SURG, V73, P712, DOI 10.1046/j.1445-2197.2003.02748.x
   Stieber JR, 2006, J SPINAL DISORD TECH, V19, P55, DOI 10.1097/01.bsd.0000163414.53732.a3
   Tumialan LM, 2011, SPINE, V36, pE973, DOI 10.1097/BRS.0b013e3181fd863b
   US Food and Drug Administration, MET ON MET HIP IMPL
   van den Broek PR, 2012, J BIOMECH, V45, P134, DOI 10.1016/j.jbiomech.2011.09.017
   van Ooij A, 2007, SPINE, V32, P223, DOI 10.1097/01.brs.0000251370.56327.c6
   van Ooij Andre, 2003, J Spinal Disord Tech, V16, P369
   Zeh A, 2007, SPINE, V32, P348, DOI 10.1097/01.brs.0000253599.89694.c0
   Zeh A, 2009, ARCH ORTHOP TRAUM SU, V129, P741, DOI 10.1007/s00402-008-0677-8
   Zigler J, 2007, SPINE, V32, P1155, DOI 10.1097/BRS.0b013e318054e377
   COCHRANE HDB SYSTEMA
NR 45
TC 14
Z9 14
U1 1
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-921X
EI 1528-1132
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD DEC
PY 2014
VL 472
IS 12
BP 3759
EP 3769
DI 10.1007/s11999-014-3751-2
PG 11
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA AT0TH
UT WOS:000344647200021
PM 25002211
OA Green Published
DA 2018-10-20
ER

PT J
AU Zhang, M
   Shu, L
   Shen, XF
   Guo, XY
   Tao, S
   Xing, BS
   Wang, XL
AF Zhang, Meng
   Shu, Liang
   Shen, Xiaofang
   Guo, Xiaoying
   Tao, Shu
   Xing, Baoshan
   Wang, Xilong
TI Characterization of nitrogen-rich biomaterial-derived biochars and their
   sorption for aromatic compounds
SO ENVIRONMENTAL POLLUTION
LA English
DT Article
DE Sorption; N-rich biochar; Aromatic compound; Interaction mechanism
ID DIFFERENT PYROLYTIC TEMPERATURES; ORGANIC CONTAMINANTS; CARBON
   NANOTUBES; MOLECULAR-STRUCTURE; ADSORPTION; SOIL; PHENANTHRENE; BIOMASS;
   CHARS; MODEL
AB Biochars from nitrogen-rich biomaterials (i.e., alpha-amylase, chitin and zein) were produced at different temperatures (i.e. 170, 250, 350 and 450 degrees C) and characterized, and their sorption for phenanthrene, naphthalene and 1-naphthol was investigated. The organic carbon content normalized-sorption coefficient (K-oc) of the tested compounds by biochars increased with increasing charring temperature, attributed to the reduction of O-containing polar moieties especially the O-alkyl components, and the newly created aromatic carbon domains. The N-heterocyclic ring structure formed during charring process may enhance pi-pi interactions between aromatics and the aromatic components in the resulting biochars. However, pi-pi interactions did not dominate sorption of aromatics by N-rich biochars. Sorption of the tested compounds by N-rich biochars was predominantly controlled by the hydrophobic interactions between these chemicals and the aromatic components in biochars. Both N- and O-containing polar moieties at the biochar surfaces negatively affected their sorption for aromatics. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, Meng; Shu, Liang; Shen, Xiaofang; Guo, Xiaoying; Tao, Shu; Wang, Xilong] Peking Univ, Coll Urban & Environm Sci, Lab Earth Surface Proc, Beijing 100871, Peoples R China.
   [Xing, Baoshan] Univ Massachusetts, Stockbridge Sch Agr, Amherst, MA 01003 USA.
RP Wang, XL (reprint author), Peking Univ, Coll Urban & Environm Sci, Lab Earth Surface Proc, Beijing 100871, Peoples R China.
EM xilong@pku.edu.cn
RI wang, xilong/M-1848-2017
OI wang, xilong/0000-0002-5668-9703; Tao, Shu/0000-0002-7374-7063
FU National Natural Science Foundation of China [41271461, 41328003,
   41390240, 41130754]; 973 Program [2014CB441101]; 111 Program [B14001];
   Startup Fund for the Peking University 100-Talent Program
FX This study was supported by the National Natural Science Foundation of
   China (41271461, 41328003, 41390240 and 41130754), 973 Program
   (2014CB441101), 111 Program (B14001) and the Startup Fund for the Peking
   University 100-Talent Program.
CR Beesley L, 2010, ENVIRON POLLUT, V158, P2282, DOI 10.1016/j.envpol.2010.02.003
   Bourke J, 2007, IND ENG CHEM RES, V46, P5954, DOI 10.1021/ie070415u
   Bridgwater AV, 2003, CHEM ENG J, V91, P87, DOI 10.1016/S1385-8947(02)00142-0
   Bushnaf KM, 2011, J CONTAM HYDROL, V126, P208, DOI 10.1016/j.jconhyd.2011.08.008
   Cao XD, 2009, ENVIRON SCI TECHNOL, V43, P3285, DOI 10.1021/es803092k
   Chefetz B, 2009, ENVIRON SCI TECHNOL, V43, P1680, DOI 10.1021/es803149u
   Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684
   Chen BL, 2009, CHEMOSPHERE, V76, P127, DOI 10.1016/j.chemosphere.2009.02.004
   Chen X, 2011, CHEMOSPHERE, V83, P1313, DOI 10.1016/j.chemosphere.2011.04.018
   Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w
   Fernandes M. B., 2003, CHEMOSPHERE, V51, P785
   Gregg S. J, 1982, ADSORPTION SURFACE A
   Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419
   Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a
   Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P7254, DOI 10.1021/es801297u
   Muller EA, 1998, CARBON, V36, P1433, DOI 10.1016/S0008-6223(98)00135-3
   Pendleton P, 1997, CARBON, V35, P1141, DOI 10.1016/S0008-6223(97)00086-9
   Piatt JJ, 1996, ENVIRON SCI TECHNOL, V30, P751, DOI 10.1021/es9406288
   Qiu M. Y., 2014, SCI REP, V4, P1
   Renner R, 2007, ENVIRON SCI TECHNOL, V41, P5932, DOI 10.1021/es0726097
   Sheng GY, 2005, ENVIRON POLLUT, V134, P457, DOI 10.1016/j.envpol.2004.09.009
   Spokas KA, 2009, CHEMOSPHERE, V77, P574, DOI 10.1016/j.chemosphere.2009.06.053
   Sun K, 2012, BIORESOURCE TECHNOL, V118, P120, DOI 10.1016/j.biortech.2012.05.008
   Sun K, 2012, ENVIRON POLLUT, V163, P167, DOI 10.1016/j.envpol.2011.12.015
   Sun K, 2011, BIORESOURCE TECHNOL, V102, P9897, DOI 10.1016/j.biortech.2011.08.036
   Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038
   Tang WJ, 2005, POLYM DEGRAD STABIL, V87, P389, DOI 10.1016/j.polymdegradstab.2004.08.006
   Wang HL, 2010, J SOIL SEDIMENT, V10, P283, DOI 10.1007/s11368-009-0111-z
   Wang JF, 2003, J AGR FOOD CHEM, V51, P5849, DOI 10.1021/jf026133g
   Wang XL, 2007, ENVIRON SCI TECHNOL, V41, P8342, DOI 10.1021/es071290n
   Wang XL, 2007, CHEMOSPHERE, V66, P1476, DOI 10.1016/j.chemosphere.2006.09.004
   Wang XL, 2010, CARBON, V48, P3721, DOI 10.1016/j.carbon.2010.06.034
   Wijnja H, 2004, J ENVIRON QUAL, V33, P265
   Zhang D, 2010, ENVIRON SCI TECHNOL, V44, P3806, DOI 10.1021/es903851q
   Zhu DQ, 2005, ENVIRON SCI TECHNOL, V39, P3990, DOI 10.1021/es050129e
   Zhu DQ, 2005, ENVIRON SCI TECHNOL, V39, P2033, DOI 10.1021/es0491376
NR 36
TC 20
Z9 21
U1 5
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
EI 1873-6424
J9 ENVIRON POLLUT
JI Environ. Pollut.
PD DEC
PY 2014
VL 195
BP 84
EP 90
DI 10.1016/j.envpol.2014.08.018
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AS7LM
UT WOS:000344437600011
PM 25194275
DA 2018-10-20
ER

PT J
AU Shiu, HT
   Goss, B
   Lutton, C
   Crawford, R
   Xiao, Y
AF Shiu, Hoi Ting
   Goss, Ben
   Lutton, Cameron
   Crawford, Ross
   Xiao, Yin
TI Formation of Blood Clot on Biomaterial Implants Influences Bone Healing
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID PLATELET-RICH-PLASMA; MESENCHYMAL STEM-CELLS; VON-WILLEBRAND-FACTOR;
   SELF-ASSEMBLED MONOLAYERS; FIBRIN NETWORK FORMATION; GROWTH-FACTOR
   RELEASE; CRITICAL-SIZE DEFECTS; IN-VITRO; THROMBIN GENERATION;
   WHOLE-BLOOD
AB The first step in bone healing is forming a blood clot at injured bones. During bone implantation, biomaterials unavoidably come into direct contact with blood, leading to a blood clot formation on its surface prior to bone regeneration. Despite both situations being similar in forming a blood clot at the defect site, most research in bone tissue engineering virtually ignores the important role of a blood clot in supporting healing. Dental implantology has long demonstrated that the fibrin structure and cellular content of a peri-implant clot can greatly affect osteoconduction and de novo bone formation on implant surfaces. This article reviews the formation of a blood clot during bone healing in relation to the use of platelet-rich plasma (PRP) gels. It is implicated that PRP gels are dramatically altered from a normal clot in healing, resulting in conflicting effect on bone regeneration. These results indicate that the effect of clots on bone regeneration depends on how the clots are formed. Factors that influence blood clot structure and properties in relation to bone healing are also highlighted. Such knowledge is essential for developing strategies to optimally control blood clot formation, which ultimately alter the healing microenvironment of bone. Of particular interest are modification of surface chemistry of biomaterials, which displays functional groups at varied composition for the purpose of tailoring blood coagulation activation, resultant clot fibrin architecture, rigidity, susceptibility to lysis, and growth factor release. This opens new scope of in situ blood clot modification as a promising approach in accelerating and controlling bone regeneration.
C1 [Shiu, Hoi Ting; Goss, Ben; Lutton, Cameron; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Sci & Engn, Brisbane, Qld 4059, Australia.
   [Goss, Ben] NZ Pty Ltd, NuVas Australia, Speed Innovat, Wilston, Qld 4051, Australia.
   [Lutton, Cameron] IP Australia, Canberra, ACT, Australia.
RP Goss, B (reprint author), NZ Pty Ltd, NuVas Australia, Speed Innovat, 2-2 Heather St, Wilston, Qld 4051, Australia.
EM bgoss@nuvasive.com; yin.xiao@qut.edu.au
OI Xiao, Yin/0000-0003-1785-3491; Crawford, Ross/0000-0001-6079-1316
FU IHBI; Queensland University of Technology
FX The financial support from IHBI and the Queensland University of
   Technology is gratefully acknowledged.
CR Agis H, 2013, J ORTHOP RES, V31, P1561, DOI 10.1002/jor.22386
   Akeda K, 2006, OSTEOARTHR CARTILAGE, V14, P1272, DOI 10.1016/j.joca.2006.05.008
   Aleman MM, 2011, J THROMB HAEMOST, V9, P2251, DOI 10.1111/j.1538-7836.2011.04488.x
   Alkhamis T M, 1988, ASAIO Trans, V34, P868
   Allen GA, 2004, J THROMB HAEMOST, V2, P402, DOI 10.1111/j.1538-7933.2003.00617.x
   Allford S. L., 2007, SURGERY, V25, P241
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708
   Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020
   Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Arpornmaeklong P., 2003, INT J ORAL MAXILLOF, V33, P60
   ASIJEE GM, 1988, BIOCHIM BIOPHYS ACTA, V954, P303, DOI 10.1016/0167-4838(88)90085-4
   Bach-Gansmo ET, 1998, THROMB RES, V92, P125, DOI 10.1016/S0049-3848(98)00121-2
   Baeyens W, 2010, Rev Med Brux, V31, P521
   Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Bartold PM, 2003, AUST DENT J, V48, P1
   Becker JC, 2004, SCAND J GASTROENTERO, V39, P927, DOI 10.1080/00365520410003371
   Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bhasin N, 2008, J VASC SURG, V48, P1497, DOI 10.1016/j.jvs.2008.07.010
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   Blomback B, 2000, THROMB RES, V99, P307, DOI 10.1016/S0049-3848(00)00242-5
   Bosetti M, 2007, BIOMOL ENG, V24, P613, DOI 10.1016/j.bioeng.2007.08.019
   Bouchard BA, 2001, CURR OPIN HEMATOL, V8, P263, DOI 10.1097/00062752-200109000-00001
   Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148
   Campbell RA, 2008, ARTERIOSCL THROM VAS, V28, P2247, DOI 10.1161/ATVBAHA.108.176008
   Campbell RA, 2009, BLOOD, V114, P4886, DOI 10.1182/blood-2009-06-228940
   Caputo A. E., 1999, STRUCTURE FUNCTION B, P201
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Carlson NE, 2002, J AM DENT ASSOC, V133, P1383, DOI 10.14219/jada.archive.2002.0054
   CARR ME, 1987, AM J PHYSIOL, V253, pH1069
   CARR ME, 1987, J LAB CLIN MED, V110, P747
   Carr ME, 2002, BLOOD COAGUL FIBRIN, V13, P193, DOI 10.1097/00001721-200204000-00004
   CARR ME, 1994, AM J PHYSIOL, V266, pH1195
   Carrieri C, 2011, J THROMB HAEMOST, V9, P154, DOI 10.1111/j.1538-7836.2010.04120.x
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Cenni Elisabetta, 2010, Musculoskelet Surg, V94, P1, DOI 10.1007/s12306-009-0048-9
   Cenni E, 2009, J ORTHOP RES, V27, P1493, DOI 10.1002/jor.20896
   Chen TM, 2013, ANN PLAS SURG, V70, P370, DOI 10.1097/SAP.0b013e31823b6880
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   Choi BH, 2004, INT J ORAL MAX SURG, V33, P56, DOI 10.1045/ijom.2003.0466
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   COLLET JP, 1993, BLOOD, V82, P2462
   Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102
   Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095
   Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354
   Cross KJ, 2003, SURG CLIN N AM, V83, P531, DOI 10.1016/S0039-6109(02)00202-5
   Davies John E, 2003, J Dent Educ, V67, P932
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   de Oliveira MA, 2010, ACTA CIR BRAS, V25, P28, DOI 10.1590/S0102-86502010000100008
   Del Corso M, 2010, ORAL SURG ORAL MED O, V110, P418, DOI 10.1016/j.tripleo.2010.05.059
   DEUEL TF, 1981, P NATL ACAD SCI-BIOL, V78, P4584, DOI 10.1073/pnas.78.7.4584
   Di Cera E, 2003, CHEST, V124, p11S, DOI 10.1378/chest.124.3_suppl.11S
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dugrillon A, 2002, INT J ORAL MAX SURG, V31, P615, DOI 10.1054/ijom.2002.0322
   Elalamy I., 2008, THROMB RES, V121, P643
   English D, 2000, FASEB J, V14, P2255, DOI 10.1096/fj.00-0134com
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P1502, DOI 10.1097/01.PRS.0000138251.07040.51
   Ernofsson M, 1997, J THORAC CARDIOV SUR, V113, P576, DOI 10.1016/S0022-5223(97)70373-8
   ESMON CT, 1995, SEMIN CELL BIOL, V6, P257, DOI 10.1006/scel.1995.0034
   Evans-Nguyen KM, 2005, LANGMUIR, V21, P1691, DOI 10.1021/la047303h
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   Fan W, 2011, DIFFERENTIATION, V81, P181, DOI 10.1016/j.diff.2010.12.003
   Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647
   Frechette JP, 2005, J DENT RES, V84, P434, DOI 10.1177/154405910508400507
   Gandhi A, 2006, BONE, V38, P540, DOI 10.1016/j.bone.2005.10.019
   Geer CB, 2007, ACTA BIOMATER, V3, P663, DOI 10.1016/j.actbio.2007.03.004
   Gessmann J, 2013, LANGENBECK ARCH SURG, V398, P161, DOI 10.1007/s00423-012-1015-8
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325
   Giovanini AF, 2011, J ORTHOP RES, V29, P457, DOI 10.1002/jor.21263
   Giovanini AF, 2010, BONE, V46, P1597, DOI 10.1016/j.bone.2010.02.026
   Gobbi G, 2003, BRIT J HAEMATOL, V121, P892, DOI 10.1046/j.1365-2141.2003.04369.x
   GOLD HK, 1991, CIRCULATION, V83, P26
   GOLINO P, 1989, CIRCULATION, V79, P154, DOI 10.1161/01.CIR.79.1.154
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grageda Edgar, 2004, Implant Dent, V13, P301
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Haemostasis Minors D. S., 2004, ANAESTH INTENSIVE CA, V5, P189
   Hale BW, 2012, AM J VET RES, V73, P313, DOI 10.2460/ajvr.73.2.313
   Handt S, 1996, BLOOD, V87, P4204
   HANTGAN RR, 1990, BLOOD, V76, P345
   Harwood P J, 2010, ORTHOP TRAUMA, V24, P9
   He S, 2005, BLOOD COAGUL FIBRIN, V16, P61, DOI 10.1097/00001721-200501000-00010
   Hench J. W., 2005, BIOMATERIALS ARTIFIC, P71
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   Horne MK, 2006, BRIT J HAEMATOL, V133, P403, DOI 10.1111/j.1365-2141.2006.06047.x
   HOSGOOD G, 1993, VET SURG, V22, P490, DOI 10.1111/j.1532-950X.1993.tb00426.x
   Iwata H, 2004, BIOCHEM BIOPH RES CO, V316, P65, DOI 10.1016/j.bbrc.2004.02.020
   Jahagirdar R., 2009, SURGERY, V27, P63
   Jambor C, 2009, ANESTH ANALG, V109, P1023, DOI 10.1213/ANE.0b013e3181b5a263
   JANG IK, 1989, CIRCULATION, V79, P920, DOI 10.1161/01.CIR.79.4.920
   Jerome WG, 2005, MICROSC MICROANAL, V11, P268, DOI 10.1017/S143192760505052X
   Jirouskova M, 1997, THROMB HAEMOSTASIS, V78, P1125
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   KELLS AF, 1995, CONNECT TISSUE RES, V31, P117, DOI 10.3109/03008209509028399
   Kim BS, 2013, J BIOMED MATER RES A, V101, P2661, DOI 10.1002/jbm.a.34567
   Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]
   Ko CL, 2013, MAT SCI ENG C-MATER, V33, P3537, DOI 10.1016/j.msec.2013.04.042
   Korbut R, 1995, J PHYSIOL PHARMACOL, V46, P409
   Kundu AK, 2009, TISSUE ENG PT A, V15, P273, DOI 10.1089/ten.tea.2008.0055
   Lacoste E, 2003, J PERIODONTOL, V74, P1498, DOI 10.1902/jop.2003.74.10.1498
   Lai BFL, 2010, BIOMATERIALS, V31, P5749, DOI 10.1016/j.biomaterials.2010.03.076
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Lee CSD, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt126
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Lozada J L, 2001, J Oral Implantol, V27, P38, DOI 10.1563/1548-1336(2001)027<0038:PPAISG>2.3.CO;2
   Gimeno FL, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-18
   Machlus KR, 2009, THROMB HAEMOSTASIS, V102, P936, DOI 10.1160/TH09-03-0180
   Mann KG, 2003, J THROMB HAEMOST, V1, P1504, DOI 10.1046/j.1538-7836.2003.00298.x
   Marieb E. N., 2001, BONE SKELETAL TISSUE, P172
   Martineau I, 2004, BIOMATERIALS, V25, P4489, DOI 10.1016/j.biomaterials.2003.11.013
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Medved L, 2003, THROMB HAEMOSTASIS, V89, P409
   Messora MR, 2008, J PERIODONTAL RES, V43, P217, DOI 10.1111/j.1600-0765.2007.01017.x
   Meyer U, 2004, INT J ORAL MAX SURG, V33, P325, DOI 10.1016/S0901-5027(03)00199-1
   Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/CIR.0000033221.73082.06
   Mooren RECM, 2007, INT J ORAL MAX SURG, V36, P626, DOI 10.1016/j.ijom.2007.03.013
   MORGENSTERN E, 1984, THROMB RES, V33, P617, DOI 10.1016/0049-3848(84)90116-6
   Moroz A, 2013, PLATELETS, V24, P219, DOI 10.3109/09537104.2012.686255
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001
   Muraglia A, 2014, PLATELETS, V25, P211, DOI 10.3109/09537104.2013.803529
   NAIR CH, 1991, THROMB RES, V61, P315, DOI 10.1016/0049-3848(91)90109-A
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Nurden AT, 2007, THROMB HAEMOSTASIS, V98, P49, DOI 10.1160/TH07-04-0262
   Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720
   OKADA M, 1985, J BIOL CHEM, V260, P1811
   ONUNDARSON PT, 1992, J LAB CLIN MED, V120, P120
   Oprea WE, 2003, J CRANIOFAC SURG, V14, P292, DOI 10.1097/00001665-200305000-00006
   Ovanesov MV, 2005, J THROMB HAEMOST, V3, P321, DOI 10.1111/j.1538-7836.2005.01128.x
   Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062
   PARISE P, 1991, BLOOD COAGUL FIBRIN, V2, P749, DOI 10.1097/00001721-199112000-00009
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   PETERSEN LC, 1992, THROMB HAEMOSTASIS, V67, P537
   Peyrou V., 1999, CONTRIBUTION ERYTHRO
   Van Pham P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt277
   PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403
   Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x
   Plescia J, 1996, BIOCHEM J, V319, P873, DOI 10.1042/bj3190873
   Rai B, 2007, J BIOMED MATER RES A, V81A, P888, DOI 10.1002/jbm.a.31142
   Rand ML, 2010, AM J HEMATOL, V85, P584, DOI 10.1002/ajh.21768
   Renne Thomas, 2007, Expert Rev Cardiovasc Ther, V5, P733, DOI 10.1586/14779072.5.4.733
   Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301
   Hernandez JCR, 2009, MACROMOL BIOSCI, V9, P766, DOI 10.1002/mabi.200800332
   Rojkjaer LP, 2007, HEMATOL ONCOL CLIN N, V21, P25, DOI 10.1016/j.hoc.2006.11.001
   Roukis TS, 2006, ADV THER, V23, P218, DOI 10.1007/BF02850128
   Roussy Y, 2007, CLIN ORAL IMPLAN RES, V18, P639, DOI 10.1111/j.1600-0501.2007.01385.x
   Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Sauls DL, 2003, J THROMB HAEMOST, V1, P300, DOI 10.1046/j.1538-7836.2003.00053.x
   Schliephake H., 2009, INT J ORAL MAXILLOF, V38, P413
   Schmugge M, 2003, TRANSFUS APHER SCI, V28, P269, DOI 10.1016/S1473-0502(03)00046-6
   Scott EM, 2004, ARTERIOSCL THROM VAS, V24, P1558, DOI 10.1161/01.ATV.0000136649.83297.bf
   SHAH GA, 1982, BIOPOLYMERS, V21, P1037, DOI 10.1002/bip.360210604
   Shiu HT, 2014, J MATER CHEM B, V2, P3009, DOI 10.1039/c4tb00009a
   Simonpieri A, 2012, CURR PHARM BIOTECHNO, V13, P1231, DOI 10.2174/138920112800624472
   Sit PS, 2001, SURF SCI, V491, P421, DOI 10.1016/S0039-6028(01)01308-5
   Sivaraman B, 2011, BIOMATERIALS, V32, P5365, DOI 10.1016/j.biomaterials.2011.04.011
   SLATER M, 1995, J ORTHOP RES, V13, P655, DOI 10.1002/jor.1100130504
   Smyth SS, 2009, J THROMB HAEMOST, V7, P1759, DOI 10.1111/j.1538-7836.2009.03586.x
   Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003
   Street J, 2000, CLIN ORTHOP RELAT R, P224
   Sugimoto M, 2002, INT J HEMATOL, V75, P19, DOI 10.1007/BF02981974
   Sundaram S, 1996, BIOMATERIALS, V17, P1041, DOI 10.1016/0142-9612(96)84681-3
   Swennen G. R. J., 2004, INT J ORAL MAXILLOF, V34, P294
   Terasawa F, 2006, THROMB RES, V118, P651, DOI 10.1016/j.thromres.2005.10.013
   Thor A, 2007, BIOMATERIALS, V28, P966, DOI 10.1016/j.biomaterials.2006.10.020
   Tomoyasu A, 2007, BIOCHEM BIOPH RES CO, V361, P62, DOI 10.1016/j.bbrc.2007.06.142
   Tosounidis T, 2009, TRAUMA, V11, P145, DOI 10.1177/1460408609335922
   Tsiridis E., 2006, HDB FRACTURES, P49
   ULEVITCH RJ, 1980, J IMMUNOL, V124, P2027
   Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028
   Undas A, 2010, THROMB RES, V125, P357, DOI 10.1016/j.thromres.2009.11.013
   Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380
   VALLES J, 1991, BLOOD, V78, P154
   Van Den Dolder J, 2006, TISSUE ENG, V12, P3067, DOI 10.1089/ten.2006.12.3067
   Veklich Y, 1998, BLOOD, V92, P4721
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Walkowiak B, 2000, THROMB RES, V99, P495, DOI 10.1016/S0049-3848(00)00282-6
   Wang H, 2007, J PHYS CHEM C, V111, P8504, DOI 10.1021/jp066960a
   Weibrich G, 2004, BONE, V34, P665, DOI 10.1016/j.bone.2003.12.010
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x
   Wolberg AS, 2010, HAEMOPHILIA, V16, P7, DOI 10.1111/j.1365-2516.2010.02253.x
   Wolberg AS, 2008, TRANSFUS APHER SCI, V38, P15, DOI 10.1016/j.transci.2007.12.005
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wolberg AS, 2005, BRIT J HAEMATOL, V131, P645, DOI 10.1111/j.1365-2141.2005.05820.x
   Xiao Y, 2004, J Int Acad Periodontol, V6, P81
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Xiao Y, 2001, J PERIODONTOL, V72, P849, DOI 10.1902/jop.2001.72.7.849
   Xie XT, 2012, BIOMATERIALS, V33, P7008, DOI 10.1016/j.biomaterials.2012.06.058
   Yamada Y, 2010, TISSUE ENG PT A, V16, P1891, DOI 10.1089/ten.TEA.2009.0732
   Yarovaya GA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P13, DOI 10.1023/A:1013991828598
   Yoshida E, 2001, THROMB HAEMOSTASIS, V86, P1521
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
NR 205
TC 24
Z9 25
U1 3
U2 46
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD DEC 1
PY 2014
VL 20
IS 6
BP 697
EP 712
DI 10.1089/ten.teb.2013.0709
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AT8TQ
UT WOS:000345205200011
PM 24906469
DA 2018-10-20
ER

PT J
AU Gilchrist, CL
   Ruch, DS
   Little, D
   Guilak, F
AF Gilchrist, Christopher L.
   Ruch, David S.
   Little, Dianne
   Guilak, Farshid
TI Micro-scale and meso-scale architectural cues cooperate and compete to
   direct aligned tissue formation
SO BIOMATERIALS
LA English
DT Article
DE Micropatterning; Actin; Tendon; Nanotopography; Mesenchymal stem cell;
   Ligament
ID COLLECTIVE CELL-MIGRATION; MESENCHYMAL STEM-CELLS; CONTACT GUIDANCE;
   ENDOTHELIAL TUBULOGENESIS; TOPOGRAPHICAL CONTROL; EXTRACELLULAR-MATRIX;
   GEOMETRIC CONTROL; DIFFERENTIATION; HYDROGELS; BEHAVIOR
AB Tissue and biomaterial microenvironments provide architectural cues that direct important cell behaviors including cell shape, alignment, migration, and resulting tissue formation. These architectural features may be presented to cells across multiple length scales, from nanometers to millimeters in size. In this study, we examined how architectural cues at two distinctly different length scales, "micro-scale" cues on the order of similar to 1-2 mu m, and "meso-scale" cues several orders of magnitude larger (>100 mu m), interact to direct aligned neo-tissue formation. Utilizing a micro-photopatterning (mu PP) model system to precisely arrange cell-adhesive patterns, we examined the effects of substrate architecture at these length scales on human mesenchymal stem cell (hMSC) organization, gene expression, and fibrillar collagen deposition. Both micro- and meso-scale architectures directed cell alignment and resulting tissue organization, and when combined, meso cues could enhance or compete against micro-scale cues. As meso boundary aspect ratios were increased, meso-scale cues overrode micro-scale cues and controlled tissue alignment, with a characteristic critical width (similar to 500 mu m) similar to boundary dimensions that exist in vivo in highly aligned tissues. Meso-scale cues acted via both lateral confinement (in a cell-density-dependent manner) and by permitting end-to-end cell arrangements that yielded greater fibrillar collagen deposition. Despite large differences in fibrillar collagen content and organization between mu PP architectural conditions, these changes did not correspond with changes in gene expression of key matrix or tendon-related genes. These findings highlight the complex interplay between geometric cues at multiple length scales and may have implications for tissue engineering strategies, where scaffold designs that incorporate cues at multiple length scales could improve neo-tissue organization and resulting functional outcomes. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Gilchrist, Christopher L.; Ruch, David S.; Little, Dianne; Guilak, Farshid] Duke Univ, Dept Orthopaed Surg, Med Ctr, Durham, NC 27710 USA.
   [Guilak, Farshid] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
RP Guilak, F (reprint author), Duke Univ, Dept Orthopaed Surg, Med Ctr, MSRB 375,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Little, Dianne/H-5994-2011
OI Little, Dianne/0000-0002-6948-2453; Guilak, Farshid/0000-0001-7380-0330
FU Synthes USA; NIH [AR065888, AR059784, AR065764, AG15768, AR48182,
   AR50245, AR48852, AG46927]
FX This study was supported in part by Synthes USA (unrestricted
   fellowship), NIH grants AR065888, AR059784, AR065764, AG15768, AR48182,
   AR50245, AR48852, and AG46927. The authors thank Dan Sykora for help
   with image analysis and Dr. Holly Leddy for help with statistical
   analyses.
CR Angelini TE, 2011, P NATL ACAD SCI USA, V108, P4714, DOI 10.1073/pnas.1010059108
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Birk DE, 1997, EUR J CELL BIOL, V72, P352
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chainani A, 2013, TISSUE ENG PT A, V19, P2594, DOI [10.1089/ten.tea.2013.0165, 10.1089/ten.TEA.2013.0165]
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chou CL, 2013, TISSUE ENG PT A, V19, P1081, DOI [10.1089/ten.tea.2012.0177, 10.1089/ten.TEA.2012.0177]
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Derwin KA, 1999, J BIOMECH ENG-T ASME, V121, P598, DOI 10.1115/1.2800859
   DICKINSON RB, 1994, ANN BIOMED ENG, V22, P342, DOI 10.1007/BF02368241
   Doxzen K, 2013, INTEGR BIOL-UK, V5, P1026, DOI 10.1039/c3ib40054a
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Duclos G, 2014, SOFT MATTER, V10, P2346, DOI 10.1039/c3sm52323c
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Gallant ND, 2007, J NANOSCI NANOTECHNO, V7, P803, DOI 10.1166/jnn.2007.507
   Garrigues NW, 2010, J MATER CHEM, V20, P8962, DOI 10.1039/c0jm01880e
   Gjorevski N, 2012, BIOPHYS J, V103, P152, DOI 10.1016/j.bpj.2012.05.048
   Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545
   Guilak F, 2014, J BIOMECH, V47, P1933, DOI 10.1016/j.jbiomech.2014.04.019
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Kalson NS, 2013, P NATL ACAD SCI USA, V110, pE4743, DOI 10.1073/pnas.1314348110
   Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006
   Klumpers DD, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0215
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   Kshitiz, 2012, INTEGR BIOL-UK, V4, P1008, DOI 10.1039/c2ib20080e
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Legant WR, 2009, P NATL ACAD SCI USA, V106, P10097, DOI 10.1073/pnas.0900174106
   Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]
   Li B, 2009, J BIOMECH, V42, P1622, DOI 10.1016/j.jbiomech.2009.04.033
   Li JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035003
   Londono C, 2014, P NATL ACAD SCI USA, V111, P1807, DOI 10.1073/pnas.1321852111
   Lopez-Bosque MJ, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/25/255305
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07
   Riley GP, 1996, AM J PATHOL, V149, P933
   Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432
   Seunarine K, 2009, IEEE T NANOBIOSCI, V8, P219, DOI 10.1109/TNB.2009.2016477
   STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8
   Thorpe CT, 2013, EUR CELLS MATER, V25, P48, DOI 10.22203/eCM.v025a04
   WOJCIAKSTOTHARD B, 1995, CELL BIOL INT, V19, P485, DOI 10.1006/cbir.1995.1092
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
NR 56
TC 28
Z9 29
U1 1
U2 86
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2014
VL 35
IS 38
BP 10015
EP 10024
DI 10.1016/j.biomaterials.2014.08.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS3WY
UT WOS:000344207100003
PM 25263687
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Huang, YJ
   Hsu, SH
AF Huang, Yen-Jang
   Hsu, Shan-hui
TI Acquisition of epithelial-mesenchymal transition and cancer stem-like
   phenotypes within chitosan-hyaluronan membrane-derived 3D tumor
   spheroids
SO BIOMATERIALS
LA English
DT Article
DE Tumor spheroids; Hyaluronan; Cancer stem cell; Epithelial-mesenchymal
   transition; Multidrug resistance
ID CELL LUNG-CANCER; PROGNOSTIC VALUE; DRUG-RESISTANCE; MICROENVIRONMENT;
   SCAFFOLDS; CD44; ADENOCARCINOMA; BIOMATERIALS; COMBINATION; EXPRESSION
AB Cancer drug development has to go through rigorous testing and evaluation processes during pre-clinical in vitro studies. However, the conventional two-dimensional (2D) in vitro culture is often discounted by the insufficiency to present a more typical tumor microenvironment. The multicellular tumor spheroids have been a valuable model to provide more comprehensive assessment of tumor in response to therapeutic strategies. Here, we applied chitosan-hyaluronan (HA) membranes as a platform to promote three-dimensional (3D) tumor spheroid formation. The biological features of tumor spheroids of human non-small cell lung cancer (NSCLC) cells on chitosan-HA membranes were compared to those of 2D cultured cells in vitro. The cells in tumor spheroids cultured on chitosan-HA membranes showed higher levels of stem-like properties and epithelial mesenchymal transition (EMT) markers, such as NANOG, SOX2, CD44, CD133, N-cadherin, and vimentin, than 2D cultured cells. Moreover, they exhibited enhanced invasive activities and multidrug resistance by the upregulation of MMP2, MMP9, BCRC5, BCL2, MDR1, and ABCG2 as compared with 2D cultured cells. The grafting densities of HA affected the tumor sphere size and mRNA levels of genes on the substrates. These evidences suggest that chitosan-HA membranes may offer a simple and valuable biomaterial platform for rapid generation of tumor spheroids in vitro as well as for further applications in cancer stem cell research and cancer drug screening. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Huang, Yen-Jang; Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
   [Hsu, Shan-hui] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4 Roosevelt Rd, Taipei 10617, Taiwan.
EM shhsu@mail.nchu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU Program for Stem Cell and Regenerative Medicine Frontier Research -
   National Science Council Taiwan (NSC), Taiwan [NSC102-2321-B-002-033]
FX This research was supported by the Program for Stem Cell and
   Regenerative Medicine Frontier Research (NSC102-2321-B-002-033)
   sponsored by the National Science Council Taiwan (NSC), Taiwan. We are
   grateful to Dr. Yuh-Shan Jou for his assistance with A549 and H1299
   cells.
CR Alamgeer M, 2013, RESPIROLOGY, V18, P757, DOI 10.1111/resp.12094
   Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92
   Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328
   Chow G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/485468
   Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
   Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590
   Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15
   Fan YL, 2013, ONCOL LETT, V6, P1174, DOI 10.3892/ol.2013.1555
   Florczyk SJ, 2013, BIOMATERIALS, V34, P10143, DOI 10.1016/j.biomaterials.2013.09.034
   GAZE MN, 1992, BRIT J CANCER, V66, P1048, DOI 10.1038/bjc.1992.408
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Hsu SH, 2013, BIOMATERIALS, V34, P4725, DOI 10.1016/j.biomaterials.2013.03.031
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763
   Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655
   Kimlin LC, 2013, MOL CARCINOGEN, V52, P167, DOI 10.1002/mc.21844
   Kong Dejuan, 2011, Cancers (Basel), V3, P716, DOI 10.3390/cancers30100716
   Lee J, 2009, BIOMATERIALS, V30, P4687, DOI 10.1016/j.biomaterials.2009.05.024
   Lenartz D, 1998, ANTICANCER RES, V18, P1011
   Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045
   Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893
   Okudela K, 2012, PATHOL INT, V62, P792, DOI 10.1111/pin.12019
   Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x
   Pallier K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029954
   Pirinen R, 2001, INT J CANCER, V95, P12, DOI 10.1002/1097-0215(20010120)95:1<12::AID-IJC1002>3.0.CO;2-E
   Ramalingam S, 2008, ONCOLOGIST, V13, P5, DOI 10.1634/theoncologist.13-S1-5
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Ryu HS, 2012, HUM PATHOL, V43, P520, DOI 10.1016/j.humpath.2011.07.003
   Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460
   Siegel R, 2012, CA-CANCER J CLIN, V2012, P10, DOI DOI 10.3322/CAAC.20138
   Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215
   Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Torisawa YS, 2005, ONCOL REP, V13, P1107
   Wang T, 2014, ONCOL LETT, V7, P1102, DOI 10.3892/ol.2014.1816
   Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209
   Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023
NR 37
TC 29
Z9 30
U1 2
U2 67
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2014
VL 35
IS 38
BP 10070
EP 10079
DI 10.1016/j.biomaterials.2014.09.010
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS3WY
UT WOS:000344207100008
PM 25282622
DA 2018-10-20
ER

PT J
AU Wang, LP
   Ren, J
   Yao, MQ
   Yang, XC
   Yang, W
   Li, Y
AF Wang, Li-ping
   Ren, Jie
   Yao, Meng-qi
   Yang, Xiao-ci
   Yang, Wu
   Li, Yan
TI Synthesis and characterization of self-oscillating P(AA-co-AM)/PEG
   semi-IPN hydrogels based on a pH oscillator in closed system
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE P(AA-co-AM)/PEG semi-IPN hydrogel; Self-oscillating; pH-responsive
ID POLYMER GEL; POLY(ETHYLENE GLYCOL); ENZYME IMMOBILIZATION;
   DRUG-DELIVERY; TRANSPORT; BEHAVIOR; DESIGN; MOTION; CHAINS; ACID
AB Various semi-interpenetrating polymer network (semi-IPN) hydrogels composed of pore-forming agent polyethylene glycol (PEG), acrylic acid (AA) and acrylamide (AM) were prepared by using free radical polymerization with a two-step method. The chemical structures of the synthesized hydrogels were characterized by FTIR spectroscopy and the morphologies were studied by scanning electron microscopy (SEM) method. The swelling properties, such as the pH-responsive behavior, salt sensitivity, oscillatory swelling/de-swelling behaviors in different solutions with various pH values and self-oscillating behaviors in bath pH oscillator were investigated in detail. The results revealed that the prepared hydrogels exhibited high pH sensitivity and excellent salt sensitivity when the pH values of the medium changes from 3.0 and 7.0 and well reversible properties by undergoing a number of swelling/de-swelling recycles. In particular, the hydrogels exhibited self-oscillation behavior in a closed system containing BrO3 -SO3 Fe2-(CN)(6) H-4-(+). This study may create a new possibility as biomaterial for new self-walking actuators and other devices.
C1 [Wang, Li-ping; Ren, Jie; Yao, Meng-qi; Yang, Xiao-ci; Yang, Wu; Li, Yan] Northwest Normal Univ, Chem & Chem Engn Coll, Key Lab Bioelectrochemtry & Environm Anal Gansu, Lanzhou 730070, Peoples R China.
RP Ren, J (reprint author), Northwest Normal Univ, Chem & Chem Engn Coll, Key Lab Bioelectrochemtry & Environm Anal Gansu, Lanzhou 730070, Peoples R China.
EM jieren@nwnu.edu.cn
FU Basic Project of Science and Research of Colleges and Universities of
   Gansu Province [5001-109]; Natural Science Foundation of Gansu Province
   [1010 RJZA015]
FX This work was financially supported by the Basic Project of Science and
   Research of Colleges and Universities of Gansu Province (No. 5001-109),
   the Natural Science Foundation of Gansu Province (No. 1010 RJZA015).
CR Bong KW, 2010, LANGMUIR, V26, P8008, DOI 10.1021/la904903g
   Crook CJ, 2002, PHYS CHEM CHEM PHYS, V4, P1367, DOI 10.1039/b109977a
   Dhara D, 1999, J PHYS CHEM B, V103, P8458, DOI 10.1021/jp990443t
   FIELD RJ, 1972, J AM CHEM SOC, V94, P8649, DOI 10.1021/ja00780a001
   FLORY PJ, 1957, J POLYM SCI, V25, P429, DOI 10.1002/pol.1957.1202511104
   Horta A, 2009, MACROMOLECULES, V42, P1285, DOI 10.1021/ma802204b
   Ji L, 2012, J PHYS CHEM A, V116, P7462, DOI 10.1021/jp3024364
   Jin S., 2010, J AGR FOOD CHEM, V59, P322
   Kizilay MY, 2003, MACROMOLECULES, V36, P6856, DOI 10.1021/ma021366u
   KOKUFUTA E, 1992, MACROMOLECULES, V25, P3549, DOI 10.1021/ma00039a038
   Kuksenok O, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041406
   Kwan RCH, 2005, SENSOR ACTUAT B-CHEM, V107, P616, DOI 10.1016/j.snb.2004.11.028
   Lee Y, 2008, POLYM ADVAN TECHNOL, V19, P852, DOI 10.1002/pat.1047
   Li H, 2009, LANGMUIR, V25, P13142, DOI 10.1021/la901833m
   Liu TY, 2006, LANGMUIR, V22, P5974, DOI 10.1021/la060371e
   Liu XY, 2012, POLYM INT, V61, P1144, DOI 10.1002/pi.4192
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mirfakhrai T, 2007, MATER TODAY, V10, P30, DOI 10.1016/S1369-7021(07)70048-2
   Mitsumata T, 2000, LANGMUIR, V16, P307, DOI 10.1021/la990483o
   Murase Y, 2009, LANGMUIR, V25, P483, DOI 10.1021/la8029006
   Myung D, 2007, BIOMED MICRODEVICES, V9, P911, DOI 10.1007/s10544-006-9040-4
   Nakamaru S, 2009, J PHYS CHEM B, V113, P4609, DOI 10.1021/jp811228y
   Nguyen MK, 2010, MACROMOL RES, V18, P284, DOI 10.1007/s13233-010-0315-5
   Ninawe PR, 2012, IND ENG CHEM RES, V51, P1741, DOI 10.1021/ie200118y
   NOSZTICZIUS Z, 1979, J AM CHEM SOC, V101, P3177, DOI 10.1021/ja00506a007
   Pizzorusso G, 2012, LANGMUIR, V28, P3952, DOI 10.1021/la2044619
   Shiota T, 2013, J PHYS CHEM B, V117, P2215, DOI 10.1021/jp311993z
   Szanto TG, 2005, J PHYS CHEM A, V109, P5398, DOI 10.1021/jp050833h
   Tang QW, 2009, J MATER SCI, V44, P3712, DOI 10.1007/s10853-009-3496-6
   Taniguchi H, 2010, J PHYS CHEM B, V114, P2405, DOI 10.1021/jp911779j
   Tateyama S, 2008, J PHYS CHEM B, V112, P1777, DOI 10.1021/jp709882h
   Wu W, 2010, REACT FUNCT POLYM, V70, P684, DOI 10.1016/j.reactfunctpolym.2010.06.002
   Yoshida R, 2002, J AM CHEM SOC, V124, P8095, DOI 10.1021/ja012584q
   Zhang JP, 2006, REACT FUNCT POLYM, V66, P747, DOI 10.1016/j.reactfunctpolym.2005.11.002
   Zhang YX, 2005, POLYMER, V46, P7695, DOI 10.1016/j.polymer.2005.05.121
NR 35
TC 3
Z9 4
U1 4
U2 54
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
EI 1439-6203
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD DEC
PY 2014
VL 32
IS 12
BP 1581
EP 1589
DI 10.1007/s10118-014-1552-4
PG 9
WC Polymer Science
SC Polymer Science
GA AS9CZ
UT WOS:000344542100001
DA 2018-10-20
ER

PT J
AU You, RC
   Li, XF
   Liu, Y
   Liu, GY
   Lu, SZ
   Li, MZ
AF You, Renchuan
   Li, Xiufang
   Liu, Yu
   Liu, Guiyang
   Lu, Shenzhou
   Li, Mingzhong
TI Response of filopodia and lamellipodia to surface topography on
   micropatterned silk fibroin films
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell-surface interactions; silk fibroin; micropatterned biomaterial;
   filopodia; lamellipodia
ID MESENCHYMAL STEM-CELLS; CONTACT GUIDANCE; ASPECT-RATIO; IN-VITRO;
   DIFFERENTIATION; BIOMATERIALS; EXTENSION; BEHAVIOR; NEURONS; TENSION
AB Cell-microstructure surface interactions play a significant role in tissue engineering to guide cell spreading and migration. However, the mechanisms underlying cell-topography interactions are complex and remain elusive. To address this topic, microsphere array patterns were prepared on silk fibroin films through polystyrene microsphere self-assembly, followed by culturing rat bone marrow derived mesenchymal stem cells on the films to study cell-substrate interactions. Filopodia sensed and anchored to the microspheres to form initial attachments before spreading. Importantly, the anchored filopodia converted into lamellipodia, and this conversion initiated the directional formation of lamellipodia. Therefore, the conversion of exploratory filopodia into lamellipodia was the main driving force for directional extension of the lamellipodia. Correspondingly, cell spreading, morphology, and migration were modulated by pseudopodial recognition and conversion. This finding demonstrated that filopodia not only act as an antenna to detect microenvironment but also serve as skeleton to guide lamellipodial extension for directing cell motions. The micropatterned films promoted cell adhesion and proliferation due to accelerated lamellipodia formation and cell spreading, with recognition and conversion of filopodia into lamellipodia as a critical role in cell response to surface topography. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4206-4212, 2014.
C1 [You, Renchuan; Li, Xiufang; Liu, Yu; Liu, Guiyang; Lu, Shenzhou; Li, Mingzhong] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
RP Li, MZ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, 199 Renai Rd,Ind Pk, Suzhou 215123, Peoples R China.
EM mzli@suda.edu.cn
RI Lu, Shenzhou/P-6519-2015
OI Lu, Shenzhou/0000-0003-4188-2057
FU National Nature Science Foundation of China [31370968]; Nature Science
   Foundation of Jiangsu Province [BK20131177]; College Natural Science
   Research Project of Jiangsu Province [12KJA430003]; Priority Academic
   Program Development of Jiangsu Higher Education Institutions
FX Contract grant sponsor: National Nature Science Foundation of China;
   contract grant number: 31370968; Contract grant sponsor: Nature Science
   Foundation of Jiangsu Province; contract grant number: BK20131177;
   Contract grant sponsor: College Natural Science Research Project of
   Jiangsu Province; contract grant number: 12KJA430003; Contract grant
   sponsor: Priority Academic Program Development of Jiangsu Higher
   Education Institutions
CR Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002
   Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908
   Gasiorowski JZ, 2010, BIOMATERIALS, V31, P8882, DOI 10.1016/j.biomaterials.2010.08.026
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Guillou H, 2008, EXP CELL RES, V314, P478, DOI 10.1016/j.yexcr.2007.10.026
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kang K, 2012, ANGEW CHEM INT EDIT, V51, P2855, DOI 10.1002/anie.201106271
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Mathur A, 2012, ACTA BIOMATER, V8, P2595, DOI 10.1016/j.actbio.2012.03.025
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nam HJ, 2006, LANGMUIR, V22, P7358, DOI 10.1021/la053083b
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127
   Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010
   Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1
   Su WT, 2013, J BIOMED MATER RES A, V101, P185, DOI 10.1002/jbm.a.34318
   Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174
   Tay CY, 2011, SMALL, V7, P1361, DOI 10.1002/smll.201100046
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XL, 2013, J BIOMED MATER RES A, V101, P3388, DOI 10.1002/jbm.a.34645
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Zhang Q, 2012, ACTA BIOMATER, V8, P2628, DOI 10.1016/j.actbio.2012.03.033
NR 35
TC 14
Z9 14
U1 1
U2 41
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4206
EP 4212
DI 10.1002/jbm.a.35097
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500002
PM 24464986
DA 2018-10-20
ER

PT J
AU Browning, MB
   Cereceres, SN
   Luong, PT
   Cosgriff-Hernandez, EM
AF Browning, M. B.
   Cereceres, S. N.
   Luong, P. T.
   Cosgriff-Hernandez, E. M.
TI Determination of the in vivo degradation mechanism of PEGDA hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(ethylene glycol); hydrogel; in vivo degradation; hydrolysis;
   oxidation
ID POLY(ETHYLENE GLYCOL) HYDROGEL; CHOLESTEROL ESTERASE;
   POLYETHYLENE-GLYCOL; TISSUE; BIODEGRADATION; BIOCOMPATIBILITY;
   COMPLEMENT; SURFACES; BEHAVIOR; RELEASE
AB Poly(ethylene glycol) (PEG) hydrogels are one of the most extensively utilized biomaterials systems due to their established biocompatibility and highly tunable properties. It is widely acknowledged that traditional acrylate-derivatized PEG (PEGDA) hydrogels are susceptible to slow degradation in vivo and are therefore unsuitable for long-term implantable applications. However, there is speculation whether the observed degradation is due to hydrolysis of endgroup acrylate esters or oxidation of the ether backbone, both of which are possible in the foreign body response to implanted devices. PEG diacrylamide (PEGDAA) is a polyether-based hydrogel system with similar properties to PEGDA but with amide linkages in place of the acrylate esters. This provides a hydrolytically-stable control that can be used to isolate the relative contributions of hydrolysis and oxidation to the in vivo degradation of PEGDA. Here we show that PEGDAA hydrogels remained stable over 12 weeks of subcutaneous implantation in a rat model while PEGDA hydrogels underwent significant degradation as indicated by both increased swelling ratio and decreased modulus. As PEGDA and PEGDAA have similar susceptibility to oxidation, these results demonstrate for the first time that the primary in vivo degradation mechanism of PEGDA is hydrolysis of the endgroup acrylate esters. Additionally, the maintenance of PEGDAA hydrogel properties in vivo indicates their suitability for long-term implants. These studies serve to elucidate key information about a widely used biomaterial system to allow for better implantable device design and to provide a biostable replacement option for PEGDA in applications that require long-term stability. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4244-4251, 2014.
C1 [Browning, M. B.; Cereceres, S. N.; Luong, P. T.; Cosgriff-Hernandez, E. M.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP Cosgriff-Hernandez, EM (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
EM cosgriff.hernandez@tamu.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIH [R01 EB013297]; National Science Foundation Graduate Research
   Fellowship Program
FX This work was supported by NIH R01 EB013297 and by the National Science
   Foundation Graduate Research Fellowship Program.
CR Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Benoit DSW, 2006, TISSUE ENG, V12, P1663, DOI 10.1089/ten.2006.12.1663
   Browning MB, 2011, J BIOMED MATER RES A, V98A, P268, DOI 10.1002/jbm.a.33109
   Browning MB, 2012, BIOMACROMOLECULES, V13, P779, DOI 10.1021/bm201707z
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Christenson EM, 2007, CORROS ENG SCI TECHN, V42, P312, DOI 10.1179/174327807X238909
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Deible CR, 1998, BIOMATERIALS, V19, P1885, DOI 10.1016/S0142-9612(98)00098-2
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hawkins AM, 2011, J APPL POLYM SCI, V122, P1420, DOI 10.1002/app.34093
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hudalla GA, 2008, BIOMACROMOLECULES, V9, P842, DOI 10.1021/bm701179s
   HYUN J, 1972, ARCH BIOCHEM BIOPHYS, V152, P233, DOI 10.1016/0003-9861(72)90211-1
   HYUN J, 1971, BIOCHEM BIOPH RES CO, V44, P819, DOI 10.1016/0006-291X(71)90784-4
   LARSEN IB, 1991, SCAND J DENT RES, V99, P254
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lynn AD, 2009, J BIOMED MATER RES A, V93A, P941
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2008, PROG POLYM SCI, V33, P167, DOI 10.1016/j.progpolymsci.2007.09.006
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Reid B, J TISSUE ENG REGEN M
   Reid B, 2010, MACROMOLECULES, V43, P9588, DOI 10.1021/ma1020648
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   Schoenmakers RG, 2004, J CONTROL RELEASE, V95, P291, DOI 10.1016/j.jconrel.2003.12.009
   WEST JL, 1995, REACT POLYM, V25, P139, DOI 10.1016/0923-1137(94)00096-N
NR 42
TC 50
Z9 50
U1 6
U2 68
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4244
EP 4251
DI 10.1002/jbm.a.35096
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500006
PM 24464985
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cohen, HC
   Lieberthal, TJ
   Kao, WJ
AF Cohen, Hannah Caitlin
   Lieberthal, Tyler Jacob
   Kao, W. John
TI Poly(ethylene glycol)-containing hydrogels promote the release of
   primary granules from human blood-derived polymorphonuclear leukocytes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Neutrophil; acute inflammation; degranulation; myeloperoxidase; matrix
   metalloproteinase-9; poly(ethylene glycol)
ID ADHERENT HUMAN NEUTROPHILS; MONOCYTE ACTIVATION; ENDOTHELIAL-CELLS;
   CATHEPSIN-G; ADHESION; INTEGRIN; DEGRANULATION; PROTEINS; SURFACES;
   ELASTASE
AB Polymorphonuclear leukocytes (PMNs) are recruited to sites of injury and biomaterial implants. Once activated, PMNs can exocytose their granule subsets to recruit monocytes (MCs) and mediate MC/macrophage activation. We investigated the release of myeloperoxidase (MPO), a primary granule marker, and matrix metalloproteinase-9 (MMP-9), a tertiary granule marker, from human blood-derived PMNs cultured on poly(ethylene glycol) (PEG) hydrogels, polydimethylsiloxane (PDMS), tissue culture polystyrene (TCPS) and gelatin-PEG (GP) hydrogels, with and without the presence of the bacterial peptide formyl-Met-Leu-Phe. Supernatants from PMN cultures on PEG-containing hydrogels (i.e., PEG and GP hydrogels) had higher concentrations of MPO than those from PMN cultures on PDMS or TCPS at 2 h. PMNs on all biomaterials released comparable levels of MMP-9 at 2 h, indicating that PMNs cultured on PEG-containing hydrogels have different mechanisms of release for primary and tertiary granules. Src family kinases were involved in the release of MPO from PMNs cultured on PEG hydrogels, TCPS and GP hydrogels and in the release of MMP-9 from PMNs cultured on all four biomaterials. The increased release of primary granules from PMNs on PEG-containing hydrogels did not significantly increase MC chemotaxis, indicating that additional co-effectors in the dynamic inflammatory milieu in vivo modulate PMN-mediated MC recruitment. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4252-4261, 2014.
C1 [Cohen, Hannah Caitlin; Kao, W. John] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, Madison, WI 53705 USA.
   [Lieberthal, Tyler Jacob; Kao, W. John] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Kao, W. John] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53792 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@wisc.edu
OI Lieberthal, Tyler/0000-0002-3250-8162
FU Department of Defense through a National Defense Science and Engineering
   Graduate fellowship [NIH HL115482]
FX Contract grant sponsor: Department of Defense through a National Defense
   Science and Engineering Graduate fellowship (to H. C.); contract grant
   number: NIH HL115482
CR Abdel-Latif D, 2005, CAN J PHYSIOL PHARM, V83, P69, DOI 10.1139/Y04-123
   Abdel-Latif D, 2004, BLOOD, V104, P832, DOI 10.1182/blood-2003-07-2624
   Ahrens D, 1996, ARTHRITIS RHEUM, V39, P1576, DOI 10.1002/art.1780390919
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897
   Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BORREGAARD N, 1993, EUR J HAEMATOL, V51, P187
   Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353
   Chaly YV, 2000, EUR CYTOKINE NETW, V11, P257
   Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739
   Cohen HC, 2013, AM J PATHOL, V182, P2180, DOI 10.1016/j.ajpath.2013.02.022
   DORING G, 1994, AM J RESP CRIT CARE, V150, pS114
   Faurschou M, 2002, BBA-MOL CELL RES, V1591, P29, DOI 10.1016/S0167-4889(02)00243-4
   Heinzelmann M, 1998, J IMMUNOL, V160, P5530
   Jakus Z, 2004, J IMMUNOL, V173, P2068, DOI 10.4049/jimmunol.173.3.2068
   JANUSZ MJ, 1991, J IMMUNOL, V146, P3922
   Jethwaney D, 2007, PROT SCI, V5
   Kamen LA, 2011, J IMMUNOL, V186, P1656, DOI 10.4049/jimmunol.1002093
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   LeCabec V, 1996, P NATL ACAD SCI USA, V93, P6454, DOI 10.1073/pnas.93.13.6454
   LEE JH, 1995, PROG POLYM SCI, V20, P1043, DOI 10.1016/0079-6700(95)00011-4
   Lee TD, 2003, MICROVASC RES, V66, P38, DOI 10.1016/S0026-2862(03)00010-4
   Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200
   Lowell CA, 2011, COLD SPRING HARBOR P, V3
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Mitchell T, 2008, AM J PHYSIOL-CELL PH, V295, pC1354, DOI 10.1152/ajpcell.00239.2008
   Mocsai A, 1999, J IMMUNOL, V162, P1120
   Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5
   Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407
   NGSIKORSKI J, 1991, EXP CELL RES, V195, P504, DOI 10.1016/0014-4827(91)90402-G
   PANYUTICH AV, 1995, AM J RESP CELL MOL, V12, P351, DOI 10.1165/ajrcmb.12.3.7873202
   Rainger GE, 1998, BLOOD, V92, P4819
   Rasmussen PB, 1996, FEBS LETT, V390, P109, DOI 10.1016/0014-5793(96)00639-4
   RICHTER J, 1990, P NATL ACAD SCI USA, V87, P9472, DOI 10.1073/pnas.87.23.9472
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schymeinsky J, 2007, THROMB HAEMOSTASIS, V98, P262, DOI 10.1160/TH07-02-0156
   Soehnlein O, 2008, J CLIN INVEST, V118, P3491, DOI 10.1172/JCI35740
   Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634
   Soehnlein O, 2009, J MOL MED-JMM, V87, P1157, DOI 10.1007/s00109-009-0508-6
   Soehnlein O, 2009, BLOOD, V114, P4613, DOI 10.1182/blood-2009-06-221630
   Soehnlein O, 2009, TRENDS IMMUNOL, V30, P546, DOI 10.1016/j.it.2009.06.006
   Soehnlein O, 2009, THROMB HAEMOSTASIS, V102, P198, DOI 10.1160/TH08-11-0720
   Soehnlein O, 2009, J LEUKOCYTE BIOL, V85, P344, DOI 10.1189/jlb.0808495
   Taekema-Roelvink MEJ, 2001, J AM SOC NEPHROL, V12, P932
   Takafuji S, 2003, J INVEST ALLERG CLIN, V13, P50
   TERRITO MC, 1989, J CLIN INVEST, V84, P2017, DOI 10.1172/JCI114394
   Tuluc F, 2004, AM J PHYSIOL-CELL PH, V287, pC1264, DOI 10.1152/ajpcell.00177.2004
   Waldeck H, 2012, BIOMATERIALS, V33, P29, DOI 10.1016/j.biomaterials.2011.09.044
   WALKER BAM, 1991, J IMMUNOL, V146, P735
   Wang XT, 2011, J BIOMAT SCI-POLYM E, V22, P1343, DOI 10.1163/092050610X508400
   Xu KD, 2012, ACTA BIOMATER, V8, P2504, DOI 10.1016/j.actbio.2012.03.049
   Xu X, 2002, SCAND J IMMUNOL, V55, P178, DOI 10.1046/j.1365-3083.2002.01041.x
NR 54
TC 4
Z9 4
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4252
EP 4261
DI 10.1002/jbm.a.35101
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500007
PM 24497370
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Alexandre, N
   Ribeiro, J
   Gartner, A
   Pereira, T
   Amorim, I
   Fragoso, J
   Lopes, A
   Fernandes, J
   Costa, E
   Santos-Silva, A
   Rodrigues, M
   Santos, JD
   Mauricio, AC
   Luis, AL
AF Alexandre, Nuno
   Ribeiro, Jorge
   Gaertner, Andrea
   Pereira, Tiago
   Amorim, Irina
   Fragoso, Joao
   Lopes, Ascensao
   Fernandes, Joao
   Costa, Elisio
   Santos-Silva, Alice
   Rodrigues, Miguel
   Santos, Jose Domingos
   Mauricio, Ana Colette
   Luis, Ana Lucia
TI Biocompatibility and hemocompatibility of polyvinyl alcohol hydrogel
   used for vascular grafting-In vitro and in vivo studies
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stem cells; vascular graft; polyvinyl alcohol hydrogel;
   hemocompatibility; biocompatibility; sheep model
ID MESENCHYMAL STEM-CELLS; PROMOTING NERVE REGENERATION; ACUTE INFLAMMATORY
   RESPONSES; MOLECULAR-WEIGHT DEXTRAN; FOREIGN-BODY REACTION; HUMAN
   UMBILICAL-CORD; TISSUE; BLOOD; PVA; BIOMATERIALS
AB Polyvinyl alcohol hydrogel (PVA) is a synthetic polymer with an increasing application in the biomedical field that can potentially be used for vascular grafting. However, the tissue and blood-material interactions of such gels and membranes are unknown in detail. The objectives of this study were to: (a) assess the biocompatibility and (b) hemocompatibility of PVA-based membranes in order to get some insight into its potential use as a vascular graft. PVA was evaluated isolated or in copolymerization with dextran (DX), a biopolymer with known effects in blood coagulation homeostasis. The effects of the mesenchymal stem cells (MSCs) isolated from the umbilical cord Wharton's jelly in the improvement of PVA biocompatibility and in the vascular regeneration were also assessed. The biocompatibility of PVA was evaluated by the implantation of membranes in subcutaneous tissue using an animal model (sheep). Histological samples were assessed and the biological response parameters such as polymorphonuclear neutrophilic leucocytes and macrophage scoring evaluated in the implant/tissue interface by International Standards Office (ISO) Standard 10993-6 (annex E). According to the scoring system based on those parameters, a total value was obtained for each animal and for each experimental group. The in vitro hemocompatibility studies included the classic hemolysis assay and both human and sheep bloods were used. Relatively to biocompatibility results, PVA was slightly irritant to the surrounding tissues; PVA-DX or PVA plus MSCs groups presented the lowest score according to ISO Standard 10993-6. Also, PVA was considered a nonhemolytic biomaterial, presenting the lowest values for hemolysis when associated to DX. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4262-4275, 2014.
C1 [Alexandre, Nuno; Fragoso, Joao] Univ Evora, Dept Zootecnia, P-7002554 Evora, Portugal.
   [Alexandre, Nuno] Univ Evora, Inst Ciencias Agr & Ambientais Mediterran ICAAM, P-7002554 Evora, Portugal.
   [Ribeiro, Jorge; Gaertner, Andrea; Pereira, Tiago; Mauricio, Ana Colette; Luis, Ana Lucia] Inst Ciencias & Tecnol Agr & Agroalimentares ICET, CECA, P-4051401 Oporto, Portugal.
   [Ribeiro, Jorge; Gaertner, Andrea; Pereira, Tiago; Mauricio, Ana Colette; Luis, Ana Lucia] Univ Porto, ICBAS, Dept Clin Vet, P-4050313 Oporto, Portugal.
   [Amorim, Irina] Univ Porto, ICBAS, Dept Patol & Imunol Mol, P-4050313 Oporto, Portugal.
   [Amorim, Irina] Univ Porto IPATIMUP, Inst Portugues Patol & Imunol Mol, P-4200465 Oporto, Portugal.
   [Lopes, Ascensao; Rodrigues, Miguel; Santos, Jose Domingos] Univ Porto, Fac Engn, Dept Engn Met & Mat, CEMUC, P-4200465 Oporto, Portugal.
   [Fernandes, Joao; Costa, Elisio; Santos-Silva, Alice] Univ Porto, IBMC, P-4150180 Oporto, Portugal.
   [Fernandes, Joao] Univ Coimbra, Inst Imagem Biomed & Ciencias Vida IBILI, P-3000548 Coimbra, Portugal.
   [Costa, Elisio; Santos-Silva, Alice] Univ Porto, Fac Farm, Dept Ciencias Biol, Lab Bioquim, P-4050313 Oporto, Portugal.
RP Alexandre, N (reprint author), Univ Evora, Dept Zootecnia, Apartado 94, P-7002554 Evora, Portugal.
EM nmla@uevora.pt
RI Costa, Elisio/K-1990-2013; Santos-Silva, Alice/K-2326-2013
OI Costa, Elisio/0000-0003-1158-1480; Santos-Silva,
   Alice/0000-0002-2565-3169; Fernandes, Joao/0000-0003-1556-1698;
   Alexandre, Nuno/0000-0002-3291-9332; Lopes, Maria
   A./0000-0003-4105-8148; Pereira, Tiago/0000-0003-1050-9268; Luis, Ana
   Lucia/0000-0003-2328-7174; Santos, Jose Domingos/0000-0002-6871-9850;
   Amorim, Irina/0000-0002-2305-1631; Mauricio, Ana
   Colette/0000-0002-0018-9363; Rodrigues, Miguel/0000-0001-8391-5860
FU QREN I&DT Cluster in Development of Products for Regenerative Medicine
   and Cell Therapies [1372]; European Community FEDER fund through North
   Portugal Regional Operational Program [ON2-O Novo Norte]; Fundacao para
   a Ciencia e Tecnologia (FCT); Ministerio da Educacao e da Ciencia;
   Program Project Euronanomed [ENMED/0002/2010]; Programa Operacional
   Factores de Competitividade (Program COMPETE) [Pest-OE/AGR/UI0211/2011];
   Ministerio da Educacao e da Ciencia, Portugal [SFRH/BD/64838/2009]
FX Contract grant sponsor: QREN I&DT Cluster in Development of Products for
   Regenerative Medicine and Cell Therapies (Projects Biomat & Cell QREN
   2008); contract grant number: 1372; Contract grant sponsor: European
   Community FEDER fund through North Portugal Regional Operational Program
   2007-2013 (ON2-O Novo Norte); Contract grant sponsor: Fundacao para a
   Ciencia e Tecnologia (FCT), Ministerio da Educacao e da Ciencia and
   Program Project Euronanomed, Ref: EraNet-EuroNanoMed JTC2010; contract
   grant number: ENMED/0002/2010; Contract grant sponsor: Programa
   Operacional Factores de Competitividade (Program COMPETE); contract
   grant number: Project Pest-OE/AGR/UI0211/2011; Contract grant sponsor:
   Nuno Alexandre has a Doctoral Grant from Fundacao para a Ciencia e
   Tecnologia (FCT), Ministerio da Educacao e da Ciencia, Portugal;
   contract grant number: SFRH/BD/64838/2009
CR Abed A, 2011, J BIOMED MATER RES A, V96A, P535, DOI 10.1002/jbm.a.33007
   Abir Farshad, 2004, Vasc Endovascular Surg, V38, P483, DOI 10.1177/153857440403800601
   Alauzun JG, 2010, BIOMATERIALS, V31, P3471, DOI 10.1016/j.biomaterials.2010.01.069
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bichara DA, 2011, TISSUE ENG PT A, V17, P301, DOI [10.1089/ten.tea.2010.0322, 10.1089/ten.TEA.2010.0322]
   Bichara DA, 2010, J SURG RES, V163, P331, DOI 10.1016/j.jss.2010.03.070
   Burczak K, 1996, BIOMATERIALS, V17, P2351, DOI 10.1016/S0142-9612(96)00076-2
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   Cascone MG, 1999, J MATER SCI-MATER M, V10, P431, DOI 10.1023/A:1008983215833
   Chaouat M, 2008, ADV FUNCT MATER, V18, P2855, DOI 10.1002/adfm.200701261
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   EISENBERG S, 1969, AM J MED SCI, V257, P336, DOI 10.1097/00000441-196905000-00006
   Elakkiya T, 2013, J APPL POLYM SCI, V128, P2840, DOI 10.1002/app.38464
   Fasl H, 2010, BIOMACROMOLECULES, V11, P377, DOI 10.1021/bm9010084
   Fernandes Heloise Pöckel, 2011, Rev. Bras. Hematol. Hemoter., V33, P297, DOI 10.5581/1516-8484.20110080
   Fernandes JC, 2008, BIOMACROMOLECULES, V9, P3346, DOI 10.1021/bm800622f
   Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053
   Gartner A, 2012, DIFFERENTIATION, V84, P355, DOI 10.1016/j.diff.2012.10.001
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Greisler H, 1988, ASAIO Trans, V34, P1051
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HYON SH, 1994, J BIOMAT SCI-POLYM E, V5, P397, DOI 10.1163/156856294X00103
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Ko FN, 1997, FREE RADICAL BIO MED, V22, P215, DOI 10.1016/S0891-5849(96)00295-X
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Koh CJ, 2005, E SCHERING RES FDN W, P35
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev
   Li H, 2012, ACTA BIOMATER, V8, P4007, DOI 10.1016/j.actbio.2012.07.008
   Lindahl P, 1998, CURR OPIN NEPHROL HY, V7, P21, DOI 10.1097/00041552-199801000-00004
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Lyman DJ, 2001, J BIOMED MATER RES, V58, P221, DOI 10.1002/1097-4636(2001)58:3<221::AID-JBM1011>3.3.CO;2-M
   Marcus AJ, 2008, J CELL MOL MED, V12, P730, DOI 10.1111/j.1582-4934.2008.00221.x
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Maruoka S, 2006, CURR EYE RES, V31, P599, DOI 10.1080/02713680600813854
   Massia SP, 2000, BIOMATERIALS, V21, P2253, DOI 10.1016/S0142-9612(00)00151-4
   Mauricio AC, 2011, BIOMATERIALS APPLICATIONS FOR NANOMEDICINE, P415
   Neu B, 2008, BIOPHYS J, V95, P3059, DOI 10.1529/biophysj.108.130328
   Nie L, 2012, COLLOID SURFACE B, V100, P169, DOI 10.1016/j.colsurfb.2012.04.046
   NOGUCHI T, 1991, J APPL BIOMATER, V2, P101, DOI 10.1002/jab.770020205
   Oh SJ, 1998, HISTOCHEM CELL BIOL, V109, P349, DOI 10.1007/s004180050235
   RAE T, 1986, CRIT REV BIOCOMPAT, V2, P97
   Ratner BD, 2013, BIOMATERIALS SCI, P588
   SAWADA K, 1993, J BIOMED MATER RES, V27, P547, DOI 10.1002/jbm.820270416
   Schoen F.J., 2013, BIOMATERIALS SCI INT, P558
   Seo KH, 2009, TISSUE ENG REGEN MED, V6, P414
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Ueberrueck T, 2005, J SURG RES, V124, P305, DOI 10.1016/j.jss.2004.10.021
   Van Blitterswijk C. A., 2008, TISSUE ENG, pxii
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang LC, 2007, J MATER SCI-MATER M, V18, P1125, DOI 10.1007/s10856-007-0159-5
   Wang MB, 2008, J BIOMED MATER RES A, V85A, P418, DOI 10.1002/jbm.a.31585
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   World Health Organization, 2012, CARD DIS GLOB ATL CA
   Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762
   Zeerleder S, 2002, THROMB RES, V105, P441, DOI 10.1016/S0049-3848(02)00041-5
NR 64
TC 34
Z9 34
U1 3
U2 75
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4262
EP 4275
DI 10.1002/jbm.a.35098
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500008
PM 24488670
DA 2018-10-20
ER

PT J
AU Missana, LR
   Jammal, MV
AF Missana, Liliana R.
   Jammal, Maria V.
TI Critical size defect regeneration by rhPTH-collagen membrane as a new
   tissue engineering tool
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone regeneration; critical size defect; rhPTH; type I atelocollagen;
   grafts
ID PARATHYROID-HORMONE 1-34; GUIDED BONE REGENERATION; MODEL; RATS; MATRIX;
   TERIPARATIDE; SCAFFOLD
AB Recombinant Human Parathyroid Hormone (rhPTH 1-34) administration is an effective treatment to improve bone mass in osteoporosis. The aim of this study was to develop a Tissue Engeenering Tool for bone regeneration. We evaluated the efficacy of a freeze dried rhPTH membrane in calvarial critical size defect (CSD). Forty-four Wistar female rats (body weight 150 +/- 50 g) with CSD (5 mm) were divided into four groups: group 1: rhPTH membrane (rhPTHm); group 2: atelocollagen membrane (Cm); group 3: rhPTH and atelocollagen I (CrhPTHm); group 4: without any treatment (CG). All samples were evaluated on the 1st, 3rd, and 6th weeks (weeks) post-surgery by soft X-ray, histological and histometric studies. Soft X-ray results showed a radiolucent image with many irregular radiopaque areas. Histologically, rhPTHm was replaced by reticular bone (7%) since 3rd week, and lamellar bone ossicles (30%) at 6th week. Cm showed bone formation like composite bone type on week 1st, 3rd, and 6th (2%, 44%, and 41%, respectively). With CrhPTHm, bone formation was observed in all periods (2.4%, 48%, and 53%), showing statistical difference with CG in the 3rd and 6th wks (p=0.03 and 0.01). Our results demonstrated the effectiveness of a new biomaterial called CrhPTHm because its ability to regenerate calvarial CSD. Moreover, the membrane represents a new local intermittent delivery system allowing rhPTH slow release. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4358-4364, 2014.
C1 [Missana, Liliana R.; Jammal, Maria V.] Tucuman Univ, Sch Dent, Dept Oral Pathol, Lab Expt Pathol & Tissue Engn, San Miguel De Tucuman, Argentina.
   [Missana, Liliana R.; Jammal, Maria V.] Consejo Nacl Invest Cient & Tecn, PROIMI Biotechnol Pilot Plant Microbial Ind Proc, Lab Expt Pathol & Tissue Engn, San Miguel De Tucuman, Argentina.
RP Missana, LR (reprint author), Pje Leopoldo Lugones 80,B Ojo de Agua,T4000MFB, San Miguel De Tucuman, Argentina.
EM liliana.missana@gmail.com
OI Missana, Liliana/0000-0002-7760-4684; Jammal, Maria
   Victoria/0000-0002-1433-3004
FU CIUNT [26/J413]; CONICET
FX Contract grant sponsor: CIUNT; contract grant number: 26/J413; Contract
   grant sponsor: CONICET
CR Andreassen TT, 2004, J CRANIOFAC SURG, V15, P424, DOI 10.1097/00001665-200405000-00014
   Aybar A, 2005, ACTA ODONTOLOGICA LA, V18, P21
   Backstrom KC, 2004, AM J VET RES, V65, P1223, DOI 10.2460/ajvr.2004.65.1223
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006
   Jammal MV, 2012, J HARD TISSUE BIOL, V21, P443
   Jammal María V, 2010, Acta odontol. latinoam., V23, P33
   Jollette J, 2006, TOXICOL PATHOL, V34, P929
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Jung RE, 2007, INT J ORAL MAX IMPL, V22, P258
   Kamo K, 2010, J BONE MINER METAB, V28, P634, DOI 10.1007/s00774-010-0178-z
   Manabe T, 2007, BONE, V40, P1475, DOI 10.1016/j.bone.2007.01.015
   Missana L, 1994, JPN J ORAL BIOL, V36, P9
   Nakazawa T, 2005, BONE, V37, P711, DOI 10.1016/j.bone.2005.06.013
   Roberts WE, 1993, OSSEOINTEGRATION ORA, P157
   Rodriguez AP, 2006, J BIOMED MATER RES A, V77A, P707, DOI 10.1002/jbm.a.30645
   Rowshan HH, 2010, J ORAL MAXIL SURG, V68, P260, DOI 10.1016/j.joms.2009.09.045
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Shi S, 1996, J BONE MINER RES, V11, P735
   Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882
   Vahle JL, 2004, TOXICOL PATHOL, V32, P426, DOI 10.1080/01926230490462138
   Wei GB, 2004, BIOMATERIALS, V25, P345, DOI 10.1016/S0142-9612(03)00528-3
   Whitfield James F, 2002, Treat Endocrinol, V1, P175, DOI 10.2165/00024677-200201030-00005
   Yun JI, 2010, J CLIN PERIODONTOL, V37, P419, DOI 10.1111/j.1600-051X.2010.01547.x
   Zhang W, 2013, BIOMATERIALS, V34, P6046, DOI 10.1016/j.biomaterials.2013.04.055
NR 26
TC 4
Z9 4
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4358
EP 4364
DI 10.1002/jbm.a.35114
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500017
PM 24677532
DA 2018-10-20
ER

PT J
AU Mercuri, J
   Addington, C
   Pascal, R
   Gill, S
   Simionescu, D
AF Mercuri, Jeremy
   Addington, Caroline
   Pascal, Richard, III
   Gill, Sanjitpal
   Simionescu, Dan
TI Development and initial characterization of a chemically stabilized
   elastin-glycosaminoglycan-collagen composite shape-memory hydrogel for
   nucleus pulposus regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nucleus pulposus; tissue regeneration; biopolymer; hydrogel; stem cells
ID INTERVERTEBRAL DISC DEGENERATION; CARTILAGINOUS TISSUE-REPAIR; ADULT
   STEM-CELLS; IN-VITRO; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX;
   BACK-PAIN; REPLACEMENT; SCAFFOLD; POLYPEPTIDE
AB Nucleus pulposus (NP) is a resilient and hydrophilic tissue which plays a significant role in the biomechanical function of the intervertebral disc (IVD). Destruction of the NP extracellular matrix (ECM) is observed during the early stages of IVD degeneration. Herein, we describe the development and initial characterization of a novel biomaterial which attempts to recreate the resilient and hydrophilic nature of the NP via the construction of a chemically stabilized elastin-glycosaminoglycan-collagen (EGC) composite hydrogel. Results demonstrated that a resilient, hydrophilic hydrogel which displays a unique shape-memory sponge characteristic could be formed from a blend of soluble elastin aggregates, chondroitin-6-sulfate, hyaluronic acid and collagen following freeze-drying, stabilization with a carbodiimide and penta-galloyl glucose-based fixative, and subsequent partial degradation with glycosaminoglycan degrading enzymes. The resultant material exhibited the ability to restore its original dimensions and water content following multi-cycle mechanical compression and illustrated resistance to accelerated enzymatic degradation. Preliminary in vitro studies utilizing human adipose derived stem cells (hADSCs) demonstrated that the material was cytocompatible and supported differentiation towards an NP cell-like phenotype. In vivo biocompatibility studies illustrated host cell infiltration and evidence of active remodeling following 4 weeks of implantation. Feasibility studies demonstrated that the EGC hydrogel could be delivered via minimally invasive methods. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4380-4393, 2014.
C1 [Mercuri, Jeremy; Addington, Caroline; Pascal, Richard, III; Gill, Sanjitpal; Simionescu, Dan] Clemson Univ, Rhodes Engn Res Ctr, Dept Bioengn, Biocompatibil & Tissue Regenerat Lab, Clemson, SC 29634 USA.
   [Gill, Sanjitpal] Spartanburg Reg Healthcare Syst, Dept Orthopaed Surg, Greer, SC 29650 USA.
RP Mercuri, J (reprint author), Clemson Univ, Rhodes Engn Res Ctr, Dept Bioengn, Biocompatibil & Tissue Regenerat Lab, Clemson, SC 29634 USA.
EM jmercur@clemson.edu
OI Addington, Caroline/0000-0003-4534-8222
FU FIC NIH HHS [R03 TW008941]
CR Ahrens M, 2009, SPINE, V34, P1376, DOI 10.1097/BRS.0b013e3181a3967f
   An HS, 2003, SPINE, V28, pS86, DOI 10.1097/00007632-200308011-00015
   Baer AE, 2001, J ORTHOPAED RES, V19, P2, DOI 10.1016/S0736-0266(00)00003-6
   Bao QB, 1997, 10 ANN M INT INTR TH
   Berlemann U, 2009, EUR SPINE J, V18, P1706, DOI 10.1007/s00586-009-1136-0
   Bertagnoli R, 2002, EUR SPINE J, V11, pS143, DOI 10.1007/s00586-002-0424-8
   Bertagnoli Rudolf, 2005, Spine J, V5, P672, DOI 10.1016/j.spinee.2004.12.004
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Boelen EJH, 2005, BIOMATERIALS, V26, P6674, DOI 10.1016/j.biomaterials.2005.04.020
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   Boyd LM, 2006, EUR SPINE J, V15, pS414, DOI 10.1007/s00586-006-0172-2
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Clark RA, 2009, J INVEST DERMATOL, V130, P362
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396
   Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339
   Goupille P, 1998, SPINE, V23, P1612, DOI 10.1097/00007632-199807150-00021
   Haefeli M, 2006, SPINE, V31, P1522, DOI 10.1097/01.brs.0000222032.52336.8e
   Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009
   Isenburg JC, 2006, BIOMATERIALS, V27, P3645, DOI 10.1016/j.biomaterials.2006.02.016
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   Kafienah W, 1998, BIOCHEM J, V330, P897, DOI 10.1042/bj3300897
   Katz JN, 2006, J BONE JOINT SURG AM, V88A, P21, DOI 10.2106/JBJS.E.01273
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb
   LesMaitre CL, 2004, J PATHOL, V204, P47
   Li CQ, 2009, J MATER SCI-MATER M, V21, P741
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   Mercuri JJ, 2011, J BIOMED MATER RES A, V96A, P422, DOI 10.1002/jbm.a.33001
   Moss IL, 2011, SPINE, V36, P1022, DOI 10.1097/BRS.0b013e3181e7b705
   MOW VC, 1997, BASIC ORTHOPAEDIC BI
   NARAYANAN AS, 1969, BIOCHEM J, V114, P11, DOI 10.1042/bj1140011
   Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Rutges JPHJ, 2008, J PATHOL, V214, P523, DOI 10.1002/path.2317
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   Thomas J, 2004, J BIOMED MATER RES B, V69B, P135, DOI 10.1002/jbm.b.20023
   Tu YD, 2008, BIOMACROMOLECULES, V9, P1739, DOI 10.1021/bm7013153
   Vernengo J, 2008, J BIOMED MATER RES B, V84B, P64, DOI 10.1002/jbm.b.30844
   Wardlaw D, 2008, MOTION PRESERVATION, P431
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Yang SH, 2005, J BIOMED MATER RES B, V74B, P488, DOI 10.1002/jbm.b.30221
   Yang SH, 2008, ARTIF ORGANS, V32, P70, DOI 10.1111/j.1525-1594.2007.00458.x
   Yoon T., 2007, NONFUSION TECHNOLOGI
   Yu J, 2002, BIOCHEM SOC T, V30, P848, DOI 10.1042/bst0300848
NR 50
TC 12
Z9 14
U1 4
U2 55
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4380
EP 4393
DI 10.1002/jbm.a.35104
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500020
PM 24497431
DA 2018-10-20
ER

PT J
AU Rochford, ETJ
   Subbiahdoss, G
   Moriarty, TF
   Poulsson, AHC
   van der Mei, HC
   Busscher, HJ
   Richards, RG
AF Rochford, Edward T. J.
   Subbiahdoss, Guruprakash
   Moriarty, T. Fintan
   Poulsson, Alexandra H. C.
   van der Mei, Henny C.
   Busscher, Henk J.
   Richards, R. Geoff
TI An in vitro investigation of bacteria-osteoblast competition on oxygen
   plasma-modified PEEK
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Staphylococcus; biomaterial-associated infections; bacterial adhesion;
   coculture; PEEK; plasma treatment; osteoblasts; surface modification
ID BIOMATERIAL SURFACE-CHEMISTRY; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM
   FORMATION; XDLVO THEORIES; ADHESION; IMPLANTS; CELLS; EXPRESSION;
   INFECTION; AUREUS
AB Polyetheretherketone (PEEK) films were oxygen plasma treated to increase surface free energy and characterized by X-ray photoelectron microscopy, atomic force microscopy, and water contact angles. A parallel plate flow chamber was used to measure Staphylococcus epidermidis, Staphylococcus aureus, and U-2 OS osteosarcomal cell-line adhesion to the PEEK films in separate monocultures. In addition, bacteria and U-2 OS cells were cocultured to model competition between osteoblasts and contaminating bacteria for the test surfaces. Plasma treatment of the surfaces increased surface oxygen content and decreased the hydrophobicity of the materials, but did not lead to a significant difference in bacterial or U-2 OS cell adhesion in the monocultures. In the S. epidermidis coculture experiments, the U-2 OS cells adhered in greater numbers on the treated surfaces compared to the untreated PEEK and spread to a similar extent. However, in the presence of S. aureus, cell death of the U-2 OS occurred within 10 h on all surfaces. The results of this study suggest that oxygen plasma treatment of PEEK may maintain the ability of osteoblast-like cells to adhere and spread, even in the presence of S. epidermidis contamination, without increasing the risk of preoperative bacterial adhesion. Therefore, oxygen plasma-treated PEEK remains a promising method to improve implant surface free energy for osseointegration. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4427-4434, 2014.
C1 [Rochford, Edward T. J.; Moriarty, T. Fintan; Poulsson, Alexandra H. C.; Richards, R. Geoff] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Rochford, Edward T. J.; Richards, R. Geoff] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.
   [Subbiahdoss, Guruprakash; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands.
RP Moriarty, TF (reprint author), AO Res Inst Davos, CH-7270 Davos, Switzerland.
EM fintan.moriarty@aofoundation.org
OI Richards, Robert/0000-0002-7778-2480; Moriarty,
   Fintan/0000-0003-2307-0397
FU Invibio Biomaterial Solutions
FX Contract grant sponsor: Invibio Biomaterial Solutions
CR Alexander EH, 2001, INFECT IMMUN, V69, P1581, DOI 10.1128/IAI.69.3.1581-1586.2001
   Amanatides E, 2006, SURF COAT TECH, V200, P6331, DOI 10.1016/j.surfcoat.2005.11.002
   Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Azeredo J, 1999, COLLOID SURFACE B, V14, P141, DOI 10.1016/S0927-7765(99)00031-4
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Bayoudh S, 2009, COLLOID SURFACE B, V73, P1, DOI 10.1016/j.colsurfb.2009.04.030
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Engels-Deutsch M, 2011, ARCH ORAL BIOL, V56, P22, DOI 10.1016/j.archoralbio.2010.08.010
   Fernandez ICS, 2011, BIOMATERIALS, V32, P979, DOI 10.1016/j.biomaterials.2010.10.011
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, J MATER SCI-MATER M, V21, P963, DOI 10.1007/s10856-009-3975-y
   Khonsari RH, 2013, SEVERE INFECT COMPLI
   Kieswetter K, 1996, CRIT REV ORAL BIOL M, V7, P329, DOI 10.1177/10454411960070040301
   Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952
   Krsko P, 2009, ACTA BIOMATER, V5, P589, DOI 10.1016/j.actbio.2008.08.025
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lee JH, 2010, ACTA BIOMATER, V6, P4422, DOI 10.1016/j.actbio.2010.05.021
   MacKintosh EE, 2006, J BIOMED MATER RES A, V78A, P836, DOI 10.1002/jbm.a.30905
   Marriott I, 2004, IMMUNOL RES, V30, P291, DOI 10.1385/IR:30:3:291
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Poulsson A.H.C., 2009, Patent No. [WO 2009/149827 A1, 2009149827, W02009/149827A1]
   Poulsson AHC, 2011, PEEK BIOMATERIALS HD, P145
   Poulsson AHC, 2014, BIOMATERIALS, V35, P3717, DOI 10.1016/j.biomaterials.2013.12.056
   Reott MA, 2008, FEMS MICROBIOL LETT, V278, P185, DOI 10.1111/j.1574-6968.2007.00988.x
   Rochford ETJ, 2014, COLLOID SURFACE B, V113, P213, DOI 10.1016/j.colsurfb.2013.09.012
   Rowan B, 2002, LANGMUIR, V18, P9914, DOI 10.1021/la020664h
   Rozhok S, 2006, LANGMUIR, V22, P11251, DOI 10.1012/la0609726
   Sharma PK, 2002, ADV COLLOID INTERFAC, V98, P341, DOI 10.1016/S0001-8686(02)00004-0
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Tant M.R., 1995, ACS SYM SER, P1
   Tateishi T, 2013, J BIOMED MAT RES A
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Ul A, 2013, J BIOMED MAT RES A
   Valour F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067240
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
NR 38
TC 9
Z9 9
U1 6
U2 52
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4427
EP 4434
DI 10.1002/jbm.a.35130
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500024
PM 24616271
DA 2018-10-20
ER

PT J
AU Soicher, MA
   Christiansen, BA
   Stover, SM
   Leach, JK
   Yellowley, CE
   Griffiths, LG
   Fyhrie, DP
AF Soicher, Matthew A.
   Christiansen, Blaine A.
   Stover, Susan M.
   Leach, J. Kent
   Yellowley, Clare E.
   Griffiths, Leigh G.
   Fyhrie, David P.
TI Remineralized bone matrix as a scaffold for bone tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mineralization; bone graft; brushite; collagen; matrix; MSCs
ID MESENCHYMAL STEM-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX;
   CALCIUM-PHOSPHATE; ANTIGEN REMOVAL; DIFFERENTIATION; MINERALIZATION;
   SOLUBILIZATION; PROLIFERATION; REGENERATION
AB There is a need for improved biomaterials for use in treating non-healing bone defects. A number of natural and synthetic biomaterials have been used for the regeneration of bone tissue with mixed results. One approach is to modify native tissue via decellularization or other treatment for use as natural scaffolding for tissue repair. In this study, our goal was to improve on our previously published alternating solution immersion (ASI) method to fabricate a robust, biocompatible, and mechanically competent biomaterial from natural demineralized bone matrix (DBM). The improved method includes an antigen removal (AR) treatment step which improves mineralization and stiffness while removing unwanted proteins. The chemistry of the mineral in the remineralized bone matrix (RBM) was consistent with dicalcium phosphate dihydrate (brushite), a material used clinically in bone healing applications. Mass spectrometry identified proteins removed from the matrix with AR treatment to include -2 HS-glycoprotein and osteopontin, noncollagenous proteins (NCPs) and known inhibitors of biomineralization. Additionally, the RBM supported the survival, proliferation, and differentiation of human mesenchymal stromal cells (MSCs) in vitro as well or better than other widely used biomaterials including DBM and PLG scaffolds. DNA content increased more than 10-fold on RBM compared to DBM and PLG; likewise, osteogenic gene expression was significantly increased after 1 and 2 weeks. We demonstrated that ASI remineralization has the capacity to fabricate mechanically stiff and biocompatible RBM, a suitable biomaterial for cell culture applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4480-4490, 2014.
C1 [Soicher, Matthew A.; Christiansen, Blaine A.; Leach, J. Kent; Fyhrie, David P.] Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Davis, CA 95616 USA.
   [Soicher, Matthew A.; Christiansen, Blaine A.; Stover, Susan M.; Leach, J. Kent; Fyhrie, David P.] Univ Calif Davis, Biomed Engn Grad Grp, Davis, CA 95616 USA.
   [Stover, Susan M.; Yellowley, Clare E.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.
   [Leach, J. Kent; Fyhrie, David P.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Griffiths, Leigh G.] Univ Calif Davis, Dept Vet Med Med & Epidemiol, Davis, CA 95616 USA.
RP Soicher, MA (reprint author), Univ Calif Davis, Sch Med, Dept Orthopaed Surg, Davis, CA 95616 USA.
EM masoicher@ucdavis.edu
RI Christiansen, Blaine/F-9021-2010
OI Christiansen, Blaine/0000-0002-0105-6458
FU National Institutes of Health (NIH) [AR040776]; David Linn Endowed Chair
   in Orthopaedic Surgery (DPF); Schwall Medical Research Fellowship;
   Howard Hughes Medical Institute Training Fellowship; Integrating
   Medicine into Basic Science (HHMI: IMBS)
FX Contract grant sponsor: National Institutes of Health (NIH); contract
   grant number: AR040776; Contract grant sponsor: David Linn Endowed Chair
   in Orthopaedic Surgery (DPF); Contract grant sponsor: a Schwall Medical
   Research Fellowship; Contract grant sponsor: Howard Hughes Medical
   Institute Training Fellowship; Contract grant sponsor: Integrating
   Medicine into Basic Science (HHMI: IMBS)
CR Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083
   Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081
   GENTILI C, 1993, J CELL BIOL, V122, P703, DOI 10.1083/jcb.122.3.703
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   He JW, 2010, TISSUE ENG PT A, V16, P127, DOI 10.1089/ten.TEA.2009.0255
   Healthcare Cost and Utilization Project, 2011, HCUP FACTS FIG STAT
   Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200
   IWATA H, 2002, CLIN ORHTOP, V395, P99
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   Kim SW, 2013, MAT SCI ENG C-MATER, V33, P2808, DOI 10.1016/j.msec.2013.03.011
   Klammert U, 2009, ACTA BIOMATER, V5, P727, DOI 10.1016/j.actbio.2008.08.019
   Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563
   Makhluf HA, 2000, BIOCHEM BIOPH RES CO, V268, P669, DOI 10.1006/bbrc.2000.2182
   Martin RE, 1998, J PETROL TECHNOL, V50, P14
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   NANCOLLAS GH, 1989, ANAT RECORD, V224, P234, DOI 10.1002/ar.1092240213
   Price PA, 2009, J BIOL CHEM, V284, P17092, DOI 10.1074/jbc.M109.007013
   RISTELI L, 1993, ANN MED, V25, P385, DOI 10.3109/07853899309147301
   ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088
   Rosen C. J., 2009, PRIMER METABOLIC BON
   Schneider G, 2010, J MATER SCI-MATER M, V21, P2853, DOI 10.1007/s10856-010-4143-0
   Selvam S, 2009, TISSUE ENG PART C-ME, V15, P463, DOI 10.1089/ten.tec.2008.0431
   Shahabipour F, 2013, IN VITRO CELL DEV-AN, V49, P440, DOI 10.1007/s11626-013-9591-7
   Soicher MA, 2013, J MECH BEHAV BIOMED, V26, P109, DOI 10.1016/j.jmbbm.2013.05.007
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tsiridis E, 2009, EXPERT OPIN BIOL TH, V9, P9, DOI 10.1517/14712590802622473 
   Viateau V, 2016, J TISSUE ENG REGEN M, V10, pE177, DOI 10.1002/term.1782
   Wong ML, 2013, ACTA BIOMATER, V9, P6492, DOI 10.1016/j.actbio.2012.12.034
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Yeni YN, 2002, ANN BIOMED ENG, V30, P217, DOI 10.1114/1.1451078
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 36
TC 5
Z9 5
U1 0
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4480
EP 4490
DI 10.1002/jbm.a.35118
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500030
PM 24616346
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gohil, SV
   Adams, DJ
   Maye, P
   Rowe, DW
   Nair, LS
AF Gohil, Shalini V.
   Adams, Douglas J.
   Maye, Peter
   Rowe, David W.
   Nair, Lakshmi S.
TI Evaluation of rhBMP-2 and bone marrow derived stromal cell mediated bone
   regeneration using transgenic fluorescent protein reporter mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE fluorescent protein reporter mouse; bone morphogenetic proteins; stem
   cells; bone regeneration; calvarial bone defect model
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; PROGENITOR CELLS;
   IN-VIVO; CONTROLLED-RELEASE; MURINE BONE; DELIVERY; DEFECTS; TISSUE;
   DIFFERENTIATION
AB The aim of the study is use of transgenic fluorescent protein reporter mouse models to understand the cellular processes in recombinant human bone morphogenetic protein-2 (rhBMP-2) mediated bone formation. Bilateral parietal calvarial bone defects in Col3.6Topaz transgenic fluorescent osteoblast reporter mouse were used to understand the bone formation in the presence and absence of rhBMP2 and/or Col3.6Cyan bone marrow derived stromal cells (BMSCs), using collagen-hydroxyapatite matrix (Healos) as a biomaterial. The bone regeneration was not confined to the site of BMP-2 implantation and significant bone formation was observed in the neighboring defect site. Osteogenic cellular activity with overlying alizarin complexone staining was observed in both the defects indicating host cell induced mineralization. However, implantation of BMSCs along with rhBMP-2 demonstrated a donor cell derived bone formation. The presence of rhBMP-2 did not support host cell recruitment in the presence of donor cells. This study demonstrates the potential of multiple fluorescent reporters to understand the cellular processes involved in the bone regeneration process using biomaterials, growth factors, and/or stem cells. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 4568-4580, 2014.
C1 [Gohil, Shalini V.; Adams, Douglas J.; Nair, Lakshmi S.] Univ Connecticut, Ctr Hlth, Dept Orthoped Surg, Farmington, CT 06032 USA.
   [Gohil, Shalini V.; Nair, Lakshmi S.] Univ Connecticut, Ctr Hlth, Raymond Beverly Sackler Ctr Biomed Biol Phys & En, Inst Regenerat Engn, Farmington, CT 06032 USA.
   [Maye, Peter; Rowe, David W.] Univ Connecticut, Ctr Hlth, Ctr Regenerat Med & Skeletal Dev, Dept Reconstruct Sci, Farmington, CT 06030 USA.
   [Maye, Peter; Rowe, David W.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Nair, Lakshmi S.] Univ Connecticut, Dept Biomed Engn, Storrs, CT 06269 USA.
RP Nair, LS (reprint author), Univ Connecticut, Ctr Hlth, Dept Orthoped Surg, Farmington, CT 06032 USA.
EM nair@uchc.edu
FU U.S. Army Medical Research and Materiel Command [W81WXH-10-1-0653]
FX Liping Wang and Jian Ping Huang are acknowledged for experimental
   support; Li Chen is acknowledged for collection and assembly of data.
   W81WXH-10-1-0653, U.S. Army Medical Research and Materiel Command is
   acknowledged for the funding.
CR Akita S, 2004, WOUND REPAIR REGEN, V12, P252, DOI 10.1111/j.1067-1927.2004.012118.x
   Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Burastero G, 2010, BONE, V47, P117, DOI 10.1016/j.bone.2010.03.023
   Burks Martin V, 2010, J Long Term Eff Med Implants, V20, P277
   Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Freilich M, 2008, BONE, V43, P781, DOI 10.1016/j.bone.2008.05.021
   Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200
   Jiang X, 2005, J HISTOCHEM CYTOCHEM, V53, P593, DOI 10.1369/jhc.4A6401.2005
   Jo S, 2013, J BIOMED MATER RES A, V101, P892, DOI 10.1002/jbm.a.34354
   Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15
   Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6
   Kimura Y, 2010, TISSUE ENG PT A, V16, P1263, DOI 10.1089/ten.TEA.2009.0322
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kraiwattanapong C, 2005, SPINE, V30, P1001, DOI 10.1097/01.brs.0000160997.91502.3b
   Lee TC, 2003, J ANAT, V203, P161, DOI 10.1046/j.1469-7580.2003.00211.x
   Li F, 2012, BIOCHEM BIOPH RES CO, V426, P475, DOI 10.1016/j.bbrc.2012.08.095
   Liu YL, 2010, BONE, V47, P916, DOI 10.1016/j.bone.2010.07.022
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Otsuru S, 2007, BIOCHEM BIOPH RES CO, V354, P453, DOI 10.1016/j.bbrc.2006.12.226
   Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667
   Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497
   Ripamonti U, 2001, J BONE JOINT SURG AM, V83A, pS116
   Rodrigues Melanie, 2010, Stem Cell Res Ther, V1, P32, DOI 10.1186/scrt32
   Rowe D., 2011, IMPROVING SOLDIER RE, P1
   Schantz JT, 2012, J MECH BEHAV BIOMED, V11, P132, DOI 10.1016/j.jmbbm.2012.02.008
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624
   Ushiku C, 2010, J ORTHOP RES, V28, P1338, DOI 10.1002/jor.21105
   Verma S, 2011, NANOMEDICINE-UK, V6, P157, DOI [10.2217/nnm.10.157, 10.2217/NNM.10.146]
   VIATEAU V, 2008, SOURCEBOOK MODELS BI, P725
   Xiao W, 2013, ACTA BIOMATER, V9, P8374, DOI 10.1016/j.actbio.2013.05.029
   Xie GP, 2010, J MATER SCI-MATER M, V21, P1875, DOI 10.1007/s10856-010-4038-0
   Yu XH, 2013, J TISSUE ENG REGEN M, V7, P974, DOI 10.1002/term.1490
   Zara JN, 2011, TISSUE ENG PT A, V17, P1389, DOI [10.1089/ten.TEA.2010.0555, 10.1089/ten.tea.2010.0555]
NR 39
TC 7
Z9 7
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC
PY 2014
VL 102
IS 12
BP 4568
EP 4580
DI 10.1002/jbm.a.35122
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AS6OL
UT WOS:000344382500039
PM 24677665
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Ozdil, D
   Aydin, HM
AF Ozdil, Deniz
   Aydin, Halil Murat
TI Polymers for medical and tissue engineering applications
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE polymers; tissues and organs; scaffolds; tissue engineering
ID MESENCHYMAL STEM-CELLS; IN-VITRO DEGRADATION; ENDOTHELIAL GROWTH-FACTOR;
   POLY(PROPYLENE FUMARATE) SCAFFOLDS; PHOTOCROSSLINKED ANHYDRIDE SYSTEMS;
   POLY(ETHYLENE GLYCOL) HYDROGELS; BONE MORPHOGENETIC PROTEIN-2;
   HYALURONIC-ACID HYDROGELS; DRUG-DELIVERY-SYSTEM; MARROW STROMAL CELLS
AB Recent decades have seen great advancements in medical research into materials, both natural and synthetic, that facilitate the repair and regeneration of compromised tissues through the delivery and support of cells and/or biomolecules. Biocompatible polymeric materials have become the most heavily investigated materials used for such purposes. Naturally-occurring and synthetic polymers, including their various composites and blends, have been successful in a range of medical applications, proving to be particularly suitable for tissue engineering (TE) approaches. The increasing advances in polymeric biomaterial research combined with the developments in manufacturing techniques have expanded capabilities in tissue engineering and other medical applications of these materials. This review will present an overview of the major classes of polymeric biomaterials, highlight their key properties, advantages, limitations and discuss their applications. (c) 2014 Society of Chemical Industry
C1 [Ozdil, Deniz; Aydin, Halil Murat] Hacettepe Univ Technopolis, BMT Calsis Co, TR-06800 Ankara, Turkey.
   [Aydin, Halil Murat] Hacettepe Univ, Dept Environm Engn, TR-06800 Ankara, Turkey.
   [Aydin, Halil Murat] Hacettepe Univ, Bioengn Div, TR-06800 Ankara, Turkey.
   [Aydin, Halil Murat] Hacettepe Univ, Ctr Bioengn, TR-06800 Ankara, Turkey.
RP Aydin, HM (reprint author), Hacettepe Univ, Dept Environm Engn, TR-06800 Ankara, Turkey.
EM hmaydin@hacettepe.edu.tr
RI Bayram, Cem/D-7403-2013; Aydin, Halil Murat/O-6408-2018
OI Bayram, Cem/0000-0001-8717-4668; 
CR Adrian Gestos PGW, 2010, SOFT MATTER, V6, P1045
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Allcock HR, 1999, MACROMOL SYMP, V144, P33, DOI 10.1002/masy.19991440105
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Anderson KS, 2008, POLYM REV, V48, P85, DOI 10.1080/15583720701834216
   Araujo JV, 2014, J BIOMED MAT RES A
   ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155
   ATTAWIA MA, 1995, J BIOMED MATER RES, V29, P1233, DOI 10.1002/jbm.820291010
   Aydin HM, 2006, INT J ARTIF ORGANS, V29, P873
   Aydin HM, 2016, J TISSUE ENG REGEN M, V10, pE14, DOI 10.1002/term.1759
   Aydin HM, 2013, BIOMATER SCI-UK, V1, P503, DOI 10.1039/c3bm00157a
   Aydin HM, 2009, J TISSUE ENG REGEN M, V3, P470, DOI 10.1002/term.187
   Aydin HM, 2011, ADV ENG MATER, V13, pB511, DOI 10.1002/adem.201180005
   Aydin Halil Murat, 2011, Hacettepe Journal of Biology and Chemistry, V39, P23
   Aydin HM, 2011, J BIOACT COMPAT POL, V26, P207, DOI 10.1177/0883911511399411
   Aydin HM, 2009, ADV ENG MATER, V11, pB83, DOI 10.1002/adem.200900030
   Aydin HM, 2004, J BIOACT COMPAT POL, V19, P383, DOI 10.1177/0883911504046688
   Azhar FF, 2014, DES MONOMERS POLYM, V17, P654, DOI 10.1080/15685551.2014.907621
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   BEHRAVESH E, 1999, CLIN ORTHOP S, V367, pS118
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bergstrand A, 2014, INT J POLYM SCI
   Berkland C, 2007, PHARM RES, V24, P1007, DOI 10.1007/s11095-006-9197-9
   Bertram JP, 2009, ACTA BIOMATER, V5, P2860, DOI 10.1016/j.actbio.2009.04.012
   Birk DE, 2005, TOP CURR CHEM, V247, P185, DOI 10.1007/b103823
   Bolland BJRF, 2008, BIOMATERIALS, V29, P3221, DOI 10.1016/j.biomaterials.2008.04.017
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Bourke SL, 2003, ADV DRUG DELIVER REV, V55, P447, DOI 10.1016/S0169-409X(03)00038-3
   Bruns H, 2005, TISSUE ENG, V11, P1718, DOI 10.1089/ten.2005.11.1718
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cai W, 2008, MATER LETT, V62, P2171, DOI 10.1016/j.matlet.2007.11.042
   Cai ZJ, 2006, J MATER SCI-MATER M, V17, P1297, DOI 10.1007/s10856-006-0604-x
   Cao N, 2011, BIOMATERIALS, V32, P2222, DOI 10.1016/j.biomaterials.2010.11.061
   Carrillo-Conde B, 2010, ACTA BIOMATER, V6, P3110, DOI 10.1016/j.actbio.2010.01.040
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Cha EJ, 2009, EUR J PHARM SCI, V38, P341, DOI 10.1016/j.ejps.2009.08.006
   Chan AW, 2009, BIOMACROMOLECULES, V10, P609, DOI 10.1021/bm801316z
   Chang KY, 2010, J BIOMED MATER RES A, V92A, P712, DOI 10.1002/jbm.a.32198
   Chasin M LR, 1990, BIODEGRADABLE POLYM, P71
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2011, J MECH BEHAV BIOMED, V4, P1805, DOI 10.1016/j.jmbbm.2011.05.038
   Chen QZ, 2010, SOFT MATTER, V6, P4715, DOI 10.1039/c0sm00213e
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Chiu HC, 1997, J BIOMED MATER RES, V34, P381, DOI 10.1002/(SICI)1097-4636(19970305)34:3<381::AID-JBM13>3.0.CO;2-J
   Christenson EM, 2007, BIOMACROMOLECULES, V8, P3806, DOI 10.1021/bm7007235
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Chu PP, 2010, POLYMER, V51, P1386, DOI 10.1016/j.polymer.2010.01.042
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Chung C, 2006, TISSUE ENG, V12, P2665, DOI 10.1089/ten.2006.12.2665
   Colonna C, 2007, J MICROENCAPSUL, V24, P553, DOI 10.1080/02652040701449608
   Conconi MT, 2004, J BIOMED MATER RES A, V71A, P669, DOI 10.1002/jbm.a.30198
   Converse GL, 2012, ACTA BIOMATER, V6, P856
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Crapo PM, 2010, BIOMATERIALS, V31, P1626, DOI 10.1016/j.biomaterials.2009.11.035
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   De Somer F, 2008, J BIOMED MATER RES A, V86A, P1106, DOI 10.1002/jbm.a.31705
   Deng C, 2006, BIOMACROMOLECULES, V7, P590, DOI 10.1021/bm050678c
   Deng M, 2008, BIOMATERIALS, V29, P337, DOI 10.1016/j.biomaterials.2007.09.029
   Determan AS, 2004, J CONTROL RELEASE, V100, P97, DOI 10.1016/j.jconrel.2004.08.006
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Donini C, 2002, INT J PHARM, V245, P83, DOI 10.1016/S0378-5173(02)00335-6
   Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7
   Dror Y, 2008, BIOMACROMOLECULES, V9, P2749, DOI 10.1021/bm8005243
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Edwards SL, 2012, J BIOMED MATER RES A, V100A, P3326, DOI 10.1002/jbm.a.34286
   Elbert DL, 1998, J BIOMED MATER RES, V42, P55, DOI 10.1002/(SICI)1097-4636(199810)42:1<55::AID-JBM8>3.0.CO;2-N
   ELING B, 1982, POLYMER, V23, P1587, DOI 10.1016/0032-3861(82)90176-8
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Eschbach L, 2000, INJURY, V31, pS22
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Eyrich D, 2007, TISSUE ENG, V13, P2207, DOI 10.1089/ten.2006.0358
   Feng XL, 2010, ACS APPL MATER INTER, V2, P2429, DOI 10.1021/am100435k
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fleige E, 2012, ADV DRUG DELIVER REV, V64, P866, DOI 10.1016/j.addr.2012.01.020
   FRANCIS G, 1975, BIOCHEM J, V145, P287, DOI 10.1042/bj1450287
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Fujihara K, 2004, BIOMATERIALS, V25, P3877, DOI 10.1016/j.biomaterials.2003.10.050
   Fujihara K, 2003, BIOMATERIALS, V24, P2661, DOI 10.1016/S0142-9612(03)00065-6
   Gan ZH, 1999, POLYMER, V40, P2859, DOI 10.1016/S0032-3861(98)00549-7
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Gavenis K, 2010, INT J ARTIF ORGANS, V33, P45
   Gayakwad SG, 2009, J MICROENCAPSUL, V26, P692, DOI 10.3109/02652040802666910
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   Gopferich A, 2002, ADV DRUG DELIVER REV, V54, P911, DOI 10.1016/S0169-409X(02)00051-0
   Gou ML, 2011, CURR DRUG TARGETS, V12, P1131, DOI 10.2174/138945011795906642
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gryparis EC, 2007, DRUG DELIV, V14, P371, DOI 10.1080/10717540701202937
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Haddadi A, 2008, J MICROENCAPSUL, V25, P379, DOI 10.1080/02652040802000714
   Hahn MS, 2006, BIOMATERIALS, V27, P1104, DOI 10.1016/j.biomaterials.2005.07.022
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265
   Hedberg EL, 2002, IEEE, V1, P472
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Heller J, 2004, BIOMACROMOLECULES, V5, P1625, DOI 10.1021/bm040049n
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012
   Hsu FY, 2010, J BIOMED MATER RES B, V95B, P29, DOI 10.1002/jbm.b.31679
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang NS, 2006, BIOMATERIALS, V27, P6015, DOI 10.1016/j.biomaterials.2006.06.033
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ifkovits JL, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034104
   Ionescu LC, 2010, BIOMATERIALS, V31, P4113, DOI 10.1016/j.biomaterials.2010.01.098
   Isaksson K, 2010, EUR SURG RES, V44, P17, DOI 10.1159/000258654
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Islam A, 2012, CARBOHYD POLYM, V88, P1055, DOI 10.1016/j.carbpol.2012.01.070
   Ivanov AE, 2001, J CHROMATOGR A, V907, P115, DOI 10.1016/S0021-9673(00)00959-6
   Jaafar IH, 2010, J MATER SCI, V45, P2525, DOI 10.1007/s10853-010-4259-0
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   JHON MS, 1973, J BIOMED MATER RES, V7, P509, DOI 10.1002/jbm.820070604
   Jiang B, 2013, TISSUE ENG PT A, V19, P224, DOI 10.1089/ten.tea.2012.0120
   Jin XB, 2008, J BIOMED MATER RES A, V86A, P1077, DOI 10.1002/jbm.a.31656
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   JOCKISCH KA, 1992, J BIOMED MATER RES, V26, P133, DOI 10.1002/jbm.820260202
   Joglekar M, 2013, BIOTECHNOL J, V8, P931, DOI 10.1002/biot.201300073
   JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195
   Ju CY, 2013, J PHARM SCI-US, V102, P2707, DOI 10.1002/jps.23649
   Kakizawa Y, 2004, J CONTROL RELEASE, V97, P345, DOI 10.1016/j.jconrel.2004.03.031
   Kang XH, 2007, BIOMATERIALS, V28, P450, DOI 10.1016/j.biomaterials.2006.08.052
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karahaliloglu Z, 2013, J APPL POLYM SCI, V128
   Karal-Yilmaz O, 2006, J MATER SCI-MATER M, V17, P213, DOI 10.1007/s10856-006-7307-1
   Katzer A, 2002, BIOMATERIALS, V23, P1749, DOI 10.1016/S0142-9612(01)00300-3
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   Ke TY, 2006, MAGN RESON IMAGING, V24, P931, DOI 10.1016/j.mri.2006.03.009
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Khan W, 2007, ACTA BIOMATER, V3, P541, DOI 10.1016/j.actbio.2007.01.006
   Kharas GB, 1997, J APPL POLYM SCI, V66, P1123
   Kim CW, 2008, J BIOMED MATER RES A, V85A, P1114, DOI 10.1002/jbm.a.31633
   Kim JH, 2006, J CONTROL RELEASE, V111, P228, DOI 10.1016/j.jconrel.2005.12.013
   Kim M, 2012, NORTHEAST BIOENGIN C, P211, DOI 10.1109/NEBC.2012.6207038
   Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   Kojima K, 2004, J VET MED SCI, V66, P1595, DOI 10.1292/jvms.66.1595
   KOMATSU K, 1993, ARCH ORAL BIOL, V38, P369, DOI 10.1016/0003-9969(93)90207-3
   Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253
   Kosir MA, 2000, J SURG RES, V92, P45, DOI 10.1006/jsre.2000.5840
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kyriakides TR, J CONTROL RELEASE, V78, p295 
   Lakshimi S.N., 2007, PROG POLYM SCI, V32, P762
   Lakshmi S, 2003, ADV DRUG DELIVER REV, V55, P467, DOI 10.1016/S0169-409X(03)00039-5
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   LAURENCIN CT, 1987, J BIOMED MATER RES, V21, P1231, DOI 10.1002/jbm.820211006
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee J, 2007, KEY ENG MATER, V342-343, P141, DOI 10.4028/www.scientific.net/KEM.342-343.141
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SJ, 2014, J NANOSCI NANOTECHNO, V14, P7488, DOI 10.1166/jnn.2014.9581
   Lepoittevin B, 2002, POLYMER, V43, P4017, DOI 10.1016/S0032-3861(02)00229-X
   Lewandrowski KU, 1999, TISSUE ENG, V5, P305, DOI 10.1089/ten.1999.5.305
   Li DH, 2007, CARBOHYD POLYM, V67, P40, DOI 10.1016/j.carbpol.2006.04.022
   Li G, 2002, J ORTHOPAED RES, V20, P887, DOI 10.1016/S0736-0266(01)00184-X
   Li JM, 2009, ACTA PHARMACOL SIN, V30, P1337, DOI 10.1038/aps.2009.125
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liang WH, 2010, J BIOMED MATER RES A, V94A, P1050, DOI 10.1002/jbm.a.32774
   Lim SM, 2010, J MATER SCI-MATER M, V21, P2593, DOI 10.1007/s10856-010-4118-1
   Liu BS, 2008, MACROMOL BIOSCI, V8, P432, DOI 10.1002/mabi.200700211
   Liu QY, 2007, J APPL POLYM SCI, V104, P1131, DOI 10.1002/app.25606
   Liu XY, 2010, ASAIO J, V56, P241, DOI 10.1097/MAT.0b013e3181d7b8e3
   Lu HH, 2010, ANN BIOMED ENG, V38, P2142, DOI 10.1007/s10439-010-0046-y
   Lue SJ, 2007, J MEMBRANE SCI, V301, P142, DOI 10.1016/j.memsci.2007.06.020
   Lukashev M, 2007, MULT SCLER, V13, pS149
   Ma GP, 2010, CARBOHYD POLYM, V79, P620, DOI 10.1016/j.carbpol.2009.09.015
   Ma PX, 1995, MATER RES SOC SYMP P, V394, P99, DOI 10.1557/PROC-394-99
   Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546
   MALNATI GA, 1983, VET SURG, V12, P24, DOI 10.1111/j.1532-950X.1983.tb00697.x
   Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307
   Martins AM, 2010, J MATER CHEM, V20, P1638, DOI 10.1039/b916259n
   Masaeli E, 2012, J BIOMED MATER RES A, V100A, P1907, DOI 10.1002/jbm.a.34131
   Matsusaki M, 2007, J BIOMAT SCI-POLYM E, V18, P775, DOI 10.1163/156856207781034160
   Matsusaki M, 2007, BIOMATERIALS, V28, P2729, DOI 10.1016/j.biomaterials.2007.02.015
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   Mekhail M, 2014, CARBOHYD POLYM, V108, P91, DOI 10.1016/j.carbpol.2014.03.021
   Melrose J, 2008, J CHEM TECHNOL BIOT, V83, P444, DOI 10.1002/jctb.1857
   Meng X, 2011, PHARM DEV TECHNOL, V16, P22, DOI 10.3109/10837450903479947
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mohanna PN, 2003, J ANAT, V203, P553, DOI 10.1046/j.1469-7580.2003.00243.x
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nath N, 2002, ADV MATER, V14, P1243, DOI 10.1002/1521-4095(20020903)14:17<1243::AID-ADMA1243>3.0.CO;2-M
   Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391
   Ng SY, 1997, MACROMOLECULES, V30, P770, DOI 10.1021/ma9610626
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Niu GG, 2011, POLYMER, V52, P2524, DOI 10.1016/j.polymer.2011.04.011
   Nottelet B, 2007, BIOMACROMOLECULES, V8, P2594, DOI 10.1021/bm700449c
   Olmez SS, 2007, PHARMAZIE, V62, P423, DOI 10.1691/ph.2007.6.6140
   Omidian H, 2005, J CONTROL RELEASE, V102, P3, DOI 10.1016/j.jconrel.2004.09.028
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Otto J, 2010, J INVEST SURG, V23, P190, DOI 10.3109/08941931003739741
   PACHENCE JM, 2000, PRINCIPLES TISSUE EN, P263
   Papadopoulos A, 2011, TISSUE ENG PT A, V17, P161, DOI [10.1089/ten.tea.2010.0253, 10.1089/ten.TEA.2010.0253]
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park JS, 2010, J BIOMED MATER RES A, V92A, P806, DOI 10.1002/jbm.a.32388
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Park MR, 2010, J CONTROL RELEASE, V147, P359, DOI 10.1016/j.jconrel.2010.07.126
   Park SH, 2005, ARTIF ORGANS, V29, P838, DOI 10.1111/j.1525-1594.2005.00137.x
   Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028
   Patrick JC MA, 1998, FRONTIERS TISSUE ENG
   Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0
   Peng L, 2009, J BIOMED MATER RES A, V90A, P564, DOI 10.1002/jbm.a.32117
   Peng T, 1998, J APPL POLYM SCI, V70, P2133, DOI 10.1002/(SICI)1097-4628(19981212)70:11<2133::AID-APP6>3.0.CO;2-P
   Peter SJ, 1998, J BIOMED MATER RES, V41, P1
   Petersen LK, 2010, ACTA BIOMATER, V6, P3873, DOI 10.1016/j.actbio.2010.04.004
   Peura M, 2010, J BIOMED MATER RES A, V95A, P658, DOI 10.1002/jbm.a.32881
   Portilla-Arias JA, 2009, J BIOMAT SCI-POLYM E, V20, P1065, DOI 10.1163/156856209X444420
   Potta T, 2009, BIOMATERIALS, V30, P6178, DOI 10.1016/j.biomaterials.2009.08.015
   Prasad CK, 2008, ACTA BIOMATER, V4, P182, DOI 10.1016/j.actbio.2007.05.012
   PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P189
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Qi J, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015006
   Qi XP, 2009, J BIOMED MATER RES A, V89A, P980, DOI 10.1002/jbm.a.32054
   Qiu LY, 2000, J APPL POLYM SCI, V77, P2987, DOI 10.1002/1097-4628(20000923)77:13<2987::AID-APP24>3.0.CO;2-F
   Qiu ZC, 2011, POLYM ADVAN TECHNOL, V22, P993, DOI 10.1002/pat.1606
   REED AM, 1981, POLYMER, V22, P494, DOI 10.1016/0032-3861(81)90168-3
   Regev O, 2010, INT J BIOL MACROMOL, V47, P261, DOI 10.1016/j.ijbiomac.2010.04.012
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Reusch RN, 1992, BIOCHIM BIOPHYS ACTA, V1123, P3340
   Rich A, 2001, MED ENG, P235
   Rodrigues IR, 2007, REACT FUNCT POLYM, V67, P708, DOI 10.1016/j.reactfunctpolym.2007.05.010
   Roeder RK, 2012, PDL HANDB SER, P163, DOI 10.1016/B978-1-4377-4463-7.10011-9
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sahni A, 2000, BLOOD, V96, P3772
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   Salman HH, 2009, VACCINE, V27, P4784, DOI 10.1016/j.vaccine.2009.05.091
   Sant S, 2011, J TISSUE ENG REGEN M, V5, P283, DOI 10.1002/term.313
   Sarikaya B, 2014, J TISSUE ENG REGEN M, V8, P410
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Scholes SC, 2009, P I MECH ENG H, V223, P13, DOI 10.1243/09544119JEIM471
   Scolozzi P, 2007, J CRANIOFAC SURG, V18, P224, DOI 10.1097/01.scs.0000249359.56417.7e
   Scotchford CA, 2003, BIOMATERIALS, V24, P4871, DOI 10.1016/S0142-9612(03)00403-4
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Seidlits SK, 2011, ACTA BIOMATER, V7, P2401, DOI 10.1016/j.actbio.2011.03.024
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Shen ZY, 2011, PHARMACOL RES, V63, P51, DOI 10.1016/j.phrs.2010.10.012
   Shi R, 2009, INT J MOL SCI, V10, P4223, DOI 10.3390/ijms10104223
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Singh A, 2006, BIOMACROMOLECULES, V7, P914, DOI 10.1021/bm050752r
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Srivastava A, 2010, J MATER SCI-MATER M, V21, P2937, DOI 10.1007/s10856-010-4124-3
   Stahl PJ, 2010, BIOMACROMOLECULES, V11, P2336, DOI 10.1021/bm100465q
   Stampfl U, 2008, CARDIOVASC INTER RAD, V31, P1184, DOI 10.1007/s00270-008-9392-7
   Sun L, 2009, J MATER SCI-MATER M, V20, P2035, DOI 10.1007/s10856-009-3765-6
   Sun Y, 2008, INT J NANOMED, V3, P249
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200
   Tahara K, 2010, INT J PHARMACEUT, V392, P311, DOI 10.1016/j.ijpharm.2010.03.042
   Takehara M, 2010, BIOTECHNOL LETT, V32, P1299, DOI 10.1007/s10529-010-0294-9
   Tamayo I, 2010, CLIN VACCINE IMMUNOL, V17, P1356, DOI 10.1128/CVI.00164-10
   Tan CS, 2009, J BIOMED MATER RES A, V91A, P866, DOI 10.1002/jbm.a.32297
   Tang CK, 2008, VACCINE, V26, P3827, DOI 10.1016/j.vaccine.2008.05.008
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Thomas C, 2010, PHARM RES-DORDR, V27, P905, DOI 10.1007/s11095-010-0094-x
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Tran RT, 2014, J BIOMED MATER RES A, V102, P2793, DOI 10.1002/jbm.a.34952
   Ueda H, 2003, ADV DRUG DELIVER REV, V55, P501, DOI 10.1016/S0169-409X(03)00037-1
   UHRICH KE, 1995, MACROMOLECULES, V28, P2184, DOI 10.1021/ma00111a012
   Van S, 2010, INT J NANOMED, V5, P825, DOI 10.2147/IJN.S13482
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Vavken P, 2011, KNEE, V18, P42, DOI 10.1016/j.knee.2009.12.008
   Vega E, 2008, J PHARM SCI-US, V97, P5306, DOI 10.1002/jps.21383
   Vehof JWM, 2002, J BIOMED MATER RES, V60, P241, DOI 10.1002/jbm.10073
   Verret V, 2011, BIOMATERIALS, V32, P339, DOI 10.1016/j.biomaterials.2010.09.001
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Villanueva I, 2010, MATRIX BIOL, V29, P51, DOI 10.1016/j.matbio.2009.08.004
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   von Wilmowsky C, 2009, J BIOACT COMPAT POL, V24, P169, DOI 10.1177/0883911508101149
   von Wilmowsky C, 2008, J BIOMED MATER RES A, V87A, P896, DOI 10.1002/jbm.a.31822
   Wadhwa S, 2010, MOL PHARMACEUT, V7, P854, DOI 10.1021/mp1000058
   Wang JZ, 2010, J BIOMED MATER RES A, V93A, P910, DOI 10.1002/jbm.a.32590
   Wang JP, 2010, INT J PHARMACEUT, V400, P194, DOI 10.1016/j.ijpharm.2010.08.026
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Ward JH, 2000, MACROMOLECULES, V33, P5137, DOI 10.1021/ma000001b
   Weber C, 2012, PROG POLYM SCI, V37, P686, DOI 10.1016/j.progpolymsci.2011.10.002
   Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956
   Weikel AL, 2010, BIOMATERIALS, V31, P8507, DOI 10.1016/j.biomaterials.2010.07.094
   Weiner AA, 2008, BIOMATERIALS, V29, P2400, DOI 10.1016/j.biomaterials.2008.01.013
   Weiner AA, 2007, BIOMATERIALS, V28, P5259, DOI 10.1016/j.biomaterials.2007.08.022
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wolfe MS, 2002, J BIOMED MATER RES, V61, P159, DOI 10.1002/jbm.10058
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xia F, 2007, ADV MATER, V19, P2520, DOI 10.1002/adma.200602334
   Xia WS, 2008, BIORESOURCE TECHNOL, V99, P6751, DOI 10.1016/j.biortech.2008.01.011
   Xie JW, 2006, PHARM RES, V23, P1817, DOI 10.1007/s11095-006-9036-z
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yang R, 2009, INT J PHARMACEUT, V371, P142, DOI 10.1016/j.ijpharm.2008.12.007
   Yannas IV, 2004, CLASSES MAT USED MED
   Ye ML, 2010, J CONTROL RELEASE, V146, P241, DOI 10.1016/j.jconrel.2010.05.011
   Ye WP, 1997, REACT FUNCT POLYM, V32, P161, DOI 10.1016/S1381-5148(96)00081-8
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yu SC, 2005, BIOMATERIALS, V26, P2343, DOI 10.1016/j.biomaterials.2004.07.028
   Yuan H, 2010, MOL PHARMACEUT, V7, P953, DOI 10.1021/mp1000923
   Zehr KJ, 2007, ANN THORAC SURG, V84, P1048, DOI 10.1016/j.athoracsur.2007.01.012
   Zhang QS, 2010, MAT SCI ENG C-MATER, V30, P160, DOI 10.1016/j.msec.2009.09.013
   Zhang QY, 2014, ACTA BIOMATER, V10, P1167, DOI 10.1016/j.actbio.2013.12.017
   Zhang R., 2001, METHODS TISSUE ENG, P715
   Zhang RY, 2000, ABSTR PAP AM CHEM S, V220, pU251
   Zhang YQ, 2007, BIOTECHNOL APPL BIOC, V46, P197, DOI 10.1042/BA2060163
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zhao HG, 2009, J BIOMED MATER RES B, V88B, P240, DOI 10.1002/jbm.b.31174
   Zhao Y, 2013, BIOMATERIALS, V34, P9264, DOI 10.1016/j.biomaterials.2013.08.071
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004
NR 345
TC 32
Z9 33
U1 3
U2 203
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD DEC
PY 2014
VL 89
IS 12
BP 1793
EP 1810
DI 10.1002/jctb.4505
PG 18
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA AS6MH
UT WOS:000344377100001
DA 2018-10-20
ER

PT J
AU Barua, S
   Chattopadhyay, P
   Phukan, MM
   Konwar, BK
   Karak, N
AF Barua, Shaswat
   Chattopadhyay, Pronobesh
   Phukan, Mayur M.
   Konwar, Bolin K.
   Karak, Niranjan
TI Hyperbranched epoxy/MWCNT-CuO-nystatin nanocomposite as a high
   performance, biocompatible, antimicrobial material
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE hyperbranched epoxy; carbon nanotube; copper oxide nanoparticles;
   nanocomposite; nystatin; antimicrobial; biocompatible
AB Hyperbranched epoxy MWCNT-CuO-nystatin nanocomposite has been presented here as an advanced antimicrobial high performance material. The material showed significant improvement of mechanical properties (tensile strength from 38 to 63 MPa) over the pristine matrix without effecting elongation. MWCNT was modified by a non-ionic surfactant, triton X-100, wherein copper oxide nanoparticles were anchored in situ by a 'green' method. Further, sonochemical immobilization of nystatin enhanced the stability of the system. The immobilized nanohybrid system was incorporated into the hyperbranched matrix in 1, 2 and 3 wt%. The resultant system proved its ability to prevent bacterial, fungal and microalgal fouling against the tested strains, Staphylococcus aureus, Candida albicans and Chlorella sp. Additionally, this system is quite compatible with rat heart cells. Furthermore, in vivo assessment showed that this could be utilized as an implantable antimicrobial biomaterial. Thus, the overall study pointed out that the prepared material may have immense utility in marine industry as well as in biomedical domain to address microbial fouling, without inducing any toxicity to higher organisms.
C1 [Barua, Shaswat; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Napaam 784028, Assam, India.
   [Chattopadhyay, Pronobesh] Def Res Lab, Tezpur, Assam, India.
   [Phukan, Mayur M.; Konwar, Bolin K.] Tezpur Univ, Dept Mol Biol & Biotechnol, Napaam 784028, Assam, India.
RP Barua, S (reprint author), Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Napaam 784028, Assam, India.
EM karakniranjan@yahoo.com
FU NRB [DNRD/05/4003/NRB/251]; SAP (UGC), India [F.3-30/2009(SAP-II)]; FIST
   program (DST), India [Sr/FST/CSI-203/209/1]
FX The authors express their gratitude to NRB for financial assistance
   through Grant no. DNRD/05/4003/NRB/251, dated 29.02.12., SAP (UGC),
   India, through Grant no. F.3-30/2009(SAP-II) and FIST program-2009
   (DST), India, through Grant no. Sr/FST/CSI-203/209/1, dated 06.05.2010.
   SAIF, NEHU Shillong is acknowledged for the TEM imaging. Mr Partha Jyoti
   Borthakur, DigiScatch, Jorhat is highly acknowledged for his help in
   preparation of the graphical abstract.
CR Allaoui A, 2002, COMPOS SCI TECHNOL, V62, P1993, DOI 10.1016/S0266-3538(02)00129-X
   Anyaogu KC, 2008, LANGMUIR, V24, P4340, DOI 10.1021/la800102f
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Barua S, 2014, RSC ADV, V4, P9777, DOI 10.1039/c3ra46835f
   Barua S, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025006
   Barua S, 2013, RSC ADV, V3, P14997, DOI 10.1039/c3ra42209g
   Barua S, 2013, CHEM ENG SCI, V95, P138, DOI 10.1016/j.ces.2013.03.026
   Chesworth JC, 2004, AQUAT TOXICOL, V66, P293, DOI [10.1016/j.aquatox.2003.10.002, 10.1016/j.qauatox.2003.10.002]
   Dohmen PM, 2008, J HOSP INFECT, V70, P15, DOI 10.1016/S0195-6701(08)60019-5
   Felten A, 2006, NANOTECHNOLOGY, V17, P1954, DOI 10.1088/0957-4484/17/8/026
   Fuchs AV, 2013, BIOMATER SCI-UK, V1, P470, DOI 10.1039/c2bm00155a
   Gojny FH, 2003, CHEM PHYS LETT, V370, P820, DOI 10.1016/S0009-2614(03)00187-8
   Guo WH, 2012, J MATER CHEM, V22, P903, DOI 10.1039/c1jm13769g
   Hagger JA, 2002, AQUAT TOXICOL, V57, P243, DOI 10.1016/S0166-445X(01)00200-4
   Kanz T, 1969, U TEXAS PUBLICATION, V6924
   Karousis N, 2010, CHEM REV, V110, P5366, DOI 10.1021/cr100018g
   Li N, 2010, LANGMUIR, V26, P9315, DOI 10.1021/la100215z
   Liu S, 2009, ACS NANO, V12, P3891
   Mandru M, 2013, CELL CHEM TECHNOL, V47, P5
   Park C, 2002, CHEM PHYS LETT, V364, P303, DOI 10.1016/S0009-2614(02)01326-X
   Park JS, 2012, J MATER CHEM, V22, P12695, DOI 10.1039/c2jm30710c
   Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026
   Pramanik S, 2013, CARBON, V55, P34, DOI 10.1016/j.carbon.2012.11.062
   Reusmann G, 2002, MACROMOL SYMP, V187, P235, DOI 10.1002/1521-3900(200209)187:1<235::AID-MASY235>3.0.CO;2-L
   Sivakumar PM, 2014, BIOMATER SCI-UK, V2, P990, DOI 10.1039/c3bm60312a
   Tessonnier JP, 2009, ACS NANO, V3, P2081, DOI 10.1021/nn900647q
   Vaisman L, 2006, ADV FUNCT MATER, V16, P357, DOI 10.1002/adfm.200500142
   Valodkar M, 2011, MATER CHEM PHYS, V128, P83, DOI 10.1016/j.matchemphys.2011.02.039
   Wu HC, 2010, J MATER CHEM, V20, P1036, DOI 10.1039/b911099m
   Wu XL, 2011, IND ENG CHEM RES, V50, P891, DOI 10.1021/ie1018029
   Xiao LL, 2013, ACS APPL MATER INTER, V5, P10074, DOI 10.1021/am402635p
   Yang JG, 2006, CHEM LETT, V35, P1190, DOI 10.1246/cl.2006.1190
NR 32
TC 3
Z9 3
U1 0
U2 4
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD DEC
PY 2014
VL 1
IS 4
AR 045402
DI 10.1088/2053-1591/1/4/045402
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA V43ET
UT WOS:000209665400064
DA 2018-10-20
ER

PT J
AU Rea, I
   Martucci, NM
   De Stefano, L
   Ruggiero, I
   Terracciano, M
   Dardano, P
   Migliaccio, N
   Arcari, P
   Tate, R
   Rendina, I
   Lamberti, A
AF Rea, Ilaria
   Martucci, Nicola M.
   De Stefano, Luca
   Ruggiero, Immacolata
   Terracciano, Monica
   Dardano, Principia
   Migliaccio, Nunzia
   Arcari, Paolo
   Tate, Rosarita
   Rendina, Ivo
   Lamberti, Annalisa
TI Diatomite biosilica nanocarriers for siRNA transport inside cancer cells
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Diatomite; Porous material; Surface modification; Photoluminescence;
   Nanovector; Drug delivery
ID MESOPOROUS SILICA NANOPARTICLES; MAMMALIAN-CELLS; DRUG-DELIVERY;
   MICROPARTICLES; PURIFICATION; SYSTEM; ACID; CHALLENGES; PRINCIPLES;
   RELEASE
AB Background: Diatomite is a natural porous biomaterial of sedimentary origin, formed by fragments of diatom siliceous skeletons, called "frustules". Due to large availability in many areas of the world, chemical stability, and non-toxicity, these fossil structures have been widespread used in lot of industrial applications, such as food production, water extracting agent, production of cosmetics and pharmaceutics. However, diatomite is surprisingly still rarely used in biomedical applications. In this work, we exploit diatomite nanoparticles for small interfering ribonucleic acid (siRNA) transport inside human epidermoid cancer cells (H1355).
   Methods: Morphology and composition of diatomite microfrustules (average size lower than 40 mu m) are investigated by scanning electron microscopy equipped by energy dispersive X-ray spectroscopy, Fourier transform infrared analysis, and photoluminescence measurements. Nanometric porous particles (average size lower than 450 nm) are obtained by mechanical crushing, sonication, and filtering of micrometric frustules. siRNA bioconjugation is performed on both micrometric and nanometric fragments by silanization.
   Results: In-vitro experiments show very low toxicity on exposure of the cells to diatomite nanoparticle concentration up to 300 mu g/ml for 72 h. Confocal microscopy imaging performed on cancer cells incubated with siRNA conjugated nanoparticles demonstrates a cytoplasmatic localization of vectors. Gene silencing by delivered siRNA is also demonstrated.
   Conclusion: Our studies endorse diatomite nanoparticles as non-toxic nanocarriers for siRNA transport in cancer cells.
   General significance: siRNA is a powerful molecular tool for cancer treatment but its delivery is inefficient due to the difficulty to penetrate the cell membrane. siRNA-diatomite nanoconjugate may be well suited for delivery of therapeutic to cancer cells. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Rea, Ilaria; De Stefano, Luca; Terracciano, Monica; Dardano, Principia; Rendina, Ivo] CNR, Inst Microelect & Microsyst, I-80125 Naples, Italy.
   [Martucci, Nicola M.; Ruggiero, Immacolata; Migliaccio, Nunzia; Arcari, Paolo; Lamberti, Annalisa] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.
   [Terracciano, Monica] Univ Naples Federico II, Dept Pharm, Naples, Italy.
   [Tate, Rosarita] CNR, Inst Genet & Biophys, I-80125 Naples, Italy.
RP Rea, I (reprint author), CNR, Inst Microelect & Microsyst, I-80125 Naples, Italy.
EM ilaria.rea@na.imm.cnr.it
RI Rendina, Ivo/F-8266-2013
OI Rendina, Ivo/0000-0002-3861-373X; Dardano,
   Principia/0000-0002-0616-3914; Rea, Ilaria/0000-0003-0568-9911;
   Terracciano, Monica/0000-0001-6367-2419; De Stefano,
   Luca/0000-0002-9442-4175
FU Italian National Operative Program [PON01 02782]; POR Campania FSE
FX The authors thank the DEREF S.p.A. for kindly providing the diatomite
   earth sample. The authors also thank S. Arbucci of the IGB-CNR
   Integrated Microscopy Facility for assistance with confocal microscopy
   acquisition, and G. Narciso of ICTP-CNR for EDS analysis. This work has
   been partially supported by Italian National Operative Program PON01
   02782 and POR Campania FSE 2007-2013 (4-5), Project CREME.
CR Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005
   Bariana M, 2013, INT J PHARMACEUT, V443, P230, DOI 10.1016/j.ijpharm.2012.12.012
   BENS EM, 1967, NATURE, V216, P1046, DOI 10.1038/2161046a0
   CARTER MJ, 1993, NUCLEIC ACIDS RES, V21, P1044, DOI 10.1093/nar/21.4.1044
   Chaneac C, 1996, J MATER CHEM, V6, P1905, DOI 10.1039/jm9960601905
   Chen AM, 2009, SMALL, V5, P2673, DOI 10.1002/smll.200900621
   De Stefano L, 2008, ACTA BIOMATER, V4, P126, DOI 10.1016/j.actbio.2007.09.003
   De Stefano L, 2009, BIOSENS BIOELECTRON, V24, P1580, DOI 10.1016/j.bios.2008.08.016
   De Stefano L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0160
   Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187
   Goren R, 2002, SCAND J METALL, V31, P115, DOI 10.1034/j.1600-0692.2002.310205.x
   Goren R, 2002, BRIT CERAM T, V101, P177, DOI 10.1179/096797802225003361
   Khraisheh MAM, 2005, WATER RES, V39, P922, DOI 10.1016/j.watres.2004.12.008
   Kim JY, 2009, J COLLOID INTERF SCI, V329, P114, DOI 10.1016/j.jcis.2008.09.031
   Kim SW, 2010, J CONTROL RELEASE, V143, P335, DOI 10.1016/j.jconrel.2010.01.009
   Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901
   Lin YS, 2009, CHEM MATER, V21, P3979, DOI 10.1021/cm901259n
   Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134
   Mai WX, 2013, INTEGR BIOL-UK, V5, P19, DOI 10.1039/c2ib20137b
   Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730
   Nakamura Y, 2007, J CONTROL RELEASE, V119, P360, DOI 10.1016/j.jconrel.2007.03.010
   Parker AR, 2007, NAT NANOTECHNOL, V2, P347, DOI 10.1038/nnano.2007.152
   Ruggiero I, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-329
   San O, 2009, INT J MINER PROCESS, V93, P6, DOI 10.1016/j.minpro.2009.04.007
   Serda RE, 2011, BBA-GEN SUBJECTS, V1810, P317, DOI 10.1016/j.bbagen.2010.05.004
   Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019
   Setaro A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768027
   Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385
   Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q
   Terracciano M., 2013, J EUR OPT SOC-RAPID, V8, P1303
   Wang Y, 2013, APPL MICROBIOL BIOT, V97, P453, DOI 10.1007/s00253-012-4568-0
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Xiaohua Q, 2007, POLYM ADVAN TECHNOL, V18, P184
   Xu F, 2003, ADV MATER, V15, P1751, DOI 10.1002/adma.200305287
   Zhang H, 2013, BIOMATERIALS, V34, P9210, DOI 10.1016/j.biomaterials.2013.08.035
NR 35
TC 25
Z9 26
U1 0
U2 71
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD DEC
PY 2014
VL 1840
IS 12
BP 3393
EP 3403
DI 10.1016/j.bbagen.2014.09.009
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AR8TK
UT WOS:000343847000012
PM 25224732
DA 2018-10-20
ER

PT J
AU Iqbal, N
   Kadir, MRA
   Bin Mahmood, NH
   Yusoff, MFM
   Siddique, JA
   Salim, N
   Froemming, GRA
   Sarian, MN
   Raghavendran, HRB
   Kamarul, T
AF Iqbal, Nida
   Kadir, Mohammed Rafiq Abdul
   Bin Mahmood, Nasrul Humaimi
   Yusoff, Mohammad Faiz Mohammad
   Siddique, Jamal Akhter
   Salim, Norita
   Froemming, Gabriele R. A.
   Sarian, Murni Nazira
   Raghavendran, Hanumantha Rao Balaji
   Kamarul, Tunku
TI Microwave synthesis, characterization, bioactivity and in vitro
   biocompatibility of zeolite-hydroxyapatite (Zeo-HA) composite for bone
   tissue engineering applications
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Hydroxyapatite; Zeolite; Bioactivity and biocompatibility;
   Microwave radiations
ID NATURAL ZEOLITE; NANOPARTICLES; BIOMATERIALS; SILICA; ANTIBACTERIAL;
   INTERFACE; MEMBRANES; SURFACE
AB In the present study, bioactive composites composed of hydroxyapatite (HA) and zeolite-Y were successfully synthesized by using a cost-effective microwave-assisted wet precipitation method. The phase purity, functional groups, surface topography, and elemental composition of the composite materials were examined by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), field emission scanning electron microscopy (FESEM), and energy dispersive X-ray spectroscopy (EDX), respectively. The XRD, FUR, and EDX results confirmed the presence of zeolite with HA, demonstrating the formation of zeolite HA composites. FESEM findings revealed that the particles had spherical morphology. The in vitro bioactivity assay using simulated body fluid (SBF) showed that the silica-based materials had the ability to support and accelerate the formation of dense layer. The cell viability of normal human osteoblast (NHOst) cells on the composites was confirmed by using cytotoxicity assay. In addition, FESEM results affirmed that the material supported adhesion of NHOst cells on its surface. In conclusion, the nano-structured zeolite HA composites developed in this study showed good bioactivity and in vitro cell compatibility, and, therefore, may be considered as a potential candidate for bone tissue engineering applications. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Iqbal, Nida; Kadir, Mohammed Rafiq Abdul; Bin Mahmood, Nasrul Humaimi; Yusoff, Mohammad Faiz Mohammad; Siddique, Jamal Akhter; Sarian, Murni Nazira] Univ Teknol Malaysia, Fac Biosci & Med Engn, Med Devices & Technol Grp MEDITEG, Johor Baharu 81310, Johor, Malaysia.
   [Salim, Norita; Froemming, Gabriele R. A.] Univ Teknol MARA, Fac Med, IMMB, Sungai Buloh 47000, Selangor, Malaysia.
   [Raghavendran, Hanumantha Rao Balaji; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg, NOCERAL,Tissue Engn Grp, Kuala Lumpur 50603, Malaysia.
RP Kadir, MRA (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Med Devices & Technol Grp MEDITEG, Johor Baharu 81310, Johor, Malaysia.
EM rafiq@biomedical.utm.my
RI balaji raghavendran, hanumantha rao/B-8507-2012; Froemming,
   Gabriele/C-3274-2013; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/B-9633-2011
OI Froemming, Gabriele/0000-0002-5931-1968; Tunku Zainol Abidin, Tunku
   Kamarul Zaman/0000-0002-6028-1313
FU eScienceFund Grant (Ministry of Science, Technology and Innovation
   Malaysia); FRGS Grant (Ministry of Education Malaysia); UTM Research
   University Grants; HIR-MOE [UM.C/625/1/HIR/ MOHE/CHAN/03]; University
   Malaya
FX The authors acknowledge Dr. Hendra Hermawan from the Faculty of
   Biosciences and Medical Engineering, Universiti Teknologi Malaysia
   (UTM), Malaysia for providing cell culture facilities. The authors would
   like to acknowledge the financial support provided by the eScienceFund
   Grant (Ministry of Science, Technology and Innovation Malaysia), the
   FRGS Grant (Ministry of Education Malaysia) and UTM Research University
   Grants. Authors thank HIR-MOE Reference number - UM.C/625/1/HIR/
   MOHE/CHAN/03, account number - A00000350001, University Malaya for their
   support.
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Beheri HH, 2013, MATER DESIGN, V44, P461, DOI 10.1016/j.matdes.2012.08.020
   Bohner M, 2012, J EUR CERAM SOC, V32, P2663, DOI 10.1016/j.jeurceramsoc.2012.02.028
   Ceyhan T, 2007, J MATER SCI-MATER M, V18, P1557, DOI 10.1007/s10856-007-3049-y
   Colella C, 2011, CLAY MINER, V46, P295, DOI 10.1180/claymin.2011.046.2.295
   Holmberg A. Brett, 2003, MICROPOR MESOPOR MAT, V59, P13
   Iqbal N., 2012, APPL PHYS, V12, P1755
   Iqbal N, 2014, CERAM INT, V40, P4507, DOI 10.1016/j.ceramint.2013.08.125
   Iqbal N, 2013, MATER RES BULL, V48, P3172, DOI 10.1016/j.materresbull.2013.04.068
   Klaas D.G., 1993, CERAM INT, V19, P363
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   Liu ZF, 2012, MATER TECHNOL, V27, P267, DOI 10.1179/1753555712Y.0000000011
   Lu JX, 2012, MICROPOR MESOPOR MAT, V163, P221, DOI 10.1016/j.micromeso.2012.06.037
   Musskaya ON, 2011, GLASS PHYS CHEM+, V37, P525, DOI 10.1134/S1087659611050075
   Ninan N., 2013, ACS APPL MATER INTER, V5, P194
   Oudadesse H, 2008, APPL SURF SCI, V255, P593, DOI 10.1016/j.apsusc.2008.06.086
   Peng F, 2012, J NANOSCI NANOTECHNO, V12, P2774, DOI 10.1166/jnn.2012.5714
   Sanchez M.M.J., 2012, MATER LETT, V74, P50
   Swenson P, 2012, DESALINATION, V286, P442, DOI 10.1016/j.desal.2011.12.008
   Sygnatowicz M, 2009, MAT SCI ENG C-BIO S, V29, P1071, DOI 10.1016/j.msec.2008.08.036
   Taufiqurrahmi N, 2011, IOP CONF SER-MAT SCI, V17, DOI 10.1088/1757-899X/17/1/012030
   Tavolaro A, 2013, MICROPOR MESOPOR MAT, V167, P62, DOI 10.1016/j.micromeso.2012.04.024
   Thostenson ET, 1999, COMPOS PART A-APPL S, V30, P1055, DOI 10.1016/S1359-835X(99)00020-2
   Wang XH, 2012, CURR OPIN BIOTECH, V23, P570, DOI 10.1016/j.copbio.2012.01.018
   Watanabe Y, 2006, J EUR CERAM SOC, V26, P469, DOI 10.1016/j.jeurceramsoc.2005.07.024
   Yamashita H, 2007, CHEM LETT, V36, P348, DOI 10.1246/cl.2007.348
   Yasutaka K., 2009, J MATER CHEM, V19, P7263
   Ye XY, 2012, MATER LETT, V85, P64, DOI 10.1016/j.matlet.2012.07.001
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
   Zhou XQ, 2007, ELECTROCHEM COMMUN, V9, P1525, DOI 10.1016/j.elecom.2007.02.018
NR 31
TC 9
Z9 9
U1 1
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD DEC
PY 2014
VL 40
IS 10
BP 16091
EP 16097
DI 10.1016/j.ceramint.2014.07.038
PN B
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AR1IE
UT WOS:000343338100002
DA 2018-10-20
ER

PT J
AU Ribeiro, S
   Costa, P
   Ribeiro, C
   Sencadas, V
   Botelho, G
   Lanceros-Mendez, S
AF Ribeiro, S.
   Costa, P.
   Ribeiro, C.
   Sencadas, V.
   Botelho, G.
   Lanceros-Mendez, S.
TI Electrospun styrene-butadiene-styrene elastomer copolymers for tissue
   engineering applications: Effect of butadiene/styrene ratio, block
   structure, hydrogenation and carbon nanotube loading on physical
   properties and cytotoxicity
SO COMPOSITES PART B-ENGINEERING
LA English
DT Article
DE Polymer-matrix composites (PMCs); Elasticity; Mechanical properties;
   Mechanical testing
ID STRAIN SENSOR APPLICATIONS; ELECTROMECHANICAL PROPERTIES; BIOMEDICAL
   APPLICATIONS; SCAFFOLD MATERIAL; FIBERS; COMPOSITES; BIOCOMPATIBILITY;
   STIMULATION; BIOMATERIAL; ORIENTATION
AB Different copolymers of styrene-butadiene-styrene (SBS) and hydrogenated SBS, styrene-ethylene/butylene-styrene (SEBS) were processed by electrospinning with micrometers fiber diameters. The effect of butadiene/styrene ratio, linear or radial block structure, hydrogenation, and carbon nanotube (CNT) loading on the overall material properties is reported. SEBS has higher initial modulus and mechanical hysteresis when compared to SBS. The mechanical hysteresis decreases with the number of applied cycles. The inclusion of CNTs increases the nanocomposites mechanical hysteresis and electrical conductivity independently on the copolymer matrix. The amount of styrene monomer within the samples is within the range allowed for food packaging applications. Finally, SBS and SEBS pristine samples and SEBS composites do not show cytotoxicity. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ribeiro, S.; Costa, P.; Ribeiro, C.; Sencadas, V.; Lanceros-Mendez, S.] Univ Minho, Ctr Dept Fis, P-4710057 Braga, Portugal.
   [Sencadas, V.] Escola Super Tecnol, Inst Politecn Coivado & Ave, P-4750810 Barcelos, Portugal.
   [Botelho, G.] Univ Minho, Ctr Dept Quim, P-4710057 Braga, Portugal.
RP Lanceros-Mendez, S (reprint author), Univ Minho, Ctr Dept Fis, Campus Gualtar, P-4710057 Braga, Portugal.
EM lanceros@fisica.uminho.pt
RI Botelho, Gabriela/M-4538-2013; Sencadas, Vitor/A-3932-2008;
   lanceros-mendez, senentxu/A-1730-2011
OI Botelho, Gabriela/0000-0002-4680-0834; Sencadas,
   Vitor/0000-0003-1986-1348; lanceros-mendez,
   senentxu/0000-0001-6791-7620; Ribeiro, Clarisse/0000-0002-9120-4847;
   Costa, Pedro/0000-0001-9887-0925; Ribeiro, Sylvie/0000-0002-7175-6273
FU FEDER funds through the "Programa Operacional Fatores de Competitividade
   - COMPETE"; FCT - Fundacao para a Ciencia e a Tecnologia
   [PTDC/CTM-NAN/112574/2009, PEST-C/FIS/UI607/2011,
   PEST-C/QUI/UIO686/2013]; Matepro -Optimizing Materials and Processes
   [NORTE-07-0124-FEDER-000037]; "Programa Operacional Regional do Norte"
   under the "Quadro de Referencia Estrategico Nacional" (QREN), through
   the "Fundo Europeu de Desenvolvimento Regional" (FEDER) [ON.2]; FCT
   [SFRH/BD/64276/2009, SFRH/BPD/63148/2009, SFRH/BPD/90870/2012]
FX This work is funded by FEDER funds through the "Programa Operacional
   Fatores de Competitividade - COMPETE" and by national funds arranged by
   FCT - Fundacao para a Ciencia e a Tecnologia, project references
   PTDC/CTM-NAN/112574/2009, PEST-C/FIS/UI607/2011 and
   PEST-C/QUI/UIO686/2013. The authors also thank funding from Matepro
   -Optimizing Materials and Processes", ref. NORTE-07-0124-FEDER-000037",
   co-funded by the "Programa Operacional Regional do Norte" (ON.2 - O Novo
   Norte), under the "Quadro de Referencia Estrategico Nacional" (QREN),
   through the "Fundo Europeu de Desenvolvimento Regional" (FEDER). PC, VS,
   and CR, thank the FCT for the SFRH/BD/64276/2009, SFRH/BPD/63148/2009
   and SFRH/BPD/90870/2012 Grants, respectively. Thanks to Dynasol (Spain)
   by supply several thermoplastic elastomers.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Ahmad M, 2007, J ENVIRON SCI-CHINA, V19, P421, DOI 10.1016/S1001-0742(07)60070-9
   Arinstein A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056303
   Aviss KJ, 2010, EUR CELLS MATER, V19, P193, DOI 10.22203/eCM.v019a19
   Ayoub G, 2011, J MECH PHYS SOLIDS, V59, P473, DOI 10.1016/j.jmps.2010.09.016
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Casper CL, 2004, MACROMOLECULES, V37, P573, DOI 10.1021/ma0351975
   Chan B., 2008, EUR SPINE J, V17, P467, DOI DOI 10.1007/S00586-008-0745-3
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Costa P, 2014, COMPOS PART B-ENG, V61, P136, DOI 10.1016/j.compositesb.2014.01.048
   Costa P, 2014, COMPOS PART B-ENG, V57, P242, DOI 10.1016/j.compositesb.2013.10.006
   Costa P, 2013, SENSOR ACTUAT A-PHYS, V201, P458, DOI 10.1016/j.sna.2013.08.007
   Costa P., 2012, J MATER SCI, V48, P1172
   Drozdov AD, 2009, INT J SOLIDS STRUCT, V46, P2298, DOI 10.1016/j.ijsolstr.2009.01.015
   Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002
   Gelbke HP, 2014, FOOD CHEM TOXICOL, V64, P258, DOI 10.1016/j.fct.2013.11.039
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Haider S, 2012, THERMOPLASTIC COMPOS
   Haniu H, 2012, J NANOMATER
   Holzer S, 2013, EUR POLYM J, V49, P261, DOI 10.1016/j.eurpolymj.2012.06.001
   International Conference on Thermoplastic Elastomers RTL, 2004, TPE 2004 7 INT C NEW
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Juarez D, 2011, EUR POLYM J, V47, P153, DOI 10.1016/j.eurpolymj.2010.11.004
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Kroustalli A, 2013, J MATER SCI-MATER M, V24, P2889, DOI 10.1007/s10856-013-5029-8
   Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013
   Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413
   Li XM, 2013, COLLOID SURFACE B, V102, P210, DOI 10.1016/j.colsurfb.2012.08.010
   Martins PM, 2013, RSC ADV, V3, P17938, DOI 10.1039/c3ra43499k
   Mazinani S, 2009, POLYMER, V50, P3329, DOI 10.1016/j.polymer.2009.04.070
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Otero TF, 2012, ELECTROCHIM ACTA, V84, P112, DOI 10.1016/j.electacta.2012.03.097
   Portuguese Standard, 1989, NP3993
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Ranade SV, 2005, ACTA BIOMATER, V1, P137, DOI 10.1016/j.actbio.2004.09.004
   Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641
   Raul M., 2013, BIOMED MATER, V8
   Ribeiro C, 2010, SOFT MATER, V8, P274, DOI 10.1080/1539445X.2010.495630
   Rungswang W, 2011, POLYMER, V52, P844, DOI 10.1016/j.polymer.2010.12.019
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Tzoneva R, 2011, J BIOMAT SCI-POLYM E, V22, P2205, DOI 10.1163/092050610X537147
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wong M, 2003, POLYMER, V44, P7757, DOI [10.1016/j.polymer.2003.10.011, 10.1016/Sj.polymer.2003.10.011]
NR 46
TC 16
Z9 16
U1 8
U2 91
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-8368
EI 1879-1069
J9 COMPOS PART B-ENG
JI Compos. Pt. B-Eng.
PD DEC
PY 2014
VL 67
BP 30
EP 38
DI 10.1016/j.compositesb.2014.06.025
PG 9
WC Engineering, Multidisciplinary; Materials Science, Composites
SC Engineering; Materials Science
GA AR1HX
UT WOS:000343337400004
DA 2018-10-20
ER

PT J
AU Ciocca, L
   Donati, D
   Lesci, IG
   Dozza, B
   Duchi, S
   Mezini, O
   Spadari, A
   Romagnoli, N
   Scotti, R
   Roveri, N
AF Ciocca, L.
   Donati, D.
   Lesci, I. G.
   Dozza, B.
   Duchi, S.
   Mezini, O.
   Spadari, A.
   Romagnoli, N.
   Scotti, R.
   Roveri, N.
TI Custom-made novel biomimetic composite scaffolds for the bone
   regenerative medicine
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial engineering; Composite scaffold; Rapid prototyping; Cell
   seeding
AB The aim of this pilot study was to test a new customized biomimetic composite scaffolds to restore bone defects using CAD-CAM technology. The new biomaterial was synthesized using biomimetic mineralized collagen, and poly (epsilon-caprolactone) (PCL). The mold used in scaffolding, the surgical guide, and the bony plate used during the surgery, were rapid prototyped (CAD-CAM technology). Our in vitro results showed that sheep mesenchymal stem cells (MSC) seeding efficiency was very high (>94%). Furthermore, cells can adhere, grow and maintain cell viability up to 7 days of in vitro cultivation on the scaffold as revealed by SEM and confocal laser scanning microscope analysis. These results are indicative of good scaffold biocompatibility. The use of the sheep experimental model allowed exploring the efficacy of the customized bony plate used to give extra mechanical support to the scaffold, the potential of CAD-CAM technology in customization of the scaffold, and the in vivo biomimetic properties of the composite biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ciocca, L.; Scotti, R.] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Bologna, Italy.
   [Donati, D.; Dozza, B.; Duchi, S.] Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Osteoarticular Regenerat Lab,Rizzoli Orthopaed In, Bologna, Italy.
   [Lesci, I. G.; Mezini, O.; Roveri, N.] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy.
   [Spadari, A.; Romagnoli, N.] Univ Bologna, Alma Mater Studiorum, Fac Vet Med, Bologna, Italy.
RP Ciocca, L (reprint author), Univ Bologna, Alma Mater Studiorum, Dept Biomed & Neuromotor Sci, Via S Vitale 59, Bologna, Italy.
EM leonardo.ciocca@unibo.it
RI Ciocca, Leonardo/K-4641-2015
OI Ciocca, Leonardo/0000-0002-2127-484X; Dozza,
   Barbara/0000-0002-7604-0039; DONATI, DAVIDE MARIA/0000-0002-9170-0576;
   Duchi, Serena/0000-0002-6418-3323
CR Ciocca L, 2013, BIOMED RES INT, DOI 10.1155/2013/549762
   Gabelnick HL, 1983, ADV HUMAN FERTILITY, V2, P149
   Ge J, 2007, MAT SCI ENG C-BIO S, V27, P46, DOI 10.1016/j.msec.2006.01.006
   HIDALGO DA, 1989, ANN PLAS SURG, V23, P498, DOI 10.1097/00000637-198912000-00005
   Pierini M, 2013, J BONE JOINT SURG AM, V95A, P1101, DOI 10.2106/JBJS.L.00429
   Yoo JJ, 2014, CERAM INT, V40, P3079, DOI 10.1016/j.ceramint.2013.09.138
NR 6
TC 2
Z9 2
U1 1
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD DEC 1
PY 2014
VL 136
BP 393
EP 396
DI 10.1016/j.matlet.2014.08.097
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AR5QM
UT WOS:000343638700103
DA 2018-10-20
ER

PT J
AU Pandey, AK
   Biswas, K
AF Pandey, Ajoy Kumar
   Biswas, Koushik
TI In vitro cytocompatibility, ageing and wear behavior of ceria stabilized
   zirconia bioceramic
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Sintering; Wear resistance; Apatite; Biomedical applications;
   Osteoconduction
ID ORTHORHOMBIC ZIRCONIA; NEUTRON-DIFFRACTION; APATITE FORMATION; MG-PSZ;
   ZRO2; TRANSFORMATION; BIOMATERIAL; CERAMICS; FRACTURE; BONE
AB Nano sized ceria stabilized zirconia (CSZ) powders were synthesized by co-precipitation method and then sintered conventionally to near full density. Ageing stability of developed materials was predicted through in vitro hydrothermal treatment in the presence of simulated body fluid (SBF). Fretting wear test at different loads was carried out using balls on flat geometry at different intervals of hydrothermal treatment to observe the effects of surface ageing on wear properties. Wear volume, specific wear rate and wear depth were estimated through 3D profile scan of the worn out surface by a surface profiler and it was found that the developed material became more wear resistant with the increase in hydrothermal treatment duration. XRD analysis and hardness study suggest that formation of orthorhombic zirconia during hydrothermal treatment improves the surface hardness (from 946 +/- 86 HV20 to 964 +/- 39 HV20 after 100 h of hydrothermal treatment) which in turn enhances wear resistance. In vitro cytocompatibility of the developed materials was inferred through the formation of hydroxyapatite-like layer on the surface of the material when soaked in SBF at 37.5 degrees C. Cytocompatibility was further ensured by studding attachment of multilayered human osteoblast cells (MG63) on the surface during cell culture. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Pandey, Ajoy Kumar] Natl Inst Technol Warangal, Dept Met & Mat Engn, Warangal 506004, Andhra Pradesh, India.
   [Biswas, Koushik] Indian Inst Technol, Dept Met & Mat Engn, Kharagpur 721302, W Bengal, India.
RP Pandey, AK (reprint author), Natl Inst Technol Warangal, Dept Met & Mat Engn, Warangal 506004, Andhra Pradesh, India.
EM ajoy100@gmail.com
FU Department of Biotechnology, Ministry of Science and Technology, New
   Delhi, India [BT/PR9385/MED/32/10/2007]
FX The authors would like to take the privilege to acknowledge the
   financial support from Department of Biotechnology, Ministry of Science
   and Technology, New Delhi, India (Sanction Ref. no.
   BT/PR9385/MED/32/10/2007), and technical or infrastructural supports
   from Prof. S. Dhara and Mr. Falguni Pati of School of Medical.Science
   and Technology, IIT Kharagpur and Prof. J. Dutta Majumdar, Prof. T.
   Kundu and Mr. Dilip Chakraborty of Metallurgical and Materials
   Engineering, IIT Kharagpur.
CR Aguiar AA, 2008, MATER SCI FORUM, V591-593, P697, DOI 10.4028/www.scientific.net/MSF.591-593.697
   [Anonymous], 2008, F234503 ASTM
   [Anonymous], 2008, C132708 ASTM
   Chevalier B.C.J., 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 1997, BIOCERAMICS, P10
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Gravie R., 1975, NATURE, V258, P703
   Gremillard J.C.L., 2004, J EUR CERAM SOC, V24, P3483
   HANNINK RHJ, 1994, J AM CERAM SOC, V77, P571, DOI 10.1111/j.1151-2916.1994.tb07031.x
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   HASHIBA M, 1989, J MATER SCI, V24, P873, DOI 10.1007/BF01148770
   HOWARD CJ, 1990, J AM CERAM SOC, V73, P2828, DOI 10.1111/j.1151-2916.1990.tb06682.x
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kisi EH, 1998, J AM CERAM SOC, V81, P741
   KISI EH, 1989, J AM CERAM SOC, V72, P1757, DOI 10.1111/j.1151-2916.1989.tb06322.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   MARSHALL DB, 1989, J AM CERAM SOC, V72, P218, DOI 10.1111/j.1151-2916.1989.tb06104.x
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   OHTAKA O, 1990, P JPN ACAD B-PHYS, V66, P193, DOI 10.2183/pjab.66.193
   Pandey AK, 2014, MATER CHEM PHYS, V146, P456, DOI 10.1016/j.matchemphys.2014.03.053
   Pandey AK, 2011, CERAM INT, V37, P257, DOI 10.1016/j.ceramint.2010.08.041
   Piconi C, 2006, J MATER SCI-MATER M, V17, P289, DOI 10.1007/s10856-006-7316-0
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SATO T, 1985, J AM CERAM SOC, V68, P356, DOI 10.1111/j.1151-2916.1985.tb15239.x
   Takadama H., 2004, Ceramic Engineering and Science Proceedings, V25, P571
   Yoshimura T.N.M., 1987, J MATER SCI LETT, V6, P465
NR 29
TC 7
Z9 7
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD DEC
PY 2014
VL 40
IS 10
BP 15889
EP 15895
DI 10.1016/j.ceramint.2014.07.117
PN A
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AR1OD
UT WOS:000343353600061
DA 2018-10-20
ER

PT J
AU Varkey, M
   Ding, J
   Tredget, EE
AF Varkey, Mathew
   Ding, Jie
   Tredget, Edward E.
CA Wound Healing Res Grp
TI The effect of keratinocytes on the biomechanical characteristics and
   pore microstructure of tissue engineered skin using deep dermal
   fibroblasts
SO BIOMATERIALS
LA English
DT Article
DE Tissue engineered skin; Biomechanical characteristics; Pore
   microstructure; Keratinocytes
ID SMOOTH MUSCLE ACTIN; LYSYL OXIDASE; HYPERTROPHIC SCARS; FIBROSIS;
   COLLAGEN; MATRIX; MECHANISMS; GROWTH; CELLS
AB Fibrosis affects most organs, it results in replacement of normal parenchymal tissue with collagen-rich extracellular matrix, which compromises tissue architecture and ultimately causes loss of function of the affected organ. Biochemical pathways that contribute to fibrosis have been extensively studied, but the role of biomechanical signaling in fibrosis is not clearly understood. In this study, we assessed the effect keratinocytes have on the biomechanical characteristics and pore microstructure of tissue engineered skin made with superficial or deep dermal fibroblasts in order to determine any biomaterial-mediated anti-fibrotic influences on tissue engineered skin. Tissue engineered skin with deep dermal fibroblasts and keratinocytes were found to be less stiff and contracted and had reduced number of myofibroblasts and lower expression of matrix crosslinking factors compared to matrices with deep fibroblasts alone. However, there were no such differences between tissue engineered skin with superficial fibroblasts and keratinocytes and matrices with superficial fibroblasts alone. Also, tissue engineered skin with deep fibroblasts and keratinocytes had smaller pores compared to those with superficial fibroblasts and keratinocytes; pore size of tissue engineered skin with deep fibroblasts and keratinocytes were not different from those matrices with deep fibroblasts alone. A better understanding of biomechanical characteristics and pore microstructure of tissue engineered skin may prove beneficial in promoting normal wound healing over pathologic healing. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Varkey, Mathew; Ding, Jie; Tredget, Edward E.] Univ Alberta, Div Plast & Reconstruct Surg, Edmonton, AB T6G 2B7, Canada.
   [Tredget, Edward E.] Univ Alberta, Edmonton, AB T6G 2B7, Canada.
RP Tredget, EE (reprint author), Univ Alberta, 2D3-81 WMSHC,8440-112 St, Edmonton, AB T6G 2B7, Canada.
EM etredget@ualberta.ca
FU Canadian Institutes of Health Research; Alberta Heritage Foundation of
   Medical Research; University of Alberta
FX This work was supported by Canadian Institutes of Health Research,
   Alberta Heritage Foundation of Medical Research, and the Firefighter's
   Burn Trust Fund of the University of Alberta.
CR Amadeu Thais Porto, 2003, Int J Low Extrem Wounds, V2, P60, DOI 10.1177/1534734603256155
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7
   Clark JA, 1996, BURNS, V22, P443, DOI 10.1016/0305-4179(96)00038-1
   Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8
   Curtis ASG, 1998, J BIOMAT SCI-POLYM E, V9, P1313, DOI 10.1163/156856298X00415
   Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729
   Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Hold GL, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-6
   Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413
   MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524
   MURAWAKI Y, 1991, HEPATOLOGY, V14, P1167, DOI 10.1016/0270-9139(91)90145-L
   Nikolovska K, 2014, MATRIX BIOL, V35, P91, DOI 10.1016/j.matbio.2014.01.003
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   RUDOLPH R, 1987, CLIN PLAST SURG, V14, P253
   Scott PG, 2000, HAND CLIN, V16, P271
   Sivakumar P, 2008, MOL CELL BIOCHEM, V307, P159, DOI 10.1007/s11010-007-9595-2
   Takagi R, 2011, J TISSUE ENG REGEN M, V5, pE63, DOI 10.1002/term.337
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Varkey M, 2014, TISSUE ENG PT A, V20, P716, DOI 10.1089/ten.TEA.2013.0434
   Varkey M, 2011, BIOMATERIALS, V32, P7581, DOI 10.1016/j.biomaterials.2011.06.070
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
   Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015
NR 30
TC 6
Z9 7
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2014
VL 35
IS 36
BP 9591
EP 9598
DI 10.1016/j.biomaterials.2014.07.048
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ6AR
UT WOS:000342890200004
PM 25176070
DA 2018-10-20
ER

PT J
AU Huang, HJ
   Zhang, X
   Hu, XQ
   Shao, ZX
   Zhu, JX
   Dai, LH
   Man, ZT
   Yuan, L
   Chen, HF
   Zhou, CY
   Ao, YF
AF Huang, Hongjie
   Zhang, Xin
   Hu, Xiaoqing
   Shao, Zhenxing
   Zhu, Jingxian
   Dai, Linghui
   Man, Zhentao
   Yuan, Lan
   Chen, Haifeng
   Zhou, Chunyan
   Ao, Yingfang
TI A functional biphasic biomaterial homing mesenchymal stem cells for in
   vivo cartilage regeneration
SO BIOMATERIALS
LA English
DT Article
DE Affinity peptide; Cartilage repair; Functional biomaterials; Mesenchymal
   stem cells homing; Tissue engineering
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; CORTICAL BONE-MATRIX;
   ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; CHONDRAL DEFECTS; REPAIR;
   MICROFRACTURE; KNEE; CHITOSAN; RABBIT
AB Cartilage regeneration after trauma is still a great challenge for clinicians and researchers due to many reasons, such as joint load-bearing, synovial movement and the paucity of endogenous repair cells. To overcome these limitations, we constructed a functional biomaterial using a biphasic scaffold platform and a bone-derived mesenchymal stem cells (BMSCs)-specific affinity peptide. The biphasic scaffold platform retains more cells homogeneously within the sol-gel transition of chitosan and provides sufficient solid matrix strength. This biphasic scaffold platform is functionalized with an affinity peptide targeting a cell source of interest, BMSCs. The presence of conjugated peptide gives this system a biological functionality towards BMSC-specific homing both in vitro and in vivo. The functional biomaterial can stimulate stem cell proliferation and chondrogenic differentiation during in vitro culture. Six months after in vivo implantation, compared with routine surgery or control scaffolds, the functional biomaterials induced superior cartilage repair without complications, as indicated by histological observations, magnetic resonance imaging and biomechanical properties. Beyond cartilage repair, this functional biphasic scaffold may provide a biomaterial framework for one-step tissue engineering strategy by homing endogenous cells to stimulate tissue regeneration. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Huang, Hongjie; Zhang, Xin; Hu, Xiaoqing; Shao, Zhenxing; Man, Zhentao; Ao, Yingfang] Peking Univ, Hosp 3, Inst Sports Med, Beijing Key Lab Sports Injuries, Beijing 100191, Peoples R China.
   [Zhu, Jingxian; Dai, Linghui; Zhou, Chunyan] Peking Univ, Beijing Key Lab Sports Injuries, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China.
   [Yuan, Lan] Peking Univ, Med & Healthy Anal Ctr, Beijing 100191, Peoples R China.
   [Chen, Haifeng] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
RP Ao, YF (reprint author), Peking Univ, Hosp 3, Inst Sports Med, Beijing Key Lab Sports Injuries, 49 North Garden Rd, Beijing 100191, Peoples R China.
EM chunyanzhou@bjmu.edu.cn; yingfang.ao@gmail.com
OI Shao, Zhenxing/0000-0001-5811-1254; ao, yingfang/0000-0002-8909-2022
FU National Natural Science Foundation of China [90919022, 81101390];
   Specialized Research Fund for the Doctoral Program of Higher Education
   [20110001130001]; Leading Academic Discipline Project of Beijing
   Education Bureau
FX This work was supported by grants from the National Natural Science
   Foundation of China (Grant Nos. 90919022, 81101390), Specialized
   Research Fund for the Doctoral Program of Higher Education
   (20110001130001), Leading Academic Discipline Project of Beijing
   Education Bureau. We are grateful to Prof. Ming Qiang, who provided the
   expertise and facility needed in nanoindentation analysis, and Dr. Qiang
   Zhao for help in Cartilage Magnetic Resonance Imaging.
CR BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Cao YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066444
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Dai LH, 2014, AM J SPORT MED, V42, P583, DOI 10.1177/0363546513518415
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Dessi M, 2013, J BIOMED MATER RES A, V101, P2984, DOI 10.1002/jbm.a.34592
   Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986
   Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016
   Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0
   Gao JZ, 2004, CLIN ORTHOP RELAT R, pS62, DOI 10.1097/01.blo.0000143819.82510.0d
   Gomoll AH, 2012, J KNEE SURG, V25, P9, DOI 10.1055/s-0031-1299654
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Huang HJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035008
   Ichinose S, 2005, CLIN EXP PHARMACOL P, V32, P561, DOI 10.1111/j.1440-1681.2005.04231.x
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim YS, 2013, AM J SPORT MED, V41, P1090, DOI 10.1177/0363546513479018
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Kon E, 2009, AM J SPORT MED, V37, P33, DOI 10.1177/0363546508323256
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee KBL, 2012, ANN ACAD MED SINGAP, V41, P511
   Li TZ, 2012, ADV FUNCT MATER, V22, P4292, DOI 10.1002/adfm.201102695
   Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040
   Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x
   Naveena N, 2012, J MATER CHEM, V22, P5239, DOI 10.1039/c1jm14401d
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Reys LL, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045002
   Rodriguez-Merchan E Carlos, 2012, Am J Orthop (Belle Mead NJ), V41, P236
   Roelofs AJ, 2013, OSTEOARTHR CARTILAGE, V21, P892, DOI 10.1016/j.joca.2013.04.008
   Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Sharma B, 2013, SCI TRANSL MED, V5, P167
   Sukarto A, 2012, BIOMACROMOLECULES, V13, P2490, DOI 10.1021/bm300733n
   Van Assche D, 2010, KNEE SURG SPORT TR A, V18, P486, DOI 10.1007/s00167-009-0955-1
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang DA, 2004, ADV FUNCT MATER, V14, P1152, DOI 10.1002/adfm.200305018
   Zhang X, 2008, BIOMATERIALS, V29, P4616, DOI 10.1016/j.biomaterials.2008.07.051
NR 47
TC 40
Z9 42
U1 5
U2 159
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2014
VL 35
IS 36
BP 9608
EP 9619
DI 10.1016/j.biomaterials.2014.08.020
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ6AR
UT WOS:000342890200006
PM 25176065
DA 2018-10-20
ER

PT J
AU Zachman, AL
   Wang, XT
   Tucker-Schwartz, JM
   Fitzpatrick, ST
   Lee, SH
   Guelcher, SA
   Skala, MC
   Sung, HJ
AF Zachman, Angela L.
   Wang, Xintong
   Tucker-Schwartz, Jason M.
   Fitzpatrick, Sean T.
   Lee, Sue H.
   Guelcher, Scott A.
   Skala, Melissa C.
   Sung, Hak-Joon
TI Uncoupling angiogenesis and inflammation in peripheral artery disease
   with therapeutic peptide-loaded microgels
SO BIOMATERIALS
LA English
DT Article
DE Polymer; Polycaprolactone; Polyethylene glycol; Angiogenesis;
   Inflammation; Peptide
ID TUMOR-NECROSIS-FACTOR; FIBROBLAST-GROWTH-FACTOR; NF-KAPPA-B;
   INTERMITTENT CLAUDICATION; SUSTAINED-RELEASE; CELL-ADHESION; IN-VITRO;
   MODEL; ATHEROSCLEROSIS; HINDLIMB
AB Peripheral artery disease (PAD) is characterized by vessel occlusion and ischemia in the limbs. Treatment for PAD with surgical interventions has been showing limited success. Moreover, recent clinical trials with treatment of angiogenic growth factors proved ineffective as increased angiogenesis triggered severe inflammation in a proportionally coupled fashion. Hence, the overarching goal of this research was to address this issue by developing a biomaterial system that enables controlled, dual delivery of proangiogenic C16 and anti-inflammatory Ac-SDKP peptides in a minimally-invasive way. To achieve the goal, a peptide-loaded injectable microgel system was developed and tested in a mouse model of PAD. When delivered through multiple, low volume injections, the combination of C16 and Ac-SDKP peptides promoted angiogenesis, muscle regeneration, and perfusion recovery, while minimizing detrimental inflammation. Additionally, this peptide combination regulated inflammatory TNF-alpha pathways independently of MMP-9 mediated pathways of angiogenesis in vitro, suggesting a potential mechanism by which angiogenic and inflammatory responses can be uncoupled in the context of PAD. This study demonstrates a translatable potential of the dual peptide-loaded injectable microgel system for PAD treatment. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zachman, Angela L.; Wang, Xintong; Tucker-Schwartz, Jason M.; Fitzpatrick, Sean T.; Lee, Sue H.; Guelcher, Scott A.; Skala, Melissa C.; Sung, Hak-Joon] Vanderbilt Univ, Nashville, TN 37235 USA.
RP Sung, HJ (reprint author), Vanderbilt Univ, VU Stn B 351631, Nashville, TN 37235 USA.
EM hak-joon.sung@vanderbilt.edu
FU NIH [HL091465, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126];
   NSF [DMR 1006558]; AHA [12PRE12070196]
FX This study was supported by NIH HL091465, NSF DMR 1006558, and AHA
   Predoctoral Fellowship 12PRE12070196. The authors would also like to
   acknowledge the use of resources at the Vanderbilt Institute of
   Nanoscale Science and Engineering (VINSE), a facility renovated under
   NSF ARI-R2 DMR-0963361. Confocal images were performed in part through
   the use of the VUMC Cell Imaging Shared Resource (supported by NIH
   grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126).
   <SUP>1</SUP>H NMR was conducted in the Small Molecule NMR Facility Core,
   and the Translational Pathology Shared Resources Core assisted in the
   preparation and staining of histological specimens. The authors would
   also like to acknowledge Dr. Ambra Pozzi for providing mouse aortic
   endothelial cells.
CR Alexandru N, 2012, THROMB RES, V129, P116, DOI 10.1016/j.thromres.2011.09.026
   Bailey LO, 2004, J BIOMED MATER RES A, V69A, P305, DOI 10.1002/jbm.a.20134
   Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607
   Bennett PC, 2011, THERAPEUTIC ANGIOGENESIS FOR VASCULAR DISEASES, P339, DOI 10.1007/978-90-481-9495-7_15
   BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0
   Biscetti F, 2012, INT J CARDIOL
   Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5
   Camargo LD, 2013, FREE RADICAL BIO MED, V65, P1398, DOI 10.1016/j.freeradbiomed.2013.09.028
   Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010
   Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368
   Cooper LT, 2001, VASC MED, V6, P235, DOI 10.1177/1358836X0100600406
   Crowder SW, 2012, ACTA BIOMATER, V8, P559, DOI 10.1016/j.actbio.2011.10.003
   Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381
   Das S, 2014, BIOMATERIALS, V35, P196, DOI 10.1016/j.biomaterials.2013.09.105
   Drexler W, 2004, J BIOMED OPT, V9, P47, DOI 10.1117/1.1629679
   Fan WW, 2013, AGING CELL, V12, P32, DOI 10.1111/acel.12014
   Fleiner M, 2004, CIRCULATION, V110, P2843, DOI 10.1161/01.CIR.0000146787.16297.E8
   Foukas LC, 1998, J BIOL CHEM, V273, P14813, DOI 10.1074/jbc.273.24.14813
   Gardner AW, J VASC SURG
   Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1
   Gimenez S, 2001, J BIOACT COMPAT POL, V16, P32, DOI 10.1106/MF92-TCJC-KC2X-J0FB
   Grisar JC, 2011, BIOMARK MED, V5, P731, DOI [10.2217/BMM.11.92, 10.2217/bmm.11.92]
   Grochot-Przeczek A, 2013, GENE, V525, P220, DOI 10.1016/j.gene.2013.03.097
   Gupta MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028935
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hamburg NM, 2013, CURR VASC PHARM
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171
   Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019
   Johnson C, 2004, CIRC RES, V94, P262, DOI 10.1161/01.RES.0000111527.42357.62
   Kuratomi Y, 2002, BRIT J CANCER, V86, P1169, DOI 10.1038/sj/bjc/6600187
   Lazarous DF, 2000, J AM COLL CARDIOL, V36, P1239, DOI 10.1016/S0735-1097(00)00882-2
   Lederman RJ, 2002, LANCET, V359, P2053, DOI 10.1016/S0140-6736(02)08937-7
   Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006
   Li H, 2007, MOL CELL BIOL, V27, P2676, DOI 10.1128/MCB.01748-06
   Li J, 2010, MICROVASC RES, V80, P10, DOI 10.1016/j.mvr.2009.12.002
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Libby P, 2006, J AM COLL CARDIOL, V48, pA33, DOI 10.1016/j.jacc.2006.08.011
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Liu E, 2009, COMB CHEM HIGH T SCR, V12, P646, DOI 10.2174/138620709788923737
   Llorente-Cortes V, 2014, EUR J CLIN INVEST, V44, P539, DOI 10.1111/eci.12267
   Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004
   Maiuri MC, 2004, AM J PATHOL, V165, P115, DOI 10.1016/S0002-9440(10)63280-4
   Malinda KM, 1999, FASEB J, V13, P53
   Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181
   Mercanzini A, 2010, J CONTROL RELEASE, V145, P196, DOI 10.1016/j.jconrel.2010.04.025
   Minh KN, 2010, MACROMOL BIOSCI, V10, P563, DOI 10.1002/mabi.200900402
   Pacilli A, 2010, ANN VASC SURG, V24, P258, DOI 10.1016/j.avsg.2008.12.003
   Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175
   Ponce ML, 1999, CIRC RES, V84, P688, DOI 10.1161/01.RES.84.6.688
   Poole KM, 2013, AM J PHYSIOL-HEART C, V305, pH1168, DOI 10.1152/ajpheart.00362.2013
   Raghu H, 2010, BMC CANC, V10
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Seidler RW, 2005, PHARM RES, V22, P1685, DOI 10.1007/s11095-005-6334-9
   SHERRY B, 1988, J CELL BIOL, V107, P1269, DOI 10.1083/jcb.107.4.1269
   Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657
   Siwik DA, 2000, CIRC RES, V86, P1259, DOI 10.1161/01.RES.86.12.1259
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sun HF, 2012, J BIOMED MATER RES B, V100B, P788, DOI 10.1002/jbm.b.32512
   Sung HJ, 2005, TISSUE ENG, V11, P267, DOI 10.1089/ten.2005.11.267
   Tseng HC, 2013, PLOS ONE, V8
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Vajanto I, 2002, J GENE MED, V4, P371, DOI 10.1002/jgm.287
   Voskuil M, 2003, AM J PHYSIOL-HEART C, V284, pH1422, DOI 10.1152/ajpheart.00506.2002
   WARDELL K, 1993, IEEE T BIO-MED ENG, V40, P309, DOI 10.1109/10.222322
   Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89
   Yang F., 2014, INFLAMMATION
   Yu SS, 2011, BIOMACROMOLECULES, V12, P4357, DOI 10.1021/bm201328k
   Zachman AL, 2012, TISSUE ENG PART A, V19, P437
   Zachman AL, 2013, ACTA BIOMATER, V9, P4964, DOI 10.1016/j.actbio.2012.10.038
NR 72
TC 11
Z9 11
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2014
VL 35
IS 36
BP 9635
EP 9648
DI 10.1016/j.biomaterials.2014.08.011
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ6AR
UT WOS:000342890200008
PM 25154665
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Takeda, YS
   Xu, QB
AF Takeda, Yuji S.
   Xu, Qiaobing
TI Fabrication of 2D and 3D Constructs from Reconstituted Decellularized
   Tissue Extracellular Matrices
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Decellularized ECM; Reconstitution; 3D Tissue Scaffold; Micropatterning;
   Lyophilization
ID MECHANICAL-PROPERTIES; SCAFFOLD DESIGN; CROSS-LINKING; LIVER-TISSUE;
   COLLAGEN; TECHNOLOGIES; ADHESION; PLATFORM; CELLS; GELS
AB We demonstrated a novel process to reconstitute a decellularized extracellular matrix (Recon-ECM) of heart and liver tissue using a combination of mechanical homogenization and enzymatic digestion. Such Recon-ECM was used as a biomaterial to produce flat or micro-patterned 2D films after crosslinking using replica molding. The mechanical properties of the resulting films were tuned by changing the type of crosslinking reagents. We also demonstrated the fabrication of mechanically robust 3D scaffolds by freeze-drying of the Recon-ECM solution. The porosity of the 3D scaffold was controlled by changing the concentration of the Recon-ECM. HepG2 cells were used to investigate the potential substrate of these engineered 2D patterned and 3D porous structures. The cell attachment, proliferation, and urea synthesis were evaluated, and the results indicate that the scaffold generated from Recon-ECM provides a biologically friendly environment for cells to grow. This method provides a new way to use decellularized ECM as a source of biomaterial to produce novel scaffolds with better controlled micro- and nano-scale structures, tunable physicochemical properties with desired biological functions.
C1 [Takeda, Yuji S.; Xu, Qiaobing] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Xu, QB (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM Qiaobing.xu@tufts.edu
FU NIH [R03 EB 017402]; Pew Scholar for Biomedical Sciences program from
   Pew Charitable Trusts
FX Qiaobing Xu acknowledges the support from NIH (R03 EB 017402) and Pew
   Scholar for Biomedical Sciences program from Pew Charitable Trusts. The
   authors thank Tahmid Lahman for helping prepare the ECM films and
   Nicholas Bayhi and Kyle A. Alberti for proofreading the manuscript. The
   authors also would like to thank Lindsay S. Wray and Dr. Jelena
   Rnjak-Kovacina for kindly providing the linear wire array.
CR Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dai XS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494008
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Gantenbein-Ritter B, 2011, METHODS MOL BIOL, V740, P127, DOI 10.1007/978-1-61779-108-6_14
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Kajbafzadeh AM, 2013, TISSUE ENG PART C-ME, V19, P642, DOI [10.1089/ten.tec.2012.0334, 10.1089/ten.TEC.2012.0334]
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Shirakigawa N, 2012, J BIOSCI BIOENG, V114, P546, DOI 10.1016/j.jbiosc.2012.05.022
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Tagaya M, 2011, MACROMOL BIOSCI, V11, P1586, DOI 10.1002/mabi.201100182
   Tamura T, 2008, J MATER SCI-MATER M, V19, P2071, DOI 10.1007/s10856-007-3305-1
   Tierney CM, 2009, J MECH BEHAV BIOMED, V2, P202, DOI 10.1016/j.jmbbm.2008.08.007
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   WYBENGA DR, 1971, CLIN CHEM, V17, P891
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 35
TC 1
Z9 1
U1 0
U2 34
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD DEC
PY 2014
VL 10
IS 12
BP 3631
EP 3637
DI 10.1166/jbn.2014.1876
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AQ4TW
UT WOS:000342793600012
PM 26000376
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Latifi, A
   Imani, M
   Khorasani, MT
   Joupari, MD
AF Latifi, Afrooz
   Imani, Mohammad
   Khorasani, Mohammad Taghi
   Joupari, Morteza Daliri
TI Plasma surface oxidation of 316L stainless steel for improving adhesion
   strength of silicone rubber coating to metal substrate
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE 316L stainless steel; Plasma oxidation; Surface characterization;
   Silicone rubber; Pull-off test; Adhesion strength
ID ATMOSPHERIC-PRESSURE PLASMA; IN-VITRO; RELEASE; 316-STAINLESS-STEEL;
   IMPLANTATION; TEMPERATURE; DEPOSITION; FILMS; JET
AB Stainless steel 316L is one of the most widely used materials for fabricating of biomedical devices hence, improving its surface properties is still of great interest and challenging in biomaterial sciences. Plasma oxidation, in comparison to the conventional chemical or mechanical methods, is one of the most efficient methods recently used for surface treatment of biomaterials. Here, stainless steel specimens were surface oxidized by radio-frequency plasma irradiation operating at 34 MHz under pure oxygen atmosphere. Surface chemical composition of the samples was significantly changed after plasma oxidation by appearance of the chromium and iron oxides on the plasma-oxidized surface. A wettable surface, possessing high surface energy (83.19 mN m(-1)), was observed after plasma oxidation. Upon completion of the surface modification process, silicone rubber was spray coated on the plasma-treated stainless steel surface. Morphology of the silicone rubber coating was investigated by scanning electron microscopy (SEM). A uniform coating was formed on the oxidized surface with no delamination at polymer-metal interface. Pull-off tests showed the lowest adhesion strength of coating to substrate (0.12 MPa) for untreated specimens and the highest (0.89 MPa) for plasma-oxidized ones. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Latifi, Afrooz] Islamic Azad Univ, Sci & Res Branch, Biomed Engn Fac, Dept Biomat, Tehran, Iran.
   [Imani, Mohammad] Iran Polymer & Petrochem Inst, Novel Drug Delivery Syst Dept, Tehran, Iran.
   [Khorasani, Mohammad Taghi] Iran Polymer & Petrochem Inst, Biomat Dept, Tehran, Iran.
   [Joupari, Morteza Daliri] Natl Inst Genet Engn & Biotechnol, Anim & Marine Biotechnol Dept, Tehran, Iran.
RP Latifi, A (reprint author), Islamic Azad Univ, Sci & Res Branch, Biomed Engn Fac, Dept Biomat, Tehran, Iran.
EM afroozlatifi@yahoo.com
CR Bege N, 2012, EUR J PHARM BIOPHARM, V80, P562, DOI 10.1016/j.ejpb.2011.12.006
   Chen M, 2009, APPL SURF SCI, V255, P7257, DOI 10.1016/j.apsusc.2009.03.079
   Chuang MJ, 2010, THIN SOLID FILMS, V518, P2290, DOI 10.1016/j.tsf.2008.10.146
   Donik C, 2009, APPL SURF SCI, V255, P7056, DOI 10.1016/j.apsusc.2009.03.041
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Fernandez ICS, 2010, ACTA BIOMATER, V6, P1119, DOI 10.1016/j.actbio.2009.08.040
   Gheorghiu-de La Rocque A, 1998, J NON-CRYST SOLIDS, V227, P59, DOI 10.1016/S0022-3093(98)00358-5
   Ghods P, 2011, APPL SURF SCI, V257, P4669, DOI 10.1016/j.apsusc.2010.12.120
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   Haidopoulos M, 2006, J MATER SCI-MATER M, V17, P647, DOI 10.1007/s10856-006-9228-4
   Haidopoulos M, 2005, SURF COAT TECH, V197, P278, DOI 10.1016/j.surfcoat.2004.10.113
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Kim MC, 2003, SURF COAT TECH, V174, P839, DOI 10.1016/S0257-8972(03)00560-7
   Latifi A, 2013, SURF COAT TECH, V221, P1, DOI 10.1016/j.surfcoat.2013.01.020
   Lee CJ, 2009, J MATER PROCESS TECH, V209, P4769, DOI 10.1016/j.jmatprotec.2008.11.043
   Lewis AL, 2002, BIOMATERIALS, V23, P1697, DOI 10.1016/S0142-9612(01)00297-6
   Li Y, 2009, THIN SOLID FILMS, V517, P3208, DOI 10.1016/j.tsf.2008.10.098
   Lin JW, 2011, NUCL INSTRUM METH B, V269, P1801, DOI 10.1016/j.nimb.2011.05.004
   Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0
   Marciano FR, 2009, APPL SURF SCI, V255, P8377, DOI 10.1016/j.apsusc.2009.05.091
   McBride MC, 2009, BIOMATERIALS, V30, P6739, DOI 10.1016/j.biomaterials.2009.08.047
   Mochizuki A, 2011, MAT SCI ENG C-MATER, V31, P567, DOI 10.1016/j.msec.2010.11.019
   Morshed MM, 2003, SURF COAT TECH, V163, P541, DOI 10.1016/S0257-8972(02)00619-9
   Nazneen F, 2012, J SOLID STATE ELECTR, V16, P1389, DOI 10.1007/s10008-011-1539-9
   O'Shaughnessy WS, 2009, THIN SOLID FILMS, V517, P3612, DOI 10.1016/j.tsf.2009.01.192
   Okado J, 2008, SURF COAT TECH, V202, P5595, DOI 10.1016/j.surfcoat.2008.06.033
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   Prasad GR, 2005, SURF COAT TECH, V200, P1031, DOI 10.1016/j.surfcoat.2005.02.009
   Rogero SO, 2005, NUCL INSTRUM METH B, V236, P521, DOI 10.1016/j.nimb.2005.04.031
   SEO M, 1980, T JPN I MET, V21, P805, DOI 10.2320/matertrans1960.21.805
   Shinonaga Y, 2009, DENT MATER J, V28, P735, DOI 10.4012/dmj.28.735
   Simmons A, 2008, BIOMATERIALS, V29, P2987, DOI 10.1016/j.biomaterials.2008.04.007
   Tiwari A, 2008, SURF COAT TECH, V202, P4620, DOI 10.1016/j.surfcoat.2008.03.030
   Vesel A, 2007, VACUUM, V82, P228, DOI 10.1016/j.vacuum.2007.07.014
   Zeno W., 1999, ORGANIC COATINGS SCI
   Zhang F, 2001, BIOMATERIALS, V22, P1541, DOI 10.1016/S0142-9612(00)00310-0
NR 36
TC 7
Z9 9
U1 5
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD NOV 30
PY 2014
VL 320
BP 471
EP 481
DI 10.1016/j.apsusc.2014.09.084
PG 11
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AU1SG
UT WOS:000345399900061
DA 2018-10-20
ER

PT J
AU Hu, Y
   Catchmark, JM
   Zhu, YJ
   Abidi, N
   Zhou, X
   Wang, JH
   Liang, NY
AF Hu, Yang
   Catchmark, Jeffrey M.
   Zhu, Yongjun
   Abidi, Noureddine
   Zhou, Xin
   Wang, Jinhui
   Liang, Nuanyi
TI Engineering of porous bacterial cellulose toward human fibroblasts
   ingrowth for tissue engineering
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID MECHANICAL-PROPERTIES; MICROBIAL CELLULOSE; COMPOSITES; CELLULASES;
   SCAFFOLDS; WATER; SIZE
AB From the view of tissue engineering, the deficiency in porosity has impeded further application of bacterial cellulose (BC) as a super biomaterial. In this study, we used a combination method consisting of acetic acid treatment and freeze-drying operation to improve the porous profile of BC, as well as a simple and fast method to measure the thickness, density, and porosity of BC. Results have shown a significant improvement in the porosity of the inner structure of BC treated with acetic acid and freeze-drying. Microscopic observation by scanning electron microscopy exhibited explicit evidences that more orderly porous layer-by-layer structures and more pores were formed along the cross section of modified BC as compared with the control. The enhancement of mechanical properties and crystallinity of modified BC was also demonstrated due to the improvement of material porosity in the particular extent from 50.3 to 76.43%. Cell culture of human fibroblast cells exhibited good cell viability on modified BC, suggesting that a better porous profile of BC on the surface and cross section helps facilitate cells to attach, as well as potentially promotes cells to grow in. These significant results may open the possibility of producing BC nanomaterials for tissue engineering with desirable properties.
C1 [Hu, Yang; Zhu, Yongjun; Zhou, Xin; Wang, Jinhui; Liang, Nuanyi] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organs Degenerat, Shenzhen 518055, Guangdong, Peoples R China.
   [Hu, Yang; Zhu, Yongjun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen Key Lab Marine Biomed Mat, Shenzhen 518055, Guangdong, Peoples R China.
   [Hu, Yang; Catchmark, Jeffrey M.] Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA.
   [Hu, Yang; Catchmark, Jeffrey M.] Penn State Univ, Ctr Nanocellulos, University Pk, PA 16802 USA.
   [Hu, Yang; Abidi, Noureddine] Texas Tech Univ, Fiber & Biopolymer Res Inst, Dept Plant & Soil Sci, Lubbock, TX 79403 USA.
RP Hu, Y (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organs Degenerat, Shenzhen 518055, Guangdong, Peoples R China.
EM yang.hu@siat.ac.cn
FU Pennsylvania State University Material Research Institute Nano
   Fabrication Network; National Science Foundation [0335765]; National
   Nanotechnology Infrastructure Network; Cornell University; National
   Natural Science Foundation of China [31370978]; Guangdong Natural
   Science Foundation [S2013040014248]; Development of Strategic Emerging
   Industries of the Shenzhen Basic Research project
   [JCYJ20130402113127522, JCYJ20120831180118537]; Shenzhen Peacock program
   [110811003586331]
FX This work was supported by the Pennsylvania State University Material
   Research Institute Nano Fabrication Network and the National Science
   Foundation Cooperative agreement no. 0335765, National Nanotechnology
   Infrastructure Network, with Cornell University; the National Natural
   Science Foundation of China, no. 31370978; the Guangdong Natural Science
   Foundation no. S2013040014248; the Development of Strategic Emerging
   Industries of the Shenzhen Basic Research project no.
   JCYJ20130402113127522, no. JCYJ20120831180118537; the Shenzhen Peacock
   program no. 110811003586331.
CR Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Engelund ET, 2013, WOOD SCI TECHNOL, V47, P141, DOI 10.1007/s00226-012-0514-7
   Fu LN, 2013, CARBOHYD POLYM, V92, P1432, DOI 10.1016/j.carbpol.2012.10.071
   Gavillon R, 2008, BIOMACROMOLECULES, V9, P269, DOI 10.1021/bm700972k
   Gu J, 2014, CELLULOSE, V21, P275, DOI 10.1007/s10570-013-0115-0
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hu Y, 2010, LETT APPL MICROBIOL, V51, P109, DOI 10.1111/j.1472-765X.2010.02866.x
   Hu Y., 2014, BIOMACROMOLECULES, V14, P3444
   Hu Y, 2011, J BIOMED MATER RES B, V97B, P114, DOI 10.1002/jbm.b.31792
   Hu Y, 2011, ACTA BIOMATER, V7, P2835, DOI 10.1016/j.actbio.2011.03.028
   Hu Y, 2010, BIOMACROMOLECULES, V11, P1727, DOI 10.1021/bm100060v
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kato N, 2004, COLLOID SURFACE B, V38, P191, DOI 10.1016/j.colsurfb.2004.01.018
   Keshk S.M., 2014, J BIOPROCESS BIOTECH, V4, P150, DOI DOI 10.4172/2155-9821.1000150
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lin SP, 2013, CELLULOSE, V20, P2191, DOI 10.1007/s10570-013-9994-3
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Nge TT, 2010, CELLULOSE, V17, P349, DOI 10.1007/s10570-009-9394-x
   Park S, 2006, CARBOHYD POLYM, V66, P97, DOI 10.1016/j.carbpol.2006.02.026
   Peng YC, 2012, CELLULOSE, V19, P91, DOI 10.1007/s10570-011-9630-z
   Peng Z., 2010, J MACROMOL SCI B, V50, P340
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Takamuku T, 2007, J PHYS CHEM B, V111, P9270, DOI 10.1021/jp0724976
   Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3
NR 30
TC 13
Z9 13
U1 1
U2 21
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0884-2914
EI 2044-5326
J9 J MATER RES
JI J. Mater. Res.
PD NOV 28
PY 2014
VL 29
IS 22
BP 2682
EP 2693
DI 10.1557/jmr.2014.315
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AW7FG
UT WOS:000346429500009
DA 2018-10-20
ER

PT J
AU Kasputis, T
   Pieper, A
   Schubert, M
   Pannier, AK
AF Kasputis, Tadas
   Pieper, Alex
   Schubert, Mathias
   Pannier, Angela K.
TI Dynamic analysis of DNA nanoparticle immobilization to model biomaterial
   substrates using combinatorial spectroscopic ellipsometry and quartz
   crystal microbalance with dissipation
SO THIN SOLID FILMS
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Spectroscopic Ellipsometry (ICSE)
CY MAY 26-31, 2013
CL Kyoto, JAPAN
DE Spectroscopic ellipsometry; Quartz crystal microbalance with
   dissipation; DNA nanoparticles; Nonviral gene delivery; Adsorption;
   Surface immobilization
ID GENE DELIVERY-SYSTEMS; SURFACE; ADSORPTION; COMPLEXES; BIOMOLECULES;
   FIBRONECTIN; SILICON; FILMS; GOLD
AB Gene expression within cells can be altered through gene delivery approaches, which have tremendous potential for gene therapy, tissue engineering, and diagnostics. Substrate-mediated gene delivery describes the delivery of plasmid DNA or DNA complexed with nonviral vectors to cells from a surface, with the DNA immobilized to a substrate through specific or nonspecific interactions. In this work, DNA-nanoparticle (DNA-NP) adsorption to substrates is evaluated using combinatorial, in situ spectroscopic ellipsometry and quartz crystal microbalance with dissipation (SE/QCM-D), to evaluate the basic dynamic processes involved in the adsorption and immobilization of DNA-NP complexes to substrates. The concentration of DNA-NP solutions influences the adsorbed DNA-NP surface mass, which increases by a factor of approximately 6 (detected by SE) and approximately 4.5-fold (detected by QCM-D), as the DNA concentration increases from 1.5 mu g/mL to 15 mu g/mL, with an increase in layer porosity. In addition, SE/QCM-D analysis indicates that DNA-NP adsorption rates, surface coverage densities, and volume fractions are dependent on the type of substrate: gold (Au) and silicon dioxide substrates, protein-coated and uncoated substrates, and surfaces modified with alkanethiol self assembled monolayers (SAMs). These studies also demonstrate that the influence of an adsorbed protein layer on resulting DNA-NP immobilization efficiency is substrate dependent. For example, Au surfaces coated with fetal bovine serum (FBS) resulted in two-fold greater mass of adsorbed DNA-NPs, compared to DNA-NP adsorption to FBS-coated SAM substrates. This investigation offers insights into dynamic DNA-NP surface adsorption processes, characteristics of the immobilized DNA-NP layer, and demonstrates substrate-dependent DNA-NP adsorption. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kasputis, Tadas; Pieper, Alex; Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA.
   [Schubert, Mathias] Univ Nebraska, Dept Elect Engn, Lincoln, NE 68583 USA.
   [Schubert, Mathias; Pannier, Angela K.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68583 USA.
   [Kasputis, Tadas; Pieper, Alex; Schubert, Mathias; Pannier, Angela K.] Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68583 USA.
RP Pannier, AK (reprint author), Univ Nebraska, Dept Biol Syst Engn, 231 LW Chase Hall, Lincoln, NE 68583 USA.
EM apannier2@unl.edu
RI Schubert, Mathias/B-2676-2017
OI Schubert, Mathias/0000-0001-6238-663X
CR Benesch J, 2010, ACTA BIOMATER, V6, P3499, DOI 10.1016/j.actbio.2010.03.027
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058
   Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bittrich E, 2010, BIOINTERPHASES, V5, P1, DOI 10.1116/1.3530841
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Dhaliwal A, 2010, ACTA BIOMATER, V6, P3436, DOI 10.1016/j.actbio.2010.03.038
   Fears KP, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-20
   Fears KP, 2013, J AM CHEM SOC, V135, P15040, DOI 10.1021/ja404346p
   Jang JH, 2006, J BIOMED MATER RES A, V77A, P50, DOI 10.1002/jbm.a.30643
   Kasputis T, 2013, J PHYS CHEM C, V117, P13971, DOI 10.1021/jp402055h
   Kimura-Suda H, 2003, J AM CHEM SOC, V125, P9014, DOI 10.1021/ja035756n
   Lai E, 2001, BIOPHYS J, V80, P864, DOI 10.1016/S0006-3495(01)76065-1
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Midwood KS, 2004, LANGMUIR, V20, P5501, DOI 10.1021/la049506b
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Pannier AK, 2008, ACTA BIOMATER, V4, P26, DOI 10.1016/j.actbio.2007.08.008
   Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Parker A. L., 2003, EXPERT REV MOL MED, V5
   Patil SD, 2005, AAPS J, V7, pE61, DOI 10.1208/aapsj070109
   Rodenhausen KB, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3653880
   Rodenhausen KB, 2011, THIN SOLID FILMS, V519, P2772, DOI 10.1016/j.tsf.2010.11.079
   Rodenhausen KB, 2011, THIN SOLID FILMS, V519, P2817, DOI 10.1016/j.tsf.2010.11.081
   Rodenhausen KB, 2012, OPT EXPRESS, V20, P5419, DOI 10.1364/OE.20.005419
   Schmidt D, 2011, THIN SOLID FILMS, V519, P2645, DOI 10.1016/j.tsf.2010.12.111
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Wiethoff CM, 2003, J PHARM SCI, V92, P203, DOI 10.1002/jps.10286
   Zhao D, 2011, INT J PHARMACEUT, V413, P260, DOI 10.1016/j.ijpharm.2011.04.040
NR 34
TC 3
Z9 3
U1 0
U2 32
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0040-6090
J9 THIN SOLID FILMS
JI Thin Solid Films
PD NOV 28
PY 2014
VL 571
BP 637
EP 643
DI 10.1016/j.tsf.2014.01.046
PN 3
PG 7
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA AW1ND
UT WOS:000346055200057
OA Green Published
DA 2018-10-20
ER

PT J
AU Goncalves, JPL
   Shaikh, AQ
   Reitzig, M
   Kovalenko, DA
   Michael, J
   Beutner, R
   Cuniberti, G
   Scharnweber, D
   Opitz, J
AF Goncalves, Juliana P. L.
   Shaikh, Afnan Q.
   Reitzig, Manuela
   Kovalenko, Daria A.
   Michael, Jan
   Beutner, Rene
   Cuniberti, Gianaurelio
   Scharnweber, Dieter
   Opitz, Joerg
TI Detonation nanodiamonds biofunctionalization and immobilization to
   titanium alloy surfaces as first steps towards medical application
SO BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
DE biofunctionalization; carbon-nanomaterials; detonation nanodiamond;
   electrochemical immobilization; surface modification; titanium alloy
ID FUNCTIONALIZED NANODIAMONDS; FLUORESCENT NANODIAMONDS;
   MECHANICAL-PROPERTIES; DIAMOND; ACIDS; COMPOSITES; IMPLANTS; COATINGS;
   DELIVERY; CENTERS
AB Due to their outstanding properties nanodiamonds are a promising nanoscale material in various applications such as microelectronics, polishing, optical monitoring, medicine and biotechnology. Beyond the typical diamond characteristics like extreme hardness or high thermal conductivity, they have additional benefits as intrinsic fluorescence due to lattice defects without photo-bleaching, obtained during the high pressure high temperature process. Further the carbon surface and its various functional groups in consequence of the synthesis, facilitate additional chemical and biological modification. In this work we present our recent results on chemical modification of the nanodiamond surface with phosphate groups and their electrochemically assisted immobilization on titanium-based materials to increase adhesion at biomaterial surfaces. The starting material is detonation nanodiamond, which exhibits a heterogeneous surface due to the functional groups resulting from the nitrogen-rich explosives and the subsequent purification steps after detonation synthesis. Nanodiamond surfaces are chemically homogenized before proceeding with further functionalization. Suspensions of resulting surface-modified nanodiamonds are applied to the titanium alloy surfaces and the nanodiamonds subsequently fixed by electrochemical immobilization. Titanium and its alloys have been widely used in bone and dental implants for being a metal that is biocompatible with body tissues and able to bind with adjacent bone during healing. In order to improve titanium material properties towards biomedical applications the authors aim to increase adhesion to bone material by incorporating nanodiamonds into the implant surface, namely the anodically grown titanium dioxide layer. Differently functionalized nanodiamonds are characterized by infrared spectroscopy and the modified titanium alloys surfaces by scanning and transmission electron microscopy. The process described shows an adsorption and immobilization of modified nanodiamonds on titanium; where aminosilanized nanodiamonds coupled with O-phosphorylethanolamine show a homogeneous interaction with the titanium substrate.
C1 [Goncalves, Juliana P. L.; Shaikh, Afnan Q.; Reitzig, Manuela; Kovalenko, Daria A.; Michael, Jan; Opitz, Joerg] Fraunhofer Inst Ceram Technol & Syst Mat Diagnost, D-01109 Dresden, Germany.
   [Shaikh, Afnan Q.; Kovalenko, Daria A.; Beutner, Rene; Cuniberti, Gianaurelio; Scharnweber, Dieter; Opitz, Joerg] Tech Univ Dresden, Max Bergmann Ctr Biomat MBC, D-01069 Dresden, Germany.
   [Michael, Jan] Tech Univ Dresden, Chair Gen Biochem, D-01069 Dresden, Germany.
RP Opitz, J (reprint author), Fraunhofer Inst Ceram Technol & Syst Mat Diagnost, Maria Reiche Str 2, D-01109 Dresden, Germany.
EM joerg.opitz@ikts-md.fraunhofer.de
RI Kovalenko, Daria/S-3541-2017; Cuniberti, Gianaurelio/B-7192-2008
OI Cuniberti, Gianaurelio/0000-0002-6574-7848; Goncalves,
   Juliana/0000-0002-6634-9876; Opitz, Joerg/0000-0003-3142-2479
FU European Commission; DAAD/HEC scholarship [A/11/92671]
FX The authors thank Yvonne Standke for help with the SEM measurements and
   Dr. Uwe Muhle for assistance with the STEM measurements. This project
   has been funded with support from the European Commission and a DAAD/HEC
   scholarship A/11/92671. This publication reflects the views only of the
   authors, and the Commission cannot be held responsible for any use which
   may be made of the information contained therein.
CR Bacakova L, 2014, PHYS STATUS SOLIDI A, V211, P2688, DOI 10.1002/pssa.201431402
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Beutner R., 2007, BIOMATERIALEN, V8, P25, DOI [10.1515/BIOMAT.2007.8.1.25, DOI 10.1515/BIOMAT.2007.8.1.25]
   Beutner R, 2010, J R SOC INTERFACE, V7, pS93, DOI 10.1098/rsif.2009.0418.focus
   Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047
   Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Coates J., 2000, ENCY ANAL CHEM
   DAVIES G, 1992, PHYS REV B, V46, P13157, DOI 10.1103/PhysRevB.46.13157
   Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j
   Fox K, 2013, J MATER SCI-MATER M, V24, P849, DOI 10.1007/s10856-013-4860-2
   Fu CC, 2007, P NATL ACAD SCI USA, V104, P727, DOI 10.1073/pnas.0605409104
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Gong WQ, 2001, INT J MINER PROCESS, V63, P147, DOI 10.1016/S0301-7516(01)00045-X
   Hannstein I., 2009, P SPIE
   Hannstein I, 2009, MATER TEST, V51, P659, DOI 10.3139/120.110054
   Harlow GE, 2005, ELEMENTS, V1, P67, DOI 10.2113/gselements.1.2.67
   Huang H, 2007, NANO LETT, V7, P3305, DOI 10.1021/nl071521o
   Kaur R, 2012, INT J NANOMED, V7, P3851, DOI 10.2147/IJN.S32877
   Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036
   Krueger A, 2008, LANGMUIR, V24, P4200, DOI 10.1021/la703482v
   Krueger A, 2008, CHEM-EUR J, V14, P1382, DOI 10.1002/chem.200700987
   Krueger A, 2012, ADV FUNCT MATER, V22, P890, DOI 10.1002/adfm.201102670
   Liu KK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315106
   Michael J, 2007, J BIOMED MATER RES B, V80B, P146, DOI 10.1002/jbm.b.30579
   Michael J, 2009, BIOCONJUGATE CHEM, V20, P710, DOI 10.1021/bc800372e
   Michelmore A, 2000, PHYS CHEM CHEM PHYS, V2, P2985, DOI 10.1039/b001213k
   Mita Y, 1996, PHYS REV B, V53, P11360, DOI 10.1103/PhysRevB.53.11360
   Mkandawire M, 2009, J BIOPHOTONICS, V2, P596, DOI 10.1002/jbio.200910002
   Mochalin VN, 2012, NAT NANOTECHNOL, V7, P11, DOI [10.1038/nnano.2011.209, 10.1038/NNANO.2011.209]
   Mutin PH, 2004, CHEM MATER, V16, P5670, DOI 10.1021/cm035367s
   Scharnweber D, 2007, J MATER SCI-MATER M, V18, P391, DOI 10.1007/s10856-006-0704-7
   Scharnweber D, 2004, BIOMATERIALS, V25, P2371, DOI 10.1016/j.biomaterials.2003.09.025
   Schietinger S, 2008, NANO LETT, V8, P3911, DOI 10.1021/nl8023627
   Schliephake H, 2012, EUR CELLS MATER, V23, P161, DOI 10.22203/eCM.v023a12
   Schliephake H, 2012, BIOMATERIALS, V33, P1315, DOI 10.1016/j.biomaterials.2011.10.027
   Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v
   Shenderova OA, 2002, CRIT REV SOLID STATE, V27, P227, DOI 10.1080/10408430208500497
   Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i
   Xing Z, 2013, TISSUE ENG PT A, V19, P1783, DOI [10.1089/ten.TEA.2012.0336, 10.1089/ten.tea.2012.0336]
   Yu M, 2014, J MATER SCI, V49, P3629, DOI 10.1007/s10853-014-8066-x
   Yu SJ, 2005, J AM CHEM SOC, V127, P17604, DOI 10.1021/ja0567081
   Zhang QW, 2012, BIOMATERIALS, V33, P5067, DOI 10.1016/j.biomaterials.2012.03.063
   Zhang XQ, 2011, ADV MATER, V23, P4770, DOI 10.1002/adma.201102263
NR 43
TC 8
Z9 9
U1 0
U2 48
PU BEILSTEIN-INSTITUT
PI FRANKFURT AM MAIN
PA TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN, 60487, GERMANY
SN 1860-5397
J9 BEILSTEIN J ORG CHEM
JI Beilstein J. Org. Chem.
PD NOV 26
PY 2014
VL 10
BP 2765
EP 2773
DI 10.3762/bjoc.10.293
PG 9
WC Chemistry, Organic
SC Chemistry
GA AW7SU
UT WOS:000346465500001
PM 25550742
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mokkaphan, J
   Banlunara, W
   Palaga, T
   Sombuntham, P
   Wanichwecharungruang, S
AF Mokkaphan, Jiratchaya
   Banlunara, Wijit
   Palaga, Tanapat
   Sombuntham, Premsuda
   Wanichwecharungruang, Supason
TI Silicone Surface with Drug Nanodepots for Medical Devices
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silicone surface; drug release; surface functionalization; inflammation
   implantation; endotracheal tube
ID CONTROLLED-RELEASE; INTRAVAGINAL RING; BIOMATERIAL; DELIVERY; RUBBER;
   FUNCTIONALIZATION; IMPLANTATION; INFECTIONS; CATHETERS; ADHESION
AB An ideal surface of poly(dimethylsiloxane) (PDMS) medical devices requires sustained drug release to combat various tissue responses and infection. At present, a noncovalent surface coating with drug molecules using binders possesses a detachment problem, while covalently linking drug molecules to the surface provides no releasable drug. Here, a platform that allows the deposition of diverse drugs onto the PDMS surface in an adequate quantity with reliable attachment and a sustained-release character is demonstrated. First, a PDMS surface with carboxyl functionality (PDMS-COOH) is generated by subjecting a PDMS piece to an oxygen plasma treatment to obtain silanol moieties on its surface, then condensing the silanols with (3-aminopropyl)triethoxysilane molecules to generate amino groups, and finally reacting the amino groups with succinic anhydride. The drug-loaded carriers with hydroxyl groups on their surface can then be esterified to PDMS-COOH, resulting in a PDMS surface covalently grafted with drug-filled nanocarriers so that the drugs inside the securely grafted carriers can be released. Demonstrated here is the covalent linking of the surface of a PDMS endotracheal tube with budesonide-loaded ethylcellulose nanoparticles. A secure and high drug accumulation at the surface of the tubes (0.025 mg/cm(2)) can be achieved without changes in its bulk property such as hardness (Shore-A), and sustained release of budesonide with a high release flux during the first week followed by a reduced release flux over the subsequent 3 weeks can be obtained. In addition, the grafted tube possesses more hydrophilic surface and thus is more tissue-compatible. The grafted PDMS pieces show a reduced in vitro inflammation in cell culture and a lower level of in vivo tissue responses, including a reduced level of inflammation, compared to the unmodified PDMS pieces, when implanted in rats. Although demonstrated with budesonide and a PDMS endotracheal tube, this platform of grafting a PDMS surface with drug-loaded particles can be applied to other drugs and other devices.
C1 [Mokkaphan, Jiratchaya] Chulalongkorn Univ, Program Petrochem & Polymer Sci, Fac Sci, Bangkok 10330, Thailand.
   [Banlunara, Wijit] Chulalongkorn Univ, Dept Pathol, Fac Vet Sci, Bangkok 10330, Thailand.
   [Palaga, Tanapat] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok 10330, Thailand.
   [Sombuntham, Premsuda] Chulalongkorn Univ, Dept Otolaryngol Head & Neck Surg, Fac Med, Bangkok 10330, Thailand.
   [Wanichwecharungruang, Supason] Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok 10330, Thailand.
   [Palaga, Tanapat; Wanichwecharungruang, Supason] Chulalongkorn Univ, Nanotec CU Ctr Excellence Food & Agr, Bangkok 10330, Thailand.
RP Wanichwecharungruang, S (reprint author), Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok 10330, Thailand.
EM psupason@chula.ac.th
FU Ratchadapiseksompot Endowment Fund of Chulalongkorn University
   [RES560530097-Adv Mat]; Nanotec-CU Center of Excellence on Food and
   Agriculture
FX This work was financially supported by the Ratchadapiseksompot Endowment
   Fund of Chulalongkorn University (RES560530097-Adv Mat) and Nanotec-CU
   Center of Excellence on Food and Agriculture.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Algieri C, 2013, J APPL POLYM SCI, V128, P754, DOI 10.1002/app.38102
   Brown MT, 1996, ANN OTO RHINOL LARYN, V105, P624, DOI 10.1177/000348949610500807
   Chen SY, 2011, EJSO-EUR J SURG ONC, V37, P300, DOI 10.1016/j.ejso.2011.01.015
   Daneshpour N, 2013, EUR J PHARM BIOPHARM, V83, P106, DOI 10.1016/j.ejpb.2012.09.005
   de Givenchy EPT, 2009, LANGMUIR, V25, P6448, DOI 10.1021/la900064m
   Forbes CJ, 2014, J PHARM SCI-US, V103, P1422, DOI 10.1002/jps.23913
   Goncalves S, 2013, COLLOID SURFACE B, V109, P228, DOI 10.1016/j.colsurfb.2013.03.050
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Karami S, 2014, INT J PHARMACEUT, V460, P158, DOI 10.1016/j.ijpharm.2013.10.002
   Kidsaneepoiboon P, 2011, J MATER CHEM, V21, P7922, DOI 10.1039/c0jm04271d
   Kourtzelis I, 2013, FASEB J, V27, P2768, DOI 10.1096/fj.12-225888
   Lee D, 2012, SENSOR ACTUAT B-CHEM, V162, P425, DOI 10.1016/j.snb.2011.12.017
   Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p
   Malcolm RK, 2004, J CONTROL RELEASE, V97, P313, DOI 10.1016/j.jconrel.2004.03.029
   Meslemani D., 2009, LARYNGOSCOPE S1, V119, P122
   OKADA T, 1995, J BIOMAT SCI-POLYM E, V7, P171, DOI 10.1163/156856295X00689
   Packham D. E., 2002, SURFACES CHEM APPL, P317
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Richey T, 2000, BIOMATERIALS, V21, P1057, DOI 10.1016/S0142-9612(99)00281-1
   Roth J, 2008, LANGMUIR, V24, P12603, DOI 10.1021/la801970s
   Sansukcharearnpon A, 2010, INT J PHARMACEUT, V391, P267, DOI 10.1016/j.ijpharm.2010.02.020
   Soulas DN, 2012, IND ENG CHEM RES, V51, P7126, DOI 10.1021/ie300540x
   SUCHATLAMPONG C, 1986, DENT MATER, V2, P135, DOI 10.1016/S0109-5641(86)80010-0
   Suwannateep N, 2011, J CONTROL RELEASE, V151, P176, DOI 10.1016/j.jconrel.2011.01.011
   Tu Q, 2013, COLLOID SURFACE B, V102, P361, DOI 10.1016/j.colsurfb.2012.08.033
   Wangthong S, 2010, J ETHNOPHARMACOL, V132, P466, DOI 10.1016/j.jep.2010.08.046
   Waters MGJ, 1999, J PROSTHET DENT, V81, P439, DOI 10.1016/S0022-3913(99)80011-0
   Wattanasatcha A, 2012, INT J PHARMACEUT, V434, P360, DOI 10.1016/j.ijpharm.2012.06.017
   Williams DL, 2012, BIOMATERIALS, V33, P8641, DOI 10.1016/j.biomaterials.2012.08.003
   Woolfson AD, 2003, J CONTROL RELEASE, V91, P465, DOI 10.1016/S0168-3659(03)00277-3
   Woolfson AD, 1999, J CONTROL RELEASE, V61, P319, DOI 10.1016/S0168-3659(99)00148-0
   Xu DW, 2013, COLLOID SURFACE B, V110, P225, DOI 10.1016/j.colsurfb.2013.04.050
NR 34
TC 10
Z9 10
U1 3
U2 48
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD NOV 26
PY 2014
VL 6
IS 22
BP 20188
EP 20196
DI 10.1021/am505566m
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AU6OF
UT WOS:000345721400089
PM 25314005
DA 2018-10-20
ER

PT J
AU Ge, YY
   Li, ZL
   Kong, Y
   Song, QP
   Wang, KQ
AF Ge, Yuanyuan
   Li, Zhili
   Kong, Yan
   Song, Quanpeng
   Wang, Kunqi
TI Heavy metal ions retention by bi-functionalized lignin: Synthesis,
   applications, and adsorption mechanisms
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Lignin; Biomaterial; Heavy metal ion; Adsorption; Wastewater
ID HARD/SOFT ACID/BASE PRINCIPLE; SUGAR-CANE BAGASSE; AQUEOUS-SOLUTION;
   SELECTIVE REMOVAL; COPPER(II) IONS; KRAFT LIGNIN; EQUILIBRIUM; SORPTION;
   CADMIUM; CD(II)
AB Bi-functionalized lignin with amino and sulfonic groups (ASL) was synthesized via Mannich reaction and sulfomethylation. It was systematically characterized by FT-IR, element analysis, surface charge and XPS. Effects of initial pH, contact time and initial metal ion concentration on the adsorption of Cu(II) and Pb(II) onto ALS were studied. Results indicated that the biosorbent showed excellent performance for metals even from low pH solutions. The adsorption kinetics and isotherms could be described well with Pseudo-second-order and D-R model, respectively. Further investigation of the metal-loaded ASL by FT-IR and XPS elucidated the amino and sulfonic groups reacted with metals in different way. (C) 2014 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Ge, Yuanyuan; Li, Zhili; Kong, Yan; Song, Quanpeng; Wang, Kunqi] Guangxi Univ, Guangxi Key Lab Petrochem Resource Proc & Proc In, Sch Chem & Chem Engn, Nanning 530004, Peoples R China.
RP Li, ZL (reprint author), Guangxi Univ, Guangxi Key Lab Petrochem Resource Proc & Proc In, Sch Chem & Chem Engn, Nanning 530004, Peoples R China.
EM cezli@foxmail.com
FU National Natural Science Foundation of China [21264002]; Scientific
   Research Foundation of Guangxi University [XJZ120279]; Guangxi Key
   Laboratory of Petrochemical Resource Processing and Process
   Intensification Technology [2012Z07]
FX We greatly acknowledge the support from the National Natural Science
   Foundation of China (21264002), Scientific Research Foundation of
   Guangxi University (XJZ120279), and Guangxi Key Laboratory of
   Petrochemical Resource Processing and Process Intensification Technology
   (2012Z07).
CR Ahmad M, 2012, J IND ENG CHEM, V18, P198, DOI 10.1016/j.jiec.2011.11.013
   Ayers PW, 2007, FARADAY DISCUSS, V135, P161, DOI 10.1039/b606877d
   Ayers PW, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2196882
   BARBER M, 1973, J CHEM SOC F2, V69, P551
   Barker B, 1999, J CHEM EDUC, V76, P1706, DOI 10.1021/ed076p1706
   BATTISTONI C, 1984, J CHEM SOC DALTON, P1293, DOI 10.1039/dt9840001293
   Biniak S, 1999, LANGMUIR, V15, P6117, DOI 10.1021/la9815704
   Bolan NS, 1999, ADV AGRON, V67, P87, DOI 10.1016/S0065-2113(08)60514-3
   Chang Q, 2008, J HAZARD MATER, V159, P548, DOI 10.1016/j.jhazmat.2008.02.053
   Da'na E, 2011, CHEM ENG J, V166, P445, DOI 10.1016/j.cej.2010.11.016
   Dabrowski A, 2004, CHEMOSPHERE, V56, P91, DOI 10.1016/j.chemosphere.2004.03.006
   Dalimova GN, 2006, CHEM NAT COMPD+, V42, P479, DOI 10.1007/s10600-006-0185-4
   Demirbas A, 2004, J HAZARD MATER, V109, P221, DOI 10.1016/j.jhazmat.2004.04.002
   Dikici H, 2010, B ENVIRON CONTAM TOX, V84, P147, DOI 10.1007/s00128-009-9899-x
   Dimos K, 2009, MICROPOR MESOPOR MAT, V126, P65, DOI 10.1016/j.micromeso.2009.05.021
   Dlamini DS, 2012, MATER CHEM PHYS, V133, P369, DOI 10.1016/j.matchemphys.2012.01.040
   Duesberg GS, 2004, SYNTHETIC MET, V142, P263, DOI 10.1016/j.synthmet.2003.09.009
   Erdem E, 2004, J COLLOID INTERF SCI, V280, P309, DOI 10.1016/j.jcis.2004.08.028
   Ferrah N, 2011, DESALINATION, V269, P17, DOI 10.1016/j.desal.2010.11.035
   Gosselink RJA, 2004, IND CROP PROD, V20, P121, DOI 10.1016/j.indcrop.2004.04.015
   Gubbuk IH, 2009, DESALINATION, V249, P1243, DOI 10.1016/j.desal.2009.01.032
   Guo XY, 2008, J HAZARD MATER, V151, P134, DOI 10.1016/j.jhazmat.2007.05.065
   Gupta VK, 2009, CRIT REV ENV SCI TEC, V39, P783, DOI 10.1080/10643380801977610
   Harmita H, 2009, BIORESOURCE TECHNOL, V100, P6183, DOI 10.1016/j.biortech.2009.06.093
   Hergert H. L., 1971, LIGNINS OCCURRENCE F, P267
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   Ibrahim NA, 2005, J POLYM RES, V12, P173, DOI 10.1007/s10965-004-1865-z
   Javaid A, 2011, BIOMASS BIOENERG, V35, P1675, DOI 10.1016/j.biombioe.2010.12.035
   Jiang T., 2009, LIGNIN
   Kannamba B, 2010, J HAZARD MATER, V175, P939, DOI 10.1016/j.jhazmat.2009.10.098
   Koch HF, 2001, SEPAR SCI TECHNOL, V36, P137, DOI 10.1081/SS-100000857
   Lasheen MR, 2012, SOLID STATE SCI, V14, P202, DOI 10.1016/j.solidstatesciences.2011.11.029
   Laus R, 2011, BIORESOURCE TECHNOL, V102, P8769, DOI 10.1016/j.biortech.2011.07.057
   Li ZL, 2011, J PHYS CHEM C, V115, P24865, DOI 10.1021/jp2083117
   Li ZL, 2011, J BRAZIL CHEM SOC, V22, P1866, DOI 10.1590/S0103-50532011001000006
   Liu CK, 2008, WATER RES, V42, P1511, DOI 10.1016/j.watres.2007.10.031
   Liu Y, 2006, J HAZARD MATER, V137, P1149, DOI 10.1016/j.jhazmat.2006.03.057
   Lu QF, 2012, BIORESOURCE TECHNOL, V104, P111, DOI 10.1016/j.biortech.2011.10.055
   Matlock MM, 2001, J HAZARD MATER, V82, P55, DOI 10.1016/S0304-3894(00)00353-8
   McCloskey JT, 1996, ENVIRON TOXICOL CHEM, V15, P1730, DOI 10.1897/1551-5028(1996)015<1730:PTRTOM>2.3.CO;2
   Milczarek G, 2009, LANGMUIR, V25, P10345, DOI 10.1021/la9008575
   Mohan D, 2006, J COLLOID INTERF SCI, V297, P489, DOI 10.1016/j.jcis.2005.11.023
   Onyango MS, 2004, J COLLOID INTERF SCI, V279, P341, DOI 10.1016/j.jcis.2004.06.038
   Orozco-Guareno E, 2010, J COLLOID INTERF SCI, V349, P583, DOI 10.1016/j.jcis.2010.05.048
   Ozcan A, 2005, J HAZARD MATER, V124, P200, DOI 10.1016/j.hazmat.2005.05.007
   Pehlivan E, 2006, J HAZARD MATER, V134, P149, DOI 10.1016/j.jhazmat.2005.10.052
   Peternele WS, 1999, BIORESOURCE TECHNOL, V68, P95, DOI 10.1016/S0960-8524(98)00083-2
   Qu RJ, 2005, EUR POLYM J, V41, P1525, DOI 10.1016/j.europolymj.2005.02.003
   Quang DV, 2012, J IND ENG CHEM, V18, P83, DOI 10.1016/j.jiec.2011.11.089
   Saad M, 2011, J AGR FOOD CHEM, V59, P1527, DOI 10.1021/jf102315h
   Sciban MB, 2011, ECOL ENG, V37, P2092, DOI 10.1016/j.ecoleng.2011.08.006
   Srivastava VC, 2006, J HAZARD MATER, V134, P257, DOI 10.1016/j.jhazmat.2005.11.052
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Tseng RL, 2010, J TAIWAN INST CHEM E, V41, P661, DOI 10.1016/j.jtice.2010.01.014
   VOLMER M, 1990, SURF INTERFACE ANAL, V16, P278, DOI 10.1002/sia.740160158
   Wu Y, 2008, BIORESOURCE TECHNOL, V99, P7709, DOI 10.1016/j.biortech.2008.01.069
   Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u
NR 58
TC 47
Z9 51
U1 14
U2 138
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
EI 1876-794X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD NOV 25
PY 2014
VL 20
IS 6
BP 4429
EP 4436
DI 10.1016/j.jiec.2014.02.011
PG 8
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA AR6JT
UT WOS:000343690600067
DA 2018-10-20
ER

PT J
AU Zhou, P
   Deng, Y
   Lyu, B
   Zhang, RR
   Zhang, H
   Ma, HW
   Lyu, YL
   Wei, SC
AF Zhou, Ping
   Deng, Yi
   Lyu, Beier
   Zhang, Ranran
   Zhang, Hai
   Ma, Hongwei
   Lyu, Yalin
   Wei, Shicheng
TI Rapidly-Deposited Polydopamine Coating via High Temperature and Vigorous
   Stirring: Formation, Characterization and Biofunctional Evaluation
SO PLOS ONE
LA English
DT Article
ID MULTIFUNCTIONAL COATINGS; DOPAMINE; POLYMER; IMMOBILIZATION; SURFACES;
   POLY(DOPAMINE); ANTIBACTERIAL; COPOLYMERS; INTERFACES; GROWTH
AB Polydopamine (PDA) coating provides a promising approach for immobilization of biomolecules onto almost all kinds of solid substrates. However, the deposition kinetics of PDA coating as a function of temperature and reaction method is not well elucidated. Since dopamine self-polymerization usually takes a long time, therefore, rapid-formation of PDA film becomes imperative for surface modification of biomaterials and medical devices. In the present study, a practical method for preparation of rapidly-deposited PDA coating was developed using a uniquely designed device, and the kinetics of dopamine self-polymerization was investigated by QCM sensor system. It was found that high temperature and vigorous stirring could dramatically speed up the formation of PDA film on QCM chip surface. Surface characterization, BSA binding study, cell viability assay and antibacterial test demonstrates that the polydopamine coating after polymerization for 30 min by our approach exhibits similar properties to those of 24 h counterpart. The method has a great potential for rapid-deposition of polydopamine films to modify biomaterial surfaces.
C1 [Zhou, Ping; Deng, Yi; Wei, Shicheng] Peking Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Beijing 100871, Peoples R China.
   [Zhou, Ping; Deng, Yi; Wei, Shicheng] Peking Univ, Acad Adv Interdisciplinary Studies, Ctr Biomed Mat & Tissue Engn, Beijing 100871, Peoples R China.
   [Lyu, Beier; Ma, Hongwei] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Suzhou, Peoples R China.
   [Zhang, Ranran; Zhang, Hai; Wei, Shicheng] Capital Med Univ, Beijing Anzhen Hosp, Dept Stomatol, Beijing, Peoples R China.
   [Zhang, Hai] Univ Washington, Sch Dent, Dept Restorat Dent, Washington, DC USA.
RP Lyu, YL (reprint author), Capital Med Univ, Beijing Anzhen Hosp, Dept Stomatol, Beijing, Peoples R China.
EM lvyalin@vip.sina.com; sc-wei@pku.edu.cn
RI Zhou, Ping/N-4224-2016
FU National Natural Science Foundation [81371697]; Beijing Natural Science
   Foundation [7132124]; Peking University [985]
FX This work was supported by the National Natural Science Foundation
   (81371697), www.nsfc.gov.cn, to SCW; Beijing Natural Science Foundation
   (7132124), www.bjnsf.org, to SCW; Peking University's 985 Grant,
   www.pku.edu.cn, to SCW. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR [Anonymous], 1959, Z ANGEW PHYS, V155, P206
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Bhang SH, 2013, BIOCHEM BIOPH RES CO, V430, P294
   Brubaker CE, 2012, LANGMUIR, V28, P2200, DOI 10.1021/la300044v
   Cho JH, 2013, ACS APPL MATER INTER, V5, P3794, DOI 10.1021/am400455p
   Cui JW, 2012, BIOMACROMOLECULES, V13, P2225, DOI 10.1021/bm300835r
   Delpeux S, 1998, EUR POLYM J, V34, P905, DOI 10.1016/S0014-3057(97)00225-5
   Ding X, 2012, BIOMATERIALS, V33, P6593, DOI 10.1016/j.biomaterials.2012.06.001
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Fatisson J, 2011, BIOSENS BIOELECTRON, V26, P3207, DOI 10.1016/j.bios.2010.12.027
   He S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0169
   HERLINGER E, 1995, J CHEM SOC PERK T 2, P259, DOI 10.1039/p29950000259
   Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k
   Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011
   Li H, 2013, BIOSENS BIOELECTRON, V41, P809, DOI 10.1016/j.bios.2012.10.021
   Luo RF, 2013, ACS APPL MATER INTER, V5, P1704, DOI 10.1021/am3027635
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Ou JF, 2009, J PHYS CHEM C, V113, P20429, DOI 10.1021/jp9073416
   Paulo CSO, 2010, BIOMACROMOLECULES, V11, P2810, DOI 10.1021/bm100893r
   Peng HP, 2013, BIOSENS BIOELECTRON, V42, P293, DOI 10.1016/j.bios.2012.10.074
   Pop-Georgievski O, 2012, LANGMUIR, V28, P14273, DOI 10.1021/la3029935
   Rim NG, 2012, COLLOID SURFACE B, V91, P189, DOI 10.1016/j.colsurfb.2011.10.057
   Shin YM, 2011, COLLOID SURFACE B, V87, P79, DOI 10.1016/j.colsurfb.2011.05.004
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   Tsai WB, 2011, ACTA BIOMATER, V7, P4187, DOI 10.1016/j.actbio.2011.07.024
   Vincent B, 2012, COLLOID INTERFACE SC, V386, P366
   Wang LQ, 2011, INVEST OPHTH VIS SCI, V52, P7392, DOI 10.1167/iovs.11-7601
   Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956
   Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a
   Zheng LZ, 2012, THIN SOLID FILMS, V520, P2776, DOI 10.1016/j.tsf.2011.12.017
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
   Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027
NR 36
TC 26
Z9 26
U1 5
U2 64
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2014
VL 9
IS 11
AR e113087
DI 10.1371/journal.pone.0113087
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX4MM
UT WOS:000346906600028
PM 25415328
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Qin, XH
   Gruber, P
   Markovic, M
   Plochberger, B
   Klotzsch, E
   Stampfl, J
   Ovsianikov, A
   Liska, R
AF Qin, Xiao-Hua
   Gruber, Peter
   Markovic, Marica
   Plochberger, Birgit
   Klotzsch, Enrico
   Stampfl, Juergen
   Ovsianikov, Aleksandr
   Liska, Robert
TI Enzymatic synthesis of hyaluronic acid vinyl esters for two-photon
   microfabrication of biocompatible and biodegradable hydrogel constructs
SO POLYMER CHEMISTRY
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; 3D CELL-CULTURE; REGENERATIVE MEDICINE;
   CLICK CHEMISTRY; IN-SITU; MECHANICAL-PROPERTIES; FABRICATION;
   BIOMATERIALS; FATE; PHOTOPOLYMERIZATION
AB Two-photon polymerization (2PP) allows 3D microfabrication of biomaterial scaffolds with user-defined geometry. This technique is highly promising for 3D cell culture and tissue engineering. However, biological applications of 2PP require photopolymerizable hydrogels with high reactivity and low cytotoxicity. This paper describes a novel hydrogel system based on hyaluronic acid vinyl esters (HA-VE), which enabled fast 2PP-fabrication of 3D hydrogel constructs with mu m-scale accuracy. A series of HA-VE macromers with tunable degrees of substitution were synthesized by lipase-catalyzed transesterification. HA-VE gels were proved to be injectable, photocurable, enzymatically degradable and mechanically comparable to various soft tissues. Owing to the unique molecular design, degradation products of HA-VE gels through hydrolysis are non-toxic polyvinyl alcohol and adipic acid. Furthermore, HA-VE gels were systematically characterized and compared to HA-acrylates (HA-AC) and HA-methacrylates (HA-MA) gels including macromer cytotoxicity, photoreactivity, swelling, and gel stiffness. Cytotoxicity assay with L929 fibroblasts revealed that HA-VE was significantly less toxic than HA-AC (P < 0.01) and HA-MA (P < 0.05). Crosslinking efficiency of HA-VE was comparable to HA-AC and much higher than HA-MA. Although the reactivity of HA-VE for homopolymerization was insufficient for 2PP, it was demonstrated that thiol-ene chemistry could substantially improve its reactivity. This optimization led to 2PP-fabrication of a HA-VE hydrogel construct with mu m-scale accuracy. Low cytotoxicity, high reactivity and good biodegradability makes HA-VE promising candidates for biological applications in cell culture and tissue engineering.
C1 [Qin, Xiao-Hua; Liska, Robert] Vienna Univ Technol, Inst Appl Synthet Chem, Austrian Cluster Tissue Regenerat, A-1060 Vienna, Austria.
   [Gruber, Peter; Markovic, Marica; Stampfl, Juergen; Ovsianikov, Aleksandr] Vienna Univ Technol, Inst Mat Sci & Technol, Austrian Cluster Tissue Regenerat, A-1040 Vienna, Austria.
   [Plochberger, Birgit; Klotzsch, Enrico] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria.
RP Liska, R (reprint author), Vienna Univ Technol, Inst Appl Synthet Chem, Austrian Cluster Tissue Regenerat, Getreidemarkt 6, A-1060 Vienna, Austria.
EM robert.liska@tuwien.ac.at
RI Klotzsch, Enrico/J-8831-2012; Ovsianikov, Aleksandr/K-8128-2015; QIN,
   Xiao-Hua/E-6357-2015; Liska, Robert/C-2814-2008
OI Klotzsch, Enrico/0000-0002-7577-9042; Ovsianikov,
   Aleksandr/0000-0001-5846-0198; QIN, Xiao-Hua/0000-0001-8355-3230; Liska,
   Robert/0000-0001-7865-1936
FU China Scholarship Council [2009688014]; European Research Council
   [307701]; European Science Foundation (P2M Network)
FX Mr Severin Muhleder (LBI-Trauma, Vienna), Dr Jan Torgersen (TU Vienna)
   and Dr Wolfgang Holnthoner (LBI-Trauma) are gratefully acknowledged for
   their essential role at the initial stage of this study. Dr Zhiquan Li
   (TU Vienna) is particularly thanked for the synthesis of photoinitiator.
   Financial support from the China Scholarship Council (no. 2009688014),
   European Research Council (Starting grant no. 307701) and European
   Science Foundation (P2M Network) is acknowledged.
CR Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Annabi N, 2014, ADV MATER, V26, P85, DOI 10.1002/adma.201303233
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Burdick J. A., 2011, ADV MATER, V23, P41
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Gautam R, 2012, J BIOMED MATER RES B, V100B, P1444, DOI 10.1002/jbm.b.32673
   GOSS CA, 1991, ANAL CHEM, V63, P85, DOI 10.1021/ac00001a018
   Gross R. A., 2007, [No title captured], Patent No. [WO, 2007106738A2, 2007106738]
   Guillame-Gentil O, 2010, ADV MATER, V22, P5443, DOI 10.1002/adma.201001747
   HELD KD, 1987, RADIAT RES, V112, P544, DOI 10.2307/3577106
   Heller C, 2011, J POLYM SCI POL CHEM, V49, P650, DOI 10.1002/pola.24476
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Kasko AM, 2010, FUTURE MED CHEM, V2, P1669, DOI 10.4155/FMC.10.253
   Kennedy GL, 2002, DRUG CHEM TOXICOL, V25, P191, DOI 10.1081/DCT-120003259
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Ki CS, 2013, BIOMACROMOLECULES, V14, P3017, DOI 10.1021/bm4004496
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kowitsch A, 2011, BIOTECHNOL APPL BIOC, V58, P376, DOI 10.1002/bab.41
   LaFratta CN, 2007, ANGEW CHEM INT EDIT, V46, P6238, DOI 10.1002/anie.200603995
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Li ZQ, 2013, RSC ADV, V3, P15939, DOI 10.1039/c3ra42918k
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mautner A, 2013, J POLYM SCI POL CHEM, V51, P203, DOI 10.1002/pola.26365
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   Ossipov DA, 2010, CHEM COMMUN, V46, P8368, DOI 10.1039/c0cc03055d
   Ovsianikov A, 2014, LANGMUIR, V30, P3787, DOI 10.1021/la402346z
   Ovsianikov A, 2012, EXPERT REV MED DEVIC, V9, P613, DOI [10.1586/erd.12.48, 10.1586/ERD.12.48]
   Qin XH, 2013, J POLYM SCI POL CHEM, V51, P4799, DOI 10.1002/pola.26903
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Schoen I, 2013, ANNU REV MATER RES, V43, P589, DOI 10.1146/annurev-matsci-062910-100407
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Takahashi A, 2013, BIOMACROMOLECULES, V14, P3581, DOI 10.1021/bm4009606
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Torgersen J, 2013, ADV FUNCT MATER, V23, P4542, DOI 10.1002/adfm.201203880
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   Uyama H, 2006, ADV POLYM SCI, V194, P133, DOI 10.1007/12_031
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang N, 2005, BIOORG MED CHEM LETT, V15, P4064, DOI 10.1016/j.bmcl.2005.06.011
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 57
TC 24
Z9 25
U1 8
U2 101
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PD NOV 21
PY 2014
VL 5
IS 22
BP 6523
EP 6533
DI 10.1039/c4py00792a
PG 11
WC Polymer Science
SC Polymer Science
GA AR6OX
UT WOS:000343703900016
DA 2018-10-20
ER

PT J
AU Lee, SH
   Lee, Y
   Chun, YW
   Crowder, SW
   Young, PP
   Park, KD
   Sung, HJ
AF Lee, Sue Hyun
   Lee, Yunki
   Chun, Young Wook
   Crowder, Spencer W.
   Young, Pampee P.
   Park, Ki Dong
   Sung, Hak-Joon
TI In Situ Crosslinkable Gelatin Hydrogels for Vasculogenic Induction and
   Delivery of Mesenchymal Stem Cells
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID EXTRACELLULAR-MATRIX; ENDOTHELIAL DIFFERENTIATION; OSTEOGENIC
   DIFFERENTIATION; TISSUE; ANGIOGENESIS; VITRO; PROLIFERATION;
   REGENERATION; PEPTIDES; COLLAGEN
AB Clinical trials utilizing mesenchymal stem cells (MSCs) for severe vascular diseases have highlighted the need to effectively engraft cells and promote pro-angiogenic activity. A functional material accomplishing these two goals is an ideal solution as spatiotemporal and batch-to-batch variability in classical therapeutic delivery can be minimized, and tissue regeneration would begin rapidly at the implantation site. Gelatin may serve as a promising biomaterial due to its excellent biocompatibility, biodegradability, and non-immuno/antigenicity. However, the dissolution of gelatin at body temperature and quick enzymatic degradation in vivo have limited its use thus far. To overcome these challenges, an injectable, in situ crosslinkable gelatin was developed by conjugating enzymatically crosslinkable hydroxyphenyl propionic acid (GHPA). When MSCs are cultured in 3D in vitro or injected in vivo in GHPA, spontaneous endothelial differentiation occurs, as evidenced by marked increases in endothlelial cell marker expressions (Flk1, Tie2, ANGPT1, vWF) in addition to forming an extensive perfusable vascular network after 2-week subcutaneous implantation. Additionally, favorable host macrophage response is achieved with GHPA as shown by decreased iNOS and increased MRC1 expression. These results indicate GHPA as a promising soluble factor-free cell delivery template which induces endothelial differentiation of MSCs with robust neovasculature formation and favorable host response.
C1 [Lee, Sue Hyun; Chun, Young Wook; Crowder, Spencer W.; Sung, Hak-Joon] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
   [Lee, Sue Hyun; Chun, Young Wook; Crowder, Spencer W.; Sung, Hak-Joon] Vanderbilt Univ, Med Ctr, Ctr Stem Cell Biol, Nashville, TN 37235 USA.
   [Lee, Yunki; Park, Ki Dong] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.
RP Lee, SH (reprint author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.
EM hak-joon.sung@vanderbilt.edu
FU NSF DMR 1006558NSF CAREER CBET 1056046; National Research Foundation of
   Korea - Ministry of Science; ICT & Future Planning
   [NRF-2012R1A2A2A06046885]; NIH [1S10RR027485-01, CA68485, DK20593,
   DK58404, HD15052, DK59637, EY08126];  [NIH HL091465];  [NIH 1UH2
   TR000491]
FX This study was supported by NIH HL091465, NIH 1UH2 TR000491, NSF DMR
   1006558, NSF CAREER CBET 1056046, and Basic Science Research Program
   through the National Research Foundation of Korea (NRF) grant funded by
   the Ministry of Science, ICT & Future Planning
   (NRF-2012R1A2A2A06046885). The authors would also like to acknowledge
   the use of resources at the Vanderbilt Institute of Nanoscale Science
   and Engineering (VINSE), a facility renovated under NSF ARI-R2
   DMR-0963361, and the Vanderbilt Institute for Integrative Biosystems
   Research and Education (VIIBRE) Automated Biosystems Core at Vanderbilt
   University, which was established by NIH grant 1S10RR027485-01. Confocal
   images were performed in part through the use of the VUMC Cell Imaging
   Shared Resource (supported by NIH grants CA68485, DK20593, DK58404,
   HD15052, DK59637 and EY08126). <SUP>1</SUP>H-NMR was conducted in the
   Vanderbilt Small Molecule NMR Facility Core, and the Vanderbilt
   Translational Pathology Shared Resources Core assisted in the
   preparation and staining of histological specimens.
CR AGREN MS, 1994, BRIT J DERMATOL, V131, P634, DOI 10.1111/j.1365-2133.1994.tb04974.x
   Alfaro MP, 2012, CELL TRANSPLANT, V21, P1065, DOI 10.3727/096368911X612477
   Alfaro MP, 2011, VITAM HORM, V87, P39, DOI 10.1016/B978-0-12-386015-6.00023-8
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Cao Y, 2005, BIOCHEM BIOPH RES CO, V332, P370, DOI 10.1016/j.bbrc.2005.04.135
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Deskins D. L., 2012, J VIS EXPT, V62, pe3885
   Dreesmann L, 2007, BIOMATERIALS, V28, P5536, DOI 10.1016/j.biomaterials.2007.08.040
   Duncan GS, 1999, J IMMUNOL, V162, P3022
   Gorgieva S, 2011, BIOMATERIALS APPLICATIONS FOR NANOMEDICINE, P17
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Gupta A, 2005, BIOMACROMOLECULES, V6, P1623, DOI 10.1021/bm0492430
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Lee Y, 2013, J MATER CHEM B, V1, P2407, DOI [10.1039/c3tb00578j, 10.1039/C3TB00578J]
   Liu JW, 2007, J THROMB HAEMOST, V5, P826, DOI 10.1111/j.1538-7836.2007.02381.x
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Menge T, 2013, STEM CELLS DEV, V22, P148, DOI 10.1089/scd.2012.0165
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Portalska KJ, 2013, TISSUE ENG PT A, V19, P2318, DOI [10.1089/ten.tea.2012.0646, 10.1089/ten.TEA.2012.0646]
   Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13
   Ruegg C, 2010, RECENT RESULTS CANC, V180, P83, DOI 10.1007/978-3-540-78281-0_6
   Saraswati S, 2012, WOUND REPAIR REGEN, V20, P185, DOI 10.1111/j.1524-475X.2012.00767.x
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9
   Starin WA, 1918, J INFECT DIS, V23, P139, DOI 10.1086/infdis/23.2.139
   Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009
   Wang CH, 2013, BIOMATERIALS, V34, P4223, DOI 10.1016/j.biomaterials.2013.02.062
   Wang LS, 2012, ACTA BIOMATER, V8, P1826, DOI 10.1016/j.actbio.2012.02.002
   Wang LS, 2010, BIOMATERIALS, V31, P1148, DOI 10.1016/j.biomaterials.2009.10.042
   Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036
   Zachman AL, 2013, TISSUE ENG PT A, V19, P437, DOI [10.1089/ten.tea.2012.0158, 10.1089/ten.TEA.2012.0158]
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 46
TC 20
Z9 20
U1 2
U2 41
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD NOV 19
PY 2014
VL 24
IS 43
BP 6771
EP 6781
DI 10.1002/adfm.201401110
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AT9CO
UT WOS:000345225800004
PM 26327818
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Pan, JF
   Liu, NH
   Sun, H
   Xu, F
AF Pan, Jian-feng
   Liu, Ning-hua
   Sun, Hui
   Xu, Feng
TI Preparation and Characterization of Electrospun PLCL/Poloxamer
   Nanofibers and Dextran/Gelatin Hydrogels for Skin Tissue Engineering
SO PLOS ONE
LA English
DT Article
ID DRUG-DELIVERY; BLOCK-COPOLYMERS; SCAFFOLDS; REGENERATION; SUBSTITUTES;
   FABRICATION; GELATIN; MATS
AB In this study, two different biomaterials were fabricated and their potential use as a bilayer scaffold for skin tissue engineering applications was assessed. The upper layer biomaterial was a Poly(epsilon-caprolactone-co-lactide)/Poloxamer (PLCL/Poloxamer) nanofiber membrane fabricated using electrospinning technology. The PLCL/Poloxamer nanofibers (PLCL/Poloxamer, 9/1) exhibited strong mechanical properties (stress/strain values of 9.37 +/- 0.38 MPa/187.43 +/- 10.66%) and good biocompatibility to support adipose-derived stem cells proliferation. The lower layer biomaterial was a hydrogel composed of 10% dextran and 20% gelatin without the addition of a chemical crosslinking agent. The 5/5 dextran/gelatin hydrogel displayed high swelling property, good compressive strength, capacity to present more than 3 weeks and was able to support cells proliferation. A bilayer scaffold was fabricated using these two materials by underlaying the nanofibers and casting hydrogel to mimic the structure and biological function of native skin tissue. The upper layer membrane provided mechanical support in the scaffold and the lower layer hydrogel provided adequate space to allow cells to proliferate and generate extracellular matrix. The biocompatibility of bilayer scaffold was preliminarily investigated to assess the potential cytotoxicity. The results show that cell viability had not been affected when cocultured with bilayer scaffold. As a consequence, the bilayer scaffold composed of PLCL/Poloxamer nanofibers and dextran/gelatin hydrogels is biocompatible and possesses its potentially high application prospect in the field of skin tissue engineering.
C1 [Pan, Jian-feng; Liu, Ning-hua; Sun, Hui] Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 6, Shanghai 200030, Peoples R China.
   [Xu, Feng] Kunshan Tradit Chinese Med Hosp, Dept Orthopaed, Suzhou, Jiangsu, Peoples R China.
RP Sun, H (reprint author), Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 6, Shanghai 200030, Peoples R China.
EM sunshine20002000@126.com
CR Adams DC, 2005, DERMATOL SURG, V31, P1055
   Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013
   Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Ding FY, 2013, J MATER CHEM B, V1, P1729, DOI 10.1039/c3tb00517h
   Fu Y, 2012, BIOMATERIALS, V33, P48, DOI 10.1016/j.biomaterials.2011.09.031
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Hajiali H, 2011, INT J NANOMED, V6, P2133, DOI 10.2147/IJN.S24312
   Hassanzadeh P, 2013, J MATER CHEM B, V1, P4217, DOI [10.1039/c3tb20782j, 10.1039/C3TB20782J]
   Heimbach DM, 2003, J BURN CARE REHABIL, V24, P42, DOI 10.1097/01.BCR.0000045659.08820.00
   Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Jung Y, 2008, J BIOMAT SCI-POLYM E, V19, P1073, DOI 10.1163/156856208784909336
   Kim SH, 2006, J BIOMAT SCI-POLYM E, V17, P1359, DOI 10.1163/156856206778937244
   Kim Y, 2013, J MATER CHEM B, V1, P3185, DOI 10.1039/c3tb20485e
   KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kuwazuru O, 2008, MED ENG PHYS, V30, P516, DOI 10.1016/j.medengphy.2007.06.001
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lin GY, 2013, J MATER CHEM B, V1, P1249, DOI 10.1039/c2tb00468b
   Liu SJ, 2010, J MEMBRANE SCI, V355, P53, DOI 10.1016/j.memsci.2010.03.012
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Mo XM, 2010, J BIOMED MATER RES A, V94A, P326, DOI 10.1002/jbm.a.32788
   Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742
   Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Priya SG, 2008, TISSUE ENG PART B-RE, V14, P105, DOI 10.1089/teb.2007.0318
   Rieger KA, 2013, J MATER CHEM B, V1, P4531, DOI 10.1039/c3tb20795a
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Spitzenberger TJ, 2006, J CEREB BLOOD FLOW M, V27, P1033
   Sun XM, 2014, J MATER CHEM B, V2, P3636, DOI 10.1039/c3tb21814g
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.TEA.2010.0568, 10.1089/ten.tea.2010.0568]
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
NR 39
TC 28
Z9 32
U1 4
U2 77
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 18
PY 2014
VL 9
IS 11
AR e112885
DI 10.1371/journal.pone.0112885
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AX7UZ
UT WOS:000347121300061
PM 25405611
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Wang, X
   Liu, SJ
   Qi, YM
   Zhao, LC
   Cui, CX
AF Wang, Xin
   Liu, Shuang Jin
   Qi, Yu Min
   Zhao, Li Chen
   Cui, Chun Xiang
TI Behavior of potassium titanate whisker in simulated body fluid
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Potassium titanate; Simulated body fluid; Microstructure;
   Phase transformation; Biocompatibility
ID SURFACE MODIFICATION; METALLIC BIOMATERIALS; IN-VITRO; TITANIUM; ALLOYS;
   BIOCOMPATIBILITY; FABRICATION; K2TI6O13
AB Two sintering products containing potassium titanates were fabricated and cultivated in simulated body fluid for 12 days. It was found that the molar ratio of titanium/potassium of potassium titanate is a key factor to control the behavior of potassium titanate in body fluid environment. Low potassium titanates such as K2Ti2O5 and K2Ti4O9 transformed into calcium titanate due to its intrinsic characteristics of ion exchange. However, potassium hexatitanate was structurally stable adsorbing needle-like hydroxyapatite. The experimental results indicated that potassium hexatitanate possesses excellent biocompatibility which is better than low potassium titanates. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Wang, Xin; Liu, Shuang Jin; Qi, Yu Min; Zhao, Li Chen; Cui, Chun Xiang] Hebei Univ Technol, Sch Mat Sci & Engn, Key Lab New Type Funct Mat Hebei Prov, Tianjin 300130, Peoples R China.
RP Cui, CX (reprint author), Hebei Univ Technol, Sch Mat Sci & Engn, Key Lab New Type Funct Mat Hebei Prov, Dingzigu Rd, Tianjin 300130, Peoples R China.
EM hutcui@hebut.edu.cn
RI Wang, Xin/F-8920-2014; 樊, 樊亚琴/E-7242-2015
OI Wang, Xin/0000-0002-9992-4195; 
FU Key Foundation Project of Hebei Province Applied and Fundamental
   Research [11965151D]
FX The project was aided financially by Key Foundation Project of Hebei
   Province Applied and Fundamental Research (No. 11965151D).
CR Chou DT, 2013, ACTA BIOMATER, V9, P8593, DOI 10.1016/j.actbio.2013.04.016
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Cui CX, 2003, RARE METAL MAT ENG, V32, P627
   Duarte LT, 2013, CORROS SCI, V72, P35, DOI 10.1016/j.corsci.2013.02.007
   Hanawa T, 1999, MAT SCI ENG A-STRUCT, V267, P260, DOI 10.1016/S0921-5093(99)00101-X
   Li J, 2012, MATER LETT, V79, P136, DOI 10.1016/j.matlet.2012.04.003
   Li YB, 2008, ADV MAT RES, V47-50, P1351, DOI 10.4028/www.scientific.net/AMR.47-50.1351
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu Z, 2012, MATER DESIGN, V39, P444, DOI 10.1016/j.matdes.2012.03.013
   Okazaki Y, 2005, BIOMATERIALS, V26, P11, DOI 10.1016/j.biomaterials.2004.02.005
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qi Yumin, 2007, Frontiers of Materials Science in China, V1, P252, DOI 10.1007/s11706-007-0045-6
   Ryhanen J, 1997, J BIOMED MATER RES, V35, P451
   Satoh K, 2013, SURF COAT TECH, V232, P298, DOI 10.1016/j.surfcoat.2013.05.018
   Silva-Bermudez P, 2013, SURF COAT TECH, V233, P147, DOI 10.1016/j.surfcoat.2013.04.028
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Yu DM, 2000, COMPOS SCI TECHNOL, V60, P499, DOI 10.1016/S0266-3538(99)00149-9
NR 18
TC 3
Z9 3
U1 5
U2 77
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD NOV 15
PY 2014
VL 135
BP 139
EP 142
DI 10.1016/j.matlet.2014.07.145
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AQ1GF
UT WOS:000342529200036
DA 2018-10-20
ER

PT J
AU Tamura, A
   Yui, N
AF Tamura, Atsushi
   Yui, Nobuhiko
TI Threaded macromolecules as a versatile framework for biomaterials
SO CHEMICAL COMMUNICATIONS
LA English
DT Article
ID SUSTAINED-RELEASE SYSTEM; CATIONIC CYCLODEXTRIN POLYROTAXANES;
   DRUG-DELIVERY SYSTEMS; DISEASE-TYPE-C; OF-THE-ART; GENE DELIVERY;
   ALPHA-CYCLODEXTRIN; GAMMA-CYCLODEXTRIN; INCLUSION COMPLEXATION;
   POLY(ETHYLENE GLYCOL)
AB Polyrotaxanes (PRXs) are a class of supramolecular threaded macromolecules, in which cyclic molecules are threaded onto the main- or side-chain of polymers. To date, various studies have been conducted on the synthesis of PRXs, and various combinations of cyclic molecules and polymers that can form a PRX have been discovered. Among these combinations, PRXs composed of cyclodextrins (CDs) and a linear polymer have attracted much attention and have been investigated by many researchers. Because of the non-covalently associated characteristic of PRXs, these supermotecules. exhibit unique properties, such as the dynamic motion of the threaded cyclic molecules along a polymer axle and complete dissociation of the supramolecutar structure, that are never observed in other synthetic polymers. These inherent properties of PRXs are of interest in the design of novel biomaterials, such as hydrogels, scaffolds in tissue engineering, drug delivery carriers, and polymer-drug conjugates. Thus, various studies have been conducted to utilize PRXs as a framework for biomaterials. In this review, we describe the recent progress in biomaterial application of PRXs such as drug delivery and gene delivery.
C1 [Tamura, Atsushi; Yui, Nobuhiko] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, Tokyo, Tokyo 1010062, Japan.
RP Yui, N (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Dept Organ Biomat, 2-3-10 Kanda Surugadai, Tokyo, Tokyo 1010062, Japan.
EM yui.org@tmd.ac.jp
OI Tamura, Atsushi/0000-0003-0235-7364
FU Ministry of Education, Culture, Sports, Science, and Technology (MEXT)
   of Japan [23107004, 2306]; MEXT of japan [26750155]
FX This work was financially supported by a Grant-in-Aid for Scientific
   Research (No. 23107004) on Innovative Areas "Nanomedicine Molecular
   Science" (No. 2306) from the Ministry of Education, Culture, Sports,
   Science, and Technology (MEXT) of Japan (to N.Y.), a Grant-in-Aid for
   Young Scientists (B) (No. 26750155) from the MEXT of japan (to A.T.),
   and the Mochida Memorial Foundation for Medical and Pharmaceutical
   Research (to A.T.).
CR Abu Hashim II, 2010, INT J PHARMACEUT, V392, P83, DOI 10.1016/j.ijpharm.2010.03.026
   Albuzat T, 2012, J MATER CHEM, V22, P8558, DOI 10.1039/c2jm16425f
   Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Bilkova E, 2011, INT J PHARMACEUT, V414, P42, DOI 10.1016/j.ijpharm.2011.04.060
   Bin Imran A, 2008, CHEM COMMUN, P5227, DOI 10.1039/b810290b
   Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
   Cacialli F, 2002, NAT MATER, V1, P160, DOI 10.1038/nmat750
   Ceccato M, 1997, LANGMUIR, V13, P2436, DOI 10.1021/la9609231
   Choi HS, 2005, MACROMOLECULES, V38, P9878, DOI 10.1021/ma051400f
   Choi HS, 2004, MACROMOLECULES, V37, P6705, DOI 10.1021/ma049215+
   Dam HH, 2013, LANGMUIR, V29, P7203, DOI 10.1021/la304580x
   Dam HH, 2012, ACS NANO, V6, P4686, DOI 10.1021/nn301045z
   Dam HH, 2011, ADV MATER, V23, P3026, DOI 10.1002/adma.201101210
   Dandekar P, 2012, J CONTROL RELEASE, V164, P387, DOI 10.1016/j.jconrel.2012.06.040
   Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968
   Davidson CD, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006951, 10.1371/journal.pone.0005136]
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576
   Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Fang L, 2010, CHEM SOC REV, V39, P17, DOI 10.1039/b917901a
   Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423
   Guo MY, 2009, SOFT MATTER, V5, P495, DOI 10.1039/b813556h
   HARADA A, 1995, MACROMOLECULES, V28, P8406, DOI 10.1021/ma00128a060
   Harada A, 1997, MACROMOL RAPID COMM, V18, P535, DOI 10.1002/marc.1997.030180701
   HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0
   Harada A, 1999, POLYM J, V31, P1095, DOI 10.1295/polymj.31.1095
   HARADA A, 1994, NATURE, V370, P126, DOI 10.1038/370126a0
   Harada A, 1997, ADV POLYM SCI, V133, P141
   Harada A, 2009, CHEM REV, V109, P5974, DOI 10.1021/cr9000622
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Higashi T, 2008, BIOMATERIALS, V29, P3866, DOI 10.1016/j.biomaterials.2008.06.019
   Higashi T, 2007, BIOORG MED CHEM LETT, V17, P1871, DOI 10.1016/j.bmcl.2007.01.029
   Higashi T, 2009, INT J PHARMACEUT, V374, P26, DOI 10.1016/j.ijpharm.2009.02.017
   Higashi T, 2009, CHEM PHARM BULL, V57, P541, DOI 10.1248/cpb.57.541
   Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang FH, 2005, PROG POLYM SCI, V30, P982, DOI 10.1016/j.progpolymsci.2005.07.003
   Huang J, 2008, POLYM INT, V57, P714, DOI 10.1002/pi.2396
   Huh KM, 2001, MACROMOLECULES, V34, P2402, DOI 10.1021/ma0018648
   Huh KM, 2001, MACROMOLECULES, V34, P8657, DOI 10.1021/ma0106649
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ichi T, 2003, J BIOMAT SCI-POLYM E, V14, P567, DOI 10.1163/15685620360674254
   Ichi T, 2001, BIOMACROMOLECULES, V2, P204, DOI 10.1021/bm005617n
   Imran A. B., 2010, MACROMOLECULES, V43, P1975
   Ito K, 2007, POLYM J, V39, P489, DOI 10.1295/polymj.PJ2006239
   Ji XF, 2014, ACS MACRO LETT, V3, P110, DOI 10.1021/mz400528a
   Ji XF, 2013, ADV MATER, V25, P5725, DOI 10.1002/adma.201301654
   Ji XF, 2012, MACROMOLECULES, V45, P6457, DOI 10.1021/ma301162s
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Joung YK, 2007, ADV MATER, V19, P396, DOI 10.1002/adma.200600604
   Juliano R, 2009, MOL PHARMACEUT, V6, P686, DOI 10.1021/mp900093r
   Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1
   Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971
   Khalil IA, 2007, GENE THER, V14, P682, DOI 10.1038/sj.gt.3302910
   Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200
   Kida T, 2008, CHEM LETT, V37, P1120, DOI 10.1246/cl.2008.1120
   Kulkarni A, 2013, MOL PHARMACEUT, V10, P1299, DOI 10.1021/mp300449t
   Kulkarni A, 2013, INTEGR BIOL-UK, V5, P115, DOI 10.1039/c2ib20107k
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lee JS, 2012, J CONTROL RELEASE, V161, P473, DOI 10.1016/j.jconrel.2011.10.005
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SC, 2004, MACROMOLECULES, V37, P7464, DOI 10.1021/ma048666r
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   LI J, 1994, POLYM J, V26, P1019, DOI 10.1295/polymj.26.1019
   Li J, 2003, J BIOMED MATER RES A, V65A, P196, DOI 10.1002/jbm.a.10444
   Li J, 2001, MACROMOLECULES, V34, P7236, DOI 10.1021/ma010742s
   Li J, 2008, ADV DRUG DELIVER REV, V60, P1000, DOI 10.1016/j.addr.2008.02.011
   Li J, 2006, ADV MATER, V18, P2969, DOI 10.1002/adma.200600812
   Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106
   Liu Y, 2007, J AM CHEM SOC, V129, P10656, DOI 10.1021/ja073882b
   Ma D, 2011, J COLLOID INTERF SCI, V359, P399, DOI 10.1016/j.jcis.2011.04.032
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   Mayumi K, 2010, POLYMER, V51, P959, DOI 10.1016/j.polymer.2009.12.019
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e
   Miura T, 2011, MACROMOLECULES, V44, P3723, DOI 10.1021/ma200257z
   Miyata K, 2012, CHEM SOC REV, V41, P2562, DOI 10.1039/c1cs15258k
   Moon C, 2007, J CONTROL RELEASE, V124, P43, DOI 10.1016/j.jconrel.2007.08.029
   Moon C, 2008, J BIOMED MATER RES A, V84A, P238, DOI 10.1002/jbm.a.31452
   Motornov M, 2010, PROG POLYM SCI, V35, P174, DOI 10.1016/j.progpolymsci.2009.10.004
   Motoyama K, 2012, BIOORGAN MED CHEM, V20, P1425, DOI 10.1016/j.bmc.2011.12.060
   Nagahama K, 2010, CHEM LETT, V39, P250, DOI 10.1246/cl.2010.250
   OGATA N, 1976, J POLYM SCI POL LETT, V14, P459, DOI 10.1002/pol.1976.130140803
   Ohya Y, 2007, MACROMOLECULES, V40, P6441, DOI 10.1021/ma071198b
   Okumura H, 2000, MACROMOLECULES, V33, P4297, DOI 10.1021/ma991934e
   Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T
   Ooya T, 2006, J AM CHEM SOC, V128, P3852, DOI 10.1021/ja055868+
   Ooya T, 2003, J AM CHEM SOC, V125, P13016, DOI 10.1021/ja034583z
   Ooya T, 1999, J CONTROL RELEASE, V58, P251, DOI 10.1016/S0168-3659(98)00163-1
   OOYA T, 1995, MACROMOL RAPID COMM, V16, P259, DOI 10.1002/marc.1995.030160405
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Ren LX, 2008, MACROMOLECULES, V41, P5295, DOI 10.1021/ma800632m
   Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5
   Shaheen SM, 2011, BIOMATERIALS, V32, P6342, DOI 10.1016/j.biomaterials.2011.05.014
   Shaheen SM, 2011, NUCLEIC ACIDS RES, V39, pE48, DOI 10.1093/nar/gkq1327
   Steinbrunn MB, 1996, ANGEW CHEM INT EDIT, V35, P2139, DOI 10.1002/anie.199621391
   Tamura A, 2014, POLYM CHEM-UK, V5, P4511, DOI 10.1039/c4py00379a
   Tamura A, 2014, MACROMOL CHEM PHYS, V215, P648, DOI 10.1002/macp.201300774
   Tamura A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04356
   Tamura A, 2013, J MATER CHEM B, V1, P3535, DOI 10.1039/c3tb20514b
   Tamura A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02252
   Tamura A, 2013, BIOMATERIALS, V34, P2480, DOI 10.1016/j.biomaterials.2012.12.006
   Tamura A, 2010, NANOMEDICINE-UK, V5, P1089, DOI [10.2217/nnm.10.76, 10.2217/NNM.10.76]
   Tanaka Y, 2014, MOLEC GENET METAB RE, V1, P19, DOI 10.1016/j.ymgmr.2013.12.003
   Tardy BL, 2014, BIOMACROMOLECULES, V15, P53, DOI 10.1021/bm401244a
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Urano Y, 2005, J AM CHEM SOC, V127, P4888, DOI 10.1021/ja043919h
   Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x
   Wang J, 2006, J AM CHEM SOC, V128, P3703, DOI 10.1021/ja056775v
   Wang J, 2011, POLYM CHEM-UK, V2, P931, DOI 10.1039/c0py00360c
   WATANABE J, 2000, J ARTIF ORGANS, V3, P136
   Wenz G, 2006, CHEM REV, V106, P782, DOI 10.1021/cr970027+
   Wenz G, 2009, ADV POLYM SCI, V222, P1, DOI 10.1007/12_2008_13
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Wu YL, 2009, ANGEW CHEM INT EDIT, V48, P3842, DOI 10.1002/anie.200805341
   Xue M, 2012, ACCOUNTS CHEM RES, V45, P1294, DOI 10.1021/ar2003418
   Yamada Y, 2012, CHEMPHYSCHEM, V13, P1161, DOI 10.1002/cphc.201100800
   Yamada Y, 2012, BIOMATERIALS, V33, P3952, DOI 10.1016/j.biomaterials.2012.01.049
   Yamada Y, 2010, BIOL PHARM BULL, V33, P1218, DOI 10.1248/bpb.33.1218
   Yamashita A, 2006, CHEMBIOCHEM, V7, P297, DOI 10.1002/cbic.200500348
   Yamashita A, 2008, J CONTROL RELEASE, V131, P137, DOI 10.1016/j.jconrel.2008.07.011
   Yamashita A, 2006, NAT PROTOC, V1, P2861, DOI 10.1038/nprot.2006.438
   Yan XZ, 2012, CHEM SOC REV, V41, P6042, DOI 10.1039/c2cs35091b
   Yan XZ, 2012, ADV MATER, V24, P362, DOI 10.1002/adma.201103220
   Yang C, 2007, BIOMACROMOLECULES, V8, P3365, DOI 10.1021/bm700472t
   Yang C, 2009, J PHYS CHEM B, V113, P7903, DOI 10.1021/jp901302f
   Yang CA, 2009, J BIOMED MATER RES A, V89A, P13, DOI 10.1002/jbm.a.31976
   Yang ZC, 2013, CHEM MATER, V25, P704, DOI 10.1021/cm303513y
   Yu SL, 2013, ANGEW CHEM INT EDIT, V52, P7272, DOI 10.1002/anie.201301397
   Yui N, 2006, CHEM-EUR J, V12, P6730, DOI 10.1002/chem.200600370
   Yui N, 2009, ADV POLYM SCI, V222, P55, DOI 10.1007/12_2008_8
   Zhang JX, 2012, PROG POLYM SCI, V37, P1130, DOI 10.1016/j.progpolymsci.2011.11.005
   Zhang XW, 2008, J POLYM SCI POL CHEM, V46, P5283, DOI 10.1002/pola.22856
   Zhang XW, 2009, POLYMER, V50, P4343, DOI 10.1016/j.polymer.2009.07.006
   Zhang XW, 2009, SOFT MATTER, V5, P4797, DOI 10.1039/b914664d
   Zhang ZB, 2011, ANGEW CHEM INT EDIT, V50, P1397, DOI 10.1002/anie.201006693
   Zhao SP, 2006, J PHYS CHEM B, V110, P12225, DOI 10.1021/jp057506u
   Zheng B, 2012, CHEM SOC REV, V41, P1621, DOI 10.1039/c1cs15220c
   Zhou Y, 2012, MOL PHARMACEUT, V9, P1067, DOI 10.1021/mp200315c
NR 145
TC 30
Z9 30
U1 2
U2 46
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD NOV 14
PY 2014
VL 50
IS 88
BP 13433
EP 13446
DI 10.1039/c4cc03709j
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS0KE
UT WOS:000343965300003
PM 25036737
DA 2018-10-20
ER

PT J
AU Luo, LQ
   Li, GF
   Luan, D
   Yuan, QP
   Wei, Y
   Wang, X
AF Luo, Lingqiong
   Li, Guofeng
   Luan, Di
   Yuan, Qipeng
   Wei, Yen
   Wang, Xing
TI Antibacterial Adhesion of Borneol-Based Polymer via Surface Chiral
   Stereochemistry
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE antibacterial adhesion; biomaterial; borneol; chirality;
   stereochemistry; polymer
ID ANTIFOULING COATINGS; BACTERIAL ADHESION; BIOFILM FORMATION; CELL
   BEHAVIORS; ESSENTIAL OILS; MEMBRANES; PEPTIDES; DESIGN; FILMS
AB During its adhesion on external surfaces, a cell exhibits obvious inclination to different molecular chirality, which encourages us to develop a new type of antibacterial material catering to the "chiral taste" of bacteria. On the basis of the natural product borneol (a camphane-type bicyclic monoterpene), a series of borneol-based polymer, polyborneolacrylate (PBA), was successfully prepared and showed superior antibacterial adhesion properties resulting from the borneol isomers on material surface. The results of this study reveal that bacteria simply dislike this type of stubborn surface of PBA, and the PBA surface stereochemistry contributes to the interfacial antibacterial activities. The PBA polymers were evaluated as noncytotoxic and can be simply synthesized, demonstrating their great potential for biomedical applications.
C1 [Luo, Lingqiong; Li, Guofeng; Luan, Di; Yuan, Qipeng; Wang, Xing] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.
   [Wei, Yen] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
   [Wei, Yen] Tsinghua Univ, Tsinghua Ctr Frontier Polymer Res, Beijing 100084, Peoples R China.
RP Wang, X (reprint author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.
EM wangxing@mail.buct.edu.cn
RI Wei, Yen/H-5329-2012
FU National Natural Science Foundation of China [21204004]; Beijing Natural
   Science Foundation [2132040]; Specialized Research Fund for the Doctoral
   Program of Higher Education [20120010120011]
FX The authors thank the National Natural Science Foundation of China
   (21204004), the Beijing Natural Science Foundation (2132040), and the
   Specialized Research Fund for the Doctoral Program of Higher Education
   (20120010120011) for their funding support. Helpful discussions with
   Prof. L. Tao, of the Dept. of Chemistry, Tsinghua University, are
   greatly appreciated.
CR Ait-Ouazzou A, 2011, INNOV FOOD SCI EMERG, V12, P320, DOI 10.1016/j.ifset.2011.04.004
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x
   El-Gindi J, 2012, ANGEW CHEM INT EDIT, V51, P3716, DOI 10.1002/anie.201109144
   Garcia-Fernandez L, 2013, ADV MATER, V25, P529, DOI 10.1002/adma.201203362
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Granger RE, 2005, BIOCHEM PHARMACOL, V69, P1101, DOI 10.1016/j.bcp.2005.01.002
   Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   Haug BE, 2007, CURR MED CHEM, V14, P1, DOI 10.2174/092986707779313435
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hu WB, 2010, ACS NANO, V4, P4317, DOI 10.1021/nn101097v
   Kalemba D, 2003, CURR MED CHEM, V10, P813, DOI 10.2174/0929867033457719
   Kristensen JB, 2008, BIOTECHNOL ADV, V26, P471, DOI 10.1016/j.biotechadv.2008.05.005
   Lejars M, 2012, CHEM REV, V112, P4347, DOI 10.1021/cr200350v
   Mai LM, 2003, BIOMATERIALS, V24, P3005, DOI 10.1016/S0142-9612(03)00126-1
   Neu TR, 1996, MICROBIOL REV, V60, P151
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65
   Salditt T, 2006, BBA-BIOMEMBRANES, V1758, P1483, DOI 10.1016/j.bbamem.2006.08.002
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Sun TL, 2011, CHEM SOC REV, V40, P2909, DOI 10.1039/c0cs00124d
   Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]
   Wang LN, 2011, J AGR FOOD CHEM, V59, P12411, DOI 10.1021/jf203165k
   Wang X, 2012, LANGMUIR, V28, P2791, DOI 10.1021/la204143g
   Wang X, 2011, ADV FUNCT MATER, V21, P3276, DOI 10.1002/adfm.201101032
   Wang X, 2010, SOFT MATTER, V6, P3851, DOI 10.1039/c0sm00151a
   Wong GCL, 2011, MRS BULL, V36, P339, DOI 10.1557/mrs.2011.64
   Zhou H., 2014, IEEE T INTELL TRANSP, p1 
NR 30
TC 19
Z9 19
U1 7
U2 68
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD NOV 12
PY 2014
VL 6
IS 21
BP 19371
EP 19377
DI 10.1021/am505481q
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AT5IY
UT WOS:000344978200122
PM 25331199
DA 2018-10-20
ER

PT J
AU Bayrakdar, H
   Yalcin, O
   Cengiz, U
   Ozum, S
   Anigi, E
   Topel, O
AF Bayrakdar, H.
   Yalcin, O.
   Cengiz, U.
   Ozum, S.
   Anigi, E.
   Topel, O.
TI Comparison effects and electron spin resonance studies of alpha-Fe2O4
   spinel type ferrite nanoparticles
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Electron spin resonance; Magnetic nanoparticles; g-Factor; Spinel
   ferrite
ID MAGNETIC-RESONANCE; FERROMAGNETIC-RESONANCE; COMPOSITE NANOPARTICLES;
   PARAMAGNETIC-RESONANCE; BIOMATERIAL SYSTEM; MAGNETORESISTANCE;
   INHOMOGENEITIES; CRYSTALLINE; DELIVERY; JUNCTION
AB alpha-Fe2O4 spinel type ferrite nanoparticles have been synthesized by cetyltrimethylammonium bromide (CTAB) and ethylenediaminetetraacetic acid (EDTA) assisted hydrothermal route by using NaOH solution. Electron spin resonance (ESR/EPR) measurements of alpha-Fe2O4 nanoparticles have been performed by a conventional x-band spectrometer at room temperature. The comparison effect of nanoparticles prepared by using CTAB and EDTA in different alpha-doping on the structural and morphological properties have been investigated in detail. The effect of EDTA-assisted synthesis for alpha-Fe2O4 nanoparticles are refined, and thus the spectroscopic g-factor are detected by using ESR signals. These samples can be considered as great benefits for magnetic recording media, electromagnetic and drug delivery applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Bayrakdar, H.] Canakkale Onsekiz Mart Univ, TR-17100 Canakkale, Turkey.
   [Yalcin, O.] Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
   [Cengiz, U.] Canakkale Onsekiz Mart Univ, Dept Chem Engn, TR-17100 Canakkale, Turkey.
   [Ozum, S.] Nigde Univ, Inst Sci, TR-51240 Nigde, Turkey.
   [Anigi, E.] Gebze Inst Technol, Dept Phys, TR-41400 Gebze, Kocaeli, Turkey.
   [Topel, O.] Akdeniz Univ, Fac Sci, Dept Chem, TR-07058 Antalya, Turkey.
RP Yalcin, O (reprint author), Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
EM o.yalcin@nigde.edu.tr
RI Cengiz, Ugur/F-6410-2011; Topel, Onder/C-2273-2016
OI Cengiz, Ugur/0000-0002-0400-3351; Topel, Onder/0000-0003-1584-5519
FU Scientific and Technological Research Council of Turkey (TUBiTAK)
   [112E044]
FX The authors are grateful to the Scientific and Technological Research
   Council of Turkey (TUBiTAK, Contract No. 112E044) for financial support
   of this study.
CR Al-Heniti SH, 2014, J NANOSCI NANOTECHNO, V14, P3765, DOI 10.1166/jnn.2014.8913
   Andersson DA, 2013, PHYS CHEM CHEM PHYS, V15, P15550, DOI 10.1039/c3cp50312g
   Bayrakdar H, 2013, J MAGN MAGN MATER, V343, P86, DOI 10.1016/j.jmmm.2013.04.079
   Bayrakdar H, 2011, J MAGN MAGN MATER, V323, P1882, DOI 10.1016/j.jmmm.2011.02.030
   de Biasi E, 2003, J MAGN MAGN MATER, V262, P235, DOI 10.1016/S0304-8853(02)01496-8
   Faham M, 2014, ADV MATER RES-SWITZ, V829, P274, DOI 10.4028/www.scientific.net/AMR.829.274
   Gazeau F, 1999, J MAGN MAGN MATER, V202, P535, DOI 10.1016/S0304-8853(99)00156-0
   Gazeau F, 1998, J MAGN MAGN MATER, V186, P175, DOI 10.1016/S0304-8853(98)00080-8
   Joshi JP, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.024410
   Kartopu G, 2010, ELECTRODEPOSITED NANOWIRES AND THEIR APPLICATIONS, P113
   Klencsar Z, 2013, SOLID STATE SCI, V24, P90, DOI 10.1016/j.solidstatesciences.2013.07.010
   Koksharov YA, 2001, J APPL PHYS, V89, P2293, DOI 10.1063/1.1332417
   Koksharov Yu. A., 2000, PHYS REV B, V63
   Noginov MM, 2008, J MAGN MAGN MATER, V320, P2228, DOI 10.1016/j.jmmm.2008.04.154
   Panda J, 2013, AIP CONF PROC, V1512, P1120, DOI 10.1063/1.4791440
   Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799
   Prodan D, 1999, MEAS SCI TECHNOL, V10, pL41, DOI 10.1088/0957-0233/10/9/101
   Radu L., 2006, NSTI NANOTECH, V2, P279
   RAIKHER YL, 1994, PHYS REV B, V50, P6250, DOI 10.1103/PhysRevB.50.6250
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rao S.S., 2008, J PHYS D, V41
   Ravi S, 2014, CURR APPL PHYS, V14, P259, DOI 10.1016/j.cap.2013.11.024
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rozenberg E, 2007, PHYS STATUS SOLIDI B, V244, P4554, DOI 10.1002/pssb.200777419
   Sanchez RD, 1999, J PHYS-CONDENS MAT, V11, P5643, DOI 10.1088/0953-8984/11/29/311
   Shames AI, 2002, J APPL PHYS, V91, P7929, DOI 10.1063/1.1446129
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Yalcin O., 2013, FERROMAGNETIC RESONA
   Yalcin O., 2012, NANOTECHNOLOGY NANOM
   Yalcin O, 2013, J MAGN MAGN MATER, V343, P157, DOI 10.1016/j.jmmm.2013.05.009
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
NR 32
TC 0
Z9 0
U1 1
U2 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD NOV 11
PY 2014
VL 132
BP 160
EP 164
DI 10.1016/j.saa.2014.04.163
PG 5
WC Spectroscopy
SC Spectroscopy
GA AN1GN
UT WOS:000340330800019
PM 24858357
DA 2018-10-20
ER

PT J
AU Choi, YC
   Choi, JS
   Woo, CH
   Cho, YW
AF Choi, Young Chan
   Choi, Ji Suk
   Woo, Chang Hee
   Cho, Yong Woo
TI Stem cell delivery systems inspired by tissue-specific niches
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Stem cell; Stem cell-based therapy; Stem cell delivery system (SCDS);
   Niche; Microenvironment
ID HUMAN ADIPOSE-TISSUE; EXTRACELLULAR-MATRIX SCAFFOLDS; DIFFERENTIATION
   IN-VIVO; SIZE GRADIENT SCAFFOLD; GROWTH-FACTOR; REGENERATIVE MEDICINE;
   CHONDROGENIC DIFFERENTIATION; NANOFIBROUS SCAFFOLDS; PORE-SIZE;
   OSTEOGENIC-DIFFERENTIATION
AB Since stem cells have the capacity to differentiate into a variety of cell types, stem cell delivery systems (SCDSs) can be effective therapeutic strategies for a multitude of diseases and disorders. For stem cell-based therapy, stem cells are introduced directly (or peripherally) into a target tissue via different delivery systems. Despite initial promising results obtained from preclinical studies, a number of technical hurdles must be overcome for ultimate clinical utility of stem cells. A key aspect of SCDSs is how to create local environments, called stem cell niches, for improvement of survival and engraftment as well as the fate of transplanted stem cells. The stem cell niches encompassing a wide range of biochemical, biophysical, and biomechanical cues play a guidance role to modulate stem cell behaviors such as adhesion, proliferation, and differentiation. Recent studies have tried to decipher the complex interplay between stem cells and niches, and thereafter to engineer SCDS, mimicking dynamic stem cell niches encompassing a wide range of biochemical, biophysical, and biomechanical cues. Here, we discuss the biological role of stem cell niches and highlight recent progress in SCDS to mimic stem cell niches, particularly focusing on important biomaterial properties for modulating stem cell fate. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Choi, Young Chan; Choi, Ji Suk; Woo, Chang Hee; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
RP Cho, YW (reprint author), Hanyang Univ, Dept Chem Engn, ERICA Campus,55 Hanyangdaehak Ro, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU National Research Foundation of Korea (NRF) - Korean Government (MSIP)
   [2008-0061891, 2013R1A1A2011993]; Bio & Medical Technology Development
   Program [2011-0019774]
FX This work was supported by the National Research Foundation of Korea
   (NRF)grant (No. 2008-0061891) funded by the Korean Government (MSIP).
   This work was also supported by the Bio & Medical Technology Development
   Program (Grant No. 2011-0019774) and the Basic Science Research Program
   (Grant No. 2013R1A1A2011993) through the National Research Foundation of
   Korea (NRF) funded by the Korean government (MSIP).
CR Aarvold A, 2013, J BIOMED MATER RES A, V101, P3431, DOI 10.1002/jbm.a.34646
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Basile P, 2008, MOL THER, V16, P466, DOI 10.1038/sj.mt.6300395
   Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Berzat A, 2010, EMBO J, V29, P2734, DOI 10.1038/emboj.2010.170
   BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5
   Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5
   Brun-Graeppi AKAS, 2011, J CONTROL RELEASE, V149, P209, DOI 10.1016/j.jconrel.2010.09.023
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   CACIOPPO JT, 1983, PSYCHOPHYSIOLOGY, V20, P269, DOI 10.1111/j.1469-8986.1983.tb02154.x
   Ceccarelli J, 2012, CELL MOL BIOENG, V5, P463, DOI 10.1007/s12195-012-0242-y
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chang JC, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055002
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   Choi JS, 2012, TISSUE ENG PT A, V18, P80, DOI 10.1089/ten.tea.2011.0103
   Choi JS, 2011, CELL TISSUE RES, V345, P415, DOI 10.1007/s00441-011-1223-5
   Choi JS, 2011, J BIOMED MATER RES A, V97A, P292, DOI 10.1002/jbm.a.33056
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Choi YC, 2012, TISSUE ENG PART C-ME, V18, P866, DOI [10.1089/ten.tec.2012.0009, 10.1089/ten.TEC.2012.0009]
   Connelly JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027259
   Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI [10.1038/ncb, 10.1038/ncb2074]
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Dahl M., 2013, J CRANIOMAXILLOFAC S, V42, P41
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   de Girolamo L, 2013, CURR PHARM DESIGN, V19, P2459, DOI 10.2174/1381612811319130015
   del Campo A, 2008, CHEM REV, V108, P911, DOI 10.1021/cr050018y
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Fink T, 2004, STEM CELLS, V22, P1346, DOI 10.1634/stemcells.2004-0038
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176
   Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22
   Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gojo S, 2003, EXP CELL RES, V288, P51, DOI 10.1016/S0014-4827(03)00132-0
   Guo SZ, 2010, SPINAL CORD, V48, P576, DOI 10.1038/sc.2009.170
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Han D, 2011, POLYMERS-BASEL, V3, P1684, DOI 10.3390/polym3041684
   Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103
   Hopkins RA, 2005, CIRCULATION, V111, P2712, DOI 10.1161/CIRCULATIONAHA.104.527820
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319
   Jung HH, 2010, J CONTROL RELEASE, V147, P84, DOI 10.1016/j.jconrel.2010.06.020
   Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim BS, 2012, CELL TISSUE RES, V348, P559, DOI 10.1007/s00441-012-1391-y
   Kim BS, 2010, J BIOMAT SCI-POLYM E, V21, P1701, DOI 10.1163/092050609X12548957288848
   Kim HO, 2013, TISSUE ENG REGEN MED, V10, P93, DOI 10.1007/s13770-013-0010-7
   Kim JD, 2010, POLYMER, V51, P2147, DOI 10.1016/j.polymer.2010.03.038
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Kim SH, 2012, COLLOID SURFACE B, V90, P36, DOI 10.1016/j.colsurfb.2011.09.035
   Kim TH, 2013, MACROMOL RES, V21, P878, DOI 10.1007/s13233-013-1099-1
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Kooreman NG, 2010, J R SOC INTERFACE, V7, pS753, DOI 10.1098/rsif.2010.0353.focus
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Kuo YC, 2013, COLLOID SURFACE B, V104, P194, DOI 10.1016/j.colsurfb.2013.01.001
   Kuroda T, 2013, BIOL PHARM BULL, V36, P189, DOI 10.1248/bpb.b12-00970
   Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425
   Li HQ, 2012, ACTA BIOMATER, V8, P531, DOI 10.1016/j.actbio.2011.09.029
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003
   Lu ZF, 2012, NANOMED-NANOTECHNOL, V8, P507, DOI 10.1016/j.nano.2011.07.012
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lyons FG, 2010, BIOMATERIALS, V31, P9232, DOI 10.1016/j.biomaterials.2010.08.056
   Matyash M, 2012, TISSUE ENG PT A, V18, P55, DOI [10.1089/ten.tea.2011.0097, 10.1089/ten.TEA.2011.0097]
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Mitra J, 2013, RSC ADV, V3, P11073, DOI 10.1039/c3ra23315d
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Murtuza B, 2009, TISSUE ENG PART B-RE, V15, P443, DOI 10.1089/ten.TEB.2009.0006
   Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874
   Nardo P.D., 2011, STEM CELL ENG ENG ST, P41
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Naveiras O, 2006, CELL MOL LIFE SCI, V63, P760, DOI 10.1007/s00018-005-5469-5
   Noth U, 2008, NAT CLIN PRACT RHEUM, V4, P371, DOI 10.1038/ncprheum0816
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   Oh JS, 2010, NEUROSCI LETT, V472, P215, DOI 10.1016/j.neulet.2010.02.008
   Oh SH, 2010, BIOMACROMOLECULES, V11, P1948, DOI 10.1021/bm100199m
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Park K, 2013, J CONTROL RELEASE, V168, P103, DOI 10.1016/j.jconrel.2013.04.003
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Perez RA, 2014, ACTA BIOMATER, V10, P520, DOI 10.1016/j.actbio.2013.09.042
   Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]
   Proksch S, 2012, CELL TRANSPLANT, V21, P2455, DOI 10.3727/096368912X637037
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Roeder I, 2011, BLOOD CELL MOL DIS, V46, P308, DOI 10.1016/j.bcmd.2011.03.001
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Santos E, 2013, J CONTROL RELEASE, V170, P1, DOI 10.1016/j.jconrel.2013.04.015
   Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Sun YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037178
   Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Sutter W. W., 2007, Clinical Techniques in Equine Practice, V6, P198, DOI 10.1053/j.ctep.2007.08.006
   Taichman RS, 2010, STEM CELLS DEV, V19, P1557, DOI 10.1089/scd.2009.0445
   Tandon N, 2013, BIOTECHNOL ADV, V31, P1020, DOI 10.1016/j.biotechadv.2013.03.007
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020
   Tse J.R., 2009, PLOS ONE, V6
   Tseng QZ, 2012, P NATL ACAD SCI USA, V109, P1506, DOI 10.1073/pnas.1106377109
   Turner AEB, 2012, TISSUE ENG PART C-ME, V18, P186, DOI [10.1089/ten.tec.2011.0246, 10.1089/ten.TEC.2011.0246]
   Turner AEB, 2012, BIOMATERIALS, V33, P4490, DOI 10.1016/j.biomaterials.2012.03.026
   Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028
   Uriel S, 2009, TISSUE ENG PART C-ME, V15, P309, DOI 10.1089/ten.tec.2008.0309
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wu KC, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/5/054401
   Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821
   Wysocki J, 2009, FOLIA MORPHOL, V68, P13
   Yamamoto Y, 2013, BIORESEARCH OPEN ACC, V2, P199, DOI 10.1089/biores.2013.0004
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
   Yu J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt234
   Zhang H, 2011, INTERFACE FOCUS, V1, P792, DOI 10.1098/rsfs.2011.0035
NR 165
TC 11
Z9 11
U1 0
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD NOV 10
PY 2014
VL 193
BP 42
EP 50
DI 10.1016/j.jconrel.2014.06.032
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AS4FO
UT WOS:000344229000006
PM 24979211
DA 2018-10-20
ER

PT J
AU Wetterling, J
   Mattsson, T
   Theliander, H
AF Wetterling, Jonas
   Mattsson, Tuve
   Theliander, Hans
TI Effects of surface structure on the filtration properties of
   microcrystalline cellulose
SO SEPARATION AND PURIFICATION TECHNOLOGY
LA English
DT Article
DE Dead-end filtration; Local filtration properties; Compressible filter
   cake; Microcrystalline cellulose; Surface structure
ID DEAD-END FILTRATION; LOCAL FILTRATION; CAKE FILTRATION; SUSPENSIONS;
   FLOW; SEDIMENTATION; PARTICLES; POROSITY; ULTRAFILTRATION; SOLIDOSITY
AB The filtration of biomaterials is often a challenge due to high filtration resistances and the formation of compressible filter cakes. This study investigates how the local filtration properties of microcrystalline cellulose, a biomaterial forming compressible filter cakes, are affected by the surface structure of its particles. The surface structure was modified through mechanical shearing and the treatment resulted in an increased surface ruggedness along with a small decrease in particle size distribution. The mechanical treatment was found to increase the local specific filtration resistance to a large extent whereas no significant change to the local filter cake solidosity was observed. The relationship between the local solidosity of the filter cake and the local specific filtration resistance could be described by a cell model as flow around porous spheres with negligible permeability. The effect of an increased surface ruggedness was represented in this model as an increased specific surface area subjected to drag as well as a decrease in particle solidosity. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Theliander, Hans] Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
   Chalmers, Royal Inst Technol, Wallenberg Wood Sci Ctr, SE-10044 Stockholm, Sweden.
RP Theliander, H (reprint author), Chalmers, Dept Chem & Biol Engn, SE-41296 Gothenburg, Sweden.
EM hanst@chalmers.se
OI Mattsson, Tuve/0000-0002-4699-2063; Wetterling,
   Jonas/0000-0002-6738-725X
FU Chalmers Energy Initiative; Knut and Alice Wallenberg Foundation
FX The financial support of Chalmers Energy Initiative and the Knut and
   Alice Wallenberg Foundation is gratefully acknowledged. Johannes
   Thunberg at the Wallenberg Wood Science Center is thanked for valuable
   help with the SEM characterisation of the material.
CR BERGSTROM L, 1992, J CHEM SOC FARADAY T, V88, P3201, DOI 10.1039/ft9928803201
   BIERCK BR, 1988, J WATER POLLUT CON F, V60, P645
   Bockstal F., 1985, FILTR SEPARAT, V22, P255
   BOWEN WR, 1995, CHEM ENG SCI, V50, P1707, DOI 10.1016/0009-2509(95)00026-2
   Carman P.C., 1937, T I CHEM ENG-LOND, V15, P150, DOI DOI 10.1016/S0263-8762(97)80003-2
   Coulson J.M, 1949, T I CHEM ENG-LOND, V27, P237
   Deo S, 2009, J POROUS MEDIA, V12, P347, DOI 10.1615/JPorMedia.v12.i4.50
   FATHINAJAFI M, 1995, SEPAR TECHNOL, V5, P165, DOI 10.1016/0956-9618(94)00115-9
   Fu LF, 1998, J MEMBRANE SCI, V149, P221
   HAPPEL J, 1958, AICHE J, V4, P197, DOI 10.1002/aic.690040214
   Haselton W. R., 1955, TAPPI, V38, P716
   HORSFIELD MA, 1989, J MAGN RESON, V81, P593, DOI 10.1016/0022-2364(89)90098-X
   Johansson C., 2003, FILTRATION, V3, P114
   Koenders MA, 1996, CHEM ENG SCI, V51, P3897, DOI 10.1016/0009-2509(96)00236-9
   Kohnke T, 2011, BIOMACROMOLECULES, V12, P2633, DOI 10.1021/bm200437m
   Krawczyk G, 2009, WOODHEAD PUBL FOOD S, P740, DOI 10.1533/9781845695873.740
   LaHeij EJ, 1996, AICHE J, V42, P953, DOI 10.1002/aic.690420408
   Larue O, 2003, SEP PURIF TECHNOL, V31, P177, DOI 10.1016/S1383-5866(02)00182-X
   Mattsson T, 2013, CHEM ENG RES DES, V91, P1155, DOI 10.1016/j.cherd.2013.01.007
   Mattsson T, 2012, SEP PURIF TECHNOL, V96, P139, DOI 10.1016/j.seppur.2012.05.029
   Mattsson T, 2012, CHEM ENG SCI, V72, P51, DOI 10.1016/j.ces.2012.01.022
   Mattsson T, 2011, CHEM ENG SCI, V66, P4573, DOI 10.1016/j.ces.2011.06.012
   Okamura S., 1955, CHEM ENG JAPAN, V19, P104
   RIETEMA K, 1953, CHEM ENG SCI, V2, P88, DOI 10.1016/0009-2509(53)80015-1
   Ruth BF, 1935, IND ENG CHEM, V27, P708, DOI 10.1021/ie50306a024
   Sedin P, 2003, CHEM ENG RES DES, V81, P1393, DOI 10.1205/026387603771339618
   SHIRATO M, 1969, AICHE J, V15, P405, DOI 10.1002/aic.690150320
   Shirato M., 1971, J CHEM ENG JAPAN, V4, P172
   Sjostrom E, 1989, NORD PULP PAP RES J, V4, P90, DOI DOI 10.3183/NPPRJ-1989-04-02-P090-093
   STONE JE, 1965, PULP PAPER MAG CAN, V66, pT407
   Tien C, 1997, AICHE J, V43, P33, DOI 10.1002/aic.690430106
   Tiller F., 1980, J CHIN INST CHEM ENG, V11, P61
   TILLER FM, 1995, AICHE J, V41, P1153, DOI 10.1002/aic.690410511
   Wakeman R.J., 1989, FILTR SEPARAT, V26, P277
   WYLLIE MRJ, 1955, IND ENG CHEM, V47, P1379, DOI 10.1021/ie50547a037
NR 35
TC 5
Z9 6
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1383-5866
EI 1873-3794
J9 SEP PURIF TECHNOL
JI Sep. Purif. Technol.
PD NOV 5
PY 2014
VL 136
BP 1
EP 9
DI 10.1016/j.seppur.2014.08.031
PG 9
WC Engineering, Chemical
SC Engineering
GA AT3JJ
UT WOS:000344831100001
DA 2018-10-20
ER

PT J
AU Socarras, TO
   Vasconcelos, AC
   Campos, PP
   Pereira, NB
   Souza, JPC
   Andrade, SP
AF Oviedo Socarras, Teresa
   Vasconcelos, Anilton C.
   Campos, Paula P.
   Pereira, Nubia B.
   Souza, Jessica P. C.
   Andrade, Silvia P.
TI Foreign Body Response to Subcutaneous Implants in Diabetic Rats
SO PLOS ONE
LA English
DT Article
ID INFLAMMATORY ANGIOGENESIS; GROWTH-FACTOR; MICE; MODEL; MECHANISMS;
   APOPTOSIS; MOUSE
AB Implantation of synthetic matrices and biomedical devices in diabetic individuals has become a common procedure to repair and/or replace biological tissues. However, an adverse foreign body reaction that invariably occurs adjacent to implant devices impairing their function is poorly characterized in the diabetic environment. We investigated the influence of this condition on the abnormal tissue healing response in implants placed subcutaneously in normoglycemic and streptozotocin-induced diabetes in rats. In polyether-polyurethane sponge discs removed 10 days after implantation, the components of the fibrovascular tissue (angiogenesis, inflammation, fibrogenesis, and apoptosis) were assessed. Intra-implant levels of hemoglobin and vascular endothelial growth factor were not different after diabetes when compared with normoglycemic counterparts. However, there were a lower number of vessels in the fibrovascular tissue from diabetic rats when compared with vessel numbers in implants from non-diabetic animals. Overall, the inflammatory parameters (neutrophil accumulation - myeloperoxidase activity, tumor necrosis factor alpha, and monocyte chemotactic protein-1 levels and mast cell counting) increased in subcutaneous implants after diabetes induction. However, macrophage activation (N-acetyl-beta-D-glucosaminidase activity) was lower in implants from diabetic rats when compared with those from normoglycemic animals. All fibrogenic markers (transforming growth factor beta 1 levels, collagen deposition, fibrous capsule thickness, and foreign body giant cells) decreased after diabetes, whereas apoptosis (TUNEL) increased. Our results showing that hyperglycemia down regulates the main features of the foreign body reaction induced by subcutaneous implants in rats may be relevant in understanding biomaterial integration and performance in diabetes.
C1 [Oviedo Socarras, Teresa; Vasconcelos, Anilton C.; Campos, Paula P.; Pereira, Nubia B.; Souza, Jessica P. C.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.
   [Oviedo Socarras, Teresa] Univ Cordoba, Dept Livestock Sci, Monteria, Cordoba, Colombia.
   [Andrade, Silvia P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.
RP Campos, PP (reprint author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.
EM paulapc@icb.ufmg.br
RI Vasconcelos, Anilton/L-9861-2014
OI Vasconcelos, Anilton/0000-0001-6202-580X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   CNPq-processo [481659/2012-9]
FX The work was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico CNPq-processo no481659/2012-9
   http://www.cnpq.br/. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Altavilla D, 2001, DIABETES, V50, P667, DOI 10.2337/diabetes.50.3.667
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Araujo FA, 2011, CLIN EXP PHARMACOL P, V38, P262, DOI 10.1111/j.1440-1681.2011.05496.x
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   BAILEY PJ, 1988, METHOD ENZYMOL, V162, P327
   Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263
   Campos PP, 2008, WOUND REPAIR REGEN, V16, P416, DOI 10.1111/j.1524-475X.2008.00381.x
   Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951
   Darby IA, 1997, INT J BIOCHEM CELL B, V29, P191, DOI 10.1016/S1357-2725(96)00131-8
   Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Ferreira MAND, 2004, BRIT J PHARMACOL, V141, P1185, DOI 10.1038/sj.bjp.0705731
   Gerritsen R, 2000, J MATER SCI-MATER M, V11, P499
   KAHN AM, 1993, HYPERTENSION, V22, P735, DOI 10.1161/01.HYP.22.5.735
   KILZER P, 1985, DIABETES, V34, P333, DOI 10.2337/diabetes.34.4.333
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Le Nga N, 2011, J Diabetes Sci Technol, V5, P605
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mendes JB, 2007, J BIOMED MATER RES B, V83B, P408, DOI 10.1002/jbm.b.30810
   Mendes JB, 2009, MICROVASC RES, V78, P265, DOI 10.1016/j.mvr.2009.08.008
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   Rai N K, 2005, J Wound Care, V14, P277
   Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y
   Thomson SE, 2010, DIABETOLOGIA, V53, P572, DOI 10.1007/s00125-009-1610-6
   Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487
NR 30
TC 12
Z9 12
U1 1
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 5
PY 2014
VL 9
IS 11
AR e110945
DI 10.1371/journal.pone.0110945
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS9IQ
UT WOS:000344556900027
PM 25372281
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Naeimi, M
   Fathi, M
   Rafienia, M
   Bonakdar, S
AF Naeimi, Mitra
   Fathi, Mohammadhossein
   Rafienia, Mohammad
   Bonakdar, Shahin
TI Silk Fibroin-Chondroitin Sulfate-Alginate Porous Scaffolds: Structural
   Properties and In Vitro Studies
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; biomedical applications; porous materials
ID COMPOSITE SCAFFOLDS; CROSS-LINKING; TISSUE; CHITOSAN; PROTEIN;
   BIOMATERIAL; COLLAGEN; ACID
AB The development of porous biodegradable scaffolds is of great interest in tissue engineering. In this regard, exploration of novel biocompatible materials is needed. Silk fibroin-chondroitin sulfate-sodium alginate (SF-CHS-SA) porous hybrid scaffolds were successfully prepared via lyophilization method and crosslinked by 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide-ethanol treatment. According to the scanning electron microscopy studies, mean pore diameters of the scaffolds were in the range of 60-187 mu m. The porosity percentage of the scaffold with SF-CHS-SA ratio of 70 : 15 : 15 (w/w/w %) was 92.4 +/- 3%. Attenuated total reflectance Fourier transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry results confirmed the transition from amorphous random coil to crystalline beta-sheet in treated SF-CHS-SA scaffold. Compressive modulus was significantly improved in hybrid scaffold with SF-CHS-SA ratio of 70 : 15 : 15 (3.3560.15 MPa). Cytotoxicity assay showed that the scaffolds have no toxic effects on chondrocytes. Attachment of chondrocytes was much more improved within the SF-CHS-SA hybrid scaffold. Real-time polymerase chain reaction analyses showed a significant increase in gene expression of collagen type II, aggrecan, and SOX9 and decrease in gene expression of collagen type I for SF-CHS-SA compared with SF scaffold. This novel hybrid scaffold can be a good candidate to be utilized as an efficient scaffold for cartilage tissue engineering. (C) 2014 Wiley Periodicals, Inc.
C1 [Naeimi, Mitra; Fathi, Mohammadhossein] Isfahan Univ Technol, Dept Mat Engn, Biomat Res Grp, Esfahan 8415683111, Iran.
   [Naeimi, Mitra] Isfahan Univ Med Sci, Esfahan, Iran.
   [Fathi, Mohammadhossein] Isfahan Univ Med Sci, Dent Mat Res Ctr, Esfahan 8174673461, Iran.
   [Rafienia, Mohammad] Isfahan Univ Med Sci, Biosensor Res Ctr, Esfahan 81744176, Iran.
   [Bonakdar, Shahin] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran 1316943551, Iran.
RP Naeimi, M (reprint author), Isfahan Univ Technol, Dept Mat Engn, Biomat Res Grp, Esfahan 8415683111, Iran.
EM m.naeimi@ma.iut.ac.ir
OI Bonakdar, Shahin/0000-0001-8759-3790
CR Bhardwaj N, 2011, INT J BIOL MACROMOL, V49, P260, DOI 10.1016/j.ijbiomac.2011.04.013
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Chen WC, 2011, J BIOSCI BIOENG, V111, P226, DOI 10.1016/j.jbiosc.2010.10.002
   Farokhi M, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39980
   Garcia-Fuentes M, 2008, BIOMATERIALS, V29, P633, DOI 10.1016/j.biomaterials.2007.10.024
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lua Q., 2011, BIOMACROMOLECULES, V12, P1080
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Ming J., 2013, POLYM ENG SCI, V54, P129
   Moraes MA, 2010, POLYMERS, V2, P719, DOI DOI 10.3390/P0LYM2040719
   Peng CK, 2006, J APPL POLYM SCI, V99, P2091, DOI 10.1002/app.22730
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Shang SM, 2013, CARBOHYD POLYM, V93, P561, DOI 10.1016/j.carbpol.2012.12.038
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Shokrgozar MA, 2013, J MATER SCI-MATER M, V24, P2449, DOI 10.1007/s10856-013-4995-1
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Venkatesan J, 2012, INT J BIOL MACROMOL, V51, P1033, DOI 10.1016/j.ijbiomac.2012.08.020
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CC, 2012, BIOMATERIALS, V33, P120, DOI 10.1016/j.biomaterials.2011.09.042
   Xiao XF, 2008, MATER CHEM PHYS, V112, P838, DOI 10.1016/j.matchemphys.2008.06.055
   Yan L. P., 2011, ACTA BIOMATER, V8, P289
   Yan S., 2010, J FIBER BIOENG INFOR, V3, P62
   Yan SQ, 2013, ACTA BIOMATER, V9, P6771, DOI 10.1016/j.actbio.2013.02.016
   Yang CR, 2012, B MATER SCI, V35, P913, DOI 10.1007/s12034-012-0376-5
   Zhang L, 2011, CARBOHYD POLYM, V84, P118, DOI 10.1016/j.carbpol.2010.11.009
NR 35
TC 7
Z9 7
U1 3
U2 68
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD NOV 5
PY 2014
VL 131
IS 21
AR 41048
DI 10.1002/app.41048
PG 9
WC Polymer Science
SC Polymer Science
GA AN2GD
UT WOS:000340401400073
DA 2018-10-20
ER

PT J
AU Brown, BN
   Sicari, BM
   Badylak, SE
AF Brown, Bryan N.
   Sicari, Brian M.
   Badylak, Stephen E.
TI Rethinking regenerative medicine: a macropnage-centered approach
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE regenerative medicine; biomaterials; host response; foreign-body
   reaction; stem cells; macrophages
ID MESENCHYMAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; SPINAL-CORD-INJURY;
   SKELETAL-MUSCLE REGENERATION; ACUTE MYOCARDIAL-INFARCTION; FOREIGN-BODY
   REACTION; FACTOR-KAPPA-B; MACROPHAGE PHENOTYPE; EXTRACELLULAR-MATRIX;
   TNF-ALPHA
AB Regenerative medicine, a multi-disciplinary approach that seeks to restore form and function to damaged or diseased tissues and organs, has evolved significantly during the past decade. By adapting and integrating fundamental knowledge from cell biology, polymer science, and engineering, coupled with an increasing understanding of the mechanisms which underlie the pathogenesis of specific diseases, regenerative medicine has the potential for innovative and transformative therapies for heretofore unmet medical needs. However, the translation of novel technologies from the benchtop to animal models and clinical settings is non-trivial and requires an understanding of the mechanisms by which the host will respond to these novel therapeutic approaches. The role of the innate immune system, especially the role of macrophages, in the host response to regenerative medicine based strategies has recently received considerable attention. Macrophage phenotype and function have been suggested as critical and determinant factors in downstream outcomes. The constructive and regulatory, and in fact essential, role of macrophages in positive outcomes represents a significant departure from the classical paradigms of host biomaterial interactions, which typically consider activation of the host immune system as a detrimental event. It appears desirable that emerging regenerative medicine approaches should not only accommodate but also promote the involvement of the immune system to facilitate positive outcomes. Herein, we describe the current understanding of macrophage phenotype as it pertains to regenerative medicine and suggest that improvement of our understanding of context-dependent macrophage polarization will lead to concurrent improvement in outcomes.
C1 [Brown, Bryan N.; Sicari, Brian M.; Badylak, Stephen E.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA.
   [Brown, Bryan N.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA.
   [Sicari, Brian M.; Badylak, Stephen E.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA.
RP Badylak, SE (reprint author), McGowan Inst Regenerat Med, Suite 300,450 Technol Dr, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
RI Siegmund, Britta/E-6929-2018
OI Siegmund, Britta/0000-0002-0055-958X; Badylak,
   Stephen/0000-0003-3555-0689
CR Adamson R, 2009, J Wound Care, V18, P349
   Adutler-Lieber S, 2013, J CARDIOVASC PHARM T, V18, P78, DOI 10.1177/1074248412453875
   Akira S, 2013, DIABETES OBES METAB, V15, P10, DOI 10.1111/dom.12151
   ALBINA JE, 1990, J IMMUNOL, V144, P3877
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Bondesen BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1651, DOI 10.1152/ajpcell.00518.2005
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655
   Capobianco A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00009
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005
   Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236
   Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807
   Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9
   Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180
   Eggenhofer E, 2012, TRANSPLANT RES, V1, DOI 10.1186/2047-1440-1-12
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Fan Y, 1996, MUSCLE NERVE, V19, P853, DOI 10.1002/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8
   Faulk DM, 2014, BIOMATERIALS, V35, P8585, DOI 10.1016/j.biomaterials.2014.06.057
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Galli SJ, 2011, NAT IMMUNOL, V12, P1035, DOI 10.1038/ni.2109
   Gao S, 2014, EXP BIOL MED, V239, P366, DOI 10.1177/1535370213518169
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Geng YQ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt469
   Gharaibeh B, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt72
   Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045
   Glimm H, 2000, BLOOD, V96, P4185
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Godwin JW, 2014, DIFFERENTIATION, V87, P66, DOI 10.1016/j.diff.2014.02.002
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Guerette B, 1997, CELL TRANSPLANT, V6, P101, DOI 10.1016/S0963-6897(96)00230-8
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   HENSON PM, 1971, J IMMUNOL, V107, P1547
   Hernandez-Pando R, 2000, IMMUNOLOGY, V100, P352, DOI 10.1046/j.1365-2567.2000.00025.x
   Hines DJ, 2009, GLIA, V57, P1610, DOI 10.1002/glia.20874
   Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004
   HUARD J, 1994, HUM GENE THER, V5, P949, DOI 10.1089/hum.1994.5.8-949
   Huebener P, 2013, BBA-MOL BASIS DIS, V1832, P1005, DOI 10.1016/j.bbadis.2012.11.017
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   KOVACS EJ, 1991, IMMUNOL TODAY, V12, P17, DOI 10.1016/0167-5699(91)90107-5
   Langen RCJ, 2006, AM J RESP CELL MOL, V35, P689, DOI 10.1165/rcmb.2006-0103OC
   Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com
   Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463
   Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x
   Le Blanc K, 2006, CYTOTHERAPY, V8, P559, DOI 10.1080/14653240601045399
   Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611
   Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126
   Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002
   Liu D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-659
   Longbrake EE, 2007, J NEUROCHEM, V102, P1083, DOI 10.1111/j.1471-4159.2007.04617.x
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mahbub S, 2012, J INTERF CYTOK RES, V32, P18, DOI 10.1089/jir.2011.0058
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493
   McLennan IS, 1996, J ANAT, V188, P17
   MILLS CD, 1992, J IMMUNOL, V149, P2709
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10
   Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469
   Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   MUIR AR, 1965, J ANAT, V99, P435
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017
   Perez-Ilzarbe M, 2008, EUR J HEART FAIL, V10, P1065, DOI 10.1016/j.ejheart.2008.08.002
   Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149
   Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528
   Prinz M, 2014, ACTA NEUROPATHOL, V128, P319, DOI 10.1007/s00401-014-1267-1
   Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Schwartz M, 2010, BRAIN BEHAV IMMUN, V24, P1054, DOI 10.1016/j.bbi.2010.01.010
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Sicari BM, 2014, ANAT REC, V297, P51, DOI 10.1002/ar.22794
   Sindrilaru A, 2013, ADV WOUND CARE, V2, P357, DOI 10.1089/wound.2012.0407
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Smith KA, 2012, COMPARATIVE MED, V62, P303
   Song XL, 2015, INFLAMMATION, V38, P485, DOI 10.1007/s10753-014-9954-6
   Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013
   Stout RD, 2010, J LEUKOCYTE BIOL, V87, P19, DOI 10.1189/jlb.0509311
   STPIERRE BA, 1994, J APPL PHYSIOL, V77, P290
   Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   Teixeira CFP, 2003, MUSCLE NERVE, V28, P449, DOI 10.1002/mus.10453
   Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228
   Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wise AF, 2014, AM J PHYSIOL-RENAL, V306, pF1222, DOI 10.1152/ajprenal.00675.2013
   Wolf MT, 2015, TISSUE ENG PART C-ME, V21, P148, DOI [10.1089/ten.TEC.2014.0167, 10.1089/ten.tec.2014.0167]
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
   Wolf MT, 2014, J BIOMED MATER RES A, V102, P234, DOI 10.1002/jbm.a.34671
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wozniak AC, 2005, MUSCLE NERVE, V31, P283, DOI 10.1002/mus.20263
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Yang LQ, 2005, J CLIN NEUROSCI, V12, P276, DOI 10.1016/j.jocn.2004.06.011
   Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004
   Yannarelli G, 2013, CELL TRANSPLANT, V22, P1651, DOI 10.3727/096368912X657675
   Zador E, 2001, MUSCLE NERVE, V24, P1058, DOI 10.1002/mus.1110
   Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006
NR 148
TC 63
Z9 63
U1 1
U2 32
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD NOV 4
PY 2014
VL 5
AR 510
DI 10.3389/fimmu.2014.00510
PG 11
WC Immunology
SC Immunology
GA CI1QO
UT WOS:000354519400001
PM 25408693
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Balk, M
   Behl, M
   Nochel, U
   Lendlein, A
AF Balk, Maria
   Behl, Marc
   Noechel, Ulrich
   Lendlein, Andreas
TI Shape-Memory Hydrogels with Crystallizable Oligotetrahydrofuran Side
   Chains
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 12th International Polymers for Advanced Technologies conference (PAT)
CY SEP 29-OCT 02, 2013
CL Berlin, GERMANY
DE crystallization; hydrogels; oligotetrahydrofuran; polyether;
   stimuli-sensitive polymers
AB Stimuli-sensitive materials, such as shape-memory polymers (SMP) have attracted tremendous interest in the field of biomedical applications and Regenerative Therapies. In case of implants intended for soft tissue, adequate elastic properties can be mimicked by water swollen hydrophilic polymer networks (i.e. hydrogels) and can be equipped with a shape-memory capability. Shape-memory hydrogels (SMHs) having body compatible transition temperatures (T-trans) have not been reported so far. Here we explored, whether SMHs with Ttrans <= 37 degrees C could be created consisting of the hydrophilic poly(N-vinyl pyrrolidone) segment, the crosslinker oligo(ethylene glycol) dimethacrylate (OEGDMA, M-n = 370 g.mol(-1)), and grafted crystallizable oligotetrahydrofuran (OTHF, M-n = 7.100 g.mol(-1), T-m = 31 degrees C) segments as switching domains. As function of the OTHF content (30-75 wt%), the hydrogels had a degree of swelling between 450 and 3200%, a T-trans about 26 degrees C, and soft mechanical properties in the kPa range. Therefore, these SMHs might be interesting biomaterial candidates e.g. as smart implants.
C1 [Balk, Maria; Behl, Marc; Noechel, Ulrich; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Balk, Maria; Behl, Marc; Lendlein, Andreas] Tianjin Univ, Helmholtz Zentrum Geesthacht, Joint Lab Biomat & Regenerat Med, Tianjin, Peoples R China.
   [Lendlein, Andreas] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Lendlein, Andreas/K-9553-2013; Behl, Marc/K-9429-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Behl, Marc/0000-0002-1507-0277
CR Balk M., 2012, MACROMOL MATER ENG, V12, P1184
   Dubreuil MF, 1997, MACROMOL CHEM PHYSIC, V198, P3077, DOI 10.1002/macp.1997.021981008
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   MATSUDA A, 1994, MACROMOLECULES, V27, P7695, DOI 10.1021/ma00104a027
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   Tsuchiya M, 2003, J THERM ANAL CALORIM, V72, P651, DOI 10.1023/A:1024598221061
   Wagermaier W, 2010, ADV POLYM SCI, V226, P97, DOI 10.1007/12_2009_25
NR 8
TC 3
Z9 3
U1 2
U2 15
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD NOV
PY 2014
VL 345
IS 1
SI SI
BP 8
EP 13
DI 10.1002/masy.201400043
PG 6
WC Polymer Science
SC Polymer Science
GA AW7SK
UT WOS:000346464500002
DA 2018-10-20
ER

PT J
AU Zhang, SW
   Wan, WB
   Xu, KG
   Yuan, Q
   Xing, M
AF Zhang, Shiwen
   Wan, Wenbin
   Xu, Kaige
   Yuan, Quan
   Xing, Malcolm
TI Dual-Functional Biomaterials for Bone Regeneration and Infection Control
SO Journal of Biomaterials and Tissue Engineering
LA English
DT Review
DE Dual Function; Infection; Bone Regeneration; Antibiotics; Nanosilver;
   Bone Graft; Bone Morphogenetic Proteins; Nanomaterial; Scaffold; Rat
   Model
ID CALCIUM-PHOSPHATE CEMENT; STABILIZED SEGMENTAL DEFECT; ANTIBIOTIC
   DELIVERY-SYSTEM; DRUG-DELIVERY; IN-VITRO; BIOACTIVE GLASS; CANCELLOUS
   BONE; RAT FEMUR; HYDROXYAPATITE BLOCKS; SUSTAINED-RELEASE
AB Bone graft biomaterials for replacing defected bone sites have the potential risks of infection, which may interfere with bone healing and regeneration. Reconstructing the infected sites is complex and a big concern. Significant work has been conducted in the area of local drug delivery via biomaterial carriers to eliminate the infection. There is a growing need for the investigation of biomaterials having the function of both bone regeneration and prohibiting infection. However, there is little intersection in the available literatures between antibiotic treatment and bone tissue regeneration. In this review, we introduce current dual-purpose biomaterials and experimental rat models of infected bone defects with the goal of addressing the need for biomaterials for osteointegration as well as infection control.
C1 [Zhang, Shiwen; Wan, Wenbin; Xu, Kaige; Xing, Malcolm] Univ Manitoba, Dept Mech & Mfg Engn, Winnipeg, MB R3T 2N2, Canada.
   [Zhang, Shiwen; Wan, Wenbin; Xu, Kaige; Xing, Malcolm] Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada.
   [Zhang, Shiwen; Yuan, Quan] Sichuan Univ, West China Sch Stomatol, Chengdu 610041, Peoples R China.
RP Yuan, Q (reprint author), Sichuan Univ, West China Sch Stomatol, Chengdu 610041, Peoples R China.
CR Allan I, 2001, BIOMATERIALS, V22, P1683, DOI 10.1016/S0142-9612(00)00330-6
   Ambrose CG, 2003, CLIN ORTHOP RELAT R, P279, DOI 10.1097/01.blo.0000093920.26658.ae
   [Anonymous], 1947, NED TIJDSCHR V GEN, V91, P2192
   Antoci V, 2007, CLIN ORTHOP RELAT R, P200, DOI 10.1097/BLO.0b013e31811ff866
   Arciola CR, 2011, INT J ARTIF ORGANS, V34, P771, DOI 10.5301/ijao.5000046
   ASHARANI PV, 2008, ACS NANO, V3, P279, DOI DOI 10.1021/NN800596W
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bowen TR, 2005, CLIN ORTHOP RELAT R, P205, DOI 10.1097/01.blo.0000150345.51508.74
   Brick KE, 2009, CLIN ORTHOP RELAT R, V467, P3096, DOI 10.1007/s11999-008-0599-3
   Brolmann FE, 2012, BRIT J SURG, V99, P1172, DOI 10.1002/bjs.8810
   Brooks AE, 2013, DRUG DELIV TRANSL RE, V3, P518, DOI 10.1007/s13346-013-0155-x
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Buranapanitkit B, 2005, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000165851.81386.6a
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Buttaro MA, 2005, ACTA ORTHOP, V76, P336, DOI 10.1080/00016470510030797
   Buttaro MA, 2003, ACTA ORTHOP SCAND, V74, P505, DOI 10.1080/00016470310017884
   Canal C, 2011, J MECH BEHAV BIOMED, V4, P1658, DOI 10.1016/j.jmbbm.2011.06.023
   Castro C, 2005, EUR J PHARM BIOPHARM, V60, P401, DOI 10.1016/j.ejpb.2005.02.005
   Castro C, 2003, J CONTROL RELEASE, V93, P341, DOI 10.1016/j.jconrel.2003.09.004
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   CHANG CC, 1992, J BIOMED MATER RES, V26, P197, DOI 10.1002/jbm.820260206
   Chang W, 2007, ACTA ORTHOP BELG, V73, P238
   Chen CE, 2005, ARCH ORTHOP TRAUM SU, V125, P369, DOI 10.1007/s00402-005-0794-6
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Chen XQ, 2007, J ORTHOP TRAUMA, V21, P693, DOI 10.1097/BOT.0b013e31815a7e91
   Chen XQ, 2006, J BONE JOINT SURG AM, V88A, P1510, DOI 10.2106/JBJS.E.01136
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   Cheng YK, 2008, J CLIN NEUROSCI, V15, P1115, DOI 10.1016/j.jocn.2007.09.022
   CHISHOLM BB, 1993, J ORAL MAXIL SURG, V51, P444, DOI 10.1016/S0278-2391(10)80366-0
   Cordero J, 1996, J ORTHOPAED RES, V14, P663, DOI 10.1002/jor.1100140423
   Day RE, 2005, J BONE JOINT SURG BR, V87B, P1568, DOI 10.1302/0301-620X.87B11.16384
   Diefenbeck Michael, 2006, Injury, V37 Suppl 2, pS95, DOI 10.1016/j.injury.2006.04.015
   Echezarreta-Lopez MM, 2013, INT J PHARMACEUT, V453, P641, DOI 10.1016/j.ijpharm.2013.06.036
   Edin ML, 1996, CLIN ORTHOP RELAT R, P245
   Edmondson MC, 2014, BONE JOINT RES, V3, P101, DOI 10.1302/2046-3758.34.2000223
   El-Ghannam A, 2005, J BIOMED MATER RES B, V73B, P277, DOI 10.1002/jbm.b.30209
   El-Ghannam A, 2010, J BIOMED MATER RES A, V94A, P308, DOI 10.1002/jbm.a.32705
   El-Husseiny M, 2011, J BONE JOINT SURG BR, V93B, P151, DOI 10.1302/0301-620X.93B2.24933
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008
   Gitelis S., 2002, J ORTHOPAEDIC SURG, V10
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Helgeson Melvin D, 2009, Orthopedics, V32, P323
   HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005
   Huang D, 2011, J BIOMAT SCI-POLYM E, V22, P931, DOI 10.1163/092050610X496576
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Isefuku S, 2001, J ORTHOP RES, V19, P950, DOI 10.1016/S0736-0266(01)00022-5
   ITOKAZU M, 1995, J APPL BIOMATER, V6, P167, DOI 10.1002/jab.770060304
   Itokazu M, 1998, BIOMATERIALS, V19, P817, DOI 10.1016/S0142-9612(97)00237-8
   Itokazu M, 1996, CANCER LETT, V107, P11, DOI 10.1016/0304-3835(96)04337-6
   Jones JR, 2006, BIOMATERIALS, V27, P964, DOI 10.1016/j.biomaterials.2005.07.017
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Keeling JJ, 2008, J BONE JOINT SURG AM, V90A, P2643, DOI 10.2106/JBJS.G.01326
   Ketonis C, 2011, ANTIMICROB AGENTS CH, V55, P487, DOI 10.1128/AAC.00741-10
   Ketonis C, 2010, CLIN ORTHOP RELAT R, V468, P2113, DOI 10.1007/s11999-010-1322-8
   Khoo PPC, 2006, J BONE JOINT SURG BR, V88B, P1149, DOI 10.1302/0301-620X.88B9.17500
   Kisanuki O, 2007, J ORTHOP SCI, V12, P281, DOI 10.1007/s00776-007-1124-3
   Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371
   Krisanapiboon A., 2006, J ORTHOPAEDIC SURG, V14
   Kweon C, 2011, CLIN ORTHOP RELAT R, V469, P3002, DOI 10.1007/s11999-011-1928-5
   Lee CH, 2012, J TRAUMA ACUTE CARE, V73, P255, DOI 10.1097/TA.0b013e318256a150
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lienau J, 2009, J ORTHOP RES, V27, P1133, DOI 10.1002/jor.20870
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Lindfors NC, 2003, J MATER SCI-MATER M, V14, P365, DOI 10.1023/A:1022988117526
   LINDSEY RW, 1993, CLIN ORTHOP RELAT R, P303
   Liu X, 2010, J MATER SCI-MATER M, V21, P575, DOI 10.1007/s10856-009-3897-8
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6
   McKee MD, 2002, J ORTHOP TRAUMA, V16, P622, DOI 10.1097/01.BOT.0000031145.58425.82
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   Melichercik P, 2012, FOLIA MICROBIOL, V57, P459, DOI 10.1007/s12223-011-0093-2
   Meseguer-Olmo L, 2006, J ORTHOP RES, V24, P454, DOI 10.1002/jor.20064
   Michalak KA, 2006, J BONE JOINT SURG BR, V88B, P1430, DOI 10.1302/0301-620X.88B11.18335
   Miyai T, 2008, BIOMATERIALS, V29, P350, DOI 10.1016/j.biomaterials.2007.09.040
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Nair MB, 2011, CURR OPIN BIOTECH, V22, P721, DOI 10.1016/j.copbio.2011.02.005
   Nakagawa S, 2003, NEUROL MED-CHIR, V43, P120, DOI 10.2176/nmc.43.120
   Nandakumar A, 2013, ACTA BIOMATER, V9, P5708, DOI 10.1016/j.actbio.2012.10.044
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Offenbacher S, 2008, J PERIODONTOL, V79, P1577, DOI 10.1902/jop.2008.080220
   Okike K, 2006, J BONE JOINT SURG AM, V88A, P2739, DOI 10.2106/JBJS.F.00146
   Philippe B. D., 2007, RISK BACTERIAL RESIS
   Pietrzak WS, 2000, J CRANIOFAC SURG, V11, P327, DOI 10.1097/00001665-200011040-00009
   Puska MA, 2004, J MATER SCI-MATER M, V15, P1037, DOI 10.1023/B:JMSM.0000042690.93328.e5
   Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343
   Ratier A, 2004, INT J PHARM, V274, P261, DOI 10.1016/j.ijpharm.2004.01.021
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Reves BT, 2009, J BIOMED MATER RES B, V90B, P1, DOI 10.1002/jbm.b.31390
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ristiniemi J, 2007, ACTA ORTHOP, V78, P520, DOI 10.1080/17453670710014176
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   Sasaki S, 1999, J Orthop Sci, V4, P361, DOI 10.1007/s007760050117
   Schneider OD, 2008, J MATER CHEM, V18, P2679, DOI 10.1039/b800522b
   Schneider Oliver D, 2011, Open Orthop J, V5, P63, DOI 10.2174/1874325001105010063
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Shi XT, 2009, ACTA BIOMATER, V5, P1697, DOI 10.1016/j.actbio.2009.01.010
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sintubin L, 2012, BIOTECHNOL BIOENG, V109, P2422, DOI 10.1002/bit.24570
   Southwood LL, 2004, J ORTHOPAED RES, V22, P66, DOI 10.1016/S0736-0266(03)00129-3
   Stallmann HP, 2004, J ANTIMICROB CHEMOTH, V54, P472, DOI 10.1093/jac/dkh346
   Stewart RL, 2010, J ORTHOP TRAUMA, V24, P587, DOI 10.1097/BOT.0b013e3181ed1349
   Suzuki A, 2006, J ORTHOP RES, V24, P327, DOI 10.1002/jor.20049
   Tamimi F, 2008, J BIOMED MATER RES A, V85A, P707, DOI 10.1002/jbm.a.31610
   Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967
   Thomes B, 2002, J Bone Joint Surg Br, V84, P758
   van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X
   Victor SP, 2008, J MATER SCI-MATER M, V19, P283, DOI 10.1007/s10856-006-0044-7
   Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006/1211
   Waltimo T, 2007, J DENT RES, V86, P754, DOI 10.1177/154405910708600813
   Wenke JC, 2011, EXPERT OPIN DRUG DEL, V8, P1555, DOI 10.1517/17425247.2011.628655
   Winkler H, 2000, J ANTIMICROB CHEMOTH, V46, P423, DOI 10.1093/jac/46.3.423
   Witso E, 2005, ACTA ORTHOP, V76, P481, DOI 10.1080/17453670510041457
   Witso E, 2004, ACTA ORTHOP SCAND, V75, P339, DOI 10.1080/00016470410001295
   Witso E, 1999, ACTA ORTHOP SCAND, V70, P298, DOI 10.3109/17453679908997812
   Witso E, 2000, ACTA ORTHOP SCAND, V71, P80, DOI 10.1080/00016470052943955
   Wu X, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044105
   Xie ZP, 2009, J CONTROL RELEASE, V139, P118, DOI 10.1016/j.jconrel.2009.06.012
   Yamashita Y, 1998, INT ORTHOP, V22, P247, DOI 10.1007/s002640050252
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
   Zhang L, 2010, CURR MED CHEM, V17, P585, DOI 10.2174/092986710790416290
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
   Zou Q, 2009, J BIOMED MATER RES A, V89A, P1108, DOI 10.1002/jbm.a.32199
NR 150
TC 3
Z9 3
U1 1
U2 48
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD NOV
PY 2014
VL 4
IS 11
SI SI
BP 875
EP 885
DI 10.1166/jbt.2014.1269
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA CA8BC
UT WOS:000349140500004
DA 2018-10-20
ER

PT J
AU Mohtaram, NK
   Ko, J
   Montgomery, A
   Carlson, M
   Sun, L
   Wong, A
   Robinson, M
   Jun, MBG
   Willerth, SM
AF Mohtaram, Nima Khadem
   Ko, Junghyuk
   Montgomery, Amy
   Carlson, Michael
   Sun, Lin
   Wong, Alix
   Robinson, Meghan
   Jun, Martin Byung-Guk
   Willerth, Stephanie M.
TI Multifunctional Electrospun Scaffolds for Promoting Neuronal
   Differentiation of Induced Pluripotent Stem Cells
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Induced Pluripotent Stem Cells; Nanofibers; Electrospinning; Controlled
   Release; Spinal Cord Injury; Neural Tissue Engineering
ID TISSUE REGENERATION; GROWTH-FACTORS; DRUG-DELIVERY; MOUSE EMBRYOS;
   IN-VITRO; NANOFIBERS; MATRIX; NANOTOPOGRAPHY; TOPOGRAPHY; RELEASE
AB Nanofabrication techniques can produce biomaterial scaffolds that mimic the microenvironment present in healthy tissue. In this study, we used solution electrospinning to produce nanofiber-based biomaterial scaffolds that present chemical and physical cues similar to those found in the extracellular matrix of neural tissue. These electrospun biomaterial scaffolds fabricated out of poly(gamma-caprolactone) (PCL) had different topographies consisting of randomly-oriented fibers and aligned fibers that contained different concentrations of retinoic acid (RA), a small molecule that regulates neural development. These scaffolds released RA in a controlled fashion for a month in the absence of cells. They also supported the differentiation of neural progenitors derived from mouse induced pluripotent stem cells (iPSCs) into neurons. Overall, this novel combination of multifunctional scaffolds and iPSC-derived neural progenitors serves as a promising strategy for neural tissue engineering applications.
C1 [Mohtaram, Nima Khadem; Ko, Junghyuk; Montgomery, Amy; Jun, Martin Byung-Guk; Willerth, Stephanie M.] Univ Victoria, Dept Mech Engn, STN CSC, Victoria, BC V8W 2Y2, Canada.
   [Carlson, Michael] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.
   [Sun, Lin] Univ Victoria, Dept Biol, Victoria, BC V8P 5C2, Canada.
   [Wong, Alix] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8P 5C2, Canada.
   [Robinson, Meghan] Univ Victoria, Dept Biomed Engn, Victoria, BC V8W 2Y2, Canada.
   [Willerth, Stephanie M.] Univ Victoria, Div Med Sci, STN CSC, Victoria, BC V8W 2Y2, Canada.
RP Willerth, SM (reprint author), Univ Victoria, Dept Mech Engn, STN CSC, POB 1700, Victoria, BC V8W 2Y2, Canada.
OI Willerth, Stephanie/0000-0002-1665-7723
FU Natural Sciences and Engineering Research Council (NSERC); Advanced
   Microscopy Facility at the University of Victoria
FX The authors would like to acknowledge support from Natural Sciences and
   Engineering Research Council (NSERC) through their Discovery Grant and
   from the Advanced Microscopy Facility at the University of Victoria.
CR BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   Balu R, 2011, J BIOMATER TISS ENG, V1, P30, DOI 10.1166/Mt.2011.1004
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Jiang X, 2012, ACTA BIOMATER, V8, P1290, DOI 10.1016/j.actbio.2011.11.019
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Junka R, 2013, J BIOMATER TISS ENG, V3, P494, DOI 10.1166/jbt.2013.1110
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim HN, 2013, ADV DRUG DELIVER REV, V65, P536, DOI 10.1016/j.addr.2012.07.014
   Ko J, 2014, J BIOMAT SCI-POLYM E, V25, P1, DOI 10.1080/09205063.2013.830913
   Ko J, 2012, AM J STEM CELLS, V1, P81
   Kobayashi Y., 2012, PLOS ONE, V7
   Lam HJ, 2010, TISSUE ENG PT A, V16, P2641, DOI [10.1089/ten.tea.2009.0414, 10.1089/ten.TEA.2009.0414]
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Liao S, 2011, J BIOMATER TISS ENG, V1, P111, DOI 10.1166/jbt.2011.1015
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lopez-Gonzalez R, 2012, ARCH MED RES, V43, P1, DOI 10.1016/j.arcmed.2012.01.007
   Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212
   Mahairaki V, 2011, TISSUE ENG PT A, V17, P855, DOI [10.1089/ten.tea.2010.0377, 10.1089/ten.TEA.2010.0377]
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   Mobarakeh Ghasemi-L., 2008, BIOMATERIALS, V29, P4532
   Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Pellett S, 2011, BIOCHEM BIOPH RES CO, V404, P388, DOI 10.1016/j.bbrc.2010.11.128
   Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034
   Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]
   Sheets K, 2013, J BIOMATER TISS ENG, V3, P355, DOI 10.1166/jbt.2013.1105
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tetzlaff W, 2011, J NEUROTRAUM, V28, P1611, DOI 10.1089/neu.2009.1177
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Willerth S. M., 2011, STEM CELL RES THERAP, V2
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Xie J., 2014, ACS NANO
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
NR 48
TC 9
Z9 9
U1 1
U2 38
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD NOV
PY 2014
VL 4
IS 11
SI SI
BP 906
EP 914
DI 10.1166/jbt.2014.1223
PG 9
WC Cell & Tissue Engineering
SC Cell Biology
GA CA8BC
UT WOS:000349140500007
DA 2018-10-20
ER

PT J
AU Vaz, JM
   Michel, EC
   Chevallier, P
   Beppu, MM
   Mantovani, D
AF Vaz, Juliana M.
   Michel, Eleonore C.
   Chevallier, Pascale
   Beppu, Marisa M.
   Mantovani, Diego
TI Covalent Grafting of Chitosan on Plasma-Treated Polytetrafluoroethylene
   Surfaces for Biomedical Applications
SO Journal of Biomaterials and Tissue Engineering
LA English
DT Article
DE Chitosan Characterization; Chitosan Coatings; Grafting; Plasma
   Treatment; Surface Modification
ID CHITIN; CHROMATOGRAPHY; SPECTROSCOPY; ACETYLATION; MODE; NMR
AB Surface modification of polymeric materials allows to improve the biomaterial surface properties, enabling the development of optimized materials that have mechanical and biological responses adapted or adaptable to the environment where they will be implanted. Chitosan is claimed as a biopolymer with biodegradable, biocompatible and antimicrobial properties making it particularly interesting for the development and application of new functionalized materials. However, its properties and applications strongly depend on its degree of deacetylation (DDA) and molecular weight (Mw). In this study, three types of chitosan were used and fully characterized according to their DDA and Mw by C-13 NMR, FTIR, potentiometric titration and SEC. Then, three linking arms were investigated in order to graft these three chitosan types on aminated PTFE surfaces: glutaric anhydride, poly(ethylene glycol) bis(carboxymethyl) ether and poly(ethylene-alt-maleic anhydride). The grafting efficiencies were evidenced by XPS, with an increase of chitosan characteristic bands in high resolution spectra, and by contact angle measurements, which indicated the hydrophilic character of the surfaces. Topographic changes after grafting were also observed by SEM with evidences of the grafting procedure influence. Results show the potential of conjugating plasma treatments with grafting techniques towards the development of optimized chitosan-based coatings for a wide range of applications in biomaterials and materials for health.
C1 [Vaz, Juliana M.; Michel, Eleonore C.; Chevallier, Pascale; Mantovani, Diego] Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, CRC I, Quebec City, PQ G1V 0A6, Canada.
   [Vaz, Juliana M.; Michel, Eleonore C.; Chevallier, Pascale; Mantovani, Diego] Univ Laval, CHU Quebec Res Ctr, Quebec City, PQ G1V 0A6, Canada.
   [Vaz, Juliana M.; Beppu, Marisa M.] Univ Estadual Campinas, Lab Engn & Prod Chem, Dept Mat & Engn & Bioproc, Sch Chem Engn, BR-13083852 Sao Paulo, Brazil.
RP Mantovani, D (reprint author), Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, CRC I, Quebec City, PQ G1V 0A6, Canada.
RI BEPPU, MARISA/E-1057-2012
OI Mantovani, Diego/0000-0001-9672-895X
FU National Council for Scientific and Technological Development
   (CNPq)-Brazil; Natural Sciences and Engineering Research Council of
   Canada (NSERC); Canada Research Chair Tier I for the Innovation in
   Surgery; CHU de Quebec Research Center
FX This work was supported by National Council for Scientific and
   Technological Development (CNPq)-Brazil, the Natural Sciences and
   Engineering Research Council of Canada (NSERC), the Canada Research
   Chair Tier I for the Innovation in Surgery and the CHU de Quebec
   Research Center. The authors would like to express their gratitude to
   Clayton Campelo, Maxime Cloutier, for help and guidance, as well as
   Thiago Taketa and Cynthia Mahl for technical assistance.
CR Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Brugnerotto J, 2001, POLYMER, V42, P9921, DOI 10.1016/S0032-3861(01)00557-2
   Costerton A. J. W., 2011, SCIENCE, V284, P1318
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   de Alvarenga E. S., 2011, BIOTECHNOLOGY BIOPOL, V1, P92
   Duarte ML, 2002, INT J BIOL MACROMOL, V31, P1, DOI 10.1016/S0141-8130(02)00039-9
   Feng F, 2012, PROCEDIA ENGINEER, V27, P718, DOI 10.1016/j.proeng.2011.12.511
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Heux L, 2000, BIOMACROMOLECULES, V1, P746, DOI 10.1021/bm000070y
   Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Khan TA, 2002, J PHARM PHARM SCI, V5, P205
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Michel E. C., 2014, BIOMATER, V4, P1
   Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002
   Mourya VK, 2011, POLYM SCI SER A+, V53, P583, DOI 10.1134/S0965545X11070066
   Ogino A, 2008, APPL SURF SCI, V255, P2347, DOI 10.1016/j.apsusc.2008.07.119
   Pezzoli D., 2012, PLOS ONE, V7, P4
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Sarra-Bournet C, 2009, LANGMUIR, V25, P9432, DOI 10.1021/la900652y
   Taketa T. B., 2014, MATER SCI FORUM, V783, P1226
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Vallieres K, 2007, MACROMOL BIOSCI, V7, P738, DOI 10.1002/mabi.200600267
   Van de Velde K, 2004, CARBOHYD POLYM, V58, P409, DOI 10.1016/j.carbpol.2004.08.004
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Zielinska K, 2014, HIGH ENERG CHEM+, V48, P72, DOI 10.1134/S0018143914020143
NR 29
TC 6
Z9 6
U1 2
U2 30
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD NOV
PY 2014
VL 4
IS 11
SI SI
BP 915
EP 924
DI 10.1166/jbt.2014.1262
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA CA8BC
UT WOS:000349140500008
DA 2018-10-20
ER

PT J
AU Saadaldin, SA
   Dixon, SJ
   Rizkalla, AS
AF Saadaldin, Selma A.
   Dixon, S. Jeffrey
   Rizkalla, Amin S.
TI Bioactivity and Biocompatibility of a Novel Wollastonite Glass-Ceramic
   Biomaterial
SO Journal of Biomaterials and Tissue Engineering
LA English
DT Article
DE Glass-Ceramic; Dental Implants; Wollastonite; Bioactivity;
   Hydroxyapatite; Cell Attachment; Focal Adhesion; Cell Proliferation;
   Alkaline Phosphatase
ID OSTEOBLAST-LIKE CELLS; DIFFERENT SURFACE TOPOGRAPHIES; ZIRCONIA DENTAL
   IMPLANTS; IN-VITRO; MECHANICAL-PROPERTIES; CLINICAL SUCCESS; APATITE;
   BONE; TITANIUM; COATINGS
AB Using wet chemistry, a novel wollastonite glass-ceramic (WGC) was previously synthesized for one-piece dental implant applications. It exhibited high strength, and excellent chemical durability and machinability. Objectives of the present study were to evaluate the bioactivity and biocompatibility of this WGC and to compare its properties to those of In-Ceram yttria partially stabilized zirconia (YZ). Bioactivity of WGC and YZ was assessed by soaking specimens in simulated body fluid (SBF). Scanning electron microscopy, energy dispersive X-ray spectroscopy and X-ray diffraction were used to monitor the formation of hydroxyapatite (HA) on the specimen surfaces. WGC induced the formation of bone-like carbonated HA when soaked in SBF; in contrast, YZ specimens did not exhibit bioactivity, even after being soaked in SBF for 4 weeks. In vitro biocompatibility was studied by seeding MC3T3-E1 preosteoblastic cells and calvarial osteoblasts on the specimens. Cell attachment, focal adhesion formation, cell proliferation, and alkaline phosphatase (ALP) activity were evaluated. Both WGC and YZ supported osteoblast attachment and proliferation. Cell spreading, focal adhesion formation and ALP activity were comparable on both materials indicating excellent biocompatibility of WGC. We conclude that WGC is a promising material for non-metallic dental implant applications due to its bioactivity and biocompatibility.
C1 [Saadaldin, Selma A.; Rizkalla, Amin S.] Univ Western Ontario, Dept Med Biophys, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Saadaldin, Selma A.; Dixon, S. Jeffrey; Rizkalla, Amin S.] Univ Western Ontario, Schulich Dent, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Dixon, S. Jeffrey] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Rizkalla, Amin S.] Univ Western Ontario, Dept Chem & Biochem Engn, Fac Engn, London, ON N6A 5B9, Canada.
RP Rizkalla, AS (reprint author), Univ Western Ontario, Dept Med Biophys, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
RI Rizkalla, Amin/D-8845-2015; Dixon, S./G-3657-2013
OI Rizkalla, Amin/0000-0003-0548-3817; Dixon, S./0000-0001-9162-1686
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Canadian Institutes of Health Research (CIHR) [102542]
FX This study was supported by the Natural Sciences and Engineering
   Research Council of Canada (NSERC) and the Canadian Institutes of Health
   Research (CIHR, grant number 102542). The authors thank Tim Goldhawk
   from the Western Nanofabrication Facility for assistance with SEM/EDX,
   Dr. Douglas Hamilton for providing the rat calvarial osteoblasts, Dr.
   Bedilu A. Allo for helpful comments on the manuscript, and Elizabeth
   Pruski for assistance with cell culture.
CR Aboushelib MN, 2013, J PROSTHODONT, V22, P190, DOI 10.1111/j.1532-849X.2012.00920.x
   Anusavice K, 2012, PHILLIPS SCI DENT MA
   Aubin JE, 1995, BONE, V17, P77
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Cannillo V, 2009, J EUR CERAM SOC, V29, P1665, DOI 10.1016/j.jeurceramsoc.2008.09.022
   Cao HL, 2013, INT J APPL CERAM TEC, V10, P1, DOI 10.1111/j.1744-7402.2012.02770.x
   Chen CC, 2006, J BIOMED MATER RES B, V78B, P146, DOI 10.1002/jbm.b.30465
   Choi AH, 2013, J DENT RES, V92, P853, DOI 10.1177/0022034513497754
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Costa DO, 2012, LANGMUIR, V28, P3871, DOI 10.1021/la203224a
   DUCHEYNE P, 1994, J CELL BIOCHEM, V56, P162, DOI 10.1002/jcb.240560207
   Ellingsen JE, 2006, PERIODONTOL 2000, V41, P136, DOI 10.1111/j.1600-0757.2006.00175.x
   FULTZ B., 2008, TRANSMISSION ELECT M, P1
   Gottlander M, 1997, CLIN ORAL IMPLAN RES, V8, P345, DOI 10.1034/j.1600-0501.1997.080501.x
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Ito H, 2013, DENT MATER J, V32, P122, DOI 10.4012/dmj.2012-208
   Jayaswal Gaurav P, 2010, J Indian Prosthodont Soc, V10, P8, DOI 10.1007/s13191-010-0002-4
   Joint Committee on Powder Diffraction Standards, 1974, SEL POW DIFFR DAT MI
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lee DH, 2009, INT J MOD PHYS B, V23, P1535, DOI 10.1142/S0217979209061226
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Liu YT, 2013, COLLOID SURFACE B, V106, P37, DOI 10.1016/j.colsurfb.2013.01.023
   Magallanes-Perdomo M, 2011, J EUR CERAM SOC, V31, P1549, DOI 10.1016/j.jeurceramsoc.2011.03.007
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mistry S, 2011, AUST DENT J, V56, P68, DOI 10.1111/j.1834-7819.2010.01305.x
   Moller B, 2012, INT J ORAL MAX SURG, V41, P638, DOI 10.1016/j.ijom.2012.02.004
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Ozkurt Z, 2010, J PROSTHODONT, V19, P64, DOI 10.1111/j.1532-849X.2009.00513.x
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   Popescu SM, 2010, METAL INT, V15, P14
   Rawlings Rees D., 1993, Clinical Materials, V14, P155, DOI 10.1016/0267-6605(93)90038-9
   Rea SM, 2004, BIOMATERIALS, V25, P4503, DOI 10.1016/j.biomaterials.2003.11.016
   Saadaldin SA, 2014, DENT MATER, V30, P364, DOI 10.1016/j.dental.2013.12.007
   Saadaldin SA, 2013, DENT MATER, V29, P645, DOI 10.1016/j.dental.2013.03.013
   SAUTIER JM, 1994, CALCIFIED TISSUE INT, V55, P458, DOI 10.1007/BF00298560
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   Wang M, 2004, BIOL MED PHYS BIOMED, P1
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195
   Zhang FM, 2008, J MATER SCI-MATER M, V19, P167, DOI 10.1007/s10856-006-0056-3
   Zhu HL, 2010, MAT SCI ENG C-MATER, V30, P132, DOI 10.1016/j.msec.2009.09.009
NR 53
TC 3
Z9 3
U1 3
U2 19
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD NOV
PY 2014
VL 4
IS 11
SI SI
BP 939
EP 946
DI 10.1166/jbt.2014.1261
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA CA8BC
UT WOS:000349140500010
DA 2018-10-20
ER

PT J
AU Gupta, S
   Amoako, KA
   Suhaib, A
   Cook, KE
AF Gupta, Surbhi
   Amoako, Kagya A.
   Suhaib, Ahmed
   Cook, Keith E.
TI Multi-Modal, Surface-Focused Anticoagulation Using
   Poly-2-methoxyethylacrylate Polymer Grafts and Surface Nitric Oxide
   Release
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; SELF-ASSEMBLED MONOLAYERS; PROTEIN
   ADSORPTION; EXTRACORPOREAL-CIRCULATION; PARTICULATE SUSPENSIONS;
   BIOLOGICAL APPLICATIONS; CARDIOPULMONARY BYPASS; ZWITTERIONIC MATERIALS;
   BLOOD COMPATIBILITY; STRONG RESISTANCE
AB This study examines platelet adhesion on surfaces that combine coatings to limit protein adsorption along with "anti-platelet" nitric oxide (NO) release. Uncoated and poly-2-methoxyethylacrylate (PMEA) coated, gas permeable polypropylene (PP) membranes were placed in a bioreactor to separate plasma and gas flows. Nitrogen with 100/500/1000 ppm of NO was supplied to the gas side as a proof of concept. On the plasma side, platelet rich plasma (PRP, 1 x 108 cell/mL) was recirculated at low (60)/high (300) flows (mL/min). After 8 hours, adsorbed platelets on PP was quantified via a lactate dehydrogenase assay. Compared to plain PP, the PMEA coating alone reduced adsorption by 17.4 +/- 9.2% and 29.6 +/- 16.6% at low and high flow (p < 0.05), respectively. NO was more effective at low plasma flow. At 100 and 500 ppm of NO, adsorption fell by 37.9 +/- 6.1% and 100 +/- 4.7%, (p < 0.001), on plain PP. At high flow with 100, 500, and 1000 ppm of NO, adsorption reduced by 17.9 +/- 17.8%, 46.4 +/- 23.2%, and 100 +/- 4.8%, (p < 0.001), respectively. On PMEA-coated PP with only 100 ppm, adsorption fell by 69.7 +/- 6.8 and 65.6% +/- 16.9%, (p < 0.001), at low and high flows respectively. Therefore, the combination of an anti-adsorptive coating with NO has great potential to reduce platelet adhesion and coagulation at biomaterial surfaces.
C1 [Gupta, Surbhi] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA.
   [Amoako, Kagya A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
   [Amoako, Kagya A.] Univ Michigan, Dept Cardiol, Ann Arbor, MI 48109 USA.
   [Suhaib, Ahmed] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Cook, Keith E.] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA.
RP Cook, KE (reprint author), Dept Biomed Engn, 3321 PTC,700 Technology Dr, Pittsburgh, PA 15213 USA.
EM keicook@andrew.cmu.edu
FU NIH [R01 HL089043]
FX This work was supported by NIH grant R01 HL089043. We also thank Dr.
   Robert Bartlett and the University of Michigan Extracorporeal Life
   Support Laboratory for their assistance.
CR Ali A, 2004, J CLIN PHARMACOL, V44, P1328, DOI 10.1177/0091270004269559
   Amoako K. A., 2012, ASAIO J, V58, P539
   Amoako KA, 2013, J BIOMED MATER RES A, V101, P3511, DOI 10.1002/jbm.a.34655
   Amoako KA, 2012, ASAIO J, V58, P238, DOI 10.1097/MAT.0b013e31824abed5
   Amoako KA, 2011, ASAIO J, V57, P539, DOI 10.1097/MAT.0b013e31823b9692
   Bartlett RH, 2000, JAMA-J AM MED ASSOC, V283, P904, DOI 10.1001/jama.283.7.904
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Bugliarello G., 1970, VELO BIORHEOL, V7, P85
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2006, LANGMUIR, V22, P2418, DOI 10.1021/la052851w
   Chung YC, 2005, BIOMATERIALS, V26, P2313, DOI 10.1016/j.biomaterials.2004.06.043
   Cussler E. L., 1997, DIFFUSION MASS TRANS
   DAS RN, 1975, B MATH BIOL, V37, P459, DOI 10.1016/S0092-8240(75)80042-5
   Defraigne JO, 2000, ANN THORAC SURG, V70, P2075, DOI 10.1016/S0003-4975(00)01838-5
   Feng W, 2006, BIOMATERIALS, V27, P847, DOI 10.1016/j.biomaterials.2005.07.006
   Feng W, 2005, LANGMUIR, V21, P5980, DOI 10.1021/la050277i
   Gaberc-Porekar V, 2008, CURR OPIN DRUG DISC, V11, P242
   GUPTA BB, 1982, J BIOMECH ENG-T ASME, V104, P129, DOI 10.1115/1.3138326
   Handa H, 2013, J MATER CHEM B, V1, P3578, DOI 10.1039/c3tb20277a
   Hoel TN, 2004, PERFUSION-UK, V19, P177, DOI 10.1191/0267659104pf737oa
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kitano Y, 1997, J PEDIATR SURG, V32, P691, DOI 10.1016/S0022-3468(97)90007-5
   Korn RL, 1996, J THORAC CARDIOV SUR, V111, P1073, DOI 10.1016/S0022-5223(96)70384-7
   Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   Massey B.S., 2011, MECH FLUIDS
   Murad F., 1999, BIOSCIENCE REP, V19, P453
   Murphy JA, 2001, PERFUSION-UK, V16, P460, DOI 10.1177/026765910101600605
   Reynolds MM, 2004, FREE RADICAL BIO MED, V37, P926, DOI 10.1016/j.freeradbiomed.2004.06.019
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   VEIL KR, 1995, CIRCULATION, V92, P2337
   Vijay V, 2003, PERFUSION-UK, V18, P41, DOI 10.1191/0267659103pf626oa
   Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   Wu YD, 2007, SENSOR ACTUAT B-CHEM, V121, P36, DOI 10.1016/j.snb.2006.09.025
   Zacharia IG, 2005, ANN BIOMED ENG, V33, P214, DOI 10.1007/s10439-004-8980-9
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhou ZR, 2005, BIOMATERIALS, V26, P6506, DOI 10.1016/j.biomaterials.2005.04.046
NR 40
TC 5
Z9 5
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD NOV
PY 2014
VL 1
IS 8
AR 1400012
DI 10.1002/admi.201400012
PG 7
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AZ5UJ
UT WOS:000348285900003
DA 2018-10-20
ER

PT J
AU Deligianni, DD
AF Deligianni, Despina D.
TI Multiwalled carbon nanotubes enhance human bone marrow mesenchymal stem
   cells' spreading but delay their proliferation in the direction of
   differentiation acceleration
SO CELL ADHESION & MIGRATION
LA English
DT Editorial Material
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; ADHESION; FUNCTIONALIZATION;
   OSTEOBLASTS; MECHANISMS; EXPRESSION; SCAFFOLDS; ROUGHNESS; RESPONSES
AB Investigating the ability of films of pristine (purified, without any functionalization) multiwalled carbon nanotubes (MWCNTs) to influence human bone marrow mesenchymal stem cells' (hBMSCs) proliferation, morphology, and differentiation into osteoblasts, we concluded to the following: A. MWCNTs delay the proliferation of hBMSCs but increase their differentiation. The enhancement of the differentiation markers could be a result of decreased proliferation and maturation of the extracellular matrix B. Cell spread on MWCNTs toward a polygonal shape with many thin filopodia to attach to the surfaces. Spreading may be critical in supporting osteogenic differentiation in pre-osteoblastic progenitors, being related with cytoskeletal tension. C. hBMSCs prefer MWCNTs than tissue plastic to attach and grow, being non-toxic to these cells. MWCNTs can be regarded as osteoinductive biomaterial topographies for bone regenerative engineering.
C1 Univ Patras, Dept Mech Engn & Aeronaut, GR-26110 Patras, Greece.
RP Deligianni, DD (reprint author), Univ Patras, Dept Mech Engn & Aeronaut, GR-26110 Patras, Greece.
EM deligian@mech.upatras.gr
CR Akasaka T, 2009, BIO-MED MATER ENG, V19, P147, DOI 10.3233/BME-2009-0574
   Aoki N, 2007, DENT MATER J, V26, P178, DOI 10.4012/dmj.26.178
   Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Boettiger D, 2012, CURR OPIN CELL BIOL, V24, P592, DOI 10.1016/j.ceb.2012.07.002
   Born AK, 2009, EUR CELLS MATER, V18, P49
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Chang JC, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055002
   Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003
   George JH, 2006, J EXP NANOSCI, V1, P1, DOI 10.1080/17458080500463149
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Ishikawa K, 2010, J BIOMED NANOTECHNOL, V6, P59, DOI 10.1166/jbn.2010.1092
   Khang D, 2008, J BIOMED MATER RES A, V86A, P253, DOI 10.1002/jbm.a.31803
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Knabe C, 2005, CLIN ORAL IMPLAN RES, V16, P119, DOI 10.1111/j.1600-0501.2004.01066.x
   Kroustalli AA, 2013, ANN BIOMED ENG, V41, P2655, DOI 10.1007/s10439-013-0860-0
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Reddy ARN, 2010, TOXICOLOGY, V272, P11, DOI 10.1016/j.tox.2010.03.017
   Schofer MD, 2011, J MATER SCI-MATER M, V22, P1753, DOI 10.1007/s10856-011-4341-4
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Tsukahara T, 2011, MOL CELL BIOCHEM, V352, P57, DOI 10.1007/s11010-011-0739-z
   Tutak W, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/25/255101
   Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhang DW, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/47/475102
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 35
TC 7
Z9 7
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1933-6918
EI 1933-6926
J9 CELL ADHES MIGR
JI Celll Adhes. Migr.
PD NOV-DEC
PY 2014
VL 8
IS 6
BP 558
EP 562
DI 10.4161/cam.32124
PG 5
WC Cell Biology
SC Cell Biology
GA AZ8FY
UT WOS:000348451600005
PM 25482646
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Kangas, H
   Tamminen, T
   Liitia, T
   Hakala, TK
   Vorwerg, W
   Poppius-Levlin, K
AF Kangas, Heli
   Tamminen, Tarja
   Liitia, Tiina
   Hakala, Terhi K.
   Vorwerg, Waltraud
   Poppius-Levlin, Kristiina
TI LIGNOFIBRE (LGF) PROCESS - A FLEXIBLE BIOREFINERY FOR LIGNOCELLULOSICS
SO CELLULOSE CHEMISTRY AND TECHNOLOGY
LA English
DT Article
DE organosolv; acetic acid; ethanol; phosphinic acid; cellulose fibres;
   lignin; composite; nanocellulose; dissolving pulp; hydrolysability;
   bioethanol fermentation
ID PULPS; WOOD
AB LignoFibre (LGF) organosolv process is a potential novel fractionation method for biomass, yielding cellulose, lignin and hemicelluloses. Depending on the solvent used, the LGF fractions have potential in numerous biomaterial and chemical applications. Unbleached acetic acid LGF cellulose fibres showed promising results as reinforcement fibres in composites, while bleached fibres could be used for dissolving pulps and cellulose derivatives as well as for nanocellulose manufacturing. Ethanol LGF pulps are suitable material for enzymatic hydrolysis and further fermentation of the monomeric sugars into bioethanol. Based on its material properties, sulphur-free LGF lignin has potential as an additive in bioplastics or in resin applications. The sugar-based compounds could serve as platform chemicals and studies on their recovery from the cooking liquor at high yield and purity are currently on-going.
C1 [Kangas, Heli; Tamminen, Tarja; Liitia, Tiina; Hakala, Terhi K.; Poppius-Levlin, Kristiina] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland.
   [Vorwerg, Waltraud] Fraunhofer Inst Appl Polymer Res IAP, D-14476 Potsdam, Germany.
RP Kangas, H (reprint author), VTT Tech Res Ctr Finland, POB 1000, FI-02044 Espoo, Finland.
EM heli.kangas@vtt.fi
FU European Community's Seventh Framework Programme FP7 [CP-IP 228589-2
   AFORE, KBBE-2009-3-244369]; Academy of Finland [252564]
FX The research leading to these results has received funding from the
   European Community's Seventh Framework Programme FP7/2007-2013 under
   grant agreement no CP-IP 228589-2 AFORE and KBBE-2009-3-244369 LignoDeco
   (a EU/Brazil co-operation project). Financial support from Academy of
   Finland (grant No. 252564) is also gratefully acknowledged.
CR Anttila J., 2009, Patent, Patent No. [WO2009060126, 2009060126]
   Arato C, 2005, APPL BIOCHEM BIOTECH, V121, P871
   GOLDSCHMID O, 1971, LIGNINS OCCURRENCE F, P241
   JAKOBSONS J, 1995, HOLZFORSCHUNG, V49, P51, DOI 10.1515/hfsg.1995.49.1.51
   Kangas H., 2012, P 12 EUR WORKSH LIGN, P312
   Kangas H, 2013, J-FOR, V3, P48
   Kangas H, 2014, NORD PULP PAP RES J, V29, P129
   Lahtinen P, 2014, BIORESOURCES, V9, P2115
   Liitia T., 2013, P 17 INT S WOOD FIBR
   Liitia T., 2014, P 13 EUR WORKSH LIGN, P79
   Mehrotra R. N., 2013, EUR CHEM B, V2, P758
   Mikkonen H., 2009, Process for defibering a fibrous material, Patent No. [WO2007/066007, 2007066007]
   Negro MJ, 2003, BIOMASS BIOENERG, V25, P301, DOI 10.1016/S0961-9534(03)00017-5
   Nimz H. H., 1986, German patent, Patent No. [DE 34.45.132.A1 12, 3445132]
   Pan XJ, 2006, HOLZFORSCHUNG, V60, P398, DOI 10.1515/HF.2006.062
   Pye K., 1987, PIMA, V69, P21
   Rovio S, 2010, J CHROMATOGR A, V1217, P1407, DOI 10.1016/j.chroma.2009.12.032
   Sannigrahi P, 2011, ENERG ENVIRON SCI, V4, P1306, DOI 10.1039/c0ee00378f
   Sluiter A., 2008, LAB ANAL PROCEDURE L
   Sundquist J., 1997, ENV FRIENDLY TECHNOL, P157
   Tamminen T., 2014, P 247 ACS NAT M DALL
   Tenkanen M, 2000, J BIOTECHNOL, V78, P149, DOI 10.1016/S0168-1656(99)00240-0
   Xing R, 2011, ENERG ENVIRON SCI, V4, P2193, DOI 10.1039/c1ee01022k
NR 23
TC 3
Z9 3
U1 2
U2 16
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0576-9787
J9 CELL CHEM TECHNOL
JI Cell Chem. Technol.
PD NOV-DEC
PY 2014
VL 48
IS 9-10
BP 765
EP 771
PG 7
WC Materials Science, Paper & Wood
SC Materials Science
GA CA0OD
UT WOS:000348615900001
DA 2018-10-20
ER

PT J
AU Le Long, E
   Rebibo, JD
   Caremel, R
   Grise, P
AF Le Long, Erwann
   Rebibo, John David
   Caremel, Romain
   Grise, Philippe
TI Efficacy of Pelvisoft (R) Biomesh for cystocele repair: assessment of
   long-term results
SO INTERNATIONAL BRAZ J UROL
LA English
DT Article
DE Cystocele; Biocompatible Materials; Prolapse
ID PELVIC ORGAN PROLAPSE; SEXUAL FUNCTION; URINARY-INCONTINENCE; ANTERIOR
   COLPORRHAPHY; POLYPROPYLENE MESH; VAGINAL PROLAPSE; RANDOMIZED-TRIAL;
   PORCINE DERMIS; FOLLOW-UP; SURGERY
AB Introduction and Hypothesis: To our knowledge a study regarding the efficacy of Pelvisoft (R) Biomesh for cystocele repair has not previously been reported in the literature. The aim of our study was to assess the long-term efficacy, subjective outcomes and complications in the use of a non-synthetic porcine skin mesh graft (Pelvisoft (R) Biomesh) associated with transvaginal anterior colporrhaphy in the treatment of cystocele prolapse.
   Materials and Methods: A retrospective study was performed at a single centre. Thirty- three women aged 35-77 years underwent cystocele repair using Pelvisoft (R) graft between December 2005 and June 2009. Twenty-nine women who underwent transvaginal cystocele repair with Pelvisoft (R) Biomesh for over a 2 years period were assessed. Four patients were lost to follow-up. Cystocele repair was performed via the vaginal route using Pelvisoft (R) Biomesh implant by inserting it in the anterior vaginal wall.
   Results: The median follow-up time was 54.0 months. The rate of recurrence was 17.3%. A total of 6.9% of patients presented early mesh exposure treated by conservative treatment. The mean PFDI-20 score was 72.2. Among sexually active women, the mean PISQ 12 was 33.9 but 56.2% had dyspareunia. After surgery, 6 patients had de novo intercourse.
   Conclusions: Our results show that the use of Pelvisoft (R) biomaterial associated with anterior colporrhaphy for cystocele repair appears to be safe with acceptable failure and complication rates at long term. Nevertheless, an adverse impact on sexual function was reported by the majority of patients.
C1 [Le Long, Erwann; Rebibo, John David; Caremel, Romain; Grise, Philippe] Rouen Univ Hosp, F-76031 Rouen, France.
RP Grise, P (reprint author), Dept Urol, 1 Rue Germont, F-76031 Rouen, France.
EM philippe.grise@chu-rouen.fr
CR Azar M, 2008, INT UROGYNECOL J, V19, P53, DOI 10.1007/s00192-007-0399-4
   Bellon JM, 1998, BIOMATERIALS, V19, P669, DOI 10.1016/S0142-9612(97)00162-2
   Belot F, 2005, Gynecol Obstet Fertil, V33, P970, DOI 10.1016/j.gyobfe.2005.10.023
   Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0
   Dahlgren E, 2011, ACTA OBSTET GYN SCAN, V90, P1393, DOI 10.1111/j.1600-0412.2011.01270.x
   de Tayrac R, 2007, J Gynecol Obstet Biol Reprod (Paris), V36, P738
   Dell JR, 2005, INT UROGYNECOL J, V16, P44, DOI 10.1007/s00192-004-1217-x
   Denman MA, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.051
   Gomelsky A, 2004, J UROLOGY, V171, P1581, DOI 10.1097/01.ju.0000115956.25769.0a
   Handa VL, 2007, AM J OBSTET GYNECOL, V197, P629
   Handel LN, 2007, J UROLOGY, V178, P153, DOI 10.1016/j.juro.2007.03.041
   Helstrom L, 2005, ACTA OBSTET GYN SCAN, V84, P79, DOI 10.1111/j.0001-6349.2005.00668.x
   Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819
   Hoda MR, 2011, J SEX MED, V8, P914, DOI 10.1111/j.1743-6109.2010.01959.x
   Konstantinovic ML, 2010, NEUROUROL URODYNAM, V29, P488, DOI 10.1002/nau.20755
   Letouzey V, 2010, EUR J OBSTET GYN R B, V151, P101, DOI 10.1016/j.ejogrb.2010.03.013
   Meschia M, 2007, J UROLOGY, V177, P192, DOI 10.1016/j.juro.2006.08.100
   Mistrangelo E, 2007, J MINIM INVAS GYN, V14, P564, DOI 10.1016/j.jmig.2007.04.017
   Natale F, 2009, INT UROGYNECOL J, V20, P75, DOI 10.1007/s00192-008-0732-6
   Nieminen K, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.030
   Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6
   Rane A, 2012, AUST NZ J OBSTET GYN, V52, P28, DOI 10.1111/j.1479-828X.2011.01384.x
   Rogers RG, 2004, INT UROGYNECOL J, V15, P219, DOI 10.1007/s00192-004-1167-3
   Sand PK, 2001, AM J OBSTET GYNECOL, V184, P1357, DOI 10.1067/mob.2001.115118
   Sentilhes L, 2008, INT UROGYNECOL J, V19, P763, DOI 10.1007/s00192-007-0521-7
   Simon M, 2011, EUR J OBSTET GYN R B, V158, P104, DOI 10.1016/j.ejogrb.2011.04.027
   Vollebregt A, 2011, BJOG-INT J OBSTET GY, V118, P1518, DOI 10.1111/j.1471-0528.2011.03082.x
   Weber AM, 2000, AM J OBSTET GYNECOL, V182, P1610, DOI 10.1067/mob.2000.107436
   Zheng F, 2005, NEUROUROL URODYNAM, V24, P362, DOI 10.1002/nau.20148
NR 29
TC 2
Z9 2
U1 0
U2 1
PU BRAZILIAN SOC UROL
PI RIO DE JANEIRO
PA RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL
SN 1677-5538
EI 1677-6119
J9 INT BRAZ J UROL
JI Int. Braz J Urol
PD NOV-DEC
PY 2014
VL 40
IS 6
BP 828
EP 834
DI 10.1590/S1677-5538.IBJU.2014.06.15
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA CA0KU
UT WOS:000348607500015
PM 25615252
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Erickson, DP
   Renzetti, S
   Jurgens, A
   Campanella, OH
   Hamaker, BR
AF Erickson, Daniel P.
   Renzetti, Stefano
   Jurgens, Albert
   Campanella, Osvaldo H.
   Hamaker, Bruce R.
TI Modulating state transition and mechanical properties of viscoelastic
   resins from maize zein through interactions with plasticizers and
   co-proteins
SO JOURNAL OF CEREAL SCIENCE
LA English
DT Article
DE Zein; Viscoelasticity; Glass transition; Secondary structure
ID WHEAT GLUTEN PROTEINS; BETA-SHEET STRUCTURE; SECONDARY STRUCTURE;
   INFRARED-SPECTROSCOPY; FTIR SPECTROSCOPY; OLEIC-ACID; BEHAVIOR; WATER;
   TEMPERATURE; FILMS
AB Viscoelastic properties have been observed in maize zein above its glass transition temperature; however, current understanding of how these viscoelastic polymers can be further manipulated for optimal performance is limited. Using resins formed via precipitation from aqueous ethanolic environments, this study presents a framework for understanding how state transition and viscoelastic properties of zein can be controlled through interactions with plasticizers and co-proteins. Resins plasticized with oleic acid exhibited reduced water absorption and glass transition temperatures and formed low elasticity/high extensibility resins. Incorporation of casein increased water absorption and glass transition temperatures and imparted a four-fold increase in material strength/elasticity, as compared to zein alone. Plasticizers and co-proteins influenced zein secondary structure in the resin systems by decreasing and increasing low-frequency beta-sheet structures (1640-1615 cm(-1)), respectively. This work demonstrates that specific protein/plasticizer and protein/co-protein interactions are capable of promoting fundamental differences to zein's behavior in viscoelastic systems and could serve as a basis for improving the functional properties of this underutilized material in various food and biomaterial applications. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Erickson, Daniel P.; Campanella, Osvaldo H.; Hamaker, Bruce R.] Purdue Univ, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA.
   [Renzetti, Stefano; Jurgens, Albert] TNO, Expertise Grp Funct Ingredients, NL-3700 AJ Zeist, Netherlands.
RP Hamaker, BR (reprint author), Purdue Univ, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA.
EM hamakerb@purdue.edu
OI Campanella, Osvaldo/0000-0002-2281-5185
FU United States Department of Agriculture-Agricultural and Food Research
   Initiative (USDA-AFRI) [2009-65503-05785]
FX This study was supported by the United States Department of
   Agriculture-Agricultural and Food Research Initiative (USDA-AFRI) Grant
   2009-65503-05785.
CR Al-Muhtaseb AH, 2002, FOOD BIOPROD PROCESS, V80, P118, DOI 10.1205/09603080252938753
   ANDERSON RB, 1946, J AM CHEM SOC, V68, P686, DOI 10.1021/ja01208a049
   BANKER GS, 1966, J PHARM SCI, V55, P81, DOI 10.1002/jps.2600550118
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   DIAMANTE LM, 1992, J DAIRY RES, V59, P307, DOI 10.1017/S0022029900030582
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   Erickson DP, 2012, TRENDS FOOD SCI TECH, V24, P74, DOI 10.1016/j.tifs.2011.10.008
   Fevzioglu M., 2012, THESIS PURDUE U W LA
   Fevzioglu M, 2012, J CEREAL SCI, V55, P265, DOI 10.1016/j.jcs.2011.12.002
   Georget DMR, 2006, BIOMACROMOLECULES, V7, P469, DOI 10.1021/bm050667j
   Gillgren T, 2009, BIOMACROMOLECULES, V10, P1135, DOI 10.1021/bm801374q
   Gong S., 2006, BIOMATERIALS, V27, P3792
   Keten S, 2010, J R SOC INTERFACE, V7, P1709, DOI 10.1098/rsif.2010.0149
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lai HM, 1999, J APPL POLYM SCI, V71, P1267, DOI 10.1002/(SICI)1097-4628(19990222)71:8<1267::AID-APP7>3.0.CO;2-O
   LAWTON JW, 1992, CEREAL CHEM, V69, P351
   Mejia CD, 2007, J CEREAL SCI, V45, P353, DOI 10.1016/j.jcs.2006.09.009
   Mejia CD, 2012, J AGR FOOD CHEM, V60, P2316, DOI 10.1021/jf203073a
   PEZOLET M, 1992, FEBS LETT, V299, P247, DOI 10.1016/0014-5793(92)80125-Z
   Rombouts I, 2012, J AGR FOOD CHEM, V60, P10133, DOI 10.1021/jf3024672
   Santosa FXB, 1999, J AGR FOOD CHEM, V47, P2070, DOI 10.1021/jf981154p
   SHEWRY PR, 1990, BIOCHEM J, V267, P1
   Shivu B, 2013, BIOCHEMISTRY-US, V52, P5176, DOI 10.1021/bi400625v
   SONG M, 1995, POLYMER, V36, P3313, DOI 10.1016/0032-3861(95)99430-3
   Sperling L. H., 1992, INTRO PHYS POLYM SCI
   Taylor J, 2013, CEREAL CHEM, V90, P344, DOI 10.1094/CCHEM-12-12-0165-IA
   Wang Q, 2008, FOOD BIOPHYS, V3, P174, DOI 10.1007/s11483-008-9080-9
   Wellner N, 2005, BIOMACROMOLECULES, V6, P255, DOI 10.1021/bm049584d
   Wellner N, 1996, BIOCHEM J, V319, P741, DOI 10.1042/bj3190741
   Xu H, 2012, J AGR FOOD CHEM, V60, P10075, DOI 10.1021/jf302940j
NR 30
TC 11
Z9 11
U1 2
U2 32
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0733-5210
EI 1095-9963
J9 J CEREAL SCI
JI J. Cereal Sci.
PD NOV
PY 2014
VL 60
IS 3
BP 576
EP 583
DI 10.1016/j.jcs.2014.08.001
PG 8
WC Food Science & Technology
SC Food Science & Technology
GA AY5DF
UT WOS:000347592700017
DA 2018-10-20
ER

PT J
AU Jhan, YY
   Tsay, RY
AF Jhan, Yong-Yu
   Tsay, Ruey-Yug
TI Salt effects on the hydration behavior of zwitterionic poly(sulfobetaine
   methacrylate) aqueous solutions
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article; Proceedings Paper
CT 4th Asian Symposium on Advanced Materials - Chemistry, Physics and
   Biomedicine of Functional and Novel Materials (ASAM)
CY OCT 22-25, 2013
CL Natl Taiwan Univ Sci & Technol, Taipei, TAIWAN
HO Natl Taiwan Univ Sci & Technol
DE Hydration; Salt effects; Zwitterionic; Poly(SBMA)
ID BLOOD COMPATIBILITY; WATER-STRUCTURE; POLY(2-METHOXYETHYL ACRYLATE);
   NONSPECIFIC ADSORPTION; COLD CRYSTALLIZATION; THERMAL-ANALYSIS;
   SURFACES; SYSTEMS; PROTEIN; BUFFER
AB Hydration behavior of a biomaterial is thought to be closely related to its bio/blood compatibility and subsequent biological responses. Poly(sulfobetaine methacrylate) (pSBMA) is one of the biomimetic materials that exhibits excellent biocompatibility. It has been reported that the zwitterionic pSBMA exhibits "antipolyelectrolyte" behavior, which changes polymer conformations and antifouling properties, in solutions containing salt ions. In this study, we identified water hydrated states of pSBMA by thermal analysis of DSC in various salt concentrations. With the addition of miniscule salts, ions are attracted to the zwitterionic groups and the hydrated states are significantly changed. The attracted ions promote the incorporation of water molecules into polymer chains and enhance the solubility of pSBMA. Nevertheless, when large amounts of salts are added into the system, the excess ions tend to bind with free water molecules, which may impose an osmotic pressure on the hydrated pSBMA molecules and causes the shrinkage of the molecules. The present results demonstrated that salt has a significant effect on pSBMA-water interactions, which may affect the biocompatibility of the material. (C) 2014 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Jhan, Yong-Yu; Tsay, Ruey-Yug] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Tsay, RY (reprint author), Natl Yang Ming Univ, Inst Biomed Engn, 155,Sec 2,Li Nung St, Taipei 112, Taiwan.
EM tsay@ym.edu.tw
CR Azzaroni O, 2006, ANGEW CHEM, V118, P1802
   Branca C, 2002, J PHYS CHEM B, V106, P10272, DOI 10.1021/jp014345v
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Dong ZX, 2011, LANGMUIR, V27, P15282, DOI 10.1021/la2038558
   Georgiev GS, 2006, BIOMACROMOLECULES, V7, P1329, DOI 10.1021/bm050938q
   Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0
   Hatakeyama T, 2010, ACTA BIOMATER, V6, P2077, DOI 10.1016/j.actbio.2009.12.018
   Hatakeyama T, 2012, THERMOCHIM ACTA, V532, P159, DOI 10.1016/j.tca.2011.01.027
   Hatakeyma T, 2007, THERMOCHIM ACTA, V465, P59, DOI 10.1016/j.tca.2007.09.005
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Kamasa P, 2007, THERMOCHIM ACTA, V464, P29, DOI 10.1016/j.tca.2007.08.001
   Lalani R, 2011, POLYMER, V52, P5344, DOI 10.1016/j.polymer.2011.09.015
   Morisaku T, 2008, POLYMER, V49, P4652, DOI 10.1016/j.polymer.2008.08.025
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Schlenoff JB, 2014, LANGMUIR, V30, P9625, DOI 10.1021/la500057j
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Tanaka M, 2000, POLYM INT, V49, P1709, DOI 10.1002/1097-0126(200012)49:12<1709::AID-PI601>3.0.CO;2-L
   Tanaka M, 2004, J BIOMED MATER RES A, V68A, P684, DOI 10.1002/jbm.a.20088
   Tanaka M, 2002, BIOMACROMOLECULES, V3, P36, DOI 10.1021/bm010072y
   Tanaka M, 2013, POLYM J
   Tanaka M, 2010, J BIOMAT SCI-POLYM E, V21, P1849, DOI 10.1163/092050610X517220
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Yoshida H, 1993, J INTELLIGENT MAT, V4, P543
NR 23
TC 4
Z9 4
U1 6
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD NOV
PY 2014
VL 45
IS 6
BP 3139
EP 3145
DI 10.1016/j.jtice.2014.08.022
PG 7
WC Engineering, Chemical
SC Engineering
GA AY7LS
UT WOS:000347742300040
DA 2018-10-20
ER

PT J
AU Wei, WB
   Song, W
   Zhang, SB
AF Wei, Wenbang
   Song, Wei
   Zhang, Shuangbao
TI Preparation and Characterization of Hydroxyapatite-Poly(Vinyl Alcohol)
   Composites Reinforced with Cellulose Nanocrystals
SO BIORESOURCES
LA English
DT Article
DE Preparation and characterization; HAp/PVA composite gels; Cellulose
   nanocrystals; Reinforcement; Articular cartilage repair
ID MECHANICAL-PROPERTIES; ARTICULAR-CARTILAGE; PVA-HYDROGEL; IN-VIVO;
   NANOCOMPOSITE; SCAFFOLDS; POLYMERS; WHISKERS
AB Hydroxyapatite/poly(vinyl alcohol) (Hap/PVA) composites have been proposed as a promising biomaterial for use in articular cartilage repair. In this study, HAp/PVA composite gels reinforced with cellulose nanocrystals (CNC) were prepared using the freeze/thaw method. The influence of CNC as a reinforcement on the structure of composite gels was investigated via Fourier transform infrared spectroscopy (FT-IR), Xray powder diffraction (XRD), and scanning electron microscopy (SEM). The mechanical properties and thermal stability of the composite gels were also studied. The FT-IR and XRD results indicated that the HAp/PVA/CNC composite gels were formed by hydrogen bonding. SEM morphology showed that the CNC served as an enhancement phase that interpenetrated the network of the HAp/PVA composite gels. The tensile strength and tensile modulus of the composites improved with increasing dosage of CNC. The thermal stability measurements indicated that the thermal stability of the HAp/PVA composites was slightly improved with the addition of the CNC.
C1 [Wei, Wenbang; Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, Coll Mat Sci & Technol, MOE Key Lab Wooden Mat Sci & Applicat, Beijing 100083, Peoples R China.
   [Wei, Wenbang; Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, Coll Mat Sci & Technol, Beijing Key Lab Wood Sci & Engn, Beijing 100083, Peoples R China.
   [Wei, Wenbang; Song, Wei; Zhang, Shuangbao] Beijing Forestry Univ, Coll Mat Sci & Technol, MOE Engn Res Ctr Forestry Biomass Mat & Bioenergy, Beijing 100083, Peoples R China.
   [Wei, Wenbang] Guangxi Ecoengn Vocat & Tech Coll, Liuzhou 545004, Peoples R China.
RP Zhang, SB (reprint author), Beijing Forestry Univ, Coll Mat Sci & Technol, MOE Key Lab Wooden Mat Sci & Applicat, Beijing 100083, Peoples R China.
EM shuangbaozhang@126.com
FU Beijing Municipal Natural Science Foundation [2122045]; Science &
   Technology Research Project of Guangxi University Education Department
   [2013YB321]; Wood Saving & Substitution Project [2013-3004];
   Co-construction Project of Beijing Municipal Commission of Education;
   Beijing Municipal Co-construction Project
FX The authors are grateful for grants from the Beijing Municipal Natural
   Science Foundation (2122045), the Science & Technology Research Project
   of Guangxi University Education Department (2013YB321), the Wood Saving
   & Substitution Project (2013-3004), the Co-construction Project of
   Beijing Municipal Commission of Education of 2012, and the Beijing
   Municipal Co-construction Project of 2010.
CR Ahn ES, 2001, NANO LETT, V1, P149, DOI 10.1021/nl0055299
   Arvind S., 2007, MAT SCI ENG C, V27, P70
   Balasundaram G, 2007, MACROMOL BIOSCI, V7, P635, DOI 10.1002/mabi.200600270
   Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   CANDANEDO SB, 2005, BIOMACROMOLECULES, V6, P1048
   Chiellini E, 2003, PROG POLYM SCI, V28, P963, DOI 10.1016/S0079-6700(02)00149-1
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Eichhorn SJ, 2011, SOFT MATTER, V7, P303, DOI 10.1039/c0sm00142b
   Gonzalez JS, 2014, J MECH BEHAV BIOMED, V34, P47, DOI 10.1016/j.jmbbm.2014.01.019
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   He M, 2012, CARBOHYD POLYM, V87, P2512, DOI 10.1016/j.carbpol.2011.11.029
   Huang H. Y., 1997, CLIN NEUROL NEUROSUR, V99, P20
   HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200
   Jia N, 2010, SCI ADV MATER, V2, P210, DOI 10.1166/sam.2010.1086
   KEMPSON GE, 1979, ADULT ARTICULAR CART, P333
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Lu P, 2010, CARBOHYD POLYM, V82, P329, DOI 10.1016/j.carbpol.2010.04.073
   Ma R., 2010, MAT SCI ENG C, V29, P1979
   Nassif N, 2010, CHEM MATER, V22, P3653, DOI 10.1021/cm903596q
   Pan YS, 2007, KEY ENG MATER, V330-332, P1297, DOI 10.4028/www.scientific.net/KEM.330-332.1297
   Pan YS, 2010, J WUHAN UNIV TECHNOL, V25, P474, DOI 10.1007/s11595-010-0026-y
   Pushpakanth S, 2008, MATER CHEM PHYS, V107, P492, DOI 10.1016/j.matchemphys.2007.08.029
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Samir MASA, 2004, MACROMOLECULES, V37, P1386, DOI 10.1021/ma030532a
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Maiolo AS, 2012, MAT SCI ENG C-MATER, V32, P1490, DOI 10.1016/j.msec.2012.04.030
   Siqueira G, 2009, BIOMACROMOLECULES, V10, P425, DOI 10.1021/bm801193d
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Sun XX, 2014, COLLOID POLYM SCI, V292, P1073, DOI 10.1007/s00396-013-3155-y
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Wu G, 2008, MATER CHEM PHYS, V107, P364, DOI 10.1016/j.matchemphys.2007.07.028
   Zhang DK, 2010, J BIONIC ENG, V7, P235, DOI 10.1016/S1672-6529(10)60246-6
   Zheng-Qiu G, 1998, BIO-MED MATER ENG, V8, P75
NR 35
TC 6
Z9 6
U1 3
U2 28
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PD NOV
PY 2014
VL 9
IS 4
BP 6087
EP 6099
PG 13
WC Materials Science, Paper & Wood
SC Materials Science
GA AU1RC
UT WOS:000345396900027
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Ge, YY
   Wei, Q
   Li, ZL
AF Ge, Yuanyuan
   Wei, Qiang
   Li, Zhili
TI Preparation and Evaluation of the Free Radical Scavenging Activities of
   Nanoscale Lignin Biomaterials
SO BIORESOURCES
LA English
DT Article
DE Lignin; Nanomaterial; Biomaterial; Antioxidant; Free radical
ID ANTIOXIDANT PROPERTIES; SOFT NANOMATERIALS; EXTRACTION; PROGRESS;
   BAGASSE
AB There is much research on nanomaterial from natural polymer because of its biocompatibility, abundance, and non-toxicity. This work is devoted to the study of free radical scavenging activities (FRSA) of nanoscale lignin biomaterials, which are recognized as promising natural antioxidants. The nanoscale lignin biomaterials were prepared from alkaline lignin by a solution-precipitation method with either ethylene glycol (NL1) or alkaline solution (NL2). Structural analysis of the nanoscale lignin biomaterials were conducted by Scanning electron microscopy (SEM), laser particle size analyzer, Fourier transform-infrared spectroscopy (FT-IR), potentiometric titration, and gel permeation chromatography (GPC). The results indicated that NL2 had a smaller average particle size (278 +/- 13 nm) than NL1 (375 +/- 18 nm) and contained more phenolic hydroxyl groups (2.35 +/- 0.11 mmol/g) and had a lower weight-average molecular weight (M-w = 6510 +/- 320). The FRSA of the biomaterials towards hydroxyl free radicals were measured and compared with the alkaline lignin. Some structure-activity relationships were proposed based on the analysis of experiment data, which revealed NL2 (IC50 = 0.18 +/- 0.01 mg/mL) had a 3.33 fold higher activity than NL1 (IC50 = 0.60 +/- 0.05 mg/mL), which could be attributed to the smaller particle size, more phenolic hydroxyl group, and lower weight-average molecular weight.
C1 [Ge, Yuanyuan; Wei, Qiang; Li, Zhili] Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
RP Li, ZL (reprint author), Guangxi Univ, Sch Chem & Chem Engn, Guangxi Key Lab Petrochem Resource Proc & Proc In, Nanning 530004, Peoples R China.
EM lizhili@gxu.edu.cn
FU National Natural Science Foundation of China [21264002, 21464002];
   Scientific Foundation of Guangxi University [XJZ120279]
FX The authors are grateful for the support of the National Natural Science
   Foundation of China (No. 21264002, No. 21464002) and Scientific
   Foundation of Guangxi University (Grant. No. XJZ120279).
CR Barclay LRC, 1997, J WOOD CHEM TECHNOL, V17, P73, DOI 10.1080/02773819708003119
   Dizhbite T, 2004, BIORESOURCE TECHNOL, V95, P309, DOI 10.1016/j.biortech.2004.02.024
   El Kadib A, 2014, J NANOSCI NANOTECHNO, V14, P308, DOI 10.1166/jnn.2014.9012
   Ge YY, 2014, J MATER CHEM A, V2, P2136, DOI 10.1039/c3ta14333c
   Grace MH, 2014, J AGR FOOD CHEM, V62, P4007, DOI 10.1021/jf403810y
   Hergert H. L, 1971, LEGNINS OCCUSSENCE F
   Hussin MH, 2014, IND CROP PROD, V52, P544, DOI 10.1016/j.indcrop.2013.11.026
   John G, 2006, SOFT MATTER, V2, P909, DOI 10.1039/b609422h
   Kim JI, 2009, J FOOD SCI, V74, pC362, DOI 10.1111/j.1750-3841.2009.01160.x
   Kortenska VD, 2002, EUR J LIPID SCI TECH, V104, P513, DOI 10.1002/1438-9312(200208)104:8<513::AID-EJLT513>3.0.CO;2-9
   Li ZL, 2012, INT J BIOL MACROMOL, V51, P1116, DOI 10.1016/j.ijbiomac.2012.09.004
   Li ZL, 2011, J PHYS CHEM C, V115, P24865, DOI 10.1021/jp2083117
   Li ZL, 2011, J BRAZIL CHEM SOC, V22, P1866, DOI 10.1590/S0103-50532011001000006
   Lu Q, 2012, FOOD CHEM, V135, P63, DOI 10.1016/j.foodchem.2012.04.070
   Miyake Y, 1999, J AGR FOOD CHEM, V47, P3151, DOI 10.1021/jf980999y
   Ogata M, 1997, J AM OIL CHEM SOC, V74, P557, DOI 10.1007/s11746-997-0180-3
   Pan XJ, 2006, J AGR FOOD CHEM, V54, P5806, DOI 10.1021/jf0605392
   Salem MZM, 2014, BIORESOURCES, V9, P2382
   Thakur VK, 2014, ACS SUSTAIN CHEM ENG, V2, P1072, DOI 10.1021/sc500087z
   Ugartondo V, 2008, BIORESOURCE TECHNOL, V99, P6683, DOI 10.1016/j.biortech.2007.11.038
   Vadez-Morales M, 2014, J AGR FOOD CHEM, V62, P5281, DOI 10.1021/jf5012374
   Vinardell MP, 2008, IND CROP PROD, V27, P220, DOI 10.1016/j.indcrop.2007.07.011
NR 22
TC 19
Z9 20
U1 2
U2 20
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PD NOV
PY 2014
VL 9
IS 4
BP 6699
EP 6706
PG 8
WC Materials Science, Paper & Wood
SC Materials Science
GA AU1RC
UT WOS:000345396900073
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Schmitz, T
   Warmuth, F
   Werner, E
   Hertl, C
   Groll, J
   Gbureck, U
   Moseke, C
AF Schmitz, Tobias
   Warmuth, Franziska
   Werner, Ewald
   Hertl, Cornelia
   Groll, Juergen
   Gbureck, Uwe
   Moseke, Claus
TI Physical and chemical characterization of Ag-doped Ti coatings produced
   by magnetron sputtering of modular targets
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Physical vapor deposition; Surface functionalization; Biomaterial;
   Release
ID CRYSTALLOGRAPHIC STRUCTURE; KNEE ARTHROPLASTY; UNITED-STATES; FILMS; HIP
AB Silver-doped Ti films were produced using a single magnetron sputtering source equipped with a titanium target containing implemented silver modules under variation of bias voltage and substrate temperature. The Ti(Ag) films were characterized regarding their morphology, contact angle, phase composition, silver content and distribution as well as the elution of Ag+ ions into cell media.
   SEM and AFM pictures showed that substrate heating during film deposition supported the formation of even and dense surface layers with small roughness values, an effect that could even be enforced, when a substrate bias voltage was applied instead. The deposition of both Ti and Ag was confirmed by X-ray diffraction. ICP-MS and EDX showed a clear correlation between the applied sputtering parameters and the silver content of the coatings. Surface-sensitive XPS measurements revealed that higher substrate temperatures led to an accumulation of Ag in the near-surface region, while the application of a bias voltage had the opposite effect. Additional elution measurements using ICP-MS showed that the release kinetics depended on the amount of silver located at the film surface and hence could be tailored by variation of the sputter parameters. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Schmitz, Tobias; Warmuth, Franziska; Groll, Juergen; Gbureck, Uwe; Moseke, Claus] Univ Wurzburg, Sch Dent, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany.
   [Schmitz, Tobias] Univ Wurzburg, Univ Hosp, Inst Tissue Engn & Regenerat Med, D-97070 Wurzburg, Germany.
   [Werner, Ewald; Hertl, Cornelia] Tech Univ Munich, Inst Mat Sci & Mech Mat, D-85748 Garching, Germany.
RP Moseke, C (reprint author), Univ Wurzburg, Sch Dent, Dept Funct Mat Med & Dent, Pleicherwall 2, D-97070 Wurzburg, Germany.
EM claus.moseke@fmz.uni-wuerzburg.de
RI Groll, Jurgen/F-4202-2012; Moseke, Claus/H-8982-2018; Moseke,
   Claus/G-5966-2012; Gbureck, Uwe/G-1430-2012
OI Groll, Jurgen/0000-0003-3167-8466; 
FU Deutsche Forschungsgemeinschaf [DFG Gb1/13-2]
FX The authors wish to thank the Deutsche Forschungsgemeinschaft for their
   financial support (DFG Gb1/13-2).
CR Alfonso JE, 2005, PHYS STATUS SOLIDI C, V2, P3786, DOI 10.1002/pssc.200461766
   Claes L. K., 2012, AE MANUAL ENDOPROTHE
   de los Arcos T, 2002, VACUUM, V67, P463, DOI 10.1016/S0042-207X(02)00232-4
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Gasbarra E., 2013, AGING CLIN EXP RE S1, V25, P61
   Hsieh JH, 2008, SURF COAT TECH, V202, P5586, DOI 10.1016/j.surfcoat.2008.06.107
   Huang HL, 2010, SURF COAT TECH, V205, P1636, DOI 10.1016/j.surfcoat.2010.07.096
   Iordanova I, 2011, MATER TECHNOL, V26, P40, DOI 10.1179/175355511X12941605982343
   Ip M, 2006, J MED MICROBIOL, V55, P59, DOI 10.1099/jmm.0.46124-0
   JCPDS, 1990, 140 JCPDS INT CTR DI
   Kelly PJ, 2010, SURF COAT TECH, V205, P1606, DOI 10.1016/j.surfcoat.2010.07.029
   Kelly PJ, 2009, SURF COAT TECH, V204, P1137, DOI 10.1016/j.surfcoat.2009.05.012
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844
   Marini M, 2007, BIOMACROMOLECULES, V8, P1246, DOI 10.1021/bm060721b
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Moseke C, 2011, J MATER SCI-MATER M, V22, P2711, DOI 10.1007/s10856-011-4457-6
   Otto M, 2008, Pathologe, V29 Suppl 2, P232, DOI 10.1007/s00292-008-1070-7
   SIGMUND P, 1969, PHYS REV, V184, P383, DOI 10.1103/PhysRev.184.383
   Sigmund P, 2012, THIN SOLID FILMS, V520, P6031, DOI 10.1016/j.tsf.2012.06.003
   Smith TM, 2009, OKOLOGIE
   STUART RV, 1962, J APPL PHYS, V33, P2345, DOI 10.1063/1.1728959
   THORNTON JA, 1977, ANNU REV MATER SCI, V7, P239, DOI 10.1146/annurev.ms.07.080177.001323
   Vitos L, 1998, SURF SCI, V411, P186, DOI 10.1016/S0039-6028(98)00363-X
   Zhao L, 2009, J BIOMED MATER RES B, V1, P470
   Zhao TT, 2011, J MATER SCI, V46, P2529, DOI 10.1007/s10853-010-5104-1
NR 27
TC 2
Z9 2
U1 0
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD NOV 1
PY 2014
VL 44
BP 126
EP 131
DI 10.1016/j.msec.2014.08.024
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AU7YZ
UT WOS:000345815400016
PM 25280688
DA 2018-10-20
ER

PT J
AU Kochhar, A
   Wu, I
   Mohan, R
   Conde-Green, A
   Hillel, AT
   Byrne, PJ
   Elisseeff, JH
AF Kochhar, Amit
   Wu, Iwen
   Mohan, Raja
   Conde-Green, Alexandra
   Hillel, Alexander T.
   Byrne, Patrick J.
   Elisseeff, Jennifer H.
TI A Comparison of the Rheologic Properties of an Adipose-Derived
   Extracellular Matrix Biomaterial, Lipoaspirate, Calcium Hydroxylapatite,
   and Cross-linked Hyaluronic Acid
SO JAMA FACIAL PLASTIC SURGERY
LA English
DT Article
ID SOFT-TISSUE AUGMENTATION; FAT; FILLERS; BREAST
AB IMPORTANCE Acquired soft-tissue injury with resultant volume loss may cause significant deformity in size, shape, and body or facial contour. Current autologous fat transfer techniques have several limitations, including availability, donor site morbidity, and unpredictable rates of resorption. We present an extracellular matrix (ECM) biomaterial derived from human adipose tissue as an off-the-shelf alternative for soft-tissue volume restoration and compare clinically relevant rheologic properties.
   OBJECTIVES To determine the rheologic properties of adipose-derived ECM and to compare it with lipoaspirate, calcium hydroxylapatite, and cross-linked hyaluronic acid.
   DESIGN, SETTING, AND PARTICIPANTS Adipose-derived ECM (n = 4), lipoaspirate acquired from aesthetic liposuction (n = 4), calcium hydroxylapatite (n = 4), and cross-linked hyaluronic acid (n = 4) were obtained to determine the viscoelastic properties.
   INTERVENTIONS Dynamic frequency oscillation measurements were conducted using a rheometer (ARES-G2; TA Instruments). All injections were performed using a 20-gauge needle, and all measurements were performed using serrated 25-mm parallel-plate geometry with a 1.0-mm gap at 37 degrees C.
   MAIN OUTCOMES AND MEASURES Oscillation measurements for storage modulus, a measure of the elastic properties, and complex viscosity were obtained over an angular frequency range of 0.01 to 100 rad/s.
   RESULTS At 1 Hz, adipose-derived ECM had a mean (SD) storage modulus of 713.2 (42.9) Pa and a mean (SD) complex viscosity of 115.8 (6.9) Pa/s. Lipoaspirate had a mean (SD) storage modulus of 382.1 (66.8) Pa and a mean (SD) complex viscosity of 61.5 (10.7) Pa/s. Calcium hydroxylapatite had a mean (SD) storage modulus of 1122.1 (67.1) Pa and a mean (SD) complex viscosity of 207.2 (11.6) Pa/s. Cross-linked hyaluronic acid had a mean (SD) storage modulus of 63.9 (3.0) Pa and a mean (SD) complex viscosity of 10.9 (0.5) Pa/s.
   CONCLUSIONS AND RELEVANCE Of the 4 materials tested, calcium hydroxylapatite has the highest mean storage modulus and mean complex viscosity, and hyaluronic acid has the lowest. The viscoelastic properties of adipose-derived ECM are most similar to those of lipoaspirate, suggesting that it may be an ideal candidate for soft-tissue reconstruction.
C1 [Kochhar, Amit; Hillel, Alexander T.; Byrne, Patrick J.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21287 USA.
   [Conde-Green, Alexandra; Hillel, Alexander T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Mohan, Raja] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD 21287 USA.
   [Conde-Green, Alexandra] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Div Burn Surg, Baltimore, MD 21287 USA.
   [Byrne, Patrick J.] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Div Facial Plast & Reconstruct Surg, Baltimore, MD 21287 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, 400 N Broadway,Smith 5035, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
FU National Institute of Dental and Craniofacial Research, National
   Institutes of Health [5R01DE016887-04]; Department of Defense
   [W81CWH-I1-2-002]
FX This work was supported by grant 5R01DE016887-04 from the National
   Institute of Dental and Craniofacial Research, National Institutes of
   Health, and by grant W81CWH-I1-2-002 from the Department of Defense (Dr
   Elisseeff).
CR Ashinoff R, 2000, CLIN PLAST SURG, V27, P479
   BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033
   Coleman S R, 1998, Aesthet Surg J, V18, P388, DOI 10.1016/S1090-820X(98)70098-6
   Conde-Green A, 2013, AESTHET SURG J, V33, P713, DOI 10.1177/1090820X13487371
   HORL HW, 1991, ANN PLAS SURG, V26, P248
   Kablik J, 2009, DERMATOL SURG, V35, P302, DOI 10.1111/j.1524-4725.2008.01046.x
   Katz AJ, 1999, CLIN PLAST SURG, V26, P587
   Klein AW, 2000, DERMATOL SURG, V26, P1096, DOI 10.1046/j.1524-4725.2000.00512.x
   Langstein HN, 1999, SEMIN SURG ONCOL, V17, P52, DOI 10.1002/(SICI)1098-2388(199907/08)17:1<52::AID-SSU7>3.0.CO;2-I
   Patrick C. W., 1998, FRONTIERS TISSUE ENG
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   Sundaram H, 2010, DERMATOL SURG, V36, P1859, DOI 10.1111/j.1524-4725.2010.01743.x
   von Heimburg D, 2005, RESP PHYSIOL NEUROBI, V146, P107, DOI 10.1016/j.resp.2004.12.013
   von Heimburg D., 2003, International Journal of Artificial Organs, V26, P1064
   Wu I, 2012, PLAST RECONSTR SURG, V129, P1247, DOI 10.1097/PRS.0b013e31824ec3dc
NR 17
TC 7
Z9 7
U1 0
U2 16
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6076
EI 2168-6092
J9 JAMA FACIAL PLAST SU
JI JAMA Facial Plast. Surg.
PD NOV-DEC
PY 2014
VL 16
IS 6
BP 405
EP 409
DI 10.1001/jamafacial.2014.480
PG 5
WC Surgery
SC Surgery
GA AU2IT
UT WOS:000345442100005
PM 25102942
OA Bronze
DA 2018-10-20
ER

PT J
AU Teng, CP
   Mya, KY
   Win, KY
   Yeo, CC
   Low, M
   He, CB
   Han, MY
AF Teng, Choon Peng
   Mya, Khine Yi
   Win, Khin Yin
   Yeo, Chee Chuan
   Low, Michelle
   He, Chaobin
   Han, Ming-Yong
TI Star-shaped polyhedral oligomeric
   silsesquioxane-polycaprolactone-polyurethane as biomaterials for tissue
   engineering application
SO NPG ASIA MATERIALS
LA English
DT Article
ID THERMOMECHANICAL PROPERTIES; POSS; DEGRADATION; NANOCOMPOSITES;
   SCAFFOLDS; NETWORKS; HYBRIDS; DESIGN
AB Polyhedral oligomeric silsesquioxane (POSS) is a unique molecule that is composed of an inorganic silica core with eight organic functional arms, which can be used as a nucleus for covalent bonding to create star-shaped block copolymers with improved mechanical and biological properties. In this work, highly porous star-shaped POSS-polycaprolactone-polyurethane (POSS-PCL-PU) films were synthesized as scaffold biomaterials for tissue engineering. These films have an interesting morphology consisting of rough spherulites with filamentous structures spreading out from their centers; the unique nanotopography was shown to be suitable for cell growth. In vitro degradation was monitored for 52 weeks in terms of the weight loss and morphology changes of the films. The degradation profile exhibited a slow initial weight loss of <1% during the first 24 weeks, followed by a rapid weight loss of similar to 18% in the following 28 weeks. The films demonstrated excellent biocompatibility and cell-substrate affinity, with a high cell viability of >95% and rapid cell proliferation. The high porosity, unique surface nanotopography and excellent biocompatibility of the star-shaped POSS-PCL-PU film make it a great candidate as a tissue engineering scaffold biomaterial.
C1 [Teng, Choon Peng; Mya, Khine Yi; Win, Khin Yin; Yeo, Chee Chuan; Low, Michelle; He, Chaobin; Han, Ming-Yong] Inst Mat Res & Engn, Singapore 117602, Singapore.
   [Teng, Choon Peng; Han, Ming-Yong] Natl Univ Singapore, Dept Biomed Engn, Singapore 117548, Singapore.
   [He, Chaobin] Natl Univ Singapore, Dept Mat Sci & Engn, Singapore 117548, Singapore.
RP Win, KY (reprint author), Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
EM yw-khin@imre.a-star.edu.sg; my-han@imre.a-star.edu.sg
RI He, Chaobin/G-5755-2011
OI He, Chaobin/0000-0001-8200-8337; Win, Khin Yin/0000-0002-8306-942X
FU Institute of Materials Research and Engineering (IMRE); Agency of
   Science Technology and Research (A*STAR) in Singapore; National
   University of Singapore
FX This study was supported by the Institute of Materials Research and
   Engineering (IMRE), the Agency of Science Technology and Research
   (A*STAR) in Singapore and the National University of Singapore. We thank
   Dr Yap Fung Ling from IMRE for her help with performing the AFM
   measurements and express our thanks to the Confocal Microscopy Unit,
   National University Health System.
CR Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   Gu XZ, 2011, BIOMACROMOLECULES, V12, P3066, DOI 10.1021/bm2006938
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Knight PT, 2010, J BIOMED MATER RES A, V94A, P333, DOI 10.1002/jbm.a.32806
   Knight PT, 2009, MACROMOLECULES, V42, P6596, DOI 10.1021/ma901237h
   Lai YS, 2009, MATER CHEM PHYS, V117, P91, DOI 10.1016/j.matchemphys.2009.05.006
   Le X., 2013, INT J BIOMATER, V2013
   Lee KS, 2013, POLYM INT, V62, P64, DOI 10.1002/pi.4309
   Liu HZ, 2005, MACROMOL RAPID COMM, V26, P196, DOI 10.1002/marc.200400465
   Liu YH, 2006, POLYMER, V47, P6814, DOI 10.1016/j.polymer.2006.07.050
   Matejka L, 2012, EUR POLYM J, V48, P260, DOI 10.1016/j.eurpolymj.2011.11.009
   Mya KY, 2009, J POLYM SCI POL CHEM, V47, P4602, DOI 10.1002/pola.23512
   Mya KY, 2011, J MATER CHEM, V21, P4827, DOI 10.1039/c0jm04459h
   Nanda AK, 2006, MACROMOLECULES, V39, P7037, DOI 10.1021/ma060809h
   Neumann D, 2002, J AM CHEM SOC, V124, P13998, DOI 10.1021/ja0275921
   Oseni AO, 2015, J TISSUE ENG REGEN M, V9, pE27, DOI 10.1002/term.1693
   Raftopoulos KN, 2010, POLYMER, V51, P709, DOI 10.1016/j.polymer.2009.11.067
   Raghunath J, 2009, J BIOMED MATER RES A, V91A, P834, DOI 10.1002/jbm.a.32335
   Saltzman W. M., 2011, PRINCIPLES TISSUE EN, P279
   She MS, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2013.5
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Tanaka K, 2013, B CHEM SOC JPN, V86, P1231, DOI 10.1246/bcsj.20130182
   Tanaka K, 2013, POLYM J, V45, P247, DOI 10.1038/pj.2012.154
   Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeh CC, 2009, J MED BIOL ENG, V29, P92
NR 31
TC 12
Z9 12
U1 5
U2 53
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD NOV
PY 2014
VL 6
AR e142
DI 10.1038/am.2014.102
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA AU5UE
UT WOS:000345670900001
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Slaughter, MS
   Soucy, KG
   Matheny, RG
   Lewis, BC
   Hennick, MF
   Choi, Y
   Monreal, G
   Sobieski, MA
   Giridharan, GA
   Koenig, SC
AF Slaughter, Mark S.
   Soucy, Kevin G.
   Matheny, Robert G.
   Lewis, Beecher C.
   Hennick, Michael F.
   Choi, Young
   Monreal, Gretel
   Sobieski, Michael A.
   Giridharan, Guruprasad A.
   Koenig, Steven C.
TI Development of an Extracellular Matrix Delivery System for Effective
   Intramyocardial Injection in Ischemic Tissue
SO ASAIO JOURNAL
LA English
DT Article
DE heart failure; ECM; injection device; cardiac regeneration; biomaterials
ID ACUTE MYOCARDIAL-INFARCTION; HEART-FAILURE; INTRACORONARY INJECTION;
   BOVINE MODEL; THERAPY; REPAIR; BIOMATERIAL; SCAFFOLD; SUPPORT; INJURY
AB Biomaterials with direct intramyocardial injection devices have been developed and are being investigated as a potential cardiac regenerative therapy for end-stage ischemic heart failure. Decellularized extracellular matrix (ECM) has been shown to improve cardiac function and attenuate or reverse pathologic remodeling cascades. CorMatrix Cardiovascular, Inc. has developed a porcine small intestinal submucosa-derived particulate extracellular matrix (P-ECM) and ECM Delivery System to provide uniform and controlled intramyocardial delivery of the injectable P-ECM material into infarcted regions. The CorMatrix ECM Delivery System is composed of a Multi-Needle P-ECM Syringe Assembly, Automated Injection Controller, and Tissue Depth Measurement System (portable ultrasound). Feasibility of the P-ECM delivery system was tested intraoperatively in a chronic ischemic heart failure bovine model (n = 11), and demonstrated the ability to control injection volume (0.1-1.0 ml) and depth of penetration (3-5 mm) under regulated injection pressure (150 psi CO2) into the ischemic region. Targeted intramyocardial delivery of P-ECM may improve efficacy and enable development of novel patient-specific therapy.
C1 [Slaughter, Mark S.; Soucy, Kevin G.; Monreal, Gretel; Sobieski, Michael A.; Koenig, Steven C.] Univ Louisville, Cardiovasc Innovat Inst, Dept Cardiovasc & Thorac Surg, Louisville, KY 40202 USA.
   [Slaughter, Mark S.; Soucy, Kevin G.; Choi, Young; Sobieski, Michael A.; Giridharan, Guruprasad A.; Koenig, Steven C.] Univ Louisville, Dept Bioengn, Louisville, KY 40202 USA.
   [Matheny, Robert G.; Lewis, Beecher C.; Hennick, Michael F.] CorMatrix Cardiovasc Inc, Roswell, GA USA.
RP Koenig, SC (reprint author), Univ Louisville, Cardiovasc Innovat Inst, Dept Bioengn, 302 East Muhammad Ali Blvd,Room 408, Louisville, KY 40202 USA.
EM steven.koenig@louisville.edu
FU CorMatrix Cardiovascular, Inc.
FX Funding for this project was provided, in part, by research support from
   CorMatrix Cardiovascular, Inc. (Roswell, GA).
CR ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Bartoli CR, 2013, ARTIF ORGANS, V37, pE202, DOI 10.1111/aor.12129
   Birks EJ, 2013, CIRC RES, V113, P777, DOI 10.1161/CIRCRESAHA.113.301413
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Drakos SG, 2011, CURR OPIN CARDIOL, V26, P245, DOI 10.1097/HCO.0b013e328345af13
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Heidenreich PA, 2013, CIRC-CARDIOVASC QUAL, V6, P687, DOI 10.1161/CIRCOUTCOMES.113.000199
   Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kornowski R, 2000, J AM COLL CARDIOL, V35, P1031, DOI 10.1016/S0735-1097(99)00642-7
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lindsey ML, 2003, ANN MED, V35, P316, DOI 10.1080/07853890310001285
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   McCall FC, 2012, NAT PROTOC, V7, P1479, DOI 10.1038/nprot.2012.075
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Rosen Michael, 2005, Surg Innov, V12, P227, DOI 10.1177/155335060501200307
   Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446
   Sherwood LC, 2013, ASAIO J, V59, P221, DOI 10.1097/MAT.0b013e3182894e66
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Soucy KG, 2013, ASAIO J, V59, P355, DOI 10.1097/MAT.0b013e31829f9bb3
   Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Toeg HD, 2013, ANN THORAC SURG, V96, P1686, DOI 10.1016/j.athoracsur.2013.06.063
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
NR 33
TC 8
Z9 8
U1 1
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1058-2916
EI 1538-943X
J9 ASAIO J
JI Asaio J.
PD NOV-DEC
PY 2014
VL 60
IS 6
BP 730
EP 736
DI 10.1097/MAT.0000000000000146
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA AU0FO
UT WOS:000345299200020
PM 25232775
OA Bronze
DA 2018-10-20
ER

PT J
AU Yamada, M
   Hara, S
   Yamada, T
   Katagiri, F
   Hozumi, K
   Nomizu, M
AF Yamada, Masanori
   Hara, Sachiko
   Yamada, Tetsuya
   Katagiri, Fumihiko
   Hozumi, Kentaro
   Nomizu, Motoyoshi
TI Double-Stranded DNA Stereoselectively Promotes Aggregation of
   Amyloid-Like Fibrils and Generates Peptide/DNA Matrices
SO BIOPOLYMERS
LA English
DT Article
DE cell adhesion; DNA; laminin; peptide; scaffold
ID LAMININ ALPHA-1 CHAIN; CELL-BINDING SEQUENCES; IKVAV SEQUENCE; A-CHAIN;
   SYNTHETIC PEPTIDES; CHARGE-TRANSPORT; CONGO RED; IN-VITRO;
   IDENTIFICATION; EXPRESSION
AB An amyloidogenic LAM-L peptide (AASIKVAVSADR, all-L configuration) derived from laminin promoted cell adhesion, neurite outgrowth, and angiogenesis. Here, we prepared novel matrices using double-stranded DNA and the LAM-L peptide. Double-stranded DNA promoted aggregation of amyloid-like fibrils and generated a LAM-L/DNA matrix through electrostatic interactions between the phosphate groups of DNA and the amino groups of LAM-L. This formation of peptide/DNA matrix depends on the Ile-Lys-Val-Ala-Val (IKVAV) sequence in the peptide, since LAM-RM peptide (AASVVIAKSADR), which is scrambled peptide of LAM-L, did not form a matrix with DNA. Further, LAM-D (all-D configuration of LAM-L), which forms amyloid-like fibrils and promotes similar biological activities as LAM-L, did not form amyloid-like fibrils with DNA, suggesting that DNA selectively interacts with the L-configured peptide. Moreover, the LAM-L/DNA matrices showed stronger cell attachment activity compared with LAM-L alone, suggesting the LAM-L/DNA matrices have potential for use as a novel biomaterial in tissue engineering. (c) 2014 Wiley Periodicals, Inc. Biopolymers (Pept Sci) 102: 465-472, 2014.
C1 [Yamada, Masanori; Hara, Sachiko] Okayama Univ Sci, Dept Chem, Fac Sci, Kita Ku, Okayama 7000005, Japan.
   [Yamada, Tetsuya] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan.
   [Katagiri, Fumihiko; Hozumi, Kentaro; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan.
RP Yamada, M (reprint author), Okayama Univ Sci, Dept Chem, Fac Sci, Kita Ku, Okayama 7000005, Japan.
EM myamada@chem.ous.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [25410195]; MEXT
FX Contract grant sponsor: the Grants-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan; Contract grant number: 25410195; Contract grant sponsor: The
   matching fund subsidy for private universities from MEXT
CR Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Bondy SC, 1999, NEUROSCI LETT, V267, P25, DOI 10.1016/S0304-3940(99)00307-9
   Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200
   Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612
   COLOGNATO H, 2000, DEV DYNAM, V18, P13
   Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2
   Genereux JC, 2010, CHEM REV, V110, P1642, DOI 10.1021/cr900228f
   GLENNER GG, 1972, J HISTOCHEM CYTOCHEM, V20, P821, DOI 10.1177/20.10.821
   GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8
   GUILLAMEGENTIL O, 2009, ADV MATER, V22, P5443
   Howie AJ, 2009, MICRON, V40, P285, DOI 10.1016/j.micron.2008.10.002
   Iivanainen A, 1999, J BIOL CHEM, V274, P14107, DOI 10.1074/jbc.274.20.14107
   JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4
   KANEMOTO T, 1990, P NATL ACAD SCI USA, V87, P2279, DOI 10.1073/pnas.87.6.2279
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   KIBBEY MC, 1992, J NATL CANCER I, V84, P1633, DOI 10.1093/jnci/84.21.1633
   Kisilevsky R, 2000, J STRUCT BIOL, V130, P99, DOI 10.1006/jsbi.2000.4222
   KLEINMAN HK, 1991, ARCH BIOCHEM BIOPHYS, V290, P320, DOI 10.1016/0003-9861(91)90547-V
   Lendel C, 2010, BIOCHEMISTRY-US, V49, P1358, DOI 10.1021/bi902005t
   Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000
   Liu XD, 2007, ADV POLYM SCI, V209, P149, DOI 10.1007/12_2006_106
   Liu XD, 2009, ANAL BIOCHEM, V393, P67, DOI 10.1016/j.ab.2009.06.020
   Liu XD, 2008, CHEM SOC REV, V37, P2745, DOI 10.1039/b801433g
   Luckey M, 2000, FEBS LETT, V468, P23, DOI 10.1016/S0014-5793(00)01184-4
   McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x
   Merino EJ, 2008, CURR OPIN CHEM BIOL, V12, P229, DOI 10.1016/j.cbpa.2008.01.046
   Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685
   NOMIZU M, 1992, J BIOL CHEM, V267, P14118
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   OHGA Y, 2009, BIOMATERIALS, V35, P6731
   Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005
   SAENGER W, 1987, PRINCIPLES NUCL ACID
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simmel FC, 2005, SMALL, V1, P284, DOI 10.1002/smll.200400111
   Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   WARING MJ, 1981, ANNU REV BIOCHEM, V50, P159, DOI 10.1146/annurev.bi.50.070181.001111
   Yamada M, 2002, CHEM-EUR J, V8, P1407, DOI 10.1002/1521-3765(20020315)8:6<1407::AID-CHEM1407>3.0.CO;2-L
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yamada M, 2002, ENVIRON SCI TECHNOL, V36, P949, DOI 10.1021/es011008r
   Yamada M., 2009, ANAL CHIM ACTA, V674, P249
   Yamada M, 2008, POLYMER, V49, P4658, DOI 10.1016/j.polymer.2008.08.027
   Yamada M, 2008, BIOMACROMOLECULES, V9, P3341, DOI 10.1021/bm800984p
   Yuan C, 2007, FEBS LETT, V581, P241, DOI 10.1016/j.febslet.2006.12.019
   Zhang LJ, 2007, SEP PURIF TECHNOL, V55, P388, DOI 10.1016/j.seppur.2006.12.016
   Zou ZW, 2009, MAT SCI ENG C-MATER, V29, P2099, DOI 10.1016/j.msec.2009.04.009
NR 52
TC 3
Z9 3
U1 2
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD NOV
PY 2014
VL 102
IS 6
BP 465
EP 472
DI 10.1002/bip.22571
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AU1EX
UT WOS:000345364900006
PM 25283385
DA 2018-10-20
ER

PT J
AU Tsukanaka, M
   Yamamoto, K
   Fujibayashi, S
   Pattanayak, DK
   Matsushita, T
   Kokubo, T
   Matsuda, S
   Akiyama, H
AF Tsukanaka, Masako
   Yamamoto, Koji
   Fujibayashi, Shunsuke
   Pattanayak, Deepak K.
   Matsushita, Tomiharu
   Kokubo, Tadashi
   Matsuda, Shuichi
   Akiyama, Haruhiko
TI Evaluation of bioactivity of alkali- and heat-treated titanium using
   fluorescent mouse osteoblasts
SO JOURNAL OF BONE AND MINERAL METABOLISM
LA English
DT Article
DE Fluorescence imaging; Bone-bonding ability; Biomaterial evaluation;
   Osteoblast calcification; Col1a1
ID MESENCHYMAL STEM-CELLS; IN-VITRO; BONE; EXPRESSION; PROTEIN; TISSUE;
   DIFFERENTIATION; BIOMATERIALS; SURFACES; ASSAY
AB Stimulation of osteoblast proliferation and differentiation is important for the in vivo bone-bonding ability of biomaterials. Previous in vitro studies have used biochemical assays to analyze osteoblast-specific gene expression in cultured osteoblasts. In this study, we generated transgenic mice harboring a monomeric red fluorescent protein 1 transgene under the control of a 2.3-kb fragment of the Col1a1 promoter, which is active specifically in osteoblasts and osteocytes. We established a fluorescent primary osteoblast culture system to allow noninvasive observation of osteoblast proliferation and differentiation on opaque materials in vitro. We used this system to evaluate alkali-and heat-treated titanium, which has a strong bone-bonding ability in vivo, and we observed a rapid increase in fluorescence intensity and characteristic multifocal nodule formation. A cell proliferation assay and RT-PCR to examine osteoblast-specific gene expression showed increased osteoblast proliferation and differentiation consistent with the fluorescence observations. This mouse model allowed us to use fluorescence intensity to visualize and quantify in vivo newly formed bone around implanted materials in femurs. The use of these fluorescent osteoblasts is a promising method for simple screening of the bone-bonding ability of new materials.
C1 [Tsukanaka, Masako; Yamamoto, Koji; Fujibayashi, Shunsuke; Matsuda, Shuichi; Akiyama, Haruhiko] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Kyoto 6068507, Japan.
   [Pattanayak, Deepak K.; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan.
RP Akiyama, H (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Sakyo Ku, Shogoinkawahara Cho 54, Kyoto 6068507, Japan.
EM hakiyama@kuhp.kyoto-u.ac.jp
OI Matsuda, Shuichi/0000-0003-0802-1255
FU Foundation for the Promotion of Ion Engineering
FX We thank Roger Y. Tsien for valuable help. This work was supported by
   the Foundation for the Promotion of Ion Engineering.
CR Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Boskey AL, 2003, CALCIFIED TISSUE INT, V72, P533, DOI 10.1007/s00223-003-1002-8
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228
   Declerq HA, 2005, BIOMATERIALS, V26, P4964, DOI 10.1016/j.biomaterials.2005.01.025
   Flock A, 1998, J NEUROCYTOL, V27, P507, DOI 10.1023/A:1006999725663
   Gade TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022608
   Goto T, 2003, BIOMATERIALS, V24, P3885, DOI 10.1016/S0142-9612(03)00258-8
   Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11
   Iris Bar, 2003, J Bone Miner Res, V18, P570
   Isaac J, 2010, EUR CELLS MATER, V20, P178
   Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309
   Kuhn LT, 2010, TISSUE ENG PART C-ME, V16, P1357, DOI 10.1089/ten.TEC.2009.0701
   Long JZ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-20
   Maeda M, 2007, J BIOCHEM, V141, P729, DOI 10.1093/jb/mvm077
   Maniatopoulos C, 1986, Int J Oral Maxillofac Implants, V1, P31
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nishio K, 2000, J BIOMED MATER RES, V52, P652, DOI 10.1002/1097-4636(20001215)52:4<652::AID-JBM9>3.3.CO;2-N
   ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   WONG GL, 1975, P NATL ACAD SCI USA, V72, P3167, DOI 10.1073/pnas.72.8.3167
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Zhu HX, 2005, GENESIS, V42, P86, DOI 10.1002/gene.20129
NR 25
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0914-8779
EI 1435-5604
J9 J BONE MINER METAB
JI J. Bone Miner. Metab.
PD NOV
PY 2014
VL 32
IS 6
BP 660
EP 670
DI 10.1007/s00774-013-0544-8
PG 11
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA AU0AQ
UT WOS:000345285900007
PM 24311310
DA 2018-10-20
ER

PT J
AU Habesoglu, M
   Oysu, C
   Sahin, S
   Sahin-Yilmaz, A
   Korkmaz, D
   Tosun, A
   Karaaslan, A
AF Habesoglu, Mehmet
   Oysu, Cagatay
   Sahin, Serap
   Sahin-Yilmaz, Asli
   Korkmaz, Deniz
   Tosun, Ahmet
   Karaaslan, Ahmet
TI Platelet-Rich Fibrin Plays a Role on Healing of Acute-Traumatic Ear Drum
   Perforation
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Platelet-rich fibrin; ear drum perforation
ID TYMPANIC MEMBRANE PERFORATIONS; FAT GRAFT MYRINGOPLASTY;
   EPIDERMAL-GROWTH-FACTOR; REPAIR
AB Objective: Our objective was to demonstrate the effects of platelet-rich fibrin (PRF) for the healing of acute ear drum perforation.
   Methods: Thirty-two patients with acute traumatic ear drum perforations were randomly separated into 2 groups. In group 1 (n = 14), PRF was used for the repair of ear drum perforation; in group 2 (n = 18), we did not make any intervention.
   Results: At initial inspection, perforation sizes were measured as 10.93 +/- 3.58 mm(2) in group 1 and 10.05 +/- 4.02 mm(2) in group 2. After 1 month, perforation sizes were 1.35 +/- 2.53 mm(2) in group 1 and 4.44 perpendicular to 3.34 mm(2) in group 2 (P < 0.01). In the study group, the rate of ear drum closure was 64.3% and in the control group it was 22.2% (P < 0.05).
   Conclusion: Here we found that PRF is a biomaterial that quickens the healing of ear drum which is autogenous and simply prepared.
C1 [Habesoglu, Mehmet; Oysu, Cagatay; Sahin, Serap; Sahin-Yilmaz, Asli; Korkmaz, Deniz; Tosun, Ahmet; Karaaslan, Ahmet] Umraniye Training & Res Hosp, Dept Otorhinolaryngol, TR-9034764 Istanbul, Turkey.
RP Habesoglu, M (reprint author), Umraniye Training & Res Hosp, Dept Otorhinolaryngol, TR-9034764 Istanbul, Turkey.
EM mhabesoglu@yahoo.com
CR Berthold E, 1879, MED CHIR CENTRALB, V14, P195
   Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, pI
   Blake C.J., 1887, T 1 C INT OT SOC, P125
   Chauvin K, 1999, OTOLARYNG HEAD NECK, V121, P43, DOI 10.1016/S0194-5998(99)70122-1
   Davis VL, 2012, J ORAL IMPLANTOL
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Erkilet E, 2009, J LARYNGOL OTOL, V123, P482, DOI 10.1017/S0022215108003848
   Fiorino F, 2007, EUR ARCH OTO-RHINO-L, V264, P1125, DOI 10.1007/s00405-007-0323-z
   Kartush JM, 2000, AM J OTOL, V21, P615
   Koc S, 2013, EUR ARCH OTO-RHINO-L, V270, P1629, DOI 10.1007/s00405-012-2040-5
   Lee JW, 2013, ARCH PLAST SURG-APS, V40, P530, DOI 10.5999/aps.2013.40.5.530
   McFeely WJ, 2000, OTOLARYNG HEAD NECK, V123, P17, DOI 10.1067/mhn.2000.105920
   MERWIN GE, 1980, LARYNGOSCOPE, V90, P853
   Navarrete Alvaro ML, 2011, ISRN SURG, V2011
   RAMSAY HA, 1995, OTOLARYNG HEAD NECK, V113, P375, DOI 10.1016/S0194-5998(95)70071-4
   Saliba I, 2011, LARYNGOSCOPE, V121, P375, DOI 10.1002/lary.21365
   Thomassin J-M, 2004, Ann Otolaryngol Chir Cervicofac, V121, P346
   Wiltfang J, 2005, 2 INT S GROWTH FACT
NR 19
TC 7
Z9 7
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD NOV
PY 2014
VL 25
IS 6
BP 2056
EP 2058
DI 10.1097/SCS.0000000000001140
PG 3
WC Surgery
SC Surgery
GA AT5XB
UT WOS:000345012000057
PM 25377966
DA 2018-10-20
ER

PT J
AU Hung, CJ
   Hsu, HI
   Lin, CC
   Huang, TH
   Wu, BC
   Kao, CT
   Shie, MY
AF Hung, Chi-Jr
   Hsu, Hsin-I.
   Lin, Chi-Chang
   Huang, Tsui-Hsien
   Wu, Buor-Chang
   Kao, Chia-Tze
   Shie, Ming-You
TI The Role of Integrin alpha v in Proliferation and Differentiation of
   Human Dental Pulp Cell Response to Calcium Silicate Cement
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Calcium silicate cement; fibronectin; human dental pulp cell; integrin
   alpha v; odontogenesis
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO; SURFACE-CHEMISTRY; BONE-MARROW;
   ADHESION; EXPRESSION; OSTEOGENESIS; OSTEOBLASTS; PROGRESSION; VIABILITY
AB Introduction: It has been proved that integrin alpha v activity is related to cell proliferation, differentiation, migration, and organ development. However, the biological functions of integrin av in human dental pulp cells (hDPCs) cultured on silicate-based materials have not been explored. The aim of this study was to investigate the role of integrin av in the proliferation and odontogenic differentiation of hDPCs cultured with the effect of calcium silicate (CS) cement and (beta-tricalcium phosphate (TCP) cement. Methods: In this study, hDPCs were cultured on CS and TCP materials, and we evaluated fibronectin (FN) secretion and integrin av expression during the cell attachment stage. After small interfering RNA transfection targeting integrin av, the proliferation and odontogenesis differentiation behavior of hDPCs were analyzed. Results: The results indicate that CS releases Si ion increased FN secretion and adsorption, which promote cell attachment more effectively than TCP. The CS cement facilitates FN and alpha v subintegrin expression. However, the FN adsorption and integrin expression of TCP are similar to that observed in the control dish. Integrin av small interfering RNA inhibited odontogenic differentiation of hDPCs with the decreased formation of mineralized nodules on CS. It also down-regulated the protein expression of multiple markers of odontogenesis and the expression of dentin sialophosphoprotein protein. Conclusions: These results establish composition-dependent differences in integrin binding and its effectiveness as a mechanism regulating cellular responses to biomaterial surface.
C1 [Hung, Chi-Jr; Huang, Tsui-Hsien; Wu, Buor-Chang; Kao, Chia-Tze; Shie, Ming-You] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.
   [Hung, Chi-Jr; Huang, Tsui-Hsien; Wu, Buor-Chang; Kao, Chia-Tze] Chung Shan Med Univ, Inst Oral Sci, Taichung, Taiwan.
   [Hsu, Hsin-I.] Chung Shan Med Univ, Dept Stomatol, Taichung, Taiwan.
   [Lin, Chi-Chang] Tunghai Univ, Dept Chem & Mat Engn, Taichung 40704, Taiwan.
RP Kao, CT (reprint author), Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.
EM ctk@csmu.edu.tw; eviltacasi@gmail.com
OI Shie, Ming-You/0000-0002-0650-4344
FU National Science Council Taiwan of Taiwan [NSC 101-2314-B-040-011-MY3];
   THU project of Global Research and Education on Environment and Society
   [GREEnS 001]
FX Supported by a grant from the National Science Council Taiwan (NSC
   101-2314-B-040-011-MY3) of Taiwan and the THU project of Global Research
   and Education on Environment and Society (GREEnS 001).
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bouafsoun A, 2007, MACROMOL BIOSCI, V7, P599, DOI 10.1002/mabi.200600263
   Chen CC, 2011, INT ENDOD J, V44, P836, DOI 10.1111/j.1365-2591.2011.01890.x
   Chen CL, 2010, J ENDODONT, V36, P465, DOI 10.1016/j.joen.2009.12.008
   Chen CL, 2009, J ENDODONT, V35, P682, DOI 10.1016/j.joen.2009.02.002
   Chou MY, 2014, J ENDODONT, V40, P818, DOI 10.1016/j.joen.2013.09.041
   Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj/neo/7900224
   Ding SJ, 2008, J ENDODONT, V34, P748, DOI 10.1016/j.joen.2008.02.041
   Fromigue O, 2012, J CELL BIOCH, p[3029, 113]
   Goessler UR, 2009, J CELL MOL MED, V13, P1175, DOI 10.1111/j.1582-4934.2008.00451.x
   Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106
   Huang S.C., 2014, INT ENDOD J
   Huang TH, 2008, J ENDODONT, V34, P590, DOI 10.1016/j.joen.2008.02.002
   Hung CJ, 2014, J DENT SCI, V9, P158, DOI 10.1016/j.jds.2013.08.002
   Hung CJ, 2013, J ENDODONT, V39, P1557, DOI 10.1016/j.joen.2013.07.004
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kang YQ, 2012, BIOMATERIALS, V33, P6998, DOI 10.1016/j.biomaterials.2012.06.061
   Kao CT, 2009, J ENDODONT, V35, P239, DOI 10.1016/j.joen.2008.10.023
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679
   Liu CH, 2014, INT ENDOD J, V47, P843, DOI 10.1111/iej.12227
   Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Shie MY, 2012, INT ENDOD J, V45, P337, DOI 10.1111/j.1365-2591.2011.01981.x
   Shie MY, 2014, J BIOMED MATER RES A, V102, P769, DOI 10.1002/jbm.a.34737
   Shie MY, 2013, BIOMATERIALS, V34, P6589, DOI 10.1016/j.biomaterials.2013.05.075
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Shroff K, 2012, LANGMUIR, V28, P1858, DOI 10.1021/la203322t
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Su CC, 2014, MAT SCI ENG C-MATER, V37, P156, DOI 10.1016/j.msec.2014.01.010
   TORABINEJAD M, 1993, J ENDODONT, V19, P591, DOI 10.1016/S0099-2399(06)80271-2
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Vohra S, 2008, J MATER SCI-MATER M, V19, P3567, DOI 10.1007/s10856-008-3525-z
   Wei W, 2012, J ENDODONT, V38, P936, DOI 10.1016/j.joen.2012.03.020
   Wu BC, 2014, J ENDODONT, V40, P1105, DOI 10.1016/j.joen.2013.12.019
   Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709
   Zurick KM, 2012, J BIOMED MATER RES A, V100A, P2492, DOI 10.1002/jbm.a.34159
NR 37
TC 22
Z9 22
U1 1
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
EI 1878-3554
J9 J ENDODONT
JI J. Endod.
PD NOV
PY 2014
VL 40
IS 11
BP 1802
EP 1809
DI 10.1016/j.joen.2014.07.016
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AT5JP
UT WOS:000344979900012
PM 25218525
DA 2018-10-20
ER

PT J
AU Li, X
   Xu, CP
   Hou, YL
   Song, JQ
   Cui, Z
   Yu, B
AF Li, Xue
   Xu, Chang-Peng
   Hou, Yi-Long
   Song, Jin-Qi
   Cui, Zhuang
   Yu, Bin
TI Are Platelet Concentrates an Ideal Biomaterial for Arthroscopic Rotator
   Cuff Repair? A Meta-analysis of Randomized Controlled Trials
SO ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY
LA English
DT Article
ID CONTROLLED CLINICAL-TRIAL; RICH FIBRIN MATRIX; SINGLE-ROW; BIOLOGIC
   AUGMENTATION; GROWTH-FACTORS; PLASMA; TENDON; TEARS; LEUKOCYTE;
   SUPRASPINATUS
AB Purpose: The present study aims to conduct a meta-analysis of Level I evidence studies to investigate the efficacy of concomitant platelet concentrate (PC) used in arthroscopic rotator cuff repair. Methods: We systematically searched electronic databases to identify randomized controlled trials (RCTs) evaluating the role of PC augmentation in arthroscopic rotator cuff repairs for patients with full-thickness tears. The search strategy followed the requirements in the Cochrane Library Handbook. The primary outcome was retearing of the rotator cuff. Functional outcomes were analyzed in terms of Constant score, specific Constant pain score, University of California, Los Angeles (UCLA) shoulder score, Simple Shoulder Test (SST) score, and American Shoulder and Elbow Surgeons (ASES) score. Results: Seven studies with a total of 417 patients available at the latest follow-up reporting data about retears were analyzed in this meta-analysis. However, 4 studies with Constant scores (n = 237), 3 studies with UCLA scores (n = 168), 2 studies with Constant pain scores (n = 164), 2 studies with ASES scores (n = 101), and 2 studies with SST scores (n = 121) were analyzed. The retear rates and functional scores showed that there was no significant efficacy of PC application in arthroscopic rotator cuff repairs. Conclusions: This meta-analysis of high-level evidence suggests that PCs have no benefit regarding retear rate and overall clinical outcomes for the arthroscopic repair of full-thickness rotator cuff tears.
C1 [Li, Xue] Guangzhou Univ Chinese Med, Foshan Hosp Tradit Chinese Med, Dept Orthopaed, Guangzhou, Guangdong, Peoples R China.
   [Li, Xue; Hou, Yi-Long; Song, Jin-Qi; Cui, Zhuang; Yu, Bin] Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, Guangzhou 510515, Guangdong, Peoples R China.
   [Xu, Chang-Peng] Southern Med Univ, Nanfang Hosp, Key Lab Bone & Cartilage Regenerat Med, Guangzhou 510515, Guangdong, Peoples R China.
RP Yu, B (reprint author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed & Traumatol, 1838 Guangzhou Ave North, Guangzhou 510515, Guangdong, Peoples R China.
EM 151961353@qq.com
FU Production, Academy, and Research Foundation of Guangdong Province
   [2011B090400016]
FX Supported by Production, Academy, and Research Foundation of Guangdong
   Province (2011B090400016). The authors report that they have no
   conflicts of interest in the authorship and publication of this article.
CR Anitua E, 2006, TRENDS BIOTECHNOL, V24, P227, DOI 10.1016/j.tibtech.2006.02.010
   Antuna S, 2013, ACTA ORTHOP BELG, V79, P25
   Arnoczky SP., 2011, AM J SPORTS MED, V39, pNP9
   Arnoczky SP, 2011, AM J SPORT MED, V39, pNP8, DOI 10.1177/0363546511410381
   Barber FA, 2011, ARTHROSCOPY, V27, P1029, DOI 10.1016/j.arthro.2011.06.010
   Boileau P, 2005, J BONE JOINT SURG AM, V87A, P1229, DOI 10.2106/JBJS.D.02035
   Carbone S, 2012, J SHOULDER ELB SURG, V21, P56, DOI 10.1016/j.jse.2011.01.039
   Castricini R, 2011, AM J SPORT MED, V39, P258, DOI 10.1177/0363546510390780
   Chahal J, 2012, ARTHROSCOPY, V28, P1718, DOI 10.1016/j.arthro.2012.03.007
   Chignon-Sicard B, 2012, PLAST RECONSTR SURG, V130, p819E, DOI 10.1097/PRS.0b013e31826d1711
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002
   Gartsman GM, 2004, J SHOULDER ELB SURG, V13, P424, DOI 10.1016/j.jse.2004.02.006
   Gerhardt C, 2012, AM J SPORT MED, V40, P2777, DOI 10.1177/0363546512462123
   Gumina S, 2012, J BONE JOINT SURG AM, V94A, P1345, DOI [10.2106/JBJS.K.00394, 10.2106/JBJS.k.00394]
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Jo CH, 2011, AM J SPORT MED, V39, P2082, DOI 10.1177/0363546511413454
   Kim DH, 2006, AM J SPORT MED, V34, P407, DOI 10.1177/0363546505281238
   Lehman Christopher, 1995, Bulletin Hospital for Joint Diseases, V54, P30
   Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S01406736(08)61764-X
   Lubkowska A, 2012, J Biol Regul Homeost Agents, V26, p3S
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Mazzocca AD, 2005, AM J SPORT MED, V33, P1861, DOI 10.1177/0363546505279575
   Milano G, 2008, KNEE SURG SPORT TR A, V16, P75, DOI 10.1007/s00167-007-0382-0
   Mishra A, 2006, AM J SPORT MED, V34, P1774, DOI 10.1177/0363546506288850
   Moher D, 2005, EXPLORE-NY, V1, P40, DOI 10.1016/j.explore.2004.11.001
   Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014
   Orrego M, 2008, ARTHROSCOPY, V24, P1373, DOI 10.1016/j.arthro.2008.07.016
   Park MC, 2007, J SHOULDER ELB SURG, V16, P469, DOI 10.1016/j.jse.2006.09.011
   Perut F, 2013, CYTOTHERAPY, V15, P830, DOI 10.1016/j.jcyt.2013.01.220
   Randelli P, 2011, J SHOULDER ELB SURG, V20, P518, DOI 10.1016/j.jse.2011.02.008
   Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2485, DOI 10.2106/JBJS.C.01627
   Rodeo SA, 2007, J SHOULDER ELB SURG, V16, p191S, DOI 10.1016/j.jse.2007.03.012
   Rodeo SA, 2012, AM J SPORT MED, V40, P1234, DOI 10.1177/0363546512442924
   Ruiz-Moneo P, 2013, ARTHROSCOPY, V29, P2, DOI 10.1016/j.arthro.2012.08.014
   Sheibani-Rad S, 2013, ARTHROSCOPY, V29, P343, DOI 10.1016/j.arthro.2012.11.019
   Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154
   Weber SC, 2013, AM J SPORT MED, V41, P263, DOI 10.1177/0363546512467621
   Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x
NR 39
TC 14
Z9 15
U1 0
U2 9
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0749-8063
EI 1526-3231
J9 ARTHROSCOPY
JI Arthroscopy
PD NOV
PY 2014
VL 30
IS 11
BP 1483
EP 1490
DI 10.1016/j.arthro.2014.03.020
PG 8
WC Orthopedics; Sport Sciences; Surgery
SC Orthopedics; Sport Sciences; Surgery
GA AS8DU
UT WOS:000344481200019
PM 24913394
DA 2018-10-20
ER

PT J
AU Yang, J
   van Lith, R
   Baler, K
   Hoshi, RA
   Ameer, GA
AF Yang, Jian
   van Lith, Robert
   Baler, Kevin
   Hoshi, Ryan A.
   Ameer, Guillermo A.
TI A Thermoresponsive Biodegradable Polymer with Intrinsic Antioxidant
   Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID OXIDATIVE STRESS; POLY(ETHYLENE GLYCOL); N-ISOPROPYLACRYLAMIDE;
   CONTROLLED-RELEASE; LIGHT-SCATTERING; BLOCK-COPOLYMER; DRUG-DELIVERY;
   POLY(N-ISOPROPYLACRYLAMIDE); HYDROGELS; TEMPERATURE
AB Oxidative stress in tissue can contribute to chronic inflammation that impairs wound healing and the efficacy of cell-based therapies and medical devices. We describe the synthesis and characterization of a biodegradable, thermoresponsive gel with intrinsic antioxidant properties suitable for the delivery of therapeutics. Citric acid, poly(ethylene glycol) (PEG), and poly-N-isopropylacrylamide (PNIPAAm) were copolymerized by sequential polycondensation and radical polymerization to produce poly(polyethylene glycol citrate-co-N-isopropylacrylamide) (PPCN). PPCN was chemically characterized, and the thermoresponsive behavior, antioxidant properties, morphology, potential for protein and cell delivery, and tissue compatibility in vivo were evaluated. The PPCN gel has a lower critical solution temperature (LCST) of 26 degrees C and exhibits intrinsic antioxidant properties based on its ability to scavenge free radicals, chelate metal ions, and inhibit lipid peroxidation. PPCN displays a hierarchical architecture of micropores and nanofibers, and contrary to typical thermoresponsive polymers, such as PNIPAAm, PPCN gel maintains its volume upon formation. PPCN efficiently entrapped and slowly released the chemokine SDF-1 alpha and supported the viability and proliferation of vascular cells. Subcutaneous injections in rats showed that PPCN gels are resorbed over time and new connective tissue formation takes place without signs of significant inflammation. Ultimately, this intrinsically antioxidant, biodegradable, thermoresponsive gel could potentially be used as an injectable biomaterial for applications where oxidative stress in tissue is a concern.
C1 [Yang, Jian; van Lith, Robert; Baler, Kevin; Hoshi, Ryan A.; Ameer, Guillermo A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Ameer, Guillermo A.] Northwestern Univ, Sch Med, Dept Surg, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Ameer, Guillermo A.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.
   [Ameer, Guillermo A.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol Med, Chicago, IL 60611 USA.
RP Ameer, GA (reprint author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
EM g-ameer@northwestern.edu
RI Yang, Jian/F-1462-2011; Ameer, Guillermo/B-6765-2009
OI Yang, Jian/0000-0003-2015-0308; 
FU National Institutes of Health under Ruth L. Kirschtein National Research
   Service Award from the National Institute of Biomedical Imaging and
   Bioengineering [1F31EB014698-01, 5R01EB017129-02]; MRSEC program at the
   Materials Research Center, Nanonascale Science and Engineering Center of
   the National Science Foundation [NSF DMR-0520513, EEC-0118025/003];
   State of Illinois; Northwestern University; National Center for Research
   Resources [5UL1RR025741]; National Center for Advancing Translational
   Sciences [8UL1TR000150]
FX This research was supported in part by the National Institutes of Health
   under Ruth L. Kirschtein National Research Service Award 1F31EB014698-01
   (KB) and grant 5R01EB017129-02 (GAA) both from the National Institute of
   Biomedical Imaging and Bioengineering, and made use of the NUANCE and
   IMSERC Centers at Northwestern University, which have received support
   from the MRSEC program (NSF DMR-0520513) at the Materials Research
   Center, Nanonascale Science and Engineering Center (EEC-0118025/003),
   both programs of the National Science Foundation; the State of Illinois;
   and Northwestern University. This work was also supported by the
   National Center for Research Resources, Grant 5UL1RR025741, and is now
   at the National Center for Advancing Translational Sciences, Grant
   8UL1TR000150. The authors thank Xue Song Wang for help with histology.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the NIH.
CR Abandansari HS, 2013, POLYMER, V54, P1329, DOI 10.1016/j.polymer.2013.01.004
   Abbott DA, 2009, APPL ENVIRON MICROB, V75, P2320, DOI 10.1128/AEM.00009-09
   Abrescia P, 2005, EXPERT REV CARDIOVAS, V3, P159, DOI 10.1586/14779072.3.1.159
   Ahmad N, 2013, PROTOPLASMA, V250, P1327, DOI 10.1007/s00709-013-0516-9
   Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916
   Badi N, 2009, J CONTROL RELEASE, V140, P224, DOI 10.1016/j.jconrel.2009.04.012
   Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330
   Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047
   Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X
   Brun-Graeppi AKAS, 2011, J CONTROL RELEASE, V149, P209, DOI 10.1016/j.jconrel.2010.09.023
   Cellesi F, 2012, THER DELIV, V3, P1395, DOI [10.4155/TDE.12.114, 10.4155/tde.12.114]
   Cheng H, 2009, BIOMATERIALS, V30, P1246, DOI 10.1016/j.biomaterials.2008.11.002
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Cimen EK, 2005, J APPL POLYM SCI, V95, P573, DOI 10.1002/app.21260
   Coates J., 2000, ENCY ANAL CHEM
   Comolli N, 2009, ACTA BIOMATER, V5, P1046, DOI 10.1016/j.actbio.2008.10.008
   Cui HT, 2014, MACROMOL BIOSCI, V14, P440, DOI 10.1002/mabi.201300366
   Dai WF, 2010, J MATER SCI-MATER M, V21, P1881, DOI 10.1007/s10856-010-4049-x
   Day SM, 2003, CIRCULATION, V107, P2601, DOI 10.1161/01.CIR.0000066910.02844.D0
   Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941
   Deible CR, 1998, J BIOMED MATER RES, V41, P251
   Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002
   Dobrun LA, 2011, J STRUCT CHEM+, V52, P1161, DOI 10.1134/S0022476611060229
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Gan TT, 2010, J MATER CHEM, V20, P5937, DOI 10.1039/c0jm00338g
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gil MI, 2000, J AGR FOOD CHEM, V48, P4581, DOI 10.1021/jf000404a
   Guan JJ, 2008, BIOMACROMOLECULES, V9, P1283, DOI 10.1021/bm701265j
   Hacker MC, 2008, BIOMACROMOLECULES, V9, P1558, DOI 10.1021/bm8000414
   Ham MJ, 2008, POLYM ENG SCI, V48, P2439, DOI 10.1002/pen.21200
   Han DK, 1998, J BIOMAT SCI-POLYM E, V9, P667
   Haraguchi K, 2010, MACROMOLECULES, V43, P4294, DOI 10.1021/ma902693x
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI [10.1080/10601326808051910, DOI 10.1080/10601326808051910]
   Huang LH, 2009, J APPL POLYM SCI, V113, P3222, DOI 10.1002/app.30025
   Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032
   Jasionowski M, 2004, J MATER SCI-MATER M, V15, P575, DOI 10.1023/B:JMSM.0000026379.24560.a2
   Juni RP, 2013, J AM COLL CARDIOL, V61, P1471, DOI 10.1016/j.jacc.2012.11.068
   Kavanagh CA, 2004, PHARMACOL THERAPEUT, V102, P1, DOI 10.1016/j.pharmthera.2003.01.001
   Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2
   Klouda L., 2008, EUR J PHARM BIOPHARM, V68
   Kong B, 2009, BIOMATERIALS, V30, P5514, DOI 10.1016/j.biomaterials.2009.07.016
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019
   Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338
   Li LH, 2008, LANGMUIR, V24, P13632, DOI 10.1021/la802556e
   Lin HH, 2001, MACROMOLECULES, V34, P3710, DOI 10.1021/ma001852m
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Loguercio AD, 2004, J DENT, V32, P459, DOI 10.1016/j.jdent.2004.02.010
   Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021
   Lowman AM, 1997, MACROMOLECULES, V30, P4959, DOI 10.1021/ma970399k
   Lu SY, 2011, CHEM ENG J, V173, P241, DOI 10.1016/j.cej.2011.07.052
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Malmstadt N, 2004, LAB CHIP, V4, P412, DOI 10.1039/b315394k
   Manke A, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/942916
   Mizutani A, 2008, BIOMATERIALS, V29, P2073, DOI 10.1016/j.biomaterials.2009.01.004
   Muzykantov VR, 2001, J CONTROL RELEASE, V71, P1, DOI 10.1016/S0168-3659(01)00215-2
   Ohya S, 2005, BIOMATERIALS, V26, P655, DOI 10.1016/j.biomaterials.2004.03.002
   OLIVER GC, 1968, J CLIN INVEST, V47, P1035, DOI 10.1172/JCI105793
   OTAKE K, 1990, MACROMOLECULES, V23, P283, DOI 10.1021/ma00203a049
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Perez C, 2002, INT J PHARM, V248, P193, DOI 10.1016/S0378-5173(02)00435-0
   Pollock JF, 2010, ACTA BIOMATER, V6, P1307, DOI 10.1016/j.actbio.2009.11.027
   Prieto MA, 2012, J AGR FOOD CHEM, V60, P8983, DOI 10.1021/jf302218g
   Ren JM, 2013, INT J BIOL MACROMOL, V53, P77, DOI 10.1016/j.ijbiomac.2012.11.011
   Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Selvam S, 2011, BIOMATERIALS, V32, P7785, DOI 10.1016/j.biomaterials.2011.07.020
   Shibayama M, 1996, MACROMOLECULES, V29, P6535, DOI 10.1021/ma960320w
   Silva AKA, 2008, BIOMACROMOLECULES, V10, P9, DOI [10.1021/bm801103c, DOI 10.1021/BM801103C]
   Spizzirri UG, 2011, CARBOHYD POLYM, V84, P517, DOI 10.1016/j.carbpol.2010.12.015
   Suggs LJ, 1999, BIOMATERIALS, V20, P683, DOI 10.1016/S0142-9612(98)00226-9
   Sun BJ, 2007, APPL SPECTROSC, V61, P765, DOI 10.1366/000370207781393271
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tikekar RV, 2013, FOOD RES INT, V54, P44, DOI 10.1016/j.foodres.2013.06.004
   van Lith R., 2014, BIOMATERIALS, V35, P8013
   Wang YC, 2009, BIOMACROMOLECULES, V10, P66, DOI 10.1021/bm800808q
   Watson BM, 2014, BIOMACROMOLECULES, V15, P1788, DOI 10.1021/bm500175e
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
   Wu C, 1997, J MACROMOL SCI PHYS, VB36, P345, DOI 10.1080/00222349708212388
   Xiao F, 2009, COLLOID SURFACE B, V71, P13, DOI 10.1016/j.colsurfb.2008.12.040
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yang J., 2004, ADV MAT, V16
   Yin YZ, 2014, SOFT MATTER, V10, P3374, DOI 10.1039/c3sm53117a
   YOSHIOKA H, 1994, J MACROMOL SCI PURE, VA31, P109
   Zhang XZ, 2004, BIOMATERIALS, V25, P4719, DOI 10.1016/j.biomaterials.2003.11.040
   Zhou J, 2012, FREE RADICAL BIO MED, V52, P218, DOI 10.1016/j.freeradbiomed.2011.10.452
NR 89
TC 41
Z9 42
U1 2
U2 85
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2014
VL 15
IS 11
BP 3942
EP 3952
DI 10.1021/bm5010004
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AT1WI
UT WOS:000344721400008
PM 25295411
DA 2018-10-20
ER

PT J
AU Peng, YF
   Munoz-Pinto, DJ
   Chen, MT
   Decatur, J
   Hahn, M
   Gross, RA
AF Peng, Yifeng
   Munoz-Pinto, Dany J.
   Chen, Mingtao
   Decatur, John
   Hahn, Mariah
   Gross, Richard A.
TI Poly(sophorolipid) Structural Variation: Effects on Biomaterial Physical
   and Biological Properties
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OPENING METATHESIS POLYMERIZATION; CLICK
   CHEMISTRY; CANDIDA-BOMBICOLA; IN-VITRO; MICROBIAL-PRODUCTION;
   EXPERIMENTAL SEPSIS; SOPHOROLIPIDS; GLYCOPOLYMERS; ACID
AB Diacetylated lactonic sophorolipids (polyLSL[6'Ac,6?Ac]), a biosurfactant, can be efficiently polymerized by ring-opening metathesis polymerization (ROMP). In this paper, enzyme-mediated chemical transformations are developed to regioselectively modify LSL[6'Ac,6?Ac] at sophorose primary hydroxyl positions (6' and 6?). The resulting modified LSLs were polymerized to expand polyLSL structural diversity, that is, polyLSL[6'OH,6?Ac], polyLSL[6'OH,6?OH], polyLSL[6'Bu,6?Ac], polyLSL[6'N3,6?Ac], and polyLSL[6'MA,6?Ac]. Controlled placement of azide and methacrylate at sophorolipid moieties enables the use of "click" reactions to introduce bioactive groups. Thermal analyses of polyLSLs showed that the acylation pattern at sugar moieties has a remarkable effect on chain stiffness and crystallinity. Films of polyLSL[6'Ac,6?Ac], polyLSL[6'OH,6?Ac], and polyLSL[6'Bu,6?Ac] exhibited nonbrittle behaviors with compressive elastic moduli ranging from similar to 1.5 to similar to 4.9 MPa. PolyLSLs were cytocompatible with human mesenchymal stem cells (h-MSCs), and examination of material-induced osteogenic cell lineage progression uncovered a dependence on polyLSL substitution at sophorose 6'-sites. This research reveals opportunities to regulate polyLSL physical properties and cell response behaviors by variation in substituents at polyLSL sophorolipid moieties.
C1 [Peng, Yifeng; Gross, Richard A.] Rensselaer Polytech Inst, Dept Biol & Chem, Troy, NY 12180 USA.
   [Munoz-Pinto, Dany J.; Hahn, Mariah; Gross, Richard A.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Munoz-Pinto, Dany J.; Hahn, Mariah; Gross, Richard A.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Decatur, John] Columbia Univ, NMR Ctr, Dept Chem, New York, NY 10027 USA.
   [Peng, Yifeng; Chen, Mingtao] NYU, Polytech Sch Engn, Dept Chem & Biomol Engn, Metro Tech Ctr 6, Brooklyn, NY 11201 USA.
RP Gross, RA (reprint author), Rensselaer Polytech Inst, Dept Biol & Chem, 110 8th St, Troy, NY 12180 USA.
EM grossr@rpi.edu
RI Hahn, Mariah/G-3998-2014; Peng, Yifeng/N-3375-2014
OI Hahn, Mariah/0000-0001-8794-129X; Peng, Yifeng/0000-0002-1273-8171
FU National Science Foundation Office of International Science and
   Engineering (NSFOISE) [1214469]; Office of Industrial Innovation and
   Partnership (IIP) [1114990]
FX The authors are grateful for funding received from the National Science
   Foundation Office of International Science and Engineering (NSFOISE)
   under Award No. 1214469 and the Office of Industrial Innovation and
   Partnership (IIP) under Award No. 1114990 for their financial support of
   this research.
CR Adnan S., 2011, J CHEM TECHNOL BIOT, V87, P431
   Ahmed M, 2013, EUR POLYM J, V49, P3010, DOI 10.1016/j.eurpolymj.2013.06.025
   ASMER HJ, 1988, J AM OIL CHEM SOC, V65, P1460, DOI 10.1007/BF02898308
   Baccile N, 2012, ACS NANO, V6, P4763, DOI 10.1021/nn204911k
   Balci M, 2005, BASIC 1H 13C NMR SPE, P228
   Becer CR, 2012, MACROMOL RAPID COMM, V33, P742, DOI 10.1002/marc.201200055
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bisht KS, 2000, MACROMOLECULES, V33, P6208, DOI 10.1021/ma0001537
   Bisht KS, 1999, J ORG CHEM, V64, P780, DOI 10.1021/jo981497m
   Bluth MH, 2006, CRIT CARE MED, V34, P188, DOI 10.1097/01.CCM.0000196212.56885.50
   Burdick JA, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P1, DOI 10.1007/978-3-7091-0385-2_1
   Campidelli S, 2008, J AM CHEM SOC, V130, P11503, DOI 10.1021/ja8033262
   Chatterjee AK, 2003, J AM CHEM SOC, V125, P11360, DOI 10.1021/ja0214882
   Codari F, 2012, POLYM DEGRAD STABIL, V97, P2460, DOI 10.1016/j.polymdegradstab.2012.06.026
   Cooley CB, 2009, J AM CHEM SOC, V131, P16401, DOI 10.1021/ja907363k
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   DEKOSTER CG, 1995, ANAL BIOCHEM, V230, P135, DOI 10.1006/abio.1995.1448
   Deshayes S, 2013, J POLYM SCI POL CHEM, V51, P3531, DOI 10.1002/pola.26765
   Elchinger PH, 2011, POLYMERS-BASEL, V3, P1607, DOI 10.3390/polym3041607
   Felse PA, 2007, ENZYME MICROB TECH, V40, P316, DOI 10.1016/j.enzmictec.2006.04.013
   Fishman JM, 2013, ANGEW CHEM INT EDIT, V52, P5061, DOI 10.1002/anie.201300293
   Fringant C, 1996, POLYMER, V37, P2663, DOI 10.1016/0032-3861(96)87626-9
   Fu SL, 2007, J AM COLL SURGEONS, V205, pS44, DOI 10.1016/j.jamcollsurg.2007.06.103
   Gao W, 2007, MACROMOLECULES, V40, P145, DOI 10.1021/ma0620159
   Geihe EI, 2012, P NATL ACAD SCI USA, V109, P13171, DOI 10.1073/pnas.1211361109
   Ghassemi AH, 2009, J CONTROL RELEASE, V138, P57, DOI 10.1016/j.jconrel.2009.04.025
   Gibson MI, 2009, BIOMACROMOLECULES, V10, P328, DOI 10.1021/bm801069x
   Goldstein I. J., 1973, BBA-PROTEINS PROTEOM, V30, P500
   GOLDSTEIN IJ, 1967, BIOCHEMISTRY-US, V6, P2373, DOI 10.1021/bi00860a012
   GORIN PA, 1961, CAN J CHEM, V39, P846, DOI 10.1139/v61-104
   Gregory TR, 2000, GENOME, V43, P895, DOI 10.1139/gen-43-5-895
   Guzman D. D., SOPHOROLIPIDS MAHUA
   Hagler M, 2007, J ALLERGY CLIN IMMUN, V119, pS263, DOI 10.1016/j.jaci.2006.12.399
   Hardin R, 2007, J SURG RES, V142, P314, DOI 10.1016/j.jss.2007.04.025
   Hasegawa T, 2006, CARBOHYD RES, V341, P35, DOI 10.1016/j.carres.2005.10.009
   Hu Yongmei, 2003, Biotechnology Progress, V19, P303, DOI 10.1021/bp0201197
   Jansen EJP, 2005, BIOMATERIALS, V26, P4423, DOI 10.1016/j.biomaterials.2004.11.001
   Karen M. J., 2011, BIOTECHNOL BIOENG, V108, P2923
   Kraus KH, 2006, VET SURG, V35, P232, DOI 10.1111/j.1532-950X.2006.00142.x
   Kumar R, 2002, MACROMOLECULES, V35, P6835, DOI 10.1021/ma020041a
   Lallana E, 2012, PHARM RES-DORDR, V29, P902, DOI 10.1007/s11095-012-0683-y
   Leemhuis M, 2008, EUR POLYM J, V44, P308, DOI 10.1016/j.eurpolymj.2007.12.004
   Levengood SKL, 2014, J MATER CHEM B, V2, P3161, DOI 10.1039/c4tb00027g
   Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Lowe AB, 2010, POLYM CHEM-UK, V1, P17, DOI 10.1039/b9py00216b
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Mueller CM, 2006, FASEB J, V20, pA204
   Munoz-Pinto DJ, 2012, TISSUE ENG PT A, V18, P1710, DOI [10.1089/ten.TEA.2011.0348, 10.1089/ten.tea.2011.0348]
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nandivada H, 2007, ADV MATER, V19, P2197, DOI 10.1002/adma.200602739
   Narain R., 2011, ENG CARBOHYDRATE BAS
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Noga DE, 2008, BIOMACROMOLECULES, V9, P2056, DOI 10.1021/bm800292Z
   Otto RT, 1999, APPL MICROBIOL BIOT, V52, P495, DOI 10.1007/s002530051551
   Ouhib R, 2009, CARBOHYD POLYM, V77, P32, DOI 10.1016/j.carbpol.2008.11.038
   Peng YF, 2013, MACROMOLECULES, V46, P3293, DOI 10.1021/ma400291c
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puls J, 2011, J POLYM ENVIRON, V19, P152, DOI 10.1007/s10924-010-0258-0
   Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Ronkvist AM, 2009, MACROMOLECULES, V42, P6086, DOI 10.1021/ma900530j
   Ronkvist AM, 2009, MACROMOLECULES, V42, P5128, DOI 10.1021/ma9005318
   Seyednejad H, 2011, J CONTROL RELEASE, V152, P168, DOI 10.1016/j.jconrel.2010.12.016
   Skaanderup PR, 2002, SYNTHESIS-STUTTGART, P1721
   Song EH, 2012, BIOMATERIALS, V33, P6889, DOI 10.1016/j.biomaterials.2012.06.025
   Stengel I, 2011, J MATER CHEM, V21, P3726, DOI 10.1039/c0jm03750h
   Suzuki S, 2012, BIOMATERIALS SURG OP
   Thirumurugan P, 2013, CHEM REV, V113, P4905, DOI 10.1021/cr200409f
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Ting SRS, 2010, POLYM CHEM-UK, V1, P1392, DOI 10.1039/c0py00141d
   Van Bogaert INA, 2007, APPL MICROBIOL BIOT, V76, P23, DOI 10.1007/s00253-007-0988-7
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Wyman C. E., 2004, POLYSACCHARIDES STRU
   Xiao NY, 2011, SOFT MATTER, V7, P10834, DOI 10.1039/c1sm06181j
   Zhang L, 2004, COLLOID SURFACE A, V240, P75, DOI 10.1016/j.colsurfa.2004.02.016
   Zhang L, 2008, MACROMOL RAPID COMM, V29, P123, DOI 10.1002/marc.200700663
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
   Zhou SQ, 2004, LANGMUIR, V20, P7926, DOI 10.1021/la048590s
   Zini E., 2008, MACROMOLECULES, V42, P7463
NR 83
TC 14
Z9 14
U1 3
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV
PY 2014
VL 15
IS 11
BP 4214
EP 4227
DI 10.1021/bm501255j
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AT1WI
UT WOS:000344721400036
PM 25316187
DA 2018-10-20
ER

PT J
AU Li, KB
   Zhang, YH
   Dang, Y
   Wei, H
   Wang, QQ
AF Li, Kebin
   Zhang, Yanhui
   Dang, Yan
   Wei, Hong
   Wang, Qiquan
TI Removal of Cr(VI) from Aqueous Solutions Using Buckwheat (Fagopyrum
   esculentum Moench) Hull through Adsorption-Reduction: Affecting Factors,
   Isotherm, and Mechanisms
SO CLEAN-SOIL AIR WATER
LA English
DT Article
DE Adsorption mechanism; Biomass; Biosorption; Heavy metals; Wastewater
   treatment
ID LOW-COST BIOSORBENTS; HEXAVALENT CHROMIUM; ASPERGILLUS-NIGER; FUNGAL
   BIOMASS; HEAVY-METALS; BIOSORPTION; WASTE; EQUILIBRIUM; PRODUCTS;
   CR(III)
AB Cr(VI) is a highly toxic pollutant and its contamination frequently occurs in aqueous environment. As an agricultural waste byproduct, buckwheat hull was used in this study as a low-cost biomaterial to remove Cr(VI) from aqueous solutions. The biomass was characterized using scanning electron microscopy, X-ray photoelectron spectroscopy (XPS), and Fourier transform infrared (FT-IR) spectroscopy. The performance of buckwheat hull on Cr(VI) removal was investigated using the batch experiments. The effect of affecting factors, such as solution pH, initial concentration of Cr(VI), adsorbent dose, temperature, and contact time, were carefully examined. The obtained results revealed that pH had significant effect on Cr(VI) removal and the optimal pH was about 2.0. Increase of adsorbent dose was favorable to the increase of removal ratio, but it decreased the adsorption capacity. Among Langmuir, Freundlich, and Dubinin-Radushkevich models, the Langmuir model was found to best fit the adsorption isotherms of Cr(VI) on buckwheat hull. The maximum adsorption capacity at 45 degrees C was 63.61mgg(-1). The thermodynamic parameters (G degrees, H degrees, and E) analysis indicated that the adsorption process was a spontaneous, endothermic and chemisorption process. In addition, XPS analysis revealed that the adsorbed Cr(VI) was partially reduced to Cr(III). FT-IR spectra indicated that the carboxyl and amino groups were involved in chromium adsorption. From these results, the most probable mechanisms for removal of Cr(VI) using buckwheat hull were found to be electrostatic attraction, chemical reduction, and complex interaction.
C1 [Li, Kebin; Zhang, Yanhui; Dang, Yan] NW Univ Xian, Sch Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol Chem, Minist Educ China, Xian 710069, Peoples R China.
   [Wei, Hong] Xian Univ Technol, Minist Educ China, Key Lab Northwest Water Resources Environm & Ecol, Xian, Peoples R China.
   [Wang, Qiquan] Delaware State Univ, Dept Chem, Dover, DE USA.
RP Li, KB (reprint author), NW Univ Xian, Sch Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol Chem, Minist Educ China, Xian 710069, Peoples R China.
EM kebin68li@163.com
FU Natural Science Foundation of Shaanxi Province [2013JM2011]; Scientific
   Research Plan Projects of Education Department of Shaanxi Province
   [12JK0643]
FX The authors would like to acknowledge financial support for this work
   provided by the Natural Science Foundation of Shaanxi Province
   (2013JM2011), and the Scientific Research Plan Projects of Education
   Department of Shaanxi Province (No. 12JK0643).
CR Abbas M, 2008, WATER AIR SOIL POLL, V191, P139, DOI 10.1007/s11270-007-9613-8
   Alam JB, 2005, SEP PURIF TECHNOL, V42, P85, DOI 10.1016/j.seppur.2004.06.006
   Alam MZ, 2011, CLEAN-SOIL AIR WATER, V39, P226, DOI 10.1002/clen.201000259
   Arief VO, 2008, CLEAN-SOIL AIR WATER, V36, P937, DOI 10.1002/clen.200800167
   Bai S, 2001, BIORESOURCE TECHNOL, V79, P73, DOI 10.1016/S0960-8524(00)00107-3
   Bajpai J, 2004, COLLOID SURFACE A, V236, P81, DOI 10.1016/j.colsurfa.2004.01.021
   Bayramoglu G, 2005, J HAZARD MATER, V119, P219, DOI 10.1016/j.jhazmat.2004.12.022
   BELLAMY LJ, 1975, INFRARED SPECTRA COM
   COTTON AF, 1988, ADV INORGANIC CHEM
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   Gabr RM, 2009, WORLD J MICROB BIOT, V25, P1695, DOI 10.1007/s11274-009-0063-x
   Gardea-Torresdey J. L., 2000, J HAZARD MAT B, VB80, P75
   Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013
   Hromadkova Z, 2003, ULTRASON SONOCHEM, V10, P127, DOI 10.1016/S1350-4177(03)00094-4
   Hsu NH, 2009, ENVIRON SCI TECHNOL, V43, P8801, DOI 10.1021/es901872x
   Kumar R, 2008, CHEM ENG J, V135, P202, DOI 10.1016/j.cej.2007.03.004
   Lin Rufa, 2005, Food Science, China, V26, P259
   Malkoc E, 2007, SEP PURIF TECHNOL, V54, P291, DOI 10.1016/j.seppur.2006.09.017
   Manning BA, 2007, ENVIRON SCI TECHNOL, V41, P586, DOI 10.1021/es061721m
   Minamisawa M, 2004, J AGR FOOD CHEM, V52, P5606, DOI 10.1021/jf0496402
   Miretzky P, 2010, J HAZARD MATER, V180, P1, DOI 10.1016/j.jhazmat.2010.04.060
   Mukoda T, 2001, BIOL PHARM BULL, V24, P209, DOI 10.1248/bpb.24.209
   Mungasavalli DP, 2007, COLLOID SURFACE A, V301, P214, DOI 10.1016/j.colsurfa.2006.12.060
   Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015
   Nakano Y, 2001, WATER RES, V35, P496, DOI 10.1016/S0043-1354(00)00279-7
   Ozer A, 2003, J HAZARD MATER, V100, P219, DOI 10.1016/S0304-3894(03)00109-2
   Parimala V, 2004, B ENVIRON CONTAM TOX, V73, P31, DOI 10.1007/s00128-004-0389-x
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Raji C, 1998, WATER RES, V32, P3772, DOI 10.1016/S0043-1354(98)00150-X
   Seh-Bardan B. J., 2012, CLEAN-SOIL AIR WATER, V41, P356
   Seki Y, 2005, J COLLOID INTERF SCI, V287, P1, DOI 10.1016/j.jcis.2004.10.072
   Singh KK, 2005, J COLLOID INTERF SCI, V290, P61, DOI 10.1016/j.jcis.2005.04.011
   Taj RY, 2009, CLEAN-SOIL AIR WATER, V37, P787, DOI 10.1002/clen.200900104
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Wang XS, 2008, J HAZARD MATER, V153, P1176, DOI 10.1016/j.jhazmat.2007.09.079
   Zubair A, 2008, WATER AIR SOIL POLL, V191, P305, DOI 10.1007/s11270-008-9626-y
NR 39
TC 6
Z9 6
U1 2
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1863-0650
EI 1863-0669
J9 CLEAN-SOIL AIR WATER
JI Clean-Soil Air Water
PD NOV
PY 2014
VL 42
IS 11
BP 1549
EP 1557
DI 10.1002/clen.201300399
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Environmental Sciences; Marine
   & Freshwater Biology; Water Resources
SC Science & Technology - Other Topics; Environmental Sciences & Ecology;
   Marine & Freshwater Biology; Water Resources
GA AT2PX
UT WOS:000344777700009
DA 2018-10-20
ER

PT J
AU Akar, ST
   Sayin, F
   Turkyilmaz, S
   Akar, T
AF Akar, Sibel Tunali
   Sayin, Fatih
   Turkyilmaz, Serpil
   Akar, Tamer
TI Multivariate optimization of the decolorization process by surface
   modified biomaterial: Box-Behnken design and mechanism analysis
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Pyracantha coccinea (P. coccinea); Modified biosorbent; Dye biosorption;
   Kinetics; Isotherms; Response surface methodology (RSM)
ID DRIED RHIZOPUS-ARRHIZUS; CAPSICUM-ANNUUM SEEDS; G REACTIVE DYE;
   AQUEOUS-SOLUTION; METHYL-VIOLET; WASTE BIOMASS; BASIC DYE; WOOD SAWDUST;
   BAKERS-YEAST; BIOSORPTION
AB A natural biosorbent obtained from Pyracantha coccinea was modified with an anionic surfactant to facilitate its dye removal ability. Modified biosorbent was successfully employed for the decolorization of Methyl Violet (MV)-contaminated solutions. A three-variable Box-Behnken design for response surface methodology was used to examine the function of independent operating variables. Optimum pH and biosorbent amount were found to be 6.0 and 0.055 g, respectively. The effects of temperature and ionic strength on the dye removal performance of biosorbent were also investigated. A biosorption equilibrium was attained within 30 min and experimental data fitted well to the pseudo-second-order model. The Langmuir isotherm model fitted adequately to the equilibrium data. The maximum monolayer biosorption capacity of the modified biosorbent was found to be 254.88 mg g(-1). Good biosorption yields were also recorded in continuous biosorption system. Ion exchange and complexation could be suggested as possible mechanisms for the biosorption. The developed modified biosorbent was regenerated up to 80.30% by 0.005 M HCl. At real wastewater conditions, it has 86.23 +/- 0.21 and 94.51 +/- 1.09% dye removal yields in batch and column systems, respectively. Modified biomaterial can be used as an effective biosorbent for the removal of MV dye from aqueous solution with high biosorption performance.
C1 [Akar, Sibel Tunali; Sayin, Fatih; Akar, Tamer] Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
   [Turkyilmaz, Serpil] Bilecik Seyh Edebali Univ, Fac Arts & Sci, Dept Math, Bilecik, Turkey.
RP Akar, ST (reprint author), Eskisehir Osmangazi Univ, Fac Arts & Sci, Dept Chem, Campus Meselik, TR-26480 Eskisehir, Turkey.
EM stunaliakar2@gmail.com
CR Ahmaruzzaman M, 2011, IND ENG CHEM RES, V50, P13589, DOI 10.1021/ie201477c
   Akar ST, 2011, CHEM ENG J, V168, P125, DOI 10.1016/j.cej.2010.12.049
   Akar T, 2010, BIORESOURCE TECHNOL, V101, P7271, DOI 10.1016/j.biortech.2010.04.044
   Akar T, 2009, J HAZARD MATER, V171, P865, DOI 10.1016/j.jhazmat.2009.06.085
   Akar T, 2009, J HAZARD MATER, V168, P1302, DOI 10.1016/j.jhazmat.2009.03.011
   Aksu Z, 2006, SEP PURIF TECHNOL, V48, P24, DOI 10.1016/j.seppur.2005.07.017
   Aksu Z, 2008, CHEM ENG J, V142, P23, DOI 10.1016/j.cej.2007.11.005
   Aksu Z, 2007, J HAZARD MATER, V143, P362, DOI 10.1016/j.jhazmat.2006.09.039
   Aksu Z, 2007, CHEM ENG J, V127, P177, DOI 10.1016/j.cej.2006.09.014
   Allen SJ, 2005, IND ENG CHEM RES, V44, P1942, DOI 10.1021/ie0489507
   Anjaneya O, 2009, INT BIODETER BIODEGR, V63, P782, DOI 10.1016/j.ibiod.2009.06.005
   Aravindhan R, 2007, J HAZARD MATER, V142, P68, DOI 10.1016/j.jhazmat.2006.07.058
   Asgher M, 2012, ECOL ENG, V38, P79, DOI 10.1016/j.ecoleng.2011.10.004
   Barron-Zambrano J, 2010, J ENVIRON MANAGE, V91, P2669, DOI 10.1016/j.jenvman.2010.07.033
   Belala Z, 2011, DESALINATION, V271, P80, DOI 10.1016/j.desal.2010.12.009
   Bhatnagar A, 2010, ADV COLLOID INTERFAC, V160, P1, DOI 10.1016/j.cis.2010.06.011
   Bingol A, 2009, J HAZARD MATER, V161, P747, DOI 10.1016/j.jhazmat.2008.04.018
   Crini G, 2008, DYES PIGMENTS, V77, P415, DOI 10.1016/j.dyepig.2007.07.001
   Daneshvar E, 2012, CHEM ENG J, V195, P297, DOI 10.1016/j.cej.2012.04.074
   Das Saha P, 2012, COLLOID SURFACE B, V92, P262, DOI 10.1016/j.colsurfb.2011.11.057
   Dubinin M, 1947, CHEM ZENTR, V1, P875
   El-Sersy Nermeen A, 2007, BIOTECHNOLOGY, V6, P34
   Fan H, 2012, J TAIWAN INST CHEM E, V43, P386, DOI 10.1016/j.jtice.2011.11.001
   Farah JY, 2007, J HAZARD MATER, V148, P402, DOI 10.1016/j.jhazmat.2007.02.053
   Fernandez ME, 2012, BIORESOURCE TECHNOL, V106, P55, DOI 10.1016/j.biortech.2011.12.003
   Freundlich H., 1906, ABSORPTION LOSUNGEN
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Hameed BH, 2008, J HAZARD MATER, V154, P204, DOI 10.1016/j.jhazmat.2007.10.010
   Han RP, 2007, J HAZARD MATER, V141, P713, DOI 10.1016/j.jhazmat.2006.07.031
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   Kaushik P, 2009, ENVIRON INT, V35, P127, DOI 10.1016/j.envint.2008.05.010
   Khambhaty Y, 2012, ECOL ENG, V41, P74, DOI 10.1016/j.ecoleng.2012.01.002
   Kiran B, 2007, CHEM ENG J, V126, P147, DOI 10.1016/j.cej.2006.09.002
   Kumar R, 2011, DESALINATION, V265, P112, DOI 10.1016/j.desal.2010.07.040
   Kwon OJ, 2008, CHEM ENG J, V140, P466, DOI 10.1016/j.cej.2007.11.037
   LAGERGREN S, 1989, KUNGLIGA SVENSKA VET, V24, P1
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Li P, 2010, J HAZARD MATER, V179, P43, DOI 10.1016/j.jhazmat.2010.02.054
   Liu L, 2012, CHEM ENG J, V187, P210, DOI 10.1016/j.cej.2012.01.136
   Loukidou MX, 2003, WATER RES, V37, P4544, DOI 10.1016/S0043-1354(03)00415-9
   Mall ID, 2006, DYES PIGMENTS, V69, P210, DOI 10.1016/j.dyepig.2005.03.013
   Mona S, 2011, ECOL ENG, V37, P1589, DOI 10.1016/j.ecoleng.2011.04.005
   Montgomery D C, 2005, DESIGN ANAL EXPT
   Nanseu-Njiki CP, 2010, J HAZARD MATER, V179, P63, DOI 10.1016/j.jhazmat.2010.02.058
   Oei BC, 2009, BIORESOURCE TECHNOL, V100, P4292, DOI 10.1016/j.biortech.2009.03.063
   Ofomaja AE, 2008, CHEM ENG J, V143, P85, DOI 10.1016/j.cej.2007.12.019
   Ofomaja AE, 2008, BIORESOURCE TECHNOL, V99, P5411, DOI 10.1016/j.biortech.2007.11.018
   Ofomaja AE, 2011, BIOMASS BIOENERG, V35, P4112, DOI 10.1016/j.biombioe.2011.05.024
   Ozcan AS, 2007, SEPAR SCI TECHNOL, V42, P137, DOI 10.1080/01496390600956977
   Pouralinazar F, 2012, J SUPERCRIT FLUID, V62, P88, DOI 10.1016/j.supflu.2011.12.009
   Pratibha R, 2010, DESALINATION, V264, P102, DOI 10.1016/j.desal.2010.07.011
   Saleem M, 2005, COLLOID SURFACE A, V260, P183, DOI 10.1016/j.colsurfa.2005.03.007
   Senturk HB, 2010, DESALINATION, V252, P81, DOI 10.1016/j.desal.2009.10.021
   Sharma P, 2009, J HAZARD MATER, V164, P1024, DOI 10.1016/j.jhazmat.2008.08.104
   Tian Y, 2010, CHEM ENG J, V165, P474, DOI 10.1016/j.cej.2010.09.037
   Tunali S, 2007, J ENVIRON SCI HEAL A, V42, P591, DOI 10.1080/10934520701244359
   Vijayaraghavan K, 2008, CHEM ENG J, V145, P1, DOI 10.1016/j.cej.2008.02.011
   Vijayaraghavan K, 2008, BIORESOURCE TECHNOL, V99, P5778, DOI 10.1016/j.biortech.2007.10.012
   Walker GM, 2000, ENVIRON POLLUT, V108, P219, DOI 10.1016/S0269-7491(99)00187-6
   Wang BE, 2008, BIORESOURCE TECHNOL, V99, P794, DOI 10.1016/j.biortech.2007.01.043
   Weber Jr WJ, 1963, J SANIT ENG DIV AM S, V89, P31
   Yeddou-Mezenner N, 2010, DESALINATION, V262, P251, DOI 10.1016/j.desal.2010.06.023
NR 62
TC 6
Z9 8
U1 0
U2 19
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD NOV
PY 2014
VL 21
IS 22
BP 13055
EP 13068
DI 10.1007/s11356-014-3245-5
PG 14
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AS9EX
UT WOS:000344546900042
PM 24996942
DA 2018-10-20
ER

PT J
AU Li, C
   Liu, IKK
   Tsao, CY
   Chan, V
AF Li, Chuan
   Liu, Isaac K-K
   Tsao, C. Y.
   Chan, Vincent
TI Neuronal differentiation of human placenta-derived multi-potent stem
   cells enhanced by cell body oscillation on gelatin hydrogel
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Human placenta-derived stem cells; gelatin hydrogel; neuronal
   differentiation; cellular image processing
ID MECHANICAL-PROPERTIES; IN-VITRO; GROWTH-FACTOR; FILMS; TISSUE;
   SCAFFOLDS; BONE; GLUTARALDEHYDE; BIOMATERIALS; REGENERATION
AB Gelatin is a biocompatible material commonly employed in biomaterial design and tissue engineering. However, there is currently a lack of research into the development of gelatin hydrogels for facilitating specific lineage development of stem cells. In this study, the neuronal differentiation of human placenta-derived multi-potent (stem) cells was systematically optimized through the engineering of the gelatin hydrogel properties. The swelling ratio of Type A or Type B gelatin hydrogel changes during hydrogel formation in the gelatin concentration ranges from 16 to 6 wt%. In general, placenta-derived multi-potent (stem) cells effectively adhere on both, acidic and basic gelatin hydrogels with different swelling ratios as shown by the high attachment ratio of around 80%. Interestingly, adhered placenta-derived multi-potent (stem) cells had significant cell body oscillations on either 6 or 10 wt% gelatin hydrogels during the first 3 h of cell seeding. For placenta-derived multi-potent (stem) cells pre-cultured on 6 and 10 wt% gelatin hydrogel for either 2 or 12 h and subjected to 3-isobutyl-1-methylxanthine to induce neuronal differentiation, the periodic contraction and extension of placenta-derived multi-potent (stem) cells pre-cultured for 2 h successfully directed the cells into neuron-like lineages. In contrast, the lack of cell body oscillation restrained the placenta-derived multi-potent (stem) cells pre-cultured for 12 h from differentiating into neuronal cells on the same gelatin hydrogels in response to 3-isobutyl-1-methylxanthine stimulation. Overall, the possibility of engineering the properties of gelatin hydrogel to trigger stem cell development into a neuronal lineage through cell body oscillations was clearly demonstrated.
C1 [Li, Chuan] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 11221, Taiwan.
   [Li, Chuan; Tsao, C. Y.] Natl Cent Univ, Dept Mech Engn, Jhongli, Taiwan.
   [Liu, Isaac K-K] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England.
   [Chan, Vincent] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
RP Li, C (reprint author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei 11221, Taiwan.
EM cli10@cc.ncu.edu.tw; mvchan@ntu.edu.sg
RI Chan, Vincent/G-6197-2010
OI Chan, Vincent/0000-0003-2149-4479
FU Ministry of Science and Technology, Taiwan [NSC 100-2221-E-008 -057, NSC
   101-2221-E- 008 -007]
FX We would like to thank the Research Center of Cathay General Hospital
   for their facilities and administrative support. We would like to thank
   Dr Chih-Cheng Chien and Dr Yu-Che Cheng from General Cathay Hospital for
   their academic guidance on all of the biological experiments. Part of
   this study is supported by the Ministry of Science and Technology,
   Taiwan under contract number NSC 100-2221-E-008 -057 and NSC 101-2221-E-
   008 -007.
CR Araki M, 2005, J NEUROPHYSIOL, V94, P2644, DOI 10.1152/jn.00502.2005
   Aydin HM, 2011, J BIOACT COMPAT POL, V26, P207, DOI 10.1177/0883911511399411
   Bai Y, 2013, J BIOACT COMPAT POLY, V28, P126
   Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x
   BEAVO JA, 1995, PHYSIOL REV, V75, P725
   Chang YJ, 2010, CELLS TISSUES ORGANS, V192, P93, DOI 10.1159/000295774
   CHATTERJI PR, 1989, J APPL POLYM SCI, V37, P2203, DOI 10.1002/app.1989.070370812
   Chen L, 2009, CELL MOL BIOL LETT, V14, P528, DOI 10.2478/s11658-009-0015-3
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116
   Choudhury NA, 2008, J ELECTROCHEM SOC, V155, pA74, DOI 10.1149/1.2803501
   Denavi GA, 2009, FOOD HYDROCOLLOID, V23, P2094, DOI 10.1016/j.foodhyd.2009.03.007
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   Gao CJ, 2007, J BIOMAT SCI-POLYM E, V18, P799, DOI 10.1163/156856207781367710
   Gioffre M, 2012, J BIOACT COMPAT POL, V27, P67, DOI 10.1177/0883911511431484
   Gorgieva S, 2012, J BIOMED MATER RES A, V100A, P1655, DOI 10.1002/jbm.a.34106
   Huang H-I, 2007, CURR PROTOC STEM CEL, V1
   Izzo AA, 1997, BRIT J PHARMACOL, V121, P768, DOI 10.1038/sj.bjp.0701142
   Jang SA, 2011, J FOOD SCI, V76, pC218, DOI 10.1111/j.1750-3841.2010.02026.x
   Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Kuo YC, 2013, COLLOID SURFACE B, V103, P595, DOI 10.1016/j.colsurfb.2012.11.001
   Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c
   Ma HY, 2012, CELL TRANSPLANT, V21, P857, DOI 10.3727/096368911X612486
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   Mukherjee I, 2013, J THERM ANAL CALORIM, V114, P1161, DOI 10.1007/s10973-013-3166-4
   Pessina A, 2006, CURR MED RES OPIN, V22, P2287, DOI 10.1185/030079906X148517
   Rosellini E, 2009, J BIOMED MATER RES A, V91A, P447, DOI 10.1002/jbm.a.32216
   Slade L, COLLAGEN FOOD, V4, P251
   Sobral PJA, 2001, FOOD HYDROCOLLOID, V15, P377, DOI 10.1016/S0268-005X(01)00060-1
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Tan S, 2014, BIOMATERIALS, V35, P5294, DOI 10.1016/j.biomaterials.2014.02.040
   Tan WJ, 2005, BIOMATERIALS, V26, P891, DOI 10.1016/j.biomaterials.2004.03.041
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Tio M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009398
   Verina T, 2013, PEDIATR NEUROL, V48, P346, DOI 10.1016/j.pediatrneurol.2012.10.010
   Wallace VA, 1999, EXP EYE RES, V69, P617, DOI 10.1006/exer.1999.0741
   Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008
   Xu J, 2012, INT J PHARMACEUT, V427, P21, DOI 10.1016/j.ijpharm.2011.05.036
   Yakimets I, 2005, POLYMER, V46, P12577, DOI 10.1016/j.polymer.2005.10.090
   Yao R, 2009, J BIOACT COMPAT POL, V24, P5, DOI 10.1177/0883911508099367
NR 41
TC 1
Z9 1
U1 0
U2 20
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD NOV
PY 2014
VL 29
IS 6
BP 529
EP 544
DI 10.1177/0883911514553903
PG 16
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA AT0WZ
UT WOS:000344654800001
DA 2018-10-20
ER

PT J
AU Barton, MJ
   Morley, JW
   Mahns, DA
   Mawad, D
   Wuhrer, R
   Fania, D
   Frost, SJ
   Loebbe, C
   Lauto, A
AF Barton, Matthew J.
   Morley, John W.
   Mahns, David A.
   Mawad, Damia
   Wuhrer, Richard
   Fania, David
   Frost, Samuel J.
   Loebbe, Christian
   Lauto, Antonio
TI Tissue repair strength using chitosan adhesives with different
   physical-chemical characteristics
SO JOURNAL OF BIOPHOTONICS
LA English
DT Article
DE biomaterial; chitosan; photochemical-tissue-bonding; molecular weight;
   degree-of-deacetylation and rose Bengal
ID IN-VIVO; BIOMEDICAL APPLICATIONS; FILMS; VITRO; GLUE
AB A range of chitosan-based biomaterials have recently been used to perform sutureless, laser-activated tissue repair. Laser-activation has the advantage of bonding to tissue through a non-contact, aseptic mechanism. Chitosan adhesive films have also been shown to adhere to sheep intestine strongly without any chemical modification to chitosan. In this study, we continue to investigate chitosan adhesive films and explore the impact on the tissue repair strength and tensile strength characteristics of four types of adhesive film based on chitosan with different molecular weight and degree of deacetylation. Results showed that adhesives based on chitosan with medium molecular weight achieved the highest bonding strength, tensile strength and E-modulus when compared to the other adhesives. ((c) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)
C1 [Barton, Matthew J.; Morley, John W.; Mahns, David A.; Lauto, Antonio] Univ Western Sydney, Sch Med, Penrith, NSW 2751, Australia.
   [Morley, John W.; Mahns, David A.; Lauto, Antonio] Univ Western Sydney, MARCS Inst, Bioelect & Neurosci BENS Res Grp, Penrith, NSW 2751, Australia.
   [Mawad, Damia] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, Dept Mat, London SW7 2AZ, England.
   [Mawad, Damia] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England.
   [Wuhrer, Richard] Univ Western Sydney, Adv Mat Characterisat Facil, Penrith, NSW 2751, Australia.
   [Fania, David; Frost, Samuel J.] Univ Western Sydney, Sch Sci & Hlth, Penrith, NSW 2751, Australia.
   [Loebbe, Christian] Scitech Pty Ltd, Preston, Vic 3072, Australia.
RP Lauto, A (reprint author), Univ Western Sydney, Sch Med, Locked Bag 1797, Penrith, NSW 2751, Australia.
EM a.lauto@uws.edi.au
OI Mahns, David/0000-0003-2131-9638; Frost, Samuel/0000-0001-5275-1699
CR Au V, 2000, ARCH BIOCHEM BIOPHYS, V384, P133, DOI 10.1006/abbi.2000.2070
   Autumn K, 2000, NATURE, V405, P681
   Barton MJ, 2015, J BIOPHOTONICS, V8, P196, DOI 10.1002/jbio.201300129
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Encinas MV, 2009, POLYMER, V50, P2762, DOI 10.1016/j.polymer.2009.04.024
   Esposito G, 2013, LASER SURG MED, V45, P318, DOI 10.1002/lsm.22145
   Foster LJR, 2010, BIOMACROMOLECULES, V11, P3563, DOI 10.1021/bm101028g
   Gartner C, 2011, BIOMACROMOLECULES, V12, P1380, DOI 10.1021/bm200193u
   Hoffmann B, 2009, J MATER SCI-MATER M, V20, P2001, DOI 10.1007/s10856-009-3782-5
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A., 2012, J VIS EXP, V68
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   Lauto A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-47
   Leceta I, 2013, CARBOHYD POLYM, V93, P339, DOI 10.1016/j.carbpol.2012.04.031
   Matteini P, 2012, J BIOPHOTONICS, V5, P868, DOI 10.1002/jbio.201200115
   Matteini P, 2010, ADV MATER, V22, P4313, DOI 10.1002/adma.201002228
   Nguyen S, 2009, CARBOHYD POLYM, V75, P528, DOI 10.1016/j.carbpol.2008.08.013
   Ryu JH, 2011, BIOMACROMOLECULES, V12, P2653, DOI 10.1021/bm200464x
   Serrero A, 2011, BIOMACROMOLECULES, V12, P1556, DOI 10.1021/bm101505r
   Shahbazi J, 2011, LASER SURG MED, V43, P490, DOI 10.1002/lsm.21076
   Xu JK, 2012, LANGMUIR, V28, P14010, DOI 10.1021/la3025414
   Yamada K, 2000, BIOMACROMOLECULES, V1, P252, DOI 10.1021/bm0003009
   Yang TL, 2011, INT J MOL SCI, V12, P1936, DOI 10.3390/ijms12031936
   Yuan YL, 2011, MATERIALS, V4, P1399, DOI 10.3390/ma4081399
NR 24
TC 11
Z9 12
U1 3
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1864-063X
EI 1864-0648
J9 J BIOPHOTONICS
JI J. Biophotonics
PD NOV
PY 2014
VL 7
IS 11-12
BP 948
EP 955
DI 10.1002/jbio.201300148
PG 8
WC Biochemical Research Methods; Biophysics; Optics
SC Biochemistry & Molecular Biology; Biophysics; Optics
GA AT0WB
UT WOS:000344651800010
PM 24395818
DA 2018-10-20
ER

PT J
AU Soares, LGP
   Marques, AMC
   Guarda, MG
   Aciole, JMS
   Andrade, AS
   Pinheiro, ALB
   Silveira, L
AF Soares, Luiz Guilherme P.
   Marques, Aparecida Maria C.
   Guarda, Milena G.
   Aciole, Jouber Mateus S.
   Andrade, Aline S.
   Pinheiro, Antonio Luiz B.
   Silveira, Landulfo, Jr.
TI Raman spectroscopic study of the repair of surgical bone defects grafted
   or not with biphasic synthetic micro-granular HA plus beta-calcium
   triphosphate irradiated or not with lambda 850 nm LED light
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Bone repair; Hydroxyapatite; LED phototherapy
ID INFRARED-LASER PHOTOBIOMODULATION; MINERAL TRIOXIDE AGGREGATE; EMITTING
   DIODE IRRADIATION; MORPHOGENETIC PROTEINS; RODENT MODEL; REGENERATION;
   PHOTOTHERAPY; THERAPY; RABBITS; RATS
AB The handling of bone losses due to different etiologic factors is difficult and many techniques are aim to improve repair, including a wide range of biomaterials and, recently, photobioengineering. This work aimed to assess, through Raman spectroscopy, the level of bone mineralization using the intensities of the Raman peaks of both inorganic (similar to 960, similar to 1,070, and 1,077 cm(-1)) and organic (similar to 1,454 and similar to 1,666 cm(-1)) contents of bone tissue. Forty rats were divided into four groups each subdivided into two subgroups according to the time of sacrifice (15 and 30 days). Surgical bone defects were made on the femur of each animal with a trephine drill. On animals of group clot, the defect was filled only by blood clot, on group LED, the defect filled with the clot was further irradiated. On animals of groups biomaterial and LED + biomaterial, the defect was filled by biomaterial and the last one was further irradiated (lambda 850 +/- 10 nm, 150 mW, I broken vertical bar similar to 0.5 cm(2), 20 J/cm(2)-session, 140 J/cm(2)-treatment) at 48-h intervals and repeated for 2 weeks. At both 15th and 30th days following sacrifice, samples were taken and analyzed by Raman spectroscopy. At the end of the experimental time, the intensity of hydroxyapatite (HA) (similar to 960 cm(-1)) were higher on group LED + biomaterial and the peaks of both organic content (similar to 1,454 and similar to 1,666 cm(-1)) and transitional HA (similar to 1,070 and similar to 1,077 cm(-1)) were lower on the same group. It is concluded that the use of LED phototherapy associated to biomaterial was effective in improving bone healing on bone defects as a result of the increasing deposition of HA measured by Raman spectroscopy.
C1 [Soares, Luiz Guilherme P.; Marques, Aparecida Maria C.; Guarda, Milena G.; Aciole, Jouber Mateus S.; Andrade, Aline S.; Pinheiro, Antonio Luiz B.] Univ Fed Bahia, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Marques, Aparecida Maria C.; Pinheiro, Antonio Luiz B.] Univ Sao Paulo, Natl Inst Opt & Photon, Phys Inst Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Pinheiro, Antonio Luiz B.; Silveira, Landulfo, Jr.] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose de Campos Rod, BR-12247004 Sao Jose Dos Campos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM luizguilherme_@hotmail.com; cidamarques77@hotmail.com;
   mileguarda@hotmail.com; jouber_aciole@hotmail.com;
   alinesilvaodonto@yahoo.com.br; albp@ufba.br; landulfo.silveira@gmail.com
RI Pinheiro, Antonio Luiz/A-1962-2008; Silveira, Landulfo/I-2474-2012; Sao
   Carlos Institute of Physics, IFSC/USP/M-2664-2016
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321; Silveira,
   Landulfo/0000-0002-6616-3334; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for providing financial support for this
   project.
CR Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Gross J S, 1997, Compend Contin Educ Dent, V18, P1013
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Okagbare PI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090502
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 2003, DENT MED PROBL, V40, P37
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
NR 27
TC 4
Z9 4
U1 0
U2 14
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD NOV
PY 2014
VL 29
IS 6
BP 1927
EP 1936
DI 10.1007/s10103-014-1601-9
PG 10
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA AS9CA
UT WOS:000344539700020
PM 25027176
DA 2018-10-20
ER

PT J
AU Wang, C
   Li, Y
AF Wang, C.
   Li, Y.
TI Synthesis, characterisation and photocatalytic activity of natural
   zeolite supported Fe/S and Cr/S codoped nanoTiO(2) photocatalysts
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Natural zeolite; Fe/S codoping; Cr/S codoping; TiO2; Photocatalysts
ID FERRITE COMPOSITE NANOPARTICLES; VISIBLE-LIGHT IRRADIATION; DOPED TIO2;
   FE3+-TIO2 PHOTOCATALYSTS; BIOMATERIAL SYSTEM; DEGRADATION; COATINGS;
   SULFUR; CARBON; WATER
AB Natural zeolite supported Fe/S and Cr/S codoped nanoTiO(2) photocatalysts were synthesised by TiCl4 hydrolysis method. The materials were characterised by X-ray diffraction, Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy, ultraviolet-visible diffuse reflection spectroscopy and photoluminescence. The photocatalytic activity was evaluated by the degradation of methyl orange in aqueous solution. The results showed that photocatalytic activity of Fe/S codoped sample was higher than that of Fe and S doped samples respectively, although Fe/S codoping further enhanced recombination rate of TiO2 electron-hole pairs. The photocatalytic activity of Cr/S doped sample was higher than that of S doped sample, but a little lower than that of Cr doped sample. Further studies on how to decrease the recombination rate of electron-hole pairs and improve the photocatalytic activity of ions codoped photocatalysts should be investigated.
C1 [Wang, C.] Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Peoples R China.
   [Wang, C.] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 2V4, Canada.
   [Li, Y.] Shijiazhuang Univ Econ, Inst Mat Sci & Engn, Shijiazhuang 050031, Peoples R China.
RP Wang, C (reprint author), Shaanxi Univ Sci & Technol, Sch Mat Sci & Engn, Xian 710021, Peoples R China.
EM wangchengtj@163.com
FU Hebei Natural Science Foundation, China [E2008000537]; State Key
   Laboratory of Advanced Technology for Materials Synthesis and Processing
   (Wuhan University of Technology) [2013-KF-13]; Foundation of Shaanxi
   University of Science and Technology [BJ12-18]; Shaanxi Natural Science
   Foundation, China [2013JQ6007]
FX The project supported by the Hebei Natural Science Foundation, China
   (Grant No. E2008000537), State Key Laboratory of Advanced Technology for
   Materials Synthesis and Processing (Wuhan University of Technology) (No.
   2013-KF-13), Foundation of Shaanxi University of Science and Technology
   (No. BJ12-18) and Shaanxi Natural Science Foundation, China (Grant No.
   2013JQ6007).
CR Akurati KK, 2008, APPL CATAL B-ENVIRON, V79, P53, DOI 10.1016/j.apcatb.2007.09.036
   Cai HS, 2008, J RARE EARTH, V26, P71, DOI 10.1016/S1002-0721(08)60040-X
   Cho J, 2008, J NANOPART RES, V10, P99, DOI 10.1007/s11051-007-9230-x
   Hamadanian M, 2011, DESALINATION, V281, P319, DOI 10.1016/j.desal.2011.08.028
   Huang ML, 2008, DYES PIGMENTS, V77, P327, DOI 10.1016/j.dyepig.2007.01.026
   Hung WC, 2008, APPL SURF SCI, V255, P2205, DOI 10.1016/j.apsusc.2008.07.079
   Jin ZL, 2006, J MOL CATAL A-CHEM, V259, P275, DOI 10.1016/j.molcata.2006.06.035
   Jing LQ, 2004, J SOLID STATE CHEM, V177, P3375, DOI 10.1016/j.jssc.2004.05.064
   Kim DH, 2004, J ALLOY COMPD, V375, P259, DOI 10.1016/j.jallcom.2003.11.044
   Li YZ, 2010, LANGMUIR, V26, P591, DOI 10.1021/la902117c
   Marcos P. S., 2003, ENVIRON SCI TECHNOL, V37, P2296
   Marcos PS, 2008, J PHOTOCH PHOTOBIO A, V197, P125, DOI 10.1016/j.jphotochem.2007.12.017
   Niu YX, 2013, CATAL TODAY, V201, P159, DOI 10.1016/j.cattod.2012.04.035
   Qourzal S, 2009, MAT SCI ENG C-BIO S, V29, P1616, DOI 10.1016/j.msec.2008.12.024
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tayade RJ, 2007, IND ENG CHEM RES, V46, P369, DOI 10.1021/ie060641o
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang BQ, 2006, APPL SURF SCI, V252, P2817, DOI 10.1016/j.apsusc.2005.04.025
   Wang C, 2014, MATER TECHNOL, V29, P204, DOI 10.1179/1753555714Y.0000000127
   Wang C, 2012, APPL SURF SCI, V258, P4328, DOI 10.1016/j.apsusc.2011.12.108
   Wang C, 2011, APPL CLAY SCI, V53, P646, DOI 10.1016/j.clay.2011.05.017
   Wang C, 2011, APPL SURF SCI, V257, P6873, DOI 10.1016/j.apsusc.2011.03.021
   Watanabe T, 2000, J SOL-GEL SCI TECHN, V19, P71, DOI 10.1023/A:1008762121743
   Wu XW, 2009, APPL PHYS A-MATER, V97, P243, DOI 10.1007/s00339-009-5212-4
   Yang X, 2007, J CATAL, V252, P296, DOI 10.1016/j.jcat.2007.09.014
   Yang XX, 2009, APPL CATAL B-ENVIRON, V91, P657, DOI 10.1016/j.apcatb.2009.07.006
   Yu JC, 2002, CHEM MATER, V14, P3808, DOI 10.1021/cm020027c
   Zhang G. K., 2008, LANGMUIR, V23, P1026
   Zhang XW, 2005, CARBON, V43, P1700, DOI 10.1016/j.carbon.2005.02.013
   Zhu JF, 2006, J PHOTOCH PHOTOBIO A, V180, P196, DOI 10.1016/j.jphotochem.2005.10.017
   Znad H, 2009, J MOL CATAL A-CHEM, V314, P55, DOI 10.1016/j.molcata.2009.08.017
NR 33
TC 1
Z9 2
U1 1
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD NOV
PY 2014
VL 29
IS 6
BP 372
EP 376
DI 10.1179/1753555714Y.0000000169
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AT1SQ
UT WOS:000344714700009
DA 2018-10-20
ER

PT J
AU Xu, H
   Zhang, W
   Li, Y
   Ye, FF
   Yin, PP
   Yu, X
   Hu, MN
   Fu, YS
   Wang, C
   Shang, DJ
AF Xu, Huan
   Zhang, Wei
   Li, Yan
   Ye, Fei F.
   Yin, Peng P.
   Yu, Xiu
   Hu, Mei N.
   Fu, Yuan S.
   Wang, Che
   Shang, De J.
TI The Bifunctional Liposomes Constructed by
   Poly(2-ethyl-oxazoline)-cholesteryl Methyl Carbonate: an Effectual
   Approach to Enhance Liposomal Circulation Time, pH-Sensitivity and
   Endosomal Escape
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE bifunctional; liposomes; long-circulating; pH-sensitive;
   poly(2-ethyl-oxazoline)
ID INTRACELLULAR DELIVERY; GENE DELIVERY; PEG; MICELLES; NANOPARTICLES;
   DETERGENTS; COPOLYMERS; EFFICIENT; PROTEINS; VESICLES
AB A novel bifunctional liposome with long-circulating and pH-sensitive properties was constructed using poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate (PEtOz-CHMC) in this study.
   PEtOz-CHMC was synthesized and characterized by TLC, IR and H-1-NMR. The obtained PEtOz lipid was inserted into liposomes by the post-insertion method. Through a series of experiments, such as drug release, tumor cell uptake, cytotoxicity, calcium-induced aggregation, pharmacokinetic experiments, etc., the pH-sensitive and long-circulating properties of PEtOzylated liposomes was identified.
   PEtOz-CHMC modified liposomes (PEtOz-L) showed increased calcein release at low pH. Flow cytometric analysis results showed that the fusion and cellular uptake of PEtOz-L could be promoted significantly at pH 6.4 compared with those at pH 7.4. Confocal laser scanning microscope observations revealed that PEtOz-L could respond to low endosomal pH and directly released the fluorescent tracer into the cytoplasm. MTT assays in HeLa cells demonstrated that doxorubicin hydrochloride (DOX) loaded PEtOz-L exhibited stronger anti-tumor activity in a medium at pH 6.4 than in a medium pH 7.4. PEtOz-L remained stable when these liposomes were incubated in calcium chloride solution. The cumulative calcein release rate of PEtOz-L was significantly lower than that of CL when the liposomes were dialysed in PBS. The pharmacokinetic experiments of liposomes in rats showed that t (1/2) and AUC of PEtOz-L were 4.13 times and 4.71 times higher than those of CL.
   PEtOzylated liposomes exhibits excellent long-circulating and pH-sensitive properties. Our results suggest that PEtOz is a promising biomaterial for the modification of liposome in drug delivery.
C1 [Xu, Huan; Zhang, Wei; Li, Yan; Ye, Fei F.; Yin, Peng P.; Yu, Xiu; Hu, Mei N.; Wang, Che] Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian 116029, Peoples R China.
   [Fu, Yuan S.] Dalian Med Univ, Dept Anat, Coll Basic Med Sci, Dalian 116044, Peoples R China.
   [Shang, De J.] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian 116081, Peoples R China.
RP Xu, H (reprint author), Liaoning Normal Univ, Dept Pharm, Sch Chem & Chem Engn, Dalian 116029, Peoples R China.
EM huan.xu1@163.com
RI Wang, Che/A-2784-2015
FU National Natural Science Foundation of China [81102394]; China
   Postdoctoral Science Foundation [2013M530899]
FX This work was supported by National Natural Science Foundation of China
   (81102394) and China Postdoctoral Science Foundation funded project
   (2013M530899)
CR Anabousi S, 2005, EUR J PHARM BIOPHARM, V60, P295, DOI 10.1016/j.ejpb.2004.12.009
   Asokan A, 2005, J CONTROL RELEASE, V106, P146, DOI 10.1016/j.jconrel.2005.04.010
   BANGHAM JA, 1978, BIOCHIM BIOPHYS ACTA, V511, P388, DOI 10.1016/0005-2736(78)90275-4
   Basile L, 2012, INT J PHARMACEUT, V426, P231, DOI 10.1016/j.ijpharm.2012.01.038
   COUVREUR P, 1993, ADV DRUG DELIVER REV, V10, P141, DOI 10.1016/0169-409X(93)90046-7
   Dadashzadeh S, 2008, INT J PHARMACEUT, V353, P251, DOI 10.1016/j.ijpharrn.2007.11.030
   Di ML, 2008, BIOCHIM BIOPHYS ACTA, V1778, P2749
   Garg A, 2011, CURR PHARM BIOTECHNO, V12, P1135, DOI 10.2174/138920111796117328
   Han HD, 2007, J CONTROL RELEASE, V120, P161, DOI 10.1016/j.jconrel.2007.03.020
   HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9
   Hatakeyama H, 2011, BIOMATERIALS, V32, P4306, DOI 10.1016/j.biomaterials.2011.02.045
   Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001
   Holland JW, 1996, BIOCHEMISTRY-US, V35, P2618, DOI 10.1021/bi952000v
   Hsiue GH, 2006, BIOCONJUGATE CHEM, V17, P781, DOI 10.1021/bi050317u
   Hsiue GH, 2006, INT J PHARM, V317, P69, DOI 10.1016/j.ijpharm.2006.03.002
   Kim JY, 2009, BIOMATERIALS, V30, P5751, DOI 10.1016/j.biomaterials.2009.07.021
   Lee SC, 2007, LANGMUIR, V23, P488, DOI 10.1021/la0623580
   Mero A, 2008, J CONTROL RELEASE, V125, P87, DOI 10.1016/j.jconrel.2007.10.010
   MIYAMOTO M, 1990, MACROMOLECULES, V23, P3201, DOI 10.1021/ma00215a001
   Nakamura K, 2012, BBA-BIOMEMBRANES, V1818, P2801, DOI 10.1016/j.bbamem.2012.06.019
   Piperoudi S, 2006, CHEM PHYS LIPIDS, V139, P96, DOI 10.1016/j.chemphyslip.2005.11.003
   Seow WY, 2007, BIOMATERIALS, V28, P1730, DOI 10.1016/j.biomaterials.2006.11.039
   Shi GF, 2002, J CONTROL RELEASE, V80, P309, DOI 10.1016/S0168-3659(02)00017-2
   Simoes S, 2001, BBA-BIOMEMBRANES, V1515, P23, DOI 10.1016/S0005-2736(01)00389-3
   SZOKA F, 1978, P NATL ACAD SCI USA, V75, P4194, DOI 10.1073/pnas.75.9.4194
   Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026
   Wang CH, 2003, BIOMACROMOLECULES, V4, P1487, DOI 10.1021/bm034190s
   Wang CH, 2009, BIOMATERIALS, V30, P3352, DOI 10.1016/j.biomaterials.2009.02.041
   Wang X, 2011, ACTA BIOMATER, V7, P4149, DOI 10.1016/j.actbio.2011.07.011
   Wiesbrock F, 2004, MACROMOL RAPID COMM, V25, P1895, DOI 10.1002/marc.200400369
   WOODLE MC, 1994, BIOCONJUGATE CHEM, V5, P493, DOI 10.1021/bc00030a001
   Xu H, 2008, J CONTROL RELEASE, V130, P238, DOI 10.1016/j.jconrel.2008.05.009
   Yoshino K, 2012, COLLOID SURFACE A, V397, P73, DOI 10.1016/j.colsurfa.2012.01.035
   Zalipsky S, 1996, J PHARM SCI, V85, P133, DOI 10.1021/js9504043
NR 34
TC 9
Z9 15
U1 1
U2 43
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD NOV
PY 2014
VL 31
IS 11
BP 3038
EP 3050
DI 10.1007/s11095-014-1397-0
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AS9HN
UT WOS:000344554000010
PM 24805279
DA 2018-10-20
ER

PT J
AU Bracaglia, LG
   Yu, L
   Hibino, N
   Fisher, JP
AF Bracaglia, Laura G.
   Yu, Li
   Hibino, Narutoshi
   Fisher, John P.
TI Reinforced Pericardium as a Hybrid Material for Cardiovascular
   Applications
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID POLY(PROPYLENE FUMARATE); MECHANICAL-PROPERTIES; BOVINE PERICARDIUM;
   CROSS-LINKING; HEART-VALVES; IN-VITRO; GLUTARALDEHYDE; CALCIFICATION;
   BIOMATERIALS; INFLAMMATION
AB Pericardium-based cardiovascular devices are currently bound by a 10-year maximum lifetime due to detrimental calcification and degradation. The goal of this work is to develop a novel synthetic material to create a lasting replacement for malfunctioning or diseased tissue in the cardiovascular system. This study couples poly(propylene fumarate) (PPF) and a natural biomaterial together in an unprecedented hybrid composite and evaluates the composite versus the standard glutaraldehyde-treated tissue. The polymer reinforcement is hypothesized to provide initial physical protection from proteolytic enzymes and degradation, but leave the original collagen and elastin matrix unaltered. The calcification rate and durability of the hybrid material are evaluated in vitro and in an in vivo subdermal animal model. Results demonstrate that PPF is an effective support and leads to significantly less calcium deposition, important metrics when evaluating cardiovascular material. By avoiding chemical crosslinking of the tissue and associated side effects, PPF-reinforced pericardium as a biohybrid material offers a promising potential direction for further development in cardiovascular material alternatives. Eliminating the basis for the majority of cardiovascular prosthetic failures could revolutionize expectations for extent of cardiovascular repair.
C1 [Bracaglia, Laura G.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Yu, Li] Wuhan Univ, Zhongnan Hosp, Wuhan 430072, Peoples R China.
   [Hibino, Narutoshi] Nationwide Childrens Hosp, Dept Cardiothorac Surg, Columbus, OH USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
FU Sheikh Zayed Institute for Pediatric Surgical Innovation at the
   Children's National Medical and University of Maryland A. James Clark
   School of Engineering Seed Grant; National Institutes of Health [R01
   AR061460]
FX This work was supported by the Sheikh Zayed Institute for Pediatric
   Surgical Innovation at the Children's National Medical and University of
   Maryland A. James Clark School of Engineering Seed Grant, as well as the
   National Institutes of Health under the Award Number R01 AR061460.
CR CARPENTIER A, 1969, J THORAC CARDIOV SUR, V58, P467
   Cohn D., 1987, CLIN MATER, V2, P115
   Dweck MR, 2012, CIRCULATION, V125, P76, DOI 10.1161/CIRCULATIONAHA.111.051052
   Eckert CE, 2013, ACTA BIOMATER, V9, P4653, DOI 10.1016/j.actbio.2012.09.031
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2004, J BIOMED MATER RES A, V68A, P428, DOI 10.1002/jbm.a.20073
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   KUMAR SP, 1995, J CARDIAC SURG, V10, P545, DOI 10.1111/j.1540-8191.1995.tb00630.x
   Leong J, 2013, J BIOMATER APPL, V27, P948, DOI 10.1177/0885328211430542
   Mohler ER, 2001, CIRCULATION, V103, P1522
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Sinha P, 2012, J THORAC CARDIOV SUR, V143, P224, DOI 10.1016/j.jtcvs.2011.09.043
   Sung HW, 1997, J BIOMED MATER RES, V35, P147
   TAMURA K, 1995, J THORAC CARDIOV SUR, V110, P224, DOI 10.1016/S0022-5223(05)80029-7
   Vande Geest JP, 2006, J BIOMECH, V39, P1324, DOI DOI 10.1016/J.JBIOMECH.2005.03.003
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
NR 23
TC 8
Z9 8
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV 1
PY 2014
VL 20
IS 21-22
BP 2807
EP 2816
DI 10.1089/ten.tea.2014.0516
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AS9XU
UT WOS:000344592600001
PM 25236439
OA Green Published
DA 2018-10-20
ER

PT J
AU Bouvet-Gerbettaz, S
   Boukhechba, F
   Balaguer, T
   Schmid-Antomarchi, H
   Michiels, JF
   Scimeca, JC
   Rochet, N
AF Bouvet-Gerbettaz, Sebastien
   Boukhechba, Florian
   Balaguer, Thierry
   Schmid-Antomarchi, Heidy
   Michiels, Jean-Francois
   Scimeca, Jean-Claude
   Rochet, Nathalie
TI Adaptive Immune Response Inhibits Ectopic Mature Bone Formation Induced
   by BMSCs/BCP/Plasma Composite in Immune-Competent Mice
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; FOREIGN-BODY REACTION; MARROW STROMAL CELLS;
   CALCIUM-PHOSPHATE MICROPARTICLES; IN-VIVO; MT1-MMP-DEFICIENT MICE;
   TELOMERASE EXPRESSION; MT1-MMP; BIOMATERIALS; GP130
AB A combination of autologous bone marrow stromal cells (BMSCs) and biomaterials is a strategy largely developed in bone tissue engineering, and subcutaneous implantation in rodents or large animals is often a first step to evaluate the potential of new biomaterials. This study aimed at investigating the influence of the immune status of the recipient animal on BMSCs-induced bone formation. BMSCs prepared from C57BL/6 mice, composed of a mixture of mesenchymal stromal and monocytic cells, were combined with a biomaterial that consisted of biphasic calcium phosphate (BCP) particles and plasma clot. This composite was implanted subcutaneously either in syngenic C57BL/6 immune-competent mice or in T-lymphocyte-deficient Nude (Nude) mice. Using histology, immunohistochemistry, and histomorphometry, we show here that this BMSC/BCP/plasma clot composite implanted in Nude mice induces the formation of mature lamellar bone associated to hematopoietic areas and numerous vessels. Comparatively, implantation in C57BL/6 results in the formation of woven bone without hematopoietic tissue, a lower number of new vessels, and numerous multinucleated giant cells (MNGCs). In situ hybridization, which enabled to follow the fate of the BMSCs, revealed that BMSCs implanted in Nude mice survived longer than BMSCs implanted in C57BL/6 mice. Quantitative expression analysis of 280 genes in the implants indicated that the differences between C57BL/6 and Nude implants corresponded almost exclusively to genes related to the immune response. Gene expression profile in C57BL/6 implants was consistent with a mild chronic inflammation reaction characterized by Th1, Th2, and cytotoxic T-lymphocyte activation. In the implants retrieved from T-deficient Nude mice, Mmp14, Il6st, and Tgfbr3 genes were over-expressed, suggesting their putative role in bone regeneration and hematopoiesis. In conclusion, we show here that the T-mediated inflammatory microenvironment is detrimental to BMSCs-induced bone formation and shortens the survival of implanted cells. Conversely, the lack of T-lymphocyte reaction in T-deficient animals is beneficial to BMSCs-induced mature bone formation. This should be taken into account when evaluating cell/biomaterial composites in these models.
C1 [Bouvet-Gerbettaz, Sebastien; Boukhechba, Florian; Balaguer, Thierry; Schmid-Antomarchi, Heidy; Michiels, Jean-Francois; Scimeca, Jean-Claude; Rochet, Nathalie] UFR Med, F-06107 Nice, France.
   [Bouvet-Gerbettaz, Sebastien; Boukhechba, Florian; Balaguer, Thierry; Schmid-Antomarchi, Heidy; Michiels, Jean-Francois; Scimeca, Jean-Claude; Rochet, Nathalie] Univ Nice Sophia Antipolis, F-06100 Nice, France.
   [Bouvet-Gerbettaz, Sebastien] UFR Odontol, F-06357 Nice, France.
   [Boukhechba, Florian; Balaguer, Thierry; Schmid-Antomarchi, Heidy; Scimeca, Jean-Claude; Rochet, Nathalie] CNRS, UMR7277, F-06108 Nice, France.
   [Boukhechba, Florian; Balaguer, Thierry; Schmid-Antomarchi, Heidy; Scimeca, Jean-Claude; Rochet, Nathalie] INSERM, U1091, F-06108 Nice, France.
   [Balaguer, Thierry] CHU Nice, Serv Chirurg Plast, F-06202 Nice, France.
   [Michiels, Jean-Francois] CHU Nice, Serv Anatomopathol, F-06202 Nice, France.
RP Rochet, N (reprint author), UFR Med, F-06107 Nice, France.
EM nathalie.rochet@unice.fr
RI ROCHET, Nathalie/N-1819-2018
OI ROCHET, Nathalie/0000-0002-9995-6699; Scimeca,
   Jean-Claude/0000-0003-3773-6110
FU Centre National de la Recherche Scientifique (CNRS); Fondation de
   l'Avenir
FX The authors are very grateful to Dr. Diane S. Krause for the gift of the
   Y probe and to Graftys SA for supplying BCP particles, to Aude
   Mallavialle at the Plateforme d'Etude du Transcriptome (CHU de Nice,
   Canceropole PACA, France) for excellent technical assistance, and to
   Isabelle Sudaka (CHU de Nice, Laboratoire d'hematologie biologique) for
   a very helpful discussion. This work was supported by grants from the
   Centre National de la Recherche Scientifique (CNRS) and the Fondation de
   l'Avenir.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255
   Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Beertsen W, 2003, CONNECT TISSUE RES, V44, P298, DOI 10.1080/03008200390181807
   Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955
   Boukhechba F, 2011, TISSUE ENG PT A, V17, P2267, DOI [10.1089/ten.tea.2010.0461, 10.1089/ten.TEA.2010.0461]
   Bouvet-Gerbettaz S, 2009, LASER SURG MED, V41, P291, DOI 10.1002/lsm.20759
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Christenbury J. D., 1977, P OKLA ACAD SCI, V57, P12
   Chun TH, 2004, J CELL BIOL, V167, P757, DOI 10.1083/jcb.200405001
   Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401
   Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9
   Fang DJ, 2007, STEM CELLS, V25, P1021, DOI 10.1634/stemcells.2006-0576
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Ghanaati S., 2012, BIOMED MATER, V7, P1
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581
   Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1
   Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kirkbride KC, 2008, J BIOL CHEM, V283, P7628, DOI 10.1074/jbc.M704883200
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lange T, 2011, BIOMATERIALS, V32, P4067, DOI 10.1016/j.biomaterials.2011.02.039
   Lange T, 2009, BIOMATERIALS, V30, P5312, DOI 10.1016/j.biomaterials.2009.06.023
   Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542
   Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Nishida C, 2012, BLOOD, V119, P5405, DOI 10.1182/blood-2011-11-390849
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Schmidt-Bleek K, 2014, J TISSUE ENG REGEN M, V8, P120, DOI 10.1002/term.1505
   Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Sims NA, 2010, BMB REP, V43, P513, DOI 10.5483/BMBRep.2010.43.8.513
   Tasso R, 2009, TISSUE ENG PT A, V15, P2203, DOI 10.1089/ten.tea.2008.0269
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Theise ND, 2002, EXP HEMATOL, V30, P1333, DOI 10.1016/S0301-472X(02)00931-1
   Toben D, 2011, J BONE MINER RES, V26, P113, DOI 10.1002/jbmr.185
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213
   Xia Z, 2006, J CELL BIOCHEM, V98, P966, DOI 10.1002/jcb.20730
   Yao LB, 2005, BLOOD, V106, P4093, DOI 10.1182/blood-2005-02-0671
NR 50
TC 10
Z9 13
U1 1
U2 25
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV 1
PY 2014
VL 20
IS 21-22
BP 2950
EP 2962
DI 10.1089/ten.tea.2013.0633
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AS9XU
UT WOS:000344592600014
PM 24785826
DA 2018-10-20
ER

PT J
AU Kwon, BJ
   Lee, MH
   Koo, MA
   Han, JJ
   Park, JC
AF Kwon, Byeong-Ju
   Lee, Mi Hee
   Koo, Min-Ah
   Han, Jae-Jin
   Park, Jong-Chul
TI Ethyl-3,4-Dihydroxybenzoate with a Dual Function of Induction of
   Osteogenic Differentiation and Inhibition of Osteoclast Differentiation
   for Bone Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-VITRO; ALGINATE; EXPRESSION; OSTEOBLAST;
   COLLAGEN; PROLIFERATION; ENHANCEMENT; MECHANISMS; PRECURSORS
AB The current approach in biomaterial design of bone implants is to induce in situ regeneration of bone tissue, thus improving integration of the implants and reducing their failure. Therefore, ethyl-3,4-dihydroxybenzoate (EDHB), which stimulates differentiation of osteoblasts and the resultant bone formation, should be studied. In this study, the osteoinductive ability of EDHB in preosteoblasts and human mesenchymal stem cells was examined. EDHB for future use in bone tissue engineering was evaluated by examination of early markers of differentiation (such as alkaline phosphatase [ALP] activity and collagen type I expression) and late markers of osteoblast differentiation (bone nodule formation). As bone remodeling and implant osteointegration depend not only on osteoblast response but also on interaction of the biomaterial with bone-resorbing osteoclasts, differentiation of osteoclasts in response to the compounds was also observed. For in vivo study, alginate gel comprised of EDHB and cells was transplanted into the back subcutis of mice. Our results show that EDHB might have beneficial effects through regulation of both osteoblast and osteoclast differentiation. Therefore, we suggest that EDHB could be a strong candidate for dual regulation to increase osteoblast differentiation and decrease osteoclast differentiation.
C1 [Kwon, Byeong-Ju; Lee, Mi Hee; Koo, Min-Ah; Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, Seoul 120752, South Korea.
   [Kwon, Byeong-Ju; Lee, Mi Hee; Koo, Min-Ah; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea.
   [Han, Jae-Jin] 119 Ajou Univ Ind Cooperat Fdn, Suwon, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM parkjc@yuhs.ac
FU National Research Foundation of Korea (NRF) - Ministry of Science, ICT &
   Future Planning [2005-2000117]; Brain Korea 21 PLUS Project for Medical
   Science, Yonsei University
FX This research was supported by the National Research Foundation of Korea
   (NRF) funded by the Ministry of Science, ICT & Future Planning (Grant
   No. 2005-2000117). This work was supported by the Brain Korea 21 PLUS
   Project for Medical Science, Yonsei University.
CR Aubin J. E., 2002, PRINCIPLES BONE BIOL, V1, P59
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Beier JP, 2011, CELL BIOL INT, V35, P397, DOI 10.1042/CBI20100417
   Bernhardt A, 2010, J BIOMED MATER RES A, V95A, P848, DOI 10.1002/jbm.a.32856
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0
   Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Cowan CM, 2005, CURR TOP DEV BIOL, V66, P239, DOI 10.1016/S0070-2153(05)66008-5
   Cuetara BLV, 2006, IN VITRO CELL DEV-AN, V42, P182
   Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003
   De Boer J, 2006, TISSUE ENG, V12, P2927
   Do SH, 2008, MENOPAUSE, V15, P676, DOI 10.1097/gme.0b013e31815bb687
   Garimella R, 2008, J HISTOCHEM CYTOCHEM, V56, P569, DOI 10.1369/jhc.2008.950394
   Gotoh M, 2002, EUR J PHARMACOL, V451, P19, DOI 10.1016/S0014-2999(02)02183-0
   Heino TJ, 2008, CURR STEM CELL RES T, V3, P131, DOI 10.2174/157488808784223032
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Higashinakagawa M, 1999, Kokubyo Gakkai Zasshi, V66, P118
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kanakaris NK, 2007, INJURY, V38, pS65, DOI 10.1016/S0020-1383(07)80011-8
   Karsdal MA, 2008, BIOCHEM BIOPH RES CO, V366, P483, DOI 10.1016/j.bbrc.2007.11.168
   Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109
   Karst M, 2004, J CELL PHYSIOL, V200, P99, DOI 10.1002/jcp.20036
   Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x
   Kim YJ, 2006, BIOCHEM PHARMACOL, V72, P1268, DOI 10.1016/j.bcp.2006.08.021
   Koh AJ, 2005, ENDOCRINOLOGY, V146, P4584, DOI 10.1210/en.2005-0333
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CSD, 2010, BIOMATERIALS, V31, P4926, DOI 10.1016/j.biomaterials.2010.03.001
   Lee KY, 2003, J CONTROL RELEASE, V87, P49, DOI 10.1016/S0168-3659(02)00349-8
   Li B, 2008, J BIOCHEM, V144, P643, DOI 10.1093/jb/mvn115
   Man Y, 2012, BIOMATERIALS, V33, P8802, DOI 10.1016/j.biomaterials.2012.08.054
   Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673
   Orban JM, 2002, TISSUE ENG, V8, P529, DOI 10.1089/107632702760240454
   Orriss IR, 2007, ENDOCRINOLOGY, V148, P4208, DOI 10.1210/en.2007-0066
   Park DJ, 2005, J CRANIO MAXILL SURG, V33, P50, DOI 10.1016/j.jcms.2004.05.011
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Porada Christopher D, 2006, Curr Stem Cell Res Ther, V1, P365
   Rocnik EF, 1998, J CLIN INVEST, V101, P1889, DOI 10.1172/JCI1025
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Saito N, 2003, BONE, V32, P381, DOI 10.1016/S8756-3282(03)00028-0
   SASAKI T, 1987, J BIOL CHEM, V262, P9397
   Stocum DL, 2001, WOUND REPAIR REGEN, V9, P429, DOI 10.1046/j.1524-475x.2001.00429.x
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Thomas GP, 2001, J ENDOCRINOL, V170, P451, DOI 10.1677/joe.0.1700451
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Vali B, 2007, J NUTR BIOCHEM, V18, P341, DOI 10.1016/j.jnutbio.2006.06.005
   Wee S, 1998, ADV DRUG DELIVERY RE, V4, P267, DOI DOI 10.1016/S0169-409X(97)00124-5
   Yoo JU, 1998, CLIN ORTHOP RELAT R, pS73
   Zhao JY, 2010, TISSUE ENG PT A, V16, P233, DOI [10.1089/ten.tea.2009.0165, 10.1089/ten.TEA.2009.0165]
NR 55
TC 3
Z9 4
U1 0
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV 1
PY 2014
VL 20
IS 21-22
BP 2975
EP 2984
DI 10.1089/ten.tea.2013.0567
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AS9XU
UT WOS:000344592600016
PM 24784993
OA Green Published
DA 2018-10-20
ER

PT J
AU Smith, RM
   Shikanov, A
   Kniazeva, E
   Ramadurai, D
   Woodruff, TK
   Shea, LD
AF Smith, Rachel M.
   Shikanov, Ariella
   Kniazeva, Ekaterina
   Ramadurai, Deepa
   Woodruff, Teresa K.
   Shea, Lonnie D.
TI Fibrin-Mediated Delivery of an Ovarian Follicle Pool in a Mouse Model of
   Infertility
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HORMONE-INDEPENDENT DIFFERENTIATION; BREAST-CANCER; KIT-LIGAND;
   IN-VITRO; ORTHOTOPIC TRANSPLANTATION; FERTILITY PRESERVATION; PREANTRAL
   FOLLICLES; STROMAL CELLS; THECA CELLS; TISSUE
AB The cryopreservation and autotransplantation of ovarian tissue is emerging as a powerful approach for preserving fertility. However, for cancer patients, it may not be possible to transplant ovarian tissue due to the risk of re-seeding disease. We investigated strategies for transplantation of individually isolated follicles to minimize the risk of re-introducing cancer cells present within the vasculature of ovarian stroma. Procedures for large-scale isolation of early-stage follicles and their encapsulation into fibrin hydrogels were developed. For in vivo validation studies, mice were ovariectomized and transplanted with encapsulated follicles into the ovarian bursa. A substantial increase in the number of secondary follicles was observed in the graft at 9 days after transplantation, and antral follicles by day 21, demonstrating primordial follicle recruitment into the growing pool. Initially, elevated follicle-stimulating hormone levels declined substantially by day 21, indicating feedback from the graft; presence of corpora lutea showed the graft's capability of restoring hormone cyclicity. Taken together, the transplanted follicles were able to engraft, mature, and restore ovarian function in an infertile mouse. This biomaterial may, thus, provide a platform for follicle transplantation with a low risk of cancer contamination and for developing strategies that preserve fertility for women facing a cancer diagnosis.
C1 [Smith, Rachel M.; Kniazeva, Ekaterina; Ramadurai, Deepa; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shikanov, Ariella] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Woodruff, Teresa K.] Northwestern Univ, Dept Obstet & Gynecol, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,Technol Inst Tech E136, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
OI Woodruff, Teresa/0000-0002-1197-3399; Shikanov,
   Ariella/0000-0003-0159-6419
FU National Institutes of Health [U54 HD076188]
FX This work was funded by the National Institutes of Health grant U54
   HD076188.
CR Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244
   Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201
   Anderson RA, 2007, J CLIN ONCOL, V25, P1630, DOI 10.1200/JCO.2006.09.3666
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Bristol-Gould SK, 2006, DEV BIOL, V298, P149, DOI 10.1016/j.ydbio.2006.06.023
   CARROLL J, 1993, HUM REPROD, V8, P1163, DOI 10.1093/oxfordjournals.humrep.a138221
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Da Silva-Buttkus P, 2009, P NATL ACAD SCI USA, V106, P456, DOI 10.1073/pnas.0810012106
   David A, 2012, HUM REPROD, V27, P1088, DOI 10.1093/humrep/des013
   Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437
   Deponti D, 2012, TISSUE ENG PT A, V18, P1109, DOI [10.1089/ten.tea.2011.0272, 10.1089/ten.TEA.2011.0272]
   DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146
   Doimans MM, 2008, REPROD BIOMED ONLINE, V16, P705
   Dolmans MM, 2007, REPRODUCTION, V134, P253, DOI 10.1530/REP-07-0131
   Dolmans MM, 2013, FERTIL STERIL, V99, P1514, DOI 10.1016/j.fertnstert.2013.03.027
   Dolmans MM, 2012, BLOOD, V120, P4275, DOI 10.1182/blood-2012-07-439539
   Dolmans MM, 2006, HUM REPROD, V21, P413, DOI 10.1093/humrep/dei320
   Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X
   Donnez J., 2011, FERTIL STERIL, V95
   Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030
   Donnez J, 2012, FERTIL STERIL, V98, P720, DOI 10.1016/j.fertnstert.2012.05.017
   Donnez J, 2009, SEMIN REPROD MED, V27, P472, DOI 10.1055/s-0029-1241057
   Elharroudi T, 2008, J CANC RES THER, V4, P195
   Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699
   Ernst EH, 2013, J ASSIST REPROD GEN, V30, P975, DOI 10.1007/s10815-013-0026-x
   Ernst E, 2010, HUM REPROD, V25, P1280, DOI 10.1093/humrep/deq033
   Falcone T, 2004, FERTIL STERIL, V81, P243, DOI 10.1016/j.fertnstert.2003.06.031
   Gavish Z, 2014, HUM REPROD, V29, P989, DOI 10.1093/humrep/deu015
   HARRISON RG, 2002, BIOSEPARATIONS SCI E
   Hornick JE, 2013, REPRODUCTION, V145, P19, DOI 10.1530/REP-12-0233
   Huang CTF, 2001, BIOL REPROD, V64, P451, DOI 10.1095/biolreprod64.2.451
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010
   Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454
   Kim JW, 2008, PEDIATR SURG INT, V24, P1269, DOI 10.1007/s00383-008-2253-2
   Kruyt MC, 2003, TISSUE ENG, V9, P105, DOI 10.1089/107632703762687582
   Kyono K, 2010, FERTIL STERIL, V93, P2429, DOI 10.1016/j.fertnstert.2009.08.031
   Liu L, 2008, HUM REPROD, V23, P122, DOI 10.1093/humrep/dem348
   Lobo RA, 2005, NEW ENGL J MED, V353, P64, DOI 10.1056/NEJMra043475
   Luyckx V, 2014, FERTIL STERIL, V101, P1149, DOI 10.1016/j.fertnstert.2013.12.025
   MAGOFFIN DA, 1995, ENDOCRINE, V3, P107, DOI 10.1007/BF02990061
   Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237
   Meirow D, 2008, HUM REPROD, V23, P1007, DOI 10.1093/humrep/den055
   Mimura T, 2004, EXP EYE RES, V79, P231, DOI 10.1016/j.exer.2004.05.001
   MONTERROSO V, 1993, AM J SURG PATHOL, V17, P154, DOI 10.1097/00000478-199302000-00007
   Nakayama K, 2008, NAT CLIN PRACT ONCOL, V5, P78, DOI 10.1038/ncponc1016
   Nilsson EE, 2004, MOL CELL ENDOCRINOL, V214, P19, DOI 10.1016/j.mce.2003.12.001
   Oktem O, 2007, CANCER, V110, P2222, DOI 10.1002/cncr.23071
   Orisaka M, 2006, BIOL REPROD, V75, P734, DOI 10.1095/biolreprod.105.050344
   Parrott JA, 2000, MOL REPROD DEV, V55, P55, DOI 10.1002/(SICI)1098-2795(200001)55:1<55::AID-MRD8>3.0.CO;2-L
   Partridge AH, 2004, J CLIN ONCOL, V22, P4174, DOI 10.1200/jco.2004.01.159
   PEDERSEN T, 1970, J REPROD FERTIL, V21, P81
   Perlman S, 2005, INT J GYNECOL CANCER, V15, P554, DOI 10.1111/j.1525-1438.2005.15324.x
   Piver P., 2009, HUM REPROD, V15, P2009
   Rebar R. W., 2001, PRINCIPLES PRACTICE, P744
   Roux C, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.12.022
   Sanchez-Serrano M, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.09.046
   Schover LR, 2002, J CLIN ONCOL, V20, P1880, DOI 10.1200/JCO.2002.07.175
   Schroder CP, 2004, HUM REPROD, V19, P1069, DOI 10.1093/humrep/deh244
   Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.tea.2011.0204, 10.1089/ten.TEA.2011.0204]
   Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032
   Silber SJ, 2012, MOL HUM REPROD, V18, P59, DOI 10.1093/molehr/gar082
   Silber SJ, 2010, CANCER TREAT RES, V156, P41, DOI 10.1007/978-1-4419-6518-9_4
   Sklar EM, 2006, AM J NEURORADIOL, V27, P1602
   Skory RM, 2013, MOL REPROD DEV, V80, P132, DOI 10.1002/mrd.22144
   Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048
   Vanacker J, 2012, BIOMATERIALS, V33, P6079, DOI 10.1016/j.biomaterials.2012.05.015
NR 67
TC 14
Z9 14
U1 0
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD NOV 1
PY 2014
VL 20
IS 21-22
BP 3021
EP 3030
DI 10.1089/ten.tea.2013.0675
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AS9XU
UT WOS:000344592600020
PM 24802617
OA Green Published
DA 2018-10-20
ER

PT J
AU Kuhn, A
   Nieters, A
   Kottgen, A
   Goek, ON
   Michels, K
   Nothlings, U
   Jacobs, G
   Meisinger, C
   Pessler, F
   Akmatov, MF
   Kuhnisch, J
   Moebus, S
   Glocker, E
   Naus, S
   Keimling, M
   Leitzmann, M
   Linseisen, J
   Sarioglu, H
   von Toerne, C
   Hauck, SM
   Wallaschofski, H
   Wichmann, HE
   Illig, T
AF Kuehn, A.
   Nieters, A.
   Koettgen, A.
   Goek, O. N.
   Michels, K.
   Noethlings, U.
   Jacobs, G.
   Meisinger, C.
   Pessler, F.
   Akmatov, M. F.
   Kuehnisch, J.
   Moebus, S.
   Glocker, E.
   Naus, S.
   Keimling, M.
   Leitzmann, M.
   Linseisen, J.
   Sarioglu, H.
   von Toerne, C.
   Hauck, S. M.
   Wallaschofski, H.
   Wichmann, H. E.
   Illig, Thomas
TI Feasibility and quality development of biomaterials in the pretest
   studies of the German National Cohort
SO BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ
LA English
DT Article
DE Biomaterials; Standard operation procedure; Pre-analytics; Artefacts;
   Feasibility study
AB The German National Cohort (GNC) is designed to address research questions concerning a wide range of possible causes of major chronic diseases (e.g. cancer, diabetes, infectious, allergic, neurologic and cardiovascular diseases) as well as to identify risk factors and prognostic biomarkers for early diagnosis and prevention of these diseases. The collection of biomaterials in combination with extensive information from questionnaires and medical examinations represents one of the central study components.
   In two pretest studies of the German National Cohort conducted between 2011 and 2013, a range of biomaterials from a defined number of participants was collected. Ten study centres were involved in pretest 1 and 18 study centres were involved in pretest 2. Standard operation procedures (SOP) were developed and evaluated to minimize pre-analytical artefacts during biosample collection. Within the pretest studies different aspects concerning feasibility of sample collection/preparation [pretest 1 (a)] and quality control of biomarkers and proteome analyses were investigated [pretest 1 (b), (c)]. Additionally, recruitment of study participants for specific projects and examination procedures of all study centres in a defined time period according to common standards as well as transportation and decentralized storage of biological samples were tested (pretest 2). These analyses will serve as the basis for the biomaterial collection in the main study of the GNC starting in 2014.
   Participants, randomly chosen from the population (n = 1000 subjects recruited at ten study sites in pretest 1) were asked to donate blood, urine, saliva and stool samples. Additionally, nasal and oropharyngeal swabs were collected at the study sites and nasal swabs were collected by the participants at home. SOPs for sample collection, preparation, storage and transportation were developed and adopted for pretest 2. In pretest 2, 18 study sites (n = 599 subjects) collected biomaterials mostly identical to pretest 1. Biomarker analyses to test the quality of the biomaterials were performed.
   In pretest 1 and 2, it was feasible to collect all biomaterials from nearly all invited participants without major problems. The mean response rate of the subjects was 95 %. As one important result we found for example that after blood draw the cellular fraction should be separated from the plasma and serum fractions during the first hour with no significant variation for up to 6 h at 4 a"integral for all analysed biomarkers. Moreover, quality control of samples using a proteomics approach showed no significant clustering of proteins according to different storage conditions. All developed SOPs were validated for use in the main study after some adaptation and modification. Additionally, electronic and paper documentation sheets were developed and tested to record time stamps, volumes, freezing times, and aliquot numbers of the collected biomaterials.
   The collection of the biomaterials was feasible without major problems at all participating study sites. However, the processing times were in some cases too long. To avoid pre-analytical artefacts in sample collection, appropriate standardisation among the study sites is necessary. To achieve this, blood and urine collection will have to be adapted to specific conditions of usage of liquid handling robots, which will be available at all participating study centres in the main study of the GNC. Strict compliance with the SOPs, thorough training of the staff and accurate documentation are mandatory to obtain high sample quality for later analyses. The so obtained biomaterials represent a valuable resource for research on infectious and other common complex diseases in the GNC.
C1 [Kuehn, A.; Linseisen, J.; Wichmann, H. E.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Muenchen, Inst Epidemiol 1, Neuherberg, Germany.
   [Nieters, A.; Glocker, E.; Naus, S.] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany.
   [Koettgen, A.; Goek, O. N.; Michels, K.] Univ Med Ctr Freiburg, Dept Internal Med 4, Freiburg, Germany.
   [Noethlings, U.] Univ Bonn, Inst Nutr & Food Sci, Bonn, Germany.
   [Jacobs, G.] Univ Kiel, Inst Epidemiol, Biobank Popgen, Kiel, Germany.
   [Meisinger, C.] German Res Ctr Environm Hlth GmbH, Inst Epidemiol 2, Helmholtz Zentrum Muenchen, Neuherberg, Germany.
   [Pessler, F.; Akmatov, M. F.] Helmholtz Ctr Infect Res, Braunschweig, Germany.
   [Pessler, F.; Akmatov, M. F.] TWINCORE Ctr Expt & Clin Infect Res, Hannover, Germany.
   [Kuehnisch, J.] Clin Ludwig Maximilians Univ, Munich, Germany.
   [Moebus, S.] Univ Klinikum Essen, Inst Med Comp Sci Biometry & Epidemiol, Essen, Germany.
   [Keimling, M.; Leitzmann, M.] Univ Regensburg, Inst Epidemiol & Prevent Med, D-93053 Regensburg, Germany.
   [Sarioglu, H.; von Toerne, C.; Hauck, S. M.] German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, Helmholtz Zentrum Muenchen, Neuherberg, Germany.
   [Wallaschofski, H.] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.
   [Illig, Thomas] Hannover Med Sch, HUB, D-30625 Hannover, Germany.
RP Illig, T (reprint author), Hannover Med Sch, HUB, Feodor Lynen Str 15, D-30625 Hannover, Germany.
EM illig.thomas@mh-hannover.de
RI von Toerne, Christine/B-2233-2013; Hauck, Stefanie/B-3300-2013;
   Nothlings, Ute/B-2713-2010; Meisinger, Christine/B-5358-2014
OI von Toerne, Christine/0000-0002-4132-4322; Hauck,
   Stefanie/0000-0002-1630-6827; Linseisen, Jakob/0000-0002-9386-382X;
   Meisinger, Christa/0000-0002-9026-6544
FU Federal Ministry of Education and Research (BMBF), Forderkennzeichen
   [01ER1001/A-I, 01ER1203]; Helmholtz Association; Leibniz Association;
   Emmy Noether Programme of the German Research Foundation [KO 3598/2-1]
FX The authors thank all people at the study sites who were involved in the
   studies. This project was conducted in the context of the pretest
   studies of the German National Cohort (www.nationale-kohorte.de). These
   were funded by the Federal Ministry of Education and Research (BMBF),
   Forderkennzeichen 01ER1001/A-I, 01ER1203 and were supported by the
   Helmholtz Association as well as participating universities and
   Institutes of the Leibniz Association. AK and ONG were funded by the
   Emmy Noether Programme of the German Research Foundation (KO 3598/2-1 to
   AK).
CR ISBER, 2012, BEST PRACT REP, V10
   National Cancer Institute, 2011, BEST PRACT BIOSP RES
NR 2
TC 3
Z9 3
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1436-9990
EI 1437-1588
J9 BUNDESGESUNDHEITSBLA
JI Bundesgesundheitsblatt-Gesund.
PD NOV
PY 2014
VL 57
IS 11
BP 1255
EP 1263
DI 10.1007/s00103-014-2048-7
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AS5ZM
UT WOS:000344344900003
PM 25293886
DA 2018-10-20
ER

PT J
AU Rahman, ZU
   Pompa, L
   Haider, W
AF Rahman, Zia Ur
   Pompa, Luis
   Haider, Waseem
TI Influence of Electropolishing and Magnetoelectropolishing on Corrosion
   and Biocompatibility of Titanium Implants
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE biomaterial; corrosion and wear; titanium
ID 316L STAINLESS-STEEL; SURFACE OXIDE-FILM; BIOMEDICAL APPLICATIONS;
   CELL-ADHESION; ROUGHNESS; ALLOYS; WETTABILITY; OSTEOBLAST;
   OSSEOINTEGRATION; BIOMATERIAL
AB Titanium alloys are playing a vital role in the field of biomaterials due to their excellent corrosion resistance and biocompatibility. These alloys enhance the quality and longevity of human life by replacing or treating various parts of the body. However, as these materials are in constant contact with the aggressive body fluids, corrosion of these alloys leads to metal ions release. These ions leach to the adjacent tissues and result in adverse biological reactions and mechanical failure of implant. Surface modifications are used to improve corrosion resistance and biological activity without changing their bulk properties. In this investigation, electropolishing and magnetoelectropolishing were carried out on commercially pure titanium, Ti6Al4V, and Ti6Al4V-ELI. These surface modifications are known to effect surface charge, chemistry, morphology; wettability, corrosion resistance, and biocompatibility of these materials. In vitro cyclic potentiodynamic polarization tests were conducted in phosphate buffer saline in compliance with ASTM standard F-2129-12. The surface morphology, roughness, and wettability of these alloys were studied using scanning electron microscope, atomic force microscope, and contact angle meter, respectively. Moreover, biocompatibility of titanium alloys was assessed by growing MC3T3 pre-osteoblast cells on them.
C1 [Rahman, Zia Ur; Pompa, Luis; Haider, Waseem] Univ Texas Pan Amer, Dept Mech Engn, Edinburg, TX 78539 USA.
RP Rahman, ZU (reprint author), Univ Texas Pan Amer, Dept Mech Engn, 1201 W Univ Dr, Edinburg, TX 78539 USA.
EM haiderw@utpa.edu
CR Ahmad Z., 1999, PRINCIPLES CORROSION, P271
   AL-Mangour B, 2013, SURF COAT TECH, V216, P297, DOI 10.1016/j.surfcoat.2012.11.061
   Alvarez RB, 2010, CORROS SCI, V52, P1635, DOI 10.1016/j.corsci.2010.01.018
   AUGUST AC, 1986, J BONE JOINT SURG BR, V68, P520
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Brunette D. M., 2001, TITANIUM MED, P145
   Cremasco A, 2011, MAT SCI ENG C-MATER, V31, P833, DOI 10.1016/j.msec.2010.12.013
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   FEIGHAN JE, 1995, J BONE JOINT SURG AM, V77, P1380, DOI 10.2106/00004623-199509000-00015
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gurappa I, 2002, MATER CHARACT, V49, P73, DOI 10.1016/S1044-5803(02)00320-0
   Haider W., 2010, THESIS FIU ELECT
   Hanawa T, 1998, J BIOMED MATER RES, V40, P530, DOI 10.1002/(SICI)1097-4636(19980615)40:4<530::AID-JBM3>3.0.CO;2-G
   Hryniewicz T, 2009, SURF COAT TECH, V203, P1508, DOI 10.1016/j.surfcoat.2008.11.028
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [10.2174/1877610801002010040, DOI 10.2174/1877610801002010040]
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Oldani C., 2012, RECENT ADV ORTHOPLAS
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schoen F.J., 2001, BIOMATERIALS SCI INT, P35
   Shamsul J. B., 2007, J APPL SCI RES, V3, P1544
   Shen H, 2011, MECH MATER, V43, P420, DOI 10.1016/j.mechmat.2011.06.002
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Tanaka Y, 2008, MATER TRANS, V49, P805, DOI 10.2320/matertrans.MRA20073171
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Virtanen S, 2008, ACTA BIOMATER, V4, P468, DOI 10.1016/j.actbio.2007.12.003
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zhdanov VP, 2008, CHEM PHYS LETT, V452, P285, DOI 10.1016/j.cplett.2008.01.006
NR 40
TC 14
Z9 14
U1 1
U2 39
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD NOV
PY 2014
VL 23
IS 11
BP 3907
EP 3915
DI 10.1007/s11665-014-1205-3
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA AS5TA
UT WOS:000344331200011
DA 2018-10-20
ER

PT J
AU Andrade, GF
   Gomide, VS
   da Silva, AC
   Goes, AM
   de Sousa, EMB
AF Andrade, Gracielle Ferreira
   Gomide, Viviane Silva
   da Silva Junior, Armando Cunha
   Goes, Alfredo Miranda
   Barros de Sousa, Edesia Martins
TI An in situ synthesis of mesoporous SBA-16/hydroxyapatite for
   ciprofloxacin release: in vitro stability and cytocompatibility studies
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RESPONSIVE CONTROLLED-RELEASE; MESENCHYMAL STEM-CELLS; MARROW STROMAL
   CELLS; SILICA NANOPARTICLES; OLIGOMERIC SURFACTANT; BIOACTIVE GLASSES;
   CALCIUM-PHOSPHATE; DRUG-DELIVERY; HYDROXYAPATITE; CARRIER
AB The present work developed a biomaterial (HA/SBA-16) based on the growth of calcium phosphate (HA) particles within an organized silica structure (SBA-16) to evaluate its application as a drug delivery system. The samples were charged with ciprofloxacin as a model drug and in vitro release assays were carried out. The samples were characterized by elemental analysis (CHN), Fourier transform infrared spectroscopy, nitrogen adsorption, scanning electron microscopy (SEM), transmission electron microscopy (TEM), small angle X-ray scattering (SAXS) and X-ray diffraction. The results obtained by TEM, SEM and SAXS reveal a well-defined cubic arrangement of a uniform spherical mesoporous structure, an intrinsic characteristic of these materials, which indicated that SBA-16 and HA/SBA-16 could potentially encapsulate bioactive molecules by means of ordered mesopores. It was found that both surface interaction and pore volume affect the rate and amount of ciprofloxacin released from the mesoporous materials. In vitro assays were performed to evaluate the adhesion, viability, and growth behavior of human adipose tissue-derived stem cells (hADSC) on SBA-16 and HA/SBA-16 nanocomposites to verify their potential as a scaffold for application in bone-tissue engineering using MTT assay and alkaline phosphatase activity tests. The results showed that the materials are promising systems for bone repair, providing a good environment for the adhesion and proliferation of rat mesenchymal stem cells and hADSC in vitro.
C1 [Andrade, Gracielle Ferreira; Gomide, Viviane Silva; Barros de Sousa, Edesia Martins] CDTN, CNEN, SENAN, BR-30270901 Belo Horizonte, MG, Brazil.
   [Andrade, Gracielle Ferreira; da Silva Junior, Armando Cunha] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil.
   [Goes, Alfredo Miranda] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil.
RP de Sousa, EMB (reprint author), CDTN, CNEN, SENAN, Av Presidente Antonio Carlos 6627 Campus UFMG, BR-30270901 Belo Horizonte, MG, Brazil.
EM sousaem@cdtn.br
RI Cunha, Armando/G-1157-2012
OI Cunha, Armando/0000-0002-1161-8936
FU CAPES; CNPq; FAPEMIG
FX This work was supported by funding from CAPES, CNPq, and FAPEMIG.
   Experiments and analyses involving electron microscopy were performed in
   the Microscopy Center of the Federal University of Minas Gerais, Belo
   Horizonte, Brazil (http://www.microscopia.ufmg.br).
CR Andersson J, 2005, BIOMATERIALS, V26, P6827, DOI 10.1016/j.biomaterials.2005.05.002
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Babic S, 2007, TRENDS ANAL CHEM, V26, P1
   Bellah MM, 2012, J NANOMATER, DOI 10.1155/2012/486301
   Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
   Bosetti M, 2005, BIOMATERIALS, V26, P3873, DOI 10.1016/j.biomaterials.2004.09.059
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Brown SC, 2007, ADV POWDER TECHNOL, V18, P69, DOI 10.1163/156855207779768214
   Cheng CF, 2003, CHEM PHYS LETT, V382, P496, DOI 10.1016/j.cplett.2003.10.122
   Chung TH, 2007, BIOMATERIALS, V28, P2959, DOI 10.1016/j.biomaterials.2007.03.006
   CORNELL CN, 1992, CLIN ORTHOP RELAT R, P297
   Desevaux C, 2002, J CONTROL RELEASE, V82, P95, DOI 10.1016/S0168-3659(02)00132-3
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Doadrio JC, 2006, J MATER CHEM, V16, P462, DOI 10.1039/b510101h
   Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g
   Elsaesser A, 2012, ADV DRUG DELIVER REV, V64, P129, DOI 10.1016/j.addr.2011.09.001
   Fan W, 2012, MATER LETT, V81, P16, DOI 10.1016/j.matlet.2012.04.142
   Fathi MH, 2007, MATER LETT, V61, P3978, DOI 10.1016/j.matlet.2007.01.028
   Fisichella M, 2009, TOXICOL IN VITRO, V23, P697, DOI 10.1016/j.tiv.2009.02.007
   Giri S, 2005, ANGEW CHEM INT EDIT, V44, P5038, DOI 10.1002/anie.200501819
   Gobin O S, 2006, THEIS LAVAL U STE FO
   Hu YC, 2012, MICROPOR MESOPOR MAT, V147, P94, DOI 10.1016/j.micromeso.2011.06.001
   Hu YC, 2011, J COLLOID INTERF SCI, V363, P410, DOI 10.1016/j.jcis.2011.07.022
   Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje
   Kayser FH, 1981, LOCAL ANTIBIOTIC TRE, P1
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lin YS, 2005, CHEM MATER, V17, P4570, DOI 10.1021/cm051014c
   Meng, 2013, ACS NANO, V7, P994
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Radin S, 2005, J BIOMED MATER RES A, V73A, P21, DOI 10.1002/jbm.a.30241
   Sakamoto Y, 2000, NATURE, V408, P449, DOI 10.1038/35044040
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Tao ZM, 2008, NANO LETT, V8, P1517, DOI 10.1021/nl080250u
   Vallet-Regi Maria, 2008, Open Biomed Eng J, V2, P1, DOI 10.2174/1874120700802010001
   Wang LM, 2004, MICROPOR MESOPOR MAT, V67, P135, DOI 10.1016/j.micromeso.2003.10.015
   Wang P, 2008, ACTA MATER, V56, P1144, DOI 10.1016/j.actamat.2007.11.006
   Xia ZG, 2009, MATER RES BULL, V44, P1626, DOI 10.1016/j.materresbull.2009.04.014
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Zhang Y, 2002, J BIOMED MATER RES, V62, P378, DOI 10.1002/jbm.10312
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
   Zhu YJ, 2008, CHINESE J CATAL, V29, P1067, DOI 10.1016/S1872-2067(09)60001-2
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zyman Z, 2012, J CRYST GROWTH, V353, P5, DOI 10.1016/j.jcrysgro.2012.04.041
NR 46
TC 12
Z9 13
U1 2
U2 44
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2014
VL 25
IS 11
BP 2527
EP 2540
DI 10.1007/s10856-014-5273-6
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR9WN
UT WOS:000343927300007
PM 25056197
DA 2018-10-20
ER

PT J
AU Krishnan, M
   Tiwari, B
   Seema, S
   Kalra, N
   Biswas, P
   Rajeswari, K
   Suresh, MB
   Johnson, R
   Gokhale, NM
   Iyer, SR
   Londhe, S
   Arora, V
   Tripathi, RP
AF Krishnan, Manu
   Tiwari, Brijesh
   Seema, Saraswathy
   Kalra, Namitha
   Biswas, Papiya
   Rajeswari, Kotikalapudi
   Suresh, Madireddy Buchi
   Johnson, Roy
   Gokhale, Nitin M.
   Iyer, Satish R.
   Londhe, Sanjay
   Arora, Vimal
   Tripathi, Rajendra P.
TI Transparent magnesium aluminate spinel: a prospective biomaterial for
   esthetic orthodontic brackets
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; MGAL2O4 SPINEL; CERAMIC BRACKETS; BIOCOMPATIBILITY; ASSAY;
   FABRICATION; MECHANISMS; MODELS
AB Adult orthodontics is recently gaining popularity due to its importance in esthetics, oral and general health. However, none of the currently available alumina or zirconia based ceramic orthodontic brackets meet the esthetic demands of adult patients. Inherent hexagonal lattice structure and associated birefringence limits the visible light transmission in polycrystalline alumina and make them appear white and non transparent. Hence focus of the present study was to assess the feasibility of using magnesium aluminate (MgAl2O4) spinel; a member of the transparent ceramic family for esthetic orthodontic brackets. Transparent spinel specimens were developed from commercially available white spinel powder through colloidal shaping followed by pressureless sintering and hot isostatic pressing at optimum conditions of temperature and pressure. Samples were characterized for chemical composition, phases, density, hardness, flexural strength, fracture toughness and optical transmission. Biocompatibility was evaluated with in-vitro cell line experiments for cytotoxicity, apoptosis and genotoxicity. Results showed that transparent spinel samples had requisite physico-chemical, mechanical, optical and excellent biocompatibility for fabricating orthodontic brackets. Transparent spinel developed through this method demonstrated its possibility as a prospective biomaterial for developing esthetic orthodontic brackets.
C1 [Krishnan, Manu; Tiwari, Brijesh] DRDO, INMAS, Dept Dent Res & Implantol, Delhi 110054, India.
   [Seema, Saraswathy] Guru Gobind Singh Indraprastha Univ, Sch Med & Paramed Hlth Sci, Base Hosp, Delhi 110010, India.
   [Kalra, Namitha] DRDO, INMAS, Div Radiat Biosci, Delhi 110054, India.
   [Biswas, Papiya; Rajeswari, Kotikalapudi; Suresh, Madireddy Buchi; Johnson, Roy] Int Adv Res Ctr Powder Met & New Mat ARCI, Ctr Ceram Proc, Hyderabad 500005, Andhra Pradesh, India.
   [Gokhale, Nitin M.] DRDO, NMRL, Mumbai, Maharashtra, India.
   [Iyer, Satish R.; Arora, Vimal] Army Dent Ctr Res & Referral, Delhi 110010, India.
   [Londhe, Sanjay] Army Dent Ctr Res & Referral, Dept Orthodont, Delhi 110010, India.
   [Tripathi, Rajendra P.] DRDO, INMAS, Delhi 110054, India.
RP Krishnan, M (reprint author), DRDO, INMAS, Dept Dent Res & Implantol, Delhi 110054, India.
EM manukrishnanin@yahoo.co.in
CR Apetz R, 2003, J AM CERAM SOC, V86, P480, DOI 10.1111/j.1151-2916.2003.tb03325.x
   Bishara SE, 2000, AM J ORTHOD DENTOFAC, V117, P595, DOI 10.1016/S0889-5406(00)70212-5
   Bodhak S, 2011, J MATER SCI-MATER M, V22, P1511, DOI 10.1007/s10856-011-4332-5
   Bollen AM, 2008, J DENT EDUC, V72, P912
   BRANTLEY WA, 2001, ORTHODONTIC MAT SCI, P144
   Cheng JP, 2002, MATER LETT, V56, P587, DOI 10.1016/S0167-577X(02)00557-8
   Cho MH, 2008, TOXICOL IN VITRO, V22, P1099, DOI 10.1016/j.tiv.2008.02.013
   Choo H, 2011, AM J ORTHOD DENTOFAC, V140, pE251, DOI 10.1016/j.ajodo.2011.06.029
   Vitral JCD, 2010, AM J ORTHOD DENTOFAC, V137, P665, DOI 10.1016/j.ajodo.2008.07.017
   Ganesh I, 2013, INT MATER REV, V58, P63, DOI 10.1179/1743280412Y.0000000001
   Goldstein A, 2008, J AM CERAM SOC, V91, P4141, DOI 10.1111/j.1551-2916.2008.02788.x
   HALLSTEDT B, 1992, J AM CERAM SOC, V75, P1497, DOI 10.1111/j.1151-2916.1992.tb04216.x
   Handelman CS, 2013, SEMIN ORTHOD, V19, P55, DOI 10.1053/j.sodo.2012.11.004
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Ho Matthew L, 2011, Neurol Int, V3, pe15, DOI 10.4081/ni.2011.e15
   Itatani K, 2006, J EUR CERAM SOC, V26, P639, DOI 10.1016/j.jeurceramsoc.2005.06.011
   Karamouzos A, 1997, AM J ORTHOD DENTOFAC, V112, P34, DOI 10.1016/S0889-5406(97)70271-3
   Kasibhatla S., 2006, COLD SPRING HARB PRO, V2006
   Kirsch-Volders M, 2011, MUTAGENESIS, V26, P177, DOI 10.1093/mutage/geq068
   Krell A, 2009, J EUR CERAM SOC, V29, P275, DOI 10.1016/j.jeurceramsoc.2008.03.024
   Li JG, 2000, J AM CERAM SOC, V83, P961
   Lobbezoo F, 2008, J ORAL REHABIL, V35, P509, DOI 10.1111/j.1365-2842.2008.01853.x
   Morita K, 2009, J MATER RES, V24, P2863, DOI 10.1557/JMR.2009.0335
   Negroiu G, 2008, J MATER SCI-MATER M, V19, P1537, DOI 10.1007/s10856-007-3300-6
   Orrenius S, 2011, TOXICOL SCI, V119, P3, DOI 10.1093/toxsci/kfq268
   Pabari S, 2011, AM J ORTHOD DENTOFAC, V140, pE263, DOI 10.1016/j.ajodo.2011.06.022
   Plumb JA, 1999, METH MOLEC MED, V28, P25, DOI 10.1385/1-59259-687-8:25
   Rosvall MD, 2009, AM J ORTHOD DENTOFAC, V135, DOI [10.1016/j.ajodo.2008.09.020, 10.1016/j.ajodo.2008.07.011]
   Russell JS, 2005, J ORTHOD, V32, P146, DOI 10.1179/146531205225021024
   SCOTT GE, 1988, ANGLE ORTHOD, V58, P5
   Sickafus KE, 1999, J AM CERAM SOC, V82, P3279
   Suarez M, 2012, SINTERING TRANSPAREN
   Swartz M L, 1988, J Clin Orthod, V22, P82
   Villalobos GR, 2005, J AM CERAM SOC, V88, P1321, DOI 10.1111/j.1551-2916.2005.00209.x
   WANG CT, 1992, J AM CERAM SOC, V75, P2240, DOI 10.1111/j.1151-2916.1992.tb04490.x
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 36
TC 3
Z9 3
U1 2
U2 50
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2014
VL 25
IS 11
BP 2591
EP 2599
DI 10.1007/s10856-014-5268-3
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR9WN
UT WOS:000343927300013
PM 25027301
DA 2018-10-20
ER

PT J
AU Minol, JP
   Baraki, H
   Akhyari, P
   Bagaev, E
   Suprunov, M
   Brandes, G
   Bara, C
   Hort, W
   Hurschler, C
   Sigler, M
   Haverich, A
   Hilfiker, A
   Lichtenberg, A
AF Minol, Jan-Philipp
   Baraki, Hassina
   Akhyari, Payam
   Bagaev, Eric
   Suprunov, Marc
   Brandes, Gudrun
   Bara, Christoph
   Hort, Waldemar
   Hurschler, Christof
   Sigler, Matthias
   Haverich, Axel
   Hilfiker, Andres
   Lichtenberg, Artur
TI Tracheal cartilage - evaluating the potential of a novel biomaterial for
   reconstructive cardiovascular procedures
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE tissue engineering; regenerative medicine; biomaterial; cartilage; heart
   valve; mitral valve repair; trachea; transplantation
ID ENGINEERED HEART-VALVES; TISSUE; REPAIR; GRAFTS
AB Modern cardiovascular medicine aims for procedures that preferably involve biological materials and, ideally, living implants. Thereby, the regenerative capacity of the target organ may be preserved or even supported, with a potential implant growth capacity during the following time. In the current study we sought to evaluate the integrative capacity of vital and non-vital tracheal cartilage rings (TCRs) of allogenic or xenogenic origin (allo-/xeno-vTCR; allo-/xeno-nvTCR) as biomaterials under the in vivo functional load of the circulatory system. Ovine and porcine vTCRs and nvTCRs were implanted in the mitral valve (MV) position for 3 and 9 months (n=3 each), respectively, in lambs. MV function and TCR position were analysed by echocardiography. Tissue morphology (planimetry), vitality (live/dead-assay) and implant endothelialization (scanning electron microscopy) were analysed. No functional impairment or significant MV insufficiency or stenosis was observed in any group. TCR shrinkage was observed in all xeno-TCRs and allo-nvTCRs at 3 months. Only TCRs of allogenic groups at 9 months and allo-vTCRs at 3 months showed a ring area comparable to its size at implantation. Moreover, allogenic vital cartilage showed superior tissue integration, greater endothelialization, less inflammation and calcification. Interestingly, in this group viable cartilage cells were found up to 9 months after implantation. Allogenic viable cartilage may represent a well-suited living material for reconstructive cardiovascular procedures, and further studies are warranted to elucidate the benefits of this novel material, particularly as a structurally supportive component in growing recipients. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Baraki, Hassina; Bagaev, Eric; Suprunov, Marc; Bara, Christoph; Haverich, Axel; Hilfiker, Andres] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Hannover, Germany.
   [Minol, Jan-Philipp; Akhyari, Payam; Lichtenberg, Artur] Univ Hosp, Dept Cardiovasc Surg, D-40225 Dusseldorf, Germany.
   [Brandes, Gudrun] Hannover Med Sch, Dept Cell Biol, Hannover, Germany.
   [Hort, Waldemar] Univ Dusseldorf, Dept Pathol, Dusseldorf, Germany.
   [Hurschler, Christof] Hannover Med Sch, Dept Orthopaed, Lab Biomech & Biomat, Hannover, Germany.
   [Sigler, Matthias] Univ Gottingen, Dept Paediat Cardiol & Paediat Intens Care Med, Gottingen, Germany.
RP Akhyari, P (reprint author), Univ Hosp, Dept Cardiovasc Surg, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM Payam.Akhyari@med.uni-duesseldorf.de
OI Akhyari, Payam/0000-0002-6452-8678
FU Braukmann-Wittenberg Foundation, Lower Saxony, Germany
FX We thank E. Godehardt for support in the statistical evaluation; S. E.
   Dorfman for critically reading and editing the manuscript; A. Loos, A.
   Beck, W. Neumann and G. Preiss for technical support; and R. Katt, A.
   Diers-Ketterkat, K. Peschel and P. Ziehme for administrative and
   logistical work. This study was funded by the Braukmann-Wittenberg
   Foundation, Lower Saxony, Germany.
CR Alis ML, 1996, CARDIOVASC SURG, V4, P543
   Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Carpentiers A, 1977, OPERATIVE SURG, P65
   Chikwe J, 2010, NAT REV CARDIOL, V7, P711, DOI 10.1038/nrcardio.2010.164
   Foth R, 2009, CIRC-CARDIOVASC INTE, V2, P90, DOI 10.1161/CIRCINTERVENTIONS.108.810507
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Lichtenberg A, 2006, CIRCULATION, V114, pI559, DOI 10.1161/CIRCULATIONAHA.105.001206
   Lichtenberg A, 2006, J HEART VALVE DIS, V15, P287
   Lichtenberg A, 2005, BIOMATERIALS, V26, P555, DOI 10.1016/j.biomaterials.2004.02.063
   MESSINEO A, 1992, J PEDIATR SURG, V27, P1131, DOI 10.1016/0022-3468(92)90574-Q
   Mobasheri A, 2009, HISTOL HISTOPATHOL, V24, P347, DOI 10.14670/HH-24.347
   Nakajima H, 2006, CIRC RES, V98, P141, DOI 10.1161/01.RES.0000197783.70106.4a
   Ozawa T, 2002, CIRCULATION, V106, pI176, DOI 10.1161/01.cir.0000032901.55215.cc
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Schubert T, 2009, INT J MOL MED, V23, P455, DOI 10.3892/ijmm_00000151
   Schwartz CF, 2004, J CARDIOVASC SURG, V45, P419
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Tojo T, 1998, ANN THORAC SURG, V66, P209, DOI 10.1016/S0003-4975(98)00270-7
   Tudorache I, 2007, J HEART VALVE DIS, V16, P567
NR 19
TC 0
Z9 0
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD NOV
PY 2014
VL 8
IS 11
BP 850
EP 861
DI 10.1002/term.1585
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AS5UU
UT WOS:000344335700002
PM 22837178
DA 2018-10-20
ER

PT J
AU Douglas, TEL
   Wlodarczyk, M
   Pamula, E
   Declercq, HA
   de Mulder, ELW
   Bucko, MM
   Balcaen, L
   Vanhaecke, F
   Cornelissen, R
   Dubruel, P
   Jansen, JA
   Leeuwenburgh, SCG
AF Douglas, T. E. L.
   Wlodarczyk, M.
   Pamula, E.
   Declercq, H. A.
   de Mulder, E. L. W.
   Bucko, M. M.
   Balcaen, L.
   Vanhaecke, F.
   Cornelissen, R.
   Dubruel, P.
   Jansen, J. A.
   Leeuwenburgh, S. C. G.
TI Enzymatic mineralization of gellan gum hydrogel for bone
   tissue-engineering applications and its enhancement by polydopamine
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE mineralization; polydopamine; bone tissue engineering; hydrogel;
   composite; enzyme; biomimetic
ID ALKALINE-PHOSPHATASE; IN-VIVO; BIOMATERIAL; DIFFERENTIATION;
   HYDROXYAPATITE; INACTIVATION; COMPOSITES; TRANSITION; STIFFNESS; CELLS
AB Interest is growing in the use of hydrogels as bone tissue-engineering (TE) scaffolds due to advantages such as injectability and ease of incorporation of active substances such as enzymes. Hydrogels consisting of gellan gum (GG), an inexpensive calcium-crosslinkable polysaccharide, have been applied in cartilage TE. To improve GG suitability as a material for bone TE, alkaline phosphatase (ALP), an enzyme involved in mineralization of bone by cleaving phosphate from organic phosphate, was incorporated into GG hydrogels to induce mineralization with calcium phosphate (CaP). Incorporated ALP induced formation of apatite-like material on the submicron scale within GG gels, as shown by FTIR, SEM, EDS, XRD, ICP-OES, TGA and von Kossa staining. Increasing ALP concentration increased amounts of CaP as well as stiffness. Mineralized GG was able to withstand sterilization by autoclaving, although stiffness decreased. In addition, mineralizability and stiffness of GG was enhanced by the incorporation of polydopamine (PDA). Furthermore, mineralization of GG led to enhanced attachment and vitality of cells in vitro while cytocompatibility of the mineralized gels was comparable to one of the most commonly used bone substitute materials. The results proved that ALP-mediated enzymatic mineralization of GG could be enhanced by functionalization with PDA. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Douglas, T. E. L.; Jansen, J. A.; Leeuwenburgh, S. C. G.] Radboud Univ Nijmegen, Dept Biomat, Med Ctr, NL-6500 HB Nijmegen, Netherlands.
   [Douglas, T. E. L.; Dubruel, P.] Univ Ghent, Dept Organ Chem, Polymer Chem & Biomat PBM Grp, B-9000 Ghent, Belgium.
   [Wlodarczyk, M.; Pamula, E.; Bucko, M. M.] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, Krakow, Poland.
   [Declercq, H. A.; Cornelissen, R.] Univ Ghent, Dept Basic Med Sci, Histol Grp, Ghent, Belgium.
   [de Mulder, E. L. W.] Radboud Univ Nijmegen, Med Ctr, Dept Orthoped, NL-6500 HB Nijmegen, Netherlands.
   [Balcaen, L.; Vanhaecke, F.] Univ Ghent, Dept Analyt Chem, B-9000 Ghent, Belgium.
RP Douglas, TEL (reprint author), Univ Ghent, Dept Organ Chem, Polymer Chem & Biomat PBM Grp, Krijgslaan 281 S4, B-9000 Ghent, Belgium.
EM Timothy.Douglas@UGent.be
RI Leeuwenburgh, S.C.G./L-4483-2015; Balcaen, Lieve/H-5129-2015; Jansen,
   John/H-8055-2014
OI Leeuwenburgh, S.C.G./0000-0003-1471-6133; Balcaen,
   Lieve/0000-0002-1800-6932; 
FU Agentschap NL [SHM08717]; NWO VENI program, The Netherlands; Research
   Foundation Flanders (FWO); Ghent University through a BOF grant
FX The authors thank Agentschap NL (IOP self-healing materials, Project no.
   SHM08717) and the NWO VENI program, The Netherlands, for financial
   support. Timothy Douglas and Lieve Balcaen acknowledge the Research
   Foundation Flanders (FWO) for support in the framework of postdoctoral
   fellowships. Heidi Declercq thanks Ghent University for financial
   support through a BOF grant. Vincent Cuijpers, Natasja van Dijk, Leen
   Pieters and Toke Thiron are thanked for technical assistance. Volker
   Gassling and Nicolai Purcz are thanked for providing BioOss.
CR BESMAN M, 1985, J BIOL CHEM, V260, P1190
   Boss GW, 2005, BIOMATERIALS, V26, P3901
   Chirdon WM, 2003, J BIOMED MATER RES B, V66B, P532, DOI 10.1002/jbm.b.10041
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans N. D., 2009, EUR CELLS MATER, V18, P13
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fadiloglu S, 2004, FOOD TECHNOL BIOTECH, V42, P27
   Fans J, 2010, ACTA BIOMATER, V6, P1178
   Fialho AM, 2008, APPL MICROBIOL BIOT, V79, P889, DOI 10.1007/s00253-008-1496-0
   Filmon R, 2002, BONE, V30, P152, DOI 10.1016/S8756-3282(01)00634-2
   Filmon R, 2000, J BIOMAT SCI-POLYM E, V11, P849, DOI 10.1163/156856200744057
   Giavasis I, 2000, CRIT REV BIOTECHNOL, V20, P177, DOI 10.1080/07388550008984169
   Gkioni K, 2010, TISSUE ENG PART B-RE, V16, P577, DOI [10.1089/ten.teb.2010.0462, 10.1089/ten.TEB.2010.0462]
   Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012
   Hong S, 2011, NANOMEDICINE-UK, V6, P793, DOI [10.2217/nnm.11.76, 10.2217/NNM.11.76]
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Jennissen HP, 2007, MATERIALWISS WERKST, V38, P1035, DOI 10.1002/mawe.200700247
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Lees H, 2007, SCIENCE, V318, P426
   Leeuwenburgh SCG, 2010, ACTA BIOMATER, V6, P836, DOI 10.1016/j.actbio.2009.09.005
   Leeuwenburgh SCG, 2007, J BIOMAT SCI-POLYM E, V18, P1547
   Legeross RZ, 1991, CALCIUM PHOSPHATES O
   Lombardi P, 2000, J FOOD PROTECT, V63, P970, DOI 10.4315/0362-028X-63.7.970
   Miyoshi E, 1996, CARBOHYD POLYM, V30, P109, DOI 10.1016/S0144-8617(96)00093-8
   NEALE FC, 1965, J CLIN PATHOL, V18, P359, DOI 10.1136/jcp.18.3.359
   Okamoto T, 1996, CARBOHYD POLYM, V30, P149, DOI 10.1016/S0144-8617(96)00074-4
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Ryus J, 2010, ADV FUNCT MATER, V20, P2132
   Schouten C, 2009, BIOMATERIALS, V30, P6407, DOI 10.1016/j.biomaterials.2009.08.001
   Spoerke ED, 2009, ADV MATER, V21, P425, DOI 10.1002/adma.200802242
   Yamauchi K, 2004, BIOMATERIALS, V25, P5481, DOI 10.1016/j.biomaterials.2003.12.057
NR 33
TC 31
Z9 31
U1 6
U2 84
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD NOV
PY 2014
VL 8
IS 11
BP 906
EP 918
DI 10.1002/term.1616
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AS5UU
UT WOS:000344335700007
PM 23038649
DA 2018-10-20
ER

PT J
AU Focaroli, S
   Teti, G
   Salvatore, V
   Durante, S
   Belmonte, MM
   Giardino, R
   Mazzotti, A
   Bigi, A
   Falconi, M
AF Focaroli, Stefano
   Teti, Gabriella
   Salvatore, Viviana
   Durante, Sandra
   Belmonte, Monica Mattioli
   Giardino, Roberto
   Mazzotti, Antonio
   Bigi, Adriana
   Falconi, Mirella
TI Chondrogenic Differentiation of Human Adipose Mesenchimal Stem Cells:
   Influence of a Biomimetic Gelatin Genipin Crosslinked Porous Scaffold
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE tissue engineering; chondrogenic markers; ultrastructure
ID HUMAN BONE-MARROW; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   ARTICULAR-CARTILAGE; TISSUE; REGENERATION; DEFECTS; COMPOSITE;
   PHOSPHATE; ALGINATE; MATRIX
AB Human adipose derived stem cells have shown chondrogenic differentiation potential in cartilage tissue engineering in combination with biomimetic materials. In this study, the chondrogenic potential of a porous gelatin based scaffold genipin (GNP) crosslinked was investigated in human mesenchymal stem cells obtained from adipose tissue. Cells were cultured up to 4 weeks on the scaffold and on monolayer, MTT assay was performed to evaluate cell viability, light, and transmission electron microscopy were carried out to demonstrate cell proliferation, scaffold adhesion, and cell colonization inside the porous architecture of the biomaterial. The expression of chondrogenic markers such as SOX9, collagen type II, aggregan, and versican was investigated by Real Time PCR. Results showed an high cell viability, adhesion, and colonization of the scaffold. Real Time PCR data demonstrated an upregulation of all the chondrogenic markers analyzed. In conclusion, 3D gelatin GNP crosslinked porous scaffold provides an improved environment for chondrogenic differentiation of stem cells compared with cell monolayer culture system. Microsc. Res. Tech. 77:928-934, 2014. (c) 2014 Wiley Periodicals, Inc.
C1 [Focaroli, Stefano; Teti, Gabriella; Salvatore, Viviana; Durante, Sandra; Falconi, Mirella] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, I-40126 Bologna, Italy.
   [Belmonte, Monica Mattioli] Univ Politecn Marche, Sch Med, Dept Clin & Mol Sci, I-60126 Ancona, Italy.
   [Giardino, Roberto] Rizzoli Orthoped Inst, Rizzoli Res Innovat Technol RIT, Labs Preclin & Surg Studies & Biocompatibil Innov, I-40136 Bologna, Italy.
   [Mazzotti, Antonio] Rizzoli Orthoped Inst, Orthopaed & Traumatol Clin 1, I-40136 Bologna, Italy.
   [Bigi, Adriana] Univ Bologna, Dept Chem G Ciamician, I-40128 Bologna, Italy.
RP Falconi, M (reprint author), Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Via Irnerio 48, I-40126 Bologna, Italy.
EM mirella.falconi@unibo.it
RI Bigi, adriana/R-6341-2016; Mattioli-Belmonte, Monica/J-5861-2012
OI Bigi, adriana/0000-0003-2668-8627; Durante, Sandra/0000-0002-3723-8659;
   mazzotti, antonio/0000-0001-9974-4787; Salvatore,
   Viviana/0000-0002-1303-5435; teti, gabriella/0000-0001-9817-8437
FU FIRB grant, Italian Ministry of Research and Technology (MURST)
   [RBAP10MLK7_005]; PRIN grant, Italian Ministry of Research and
   Technology (MURST); Fondazione del Monte di Bologna and Ravenna grant
FX Contract grant sponsor: FIRB grant, Italian Ministry of Research and
   Technology (MURST); Contract grant number: RBAP10MLK7_005; Contract
   grant sponsor: PRIN 2009 grant, Italian Ministry of Research and
   Technology (MURST); Contract grant sponsor: Fondazione del Monte di
   Bologna and Ravenna 2012 grant.
CR Afizah H, 2007, TISSUE ENG, V13, P659, DOI 10.1089/ten.2006.0118
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Biant LC, 2007, J BONE JOINT SURG BR, V89B, P1110, DOI 10.1302/0301-620X.89B8
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Da-Ae Y, 2012, INT J STEM CELLS, V5, P16
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Dragoo JL, 2005, PLAST RECONSTR SURG, V115, P1665, DOI 10.1097/01.PRS.0000161459.90856.AB
   Eyre D R, 2002, Biochem Soc Trans, V30, P893
   Fong ELS, 2012, ADV MATER, V24, P4995, DOI 10.1002/adma.201201762
   Fraser John K., 2008, V449, P59, DOI 10.1007/978-1-60327-169-1_4
   Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9
   Herlofsen SR, 2011, TISSUE ENG PT A, V17, P1003, DOI [10.1089/ten.tea.2010.0499, 10.1089/ten.TEA.2010.0499]
   Huang JI, 2005, J ORTHOP RES, V23, P1383, DOI 10.1016/j.orthres.2005.03.018
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Kim H. J., 2012, J TISSUE ENG, V3
   McAlinden A, 2014, MATRIX BIOL, V34, P105, DOI 10.1016/j.matbio.2013.09.006
   MCNICKLE AG, 2008, SPORTS MED ARTHROSC, V16, P196, DOI DOI 10.1097/JSA.0B013E31818CDB82
   Minas T, 1997, ORTHOPEDICS, V20, P525
   MINAS T, 2001, CLIN ORTHOP S, V391, pS349
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Panzavolta S, 2009, ACTA BIOMATER, V5, P636, DOI 10.1016/j.actbio.2008.08.017
   Panzavolta S, 2013, J BIOMED MATER RES A, V101, P3560, DOI 10.1002/jbm.a.34662
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   Rodriguez AM, 2005, BIOCHIMIE, V87, P125, DOI 10.1016/j.biochi.2004.11.007
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Wei YY, 2009, CELL TRANSPLANT, V18, P159, DOI 10.3727/096368909788341261
   Xiao J, 2001, TRANSFUSION, V52, P2551
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P711, DOI 10.1016/S0142-9612(98)00199-9
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
   Zhang ZJ, 2012, J CELL BIOCHEM, V113, P888, DOI 10.1002/jcb.23418
NR 35
TC 10
Z9 10
U1 0
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD NOV
PY 2014
VL 77
IS 11
BP 928
EP 934
DI 10.1002/jemt.22417
PG 7
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA AS5XC
UT WOS:000344338900010
PM 25099470
DA 2018-10-20
ER

PT J
AU Karimi, M
   Heuchel, M
   Weigel, T
   Kratz, K
   Lendlein, A
AF Karimi, Mohammad
   Heuchel, Matthias
   Weigel, Thomas
   Kratz, Karl
   Lendlein, Andreas
TI Influence of expansion cooling regime on morphology of
   poly(epsilon-caprolactone) foams prepared by pressure quenching using
   supercritical CO2
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 12th Conference on Polymers for Advanced Technologies (PAT)
CY 2013
CL Belin, GERMANY
DE poly(epsilon-caprolactone); foaming; crystallization; thermodynamics;
   differential scanning calorimetry (DSC); melting point; supercritical
   carbon dioxide
ID CARBON-DIOXIDE; CRYSTALLIZATION; NUCLEATION; PCL
AB Creation of foam structures from hydrolytically degradable poly(epsilon-caprolactone) (PCL) is a current task in biomaterial research. One example are degradable scaffolds. The thermodynamic and kinetic conditions in a supercritical CO2 (scCO(2)) supported foaming process of PCL can influence the resulting morphology of the foam. PCL foaming with scCO(2) was systematically investigated in the pressure range from 78 to 200bar at temperatures between 25 degrees C and 50 degrees C with the help of a view cell. PCL foams could be obtained at both conditions above the pressure dependent melting temperature as well as below this temperature, i.e. from supercooled melt states. Differential scanning calorimetry investigations of the PCL foam samples were used for the analysis of the relationship between pore morphology and foaming conditions. Three characteristic regions could be distinguished in the PCL/CO2 phase diagram. Only when the foaming was conducted above the critical temperature of CO2, a significant influence of the depressurization rate could be observed. Here, an increase in the quenching rate resulted in a decreasing pore size while the pore density was found to increase. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Karimi, Mohammad] Amirkabir Univ Technol, Dept Text Engn, Tehran 15914, Iran.
   [Karimi, Mohammad; Heuchel, Matthias; Weigel, Thomas; Kratz, Karl; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM Andreas.Lendlein@hzg.de
RI Heuchel, Matthias/B-8271-2011; Lendlein, Andreas/K-9553-2013; Kratz,
   Karl/K-7115-2013
OI Heuchel, Matthias/0000-0002-3860-1835; Lendlein,
   Andreas/0000-0003-4126-4670; Kratz, Karl/0000-0002-9229-4266
CR Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Cotugno S, 2005, IND ENG CHEM RES, V44, P1795, DOI 10.1021/ie049445c
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Jacobs LJM, 2008, GREEN CHEM, V10, P731, DOI 10.1039/b801895b
   Jenkins MJ, 2006, EUR POLYM J, V42, P3145, DOI 10.1016/j.eurpolymj.2006.07.022
   Karimi M, 2012, J SUPERCRIT FLUID, V61, P175, DOI 10.1016/j.supflu.2011.09.022
   Kiran E, 2008, POLYMER, V49, P1853, DOI 10.1016/j.polymer.2008.02.017
   Kiran E, 2009, J SUPERCRIT FLUID, V47, P466, DOI 10.1016/j.supflu.2008.11.010
   Luetzow K, 2007, J BIOMECH, V40, pS80, DOI 10.1016/j.jbiomech.2007.02.022
   Naguib HE, 2004, J APPL POLYM SCI, V91, P2661, DOI 10.1002/app.13448
   Reignier J, 2006, POLYMER, V47, P5012, DOI 10.1016/j.polymer.2006.05.040
   SANCHEZ IC, 1978, MACROMOLECULES, V11, P1145, DOI 10.1021/ma60066a017
   Shieh YT, 2005, J SUPERCRIT FLUID, V33, P183, DOI 10.1016/j.supflu.2004.06.002
   Sisson AL, 2013, POLYMER, V54, P4333, DOI 10.1016/j.polymer.2013.04.045
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wurm A, 2012, MACROMOLECULES, V45, P3816, DOI 10.1021/ma300363b
NR 18
TC 2
Z9 2
U1 1
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD NOV
PY 2014
VL 25
IS 11
SI SI
BP 1349
EP 1355
DI 10.1002/pat.3371
PG 7
WC Polymer Science
SC Polymer Science
GA AS0UU
UT WOS:000343994800023
DA 2018-10-20
ER

PT J
AU Altomare, DF
AF Altomare, D. F.
TI Comments to "Perianal injectable bulking agents as treatment for faecal
   incontinence in adults"
SO TECHNIQUES IN COLOPROCTOLOGY
LA English
DT Editorial Material
AB Objectives To determine the effectiveness of perianal injection of bulking agents for the treatment of faecal incontinence in adults.
   Search strategy We searched the Cochrane Incontinence Group Specialised Register of trials (searched 10 June 2009), ZETOC (searched 18 July 2009), clinical trials registries (searched 18 July 2009) and the reference lists of relevant articles.
   Selection criteria All randomised or quasi-randomised controlled trials comparing use of injectable bulking agents for faecal incontinence with any alternative treatments or placebo were reviewed to evaluate the therapeutic effects. Case-control and cohort studies were also reviewed to assess risks and complications associated with the treatment.
   Main results Four eligible randomised trials were identified with a total of 176 patients. All trials but one were at an uncertain or high risk of bias. Most trials reported a shortterm benefit from injections regardless of the material used as outcome measures improved over time. A silicone biomaterial (PTQ) was shown to provide some advantages and was safer in treating faecal incontinence than carboncoated beads (Durasphere (R)) in the short term. Similarly, there were short-term benefits from injections delivered under ultrasound guidance compared with digital guidance. However, PTQ did not demonstrate obvious clinical benefit compared with control injection of normal saline. No longterm evidence on outcomes was available, and further conclusions were not warranted from the available data.
   Authors' conclusions A definitive conclusion cannot be drawn regarding the effectiveness of perianal injection of bulking agents for faecal incontinence due to the limited number of identified trials together with methodological weaknesses. Within the available data, however, we found no reliable evidence for effectiveness of one treatment over another in improving faecal incontinence. Larger welldesigned trials with adequate numbers of subjects using reliable validated outcome measures are needed to allow definitive assessment of the treatment for both effectiveness and safety.
C1 Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy.
RP Altomare, DF (reprint author), Univ Bari, Dept Emergency & Organ Transplantat, Bari, Italy.
EM donatofrancesco.altomare@uniba.it
OI Altomare, Donato Francesco/0000-0001-8980-2752
CR Maeda Y, 2013, COCHRANE DB SYST REV, V28, P2
   Ratto C, 2011, BRIT J SURG, V98, P1644, DOI 10.1002/bjs.7699
NR 2
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1123-6337
EI 1128-045X
J9 TECH COLOPROCTOL
JI Tech. Coloproctology
PD NOV
PY 2014
VL 18
IS 11
BP 1139
EP 1140
DI 10.1007/s10151-014-1218-9
PG 2
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA AS5XW
UT WOS:000344340800029
PM 25261078
DA 2018-10-20
ER

PT J
AU Fang, J
   Ye, SH
   Shankarraman, V
   Huang, YX
   Mo, XM
   Wagner, WR
AF Fang, Jun
   Ye, Sang-Ho
   Shankarraman, Venkat
   Huang, Yixian
   Mo, Xiumei
   Wagner, William R.
TI Biodegradable poly(ester urethane)urea elastomers with variable amino
   content for subsequent functionalization with phosphorylcholine
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biodegradable polyurethane; Bulk modification; Zwitterion;
   Cardiovascular biomaterial
ID SELF-ASSEMBLED MONOLAYERS; REDUCED THROMBOGENICITY; SMALL-DIAMETER;
   DRUG-DELIVERY; POLYURETHANES; SCAFFOLDS; POLYMER; SURFACE;
   CYTOCOMPATIBILITY; DEGRADATION
AB While surface modification is well suited for imparting biomaterials with specific functionality for favorable cell interactions, the modification of degradable polymers would be expected to provide only temporary benefit. Bulk modification by incorporating pendant reactive groups for subsequent functionalization of biodegradable polymers would provide a more enduring approach. Towards this end, a series of biodegradable poly(ester urethane)urea elastomers with variable amino content (PEUU-NH2 polymers) were developed. Carboxylated phosphorycholine was synthesized and conjugated to the PEUU-NH2 polymers for subsequent bulk functionalization to generate PEUU-PC polymers. Synthesis was verified by proton nuclear magnetic resonance, X-ray photoelectron spectroscopy and attenuated total reflection Fourier transform infrared spectroscopy. The impact of amine incorporation and phosphorylcholine conjugation was shown on mechanical, thermal and degradation properties. Water absorption increased with increasing amine content, and further with PC conjugation. In wet conditions, tensile strength and initial modulus generally decreased with increasing hydrophilicity, but remained in the range of 5-30 MPa and 10-20 MPa, respectively. PC conjugation was associated with significantly reduced platelet adhesion in blood contact testing and the inhibition of rat vascular smooth muscle cell proliferation. These biodegradable PEUU-PC elastomers offer attractive properties for applications as non-thrombogenic, biodegradable coatings and for blood-contacting scaffold applications. Further, the PEUU-NH2 base polymers offer the potential to have multiple types of biofunctional groups conjugated onto the backbone to address a variety of design objectives. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Fang, Jun; Mo, Xiumei] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
   [Fang, Jun; Ye, Sang-Ho; Shankarraman, Venkat; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Fang, Jun; Ye, Sang-Ho; Shankarraman, Venkat; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Huang, Yixian] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15219 USA.
   [Mo, Xiumei] Donghua Univ, Coll Chem & Chem Engn & Biol Engn, Shanghai 201620, Peoples R China.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI Ye, Sang-Ho/H-5294-2011; mo, xiumei/C-9340-2013
OI Ye, Sang-Ho/0000-0002-4760-9812; 
FU China Scholarship Council [201206630040]; Fundamental Research Funds for
   the Central Universities [12D10631]; National Nature Science Foundation
   of China [31271035, 31470941]; Science and Technology Commission of
   Shanghai Municipality [11nm0506200]; National Research Foundation for
   the Doctoral Program of Higher Education of China [20130075110005]; NSF
   Engineering Research Center for Revolutionizing Metallic Biomaterials
   (ERC-RMB) [0812348]; NESAC/BIO at the University of Washington (NIH) [EB
   002027]
FX This research was supported by the China Scholarship Council
   (201206630040), Fundamental Research Funds for the Central Universities
   (12D10631), National Nature Science Foundation of China (31271035,
   31470941), Science and Technology Commission of Shanghai Municipality
   (11nm0506200) and The National Research Foundation for the Doctoral
   Program of Higher Education of China (20130075110005). This research was
   also supported by the NSF Engineering Research Center for
   Revolutionizing Metallic Biomaterials (ERC-RMB) (Award #0812348,
   National Science Foundation).We appreciate the XPS surface analysis
   provided by NESAC/BIO at the University of Washington (NIH grant EB
   002027) and Prof. Kazuhiko Ishihara at the University of Tokyo for
   providing the MPC monomer. We would also like to thank the Center for
   Biological Imaging (CBI) at the University of Pittsburgh for their kind
   assistance with SEM imaging.
CR AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4
   Cao J, 2013, J BIOMED MATER RES A, V101, P909, DOI 10.1002/jbm.a.34384
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Cherng JY, 2013, INT J PHARMACEUT, V450, P145, DOI 10.1016/j.ijpharm.2013.04.063
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   Eceiza A, 2008, POLYM ENG SCI, V48, P297, DOI 10.1002/pen.20905
   Fournier D, 2008, MACROMOLECULES, V41, P4622, DOI 10.1021/ma800189z
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Gao B, 2013, MAT SCI ENG C-MATER, V33, P2871, DOI 10.1016/j.msec.2013.03.007
   Gisselfalt K, 2002, BIOMACROMOLECULES, V3, P951, DOI 10.1021/bm025535u
   Guan JJ, 2006, CELL TRANSPLANT, V15, pS17, DOI 10.3727/000000006783982412
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2005, BIOMACROMOLECULES, V6, P2833, DOI 10.1021/bm0503322
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Hashizume R, 2013, BIOMATERIALS, V34, P7353, DOI 10.1016/j.biomaterials.2013.06.020
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Hong Y., 2011, TISSUE ENG PART C-ME, V18, P122
   Hong Y, 2012, BIOMACROMOLECULES, V13, P3686, DOI 10.1021/bm301158j
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Hung K.C., 2014, ADV HEALTHC MAT
   Jun HW, 2005, BIOMACROMOLECULES, V6, P838, DOI 10.1021/bm049419y
   Ma CF, 2011, ACS APPL MATER INTER, V3, P455, DOI 10.1021/am101039q
   Mirza A, 2008, J VASC SURG, V47, P1313, DOI 10.1016/j.jvs.2007.12.038
   Morral-Ruiz G, 2013, J CONTROL RELEASE, V171, P163, DOI 10.1016/j.jconrel.2013.06.027
   Niu YQ, 2014, BIOMATERIALS, V35, P4266, DOI 10.1016/j.biomaterials.2014.02.013
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Smith RS, 2012, SCI TRANSL MED, V4, P153
   Song NJ, 2013, BIOMACROMOLECULES, V14, P4407, DOI 10.1021/bm401342t
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Xu Y, 2010, ANN BIOMED ENG, V38, P1938, DOI 10.1007/s10439-010-0025-3
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang LX, 2011, BIOMACROMOLECULES, V12, P2032, DOI 10.1021/bm2003658
   Zhang K, 2014, J BIOMED MATER RES A, V102, P588, DOI 10.1002/jbm.a.34714
NR 43
TC 22
Z9 22
U1 7
U2 114
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4639
EP 4649
DI 10.1016/j.actbio.2014.08.008
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400009
PM 25132273
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lachke, MW
   Augustin, V
   Kleer, S
   Tschernig, T
   Menger, MD
AF Lachke, M. W.
   Augustin, V.
   Kleer, S.
   Tschernig, T.
   Menger, M. D.
TI Locally applied macrophage-activating lipopeptide-2 (MALP-2) promotes
   early vascularization of implanted porous polyethylene (Medpor (R))
SO ACTA BIOMATERIALIA
LA English
DT Article
DE MALP-2; Polyethylene; Vascularization; Incorporation; Dorsal skinfold
   chamber
ID HOST TISSUE; PANCREATIC-CARCINOMA; ORBITAL IMPLANTS; MICE; SCAFFOLDS;
   ANGIOGENESIS; BIOMATERIALS; STIMULATION; INJECTION; INFECTION
AB Porous polyethylene (Medpor (R)) is frequently used in craniofacial reconstructive surgery. Rapid vascularization of the biomaterial crucially contributes to its adequate incorporation without complications. Macrophage-activating lipopeptide-2 (MALP-2) is a toll-like receptor (TLR)-2/6 agonist with pro-angiogenic properties. Herein we analyzed whether local single-shot application of MALP-2 improves the angiogenic host tissue response to Medpor (R). Medpor (R) (3 mm x 3 mm x 0.25 mm) was implanted into dorsal skinfold chambers of BALB/c mice topically exposed to different MALP-2 doses (0.1 and 0.5 mu g) or vehicle (control). The vascularization of the implants and the inflammatory foreign body reaction was analyzed using intravital fluorescence microscopy, histology and immunohistochemistry over 14 days. MALP-2 treatment dose-dependently improved the vascularization of Medpor (R), as indicated by a significantly higher functional microvessel density at the border and center of the implants when compared to controls. This was associated with a temporary increase of adherent leukocytes in host tissue venules during the first 3 days after implantation. At day 14, implants in MALP-2-treated chambers were surrounded by granulation tissue, which exhibited a significantly higher density of CD31-positive microvessels and number of F4/80-positive macrophages when compared to controls. Additional biomaterial-free chambers did not show any signs of angiogenesis when treated with MALP-2. This indicates that locally applied MALP-2 effectively stimulates the early vascularization of Medpor (R) without inducing any local or systemic side effects. Accordingly, this easy approach may further improve the rapid incorporation of this biomaterial at the implantation site. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lachke, M. W.; Augustin, V.; Kleer, S.; Menger, M. D.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   [Tschernig, T.] Univ Saarland, Inst Anat, D-66421 Homburg, Germany.
RP Lachke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uks.eu
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   De Vriese AS, 2000, J VASC RES, V37, P26, DOI 10.1159/000025710
   Deiters U, 2004, EXP DERMATOL, V13, P731, DOI 10.1111/j.0906-6705.2004.00233.x
   Deiters U, 2003, INFECT IMMUN, V71, P4456, DOI 10.1128/IAI.71.8.4456-4462.2003
   Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11
   Ehrmantraut S, 2012, TISSUE ENG PT A, V18, P1562, DOI [10.1089/ten.TEA.2011.0340, 10.1089/ten.tea.2011.0340]
   Grote K, 2013, EUR CELLS MATER, V26, P66, DOI 10.22203/eCM.v026a05
   Grote K, 2013, ARTERIOSCL THROM VAS, V33, P2097, DOI 10.1161/ATVBAHA.113.301799
   Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Jeanmonod P, 2013, J VASC SURG, V58, P1637, DOI 10.1016/j.jvs.2013.02.012
   Jung SK, 2012, BRIT J OPHTHALMOL, V96, P494, DOI 10.1136/bjophthalmol-2011-300132
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Laschke MW, 2012, EUR CELLS MATER, V24, P266, DOI 10.22203/eCM.v024a19
   Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Laschke MW, 2009, J BIOMED MATER RES B, V91B, P497, DOI 10.1002/jbm.b.31423
   Luhrmann A, 2005, VACCINE, V23, P4721, DOI 10.1016/j.vaccine.2005.05.009
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951
   Naik MN, 2007, OPHTHAL PLAST RECONS, V23, P463, DOI 10.1097/IOP.0b013e318158ec8e
   Naumann A, 2011, HNO, V59, P268, DOI 10.1007/s00106-010-2226-3
   Niebuhr M, 2008, EXP DERMATOL, V17, P1052, DOI 10.1111/j.1600-0625.2008.00750.x
   Niechajev I, 2012, AESTHET PLAST SURG, V36, P917, DOI 10.1007/s00266-012-9911-4
   Reppe K, 2009, AM J RESP CELL MOL, V40, P474, DOI 10.1165/rcmb.2008-0071OC
   Rharbaoui F, 2002, EUR J IMMUNOL, V32, P2857, DOI 10.1002/1521-4141(2002010)32:10<2857::AID-IMMU2857>3.0.CO;2-R
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Schmidt J, 2007, BRIT J CANCER, V97, P598, DOI 10.1038/sj.bjc.6603903
   Schneider C, 2004, GUT, V53, P355, DOI 10.1136/gut.2003.026005
   Sclafani AP, 1997, ARCH OTOLARYNGOL, V123, P328
   Stelter K, 2007, RHINOLOGY, V45, P325
   Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670
   Winkler AA, 2012, ARCH FACIAL PLAST S, V14, P437, DOI 10.1001/archfacial.2012.583
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
NR 35
TC 7
Z9 7
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4661
EP 4669
DI 10.1016/j.actbio.2014.07.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400011
PM 25062995
DA 2018-10-20
ER

PT J
AU Nehilla, BJ
   Nataraj, N
   Gaborski, TR
   McGrath, JL
AF Nehilla, Barrett J.
   Nataraj, Nakul
   Gaborski, Thomas R.
   McGrath, James L.
TI Endothelial vacuolization induced by highly permeable silicon membranes
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanoporous materials; Biomaterials; Silicon; Membranes; Tissue
   engineering
ID BLOOD-BRAIN-BARRIER; IN-VITRO MODEL; CAPILLARY MORPHOGENESIS;
   INTERSTITIAL FLOW; LUMEN FORMATION; POROUS SILICON; TUBE FORMATION;
   CELLS; INTEGRIN; TISSUES
AB Assays for initiating, controlling and studying endothelial cell behavior and blood vessel formation have applications in developmental biology, cancer and tissue engineering. In vitro vasculogenesis models typically combine complex three-dimensional gels of extracellular matrix proteins with other stimuli like growth factor supplements. Biomaterials with unique micro- and nanoscale features may provide simpler substrates to study endothelial cell morphogenesis. In this work, patterns of nanoporous, nanothin silicon membranes (porous nanocrystalline silicon, or pnc-Si) are fabricated to control the permeability of an endothelial cell culture substrate. Permeability on the basal surface of primary and immortalized endothelial cells causes vacuole formation and endothelial organization into capillary-like structures. This phenomenon is repeatable, robust and controlled entirely by patterns of free-standing, highly permeable pnc-Si membranes. Pnc-Si is a new biomaterial with precisely defined micro- and nanoscale features that can be used as a unique in vitro platform to study endothelial cell behavior and vasculogenesis. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Nehilla, Barrett J.; McGrath, James L.] Univ Rochester, Dept Biomed Engn, Rochester, NY 14627 USA.
   [Nataraj, Nakul; Gaborski, Thomas R.] SiMPore Inc, West Henrietta, NY 14586 USA.
RP McGrath, JL (reprint author), Univ Rochester, Dept Biomed Engn, Box 270168, Rochester, NY 14627 USA.
EM jmcgrath@bme.rochester.edu
OI Gaborski, Thomas/0000-0002-3676-3208; Nataraj, Nakul/0000-0002-6772-8288
FU National Science Foundation [DMR0722653]; Center for Emerging and
   Innovative Sciences (CEIS); SiMPore, Inc.
FX The authors thank Dr. Alison C.P. Elder at the University of Rochester
   for helpful discussions and advice. We thank David Z. Fang for TEM and
   pnc-Si thermal treatments and Nikita Petukhov for assistance with
   diffusion experiments. We also thank Dr. Richard E. Waugh and Brian L.
   McIntyre who provided access to the AFM and SEM equipment in their
   laboratories at the University of Rochester. Financial support was
   provided by National Science Foundation DMR0722653, the Center for
   Emerging and Innovative Sciences (CEIS), and SiMPore, Inc.
CR Agrawal AA, 2010, BIOMATERIALS, V31, P5408, DOI 10.1016/j.biomaterials.2010.03.041
   Ali S, 2013, BIORESEARCH OPEN ACC, V2, P241, DOI 10.1089/biores.2013.0021
   Bayless KJ, 2002, J CELL SCI, V115, P1123
   Bielaszewska M, 2009, THROMB HAEMOSTASIS, V102, P1080, DOI 10.1160/TH09-07-0499
   BRIGHTMA.MW, 1969, J CELL BIOL, V40, P648, DOI 10.1083/jcb.40.3.648
   Csoka B, 2004, J BIOCHEM BIOPH METH, V61, P57, DOI 10.1016/j.jbbm.2004.03.001
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Davis GE, 2000, IN VITRO CELL DEV-AN, V36, P513
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707
   Desai TA, 2004, ADV DRUG DELIVER REV, V56, P1661, DOI 10.1016/j.addr.2003.11.006
   Fang DZ, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454134
   Fu BM, 1995, AM J PHYSIOL-HEART C, V269, pH2124
   Gaborski TR, 2010, ACS NANO, V4, P6973, DOI 10.1021/nn102064c
   Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8
   GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x
   Harris SG, 2003, BIOTECHNOL BIOPROC E, V8, P246, DOI 10.1007/BF02942273
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Kavalenka MN, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/14/145706
   Kim E, 2008, J AM CHEM SOC, V130, P4230, DOI 10.1021/ja711258w
   Koh JT, 2004, EXP CELL RES, V294, P172, DOI 10.1016/j.yexcr.2003.11.008
   Kuiper S, 1998, J MEMBRANE SCI, V150, P1, DOI 10.1016/S0376-7388(98)00197-5
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4
   Morissette G, 2004, J PHARMACOL EXP THER, V310, P395, DOI 10.1124/jpet.104.066084
   Ng CP, 2004, MICROVASC RES, V68, P258, DOI 10.1016/j.mvr.2004.08.002
   Olsson AK, 2004, CANCER RES, V64, P599, DOI 10.1158/0008-5472.CAN-03-1941
   Pedrigi RM, 2011, EXP EYE RES, V92, P57, DOI 10.1016/j.exer.2010.11.003
   Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101
   Sarkar R, 2006, BIOPHYS CHEM, V123, P40, DOI 10.1016/j.bpc.2006.04.006
   Snyder JL, 2011, J MEMBRANE SCI, V369, P119, DOI 10.1016/j.memsci.2010.11.056
   Striemer CC, 2007, NATURE, V445, P749, DOI 10.1038/nature05532
   Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annure/bioeng.9.060906.151850
   Tolsma SS, 1997, MICROVASC RES, V54, P13, DOI 10.1006/mvre.1997.2015
   Torchilin VP, 2006, ADV DRUG DELIVER REV, V58, P1532, DOI 10.1016/j.addr.2006.09.009
   Vera RH, 2009, TISSUE ENG PT A, V15, P175, DOI 10.1089/ten.tea.2007.0314
   Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785
   Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016
NR 42
TC 3
Z9 3
U1 1
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4670
EP 4677
DI 10.1016/j.actbio.2014.07.022
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400012
PM 25072618
DA 2018-10-20
ER

PT J
AU Ogle, ME
   Sefcik, LS
   Awojoodu, AO
   Chiappa, NF
   Lynch, K
   Peirce-Cottler, S
   Botchwey, EA
AF Ogle, Molly E.
   Sefcik, Lauren S.
   Awojoodu, Anthony O.
   Chiappa, Nathan F.
   Lynch, Kevin
   Peirce-Cottler, Shayn
   Botchwey, Edward A.
TI Engineering in vivo gradients of sphingosine-1-phosphate receptor
   ligands for localized microvascular remodeling and inflammatory cell
   positioning
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Sphingolipid; Vascular remodeling; Cell recruitment; In vivo gradient
ID SPHINGOSINE 1-PHOSPHATE; HEMATOPOIETIC STEM; PROGENITOR CELLS;
   DRUG-RELEASE; FTY720; DELIVERY; RECRUITMENT; MIGRATION; ARTERIOGENESIS;
   PROLIFERATION
AB Biomaterial-mediated controlled release of soluble signaling molecules is a tissue engineering approach to spatially control processes of inflammation, microvascular remodeling and host cell recruitment, and to generate biochemical gradients in vivo. Lipid mediators, such as sphingosine 1-phosphate (SIP), are recognized for their essential roles in spatial guidance, signaling and highly regulated endogenous gradients. SIP and pharmacological analogs such as FTY720 are therapeutically attractive targets for their critical roles in the trafficking of cells between blood and tissue spaces, both physiologically and pathophysiologically. However, the interaction of locally delivered sphingolipids with the complex metabolic networks controlling the flux of lipid species in inflamed tissue has yet to be elucidated. In this study, complementary in vitro and in vivo approaches are investigated to identify relationships between polymer composition, drug release kinetics, SIP metabolic activity, signaling gradients and spatial positioning of circulating cells around poly(lactic-co-glycolic acid) biomaterials. Results demonstrate that biomaterial-based gradients of SIP are short-lived in the tissue due to degradation by SW lyase, an enzyme that irreversibly degrades intracellular SIP. On the other hand, in vivo gradients of the more stable compound, FTY720, enhance microvascular remodeling by selectively recruiting an anti-inflammatory subset of monocytes (SlP(3)(high)) to the biomaterial. Results highlight the need to better understand the endogenous balance of lipid import/export machinery and lipid kinase/phosphatase activity in order to design biomaterial products that spatially control the innate immune environment to maximize regenerative potential. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ogle, Molly E.; Awojoodu, Anthony O.; Chiappa, Nathan F.; Botchwey, Edward A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Ogle, Molly E.; Awojoodu, Anthony O.; Chiappa, Nathan F.; Botchwey, Edward A.] Emory Univ, Atlanta, GA 30332 USA.
   [Sefcik, Lauren S.] Lafayette Coll, Dept Chem & Biomol Engn, Easton, PA 18042 USA.
   [Lynch, Kevin] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22903 USA.
   [Peirce-Cottler, Shayn; Botchwey, Edward A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22903 USA.
RP Botchwey, EA (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 315 Ferst Dr, Atlanta, GA 30332 USA.
EM edward.botchwey@bme.gatech.edu
FU National Institutes of Health [K01 AR052352-01A1, R01AR056445-01A2,
   R01DE01 9935-01]
FX We thank Cynthia Huang and Shaun Tanner for assistance in the HPLC-MS
   and dorsal skinfold window chamber procedure. Sources of support for
   this study include the National Institutes of Health Grants K01
   AR052352-01A1, R01AR056445-01A2 and R01DE01 9935-01 to E.A.B.
CR Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Alewijnse AE, 2008, EUR J PHARMACOL, V585, P292, DOI 10.1016/j.ejphar.2008.02.089
   Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232
   Amann LC, 2010, PHARM RES-DORDR, V27, P1730, DOI 10.1007/s11095-010-0152-4
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200
   Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200
   Bode C, 2012, ARCH IMMUNOL THER EX, V60, P3, DOI 10.1007/s00005-011-0159-5
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108
   Cimetta E, 2010, LAB CHIP, V10, P3277, DOI 10.1039/c0lc00033g
   Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779
   Das A, 2013, BIOMATERIALS, V34, P9853, DOI 10.1016/j.biomaterials.2013.08.015
   Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1047/jbc.M412356200
   Dawson G, 2011, BIOCHEM BIOPH RES CO, V404, P321, DOI 10.1016/j.bbrc.2010.11.115
   Doyle ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032815
   Eperon S, 2008, INT J PHARMACEUT, V352, P240, DOI 10.1016/j.ijpharm.2007.10.054
   Faisant N, 2002, EUR J PHARM SCI, V15, P355, DOI 10.1016/S0928-0987(02)00023-4
   Farahat WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037333
   Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614
   Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926
   Hale JJ, 2004, BIOORGAN MED CHEM, V12, P4803, DOI 10.1016/j.bmc.2004.07.020
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941
   Hisano Y, 2011, J BIOL CHEM, V286, P1758, DOI 10.1074/jbc.M110.171116
   Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003
   Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3
   Ikeda M, 2004, BIOCHEM BIOPH RES CO, V325, P338, DOI 10.1016/j.bbrc.2004.10.036
   Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474
   Kawanabe T, 2007, J DERMATOL SCI, V48, P53, DOI 10.1016/j.jdermsci.2007.06.002
   Kimura T, 2003, ARTERIOSCL THROM VAS, V23, P1283, DOI 10.1161/01.ATV.0000079011.67194.5A
   Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338
   Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200
   Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200
   Lee H, 2000, AM J PHYSIOL-CELL PH, V278, pC612
   Lewis ND, 2013, J IMMUNOL, V190, P3533, DOI 10.4049/jimmunol.1201810
   Massberg S, 2009, ANN NY ACAD SCI, V1176, P87, DOI 10.1111/j.1749-6632.2009.04609.x
   Mechtcheriakova D, 2007, FEBS LETT, V581, P3063, DOI 10.1016/j.febslet.2007.05.069
   OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0
   Oyama O, 2008, CARDIOVASC RES, V78, P301, DOI 10.1093/cvr/cvn002
   Pan CJ, 2006, J CONTROL RELEASE, V116, P42, DOI 10.1016/j.jcornel.2006.08.023
   Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2
   Peest U, 2008, J CELL BIOCHEM, V104, P756, DOI 10.1002/jcb.21665
   Ramchandani M, 1998, J CONTROL RELEASE, V54, P167, DOI 10.1016/S0168-3659(97)00113-2
   Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059
   Sasaki H, 2009, BIOPHYS J, V96, P2727, DOI 10.1016/j.bpj.2008.12.3926
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sefcik LS, 2010, TISSUE ENG PART B-RE, V16, P361, DOI [10.1089/ten.teb.2009.0611, 10.1089/ten.TEB.2009.0611]
   Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]
   Sefcik Lauren S, 2008, Organogenesis, V4, P215
   Sensken SC, 2011, J IMMUNOL, V186, P3432, DOI 10.4049/jimmunol.1002169
   Sensken SC, 2009, J PHARMACOL EXP THER, V328, P963, DOI 10.1124/jpet.108.148163
   Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310
   Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974
   Swain J, 2013, PHYS CHEM CHEM PHYS, V15, P17962, DOI 10.1039/c3cp53148a
   Walter DH, 2007, ARTERIOSCL THROM VAS, V27, P275, DOI 10.1161/01.ATV.0000254669.12675.70
   Wang Y, 2013, INTEGR BIOL-UK, V5, P481, DOI 10.1039/c3ib20249f
   Wang YN, 2011, BIOMATERIALS, V32, P4903, DOI 10.1016/j.biomaterials.2011.03.027
   Wieghaus KA, 2008, BIOMATERIALS, V29, P4698, DOI 10.1016/j.biomaterials.2008.08.029
   Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018805
NR 62
TC 19
Z9 19
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4704
EP 4714
DI 10.1016/j.actbio.2014.08.007
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400016
PM 25128750
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Alsop, AT
   Pence, JC
   Weisgerber, DW
   Harley, BAC
   Bailey, RC
AF Alsop, Aurora T.
   Pence, Jacquelyn C.
   Weisgerber, Daniel W.
   Harley, Brendan A. C.
   Bailey, Ryan C.
TI Photopatterning of vascular endothelial growth factor within
   collagen-glycosaminoglycan scaffolds can induce a spatially confined
   response in human umbilical vein endothelial cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Collagen; Scaffold; Vascularization; Photolithography; VEGF
ID GAG SCAFFOLDS; EXTRACELLULAR-MATRIX; FACTOR SUPPLEMENTATION; IMMOBILIZED
   GRADIENTS; TENOCYTE BIOACTIVITY; PERIPHERAL-NERVES; PORE-SIZE; VEGF;
   PHOSPHORYLATION; REGENERATION
AB Biomolecular signals within the native extracellular matrix are complex, with bioactive factors found in both soluble and sequestered states. In the design of biomaterials for tissue engineering applications it is increasingly clear that new approaches are required to locally tailor the biomolecular environment surrounding cells within the matrix. One area of particular focus is strategies to improve the speed or quality of vascular ingrowth and remodeling. While the addition of soluble vascular endothelial growth factor (VEGF) has been shown to improve vascular response, strategies to immobilize such signals within a biomaterial offer the opportunity to optimize efficiency and to explore spatially defined patterning of such signals. Here we describe the use of benzophenone (BP) photolithography to decorate three-dimensional collagen-glycosaminoglycan (CG) scaffolds with VEGF in a spatially defined manner. In this effort we demonstrate functional patterning of a known agonist of vascular remodeling and directly observe phenotypic effects induced by this immobilized cue. VEGF was successfully patterned in both stripes and square motifs across the scaffold with high specificity (on:off pattern signal). The depth of patterning was determined to extend up to 500 mu m into the scaffold microstructure. Notably, photopattemed VEGF retained native functionality as it was shown to induce morphological changes in human umbilical vein cells indicative of early vasculogenesis. Immobilized VEGF led to greater cell infiltration into the scaffold and the formation of immature vascular network structures. Ultimately, these results suggest that BP-mediated photolithography is a facile method to spatially control the presentation of instructive biological cues to cells within CG scaffolds. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Alsop, Aurora T.; Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Pence, Jacquelyn C.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Weisgerber, Daniel W.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Bailey, RC (reprint author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
EM baileyrc@illinois.edu
OI Bailey, Ryan/0000-0003-1021-4267; Harley, Brendan/0000-0001-5458-154X
FU Division of Materials Research within the National Science Foundation
   [1105300]; UIUC from National Science Foundation (NSF) [0965918]; IGERT:
   Training the Next Generation of Researchers in Cellular & Molecular
   Mechanics and BioNanotechnology; Alfred P. Sloan Foundation; 3M
   Corporation
FX The authors would like to acknowledge Dr Mayandi Sivaguru (IGB, UIUC)
   for assistance with fluorescence imaging. This material is based upon
   work supported by the Division of Materials Research within the National
   Science Foundation through Grant 1105300. D.W.W. was funded at UIUC from
   National Science Foundation (NSF) Grant 0965918 IGERT: Training the Next
   Generation of Researchers in Cellular & Molecular Mechanics and
   BioNanotechnology. R.C.B. also acknowledges support from the Alfred P.
   Sloan Foundation and the 3M Corporation.
CR Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Anderson SM, 2011, INTEGR BIOL-UK, V3, P887, DOI 10.1039/c1ib00037c
   Anderson SM, 2009, BIOMATERIALS, V30, P4618, DOI 10.1016/j.biomaterials.2009.05.030
   Caliari S. R., 2014, TISSUE ENG A
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2014, J BIOMED MATER RES A, V102, P917, DOI 10.1002/jbm.a.35058
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044
   Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Davidenko N, 2010, ACTA BIOMATER, V6, P3957, DOI 10.1016/j.actbio.2010.05.005
   Davies NH, 2012, TISSUE ENG PT A, V18, P26, DOI 10.1089/ten.tea.2011.0192
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esser S, 1998, J CELL SCI, V111, P1853
   Gonnerman EA, 2012, BIOMATERIALS, V33, P8812, DOI 10.1016/j.biomaterials.2012.08.051
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   He QF, 2011, ACTA BIOMATER, V7, P1084, DOI 10.1016/j.actbio.2010.10.022
   Herman CT, 2011, INTEGR BIOL-UK, V3, P779, DOI 10.1039/c0ib00151a
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   HUANG C, 1977, J BIOMED MATER RES, V11, P137, DOI 10.1002/jbm.820110113
   Jungreuthmayer C, 2009, MED ENG PHYS, V31, P420, DOI 10.1016/j.medengphy.2008.11.003
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lynn AK, 2010, J BIOMED MATER RES A, V92A, P1057, DOI 10.1002/jbm.a.32415
   Martin TA, 2011, ACS APPL MATER INTER, V3, P3762, DOI 10.1021/am2009597
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   McCoy RJ, 2012, BIOTECHNOL BIOENG, V109, P1583, DOI 10.1002/bit.24424
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002
   Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Renth AN, 2012, TISSUE ENG PART B-RE, V18, P341, DOI 10.1089/ten.teb.2012.0080
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   SILVER FH, 1978, THROMB RES, V13, P267, DOI 10.1016/0049-3848(78)90014-2
   Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068
   Toh CR, 2009, LANGMUIR, V25, P8894, DOI 10.1021/la9019537
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   YANNAS AV, 1967, NATURE, V215, P509
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang BY, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4818837
NR 54
TC 12
Z9 12
U1 2
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4715
EP 4722
DI 10.1016/j.actbio.2014.07.002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400017
PM 25016280
DA 2018-10-20
ER

PT J
AU Parks, AC
   Sung, K
   Wu, BM
AF Parks, Abigail C.
   Sung, Kevin
   Wu, Benjamin M.
TI A three-dimensional in vitro model to quantify inflammatory response to
   biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Co-culture; Inflammation; Fibroblast; Monocyte; Cytokine
ID NECROSIS-FACTOR PRODUCTION; COLONY-STIMULATING FACTOR; DENDRITIC CELLS;
   TNF-ALPHA; GM-CSF; INTERLEUKIN-6; MONOCYTES; FIBROBLASTS; COCULTURE;
   MACROPHAGES
AB In vivo models are the gold standard for predicting the clinical biomaterial-host response due to the scarcity of in vitro model systems that recapitulate physiological settings. However, the simplicity, control and relatively lower cost of in vitro models make them more appropriate to quantify the contribution by each cell, material and molecule within the healing environment. In this study, human fibroblasts and monocytes are co-cultured in a three-dimensional (3-D) tissue model to study foreign body response by observing morphological changes and monitoring inflammatory cytokine production with multiplex quantitative protein analysis. While control monocultures of either cell type alone produced low levels of cytokines, their interactions in co-culture led to morphological changes and increased release of inflammatory cytokines. When challenged with a well-characterized biopolymer, poly(lactic-co-glycolic acid), the co-cultured human cells secreted elevated levels of IL-1 beta, IL-6, GM-CSF and TNF-alpha. This 3-D in vitro co-culture model may serve as a building block towards a versatile platform to study mechanisms of material-host interactions by co-culturing cells with engineered phenotypes and reporter systems, or predict patient-specific biocompatibility by using the individual patients' cells. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Parks, Abigail C.; Sung, Kevin; Wu, Benjamin M.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
   [Wu, Benjamin M.] Univ Calif Los Angeles, Div Adv Prosthodont, Los Angeles, CA 90095 USA.
   [Wu, Benjamin M.] Univ Calif Los Angeles, Weintraub Ctr Reconstruct Biotechnol, Los Angeles, CA 90095 USA.
RP Wu, BM (reprint author), Univ Calif Los Angeles, Dept Bioengn, 420 Westwood Plaza,Box 951600, Los Angeles, CA 90095 USA.
EM benwu@ucla.edu
CR ADERKA D, 1989, J IMMUNOL, V143, P3517
   Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Boxman ILA, 1996, ARCH DERMATOL RES, V288, P391, DOI 10.1007/BF02507108
   Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763
   Chung AS, 2009, J BIOMED MATER RES A, V89A, P841, DOI 10.1002/jbm.a.32431
   Collins LM, 2009, PSYCHOL METHODS, V14, P202, DOI 10.1037/a0015826
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Ding TT, 2007, J MATER SCI-MATER M, V18, P2233, DOI 10.1007/s10856-007-3014-9
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P1
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Festing Michael F W, 2002, ILAR J, V43, P244
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GREVE JW, 1990, GUT, V31, P198, DOI 10.1136/gut.31.2.198
   Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063
   Hamilton JA, 2002, TRENDS IMMUNOL, V23, P403, DOI 10.1016/S1471-4906(02)02260-3
   Ho WJ, 2010, CANCER SCI, V101, P2637, DOI 10.1111/j.1349-7006.2010.01723.x
   Iwasaki Y, 2002, BIOMATERIALS, V23, P3897, DOI 10.1016/S0142-9612(02)00135-7
   JANSEN JH, 1992, J EXP MED, V175, P1151, DOI 10.1084/jem.175.4.1151
   Kim JW, 2011, ANTICANCER RES, V31, P3237
   Kishida A, 1996, BIOMATERIALS, V17, P1301, DOI 10.1016/0142-9612(96)88675-3
   Kolesar L, 2012, IMMUNOL RES, V52, P269, DOI 10.1007/s12026-012-8338-y
   Labeta MO, 2000, J EXP MED, V191, P1807, DOI 10.1084/jem.191.10.1807
   Levorson EJ, 2014, ACTA BIOMATER, V10, P1824, DOI 10.1016/j.actbio.2013.12.026
   Li N, 2013, TISSUE ENG PART C-ME, V19, P708, DOI [10.1089/ten.TEC.2012.0463, 10.1089/ten.tec.2012.0463]
   Neumann FJ, 1997, ARTERIOSCL THROM VAS, V17, P3399, DOI 10.1161/01.ATV.17.12.3399
   Nicolete R, 2011, INT IMMUNOPHARMACOL, V11, P1557, DOI 10.1016/j.intimp.2011.05.014
   Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480
   REDDI K, 1995, CYTOKINE, V7, P287, DOI 10.1006/cyto.1995.0034
   SCHANDENE L, 1992, IMMUNOLOGY, V76, P30
   Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017
   Soderquist RG, 2010, PHARM RES-DORDR, V27, P841, DOI 10.1007/s11095-010-0077-y
   Sundararaj KP, 2009, J BIOL CHEM, V284, P13714, DOI 10.1074/jbc.M806573200
   Takahashi M, 1996, CIRCULATION, V93, P1185, DOI 10.1161/01.CIR.93.6.1185
   Thomas RJ, 2005, CELLS TISSUES ORGANS, V181, P67, DOI 10.1159/000091096
   VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.iy.08.040190.001345
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yoon SJ, 2008, TISSUE ENG PT A, V14, P539, DOI 10.1089/tea.2007.0129
   Zeng QO, 2010, BIOMATERIALS, V31, P5772, DOI 10.1016/j.biomaterials.2010.04.022
   Zhu YK, 2001, RESPIR RES, V2, P295, DOI 10.1186/rr72
NR 44
TC 4
Z9 4
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4742
EP 4749
DI 10.1016/j.actbio.2014.07.029
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400020
PM 25091291
DA 2018-10-20
ER

PT J
AU McLane, JS
   Rivet, CJ
   Gilbert, RJ
   Ligon, LA
AF McLane, Joshua S.
   Rivet, Christopher J.
   Gilbert, Ryan J.
   Ligon, Lee A.
TI A biomaterial model of tumor stromal microenvironment promotes
   mesenchymal morphology but not epithelial to mesenchymal transition in
   epithelial cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Electrospun fibers; Epithelial cells; Epithelial to mesenchymal
   transition; Topography; Breast cancer
ID HUMAN-BREAST-CANCER; MAMMARY-TUMORS; COLLAGEN; PROGRESSION; FIBRONECTIN;
   MIGRATION; INTERFACE; ALIGNMENT; ADHESION; DISEASE
AB The stromal tissue surrounding most carcinomas is comprised of an extracellular matrix densely packed with collagen-I fibers, which are often highly aligned in metastatic disease. Here we developed an in vitro model to test the effect of an aligned fibrous environment on cancer cell morphology and behavior, independent of collagen ligand presentation. We grew cells on a biomimetic surface of aligned electrospun poly-L-lactic acid (PLLA) fibers and then examined the effect of this environment on growth rate, morphology, cytoskeletal organization, biochemical and genetic markers of epithelial to mesenchymal transition (EMT), cell surface adhesion, and cell migration. We grew a phenotypically normal breast epithelial cell line (MCF10A) and an invasive breast cancer cell line (MDA-MB-231) on three different substrates: typical flat culture surface (glass or plastic), flat PLLA (glass coated with PLLA) or electrospun PLLA fibers. Cells of both types adopted a more mesenchymal morphology when grown on PLLA fibers, and this effect was exaggerated in the more metastatic-like MDA-MB-231 cells. However, neither cell type underwent the changes in gene expression indicative of EMT despite the changes in cell shape, nor did they exhibit the decreased adhesive strength or increased migration typical of metastatic cells. These results suggest that changes in cell morphology alone do not promote a more mesenchymal phenotype and consequently that the aligned fibrous environment surrounding epithelial cancers may not promote EMT solely through topographical cues. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [McLane, Joshua S.; Rivet, Christopher J.; Gilbert, Ryan J.; Ligon, Lee A.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary, Troy, NY 12180 USA.
   [McLane, Joshua S.; Ligon, Lee A.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.
   [Rivet, Christopher J.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
RP Ligon, LA (reprint author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary, 110 8th St, Troy, NY 12180 USA.
EM ligonl@rpi.edu
OI Ligon, Lee/0000-0002-5735-3654; McLane, Joshua/0000-0003-4077-7597
FU American Cancer Society [RSG-10-245-01-CSM]; National Science
   Foundation, Biomaterials Program CAREER Award [1150125]
FX We would like to thank Dr. Chris Bjornsson for help with qRT-PCR and
   cell imaging. We thank Nicholas Zaccor for his assistance in the
   fabrication of the electrospun fibers. This work was supported by the
   American Cancer Society Research Scholar Grant (RSG-10-245-01-CSM) to
   L.A.L. and National Science Foundation, Biomaterials Program CAREER
   Award (1150125) to R.J.G.
CR ALON Y, 1986, INT J TISSUE REACT, V8, P401
   Balanis N, 2013, J BIOL CHEM, V288, P17954, DOI 10.1074/jbc.M113.475277
   Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x
   Bouta EM, 2011, ACTA BIOMATER, V7, P1104, DOI 10.1016/j.actbio.2010.10.016
   Cichon MA, 2010, J MAMMARY GLAND BIOL, V15, P389, DOI 10.1007/s10911-010-9195-8
   Cirri P, 2011, AM J CANCER RES, V1, P482
   Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076
   Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901
   Gjorevski N, 2012, CANCER MICROENVIRON, V5, P29, DOI 10.1007/s12307-011-0076-5
   Gonda TA, 2009, CELL CYCLE, V8, P2005, DOI 10.4161/cc.8.13.8985
   Gruschwitz R, 2010, INVEST OPHTH VIS SCI, V51, P6303, DOI 10.1167/iovs.10-5368
   Hompland T, 2013, J BIOMED OPT, V13
   Huang C, 2011, CHEM SOC REV, V40, P2417, DOI 10.1039/c0cs00181c
   Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Jain A, 2014, NAT MATER, V13, P309, DOI [10.1038/NMAT3878, 10.1038/nmat3878]
   Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343
   Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29
   Johnson J, 2009, TISSUE ENG PART C-ME, V15, P531, DOI [10.1089/ten.tec.2008.0486, 10.1089/ten.TEC.2008.0486]
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675
   LABATROBERT J, 1980, CELL BIOL INT REP, V4, P609
   Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821
   Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513
   Park J, 2014, ONCOGENE, V33, P1649, DOI 10.1038/onc.2013.118
   Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11
   Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38
   Rao SS, 2013, BIOMATERIALS, V34, P5181, DOI 10.1016/j.biomaterials.2013.03.069
   Saha S, 2012, LANGMUIR, V28, P2028, DOI 10.1021/la203846w
   Thakur RA, 2008, INT J PHARMACEUT, V364, P87, DOI 10.1016/j.ijpharm.2008.07.033
   Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8
   Vetter G, 2009, BIOCHEM BIOPH RES CO, V385, P485, DOI 10.1016/j.bbrc.2009.05.025
   Vincent-Salomon A, 2003, BREAST CANCER RES, V5, P101, DOI 10.1186/bcr578
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wang WG, 2002, CANCER RES, V62, P6278
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   WEISS P, 1952, P NATL ACAD SCI USA, V38, P264, DOI 10.1073/pnas.38.3.264
   Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613
   Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823
   Zhou F, 2009, CHINESE SCI BULL, V54, P3200, DOI [10.1007/s11434-009-0366-1, 10.1007/S11434-009-0366-1]
NR 47
TC 4
Z9 4
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4811
EP 4821
DI 10.1016/j.actbio.2014.07.016
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400027
PM 25058401
DA 2018-10-20
ER

PT J
AU Young, SL
   Chyasnavichyus, M
   Erko, M
   Barth, FG
   Fratzl, P
   Zlotnikov, I
   Politi, Y
   Tsukruk, VV
AF Young, Seth L.
   Chyasnavichyus, Marius
   Erko, Maxim
   Barth, Friedrich G.
   Fratzl, Peter
   Zlotnikov, Igor
   Politi, Yael
   Tsukruk, Vladimir V.
TI A spider's biological vibration filter: Micromechanical characteristics
   of a biomaterial surface
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomechanics; Viscoelasticity; Atomic force spectroscopy; Biosensor
   materials; Stimulus transmission
ID CUPIENNIUS-SALEI KEYS; ATOMIC-FORCE MICROSCOPE; TO-RUBBER TRANSITION;
   ARTHROPOD CUTICLE; MECHANICAL-PROPERTIES; AMORPHOUS POLYMERS; AIR-FLOW;
   TEMPERATURE; RELAXATION; ARANEAE
AB A strain-sensing lyriform organ (HS-10) found on all of the legs of a Central American wandering spider (Cupiennius salei) detects courtship, prey and predator vibrations transmitted by the plant on which it sits. It has been suggested that the viscoelastic properties of a cuticular pad directly adjacent to the sensory organ contribute to the organ's pronounced high-pass characteristics. Here, we investigate the micromechanical properties of the cuticular pad biomaterial in search of a deeper understanding of its impact on the function of the vibration sensor. These properties are considered to be an effective adaptation for the selective detection of signals for frequencies >40 Hz. Using surface force spectroscopy mapping we determine the elastic modulus of the pad surface over a temperature range of 15-40 degrees C at various loading frequencies. In the glassy state, the elastic modulus was similar to 100 MPa, while in the rubbery state the elastic modulus decreased to 20 MPa. These data are analyzed according to the principle of time-temperature superposition to construct a master curve that relates mechanical properties, temperature and stimulus frequencies. By estimating the loss and storage moduli vs. temperature and frequency it was possible to make a direct comparison with electrophysiology experiments, and it was found that the dissipation of energy occurs within a frequency window whose position is controlled by environmental temperatures. (C) 2014 Acts Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Young, Seth L.; Chyasnavichyus, Marius; Tsukruk, Vladimir V.] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Erko, Maxim; Fratzl, Peter; Zlotnikov, Igor; Politi, Yael] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.
   [Barth, Friedrich G.] Univ Vienna, Dept Neurobiol, A-1090 Vienna, Austria.
RP Tsukruk, VV (reprint author), Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
EM vladimir@mse.gatech.edu
RI Fratzl, Peter/H-9095-2012; Chyasnavichyus, Marius/D-8173-2016
OI Fratzl, Peter/0000-0003-4437-7830; Chyasnavichyus,
   Marius/0000-0003-3640-7200
FU National Science Foundation, Division of Materials Research under World
   Materials Network Award [DMR-1209332, DMR-1002810]; GT Microanalysis
   Center
FX Financial support was received from the National Science Foundation,
   Division of Materials Research under World Materials Network Award
   DMR-1209332 and DMR-1002810 as well as the GT Microanalysis Center. We
   are grateful to the Department for Neurobiology, University of Vienna
   for providing the spiders.
CR Bar-Cohen Y, 2006, BIOMIMETICS BIOL INS
   Barth F. G, 2002, SPIDERS WORLD SENSES
   Barth F. G., 2012, SENSORY PERCEPTION, P89
   BARTH FG, 1973, Z ZELLFORSCH MIK ANA, V144, P409, DOI 10.1007/BF00307585
   BARTH FG, 1988, OECOLOGIA, V77, P194, DOI 10.1007/BF00379186
   BARTH FG, 1982, J COMP PHYSIOL, V148, P175, DOI 10.1007/BF00619124
   BARTH FG, 1970, Z MORPHOL TIERE, V68, P343, DOI 10.1007/BF00376006
   Barth FG, 1997, EXS, V84, P247
   BARTH FG, 1969, Z ZELLFORSCH MIK ANA, V97, P137, DOI 10.1007/BF00331877
   BARTH FG, 1979, J ARACHNOL, V7, P255
   Barth FG, 2000, NATURWISSENSCHAFTEN, V87, P51, DOI 10.1007/s001140050010
   Barth FG, 2012, ENCY NANOTECHNOL, P127
   Barth FG, 2003, SENSORS SENSING BIOL
   Barth FG, 2012, FRONTIERS IN SENSING: FROM BIOLOGY TO ENGINEERING, P251
   BOULIGAND Y, 1972, TISSUE CELL, V4, P189, DOI 10.1016/S0040-8166(72)80042-9
   BOULIGAND Y, 1986, TISSUE CELL, V18, P621, DOI 10.1016/0040-8166(86)90025-X
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Cappella B, 2005, MACROMOLECULES, V38, P1874, DOI 10.1021/ma040135f
   Cappella B, 2006, MACROMOLECULES, V39, P9243, DOI 10.1021/ma061896g
   Chizhik SA, 1998, LANGMUIR, V14, P2606, DOI 10.1021/la980042p
   Chyasnavichyus M, 2014, LANGMUIR
   Cook S, 2006, NANOTECHNOLOGY, V17, P2135, DOI 10.1088/0957-4484/17/9/010
   Emri I, 1997, RHEOL ACTA, V36, P303, DOI 10.1007/BF00366671
   Erko M, 2013, J STRUCT BIOL, V183, P172, DOI 10.1016/j.jsb.2013.06.001
   Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603
   Gorb S, 2001, ATTACHMENT DEVICES I
   Hazel J, 1999, J BIOMECH, V32, P477, DOI 10.1016/S0021-9290(99)00013-5
   Johnson K. L., 1985, CONTACT MECH
   Klopsch C, 2012, J R SOC INTERFACE, V9, P2591, DOI 10.1098/rsif.2012.0186
   Krevelen D. W. V., 1990, PROPERTIES POLYM THE
   McConney ME, 2007, J R SOC INTERFACE, V4, P1135, DOI 10.1098/rsif.2007.1000
   McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255
   McConney ME, 2009, ADV FUNCT MATER, V19, P2527, DOI 10.1002/adfm.200900606
   McConney ME, 2009, J R SOC INTERFACE, V6, P681, DOI 10.1098/rsif.2008.0463
   Neville A. C., 1993, BIOL FIBROUS COMPOSI
   Peleshanko S, 2007, ADV MATER, V19, P2903, DOI 10.1002/adma.200701141
   Politi Y, 2012, ADV FUNCT MATER, V22, P2519, DOI 10.1002/adfm.201200063
   Roylance D., 2001, ENG VISCOELASTICITY
   Sane SP, 2009, INTEGR COMP BIOL, V49, pI8, DOI 10.1093/icb/icp112
   Schaber CF, 2012, J R SOC INTERFACE, V9, P1254, DOI 10.1098/rsif.2011.0565
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Terashima S., 1999, INFRARED RECEPTORS T
   TOBOLSKY AV, 1956, J APPL PHYS, V27, P673, DOI 10.1063/1.1722465
   Tsui OKC, 2000, MACROMOLECULES, V33, P4198, DOI 10.1021/ma991473x
   Tsukruk VV, 2012, SCANNING PROBE MICROSCOPY OF SOFT MATTER: FUNDAMENTALS AND PRACTICES, P1
   Tsukruk VV, 2000, POLYM INT, V49, P441, DOI 10.1002/(SICI)1097-0126(200005)49:5<441::AID-PI240>3.0.CO;2-U
   van Netten SM, 2006, BIOL CYBERN, V94, P67, DOI 10.1007/s00422-005-0032-x
   WILLIAMS ML, 1955, J AM CHEM SOC, V77, P3701, DOI 10.1021/ja01619a008
   Young SL, 2012, BIOMACROMOLECULES, V13, P3189, DOI 10.1021/bm300964h
NR 50
TC 10
Z9 10
U1 1
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4832
EP 4842
DI 10.1016/j.actbio.2014.07.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400029
PM 25065547
DA 2018-10-20
ER

PT J
AU Fussell, AL
   Mah, PT
   Offerhaus, H
   Niemi, SM
   Salonen, J
   Santos, HA
   Strachan, C
AF Fussell, Andrew L.
   Mah, Pei Ting
   Offerhaus, Herman
   Niemi, Sanna-Mari
   Salonen, Jarno
   Santos, Helder A.
   Strachan, Clare
TI Coherent anti-Stokes Raman scattering microscopy driving the future of
   loaded mesoporous silica imaging
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Coherent anti-Stokes Raman scattering; Microscopy; Mesoporous silica;
   Microparticles; Poorly water-soluble drugs
ID POROUS SILICON; DRUG-DELIVERY; PACLITAXEL DISTRIBUTION; SBA-15
   MICROPARTICLES; SOLID DISPERSIONS; DISSOLUTION RATE; INDOMETHACIN;
   MCM-41; RELEASE; ITRACONAZOLE
AB This study reports the use of variants of coherent anti-Stokes Raman scattering (CARS) microscopy as a novel method for improved physicochemical characterization of drug-loaded silica particles. Ordered mesoporous silica is a biomaterial that can be loaded to carry a number of biochemicals, including poorly water-soluble drugs, by allowing the incorporation of drug into nanometer-sized pores. In this work, the loading of two poorly water-soluble model drugs, itraconazole and griseofulvin, in MCM-41 silica microparticles is characterized qualitatively, using the novel approach of CARS microscopy, which has advantages over other analytical approaches used to date and is non-destructive, rapid, label free, confocal and has chemical and physical specificity. The study investigated the effect of two solvent-based loading methods, namely immersion and rotary evaporation, and microparticle size on the three-dimensional (3-D) distribution of the two loaded drugs. Additionally, hyperspectral CARS microscopy was used to confirm the amorphous nature of the loaded drugs. Z-stacked CARS microscopy suggested that the drug, but not the loading method or particle size range, affected 3-0 drug distribution. Hyperspectral CARS confirmed that the drug loaded in the MCM-41 silica microparticles was in an amorphous form. The results show that CARS microscopy and hyperspectral CARS microscopy can be used to provide further insights into the structural nature of loaded mesoporous silica microparticles as biomaterials. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Fussell, Andrew L.; Offerhaus, Herman] Univ Twente, Opt Sci Grp, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
   [Mah, Pei Ting] Univ Otago, Sch Pharm, Dunedin 9054, New Zealand.
   [Mah, Pei Ting; Santos, Helder A.; Strachan, Clare] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, FI-00014 Helsinki, Finland.
   [Niemi, Sanna-Mari; Salonen, Jarno] Univ Turku, Dept Phys & Astron, Lab Ind Phys, FI-20014 Turku, Finland.
RP Offerhaus, H (reprint author), Univ Twente, Opt Sci Grp, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.
EM H.L.Offerhaus@utwente.nl
RI Santos, Helder/B-5253-2009
OI Santos, Helder/0000-0001-7850-6309; Salonen, Jarno/0000-0002-5245-742X;
   Strachan, Clare/0000-0003-3134-8918
FU Dutch Technology Foundation STW; NWO; Technology Programme of the
   Ministry of Economic Affairs (STW OTP) [11114]; Academy of Finland
   [252215, 256394]; University of Helsinki Funds; European Research
   Council under the European Union's Seventh Framework Programme [310892]
FX A. Fussell is supported by the Dutch Technology Foundation STW, which is
   the applied science division of NWO, and the Technology Programme of the
   Ministry of Economic Affairs (STW OTP 11114). Dr. H.A. Santos
   acknowledges financial support from the Academy of Finland (decision
   nos. 252215 and 256394), The University of Helsinki Funds and the
   European Research Council under the European Union's Seventh Framework
   Programme (FP/2007-2013) Grant no. 310892. Frans Segerink is
   acknowledged for his technical assistance during SEM imaging.
CR Ambrogi V, 2007, EUR J PHARM SCI, V32, P216, DOI 10.1016/j.ejps.2007.07.005
   Ambrogi V, 2008, MICROPOR MESOPOR MAT, V113, P445, DOI 10.1016/j.micromeso.2007.12.003
   Barnes TJ, 2011, INT J PHARMACEUT, V417, P61, DOI 10.1016/j.ijpharm.2011.01.043
   Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754
   FORD JL, 1986, PHARM ACTA HELV, V61, P69
   Fussell A, 2013, EUR J PHARM BIOPHARM, V85, P1141, DOI 10.1016/j.ejpb.2013.08.012
   Garbacik ET, 2012, J RAMAN SPECTROSC, V43, P651, DOI 10.1002/jrs.4064
   Hailu SA, 2011, J PHARM SCI-US, V100, P1503, DOI 10.1002/jps.22387
   Heikkila T, 2010, EUR J PHARM BIOPHARM, V74, P483, DOI 10.1016/j.ejpb.2009.12.006
   Hellsten S, 2012, CRYSTENGCOMM, V14, P1582, DOI 10.1039/c2ce05471j
   Huang X, 2014, OPT EXPRESS, V22, P2889, DOI 10.1364/OE.22.002889
   Jarvis KL, 2010, LANGMUIR, V26, P14316, DOI 10.1021/la102367z
   Jurna M, 2009, J INNOV OPT HEAL SCI, V2, P37, DOI 10.1142/S1793545809000322
   Kang E, 2007, J CONTROL RELEASE, V122, P261, DOI 10.1016/j.jconrel.2007.05.007
   Kang EN, 2006, ANAL CHEM, V78, P8036, DOI 10.1021/ac061218s
   Kinnari P, 2011, INT J PHARMACEUT, V414, P148, DOI 10.1016/j.ijpharm.2011.05.021
   Ku MS, 2008, AAPS J, V10, P208, DOI 10.1208/s12248-008-9020-0
   Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X
   Limnell T, 2011, INT J PHARMACEUT, V416, P242, DOI 10.1016/j.ijpharm.2011.06.050
   Limnell T, 2011, J PHARM SCI-US, V100, P3294, DOI 10.1002/jps.22577
   Lu Q, 1998, PHARMACEUT RES, V15, P1202, DOI 10.1023/A:1011983606606
   Mellaerts R, 2008, EUR J PHARM BIOPHARM, V69, P223, DOI 10.1016/j.ejpb.2007.11.006
   Parekh SH, 2010, BIOPHYS J, V99, P2695, DOI 10.1016/j.bpj.2010.08.009
   Pautot S, 2003, LANGMUIR, V19, P10281, DOI 10.1021/la034532f
   Prestidge CA, 2007, PHYS STATUS SOLIDI A, V204, P3361, DOI 10.1002/pssa.200723112
   Prestidge CA, 2007, EXPERT OPIN DRUG DEL, V4, P101, DOI 10.1517/17425247.4.2.101
   Qian KK, 2012, J PHARM SCI-US, V101, P444, DOI 10.1002/jps.22779
   Sarparanta M, 2011, MOL PHARMACEUT, V8, P1799, DOI 10.1021/mp2001654
   Selvam P, 2001, IND ENG CHEM RES, V40, P3237, DOI 10.1021/ie0010666
   Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1
   Vanea E, 2013, APPL SURF SCI, V280, P144, DOI 10.1016/j.apsusc.2013.04.111
   Wang SB, 2009, MICROPOR MESOPOR MAT, V117, P1, DOI 10.1016/j.micromeso.2008.07.002
   Watanabe T, 2002, J SOLID STATE CHEM, V164, P27, DOI 10.1006/jssc.2001.9436
   Windbergs M, 2009, ANAL CHEM, V81, P2085, DOI 10.1021/ac8020856
   Yiu HHP, 2005, J MATER CHEM, V15, P3690, DOI 10.1039/b506090g
NR 35
TC 6
Z9 6
U1 1
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD NOV
PY 2014
VL 10
IS 11
BP 4870
EP 4877
DI 10.1016/j.actbio.2014.07.021
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR8XJ
UT WOS:000343854400033
PM 25064000
DA 2018-10-20
ER

PT J
AU Zhou, B
   Liu, K
   Liu, X
   Yung, KY
   Bartsch, CM
   Heckman, EM
   Bright, FV
   Swihart, MT
   Cartwright, AN
AF Zhou, Bin
   Liu, Ke
   Liu, Xin
   Yung, Ka Yi
   Bartsch, Carrie M.
   Heckman, Emily M.
   Bright, Frank V.
   Swihart, Mark T.
   Cartwright, Alexander N.
TI Enhanced Performance from a Hybrid Quenchometric Deoxyribonucleic Acid
   (DNA) Silica Xerogel Gaseous Oxygen Sensing Platform
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Deoxyribonucleic acid cetyltrimethylammonium; DNA-CTMA; Biomaterials;
   Oxygen sensor; Lifetime; Photoluminescence
ID QUENCHING BEHAVIOR; COMPLEX; SENSOR; FILMS; PHOTOLUMINESCENCE;
   BIOPOLYMER; EFFICIENCY; PHOTONICS; EMISSION; POLYMERS
AB A complex of salmon milt deoxyribonucleic acid (DNA) and the cationic surfactant cetyltrimethylammonium (CTMA) forms an organic-soluble biomaterial that can be readily incorporated within an organically modified silane-based xerogel. The photoluminescence (PL) intensity and excited-state luminescence lifetime of tris(4,7'-dipheny1-1,10'-phenanathroline) ruthenium(II) [(Ru(dPP)(3)](2+), a common O-2 responsive luminophore, increases in the presence of DNA-CTMA within the xerogel. The increase in the [Ru(dpp)(3)](2+)excited-state lifetime in the presence of DNA-CTMA arises from DNA intercalation that attenuates one or more nonradiative processes, leading to an increase in the [Ru(dpp)(3)](2+) excited-state lifetime. Prospects for the use of these materials in an oxygen sensor are demonstrated.
C1 [Zhou, Bin] KLA Tencor Corp, Milpitas, CA 95035 USA.
   [Liu, Ke; Cartwright, Alexander N.] SUNY Buffalo, Dept Elect Engn, Mat Sci & Engn Program, Buffalo, NY 14260 USA.
   [Liu, Xin; Swihart, Mark T.] SUNY Buffalo, Dept Chem & Biol Engn, Mat Sci & Engn Program, Buffalo, NY 14260 USA.
   [Yung, Ka Yi; Bright, Frank V.] SUNY Buffalo, Dept Chem, Mat Sci & Engn Program, Buffalo, NY 14260 USA.
   [Bartsch, Carrie M.; Heckman, Emily M.] Air Force Res Lab, Wright Patterson AFB, OH 45433 USA.
RP Zhou, B (reprint author), KLA Tencor Corp, 1 Technol Dr, Milpitas, CA 95035 USA.
EM binzhou@buffalo.edu
RI Cartwright, Alexander/C-4380-2008; Swihart, Mark/A-3182-2008
OI Cartwright, Alexander/0000-0002-0921-8036; Swihart,
   Mark/0000-0002-9652-687X; Bright, Frank/0000-0002-1500-5969
FU BerrieHill Research Corporation (BRC) - Air Force Laboratory at the
   Wright Patterson Air Force Base; National Science Foundation
   [CHE-0848171]
FX This research is supported by a grant from BerrieHill Research
   Corporation (BRC) under a program funded by the Air Force Laboratory at
   the Wright Patterson Air Force Base and the National Science Foundation
   under Grant No. CHE-0848171. Any opinions, findings, and conclusions or
   recommendations expressed in this material are those of the authors and
   do not necessarily reflect the views of the Wright Patterson Air Force
   Base and National Science Foundation.
CR BACON JR, 1987, ANAL CHEM, V59, P2780, DOI 10.1021/ac00150a012
   Badocco D, 2008, ANAL CHIM ACTA, V627, P239, DOI 10.1016/j.aca.2008.08.019
   Baker GA, 2000, J SOL-GEL SCI TECHN, V17, P71, DOI 10.1023/A:1008765106291
   Barnikol WKR, 1996, BIOMED TECH, V41, P170, DOI 10.1515/bmte.1996.41.6.170
   Chodavarapu V, 2007, ELECTRON LETT, V43, P688, DOI 10.1049/el:20070837
   Grote JG, 2004, J PHYS CHEM B, V108, P8584, DOI 10.1021/jp038056d
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   HARTMANN P, 1995, ANAL CHEM, V67, P88, DOI 10.1021/ac00097a015
   He GS, 2006, OPT LETT, V31, P359, DOI 10.1364/OL.31.000359
   Heckman EM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2135205
   Heckman EM, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2378400
   Kawabe Y, 2000, ADV MATER, V12, P1281, DOI 10.1002/1521-4095(200009)12:17<1281::AID-ADMA1281>3.0.CO;2-0
   Lakowicz J. R., 2007, PRINCIPLES FLUORESCE
   Lee JE, 2008, POLYMER, V49, P5417, DOI 10.1016/j.polymer.2008.10.003
   Lu X, 2001, CHEM MATER, V13, P3449, DOI 10.1021/cm011029k
   MEIER B, 1995, SENSOR ACTUAT B-CHEM, V29, P240, DOI 10.1016/0925-4005(95)01689-9
   Morin AM, 2000, J FLUORESC, V10, P7, DOI 10.1023/A:1009475210933
   Morris KJ, 2007, ANAL CHEM, V79, P9310, DOI 10.1021/ac0712796
   Shimoda LA, 2004, METHOD ENZYMOL, V381, P121
   Singh TB, 2010, ADV POLYM SCI, V223, P189, DOI 10.1007/12_2009_6
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Tao ZY, 2006, ANAL CHEM, V78, P1939, DOI 10.1021/ac051657b
   Watkins AN, 1998, APPL SPECTROSC, V52, P750, DOI 10.1366/0003702981944175
   Whiffin VS, 2004, BIOTECHNOL BIOENG, V85, P422, DOI 10.1002/bit.10802
   XU WY, 1995, ANAL CHEM, V67, P3172, DOI 10.1021/ac00114a012
   Yu Z, 2007, APPL OPTICS, V46, P1507, DOI 10.1364/AO.46.001507
   Zhan ZY, 2013, SENSOR ACTUAT B-CHEM, V176, P729, DOI 10.1016/j.snb.2012.07.046
   Zhou B, 2011, PROC SPIE, V8103, DOI 10.1117/12.892857
NR 28
TC 0
Z9 0
U1 0
U2 14
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA 5320 SPECTRUM DRIVE SUITE C, FREDERICK, MD 21703 USA
SN 0003-7028
EI 1943-3530
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD NOV
PY 2014
VL 68
IS 11
BP 1302
EP 1305
DI 10.1366/13-07430
PG 4
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA AR7YT
UT WOS:000343793600014
PM 25280266
DA 2018-10-20
ER

PT J
AU Toyotat, T
   Banno, T
   Nitta, S
   Takinoue, M
   Nomoto, T
   Natsume, Y
   Matsumura, S
   Fujinami, M
AF Toyotat, Taro
   Banno, Taisuke
   Nitta, Sachiko
   Takinoue, Masahiro
   Nomoto, Tomonori
   Natsume, Yuno
   Matsumura, Shuichi
   Fujinami, Masanori
TI Molecular Building Blocks and Their Architecture in
   Biologically/Environmentally Compatible Soft Matter Chemical Machinery
SO JOURNAL OF OLEO SCIENCE
LA English
DT Review
DE interfacial tension; quasi-elastic laser scattering method;
   environmentally benign surfactant; biocompatible polymer; emulsion;
   micelle; vesicle; protocell model; drug delivery carrier; cell/tissue
   maker; DNA computing; dissipation system
ID SUM-FREQUENCY GENERATION; ELASTIC LASER SCATTERING; UNILAMELLAR
   VESICLES; GIANT LIPOSOMES; VIBRATIONAL SPECTROSCOPY;
   PHOSPHOLIPID-VESICLES; CATIONIC SURFACTANT; WATER/NITROBENZENE
   INTERFACE; INVERTED EMULSION; LIPID-MEMBRANE
AB This review briefly summarizes recent developments in the construction of biologically/environmentally compatible chemical machinery composed of soft matter. Since environmental and living systems are open systems, chemical machinery must continuously fulfill its functions not only through the influx and generation of molecules but also via the degradation and dissipation of molecules. If the degradation or dissipation of soft matter molecular building blocks and biomaterial molecules/polymers can be achieved, soft matter particles composed of them can be used to realize chemical machinery such as self-propelled droplets, drug delivery carriers, tissue regeneration scaffolds, protocell models, cell-/tissue-markers, and molecular computing systems.
C1 [Toyotat, Taro; Banno, Taisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan.
   [Toyotat, Taro] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chuo Ku, Chiba 2608670, Japan.
   [Toyotat, Taro; Takinoue, Masahiro] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan.
   [Nitta, Sachiko] Fukuyama Univ, Fac Life Sci & Biotechnol, Dept Biotechnol, Fukuyama, Hiroshima 7290292, Japan.
   [Takinoue, Masahiro] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan.
   [Nomoto, Tomonori; Fujinami, Masanori] Chiba Univ Yayoi, Grad Sch Engn, Dept Appl Chem & Bidtechnol, Inage Ku, Chiba 2638522, Japan.
   [Natsume, Yuno] Japan Womens Univ, Dept Math & Phys Sci, Bunkyo Ku, Tokyo, Japan.
   [Matsumura, Shuichi] Keio Univ, Fac Sci & Technol, Dept Appl Chem, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Toyotat, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.
EM cttoyota@mail.ecc.u-tokyo.ac.jp
OI Banno, Taisuke/0000-0002-7480-4242; Takinoue,
   Masahiro/0000-0002-3874-2670
FU 21st Century COE Program "KEIO LCC" of The Ministry of Education,
   Culture, Sports, Science, and Technology, Japan [24104001-5]; JSPS
   [20-4190]
FX The authors are grateful to Prof. Masami Hagiya (The University of
   Tokyo) for careful reading and critical reviewing the manuscript. This
   work was partly supported by a Grant-in-Aid for Scientific Research on
   Innovative Areas "Molecular Robotics" (T.T., M.T., No. 24104001-5) and
   the 21st Century COE Program "KEIO LCC" (S.N., S.M.) of The Ministry of
   Education, Culture, Sports, Science, and Technology, Japan. S.N.
   acknowledges a Grant-in-Aid for General Scientific Research, JSPS
   Fellows (20-4190). T.T. appreciates the aid from Urakami food and food
   Culture foundation, Hayao Nakayama Foundation for Science, Technology
   and Culture, and Kayamori Foundation of Informational Science
   Advancement.
CR AHL PL, 1994, BBA-BIOMEMBRANES, V1195, P237, DOI 10.1016/0005-2736(94)90262-3
   Anastas P. T., 1998, GREEN CHEM THEORY PR
   Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898
   ANGELOVA MI, 1986, FARADAY DISCUSS, V81, P303, DOI 10.1039/dc9868100303
   Arnolds H, 2010, SURF SCI REP, V65, P45, DOI 10.1016/j.surfrep.2009.12.001
   Banno T., 2013, BIODEGRADATION LIFE, P115
   Banno T, 2012, LANGMUIR, V28, P1190, DOI 10.1021/la2045338
   Barth C, 2011, ADV MATER, V23, P477, DOI 10.1002/adma.201002270
   Bohme R, 2009, J RAMAN SPECTROSC, V40, P1452, DOI 10.1002/jrs.2433
   Dickenson NE, 2010, ANAL BIOANAL CHEM, V396, P31, DOI 10.1007/s00216-009-3040-1
   Dimitrov DS, 1987, PROG COLLOID POLYM S, V73, P48
   Ding B., 2013, SCI REP, V3, P1
   Doi M., 2013, SOFT MATTER PHYS
   Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005
   Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081
   Dufrene YF, 2012, NANO TODAY, V7, P390, DOI 10.1016/j.nantod.2012.08.002
   EDBLOM EC, 1989, J PHYS CHEM-US, V93, P2722, DOI 10.1021/j100344a007
   Falco EE, 2008, PHARM RES-DORDR, V25, P2348, DOI 10.1007/s11095-008-9620-5
   Foley P, 2012, CHEM SOC REV, V41, P1499, DOI 10.1039/c1cs15217c
   Fujii S, 2013, P NATL ACAD SCI USA, V110, P16796, DOI 10.1073/pnas.1314585110
   Fukuma T, 2007, BIOPHYS J, V92, P3603, DOI 10.1529/biophysj.106.100651
   Funakoshi K, 2007, J AM CHEM SOC, V129, P12608, DOI 10.1021/ja074029f
   GIOLANDO ST, 1995, CHEMOSPHERE, V30, P1067, DOI 10.1016/0045-6535(95)00005-S
   Grzybowski B., 2009, CHEM MOTION REACTION
   Hagiya M, 2014, ACCOUNTS CHEM RES, V47, P1681, DOI 10.1021/ar400318d
   Hamada S, 2014, CHEM COMMUN, V50, P2958, DOI 10.1039/c3cc48216b
   Hamada T, 2008, J PHYS CHEM B, V112, P14678, DOI 10.1021/jp807784j
   Hamley I., 2000, INTRO SOFT MATTER PO
   Hartschuh A, 2008, ANGEW CHEM INT EDIT, V47, P8178, DOI 10.1002/anie.200801605
   Hatayama H., 2014, ANAL SCI, V230, P225
   Ikezoe Y, 2004, J COLLOID INTERF SCI, V275, P298, DOI 10.1016/j.jcis.2003.12.046
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Kaihara S, 2009, MACROMOL BIOSCI, V9, P613, DOI 10.1002/mabi.200800308
   Kaihara S, 2009, J BIOMED MATER RES A, V90A, P863, DOI 10.1002/jbm.a.32149
   Karasawa Y, 2014, CHEM LETT, V43, P1002, DOI 10.1246/cl.140201
   KATYL RH, 1968, PHYS REV LETT, V20, P248, DOI 10.1103/PhysRevLett.20.248
   Kett PJN, 2010, LANGMUIR, V26, P9710, DOI 10.1021/la1003512
   Kim J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.119
   Kitamoto D, 2009, CURR OPIN COLLOID IN, V14, P315, DOI 10.1016/j.cocis.2009.05.009
   LANDSMAN MLJ, 1976, J APPL PHYSIOL, V40, P575
   Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624
   Lasic D.D., 1998, MED APPL LIPOSOMES
   Liu YW, 2012, LANGMUIR, V28, P2113, DOI 10.1021/la203823t
   McConney ME, 2010, POLYM REV, V50, P235, DOI 10.1080/15583724.2010.493255
   Miura S, 2014, LANGMUIR, V30, P7977, DOI 10.1021/la5018032
   Montagne K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.120
   Murata S, 2013, NEW GENERAT COMPUT, V31, P27, DOI 10.1007/s00354-012-0121-z
   Natsume Y, 2013, CHEM LETT, V42, P295, DOI 10.1246/cl.2013.295
   NEEDHAM D, 1988, BIOCHEMISTRY-US, V27, P8261, DOI 10.1021/bi00421a041
   NICOLIS G, 1977, SELF ORG NONEQUILIBR
   Nishimura K, 2012, J COLLOID INTERF SCI, V376, P119, DOI 10.1016/j.jcis.2012.02.029
   Nishimura K, 2009, LANGMUIR, V25, P10439, DOI 10.1021/la902237y
   Nishimura K, 2012, LANGMUIR, V28, P8426, DOI 10.1021/la3001703
   Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101
   Nomoto T, 2014, ANAL SCI, V30, P707, DOI 10.2116/analsci.30.707
   Nomoto T, 2014, ANAL SCI, V30, P463, DOI 10.2116/analsci.30.463
   Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103
   Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268
   OKU N, 1983, BIOCHEMISTRY-US, V22, P855, DOI 10.1021/bi00273a023
   Osawa M, 2013, P NATL ACAD SCI USA, V110, P11000, DOI 10.1073/pnas.1222254110
   Oshima S, 2014, ANAL SCI, V30, P441, DOI 10.2116/analsci.30.441
   Ota S, 2009, ANGEW CHEM INT EDIT, V48, P6533, DOI 10.1002/anie.200902182
   Pautot S, 2003, LANGMUIR, V19, P2870, DOI 10.1021/la026100v
   Peleg G, 1999, P NATL ACAD SCI USA, V96, P6700, DOI 10.1073/pnas.96.12.6700
   Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029
   Putot S., 2003, P NATL ACAD SCI USA, V100, P10718
   Ranade VV, 2011, Drug Delivery Systems, 3rd Edition, P1
   Reeve JE, 2010, PHYS CHEM CHEM PHYS, V12, P13484, DOI 10.1039/c003720f
   REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108
   Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010
   Saito H, 2007, INT SYM MICRO-NANOM, P286, DOI 10.1109/MHS.2007.4420868
   Saito H, 2009, CHEMBIOCHEM, V10, P1640, DOI 10.1002/cbic.200900205
   SAKAI K, 1991, REV SCI INSTRUM, V62, P1192, DOI 10.1063/1.1141999
   Sakai K, 2001, PHYS REV E, V63, part. no., DOI 10.1103/PhysRevE.63.046302
   Sakai T, 2008, J OLEO SCI, V57, P521, DOI 10.5650/jos.57.521
   SANO M, 1986, REV SCI INSTRUM, V57, P1158, DOI 10.1063/1.1138620
   SCRIVEN LE, 1964, J FLUID MECH, V19, P321, DOI 10.1017/S0022112064000751
   Seeman NC, 2005, TRENDS BIOCHEM SCI, V30, P119, DOI 10.1016/j.tibs.2005.01.007
   Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Shum HC, 2008, LANGMUIR, V24, P7651, DOI 10.1021/la801833a
   Stachowiak JC, 2008, P NATL ACAD SCI USA, V105, P4697, DOI 10.1073/pnas.0710875105
   Sterling C. V., 1959, AICHE J, V5, P104
   Sugiura S, 2008, LANGMUIR, V24, P4581, DOI 10.1021/la703509r
   Takiguchi K, 2008, LANGMUIR, V24, P11323, DOI 10.1021/la802031n
   Takinoue M, 2010, SMALL, V6, P2374, DOI 10.1002/smll.201000945
   Takinoue M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041921
   Takinoue M, 2009, NEW GENERAT COMPUT, V27, P107, DOI 10.1007/s00354-008-0057-5
   Tehrani-Bagha A, 2007, CURR OPIN COLLOID IN, V12, P81, DOI 10.1016/j.cocis.2007.05.006
   Terasawa H, 2012, P NATL ACAD SCI USA, V109, P5942, DOI 10.1073/pnas.1120327109
   TERHUNE RW, 1962, PHYS REV LETT, V8, P404, DOI 10.1103/PhysRevLett.8.404
   Thutupalli S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/073021
   Toyota T, 2013, ANAL SCI, V29, P911
   Toyota T, 2012, ANAL CHEM, V84, P3952, DOI 10.1021/ac2031354
   Toyota T, 2010, J COLLOID INTERF SCI, V349, P632, DOI 10.1016/j.jcis.2010.05.081
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   van Zanten TS, 2010, BBA-BIOMEMBRANES, V1798, P777, DOI 10.1016/j.bbamem.2009.09.012
   von Rybinski W, 1998, ANGEW CHEM INT EDIT, V37, P1328, DOI 10.1002/(SICI)1521-3773(19980605)37:10<1328::AID-ANIE1328>3.0.CO;2-9
   Whittenton J, 2008, LANGMUIR, V24, P8533, DOI 10.1021/la801133j
   Yamaji K, 2009, IEEE T NANOBIOSCI, V8, P325, DOI 10.1109/TNB.2009.2035278
   Yamane M, 2008, J OLEO SCI, V57, P529, DOI 10.5650/jos.57.529
   Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151
   ZHU XD, 1987, PHYS REV B, V35, P3047, DOI 10.1103/PhysRevB.35.3047
NR 104
TC 2
Z9 2
U1 4
U2 25
PU JAPAN OIL CHEMISTS SOC
PI TOKYO
PA YUSHI KOGYO KAIKAN BLDG, 13-11, NIHONBASHI 3-CHOME, CHUO-KU, TOKYO,
   103-0027, JAPAN
SN 1345-8957
EI 1347-3352
J9 J OLEO SCI
JI J. Oleo Sci.
PD NOV
PY 2014
VL 63
IS 11
BP 1085
EP 1098
DI 10.5650/jos.ess14190
PG 14
WC Chemistry, Applied; Food Science & Technology
SC Chemistry; Food Science & Technology
GA AR7TM
UT WOS:000343782700001
PM 25341502
OA Bronze
DA 2018-10-20
ER

PT J
AU Mohanta, YK
   Behera, SK
AF Mohanta, Yugal Kishore
   Behera, Sujit Kumar
TI Biosynthesis, characterization and antimicrobial activity of silver
   nanoparticles by Streptomyces sp SS2
SO BIOPROCESS AND BIOSYSTEMS ENGINEERING
LA English
DT Article
DE Streptomyces sp.; Silver nanoparticles; Antimicrobial activity; FTIR;
   DLS; SEM
ID ANTIBACTERIAL ACTIVITY; ACTINOBACTERIA; ACTINOMYCETE
AB In the present study the microbial biosynthesis of silver nanoparticles (AgNPs) by secondary metabolites of Streptomyces sp. SS2 in an eco-friendly approach has been reported. The Streptomyces sp. SS2 was isolated from the soil sediment of Similipal Biosphere Reserve. The identification of this strain was determined by phenotypical characteristics (morphological and biochemical) and molecular characterization method using 16 s rDNA sequencing. The morphological study was also done by high-resolution scanning electron microscopy. The preliminary characterization of biosynthesized silver nanoparticle was carried out using UV-Vis spectrum analysis, which showed an absorption peak at 420 nm corresponding to plasmon absorption of silver. The average size and charge (zeta potential) of the particles were found to be 67.95 +/- A 18.52 nm and -17.7 +/- A 5.30 mV, respectively. The functional groups were identified by FTIR studies and their morphology (round and spherical shape) was determined by scanning electron microscopy. The synthesized AgNPs exhibited excellent antibacterial activity against Escherichia coli (MTCC 1089), Bacillus subtilis (MTCC 7164), Staphylococcus epidermis (MTCC 3615), Vibrio cholerae (MTCC 3904) and Staphylococcus aureus (MTCC 1144). These biotechnological approaches of synthesis of nanoparticles can direct a new path in biomaterial sciences and enrich biomedical applications.
C1 [Mohanta, Yugal Kishore] North Orissa Univ, Dept Bot, Baripada 757003, Odisha, India.
   [Behera, Sujit Kumar] Indian Vet Res Inst, VPH Div, Bareilly, Uttar Pradesh, India.
RP Mohanta, YK (reprint author), North Orissa Univ, Dept Bot, Baripada 757003, Odisha, India.
EM ykmohanta@gmail.com
CR Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399
   Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Biswas M., 2011, BANGLADESH PHARM J, V14, P15
   Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8
   Gao XC, 2012, MICROBIOL RES, V167, P616, DOI 10.1016/j.micres.2012.02.008
   Jones CM., 2010, J NANOPART RES, V12, P1531, DOI DOI 10.1007/S11051-010-9900-Y
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Karthik L, 2014, BIOPROC BIOSYST ENG, V37, P261, DOI 10.1007/s00449-013-0994-3
   Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6
   Lane AL, 2011, NAT PROD REP, V28, P411, DOI 10.1039/c0np90032j
   Maldonado LA, 2009, ANTON LEEUW INT J G, V95, P111, DOI 10.1007/s10482-008-9294-3
   Mohanta TK, 2007, SCI RES ESSAYS, V2, P486
   Montalvo NF, 2005, ANTON LEEUW INT J G, V87, P29, DOI 10.1007/s10482-004-6536-x
   Morgan MC, 2009, J MICROBIOL METH, V79, P336, DOI 10.1016/j.mimet.2009.10.005
   Noginov MA, 2003, J ESSENT OIL RES, V15, P374
   Otari SV, 2012, MATER LETT, V72, P92, DOI 10.1016/j.matlet.2011.12.109
   Prakasham R. S., 2011, J MICROBIOL BIOCH TE, V6, P28
   Rauta PR, 2011, CURR SCI INDIA, V101, P548
   Sadhasivam S, 2010, COLLOID SURFACE B, V81, P358, DOI 10.1016/j.colsurfb.2010.07.036
   Samundeeswari A, 2012, BIOTECHNOL APPL BIOC, V59, P503, DOI 10.1002/bab.1054
   Sastry M, 2003, CURR SCI INDIA, V85, P162
   Sathyavathi R, 2010, ADV SCI LETT, V3, P1
   SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Verma V. C., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1
NR 26
TC 22
Z9 23
U1 2
U2 30
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1615-7591
EI 1615-7605
J9 BIOPROC BIOSYST ENG
JI Bioprocess. Biosyst. Eng.
PD NOV
PY 2014
VL 37
IS 11
BP 2263
EP 2269
DI 10.1007/s00449-014-1205-6
PG 7
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA AR7IE
UT WOS:000343752000013
PM 24842223
DA 2018-10-20
ER

PT J
AU Gentleman, MM
   Gentleman, E
AF Gentleman, Molly M.
   Gentleman, Eileen
TI The role of surface free energy in osteoblast-biomaterial interactions
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
DE Surface free energy; Wettability; Osteoblast; Cell; Biomaterial; Bone;
   Protein adsorption
ID SELF-ASSEMBLED MONOLAYERS; TOTAL KNEE ARTHROPLASTY; CELL-ADHESION;
   INTEGRIN EXPRESSION; POLYMER SURFACES; MODEL SURFACES;
   EXTRACELLULAR-MATRIX; PROTEIN ADSORPTION; INITIAL ATTACHMENT; IMPLANT
   MATERIALS
AB The clinical success of many orthopaedic implants relies on good integration between the implant and adjacent bone. As stabilising bone grows not only to the implant, but from it, the quick adhesion of bone forming cells called osteoblasts, their appropriate differentiation and ability to form mineralised bone are vital to achieve a good clinical outcome. Surface free energy can be thought of as a measure of the 'unsatisfied bond energy' resulting from 'dangling bonds' exposed at a material's surface. This unsatisfied bond energy affects protein adsorption and cell attachment, and thus controls the early stages of cell biomaterial interactions and ultimately implant fixation. When water, proteins, or cells approach a surface, their surface domains align to minimise the overall surface free energy of the interface. Determining these interactions, however, is not simple. While contact angle measurements on flat surfaces can predict some surface free energy-related interactions, this is not the case when surface topography is modified. Here, the authors review how surface free energy can be altered on self-assembled monolayers, polymers, metals and ceramics and clarify the differences between measurements of surface free energy and wettability. The authors also review how surface free energy affects protein interactions and osteoblast behaviour. The result is a clearer understanding of the effect of surface free energy on cell behaviour and an unambiguous need for further studies that isolate such effects.
C1 [Gentleman, Molly M.] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY USA.
   [Gentleman, Eileen] Kings Coll London, London SE1 9RT, England.
RP Gentleman, E (reprint author), Kings Coll London, London SE1 9RT, England.
EM eileen.gentleman@kcl.ac.uk
OI Gentleman, Eileen/0000-0003-0447-5137
FU Wellcome Trust
FX Eileen Gentleman gratefully acknowledges a Research Career Development
   Fellowship from the Wellcome Trust and continued support from the
   Rosetrees Trust.
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   BAIER RE, 1984, J BIOMED MATER RES, V18, P337, DOI 10.1002/jbm.820180404
   BALE MD, 1989, BLOOD, V74, P2698
   Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Baxter L. C., 2002, European Cells & Materials, V4, P1
   Bennett JH, 2001, ARCH ORAL BIOL, V46, P229, DOI 10.1016/S0003-9969(00)00114-X
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bobyn J. D., 1987, CLIN ORTHOP RELAT R, V244, P303
   Bragdon CR, 1996, J ARTHROPLASTY, V11, P945, DOI 10.1016/S0883-5403(96)80136-7
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Cheng Y T, 2005, APPL PHYS LETT, V86, DOI DOI 10.1063/1.1895487
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, V235, P173
   de Gennes P.-G., 2002, CAPILLARITY WETTING
   de Jonge LT, 2009, ADV FUNCT MATER, V19, P755, DOI 10.1002/adfm.200800819
   Dee K. C., 2002, INTRO TISSUEBIOMATER, V248
   Della Volpe C, 1997, J COLLOID INTERF SCI, V195, P121
   Della Volpe C, 2000, J ADHES SCI TECHNOL, V14, P235, DOI 10.1163/156856100742546
   Duffy GP, 1998, CLIN ORTHOP RELAT R, P22
   Evans ND, 2010, BIOMATERIALS, V31, P3244, DOI 10.1016/j.biomaterials.2010.01.039
   Faghihi S, 2009, J BIOMED MATER RES A, V91A, P656, DOI 10.1002/jbm.a.32275
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Furstner R, 2005, LANGMUIR, V21, P956, DOI 10.1021/la0401011
   Gandhi R, 2009, J BONE JOINT SURG BR, V91B, P889, DOI 10.1302/0301-620X.91B7.21702
   Gao LC, 2009, LANGMUIR, V25, P14105, DOI 10.1021/la902206c
   GAUTIER M, 1994, J AM CERAM SOC, V77, P323, DOI 10.1111/j.1151-2916.1994.tb06999.x
   Gentleman E, 2009, NAT MATER, V8, P763, DOI [10.1038/nmat2505, 10.1038/NMAT2505]
   Gentleman MM, 2010, LANGMUIR, V26, P1408, DOI 10.1021/la903029c
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   GUO J, 1992, PHYS REV B, V45, P13647, DOI 10.1103/PhysRevB.45.13647
   HANEIN D, 1993, J CELL SCI, V104, P275
   HANEIN D, 1993, LANGMUIR, V9, P1058, DOI 10.1021/la00028a030
   Hao L, 2005, J BIOMED MATER RES B, V73B, P148, DOI 10.1002/jbm.b.30194
   Healy KE, 1996, BIOMATERIALS, V17, P195, DOI 10.1016/0142-9612(96)85764-4
   Henrich V., 1994, SURFACE SCI METAL OX, V464
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   JONSSON U, 1982, J COLLOID INTERF SCI, V90, P148, DOI 10.1016/0021-9797(82)90408-8
   Kennedy SB, 2006, BIOMATERIALS, V27, P3817, DOI 10.1016/j.biomaterials.2006.02.044
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   KNOZINGER H, 1978, CATAL REV, V17, P31, DOI 10.1080/03602457808080878
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LEE JH, 1991, BIOMATERIALS, V12, P443
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Lim JY, 2005, TISSUE ENG, V11, P19, DOI 10.1089/ten.2005.11.19
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   LOPEZ GP, 1993, J AM CHEM SOC, V115, P5877, DOI 10.1021/ja00066a087
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Milman V, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/48/485404
   MMWR, 2003, NATL STATE MED EXPEN
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Nychka JA, 2010, JOM-US, V62, P39, DOI 10.1007/s11837-010-0107-6
   Olivares-Navarrete R, 2008, P NATL ACAD SCI USA, V105, P15767, DOI 10.1073/pnas.0805420105
   Padial-Molina M, 2011, ACTA BIOMATER, V7, P771, DOI 10.1016/j.actbio.2010.08.024
   Parhi P, 2010, J ADHES SCI TECHNOL, V24, P853, DOI 10.1163/016942409X12598231567907
   Parker DA, 2001, CLIN ORTHOP RELAT R, P68
   Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t
   Patankar NA, 2004, LANGMUIR, V20, P7097, DOI 10.1021/la049329e
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Qiu Q, 1998, J BIOMED MATER RES, V42, P117, DOI 10.1002/(SICI)1097-4636(199810)42:1<117::AID-JBM15>3.3.CO;2-0
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   SCHMALZRIED TP, 1992, CLIN ORTHOP RELAT R, P60
   Schneider GB, 2001, J DENT RES, V80, P1540, DOI 10.1177/00220345010800061201
   Schweikl H, 2007, J MATER SCI-MATER M, V18, P1895, DOI 10.1007/s10856-007-3092-8
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   SOBALLE K, 1993, ACTA ORTHOP SCAND, V64, pR1
   Stephansson SN, 2002, BIOMATERIALS, V23, P2527, DOI 10.1016/S0142-9612(01)00387-8
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Tarafder S, 2011, J BIOMED MATER RES B, V97B, P306, DOI 10.1002/jbm.b.31816
   ter Brugge PJ, 2002, TISSUE ENG, V8, P615, DOI 10.1089/107632702760240535
   Tsukimura N, 2008, J BIOMED MATER RES A, V84A, P108, DOI 10.1002/jbm.a.31422
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   van Oss C. J., 1998, VSP UTRECHT NETHERLA, P49
   Van Oss CJ, 2001, CELL MOL BIOL, V47, P721
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2011, BIOMATERIALS, V32, P6670, DOI 10.1016/j.biomaterials.2011.05.066
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Weiss RJ, 2011, ACTA ORTHOP, V82, P136, DOI 10.3109/17453674.2011.566145
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P985, DOI 10.1111/j.1600-051X.2008.01318.x
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yang Y, 2012, ACS NANO, V6, P8591, DOI 10.1021/nn301713d
   Yang ZJ, 1996, BIOMATERIALS, V17, P2131, DOI 10.1016/0142-9612(96)00044-0
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zhuang Z, 2013, ACTA BIOMATER, V9, P6732, DOI 10.1016/j.actbio.2013.02.001
NR 106
TC 44
Z9 44
U1 6
U2 96
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0950-6608
EI 1743-2804
J9 INT MATER REV
JI Int. Mater. Rev.
PD NOV
PY 2014
VL 59
IS 8
BP 417
EP 429
DI 10.1179/1743280414Y.0000000038
PG 13
WC Materials Science, Multidisciplinary
SC Materials Science
GA AR6KB
UT WOS:000343691400001
DA 2018-10-20
ER

PT J
AU Kim, M
   Park, SR
   Choi, BH
AF Kim, Moonhang
   Park, So Ra
   Choi, Byung Hyune
TI Biomaterial scaffolds used for the regeneration of spinal cord injury
   (SCI)
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Review
DE Spinal cord injury (SCI); Biomaterials; Scaffolds; Stem cells; Tissue
   engineering; Drug delivery
ID MESENCHYMAL STEM-CELLS; TEMPLATED AGAROSE SCAFFOLDS; OLFACTORY
   ENSHEATHING CELLS; MULTIPLE-CHANNEL BRIDGES; NEURAL PROGENITOR CELLS;
   NERVOUS-SYSTEM REPAIR; MARROW STROMAL CELLS; ADULT-RAT BRAIN; AXONAL
   REGENERATION; BONE-MARROW
AB This review presents a summary of various types of scaffold biomaterials used alone or together with therapeutic drugs and cells to regenerate spinal cord injury (SCI). The inhibitory environment and loss of axonal connections after SCI give rise to critical obstacles to regeneration of lost tissues and neuronal functions. Biomaterial scaffolds can provide a bridge to connect lost tissues, an adhesion site for implanted or host cells, and sustained release of therapeutic drugs in the injured spinal cord. In addition, they not only provide a structural platform, but can play active roles by inhibiting apoptosis of cells, inflammation and scar formation, and inducing neurogenesis, axonal growth and angiogenesis. Many synthetic and natural biomaterial scaffolds have been extensively investigated and tested in vitro and in animal SCI models for these purposes. We summarized the literature on the biomaterials commonly used for spinal cord regeneration in terms of historical backgrounds and current approaches.
C1 [Kim, Moonhang; Choi, Byung Hyune] Ihna Univ, Coll Med, Dept Adv Biomed Sci, Inchon, South Korea.
   [Park, So Ra] Ihna Univ, Coll Med, Dept Physiol, Inchon, South Korea.
RP Choi, BH (reprint author), Ihna Univ, Coll Med, Dept Adv Biomed Sci, Snheungdong 3ga, Inchon, South Korea.
EM bryan@inha.ac.kr
FU Inha University Research Grant; Ministry of Science, ICT & Future
   Planning Republic of Korea [2011-0019730]
FX This study was supported by the Inha University Research Grant and a
   grant of the Ministry of Science, ICT & Future Planning (2011-0019730),
   Republic of Korea.
CR Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045
   Ashton RS, 2007, BIOMATERIALS, V28, P5518, DOI 10.1016/j.biomaterials.2007.08.038
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Avitabile T, 2001, BIOMATERIALS, V22, P195, DOI 10.1016/S0142-9612(00)00169-1
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Barminko J, 2011, BIOTECHNOL BIOENG, V108, P2747, DOI 10.1002/bit.23233
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cb.07.110191.001001
   Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cai J, 2007, J BIOMED MATER RES A, V83A, P512, DOI 10.1002/jbm.a.31296
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen X, 2011, J MATER SCI-MATER M, V22, P2347, DOI 10.1007/s10856-011-4401-9
   Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cigognini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019782
   Conova L, 2011, J NEUROSURG-SPINE, V15, P594, DOI 10.3171/2011.7.SPINE11194
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   Deng Qi-Yue, 2006, Neurosci Bull, V22, P73
   Deumens R, 2013, BEHAV BRAIN RES, V237, P185, DOI 10.1016/j.bbr.2012.09.036
   Donoghue PS, 2013, TISSUE ENG PT A, V19, P497, DOI [10.1089/ten.tea.2012.0382, 10.1089/ten.TEA.2012.0382]
   Du B.L., 2013, J BIOMED MATER RES A, V102, P1715
   East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017
   Fan JA, 2011, J BIOMED MATER RES B, V97B, P271, DOI 10.1002/jbm.b.31810
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10
   Frattini F, 2012, TISSUE ENG PT A, V18, P2030, DOI [10.1089/ten.TEA.2011.0496, 10.1089/ten.tea.2011.0496]
   Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999
   Gelain F, 2006, PLOS ONE, V1, P1, DOI DOI 10.1371/JOURNAL.PONE.0000119
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Goraltchouk A, 2006, J CONTROL RELEASE, V110, P400, DOI 10.1016/j.jconrel.2005.10.019
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Grous LC, 2013, J NEUROSURG-SPINE, V18, P641, DOI 10.3171/2013.3.SPINE12874
   Guo XD, 2012, CELL TRANSPLANT, V21, P1177, DOI 10.3727/096368911X612503
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hawryluk GWJ, 2012, STEM CELLS DEV, V21, P2222, DOI 10.1089/scd.2011.0596
   He LM, 2009, TISSUE ENG PART C-ME, V15, P243, DOI 10.1089/ten.tec.2008.0255
   Hejcl A, 2009, J MATER SCI-MATER M, V20, P1571, DOI 10.1007/s10856-009-3714-4
   Hejcl A, 2013, STEM CELLS DEV, V22, P2794, DOI 10.1089/scd.2012.0616
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Hurtado A, 2011, BIOMATERIALS, V32, P6068, DOI 10.1016/j.biomaterials.2011.05.006
   Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155
   Hyun JK, 2010, J TISSUE ENG, V2010
   Ibarra C, 2000, ORTHOP CLIN N AM, V31, P411, DOI 10.1016/S0030-5898(05)70160-7
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kang KN, 2012, BIOMATERIALS, V33, P4828, DOI 10.1016/j.biomaterials.2012.03.043
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Kar S, 2013, TISSUE ENG REGEN MED, V10, P200, DOI 10.1007/s13770-012-0008-6
   Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim BG, 2010, CYTOTHERAPY, V12, P841, DOI 10.3109/14653249.2010.501784
   Kim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021744
   Kim M, 2013, TISSUE ENG REGEN MED, V10, P234, DOI 10.1007/s13770-013-1087-8
   Kim S, 2012, TISSUE ENG REGEN MED, V9, P84, DOI 10.1007/s13770-012-0034-4
   Kouhzaei S, 2013, NEUROL RES, V35, P415, DOI 10.1179/1743132812Y.0000000133
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Lee SH, 2009, NEUROL RES, V31, P996, DOI 10.1179/174313209X385626
   Li BC, 2010, J BIOMED MATER RES A, V94A, P769, DOI 10.1002/jbm.a.32727
   Li JM, 2007, J NEUROSCI METH, V165, P257, DOI 10.1016/j.jneumeth.2007.06.006
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Liu JB, 2013, CELLS TISSUES ORGANS, V198, P35, DOI 10.1159/000351665
   Liu S, 2001, NEUROSURGERY, V49, P143, DOI 10.1097/00006123-200107000-00022
   Liu Y, 2013, ACTA BIOMATER, V9, P8075, DOI 10.1016/j.actbio.2013.06.001
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nehrt A, 2010, J NEUROTRAUM, V27, P151, DOI 10.1089/neu.2009.0993
   Nisbet DR, 2009, J BIOMED MATER RES A, V89A, P24, DOI 10.1002/jbm.a.31962
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Novikova LN, 2008, BIOMATERIALS, V29, P1198, DOI 10.1016/j.biomaterials.2007.11.033
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   Oh JS, 2011, CELL TRANSPLANT, V20, P837, DOI 10.3727/096368910X539083
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Park SS, 2012, CYTOTHERAPY, V14, P584, DOI 10.3109/14653249.2012.658913
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Pertici V, 2013, ASN NEURO, V5, P149, DOI 10.1042/AN20120082
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   Pritchard CD, 2010, J NEUROSCI METH, V188, P258, DOI 10.1016/j.jneumeth.2010.02.019
   Qian LM, 2009, CHINESE MED J-PEKING, V122, P2032, DOI 10.3760/cma.j.issn.0366-6999.2009.17.014
   Rao M, 2013, TISSUE ENG REGEN MED, V10, P223, DOI 10.1007/s13770-013-1081-1
   Rauch MF, 2009, EUR J NEUROSCI, V29, P132, DOI 10.1111/j.1460-9568.2008.06567.x
   Ribeiro-Samy S, 2013, MACROMOL BIOSCI, V13, P1576, DOI 10.1002/mabi.201300178
   Roman JA, 2011, J NEUROTRAUM, V28, P2349, DOI 10.1089/neu.2010.1409
   Rooney GE, 2008, SPINE, V33, pE914, DOI 10.1097/BRS.0b013e318186b2b1
   Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260
   Rosales-Cortes M, 2003, REV NEUROLOGIA, V36, P1137
   Ruzicka J, 2013, ACTA NEUROBIOL EXP, V73, P102
   Ryu HH, 2012, J VET MED SCI, V74, P1617, DOI 10.1292/jvms.12-0065
   Ryu S, 2013, TISSUE ENG REGEN MED, V10, P39, DOI 10.1007/s13770-013-0384-6
   Shi RY, 2013, NEUROSCI BULL, V29, P460, DOI 10.1007/s12264-013-1364-5
   Shi YZ, 2010, NAT NANOTECHNOL, V5, P80, DOI [10.1038/NNANO.2009.303, 10.1038/nnano.2009.303]
   Shihabuddin LS, 2000, J NEUROSCI, V20, P8727
   Silva NA, 2013, TISSUE ENG PART C-ME, V19, P101, DOI [10.1089/ten.tec.2012.0264, 10.1089/ten.TEC.2012.0264]
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Suzuki Y, 2002, NEUROSCI LETT, V318, P121, DOI 10.1016/S0304-3940(01)02359-X
   Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2
   Tabesh H, 2009, NEUROCHEM INT, V54, P73, DOI 10.1016/j.neuint.2008.11.002
   Talac R, 2004, BIOMATERIALS, V25, P1505, DOI 10.1016/S0142-9212(03)00497-6
   Tan EYM, 2007, PHARM RES, V24, P2297, DOI 10.1007/s11095-007-9454-6
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tobias CA, 2005, J NEUROTRAUM, V22, P138, DOI 10.1089/neu.2005.22.138
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Valdes-Sanchez T., 2014, J TISSUE EN IN PRESS
   VENSTROM KA, 1993, FASEB J, V7, P996
   Venugopal J, 2005, NANOTECHNOLOGY, V16, P2138, DOI 10.1088/0957-4484/16/10/028
   Wang KK, 1998, MICROSURG, V18, P270, DOI 10.1002/(SICI)1098-2752(1998)18:4<270::AID-MICR11>3.0.CO;2-V
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Xiong Y, 2012, INT J NANOMED, V7, P1977, DOI 10.2147/IJN.S30706
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yucel D, 2010, BIOMACROMOLECULES, V11, P3584, DOI 10.1021/bm1010323
   Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181
   Zhang YQ, 2012, CELLS TISSUES ORGANS, V195, P313, DOI 10.1159/000327724
   Zimmermann U, 2001, ANN NY ACAD SCI, V944, P199, DOI 10.1111/j.1749-6632.2001.tb03833.x
   Zurita M, 2010, CYTOTHERAPY, V12, P522, DOI 10.3109/14653241003615164
NR 151
TC 15
Z9 16
U1 6
U2 57
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
EI 1699-5848
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD NOV
PY 2014
VL 29
IS 11
BP 1395
EP 1408
PG 14
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA AQ8XX
UT WOS:000343124500004
PM 24831814
DA 2018-10-20
ER

PT J
AU Rogers, CM
   Deehan, DJ
   Knuth, CA
   Rose, FRAJ
   Shakesheff, KM
   Oldershaw, RA
AF Rogers, Catherine M.
   Deehan, David J.
   Knuth, Callie A.
   Rose, Felicity R. A. J.
   Shakesheff, Kevin M.
   Oldershaw, Rachel A.
TI Biocompatibility and enhanced osteogenic differentiation of human
   mesenchymal stem cells in response to surface engineered
   poly(D,L-lactic-co-glycolic acid) microparticles
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(D,L-lactic-co-glycolic acid) microparticles; mesenchymal stem
   cells; tissue engineering; anterior cruciate ligament; biocompatibility;
   orthopedics
ID ANTERIOR CRUCIATE LIGAMENT; BREAST-CANCER CELLS; BIOMEDICAL
   APPLICATIONS; BIODEGRADABLE POLYMERS; DRUG-DELIVERY; GRAFT FAILURE;
   STROMAL CELLS; RECONSTRUCTION; TISSUE; SCAFFOLD
AB Tissue engineering strategies can be applied to enhancing osseous integration of soft tissue grafts during ligament reconstruction. Ligament rupture results in a hemarthrosis, an acute intra-articular bleed rich in osteogenic human mesenchymal stem cells (hMSCs). With the aim of identifying an appropriate biomaterial with which to combine hemarthrosis fluid-derived hMSCs (HF-hMSCs) for therapeutic application, this work has investigated the biocompatibility of microparticles manufactured from two forms of poly(D, L-lactic-co-glycolic acid) (PLGA), one synthesized with equal monomeric ratios of lactic acid to glycolic acid (PLGA 50: 50) and the other with a higher proportion of lactic acid (PLGA 85: 15) which confers a longer biodegradation time. The surfaces of both types of microparticles were functionalized by plasma polymerization with allylamine to increase hydrophilicity and promote cell attachment. HF-hMSCs attached to and spread along the surface of both forms of PLGA microparticle. The osteogenic response of HF-hMSCs was enhanced when cultured with PLGA compared with control cultures differentiated on tissue culture plastic and this was independent of the type of polymer used. We have demonstrated that surface engineered PLGA microparticles are an appropriate biomaterial for combining with HF-hMSCs and the selection of PLGA is relevant only when considering the biodegradation time for each biomedical application. (C) 2013 Wiley Periodicals, Inc.
C1 [Rogers, Catherine M.; Rose, Felicity R. A. J.; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England.
   [Deehan, David J.; Knuth, Callie A.; Oldershaw, Rachel A.] Newcastle Univ, Fac Med Sci, Inst Cellular Med, Int Ctr Life, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.
   [Deehan, David J.] Newcastle Upon Tyne NHS Hosp Fdn Trust, Freeman Hosp, Dept Orthopaed, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.
   [Oldershaw, Rachel A.] Newcastle Univ, Fac Med Sci, Int Ctr Life, North East England Stem Cell Inst, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.
RP Oldershaw, RA (reprint author), Newcastle Univ, Fac Med Sci, Inst Cellular Med, Int Ctr Life, Times Sq, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England.
EM rachel.oldershaw@ncl.ac.uk
RI Shakesheff, Kevin/O-6371-2018
OI Shakesheff, Kevin/0000-0003-3236-2439; Rose,
   Felicity/0000-0001-6640-8840
FU EPSRC [EP/H028277/1]; NESCI; Biotechnology and Biological Sciences
   Research Council [BB/G010617/1]; Engineering and Physical Sciences
   Research Council [EP/H028277/1]
FX Contract grant sponsor: EPSRC; contract grant number: EP/H028277/1;
   Contract grant sponsor: NESCI
CR Barry F, 2013, NAT REV RHEUMATOL, V9, P584, DOI 10.1038/nrrheum.2013.109
   Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Boden BP, 2010, J AM ACAD ORTHOP SUR, V18, P520, DOI 10.5435/00124635-201009000-00003
   Boden BP, 2009, AM J SPORT MED, V37, P252, DOI 10.1177/0363546508328107
   Courtney P, 2009, BEST PRACT RES CL RH, V23, P161, DOI 10.1016/j.berh.2009.01.003
   Crawford SN, 2013, ARTHROSCOPY, V29, P1566, DOI 10.1016/j.arthro.2013.04.014
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Deehan DJ, 2005, J BONE JOINT SURG BR, V87B, P889, DOI 10.1302/0301-620X.87B7.16038
   Deehan DJ, 2012, AM J STEM CELL RES, V1, P1, DOI [10.5923/j.ajscr.20120101.01, DOI 10.5923/J.AJSCR.20120101.01]
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Fishman JH, 1996, BIOCHEM BIOPH RES CO, V220, P467, DOI 10.1006/bbrc.1996.0424
   Ge ZG, 2009, J BIOMATER APPL, V23, P533, DOI 10.1177/0885328208094301
   Graziano A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000496
   Harvey A, 2005, J BONE JOINT SURG BR, V87B, P593, DOI 10.1302/0301-620X.87B5.15803
   Harvey AR, 2003, KNEE, V10, P97, DOI 10.1016/S0968-0160(02)00092-3
   Hild N, 2011, NANOSCALE, V3, P401, DOI 10.1039/c0nr00615g
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Hsu SL, 2013, ARCH ORTHOP TRAUM SU, V133, P1197, DOI 10.1007/s00402-013-1790-x
   Knuth CA, 2013, STEM CELL REV REP, V9, P599, DOI 10.1007/s12015-013-9446-3
   Kohno T, 2007, J ORTHOP SCI, V12, P67, DOI 10.1007/s00776-006-1088-8
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Lee JH, 2008, BIOCHEM BIOPH RES CO, V370, P456, DOI 10.1016/j.bbrc.2008.03.123
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Muneta T, 1997, AM J SPORT MED, V25, P69, DOI 10.1177/036354659702500113
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Norris Rory, 2012, Open Orthop J, V6, P506, DOI 10.2174/1874325001206010506
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Overstreet M, 2003, IN VITRO CELL DEV-AN, V39, P228
   Pauzenberger L, 2013, ARTHROSCOPY, V29, P1712, DOI 10.1016/j.arthro.2013.05.009
   Roberts SJ, 2008, BRIT MED BULL, V86, P7, DOI 10.1093/bmb/ldn016
   Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632
   Salmon LJ, 2006, AM J SPORT MED, V34, P721, DOI 10.1177/0363546505282626
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Siegel L, 2012, CLIN J SPORT MED, V22, P349, DOI 10.1097/JSM.0b013e3182580cd0
   Tanaka T, 2009, J BIOMED MATER RES A, V91A, P428, DOI 10.1002/jbm.a.32253
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   VERGIS A, 1995, ARTHROSCOPY, V11, P312, DOI 10.1016/0749-8063(95)90009-8
   Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
NR 41
TC 4
Z9 4
U1 2
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2014
VL 102
IS 11
BP 3872
EP 3882
DI 10.1002/jbm.a.35063
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7PC
UT WOS:000343010100011
PM 24339408
DA 2018-10-20
ER

PT J
AU Gallorini, M
   Sancilio, S
   Zara, S
   De Colli, M
   Di Giulio, M
   Cataldi, A
   di Giacomo, V
AF Gallorini, Marialucia
   Sancilio, Silvia
   Zara, Susi
   De Colli, Marianna
   Di Giulio, Mara
   Cataldi, Amelia
   di Giacomo, Viviana
TI Involvement of mitochondrial signalling pathway in HGFs/S. mitis
   coculture response to TEGDMA treatment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE human gingival fibroblasts; TEGDMA; Streptococcus mitis; saliva;
   reactive oxygen species
ID HUMAN GINGIVAL FIBROBLASTS; DENTAL RESTORATIVE MATERIALS; RESIN
   MONOMERS; 2-HYDROXYETHYL METHACRYLATE; GLUTATHIONE DEPLETION; OXIDATIVE
   STRESS; MAP KINASES; PULP CELLS; COMPOSITES; HEMA
AB Although triethylene glycol dimethacrylate (TEGDMA), a resin monomer widely used in dental practice, has been shown to have cytotoxic effects on eukaryotic cells, little is known about how the oral environment influences the cytotoxicity of this biomaterial. The aim of this study was to evaluate eukaryotic cell reaction to TEGDMA in terms of the production of reactive oxygen species (ROS), the expression of Bax, the disturbance of mitochondrial membrane potential (MMP), and the occurrence of apoptosis in an in vitro coculture model of human gingival fibroblasts (HGFs) and Streptococcus mitis strain in presence of saliva. We found that S. mitis and saliva reduced the production of ROS (from 2.2 to 1.8 fold), the occurrence of apoptosis (from 11.3 to 4.7%), and the decrease of MMP (from 0.75 to 0.9 fold) induced by TEGDMA treatment. Addition of N-acetylcysteine, a well known antioxidant, improved cell viability in all experimental conditions. The results obtained in this study suggest that the presence of S. mitis and saliva in the periodontal environment could protect cells against TEGDMA toxicity. These results, shedding more light on the biological and molecular events that occur in conjuction with TEGDMA treatment in vitro in a coculture model that mimics the environment of the oral cavity, confirm the key role played by oral bacteria and saliva in preventing toxic events that can occur in vivo in HGFs. (C) 2013 Wiley Periodicals, Inc.
C1 [Gallorini, Marialucia; Sancilio, Silvia; Zara, Susi; De Colli, Marianna; Di Giulio, Mara; Cataldi, Amelia; di Giacomo, Viviana] Univ G DAnnunzio, Dept Pharm, Chieti, Italy.
RP di Giacomo, V (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM v.digiacomo@unich.it
OI DI GIULIO, MARA/0000-0002-8375-9404; Gallorini,
   Marialucia/0000-0002-2283-4159
FU FIRB project-Accordi di Programma, "Processi degenerativi dei tessuti
   mineralizzati del cavo orale, impieghi di biomateriali e controllo delle
   interazioni con microrganismi dell'ambiente" [Cod.RBAPI095]; PRIN grant,
   "Ruolo delle protein chinasi C (PKC) nei processi di
   interazione/integrazione tra biomateriale dentale/tessuto ospite/flora
   microbica della cavita orale"
FX Contract grant sponsor: FIRB project-Accordi di Programma 2010,
   "Processi degenerativi dei tessuti mineralizzati del cavo orale,
   impieghi di biomateriali e controllo delle interazioni con microrganismi
   dell'ambiente"; contract grant number: Cod.RBAPI095; Contract grant
   sponsor: Prof. Cataldi's 2009 PRIN grant, "Ruolo delle protein chinasi C
   (PKC) nei processi di interazione/integrazione tra biomateriale
   dentale/tessuto ospite/flora microbica della cavita orale"
CR Bakopoulou A, 2011, DENT MATER, V6, P608
   Bakopoulou A, 2009, INT J MOL SCI, V10, P3861, DOI 10.3390/ijms10093861
   Cataldi A, 2013, J BIOMED MATER RES A, V101, P378, DOI 10.1002/jbm.a.34337
   Chang HH, 2012, INT ENDOD J, V45, P848, DOI 10.1111/j.1365-2591.2012.02042.x
   Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263
   di Giacomo V, 2013, INT ENDOD J, V46, P1164, DOI 10.1111/iej.12113
   Di Giulio M, 2013, J MATER SCI-MATER M, V24, P1977, DOI 10.1007/s10856-013-4949-7
   Di Giulio M, 2012, APMIS, V120, P139, DOI 10.1111/j.1600-0463.2011.02828.x
   Di Nisio C, 2013, INT ENDOD J, V46, P466, DOI 10.1111/iej.12012
   Durner J, 2012, DENT MATER, V28, P818, DOI 10.1016/j.dental.2012.04.031
   Durner J, 2010, DENT MATER, V26, P91, DOI 10.1016/j.dental.2009.08.014
   Eckhardt A, 2009, BIOMATERIALS, V30, P2006, DOI 10.1016/j.biomaterials.2008.12.045
   Geurtsen W, 1998, EUR J ORAL SCI, V106, P687, DOI 10.1046/j.0909-8836.1998.eos10602ii04.x
   Jaffer F, 2002, BIOMATERIALS, V23, P1707, DOI 10.1016/S0142-9612(01)00298-8
   Janke V, 2003, J DENT RES, V82, P814, DOI 10.1177/154405910308201010
   Khalichi P, 2004, BIOMATERIALS, V25, P5467, DOI 10.1016/j.biomaterials.2003.12.056
   Krifka S, 2013, BIOMATERIALS, V34, P4555, DOI 10.1016/j.biomaterials.2013.03.019
   Krifka S, 2010, BIOMATERIALS, V31, P2964, DOI 10.1016/j.biomaterials.2010.01.005
   Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005
   Lefeuvre M, 2005, BIOMATERIALS, V26, P5130, DOI 10.1016/j.biomaterials.2005.01.014
   MEISTER A, 1995, BBA-MOL BASIS DIS, V1271, P35, DOI 10.1016/0925-4439(95)00007-Q
   Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x
   Moharamzadeh K, 2007, J MATER SCI-MATER M, V18, P133, DOI 10.1007/s10856-006-0671-z
   Nocca G, 2011, DENT MATER, V27, pE87, DOI 10.1016/j.dental.2011.01.002
   Noda M, 2002, J DENT RES, V81, P265, DOI 10.1177/154405910208100408
   OYSAED H, 1988, J DENT RES, V67, P1289, DOI 10.1177/00220345880670100901
   Reichl FX, 2001, J DENT RES, V80, P1412, DOI 10.1177/00220345010800050501
   Schweikl H, 2007, DENT MATER, V23, P688, DOI 10.1016/j.dental.2006.06.021
   Schweikl H, 2006, J DENT RES, V85, P870, DOI 10.1177/154405910608501001
   Schwengberg S, 2005, J DENT, V33, P49, DOI 10.1016/j.jdent.2004.08.001
   Seiss M, 2007, DENT MATER, V23, P9, DOI 10.1016/j.dental.2005.11.038
   Sideridou ID, 2008, DENT MATER, V24, P737, DOI 10.1016/j.denta1.2007.08.004
   Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022
   Spahl W, 1998, J DENT, V26, P137, DOI 10.1016/S0300-5712(96)00086-3
   Stanislawski L, 2003, J BIOMED MATER RES A, V66A, P476, DOI 10.1002/jbm.a.10600
   Urcan E, 2010, BIOMATERIALS, V31, P2010, DOI 10.1016/j.biomaterials.2009.11.065
   Volk J, 2006, DENT MATER, V22, P499, DOI 10.1016/j.dental.2005.06.002
   Volk J, 2007, DENT MATER, V23, P921, DOI 10.1016/j.dental.2006.08.001
   Walensky LD, 2011, TRENDS BIOCHEM SCI, V36, P642, DOI 10.1016/j.tibs.2011.08.009
   Walther UI, 2004, ARCH ORAL BIOL, V49, P125, DOI 10.1016/j.archoralbio.2003.08.008
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wullner U, 1999, BRAIN RES, V826, P53, DOI 10.1016/S0006-8993(99)01228-7
   Yoshii E, 1997, J BIOMED MATER RES, V37, P517, DOI 10.1002/(SICI)1097-4636(19971215)37:4<517::AID-JBM10>3.0.CO;2-5
   Zara S, 2011, INT ENDOD J, V44, P1145, DOI 10.1111/j.1365-2591.2011.01935.x
NR 44
TC 4
Z9 5
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2014
VL 102
IS 11
BP 3931
EP 3938
DI 10.1002/jbm.a.35067
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7PC
UT WOS:000343010100017
PM 24339002
DA 2018-10-20
ER

PT J
AU Gotz, C
   Lim, GT
   Puskas, JE
   Altstadt, V
AF Goetz, C.
   Lim, G. T.
   Puskas, J. E.
   Altstaedt, V.
TI The effect of carbon black reinforcement on the dynamic fatigue and
   creep of polyisobutylene-based biomaterials
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Thermoplastic elastomers; SIBS; Poly(isobutylene-b-para-methylstyrene)
   block copolymer; Biomaterial; Dynamic creep
ID DIAMOND-LIKE CARBON; POLY(ALIPHATIC/AROMATIC-ESTER) COPOLYMERS;
   THERMOPLASTIC ELASTOMERS; BEHAVIOR; BIOCOMPATIBILITY; NANOCOMPOSITES;
   COMPOSITES; POLYMER
AB This paper investigates the structure-property relationship of a new generation of poly (styrene-b-isobutylene-b-styrene) (SIBS) block copolymers with a branched (dendritic) polyisobutylene core with poly(isobutylene-b-para-methylstyrene) end blocks (D_IBS), and their carbon black (CB) composites. These materials display thermoplastic elastomeric (TPE) properties, and are promising new biomaterials. It is shown that CB reinforced the block copolymer TPEs, effectively delayed the oxidative thermal degradation of the D_IBS materials, and greatly improved their dynamic fatigue performance. Specifically, the dynamic creep of a CB composite was comparable to that of chemically crosslinked and silica-reinforced medical grade silicone rubber, used as a benchmark biomaterial. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Goetz, C.; Altstaedt, V.] Univ Bayreuth, Fac Engn Sci, Dept Polymer Engn, D-95447 Bayreuth, Germany.
   [Lim, G. T.; Puskas, J. E.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Puskas, J. E.] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
RP Altstadt, V (reprint author), Univ Bayreuth, Fac Engn Sci, Dept Polymer Engn, Univ Str 30, D-95447 Bayreuth, Germany.
EM altstaedt@uni-bayreuth.de
FU German Science Foundation [Al 474/12-1]; National Science Foundation,
   USA [DMR-0509687]; NorTech/CMPND
FX The authors are grateful to the German Science Foundation (Al 474/12-1),
   National Science Foundation, USA (DMR-0509687) and by NorTech/CMPND for
   financial support. Ms. C. Kunert and Ms. A. Lang (University of
   Bayreuth) for their microscopy work, Ms. U. Kuhn for the DMTA assistance
   and Mr. P. Lane (UA Research Foundation) for the pilot plant
   polymerizations are gratefully acknowledged by the authors.
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   [Anonymous], D170802A ASTM
   ASTM International, 2007, F70307 ASTM INT
   ASTM International, 2006, D41206A ASTM INT
   ASTM International, 2006, D5026 ASTM INT
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Davis J.R., 2003, HDB MAT BIOMEDICAL D
   Drobny J. G., 2007, HDB THERMOPLASTIC EL
   Du C, 1998, BIOMATERIALS, V19, P651, DOI 10.1016/S0142-9612(97)00159-2
   Duck F., 1990, PHYS PROPERTIES TISS
   Ehrenstein G.W., 1993, HYSTERESIS MESSVERFA
   El Fray M, 2006, BIOMACROMOLECULES, V7, P844, DOI 10.1021/bm050971c
   El Fray M, 2003, POLYMER, V44, P4635, DOI 10.1016/S0032-3861(03)00417-8
   El Fray M., 2003, NANOSTRUCTURED ELAST
   Gotz C, 2012, J MECH BEHAV BIOMED, V10, P206, DOI 10.1016/j.jmbbm.2012.02.016
   Gotz C, 2009, POLYMER, V50, P5499, DOI 10.1016/j.polymer.2009.09.051
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hill R.M., 1984, J POLYM SCI B, V22, P1998
   Holden G., 2004, THERMOPLASTIC ELASTO
   Jakab E, 2005, J ANAL APPL PYROL, V74, P204, DOI 10.1016/j.jaap.2005.02.001
   Karauchi T., 1993, MAT RES, V8, P1185
   Kubova O, 2005, MATER SCI FORUM, V482, P247, DOI 10.4028/www.scientific.net/MSF.482.247
   Leyva ME, 2003, J POLYM SCI POL PHYS, V41, P2983, DOI 10.1002/polb.10627
   Lim GT, 2009, RUBBER CHEM TECHNOL, V82, P461, DOI 10.5254/1.3548258
   Mai Yiu-Wing, 2006, POLYM NANOCOMPOSITES
   More R.B., 2012, BIOMATERIALS SCI INT
   Pinchuk L, 2008, BIOMATERIALS, V29, P448, DOI 10.1016/j.biomaterials.2007.09.041
   Puskas JE, 2010, BIOMATERIALS, V31, P2477, DOI 10.1016/j.biomaterials.2009.12.003
   Puskas JE, 2009, J POLYM SCI POL CHEM, V47, P1148, DOI 10.1002/pola.23218
   Puskas JE, 2009, POLYMER, V50, P591, DOI 10.1016/j.polymer.2008.10.061
   Ratto G.B., 1998, VASCULAR SURG, V22, P244
   RENZ R, 1988, J REINF PLAST COMP, V7, P413, DOI 10.1177/073168448800700502
   Ryan A.J., 1997, PHYS GLASSY POLYM
   Sawyer LC, 2008, POLYM MICROSCOPY
   Sengupta R, 2007, POLYM ENG SCI, V47, P1956, DOI 10.1002/pen.20921
NR 35
TC 5
Z9 6
U1 2
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD NOV
PY 2014
VL 39
BP 355
EP 365
DI 10.1016/j.jmbbm.2014.08.008
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AR1IL
UT WOS:000343338800032
PM 25173236
DA 2018-10-20
ER

PT J
AU Gemini-Piperni, S
   Takamori, ER
   Sartoretto, SC
   Paiva, KBS
   Granjeiro, JM
   de Oliveira, RC
   Zambuzzi, WF
AF Gemini-Piperni, Sara
   Takamori, Esther Rieko
   Sartoretto, Suelen Cristina
   Paiva, Katiucia B. S.
   Granjeiro, Jose Mauro
   de Oliveira, Rodrigo Cardoso
   Zambuzzi, Willian Fernando
TI Cellular behavior as a dynamic field for exploring bone bioengineering:
   A closer look at cell-biomaterial interface
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Bone; Bioengineering; Osteoblast; Signal transduction; Cell behavior;
   Biomaterials; Scaffolds; Regenerative medicine; Dentistry
ID MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC CELLS; EXTRACELLULAR-MATRIX;
   OSTEOBLAST ADHESION; SIGNALING PATHWAYS; GROWTH-FACTORS; IN-VITRO;
   OSTEOCLAST DIFFERENTIATION; MORPHOGENETIC PROTEINS; REGULATORY
   MECHANISMS
AB Bone is a highly dynamic and specialized tissue, capable of regenerating itself spontaneously when afflicted by minor injuries. Nevertheless, when major lesions occur, it becomes necessary to use biomaterials, which are not only able to endure the cellular proliferation and migration, but also to substitute the original tissue or integrate itself to it. With the life expectancy growth, regenerative medicine has been gaining constant attention in the reconstructive field of dentistry and orthopedy. Focusing on broadening the therapeutic possibilities for the regeneration of injured organs, the development of biomaterials allied with the applicability of gene therapy and bone bioengineering has been receiving vast attention over the recent years. The progress of cellular and molecular biology techniques gave way to new-guided therapy possibilities. Supported by multidisciplinary activities, tissue engineering combines the interaction of physicists, chemists, biologists, engineers, biotechnologist, dentists and physicians with common goals: the search for materials that could promote and lead cell activity. A well-oriented combining of scaffolds, promoting factors, cells, together with gene therapy advances may open new avenues to bone healing in the near future. In this review, our target was to write a report bringing overall concepts on tissue bioengineering, with a special attention to decisive biological parameters for the development of biomaterials, as well as to discuss known intracellular signal transduction as a new manner to be explored within this field, aiming to predict in vitro the quality of the host cell/material and thus contributing with the development of regenerative medicine. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Gemini-Piperni, Sara; Zambuzzi, Willian Fernando] Univ Estadual Paulista, UNESP, Inst Biociencia, Lab Bioensaios & Dinam Celular,Dept Quim & Bioqui, Botucatu, SP, Brazil.
   [Gemini-Piperni, Sara] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
   [Takamori, Esther Rieko] Excell Biomed Serv, Petropolis, RJ, Brazil.
   [Sartoretto, Suelen Cristina] Univ Fed Fluminense, Dept Oral Surg, Niteroi, RJ, Brazil.
   [Paiva, Katiucia B. S.] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Extracellular Matrix Biol & Cellular Interact Grp, Sao Paulo, Brazil.
   [Granjeiro, Jose Mauro] Inst Nacl Metrol Normalizacao & Qualidade Ind INM, Diretoria Programas DIPRO Bioengn, Xerem, RJ, Brazil.
   [de Oliveira, Rodrigo Cardoso] Univ Sao Paulo, Baum Dent Sch, Dept Biol Sci, BR-17012901 Sao Paulo, Brazil.
RP Zambuzzi, WF (reprint author), Biosci Inst IBB UNESP, Dept Chem & Biochem, Bioassays & Cellular Dynam Lab, POB 510, BR-18618970 Botucatu, SP, Brazil.
EM wzambuzzi@ibb.unesp.br
RI Gemini Piperni, Sara/A-9858-2015; Paiva, Katiucia/C-3147-2012; Zambuzzi,
   Willian/F-9519-2012
OI Gemini Piperni, Sara/0000-0002-7724-9491; Paiva,
   Katiucia/0000-0002-3583-625X; Zambuzzi, Willian/0000-0002-4149-5965;
   Oliveira, Rodrigo/0000-0003-3070-5960; Granjeiro,
   Jose/0000-0002-8027-8293
FU Marie Curie International Research Staff Exchange Scheme Fellowship;
   CNPq [PQ-2]; FAPESP; S.I.N. Sistema de Implantes (Sao Paulo, SP,
   Brazil); CNPq
FX The authors would like to thank FAPESP, CNPq and S.I.N. Sistema de
   Implantes (Sao Paulo, SP, Brazil). This research was supported by a
   Marie Curie International Research Staff Exchange Scheme Fellowship to
   S.G.P. and S.S. within the 7th European Community Framework Program.
   W.F.Z. is supported by fellowship at CNPq (PQ-2). The authors are
   grateful to Mileni S. Fernandes, Marcela M. Yanai, Paula K. Herrera and
   Andressa P. Z. Sabino, from Sao Paulo University, for helping with the
   pictures.
CR Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062
   Armentano Ilaria, 2013, Recent Pat Drug Deliv Formul, V7, P9
   Bakker A, 2014, J DENT RES
   Balint R., 2014, ACTA BIOMATER
   Bastos A.S., 2012, J ORAL IMPLANTOL
   Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x
   Bertazzo S, 2010, CLIN ORAL IMPLAN RES, V21, P1411, DOI 10.1111/j.1600-0501.2010.01968.x
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Bertazzo S, 2010, LANGMUIR, V26, P3364, DOI 10.1021/la903140k
   Blokhuis TJ, 2013, INJURY, V44, pS40, DOI 10.1016/S0020-1383(13)70009-3
   Bocelli-Tyndall C., 2013, ANN RHEUM DIS
   Boskey AL, 2008, BONE, V42, P1061, DOI 10.1016/j.bone.2008.01.016
   Caplan MR, 2009, CELL BIOCHEM BIOPHYS, V54, P1, DOI 10.1007/s12013-009-9048-5
   Carreira A.C., 2014, J DENT RES
   Cavagis A., 2013, ORAL DIS
   Neto AHC, 2011, J CELL BIOCHEM, V112, P71, DOI 10.1002/jcb.22763
   Chung VHY, 2012, J CRANIOFAC SURG, V23, P1558, DOI 10.1097/SCS.0b013e31825e4e30
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c
   de Oliveira RC, 2008, CLIN ORAL IMPLAN RES, V19, P749, DOI 10.1111/j.1600-0501.2008.01521.x
   Deshpande S, 2013, J SURG RES, V185, P278, DOI 10.1016/j.jss.2013.06.063
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Ellman MB, 2013, GENE, V524, P282, DOI 10.1016/j.gene.2013.04.003
   Feng Xu, 2009, Curr Chem Biol, V3, P189
   Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550
   Garg T, 2012, CRIT REV THER DRUG, V29, P1
   Garrison KR, 2010, COCHRANE DB SYST REV
   Girard PJ, 2013, J ORTHOP TRAUMA, V27, pe220, DOI 10.1097/BOT.0b013e31827069b9
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Gulan G, 2012, COLLEGIUM ANTROPOL, V36, P617
   Guthrie K, 2013, TRENDS BIOTECHNOL, V31, P505, DOI 10.1016/j.tibtech.2013.05.007
   Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041
   Harada Hidemitsu, 2002, Odontology, V90, P1, DOI 10.1007/s102660200000
   Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578
   Herlofsen SR, 2014, STEM CELLS, V32, P1629, DOI 10.1002/stem.1642
   Heydarkhan-Hagvall S, 2012, BIOMATERIALS, V33, P2032, DOI 10.1016/j.biomaterials.2011.11.065
   Honma M, 2014, CURR OSTEOPOROS REP, V12, P115, DOI 10.1007/s11914-014-0189-0
   Hwang Yongyun, 2012, Commun Integr Biol, V5, P538, DOI 10.4161/cib.21633
   Kam LC, 2013, ANNU REV BIOMED ENG, V15, P305, DOI 10.1146/annurev-bioeng-071811-150050
   Kelleher CM, 2010, J R SOC INTERFACE, V7, pS717, DOI 10.1098/rsif.2010.0345.focus
   Kim Eun-Hee, 2014, World J Stem Cells, V6, P65, DOI 10.4252/wjsc.v6.i1.65
   Kim M, 2011, BMB REP, V44, P619, DOI 10.5483/BMBRep.2011.44.10.619
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Kinoshita Y, 2013, SCI WORLD J, DOI 10.1155/2013/863157
   Knight MN, 2013, ADV WOUND CARE, V2, P306, DOI 10.1089/wound.2012.0420
   Kode JA, 2009, CYTOTHERAPY, V11, P377, DOI 10.1080/14653240903080367
   Kumar CY, 2013, J CLIN DIAGN RES, V7, P2926
   Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X
   Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325
   Lee HJ, 2013, BIOTECHNOL PROGR, V29, P432, DOI 10.1002/btpr.1685
   Leventis MD, 2014, IMPLANT DENT, V23, P37, DOI 10.1097/ID.0000000000000030
   Levi B, 2011, ORGANOGENESIS, V7, P242, DOI 10.4161/org.7.4.17926
   Liu J, 2005, IN VITRO CELL DEV-AN, V41, P232
   Liu N., 2014, CURR STEM CELL RES T
   Mannion RJ, 2011, SPINE J, V11, P527, DOI 10.1016/j.spinee.2010.07.005
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Marie PJ, 2012, CURR OSTEOPOROS REP, V10, P190, DOI 10.1007/s11914-012-0109-0
   Martin A, 2012, ADV EXP MED BIOL, V728, P65, DOI 10.1007/978-1-4614-0887-1_4
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Mathur Shivani, 2014, Int J Oral Maxillofac Implants, V29, pe210, DOI 10.11607/jomi.te57
   McNamara LE, 2014, METHOD CELL BIOL, V119, P293, DOI 10.1016/B978-0-12-416742-1.00015-9
   Michigami Toshimi, 2014, Clin Pediatr Endocrinol, V23, P1, DOI 10.1292/cpe.23.1
   Michigami T, 2013, CELL MOL LIFE SCI, V70, P4213, DOI 10.1007/s00018-013-1346-9
   Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Mishra R., 2014, J MAT SCI MAT MED
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Murray James I, 2013, J Chem Biol, V6, P175, DOI 10.1007/s12154-013-0100-y
   Muscari C., 2014, STEM CELLS INT
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012
   Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193
   Ormsby R.T., 2013, J STEROID BIOCHEM, V13, pS0960
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Panahi Y, 2014, J IMMUNOTOXICOL, V11, P72, DOI 10.3109/1547691X.2013.797525
   Park I.S., 2013, CYTOTHERAPY
   Park JJ, 2013, BULL HOSP JT DIS, V71, P39
   Petit A, 2011, TISSUE ENG PT A, V17, P899, DOI [10.1089/ten.tea.2010.0494, 10.1089/ten.TEA.2010.0494]
   Pham PV, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-56
   Piperni S.G., 2014, BIOTECHNOL BIOENG
   Rahmany MB, 2013, ACTA BIOMATER, V9, P5431, DOI 10.1016/j.actbio.2012.11.019
   Ramiro-Gutierrez M.L., 2013, J BIOMED MAT RES A
   Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13
   Romagnoli C, 2013, CLIN CASES MINER BON, V10, P155, DOI 10.11138/ccmbm/2013.10.3.155
   Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1
   Roorda BD, 2009, CANCER BIOL THER, V8, P1239, DOI 10.4161/cbt.8.13.8688
   Rosenberg N, 2012, RAMBAM MAIMONIDES ME, V3, DOI 10.5041/RMMJ.10080
   Russo V., 2014, BIOMATERIALS
   Satija NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055769
   Sekiya S, 2013, REGEN MED, V8, P371, DOI [10.2217/RME.13.16, 10.2217/rme.13.16]
   Senoo M, 2013, ADV WOUND CARE, V2, P273, DOI 10.1089/wound.2012.0372
   Shapiro IM, 2014, AUTOPHAGY, V10, P7, DOI 10.4161/auto.26679
   Shilpashree H.S., 2013, DENT J, V79, P60
   Slavkin HC, 2014, AUST DENT J, V59, P186, DOI 10.1111/adj.12105
   SrinivasaBabu K., 2014, AM J THER
   Stasyk T, 2012, TRENDS MOL MED, V18, P43, DOI 10.1016/j.molmed.2011.11.001
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Tanaka S, 1998, J BONE MINER RES, V13, P1714, DOI 10.1359/jbmr.1998.13.11.1714
   Tang JB, 2014, WOUND REPAIR REGEN, V22, P111, DOI 10.1111/wrr.12129
   Teti A, 2009, BONE, V44, P11, DOI 10.1016/j.bone.2008.09.017
   Traub S, 2013, BIOMATERIALS, V34, P5958, DOI 10.1016/j.biomaterials.2013.04.050
   Trautvetter W, 2011, J ORAL MAXIL SURG, V69, P2753, DOI 10.1016/j.joms.2011.02.096
   Vrijens K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059045
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wegman F, 2013, BIOTECHNOL GENET ENG, V29, P206, DOI 10.1080/02648725.2013.801227
   Wegman F, 2013, TISSUE ENG PT A, V19, P2686, DOI [10.1089/ten.tea.2012.0569, 10.1089/ten.TEA.2012.0569]
   Wright JF, 2009, HUM GENE THER, V20, P698, DOI 10.1089/hum.2009.064
   Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619
   Yamashita T, 2012, WORLD J ORTHOP, V3, P175, DOI 10.5312/wjo.v3.i11.175
   Yang M., 2014, CURR STEM CELL RES T
   Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597
   Yoshikawa T, 2000, TRANSPLANTATION, V69, P128, DOI 10.1097/00007890-200001150-00022
   Zambuzzi W.F., 2014, PLOS ONE
   Zambuzzi Willian F., 2012, Braz. Dent. J., V23, P315, DOI 10.1590/S0103-64402012000400002
   Zambuzzi WF, 2011, BIOTECHNOL BIOENG, V108, P1246, DOI 10.1002/bit.23117
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
   Zambuzzi WF, 2008, CELL PHYSIOL BIOCHEM, V22, P497, DOI 10.1159/000185506
   Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236
   Zambuzzi Willian Fernando, 2006, Braz. Dent. J., V17, P274, DOI 10.1590/S0103-64402006000400002
   Zhang WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088794
NR 123
TC 10
Z9 10
U1 2
U2 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD NOV 1
PY 2014
VL 561
SI SI
BP 88
EP 98
DI 10.1016/j.abb.2014.06.019
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AQ5QI
UT WOS:000342863300011
PM 24976174
DA 2018-10-20
ER

PT J
AU Smieszek, A
   Donesz-Sikorska, A
   Grzesiak, J
   Krzak, J
   Marycz, K
AF Smieszek, Agnieszka
   Donesz-Sikorska, Anna
   Grzesiak, Jakub
   Krzak, Justyna
   Marycz, Krzysztof
TI Biological effects of sol-gel derived ZrO2 and SiO2/ZrO2 coatings on
   stainless steel surface-In vitro model using mesenchymal stem cells
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Sol-gel coatings; surface characterization; biocompatibility;
   osteoinductive properties; mesenchymal stem cells
ID UMBILICAL-CORD BLOOD; ZIRCONIUM PROPOXIDE PRECURSORS; THIN-FILMS;
   BONE-MARROW; ADIPOSE-TISSUE; MEDICAL APPLICATIONS; TITANIUM;
   HYDROXYAPATITE; PROLIFERATION; ROUGHNESS
AB The objective of this study was to determine biocompatibility of zirconia-based coatings obtained by the sol-gel method. Two matrices, ZrO2 and SiO2/ZrO2, were created and applied on stainless steel type 316L with dip-coating technique. The morphology and topography of biomaterials' surface were characterized using energy-dispersive X-ray spectroscopy and atomic force microscopy, while chemical composition was analyzed by Raman spectroscopy. Additionally, wettability and surface free energy were characterized. Biocompatibility of obtained biomaterials was evaluated using an invitro model employing mesenchymal stem cells (MSCs) of adipose and bone marrow origin. Biological analysis included determination of proliferation activity and morphology of MSCs in cultures on synthesized biomaterials. Osteoinductive properties of biomaterials were determined both in non-osteogenic, as well as osteogenic conditions. The results showed that investigated biomaterials exerted different impact on MSCs. Biomaterial with ZrO2 layer was more biocompatible for adipose-derived MSCs, while SiO2/ZrO2 layer promoted proliferation of bone marrow derived MSCs. Moreover, hybrid coating exhibited greater osteoinductive properties than ZrO2 coating, both on cultures with adipose-derived stromal (stem) cells and bone marrow stromal cells. Observed biological effects may result not only from different chemical composition, but also from diverse wettability. The ZrO2 coating was characterized as hydrophobic layer, while SiO2/ZrO2 exhibited hydrophilic properties. The results obtained suggest that behavior of MSCs in response to the biomaterial may vary depending on their origin, therefore we postulate, that screening analysis of implants' biocompatibility, should incorporate model applying both adipose- and bone marrow derived MSCs.
C1 [Smieszek, Agnieszka; Grzesiak, Jakub; Marycz, Krzysztof] Univ Environm & Life Sci, Electron Microscopy Lab, Wroclaw, Poland.
   [Smieszek, Agnieszka; Marycz, Krzysztof] Wroclawskie Ctr Badan EIT, Wroclaw, Poland.
   [Donesz-Sikorska, Anna; Krzak, Justyna] Wroclaw Univ Technol, Inst Mat Sci & Appl Mech, PL-50370 Wroclaw, Poland.
RP Smieszek, A (reprint author), Wroclaw Univ Environm & Life Sci, Kozuchowska 5b, PL-50631 Wroclaw, Poland.
EM smieszek.agnieszka@gmail.com
RI KRZAK, JUSTYNA/G-4511-2015; Smieszek, Agnieszka/A-4887-2017; Marycz,
   Krzysztof/A-2249-2017
OI KRZAK, JUSTYNA/0000-0002-1525-5589; Smieszek,
   Agnieszka/0000-0002-7314-9821; 
FU Wroclaw Research Centre EIT + under the project "Biotechnologies and
   advanced medical technologies''-BioMed from the European Regional
   Development Fund (Operational Program Innovative Economy)
   [POIG.01.01.02-02-003/08, 1.1.2]
FX The research was supported by Wroclaw Research Centre EIT + under the
   project "Biotechnologies and advanced medical technologies''-BioMed
   (POIG.01.01.02-02-003/08) financed from the European Regional
   Development Fund (Operational Program Innovative Economy, 1.1.2).
CR Ballarre Josefina, 2012, International Journal of Nano and Biomaterials, V4, P33, DOI 10.1504/IJNBM.2012.048216
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Ben-Nissan B, 2006, NANOMEDICINE-UK, V1, P311, DOI 10.2217/17435889.1.3.311
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Caruso R, 2001, J MATER RES, V16, P2391, DOI 10.1557/JMR.2001.0328
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Chang SM, 2005, THIN SOLID FILMS, V489, P17, DOI 10.1016/j.tsf.2005.04.076
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   Donesz-Sikorska A, 2014, J BIOMATER APPL
   Dwivedi R, 2011, J ALLOY COMPD, V509, P6848, DOI 10.1016/j.jallcom.2011.03.138
   Ehrhart G, 2006, THIN SOLID FILMS, V496, P227, DOI 10.1016/j.tsf.2005.08.309
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Garfinkel A, 2004, P NATL ACAD SCI USA, V101, P9247, DOI 10.1073/pnas.0308436101
   GROSS KA, 1994, J MATER SCI-MATER M, V5, P219, DOI 10.1007/BF00121092
   Grzesiak J, 2013, INT J MORPHOL, V31, P826, DOI 10.4067/S0717-95022013000300008
   Houmard M, 2009, SURF SCI, V603, P2698, DOI 10.1016/j.susc.2009.07.005
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kalinski K, 2012, J ELECTRON MICROSC, V61, P47, DOI 10.1093/jmicro/dfr086
   Kashani IR, 2009, ARCH MED SCI, V5, P149
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kibbe W.A., 2007, NUCLEIC ACIDS RES, V35, P43
   Krzak-Ros J, 2009, ACTA BIOENG BIOMECH, V11, P21
   Kyllonen L, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt165
   Lim YJ, 2001, INT J ORAL MAX IMPL, V16, P333
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   LIVAGE J, 1988, PROG SOLID STATE CH, V18, P259, DOI 10.1016/0079-6786(88)90005-2
   Mahadik SA, 2012, J SOL-GEL SCI TECHN, V63, P580, DOI 10.1007/s10971-012-2798-3
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Marycz K, 2014, J BIOMED MATER RES A, V102, P4017, DOI 10.1002/jbm.a.35072
   Marycz K, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/6/065004
   Matassi F, 2013, CLIN CASES MINER BON, V10, P111, DOI 10.11138/ccmbm/2013.10.2.111
   MAXIAN SH, 1993, J BIOMED MATER RES, V27, P17
   Murakami A, 2012, NANOMED-NANOTECHNOL, V8, P374, DOI 10.1016/j.nano.2011.07.001
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Nouri E, 2011, SURF COAT TECH, V205, P5109, DOI 10.1016/j.surfcoat.2011.05.024
   Padial-Molina M, 2011, ACTA BIOMATER, V7, P771, DOI 10.1016/j.actbio.2010.08.024
   Randeniya L, 2010, ACTA BIOMATER, V6, P4154, DOI 10.1016/j.actbio.2010.04.014
   Ravichandran R, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015001
   Salahinejad E, 2013, J BIOMED NANOTECHNOL, V9, P1327, DOI 10.1166/jbn.2013.1619
   Schraufstatter IU, 2011, FRONT BIOSCI-LANDMRK, V16, P2271, DOI 10.2741/3853
   Schubert U, 2003, J SOL-GEL SCI TECHN, V26, P47, DOI 10.1023/A:1020729100148
   Socrates G, 2001, INFRARED RAMAN CHARA, p[61, 94, 302]
   Spijksma GI, 2009, INT J MOL SCI, V10, P4977, DOI 10.3390/ijms10114977
   Spijksma GI, 2004, CHEM COMMUN, P1874, DOI 10.1039/b406012a
   Steinemann SG, 1980, EVALUATION BIOMATERI, P20
   Toupadakis CA, 2010, AM J VET RES, V71, P1237, DOI 10.2460/ajvr.71.10.1237
   Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030
   Uhlmann I, 2013, THIN SOLID FILMS, V527, P200, DOI 10.1016/j.tsf.2012.08.007
   Viazzi C, 2006, SURF COAT TECH, V201, P3889, DOI 10.1016/j.surfcoat.2006.07.241
   Wang D, 2009, PROG ORG COAT, V64, P327, DOI 10.1016/j.porgcoat.2008.08.010
   Whitehead SA, 1999, DENT MATER, V15, P79, DOI 10.1016/S0109-5641(99)00017-2
   Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163
   Zippel Nina, 2010, Recent Pat Biotechnol, V4, P1, DOI 10.2174/187220810790069497
NR 60
TC 22
Z9 22
U1 1
U2 61
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD NOV
PY 2014
VL 29
IS 5
BP 699
EP 714
DI 10.1177/0885328214545095
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ5ES
UT WOS:000342829700006
PM 25074359
DA 2018-10-20
ER

PT J
AU Lewis, KM
   Spazierer, D
   Slezak, P
   Baumgartner, B
   Regenbogen, J
   Gulle, H
AF Lewis, Kevin M.
   Spazierer, Daniel
   Slezak, Paul
   Baumgartner, Bernhard
   Regenbogen, Johannes
   Gulle, Heinz
TI Swelling, sealing, and hemostatic ability of a novel biomaterial: A
   polyethylene glycol-coated collagen pad
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE PEG-coated collagen pad; hemopatch; Tachosil; Evarrest; Veriset; in
   vitro swell; in vitro adherence
ID OXIDIZED REGENERATED CELLULOSE; CAUDA-EQUINA SYNDROME; POLYMERIC
   SEALANT; CONTROLLED-TRIAL; AIR LEAKAGE; SURGERY; HYDROGEL; EFFICACY;
   SAFETY; DECOMPRESSION
AB Trends in the development of hemostatic agents are towards self-adhering pads. This study investigates a novel biomaterial made of a polyethylene glycol-coated collagen pad (PCC). The swelling and adherence of PCC were investigated in vitro, and the hemostatic and sealing ability was investigated in vivo. In vitro, the maximum swell of PCC submerged in human plasma for 24h is 65%. The greatest swell was in thickness, averaging 24% to a mean thickness of 2.5 +/- 0.19mm (mean +/- SD) (N=20). PCC withstood clinically relevant pressures when applied to a collagen casing washed with bile, lymph, urine, saline, and cerebrospinal fluid mixed at 33% and 67% with blood. In vivo, PCC provided complete hemostasis when applied to severe, arterial bleeds of actively ventilated pulmonary parenchyma at 3, 5, 8, and 10min after application in a heparinized porcine pulmonary segmentectomy model. The mean rate of bleeding was 17.7 +/- 8.6ml/min. The lungs were ventilated at 15 +/- 4 breaths per min and an airway pressure of 19 +/- 2cm H2O. PCC had no incidence of hematoma and an 11% incidence of intraoperative air leak (N=36). These data are promising for future clinical application of a new versatile, self-adhering hemostatic sealing pad consisting of a polyethylene glycol-coated collagen.
C1 [Lewis, Kevin M.; Baumgartner, Bernhard] Baxter Healthcare Corp, Deerfield, IL 60015 USA.
   [Spazierer, Daniel; Regenbogen, Johannes; Gulle, Heinz] Baxter Innovat GmbH, Vienna, Austria.
   [Slezak, Paul] AUVA Res Ctr, Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria.
RP Lewis, KM (reprint author), Baxter Healthcare Corp, One Baxter Pkwy, Deerfield, IL 60015 USA.
EM kevin_lewis@baxter.com
FU Competence Headquarters Programme of the Austrian Research Promotion
   Agency (FFG) [836859]; Baxter Healthcare Corporation
FX This work was funded by the Competence Headquarters Programme of the
   Austrian Research Promotion Agency (FFG), Project Number 836859, and
   Baxter Healthcare Corporation.
CR Agger P, 2010, J TRAUMA, V68, P838, DOI 10.1097/TA.0b013e3181b1388c
   ALANDER DH, 1995, SPINE, V20, P970, DOI 10.1097/00007632-199504150-00016
   Allen MS, 2004, ANN THORAC SURG, V77, P1792, DOI 10.1016/j.athoracsur.2003.10.049
   Arat YO, 2006, OPHTHALMOLOGY, V113, P333, DOI 10.1016/j.ophtha.2005.11.003
   Banerjee T, 1998, SOUTHERN MED J, V91, P481, DOI 10.1097/00007611-199805000-00016
   Blackburn SL, 2007, J NEUROSURG, V106, P302, DOI 10.3171/ped.2007.106.4.302
   Boogaarts JD, 2005, NEUROSURGERY, V57, P146, DOI 10.1227/01.NEU.0000164384.05351.59
   Boonstra EA, 2009, HPB, V11, P306, DOI 10.1111/j.1477-2574.2009.00065.x
   Borly L, 1996, CLIN PHYSIOL, V16, P145
   Brodbelt AR, 2002, ANN ROY COLL SURG, V84, P97
   DINEEN P, 1977, SURGERY, V82, P576
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Eto K, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-1
   Filosso PL, 2013, INTERACT CARDIOV TH, V16, P661, DOI 10.1093/icvts/ivs571
   Fischer CP, 2013, J AM COLL SURGEONS, V217, P385, DOI 10.1016/j.jamcollsurg.2013.02.036
   Friedman J, 2001, Spine (Phila Pa 1976), V26, pE485, DOI 10.1097/00007632-200110150-00029
   Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1
   Glickman M, 2002, ARCH SURG-CHICAGO, V137, P326, DOI 10.1001/archsurg.137.3.326
   Hutchinson RW, 2013, CELLULOSE, V20, P537, DOI 10.1007/s10570-012-9828-8
   Institute for Laboratory Animal Research, 2011, GUIDE CARE USE LAB A
   Lewis KM, 2013, EUR SURG, V45, P213, DOI 10.1007/s10353-013-0222-z
   Lewis KM, 2014, ISRN SURG, V4, DOI [10.1155/2014/930803, DOI 10.1155/2014/930803]
   Maisano F, 2009, EUR J CARDIO-THORAC, V36, P708, DOI 10.1016/j.ejcts.2009.04.057
   Malbrain MLNG, 2006, CRIT CARE, V10, DOI 10.1186/cc4962
   Marta GM, 2010, EUR J CARDIO-THORAC, V38, P683, DOI 10.1016/j.ejcts.2010.03.061
   Menovsky T, 2011, MINIM INVAS NEUROSUR, V54, P257, DOI 10.1055/s-0031-1284394
   NAPOLEONE CP, 2007, INTERACT CARDIOV TH, V6, P21
   Neuman BJ, 2012, CLIN ORTHOP RELAT R, V470, P1640, DOI 10.1007/s11999-011-2071-z
   Ollinger R, 2013, HPB, V15, P548, DOI 10.1111/hpb.12009
   Rena Ottavio, 2009, Interact Cardiovasc Thorac Surg, V9, P973, DOI 10.1510/icvts.2009.202770
   Thavarajah D, 2010, SPINE, V35, pE25, DOI 10.1097/BRS.0b013e3181b9fc45
   Wallace DG, 2001, J BIOMED MATER RES, V58, P545, DOI 10.1002/jbm.1053
NR 32
TC 10
Z9 10
U1 2
U2 48
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD NOV
PY 2014
VL 29
IS 5
BP 780
EP 788
DI 10.1177/0885328214545500
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ5ES
UT WOS:000342829700013
PM 25085811
DA 2018-10-20
ER

PT J
AU Shinozaki, Y
   Toda, M
   Ohno, J
   Kawaguchi, M
   Kido, H
   Fukushima, T
AF Shinozaki, Yosuke
   Toda, Masako
   Ohno, Jun
   Kawaguchi, Minoru
   Kido, Hirofumi
   Fukushima, Tadao
TI Evaluation of bone formation guided by DNA/protamine complex with FGF-2
   in an adult rat calvarial defect model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE DNA; protamine; fibroblast growth factor-2; bone regeneration; elderly
ID DNA-CHITOSAN COMPLEXES; CRITICAL-SIZE; MINERALIZATION; MICROSPHERES;
   REGENERATION; EXPRESSION; PROTAMINE; BMP-2; PASTE
AB DNA/protamine complex paste (D/P) and D/P complex paste with Fibroblast Growth Factor-2 (FGF-2) (D/P-FGF) were prepared to investigate their new bone formation abilities using an similar to 40-week-old rat calvarial defect model. It was found that D/P could release FGF-2 proportionally in an in vitro experiment with an enzyme-linked immunosorbent assay. It was also found that aging adversely affected self-bone healing of rats by comparison with the results in a previous study using 10-week-old rats. Microcomputed tomography and histopathological examinations showed that new bone formation abilities of D/P and D/P-FGF were superior to that of the control (sham operation). Control, D/P and D/P-FGF showed newly formed bone areas of 6.7, 58.3, and 67.0%, respectively, 3 months after the operation. Moreover, it was found that FGF-2 could support the osteoanagenesis ability of D/P. It was considered that FGF-2 could play an important role in new bone formation at early stages because it induced the genes such as collagen I, CBFA, OSX, and OPN, which are initiated first in the process of osteogenesis. Therefore, D/P-FGF will be a useful injectable biomaterial with biodegradable properties for the repair of bone defects in the elderly. (C) 2014 Wiley Periodicals, Inc.
C1 [Shinozaki, Yosuke; Kido, Hirofumi] Fukuoka Dent Coll, Oral Implantol sect, Dept Oral Rehabil, Fukuoka, Japan.
   [Toda, Masako] Fukuoka Dent Coll, Div Pediat Dent, Dept Oral Growth & Dev, Fukuoka, Japan.
   [Ohno, Jun] Fukuoka Dent Coll, Pathol Sect, Dept Morphol Biol, Fukuoka, Japan.
   [Kawaguchi, Minoru] Fukuoka Dent Coll, Bioengn Sect, Dept Dent Engn, Fukuoka, Japan.
   [Fukushima, Tadao] Fukuoka Dent Coll, Ctr Regenerat Med, Fukuoka, Japan.
RP Shinozaki, Y (reprint author), Fukuoka Dent Coll, Oral Implantol sect, Dept Oral Rehabil, Fukuoka, Japan.
EM silver33@college.fdcnet.ac.jp
FU  [23390455]
FX Contract grant sponsor: Grant-in-aid for Scientific Research (B);
   contract grant number: 23390455
CR Bosh C, 1998, J CRANIOFAC SURG, V9, P310
   Cooper GM, 2010, PLAST RECONSTR SURG, V125, P1685, DOI 10.1097/PRS.0b013e3181cb63a3
   Cowan CM, 2007, TISSUE ENG, V13, P501, DOI 10.1089/ten.2006.0141
   Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127
   Fukushima T, 2006, J BIOMED MATER RES B, V76B, P121, DOI 10.1002/jbm.b.30334
   Fukushima T, 2008, J ORAL TISSUE ENG, V6, P24
   Fukushima T, 2011, J MATER SCI-MATER M, V22, P2607, DOI 10.1007/s10856-011-4446-9
   Fukushima T, 2010, DENT MATER J, V29, P529, DOI 10.4012/dmj.2009-131
   Fukushima T, 2009, J BIOMED MATER RES B, V91B, P746, DOI 10.1002/jbm.b.31451
   Hughes-Fulford M, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-8
   Ichinohe N, 2008, TISSUE ENG PT A, V14, P1663, DOI 10.1089/ten.tea.2006.0350
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kitamura M, 2011, J DENT RES, V90, P35, DOI 10.1177/0022034510384616
   Messora MR, 2008, J PERIODONTAL RES, V43, P723, DOI 10.1111/j.1600-0765.2008.01084.x
   Mori N, 2013, J BIOMED MATER RES B, V101B, P743, DOI 10.1002/jbm.b.32877
   Shinozaki Y, 2013, J HARD TISSUE BIOL, V22, P401
   Tanaka T, 2012, Open Biomed Eng J, V6, P98, DOI 10.2174/1874120701206010098
   Yun YR, 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/218142
   Zhou LM, 2013, GENE, V516, P228, DOI 10.1016/j.gene.2012.12.056
NR 19
TC 7
Z9 7
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2014
VL 102
IS 8
BP 1669
EP 1676
DI 10.1002/jbm.b.33143
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7PM
UT WOS:000343011400008
PM 24664968
DA 2018-10-20
ER

PT J
AU Goutam, M
   Giriyapura, C
   Mishra, SK
   Gupta, S
AF Goutam, Manish
   Giriyapura, Chandu
   Mishra, Sunil Kumar
   Gupta, Siddharth
TI Titanium Allergy: A Literature Review
SO INDIAN JOURNAL OF DERMATOLOGY
LA English
DT Review
DE Allergy; contact dermatitis; lymphocyte transformation test; memory
   lymphocyte immuno-stimulation assay; polyetheretherketone; titanium
AB Titanium has gained immense popularity and has successfully established itself as the material of choice for dental implants. In both medical and dental fields, titanium and its alloys have demonstrated success as biomedical devices. Owing to its high resistance to corrosion in a physiological environment and the excellent biocompatibility that gives it a passive, stable oxide film, titanium is considered the material of choice for intraosseous use. There are certain studies which show titanium as an allergen but the resources to diagnose titanium sensivity are very limited. Attention is needed towards the development of new and precise method for early diagnosis of titanium allergy and also to find out the alternative biomaterial which can be used in place of titanium. A review of available articles from the Medline and PubMed database was done to find literature available regarding titanium allergy, its diagnosis and new alternative material for titanium.
C1 [Goutam, Manish; Giriyapura, Chandu; Mishra, Sunil Kumar; Gupta, Siddharth] Rishiraj Coll Dent Sci & Res Ctr, Dept Prosthodont & Implantol, Bhopal, Madhya Pradesh, India.
RP Goutam, M (reprint author), Rishiraj Coll Dent Sci & Res Ctr, Dept Maxillofacial Prosthodont & Implantol, Bhopal 462036, Madhya Pradesh, India.
EM drmanishgoutam@yahoo.com
RI Mishra, Sunil/P-9559-2018
OI Mishra, Sunil/0000-0003-4844-1844; GOUTAM, MANISH/0000-0002-2887-061X
CR ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   Akagawa Yasumasa, 2003, Int J Prosthodont, V16 Suppl, P28
   Basketter DA, 2000, CONTACT DERMATITIS, V42, P310
   BASS JK, 1993, AM J ORTHOD DENTOFAC, V103, P280, DOI 10.1016/0889-5406(93)70009-D
   Bircher AJ, 2001, CONTACT DERMATITIS, V45, P244, DOI 10.1034/j.1600-0536.2001.450417.x
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Chaturvedi TP, 2013, CLIN COSMET INVESTIG, V5, P57, DOI 10.2147/CCIDE.S35170
   Chuang SK, 2005, J DENT RES, V84, P54, DOI 10.1177/154405910508400109
   Egusa H, 2008, J PROSTHET DENT, V100, P344, DOI 10.1016/S0022-3913(08)60233-4
   El Salam, 2003, RECONSTRUCTIVE AESTH
   Elias CN, 2008, JOM-US, V60, P46, DOI 10.1007/s11837-008-0031-1
   Esposito M, 1999, INT J ORAL MAX IMPL, V14, P798
   Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473
   Esposito M, 1999, J BIOMED MATER RES, V48, P559, DOI 10.1002/(SICI)1097-4636(1999)48:4<559::AID-JBM23>3.0.CO;2-M
   Forte Giovanni, 2008, Inflammation & Allergy Drug Targets, V7, P145, DOI 10.2174/187152808785748146
   Frisken KW, 2002, AUST DENT J, V47, P214, DOI 10.1111/j.1834-7819.2002.tb00331.x
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hallab NJ, 2001, J BIOMED MATER RES, V56, P427, DOI 10.1002/1097-4636(20010905)56:3<427::AID-JBM1112>3.3.CO;2-5
   Haug RH, 1996, J ORAL MAXIL SURG, V54, P611, DOI 10.1016/S0278-2391(96)90644-8
   Hensten-Pettersen A, 1992, Adv Dent Res, V6, P38
   HUNT JA, 1994, J MATER SCI-MATER M, V5, P381, DOI 10.1007/BF00058968
   Ikarashi Y, 1996, BIOMATERIALS, V17, P2103, DOI 10.1016/0142-9612(96)00038-5
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Larsen JM, 2009, J ALLERGY CLIN IMMUN, V123, P486, DOI 10.1016/j.jaci.2008.09.036
   Lhotka CG, 1998, AM J SURG, V176, P320, DOI 10.1016/S0002-9610(98)00197-4
   Lim HP, 2012, J PROSTHET DENT, V108, P209, DOI 10.1016/S0022-3913(12)60163-2
   Matthew I, 1998, J ORAL MAXIL SURG, V56, P1466, DOI 10.1016/S0278-2391(98)90439-6
   Matthew IR, 1998, J ORAL MAXIL SURG, V56, P45, DOI 10.1016/S0278-2391(98)90915-6
   MITCHELL D L, 1990, International Journal of Oral and Maxillofacial Implants, V5, P79
   Muller K, 2006, NEUROENDOCRINOL LETT, V27, P31
   Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160
   Okamura T, 1999, J DENT RES, V78, P1135
   PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1
   Pigatto PD, 2011, J DERMATOL CASE REP, V5, P89, DOI [10.3315/jdcr.2011.1084, 10.3315/89jdcr.2011.1084]
   Ricciardi L, 2009, CONTACT DERMATITIS, V60, P57, DOI 10.1111/j.1600-0536.2008.01454.x
   ROITT IM, 2001, ESSENTIAL IMMUNOLOGY
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Schramm M, 2000, BIOCERAMICS HIP JOIN, p[101, 106]
   Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x
   Smith D, 1996, INT J ORAL MAXILLOF, V12, P828
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Tamai  K, 2001, Breast Cancer, V8, P90, DOI 10.1007/BF02967485
   Thomas P., 2000, BIOCERAMICS HIP JOIN, P117
   Thomas P, 2006, CONTACT DERMATITIS, V55, P199, DOI 10.1111/j.1600-0536.2006.00931.x
   TORGERSEN S, 1995, ACTA ODONTOL SCAND, V53, P65, DOI 10.3109/00016359509005948
   UNGERSBOECK A, 1995, J MATER SCI-MATER M, V6, P223, DOI 10.1007/BF00146860
   Valentine-Thon E, 2003, NEUROENDOCRINOL LETT, V24, P57
   Wood MR, 2004, J PROSTHET DENT, V92, P447, DOI 10.1016/j.prosdent.2004.08.003
   Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x
NR 49
TC 15
Z9 16
U1 1
U2 12
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0019-5154
EI 1998-3611
J9 INDIAN J DERMATOL
JI Indian J. Dermatol.
PD NOV-DEC
PY 2014
VL 59
IS 6
DI 10.4103/0019-5154.143526
PG 5
WC Dermatology
SC Dermatology
GA V44XT
UT WOS:000209782400031
PM 25484409
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Zhang, XB
   Ba, ZX
   Wang, Q
   Wu, YJ
   Wang, ZZ
   Wang, Q
AF Zhang, Xiaobo
   Ba, Zhixin
   Wang, Qian
   Wu, Yujuan
   Wang, Zhangzhong
   Wang, Qiang
TI Uniform corrosion behavior of GZ51K alloy with long period stacking
   ordered structure for biomedical application
SO CORROSION SCIENCE
LA English
DT Article
DE Magnesium; Weight loss; Polarization
ID ZN-ZR ALLOYS; MECHANICAL-PROPERTIES; MAGNESIUM ALLOYS; RARE-EARTH;
   IN-VITRO; Y ALLOYS; MG; GD; RESISTANCE; MICROSTRUCTURE
AB Mg-5Gd-1Zn-0.6Zr (wt.%, GZ51K) alloy was prepared by gravity casting in order to develop a novel, biodegradable magnesium alloy. The microstructure and corrosion behavior of the alloy exposed to simulated body fluid (SBF) were investigated under as-cast, solution and aging-treated conditions. The microstructure of the as-cast alloy consists of alpha-Mg, lamellar phase with long period stacking ordered (LPSO) structure, and eutectic phase. The LPSO phase disappears after solution treatment at 535 degrees C for 12 h, and the microstructure of the alloy after solution and aging treatment is composed of alpha-Mg and needle-like precipitates. The as-cast GZ51K alloy with LPSO structure exhibits slower corrosion rates and more uniform corrosion morphology as compared to the alloy without LPSO structure, and is thus desirable for use as a degradable biomaterial. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xiaobo; Ba, Zhixin; Wang, Qian; Wang, Zhangzhong] Nanjing Inst Technol, Sch Mat Sci & Engn, Nanjing 211167, Jiangsu, Peoples R China.
   [Zhang, Xiaobo; Ba, Zhixin; Wang, Qian; Wang, Zhangzhong] Jiangsu Key Lab Adv Struct Mat & Applicat Technol, Nanjing 211167, Jiangsu, Peoples R China.
   [Wu, Yujuan] Shanghai Jiao Tong Univ, Natl Engn Res Ctr Light Alloy Net Forming, Shanghai 200240, Peoples R China.
   [Wang, Qiang] Jiangsu Konsung Equipment Co Ltd, Danyang 212300, Peoples R China.
RP Zhang, XB (reprint author), Nanjing Inst Technol, Sch Mat Sci & Engn, Nanjing 211167, Jiangsu, Peoples R China.
EM xbxbzhang2003@163.com; wuyj@sjtu.edu.cn
FU National Natural Science Foundation of China [51301089, 51304135];
   Natural Science Foundation of Jiangsu Province [BK20130745]; Natural
   Science Foundation of the Higher Education Institutions of Jiangsu
   Province [13KJB430014]; Innovative Foundation Project for Students of
   Jiangsu Province [201411276005Z]; Qing Lan Project
FX The work was supported by National Natural Science Foundation of China
   (Nos. 51301089, 51304135), Natural Science Foundation of Jiangsu
   Province (BK20130745), Natural Science Foundation of the Higher
   Education Institutions of Jiangsu Province (13KJB430014), Innovative
   Foundation Project for Students of Jiangsu Province (201411276005Z), and
   Qing Lan Project.
CR Ding WJ, 2009, J MATER RES, V24, P1842, DOI 10.1557/JMR.2009.0215
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Grillo CA, 2014, COLLOID SURFACE B, V117, P312, DOI 10.1016/j.colsurfb.2014.02.030
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Izumi S, 2009, CORROS SCI, V51, P395, DOI 10.1016/j.corsci.2008.11.003
   Jeong YS, 2014, CORROS SCI, V82, P392, DOI 10.1016/j.corsci.2014.01.041
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kuasek J., 2013, T NONFERR METAL SOC, V23, P1215
   Leng Z, 2013, J MECH BEHAV BIOMED, V28, P332, DOI 10.1016/j.jmbbm.2013.08.012
   Liu K, 2010, MATER DESIGN, V31, P210, DOI 10.1016/j.matdes.2009.06.030
   Nie JF, 2005, SCRIPTA MATER, V53, P1049, DOI 10.1016/j.scriptamat.2005.07.004
   Peng QM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03620
   Wang JF, 2012, MATER LETT, V81, P112, DOI 10.1016/j.matlet.2012.04.130
   Yamasaki M, 2011, APPL SURF SCI, V257, P8258, DOI 10.1016/j.apsusc.2011.01.046
   Zeng XQ, 2010, ACTA METALL SIN, V46, P1041, DOI 10.3724/SP.J.1037.2009.00833
   Zhang JS, 2012, J MATER SCI TECHNOL, V28, P1157, DOI 10.1016/S1005-0302(12)60186-8
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang XB, 2013, MATER LETT, V100, P188, DOI 10.1016/j.matlet.2013.03.061
   Zhang XB, 2012, MATER SCI ENG B-ADV, V177, P1113, DOI 10.1016/j.mseb.2012.05.020
   Zhang XB, 2012, MATER LETT, V86, P42, DOI 10.1016/j.matlet.2012.07.030
   Zhao X, 2013, J MATER SCI TECHNOL, V29, P781, DOI 10.1016/j.jmst.2013.05.017
   Zhao X, 2013, MAT SCI ENG C-MATER, V33, P3627, DOI 10.1016/j.msec.2013.04.051
   Zhen R, 2012, ACTA METALL SIN, V48, P733, DOI 10.3724/SP.J.1037.2012,00156
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 26
TC 43
Z9 50
U1 2
U2 66
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-938X
EI 1879-0496
J9 CORROS SCI
JI Corrosion Sci.
PD NOV
PY 2014
VL 88
BP 1
EP 5
DI 10.1016/j.corsci.2014.07.004
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AQ1GP
UT WOS:000342530200001
DA 2018-10-20
ER

PT J
AU Shirazi, HA
   Ayatollahi, MR
AF Shirazi, H. Asgharzadeh
   Ayatollahi, M. R.
TI Biomechanical analysis of functionally graded biomaterial disc in terms
   of motion and stress distribution in lumbar spine
SO INTERNATIONAL JOURNAL OF ENGINEERING SCIENCE
LA English
DT Article
DE Functionally graded biomaterials; Artificial disc; Motion range; Stress
   distribution
ID FINITE-ELEMENT-ANALYSIS; INTERVERTEBRAL DISC; INTRADISCAL PRESSURE;
   MECHANICAL-BEHAVIOR; INTERBODY FUSION; LOAD-BEARING; FOLLOW-UP;
   DEGENERATION; SEGMENT; COMPRESSION
AB In recent decades, the development of new biomaterials for medical applications has been one of the challenging tasks for biomaterial scientists. Functionally graded biomaterials (FGBM) have been receiving an increasing attention due to their unique advantage, being able to satisfy the requirements of both mechanical and biocompatibility properties simultaneously. This paper evaluates the motion range and stress distribution of FGBM and non-FGBM artificial discs in response to different loading conditions i.e. compression, bending moment and torsion. In order to ensure the accuracy of analytical solution, the numerical solution was performed using finite element method and good agreement was found between the analytical and finite element results. In addition, the experimental data reported in the previous literature were used to predict the optimal model of artificial FGBM disc using the proposed analytical solution. The results of this study suggest that FGBM parameters can play an important role in achieving the goal of mechanical function optimization. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Shirazi, H. Asgharzadeh; Ayatollahi, M. R.] Iran Univ Sci & Technol, Sch Mech Engn, Ctr Excellence Expt Solid Mech & Dynam, Fatigue & Fracture Res Lab, Tehran 1684613114, Iran.
RP Shirazi, HA (reprint author), Iran Univ Sci & Technol, Sch Mech Engn, Ctr Excellence Expt Solid Mech & Dynam, Fatigue & Fracture Res Lab, Tehran 1684613114, Iran.
EM Hadi_shirazi@mecheng.iust.ac.ir
RI Ayatollahi, Majid R./T-2433-2017
OI Ayatollahi, Majid R./0000-0001-9840-6225
CR Adams M.A., 2007, BIOMECHANICS BACK PA
   Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005
   Adams MA, 1996, J BONE JOINT SURG BR, V78B, P965, DOI 10.1302/0301-620X78B6.1287
   Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028
   Bastian L, 2001, EUR SPINE J, V10, P295, DOI 10.1007/s005860100278
   BERKSON MH, 1979, J BIOMECH ENG-T ASME, V101, P53, DOI 10.1115/1.3426225
   Birman V, 2014, INT J ENG SCI, V78, P18, DOI 10.1016/j.ijengsci.2014.01.002
   Bono CM, 2004, SPINE, V29, P455, DOI 10.1097/01.BRS.0000090825.94611.28
   Boughton P, 2008, 25 ANN C COMP ADV CE, V22, P593
   Chen C.-S., 2001, MED ENG PHYS, V23, P485, DOI DOI 10.1016/S1350-4533(01)00076-5
   Chen SH, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-88
   Chen SH, 2009, MED ENG PHYS, V31, P244, DOI 10.1016/j.medengphy.2008.07.007
   Cheung HH, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/4/045001
   Edwards WT, 2001, SPINE, V26, P1753
   Eijkelkamp M., 2001, INT J ARTIF ORGANS, V24, P75
   Eraslan AN, 2006, ACTA MECH, V181, P43, DOI 10.1007/s00707-005-0276-5
   Ferguson SJ, 2004, J BIOMECH, V37, P213, DOI 10.1016/S0021-9290(03)00250-1
   Galbusera F, 2008, EUR SPINE J, V17, P1635, DOI 10.1007/s00586-008-0811-x
   Gay RE, 2008, SPINE J, V8, P982, DOI 10.1016/j.spinee.2007.07.398
   GREEN TP, 1994, SPINE, V19, P2683, DOI 10.1097/00007632-199412010-00016
   Huang Russel C, 2006, Spine J, V6, P242, DOI 10.1016/j.spinee.2005.04.013
   Hussain M, 2010, J MANIP PHYSIOL THER, V33, P252, DOI 10.1016/j.jmpt.2010.03.009
   Kumar MN, 2001, EUR SPINE J, V10, P309, DOI 10.1007/s005860000207
   Kuslich SD, 2000, SPINE, V25, P2656, DOI 10.1097/00007632-200010150-00018
   Lee KK, 2004, IEEE T BIO-MED ENG, V51, P393, DOI 10.1109/TBME.2003.820994
   Lei J, 2013, INT J ENG SCI, V72, P36, DOI 10.1016/j.ijengsci.2013.06.012
   Mahato NK, 2011, J NEUROSURG-SPINE, V15, P371, DOI 10.3171/2011.6.SPINE11113
   Martinez JB, 1997, MED ENG PHYS, V19, P145, DOI 10.1016/S1350-4533(96)00056-2
   McMillan DW, 1996, ANN RHEUM DIS, V55, P880, DOI 10.1136/ard.55.12.880
   MCNALLY DS, 1992, SPINE, V17, P66, DOI 10.1097/00007632-199201000-00011
   Ozturk A, 2011, INT J ENG SCI, V49, P1047, DOI 10.1016/j.ijengsci.2011.06.001
   Polikeit A, 2003, EUR SPINE J, V12, P413, DOI 10.1007/s00586-002-0505-8
   Pollintine P, 2004, J BIOMECH, V37, P197, DOI 10.1016/S0021-9290(03)00308-7
   Rahm MD, 1996, J SPINAL DISORD, V9, P392
   Ranu H S, 1990, Proc Inst Mech Eng H, V204, P141, DOI 10.1243/PIME_PROC_1990_204_248_02
   Rohlmann A, 2006, J BIOMECH, V39, P2484, DOI 10.1016/j.jbiomech.2005.07.026
   Schmidt H, 2013, J MECH BEHAV BIOMED, V17, P229, DOI 10.1016/j.jmbbm.2012.09.010
   Shahmohammadi M., 2014, TISSUE CELL
   SHIRAZIADL A, 1986, J BIOMECH, V19, P331, DOI 10.1016/0021-9290(86)90009-6
   SHIRAZIADL A, 1986, SPINE, V11, P914, DOI 10.1097/00007632-198611000-00012
   SHIRAZIADL SA, 1984, SPINE, V9, P120, DOI 10.1097/00007632-198403000-00003
   Simsek M, 2013, INT J ENG SCI, V64, P37, DOI 10.1016/j.ijengsci.2012.12.002
   Steffen T, 1998, CLIN BIOMECH, V13, P495, DOI 10.1016/S0268-0033(98)00039-4
   Tanaka N, 2001, Spine J, V1, P47, DOI 10.1016/S1529-9430(01)00006-7
   Wang WH, 2013, MED ENG PHYS, V35, P357, DOI 10.1016/j.medengphy.2012.05.013
   WHITE AA, 1990, CLIN BIOMECHANICS SP
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   Wilke HJ, 1996, J ORTHOPAED RES, V14, P500, DOI 10.1002/jor.1100140321
   Wilke HJ, 1996, J BIOMECH, V29, P549, DOI 10.1016/0021-9290(95)00037-2
   Yao J, 2006, BIOMATERIALS, V27, P377, DOI 10.1016/j.biomaterials.2005.06.036
   Zhang QH, 2008, MED ENG PHYS, V30, P1246, DOI 10.1016/j.medengphy.2008.07.012
NR 51
TC 17
Z9 17
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7225
EI 1879-2197
J9 INT J ENG SCI
JI Int. J. Eng. Sci.
PD NOV
PY 2014
VL 84
BP 62
EP 78
DI 10.1016/j.ijengsci.2014.06.008
PG 17
WC Engineering, Multidisciplinary
SC Engineering
GA AP7JA
UT WOS:000342252400006
DA 2018-10-20
ER

PT J
AU Ahmed, M
   Hamilton, G
   Seifalian, AM
AF Ahmed, Maqsood
   Hamilton, George
   Seifalian, Alexander M.
TI The performance of a small-calibre graft for vascular reconstructions in
   a senescent sheep model
SO BIOMATERIALS
LA English
DT Article
DE In vivo test; Biocompatibility; Vascular graft; Polyurethane;
   Nanocomposite
ID PROOF-OF-CONCEPT; IN-VITRO; SILSESQUIOXANE NANOCOMPOSITES;
   MECHANICAL-PROPERTIES; TRANSPLANTATION; FAILURE; CELLS
AB There is an acute clinical need for small-calibre (<6 mm) vascular grafts for surgery. The aim of this study was to evaluate the long-term performance of a small-calibre graft produced from a nanocomposite biomaterial, polyhedral oligomeric silsesquioxane poly(carbonate-urea)urethane (POSS-PCU), in a large animal model following Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP) protocols. Grafts were characterised and implanted into the left carotid artery (LCA) of senescent sheep (n = 11) for a period of 9 months. In vivo compliance and blood flow rates were measured using ultrasound wall tracking software and a Transonic flow meter. Graft patency and degree of intimal hyperplasia (IH) were examined at the study end point. Seven of the POSS-PCU grafts were free from thrombosis, IH, calcification and aneurysmal dilation, with 4 occluding within 14 days. All of the ePTFE controls (n = 4) were found to be occluded by day 32. The lumen of the patent POSS-PCU grafts was free from any cellular deposits, whilst perigraft tissue could be seen to be infiltrating into the body of the graft from the adventitia. No significant differences were detected between the blood flow rates (p = 0.3693) and compliance (p = 0.9706) of the POSS-PCU grafts and the native artery, either post-operatively or after 9 months implantation. Small-calibre vascular grafts produced from POSS-PCU offer a viable option for the clinical use in revascularisation procedures with a patency rate of 64%. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ahmed, Maqsood; Seifalian, Alexander M.] UCL, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
   [Ahmed, Maqsood] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London WC1E 6BT, England.
   [Hamilton, George; Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
EM A.Seifalian@UCL.AC.UK
FU Wellcome Trust; Engineering and Physical Sciences Research Council
   (EPSRC)
FX The authors would like to acknowledge the financial support provided by
   the Translational grant of the Wellcome Trust "Pre-clinical assessment
   of small diameter conduit made from nano-composite polymer for coronary
   artery bypass graft application" and the Engineering and Physical
   Sciences Research Council (EPSRC).
CR Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Ali M L, 1996, Cardiovasc Surg, V4, P543, DOI 10.1016/0967-2109(95)00142-5
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   Butcher JT, 2006, BIOMATERIALS, V27, P5252, DOI 10.1016/j.biomaterials.2006.05.040
   Desai M, 2011, ANN VASC SURG, V25, P530, DOI 10.1016/j.avsg.2010.12.012
   He HB, 2002, TISSUE ENG, V8, P213, DOI 10.1089/107632702753724987
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hoerstrup SP, 2006, CIRCULATION S1, V114, P1159
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kannan RY, 2007, PLAST RECONSTR SURG, V119, P1653, DOI 10.1097/01.prs.0000246404.53831.4c
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kohler TR, 1999, J VASC SURG, V30, P744, DOI 10.1016/S0741-5214(99)70114-X
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Miyamoto S, 2000, AM J CARDIOL, V85, P494, DOI 10.1016/S0002-9149(99)00779-1
   Olausson M, 2012, LANCET, V380, P230, DOI 10.1016/S0140-6736(12)60633-3
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Rosengren A, 2003, J BIOMED MATER RES A, V67A, P918, DOI 10.1002/jbm.a.10509
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   Tai NR, 2000, BRIT J SURG, V87, P1516, DOI 10.1046/j.1365-2168.2000.01566.x
   van Det RJ, 2009, EUR J VASC ENDOVASC, V37, P457, DOI 10.1016/j.ejvs.2008.11.041
   Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001
   ZILLA P, 1994, SURGERY, V116, P524
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 29
TC 22
Z9 25
U1 3
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2014
VL 35
IS 33
BP 9033
EP 9040
DI 10.1016/j.biomaterials.2014.07.008
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO9KK
UT WOS:000341674400002
PM 25106769
DA 2018-10-20
ER

PT J
AU Li, H
   Koenig, AM
   Sloan, P
   Leipzig, ND
AF Li, Hang
   Koenig, Andrew M.
   Sloan, Patricia
   Leipzig, Nic D.
TI In vivo assessment of guided neural stem cell differentiation in growth
   factor immobilized chitosan-based hydrogel scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Neural stem cells; Hydrogel scaffold; Neurons; Differentiation;
   Neurulation; Protein immobilization
ID CENTRAL-NERVOUS-SYSTEM; EXTRACELLULAR-MATRIX; FUNCTIONAL IMMOBILIZATION;
   FIBROUS CAPSULE; TISSUE; BIOCOMPATIBILITY; DELIVERY; BIOMATERIALS;
   IMPLANTATION; RAT
AB In this study, we demonstrate that a unique growth factor-biomaterial system can offer spatial control of growth factors with sustained signaling to guide the specific lineage commitment of neural stem/progenitor cells (NSPCs) in vivo. First, recombinant fusion proteins incorporating an N-terminal biotin tag and interferon-gamma (IFN-gamma), platelet derived growth factor-AA (PDGF-AA), or bone morphogenic protein-2 (BMP-2) were immobilized to a methacrylamide chitosan (MAC) based biopolymer via a streptavidin linker to specify NSPC differentiation into neurons, oligodendrocytes, or astrocytes, respectively. MAC was mixed with growth factors (immobilized or adsorbed), acrylated laminin, NSPCs, and crosslinked within chitosan conduits. This system mimics regenerative aspects of the central nervous system ECM, which is largely composed of a crosslinked polysaccharide matrix with cell-adhesive regions, and adds the new functionality of protein sequestration. We demonstrated that these growth factors are maintained at functionally significant levels for 28 d in vitro. In the main study, immobilized treatments were compared to absorbed and control treatments after 28 d in vivo (rat subcutaneous). Masson's Trichrome staining revealed that small collagen capsules formed around the chitosan conduits with an average acceptable thickness of 153.07 +/- 6.02 mu m for all groups. ED-1 staining showed mild macrophage clustering around the outside of chitosan conduits in all treatments with no macrophage invasion into hydrogel portions. Importantly, NSPC differentiation staining demonstrated that immobilized growth factors induced the majority of cells to differentiate into the desired cell types as compared with adsorbed growth factor treatments and controls by day 28. Interestingly, immobilized IFN-gamma resulted in neural rosette-like arrangements and even structures resembling neural tubes, suggesting this treatment can lead to guided dedifferentiation and subsequent neurulation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Li, Hang; Koenig, Andrew M.; Leipzig, Nic D.] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Sloan, Patricia] Akron Gen Med Ctr, Akron, OH USA.
RP Leipzig, ND (reprint author), 200 East Buchtel Common,Whitby Hall, Akron, OH 44325 USA.
EM nic.leipzig@uakron.edu
FU University of Akron; Robert Iredell Endowment; Conquer Chiari
FX We are grateful for funding from the University of Akron including the
   Robert Iredell Endowment as well as partial funding from Conquer Chiari
   that supported this work. The authors would like to thank Dr. Asanka
   Wijekoon and Elizabeth J. Endrizzi for help with protein synthesis, and
   Dr. William Landis for use of paraffin embedding and sectioning
   equipment.
CR Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   ANDERSON JM, 1981, J BIOMED MATER RES, V15, P889, DOI 10.1002/jbm.820150613
   ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   AUTIAN J, 1975, Environmental Health Perspectives, V11, P141, DOI 10.2307/3428337
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/ERI.11.59, 10.1586/eri.11.59]
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720
   Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208
   Felt O, 1998, DRUG DEV IND PHARM, V24, P979, DOI 10.3109/03639049809089942
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Fulzele SV, 2003, EUR J PHARM SCI, V20, P53, DOI 10.1016/S0928-0987(03)00168-4
   Gao WJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00321
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   IMAI Y, 1982, J BIOMED MATER RES, V16, P609, DOI 10.1002/jbm.820160508
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   JEYANTHI R, 1990, BIOMATERIALS, V11, P238, DOI 10.1016/0142-9612(90)90004-A
   Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leipzig ND, 2010, J BIOMED MATER RES A, V93A, P625, DOI 10.1002/jbm.a.32573
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li DJ, 1999, J BIOMED MATER RES, V45, P322, DOI 10.1002/(SICI)1097-4636(19990615)45:4<322::AID-JBM6>3.3.CO;2-U
   Li H., 2013, ANN BIOMED ENG, V42, P1456
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   MainilVarlet P, 1996, J MATER SCI-MATER M, V7, P713, DOI 10.1007/BF00121406
   McCormick AM, 2014, JOVE-J VIS EXP, DOI 10.3791/51295
   McCormick AM, 2013, BIOCONJUGATE CHEM, V24, P1515, DOI 10.1021/bc400058n
   Meredith RF, 2006, INT J RADIAT ONCOL, V66, pS57, DOI 10.1016/j.ijrobp.2006.04.058
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Park JH, 2003, J BIOMED MATER RES A, V64A, P309
   Pevny LH, 1998, DEVELOPMENT, V125, P1967
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020
   Rauch U, 2007, BIOCHEM SOC T, V35, P656, DOI 10.1042/BST0350656
   Sathananthan AH, 2011, MICROSC MICROANAL, V17, P520, DOI 10.1017/S1431927611000584
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722
   Wilkinson AE, 2014, J BIOMED A IN PRESS
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/NMAT3101, 10.1038/nmat3101]
   Zimmermann DR, 2008, HISTOCHEM CELL BIOL, V130, P635, DOI 10.1007/s00418-008-0485-9
NR 68
TC 39
Z9 41
U1 2
U2 193
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2014
VL 35
IS 33
BP 9049
EP 9057
DI 10.1016/j.biomaterials.2014.07.038
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO9KK
UT WOS:000341674400004
PM 25112933
DA 2018-10-20
ER

PT J
AU Qazi, TH
   Rai, R
   Boccaccini, AR
AF Qazi, Taimoor H.
   Rai, Ranjana
   Boccaccini, Aldo R.
TI Tissue engineering of electrically responsive tissues using polyaniline
   based polymers: A review
SO BIOMATERIALS
LA English
DT Review
DE Polyaniline; Polyaniline oligomers; Conducting polymers; Tissue
   engineering; Electrical stimulation
ID CONDUCTING POLYMERS; CARDIAC TISSUE; IN-VIVO; POTENTIAL APPLICATION;
   CELL-PROLIFERATION; ANILINE PENTAMER; MYOBLAST DIFFERENTIATION;
   BIOMEDICAL APPLICATIONS; NANOFIBROUS SCAFFOLDS; FACILE SYNTHESIS
AB Conducting polymers have found numerous applications as biomaterial components serving to effectively deliver electrical signals from an external source to the seeded cells. Several cell types including cardiomyocytes, neurons, and osteoblasts respond to electrical signals by improving their functional outcomes. Although a wide variety of conducting polymers are available, polyaniline (PANI) has emerged as a popular choice due to its attractive properties such as ease of synthesis, tunable conductivity, environmental stability, and biocompatibility. PANI in its pure form has exhibited biocompatibility both in vitro and in vivo, and has been combined with a host of biodegradable polymers to form composites having a range of mechanical, electrical, and surface properties. Moreover, recent studies in literature report on the functionalization of polyaniline oligomers with end segments that make it biodegradable and improve its biocompatibility, two properties which make these materials highly desirable for applications in tissue engineering. This review will discuss the features and properties of PANI based composites that make them effective biomaterials, and it provides a comprehensive summary of studies where the use of PANI as a biomaterial component has enhanced cellular function and behavior. We also discuss recent studies utilizing functionalized PANI oligomers, and conclude that electroactive PANI and its derivatives show great promise in eliciting favorable responses from various cell lines that respond to electrical stimuli, and are therefore effective biomaterials for the engineering of electrically responsive biological tissues and organs. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Qazi, Taimoor H.; Rai, Ranjana; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, Cauerstr 6, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013; Qazi, Taimoor Hasan/I-7675-2015
OI Qazi, Taimoor Hasan/0000-0002-3132-9170
CR Anand J, 1998, PROG POLYM SCI, V23, P993, DOI 10.1016/S0079-6700(97)00040-3
   ANGELOPOULOS M, 1988, MOL CRYST LIQ CRYST, V160, P151, DOI 10.1080/15421408808083010
   Azhar FF, 2014, DES MONOMERS POLYM, V17, P654, DOI 10.1080/15685551.2014.907621
   BASSETT CA, 1964, NATURE, V204, P652, DOI 10.1038/204652a0
   Ben-Valid S, 2010, J MATER CHEM, V20, P2408, DOI 10.1039/b921828a
   Bendrea AD, 2011, J BIOMATER APPL, V26, P3, DOI 10.1177/0885328211402704
   Bhadra S, 2009, PROG POLYM SCI, V34, P783, DOI 10.1016/j.progpolymsci.2009.04.003
   Bhang SH, 2012, MACROMOL BIOSCI, V12, P402, DOI 10.1002/mabi.201100333
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   BOARA G, 1995, SYNTHETIC MET, V72, P135, DOI 10.1016/0379-6779(94)02337-X
   Boomi P, 2013, COLLOID SURFACE A, V429, P51, DOI 10.1016/j.colsurfa.2013.03.053
   Borriello A, 2011, J MATER SCI-MATER M, V22, P1053, DOI 10.1007/s10856-011-4259-x
   BROWN MJ, 1994, J CELL BIOL, V127, P117, DOI 10.1083/jcb.127.1.117
   BUS JS, 1987, FOOD CHEM TOXICOL, V25, P619, DOI 10.1016/0278-6915(87)90024-X
   CAO Y, 1992, SYNTHETIC MET, V48, P91, DOI 10.1016/0379-6779(92)90053-L
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   CHIANG CK, 1977, PHYS REV LETT, V39, P1098, DOI 10.1103/PhysRevLett.39.1098
   CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6
   Chiou NR, 2005, ADV MATER, V17, P1679, DOI 10.1002/adma.200401000
   Chiu HT, 2007, POLYM-PLAST TECHNOL, V46, P1121, DOI 10.1080/03602550600916209
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Cui HT, 2012, BIOMACROMOLECULES, V13, P2881, DOI 10.1021/bm300897j
   Cullen DK, 2008, J NEURAL ENG, V5, P374, DOI 10.1088/1741-2560/5/4/002
   Di L, 2011, ACTA BIOMATER, V7, P3738, DOI 10.1016/j.actbio.2011.06.009
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Donnelly K, 2010, TISSUE ENG PART C-ME, V16, P711, DOI [10.1089/ten.tec.2009.0125, 10.1089/ten.TEC.2009.0125]
   Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/nnano.2011.160, 10.1038/NNANO.2011.160]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandes EGR, 2010, J MACROMOL SCI A, V47, P1203, DOI 10.1080/10601325.2010.518847
   FOCKE WW, 1987, J PHYS CHEM-US, V91, P5813, DOI 10.1021/j100306a059
   FREEMAN JA, 1985, J NEUROSCI RES, V13, P257, DOI 10.1002/jnr.490130118
   Fryczkowski R, 2009, SYNTHETIC MET, V159, P2266, DOI 10.1016/j.synthmet.2009.09.008
   Gaponik NP, 1999, PHYS CHEM CHEM PHYS, V1, P1787, DOI 10.1039/a808619b
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V10, P10
   Ghasemi-Mobarakeh L, 2009, TISSUE ENG PT A, V15, P3605, DOI 10.1089/ten.TEA.2008.0689
   Gizdavic-Nikolaidis M, 2011, J POLYM SCI POL CHEM, V49, P4902, DOI 10.1002/pola.24946
   Gizdavic-Nikolaidis M, 2010, MACROMOL BIOSCI, V10, P1424, DOI 10.1002/mabi.201000237
   Gizdavic-Nikolaidis MR, 2011, ACTA BIOMATER, V7, P4204, DOI 10.1016/j.actbio.2011.07.018
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Guo BL, 2012, ACTA BIOMATER, V8, P144, DOI 10.1016/j.actbio.2011.09.027
   Guo BL, 2011, MACROMOLECULES, V44, P5227, DOI 10.1021/ma2009595
   Guo B, 2011, BIOMACROMOLECULES, V12, P2601, DOI 10.1021/bm200389t
   Guo Y, 2007, BIOMACROMOLECULES, V8, P3025, DOI 10.1021/bm070266z
   HajjHassan M, 2008, SENSORS-BASEL, V8, P6704, DOI 10.3390/s8106704
   HAND RL, 1974, J AM CHEM SOC, V96, P850, DOI 10.1021/ja00810a034
   HARRISON JH, 1986, J PHARMACOL EXP THER, V238, P1045
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Hu J, 2008, BIOMACROMOLECULES, V9, P2637, DOI 10.1021/bm800705t
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Huang LH, 2007, BIOMATERIALS, V28, P1741, DOI 10.1016/j.biomaterials.2006.12.007
   HUANG WS, 1986, J CHEM SOC FARAD T 1, V82, P2385, DOI 10.1039/f19868202385
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Humpolicek P, 2012, CHEM LISTY, V106, P380
   Humpolicek P, 2012, SYNTHETIC MET, V162, P722, DOI 10.1016/j.synthmet.2012.02.024
   Ibarra LE, 2013, LASER PHYS, V23
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   Kamalesh S, 2000, J BIOMED MATER RES, V52, P467, DOI 10.1002/1097-4636(20001205)52:3<467::AID-JBM4>3.3.CO;2-Y
   Keith A, 1907, J ANAT PHYSIOL, V41, P172
   Kim HS, 2009, SYNTHETIC MET, V159, P1313, DOI 10.1016/j.synthmet.2009.02.036
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333
   Konwarh R, 2012, J MATER CHEM, V22, P15062, DOI 10.1039/c2jm32530f
   Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018
   Kucekova Z, 2013, CHEM PAP, V67, P1103, DOI 10.2478/s11696-013-0385-x
   Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leaper David J, 2006, Int Wound J, V3, P282, DOI 10.1111/j.1742-481X.2006.00265.x
   Li DF, 2008, APPL SURF SCI, V255, P581, DOI 10.1016/j.apsusc.2008.06.150
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Li LC, 2014, POLYM CHEM-UK, V5, P2880, DOI 10.1039/c3py01634j
   Li MY, 2007, CHINESE J POLYM SCI, V25, P331, DOI 10.1142/S0256767907002199
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li XF, 2002, J VASC RES, V39, P391, DOI 10.1159/000064517
   Li ZF, 2004, J COLLOID INTERF SCI, V269, P62, DOI 10.1016/S0021-9797(03)00606-4
   Liu S, 2010, APPL SURF SCI, V256, P3427, DOI 10.1016/j.apsusc.2009.12.046
   Liu YD, 2013, MACROMOL BIOSCI, V13, P356, DOI 10.1002/mabi.201200345
   Liu YD, 2012, MACROMOL BIOSCI, V12, P241, DOI 10.1002/mabi.201100227
   Liu YD, 2011, MACROMOL BIOSCI, V11, P806, DOI 10.1002/mabi.201000465
   Liu ZR, 2006, SYNTHETIC MET, V156, P721, DOI 10.1016/j.synthmet.2006.04.001
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Luo YL, 2010, J BIOMAT SCI-POLYM E, V21, P1143, DOI 10.1163/092050609X12459333183584
   MACDIARMID AG, 1989, FARADAY DISCUSS, V88, P317, DOI 10.1039/dc9898800317
   MacDiarmid AG, 2001, ANGEW CHEM INT EDIT, V40, P2581, DOI 10.1002/1521-3773(20010716)40:14<2581::AID-ANIE2581>3.0.CO;2-2
   Mattioli-Belmonte M, 2003, INT J ARTIF ORGANS, V26, P1077
   McBain VA, 2003, INVEST OPHTH VIS SCI, V44, P540, DOI 10.1167/iovs.02-0570
   McKeon KD, 2010, J APPL POLYM SCI, V115, P1566, DOI 10.1002/app.31296
   MCLEOD KJ, 1992, J BONE JOINT SURG AM, V74A, P920, DOI 10.2106/00004623-199274060-00014
   Meng SY, 2011, J BONE MINER METAB, V29, P535, DOI 10.1007/s00774-010-0257-1
   MONKMAN AP, 1991, SYNTHETIC MET, V40, P87, DOI 10.1016/0379-6779(91)91491-R
   Moura RM, 2011, ARTIF ORGANS, V35, P471, DOI 10.1111/j.1525-1594.2011.01257.x
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Nand AV, 2013, J FOOD ENG, V116, P422, DOI 10.1016/j.jfoodeng.2012.11.023
   Oren R, 2004, J BIOMAT SCI-POLYM E, V15, P1355, DOI 10.1163/1568562042368077
   OZAWA H, 1989, J CELL PHYSIOL, V138, P477, DOI 10.1002/jcp.1041380306
   Park H, 2008, J TISSUE ENG REGEN M, V2, P279, DOI 10.1002/term.93
   PATEL N, 1982, J NEUROSCI, V2, P483
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, P18
   Peng H, 2009, BIOMATERIALS, V30, P2132, DOI 10.1016/j.biomaterials.2008.12.065
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Potse M, 2009, MED BIOL ENG COMPUT, V47, P719, DOI 10.1007/s11517-009-0472-x
   Prabhakaran MP, 2011, J BIOSCI BIOENG, V112, P501, DOI 10.1016/j.jbiosc.2011.07.010
   Pullar CE, 2001, CELL MOTIL CYTOSKEL, V50, P207, DOI 10.1002/cm.10009
   Qazi TH, 2014, ACTA BIOMATER, V10, P2434, DOI 10.1016/j.actbio.2014.02.023
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rahman NA, 2013, MATER CHEM PHYS, V138, P333, DOI 10.1016/j.matchemphys.2012.11.065
   Rahman NA, 2010, SYNTHETIC MET, V160, P2015, DOI 10.1016/j.synthmet.2010.07.031
   Ramanaviciene A, 2007, J PHARM PHARMACOL, V59, P311, DOI 10.1211/jpp.59.2.0017
   Ravichandran R, 2010, J R SOC INTERFACE, V6, P7
   Riaz U, 2012, INT J POLYM MATER PO, V62, P406
   RODRIGUES MA, 1991, ELECTROCHIM ACTA, V36, P2143, DOI 10.1016/0013-4686(91)85222-S
   Roth BJ, 1997, IEEE T BIO-MED ENG, V44, P326, DOI 10.1109/10.563303
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   SANDOW A, 1952, YALE J BIOL MED, V25, P176
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shadi L, 2013, POLYM BULL, V70, P3529, DOI 10.1007/s00289-013-1038-5
   Shao SJ, 2011, BIOMATERIALS, V32, P2821, DOI 10.1016/j.biomaterials.2011.01.051
   Sharma Y, 2012, INT J BIOL MACROMOL, V51, P627, DOI 10.1016/j.ijbiomac.2012.06.014
   Shi NL, 2006, J MATER SCI TECHNOL, V22, P289
   Shi ZJ, 2012, RSC ADV, V2, P1040, DOI 10.1039/c1ra00719j
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Sinha S, 2009, J APPL POLYM SCI, V112, P3135, DOI 10.1002/app.29708
   SISKEN BF, 1989, BRAIN RES, V485, P309, DOI 10.1016/0006-8993(89)90575-1
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stout DA, 2012, INT J NANOMED, V7, P5653, DOI 10.2147/IJN.S34574
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tiwari A, 2013, BIOPOLYMERS, V99, P334, DOI 10.1002/bip.22170
   Vineis P, 1997, CANCER CAUSE CONTROL, V8, P346, DOI 10.1023/A:1018453104303
   Wang CH, 1999, SYNTHETIC MET, V102, P1313, DOI 10.1016/S0379-6779(98)01006-6
   Wang HJ, 2008, J PHYS CHEM B, V112, P2671, DOI 10.1021/jp0750957
   Wang LP, 2010, COLLOID SURFACE B, V80, P72, DOI 10.1016/j.colsurfb.2010.05.034
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Whitehead MA, 2007, J BIOMED MATER RES A, V83A, P225, DOI 10.1002/jbm.a.31547
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Xia YY, 2013, COMPOS SCI TECHNOL, V77, P37, DOI 10.1016/j.compscitech.2013.01.008
   Xu P, 2010, 3 INT C BIOM ENG INF, V4, P1719
   Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r
   You JO, 2011, NANO LETT, V11, P3643, DOI 10.1021/nl201514a
   Zelikin AN, 2002, ANGEW CHEM INT EDIT, V41, P141, DOI 10.1002/1521-3773(20020104)41:1<141::AID-ANIE141>3.0.CO;2-V
   Zhang LJ, 2011, MACROMOL CHEM PHYS, V212, P2674, DOI 10.1002/macp.201100379
   Zhang QS, 2010, MAT SCI ENG C-MATER, V30, P160, DOI 10.1016/j.msec.2009.09.013
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 147
TC 118
Z9 120
U1 11
U2 342
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2014
VL 35
IS 33
BP 9068
EP 9086
DI 10.1016/j.biomaterials.2014.07.020
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO9KK
UT WOS:000341674400006
PM 25112936
DA 2018-10-20
ER

PT J
AU Ballotta, V
   Smits, AIPM
   Driessen-Mol, A
   Bouten, CVC
   Ens, FPTB
AF Ballotta, Virginia
   Smits, Anthal I. P. M.
   Driessen-Mol, Anita
   Bouten, Carlijn V. C.
   Ens, Frank P. T. Baaij
TI Synergistic protein secretion by mesenchymal stromal cells seeded in 3D
   scaffolds and circulating leukocytes in physiological flow
SO BIOMATERIALS
LA English
DT Article
DE Cell signaling; Chemotaxis; Co-culture; Fibroblast growth factor;
   Monocytes; Shear stress
ID ENGINEERED VASCULAR AUTOGRAFTS; VALVES 1ST EXPERIENCES;
   VERSUS-HOST-DISEASE; BONE-MARROW-CELLS; STEM-CELLS; HEART-VALVES;
   IN-VIVO; MACROPHAGES; GROWTH; PROLIFERATION
AB Mesenchymal stromal cells (MSC) play an important role in natural wound healing via paracrine and juxtacrine signaling to immune cells. The aim of this study was to identify the signaling factors secreted by preseeded cells in a biomaterial and their interaction with circulating leukocytes, in the presence of physiological biomechanical stimuli exerted by the hemodynamic environment (i.e. strain and shear flow). Electrospun poly(epsilon-caprolactone)-based scaffolds were seeded with human peripheral blood mononuclear cells (PBMC) or MSC. Protein secretion was analyzed under static conditions and cyclic strain. Subsequently, the cross-talk between preseeded cells and circulating leukocytes was addressed by exposing the scaffolds to a suspension of PBMC in static transwells and in pulsatile flow. Our results revealed that PBMC exposed to the scaffold consistently secreted a cocktail of immunomodulatory proteins under all conditions tested. Preseeded MSC, on the other hand, secreted the trophic factors MCP-1, VEGF and bEGF. Furthermore, we observed a synergistic upregulation of CXCL12 gene expression and a synergistic increase in bFGF protein production by preseeded MSC exposed to PBMC in pulsatile flow. These findings identify CXCL12 and bFGF as valuable targets for the development of safe and effective acellular instructive grafts for application in in situ cardiovascular regenerative therapies. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ballotta, Virginia; Smits, Anthal I. P. M.; Driessen-Mol, Anita; Bouten, Carlijn V. C.; Ens, Frank P. T. Baaij] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands.
   [Bouten, Carlijn V. C.; Ens, Frank P. T. Baaij] ICMS, Eindhoven, Netherlands.
RP Ens, FPTB (reprint author), Eindhoven Univ Technol, Dept Biomed Engn, POB 513,GEM Z 4-117, NL-5600 MB Eindhoven, Netherlands.
EM v.ballotta@tue.nl; a.i.p.m.smits@tue.nl; a.driessen@tue.nl;
   c.v.c.bouten@tue.nl; f.p.t.baaijens@tue.nl
OI Bouten, Carlijn/0000-0003-1035-5094; Smits, Anthal/0000-0002-3665-7106
FU BioMedical Materials institute [P1.01]; Dutch Ministry of Economic
   Affairs; Nederlandse Hartstichting [DHF-2008T089]
FX This research forms part of the Project P1.01 iValve of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affairs. The financial contribution of the
   Nederlandse Hartstichting is gratefully acknowledged (Grant number
   DHF-2008T089).
CR Abe M, 2012, EUR J DERMATOL, V22, P46, DOI 10.1684/ejd.2011.1582
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002
   Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X
   Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756
   Charoenpanich A, 2011, TISSUE ENG PT A, V17, P2615, DOI 10.1089/ten.tea.2011.0107
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Colazzo F, 2011, BIOMATERIALS, V32, P119, DOI 10.1016/j.biomaterials.2010.09.003
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193
   Emmert MY, 2012, JACC-CARDIOVASC INTE, V5, P874, DOI 10.1016/j.jcin.2012.04.010
   Emmert MY, 2011, JACC-CARDIOVASC INTE, V4, P822, DOI 10.1016/j.jcin.2011.02.020
   Fisher SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064669
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002
   Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]
   Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703
   Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002
   Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Matsumura G, 2006, TISSUE ENG, V12, P3075, DOI 10.1089/ten.2006.12.3075
   Melief SM, 2013, HAEMATOLOGICA, V98, P888, DOI 10.3324/haematol.2012.078055
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Ren C, 2014, CELL BIOCHEM BIOPHYS, V69, P179, DOI 10.1007/s12013-013-9756-8
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x
   Shi YF, 2012, TRENDS IMMUNOL, V33, P136, DOI 10.1016/j.it.2011.11.004
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356
   Smits AIPM, 2014, J CELL MOL IN PRESS
   Smits AIPM, 2012, TISSUE ENG PART C-ME, V18, P475, DOI [10.1089/ten.tec.2011.0458, 10.1089/ten.TEC.2011.0458]
   Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood2004-09-3507
   Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vincentelli A, 2007, J THORAC CARDIOV SUR, V134, P424, DOI 10.1016/j.jtcvs.2007.05.005
   Volpe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037208
   Weber B, 2013, BIOMATERIALS, V34, P7269, DOI 10.1016/j.biomaterials.2013.04.059
   Weber B, 2011, EUR HEART J, V32, P2830, DOI 10.1093/eurheartj/ehr059
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Williams AR, 2011, CIRC RES, V109, P923, DOI 10.1161/CIRCRESAHA.111.243147
   Wisse E, 2006, MACROMOLECULES, V39, P7425, DOI 10.1021/ma060986i
   Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010
   Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510
NR 61
TC 16
Z9 17
U1 0
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2014
VL 35
IS 33
BP 9100
EP 9113
DI 10.1016/j.biomaterials.2014.07.042
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO9KK
UT WOS:000341674400008
PM 25112932
DA 2018-10-20
ER

PT J
AU Sahin, B
   Fife, J
   Parmar, MB
   Valencia-Serna, J
   Gul-Uludag, H
   Jiang, XY
   Weinfeld, M
   Lavasanifar, A
   Uludag, H
AF Sahin, Basak
   Fife, Jeremy
   Parmar, Manoj B.
   Valencia-Serna, Juliana
   Gul-Uludag, Hilal
   Jiang, Xiaoyan
   Weinfeld, Michael
   Lavasanifar, Afsaneh
   Uludag, Hasan
TI siRNA therapy in cutaneous T-cell lymphoma cells using polymeric
   carriers
SO BIOMATERIALS
LA English
DT Article
DE siRNA therapy; Cutaneous T-cell lymphoma; Lipophilic polymer; Non-viral
   delivery; PI3K silencing
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; SEZARY-SYNDROME; MYCOSIS-FUNGOIDES;
   DOWN-REGULATION; APOPTOSIS; EXPRESSION; DELIVERY; INHIBITION; PATHWAY;
   PROLIFERATION
AB Cutaneous T-cell lymphomas (CTCLs) arise from specific molecular aberrations that lead to uncontrolled cell proliferation. RNA interference (RNAi) with short interfering RNAs (siRNAs) is a feasible approach to interrupt aberrant signal processing in CTCL cells, but functional biomaterial carriers are needed to effectively deliver siRNAs intracellularly. Towards this goal, we explored the utility of lipid-substituted polyethylenimines (PEI) carriers in a cell model of CTCL. Using caprylic and linoleic acid substituted 2 kDa PEI (PEI-CA and PEI-LA, respectively), we showed effective delivery of siRNA to T-lymphocyte Hut78 and Jurkat cells, but silencing of a model protein (Green Fluorescent Protein, GFP) was possible only in the Hut78 cells. To enhance siRNA delivery to Hut78 cells, a high siRNA: carrier ratio used to assemble the complexes and centrifugation of cells in the presence of complexes were found effective. The toxicities of PEI-CA and PEI-LA were significantly lower than other commercial carriers, 25 kDa PEI and Lipofectamine (R) RNAiMAX. This might have contributed to reduced siRNA delivery efficiency of the latter carriers. Screening several endogenous targets led us to identify phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) and cyclin-dependent kinase 18 (CDK18) as viable targets to induce siRNA-mediated cell growth inhibition. The results of this study identified promising polymeric carriers and molecular targets that could control proliferation of CTCL cells based on RNAi therapy. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Sahin, Basak; Valencia-Serna, Juliana; Gul-Uludag, Hilal; Uludag, Hasan] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada.
   [Fife, Jeremy; Lavasanifar, Afsaneh; Uludag, Hasan] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
   [Parmar, Manoj B.; Lavasanifar, Afsaneh; Uludag, Hasan] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 1E2, Canada.
   [Jiang, Xiaoyan] Univ British Columbia, British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.
   [Jiang, Xiaoyan] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada.
   [Weinfeld, Michael] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB T6G 2G6, Canada.
RP Uludag, H (reprint author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB T6G 2G6, Canada.
EM hasan.uludag@ualberta.ca
FU Alberta Cancer Foundation (ACF) [RES0016974]; Alberta Innovates Health
   Sciences (AIHS) [RES0008654]; Natural Science and Engineering Research
   Council of Canada (NSERC) [RES0020412]; Women & Children's Research
   Institute (WCHRI); Faculty of Medicine, U. of Alberta; Alberta Innovates
   [201400347, 201400342]
FX This project was financially supported by operating grants from Alberta
   Cancer Foundation (ACF) (RES0016974), Alberta Innovates Health Sciences
   (AIHS) (RES0008654) and Natural Science and Engineering Research Council
   of Canada (NSERC) (RES0020412). We thank Dr. V. Somayaji for NMR
   analysis of polymers and Mr. C. Kucharski for technical help with cell
   culture. B.S. was supported by graduate studentships from Women &
   Children's Research Institute (WCHRI) and Faculty of Medicine, U. of
   Alberta.
CR Ali HM, 2012, EXPERT REV CLIN PHAR, V5, P403, DOI [10.1586/ecp.12.33, 10.1586/ECP.12.33]
   Aliabadi HM, 2013, J CONTROL RELEASE, V172, P219, DOI 10.1016/j.jconrel.2013.08.012
   Aliabadi HM, 2011, MOL PHARMACEUT, V8, P1821, DOI 10.1021/mp200176v
   Aliabadi HM, 2011, MACROMOL BIOSCI, V11, P662, DOI 10.1002/mabi.201000402
   Bahadur KCR, 2011, ACTA BIOMATER, V7, P2209, DOI 10.1016/j.actbio.2011.01.027
   Basiouni S., 2012, BIOTECHNIQUES, P1
   Batista DAS, 2006, GENE CHROMOSOME CANC, V45, P383, DOI 10.1002/gcc.20302
   Braun FCM, 2011, LEUKEMIA, V25, P1494, DOI 10.1038/leu.2011.101
   Cudillo L, 2009, BONE MARROW TRANSPL, V43, P347, DOI 10.1038/bmt.2008.333
   Dass CR, 2007, DNA CELL BIOL, V26, P599, DOI 10.1089/dna.2006.0531
   GAZDAR AF, 1980, BLOOD, V55, P409
   GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403
   Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152
   Kamstrup MR, 2010, BLOOD, V116, P2504, DOI 10.1182/blood-2009-12-260216
   Karanam NK, 2010, J PROTEOME RES, V9, P3799, DOI 10.1021/pr901096u
   Kiessling MK, 2011, BLOOD, V117, P2433, DOI 10.1182/blood-2010-09-305128
   Kiessling MK, 2009, CANCER RES, V69, P2365, DOI 10.1158/0008-5472.CAN-08-3221
   Kopp KL, 2013, CELL CYCLE, V12, P1939, DOI 10.4161/cc.24987
   Krejsgaard T, 2011, J INVEST DERMATOL, V131, P1331, DOI 10.1038/jid.2011.27
   Landry B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044197
   Lansigan F, 2010, DRUGS, V70, P273, DOI 10.2165/11532190-000000000-00000
   Lauenborg B, 2010, APMIS, V118, P719, DOI 10.1111/j.1600-0463.2010.02669.x
   Maeda Y, 2011, VIRUS RES, V155, P368, DOI 10.1016/j.virusres.2010.10.010
   Manfe V, 2012, J INVEST DERMATOL, V132, P1487, DOI 10.1038/jid.2012.10
   Mao X, 2002, BRIT J DERMATOL, V147, P464, DOI 10.1046/j.1365-2133.2002.04966.x
   Marra E, 2013, J CELL PHYSIOL, V228, P58, DOI 10.1002/jcp.24103
   Martin-Sanchez E, 2013, HAEMATOL-HEMATOL J, V98, P57, DOI 10.3324/haematol.2012.068510
   Marzec M, 2008, BLOOD, V111, P2181, DOI 10.1182/blood-2006-06-095182
   McKenzie RCT, 2012, LEUKEMIA, V26, P323, DOI 10.1038/leu.2011.198
   Miele E, 2012, INT J NANOMED, V7, P3637, DOI 10.2147/IJN.S23696
   Mirandola L, 2012, J PATHOL, V226, P713, DOI 10.1002/path.3015
   Nakayama T, 2012, ANTICANCER RES, V32, P1367
   Neamnark A, 2009, MOL PHARMACEUT, V6, P1798, DOI 10.1021/mp900074d
   Nihal M, 2011, CELL CYCLE, V10, P1303, DOI 10.4161/cc.10.8.15353
   Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966
   Ri M, 2009, CANCER SCI, V100, P341, DOI 10.1111/j.1349-7006.2008.01038.x
   Samstag Y, 2005, ADV ENZYME REGUL, V45, P52, DOI 10.1016/j.advenzreg.2005.02.005
   SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505
   Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099
   Singha K, 2011, NUCLEIC ACID THER, V21, P133, DOI 10.1089/nat.2011.0293
   Verma NK, 2010, CELL MOL BIOL LETT, V15, P342, DOI 10.2478/s11658-010-0008-2
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Wollina U, 2012, INT J DERMATOL, V51, P1019, DOI 10.1111/j.1365-4632.2011.05337.x
   Wozniak MB, 2010, HAEMATOL-HEMATOL J, V95, P613, DOI 10.3324/haematol.2009.013870
   Zhang Y, 2000, J VIROL, V74, P2011, DOI 10.1128/JVI.74.4.2011-2016.2000
   Zhao XB, 2009, EXPERT OPIN DRUG DEL, V6, P673, DOI 10.1517/17425240902992894
   Zimmerman DW, 1997, J EDUC BEHAV STAT, V22, P349, DOI 10.2307/1165289
NR 47
TC 4
Z9 4
U1 1
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2014
VL 35
IS 34
BP 9382
EP 9394
DI 10.1016/j.biomaterials.2014.07.029
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AP2KO
UT WOS:000341901300014
PM 25128374
DA 2018-10-20
ER

PT J
AU Torres, Y
   Trueba, P
   Pavon, J
   Montealegre, I
   Rodriguez-Ortiz, JA
AF Torres, Y.
   Trueba, P.
   Pavon, J.
   Montealegre, I.
   Rodriguez-Ortiz, J. A.
TI Designing, processing and characterisation of titanium cylinders with
   graded porosity: An alternative to stress-shielding solutions
SO MATERIALS & DESIGN
LA English
DT Article
DE Porous titanium; Powder metallurgy; Functionally graded material;
   Biomaterial; Stress shielding
ID POWDER-METALLURGY TECHNIQUE; POROUS TITANIUM; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; SPACE-HOLDER; TI; IMPLANTS; ALLOYS; PORES; NACL
AB Bone resorption events and consequent failure of titanium implants are frequently related to stress-shielding problems, due to stiffness mismatch with respect to bone. This is a mechanical incompatibility problem, which is difficult to resolve because of the challenge of replacing highly anisotropic biomechanical systems, as is the case of dental implants. This work describes the designing, processing and characterisation of cylindrical titanium samples with a longitudinally graded porosity obtained by conventional powder-metallurgy techniques. The design concept used was biomimetic, based on the stiffness properties of the tissues to be in contact with titanium dental implants. Processing conditions were optimised in terms of different parameters: structural integrity, porosity and mechanical properties. The influence of sintering temperature was evaluated in search of optimum results under the above criteria. The behaviour of longitudinal porosity and Young's modulus were consistent with the preliminary design concept from the original biomechanical system. Mechanical strength results were reasonably suitable for dental applications and they were favourably sensitive to increasing sintering temperature, due to a stronger adhesion between initial green layers of cylindrical samples. Results showed that it is possible to obtain a desired longitudinal gradient in Young's modulus, as well as suitable yield strength values. The optimised processing described suggests that it is a plausible candidate for manufacturing dental implants with a good balance between reduced stress shielding and suitable mechanical strength, which encourages us to undertake further work along the same lines. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Torres, Y.; Trueba, P.; Montealegre, I.; Rodriguez-Ortiz, J. A.] Univ Seville, Dept Engn & Sci Mat & Transportat, Seville, Spain.
   [Pavon, J.] Univ Antioquia, Bioengn Programme, Grp Adv Biomat & Regenerat Med, Medellin, Colombia.
   [Pavon, J.] Univ Illinois, Coll Engn, Dept Nucl Plasma & Radiol Engn, Urbana, IL USA.
RP Torres, Y (reprint author), Univ Seville, Dept Engn & Sci Mat & Transportat, Seville, Spain.
EM ytorres@us.es
RI Montealegre-Melendez, Isabel/L-3350-2014; Rodriguez-Ortiz, Jose
   A./C-5542-2011; Torres, Yadir/I-9902-2017
OI Montealegre-Melendez, Isabel/0000-0001-8598-0578; Rodriguez-Ortiz, Jose
   A./0000-0001-8942-5555; Pavon-Palacio, Juan-Jose/0000-0002-2693-9708
FU Ministerio de Economia y Competitividad (MINECO), Spain [MAT2010-20855]
FX This work was supported by the Ministerio de Economia y Competitividad
   (MINECO), Spain, through the project Ref. MAT2010-20855. In addition,
   the authors wish to thank I. Rube and M. C. Martin for their
   collaboration in some of the experimental tasks of this paper.
CR An YB, 2005, MATER LETT, V59, P2178, DOI 10.1016/j.matlet.2005.02.059
   ASM-Intemational, 1989, NOND EV QUAL CONTR
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P1996, DOI 10.1016/j.actbio.2008.06.005
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Chino Y, 2008, ACTA MATER, V56, P105, DOI 10.1016/j.actamat.2007.09.002
   COLLINS E. W., 1984, PHYS METALLURGY TITA
   CROWNINSHIELD RD, 2006, CLIN ORTHOP RELAT R, V443, P266
   Currey J., 1998, HDB BIOMATERIALS PRO
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Jha N, 2013, MATER DESIGN, V47, P810, DOI 10.1016/j.matdes.2013.01.005
   Kikuchi M, 2006, DENT MATER, V22, P641, DOI 10.1016/j.dental.2005.05.015
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Laptev A, 2004, POWDER METALL, V47, P85, DOI 10.1179/003258904225015536
   Lee JW, 2013, MATER TRANS, V54, P137, DOI 10.2320/matertrans.MC201211
   Li BQ, 2013, MATER DESIGN, V50, P613, DOI 10.1016/j.matdes.2013.02.082
   Miao XG, 2010, MATERIALS, V3, P26, DOI 10.3390/ma3010026
   Naito Y, 2013, J BIOMED MATER RES B, V101B, P1090, DOI 10.1002/jbm.b.32919
   Oh IH, 2003, MATER TRANS, V44, P657, DOI 10.2320/matertrans.44.657
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oppenheimer SM, 2009, MAT SCI ENG A-STRUCT, V523, P70, DOI 10.1016/j.msea.2009.05.045
   Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Qazi JI, 2004, JOM-US, V56, P49, DOI 10.1007/s11837-004-0253-9
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Singh R, 2010, MATER TECHNOL, V25, P127, DOI 10.1179/175355510X12744412709403
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Torres Y, 2012, J MATER SCI, V47, P6565, DOI 10.1007/s10853-012-6586-9
   Torres Y, 2012, J MATER PROCESS TECH, V212, P1061, DOI 10.1016/j.jmatprotec.2011.12.015
   Torres Y, 2011, METALL MATER TRANS B, V42, P891, DOI 10.1007/s11663-011-9521-6
   Torres Y, 2014, MAT SCI ENG C-MATER, V37, P148, DOI 10.1016/j.msec.2013.11.036
   Traini T, 2008, DENT MATER, V24, P1525, DOI 10.1016/j.dental.2008.03.029
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Wiria FE, 2013, MATER DESIGN, V49, pS101
NR 35
TC 20
Z9 20
U1 1
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
EI 1873-4197
J9 MATER DESIGN
JI Mater. Des.
PD NOV
PY 2014
VL 63
BP 316
EP 324
DI 10.1016/j.matdes.2014.06.012
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA AN9SQ
UT WOS:000340949300038
DA 2018-10-20
ER

PT J
AU Shokrollahi, H
   Khorramdin, A
   Isapour, G
AF Shokrollahi, H.
   Khorramdin, A.
   Isapour, Gh.
TI Magnetic resonance imaging by using nano-magnetic particles
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Review
DE Biomaterial; Magnetic material; Inorganic compound; Chemical synthesis
ID MRI CONTRAST AGENTS; IRON-OXIDE NANOPARTICLES; BIOMEDICAL APPLICATIONS;
   DRUG-DELIVERY; FUNCTIONALIZATION; DESIGN; FIELDS; PROBES
AB Magnetism and magnetic materials play a major role in various biological applications, such as magnetic bioseparation, magnetic resonance imaging (MRI), hyperthermia treatment of cancer and drug delivery. Among these techniques, MRI is a powerful method not only for diagnostic radiology but also for therapeutic medicine that utilizes a magnetic field and radio waves. Recently, this technique has contributed greatly to the promotion of the human quality life. Thus, this paper presents a short review of the physical principles and recent advances of MRI, as well as providing a summary of the synthesis methods and properties or contrast agents, like different core materials and surfactants. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Shokrollahi, H.; Khorramdin, A.] Shiraz Univ Technol, Dept Mat Sci & Engn, Electroceram Grp, Shiraz, Iran.
   [Isapour, Gh.] Hakim Sabzevari Univ, Dept Mat & Engn, Sabzevar, Iran.
RP Shokrollahi, H (reprint author), Shiraz Univ Technol, Dept Mat Sci & Engn, Electroceram Grp, Shiraz, Iran.
EM Shokrollahi@sutech.ac.ir
CR Bahadur D, 2003, SADHANA-ACAD P ENG S, V28, P639, DOI 10.1007/BF02706451
   BERKOWIT.AE, 1968, J APPL PHYS, V39, P1261, DOI 10.1063/1.1656256
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Fardis M, 2007, J OPTOELECTRON ADV M, V9, P527
   Gopalan EV, 2009, J ALLOY COMPD, V485, P711, DOI 10.1016/j.jallcom.2009.06.033
   Gowland PA, 2005, PROG BIOPHYS MOL BIO, V87, P175, DOI 10.1016/j.pbiomolbio.2004.08.006
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Gyergyek S, 2010, J NANOPART RES, V12, P1263, DOI 10.1007/s11051-009-9833-5
   Hacliipanayis CG, 2008, SMALL, V4, P1925, DOI 10.1002/smll.200800261
   Hao R, 2010, ADV MATER, V22, P2729, DOI 10.1002/adma.201000260
   Indira T. K., 2010, INT J PHARM SCI NANO, V3, P1035, DOI DOI 10.1088/0022-3727/36/13/201
   Jun YW, 2008, ANGEW CHEM INT EDIT, V47, P5122, DOI 10.1002/anie.200701674
   Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f
   Kai Z, 2004, LANGMUIR, V20, P11312, DOI 10.1021/la047736k
   LANGEVIN D, 1992, ANNU REV PHYS CHEM, V43, P341, DOI 10.1146/annurev.physchem.43.1.341
   Laurent S, 2008, CHEM REV, V108, P2064, DOI 10.1021/cr068445e
   Lee JH, 2007, NAT MED, V13, P95, DOI 10.1038/nm1467
   Lee JH, 2006, ANGEW CHEM INT EDIT, V45, P8160, DOI 10.1002/anie.200603052
   Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703
   Maenosono S, 2008, J MAGN MAGN MATER, V320, pL79, DOI 10.1016/j.jmmm.2008.01.026
   Marrow G., 2000, T APPL SUPERCOND, V10, P744
   McRobbie DW, 2003, MRI PICTURE PROTON
   MengMeng Lin, 2008, IEEE NANOBIOSCI, V7, P298
   Mornet S, 2006, PROG SOLID STATE CH, V34, P237, DOI 10.1016/j.progsolidstchem.2005.11.010
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Pankhurst Q.A., 2009, J PHYS D, V42, P1
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Park J, 2004, NAT MATER, V3, P891, DOI 10.1038/nmat1251
   Peng JH, 2011, J MAGN MAGN MATER, V323, P133, DOI 10.1016/j.jmmm.2010.08.048
   SATO T, 1987, J MAGN MAGN MATER, V65, P252, DOI 10.1016/0304-8853(87)90044-8
   Schenck J.F., 2000, STATIC MAGN FIELDS R, V12, P2
   Schenck JF, 2005, PROG BIOPHYS MOL BIO, V87, P185, DOI 10.1016/j.pbiomolbio.2004.08.009
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   Schick F, 2005, EUR RADIOL, V15, P946, DOI 10.1007/s00330-005-2678-0
   Shellock F.G., 2001, MAGNETIC RESONANCE P
   Shinkai M, 2004, ADV BIOCHEM ENG BIOT, V91, P191
   Shokrollahi H, 2008, J MAGN MAGN MATER, V320, P463, DOI 10.1016/j.jmmm.2007.07.003
   Shokrollahi H, 2009, MATER DESIGN, V30, P3374, DOI 10.1016/j.matdes.2009.03.035
   Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018
   Tartaj P, 2003, J PHYS D APPL PHYS, V36, pR182, DOI 10.1088/0022-3727/36/13/202
   Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968
NR 43
TC 25
Z9 26
U1 5
U2 207
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD NOV
PY 2014
VL 369
BP 176
EP 183
DI 10.1016/j.jmmm.2014.06.023
PG 8
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA AM7MD
UT WOS:000340050500029
DA 2018-10-20
ER

PT J
AU Al-Ahmad, A
   Zou, P
   Solarte, DLG
   Hellwig, E
   Steinberg, T
   Lienkamp, K
AF Al-Ahmad, Ali
   Zou, Peng
   Solarte, Diana Lorena Guevara
   Hellwig, Elmar
   Steinberg, Thorsten
   Lienkamp, Karen
TI Development of a Standardized and Safe Airborne Antibacterial Assay, and
   Its Evaluation on Antibacterial Biomimetic Model Surfaces
SO PLOS ONE
LA English
DT Article
ID STAPHYLOCOCCUS-EPIDERMIDIS; POLYMERS; QUANTIFICATION; INFECTIONS;
   COATINGS; BACTERIA; ADHESION; CONTACT
AB Bacterial infection of biomaterials is a major concern in medicine, and different kinds of antimicrobial biomaterial have been developed to deal with this problem. To test the antimicrobial performance of these biomaterials, the airborne bacterial assay is used, which involves the formation of biohazardous bacterial aerosols. We here describe a new experimental set-up which allows safe handling of such pathogenic aerosols, and standardizes critical parameters of this otherwise intractable and strongly user-dependent assay. With this new method, reproducible, thorough antimicrobial data (number of colony forming units and live-dead-stain) was obtained. Poly(oxonorbornene)-based Synthetic Mimics of Antimicrobial Peptides (SMAMPs) were used as antimicrobial test samples. The assay was able to differentiate even between subtle sample differences, such as different sample thicknesses. With this new set-up, the airborne bacterial assay was thus established as a useful, reliable, and realistic experimental method to simulate the contamination of biomaterials with bacteria, for example in an intraoperative setting.
C1 [Al-Ahmad, Ali; Solarte, Diana Lorena Guevara; Hellwig, Elmar] Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, D-79106 Freiburg, Germany.
   [Zou, Peng; Lienkamp, Karen] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany.
   [Zou, Peng; Solarte, Diana Lorena Guevara; Lienkamp, Karen] Univ Freiburg, Dept Microsyst Engn IMTEK, D-79106 Freiburg, Germany.
   [Steinberg, Thorsten] Univ Freiburg, Univ Med Ctr, D-79106 Freiburg, Germany.
RP Al-Ahmad, A (reprint author), Univ Freiburg, Ctr Dent Med, Dept Operat Dent & Periodontol, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM ali.al-ahmad@uniklinik-freiburg.de
FU Freiburg Institute for Advanced Studies (FRIAS); German Research
   Foundation (DFG) [LI 1714/5-1]
FX This study was supported by the Freiburg Institute for Advanced Studies
   (FRIAS) and the German Research Foundation (DFG, LI 1714/5-1). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Al-Ahmad A, 2006, J MED MICROBIOL, V55, P109, DOI 10.1099/jmm.0.46280-0
   Al-Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073812
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Busscher H. J., 2012, SCI TRANSL MED, V4
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Choy MH, 2008, J MED MICROBIOL, V57, P1539, DOI 10.1099/jmm.0.2008/003723-0
   Dorner F, 2014, RSC POLYM CHEM SER, V10, P97
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   Gabriel GJ, 2008, LANGMUIR, V24, P12489, DOI 10.1021/la802232p
   Haenle M, 2010, HIP INT, V20, P248
   Haldar J, 2007, NAT PROTOC, V2, P2412, DOI 10.1038/nprot.2007.353
   Hannig C, 2007, ARCH ORAL BIOL, V52, P1048, DOI 10.1016/j.archoralbio.2007.05.006
   Jones D., 1991, MAINTENANCE MICROORG, P45
   Karygianni L, 2013, MATERIALS, V6, P5659, DOI 10.3390/ma6125659
   Kimmerle H, 2012, ARCH ORAL BIOL, V57, P689, DOI 10.1016/j.archoralbio.2011.11.012
   Knobben BAS, 2006, CLIN ORTHOP RELAT R, P236, DOI 10.1097/01.blo.0000229339.11351.ea
   Lienkamp K, 2008, J AM CHEM SOC, V130, P9836, DOI 10.1021/ja801662y
   Lienkamp K, 2009, CHEM-EUR J, V15, P11784, DOI 10.1002/chem.200900049
   Lienkamp K, 2009, CHEM-EUR J, V15, P11715, DOI 10.1002/chem.200900606
   Liu Y, 2008, BIOMATERIALS, V29, P4374, DOI 10.1016/j.biomaterials.2008.07.044
   Madkour AE, 2009, LANGMUIR, V25, P1060, DOI 10.1021/la802953v
   McCarthy NL, 2010, AM J INFECT CONTROL, V38, P600, DOI 10.1016/j.ajic.2010.01.006
   Steinberg T, 2013, TEST APPARATUS TESTI
   Tawakoli PN, 2013, CLIN ORAL INVEST, V17, P841, DOI 10.1007/s00784-012-0792-3
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zou P, 2012, J MATER CHEM, V22, P19579, DOI 10.1039/c2jm31695a
NR 28
TC 5
Z9 5
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 31
PY 2014
VL 9
IS 10
AR e111357
DI 10.1371/journal.pone.0111357
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0BN
UT WOS:000343943700091
PM 25360525
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Waltman, L
   van Raan, AFJ
   Smart, S
AF Waltman, Ludo
   van Raan, Anthony F. J.
   Smart, Sue
TI Exploring the Relationship between the Engineering and Physical Sciences
   and the Health and Life Sciences by Advanced Bibliometric Methods
SO PLOS ONE
LA English
DT Article
ID INTERDISCIPLINARITY; MAP
AB We investigate the extent to which advances in the health and life sciences (HLS) are dependent on research in the engineering and physical sciences (EPS), particularly physics, chemistry, mathematics, and engineering. The analysis combines two different bibliometric approaches. The first approach to analyze the 'EPS-HLS interface' is based on term map visualizations of HLS research fields. We consider 16 clinical fields and five life science fields. On the basis of expert judgment, EPS research in these fields is studied by identifying EPS-related terms in the term maps. In the second approach, a large-scale citation-based network analysis is applied to publications from all fields of science. We work with about 22,000 clusters of publications, each representing a topic in the scientific literature. Citation relations are used to identify topics at the EPS-HLS interface. The two approaches complement each other. The advantages of working with textual data compensate for the limitations of working with citation relations and the other way around. An important advantage of working with textual data is in the in-depth qualitative insights it provides. Working with citation relations, on the other hand, yields many relevant quantitative statistics. We find that EPS research contributes to HLS developments mainly in the following five ways: new materials and their properties; chemical methods for analysis and molecular synthesis; imaging of parts of the body as well as of biomaterial surfaces; medical engineering mainly related to imaging, radiation therapy, signal processing technology, and other medical instrumentation; mathematical and statistical methods for data analysis. In our analysis, about 10% of all EPS and HLS publications are classified as being at the EPS-HLS interface. This percentage has remained more or less constant during the past decade.
C1 [Waltman, Ludo; van Raan, Anthony F. J.] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.
   EPSRC, Swindon, Wilts, England.
RP Waltman, L (reprint author), Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands.
EM waltmanlr@cwts.leidenuniv.nl
CR Borner K, 2010, ATLAS SCI VISUALIZIN
   Boyack KW, 2014, J ASSOC INF SCI TECH, V65, P670, DOI 10.1002/asi.22990
   Eck NJ, 2011, ISSI NEWSLETTER, V7, P50, DOI DOI 10.1371/J0URNAL.P0NE.0054847
   Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991
   Lariviere V, 2010, J AM SOC INF SCI TEC, V61, P126, DOI 10.1002/asi.21226
   Merrill SA, 2013, ISSUES SCI TECHNOLOG
   Morillo F, 2003, J AM SOC INF SCI TEC, V54, P1237, DOI 10.1002/asi.10326
   PETERS HPF, 1993, RES POLICY, V22, P23, DOI 10.1016/0048-7333(93)90031-C
   PORTER AL, 1985, SCIENTOMETRICS, V8, P161, DOI 10.1007/BF02016934
   Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2
   Rafols I, 2012, RES POLICY, V41, P1262, DOI 10.1016/j.respol.2012.03.015
   Small H, 2014, RES POLICY, V43, P1450, DOI 10.1016/j.respol.2014.02.005
   van Eck NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062395
   van Eck NJ, 2010, J AM SOC INF SCI TEC, V61, P2405, DOI 10.1002/asi.21421
   van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3
   Van Eck NJ, MEASURING S IN PRESS
   van Raan A., 2000, PRACTISING INTERDISC, P66
   VANRAAN AFJ, 1993, SCIENTOMETRICS, V26, P169, DOI 10.1007/BF02016799
   Varmus H, 2000, APS NEWS, V9, P4
   Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2378, DOI 10.1002/asi.22748
NR 20
TC 4
Z9 6
U1 1
U2 45
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 31
PY 2014
VL 9
IS 10
AR e111530
DI 10.1371/journal.pone.0111530
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0BN
UT WOS:000343943700113
PM 25360616
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bonafe, F
   Govoni, M
   Giordano, E
   Caldarera, CM
   Guarnieri, C
   Muscari, C
AF Bonafe, Francesca
   Govoni, Marco
   Giordano, Emanuele
   Caldarera, Claudio Marcello
   Guarnieri, Carlo
   Muscari, Claudio
TI Hyaluronan and cardiac regeneration
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Review
DE Hyaluronan; Myocardial infarction; Cardiac regeneration; Adult stem
   cells
ID MESENCHYMAL STEM-CELLS; EXPERIMENTAL MYOCARDIAL-INFARCTION; ENDOTHELIAL
   PROGENITOR CELLS; MOLECULAR-WEIGHT HYALURONAN; RETINOIC ACID;
   MECHANICAL-PROPERTIES; INJECTABLE HYDROGEL; SIGNALING PATHWAYS;
   CROSS-LINKING; MIXED ESTERS
AB Hyaluronan (HA) is abundantly expressed in several human tissues and a variety of roles for HA has been highlighted. Particularly relevant for tissue repair, HA is actively produced during tissue injury, as widely evidenced in wound healing investigations. In the heart HA is involved in physiological functions, such as cardiac development during embryogenesis, and in pathological conditions including atherosclerosis and myocardial infarction. Moreover, owing to its relevant biological properties, HA has been widely used as a biomaterial for heart regeneration after a myocardial infarction. Indeed, HA and its derivatives are biodegradable and biocompatible, promote faster healing of injured tissues, and support cells in relevant processes including survival, proliferation, and differentiation. Injectable HA-based therapies for cardiovascular disease are gaining growing attention because of the benefits obtained in preclinical models of myocardial infarction. HA-based hydrogels, especially as a vehicle for stem cells, have been demonstrated to improve the process of cardiac repair by stimulating angiogenesis, reducing inflammation, and supporting local and grafted cells in their reparative functions. Solid-state HA-based scaffolds have been also investigated to produce constructs hosting mesenchymal stem cells or endothelial progenitor cells to be transplanted onto the infarcted surface of the heart. Finally, applying an ex-vivo mechanical stretching, stem cells grown in HA-based 3D scaffolds can further increase extracellular matrix production and proneness to differentiate into muscle phenotypes, thus suggesting a potential strategy to create a suitable engineered myocardial tissue for cardiac regeneration.
C1 [Bonafe, Francesca; Caldarera, Claudio Marcello; Guarnieri, Carlo; Muscari, Claudio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, I-40126 Bologna, Italy.
   [Govoni, Marco; Giordano, Emanuele; Guarnieri, Carlo; Muscari, Claudio] Univ Bologna, BioEngLab, Interdept Ctr Ind Res HST CIRI, Ozzano Dell Emilia, Italy.
   [Giordano, Emanuele] Univ Bologna, Lab Cellular & Mol Engn Silvio Cavalcanti, DEI, Cesena, Italy.
   [Bonafe, Francesca; Giordano, Emanuele; Caldarera, Claudio Marcello; Guarnieri, Carlo; Muscari, Claudio] Natl Inst Cardiovasc Res INRC, Bologna, Italy.
RP Muscari, C (reprint author), Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Via Irnerio 48, I-40126 Bologna, Italy.
EM claudio.muscari@unibo.it
OI Govoni, Marco/0000-0002-1876-8101
CR Abdalla S, 2013, INTERACT CARDIOV TH, V17, P767, DOI 10.1093/icvts/ivt277
   Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Boublik J, 2005, TISSUE ENG, V11, P1122, DOI 10.1089/ten.2005.11.1122
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Calderon L, 2010, EUR CELLS MATER, V20, P134
   Campo GM, 2012, BIOFACTORS, V38, P69, DOI 10.1002/biof.202
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Catalfamo L, 2013, INT J NANOMED, V8, P3883, DOI 10.2147/IJN.S47697
   Chang CY, 2012, BIOMATERIALS, V33, P8026, DOI 10.1016/j.biomaterials.2012.07.058
   Chen CH, 2014, AM J PHYSIOL-HEART C, V306, pH1078, DOI 10.1152/ajpheart.00801.2013
   Chen CH, 2013, MOL THER, V21, P670, DOI 10.1038/mt.2012.268
   Chen J, 2014, CARBOHYD POLYM, V102, P8, DOI 10.1016/j.carbpol.2013.10.063
   Cheng K, 2012, BIOMATERIALS, V33, P5317, DOI 10.1016/j.biomaterials.2012.04.006
   Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012
   Chi NH, 2012, BIOMATERIALS, V33, P5541, DOI 10.1016/j.biomaterials.2012.04.030
   Chopra A, 2014, BIOMATERIALS, V35, P71, DOI 10.1016/j.biomaterials.2013.09.066
   Chopra A, 2012, J BIOMECH, V45, P824, DOI 10.1016/j.jbiomech.2011.11.023
   Clause KC, 2009, TISSUE ENG PT A, V15, P1373, DOI 10.1089/ten.tea.2008.0169
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   CORTIVO R, 1991, BIOMATERIALS, V12, P727, DOI 10.1016/0142-9612(91)90020-B
   Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876
   Damodarasamy M, 2014, WOUND REPAIR REGEN, V22, P521, DOI 10.1111/wrr.12192
   DEANGELIS PL, 1994, BIOCHEMISTRY-US, V33, P9033, DOI 10.1021/bi00197a001
   DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568
   Deed R, 1997, INT J CANCER, V71, P251, DOI 10.1002/(SICI)1097-0215(19970410)71:2<251::AID-IJC21>3.0.CO;2-J
   Donegan GC, 2010, J TISSUE ENG REGEN M, V4, P83, DOI 10.1002/term.208
   Eberlein M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-20
   Eckhouse SR, 2014, SCI TRANSL MED, V6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Felzani G, 2011, ADV THER, V28, P439, DOI 10.1007/s12325-011-0016-2
   FENDERSON BA, 1993, DIFFERENTIATION, V54, P85
   Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831
   Fiumana E, 2013, J SURG RES, V179, pE21, DOI 10.1016/j.jss.2012.01.028
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Govoni M, 2014, J TISSUE ENG REGEN M, V8, P787, DOI 10.1002/term.1578
   Govoni M, 2013, BIOMED RES INT, DOI 10.1155/2013/918640
   Huang B, 2010, J BIOMED MATER RES B, V92B, P322, DOI 10.1002/jbm.b.31518
   HUANG L, 1993, J BIOL CHEM, V268, P26725
   Huebener P, 2008, J IMMUNOL, V180, P2625, DOI 10.4049/jimmunol.180.4.2625
   Humbert P, 2013, INT WOUND J, V10, P159, DOI 10.1111/j.1742-481X.2012.00957.x
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Itano N, 2008, J BIOCHEM, V144, P131, DOI 10.1093/jb/mvn046
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kichula ET, 2014, ANN BIOMED ENG, V42, P1546, DOI 10.1007/s10439-013-0937-9
   Klingbeil P, 2009, MOL CANCER RES, V7, P168, DOI 10.1158/1541-7786.MCR-08-0207
   LARSEN NE, 1993, J BIOMED MATER RES, V27, P1129, DOI 10.1002/jbm.820270903
   Leong WS, 2012, J TISSUE ENG REGEN M, V6, ps68, DOI 10.1002/term.1548
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li L, 2014, BIOMATERIALS, V35, P3903, DOI 10.1016/j.biomaterials.2014.01.050
   Lionetti V, 2010, J BIOL CHEM, V285, P9949, DOI 10.1074/jbc.M109.087254
   MacArthur JW, 2013, CIRCULATION, V128, pS79, DOI 10.1161/CIRCULATIONAHA.112.000343
   MACLENNAN AP, 1956, J GEN MICROBIOL, V15, P485, DOI 10.1099/00221287-15-3-485
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   Maleki A, 2007, CARBOHYD RES, V342, P2776, DOI 10.1016/j.carres.2007.08.021
   Marban E, 2012, HEART RHYTHM, V9, P1727, DOI 10.1016/j.hrthm.2012.07.012
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Matou-Nasri S, 2009, INT J ONCOL, V35, P761, DOI 10.3892/ijo_00000389
   Maureira P, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-93
   McGary CT, 2003, METHOD ENZYMOL, V363, P354
   MCKAY RG, 1986, CIRCULATION, V74, P693, DOI 10.1161/01.CIR.74.4.693
   Motolese A, 2013, BIOMED RES INT, V2013
   Muscari C, 2013, J CELL MOL MED, V17, P518, DOI 10.1111/jcmm.12039
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9
   Nassiri SM, 2007, J BIOMED SCI, V14, P745, DOI 10.1007/s11373-007-9188-9
   Negi LM, 2012, J DRUG TARGET, V20, P561, DOI 10.3109/1061186X.2012.702767
   Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373
   OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785
   Palumbo FS, 2010, ACTA BIOMATER, V6, P195, DOI 10.1016/j.actbio.2009.06.014
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pasquinelli G, 2009, TISSUE ENG PT A, V15, P2751, DOI 10.1089/ten.tea.2008.0232
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P370, DOI 10.1021/bc00028a015
   PREHM P, 1990, BIOCHEM J, V267, P185, DOI 10.1042/bj2670185
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Pure E, 2009, CELL SIGNAL, V21, P651, DOI 10.1016/j.cellsig.2009.01.024
   Rilla K, 2013, EXP CELL RES, V319, P2006, DOI 10.1016/j.yexcr.2013.05.021
   Sakurai K, 1997, GLYCOCONJUGATE J, V14, P723, DOI 10.1023/A:1018521501289
   Scuderi N, 2009, IN VIVO, V23, P991
   Seyfried NT, 2005, J BIOL CHEM, V280, P5435, DOI 10.1074/jbc.M411297200
   SHETLAR MR, 1979, TEX REP BIOL MED, V39, P339
   Simioniuc A, 2011, CARDIOVASC RES, V90, P546, DOI 10.1093/cvr/cvr018
   Skogh ACD, 2013, J CRANIOFAC SURG, V24, P339, DOI 10.1097/SCS.0b013e31827ff2b6
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Sokolowska M, 2014, J BIOL CHEM, V289, P4470, DOI 10.1074/jbc.M113.515106
   Spicer AP, 1997, J BIOL CHEM, V272, P8957
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Sugahara KN, 2003, J BIOL CHEM, V278, P32259, DOI 10.1074/jbc.M300347200
   TAMMI M, 1978, ATHEROSCLEROSIS, V29, P191, DOI 10.1016/0021-9150(78)90007-2
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tomihata K, 1997, J POLYM SCI POL CHEM, V35, P3553, DOI 10.1002/(SICI)1099-0518(19971130)35:16<3553::AID-POLA22>3.0.CO;2-D
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824
   Tsuda M, 2004, J BIOL CHEM, V279, P46843, DOI 10.1074/jbc.M401476200
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200
   Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200
   Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001
   WALDENSTROM A, 1991, J CLIN INVEST, V88, P1622, DOI 10.1172/JCI115475
   Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   WHEATLEY SC, 1995, CELL ADHES COMMUN, V3, P217, DOI 10.3109/15419069509081288
   Xing YJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-6
   Yang MC, 2010, BIOMATERIALS, V31, P854, DOI 10.1016/j.biomaterials.2009.09.096
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Yoon SJ, 2014, J BIOSCI BIOENG, V18, P461
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Zhao XB, 2002, J MATER SCI-MATER M, V13, P11, DOI 10.1023/A:1013618115163
NR 114
TC 14
Z9 14
U1 2
U2 32
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD OCT 30
PY 2014
VL 21
AR 100
DI 10.1186/s12929-014-0100-4
PG 13
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA AW2EJ
UT WOS:000346100700001
PM 25358954
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Huang, CJ
   Wang, LC
   Shyue, JJ
   Chang, YC
AF Huang, Chun-Jen
   Wang, Lin-Chuan
   Shyue, Jing-Jong
   Chang, Ying-Chih
TI Developing Antifouling Biointerfaces Based on Bioinspired Zwitterionic
   Dopamine through pH-Modulated Assembly
SO LANGMUIR
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; BIOLOGICAL APPLICATIONS; PROTEIN ADSORPTION;
   SURFACE; MONOLAYERS; ADHESION; CHEMISTRY; FUNCTIONALIZATION;
   PHOSPHORYLCHOLINE; IMMOBILIZATION
AB The use of synthetic biomaterials as implantable devices typically is accompanied by considerable nonspecific adsorption of proteins, cells, and bacteria. These may eventually induce adverse pathogenic problems in clinical practice, such as thrombosis and biomaterial-associated infection. Thus, an effective surface coating for medical devices has been pursued to repel nonspecific adsorption from surfaces. In this study, we employ an adhesive dopamine molecule conjugated with zwitterionic sulfobetaine moiety (SB-DA), developed based on natural mussels, as a surface ligand for the modification of TiO2. The electrochemical study shows that the SB-DA exhibits fully reversible reductionoxidation behavior at pH 3, but it is irreversible at pH 8. A contact angle goniometer and X-ray photoelectron spectroscopy were utilized to explore the surface hydration, chemical states, and bonding mechanism of SB-DA. The results indicate that the binding between hydroxyl groups of SB-DA and TiO2 converts from hydrogen bonds to bidentate binding upon the pH transition from pH 3 to 8. In order to examine the antifouling properties of SB-DA thin films, the modified substrates were brought into contact with bovine serum albumin and bacteria solutions. The fouling levels were monitored using a quartz crystal microbalance with dissipation sensor and fluorescence optical microscope. Tests showed that the sample prepared via the pH transition approach provides the best resistance to nonspecific adsorption due to the high coverage and stability of the SB-DA films. These findings support the mechanism of the pH-modulated assembly of SB-DA molecules, and for the first time we demonstrate the antifouling properties of the SB-DA to be comparable with traditional thiol-based zwitterionic self-assemblies. The success of modification with SB-DA opens an avenue for developing a biologically inspired surface chemistry and can have applications over a wide spectrum of bioapplications. The strategy of the pH transition can also be applied to other functional dopamine derivatives.
C1 [Huang, Chun-Jen; Wang, Lin-Chuan] Natl Cent Univ, Grad Inst Biomed Engn, Taoyuan 320, Taiwan.
   [Huang, Chun-Jen] Natl Cent Univ, Chem & Mat Engn Dept, Taoyuan 320, Taiwan.
   [Shyue, Jing-Jong] Acad Sinica, Res Ctr Appl Sci, Taipei 115, Taiwan.
   [Chang, Ying-Chih] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.
RP Huang, CJ (reprint author), Natl Cent Univ, Grad Inst Biomed Engn, Taoyuan 320, Taiwan.
EM cjhuang@ncu.edu.tw
RI Shyue, Jing-Jong/D-7222-2011; Huang, Chun-Jen/A-1095-2013
OI Chang, Ying-Chih/0000-0002-8375-6473
FU Ministry of Science and Technology of Taiwan [NSC 102-2221-E-008-011-];
   Center for Dynamical Biomarkers and Translational Medicine, National
   Central University [NSC 101-2911-1-008-001]
FX The authors sincerely appreciate the financial support from the Ministry
   of Science and Technology of Taiwan (NSC 102-2221-E-008-011-) and the
   Center for Dynamical Biomarkers and Translational Medicine, National
   Central University (NSC 101-2911-1-008-001). The authors also thank
   Prof. Jeng-Kuei Chang from NCU for the electrochemical measurements.
CR Amstad E, 2009, NANO LETT, V9, P4042, DOI 10.1021/nl902212q
   Amstad E, 2009, SMALL, V5, P1334, DOI 10.1002/smll.200801328
   Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932
   Bernsmann F, 2011, LANGMUIR, V27, P2819, DOI 10.1021/la104981s
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Chen Q, 2008, J PHYS CHEM C, V112, P17331, DOI 10.1021/jp8050593
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   Emmenegger CR, 2009, LANGMUIR, V25, P6328, DOI 10.1021/la900083s
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Gao CL, 2010, BIOMATERIALS, V31, P1486, DOI 10.1016/j.biomaterials.2009.11.025
   Goda T, 2013, CHEM COMMUN, V49, P8683, DOI 10.1039/c3cc44357d
   HAN S, 1995, POLYM DEGRAD STABIL, V47, P203, DOI 10.1016/0141-3910(94)00109-L
   Han S, 1997, POLYMER, V38, P317, DOI 10.1016/S0032-3861(97)88175-X
   Harris J. M., 1997, POLYETHYLENE GLYCOL
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Huang CJ, 2014, BIOINTERPHASES, V9, DOI 10.1116/1.4869300
   Huang CJ, 2010, BIOMACROMOLECULES, V11, P1231, DOI 10.1021/bm901445r
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Keller CA, 2000, PHYS REV LETT, V84, P5443, DOI 10.1103/PhysRevLett.84.5443
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Lau KHA, 2012, LANGMUIR, V28, P16099, DOI 10.1021/la302131n
   Lee D, 2012, SENSOR ACTUAT B-CHEM, V162, P425, DOI 10.1016/j.snb.2011.12.017
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Li GZ, 2008, J PHYS CHEM B, V112, P15269, DOI 10.1021/jp8058728
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Li SC, 2010, SCIENCE, V328, P882, DOI 10.1126/science.1188328
   Li YT, 2012, LANGMUIR, V28, P9707, DOI 10.1021/la301691d
   Lin P, 2014, LANGMUIR, V30, P6497, DOI 10.1021/la500243s
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Malisova B, 2010, LANGMUIR, V26, P4018, DOI 10.1021/la903486z
   McCloskey BD, 2010, POLYMER, V51, P3472, DOI 10.1016/j.polymer.2010.05.008
   MOSER J, 1991, LANGMUIR, V7, P3012, DOI 10.1021/la00060a018
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   Ou JF, 2010, PROG ORG COAT, V68, P244, DOI 10.1016/j.porgcoat.2010.01.004
   Rajh T, 2002, J PHYS CHEM B, V106, P10543, DOI 10.1021/jp021235v
   Rodenstein M, 2010, LANGMUIR, V26, P16211, DOI 10.1021/la100805z
   Shen CH, 2013, COLLOID SURFACE B, V101, P376, DOI 10.1016/j.colsurfb.2012.07.035
   Shen CH, 2011, LANGMUIR, V27, P7091, DOI 10.1021/la200906b
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   Wei H, 2013, INTEGR BIOL-UK, V5, P108, DOI 10.1039/c2ib20142a
   Wei H, 2012, NANO LETT, V12, P22, DOI 10.1021/nl202721q
   Wei W, 2013, J AM CHEM SOC, V135, P377, DOI 10.1021/ja309590f
   Yang WJ, 2013, POLYM CHEM-UK, V4, P3105, DOI 10.1039/c3py00009e
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
   Yu J, 2013, BIOMACROMOLECULES, V14, P1072, DOI 10.1021/bm301908y
   Zhou ZJ, 2013, ACS NANO, V7, P3287, DOI 10.1021/nn305991e
   Zhu YH, 2014, BIOMACROMOLECULES, V15, P1845, DOI 10.1021/bm500209a
   Zurcher S, 2006, J AM CHEM SOC, V128, P1064, DOI 10.1021/ja056256
NR 56
TC 22
Z9 22
U1 6
U2 149
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 28
PY 2014
VL 30
IS 42
BP 12638
EP 12646
DI 10.1021/la503191b
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AY7ML
UT WOS:000347744100022
PM 25283175
DA 2018-10-20
ER

PT J
AU Karam, JP
   Muscari, C
   Sindji, L
   Bastiat, G
   Bonafe, F
   Venier-Julienne, MC
   Montero-Menei, NC
AF Karam, Jean-Pierre
   Muscari, Claudio
   Sindji, Laurence
   Bastiat, Guillaume
   Bonafe, Francesca
   Venier-Julienne, Marie-Claire
   Montero-Menei, N. Claudia
TI Pharmacologically active microcarriers associated with thermosensitive
   hydrogel as a growth factor releasing biomimetic 3D scaffold for cardiac
   tissue-engineering
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Adipose-derived stem cells; Growth factors; Hydrogel; Pharmacologically
   active microcarriers; Myocardial infarction
ID MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED PHASE-1
   TRIAL; IN-VIVO; ALGINATE BIOMATERIAL; DELIVERY STRATEGIES; PLGA
   MICROSPHERES; PROTEIN DELIVERY; ISCHEMIC-HEART; SURVIVAL
AB The challenge of tissue engineering of the infarcted heart is how to improve stem cell engraftment, survival, homing, and differentiation for myocardial repair. We here propose to integrate human adipose-derived stem cells (ADSCs) and pharmacologically active microcarriers (PAMs), a three-dimensional (3D) carrier of cells and growth factors, into an injectable hydrogel (HG), to obtain a system that stimulates the survival and/or differentiation of the grafted cells toward a cardiac phenotype. PAMs are biodegradable and non-cytotoxic poly(lactic-co-glycolic acid) (PLGA) microspheres conveying cells on their 3D surface that deliver continuously and in a controlled manner a growth factor (GF) acting on the transported cells and on the microenvironment to improve engraftment. The choice of the appropriate GF and its protection during the formulation process and delivery are essential. In this study two GFs, hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-1), have been encapsulated under a solid state in order to limit their interaction with the polymer and conserve their integrity. GF precipitation conditions and release profile from PAMs have been first investigated before combining them to ADSCs. The released IGF-1 and HGF induced the protein synthesis of cardiac differentiation markers GATA4, Nkx2.5, cTn1 and CX43 after 1 week in vitro. Moreover, the GFs accelerated cell cycle progression, as suggested by the increased expression of Cyclin D1 mRNA and the widespread distribution of Ki67 protein. Integrating PAMs within the thermosensitive P407 hydrogel increased their elastic properties but decreased the transcription of most cardiac markers. In contrast, CX43 expression increased in ADSC-PAM-GF complexes embedded within the hydrogel compared to the ADSCs cultured alone in the absence of P407. These results suggest that particulate scaffolds releasing HGF and IGF-1 may be beneficial for applications in tissue-engineering strategies for myocardial repair and the association with a P407 hydrogel can increase substrate elasticity and junction connections in ADSCs. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Karam, Jean-Pierre; Sindji, Laurence; Bastiat, Guillaume; Venier-Julienne, Marie-Claire; Montero-Menei, N. Claudia] LUNAM Univ, UMR S 1066, F-49933 Angers, France.
   [Karam, Jean-Pierre; Sindji, Laurence; Bastiat, Guillaume; Venier-Julienne, Marie-Claire; Montero-Menei, N. Claudia] INSERM U1066, MINT Micro & Nanomed Biomimet, F-49933 Angers, France.
   [Muscari, Claudio; Bonafe, Francesca] Natl Inst Cardiovasc Res INRC, I-40126 Bologna, Italy.
   [Muscari, Claudio; Bonafe, Francesca] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, I-40126 Bologna, Italy.
RP Montero-Menei, NC (reprint author), LUNAM Univ Angers, UMR S 1066, INSERM U1066, 4 Rue Larrey, F-49933 Angers, France.
EM claudia.montero-menei@univ-angers.fr
RI Venier-Julienne, Marie-Claire/K-4439-2015; BASTIAT,
   Guillaume/K-4182-2015; SINDJI, Laurence/K-4421-2015
OI Venier-Julienne, Marie-Claire/0000-0003-0877-3406; 
FU Angers Loire Metropole; "Institut National de le Recherche et de la
   Sante Medical (INSERM)", France; National Institute for Cardiovascular
   Research (INRC); Fondazione dott. Carlo Fornasini (Poggio Renatico, FE),
   Italy
FX We thank the SCIAM ("Service Commun d'Imagerie et d'Analyse
   Microscopique") of Angers for the confocal microscopy images as well as
   the SCCAN ("Service Commun deCytometrie et d'Analyse Nucleotidique") of
   Angers for the use of PCR facilities. Grant information: This work was
   supported by "Angers Loire Metropole", "Institut National de le
   Recherche et de la Sante Medical (INSERM)", France, the National
   Institute for Cardiovascular Research (INRC) and Fondazione dott. Carlo
   Fornasini (Poggio Renatico, FE), Italy.
CR Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Bhavsar PK, 2000, J MOL CELL CARDIOL, V32, P95, DOI 10.1006/jmcc.1999.1058
   Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Chen XH, 2007, J CARD FAIL, V13, P874, DOI 10.1016/j.cardfail.2007.07.004
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Day RM, 2002, ONCOGENE, V21, P2201, DOI 10.1038/sj/onc/1205289
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   Di Lisi R, 1998, J BIOL CHEM, V273, P25371, DOI 10.1074/jbc.273.39.25371
   Duffy HS, 2008, NEW ENGL J MED, V358, P1397, DOI 10.1056/NEJMcibr0708922
   Dumortier G, 2006, PHARM RES, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandes S, 2009, J CELL MOL MED, V13, P3703, DOI 10.1111/j.1582-4934.2009.00740.x
   Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176
   Garbayo E, 2011, J NEUROCHEM, V119, P972, DOI 10.1111/j.1471-4159.2011.07272.x
   Giteau A, 2008, INT J PHARM, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012
   Giteau A, 2008, EUR J PHARM BIOPHARM, V70, P127, DOI 10.1016/j.ejpb.2008.03.006
   Govoni M, 2013, BIOMED RES INT, DOI 10.1155/2013/918640
   Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040
   Hawat G, 2012, J MOL CELL CARDIOL, V53, P559, DOI 10.1016/j.yjmcc.2012.07.008
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Huang SJ, 2013, CELL TRANSPLANT, V22, P701, DOI 10.3727/096368912X655127
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Karam J.P., 2014, J BIOMED MAT A UNPUB
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kitta K, 2003, J BIOL CHEM, V278, P4705, DOI 10.1074/jbc.M211616200
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   Lewis AL, 2010, THER DELIV, V1, P457, DOI 10.4155/TDE.10.17
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Li Z, 2008, CHINESE MED J-PEKING, V121, P336
   Linke A., 2005, P NATL ACAD SCI USA, V102, P66
   Lu G, 2009, CIRCULATION, V119, P2587, DOI 10.1161/CIRCULATIONAHA.108.827691
   Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575
   Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0
   Marban E, 2010, CIRCULATION, V121, P1981, DOI 10.1161/CIRCULATIONAHA.110.952580
   Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010
   Morille M, 2013, J CONTROL RELEASE, V170, P99, DOI 10.1016/j.jconrel.2013.04.017
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Muscari C, 2014, STEM CELLS INT, DOI 10.1155/2014/434169
   Muscari C, 2013, J CELL MOL MED, V17, P518, DOI 10.1111/jcmm.12039
   Musilli C, 2012, EUR J PHARM BIOPHARM, V81, P609, DOI 10.1016/j.ejpb.2012.04.014
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Paillard-Giteau A, 2010, EUR J PHARM BIOPHARM, V75, P128, DOI 10.1016/j.ejpb.2010.03.005
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Pasini A, 2013, CELL BIOCHEM BIOPHYS, V67, P255, DOI 10.1007/s12013-013-9610-z
   Penn M.S., 2010, INT J CARDIOL, V38, P1
   Penna C, 2013, J CELL MOL MED, V17, P192, DOI 10.1111/j.1582-4934.2012.01662.x
   Perez C, 2002, J PHARM PHARMACOL, V54, P301, DOI 10.1211/0022357021778448
   Peters NS, 1996, CLIN SCI, V90, P447, DOI 10.1042/cs0900447
   Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Roggia C, 2007, EXP CELL RES, V313, P921, DOI 10.1016/j.yexcr.2006.12.009
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Srinivas G, 2009, CARDIOL REV, V17, P1, DOI 10.1097/CRD.0b013e31817bd7ab
   Tatard VM, 2005, BIOMATERIALS, V26, P3727, DOI 10.1016/j.biomaterials.2004.09.042
   Thurisch B, 2009, J MOL ENDOCRINOL, V43, P157, DOI 10.1677/JME-09-0030
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11
   van Dijk A, 2008, CELL TISSUE RES, V334, P457, DOI 10.1007/s00441-008-0713-6
   Tran VT, 2012, EUR J PHARM SCI, V45, P128, DOI 10.1016/j.ejps.2011.10.030
   Vandesompele J., 2002, GENOME BIOL, V18, P3, DOI DOI 10.1186/GB-2002-3-7-RESEARCH0034
   Wang LY, 2013, CURR PHARM DESIGN, V19, P6340
   Wu KH, 2011, ANN THORAC SURG, V92, P1917, DOI 10.1016/j.athoracsur.2011.07.012
   Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472
NR 73
TC 24
Z9 24
U1 2
U2 99
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD OCT 28
PY 2014
VL 192
BP 82
EP 94
DI 10.1016/j.jconrel.2014.06.052
PG 13
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AQ0GF
UT WOS:000342460400009
PM 24998940
DA 2018-10-20
ER

PT J
AU Wang, CS
   Chang, TY
   Lin, TY
   Chen, YF
AF Wang, Cih-Su
   Chang, Tsung-Yuan
   Lin, Tai-Yuan
   Chen, Yang-Fang
TI Biologically inspired flexible quasi-single-mode random laser: An
   integration of Pieris canidia butterfly wing and semiconductors
SO SCIENTIFIC REPORTS
LA English
DT Article
ID NANOWIRE LASERS; PHOTONIC STRUCTURES; EMISSION; ARRAYS; FILMS
AB Quasi-periodic structures of natural biomaterial membranes have great potentials to serve as resonance cavities to generate ecological friendly optoelectronic devices with low cost. To achieve the first attempt for the illustration of the underlying principle, the Pieris canidia butterfly wing was embedded with ZnO nanoparticles. Quite interestingly, it is found that the bio-inspired quasi-single-mode random laser can be achieved by the assistance of the skeleton of the membrane, in which ZnO nanoparticles act as emitting gain media. Such unique characteristics can be interpreted well by the Fabry-Perot resonance existing in the window-like quasi-periodic structure of butterfly wing. Due to the inherently promising flexibility of butterfly wing membrane, the laser action can still be maintained during the bending process. Our demonstrated approach not only indicates that the natural biological structures can provide effective scattering feedbacks but also pave a new avenue towards designing bio-controlled photonic devices.
C1 [Wang, Cih-Su; Chen, Yang-Fang] Natl Taipei Univ Technol, Dept Phys, Taipei 106, Taiwan.
   [Chang, Tsung-Yuan; Lin, Tai-Yuan] Natl Taiwan Ocean Univ, Inst Optoelect Sci, Chilung 202, Taiwan.
RP Chen, YF (reprint author), Natl Taipei Univ Technol, Dept Phys, Taipei 106, Taiwan.
EM yfchen@phys.ntu.edu.tw
FU National Science Council; Ministry of Education of the Republic of China
FX This work was supported by the National Science Council and the Ministry
   of Education of the Republic of China.
CR Cao BL, 2007, ADV FUNCT MATER, V17, P1501, DOI 10.1002/adfm.200601179
   Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278
   Chen YT, 2011, OPT EXPRESS, V19, P8728, DOI 10.1364/OE.19.008728
   Chu S, 2011, NAT NANOTECHNOL, V6, P506, DOI [10.1038/nnano.2011.97, 10.1038/NNANO.2011.97]
   Fang HH, 2012, J MATER CHEM, V22, P24139, DOI 10.1039/c2jm35394f
   Gather MC, 2011, NAT PHOTONICS, V5, P406, DOI [10.1038/nphoton.2011.99, 10.1038/NPHOTON.2011.99]
   Grivas C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3376
   Huang JY, 2006, NANO LETT, V6, P2325, DOI 10.1021/nl061851t
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Johnson JC, 2002, NAT MATER, V1, P106, DOI 10.1038/nmat728
   Kozlov VG, 1998, J APPL PHYS, V84, P4096, DOI 10.1063/1.368624
   Leonetti M, 2011, NAT PHOTONICS, V5, P615, DOI [10.1038/nphoton.2011.217, 10.1038/NPHOTON.2011.217]
   Li JB, 2013, ADV MATER, V25, P833, DOI 10.1002/adma.201203692
   Ma XY, 2009, OPT EXPRESS, V17, P14426, DOI 10.1364/OE.17.014426
   Manekkathodi A, 2010, ADV MATER, V22, P4059, DOI 10.1002/adma.201001289
   Nizamoglu S., 2013, ADV MATER, V25, P5988
   Noh H, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.183901
   Polson RC, 2010, J OPT-UK, V12, DOI 10.1088/2040-8978/12/2/024010
   Sakai M, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3495993
   Saxena D, 2013, NAT PHOTONICS, V7, P963, DOI [10.1038/nphoton.2013.303, 10.1038/NPHOTON.2013.303]
   Song QH, 2010, OPT LETT, V35, P1425, DOI 10.1364/OL.35.001425
   Srinivasarao M, 1999, CHEM REV, V99, P1935, DOI 10.1021/cr970080y
   Sun YZ, 2010, P NATL ACAD SCI USA, V107, P16039, DOI 10.1073/pnas.1003581107
   Vukusic P, 2003, NATURE, V424, P852, DOI 10.1038/nature01941
   Wang CS, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3515913
   Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/NPHOTON.2013.29, 10.1038/nphoton.2013.29]
   Xu HW, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768300
   Zhang D., 2012, QRG ELECT, V13, P2342
   Zhang ZL, 2012, NANOSCALE, V4, P2606, DOI 10.1039/c2nr30284e
NR 29
TC 20
Z9 21
U1 3
U2 45
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 23
PY 2014
VL 4
AR 6736
DI 10.1038/srep06736
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR5AK
UT WOS:000343597300007
PM 25338507
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hawker, MJ
   Pegalajar-Jurado, A
   Fisher, ER
AF Hawker, Morgan J.
   Pegalajar-Jurado, Adoracion
   Fisher, Ellen R.
TI Conformal Encapsulation of Three-Dimensional, Bioresorbable Polymeric
   Scaffolds Using Plasma-Enhanced Chemical Vapor Deposition
SO LANGMUIR
LA English
DT Article
ID SURFACE CHARACTERIZATION; BIOMEDICAL APPLICATIONS; CONTINUOUS-WAVE;
   OXYGEN PLASMA; FLUOROCARBON; TISSUE; FILMS; ATTACHMENT; BIOMATERIALS;
   CHEMISTRY
AB Bioresorbable polymers such as poly(e-caprolactone) (PCL) have a multitude of potential biomaterial applications such as controlled-release drug delivery and regenerative tissue engineering. For such biological applications, the fabrication of porous three-dimensional bioresorbable materials with tunable surface chemistry is critical to maximize their surface-to-volume ratio, mimic the extracellular matrix, and increase drug-loading capacity. Here, two different fluorocarbon (FC) precursors (octofluoropropane (C3F8) and hexafluoropropylene oxide (HFPO)) were used to deposit FC films on PCL scaffolds using plasma-enhanced chemical vapor deposition (PECVD). These two coating systems were chosen with the intent of modifying the scaffold surfaces to be bio-nonreactive while maintaining desirable bulk properties of the scaffold. X-ray photoelectron spectroscopy showed high-CF2 content films were deposited on both the exterior and interior of PCL scaffolds and that deposition behavior is PECVD system specific. Scanning electron microscopy data confirmed that FC film deposition yielded conformal rather than blanket coatings as the porous scaffold structure was maintained after plasma treatment. Treated scaffolds seeded with human dermal fibroblasts (HDF) demonstrate that the cells do not attach after 72 h and that the scaffolds are noncytotoxic to HDF. This work demonstrates conformal FC coatings can be deposited on 3D polymeric scaffolds using PECVD to fabricate 3D bio-nonreactive materials.
C1 [Hawker, Morgan J.; Pegalajar-Jurado, Adoracion; Fisher, Ellen R.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
RP Fisher, ER (reprint author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
EM Ellen.Fisher@ColoState.Edu
FU National Science Foundation [CHE-1152963]; Camille and Henry Dreyfus
   Foundation Postdoctoral Program in Environmental Chemistry
FX Funding was provided by the National Science Foundation (CHE-1152963).
   A.P.J. also acknowledges support via the Camille and Henry Dreyfus
   Foundation Postdoctoral Program in Environmental Chemistry. We also
   thank Dr. Patrick McCurdy and Dr. Jeffrey Shearer for assistance with
   SEM and XPS analyses and some preliminary deposition studies.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Barry JJA, 2005, ADV FUNCT MATER, V15, P1134, DOI 10.1005/adfm.200400562
   Butoi CI, 2000, CHEM MATER, V12, P2014, DOI 10.1021/cm0002416
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Cicala G, 2003, DIAM RELAT MATER, V12, P2020, DOI 10.1016/S0925-9635(03)00293-0
   Cuddy MF, 2012, ACS APPL MATER INTER, V4, P1733, DOI 10.1021/am2018546
   d'Agostino R., 1990, PLASMA DEPOSITION TR, P95
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   Favia P, 2012, SURF COAT TECH, V211, P50, DOI 10.1016/j.surfcoat.2012.01.032
   Fisher ER, 2013, ACS APPL MATER INTER, V5, P9312, DOI 10.1021/am4025966
   Forch R, 2007, CHEM VAPOR DEPOS, V13, P280, DOI 10.1002/cvde.200604035
   France RM, 1998, CHEM MATER, V10, P1176, DOI 10.1021/cm970761+
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Godek ML, 2006, PLASMA PROCESS POLYM, V3, P485, DOI 10.1002/ppap.200600007
   Guerrouani N., 2007, J APPL POLYM SCI, V105, P1978
   Haidopoulos M., 2005, PLASMA PROCESS POLYM, V2, P424
   Hasirci N, 2010, SURF INTERFACE ANAL, V42, P486, DOI 10.1002/sia.3247
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O
   Intranuovo F, 2011, SURF COAT TECH, V205, pS548, DOI 10.1016/j.surfcoat.2011.04.069
   Intranuovo F., 2014, PLASMA PROCESS POLYM, V11, P196
   Intranuovo F, 2011, ACTA BIOMATER, V7, P3336, DOI 10.1016/j.actbio.2011.05.020
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Khang GS, 2006, BIOMATERIALS TISSUE
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Limb SJ, 1997, J VAC SCI TECHNOL A, V15, P1814, DOI 10.1116/1.580796
   Mackie NM, 1997, CHEM MATER, V9, P349, DOI 10.1021/cm960388q
   Madhumathi K, 2010, J MATER SCI-MATER M, V21, P807, DOI 10.1007/s10856-009-3877-z
   Martin IT, 2004, J VAC SCI TECHNOL A, V22, P227, DOI 10.1116/1.1638779
   Masel R., 1996, PRINCIPLES OF ADSORP
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Ong J., 2013, INTRODUCTION TO BIOM
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P162
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Sumitsawan S, 2011, ENVIRON SCI TECHNOL, V45, P6970, DOI 10.1021/es2012963
   Vert M., 2012, PURE APPL CHEM, V84
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
NR 40
TC 12
Z9 12
U1 0
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD OCT 21
PY 2014
VL 30
IS 41
BP 12328
EP 12336
DI 10.1021/la502596f
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AR5QN
UT WOS:000343638800028
PM 25247481
DA 2018-10-20
ER

PT J
AU Browne, S
   Pandit, A
AF Browne, S.
   Pandit, A.
TI Multi-modal delivery of therapeutics using biomaterial scaffolds
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; FOREIGN-BODY REACTION; VII COLLAGEN GENE;
   SIZE DEFECT MODEL; SEQUENTIAL DELIVERY; DUAL-DELIVERY; BONE
   REGENERATION; CONTROLLED-RELEASE; MYOCARDIAL-INFARCTION;
   EPIDERMOLYSIS-BULLOSA
AB Functionalisation of biomaterials with therapeutic moieties (proteins, drugs, genes) is a pre-requisite to tissue regeneration and restoration of function following injury or disease. However, up until now, single-factor delivery has not proven to be clinically efficacious, most likely due to the complex nature of pathological states. In this regard, strategies that respect the complex nature of disease can prove successful, paving the way for the delivery of several factors to modulate several stages of the pathology over time. Biomaterials offer opportunities to deliver multiple therapeutics in a temporal manner (multi-modal release) using a number of strategies. The importance of these strategies will be described, as well as the methodologies used to achieve multi-modal release. Furthermore, strategies to engineer more programmed and responsive biomaterials as multi-modal delivery systems will be explored.
C1 [Browne, S.; Pandit, A.] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933
FU Science Foundation Ireland [07/SRC/B1163]
FX The authors would like to acknowledge financial support from Science
   Foundation Ireland (Grant no. 07/SRC/B1163). The authors would like to
   thank Mr Maciej Doczyk for assistance with graphics and Mr Anthony Sloan
   for editorial assistance.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Banquet S, 2011, CIRCULATION, V124, P1059, DOI 10.1161/CIRCULATIONAHA.110.010264
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Breen A, 2008, J INVEST SURG, V21, P261, DOI 10.1080/08941930802216807
   Browne S, 2012, MOL PHARMACEUT, V9, P3099, DOI 10.1021/mp300231d
   Brudno Y, 2013, BIOMATERIALS, V34, P9201, DOI 10.1016/j.biomaterials.2013.08.007
   Chan OCM, 2008, J CONTROL RELEASE, V129, P135, DOI 10.1016/j.jconrel.2008.04.011
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143
   Daly WT, 2012, BIOMATERIALS, V33, P6660, DOI 10.1016/j.biomaterials.2012.06.002
   Dang JM, 2006, ADV DRUG DELIVER REV, V58, P487, DOI 10.1016/j.addr.2006.03.001
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   Dash BC, 2010, BIOMATERIALS, V31, P8188, DOI 10.1016/j.biomaterials.2010.07.067
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2011, J BIOMED MATER RES A, V98A, P372, DOI 10.1002/jbm.a.33112
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Enoch S., 2005, SURGERY, V23, P37, DOI DOI 10.1383/SURG.23.2.37.60352
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freeman I, 2009, BIOMATERIALS, V30, P2122, DOI 10.1016/j.biomaterials.2008.12.057
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   He SH, 2012, ACTA BIOMATER, V8, P2659, DOI 10.1016/j.actbio.2012.03.044
   Hirabara S, 2013, BIOCHEM BIOPH RES CO, V430, P519, DOI 10.1016/j.bbrc.2012.12.003
   Holladay C, 2009, J CONTROL RELEASE, V136, P220, DOI 10.1016/j.jconrel.2009.02.006
   Hong L, 2005, ANN BIOMED ENG, V33, P511, DOI 10.1007/s10439-005-2510-7
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jaklenec A, 2008, BIOMATERIALS, V29, P185, DOI 10.1016/j.biomaterials.2007.09.017
   Jarvikallio A, 1997, HUM MUTAT, V10, P338
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Keeney M, 2010, BIOMATERIALS, V31, P2893, DOI 10.1016/j.biomaterials.2009.12.041
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009
   Kinnunen K, 2006, ACTA PHYSIOL, V187, P447, DOI 10.1111/j.1748-1716.2006.01588.x
   Kirschner CM, 2013, ACTA MATER, V61, P931, DOI 10.1016/j.actamat.2012.10.037
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Kong HJ, 2008, PHARM RES, V25, P1230, DOI 10.1007/s11095-007-9526-7
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kulkarni M, 2014, BIOMATERIALS, V35, P2001, DOI 10.1016/j.biomaterials.2013.11.003
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Lei YG, 2011, J CONTROL RELEASE, V153, P255, DOI 10.1016/j.jconrel.2011.01.028
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Marui A, 2005, J VASC SURG, V41, P82, DOI 10.1016/j.jvs.2004.10.029
   Messenger MP, 2011, ADV MATER, V23, pH10, DOI 10.1002/adma.201100254
   Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x
   Nelson DM, 2014, BIOMACROMOLECULES, V15, P1, DOI 10.1021/bm4010639
   Nelson DM, 2012, J BIOMED MATER RES A, V100A, P776, DOI 10.1002/jbm.a.34015
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Numata K, 2012, BIOMACROMOLECULES, V13, P1383, DOI 10.1021/bm300089a
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prestwich GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004915
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Schaffer MR, 1997, SURGERY, V121, P513, DOI 10.1016/S0039-6060(97)90105-7
   Shi CY, 2011, BIOMATERIALS, V32, P2508, DOI 10.1016/j.biomaterials.2010.12.026
   Shin SH, 2013, J CONTROL RELEASE, V166, P38, DOI 10.1016/j.jconrel.2012.12.020
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   Singh A, 2008, MOL THER, V16, P2011, DOI 10.1038/mt.2008.206
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Su J, 2010, TISSUE ENG PT A, V16, P905, DOI [10.1089/ten.tea.2009.0488, 10.1089/ten.TEA.2009.0488]
   Sung JY, 2009, BIOMATERIALS, V30, P622, DOI 10.1016/j.biomaterials.2008.09.052
   Sy JC, 2008, NAT MATER, V7, P863, DOI 10.1038/nmat2299
   Sy JC, 2010, BIOMATERIALS, V31, P4987, DOI 10.1016/j.biomaterials.2010.02.063
   Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.TEA.2010.0551, 10.1089/ten.tea.2010.0551]
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   UITTO J, 1994, ARCH DERMATOL RES, V287, P16, DOI 10.1007/BF00370713
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Wang Z, 2010, BIOMATERIALS, V31, P7115, DOI 10.1016/j.biomaterials.2010.05.075
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yang ZZ, 2014, BIOMATERIALS, V35, P5226, DOI 10.1016/j.biomaterials.2014.03.017
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 95
TC 22
Z9 22
U1 0
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD OCT 21
PY 2014
VL 2
IS 39
BP 6692
EP 6707
DI 10.1039/c4tb00863d
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA AQ5NR
UT WOS:000342856400002
DA 2018-10-20
ER

PT J
AU Cheng, CX
   Alt, V
   Pan, LY
   Thormann, U
   Schnettler, R
   Strauss, LG
   Heinemann, S
   Schumacher, M
   Gelinsky, M
   Nies, B
   Dimitrakopoulou-Strauss, A
AF Cheng, Caixia
   Alt, Volker
   Pan, Leyun
   Thormann, Ulrich
   Schnettler, Reinhard
   Strauss, Ludwig G.
   Heinemann, Sascha
   Schumacher, Matthias
   Gelinsky, Michael
   Nies, Berthold
   Dimitrakopoulou-Strauss, Antonia
TI Application of F-18-Sodium Fluoride (NaF) Dynamic PET-CT (dPET-CT) for
   Defect Healing: A Comparison of Biomaterials in an Experimental
   Osteoporotic Rat Model
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Aortopulmonary Septal Defect; Biomarkers; Pharmacological; Osteoporosis
ID PHOSPHATE BONE-CEMENT; POSITRON-EMISSION-TOMOGRAPHY;
   MECHANICAL-PROPERTIES; STRONTIUM; SILICA; PERSPECTIVES; COMPOSITES;
   SCAFFOLDS; IMPLANTS; DESIGN
AB Background: The aim of the current study was to measure and compare the effect of various biomaterials for the healing of osteoporotic bone defects in the rat femur using F-18-sodium fluoride dPET-CT.
   Material/Methods: Osteoporosis was induced by ovariectomy and a calcium-restricted diet. After 3 months, rats were operated on to create a 4-mm wedge-shaped defect in the distal metaphyseal femur. Bone substitution materials of calcium phosphate cement (CPC), composites of collagen and silica, and iron foams with interconnecting pores were inserted. Strontium or bisphosphonate, which are well known for having positive effects in osteoporosis treatment, were added into the materials. Eighteen weeks after osteoporosis induction and 6 weeks following femoral surgery, dPET-CT studies scan were performed with F-18-Sodium Fluoride. Standardized uptake values (SUVs) and a 2-tissue compartmental learning-machine model (K1-k4, vessel density [VB], influx [ki]) were used for quantitative analysis.
   Results: k3, reflecting the formation of fluoroapatite, revealed a statistically significant increase at the biomaterial-bone interface due to the Sr release from strontium-modified calcium phosphate cement (SrCPC) compared to CPC, which demonstrated enhanced new bone formation. In addition, k3 as measured in the porous scaffold silica/collagen xerogel (Sc-B30), showed a significant increase based on Wilcoxon rank-sum test (p<0.05) as compared with monolithic silica/collagen xerogel (B30) in the defect region. Furthermore, ki, reflecting the net plasma clearance of tracer to bone mineral measured in the iron foam with coating of the bisphosphonate zoledronic acid (Fe-BP), was enhanced as compared with plain iron foam (Fe) in the defect region.
   Conclusions: k3 was the most significant parameter for the characterization of healing processes and revealed the best differentiation between the 2 different biomaterials. PET scanning using F-18-sodium fluoride seems to be a sensitive and useful method for evaluation of bone healing after replacement with these biomaterials.
C1 [Cheng, Caixia; Pan, Leyun; Strauss, Ludwig G.; Dimitrakopoulou-Strauss, Antonia] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany.
   [Alt, Volker; Thormann, Ulrich; Schnettler, Reinhard] Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg, Giessen, Germany.
   [Heinemann, Sascha] Tech Univ Dresden, Inst Mat Sci, Max Bergmann Ctr Biomat, D-01062 Dresden, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Fac Med, D-01062 Dresden, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Univ Hosp Carl Gustav Carus, Dresden, Germany.
   [Nies, Berthold] InnoTERE GmbH, Radebeul, Germany.
RP Cheng, CX (reprint author), German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany.
EM c.cheng@dkfz.de
RI Schumacher, Matthias/I-1530-2013
OI Schumacher, Matthias/0000-0001-7207-7355
FU Deutsche Forschungsgemeinschaft (German Research Foundation, DFG); 
   [Sonderforschungsbereich-Transregio 79 (SFB-TR 79)]
FX This study is part of the Sonderforschungsbereich-Transregio 79 (SFB-TR
   79) and was in part financially supported by the Deutsche
   Forschungsgemeinschaft (German Research Foundation, DFG)
CR Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002
   Alt V, 2011, ACTA BIOMATER, V7, P3773, DOI 10.1016/j.actbio.2011.06.024
   Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031
   Burger C, 1997, J NUCL MED, V38, P1818
   Cheng C, 2012, MOL IMAGING BIOL, V15, P336
   Cheng CX, 2014, INJURY, V45, P501, DOI 10.1016/j.injury.2013.11.023
   Desimone MF, 2010, J MATER CHEM, V20, P666, DOI 10.1039/b921572g
   Dimitrakopoulou-Strauss A, 2003, WORLD J NUCL MED, V2, P306
   Egli RJ, 2012, SWISS MED WEEKLY, V142
   Glorius S, 2011, ADV ENG MATER, V13, P1019, DOI 10.1002/adem.201100026
   Goldhahn J, 2008, BONE, V43, P343, DOI 10.1016/j.bone.2008.04.017
   Heinemann S, 2011, COMPOS SCI TECHNOL, V71, P1873, DOI 10.1016/j.compscitech.2011.08.023
   Heinemann S, 2011, ACS APPL MATER INTER, V3, P4323, DOI 10.1021/am200993q
   Heinemann S, 2013, BIOMATER SCI-UK, V1, P688, DOI 10.1039/c3bm00014a
   Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895
   Jones JR, 2010, P I MECH ENG H, V224, P1373, DOI 10.1243/09544119JEIM836
   Kaluzny JJ, 2012, MED SCI MONITOR, V18, pBR402
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)80005-1
   Low KL, 2010, J BIOMED MATER RES B, V94B, P273, DOI 10.1002/jbm.b.31619
   Marie PJ, 2007, BONE, V40, pS5, DOI 10.1016/j.bone.2007.02.003
   MESSA C, 1993, J CLIN ENDOCR METAB, V77, P949, DOI 10.1210/jc.77.4.949
   Mikolajczyk K, 1998, MED INFORM, V23, P207, DOI 10.3109/14639239809001400
   National Osteoporosis Foundation, 2010, CLIN GUID PREV TREAT
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Quadbeck P, PM2010 WORLD C
   Quadbeck P, 2011, ADV ENG MATER, V13, P1024, DOI 10.1002/adem.201100023
   Schumacher M, 2013, ACTA BIOMATER, V9, P9547, DOI 10.1016/j.actbio.2013.07.027
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   STRAUSS LG, 1991, J NUCL MED, V32, P623
   Strauss LG, 2007, IEEE T MED IMAGING, V26, P804, DOI 10.1109/TMI.2007.892645
   Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036
   Ventura M, 2014, J CONTROL RELEASE, V183, P138, DOI 10.1016/j.jconrel.2014.03.044
NR 32
TC 0
Z9 0
U1 0
U2 7
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD OCT 15
PY 2014
VL 20
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AS8YI
UT WOS:000344530500002
DA 2018-10-20
ER

PT J
AU Tung, YT
   Tsai, TC
   Kuo, YH
   Yen, CC
   Sun, JY
   Chang, WH
   Chen, HL
   Chen, CM
AF Tung, Yu-Tang
   Tsai, Tung-Chou
   Kuo, Yueh-Hsiung
   Yen, Chih-Ching
   Sun, Jheng-Yue
   Chang, Wen-Hui
   Chen, Hsiao-Ling
   Chen, Chuan-Mu
TI Comparison of solid-state-cultured and wood-cultured Antrodia camphorata
   in anti-inflammatory effects using NF-kappa B/luciferase inducible
   transgenic mice
SO PHYTOMEDICINE
LA English
DT Article
DE Antrodia camphorata; Solid-state-cultured mycelia; Wood-cultured
   fruiting bodies; Hyperoxia-induced inflammatory responses; NF-kappa
   B-luciferase(+/+) transgenic mice; Acute lung injury
ID HOST-BIOMATERIAL INTERACTION; DEHYDROEBURICOIC ACID; EBURICOIC ACID; B
   ACTIVATION; LACTOFERRIN; EXPRESSION; EXTRACT; CELLS; MILK; ANTIOXIDANTS
AB Purpose: Antrodia camp horata (AC), a highly valued polypore mushroom native only to Taiwan, has been traditionally used as a medicine for the treatment of food and drug intoxication, diarrhea, abdominal pain, hypertension, skin itching, and cancer. In this study, both of solid-state-cultured AC (S-AC) and woodcultured AC (W-AC) were evaluated the anti-inflammatory effects on hyperoxia-induced lung injury in NF-kappa 13-luciferase(+/+) transgenic mice.
   Methods: The homozygous transgenic mice (NF-kappa 13-luciferase(+/+)) were randomly assigned to four groups for treatment (n = 6) including Normoxia/DMSO group, Hyperoxia/DMSO group, Hyperoxia/S-AC group, and Hyperoxia/W-AC group. After 72 h of hyperoxia, we examined the bioluminescence images, reactive oxygen species (ROS), the mRNA and protein expression levels of inflammation factors, and histopathological analyses of the lung tissues.
   Results: Hyperoxia-induced lung injury significantly increased the generation of ROS, the mRNA levels of IL-6, TNF-alpha, IL-1 beta and IL-8, and the protein expression levels of IKK alpha/beta, iNOS and IL-6. Pulmonary edema and alveolar infiltration of neutrophils was also observed in the hyperoxia-induced lung tissue. However, treatment with either S-AC or W-AC obviously decreased hyperoxia-induced generation of ROS and the expression of IL-6, TNF-alpha, IL-1 beta, IL-8, IKK alpha/beta and iNOS compared to hyperoxia treatment alone. Lung histopathology also showed that treatment with either S-AC or W-AC significantly reduced neutrophil infiltration and lung edema compared to treatment with hyperoxia treated alone. To find out their major compounds, eburicoic acid and dehydroeburicoic acid were both isolated and identified from S-AC and W-AC by using HPLC, MS, and NMR spectrometry.
   Conclusions: These results demonstrated that methanolic extracts both of S-AC and W-AC have excellent anti-inflammatory activities and thus have great potential as a source for natural health products. (C) 2014 Elsevier GmbH. All rights reserved.
C1 [Tung, Yu-Tang; Tsai, Tung-Chou; Sun, Jheng-Yue; Chang, Wen-Hui; Chen, Chuan-Mu] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Dept Life Sci, Taichung 402, Taiwan.
   [Kuo, Yueh-Hsiung] China Med Univ, Dept Chinese Pharmaceut Sci & Chinese Med Resourc, Taichung 404, Taiwan.
   [Kuo, Yueh-Hsiung] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.
   [Yen, Chih-Ching] China Med Univ Hosp, Taichung 404, Taiwan.
   [Yen, Chih-Ching] China Med Univ, Taichung 404, Taiwan.
   [Chen, Hsiao-Ling] Da Yeh Univ, Dept Bioresources, Changhua 515, Taiwan.
   [Chen, Chuan-Mu] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan.
   [Chen, Chuan-Mu] Natl Chung Hsing Univ, iEGG Ctr, Taichung 402, Taiwan.
RP Chen, CM (reprint author), Natl Chung Hsing Univ, Dept Life Sci, Off Res & Dev, Kuo Kuang Rd, Taichung 402, Taiwan.
EM chchen1@dragon.nchu.edu.tw
OI Tung, Yu-Tang/0000-0002-4780-6496
FU National Science Council, the Ministry of Education, Taiwan, Republic of
   China [NSC-97-2313-B-005-004-MY3, NSC-101-2313-B-005-014-MY3]; CMU under
   the Aim for Top of the Ministry of Education, Taiwan; Department of
   Health Clinical Trial and Research Center of Excellent, Taiwan [DOH
   102-TD-C-111-004]
FX This research was supported in part by grants NSC-97-2313-B-005-004-MY3
   and NSC-101-2313-B-005-014-MY3 from the National Science Council, the
   Ministry of Education, Taiwan, Republic of China, under the Aiming for
   the Top University (ATU) program, CMU under the Aim for Top of the
   Ministry of Education, Taiwan, and the Department of Health Clinical
   Trial and Research Center of Excellent (DOH 102-TD-C-111-004), Taiwan.
CR ALMEHDI A, 1994, LAB INVEST, V70, P579
   Chen HL, 2008, VACCINE, V26, P891, DOI 10.1016/j.vaccine.2007.12.013
   Chen JY, 2012, J ETHNOPHARMACOL, V142, P811, DOI 10.1016/j.jep.2012.06.005
   Chen YJ, 2008, CANCER BIOL THER, V7, P777, DOI 10.4161/cbt.7.5.5768
   Deng JS, 2013, J AGR FOOD CHEM, V61, P5064, DOI 10.1021/jf303820k
   Fisher AB, 2008, AM J PHYSIOL-LUNG C, V295, pL1066, DOI 10.1152/ajplung.90486.2008
   Geethangili M., 2009, ALTERN MED, V2009
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hseu YC, 2002, LIFE SCI, V71, P469, DOI 10.1016/S0024-3205(02)01686-7
   Hseu YC, 2010, FOOD CHEM TOXICOL, V48, P2319, DOI 10.1016/j.fct.2010.05.066
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Hsiao G, 2003, J AGR FOOD CHEM, V51, P3302, DOI 10.1021/jf021159t
   Huang GJ, 2013, FOOD CHEM, V141, P3020, DOI 10.1016/j.foodchem.2013.03.061
   Liu DZ, 2007, J ETHNOPHARMACOL, V113, P45, DOI 10.1016/j.jep.2007.03.037
   Ma Q, 2003, MOL PHARMACOL, V64, P211, DOI 10.1124/mol.64.2.211
   Peng CC, 2007, J ETHNOPHARMACOL, V109, P93, DOI 10.1016/j.jep.2006.07.009
   Rao YK, 2007, J ETHNOPHARMACOL, V114, P78, DOI [10.1016/j.jep.2007.07.028, 10.1016/jjep.2007.07.028]
   Shen CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032812
   Shen YC, 2004, PLANTA MED, V70, P310, DOI 10.1055/s-2004-818941
   Suleyman H, 2007, PHARMACOL REP, V59, P247
   Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X
   Tsai TC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-88
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wu SC, 2007, J AGR FOOD CHEM, V55, P4670, DOI 10.1021/jf063759o
   Yen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026870
   Yen CC, 2009, J INFECT DIS, V199, P590, DOI 10.1086/596212
NR 26
TC 4
Z9 4
U1 1
U2 27
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0944-7113
EI 1618-095X
J9 PHYTOMEDICINE
JI Phytomedicine
PD OCT 15
PY 2014
VL 21
IS 12
BP 1708
EP 1716
DI 10.1016/j.phymed.2014.08.011
PG 9
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA AS4JK
UT WOS:000344241200027
PM 25442281
DA 2018-10-20
ER

PT J
AU Singh, A
   Peppas, NA
AF Singh, Ankur
   Peppas, Nicholas A.
TI Hydrogels and Scaffolds for Immunomodulation
SO ADVANCED MATERIALS
LA English
DT Article
DE immunology; hydrogels; biomaterials; scaffolds; immunomodulation;
   polymers
ID DEGRADABLE DEXTRAN HYDROGELS; REGULATORY T-CELLS; THERMAL-SENSITIVE
   HYDROGEL; HEPATITIS-B-VACCINE; IN-SITU; DENDRITIC CELLS;
   CONTROLLED-RELEASE; ADDITION-REACTIONS; MICHAEL ADDITION;
   IMMUNE-RESPONSES
AB For over two decades, immunologists and biomaterials scientists have co-existed in parallel world with the rationale of understanding the molecular profile of immune responses to vaccination, implantation, and treating incurable diseases. Much of the field of biomaterial-based immunotherapy has relied on evaluating model antigens such as chicken egg ovalbumin in mouse models but their relevance to humans has been point of much discussion. Nevertheless, such model antigens have provided important insights into the mechanisms of immune regulation and served as a proof-of-concept for plethora of biomaterial-based vaccines. After years of extensive development of numerous biomaterials for immunomodulation, it is only recently that an experimental scaffold vaccine implanted beneath the skin has begun to use the human model to study the immune responses to cancer vaccination by co-delivering patient-derived tumor lysates and immunomodulatory proteins. If successful, this scaffold vaccine will change the way we approached untreatable cancers, but more importantly, will allow a faster and more rational translation of therapeutic regimes to other cancers, chronic infections, and autoimmune diseases. Most materials reviews have focused on immunomodulatory adjuvants and micro-nano-particles. Here we provide an insight into emerging hydrogel and scaffold based immunomodulatory approaches that continue to demonstrate efficacy against immune associated diseases.
C1 [Singh, Ankur] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Dept Chem Engn, Dept Biomed Engn, Austin, TX 78712 USA.
   [Peppas, Nicholas A.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.
RP Singh, A (reprint author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
EM as2833@cornell.edu; peppas@che.utexas.edu
OI Singh, Ankur/0000-0002-3501-2277
FU National Institutes of Health [1R21 CA185236-01, EB 1R01-000346-21];
   Cornell University-Ithaca; Weill Cornell Medical College; National
   Science Foundation; Melinda and Bill Gates Foundation
FX The authors would like to acknowledge financial support by grants from
   the National Institutes of Health (1R21 CA185236-01 (A. S.), EB
   1R01-000346-21 (N.A.P)), the Cornell University-Ithaca and Weill Cornell
   Medical College seed grant (A. S.), the National Science Foundation
   (N.A.P.), and the Melinda and Bill Gates Foundation (N.A.P). The content
   is solely the responsibility of the authors and does not necessarily
   represent the official views of the funding agencies.
CR Agarwal R., 2013, P NATL ACAD SCI US
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Bondeson J, 2010, ARTHRITIS RHEUM-US, V62, P647, DOI 10.1002/art.27290
   Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291
   Chong SF, 2009, BIOMATERIALS, V30, P5178, DOI 10.1016/j.biomaterials.2009.05.078
   Chou HY, 2010, J IMMUNOL, V185, P5468, DOI 10.4049/jimmunol.1001875
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Monsalvo AC, 2011, NAT MED, V17, P195, DOI 10.1038/nm.2262
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dolgin E, 2013, NATURE, V504, pS16, DOI 10.1038/504S16a
   Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Esensten JH, 2009, NAT REV RHEUMATOL, V5, P560, DOI 10.1038/nrrheum.2009.183
   Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150
   Flaherty KT, 2012, NAT REV CANCER, V12, P349, DOI 10.1038/nrc3218
   Franssen O, 1999, J CONTROL RELEASE, V60, P211, DOI 10.1016/S0168-3659(99)00074-7
   Franssen O, 1999, J CONTROL RELEASE, V59, P219, DOI 10.1016/S0168-3659(98)00193-X
   Garcia AJ, 2014, ANN BIOMED ENG, V42, P312, DOI 10.1007/s10439-013-0870-y
   Goldring MB, 2008, ANN RHEUM DIS, V67, P75, DOI 10.1136/ard.2008.098764
   Graham JG, 2013, TISSUE ENG PT A, V19, P1465, DOI [10.1089/ten.tea.2012.0643, 10.1089/ten.TEA.2012.0643]
   Gubeli RJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02610
   Hahn SK, 2007, INT J BIOL MACROMOL, V40, P374, DOI 10.1016/j.ijbiomac.2006.09.019
   Hiemstra C, 2007, J CONTROL RELEASE, V122, P71, DOI 10.1016/j.jconrel.2007.06.011
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105
   Hori Y., 2008, ACTA BIOMATER
   Hori Y, 2008, BIOMATERIALS, V29, P3671, DOI 10.1016/j.biomaterials.2008.05.033
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Irvine DJ, 2008, SEMIN IMMUNOL, V20, P137, DOI 10.1016/j.smim.2007.10.010
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Kageyama S, 2008, CANCER SCI, V99, P601, DOI 10.1111/j.1349-7006.2007.00705.x
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Kim J, 2007, BIOMACROMOLECULES, V8, P3682, DOI 10.1021/bm700756z
   Kim JM, 2001, ACT NEUR S, V77, P77
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Kumamoto T, 2002, NAT BIOTECHNOL, V20, P64, DOI 10.1038/nbt0102-64
   Lee J, 2009, SMALL, V5, P1008, DOI 10.1002/smll.200801242
   Li XD, 2013, VACCINE, V31, P4508, DOI 10.1016/j.vaccine.2013.07.080
   Liechty WB, 2011, J CONTROL RELEASE, V155, P119, DOI 10.1016/j.jconrel.2011.06.009
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Malemud CJ, 2010, DRUG AGING, V27, P95, DOI 10.2165/11319950-000000000-00000
   Matsuo K, 2011, J CONTROL RELEASE, V149, P15, DOI 10.1016/j.jconrel.2010.05.012
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Nagaraj S, 2007, NAT MED, V13, P828, DOI 10.1038/nm1609
   Nair DP, 2014, CHEM MATER, V26, P724, DOI 10.1021/cm402180t
   Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]
   Orienti I, 2002, ARCH PHARM, V335, P89, DOI 10.1002/1521-4184(200203)335:2/3<89::AID-ARDP89>3.0.CO;2-4
   Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/NMAT3355, 10.1038/nmat3355]
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2004, EXPERT OPIN BIOL TH, V4, P881, DOI 10.1517/14712598.4.6.881
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Piersma SJ, 2011, CANCER MICROENVIRON, V4, P361, DOI 10.1007/s12307-011-0066-7
   Pradhan P., 2014, BIOMATERIALS
   Purwada A, 2014, ACTA BIOMATER, V10, P1728, DOI 10.1016/j.actbio.2013.12.036
   Roep B, 2012, NAT MED, V18, P48, DOI 10.1038/nm.2626
   Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Roy K, 2003, MOL THER, V7, P401, DOI 10.1016/1525-0016(03)00008-X
   Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041
   Schoichet M. S., 2010, MACROMOLECULES, V43, P581
   Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Sexton A, 2009, ACS NANO, V3, P3391, DOI 10.1021/nn900715g
   Singh A., 2014, ADV HEALTHC MATER, DOI [10.1002/adhm.201400051, DOI 10.1002/ADHM.201400051]
   Singh A, 2011, J CONTROL RELEASE, V155, P184, DOI 10.1016/j.jconrel.2011.06.008
   Singh A, 2009, BIOMATERIALS, V30, P5187, DOI 10.1016/j.biomaterials.2009.06.001
   St'astny M, 2002, EUR J CANCER, V38, P602, DOI 10.1016/S0959-8049(01)00421-X
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625
   Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17
   Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   Suematsu S, 2004, NAT BIOTECHNOL, V22, P1539, DOI 10.1038/nbt1039
   Suri S, 2011, BIOMED MICRODEVICES, V13, P983, DOI 10.1007/s10544-011-9568-9
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631
   Tiller JC, 2003, ANGEW CHEM INT EDIT, V42, P3072, DOI 10.1002/anie.200301647
   Tong CCL, 2012, IMMUNOL RES, V54, P266, DOI 10.1007/s12026-012-8306-6
   Tortora M, 2007, BIOMACROMOLECULES, V8, P209, DOI 10.1021/bm0607269
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029
   van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179
   Whitmire RE, 2012, BIOMATERIALS, V33, P7665, DOI 10.1016/j.biomaterials.2012.06.101
   Wu YB, 2012, EUR J PHARM BIOPHARM, V81, P486, DOI 10.1016/j.ejpb.2012.03.021
   Wu YB, 2012, BIOMATERIALS, V33, P2351, DOI 10.1016/j.biomaterials.2011.11.068
   Yao S, 2013, NAT REV DRUG DISCOV, V12, P130, DOI 10.1038/nrd3877
NR 97
TC 66
Z9 66
U1 17
U2 210
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD OCT 15
PY 2014
VL 26
IS 38
BP 6530
EP 6541
DI 10.1002/adma.201402105
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AR7MG
UT WOS:000343763200001
PM 25155610
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Filippidi, E
   Patel, AR
   Bouwens, ECM
   Voudouris, P
   Velikov, KP
AF Filippidi, Emmanouela
   Patel, Ashok R.
   Bouwens, Elisabeth C. M.
   Voudouris, Panayiotis
   Velikov, Krassimir P.
TI All-Natural Oil-Filled Microcapsules from Water-Insoluble Proteins
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE microcapsules; zein; colloids; biomaterials; polymeric materials
ID INTERNAL PHASE-SEPARATION; SHELL MICROCAPSULES; CORE MICROCAPSULES;
   EMULSION DROPLETS; ZEIN MICROSPHERES; DRUG-DELIVERY; FISH-OIL;
   MICROENCAPSULATION; ENCAPSULATION; PARTICLES
AB The formation and characterization of a novel class of all-natural digestible microcapsules containing a liquid lipid core encapsulated by a water-insoluble protein shell with tunable thickness is demonstrated. As an example of a water-insoluble protein, zein is usedthe protein of cornwhich is an attractive biomaterial from a sustainable source. The microcapsules are prepared by a direct and simple method, based on the precipitation of protein from the continuous phase of an oil-in-(water/ethanol) emulsion onto the oil droplets without the need of any surfactant. The shell thickness can be controlled by the amount of precipitated protein. An in vitro digestion assay is performed to study the lipid hydrolysis and biodegradability. The rate of lipid hydrolysis and release of fatty acids are highly dependent on the protein shell thickness. All-natural edible microcapsules with controlled degradation under gastrointestinal conditions can enable new applications for oral delivery systems. They may further be used as a model system for controlled release studies of lipophilic compounds and could promote the sustainable use of underutilized water insoluble proteins as functional biomaterials.
C1 [Filippidi, Emmanouela; Patel, Ashok R.; Bouwens, Elisabeth C. M.; Voudouris, Panayiotis; Velikov, Krassimir P.] Unilever Res Labs, Vlaardingen, Netherlands.
   [Filippidi, Emmanouela] NYU, Dept Phys, Ctr Soft Matter Res, New York, NY 10003 USA.
   [Velikov, Krassimir P.] Univ Utrecht, Debye Inst NanoMat Sci, Soft Condensed Matter Grp, NL-3584 CC Utrecht, Netherlands.
RP Filippidi, E (reprint author), Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA.
EM filippidi@nyu.edu; krassimir.velikov@Unilever.com
RI Institute (DINS), Debye/G-7730-2014; Velikov, Krassimir/C-4868-2009;
   Patel, Ashok/D-8795-2012
OI Patel, Ashok/0000-0002-3840-2473; Filippidi,
   Emmanouela/0000-0002-4044-0022
FU Food Nutrition Delta Program [FND07002]; NanoNextNL, a micro- and
   nanotechnology consortium of the Government of the Netherlands; MRI
   program of the NSF [DMR-0923251]; Alexander S. Onassis Foundation
FX This work is funded by the Food Nutrition Delta Program grant FND07002
   and NanoNextNL, a micro- and nanotechnology consortium of the Government
   of the Netherlands. The Carl Zeiss Merlin FESEM instrument was purchased
   with support from the MRI program of the NSF under award DMR-0923251. E.
   F. acknowledges the Alexander S. Onassis Foundation for financial
   support. We would like to thank Prof. O. Velev, F. C. Cheong, M. van
   Ruijven, S. Sacanna and N. J. Zuidam and G. Duchateau for their help and
   comments.
CR Akartuna I, 2009, LANGMUIR, V25, P12419, DOI 10.1021/la901916q
   Anselmi C, 2002, INT J PHARM, V242, P207, DOI 10.1016/S0378-5173(02)00159-X
   Augustin MA, 2009, CHEM SOC REV, V38, P902, DOI 10.1039/b801739p
   Bae KH, 2007, BIOMACROMOLECULES, V8, P650, DOI 10.1021/bm0608939
   Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160
   Buxton GA, 2007, SOFT MATTER, V3, P1513, DOI 10.1039/b712514c
   Chang CP, 2006, COLLOID SURFACE B, V50, P136, DOI 10.1016/j.colsurfb.2006.04.008
   Chen PW, 2012, LANGMUIR, V28, P144, DOI 10.1021/la203088u
   Chen Z, 2011, RENEW SUST ENERG REV, V15, P4624, DOI 10.1016/j.rser.2011.07.090
   Cho YH, 2003, J FOOD SCI, V68, P2717, DOI 10.1111/j.1365-2621.2003.tb05794.x
   Day JPR, 2010, J AM CHEM SOC, V132, P8433, DOI 10.1021/ja102069d
   de Folter JWJ, 2012, SOFT MATTER, V8, P6807, DOI 10.1039/c2sm07417f
   Deo N, 2003, LANGMUIR, V19, P5083, DOI 10.1021/la020854s
   Dowding PJ, 2005, LANGMUIR, V21, P5278, DOI 10.1021/la0470838
   Dowding PJ, 2004, LANGMUIR, V20, P11374, DOI 10.1021/la048561h
   Duan HW, 2005, NANO LETT, V5, P949, DOI 10.1021/nl0505391
   Gouin S, 2004, TRENDS FOOD SCI TECH, V15, P330, DOI 10.1016/j.tifs.2003.10.005
   Gun WJ, 2013, LANGMUIR, V29, P12541, DOI 10.1021/la403175w
   Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004
   Hurtado-Lopez P, 2006, J MICROENCAPSUL, V23, P303, DOI 10.1080/026520400444149
   Hurtado-Lopez P, 2005, J DRUG DELIV SCI TEC, V15, P267, DOI 10.1016/S1773-2247(05)50048-0
   Kooiman K, 2009, J CONTROL RELEASE, V133, P109, DOI 10.1016/j.jconrel.2008.09.085
   Lakkis JM, 2007, ENCAPSULATION CONTRO
   Lawton JW, 2002, CEREAL CHEM, V79, P1, DOI 10.1094/CCHEM.2002.79.1.1
   Li XN, 2010, J COLLOID INTERF SCI, V345, P46, DOI 10.1016/j.jcis.2010.01.029
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   O'Sullivan M, 2009, LANGMUIR, V25, P7962, DOI 10.1021/la9006229
   Park JK, 2000, BIOTECHNOL ADV, V18, P303, DOI 10.1016/S0734-9750(00)00040-9
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Patel A, 2010, SOFT MATTER, V6, P6192, DOI 10.1039/c0sm00800a
   Patel AR, 2013, SOFT MATTER, V9, P1428, DOI 10.1039/c2sm27200h
   Patel AR, 2010, J AGR FOOD CHEM, V58, P12497, DOI 10.1021/jf102959b
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Sun BJ, 2010, ACS APPL MATER INTER, V2, P3411, DOI 10.1021/am100860b
   Tiarks F, 2001, LANGMUIR, V17, P908, DOI 10.1021/la001276n
   Torcello-Gomez A, 2011, SOFT MATTER, V7, P6167, DOI 10.1039/c1sm05322a
   Tsuji K, 2001, J MICROENCAPSUL, V18, P137, DOI 10.1080/026520401750063856
   Wagdare NA, 2011, J COLLOID INTERF SCI, V355, P453, DOI 10.1016/j.jcis.2010.12.053
   Wang Q, 2008, FOOD BIOPHYS, V3, P174, DOI 10.1007/s11483-008-9080-9
   Wang W, 2006, J MATER CHEM, V16, P3252, DOI 10.1039/b603595g
   Wang Y, 2003, STARCH-STARKE, V55, P25, DOI 10.1002/star.200390002
   Wang Y, 2010, LANGMUIR, V26, P12897, DOI 10.1021/la101688v
   Weinbreck F, 2004, J MICROENCAPSUL, V21, P667, DOI 10.1080/02652040400008499
   White SR, 2002, NATURE, V415, P817
   Zhang ZQ, 2011, FOOD RES INT, V44, P1000, DOI 10.1016/j.foodres.2011.02.044
   Zhong QX, 2009, J FOOD PROCESS PRES, V33, P255, DOI 10.1111/j.1745-4549.2009.00390.x
   Zhong QX, 2009, FOOD CHEM, V115, P697, DOI 10.1016/j.foodchem.2008.12.063
NR 47
TC 13
Z9 14
U1 5
U2 76
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD OCT 15
PY 2014
VL 24
IS 38
BP 5962
EP 5968
DI 10.1002/adfm.201400359
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AR7NE
UT WOS:000343765600007
DA 2018-10-20
ER

PT J
AU Martin-Lara, MA
   Blazquez, G
   Trujillo, MC
   Perez, A
   Calero, M
AF Martin-Lara, M. A.
   Blazquez, G.
   Trujillo, M. C.
   Perez, A.
   Calero, M.
TI New treatment of real electroplating wastewater containing heavy metal
   ions by adsorption onto olive stone
SO JOURNAL OF CLEANER PRODUCTION
LA English
DT Article
DE Adsorption; Electroplating wastewater; Fixed-bed column; Heavy metals;
   Olive stone
ID PINE BARK; BIOSORPTION; CHROMIUM; REMOVAL; CR(VI); HEXAVALENT; COLUMN;
   BATCH; CR
AB The goal of this research was to develop new processes for the remediation of electroplating wastewater using olive stone as adsorbent material packed in fixed-bed columns. The study was performed with effluents containing chromium (VI), copper (II) and nickel (II) of an electroplating plant. First, we started our research from studying olive stone as an efficient biomaterial capable of removing chromium (VI) of both synthetic and real wastewater. The removal of chromium (VI) took place following two parallel mechanisms: the adsorption of chromium (VI) and the reduction of chromium (VI) to chromium (III) by contact with the biomass, appearing chromium (III) in the aqueous solution. Then, two fixed-bed columns were utilized for removal both chromium (VI) and chromium (III), in the first fixed-bed column, chromium (VI) was successfully removed and in the second column, the chromium (III). Finally, two types of adsorption experiments were selected for simultaneous adsorption of three metals: (1) with a first stage reduction of chromium and only one adsorption fixed-bed column; and (2) without the stage of reduction and two adsorption fixed-bed columns. The results showed that the second method was more suitable for the purposes of wastewater treatment. In the first column, chromium (VI) was completely removed. In the second column, the outlet concentration of heavy metals was 2.04, 1.48 and 0.93 mg/L for total chromium, copper (II), and nickel (II), respectively. This research provides a high efficient new alternative to clean industrial wastewater. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Martin-Lara, M. A.; Blazquez, G.; Trujillo, M. C.; Perez, A.; Calero, M.] Univ Granada, Dept Chem Engn, E-18071 Granada, Spain.
RP Blazquez, G (reprint author), Univ Granada, Dept Chem Engn, E-18071 Granada, Spain.
EM marianml@ugr.es; gblazque@ugr.es; mariactrujillo@correo.ugr.es;
   aperezm@ugr.es; mcaleroh@ugr.es
RI Blazquez, Gabriel/K-6374-2014; CALERO, MONICA/K-7540-2014
OI Blazquez, Gabriel/0000-0002-0818-6300; CALERO,
   MONICA/0000-0001-8029-8211; Perez, Antonio/0000-0002-1242-5773
CR Bartkiewicz B., 2006, OCZYSZCZANIE SCIEKOW
   Blazquez G, 2011, J IND ENG CHEM, V17, P824, DOI 10.1016/j.jiec.2011.08.003
   Blazquez G, 2011, ENVIRON PROG SUSTAIN, V30, P576, DOI 10.1002/ep.10510
   Blazquez G, 2009, CHEM ENG J, V148, P473, DOI 10.1016/j.cej.2008.09.026
   Blazquez G., 2013, J IND ENG CHEM
   Calero M, 2008, WIT TRANS ECOL ENVIR, V109, P827, DOI 10.2495/WM080841
   Chapman B., 2004, TRANSITION METALS QU
   ECCLES H, 1995, INT BIODETER BIODEGR, V35, P5, DOI 10.1016/0964-8305(95)00044-6
   Elangovan R, 2008, CHEM ENG J, V141, P99, DOI 10.1016/j.cej.2007.10.026
   Fiol N, 2003, ENVIRON CHEM LETT, V1, P135, DOI 10.1007/s10311-003-0027-6
   Hernainz F, 2008, ENVIRON PROG, V27, P469, DOI 10.1002/ep.10299
   Hernainz F., 2008, AFINIDAD, V654, P437
   Hudaya Tedi, 2013, Journal of Applied Sciences, V13, P639, DOI 10.3923/jas.2013.639.644
   Kanani Nasser, 2006, ELECTROPLATING BASIC
   Kushwaha S, 2012, BIORESOURCE TECHNOL, V116, P15, DOI 10.1016/j.biortech.2012.04.009
   Ling Wang, 2013, Applied Mechanics and Materials, V378, P318, DOI 10.4028/www.scientific.net/AMM.378.318
   Liu TY, 2013, WATER RES, V47, P6691, DOI 10.1016/j.watres.2013.09.006
   Lopez-Garcia M, 2013, BIORESOURCE TECHNOL, V139, P181, DOI 10.1016/j.biortech.2013.04.044
   Martin-Lara MA, 2013, IND ENG CHEM RES, V52, P10809, DOI 10.1021/ie401246c
   Martin-Lara MA, 2010, J ENVIRON ENG-ASCE, V136, P1389, DOI 10.1061/(ASCE)EE.1943-7870.0000281
   Ong Say Kee, 2008, NATURAL PROCESSES SY
   Orescanin V, 2013, J ENVIRON SCI HEAL A, V48, P1450, DOI 10.1080/10934529.2013.781904
   Ronda A, 2014, ENVIRON PROG SUSTAIN, V33, P192, DOI 10.1002/ep.11780
   Shouman MA, 2013, ADV PHYS CHEM, DOI 10.1155/2013/159712
   Sochacki A, 2014, CHEM ENG J, V237, P250, DOI 10.1016/j.cej.2013.10.015
   Ye SH, 2014, CARBOHYD POLYM, V101, P50, DOI 10.1016/j.carbpol.2013.09.021
   Zhao X, 2013, WATER SCI TECHNOL, V68, P1329, DOI 10.2166/wst.2013.296
NR 27
TC 49
Z9 61
U1 2
U2 88
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0959-6526
EI 1879-1786
J9 J CLEAN PROD
JI J. Clean Prod.
PD OCT 15
PY 2014
VL 81
BP 120
EP 129
DI 10.1016/j.jclepro.2014.06.036
PG 10
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA AO4YZ
UT WOS:000341348600012
DA 2018-10-20
ER

PT J
AU Zhu, XH
   Zuo, XX
   Hu, RP
   Xiao, X
   Liang, Y
   Nan, JM
AF Zhu, Xiaohua
   Zuo, Xiaoxi
   Hu, Ruiping
   Xiao, Xin
   Liang, Yong
   Nan, Junmin
TI Hydrothermal synthesis of two photoluminescent nitrogen-doped graphene
   quantum dots emitted green and khaki luminescence
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Chemical synthesis; Biomaterial; Photoluminescence spectroscopy;
   Luminescence
ID FLUORESCENT CARBON NANOPARTICLES; NANOTUBES; NANODOTS; PROBES
AB A simple and effective chemical synthesis of the photoluminescent nitrogen-doped graphene quantum dots (N-GQDs) biomaterial is reported. Using the hydrothermal treatment of graphene oxide (GO) in the presence of hydrogen peroxide (H2O2) and ammonia, the N-GQDs are synthesized through H2O2 exfoliating the GO into nanocrystals with lateral dimensions and ammonia passivating the generated active surface. Then, after a dialytic separation, two water-soluble N-GQDs with average size of about 2.1 nm/ 6.2 nm, which emit green/khaki luminescence and exhibit excitation dependent/independent photoluminescence (PL) behaviors, are obtained. In addition, it is also demonstrated that these two N-GQDs are stable over a broad pH range and have the upconversion PL property, showing this approach provides a simple and effective method to synthesize the functional N-GQDs. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhu, Xiaohua; Zuo, Xiaoxi; Hu, Ruiping; Xiao, Xin; Liang, Yong; Nan, Junmin] S China Normal Univ, Sch Chem & Environm, Key Lab Energy Convers & Energy Storage Mat Guang, Guangzhou 510006, Guangdong, Peoples R China.
RP Nan, JM (reprint author), S China Normal Univ, Sch Chem & Environm, Key Lab Energy Convers & Energy Storage Mat Guang, Guangzhou 510006, Guangdong, Peoples R China.
EM jmnan@scnu.edu.cn
FU National Natural Science Foundation of China [21175047, 21303062];
   Construction Project of the Scientific Research Conditions in Guangzhou
   [2013-163-7]; Scientific Research Foundation of Graduate School of South
   China Normal University [2013kyjj052, 2013kyjj050]
FX This work was supported by the National Natural Science Foundation of
   China (21175047, 21303062), the Construction Project of the Scientific
   Research Conditions in Guangzhou (2013-163-7), and the Scientific
   Research Foundation of Graduate School of South China Normal University
   (2013kyjj052, 2013kyjj050).
CR Anilkumar P, 2013, SMALL, V9, P545, DOI 10.1002/smll.201202000
   Bao L, 2011, ADV MATER, V23, P5801, DOI 10.1002/adma.201102866
   Bourlinos AB, 2008, CHEM MATER, V20, P4539, DOI 10.1021/cm800506r
   Fang YX, 2012, ACS NANO, V6, P400, DOI 10.1021/nn2046373
   Hu CF, 2013, J MATER CHEM B, V1, P39, DOI 10.1039/c2tb00189f
   Jiang F, 2013, NANOSCALE, V5, P1137, DOI 10.1039/c2nr33191h
   Li M., 2012, APPL PHYS LETT, V101
   Li Y, 2012, J AM CHEM SOC, V134, P15, DOI 10.1021/ja206030c
   Lin LX, 2012, CHEM COMMUN, V48, P10177, DOI 10.1039/c2cc35559k
   Liu Q, 2013, NANO LETT, V13, P2436, DOI 10.1021/nl400368v
   Lu WB, 2012, ANAL CHEM, V84, P5351, DOI 10.1021/ac3007939
   Minati L, 2012, MATER CHEM PHYS, V137, P12, DOI 10.1016/j.matchemphys.2012.08.071
   Pan DY, 2012, J MATER CHEM, V22, P3314, DOI 10.1039/c2jm16005f
   Peng H, 2009, CHEM MATER, V21, P5563, DOI 10.1021/cm901593y
   Shen JH, 2011, CHEM COMMUN, V47, P2580, DOI 10.1039/c0cc04812g
   Shi W, 2012, ANGEW CHEM INT EDIT, V51, P6432, DOI 10.1002/anie.201202533
   Viculis LM, 2003, SCIENCE, V299, P1361, DOI 10.1126/science.1078842
   Yang ST, 2009, J AM CHEM SOC, V131, P11308, DOI 10.1021/ja904843x
   Yang YH, 2012, CHEM COMMUN, V48, P380, DOI 10.1039/c1cc15678k
   Yang ZC, 2011, CARBON, V49, P5207, DOI 10.1016/j.carbon.2011.07.038
   Zhu SJ, 2012, RSC ADV, V2, P2717, DOI 10.1039/c2ra20182h
   Zhu SJ, 2011, CHEM COMMUN, V47, P6858, DOI 10.1039/c1cc11122a
   Zhu X., 2014, PART PART SYST CHARA
NR 23
TC 26
Z9 28
U1 6
U2 298
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD OCT 15
PY 2014
VL 147
IS 3
BP 963
EP 967
DI 10.1016/j.matchemphys.2014.06.043
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AO0CE
UT WOS:000340975900082
DA 2018-10-20
ER

PT J
AU Yang, FC
   Zhang, Y
   Rheinstadter, MC
AF Yang, Fei-Chi
   Zhang, Yuchen
   Rheinstaedter, Maikel C.
TI The structure of people's hair
SO PEERJ
LA English
DT Article
DE Human hair; Molecular structure; X-ray diffraction; Keratin;
   Intermediate filament; Coiled-coil proteins; Alpha helix; Cell membrane
   complex
ID X-RAY-DIFFRACTION; PHASE DPPC BILAYERS; CELL-MEMBRANE COMPLEX; HELICAL
   COILED COILS; BREAST-CANCER; ALPHA-KERATIN; INTERMEDIATE-FILAMENTS;
   PLASMA-MEMBRANE; LIPID-BILAYERS; FIBERS
AB Hair is a filamentous biomaterial consisting mainly of proteins in particular keratin. The structure of human hair is well known: the medulla is a loosely packed, disordered region near the centre of the hair surrounded by the cortex, which contains the major part of the fibre mass, mainly consisting of keratin proteins and structural lipids. The cortex is surrounded by the cuticle, a layer of dead, overlapping cells forming a protective layer around the hair. The corresponding structures have been studied extensively using a variety of different techniques, such as light, electron and atomic force microscopes, and also X-ray diffraction. We were interested in the question how much the molecular hair structure differs from person to person, between male and female hair, hair of different appearances such as colour and waviness. We included hair from parent and child, identical and fraternal twins in the study to see if genetically similar hair would show similar structural features.
   The molecular structure of the hair samples was studied using high-resolution X-ray diffraction, which covers length scales from molecules up to the organization of secondary structures. Signals due to the coiled-coil phase of alpha-helical keratin proteins, intermediate keratin filaments in the cortex and from the lipid layers in the cell membrane complex were observed in the specimen of all individuals, with very small deviations. Despite the relatively small number of individuals (12) included in this study, some conclusions can be drawn. While the general features were observed in all individuals and the corresponding molecular structures were almost identical, additional signals were observed in some specimen and assigned to different types of lipids in the cell membrane complex. Genetics seem to play a role in this composition as identical patterns were observed in hair from father and daughter and identical twins, however, not for fraternal twins. Identification and characterization of these features is an important step towards the detection of abnormalities in the molecular structure of hair as a potential diagnostic tool for certain diseases.
C1 [Yang, Fei-Chi; Zhang, Yuchen; Rheinstaedter, Maikel C.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.
RP Rheinstadter, MC (reprint author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.
EM rheinstadter@mcmaster.ca
OI Rheinstadter, Maikel/0000-0002-0558-7475
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   National Research Council Canada (NRC); Canada Foundation for Innovation
   (CFI); Ontario Ministry of Economic Development and Innovation; Early
   Researcher Award of the Province of Ontario
FX This research was funded by the Natural Sciences and Engineering
   Research Council of Canada (NSERC), the National Research Council Canada
   (NRC), the Canada Foundation for Innovation (CFI) and the Ontario
   Ministry of Economic Development and Innovation. MCR is the recipient of
   an Early Researcher Award of the Province of Ontario. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Armstrong CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066162
   Astbury W.T., 1935, Proceedings of the Royal Society of London, Series A (Mathematical and Physical Sciences), V150, P533, DOI 10.1098/rspa.1935.0121
   Astbury WT, 1934, PHILOS T R SOC LOND, V232, P333, DOI 10.1098/rsta.1934.0010
   Astbury WT, 1932, PHILOS T R SOC LOND, V230, P75, DOI 10.1098/rsta.1932.0003
   Barrett MA, 2013, SOFT MATTER, V9, P9342, DOI 10.1039/c3sm50700a
   Barrett MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034357
   BERG BO, 1972, PEDIATRICS, V49, P894
   Briki F, 2000, CELL MOL BIOL, V46, P1005
   Briki F, 1999, NATURE, V400, P226, DOI 10.1038/22244
   Busson B, 1999, J SYNCHROTRON RADIAT, V6, P1021, DOI 10.1107/S0909049599004537
   COHEN C, 1994, SCIENCE, V263, P488, DOI 10.1126/science.8290957
   Creasy RK, 2013, CREASY RESNIKS MATER
   CREWTHER WG, 1983, INT J BIOL MACROMOL, V5, P267, DOI 10.1016/0141-8130(83)90040-5
   CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0
   Franbourg A, 2003, J AM ACAD DERMATOL, V48, pS115, DOI 10.1067/mjd.2003.277
   FRASER RDB, 1962, NATURE, V193, P1052, DOI 10.1038/1931052a0
   FRASER RDB, 1986, P NATL ACAD SCI USA, V83, P1179, DOI 10.1073/pnas.83.5.1179
   FRASER RDB, 1988, INT J BIOL MACROMOL, V10, P106, DOI 10.1016/0141-8130(88)90017-7
   Furt F, 2011, PLANT CELL MONOGR, V19, P3, DOI 10.1007/978-3-642-13431-9_1
   Harroun TA, 1999, BIOPHYS J, V76, P937, DOI 10.1016/S0006-3495(99)77257-7
   Howell A, 2000, J MED GENET, V37, P297, DOI 10.1136/jmg.37.4.297
   IIDA A, 1993, NUCL INSTRUM METH B, V82, P129, DOI 10.1016/0168-583X(93)95092-J
   James V, 1999, NATURE, V398, P33, DOI 10.1038/17949
   James V, 2001, J Med Genet, V38, pE16, DOI 10.1136/jmg.38.5.e16
   James VJ, 1998, TEXT RES J, V68, P167, DOI 10.1177/004051759806800303
   Kajiura Y, 2006, J STRUCT BIOL, V155, P438, DOI 10.1016/j.jsb.2006.04.008
   KATSARAS J, 1995, BIOCHEMISTRY-US, V34, P4684, DOI 10.1021/bi00014a023
   Kreplak L, 2001, Int J Cosmet Sci, V23, P369, DOI 10.1046/j.0412-5463.2001.00118.x
   Kreplak L, 2001, BBA-PROTEIN STRUCT M, V1547, P268, DOI 10.1016/S0167-4838(01)00195-9
   Kucerka N, 2006, BIOPHYS J, V90, pL83, DOI 10.1529/biophysj.106.086017
   Kucerka N, 2005, BIOPHYS J, V88, P2626, DOI 10.1529/biophysj.104.056606
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   MERCER EH, 1953, TEXT RES J, V23, P388, DOI 10.1177/004051755302300603
   Mills TT, 2008, BIOPHYS J, V95, P669, DOI 10.1529/biophysj.107.127845
   Mills TT, 2009, GEN PHYSIOL BIOPHYS, V28, P126, DOI 10.4149/gpb_2009_02_126
   Nussbaum RL, 2007, THOMPSON THOMPSON GE, V6, P181
   Ohta N, 2005, J APPL CRYSTALLOGR, V38, P274, DOI 10.1107/S002188980403403X
   Pan JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198103
   PAULING L, 1950, J AM CHEM SOC, V72, P5349, DOI 10.1021/ja01167a545
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P261, DOI 10.1073/pnas.37.5.261
   Petrache HI, 1998, PHYS REV E, V57, P7014, DOI 10.1103/PhysRevE.57.7014
   Pinto N, 2014, BIOMACROMOLECULES, V15, P574, DOI 10.1021/bm401600a
   Poinapen D, 2013, SOFT MATTER, V9, P6804, DOI 10.1039/c3sm50355k
   Rafik E, 2004, BIOPHYS J, V86, P3893, DOI 10.1529/biophysj.103.034694
   Randebrook RJ, 1964, J SOC COSMET CHEM, V15, P691
   Rappolt M, 1996, BER BUNSEN PHYS CHEM, V100, P1153, DOI 10.1002/bbpc.19961000710
   Rheinstadter MC, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011907
   Rheinstadter MC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.108107
   Rheinstadter MC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.248106
   Robbins C. R., 2012, CHEM PHYS BEHAV HUMA
   ROGERS GE, 1959, J ULTRA MOL STRUCT R, V2, P309, DOI 10.1016/S0022-5320(59)80004-6
   Schneggenburger PE, 2011, EUR BIOPHYS J BIOPHY, V40, P417, DOI 10.1007/s00249-010-0645-4
   Swift JA, 2001, J MICROSC-OXFORD, V204, P203, DOI 10.1046/j.1365-2818.2001.00957.x
   Tristram-Nagle S, 2002, BIOPHYS J, V83, P3324, DOI 10.1016/S0006-3495(02)75333-2
   WARD WH, 1954, ADV PROTEIN CHEM, V9, P243, DOI 10.1016/S0065-3233(08)60208-9
   WELTI R, 1981, J BIOL CHEM, V256, P7528
   Wilk KE, 1995, BBA-GEN SUBJECTS, V1245, P392, DOI 10.1016/0304-4165(95)00111-5
   Yang FC, 2014, SOFT MATTER, V10, P5541, DOI 10.1039/c4sm00301b
NR 58
TC 16
Z9 16
U1 1
U2 42
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD OCT 14
PY 2014
VL 2
AR e619
DI 10.7717/peerj.619
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AY5PD
UT WOS:000347623500002
PM 25332846
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Brennan, MA
   Renaud, A
   Amiaud, J
   Rojewski, MT
   Schrezenmeier, H
   Heymann, D
   Trichet, V
   Layrolle, P
AF Brennan, Meadhbh A.
   Renaud, Audrey
   Amiaud, Jerome
   Rojewski, Markus T.
   Schrezenmeier, Hubert
   Heymann, Dominique
   Trichet, Valerie
   Layrolle, Pierre
TI Pre-clinical studies of bone regeneration with human bone marrow stromal
   cells and biphasic calcium phosphate
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-VIVO; CERAMICS; TRANSPLANTATION; SUBSTITUTES;
   EXPANSION; MODEL
AB Introduction: Repair of large bone defects remains a significant clinical challenge. Bone marrow stromal cells (BMSCs), a subset of which is known as bone marrow-derived mesenchymal stem cells, show therapeutic potential for bone regeneration. However, their isolation, expansion and implantation will need to be conducted under good manufacturing practices (GMP) at separate locations. An investigation which mimics this clinical scenario where large bone defects shall be regenerated is required before clinical trials can be initiated.
   Methods: Seven batches of 100 million human ex-vivo expanded BMSCs from five donors were transported fresh in syringes from a GMP facility in Germany to France. BMSCs were mixed with biphasic calcium phosphate (BCP) biomaterial prior to subcutaneous implantation in nude mice. The capacity of BMSCs in unison with BCP to regenerate critical sized cranial bone defects was also evaluated. BMSCs expressing luciferase were used to assess the viability and bio-distribution of implanted cells. In situ hybridization, using the human-specific repetitive Alu sequence, was performed for the identification of human cells in explants.
   Results: Eight weeks after implantation of BMSCs, mineralized bone containing mature bone marrow territories was formed in ectopic sites and in calvaria defects. Significant loss of cell viability was observed by bioluminescence imaging and only 1.5 percent of the initial number of transplanted cells remained after 37 days. After eight weeks, while explants were comprised primarily of host cells, there were also human cells attached along the periphery of BCP and embedded in osteocyte lacunae dispersed throughout the newly formed bone matrix.
   Conclusions: This study demonstrates the safety and efficacy of BMSC/BCP combinations and provides crucial information for the implementation of BMSC therapy for bone regeneration.
C1 [Brennan, Meadhbh A.; Renaud, Audrey; Amiaud, Jerome; Heymann, Dominique; Trichet, Valerie; Layrolle, Pierre] Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt, INSERM,UMR957, F-44035 Nantes, France.
   [Rojewski, Markus T.; Schrezenmeier, Hubert] German Red Cross Blood Donor Serv, Inst Clin Tranfus Med & Immunogenet, Ulm, Germany.
RP Layrolle, P (reprint author), Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt, INSERM,UMR957, 1 Rue Gaston Veil, F-44035 Nantes, France.
EM pierre.layrolle@inserm.fr
RI Layrolle, Pierre/K-9257-2015; Brennan, Meadhbh/L-2068-2015; Trichet,
   Valerie/L-1553-2015
OI Layrolle, Pierre/0000-0001-9800-5210; Rojewski,
   Markus/0000-0003-4265-0442; Brennan, Meadhbh A/0000-0002-1532-9760
FU 7th Framework Program of the European Commission: CASCADE (Cultivated
   Adult Stem Cells as Alternative for Damaged tissuE)
   [HEALTH-F5-2009-223236]; 7th Framework Program of the European
   Commission: REBORNE (Regenerating BOne defects using New biomedical
   Engineering approaches) [HEALTH-2009-1.4.2-241879]
FX This work was supported by grants from the 7th Framework Program of the
   European Commission: CASCADE (Cultivated Adult Stem Cells as Alternative
   for Damaged tissuE) (HEALTH-F5-2009-223236) and REBORNE (Regenerating
   BOne defects using New biomedical Engineering approaches)
   (HEALTH-2009-1.4.2-241879). The authors appreciate the excellent
   technical assistance of G Baur, T Becker, S Chester, D Erz, and C Spath.
CR Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Becquart P, 2012, TISSUE ENG PT A, V18, P2084, DOI [10.1089/ten.tea.2011.0690, 10.1089/ten.TEA.2011.0690]
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043
   Corre P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081599
   Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376
   Cuthbert R, 2012, CYTOTHERAPY, V14, P431, DOI 10.3109/14653249.2011.651533
   Deschepper M, 2013, STEM CELLS, V31, P526, DOI 10.1002/stem.1299
   Fang DJ, 2007, STEM CELLS, V25, P1021, DOI 10.1634/stemcells.2006-0576
   Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   Giannoni P, 2010, TISSUE ENG PT A, V16, P489, DOI [10.1089/ten.tea.2009.0041, 10.1089/ten.TEA.2009.0041]
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623
   Janicki P, 2011, EUR CELLS MATER, V21, P488, DOI 10.22203/eCM.v021a37
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Kucera T, 2012, ACTA CHIR ORTHOP TR, V79, P52
   Liu GP, 2008, CRYOBIOLOGY, V56, P209, DOI 10.1016/j.cryobiol.2008.02.008
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Mankani MH, 2007, EXP HEMATOL, V35, P995, DOI 10.1016/j.exphem.2007.01.051
   Mankani MH, 2006, STEM CELLS, V24, P2140, DOI 10.1634/stemcells.2005-0567
   Mankani MH, 2001, BIOTECHNOL BIOENG, V72, P96, DOI 10.1002/1097-0290(20010105)72:1<96::AID-BIT13>3.0.CO;2-A
   Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rousseau J, 2010, CANCER GENE THER, V17, P387, DOI 10.1038/cgt.2009.89
   Schallmoser K, 2008, TISSUE ENG PT C-METH, V14, P185, DOI 10.1089/ten.tec.2008.0060
   Schallmoser K, 2009, BIO-MED MATER ENG, V19, P271, DOI 10.3233/BME-2009-0591
   Steck E, 2010, XENOTRANSPLANTATION, V17, P153, DOI 10.1111/j.1399-3089.2010.00577.x
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Tasso R, 2009, TISSUE ENG PT A, V15, P2203, DOI 10.1089/ten.tea.2008.0269
   Tour G, 2012, J TISSUE ENG REGEN M, DOI 10.1002/term.1574
   Veronesi E, 2014, TISSUE ENG PART C-ME, V20, P239, DOI [10.1089/ten.tec.2013.0250, 10.1089/ten.TEC.2013.0250]
   Wagner-Ecker M, 2013, ACTA BIOMATER, V9, P7298, DOI 10.1016/j.actbio.2013.03.037
NR 37
TC 32
Z9 32
U1 2
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD OCT 13
PY 2014
VL 5
AR 114
DI 10.1186/scrt504
PG 15
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA AS9OZ
UT WOS:000344573000001
PM 25311054
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lai, GJ
   Shalumon, KT
   Chen, SH
   Chen, JP
AF Lai, Guo-Jyun
   Shalumon, K. T.
   Chen, Shih-Hsien
   Chen, Jyh-Ping
TI Composite chitosan/silk fibroin nanofibers for modulation of osteogenic
   differentiation and proliferation of human mesenchymal stem cells
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Silk fibroin; Electrospinning; Human mesenchymal stem cells;
   Bone tissue engineering; Composite nanofiber
ID ENHANCED CHONDROGENIC RESPONSES; INDUCED ARGON PLASMA; ARTICULAR
   CHONDROCYTES; IN-VITRO; SILK; SCAFFOLDS; OSTEOBLASTS; BIOMATERIAL;
   EXPRESSION; CULTURE
AB Nanofibrous membrane scaffolds of chitosan (CS), silk fibroin (SF) and CS/SF blend were prepared by electrospinning and studied for growth and osteogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs). The morphology and physico-chemical properties of all membrane scaffolds were compared. The influence of CS and SF on cell proliferation was assessed by the MTS assay, whereas osteogenic differentiation was determined from the Alizarin Red staining, alkaline phosphatase activity and expression of osteogenic marker genes. The osteogenic differentiation and proliferation of hMSCs were enhanced by CS and SF nanofibers, respectively. Blending CS with SF retained the osteogenesis nature of CS without negatively influencing the cell proliferative effect of SF. By taking advantage of the differentiation/proliferation cues from individual components, the electrospun CS/SF composite nanofibrous membrane scaffold is suitable for bone tissue engineering. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Lai, Guo-Jyun; Shalumon, K. T.; Chen, Shih-Hsien; Chen, Jyh-Ping] Chang Gung Univ, Dept Chem & Mat Engn, Taoyuan 333, Taiwan.
   [Chen, Jyh-Ping] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan 333, Taiwan.
RP Chen, JP (reprint author), Chang Gung Univ, 259 Wen Hwa 1st Rd, Taoyuan, Taiwan.
EM jpchen@mail.cgu.edu.tw
OI Chen, Jyh-Ping/0000-0001-6527-4801
FU National Science Council, Taiwan, ROC [NSC-100-2221-E-182-024,
   NSC-101-2221-E-182-029]; Chang Gung Memorial Hospital [CMRPD1B0241,
   CMRPD1B0242]
FX We are thankful for the financial supports from National Science
   Council, Taiwan, ROC (NSC-100-2221-E-182-024 and NSC-101-2221-E-182-029)
   and Chang Gung Memorial Hospital (CMRPD1B0241 and CMRPD1B0242).
CR Amaral IF, 2005, J BIOMED MATER RES A, V75A, P387, DOI 10.1002/jbm.a.30436
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Boskey A L, 1998, J Cell Biochem Suppl, V30-31, P83
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chen JP, 2011, COLLOID SURFACE B, V86, P169, DOI 10.1016/j.colsurfb.2011.03.038
   Cheng YX, 2014, J BIOMED NANOTECHNOL, V10, P287, DOI 10.1166/jbn.2014.1753
   Cheon YW, 2010, ARTIF ORGANS, V34, P384, DOI 10.1111/j.1525-1594.2009.00871.x
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   HASEGAWA M, 1992, J APPL POLYM SCI, V45, P1857, DOI 10.1002/app.1992.070451020
   Heinemann S, 2009, ACTA BIOMATER, V5, P1979, DOI 10.1016/j.actbio.2009.02.029
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jeong L, 2006, INT J BIOL MACROMOL, V38, P140, DOI 10.1016/j.ijbiomac.2006.02.009
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Lee H, 2011, CARBOHYD POLYM, V85, P817, DOI 10.1016/j.carbpol.2011.04.001
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lieder R, 2012, NAT PRODUCT BIOPROSP, V2, P87, DOI 10.1007/s13659-012-0017-0
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Malaval L, 1999, J CELL BIOCHEM, V74, P616
   Matsuda A, 2007, J NANOSCI NANOTECHNO, V7, P852, DOI 10.1166/jnn.2007.520
   Ogata K, 2005, J BIOMED MATER RES A, V72A, P127, DOI 10.1002/jbm.a.30146
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Rim NG, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014102
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Toskas G, 2013, CARBOHYD POLYM, V94, P713, DOI 10.1016/j.carbpol.2013.01.068
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zhang XH, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-510
   Zhang YZ, 2010, TISSUE ENG PT A, V16, P1949, DOI [10.1089/ten.tea.2009.0221, 10.1089/ten.TEA.2009.0221]
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
NR 43
TC 62
Z9 65
U1 5
U2 172
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD OCT 13
PY 2014
VL 111
BP 288
EP 297
DI 10.1016/j.carbpol.2014.04.094
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AN0VM
UT WOS:000340302100033
PM 25037354
DA 2018-10-20
ER

PT J
AU Sakai, S
   Khanmohammadi, M
   Khoshfetrat, AB
   Taya, M
AF Sakai, Shinji
   Khanmohammadi, Mehdi
   Khoshfetrat, Ali Baradar
   Taya, Masahito
TI Horseradish peroxidase-catalyzed formation of hydrogels from chitosan
   and poly(vinyl alcohol) derivatives both possessing phenolic hydroxyl
   groups
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Poly(vinyl alcohol); Horseradish peroxidase; Enzymatic
   cross-linking; Hydrogel; Antibacterial activity
ID ANTIBACTERIAL ACTIVITY; MECHANICAL-PROPERTIES; GAMMA-IRRADIATION;
   ALGINATE; POLYMER; PH; BIOMATERIAL; SCAFFOLDS; CARTILAGE; DELIVERY
AB Horseradish peroxidase-catalyzed cross-linking was applied to prepare hydrogels from aqueous solutions containing chitosan and poly(vinyl alcohol) derivatives both possessing phenolic hydroxyl groups (denoted as Ph-chitosan and Ph-PVA, respectively). Comparing the hydrogels prepared from the solution of 1.0% (w/v) Ph-chitosan and 3.0% (w/v) Ph-PVA and that of 3.0% (w/v) Ph-chitosan and 1.0% (w/v) Ph-PVA, the gelation time of the former hydrogel was 47 s, while was 10 s longer than that of the latter one. The breaking point for the former hydrogel under stretching (114% strain) was approximately twice larger than that for the latter one. The swelling ratio of the former hydrogel in saline was about half of the latter one. Fibroblastic cells did not adhere on the former hydrogel but adhered and spread on the latter one. The growth of Escherichia coli cells was fully suppressed on the latter hydrogel during 48 h cultivation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Sakai, Shinji; Taya, Masahito] Osaka Univ, Dept Mat Sci & Engn, Grad Sch Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan.
   [Khanmohammadi, Mehdi; Khoshfetrat, Ali Baradar] Sahand Univ Technol, Dept Chem Engn, Tabriz 513351996, Iran.
RP Sakai, S (reprint author), Osaka Univ, Dept Mat Sci & Engn, Grad Sch Engn Sci, Div Chem Engn, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.
EM sakai@cheng.es.osaka-u.ac.jp
OI shinji, sakai/0000-0002-1041-4798; Khanmohammadi,
   Mehdi/0000-0001-7412-299X
CR Abdeen Z, 2011, J DISPER SCI TECHNOL, V32, P1337, DOI 10.1080/01932691.2010.505869
   Abdel-Mohsen AM, 2011, J POLYM ENVIRON, V19, P1005, DOI 10.1007/s10924-011-0334-0
   Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chen CF, 2013, INT J BIOL MACROMOL, V62, P188, DOI 10.1016/j.ijbiomac.2013.08.042
   Costa ES, 2009, CARBOHYD POLYM, V76, P472, DOI 10.1016/j.carbpol.2008.11.015
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Islam A, 2012, J APPL POLYM SCI, V124, P4184, DOI 10.1002/app.35392
   Ito A, 2003, J BIOSCI BIOENG, V95, P196, DOI 10.1016/S1389-1723(03)80129-9
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Kim SJ, 2003, REACT FUNCT POLYM, V55, P53, DOI 10.1016/S1381-5148(02)00214-6
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   Koyano T, 1998, J BIOMED MATER RES, V39, P486
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kweon DK, 1999, J APPL POLYM SCI, V74, P458, DOI 10.1002/(SICI)1097-4628(19991010)74:2<458::AID-APP29>3.0.CO;2-6
   Lee F, 2009, J CONTROL RELEASE, V134, P186, DOI 10.1016/j.jconrel.2008.11.028
   Liang SM, 2009, CARBOHYD POLYM, V77, P718, DOI 10.1016/j.carbpol.2009.02.007
   Muzzarelli RAA, 2009, WOODHEAD PUBL FOOD S, P849, DOI 10.1533/9781845695873.849
   MUZZARELLI RAA, 1994, CARBOHYD POLYM, V24, P295, DOI 10.1016/0144-8617(94)90074-4
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Peniche C, 2003, MACROMOL BIOSCI, V3, P511, DOI 10.1002/mabi.200300019
   Rocasalbas G, 2013, CARBOHYD POLYM, V92, P989, DOI 10.1016/j.carbpol.2012.10.045
   Sabaa MW, 2012, J APPL POLYM SCI, V123, P3459, DOI 10.1002/app.35072
   Sakai S, 2007, BIOMACROMOLECULES, V8, P2622, DOI 10.1021/bm070300+
   Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002
   Sakai S, 2013, J MATER CHEM B, V1, P5067, DOI 10.1039/c3tb20780c
   Sakai S, 2009, J MATER CHEM, V19, P230, DOI 10.1039/b812086b
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
   Tahtat D, 2011, J MATER SCI-MATER M, V22, P2505, DOI 10.1007/s10856-011-4421-5
   Takei T, 2012, ACTA BIOMATER, V8, P686, DOI 10.1016/j.actbio.2011.10.005
   Takei T, 2013, J MATER SCI-MATER M, V24, P2479, DOI 10.1007/s10856-013-4991-5
   Teixeira LSM, 2012, BIOMATERIALS, V33, P1281, DOI 10.1016/j.biomaterials.2011.10.067
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
   Vinsova J, 2011, CURR PHARM DESIGN, V17, P3596, DOI 10.2174/138161211798194468
   Yang XM, 2008, CARBOHYD POLYM, V73, P401, DOI 10.1016/j.carbpol.2007.12.008
   Zhao L, 2003, CARBOHYD POLYM, V53, P439, DOI 10.1016/S0144-8617(03)00103-6
NR 39
TC 17
Z9 17
U1 3
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD OCT 13
PY 2014
VL 111
BP 404
EP 409
DI 10.1016/j.carbpol.2014.05.010
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AN0VM
UT WOS:000340302100047
PM 25037368
DA 2018-10-20
ER

PT J
AU Holloway, JL
   Ma, H
   Rai, R
   Burdick, JA
AF Holloway, Julianne L.
   Ma, Henry
   Rai, Reena
   Burdick, Jason A.
TI Modulating hydrogel crosslink density and degradation to control bone
   morphogenetic protein delivery and in vivo bone formation
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article; Proceedings Paper
CT 11th International Nanomedicine and Drug Delivery Symposium (NanoDDS)
CY OCT 25-27, 2013
CL San Diego, CA
DE Hydrogel; Hyaluronic acid; Bone repair; Bone morphogenetic protein;
   Calvarial defect
ID HYALURONIC-ACID HYDROGELS; MATRIX METALLOPROTEINASES; TISSUE
   REGENERATION; CALVARIAL DEFECT; DRUG-DELIVERY; SCAFFOLDS; BMP-2;
   BIOMATERIALS; RETENTION; RELEASE
AB Bone morphogenetic proteins (BMPs) show promise in therapies for improving bone formation after injury; however, the high supraphysiological concentrations required for desired osteoinductive effects, off-target concerns, costs, and patient variability have limited the use of BMP-based therapeutics. To better understand the role of biomaterial design in BMP delivery, a matrix metalloprotease (MMP)-sensitive hyaluronic acid (HA)-based hydrogel was used for BMP-2 delivery to evaluate the influence of hydrogel degradation rate on bone repair in vivo. Specifically, maleimide-modified HA (MaHA) macromers were crosslinked with difunctional MMP-sensitive peptides to permit protease-mediated hydrogel degradation and growth factor release. The compressive, rheological, and degradation properties of MaHA hydrogels were characterized as a function of crosslink density, which was varied through either MaHA concentration (1-5 wt.%) or maleimide functionalization (10-40%f). Generally, the compressive moduli increased, the time to gelation decreased, and the degradation rate decreased with increasing crosslink density. Furthermore, BMP-2 release increased with either a decrease in the initial crosslink density or an increase in collagenase concentration (non-specific MMP degradation). Lastly, two hydrogel formulations with distinct BMP-2 release profiles were evaluated in a critical-sized calvarial defect model in rats. After six weeks, minimal evidence of bone repair was observed within defects left empty or filled with hydrogels alone. For hydrogels that contained BMP-2, similar volumes of new bone tissue were formed; however, the faster degrading hydrogel exhibited improved cellular invasion, bone volume to total volume ratio, and overall defect filling. These results illustrate the importance of coordinating hydrogel degradation with the rate of new tissue formation. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Holloway, Julianne L.; Ma, Henry; Rai, Reena; Burdick, Jason A.] Univ Penn, Philadelphia, PA 19104 USA.
RP Burdick, JA (reprint author), Univ Penn, 210 S 33rd St,Skirkanich Hall Rm 240, Philadelphia, PA 19104 USA.
EM jhollo@seas.upenn.edu; herny1@seas.upenn.edu; rair@vet.penn.edu;
   burdick2@seas.upenn.edu
FU NIAMS NIH HHS [5F32 AR063598, F32 AR063598]
CR Andreu D, 1994, Methods Mol Biol, V35, P91
   Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Cooper GM, 2010, TISSUE ENG PT A, V16, P1749, DOI [10.1089/ten.tea.2009.0650, 10.1089/ten.TEA.2009.0650]
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Henle P, 2005, BONE, V37, P791, DOI 10.1016/j.bone.2005.06.015
   Hierholzer C, 2006, J BONE JOINT SURG AM, V88A, P1442, DOI 10.2106/JBJS.E.00332
   Hirakura T, 2010, J CONTROL RELEASE, V142, P483, DOI [10.1016/j.jconrel.2009.11.023, 10.1016/j.jconre1.2009.11.023]
   Huang L, 2003, J BIOMED MATER RES A, V66A, P880, DOI 10.1002/jbm.a.10535
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Khetan S., 2012, THESIS U PENNSYLVANI
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kim HD, 2002, J BIOMED MATER RES, V59, P573, DOI 10.1002/jbm.10011
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mathiowitz E, 1999, ENCY CONTROLLED DRUG, V1, P397
   Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009
   O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Purcell BP, 2012, BIOMATERIALS, V33, P7849, DOI 10.1016/j.biomaterials.2012.07.005
   Ruhe PQ, 2005, J BIOMED MATER RES A, V74A, P533, DOI 10.1002/jbm.a.30341
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393
   Vacanti CA, 1999, CLIN ORTHOP RELAT R, pS375
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 47
TC 40
Z9 41
U1 2
U2 100
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD OCT 10
PY 2014
VL 191
SI SI
BP 63
EP 70
DI 10.1016/j.jconrel.2014.05.053
PG 8
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AP7SA
UT WOS:000342275800008
PM 24905414
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Koseki, H
   Yonekura, A
   Shida, T
   Yoda, I
   Horiuchi, H
   Morinaga, Y
   Yanagihara, K
   Sakoda, H
   Osaki, M
   Tomita, M
AF Koseki, Hironobu
   Yonekura, Akihiko
   Shida, Takayuki
   Yoda, Itaru
   Horiuchi, Hidehiko
   Morinaga, Yoshitomo
   Yanagihara, Katsunori
   Sakoda, Hideyuki
   Osaki, Makoto
   Tomita, Masato
TI Early Staphylococcal Biofilm Formation on Solid Orthopaedic Implant
   Materials: In Vitro Study
SO PLOS ONE
LA English
DT Article
ID SURFACE-FREE-ENERGY; STREPTOCOCCUS-SANGUIS CH3; OF-THE-LITERATURE;
   BACTERIAL ADHESION; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE;
   QUANTITATIVE-ANALYSIS; HYDROPHOBIC SURFACES; EPIDERMIDIS BIOFILM;
   INFECTION
AB Biofilms forming on the surface of biomaterials can cause intractable implant-related infections. Bacterial adherence and early biofilm formation are influenced by the type of biomaterial used and the physical characteristics of implant surface. In this in vitro research, we evaluated the ability of Staphylococcus epidermidis, the main pathogen in implant-related infections, to form biofilms on the surface of the solid orthopaedic biomaterials, oxidized zirconium-niobium alloy, cobalt-chromium- molybdenum alloy (Co-Cr-Mo), titanium alloy (Ti-6Al-4V), commercially pure titanium (cp-Ti) and stainless steel. A bacterial suspension of Staphylococcus epidermidis strain RP62A (ATCC35984) was added to the surface of specimens and incubated. The stained biofilms were imaged with a digital optical microscope and the biofilm coverage rate (BCR) was calculated. The total amount of biofilm was determined with the crystal violet assay and the number of viable cells in the biofilm was counted using the plate count method. The BCR of all the biomaterials rose in proportion to culture duration. After culturing for 2-4 hours, the BCR was similar for all materials. However, after culturing for 6 hours, the BCR for Co-CrMo alloy was significantly lower than for Ti-6Al-4V, cp-Ti and stainless steel (P < 0.05). The absorbance value determined in the crystal violet assay and the number of viable cells on Co-Cr-Mo were not significantly lower than for the other materials (P > 0.05). These results suggest that surface properties, such as hydrophobicity or the low surface free energy of Co-Cr-Mo, may have some influence in inhibiting or delaying the two-dimensional expansion of biofilm on surfaces with a similar degree of smoothness.
C1 [Koseki, Hironobu; Yonekura, Akihiko; Shida, Takayuki; Yoda, Itaru; Horiuchi, Hidehiko; Osaki, Makoto; Tomita, Masato] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 852, Japan.
   [Morinaga, Yoshitomo; Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan.
   [Sakoda, Hideyuki] Natl Inst Hlth Sci, Div Med Devices, Tokyo, Japan.
RP Koseki, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 852, Japan.
EM koseki@nagasaki-u.ac.jp
FU JSPS KAKENHI [24592236]
FX This work was supported by JSPS KAKENHI Grant Number 24592236
   (http://www.jsps.go.jp/j-grantsinaid/16_rule/rule.html). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Braem A, 2013, J BIOMED MAT RES A
   Busscher H J, 1997, Adv Dent Res, V11, P24
   BUSSCHER HJ, 1986, APPL ENVIRON MICROB, V51, P910
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHANG CC, 1991, J ORTHOPAED RES, V9, P284, DOI 10.1002/jor.1100090217
   Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3
   Chu Vivian H, 2005, Am J Med, V118, P1416
   Clint JH, 2001, CURR OPIN COLLOID IN, V6, P28, DOI 10.1016/S1359-0294(00)00084-4
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Donlan RM, 2005, CLIN ORTHOP RELAT R, P12, DOI 10.1097/01.blo.0000175120.66051.29
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   GLANTZ PO, 1971, J COLLOID INTERF SCI, V37, P281, DOI 10.1016/0021-9797(71)90294-3
   Gottenbos B, 1999, J MATER SCI-MATER M, V10, P853, DOI 10.1023/A:1008989416939
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Henrique MA, 2004, COLLOIDS SURF BIOINT, V33, P7
   Heydorn A, 2000, MICROBIOL-SGM, V146, P2395, DOI 10.1099/00221287-146-10-2395
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   HUNTER G, 2005, J ASTM INT, V2
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lee BC, 2011, J ADV PROSTHODONT, V3, P81, DOI 10.4047/jap.2011.3.2.81
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004
   Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Sheehan E, 2004, J ORTHOPAED RES, V22, P39, DOI 10.1016/S0736-0266(03)00152-9
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   Tang PF, 2011, J NANOMATER, DOI 10.1155/2011/178921
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   VANPELT AWJ, 1985, APPL ENVIRON MICROB, V49, P1270
   Wijekoon CP, 2008, J MICROBIOL METH, V74, P94, DOI 10.1016/j.mimet.2008.03.008
   WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732
   Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9
NR 60
TC 21
Z9 21
U1 0
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 9
PY 2014
VL 9
IS 10
AR e107588
DI 10.1371/journal.pone.0107588
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0AP
UT WOS:000343941200008
PM 25299658
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Jonker, JL
   Abram, F
   Pires, E
   Coelho, AV
   Grunwald, I
   Power, AM
AF Jonker, Jaimie-Leigh
   Abram, Florence
   Pires, Elisabete
   Coelho, Ana Varela
   Grunwald, Ingo
   Power, Anne Marie
TI Adhesive Proteins of Stalked and Acorn Barnacles Display Homology with
   Low Sequence Similarities
SO PLOS ONE
LA English
DT Article
ID CEMENT PROTEINS; PHRAGMATOPOMA-CALIFORNICA; UNDERWATER ADHESIVE;
   LEPAS-ANATIFERA; MYTILUS-EDULIS; MUSSEL; SPECTROSCOPY; PLAQUE; DOPA;
   BIOMATERIAL
AB Barnacle adhesion underwater is an important phenomenon to understand for the prevention of biofouling and potential biotechnological innovations, yet so far, identifying what makes barnacle glue proteins 'sticky' has proved elusive. Examination of a broad range of species within the barnacles may be instructive to identify conserved adhesive domains. We add to extensive information from the acorn barnacles (order Sessilia) by providing the first protein analysis of a stalked barnacle adhesive, Lepas anatifera (order Lepadiformes). It was possible to separate the L. anatifera adhesive into at least 10 protein bands using SDS-PAGE. Intense bands were present at approximately 30, 70, 90 and 110 kilodaltons (kDa). Mass spectrometry for protein identification was followed by de novo sequencing which detected 52 peptides of 7-16 amino acids in length. None of the peptides matched published or unpublished transcriptome sequences, but some amino acid sequence similarity was apparent between L. anatifera and closely-related Dosima fascicularis. Antibodies against two acorn barnacle proteins (ab-cp-52k and ab-cp-68k) showed cross-reactivity in the adhesive glands of L. anatifera. We also analysed the similarity of adhesive proteins across several barnacle taxa, including Pollicipes pollicipes (a stalked barnacle in the order Scalpelliformes). Sequence alignment of published expressed sequence tags clearly indicated that P. pollicipes possesses homologues for the 19 kDa and 100 kDa proteins in acorn barnacles. Homology aside, sequence similarity in amino acid and gene sequences tended to decline as taxonomic distance increased, with minimum similarities of 18-26%, depending on the gene. The results indicate that some adhesive proteins (e. g. 100 kDa) are more conserved within barnacles than others (20 kDa).
C1 [Jonker, Jaimie-Leigh; Abram, Florence; Power, Anne Marie] Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland.
   [Pires, Elisabete; Coelho, Ana Varela] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal.
   [Grunwald, Ingo] Fraunhofer Inst Mfg Technol & Adv Mat, Dept Adhes Bonding & Surfaces, Bremen, Germany.
RP Power, AM (reprint author), Natl Univ Ireland Galway, Sch Nat Sci, Galway, Ireland.
EM annemarie.power@nuigalway.ie
RI Varela Coelho, Ana/O-3977-2014; Grunwald, Ingo/C-5662-2012; PTMS,
   RNEM/C-1589-2014; abram, florence/K-6639-2015
OI Varela Coelho, Ana/0000-0002-6143-4203; abram,
   florence/0000-0001-7522-9158; Power, Anne Marie/0000-0001-7351-2451
FU Science Foundation Ireland [09RFPMTR2311]; Department of Communications,
   Marine and Natural Resources, Government of Ireland; European
   Cooperation in the field of Scientific and Technical Research [TD0906]
FX Funding was provided by Science Foundation Ireland Contract grant number
   09RFPMTR2311 awarded to AMP (http://www.sfi.ie/), and Beaufort Marine
   Research Awards grant-aided by the Department of Communications, Marine
   and Natural Resources, Government of Ireland, awarded to AMP and co-Pls.
   Work was also supported by European Cooperation in the field of
   Scientific and Technical Research (COST Action TD0906). The funders had
   no role in study design, data collection and analysis, decision to
   publish or preparation of the manuscript.
CR Anderson KE, 1998, BIOL BULL, V194, P150, DOI 10.2307/1543045
   Bae JS, 2007, J BIOL CHEM, V282, P9251, DOI 10.1074/jbc.M610547200
   BAINBRIDGE V., 1966, P67
   Barlow DE, 2012, ANNU REV ANAL CHEM, V5, P229, DOI 10.1146/annurev-anchem-061010-113844
   BARNES H, 1976, J EXP MAR BIOL ECOL, V25, P263, DOI 10.1016/0022-0981(76)90128-3
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450
   Berglin M, 2003, COLLOID SURFACE B, V28, P107, DOI 10.1016/S0927-7765(02)00149-2
   Callow JA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1251
   Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913
   Endrizzi BJ, 2009, J ADHESION, V85, P546, DOI 10.1080/00218460902996457
   Flammang P, 2006, BIOL ADHEISVES
   Flammang P, 2009, J ADHESION, V85, P447, DOI 10.1080/00218460902996358
   Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124
   He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130
   Holowka EP, 2010, MACROMOL BIOSCI, V10, P496, DOI 10.1002/mabi.200900390
   Hwang DS, 2007, BIOMATERIALS, V28, P4039, DOI 10.1016/j.biomaterials.2007.05.028
   Hwang DS, 2007, J BIOTECHNOL, V127, P727, DOI 10.1016/j.jbiotec.2006.08.005
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698
   Jonker J-L, 2013, NATURAL ADHESIVE GOO
   Jonker JL, 2012, J MORPHOL, V273, P1377, DOI 10.1002/jmor.20067
   Kamino K, 1998, NEW DEVELOPMENTS IN MARINE BIOTECHNOLOGY, P77
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   Kamino K, 1996, BIOL BULL, V190, P403, DOI 10.2307/1543033
   Kamino K, 2013, STRUCTURAL INTERFACE, P175
   Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3
   Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8
   Kamino K, 2012, FEBS J, V279, P1750, DOI 10.1111/j.1742-4658.2012.08552.x
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Lin HC, 2013, BIOFOULING
   Lin HC, 2014, BIOFOULING, V30, P169, DOI 10.1080/08927014.2013.853051
   McEvilly P, 2011, LEPAS ANATIFERA CONC
   Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130
   Mori Y, 2007, FEBS J, V274, P6436, DOI 10.1111/j.1742-4658.2007.06161.x
   Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043
   NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221
   Naldrett MJ, 1997, MAR BIOL, V127, P629, DOI 10.1007/s002270050053
   Nicholas KB, 1997, EMBNEW NEWS, V4, P14
   Ohkawa K, 2009, J ADHESION, V85, P770, DOI 10.1080/00218460903291353
   PARKER JH, 1967, PHYS REV, V155, P712, DOI 10.1103/PhysRev.155.712
   Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458
   Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004
   Pilson M. E. Q, 2013, INTRO CHEM SEA
   Power AM, 2001, ESTUAR COAST SHELF S, V52, P349, DOI 10.1006/ecss.2000.0711
   Power AM, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P153, DOI 10.1007/978-3-7091-0286-2_9
   Raman S, 2013, INT J ADHES ADHES, V41, P140, DOI 10.1016/j.ijadhadh.2012.11.003
   Schweitzer-Stenner R, 2001, J RAMAN SPECTROSC, V32, P711, DOI 10.1002/jrs.757
   SNELI JA, 1983, CRUSTACEANA, V45, P306, DOI 10.1163/156854083X00352
   Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330
   Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d
   Suzuki R, 2005, J BIOMOL NMR, V32, P257, DOI 10.1007/s10858-005-7029-6
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   Urushida Y, 2007, FEBS J, V274, P4336, DOI 10.1111/j.1742-4658.2007.05965.x
   Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   Walker G., 1987, SYNTHETIC ADHESIVES, P112
   Wiegemann M, 2006, MAR BIOL, V149, P241, DOI 10.1007/s00227-005-0219-7
   Wolpert M, 2006, SPECTROCHIM ACTA A, V64, P987, DOI 10.1016/j.saa.2005.08.025
   Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
   Zheden V, 2014, BIOFOULING
   Zheden V, 2012, BIOL BULL-US, V223, P192, DOI 10.1086/BBLv223n2p192
NR 65
TC 5
Z9 5
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 8
PY 2014
VL 9
IS 10
AR e108902
DI 10.1371/journal.pone.0108902
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT8TE
UT WOS:000345204000026
PM 25295513
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ruan, CS
   Hu, Y
   Jiang, LX
   Cai, QQ
   Pan, HB
   Wang, HY
AF Ruan, Changshun
   Hu, Yang
   Jiang, Lixin
   Cai, Qingqing
   Pan, Haobo
   Wang, Huaiyu
TI Tunable Degradation of Piperazine-Based Polyurethane Ureas
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; biopolymers & renewable polymers; functionalization of
   polymers; ring-opening polymerization
ID DESIGN; PRODUCTS; ACID); POLY(URETHANE-UREA); CYTOCOMPATIBILITY;
   POLYMERS
AB To manipulate the degradation of polymeric biomaterial for potential applications in tissue regeneration, a series of piperazinebased polyurethane ureas (P-PUUs) were designed and prepared with poly(D, L-lactic acid) diol (PDLLA diol), 1,6-hexamethylene diisocyanate (HDI), and piperazine (PP). The number of piperazine units [Num(pp)] in the P-PUUs could be precisely calculated by a specified equation and could be controlled by the regulation of the PDLLA diol/HDI/PP ratio. Then, the in vitro degradation of the P-PUUs was investigated by the detection of the variation of the pH value, the weight loss ratio, the surface morphologies, and the molecular weight loss over 12 weeks. The results reveal that the degradation stability and the degradation rate of the P-PUUs could be manipulated by Num(pp), and a linear correlation between the degradation rate of the P-PUUs and Num(pp) in the polymer was demonstrated; this implied the tunable degradation of the P-PUUs. Such a linear correlation is expected to benefit to tissue regeneration as the degradation rate of P-PUUs for specific tissue defects can be well tuned once the tissue regenerative period is known. (C) 2014 Wiley Periodicals, Inc. This article is part of a Special Issue on Bioactive Surface Functionalization. The remaining articles appear in J. Appl. Polym. Sci. (2014) volume 131, issue 14. This note was added on 14th July 2014.
C1 [Ruan, Changshun; Hu, Yang; Jiang, Lixin; Cai, Qingqing; Pan, Haobo; Wang, Huaiyu] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organ Degenerat, Shenzhen 518055, Peoples R China.
   [Ruan, Changshun; Hu, Yang; Jiang, Lixin; Cai, Qingqing; Pan, Haobo; Wang, Huaiyu] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Marine Biomed Mat, Shenzhen 518055, Peoples R China.
RP Wang, HY (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Ctr Human Tissue & Organ Degenerat, Shenzhen 518055, Peoples R China.
EM hy.wang1@siat.ac.cn
FU National Natural Science Foundation of China [31200723, 31370978];
   Development of Strategic Emerging Industries of the Shenzhen Basic
   Research Project [JCYJ20120617122433296]; Shenzhen Peacock Program
   [110811003586331]
FX This work was supported by grants from the National Natural Science
   Foundation of China (contract grant numbers 31200723 and 31370978), the
   Development of Strategic Emerging Industries of the Shenzhen Basic
   Research Project (contract grant number JCYJ20120617122433296), and the
   Shenzhen Peacock Program (contract grant number 110811003586331).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Elliott S, 2002, J BIOMAT SCI-POLYM E, V13, P691, DOI 10.1163/156856202320269166
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Hakkarainen M, 2007, J AM CHEM SOC, V129, P6308, DOI 10.1021/ja0702871
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hoglund A, 2012, MACROMOL BIOSCI, V12, P260, DOI 10.1002/mabi.201100288
   Hu N, 2013, ASIAN J CHEM, V25, P4327
   Luo YF, 2008, EUR POLYM J, V44, P1390, DOI 10.1016/j.eurpolymj.2008.01.043
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Ruan CS, 2012, POLYM INT, V61, P524, DOI 10.1002/pi.3197
   Tsuji H, 2002, J APPL POLYM SCI, V86, P186, DOI 10.1002/app.10813
   Wang CJ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/579141
   Wang Y., 2011, POLYM DEGRAD STABIL, V95, P1687
   Wang YL, 2010, POLYM DEGRAD STABIL, V95, P549, DOI 10.1016/j.polymdegradstab.2009.12.016
   Xu HX, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045006
NR 21
TC 5
Z9 5
U1 2
U2 47
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD OCT 5
PY 2014
VL 131
IS 19
AR 40527
DI 10.1002/app.40527
PG 6
WC Polymer Science
SC Polymer Science
GA AM9YV
UT WOS:000340238300001
DA 2018-10-20
ER

PT J
AU Jiang, MR
   Guo, ZM
   Wang, CP
   Yang, YM
   Liang, XM
   Ding, F
AF Jiang, Maorong
   Guo, Zhimou
   Wang, Caiping
   Yang, Yuming
   Liang, Xinmiao
   Ding, Fei
TI Neural activity analysis of pure chito-oligomer components separated
   from a mixture of chitooligosaccharides
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Chitooligosaccharides; Chito-oligomer; Schwann cell; Dorsal root
   ganglion (DRG); Neurite outgrowth
ID MOLECULAR-WEIGHT CHITOSAN; NEURITE OUTGROWTH; NERVE GRAFTS; IN-VITRO;
   NEURONS; CELLS; ACID; REGENERATION; PATHWAY; COS
AB Chitooligosaccharides (COSs) are obtained from the in vivo and in vitro degradation of chitosan, which is a natural biomaterial used successfully for peripheral nerve repair. Also, COSs have been reported to be beneficial for the nervous system and especially able to promote peripheral nerve regeneration. To determine which component in a mixture of COSs was really responsible for the neurotrophic action of COSs, this study was performed to separate the active components of COSs and compare the neural activity of different pure components. Hydrophilic interaction liquid chromatography (HILIC) was used to separate 5 chito-oligomers with single degrees of polymerization (DPs) from a mixture of COSs. They were chitobiose, chitotriose, chitotetraose, chitopentaose, and chitohexaose with DPs of 2-6, respectively. MTT assay indicated that chitotriose induced the greatest increase in Schwann cell survival among 5 chito-oligomers. Immunocytochemistry with anti-NF-200 showed that chitotriose significantly encouraged neurite outgrowth from dorsal root ganglion (DRG) explants with the greatest effect among 5 chito-oligomers. Our results suggest that chitotriose may be a key component in COSs mixture. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
C1 [Jiang, Maorong; Wang, Caiping; Yang, Yuming; Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, JS, Peoples R China.
   [Guo, Zhimou; Liang, Xinmiao] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian 116023, LN, Peoples R China.
RP Liang, XM (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, 457 Zhongshan Rd, Dalian 116023, LN, Peoples R China.
EM liangxm@dicp.ac.cn; dingfei@ntu.edu.cn
FU National Natural Science Foundation of China [81101159]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD); Jiangsu Collaborative Innovation Center for Neuroregeneration
FX This study was supported by the National Natural Science Foundation of
   China (Grant No. 81101159), Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD) and Jiangsu Collaborative
   Innovation Center for Neuroregeneration. We thank Professor Jie Liu for
   assistance in manuscript preparation.
CR Armati P, 2007, BIOLOGY OF SCHWANN CELLS: DEVELOPMENT, DIFFERENTIATION AND IMMUNOMODULATION, pIX, DOI 10.1017/CBO9780511541605.001
   Bahar B, 2012, MOL IMMUNOL, V51, P283, DOI 10.1016/j.molimm.2012.03.027
   Bilsland J, 1999, J NEUROSCI METH, V92, P75, DOI 10.1016/S0165-0270(99)00099-0
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021
   Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026
   Fernandes JC, 2010, J MICROBIOL BIOTECHN, V20, P311, DOI 10.4014/jmb.0904.04038
   Fu Q, 2010, CARBOHYD RES, V345, P2690, DOI 10.1016/j.carres.2010.09.033
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Huang R, 2006, LIFE SCI, V78, P2399, DOI 10.1016/j.lfs.2005.09.039
   Jia ZS, 2002, CARBOHYD POLYM, V49, P393, DOI 10.1016/S0144-8617(02)00026-7
   Jiang MR, 2009, NEUROSCI LETT, V454, P239, DOI 10.1016/j.neulet.2009.03.042
   Jiao HS, 2009, BIOMATERIALS, V30, P5004, DOI 10.1016/j.biomaterials.2009.05.059
   Joodi G, 2011, INT J BIOL MACROMOL, V48, P726, DOI 10.1016/j.ijbiomac.2011.02.011
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012
   Li J, 2005, POLYM DEGRAD STABIL, V87, P441, DOI 10.1016/j.polymdegradstab.2004.09.008
   Li KC, 2012, CARBOHYD POLYM, V88, P896, DOI 10.1016/j.carbpol.2012.01.033
   Lillo L, 2008, Z NATURFORSCH C, V63, P644
   Qin CQ, 2002, POLYM DEGRAD STABIL, V76, P211, DOI 10.1016/S0141-3910(02)00016-2
   Ryu B, 2012, CARBOHYD RES, V350, P55, DOI 10.1016/j.carres.2011.12.028
   SHAO J, 2003, POLYM DEGRAD STABIL, V82, P395
   VARON S, 1979, BRAIN RES, V173, P29, DOI 10.1016/0006-8993(79)91093-X
   Varum KM, 2001, CARBOHYD POLYM, V46, P89, DOI 10.1016/S0144-8617(00)00288-5
   Weinstein D.E., 2001, CURR PROTOC NEUROSCI
   Xiong CN, 2009, CARBOHYD RES, V344, P1975, DOI 10.1016/j.carres.2009.06.036
   Xu YY, 2011, BRAIN RES, V1375, P49, DOI 10.1016/j.brainres.2010.12.029
   Yang YM, 2009, CELL BIOL INT, V33, P352, DOI 10.1016/j.cellbi.2009.01.005
   Zhou SL, 2008, NEUROSCI LETT, V444, P270, DOI 10.1016/j.neulet.2008.08.040
NR 30
TC 7
Z9 7
U1 1
U2 29
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD OCT 3
PY 2014
VL 581
BP 32
EP 36
DI 10.1016/j.neulet.2014.08.014
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA AQ5TW
UT WOS:000342872500006
PM 25128219
DA 2018-10-20
ER

PT J
AU Begam, H
   Mandal, S
   Chanda, A
   Mukherjee, J
   Nandi, SK
AF Begam, Howa
   Mandal, Somali
   Chanda, Abhijit
   Mukherjee, Jayanta
   Nandi, Samit Kumar
TI Effect of Zinc Doping on Biological Properties of Biphasic Calcium
   Phosphate Ceramics in Orthopaedic Animal Model
SO TRANSACTIONS OF THE INDIAN CERAMIC SOCIETY
LA English
DT Article
DE Zinc dopant; Wet chemical route; Bone healing; in vivo study; Biphasic
   calcium phosphate (BCP)
ID BONE-FORMATION; TRICALCIUM PHOSPHATE; GROWING RATS; IN-VITRO;
   HYDROXYAPATITE; TETRACYCLINE; BIOCERAMICS; TISSUE; BEHAVIOR; GOAT
AB Addition of dopants in biomaterial has emerged as a vital regulator of bone formation and bone regeneration due to their significant role in the biological processes. We report the effect of zinc ion doping on various properties of biphasic calcium phosphate (BCP) dense body in vitro and in vivo. Zinc (<3 wt%) was successfully incorporated into both calcium hydroxyapatite (HAp) and beta-tricalcium phosphate (TCP) via simple wet chemical route. BCP pellets were prepared by mixing HAp and TCP in a definite proportion, compacted and then sintered. The sintered pellets were checked with XRD, FTIR in addition to hardness and fracture toughness. A systematic in vivo study was conducted to evaluate healing of surgically created defects on the femur of rabbit after implantation of doped and undoped dense BCP for 4 months. Characterization of these sintered dense bodies revealed that zinc dopant had marked influence on the physical properties of the dense bodies as well as their mechanical properties. Fluorochrome labelling, histological analysis and radiology were performed post operation after two and four months to study angiogenesis, bone formation and osseous ingrowth. The findings suggested that addition of Zn dopants to the BCP ceramics demonstrated excellent bone formation and that may pave the new insight in bone tissue engineering.
C1 [Nandi, Samit Kumar] West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata 700037, India.
   [Begam, Howa; Mandal, Somali; Chanda, Abhijit] Jadavpur Univ, Sch Biosci & Engn, Kolkata 700032, India.
   [Mukherjee, Jayanta] Inst Anim Hlth & Vet Biol, Anim Resources Dev Dept, Kolkata 700037, India.
RP Nandi, SK (reprint author), West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, 37 Kshudiram Bose Sarani, Kolkata 700037, India.
EM samitnandi1967@gmail.com
FU Council of Scientific and Industrial Research
FX The authors would like to acknowledge the staff members of School of Bio
   Science & Engineering, Jadavpur University, Kolkata, India and Vice
   Chancellor of West Bengal University of Animal and Fishery Sciences,
   Kolkata, India for providing necessary help and support during the
   research work. The authors would also like to acknowledge Council of
   Scientific and Industrial Research for financial support.
CR Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Aslanidou M, 2013, CERAM INT, V39, P539, DOI 10.1016/j.ceramint.2012.06.060
   Banerjee SS, 2010, ACTA BIOMATER, V6, P4167, DOI 10.1016/j.actbio.2010.05.012
   Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P279, DOI 10.1081/CLT-100102426
   Bernhard JM, 2004, J FORAMIN RES, V34, P96, DOI 10.2113/0340096
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Chettri B., 2012, OPEN ACCESS SCI REP, V1, P2
   Costa AM, 2004, KEY ENG MAT, V254-2, P119, DOI 10.4028/www.scientific.net/KEM.254-256.119
   Dahners LE, 2002, J ORTHOP TRAUMA, V16, P345, DOI 10.1097/00005131-200205000-00009
   DHEM A, 1976, SCAND J INFECT DIS, P42
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Emadi R, 2010, MATER LETT, V64, P993, DOI 10.1016/j.matlet.2010.01.085
   Erben R. G., 2003, BONE LABELING TECHNI, P99
   FROST HM, 1958, STAIN TECHNOL, V33, P273, DOI 10.3109/10520295809111862
   GIBSON CJ, 1978, CALC TISS RES, V26, P29, DOI 10.1007/BF02013230
   Gozalian A, 2011, SCI IRAN, V18, P1614, DOI 10.1016/j.scient.2011.11.014
   Guo H, 2009, ACTA BIOMATER, V5, P268, DOI 10.1016/j.actbio.2008.07.018
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   HENCH LL, 1989, J BIOMED MATER RES, V23, P685, DOI 10.1002/jbm.820230703
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ikeuchi M, 2003, J BIOMED MATER RES A, V67A, P1115, DOI 10.1002/jbm.a.10041
   Ito A, 2002, MAT SCI ENG C-BIO S, V22, P21, DOI 10.1016/S0928-4931(02)00108-X
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jokic B, 2012, MATER LETT, V74, P155, DOI 10.1016/j.matlet.2012.01.081
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kannan S, 2011, ACTA BIOMATER, V7, P1835, DOI 10.1016/j.actbio.2010.12.009
   Kawamura H, 2000, J BIOMED MATER RES, V50, P184, DOI 10.1002/(SICI)1097-4636(200005)50:2<184::AID-JBM13>3.0.CO;2-3
   Kim T. W., 2012, CERAM INT, V38, P1974
   Konig JB, 1998, ANN ANAT, V180, P471
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kovar JL, 2011, ANAL BIOCHEM, V416, P167, DOI 10.1016/j.ab.2011.05.011
   Kundu B, 2011, J MATER SCI-MATER M, V22, P705, DOI 10.1007/s10856-010-4221-3
   Kwun IS, 2010, BONE, V46, P732, DOI 10.1016/j.bone.2009.11.003
   Li X, 2009, MAT SCI ENG C-BIO S, V29, P969, DOI 10.1016/j.msec.2008.08.021
   Manjubala I, 2005, J BIOMATER APPL, V19, P341, DOI 10.1177/0885328205048633
   Maus U, 2008, J BIOMATER APPL, V22, P559, DOI 10.1177/0885328207083311
   MILCH RA, 1958, J BONE JOINT SURG AM, V40, P897, DOI 10.2106/00004623-195840040-00013
   MOONGA BS, 1995, J BONE MINER RES, V10, P453
   MURRAY EJ, 1981, J NUTR, V111, P1641
   Nandi SK, 2008, SMALL RUMINANT RES, V75, P144, DOI 10.1016/j.smallrumres.2007.09.006
   Nandi SK, 2009, RES VET SCI, V86, P162, DOI 10.1016/j.rvsc.2008.04.008
   Nandi SK, 2008, J VET SCI, V9, P183, DOI 10.4142/jvs.2008.9.2.183
   Nery E. B., 1992, PERIODONTOLOGY, V63, P729
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   Pena J., 2003, J EUR CERAM SOC, V23, P1687
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   RAHN BA, 1971, STAIN TECHNOL, V46, P125, DOI 10.3109/10520297109067836
   Santos MH, 2008, MAT SCI ENG C-BIO S, V28, P563, DOI 10.1016/j.msec.2007.07.002
   Sopyan I, 2011, CERAM INT, V37, P3703, DOI 10.1016/j.ceramint.2011.06.033
   Steven M., 2010, TISSUE ENG PART B-RE, V16, P209
   Storrie H, 2005, BIOMATERIALS, V26, P5492, DOI 10.1016/j.biomaterials.2005.01.043
   SUZUKI HK, 1966, STAIN TECHNOL, V41, P57, DOI 10.3109/10520296609116280
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   TURNER RT, 1993, J BONE MINER RES, V8, P359
   TURNER RT, 1994, J BONE MINER RES, V9, P1419
   Wang XP, 2010, ACTA BIOMATER, V6, P962, DOI 10.1016/j.actbio.2009.08.038
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Wei X, 2009, MAT SCI ENG C-BIO S, V29, P126, DOI 10.1016/j.msec.2008.05.020
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0
   Yanagisawa K, 2006, KEY ENG MAT, V309-311, P57, DOI 10.4028/www.scientific.net/KEM.309-311.57
NR 62
TC 3
Z9 3
U1 1
U2 17
PU INDIAN CERAMIC SOC
PI KOLKATA
PA CENTRAL GLASS & CERAMIC RES INST, KOLKATA, 700 032, INDIA
SN 0371-750X
EI 2165-5456
J9 T INDIAN CERAM SOC
JI Trans. Indian Ceram. Soc.
PD OCT 2
PY 2014
VL 73
IS 4
BP 284
EP 292
DI 10.1080/0371750X.2014.929509
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA AY4IY
UT WOS:000347542600006
DA 2018-10-20
ER

PT J
AU Fu, YX
   Guan, JJ
   Guo, SC
   Guo, F
   Niu, X
   Liu, Q
   Zhang, CQ
   Nie, HR
   Wang, Y
AF Fu, Yinxin
   Guan, Junjie
   Guo, Shangchun
   Guo, Fei
   Niu, Xin
   Liu, Qiang
   Zhang, Changqing
   Nie, Huarong
   Wang, Yang
TI Human urine-derived stem cells in combination with
   polycaprolactone/gelatin nanofibrous membranes enhance wound healing by
   promoting angiogenesis
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE Human urine-derived stem cells (USCs); Angiogenesis; Endothelial cells;
   Polycaprolactone/gelatin (PCL/GT)
ID COMPOSITE TISSUE ALLOTRANSPLANTATION; SCAFFOLDS; DIFFERENTIATION;
   RECONSTRUCTION; REJECTION; THERAPY; FIBERS
AB Background: Despite advancements in wound healing techniques and devices, new treatments are needed to improve therapeutic outcomes. This study aimed to evaluate the potential use of a new biomaterial engineered from human urine-derived stem cells (USCs) and polycaprolactone/gelatin (PCL/GT) for wound healing.
   Methods: USCs were isolated from healthy individuals. To fabricate PCL/GT composite meshes, twin-nozzle electrospinning were used to spin the PCL and gelatin solutions in normal organic solvents. The morphologies and hydrophilicity properties of PCL/GT membranes were investigated. After USCs were seeded onto a PCL/GT, cell adhesion, morphology, proliferation, and cytotoxicity were examined. Then, USCs were seeded on a PCL/GT blend nanofibrous membrane and transplanted into rabbit full-thickness skin defects for wound repair. Finally, the effect of USCs condition medium on proliferation, migration, and tube formation of human umbilical vein endothelial cells (HUVECs) were performed in vitro.
   Results: USCs were successfully isolated from urine samples and expressed specific mesenchymal stem cells markers and could differentiate into osteoblasts, adipocytes, and chondrocytes. PCL/GT membrane has suitable mechanical properties similar with skin tissue and has good biocompatibility. USCs-PCL/GT significantly enhanced the healing of full-thickness skin wounds in rabbits compared to wounds treated with PCL/GT membrane alone or untreated wounds. USCs-PCL/GT-treated wounds closed much faster, with increased re-epithelialization, collagen formation, and angiogenesis. Moreover, USCs could secrete VEGF and TGF-beta 1, and USC-conditioned medium enhanced the migration, proliferation, and tube formation of endothelial cells.
   Conclusion: USCs in combination with PCL/GT significantly prompted the healing of full-thickness skin wounds in rabbits. USCs based therapy provides a novel strategy for accelerating wound closure and promoting angiogenesis.
C1 [Fu, Yinxin; Guan, Junjie; Guo, Shangchun; Niu, Xin; Zhang, Changqing; Wang, Yang] Shanghai Jiao Tong Univ, Inst Microsurg Extrem, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China.
   [Fu, Yinxin] Huazhong Univ Sci & Technol, Puai Hosp, Dept Clin Lab, Wuhan 430074, Hubei, Peoples R China.
   [Guo, Fei; Liu, Qiang; Nie, Huarong] Jiangxi Origin BioTECH Co LTD, Nanchang 330006, Peoples R China.
   [Nie, Huarong] Jiangxi Chuanqi Pharmaceut Co LTD, Nanchang 330039, Peoples R China.
RP Nie, HR (reprint author), Jiangxi Origin BioTECH Co LTD, Nanchang 330006, Peoples R China.
EM niehr@iccas.ac.cn; wangy63cn@126.com
OI Guo, Shang-Chun/0000-0001-6285-6750
FU National High Technology Research and Development Program of China
   [2012AA020506]; Major Technological Innovation Project, Jiangxi, China
   [20114ACG00800]; Science and Technology Research Project, Jiangxi, China
   [20131AFC30043]
FX This work was financially supported by The National High Technology
   Research and Development Program of China (No: 2012AA020506), Major
   Technological Innovation Project, Jiangxi, China (20114ACG00800),
   Science and Technology Research Project, Jiangxi, China (20131AFC30043).
CR Alvarez-Perez MA, 2010, BIOMACROMOLECULES, V11, P2238, DOI 10.1021/bm100221h
   ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J
   Bharadwaj S, 2013, STEM CELLS, V31, P1840, DOI 10.1002/stem.1424
   Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.tea.2010.0637, 10.1089/ten.TEA.2010.0637]
   Boa O, 2013, ADV SKIN WOUND CARE, V26, P400, DOI 10.1097/01.ASW.0000433102.48268.2a
   Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108
   Catalano E, 2013, J ARTIF ORGANS, V16, P397, DOI 10.1007/s10047-013-0734-0
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen Liwen, 2008, PLoS One, V3, pe1886, DOI 10.1371/journal.pone.0001886
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Epstein FH, 1999, NEW ENGL J MED, V341, P738, DOI DOI 10.1056/NEJM199909023411006.PMID:10471461
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Galeano M, 2004, DIABETES, V53, P2509, DOI 10.2337/diabetes.53.9.2509
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Guan JJ, 2014, TISSUE ENG PT A, V20, P1794, DOI [10.1089/ten.tea.2013.0584, 10.1089/ten.TEA.2013.0584]
   Hajiali H, 2011, INT J NANOMED, V6, P2133, DOI 10.2147/IJN.S24312
   Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8
   Hartman O, 2010, BIOMATERIALS, V31, P5700, DOI 10.1016/j.biomaterials.2010.03.017
   Hautz T, 2010, AM J TRANSPLANT, V10, P1200, DOI 10.1111/j.1600-6143.2010.03075.x
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Jacobi J, 2002, AM J PATHOL, V161, P97, DOI 10.1016/S0002-9440(10)64161-2
   Jurmeister S, 2012, MOL CELL BIOL, V32, P633, DOI 10.1128/MCB.06212-11
   Kanitakis J, 2005, EUR J DERMATOL, V15, P235
   Kim JW, 2013, VET DERMATOL, V24, P242, DOI 10.1111/vde.12011
   Lang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053980
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liang X, 2010, IEEE T BIO-MED ENG, V57, P953, DOI 10.1109/TBME.2009.2033464
   Machula H, 2014, ADV WOUND CARE, V3, P367, DOI 10.1089/wound.2013.0513
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Moise A, 2011, J Med Life, V4, P287
   Nie HR, 2010, POLYMER, V51, P3344, DOI 10.1016/j.polymer.2010.05.014
   Pajardi G, 2014, INT WOUND J IN PRESS
   Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968
   Revi D, 2013, J BIOMED A IN PRESS
   Rodrigues C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096241
   Sachewsky N, 2014, DIS MODEL MECH, V7, P953, DOI 10.1242/dmm.014480
   Wu SF, 2011, J UROLOGY, V186, P640, DOI 10.1016/j.juro.2011.03.152
   Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Yoon Y, 2003, J CLIN INVEST, V111, P717, DOI 10.1172/JCI200315830
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhou ZH, 2011, APPL SURF SCI, V258, P1670, DOI 10.1016/j.apsusc.2011.09.120
NR 46
TC 20
Z9 25
U1 2
U2 52
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD OCT 2
PY 2014
VL 12
AR 274
DI 10.1186/s12967-014-0274-2
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AT8FQ
UT WOS:000345169700001
PM 25274078
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Souza, VC
   Oliveira, JE
   Lima, SJG
   Silva, LB
AF Souza, Vanessa Castro
   Oliveira, Juliano Elvis
   Guedes Lima, Severino J.
   Silva, Lucineide Balbino
TI Influence of Vitamin C on Morphological and Thermal Behaviour of
   Biomedical UHMWPE
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 12th Brazilian Polymer Conference (CBPOL)
CY SEP 22-26, 2013
CL Florianopolis, BRAZIL
SP Univ Rouen, Univ Le Havre, Univ Nebraska, INSA Rouen, CREA, French Phys Soc, Seine Maritime Expans
DE biomedical UHMWPE; compression molding; scanning electron microscopy;
   thermal properties; vitamin C
ID MOLECULAR-WEIGHT POLYETHYLENE; IRRADIATED UHMWPE; ALPHA-TOCOPHEROL;
   WEAR; MODEL; ANTIOXIDANT; RESISTANCE; HIP
AB Biomedical Ultra-High-Molecular-Weight Polyethylene (B-UHMWPE) is widely used in orthopaedics as a biomaterial because of its mechanical properties and biocompatibility. However the adding of vitamin antioxidants can influence the inflammatory process. Thus, the objective of this study is to evaluate the influence of adding ascorbic acid (vitamin C) at different concentrations to the B-UHMWPE matrix, using for this purpose the Scanning Electron Microscopy (SEM) and Differential Scanning Calorimetry (DSC) analyses. The vitamin C was mixed with B-UHMWPE in concentrations of 0.5, 1.0 and 2.0% wt and the molding was performed with a 10MPa load at 160 degrees C for 6min. The fracture surface of cross-sectional area of B-UHMWPE modified with vitamin C showed that the vitamin is present in the polymer matrix in the form of small agglomerates, being an indication that there was no fusion of the vitamin C during the processing step. Using the technique of differential scanning calorimetry it was observed that the melting temperature remained constant as well as the crystallisation temperature, but there was a small variation in crystallinity with the addition of vitamin C. From this study, we conclude that the presence of vitamin C (ascorbic acid) did not alter the thermal properties of crystallisation and melting of B-UHMWPE.
C1 [Souza, Vanessa Castro; Oliveira, Juliano Elvis; Guedes Lima, Severino J.; Silva, Lucineide Balbino] Univ Fed Paraiba, PPCEM, BR-58051900 Joao Pessoa, Paraiba, Brazil.
RP Silva, LB (reprint author), Univ Fed Paraiba, PPCEM, Cidade Univ S-N, BR-58051900 Joao Pessoa, Paraiba, Brazil.
EM lucineide@ct.ufpb.br
CR Ameta RK, 2014, J MOL LIQ, V195, P40, DOI 10.1016/j.molliq.2014.01.029
   Bracco P, 2007, POLYM DEGRAD STABIL, V92, P2155, DOI 10.1016/j.polymdegradstab.2007.02.023
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Davey SM, 2005, BIOMATERIALS, V26, P4993, DOI 10.1016/j.biomaterials.2005.01.007
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Garcia-Diaz DF, 2011, MOL NUTR FOOD RES, V55, pS257, DOI 10.1002/mnfr.201100296
   Goswami T, 2008, MATER DESIGN, V29, P289, DOI 10.1016/j.matdes.2007.02.015
   Juran R., 1991, MODERN PLASTICS ENCY
   Krevelen D. W., PROPERTIES POLYM
   Kurtz SM, 2009, J BIOMED MATER RES A, V90A, P549, DOI 10.1002/jbm.a.32122
   Liu AQ, 2009, J BIOMED MATER RES A, V90A, P496, DOI 10.1002/jbm.a.32120
   Mendel F. J., 2013, MAT SCI ENG C, V33, P182
   Mikirova N, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-189
   Neergheen-Bhujun VS, 2014, J HERB MED, V4, P1, DOI 10.1016/j.hermed.2013.11.002
   Oral E, 2006, BIOMATERIALS, V27, P2434, DOI 10.1016/j.biomaterials.2005.11.001
   Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048
   Oral E, 2007, BIOMATERIALS, V28, P5225, DOI 10.1016/j.biomaterials.2007.08.025
   Oral E, 2006, J ARTHROPLASTY, V21, P580, DOI 10.1016/j.arth.2005.07.009
   Oral E, 2011, INT ORTHOP, V35, P215, DOI 10.1007/s00264-010-1161-y
   Rocha MF, 2010, MACROMOL SY, V296, P487, DOI 10.1002/masy.201051065
   Rowell SL, 2011, J ORTHOP RES, V29, P773, DOI 10.1002/jor.21288
   Shang T, 2014, J SURG RES, V188, P316, DOI 10.1016/j.jss.2013.11.1105
   Shi JY, 2013, J PHARMACEUT BIOMED, V77, P116, DOI 10.1016/j.jpba.2013.01.018
   Spreafico A, 2013, RHEUMATOLOGY, V52, P1667, DOI 10.1093/rheumatology/ket185
   Tomita N, 1999, J BIOMED MATER RES, V48, P474
   Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017
   Xie XL, 2003, BIOMATERIALS, V24, P1889, DOI 10.1016/S0142-9612(02)00610-5
NR 27
TC 2
Z9 2
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1360
EI 1521-3900
J9 MACROMOL SYMP
JI Macromol. Symp.
PD OCT
PY 2014
VL 344
IS 1
SI SI
BP 8
EP 13
DI 10.1002/masy.201300202
PG 6
WC Polymer Science
SC Polymer Science
GA AQ7QF
UT WOS:000343013500001
DA 2018-10-20
ER

PT J
AU Luthringer, BJC
   Feyerabend, F
   Willumeit-Romer, R
AF Luthringer, Berengere J. C.
   Feyerabend, Frank
   Willumeit-Roemer, Regine
TI Magnesium-based implants: a mini-review
SO MAGNESIUM RESEARCH
LA English
DT Review
DE biomaterial; clinical applications; implant; magnesium
ID IN-VIVO; ELUTING STENT; CORONARY-ARTERIES; MULTICENTER TRIAL; BIOACTIVE
   GLASS; ALLOYS; BONE; BIOMATERIALS; METAL; IRON
AB The goal of this review is to bring to the attention of the readership of Magnesium Research another facet of the importance of magnesium, i.e. magnesium-based biomaterials. A concise history of biomaterials and magnesium are thus presented. In addition, historical and current, clinical magnesium-based applications are presented.
C1 [Luthringer, Berengere J. C.; Feyerabend, Frank; Willumeit-Roemer, Regine] HZG, Inst Mat Res, Dept Struct Res Macromol, Geesthacht, Germany.
RP Luthringer, BJC (reprint author), HZG, Inst Mat Res, Dept Struct Res Macromol, Geesthacht, Germany.
EM berengere.luthringer@hzg.de
RI Luthringer, Berengere/G-9039-2017; Willumeit, Regine/I-8029-2013;
   Feyerabend, Frank/A-1124-2010
OI Luthringer, Berengere/0000-0002-8248-6715; Willumeit,
   Regine/0000-0002-6004-6946; Feyerabend, Frank/0000-0001-9532-0207
CR Adden N, 2006, LANGMUIR, V22, P8197, DOI 10.1021/la060754c
   Altura B M, 1991, Magnes Trace Elem, V10, P167
   Amin KAM, 2012, POLYMERS-BASEL, V4, P590, DOI 10.3390/polym4010590
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337
   [Anonymous], 2012, BIOL EVALUATION M 12
   [Anonymous], 2009, BIOL EVALUATION ME 5
   Arnett TR, 2008, J NUTR, V138, p415S
   Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049
   Blom AW, 2008, ANN ROY COLL SURG, V90, P658, DOI 10.1308/003588408X318156
   Buchheit R, 2011, IN VIVO EVALUATION C
   Burmester A, 2014, BIOMATTER, P00
   Bygrave FL, 1976, INTRO BIOINORGANIC C, P171
   Chlumsky V, 1907, MITT GRENZGEBIETEN M, V3, P416
   Ciccone W J 2nd, 2001, J Am Acad Orthop Surg, V9, P280
   Cunningham J, 2012, CLIN KIDNEY J, V5, P39, DOI 10.1093/ndtplus/sfr166
   Davis A B, 1972, Pharm Hist, V14, P139
   Davy H, 1800, PHILOS T R SOC LON B, V1, P313
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Durlach J., 1994, Magnesium Research, V7, P313
   Dwivedi P, 2013, J APPL BIOMATER FUNC, V11, P129, DOI 10.5301/JABFM.2013.11544
   Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   Farooq V, 2011, CIRC-CARDIOVASC INTE, V4, P195, DOI 10.1161/CIRCINTERVENTIONS.110.959882
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Fischer J, 2011, MATER SCI ENG B-ADV, V176, P830, DOI 10.1016/j.mseb.2011.04.008
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Haleem-Smith H, 2012, J ORTHOP RES, V30, P853, DOI 10.1002/jor.22002
   Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6
   Health N.I.o, 1982, CONS DEV C STAT, V4, p[1, 1]
   HENCH LL, 1980, BIOMATERIALS SCI, V208, P826, DOI DOI 10.1126/SCIENCE.6246576
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   HERZOG P, 1982, SCAND J GASTROENTERO, V17, P56
   Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P1597, DOI 10.2106/JBJS.J.00195
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Huse E.C., 1878, CHICAGO MED J EXAMIN, V37, P171
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kon E, 2012, J BONE JOINT SURG AM, V94A, P85
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Lam MK, 2014, AM HEART J, V167, P445, DOI 10.1016/j.ahj.2013.11.014
   Lambotte A, 1909, PRESSE MED, V17, P321
   Lensing R, 2014, J BIOMATER APPL, V28, P688, DOI 10.1177/0885328212472246
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lindtner RA, 2013, J MECH BEHAV BIOMED, V28, P232, DOI 10.1016/j.jmbbm.2013.08.008
   Luthringer BJ, 2014, J MAT SCI MAT MED
   Manfre LM, 2007, AM SOC SPIN RAD ASSR, P22
   Marcucci G, 2010, CLIN CASES MINER BON, V7, P51
   Martinez Sanchez AH, 2014, ACTA BIOMATER
   Migliavacca F, 2004, BIOMECH MODEL MECHAN, V2, P205, DOI [10.1007/s10237-004-0039-6, 10.1007/S10237-004-0039-6]
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4
   Mushahary D, 2013, INT J NANOMED, V8, P2887, DOI 10.2147/IJN.S47378
   Noyama Y, 2012, MATER TRANS, V53, P565, DOI 10.2320/matertrans.M2011358
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   Park JW, 2012, CLIN ORAL IMPLAN RES, V23, P294, DOI 10.1111/j.1600-0501.2010.02144.x
   Payr E, 1903, ZENTRALBLATT CHIR, V30, P233
   Payr E, 1900, ARCH KLIN CHIR, V62, P67
   Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Peuster M, 2006, CARDIOL YOUNG, V16, P107, DOI 10.1017/S1047951106000011
   Peuster M, 2001, HEART, V86, P563, DOI 10.1136/heart.86.5.563
   Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029
   Ragamouni S, 2013, ACTA HISTOCHEM, V115, P748, DOI 10.1016/j.acthis.2013.03.004
   Rude r, 2006, MODERN NUTR HLTH DIS
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   Schroll A, 2002, ADV MAGNESIUM RES
   Seguin G, 2014, ANTIQUITY, V88, P488, DOI 10.1017/S0003598X00101139
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun H, 2014, BONE JOINT J, V96B, P548, DOI 10.1302/0301-620X.96B4.32171
   Van de Velde K, 2002, POLYM TEST, V21, P433, DOI 10.1016/S0142-9418(01)00107-6
   Verbrugge J., 1937, B MEM SOC NAT CIR, V59, P813
   Vroman I, 2009, MATERIALS, V2, P307, DOI 10.3390/ma2020307
   Waizy H, 2014, J BIOMATER APPL, V28, P667, DOI 10.1177/0885328212472215
   Waksman R, 2013, CIRC-CARDIOVASC INTE, V6, P644, DOI 10.1161/CIRCINTERVENTIONS.113.000693
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   WALLACH S, 1988, MAGNESIUM, V7, P262
   Wang CX, 2004, MATER CHARACT, V52, P301, DOI 10.1016/j.matchar.2004.06.007
   WILFLINGSEDER P, 1981, CHIR PLAST, V6, P105, DOI 10.1007/BF00289635
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129
   Xing JH, 2001, DIS COLON RECTUM, V44, P1201, DOI 10.1007/BF02234645
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang LN, 2013, FRONT MATER SCI, V7, P227, DOI 10.1007/s11706-013-0210-z
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang ZY, 2012, ACTA BIOMATER, V8, P13, DOI 10.1016/j.actbio.2011.09.020
   Zhao SF, 2013, CLIN ORAL IMPLAN RES, V24, P34, DOI 10.1111/j.1600-0501.2011.02362.x
NR 100
TC 20
Z9 21
U1 5
U2 44
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 0953-1424
EI 1952-4021
J9 MAGNESIUM RES
JI Magnes. Res.
PD OCT-DEC
PY 2014
VL 27
IS 4
BP 142
EP 154
DI 10.1684/mrh.2015.0375
PG 13
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA CD1CU
UT WOS:000350812300001
PM 25697680
DA 2018-10-20
ER

PT J
AU Benders, KEM
   Boot, W
   Cokelaere, SM
   Van Weeren, PR
   Gawlitta, D
   Bergman, HJ
   Saris, DBF
   Dhert, WJA
   Malda, J
AF Benders, K. E. M.
   Boot, W.
   Cokelaere, S. M.
   Van Weeren, P. R.
   Gawlitta, D.
   Bergman, H. J.
   Saris, D. B. F.
   Dhert, W. J. A.
   Malda, J.
TI Multipotent Stromal Cells Outperform Chondrocytes on Cartilage-Derived
   Matrix Scaffolds
SO CARTILAGE
LA English
DT Article
DE cartilage tissue engineering; chondrocyte; extracellular matrix (ECM);
   mesenchymal stromal cell; scaffold
ID MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE;
   IN-VITRO; OSTEOCHONDRAL TISSUE; DECELLULARIZATION; DEFECTS;
   REGENERATION; KNEE; VIVO
AB Objective. Although extracellular matrix (ECM)-derived scaffolds have been extensively studied and applied in a number of clinical applications, the use of ECM as a biomaterial for (osteo) chondral regeneration is less extensively explored. This study aimed at evaluating the chondrogenic potential of cells seeded on cartilage-derived matrix (CDM) scaffolds in vitro. Design. Scaffolds were generated from decellularized equine articular cartilage and seeded with either chondrocytes or multipotent stromal cells (MSCs). After 2, 4, and 6 weeks of in vitro culture, CDM constructs were analyzed both histologically (hematoxylin and eosin, Safranin-O, collagen types I and II) and biochemically (glycosaminoglycan [ GAG] and DNA content). Results. After 4 weeks, both cell types demonstrated chondrogenic differentiation; however, the MSCs significantly outperformed chondrocytes in producing new GAG-containing cartilaginous matrix. Conclusion. These promising in vitro results underscore the potency of CDM scaffolds in (osteo) chondral defect repair.
C1 [Benders, K. E. M.; Boot, W.; Gawlitta, D.; Saris, D. B. F.; Dhert, W. J. A.; Malda, J.] Univ Med Ctr Utrecht, Dept Orthoped, NL-3508 CX Utrecht, Netherlands.
   [Cokelaere, S. M.; Van Weeren, P. R.; Malda, J.] Univ Utrecht, Dept Equine Sci, Utrecht, Netherlands.
   [Bergman, H. J.] Lingehoeve, Vet Med, Lienden, Netherlands.
   [Saris, D. B. F.] Univ Twente, MIRA Inst, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
   [Dhert, W. J. A.] Univ Utrecht, Fac Vet Sci, Utrecht, Netherlands.
RP Malda, J (reprint author), Univ Med Ctr Utrecht, Dept Orthoped, POB 85500, NL-3508 CX Utrecht, Netherlands.
EM j.malda@umcutrecht.nl
OI Boot, Willemijn/0000-0001-7150-6007; Malda, Jos/0000-0002-9241-7676
FU NICHD; Alexandre Suerman Stipendium from the University Medical Center
   Utrecht; Dutch Arthritis Foundation; VENI fellowship from the Dutch
   Technology Foundation; STW; Applied Science Division of NOW; Technology
   Program of the Ministry of Economic Affairs
FX The authors thank Prof. J. Groll (University of Wurzburg) for assistance
   with the electron microscopy. The antibody against collagen type II
   (II-II6B3), developed by T.F. Linsenmayer, was obtained from the DSHB
   developed under the auspices of the NICHD and maintained by The
   University of Iowa, Department of Biology, Iowa City, Iowa. K.B. is
   supported by the Alexandre Suerman Stipendium from the University
   Medical Center Utrecht, J.M. is supported by the Dutch Arthritis
   Foundation and D.G. is supported by a VENI fellowship from the Dutch
   Technology Foundation, STW, Applied Science Division of NOW, and the
   Technology Program of the Ministry of Economic Affairs.
CR Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359
   Armitage S, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/376251
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   D'Onofrio A, 2011, J HEART VALVE DIS, V20, P319
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Fichter A, 2006, J ORTHOP RES, V24, P63, DOI 10.1002/jor.20001
   Fitzpatrick Kelly, 2011, J Knee Surg, V24, P159
   Flanigan DC, 2010, MED SCI SPORT EXER, V42, P1795, DOI 10.1249/MSS.0b013e3181d9eea0
   Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142
   Giavaresi G, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-12
   Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Haykal S, 2013, BIOMATERIALS, V34, P5821, DOI 10.1016/j.biomaterials.2013.04.044
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Hodde J, 2002, BIOMATERIALS, V23, P1841, DOI 10.1016/S0142-9612(01)00310-6
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde J, 2007, J MATER SCI-MATER M, V18, P537, DOI 10.1007/s10856-007-2300-x
   Hodde J, 2007, J MATER SCI-MATER M, V18, P545, DOI 10.1007/s10856-007-2301-9
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hurtig MB, 2011, CARTILAGE, V2, P137, DOI 10.1177/1947603511401905
   Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Klatt AR, 2009, J ORTHOP RES, V27, P65, DOI 10.1002/jor.20716
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Malda J, 2012, OSTEOARTHR CARTILAGE, V20, P1147, DOI 10.1016/j.joca.2012.06.005
   Martel-Pelletier J, 2008, BEST PRACT RES CL RH, V22, P351, DOI 10.1016/j.berh.2008.02.001
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McIlwraith CW, 2011, CARTILAGE, V2, P317, DOI 10.1177/1947603511406531
   Meyer T, 2006, PEDIATR SURG INT, V22, P369, DOI 10.1007/s00383-006-1658-z
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Polacek M, 2011, CELL TRANSPLANT, V20, P1381, DOI 10.3727/096368910X550215
   Schuurman W, J TISSUE ENG REGEN M
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Shepherd DET, 1999, ANN RHEUM DIS, V58, P27, DOI 10.1136/ard.58.1.27
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   van Weeren P.R., 2006, EQUINE SURG, P1166
   Vardanian AJ, 2011, PLAST RECONSTR SURG, V128, p403E, DOI 10.1097/PRS.0b013e31822b6637
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Voute LC, 2011, VET REC, V168, P265, DOI 10.1136/vr.c6677
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Ytrehus B, 2007, VET PATHOL, V44, P429, DOI 10.1354/vp.44-4-429
NR 52
TC 15
Z9 14
U1 1
U2 14
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1947-6035
EI 1947-6043
J9 CARTILAGE
JI Cartilage
PD OCT
PY 2014
VL 5
IS 4
BP 221
EP 230
DI 10.1177/1947603514535245
PG 10
WC Orthopedics
SC Orthopedics
GA AZ7ZP
UT WOS:000348434700004
PM 26069701
OA Green Published
DA 2018-10-20
ER

PT J
AU Sanchez, M
   Anitua, E
   Delgado, D
   Sanchez, P
   Orive, G
   Padilla, S
AF Sanchez, Mikel
   Anitua, Eduardo
   Delgado, Diego
   Sanchez, Pello
   Orive, Gorka
   Padilla, Sabino
TI Muscle repair: platelet-rich plasma derivates as a bridge from
   spontaneity to intervention
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Tissue repair; Growth factors; Muscle; Fibrosis; Platelets;
   Platelet-rich plasma; Plasma rich in growth factors; Regeneration
ID SKELETAL-MUSCLE; SATELLITE CELLS; GROWTH-FACTORS; TISSUE-REPAIR;
   REGENERATIVE MEDICINE; EXTRACELLULAR-MATRIX; CONNECTIVE-TISSUE;
   STEM-CELLS; MACROPHAGES; INJURIES
AB Muscle injuries account for between 10% and 55% of all sporting injuries. Although the skeletal muscle is a plastic organ capable of responding efficiently to environmental changes, the appropriate treatment of muscle injuries remains a daunting clinical challenge in sports medicine. There is considerable evidence to indicate that growth factors, such as transforming growth factor-beta (TGF beta), hepatocyte growth factor (HGF) or insulin-like growth factor (IGF), and fibrin matrix are key in cellular events required for muscle repair and regeneration, namely myogenesis, angiogenesis and fibrogenesis. An innovative biological approach to the treatment of muscle injuries is the application of Plasma Rich in Growth Factors (PRGF) in intramuscular infiltrations. PRGF delivers growth factors, cytokines and adhesive proteins present in platelets and plasma, as well as other biologically-active proteins conveyed by the plasma, such as fibrinogen, prothrombin and fibronectin. This autologous, mimetic biomaterial embedded with a pool of growth factors acts as a smart dynamic scaffold, and should be applied taking into account a biological approach. A clinical trial is required to assess the functional repair outcome of PRGF infiltrations in muscle injuries. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Sanchez, Mikel] Hosp Vithas San Jose, ASU, Vitoria 01008, Spain.
   [Sanchez, Mikel; Delgado, Diego; Sanchez, Pello] Hosp Vithas San Jose, ASU Res AIE, Vitoria 01008, Spain.
   [Anitua, Eduardo; Padilla, Sabino] Biotechnol Inst BTI Vitoria, Vitoria, Spain.
   [Anitua, Eduardo; Orive, Gorka; Padilla, Sabino] Fdn Eduardo Anitua, Vitoria 01007, Spain.
RP Padilla, S (reprint author), Fdn Eduardo Anitua, C Jose Maria Cagigal 19, Vitoria 01007, Spain.
EM sabinopadilla@hotmail.com
RI Anitua, Eduardo/O-1154-2018
OI Anitua, Eduardo/0000-0002-8386-5303
CR Anitua E, 2012, J CONTROL RELEASE, V157, P317, DOI 10.1016/j.jconrel.2011.11.011
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Augustin HG, 2007, ENDOTHELIAL BIOMEDIC, P1444
   Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Bosurgi L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00062
   Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336
   Brooks SV, 2008, J PHYSIOL-LONDON, V586, P3979, DOI 10.1113/jphysiol.2008.155382
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046
   Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb
   Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693
   Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453
   Conboy I, 2011, COMPREHENSIVE BIOMAT, P345
   Cornelison DDW, 2008, J CELL BIOCHEM, V105, P663, DOI 10.1002/jcb.21892
   Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gleissner CA, 2010, J IMMUNOL, V184, P4810, DOI 10.4049/jimmunol.0901368
   Grounds MD, 1999, CURR OPIN NEUROL, V12, P535, DOI 10.1097/00019052-199910000-00007
   GROUNDS MD, 1987, J PATHOL, V153, P71, DOI 10.1002/path.1711530110
   GROUNDS MD, 1991, PATHOL RES PRACT, V187, P1
   Grounds MD, 2011, REGENERATION MUSCLE, DOI 10.1002/9780470015902.a0001106.pub2
   Grounds Miranda D., 2008, V3, P269
   Hammond JW, 2009, AM J SPORT MED, V37, P1135, DOI 10.1177/0363546508330974
   Hawke TJ, 2001, J APPL PHYSIOL, V91, P534
   Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2
   Hoying JBaS K. W., 2007, ENDOTHELIAL BIOMEDIC, P1712
   Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001
   Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714
   Jarvinen Tero A. H., 2008, V3, P217
   Kaariainen M, 2000, SCAND J MED SCI SPOR, V10, P332, DOI 10.1034/j.1600-0838.2000.010006332.x
   Kannus P, 2003, SCAND J MED SCI SPOR, V13, P150, DOI 10.1034/j.1600-0838.2003.02225.x
   Kharraz Y, 2013, MEDIAT INFLAMM, V2013, P491
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Lane N., 2010, LIFE ASCENDING 10 GR
   Li HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064923
   Loo WL, 2009, ANN ACAD MED SINGAP, V38, P733
   Marcus AJ, 1999, INFLAMMATION BASIC P, P77
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Morel BG, 2009, REGEN MED, V4, P293, DOI 10.2217/17460751.4.2.293
   Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162
   Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720
   Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690comd
   Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053
   Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8
   Pizza F., 2008, SKELETAL MUSCLE DAMA, V49, P57
   Prisk V, 2003, HISTOL HISTOPATHOL, V18, P1243, DOI 10.14670/HH-18.1243
   RANTANEN J, 1995, J NEUROPATH EXP NEUR, V54, P188, DOI 10.1097/00005072-199503000-00005
   Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088
   Saclier M, 2013, FEBS J, V280, P4118, DOI 10.1111/febs.12166
   Sanchez M, 2005, 2 WORLD C REG MED LE
   Sanchez M, 2012, OPER TECH ORTHOP, V22, P16, DOI 10.1053/j.oto.2011.11.003
   Sanchez M, 2009, SPORTS MED, V39, P345, DOI 10.2165/00007256-200939050-00002
   Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200
   Sarasa-Renedo A, 2005, SCAND J MED SCI SPOR, V15, P223, DOI 10.1111/j.1600-0838.2005.00461.x
   Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956
   Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3
   Shefer Gabi, 2008, V3, P107
   Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406
   Shortreed K, 2008, SKELETAL MUSCLE DAMA, V1, P77
   Slater Clarke R., 2008, V3, P303
   Sonnet C, 2006, J CELL SCI, V119, P2497, DOI 10.1242/jcs.02988
   Stellos K, 2010, SEMIN THROMB HEMOST, V36, P175, DOI 10.1055/s-0030-1251502
   Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Tatsumi R, 2006, AM J PHYSIOL-CELL PH, V290, pC1487, DOI 10.1152/ajpcell.00513.2005
   Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803
   Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009
   Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004
   Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021
   Wagers AJ, 2012, CELL STEM CELL, V10, P362, DOI 10.1016/j.stem.2012.02.018
   Wetzel RJ, 2013, ORTHOPEDICS, V36, pE64, DOI 10.3928/01477447-20121217-20
   Wright-Carpenter T, 2004, INT J SPORTS MED, V25, P588, DOI 10.1055/s-2004-821304
   Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f
NR 77
TC 10
Z9 10
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD OCT
PY 2014
VL 45
SU 4
BP S7
EP S14
DI 10.1016/S0020-1383(14)70004-X
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA AY0SW
UT WOS:000347308100003
PM 25384475
DA 2018-10-20
ER

PT J
AU Simu, MR
   Ciceo-Lucacel, R
   Ponta, O
   Borzan, C
   Mesaros, M
   Radu, T
AF Simu, M. R.
   Ciceo-Lucacel, R.
   Ponta, O.
   Borzan, C.
   Mesaros, M.
   Radu, T.
TI SYNTHESIS AND CHARACTERIZATION OF Ag EMBEDDED CaO-P2O5-ZrO2 GLASSES, AS
   A BIOCOMPATIBLE DENTAL MATERIAL WITH LOWER RISK FOR HUMAN HEALTH
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE Zirconium; dental materials; biocompatibility; human fibroblasts
ID IN-VITRO; SOL-GEL; CYTOTOXICITY; COMPONENTS; FIBROBLASTS; ADHESIVES;
   AMALGAM; MERCURY
AB The present article describes the synthesis and characterization of a new dental biomaterial on the type SiO2 -CaO-P2O5-ZrO2 with 0, 1, and 3, % mol Ag in order to obtain homogeneous glass composition with antibacterial activity and enhanced biocompatibility, thus reducing the risks for the patient and the dental practitioner. The structure and surface morphology of samples were characterized by X-ray diffraction (XRD), infrared (FTIR) and Raman spectroscopy, Scanning Electron Microscopy (SEM). X-ray photoelectron spectroscopy (XPS) was used to determine the nature of chemical bonding and the surface composition of the samples. The behavior of obtained samples was investigated in vitro on a human fibroblast cell line. Optical microscopy images and cell viability tests showed that our obtained samples had no negative effect on the cells morphology and behavior.
C1 [Simu, M. R.; Mesaros, M.] Iuliu Hatieganu Univ Med & Pharm, Fac Dent, Dept Conservat Dent, Cluj Napoca, Romania.
   [Ciceo-Lucacel, R.; Ponta, O.; Radu, T.] Univ Babes Bolyai, Fac Phys, R-3400 Cluj Napoca, Romania.
   [Ciceo-Lucacel, R.; Ponta, O.; Radu, T.] Univ Babes Bolyai, Interdisciplinary Res Inst Bionanosci, R-3400 Cluj Napoca, Romania.
   [Borzan, C.] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Community Med, Cluj Napoca, Romania.
RP Radu, T (reprint author), Univ Babes Bolyai, Fac Phys, R-3400 Cluj Napoca, Romania.
EM teocluj@gmail.com
RI Radu, Maria Teodora/C-2554-2012; Lucacel Ciceo, Raluca/F-2154-2013
OI Radu, Maria Teodora/0000-0002-7925-0795; 
FU European Social Found, Human Resources Development Operational Programme
   [POSDRU/159/1.5/S/138776]
FX This paper was published under the frame of European Social Found, Human
   Resources Development Operational Programme 2007-2013, project no.
   POSDRU/159/1.5/S/138776.
CR Clarkson TW, 2003, NEW ENGL J MED, V349, P1731, DOI 10.1056/NEJMra022471
   Demirci M, 2008, DENT MATER, V24, P362, DOI 10.1016/j.dental.2007.06.009
   Depprich Rita, 2008, Head Face Med, V4, P25, DOI 10.1186/1746-160X-4-25
   Geethalakshmi K., 2012, WORLD ACAD SCI ENG T, V64, P179
   Geurtsen W, 1998, J DENT RES, V77, P2012, DOI 10.1177/00220345980770121001
   Goldberg M, 2008, CLIN ORAL INVEST, V12, P1, DOI 10.1007/s00784-007-0162-8
   Goldstein J., 2003, SCANNING ELECT MICRO
   Hong ZK, 2009, J NON-CRYST SOLIDS, V355, P368, DOI 10.1016/j.jnoncrysol.2008.12.003
   Jie Q, 2004, J SOL-GEL SCI TECHN, V30, P49, DOI 10.1023/B:JSST.0000028196.09929.a3
   Krishna RM, 1998, J NON-CRYST SOLIDS, V232, P509
   Le Saout G, 2002, J RAMAN SPECTROSC, V33, P740, DOI 10.1002/jrs.911
   RATANASATHIEN S, 1995, J DENT RES, V74, P1602, DOI 10.1177/00220345950740091601
   Schmalz G, 1998, EUR J ORAL SCI, V106, P696, DOI 10.1046/j.0909-8836.1998.eos10602ii05.x
   Schweikl H, 2005, BIOMATERIALS, V26, P1713, DOI 10.1016/j.biomaterials.2004.05.025
   Spahl W, 1998, J DENT, V26, P137, DOI 10.1016/S0300-5712(96)00086-3
   Srinivasan S, 2012, CARBOHYD POLYM, V87, P274, DOI 10.1016/j.carbpol.2011.07.058
   Szep S, 2002, J BIOMED MATER RES, V63, P53, DOI 10.1002/jbm.10083
   Torque Removal, 2013, INT J ORAL IMPLANTOL, V4, P55
   VIMY MJ, 1985, J DENT RES, V64, P1069, DOI 10.1177/00220345850640080901
   Volpato CAM, 2011, ADV CERAMICS ELECT M
   Watts J. F, 2003, INTRO SURFACE ANAL X
NR 21
TC 2
Z9 2
U1 0
U2 11
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD OCT-DEC
PY 2014
VL 9
IS 4
BP 1529
EP 1536
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AW2SJ
UT WOS:000346138800026
DA 2018-10-20
ER

PT J
AU Balaz, M
   Balaz, P
   Bujnakova, Z
   Pap, Z
   Kupka, D
   Zorkovska, A
AF Balaz, M.
   Balaz, P.
   Bujnakova, Z.
   Pap, Z.
   Kupka, D.
   Zorkovska, A.
TI Mechanochemical Dechlorination of PVC by Utilizing Eggshell Waste
SO ACTA PHYSICA POLONICA A
LA English
DT Article
ID BIOMATERIAL; MEMBRANE
AB Within this work, the dechlorination of polyvinylchloride (PVC) chemical as a model by co-milling with eggshell was performed in a planetary ball mill in order to show that mechanochemistry can be utilized for the simultaneous treatment of two wastes, while the products of the treatment can be used in further applications. The products of the reaction are water-soluble calcium chloride (CaCl2), which can be used e.g. for de-icing of roads in winter and organic residue on the basis of ethylene, which can be recovered as energy source. The highest dechlorination yield (almost 97%) was achieved under following milling conditions: molar ratio between Ca and Cl: 2.34, ball-to-powder ratio: 65, rotation speed of the planet carrier: 550 rpm, milling time: 4 h and material of milling media: tungsten carbide. The optimum conditions were then applied for the removal of chlorine from industrial waste the abandoned PVC window parapet. In this case, 95% dechlorination was evidenced.
C1 [Balaz, M.; Balaz, P.; Bujnakova, Z.; Kupka, D.; Zorkovska, A.] Slovak Acad Sci, Inst Geotech, Kosice, Slovakia.
   [Pap, Z.] Univ Miskolc, Inst Raw Mat Preparat & Environm Proc, Miskolc, Hungary.
RP Balaz, M (reprint author), Slovak Acad Sci, Inst Geotech, Kosice, Slovakia.
EM balazm@saske.sk
FU Slovak Grant Agency VEGA [02/0027/13]; Agency for Science and
   Development [VV-0189-10]
FX This work was supported by Slovak Grant Agency VEGA (project 02/0027/13)
   and by Agency for Science and Development (project VV-0189-10). The
   authors express their gratitude to Jozef Sibert from Tieniace Systemy,
   s.r.o. for providing us sample of window parapet and Katarina Mrazikova
   for extensive help during experimental works.
CR Balaz M, 2014, ACTA BIOMATER, V10, P3827, DOI 10.1016/j.actbio.2014.03.020
   Balaz M, 2013, MAT SCI SEMICON PROC, V16, P1899, DOI 10.1016/j.mssp.2013.06.024
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Balaz P., 2008, MECHANOCHEMISTRY NAN
   Balaz P, 2013, CHEM SOC REV, V42, P7571, DOI 10.1039/c3cs35468g
   Guo X.Y., 2010, WASTE MANAGE, V30, P4
   Guru P.S., 2014, ADV COLL IN IN PRESS
   Inoue T, 2006, ADV POWDER TECHNOL, V17, P425, DOI 10.1163/156855206777866182
   James SL, 2012, CHEM SOC REV, V41, P413, DOI 10.1039/c1cs15171a
   King'ori AM, 2011, INT J POULT SCI, V10, P908, DOI DOI 10.3923/IJPS.2011.908.912
   Stadelman WJ, 2000, ENCY FOOD SCI TECHNO, P593
   Tongamp W, 2008, WASTE MANAGE, V28, P484, DOI 10.1016/j.wasman.2007.01.022
   Tongamp W., 2008, J MATER CYCLES WASTE, V10, P140
NR 13
TC 6
Z9 6
U1 2
U2 19
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD OCT
PY 2014
VL 126
IS 4
BP 884
EP 887
DI 10.12693/APhysPolA.126.884
PG 4
WC Physics, Multidisciplinary
SC Physics
GA AU8QA
UT WOS:000345860000005
OA Bronze
DA 2018-10-20
ER

PT J
AU Wang, ZH
   Li, N
   Li, R
   Li, YW
   Ruan, LQ
AF Wang, Zhanhui
   Li, Nan
   Li, Rui
   Li, Yawei
   Ruan, Liqun
TI Biodegradable intestinal stents: A review
SO PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL
LA English
DT Review
DE Biodegradability; Stent; Biomaterial; Polymer; Magnesium alloy
ID BENIGN ESOPHAGEAL STRICTURES; CRITICAL LIMB ISCHEMIA; MG-6ZN ALLOY
   EXTRACTS; MAGNESIUM ALLOYS; COLORECTAL STRICTURES; CORONARY-ARTERIES;
   EPITHELIAL-CELLS; METAL STENT; IN-VITRO; BIOMATERIALS
AB Biodegradable stents are an attractive alternative to self-expanding metal stents in the treatment of intestinal strictures. Biodegradable stent can be made of biodegradable polymers and biodegradable metals (magnesium alloys). An overview on current biodegradable intestinal stents is presented. The future trends and perspectives in the development of biodegradable intestinal stents are proposed. For the biodegradable polymer intestinal stents, the clinical trials have shown promising results, although improved design of stents and reduced migration rate are expected. For the biodegradable magnesium intestinal stents, results of preliminary studies indicate magnesium alloys to have good biocompatibility. With many of the key fundamental and practical issues resolved and better methods for adjusting corrosion resistance and progressing biocompatibilities of magnesium alloys, it is possible to use biodegradable intestinal stents made of magnesium alloys in hospital in the not too distant future. (C) 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
C1 [Wang, Zhanhui; Li, Rui; Li, Yawei] Zhengzhou Univ, Affiliated Luoyang Cent Hosp, Dept Surg, Luoyang, Peoples R China.
   [Li, Nan] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Li, Nan] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
   [Ruan, Liqun] Kumamoto Univ, Grad Sch Sci & Technol, Dept Mech Syst Engn, Kumamoto 8608555, Japan.
RP Li, YW (reprint author), Zhengzhou Univ, Affiliated Luoyang Cent Hosp, Dept Surg, Luoyang, Peoples R China.
EM dashengzhang999@163.com
FU Luoyang Municipal Science and Technology Development Fund [1301069A-3]
FX The authors acknowledge the financial support of the Luoyang Municipal
   Science and Technology Development Fund (No. 1301069A-3).
CR Belverde B, 2012, G CHIR, V33, P243
   Bosiers M, 2009, CARDIOVASC INTER RAD, V32, P424, DOI 10.1007/s00270-008-9472-8
   Cao Jian, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P772
   Cerna M, 2011, CARDIOVASC INTER RAD, V34, P1267, DOI 10.1007/s00270-010-0059-9
   Chen YG, 2014, J MATER SCI-MATER M, V25, P471, DOI 10.1007/s10856-013-5090-3
   Chlumsky V, 1907, MITT GRENZGEBIETEN M, V3, P416
   Deng G.Q., 2013, THESIS U S CHINA
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Goldin E., 1996, GASTROINTEST ENDOSC, V43, P294
   Griffiths EA, 2012, SURG ENDOSC, V26, P2367, DOI 10.1007/s00464-012-2192-9
   Gunatillake PA, 2003, EUR CELLS MATER, V5, P16
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hair CS, 2010, ENDOSCOPY, V42, pE132, DOI 10.1055/s-0029-1244011
   Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Janik V, 2011, EUR RADIOL, V21, P1956, DOI 10.1007/s00330-011-2131-5
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li G, 2014, J BIOMED MATER RES A, V102, P982, DOI 10.1002/jbm.a.34759
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Lock JY, 2014, J BIOMED MATER RES A, V102, P781, DOI 10.1002/jbm.a.34741
   Lorenzo-Zuniga V, 2014, WORLD J GASTROENTERO, V20, P2212, DOI 10.3748/wjg.v20.i9.2212
   LUCHTEFELD MA, 1989, DIS COLON RECTUM, V32, P733, DOI 10.1007/BF02562119
   Orive-Calzada A, 2009, ENDOSCOPY, V41, pE137, DOI 10.1055/s-0029-1214634
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Roldan FP, 2012, ENDOSCOPY, V44, P297, DOI 10.1055/s-0031-1291482
   Rejchrt S, 2011, ENDOSCOPY, V43, P911, DOI 10.1055/s-0030-1256405
   Rejchrt S, 2009, FOLIA GASTROENTEROL, V7, P7
   Repici A, 2013, SURG ENDOSC, V27, P2487, DOI 10.1007/s00464-012-2762-x
   Repici A, 2010, GASTROINTEST ENDOSC, V72, P927, DOI 10.1016/j.gie.2010.07.031
   Rodrigues C, 2013, WORLD J GASTRO ENDOS, V5, P265, DOI 10.4253/wjge.v5.i5.265
   Saito Y, 2008, DIGEST DIS SCI, V53, P330, DOI 10.1007/s10620-007-9873-6
   Saito Y, 2007, WORLD J GASTROENTERO, V13, P3977, DOI 10.3748/wjg.v13.i29.3977
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Toth E, 2011, ENDOSCOPY, V43, pE252, DOI 10.1055/s-0030-1256511
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   van Boeckel PGA, 2011, CLIN GASTROENTEROL H, V9, P653, DOI 10.1016/j.cgh.2011.04.006
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wadhwa RP, 2003, GASTROINTEST ENDOSC, V58, P207, DOI 10.1067/mge.2003.343
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Wang ZH, 2013, J BIOMATER APPL, V27, P739, DOI 10.1177/0885328211424518
   Wang ZH, 2012, MATER SCI ENG B-ADV, V177, P388, DOI 10.1016/j.mseb.2012.01.002
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Windhagen H, 2013, BIOMED ENG, V12, P1
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xin Y., 2008, ACTA BIOMATER, V4
   Yan J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025011
   Yan J, 2013, J MATER SCI-MATER M, V24, P1515, DOI 10.1007/s10856-013-4906-5
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zilberman M, 2005, J BIOMED MATER RES B, V74B, P792, DOI 10.1002/jbm.b.30319
NR 54
TC 11
Z9 11
U1 3
U2 74
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1002-0071
EI 1745-5391
J9 PROG NAT SCI-MATER
JI Prog. Nat. Sci.
PD OCT
PY 2014
VL 24
IS 5
BP 423
EP 432
DI 10.1016/j.pnsc.2014.08.008
PG 10
WC Materials Science, Multidisciplinary; Multidisciplinary Sciences
SC Materials Science; Science & Technology - Other Topics
GA AW0UF
UT WOS:000346008500003
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Zeng, RC
   Qi, WC
   Zhang, F
   Cui, HZ
   Zheng, YF
AF Zeng, Rongchang
   Qi, Weichen
   Zhang, Fen
   Cui, Hongzhi
   Zheng, Yufeng
TI In vitro corrosion of Mg-1.21Li-1.12Ca-1Y alloy
SO PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL
LA English
DT Article
DE Magnesium-lithium alloys; Microstructure; Mechanical property;
   Corrosion; Biomaterial
ID BIODEGRADABLE MAGNESIUM ALLOYS; ZN-ZR ALLOY; MG-Y ALLOY;
   MECHANICAL-PROPERTIES; VIVO CORROSION; CA ALLOY;
   ELECTROCHEMICAL-BEHAVIOR; COATED MAGNESIUM; MICROSTRUCTURE;
   BIOCOMPATIBILITY
AB The influence of the microstructure on mechanical properties and corrosion behavior of the Mg-1.21Li-1.12Ca-1Y alloy was investigated using, OM, SEM, XRD, EPMA, EDS, tensile tests and corrosion measurements. The results demonstrated that the microstructure of the Mg-1.21Li- 1.12Ca-1Y alloy was characterized by alpha-Mg substrate and intermetallic compounds Mg2Ca and Mg24Y5. Most of the fine Mg2Ca particles for the as-cast alloy were distributed along the grain boundaries, while for the as-extruded along the extrusion direction. The Mg24Y5 particles with a larger size than the Mg2Ca particles were positioned inside the grains. The mechanical properties of Mg 1.21Li 1.12Ca 1Y alloy were improved by the grain refinement and dispersion strengthening. Corrosion pits initiated at the alpha-Mg matrix neighboring the Mg2Ca particles and subsequently the alloy exhibited general corrosion and filiform corrosion as the corrosion product layer of Mg(OH)(2) and MgCO3 became compact and thick. (C) 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved
C1 [Zeng, Rongchang; Qi, Weichen; Zhang, Fen; Cui, Hongzhi] Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
   [Zeng, Rongchang] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Cofo, Qingdao 266590, Peoples R China.
   [Zeng, Rongchang] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China.
   [Zheng, Yufeng] Peking Univ, Coll Engn, Dept Mat Sci & Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
RP Zeng, RC (reprint author), Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
EM rczeng@foxmail.com
RI Zheng, Yufeng/A-4146-2010; Zeng, Rong-Chang/H-4154-2011
OI Zheng, Yufeng/0000-0002-7402-9979; Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation (NSF) of China [51241001]; NSF of
   Shandong Province [ZR2011EMM004]; SDUST Research Fund [2014TDJH104];
   Joint Innovative Center for Safe and Effective Mining Technology and
   Equipment of Coal Resources; Taishan Scholarship Project of Shandong
   Province [TS20110828]
FX This research was financially supported by National Natural Science
   Foundation (NSF) of China (51241001), NSF of Shandong Province
   (ZR2011EMM004), SDUST Research Fund (2014TDJH104), Joint Innovative
   Center for Safe and Effective Mining Technology and Equipment of Coal
   Resources and Taishan Scholarship Project of Shandong Province
   (TS20110828). Thanks also go to Prof. Rong-Shi Chen at the Institute of
   Metals Research, Chinese Academy of Sciences for his preparation in the
   ingots and undergraduate Miss Furong Zhang, graduates Mr. Meng Wang and
   Mr. Jun Wang at Chongqing University of Technology for their help in the
   metallurgical, tensile and corrosion tests.
CR Ardelean H, 2013, CORROS SCI, V73, P196, DOI 10.1016/j.corsci.2013.03.036
   Cao DX, 2008, J POWER SOURCES, V177, P624, DOI 10.1016/j.jpowsour.2007.11.037
   Chen J, 2008, T NONFERR METAL SOC, V18, pS361, DOI 10.1016/S1003-6326(10)60232-4
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014
   Jiang Bin, 2012, Journal of Shanghai Jiaotong University (Science), V17, P297, DOI 10.1007/s12204-012-1272-2
   Jiang B, 2012, PROG NAT SCI-MATER, V22, P160, DOI 10.1016/j.pnsc.2012.03.013
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9
   Li YC, 2010, MATER SCI FORUM, V654-656, P2192, DOI 10.4028/www.scientific.net/MSF.654-656.2192
   Li YC, 2011, J MATER SCI, V46, P365, DOI 10.1007/s10853-010-4843-3
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu GL, 2010, ACTA PHYS SIN-CH ED, V59, P2708
   Narayanan TSNS, 2014, PROG MATER SCI, V60, P1, DOI 10.1016/j.pmatsci.2013.08.002
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Regenera D, 2009, STRENGTH MATER+, V41, P294, DOI 10.1007/s11223-009-9127-2
   Seitz JM, 2010, ADV ENG MATER, V12, P1099, DOI 10.1002/adem.201000191
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2009, SURF COAT TECH, V203, P1107, DOI 10.1016/j.surfcoat.2008.10.004
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Waizy H, 2012, J MATER SCI, V48, P39
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wu YH, 2013, J MATER SCI TECHNOL, V29, P545, DOI 10.1016/j.jmst.2013.03.004
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036
   Zang C.Y., 2009, RARE METAL MAT ENG, V8
   Zang C.Y., 2010, SURF COAT TECH, V204, P3636
   Zeng R.C., 2011, J CHIN NONFERR MET, V1, P35
   Zeng RC, 2005, ACTA METALL SIN, V41, P307
   Zeng RC, 2014, CORROS SCI, V86, P171, DOI 10.1016/j.corsci.2014.05.006
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zeng RC, 2011, ACTA METALL SIN, V47, P1477, DOI 10.3724/SP.J.1037.2011.00325
   Zeng RC, 2011, SURF COAT TECH, V205, P3347, DOI 10.1016/j.surfcoat.2010.11.027
   Zhang CY, 2010, T NONFERR METAL SOC, V20, pS655, DOI 10.1016/S1003-6326(10)60556-0
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhang MX, 2003, SCRIPTA MATER, V48, P379, DOI 10.1016/S1359-6462(02)00457-8
   Zhang XB, 2012, J MECH BEHAV BIOMED, V9, P153, DOI 10.1016/j.jmbbm.2012.02.002
   Zhang XB, 2012, J MECH BEHAV BIOMED, V7, P77, DOI 10.1016/j.jmbbm.2011.05.026
   Zhang X, 2013, T NONFERR METAL SOC, V23, P1226, DOI 10.1016/S1003-6326(13)62587-X
   Zhang X, 2012, PROG NAT SCI-MATER, V22, P169, DOI 10.1016/j.pnsc.2012.03.014
   Zhou WR, 2013, ACTA BIOMATER, V9, P8488, DOI 10.1016/j.actbio.2013.01.032
NR 50
TC 17
Z9 18
U1 1
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1002-0071
EI 1745-5391
J9 PROG NAT SCI-MATER
JI Prog. Nat. Sci.
PD OCT
PY 2014
VL 24
IS 5
BP 492
EP 499
DI 10.1016/j.pnsc.2014.08.005
PG 8
WC Materials Science, Multidisciplinary; Multidisciplinary Sciences
SC Materials Science; Science & Technology - Other Topics
GA AW0UF
UT WOS:000346008500013
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Wang, LX
   Fang, G
   Qian, LY
   Leeflang, S
   Duszczyk, J
   Zhou, J
AF Wang, Lixiao
   Fang, Gang
   Qian, Lingyun
   Leeflang, Sander
   Duszczyk, Jurek
   Zhou, Jie
TI Forming of magnesium alloy microtubes in the fabrication of
   biodegradable stents
SO PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL
LA English
DT Article
DE Vascular stent; Microtube; Magnesium alloy; Extrusion; Drawing
ID TUBES; RESTENOSIS; IMPLANTATION; BEHAVIOR
AB Magnesium alloys have, in recent years, been recognized as highly promising biodegradable materials, especially for vascular stent applications. Forming of magnesium alloys into high-precision thin-wall tubes has however presented a technological barrier in the fabrication of vascular stents, because of the poor workability of magnesium at room temperature. In the present study, the forming processes, i.e hot indirect extrusion and multi-pass cold drawing were used to fabricate seamless microtubes of a magnesium alloy. The magnesium alloy ZM21 was selected as a representative biomaterial for biodegradable stent applications. Microtubes with an outside diameter of 2.9 mm and a wall thickness of 0.2 mm were successfully produced at the fourth pass of cold drawing without inter-pass annealing. Dimensional evaluation showed that multi-pass cold drawing was effective in correcting dimensional non-uniformity arising from hot indirect extrusion. Examinations of the microstructures of microtubes revealed the generation of a large number of twins as a result of accumulated work hardening at the third and fourth passes of cold drawing, corresponding to the significantly raised forming forces. The work demonstrated the viability of the forming process route selected for the fabrication of biodegradable magnesium alloy microtubes. (C) 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved,
C1 [Wang, Lixiao; Fang, Gang; Qian, Lingyun] Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
   [Leeflang, Sander; Duszczyk, Jurek; Zhou, Jie] Delft Univ Technol, Dept Biomech Engn, NL-2628 CD Delft, Netherlands.
RP Fang, G (reprint author), Tsinghua Univ, Dept Mech Engn, Beijing 100084, Peoples R China.
EM fangg@tsinghua.edu.cn
RI Fang, Gang/L-5586-2013; Zhou, Jie/J-3019-2012
OI Fang, Gang/0000-0002-5409-3922; Zhou, Jie/0000-0002-6484-9156; Leeflang,
   Marius Alexander/0000-0003-1702-7413
FU Beijing Natural Science Foundation [3142011]; National Natural Science
   Foundation of China [51075230]
FX The authors, Lixiao Wang, Lingyun Qian and Gang Fang, greatly appreciate
   the financial supports of the Beijing Natural Science Foundation (No.
   3142011) and the National Natural Science Foundation of China (No.
   51075230).
CR Fang G, 2013, MAT SCI ENG C-MATER, V33, P3481, DOI 10.1016/j.msec.2013.04.039
   Faraji G, 2014, J MATER SCI TECHNOL, V30, P134, DOI 10.1016/j.jmst.2013.08.010
   Furushima T, 2007, J MATER PROCESS TECH, V191, P59, DOI 10.1016/j.jmatprotec.2007.03.084
   Ge Q, 2012, MATER MANUF PROCESS, V27, P140, DOI 10.1080/10426914.2011.560231
   Ge Q, 2013, ACTA BIOMATER, V9, P8604, DOI 10.1016/j.actbio.2013.01.010
   Hanada K, 2013, MAT SCI ENG C-MATER, V33, P4746, DOI 10.1016/j.msec.2013.07.033
   Hwang YM, 2013, INT J ADV MANUF TECH, V68, P1361, DOI 10.1007/s00170-013-4927-8
   Ielasi A, 2014, INT J CARDIOL, V173, P513, DOI 10.1016/j.ijcard.2014.03.061
   Kim HS, 2008, INT J CARDIOL, V124, P118, DOI 10.1016/j.ijcard.2006.11.197
   Matsuoka H, 2010, J CARDIOL, V55, P135, DOI 10.1016/j.jjcc.2009.04.006
   Neubert V, 2007, MAT SCI ENG A-STRUCT, V462, P329, DOI 10.1016/j.msea.2005.11.077
   Poncin P., 2004, P MAT PROC MED DEV C, P279
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   van Beusekom HMM, 2010, JACC-CARDIOVASC INTE, V3, P76, DOI 10.1016/j.jcin.2009.10.016
   Vedani M., 2012, INT J MAT FORUM, V7, P31
   Werkhoven RJ, 2011, MAGNESIUM TECHNOLOGY, P419
   Zahedmanesh H, 2014, COMPUT METHOD BIOMEC, V17, P813, DOI 10.1080/10255842.2012.716830
NR 17
TC 10
Z9 12
U1 0
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1002-0071
EI 1745-5391
J9 PROG NAT SCI-MATER
JI Prog. Nat. Sci.
PD OCT
PY 2014
VL 24
IS 5
BP 500
EP 506
DI 10.1016/j.pnsc.2014.08.006
PG 7
WC Materials Science, Multidisciplinary; Multidisciplinary Sciences
SC Materials Science; Science & Technology - Other Topics
GA AW0UF
UT WOS:000346008500014
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mai, ED
   Liu, HN
AF Mai, Elbert David
   Liu, Huinan
TI Investigation on magnesium degradation under flow versus static
   conditions using a novel impedance-driven flow apparatus
SO PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL
LA English
DT Article
DE Magnesium; Degradation; Corrosion; Flow conditions; Impedance-driven
   flow apparatus; Impedance pump; Flow device
ID INDWELLING URETERAL STENT; PUMP; CORROSION; HYDROGEN; SURFACE; TUBE
AB This article reports a novel impedance-driven flow apparatus and its applicability for studying magnesium degradation under flow versus static conditions. Magnesium has potential to be an effective biomaterial for use inside the human body due to its biodegradability and biocompatibility. Magnesium undergoes degradation reactions in aqueous solutions such as body fluids, leading to mass loss and pH increase of the surrounding fluid. To compare the degradation process of magnesium under flow versus static conditions, a novel flow apparatus consisting of an impedance pump and a flow chamber was designed and constructed. In addition to low-cost, this apparatus is flexible to be sterilized and assembled, and is small enough for use inside an incubator, making it appealing for measuring and comparing magnesium degradation in vitro under flow versus static conditions. The average flow rate in this flow apparatus was 2.8 ml/s, mimicking the flow rate (2.6 tolls) in coronary artery. In a simulated body fluid (SBF), magnesium samples lost their mass at a touch faster rate under the flow condition than that under the static condition. Starting with a pH of 7.4, the SBF showed a pH increase to 8.5 under the flow condition within 96 h due to the degradation of magnesium, greater than the pH increase under the static condition. The results of this study demonstrated the effects of fluid flow on magnesium degradation using the impedance-driven flow apparatus, providing useful design guidelines for magnesium-based implants that may be exposed to body fluid flow. (C) 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.
C1 [Mai, Elbert David; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.
   [Mai, Elbert David] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Stem Cell Ctr, Dept Bioengn, Mat Sci & Engn Program, 900 Univ Ave,MSE 227, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU USA National Science Foundation BRIGE award [CBET 1125801]; Burroughs
   Wellcome Fund [1011235]; Hellman Faculty Fellowship; University of
   California Regents Faculty Fellowship; American Heart Association [AHA
   12SDG12220014]
FX The authors would like to thank the USA National Science Foundation
   BRIGE award (CBET 1125801), American Heart Association (AHA
   12SDG12220014), Burroughs Wellcome Fund (1011235), Hellman Faculty
   Fellowship (Huinan Liu), and the University of California Regents
   Faculty Fellowship (Huinan Liu) for financial support. The authors thank
   Nidhanjali Bansal, Frank Le, Michael Reyes, and Jack Tang for initial
   assistance with the construction of the flow apparatus.
CR Biezma MV, 2001, INT J HYDROGEN ENERG, V26, P515, DOI 10.1016/S0360-3199(00)00091-4
   Dineen MK, 2008, UROLOGY, V71, P873, DOI 10.1016/j.urology.2007.12.015
   Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775
   Hickerson AI, 2006, J FLUID MECH, V555, P141, DOI 10.1017/S0022112006009220
   Hickerson AI, 2005, EXP FLUIDS, V38, P534, DOI 10.1007/s00348-005-0946-z
   Johnson I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065603
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Liu HN, 2011, NANOTECHNOLOGY ENABLED IN SITU SENSORS FOR MONITORING HEALTH, P115, DOI 10.1007/978-1-4419-7291-0_6
   Lock JY, 2014, J BIOMED MATER RES A, V102, P781, DOI 10.1002/jbm.a.34741
   MONGA M, 1995, J UROLOGY, V153, P1817, DOI 10.1016/S0022-5347(01)67319-1
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Rinderknecht D, 2005, J MICROMECH MICROENG, V15, P861, DOI 10.1088/0960-1317/15/4/026
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Yenicesu M, 2004, TRANSPLANT P, V36, P1395, DOI 10.1016/j.transproceed.2004.05.077
   Zeng RC, 2014, CORROS SCI, V86, P171, DOI 10.1016/j.corsci.2014.05.006
NR 16
TC 5
Z9 5
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1002-0071
EI 1745-5391
J9 PROG NAT SCI-MATER
JI Prog. Nat. Sci.
PD OCT
PY 2014
VL 24
IS 5
BP 554
EP 560
DI 10.1016/j.pnsc.2014.08.012
PG 7
WC Materials Science, Multidisciplinary; Multidisciplinary Sciences
SC Materials Science; Science & Technology - Other Topics
GA AW0UF
UT WOS:000346008500021
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Neacsu, P
   Mazare, A
   Cimpean, A
   Park, J
   Costache, M
   Schmuki, P
   Demetrescu, I
AF Neacsu, Patricia
   Mazare, Anca
   Cimpean, Anisoara
   Park, Jung
   Costache, Marieta
   Schmuki, Patrik
   Demetrescu, Ioana
TI Reduced inflammatory activity of RAW 264.7 macrophages on titania
   nanotube modified Ti surface
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Macrophage; Inflammatory response; Lipopolysaccharide; Titanium dioxide;
   Nanotubes
ID IN-VITRO; NITRIC-OXIDE; IMPLANTS; CELLS; ACTIVATION; RECEPTORS;
   COATINGS; ADHESION; BEHAVIOR; ARRAYS
AB Macrophages play a pivotal role in the hosts response to biomaterials being considered as an essential cell type during both optimal tissue-implant integration and pathologic process of implant failure. Hence, understanding of their cellular activity on biomaterials is important for improving evaluation and design of biomaterials for biomedical applications. In the present study, we have comparatively investigated the interactions of titania nanotubes (78 nm diameter) and commercial pure Ti with RAW 264.7 macrophages in both standard and pro-inflammatory (stimulation with lipopolysaccharide, LPS) culture conditions. In vitro tests showed that TiO2 nanotubes exhibited significantly decreased inflammatory activity of macrophages with respect to cytokine and chemokine gene expression/protein secretion, induction of foreign body giant cells (FBGCs) and nitric oxide (NO) release thereby mitigating the inflammatory response induced by LPS as compared to flat Ti surface. Therefore, our results suggest a novel role of TiO2 nanotubes in modulating macrophage response in biomaterial-associated bacterial infections. Overall, the current study provides new insight into how TiO2 nanotubes can be involved in macrophage activation and supports the great promise of such surface modifications for biomedical applications. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Neacsu, Patricia; Cimpean, Anisoara; Costache, Marieta] Univ Bucharest, Dept Biochem & Mol Biol, Bucharest 050095, Romania.
   [Mazare, Anca; Schmuki, Patrik] Univ Erlangen Nurnberg, Dept Mat Sci, D-91058 Erlangen, Germany.
   [Park, Jung] Univ Erlangen Nurnberg, Dept Pediat, Div Mol Pediat, D-91052 Erlangen, Germany.
   [Demetrescu, Ioana] Univ Politech Bucharest, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Cimpean, A (reprint author), Univ Bucharest, Dept Biochem & Mol Biol, 91-95 Spl Independentei, Bucharest 050095, Romania.
EM anisoara.cimpean@bio.unibuc.ro
RI Costache, Marieta/F-2806-2016; Cimpean, Anisoara/C-2101-2011
OI Costache, Marieta/0000-0002-8103-3693; Cimpean,
   Anisoara/0000-0002-5833-3110; Mazare, Anca/0000-0002-4836-946X
FU UEFISCDI [PNII-ID-PCE 188/2011]; Deutsche Forschungsgemeinschaft (DFG);
   DFG Cluster of Excellence (Engineering of Advanced Materials, EAM)
FX Financial support for this research from the UEFISCDI (project
   PNII-ID-PCE 188/2011), Deutsche Forschungsgemeinschaft (DFG), the DFG
   Cluster of Excellence (Engineering of Advanced Materials, EAM) is
   acknowledged. Authors are thankful to Sorina Dinescu (University of
   Bucharest) for performing the qPCR technique.
CR Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Ballo A, 2011, INT J NANOMED, V6, P3415, DOI 10.2147/IJN.S25867
   Bauer S, 2013, PROG MATER SCI, V58, P261, DOI 10.1016/j.pmatsci.2012.09.001
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001
   Brammer SK, 2012, TRENDS BIOTECHNOL, V30, P315
   Chamberlain ML, 2011, J BIOMATER NANOBIOTE, V2, P293
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chun YW, 2011, CARBON, V49, P2092, DOI 10.1016/j.carbon.2011.01.044
   Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25
   Gongadze E, 2013, MINI-REV MED CHEM, V13, P194
   Goodman SB, 2010, BIOMATERIALS, V31, P5045, DOI 10.1016/j.biomaterials.2010.03.046
   Hamlet S, 2011, ACTA BIOMATER, V7, P2345, DOI 10.1016/j.actbio.2011.01.032
   Ion R, 2014, MAT SCI ENG C-MATER, V35, P411, DOI 10.1016/j.msec.2013.11.018
   Ji G, 2012, PLOS ONE, V7, P53101
   Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407
   Lamers E, 2012, NANOMED-NANOTECHNOL, V8, P308, DOI 10.1016/j.nano.2011.06.013
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Lin NJ, 2009, COMB CHEM HIGH T SCR, V12, P619, DOI 10.2174/138620709788681943
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Mazare A, 2012, BIOELECTROCHEMISTRY, V87, P124, DOI 10.1016/j.bioelechem.2012.01.002
   Mazare A, 2012, ELECTROCHIM ACTA, V66, P12, DOI 10.1016/j.electacta.2012.01.001
   Mindroiu M, 2013, MAT SCI ENG C-MATER, V33, P3353, DOI 10.1016/j.msec.2013.04.016
   Neupane MP, 2012, MATER CHEM PHYS, V134, P536, DOI 10.1016/j.matchemphys.2012.03.029
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Rani WD, 2012, ACTA BIOMATER, V8, P1976
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Smith BS, 2013, BIOMATER SCI-UK, V1, P322, DOI 10.1039/c2bm00079b
   Smith GC, 2011, ACTA BIOMATER, V7, P3209, DOI 10.1016/j.actbio.2011.05.003
   Suzuki R, 2003, J BIOMED MATER RES A, V66A, P396, DOI 10.1002/jbm.a.10001
   Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
NR 41
TC 37
Z9 37
U1 4
U2 39
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD OCT
PY 2014
VL 55
BP 187
EP 195
DI 10.1016/j.biocel.2014.09.006
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AU2YY
UT WOS:000345481500023
PM 25220343
DA 2018-10-20
ER

PT J
AU Stevens, JS
   de Luca, AC
   Downes, S
   Terenghi, G
   Schroeder, SLM
AF Stevens, Joanna S.
   de Luca, Alba C.
   Downes, Sandra
   Terenghi, Giorgio
   Schroeder, Sven L. M.
TI Immobilisation of cell-binding peptides on poly-epsilon-caprolactone
   (PCL) films: A comparative XPS study of two chemical surface
   functionalisation methods
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Applications of Surface and Interface
   Analysis (ECASIA)
CY OCT 13-18, 2013
CL Catania, ITALY
DE polymer; surface modification; substrate; RGD; biomaterial; scaffolds;
   cell response; X-ray photoelectron spectroscopy
ID RAY PHOTOELECTRON-SPECTROSCOPY; QUANTITATIVE-ANALYSIS; AMINO-ACIDS; RGD;
   ADHESION
AB Successful interaction between cells and biomaterial surfaces is crucial for biomedical devices, and incorporation of peptides such as RGD (Arg-Gly-Asp) at the polymer interface can substantially promote cell adhesion and proliferation. X-ray photoelectron spectroscopy (XPS) has been used to characterise poly-epsilon-caprolactone (PCL) films modified by aminolysis and the introduction of RGD peptides via carbodiimide (CDI) and thiol-halogen 'click' chemistry. The nitrogen signal acts as an elemental indicator for successful attachment, and changes in the chemical environment are reflected in the carbon and oxygen spectra. Chlorine and sulfur provide additional chemical indicators of reaction progress in the thiol method, with the selective nature of the Cl-S reaction reflected in the complete loss of Cl signal and appearance of S, avoiding potential amine-peptide side-reactions. Comparison of the XPS elemental concentrations indicated an estimate of 2-3% peptide functionalisation on the PCL surface for both methods, correlating with the improvement in Schwann cell response observed after peptide immobilisation. The enhanced selectivity of peptide attachment to the polymer surface demonstrated with XPS for the novel method based on thiol chemistry shows its potential for development as a biomimetic scaffold for peripheral nerve injury. Copyright (C) 2014 John Wiley & Sons, Ltd.
C1 [Stevens, Joanna S.; Schroeder, Sven L. M.] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M13 9PL, Lancs, England.
   [de Luca, Alba C.; Terenghi, Giorgio] Univ Manchester, Blond McIndoe Labs, Inst Inflammat & Repair, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England.
   [de Luca, Alba C.; Downes, Sandra] Univ Manchester, Sch Mat, Manchester M13 9PL, Lancs, England.
   [Schroeder, Sven L. M.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England.
RP Schroeder, SLM (reprint author), Univ Manchester, Sch Chem Engn & Analyt Sci, Oxford Rd, Manchester M13 9PL, Lancs, England.
EM s.schroeder@manchester.ac.uk
RI Schroeder, Sven/A-5129-2010
OI Schroeder, Sven/0000-0002-4232-5378; Stevens, Joanna/0000-0002-1013-8447
FU EPSRC; Newby Trust; EPSRC [EP/I013563/1]; Engineering and Physical
   Sciences Research Council [EP/I013563/1]
FX The authors gratefully acknowledge funding from the EPSRC for a PhD +
   fellowship for JSS and the Newby Trust for PhD funding for ACDL, and
   current EPSRC support for JSS and SLMS through a Critical Mass Grant
   (EP/I013563/1). The authors would like to thank Jean-Baptiste Guilbaud
   and Alberto Saiani for chemistry advice on the peptide immobilisation
   methods.
CR Beamson G., 2000, XPS POLYM DATABASE
   Briggs D., 1990, PRACTICAL SURFACE AN, V1
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   CLARK DT, 1976, BIOCHIM BIOPHYS ACTA, V453, P533, DOI 10.1016/0005-2795(76)90149-5
   de Luca AC, 2013, J BIOMED MATER RES A, V101, P491, DOI 10.1002/jbm.a.34345
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V68A, P615, DOI 10.1002/jbm.a.20051
   Fairley N., 2005, CASA COOKBOOK 1
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Hoyle CE, 2010, CHEM SOC REV, V39, P1355, DOI 10.1039/b901979k
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Stevens JS, 2013, SURF INTERFACE ANAL, V45, P1238, DOI 10.1002/sia.5261
   Stevens JS, 2011, ANGEW CHEM INT EDIT, V50, P9916, DOI 10.1002/anie.201103981
   Stevens JS, 2010, CRYST GROWTH DES, V10, P1435, DOI 10.1021/cg901481q
   Stevens JS, 2009, SURF INTERFACE ANAL, V41, P453, DOI 10.1002/sia.3047
   TANUMA S, 1994, SURF INTERFACE ANAL, V21, P165, DOI 10.1002/sia.740210302
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 19
TC 3
Z9 3
U1 4
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD OCT-NOV
PY 2014
VL 46
IS 10-11
BP 673
EP 678
DI 10.1002/sia.5396
PG 6
WC Chemistry, Physical
SC Chemistry
GA AT5MP
UT WOS:000344987400005
OA Green Published
DA 2018-10-20
ER

PT J
AU Oswald, S
   Gostin, PF
   Helth, A
   Abdi, S
   Giebeler, L
   Wendrock, H
   Calin, M
   Eckert, J
   Gebert, A
AF Oswald, Steffen
   Gostin, Petre-Flaviu
   Helth, Arne
   Abdi, Somayeh
   Giebeler, Lars
   Wendrock, Horst
   Calin, Mariana
   Eckert, Juergen
   Gebert, Annett
TI XPS and AES sputter-depth profiling at surfaces of biocompatible
   passivated Ti-based alloys: concentration quantification considering
   chemical effects
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Applications of Surface andInterface
   Analysis, ECASIA
CY OCT 13-18, 2013
CL Catania, ITALY
DE biomaterial; passive layer; depth profiling; AES; XPS
ID TITANIUM-ALLOYS; SPECTROSCOPY; REDUCTION
AB Ti-based materials are frequently used worldwide for orthopedic implants. New beta-type or glassy alloys with nontoxic alloying elements are investigated with expected improved biofunctionality. The surface regions and surface layers formed at the materials are decisive for the integration of the implant in the body. Thus, the investigation of the surfaces with analytical methods such as XPS and AES is an essential task. We investigated such materials with different alloying elements after electrochemical passivation by both XPS and AES depth profiling. We discuss chemical changes due to the ion sputtering and motivate the use of non-differentiated spectra for AES quantification. The behavior of the alloy elements in the investigated depth profiles is discussed. Copyright (C) 2014 John Wiley & Sons, Ltd.
C1 [Oswald, Steffen; Gostin, Petre-Flaviu; Helth, Arne; Abdi, Somayeh; Giebeler, Lars; Wendrock, Horst; Calin, Mariana; Eckert, Juergen; Gebert, Annett] IFW Dresden, Inst Komplexe Mat, D-01171 Dresden, Germany.
   [Helth, Arne; Abdi, Somayeh; Giebeler, Lars; Eckert, Juergen] Tech Univ Dresden, Inst Werkstoffwissensch, D-01062 Dresden, Germany.
RP Oswald, S (reprint author), IFW Dresden, Inst Komplexe Mat, Postfach 270116, D-01171 Dresden, Germany.
EM s.oswald@ifw-dresden.de
RI Giebeler, Lars/F-2188-2015; Gostin, Petre-Flaviu/D-2337-2011; Calin,
   Mariana/J-6398-2015
OI Giebeler, Lars/0000-0002-6703-8447; Gostin,
   Petre-Flaviu/0000-0002-0528-7093; Gebert, Annett/0000-0003-2748-3850
FU DFG [SFB/TR79]; EC [PITN-GA-2010-264635]
FX Funding from the DFG in the framework of the SFB/TR79 (project M1) and
   from the EC in the framework of FP7-ITN BioTiNet (PITN-GA-2010-264635)
   is gratefully acknowledged.
CR [Anonymous], 1994, SOFTW PACK V 9 3
   Calin M, 2013, MAT SCI ENG C-MATER, V33, P875, DOI 10.1016/j.msec.2012.11.015
   CHOUDHURY T, 1989, J PHYS D APPL PHYS, V22, P1185, DOI 10.1088/0022-3727/22/8/026
   Gostin PF, 2013, J BIOMED MATER RES B, V101B, P269, DOI 10.1002/jbm.b.32836
   Helth A, 2014, J BIOMED MATER RES B, V102, P31, DOI 10.1002/jbm.b.32976
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu G, 2000, SURF SCI, V458, P80, DOI 10.1016/S0039-6028(00)00420-9
   McCafferty E, 1999, APPL SURF SCI, V143, P92, DOI 10.1016/S0169-4332(98)00927-1
   Niinomi M, 2008, MATER TRANS, V49, P2170, DOI 10.2320/matertrans.L-MRA2008828
   Ong JL, 1998, BIOMATERIALS, V19, P455, DOI 10.1016/S0142-9612(97)00224-X
   Oswald S, 2005, APPL SURF SCI, V252, P3, DOI 10.1016/j.apsusc.2005.01.102
   SIGMUND P, 1981, SPUTTERING PARTICLE, V1, P9
   Stefanov P, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/1/012039
   Vergara LI, 1999, APPL SURF SCI, V151, P129, DOI 10.1016/S0169-4332(99)00270-6
NR 14
TC 7
Z9 7
U1 0
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD OCT-NOV
PY 2014
VL 46
IS 10-11
BP 683
EP 688
DI 10.1002/sia.5437
PG 6
WC Chemistry, Physical
SC Chemistry
GA AT5MP
UT WOS:000344987400007
DA 2018-10-20
ER

PT J
AU Szklarska, M
   Dercz, G
   Simka, W
   Losiewicz, B
AF Szklarska, Magdalena
   Dercz, Grzegorz
   Simka, Wojciech
   Losiewicz, Bozena
TI A.c. impedance study on the interfacial properties of passivated
   Ti13Zr13Nb alloy in physiological saline solution
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article; Proceedings Paper
CT 15th European Conference on Applications of Surface andInterface
   Analysis, ECASIA
CY OCT 13-18, 2013
CL Catania, ITALY
DE biomaterial; electrochemical impedance spectroscopy; corrosion
   resistance; titanium alloys
ID ELECTROCHEMICAL-BEHAVIOR; TITANIUM; ZR
AB In this work, the Ti13Zr13Nb shape memory alloy that was naturally passivated in air has been studied towards long-term corrosion performance in the physiological saline solution. The electronic impedance spectroscopy method was used to detailed study on the electrolyte vertical bar passive layer interfacial properties. The equivalent electrical circuit for the pitting corrosion was applied, and the discussion on the electrolyte vertical bar electrode interfacial properties was realized with respect to the physical meaning of the used circuit elements. The study shows that the Ti13Zr13Nb alloy is characterized by high corrosion resistance. ESI measurements revealed the formation of a protective oxide film on the Ti13Zr13Nb surface, during 20 days of exposure in 0.9% NaCl solution at 37 degrees C. In the early days of immersion, there was a slight decrease in corrosion resistance, which in the next 15 days remained unchanged, indicating very good protective properties of the formed oxide film. Performed research indicates that the Ti13Zr13Nb alloy is promising biomaterial to medical applications. Copyright (C) 2014 John Wiley & Sons, Ltd.
C1 [Szklarska, Magdalena; Dercz, Grzegorz; Losiewicz, Bozena] Univ Silesia, Inst Mat Sci, Silesian Interdisciplinary Ctr Educ & Res, PL-41500 Chorzow, Poland.
   [Simka, Wojciech] Silesian Tech Univ, Fac Chem, PL-44100 Gliwice, Poland.
RP Szklarska, M (reprint author), Univ Silesia, Inst Mat Sci, Silesian Interdisciplinary Ctr Educ & Res, 75 Pulku Piechoty 1A, PL-41500 Chorzow, Poland.
EM mszklarska@us.edu.pl; bozena.losiewicz@us.edu.pl
OI Dercz, Grzegorz/0000-0003-3682-7184; Szklarska,
   Magdalena/0000-0001-8716-630X; Simka, Wojciech/0000-0002-2648-5523
FU European Social Fund
FX Research under the FORSZT project was financed by the European Social
   Fund.
CR Bhola R., 2009, RES LETT PHYS CHEM, V2009, P1, DOI DOI 10.1155/2009/574359
   Birch JR, 2000, CORROSION, V56, P1233, DOI 10.5006/1.3280511
   Cvijovic-Alagic I, 2011, CORROS SCI, V53, P796, DOI 10.1016/j.corsci.2010.11.014
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Feng XJ, 2008, ACTA BIOMATER, V4, P318, DOI 10.1016/j.actbio.2007.08.005
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Lasia A., 1999, MODERN ASPECTS ELECT, V32
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Martins DQ, 2009, J ALLOY COMPD, V478, P111, DOI 10.1016/j.jallcom.2008.11.030
   Yu SY, 1997, CORROSION, V53, P965, DOI 10.5006/1.3290281
NR 10
TC 5
Z9 5
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD OCT-NOV
PY 2014
VL 46
IS 10-11
BP 698
EP 701
DI 10.1002/sia.5383
PG 4
WC Chemistry, Physical
SC Chemistry
GA AT5MP
UT WOS:000344987400010
DA 2018-10-20
ER

PT J
AU Poinescu, AA
   Radulescu, C
   Vasile, BS
   Ionita, I
AF Poinescu, Aurora Anca
   Radulescu, Cristiana
   Vasile, Bogdan Stefan
   Ionita, Ionica
TI Research Regarding Sol-gel Hydroxyapatite Coating on 316L Stainless
   Steel
SO REVISTA DE CHIMIE
LA English
DT Article
DE sol-gel deposition; HAp; hydroxyapatite; stainless steel; simulated
   physiological liquids
AB In this work we have developed the synthesis of hydroxyapatite films using sol-gel method on 316L stainless steel, biomaterial for medical application. On this new material were made several analyses such as: scanning electron microscopy, X-ray diffraction and measurement of Ni, Fe, Cr, Mn content that can migrate from the new material in body fluid simulation. The determination of heavy metals percentage has been made under controlled conditions in artificial plasma or serum was performed by X-ray energy dispersion fluorescence (EDXRF) and absorption spectrometric method.
C1 [Poinescu, Aurora Anca] Valahia Univ Targoviste, Fac Mat Engn & Mech, Dept Mat Engn, Targoviste 130082, Romania.
   [Radulescu, Cristiana; Ionita, Ionica] Valahia Univ Targoviste, Fac Sci & Arts, Dept Sci & Adv Technol, Targoviste 130082, Romania.
   [Vasile, Bogdan Stefan] Univ Politehn Bucuresti, Bucharest 060042, Romania.
RP Ionita, I (reprint author), Valahia Univ Targoviste, Fac Sci & Arts, Dept Sci & Adv Technol, 18-24 Unirii Blv, Targoviste 130082, Romania.
EM ioana67@gmail.com
RI Vasile, Bogdan/B-8685-2011; Radulescu, Cristiana/B-4847-2011; Ionita,
   Ionica/P-9456-2017
OI Vasile, Bogdan/0000-0002-2267-6453; Radulescu,
   Cristiana/0000-0003-1208-7732; Ionita, Ionica/0000-0002-6958-234X
CR Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   KAJZER W., 2008, J ACHIEVEMENTS MAT M, V31, P247
   Monmaturapoj N, 2008, J MET MAT MINER, V18, P15
   Nasab M.B., 2010, TRENDS BIOMATER ARTI, V24, P69
   PARK J.B, 1991, BIOMEDICAL ENG HDB
   PIETRZYK J., 2010, POWDER METALL MET C, V49
   POINESCU A.A, 2012, THESIS
   Stoica TF, 2008, THIN SOLID FILMS, V516, P8112, DOI 10.1016/j.tsf.2008.04.071
   WENA C.E, 2007, ACTA BIOMATER, V3, P403
NR 9
TC 7
Z9 7
U1 2
U2 14
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0034-7752
J9 REV CHIM-BUCHAREST
JI Rev. Chim.
PD OCT
PY 2014
VL 65
IS 10
BP 1245
EP 1248
PG 4
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA AT1UO
UT WOS:000344719500027
DA 2018-10-20
ER

PT J
AU Traini, T
   Caputi, S
   Gherlone, E
   Degidi, M
   Piattelli, A
AF Traini, Tonino
   Caputi, Sergio
   Gherlone, Enrico
   Degidi, Marco
   Piattelli, Adriano
TI Fibrin Clot Extension on Zirconia Surface for Dental Implants: A
   Quantitative In Vitro Study
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE blood-material interaction; dental; endosteal implant; fibrin; surface
   characterization
ID TITANIUM IMPLANTS; PLATELET INTERACTIONS; MINIATURE PIGS; CELL BEHAVIOR;
   BLOOD; COAGULATION; COMPLEMENT; ACTIVATION; OSSEOINTEGRATION;
   BIOMATERIAL
AB PurposeThe surface chemical and physical properties of materials used for implants have a major influence on blood clot organization. This study aims to evaluate the blood clot extension (bce) on zirconia and titanium. bce was measured in association to surface roughness (Ra) and static contact angle ().
   Materials and MethodsForty disk-shaped samples of sandblasted yttria tetragonal zirconia polycrystal (sb-YTZP), machined titanium (m-Ti), and sandblasted, high-temperature, acid-etched titanium (p-Ti) were used in the present study. About 0.2mL of human blood, immediately dropped onto the specimen's surface and left in contact for 5 minutes at room temperature, was used to measure the bce. Specimens were observed under confocal scanning laser and scanning electron microscopes.
   ResultsThe bce (meanx10(7)standard deviation [SD]x10(6)m(2)) was 2.97 +/- 6.68 for m-Ti, 5.64 +/- 6.83 for p-Ti, and 3.61 +/- 7.67 for sb-YTZP. p-Ti samples showed a significantly higher bce. Ra (mean +/- SD [m]) was 0.56 +/- 0.7 for m-Ti, 3.78 +/- 0.8 for p-Ti, and 2.68 +/- 0.6 for sb-YTZP. The difference was not significant between sb-YTZP and p-Ti. (mean +/- SD) was 55.6 +/- 5.6 for m-Ti, 48.7 +/- 2.8 for sb-YTZP, and 38.0 +/- 2.2 for p-Ti. The difference was not significant between m-Ti and sb-YTZP.
   ConclusionsThe sb-YTZP demonstrated a significantly lesser amount of bce compared with p-Ti specimens, notwithstanding that any significant difference was present between Ra and .
C1 [Traini, Tonino; Caputi, Sergio; Piattelli, Adriano] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Traini, Tonino; Gherlone, Enrico] Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, I-20132 Milan, Italy.
RP Traini, T (reprint author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, Via Olgettina 5, I-20132 Milan, Italy.
EM t.traini@gmail.com
OI Traini, Tonino/0000-0002-0265-8709
CR Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   BANGHAM AD, 1961, NATURE, V192, P1197, DOI 10.1038/1921197a0
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Davies JE, 1998, INT J PROSTHODONT, V11, P391
   Di Iorio D, 2005, J BIOMED MATER RES B, V74B, P636, DOI 10.1002/jbm.b.30251
   DRUMMOND RK, 1991, BIOMATERIALS, V12, P356, DOI 10.1016/0142-9612(91)90002-R
   Fiberg B, 2000, CLIN IMPLANT DENT R, V2, P184
   Gahlert M, 2007, CLIN ORAL IMPLAN RES, V18, P662, DOI 10.1111/j.1600-0501.2007.01401.x
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001
   Johnson K, 1996, BLOOD, V87, P5051
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Karacs A, 2003, MAT SCI ENG C-BIO S, V23, P431, DOI 10.1016/S0928-4931(02)00316-8
   Kawase T, 2003, J PERIODONTOL, V74, P858, DOI 10.1902/jop.2003.74.6.858
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim YH, 2003, INT J ORAL MAX IMPL, V18, P349
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Magnani A, 2003, MAT SCI ENG C-BIO S, V23, P315, DOI 10.1016/S0928-4931(02)00284-9
   Mosesson MW, 2000, FIBRINOLYSIS PROTEOL, V14, P182, DOI 10.1054/fipr.2000.0054
   NYGREN H, 1988, J BIOMED MATER RES, V22, P1, DOI 10.1002/jbm.820220103
   Nygren H, 1997, J BIOMED MATER RES, V34, P487, DOI 10.1002/(SICI)1097-4636(19970315)34:4<487::AID-JBM9>3.3.CO;2-6
   Oliva J, 2010, INT J ORAL MAX IMPL, V25, P336
   Ozkurt Z, 2011, J ORAL IMPLANTOL, V37, P367, DOI 10.1563/AAID-JOI-D-09-00079
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Park JY, 2000, CLIN ORAL IMPLAN RES, V11, P530, DOI 10.1034/j.1600-0501.2000.011006530.x
   Riehle MO, 2003, MAT SCI ENG C-BIO S, V23, P337, DOI 10.1016/S0928-4931(02)00282-5
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P13
   SEVASTIANOV VI, 1988, CRIT REV BIOCOMPAT, V4, P109
   SIEMSSEN PA, 1991, BRIT J UROL, V67, P83, DOI 10.1111/j.1464-410X.1991.tb15075.x
   Smith BR, 2003, THROMBOSIS HEMORRHAG, P865
   Stanford CM, 2010, INT J MOL SCI, V11, P354, DOI 10.3390/ijms11010354
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Vanzillotta PS, 2006, DENT MATER, V22, P275, DOI 10.1016/j.dental.2005.03.012
   VROMAN L, 1984, BIOMATER ARTIF CELL, V12, P307, DOI 10.3109/10731198409118838
   Yucel EA, 2003, J DENT, V31, P569, DOI 10.1016/S0300-5712(03)00113-1
NR 46
TC 6
Z9 6
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD OCT
PY 2014
VL 16
IS 5
BP 718
EP 727
DI 10.1111/cid.12038
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AS7QM
UT WOS:000344450100009
PM 23311680
DA 2018-10-20
ER

PT J
AU Giuliani, A
   Manescu, A
   Larsson, E
   Tromba, G
   Luongo, G
   Piattelli, A
   Mangano, F
   Iezzi, G
   Mangano, C
AF Giuliani, Alessandra
   Manescu, Adrian
   Larsson, Emanuel
   Tromba, Giuliana
   Luongo, Giuseppe
   Piattelli, Adriano
   Mangano, Francesco
   Iezzi, Giovanna
   Mangano, Carlo
TI In Vivo Regenerative Properties of Coralline-Derived (Biocoral) Scaffold
   Grafts in Human Maxillary Defects: Demonstrative and Comparative Study
   with Beta-Tricalcium Phosphate and Biphasic Calcium Phosphate by
   Synchrotron Radiation X-Ray Microtomography
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Article
DE biomaterials; bone regeneration; micro-CT
ID BMP-INDUCED OSTEOGENESIS; BONE-FORMATION; POROUS HYDROXYAPATITE; TISSUE
   REGENERATION; CANCELLOUS BONE; TRABECULAR BONE; CERAMICS; REPLACEMENT;
   CARBONATE; SURFACE
AB BackgroundIn recent years, there has been interest on the fabrication of systems using particulates or block-based approach for bone tissue engineering (TE) scaffolds, possessing porous interconnected structures. In fact, these particular morphologies greatly increase the surface area for more chemical and biological reactions to take place.
   PurposeThis study was designed to demonstrate the unique capability of the synchrotron radiation x-ray microtomography (micro-CT) in offering an advanced characterization of coralline-derived (Biocoral) biomaterials placed in human maxillary defects as it allows, in a nondestructive way, a complete, precise, and high-resolution three-dimensional analysis of their microstructural parameters. Moreover, the comparison between Biocoral and other biomaterials was explored to understand the mechanism of their biological behavior as bone substitute.
   Materials and MethodsImplant survival, bone regeneration, graft resorption, neovascularization, and morphometric parameters (including anisotropy and connectivity index of the structures) were evaluated by micro-CT in Biocoral and the other biomaterials after 6 to 7 months from implantation in human maxillary bone defects.
   ResultsAfter the in vivo tests, a huge amount of bone was detected in the retrieved Biocoral-based samples, coupled with a good rate of biomaterial resorption and the formation of a homogeneous and rich net of new vessels. The morphometric parameters were comparable to those obtained in the biphasic calcium phosphate-based control, with the exception of the connectivity index for which this control exhibited the most well-connected structure. This last result, together with those referred to the poor performances of the -tricalcium phosphate block-based sample, suggests that the particular scaffold morphology may play a role in the hunt the optimal scaffold structure to be implanted.
   ConclusionIn this limited study, implant success rate seems not strictly dependent on the biomaterial that is used, but on the scaffold morphology. Micro-CT technique was demonstrated to play a fundamental role in advanced characterization of bone TE constructs.
C1 [Giuliani, Alessandra; Manescu, Adrian] Univ Politecn Marche, Dip Sci Clin Specialist & Odontostomatolog, Sez Biochim Biol & Fis Applicata, Ancona, Italy.
   [Larsson, Emanuel] Univ Trieste, Dept Engn & Architect, Trieste, Italy.
   [Larsson, Emanuel; Tromba, Giuliana] Sincrotrone Trieste SCpA, Trieste, Italy.
   [Luongo, Giuseppe] Univ Naples Federico II, Dept Maxillo Facial Surg, Naples, Italy.
   [Piattelli, Adriano; Iezzi, Giovanna] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Mangano, Carlo] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy.
RP Giuliani, A (reprint author), Univ Politecn Marche, Dip Sci Clin Specialist & Odontostomatolog, Via Brecce Bianche 1, I-60131 Ancona, Italy.
EM a.giuliani@univpm.it
RI Giuliani, Alessandra/O-9097-2018; Luongo, Giuseppe/C-1291-2018
OI Giuliani, Alessandra/0000-0003-4177-7441; Luongo,
   Giuseppe/0000-0001-9104-2916
CR Atwood RC, 2004, SCRIPTA MATER, V51, P1029, DOI 10.1016/j.scriptamat.2004.08.014
   BENN DI, 1994, J SEDIMENT RES A, V64, P910
   BOSTROM RD, 1997, SYNTHETIC BIODEGRADA, P215, DOI DOI 10.1007/978-1-4612-4154-6
   Brun F, 2010, NUCL INSTRUM METH A, V615, P326, DOI 10.1016/j.nima.2010.02.063
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584
   COWIN SC, 1985, MECH MATER, V4, P137, DOI 10.1016/0167-6636(85)90012-2
   Deisinger U, 2008, KEY ENG MATER, V361-363, P915, DOI 10.4028/www.scientific.net/KEM.361-363.915
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Filmon Robert, 2009, Image Analysis & Stereology, V28, P103
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kak A. C., 2001, PRINCIPLES COMPUTERI
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kato E, 2014, CLIN IMPLANT DENT R, V16, P202, DOI 10.1111/j.1708-8208.2012.00467.x
   Kim YH, 2010, BIOMED MATER, V5, P1
   KLEIN C, 1994, BIOMATERIALS, V15, P31, DOI 10.1016/0142-9612(94)90193-7
   Knackstedt MA, 2006, BIOMATERIALS, V27, P2776, DOI 10.1016/j.biomaterials.2005.12.016
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Komlev VS, 2009, TISSUE ENG PART C-ME, V15, P425, DOI 10.1089/ten.tec.2008.0428
   KONERDING MA, 1991, SCANNING MICROSCOPY, V5, P851
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Montanan F., 2003, SYRMEP TOMO PROJECT
   Mushipe MT, 2002, BIOMATERIALS, V23, P365, DOI 10.1016/S0142-9612(01)00114-4
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Parfitt AM, 1987, BONE JISTOMORPHOMETR
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   POLLICK S, 1995, J ORAL MAXIL SURG, V53, P915, DOI 10.1016/0278-2391(95)90281-3
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   ROUDIER M, 1995, J BIOMED MATER RES, V29, P909, DOI 10.1002/jbm.820290802
   Schliephake H, 2009, J BIOMED MATER RES A, V90A, P429, DOI 10.1002/jbm.a.32104
   Stock SR, 1999, INT MATER REV, V44, P141, DOI 10.1179/095066099101528261
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x
   Wikesjo UME, 2003, J PERIODONTOL, V74, P957, DOI 10.1902/jop.2003.74.7.957
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 48
TC 23
Z9 24
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PD OCT
PY 2014
VL 16
IS 5
BP 736
EP 750
DI 10.1111/cid.12039
PG 15
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AS7QM
UT WOS:000344450100011
PM 23350548
DA 2018-10-20
ER

PT J
AU Yue, CX
   Yang, BC
AF Yue, Chongxia
   Yang, Bangcheng
TI Bioactive Titanium Surfaces with the Effect of Inhibiting Biofilm
   Formation
SO JOURNAL OF BIONIC ENGINEERING
LA English
DT Article
DE titanium; bioactive; anodic oxidation treatment; antibacterial; biofilm
   formation
ID BIOMATERIAL-CENTERED INFECTION; ANODIC-OXIDATION TREATMENT; ATOMIC-FORCE
   MICROSCOPE; TOTAL KNEE REPLACEMENT; TISSUE INTEGRATION; MICROBIAL
   ADHESION; BACTERIAL ADHESION; PLAQUE-FORMATION; METAL-SURFACES;
   FREE-ENERGY
AB Titanium metals and its alloy have been widely used in hard tissue repairing fields due to their good biocampatibility and mechanical properties. However, bioinert response and biomaterial associated infections are the main problems for their clinical application. In this study, we chose titanium plates treated with anodic oxidation (AO-Ti), alkali-heat (AH-Ti) and acid-alkali (AA-Ti) methods, which have been proved to be bioactive in vivo, to culture with Staphylococcus aureus and Escherichia coli to investigate the interaction between bioactive titanium surfaces and biofilm. We used X-ray diffraction (XRD), Scanning Electron Microscope (SEM), roughness measurement to study the physical-chemical properties of the as-received bioactive titanium surfaces, and Confocal Laser Scanning Microscope (CLSM) was employed to study the properties of biofilm formed on the biomaterial surfaces. The results indicate that the titanium surface subjected to anodic oxidation treatment is unfavorable for the formation of biofilm in vitro because the titania (TiO2) coating formed by anodizing has superior antimicrobial property than the other surfaces. Therefore, anodic oxidation surface modification is effective to endow titanium surface with bioactivity and antimicrobial property, which has the potential to improve the successful rate of the clinical application of titanium implants.
C1 [Yue, Chongxia; Yang, Bangcheng] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Yue, Chongxia; Yang, Bangcheng] Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Yang, BC (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM yangbchengc@126.com
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51362004, 31070848]; Key
   Program for Science & Technology Development of China [2012BAI18B04];
   Research Fund for the Doctoral Program of Higher Education of China
   [20110181110064]; Sichuan Province Science and Technology Innovation
   Team Program of China [2011JTD0006]; Jiangsu Collaborative Innovation
   Center of Biomedical Functional Materials, China
FX This work is supported by National Basic Research Program of China (973
   Program, 2012CB933600), National Natural Science Foundation of China (NO
   51362004, 31070848), Key Program for Science & Technology Development of
   China (No. 2012BAI18B04), Research Fund for the Doctoral Program of
   Higher Education of China (No. 20110181110064), Sichuan Province Science
   and Technology Innovation Team Program of China (No. 2011JTD0006) and
   the Jiangsu Collaborative Innovation Center of Biomedical Functional
   Materials, China. The SEM observation was assisted by the Analytical and
   Testing Center, Sichuan University.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bloomfield P, 2002, HEART, V87, P583, DOI 10.1136/heart.87.6.583
   Chen YK, 2009, SURF COAT TECH, V204, P685, DOI 10.1016/j.surfcoat.2009.09.010
   Cheng C L, 2009, J BIOMEDICAL SCI, V16, P1
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Diaz C, 2007, LANGMUIR, V23, P11206, DOI 10.1021/la700650q
   Diaz C, 2008, ARTIF ORGANS, V32, P292, DOI 10.1111/j.1525-1594.2008.00545.x
   Gan L, 2009, RARE METAL MAT ENG, V38, P1242
   Gristina A, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000145156.89115.12
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Gristina Anthony G., 1994, Clinical Microbiology Newsletter, V16, P171, DOI 10.1016/0196-4399(94)90037-X
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   HARRIS WH, 1990, NEW ENGL J MED, V323, P725, DOI 10.1056/NEJM199009133231106
   Kawai K, 2000, J PROSTHET DENT, V83, P664, DOI 10.1016/S0022-3913(00)70068-0
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Masahashi N, 2009, APPL CATAL B-ENVIRON, V90, P255, DOI 10.1016/j.apcatb.2009.03.011
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   Perry EL, 2010, J BIOMED MATER RES B, V92B, P397, DOI 10.1002/jbm.b.31528
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   Ramya S, 2010, BIOFOULING, V26, P883, DOI 10.1080/08927014.2010.529613
   Shemesh M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-51
   Shibata Y, 2010, BIOMATERIALS, V31, P8546, DOI 10.1016/j.biomaterials.2010.07.098
   Truong VK, 2009, APPL MICROBIOL BIOT, V83, P925, DOI 10.1007/s00253-009-1944-5
   Verran J, 2010, J ADHES SCI TECHNOL, V24, P2271, DOI 10.1163/016942410X508019
   Verran J, 2010, LETT APPL MICROBIOL, V50, P258, DOI 10.1111/j.1472-765X.2009.02784.x
   Wen HB, 1998, J MATER SCI-MATER M, V9, P121, DOI 10.1023/A:1008859417664
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Yang BC, 2010, J BIOMED MATER RES A, V94A, P700, DOI 10.1002/jbm.a.32743
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yousefpour M, 2006, J ELECTROANAL CHEM, V589, P96, DOI 10.1016/j.jelechem.2006.01.020
   Yue CX, 2009, SCI CHINA SER E, V52, P2269, DOI 10.1007/s11431-009-0223-0
NR 35
TC 11
Z9 11
U1 4
U2 51
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1672-6529
J9 J BIONIC ENG
JI J. Bionic Eng.
PD OCT
PY 2014
VL 11
IS 4
BP 589
EP 599
DI 10.1016/S1672-6529(14)60070-6
PG 11
WC Engineering, Multidisciplinary; Materials Science, Biomaterials;
   Robotics
SC Engineering; Materials Science; Robotics
GA AS1KN
UT WOS:000344040200009
DA 2018-10-20
ER

PT J
AU Munday, WR
   Klett, Z
   McNiff, JM
   Ko, C
AF Munday, William R.
   Klett, Zachary
   McNiff, Jennifer M.
   Ko, Christine
TI Foreign body giant cell reaction to tarSys (TM) xenograft
SO JOURNAL OF CUTANEOUS PATHOLOGY
LA English
DT Article
DE allograft; eyelid; foreign body giant cell reaction; rejection;
   xenograft
ID AUGMENTATION
AB Objective A foreign body giant cell (FBGC) reaction may occur in response to implanted xenogenic biomaterials. Here we report a FBGC reaction to the recently introduced xenogenic biomaterial, tarSys (TM), used for correction of lower eyelid retraction.
   Method: A retrospective chart review of two patients with FBGC reaction to tarSys (TM) implantation was performed.
   Results: Two patients (aged 51, 58 year) with lower eyelid retraction underwent surgical implantation of tarSys (TM) spacer grafts for correction. Both patients subsequently experienced chronic swelling requiring graft removal. Examination of the specimens showed a palisading FBGC reaction around acellular pink fibrillar material.
   Conclusion: A FBGC reaction may follow implantation of the tarSys (TM) xenograft.
C1 [Munday, William R.] Yale New Haven Med Ctr, Dept Pathol, New Haven, CT 06504 USA.
   [Klett, Zachary] Yale New Haven Med Ctr, Dept Ophthalmol, New Haven, CT 06504 USA.
   [McNiff, Jennifer M.; Ko, Christine] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.
   [McNiff, Jennifer M.; Ko, Christine] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.
RP Munday, WR (reprint author), Yale New Haven Med Ctr, Dept Pathol, 20 York St, New Haven, CT 06504 USA.
EM william.munday@yale.edu
OI Ko, Christine/0000-0003-2270-2524
CR Ambro Bryan T, 2003, Arch Facial Plast Surg, V5, P528, DOI 10.1001/archfaci.5.6.528
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Armitage S, 2012, OBSTET GYNECOL INT, DOI [10.1155/2012/376251, DOI 10.1155/2012/376251]
   Ashley RA, 2010, BJU INT, V105, P1462, DOI 10.1111/j.1464-410X.2009.08965.x
   Belcher HJCR, 2001, J HAND SURG-BRIT EUR, V26, P159, DOI 10.1054/jhsb.2001.0554
   Borrelli M, 2012, ORBIT, V31, P187, DOI 10.3109/01676830.2012.669012
   Cheung D, 2004, OPHTHAL PLAST RECONS, V20, P257, DOI 10.1097/01.IOP.0000129019.24879.C2
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   Leonard JH, 2013, EUR J PLAST SURG, V36, P733, DOI 10.1007/s00238-013-0882-8
   Liao SL, 2013, AM J OPHTHALMOL, V156, P387, DOI 10.1016/j.ajo.2013.03.017
   Saray A, 2003, AESTHET PLAST SURG, V27, P368, DOI 10.1007/s00266-003-3012-3
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Steinhoff M, 2013, J AM ACAD DERMATOL, V69, pS15, DOI 10.1016/j.jaad.2013.04.045
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
NR 15
TC 1
Z9 1
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6987
EI 1600-0560
J9 J CUTAN PATHOL
JI J. Cutan. Pathol.
PD OCT
PY 2014
VL 41
IS 10
BP 771
EP 774
DI 10.1111/cup.12374
PG 4
WC Dermatology; Pathology
SC Dermatology; Pathology
GA AS6SL
UT WOS:000344392500002
PM 25039972
DA 2018-10-20
ER

PT J
AU Srinivasan, N
   Bhagawati, M
   Ananthanarayanan, B
   Kumar, S
AF Srinivasan, Nithya
   Bhagawati, Maniraj
   Ananthanarayanan, Badriprasad
   Kumar, Sanjay
TI Stimuli-sensitive intrinsically disordered protein brushes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID POLYMER BRUSHES; POLYELECTROLYTE BRUSHES; RADICAL POLYMERIZATION;
   NEUROFILAMENT BRUSH; DENSITY; BINDING; CHAINS; ENVIRONMENT; TRANSITION;
   ADSORPTION
AB Grafting polymers onto surfaces at high density to yield polymer brush coatings is a widely employed strategy to reduce biofouling and interfacial friction. These brushes almost universally feature synthetic polymers, which are often heterogeneous and do not readily allow incorporation of chemical functionalities at precise sites along the constituent chains. To complement these synthetic systems, we introduce a biomimetic, recombinant intrinsically disordered protein that can assemble into an environment-sensitive brush. This macromolecule adopts an extended conformation and can be grafted to solid supports to form oriented protein brushes that swell and collapse dramatically with changes in solution pH and ionic strength. We illustrate the value of sequence specificity by using proteases with mutually orthogonal recognition sites to modulate brush height in situ to predictable values. This study demonstrates that stimuli-responsive brushes can be fabricated from proteins and introduces them as a new class of smart biomaterial building blocks.
C1 [Srinivasan, Nithya; Bhagawati, Maniraj; Ananthanarayanan, Badriprasad; Kumar, Sanjay] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
RP Kumar, S (reprint author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
EM skumar@berkeley.edu
RI Foundry, Molecular/G-9968-2014
FU Army Research Office [W911NF-09-1-0507]; Hellman Faculty Fund Award;
   Office of Science, Office of Basic Energy Sciences, of the US Department
   of Energy [DE-AC02-05CH11231]
FX This work was supported by a PECASE Award from the Army Research Office
   (W911NF-09-1-0507) and a Hellman Faculty Fund Award to S. K. We thank Dr
   Susan Marqusee, Dr Clayton Radke, Dr John Kuriyan, Dr Ahmet Yildiz and
   Dr Rachel Segalman from University of California, Berkeley for
   instrumental support. Work at the Molecular Foundry was supported by the
   Office of Science, Office of Basic Energy Sciences, of the US Department
   of Energy under Contract No. DE-AC02-05CH11231.
CR Ackerley S., 2003, J CELL BIOL, V161, P485
   Adiga Shashishekar P, 2012, J Funct Biomater, V3, P239, DOI 10.3390/jfb3020239
   Ayres N, 2007, LANGMUIR, V23, P3744, DOI 10.1021/la062417+
   Balastre M, 2002, MACROMOLECULES, V35, P9480, DOI 10.1021/ma011875g
   Beck R, 2010, NAT MATER, V9, P40, DOI [10.1038/NMAT2566, 10.1038/nmat2566]
   Biesalski M, 2004, J CHEM PHYS, V120, P8807, DOI 10.1063/1.1690242
   Biesalski M, 2002, J CHEM PHYS, V117, P4988, DOI 10.1063/1.1490924
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chen T, 2010, PROG POLYM SCI, V35, P94, DOI 10.1016/j.progpolymsci.2009.11.004
   Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110
   Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028
   Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081
   Hite C. K., 2012, PROTEIN SCI, V21, P531
   Ho YP, 2007, RAPID COMMUN MASS SP, V21, P1083, DOI 10.1002/rcm.2927
   Hoffman AS, 2007, PROG POLYM SCI, V32, P922, DOI 10.1016/j.progpolymsci.2007.05.005
   Houbenov N, 2003, MACROMOLECULES, V36, P5897, DOI 10.1021/ma0341869
   Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108
   ISRAELS R, 1994, MACROMOLECULES, V27, P3087, DOI 10.1021/ma00089a028
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kowalczyk SW, 2011, NAT NANOTECHNOL, V6, P433, DOI [10.1038/nnano.2011.88, 10.1038/NNANO.2011.88]
   Kumar S, 2004, BIOCHEM BIOPH RES CO, V324, P489, DOI 10.1016/j.bbrc.2004.09.076
   Kwong GA, 2013, NAT BIOTECHNOL, V31, P63, DOI 10.1038/nbt.2464
   Lego B, 2010, MACROMOLECULES, V43, P4384, DOI 10.1021/ma902588j
   Liu GM, 2006, POLYMER, V47, P3157, DOI 10.1016/j.polymer.2006.02.091
   Louguet S, 2012, POLYM CHEM-UK, V3, P1408, DOI 10.1039/c2py20089a
   Moldakarimov SB, 2001, MACROMOL THEOR SIMUL, V10, P780, DOI 10.1002/1521-3919(20011001)10:8<780::AID-MATS780>3.0.CO;2-Q
   Pasut G, 2006, ADV POLYM SCI, V192, P95, DOI 10.1007/12_022
   Ruhe J, 2004, ADV POLYM SCI, V165, P79, DOI 10.1007/b11268
   Sanjuan S, 2008, MACROMOLECULES, V41, P8721, DOI 10.1021/ma8018798
   Santner AA, 2012, BIOCHEMISTRY-US, V51, P7250, DOI 10.1021/bi300653m
   Schoch RL, 2012, P NATL ACAD SCI USA, V109, P16911, DOI 10.1073/pnas.1208440109
   Shimoboji T, 2002, P NATL ACAD SCI USA, V99, P16592, DOI 10.1073/pnas.262427799
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tcherkasskaya O, 2001, PROTEINS, V44, P244, DOI 10.1002/prot.1089
   Todd SJ, 2009, LANGMUIR, V25, P7533, DOI 10.1021/la900376h
   Tokatlian T, 2010, BIOMATERIALS, V31, P8072, DOI 10.1016/j.biomaterials.2010.07.030
   Truong M. Y., 2010, BIOMATERIALS, V31, P4344
   Tsujii Y, 2006, ADV POLYM SCI, V197, P1, DOI 10.1007/12_063
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   Uversky VN, 2009, PROTEIN J, V28, P305, DOI 10.1007/s10930-009-9201-4
   Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x
   Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Waichman S, 2010, ANAL CHEM, V82, P1478, DOI 10.1021/ac902608a
   Welch M, 2011, SOFT MATTER, V7, P297, DOI 10.1039/c0sm00035c
   Willott JD, 2014, LANGMUIR, V30, P1827, DOI 10.1021/la4047275
   Zauscher S, 2009, BIOINTERPHASES, V4, pFA1, DOI 10.1116/1.3149787
   Zelzer M, 2013, BIOMATER SCI-UK, V1, P11, DOI 10.1039/c2bm00041e
   Zelzer M, 2012, J MATER CHEM, V22, P12229, DOI 10.1039/c2jm31666h
   Zhang GZ, 2009, MACROMOL RAPID COMM, V30, P328, DOI 10.1002/marc.200800611
   Zhang HN, 2005, MACROMOLECULES, V38, P4855, DOI 10.1021/ma047501f
   Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006
   Zhulina EB, 2007, BIOPHYS J, V93, P1421, DOI 10.1529/biophysj.106.095323
   Zhulina EB, 2007, BIOPHYS J, V93, P1452, DOI 10.1529/biophysj.107.104695
   ZHULINA EB, 1995, MACROMOLECULES, V28, P1491, DOI 10.1021/ma00109a021
NR 55
TC 28
Z9 28
U1 2
U2 86
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD OCT
PY 2014
VL 5
AR 5145
DI 10.1038/ncomms6145
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AS0PU
UT WOS:000343980700009
PM 25312006
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Elahi, MF
   Guan, GP
   Wang, L
AF Elahi, M. Fazley
   Guan, Guoping
   Wang, Lu
TI HEMOCOMPATIBILITY OF SURFACE MODIFIED SILK FIBROIN MATERIALS: A REVIEW
SO REVIEWS ON ADVANCED MATERIALS SCIENCE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; PLASMA GLOW-DISCHARGE; BLOOD COMPATIBILITY;
   ANTICOAGULANT ACTIVITY; CONTROLLED-RELEASE; 2-METHACRYLOYLOXYETHYL
   PHOSPHORYLCHOLINE; POLY(ETHYLENE GLYCOL); CHEMICAL-MODIFICATION;
   BIOMATERIAL COATINGS; GRAFT-POLYMERIZATION
AB Hemocompatibility test is very common and important during development of biomaterials in direct contact with blood. Moreover, silk fibroin based biomaterials have been used in biomedical application for more than one hundred years and increasing sharply. Recent reports from our group and others have demonstrated that it has acceptable mechanical properties and patency rates in animal models. Unfortunately, pure silk fibroin shows poor hemocompatibility. Thus, the surface of a silk fibroin should be modified to improve its blood compatibility when it is used as a blood-contacting material especially for small diameter arterial prostheses. Researchers have studied hemocompatibility of silk fibroin biomaterials; however, the testing procedures vary greatly throughout different publication. Thus it is not easy to get the exact information from the literatures to performing hemocompatibility assays. Therefore, this paper reviews the studies on effects of surface modification on hemocompatibility in terms of hemolysis, anticoagulation, platelets adhesion, plasma recalcification time (PRT), activated partial thromboplastin time (APTT) and plasma prothrombin time (PT) assays of silk fibroin biomaterials. At last, other physical and biological tests which are also essential and related to the hemocompatibility testing, were also discussed in this paper.
C1 [Elahi, M. Fazley; Guan, Guoping; Wang, Lu] Donghua Univ, Coll Text, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
RP Wang, L (reprint author), Donghua Univ, Coll Text, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
EM wanglu@dhu.edu.cn
FU National Natural Science Foundation of China [51003014]; 111 project
   "Biomedical Textile Materials Science and Technology" [B07024]
FX This work has been supported by the National Natural Science Foundation
   of China (Grant No.51003014) and the 111 project "Biomedical Textile
   Materials Science and Technology" (Grant No. B07024).
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Bos GW, 1998, ARCH PHYSIOL BIOCHEM, V106, P100, DOI 10.1076/apab.106.2.100.4384
   Chen H, 2005, BIOMATERIALS, V26, P7418, DOI 10.1016/j.biomaterials.2005.05.053
   Chen HL, 2013, DIAM RELAT MATER, V38, P52, DOI 10.1016/j.diamond.2013.06.011
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   CHENOWETH DE, 1983, KIDNEY INT, V24, P764, DOI 10.1038/ki.1983.225
   Chutipakdeevong J, 2013, J APPL POLYM SCI, V130, P3634, DOI 10.1002/app.39611
   Dee K.C., 2003, INTRO TISSUE BIOMATE, P37
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Furuzono T, 1999, J APPL POLYM SCI, V73, P2541, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2541::AID-APP23>3.0.CO;2-5
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Gu JW, 2002, MAT SCI ENG C-BIO S, V20, P199, DOI 10.1016/S0928-4931(02)00033-4
   He QJ, 2010, BIOMATERIALS, V31, P1085, DOI 10.1016/j.biomaterials.2009.10.046
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   IMAI Y, 1972, J BIOMED MATER RES, V6, P165, DOI 10.1002/jbm.820060305
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Jiang XF, 2010, J WUHAN UNIV TECHNOL, V25, P969, DOI 10.1007/s11595-010-0131-y
   JINDAL KK, 1989, AM J KIDNEY DIS, V14, P507, DOI 10.1016/S0272-6386(89)80151-9
   Kainthan RK, 2006, BIOMATERIALS, V27, P5377, DOI 10.1016/j.biomaterials.2006.06.021
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Ki CS, 2007, J APPL POLYM SCI, V106, P3922, DOI 10.1002/app.26914
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Klee D., 1999, BIOMEDICAL APPL POLY, P1
   Kung FC, 2006, COLLOID SURFACE B, V47, P36, DOI 10.1016/j.colsurfb.2005.11.019
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Leitao AF, 2013, COLLOID SURFACE B, V111, P493, DOI 10.1016/j.colsurfb.2013.06.031
   Li GC, 2010, COLLOID SURFACE B, V81, P255, DOI 10.1016/j.colsurfb.2010.07.016
   Lin WC, 2005, COLLOID SURFACE B, V44, P82, DOI 10.1016/j.colsurfb.2005.05.015
   Lin YS, 2009, CHEM MATER, V21, P3979, DOI 10.1021/cm901259n
   Liu Y, 2010, APPL SURF SCI, V256, P3977, DOI 10.1016/j.apsusc.2010.01.060
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Marois Y, 1996, BIOMATERIALS, V17, P3, DOI 10.1016/0142-9612(96)80749-6
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003
   Moreno MJ, 2011, J BIOMED MATER RES B, V97B, P201, DOI 10.1002/jbm.b.31774
   Nakazawa Y, 2011, J BIOMAT SCI-POLYM E, V22, P195, DOI 10.1163/092050609X12586381656530
   Nogueira GM, 2009, J APPL POLYM SCI, V114, P617, DOI 10.1002/app.30627
   OKADA T, 1991, MAKROMOL CHEM, V192, P1705
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   RASMUSSEN JR, 1977, J AM CHEM SOC, V99, P4736, DOI 10.1021/ja00456a035
   Ren ZC, 2013, J APPL POLYM SCI, V127, P308, DOI 10.1002/app.37885
   RHODES NP, 1994, BIOMATERIALS, V15, P35, DOI 10.1016/0142-9612(94)90194-5
   Sagnella S, 2005, COLLOID SURFACE B, V42, P147, DOI 10.1016/j.colsurfb.2004.07.001
   Shen F, 2010, MAT SCI ENG C-MATER, V30, P369, DOI 10.1016/j.msec.2009.12.003
   Tamada Y, 2004, BIOMATERIALS, V25, P377, DOI 10.1016/S0142-9612(03)00533-7
   Tamada Y, 2003, J APPL POLYM SCI, V87, P2377, DOI 10.1002/app.12022
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Thomas AC, 2003, CARDIOVASC PATHOL, V12, P271, DOI 10.1016/S1054-8807(03)00086-3
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   Vallar L, 1996, ARTIF ORGANS, V20, P8, DOI 10.1111/j.1525-1594.1996.tb04412.x
   van Bilsen PHJ, 2008, COLLOID SURFACE B, V67, P46, DOI 10.1016/j.colsurfb.2008.07.013
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Wang HY, 2012, MACROMOL RES, V20, P347, DOI 10.1007/s13233-012-0012-7
   Wang S., 2007, EUR CELLS MATER, V14, P94
   Wang SD, 2011, INT J BIOL MACROMOL, V48, P345, DOI 10.1016/j.ijbiomac.2010.12.008
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z
   Zhang FM, 2013, COLLOID SURFACE B, V102, P457, DOI 10.1016/j.colsurfb.2012.02.018
   Zhang Q, 2013, COLLOID SURFACE B, V102, P354, DOI 10.1016/j.colsurfb.2012.07.037
   Zhao YL, 2013, J APPL POLYM SCI, V127, P4825, DOI 10.1002/app.38054
   Zhu ZH, 2008, J APPL POLYM SCI, V109, P2956, DOI 10.1002/app.28460
NR 77
TC 22
Z9 22
U1 4
U2 34
PU INST PROBLEMS MECHANICAL ENGINEERING-RUSSIAN ACAD SCIENCES
PI ST PTERSBURG
PA BOLSHOJ 61, VAS OSTROV, ST PTERSBURG, 199178, RUSSIA
SN 1606-5131
J9 REV ADV MATER SCI
JI Rev. Adv. Mater. Sci.
PD OCT
PY 2014
VL 38
IS 2
BP 148
EP 159
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AS2QZ
UT WOS:000344126000005
DA 2018-10-20
ER

PT J
AU Zheng, SR
   Huang, HW
   Zhang, RD
   Cao, LX
AF Zheng, Shuran
   Huang, Haiwei
   Zhang, Renduo
   Cao, Lixiang
TI Removal of Cr(VI) from aqueous solutions by fruiting bodies of the jelly
   fungus (Auricularia polytricha)
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Auricularia polytricha; Biosorption; Chromium; Fruiting body
ID HEXAVALENT CHROMIUM; BIOSORPTION; TRIVALENT; REDUCTION; ALGINATE; IONS;
   BIOSORBENTS; ADSORPTION; MECHANISM; BIOMASS
AB The aim of this study was to investigate the potential to remove chromium (Cr) from aqueous solutions using the fruiting body of Auricularia polytricha. Batch experiments were conducted under various conditions, and different models were used to characterize the biosorption process. Results showed that, for both fresh and dried fruiting bodies of A. polytricha, removal efficiencies of Cr(VI) and total Cr reached maximum values at pH values of 1 and 2, respectively. The process of Cr(VI) removal by A. polytricha included the sorption process as well as the reduction of Cr(VI) to Cr(III). Spectra of X-ray photoelectron spectroscopy of the biosorbent revealed that most of the Cr loaded on the biomass surface was in the trivalent form. The Freundlich model fitted the isotherm process better than the Langmuir model in the concentration range examined. The pseudo-second-order model well described the adsorption process of Cr onto the biomass. The biosorption capacity of Cr(VI) by fruiting bodies was much higher than that by most of other biosorbents reported. The results suggest that the fruiting bodies of A. polytricha should be a promising biomaterial for Cr removal from water contaminated by the heavy metal.
C1 [Zheng, Shuran; Huang, Haiwei; Zhang, Renduo] Sun Yat Sen Univ, Guangdong Prov Key Lab Environm Pollut Control &, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.
   [Cao, Lixiang] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.
RP Zhang, RD (reprint author), Sun Yat Sen Univ, Guangdong Prov Key Lab Environm Pollut Control &, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China.
EM zhangrd@mail.sysu.edu.cn; lssclx@163.com
FU Chinese National Natural Science Foundation [51039007, 51179212]
FX This work was partly supported by grants from the Chinese National
   Natural Science Foundation (Nos. 51039007 and 51179212).
CR Aksu Z, 2002, PROCESS BIOCHEM, V38, P175, DOI 10.1016/S0032-9592(02)00053-5
   Bajpai J, 2004, COLLOID SURFACE A, V236, P81, DOI 10.1016/j.colsurfa.2004.01.021
   Baral A., 2002, ENVIRON SCI POLICY, V5, P121, DOI DOI 10.1016/S1462-9011(02)00028-X
   Chen WY, 1996, J COLLOID INTERF SCI, V180, P135, DOI 10.1006/jcis.1996.0283
   Gadd G.M, 1990, CHEM IND, V13, P421
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Huang HW, 2012, APPL MICROBIOL BIOT, V96, P829, DOI 10.1007/s00253-011-3846-6
   Kotas J, 2000, ENVIRON POLLUT, V107, P263, DOI 10.1016/S0269-7491(99)00168-2
   Kratochvil D, 1998, ENVIRON SCI TECHNOL, V32, P2693, DOI 10.1021/es971073u
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Lazaridis NK, 2005, WATER RES, V39, P4385, DOI 10.1016/j.watres.2005.09.013
   Malkoc E, 2006, J HAZARD MATER, V138, P142, DOI 10.1016/j.jhazmat.2006.05.051
   Marta L, 2010, CHEM ENG J, V165, P517
   Mata YN, 2009, J HAZARD MATER, V163, P555, DOI 10.1016/j.jhazmat.2008.07.015
   Medeiros MG, 2003, MUTAGENESIS, V18, P19, DOI 10.1093/mutage/18.1.19
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Pan R, 2010, APPL MICROBIOL BIOT, V88, P997, DOI 10.1007/s00253-010-2821-y
   Park D, 2006, BIORESOURCE TECHNOL, V97, P1592, DOI 10.1016/j.biortech.2005.07.025
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Plaza Grazyna, 1996, Acta Microbiologica Polonica, V45, P193
   Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005
   SHEWRY PR, 1976, J ECOL, V64, P195, DOI 10.2307/2258691
   Silva B, 2012, INT BIODETER BIODEGR, V74, P116, DOI 10.1016/j.ibiod.2012.05.026
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
NR 27
TC 7
Z9 7
U1 0
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD OCT
PY 2014
VL 98
IS 20
BP 8729
EP 8736
DI 10.1007/s00253-014-5862-9
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AR7HZ
UT WOS:000343751400026
PM 24928657
DA 2018-10-20
ER

PT J
AU Bondalapati, S
   Ruvinov, E
   Kryukov, O
   Cohen, S
   Brik, A
AF Bondalapati, Somasekhar
   Ruvinov, Emil
   Kryukov, Olga
   Cohen, Smadar
   Brik, Ashraf
TI Rapid End-Group Modification of Polysaccharides for Biomaterial
   Applications in Regenerative Medicine
SO MACROMOLECULAR RAPID COMMUNICATIONS
LA English
DT Article
DE alginate hydrogels; aniline catalysis; oxime conjugation;
   polysaccharides; regenerative medicine
ID IMMOBILIZED RGD PEPTIDE; NUCLEOPHILIC CATALYSIS; ALGINATE HYDROGELS;
   BLOCK-COPOLYMERS; MOLECULAR-WEIGHT; OXIME FORMATION; G1 PHASE;
   RECOGNITION; SCAFFOLDS; SULFATION
AB Polysaccharides have emerged as important functional materials because of their unique properties such as biocompatibility, biodegradability, and availability of reactive sites for chemical modifications to optimize their properties. The overwhelming majority of the methods to modify polysaccharides employ random chemical modifications, which often improve certain properties while compromising others. On the other hand, the employed methods for selective modifications often require excess of coupling partners, long reaction times and are limited in their scope and wide applicability. To circumvent these drawbacks, aniline-catalyzed oxime formation is developed for selective modification of a variety of polysaccharides through their reducing end. Notably, it is found that for efficient oxime formation, different conditions are required depending on the composition of the specific polysaccharide. It is also shown how our strategy can be applied to improve the physical and functional properties of alginate hydrogels, which are widely used in tissue engineering and regenerative medicine applications. While the randomly and selectively modified alginate exhibits similar viscoelastic properties, the latter forms significantly more stable hydrogel and superior cell adhesive and functional properties. Our results show that the developed conjugation reaction is robust and should open new opportunities for preparing polysaccharide-based functional materials with unique properties.
C1 [Bondalapati, Somasekhar; Brik, Ashraf] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel.
   [Ruvinov, Emil; Kryukov, Olga; Cohen, Smadar] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
   [Cohen, Smadar] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Regenerat Med & Stem Cell Res Ctr, IL-84105 Beer Sheva, Israel.
RP Cohen, S (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, IL-84105 Beer Sheva, Israel.
EM scohen@bgu.ac.il; abrik@bgu.ac.il
FU Focal Technological Area Program of the Israeli National Nanotechnology
   Initiative (INNI); Israel Council of Higher Education under PBC program
FX This work was supported by the Focal Technological Area Program of the
   Israeli National Nanotechnology Initiative (INNI) (A. B. and S. C.). S.
   B. thanks the Israel Council of Higher Education for a fellowship under
   the PBC program. Professor Cohen holds the Clair and Harold Oshry
   Professor Chair in Biotechnology.
CR Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002
   Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Benediktsdottir BE, 2012, CARBOHYD POLYM, V90, P1273, DOI 10.1016/j.carbpol.2012.06.070
   Bosker WTE, 2003, MACROMOLECULES, V36, P1982, DOI 10.1021/ma020925u
   Bottazzi ME, 1999, J CELL BIOL, V146, P1255, DOI 10.1083/jcb.146.6.1255
   Dirksen A, 2006, ANGEW CHEM INT EDIT, V45, P7581, DOI 10.1002/anie.200602877
   Dirksen A, 2008, BIOCONJUGATE CHEM, V19, P2543, DOI 10.1021/bc800310p
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Guerry A, 2013, BIOCONJUGATE CHEM, V24, P544, DOI 10.1021/bc3003716
   Huang YH, 2007, POLYM DEGRAD STABIL, V92, P1072, DOI 10.1016/j.polymdegradstab.2007.02.011
   Kristiansen KA, 2010, CARBOHYD RES, V345, P1264, DOI 10.1016/j.carres.2010.02.011
   Lees A, 2006, VACCINE, V24, P716, DOI 10.1016/j.vaccine.2005.08.096
   MIMA S, 1983, J APPL POLYM SCI, V28, P1909, DOI 10.1002/app.1983.070280607
   Mizrahy S, 2012, CHEM SOC REV, V41, P2623, DOI 10.1039/c1cs15239d
   Novoa-Carballal R, 2012, CHEM COMMUN, V48, P3781, DOI 10.1039/c2cc30726j
   Pelletier S, 2000, CARBOHYD POLYM, V43, P343, DOI 10.1016/S0144-8617(00)00188-0
   Raemdonck K, 2013, ADV DRUG DELIVER REV, V65, P1123, DOI 10.1016/j.addr.2013.05.002
   Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P333, DOI 10.1021/bc3004167
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schatz C, 2010, MACROMOL RAPID COMM, V31, P1664, DOI 10.1002/marc.201000267
   Shachar M, 2011, ACTA BIOMATER, V7, P152, DOI 10.1016/j.actbio.2010.07.034
   Singh Y, 2006, CHEMBIOCHEM, V7, P1298, DOI 10.1002/cbic.200600078
   Sinitsya A, 2000, CARBOHYD POLYM, V42, P359, DOI 10.1016/S0144-8617(99)00184-8
   Styslinger TJ, 2012, J AM CHEM SOC, V134, P7507, DOI 10.1021/ja300893t
   Takano R, 2000, J CARBOHYD CHEM, V19, P1185, DOI 10.1080/07328300008544142
   Thygesen MB, 2010, J ORG CHEM, V75, P1752, DOI 10.1021/jo902425v
   Tommeraas K, 2001, CARBOHYD RES, V336, P291, DOI 10.1016/S0008-6215(01)00275-0
   Wendeler M, 2014, BIOCONJUGATE CHEM, V25, P93, DOI 10.1021/bc400380f
   Zhang Z, 2013, ACS APPL MATER INTER, V5, P10760, DOI 10.1021/am402840f
NR 34
TC 6
Z9 6
U1 0
U2 31
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1022-1336
EI 1521-3927
J9 MACROMOL RAPID COMM
JI Macromol. Rapid Commun.
PD OCT
PY 2014
VL 35
IS 20
BP 1754
EP 1762
DI 10.1002/marc.201400354
PG 9
WC Polymer Science
SC Polymer Science
GA AS1EB
UT WOS:000344020500006
DA 2018-10-20
ER

PT J
AU Kevadiya, BD
   Rajkumar, S
   Bajaj, HC
   Chettiar, SS
   Gosai, K
   Brahmbhatt, H
   Bhatt, AS
   Barvaliya, YK
   Dave, GS
   Kothari, RK
AF Kevadiya, Bhavesh D.
   Rajkumar, Shalini
   Bajaj, Hari C.
   Chettiar, Shiva Shankaran
   Gosai, Kalpeshgiri
   Brahmbhatt, Harshad
   Bhatt, Adarsh S.
   Barvaliya, Yogesh K.
   Dave, Gaurav S.
   Kothari, Ramesh K.
TI Biodegradable gelatin-ciprofloxacin-montmorillonite composite hydrogels
   for controlled drug release and wound dressing application
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biodegradation; Cell migration; Ciprofloxacin; Montmorillonite; Wound
   healing
ID OXIDATIVE STRESS MARKERS; IN-VITRO; ANTIBACTERIAL ACTIVITY; SILVER
   NANOPARTICLES; ESCHERICHIA-COLI; ANTICANCER DRUG; ORAL DELIVERY;
   LACTIC-ACID; PROLIFERATION; MIGRATION
AB This work reports intercalation of a sparingly soluble antibiotic (ciprofloxacin) into layered nanostructure silicate, montmorillonite (MMT) and its reaction with bone derived polypeptide, gelatin that yields three-dimensional composite hydrogel. Drug intercalation results in changes in MMT layered space and drug loaded MMT and gelatin creates 3D morphology with biodegradable composite hydrogels. These changes can be correlated with electrostatic interactions between the drug, MMT and the gelatin polypeptides as confirmed by X-ray diffraction patterns, thermal, spectroscopic analyses, computational modeling and 3D morphology revealed by SEM and TEM analysis. No significant changes in structural and functional properties of drug was found after intercalation in MMT layers and composite hydrogels. In vitro drug release profiles showed controlled release up to 150 h. The drug loaded composite hydrogels were tested on lung cancer cells (A549) by MTT assay. The results of in vitro cell migration and proliferation assay were promising as composite hydrogels induced wound healing progression. In vitro biodegradation was studied using proteolytic enzymes (lysozyme and protease K) at physiological conditions. This' new approach of drug intercalation into the layered nanostructure silicate by ion-exchange may have significant applications in cost-effective wound dressing biomaterial with antimicrobial property. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kevadiya, Bhavesh D.; Bajaj, Hari C.; Gosai, Kalpeshgiri; Brahmbhatt, Harshad; Bhatt, Adarsh S.] CSIR, Discipline Inorgan Mat & Catalysis, Cent Salt & Marine Chem Res Inst, Bhavnagar 364021, Gujarat, India.
   [Kevadiya, Bhavesh D.; Rajkumar, Shalini] Nirma Univ, Inst Sci, Ahmadabad 382481, Gujarat, India.
   [Chettiar, Shiva Shankaran] Veer Narmad South Gujarat Univ, Shree Ramkrishna Inst Comp Educ & Appl Sci, Dept Biotechnol, Surat, India.
   [Barvaliya, Yogesh K.; Dave, Gaurav S.] Saurashtra Univ, Dept Biochem, Rajkot 360005, Gujarat, India.
   [Kothari, Ramesh K.] Christ Coll, Dept Microbiol, Rajkot 360005, Gujarat, India.
RP Bajaj, HC (reprint author), CSIR, Discipline Inorgan Mat & Catalysis, Cent Salt & Marine Chem Res Inst, Gijubhai Badheka Marg, Bhavnagar 364021, Gujarat, India.
EM shalini.rjk@nirmauni.ac.in; hcbajaj@csmcri.org; scheti@gmail.com;
   yogeshbaravalia@yahoo.in; kothari1971@gmail.com
FU Council of Scientific and Industrial Research (CSIR), Government of
   India, New Delhi, India [CSC-0135]; Senior Research Fellowship
FX Authors are thankful to Council of Scientific and Industrial Research
   (CSIR), Government of India, New Delhi, India, for financial support
   under the project "Speciality Materials based on Engineered Clays"
   (SPEC, CSC-0135) and Senior Research Fellowship to Dr. B.D. Kevadiya.
   Authors are also thankful for help and cooperation rendered by Mr. V.
   Agarwal (FT-IR) and Mrs. Shital Patel (TGA) of the central analytical
   facility of CSMCRI.
CR Abdellaouia K.S., 2000, EUR J PHARM BIOPHARM, V50, P83
   Azami M, 2012, J BIOMAT SCI-POLYM E, V23, P2353, DOI 10.1163/156856211X617713
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Chen TH, 2003, BIOMACROMOLECULES, V4, P1558, DOI 10.1021/bm034145k
   Clarke RH, 1999, J RAMAN SPECTROSC, V30, P827, DOI 10.1002/(SICI)1097-4555(199909)30:9<827::AID-JRS454>3.0.CO;2-S
   Depan D, 2009, ACTA BIOMATER, V5, P93, DOI 10.1016/j.aetbio.2008.08.007
   Dong YC, 2005, BIOMATERIALS, V26, P6068, DOI 10.1016/j.biomaterials.2005.03.021
   Esrafilzadeh D., 2013, J CONTROL RELEASE
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   FRAGA AN, 1985, POLYMER, V26, P113, DOI 10.1016/0032-3861(85)90066-7
   Frydrych M, 2011, J MATER CHEM, V21, P9103, DOI 10.1039/c1jm10788g
   Geiser T., 2004, AM J PHYSIOL-LUNG C, V287, P448
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   Gong P, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/28/285604
   GUIDOIN R, 1987, BIOMATERIALS, V8, P433, DOI 10.1016/0142-9612(87)90079-2
   Guilherme MR, 2010, EUR POLYM J, V46, P1465, DOI 10.1016/j.eurpolymj.2010.04.008
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Hesse D, 2013, J MATER SCI-MATER M, V24, P129, DOI 10.1007/s10856-012-4769-1
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Hui A, 2012, MATERIALS, V5, P85, DOI 10.3390/ma5010085
   Johns P., 1977, SCI TECHNOLOGY GELAT, P138
   Jonas R.A., 1988, J VASC SURG, V7, P414
   Joshi G.V., 2009, INT J PHARMACEUT, V374, P53
   Joshi G.V., 2010, MICROPOR MESOPOR MAT, V132, P526
   Joshi GV, 2012, J POLYM SCI POL CHEM, V50, P423, DOI 10.1002/pola.25046
   Kanellakopoulou K, 1999, ANTIMICROB AGENTS CH, V43, P714, DOI 10.1128/AAC.43.3.714
   Ke TL, 2001, J OCUL PHARMACOL TH, V17, P555, DOI 10.1089/10807680152729248
   Kevadiya BD, 2014, COMPOS SCI TECHNOL, V90, P193, DOI 10.1016/j.compscitech.2013.11.003
   Kevadiya BD, 2013, COLLOID SURFACE B, V112, P400, DOI 10.1016/j.colsurfb.2013.07.008
   Kevadiya BD, 2012, EUR J PHARM SCI, V47, P265, DOI 10.1016/j.ejps.2012.04.009
   Kevadiya BD, 2012, EUR J PHARM BIOPHARM, V81, P91, DOI 10.1016/j.ejpb.2012.01.004
   Kevadiya BD, 2011, APPL CLAY SCI, V52, P364, DOI 10.1016/j.clay.2011.03.017
   Khan A, 2011, ARCH PHARM PRACT, V2, P116
   Lim TC, 2012, BIOMATERIALS, V33, P3446, DOI 10.1016/j.biomaterials.2012.01.037
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Martucci JF, 2010, POLYM-PLAST TECHNOL, V49, P581, DOI 10.1080/03602551003652730
   Mathur V, 2010, ACTA PHARMACEUT, V60, P111, DOI 10.2478/v10007-010-0005-z
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Nanjwade B. K., 2011, INT J PHARM BIOTECHN, V1, P23
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Pisal S, 2004, AAPS PHARMSCITECH, V5
   Rodriguez Luis G, 2005, Methods Mol Biol, V294, P23
   Rose PJ, 1987, ENCY POLYM SCI ENG, V7, P488
   SCHOR AM, 1983, J CELL SCI, V62, P267
   Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001
   Silverstein R.M., 2002, SPECTROMETRIC IDENTI
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Sisson K, 2010, J BIOMED MATER RES A, V94A, P1312, DOI 10.1002/jbm.a.32756
   Sweeney R., 2012, INT WOUND J, V9, P601
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Talan D.A., 2004, INT J ANTIMICROB AG, V23, P54
   Tom RT, 2004, LANGMUIR, V20, P1909, DOI 10.1021/la0358567
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ulubayram K, 2001, BIOMATERIALS, V22, P1345, DOI 10.1016/S0142-9612(00)00287-8
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Yuan Q, 2010, ACTA BIOMATER, V6, P1140, DOI 10.1016/j.actbio.2009.08.027
   Zheng JP, 2007, REACT FUNCT POLYM, V67, P780, DOI 10.1016/j.reactfunctpolym.2006.12.002
NR 59
TC 36
Z9 36
U1 4
U2 102
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2014
VL 122
BP 175
EP 183
DI 10.1016/j.colsurfb.2014.06.051
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AR5GK
UT WOS:000343612900023
PM 25033437
DA 2018-10-20
ER

PT J
AU Dahmen, JL
   Yang, YQ
   Greenlief, CM
   Stacey, G
   Hunt, HK
AF Dahmen, Jeremy L.
   Yang, Yongqiang
   Greenlief, C. Michael
   Stacey, Gary
   Hunt, Heather K.
TI Interfacing Whispering Gallery Mode Optical Microresonator Biosensors
   with the Plant Defense Elicitor Chitin
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Chitin; N-acetylchitooligosaccharides; Pathogen-associated molecular
   patterns; Surface biochemistry; Biosensors
ID N-ACETYLCHITOOLIGOSACCHARIDE ELICITOR; CULTURED RICE CELLS; AFFINITY
   BINDING-SITE; LABEL-FREE; PLASMA-MEMBRANE; MICROSPHERE RESONATORS;
   INNATE IMMUNITY; SMALL MOLECULES; PROTEIN; RECEPTOR
AB The biomaterial class of chitooligosaccharides (chitin), commonly found in insects and fungi, is one of the most abundant on earth. Substantial evidence implicates chitin in mediating a diverse array of plant cellular signaling events, including the induction of plant defense mechanisms against invading pests. However, these recognition and mediation mechanisms, including the binding kinetics between chitin and their plant recognition receptors, are not fully understood. Therefore, the creation of a platform capable of both interfacing with chitin and plant cell receptors, and monitoring their interactions, would significantly advance our understanding of this plant defense elicitor. Recently, a label-free, highly sensitive biosensor platform, based on Whispering Gallery Mode optical microresonators, has been developed to study such biomolecular interactions. Here, we demonstrate how this unique platform can be interfaced with chitin using simple carbohydrate chemistry. The surface chemistry is demonstrated using X-ray photoelectron spectroscopy, fluorescence microscopy, optical profilometry, ellipsometry, and contact angle measurements. The resulting surface is uniform, with an average surface roughness of 1.25 nm, and is active toward chitin recognition elements. Optical loss measurements using standard quantitative cavity analysis techniques demonstrate that the bioconjugated platforms maintain the high performance (Q>10(6)) required to track binding interactions in this system. The platform is able to detect lectin, which binds COs, at 10 mu g/mL concentration. This biosensor platform's unique capabilities for label-free, high sensitivity biodetection, when properly interfaced with the biomaterials of interest, could provide the basis for a robust analytical technique to probe the binding dynamics of chitin plant cell receptors. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Dahmen, Jeremy L.; Stacey, Gary] Univ Missouri, Div Plant Sci, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.
   [Dahmen, Jeremy L.; Stacey, Gary] Univ Missouri, Div Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.
   [Yang, Yongqiang; Hunt, Heather K.] Univ Missouri, Dept Bioengn, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.
   [Greenlief, C. Michael] Univ Missouri, Dept Chem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA.
RP Hunt, HK (reprint author), Univ Missouri, Dept Bioengn, Christopher S Bond Life Sci Ctr, 240G,1201 East Rollins St, Columbia, MO 65211 USA.
EM hunthk@missouri.edu
FU Division of Chemical Sciences, Geosciences, and Biosciences, Office of
   Basic Energy Sciences of the U.S. Department of Energy
   [DE-FG02-08ER15309]
FX The authors acknowledge Charissa A. Nowak for the help with
   ellipsometry, contact angle and profilometry measurements, Mark E.
   Anderson for the drawing of the schematic of experimental setup for
   testing microspheres' Q factor, and Benjamin S. Goldschmidt for creating
   the custom LabView sensing program. The authors also thank the MU
   International Center for Micro/Nano Systems & Nanotechnology for use of
   their equipment and expertise. This work was supported by the Division
   of Chemical Sciences, Geosciences, and Biosciences, Office of Basic
   Energy Sciences of the U.S. Department of Energy through Grant
   DE-FG02-08ER15309 to GS.
CR Acres R.G., 2012, J PHYS CHEM C
   Aissaoui N, 2012, LANGMUIR, V28, P656, DOI 10.1021/la2036778
   Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Arkles B., 2008, SILICON COMPOUNDS SI
   Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002
   Awsiuk K, 2013, COLLOID SURFACE B, V103, P253, DOI 10.1016/j.colsurfb.2012.10.047
   Awsiuk K, 2012, COLLOID SURFACE B, V90, P159, DOI 10.1016/j.colsurfb.2011.10.017
   Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647
   Borrebaeck CAK, 2000, IMMUNOL TODAY, V21, P379, DOI 10.1016/S0167-5699(00)01683-2
   BRZOSKA JB, 1994, LANGMUIR, V10, P4367, DOI 10.1021/la00023a072
   Chen H.M., 2009, APPL PHYS LETT, V94
   Dahmen J.L., 2013, REV ANAL CHEM, P1
   Day RB, 2001, PLANT PHYSIOL, V126, P1162, DOI 10.1104/pp.126.3.1162
   Dumais P, 2005, IEEE PHOTONIC TECH L, V17, P441, DOI 10.1109/LPT.2004.839430
   Erickson D, 2008, MICROFLUID NANOFLUID, V4, P33, DOI 10.1007/s10404-007-0198-8
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x
   Gorodetsky ML, 1996, OPT LETT, V21, P453, DOI 10.1364/OL.21.000453
   HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555
   Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9
   Hanumegowda NM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132076
   Hanumegowda NM, 2005, SENS LETT, V3, P315, DOI 10.1166/sl.2005.044
   Hierrezuelo J, 2014, COLLOID SURFACE B, V113, P176, DOI 10.1016/j.colsurfb.2013.09.007
   Hock B, 1997, ANAL CHIM ACTA, V347, P177, DOI 10.1016/S0003-2670(97)00167-0
   Hock B, 2002, BIOSENS BIOELECTRON, V17, P239, DOI 10.1016/S0956-5663(01)00267-6
   Horvath R, 2003, OPT LETT, V28, P1233, DOI 10.1364/OL.28.001233
   Hunt HK, 2011, OPT LETT, V36, P1092, DOI 10.1364/OL.36.001092
   Hunt HK, 2010, SENSORS-BASEL, V10, P9317, DOI 10.3390/s101009317
   Hunt HK, 2010, NANOSCALE, V2, P1544, DOI 10.1039/c0nr00201a
   Ilchenko VS, 2006, IEEE J SEL TOP QUANT, V12, P15, DOI 10.1109/JSTQE.2005.862943
   Ito Y, 1997, PLANT J, V12, P347, DOI 10.1046/j.1365-313X.1997.12020347.x
   Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286
   Kittle JD, 2012, BIOMACROMOLECULES, V13, P714, DOI 10.1021/bm201631r
   Knight JC, 1997, OPT LETT, V22, P1129, DOI 10.1364/OL.22.001129
   Kumbhat S, 2007, BIOSENS BIOELECTRON, V23, P421, DOI 10.1016/j.bios.2007.05.004
   Lenardon MD, 2010, CURR OPIN MICROBIOL, V13, P416, DOI 10.1016/j.mib.2010.05.002
   Li H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462296
   Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867
   Loos K, 1997, MACROMOL RAPID COMM, V18, P927, DOI 10.1002/marc.1997.030181006
   Matsko A. B., 2005, INTERPLANETARY NETWO, P42
   Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104
   Nagel T, 2008, SENSOR ACTUAT B-CHEM, V129, P934, DOI 10.1016/j.snb.2007.10.009
   Naveas N, 2014, COLLOID SURFACE B, V115, P310, DOI 10.1016/j.colsurfb.2013.11.026
   Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x
   Okada M, 2002, PLANT CELL PHYSIOL, V43, P505, DOI 10.1093/pcp/pcf060
   Rossman A, 2009, BIOL INVASIONS, V11, P97, DOI 10.1007/s10530-008-9322-2
   Semino CE, 1996, P NATL ACAD SCI USA, V93, P4548, DOI 10.1073/pnas.93.10.4548
   Shankaran DR, 2007, SENSOR ACTUAT B-CHEM, V121, P158, DOI 10.1016/j.snb.2006.09.014
   SHIBUYA N, 1993, FEBS LETT, V329, P75, DOI 10.1016/0014-5793(93)80197-3
   Shibuya N, 1996, PLANT CELL PHYSIOL, V37, P894, DOI 10.1093/oxfordjournals.pcp.a029030
   Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364
   Shimizu T, 2010, PLANT J, V64, P204, DOI 10.1111/j.1365-313X.2010.04324.x
   Soteropulos CE, 2012, LANGMUIR, V28, P15743, DOI 10.1021/la302041d
   Soteropulos CE, 2012, JOVE-J VIS EXP, DOI 10.3791/3866
   Soteropulos CE, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634023
   Stacey G, 1997, PLANT SOIL, V194, P161, DOI 10.1023/A:1004244104972
   Sundberg F, 2007, IMMUNOLOGY, V120, P46
   Szekacs A, 2009, APPL OPTICS, V48, pB151, DOI 10.1364/AO.48.00B151
   Tah T, 2012, COLLOID SURFACE B, V93, P195, DOI 10.1016/j.colsurfb.2012.01.004
   Tetz KA, 2006, OPT LETT, V31, P1528, DOI 10.1364/OL.31.001528
   Thakurta SG, 2012, COLLOID SURFACE A, V414, P384, DOI 10.1016/j.colsurfa.2012.08.049
   Uzun SD, 2013, COLLOID SURFACE B, V112, P74, DOI 10.1016/j.colsurfb.2013.07.049
   Vahala KJ, 2003, NATURE, V424, P839, DOI 10.1038/nature01939
   Vollmer F, 2008, P NATL ACAD SCI USA, V105, P20701, DOI 10.1073/pnas.0808988106
   Vollmer F, 2002, APPL PHYS LETT, V80, P4057, DOI 10.1063/1.1482797
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
   Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754
   White IM, 2007, IEEE SENS J, V7, P28, DOI 10.1109/JSEN.2006.887927
   White IM, 2005, OPT LETT, V30, P3189, DOI 10.1364/OL.30.003189
   Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963
   Zhang XC, 2007, PLANT PHYSIOL, V144, P623, DOI 10.1104/pp.107.097097
   Zhu JG, 2010, NAT PHOTONICS, V4, P122, DOI 10.1038/nphoton.2009.289
   Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003
NR 73
TC 6
Z9 7
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2014
VL 122
BP 241
EP 249
DI 10.1016/j.colsurfb.2014.06.067
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AR5GK
UT WOS:000343612900031
PM 25051306
DA 2018-10-20
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Biofunctionalization of gelatin microcarrier with oxidized hyaluronic
   acid for corneal keratocyte cultivation
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Biopolymer functionalization; Microcarrier culture system; Gelatin;
   Oxidized hyaluronic acid; Corneal keratocyte
ID MESENCHYMAL STEM-CELLS; LINKED AMNIOTIC MEMBRANES; DRUG-DELIVERY SYSTEM;
   CROSS-LINKING; BIODEGRADABLE SCAFFOLDS; REPAIR PHENOTYPES;
   EPITHELIAL-CELLS; HYDROGELS; CULTURE; CARRIERS
AB Development of microcarriers as alternative architecture models to traditional three-dimensional porous scaffolds can potentially eliminate the concern of extensive geographic necrosis during keratocyte cultivation. For the first time, this work was performed to evaluate the in vitro expansion of rabbit corneal keratocytes (RCKs) on the gelatin microcarrier (GMC) modified with hyaluronic acid (HA). In order to confirm the successful synthesis, the oxidized HA (oHA) samples following treatment of HA with sodium periodate were investigated by chemical characterization, including Fourier transform infrared and nuclear magnetic resonance spectroscopy. Biofunctionalization of GMC with oHA was then achieved by the formation of aldimine linkage between free amino groups in protein and aldehyde groups in oxidized polysaccharide. The grafting yield of oHA onto GMC determined by alcian blue staining assay was 26.9 +/- 0.1%. Tissue culture polystyrene (TCPS) plates and the microcarriers from either the GMC or GMC-oHA group were used for suspension culture of RCKs. Results of WST-1 assays, scanning electron microscopy, extracellular matrix production assays, and quantitative real-time reverse transcription polymerase chain reaction and Western blot analysis showed that among all the groups studied, the GMC-oHA samples could most effectively support a large scale growth of RCKs while enhancing their total collagen and glycosaminoglycan contents (i.e., indicative of biosynthetic capacity) and keratocan and ALDH1 gene and protein expressions (i.e., indicative of cell phenotype and function). It is concluded that the aforementioned keratocyte behaviors are found to be strongly dependent on the type of culture substrate (i.e., TCPS plate versus biopolymer microcarrier) and on the biomaterial functionalization (i.e., modification of gelatin with oHA). (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Taoyuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Taoyuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Taoyuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC102-2628-B-182-017-MY3]
FX This work was supported by grant NSC102-2628-B-182-017-MY3 from the
   National Science Council of Republic of China. The author is grateful to
   Meng-Heng Lai (Institute of Biochemical and Biomedical Engineering,
   Chang Gung University) for technical assistance.
CR Adhirajan N, 2007, J MICROENCAPSUL, V24, P659, DOI 10.1080/02652040701500137
   Akmal M, 2005, J BONE JOINT SURG BR, V87B, P1143, DOI 10.1302/0301-620X.87B8
   Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658
   Bouhadir KH, 1999, POLYMER, V40, P3575, DOI 10.1016/S0032-3861(98)00550-3
   Carlson EC, 2005, J BIOL CHEM, V280, P25541, DOI 10.1074/jbc.M500249200
   Cerroni B, 2011, BIOMACROMOLECULES, V12, P593, DOI 10.1021/bm101207k
   Chen YH, 2009, TISSUE ENG PT A, V15, P2001, DOI 10.1089/ten.tea.2008.0251
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Cortesi R, 1999, EUR J PHARM BIOPHARM, V47, P153, DOI 10.1016/S0939-6411(98)00076-9
   Falk T., 2012, J BIOMED BIOTECHNOL, V2012
   Fan HB, 2008, BIOMACROMOLECULES, V9, P927, DOI 10.1021/bm7013203
   Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0
   Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200
   Funderburgh ML, 2008, MOL VIS, V14, P308
   Garagorri N, 2008, ACTA BIOMATER, V4, P1139, DOI 10.1016/j.actbio.2008.05.007
   Greco RM, 1998, J CELL PHYSIOL, V177, P465, DOI 10.1002/(SICI)1097-4652(199812)177:3<465::AID-JCP9>3.0.CO;2-5
   Hahnel C, 1997, GRAEF ARCH CLIN EXP, V235, P773, DOI 10.1007/BF02332862
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Julien M, 1997, BIOMATERIALS, V18, P605, DOI 10.1016/S0142-9612(96)00155-X
   Lai JY, 2007, REACT FUNCT POLYM, V67, P1284, DOI 10.1016/j.reactfunctpolym.2007.07.060
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2013, J BIOMED NANOTECHNOL, V9, P2048, DOI 10.1166/jbn.2013.1734
   Lai JY, 2013, MAT SCI ENG C-MATER, V33, P3704, DOI 10.1016/j.msec.2013.04.059
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2012, MATERIALS, V5, P1986, DOI 10.3390/ma5101986
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2007, TRANSPLANTATION, V84, P1222, DOI 10.1097/01.tp.0000287336.09848.39
   Lai JY, 2005, AM J OPHTHALMOL, V139, P1123, DOI 10.1016/j.ajo.2004.11.052
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lee HS, 2002, J AGR FOOD CHEM, V50, P3988, DOI 10.1021/jf020159q
   Lu PL, 2008, J BIOMED MATER RES A, V86A, P108, DOI 10.1002/jbm.a.31619
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Muthusubramaniam L, 2012, J BIOMED MATER RES A, V100A, P613, DOI 10.1002/jbm.a.33284
   Ning B, 2013, J ORTHOP RES, V31, P858, DOI 10.1002/jor.22306
   Oh EJ, 2008, J BIOMED MATER RES A, V86A, P685, DOI 10.1002/ibm.a.31681
   Pei Y, 2006, EXP EYE RES, V83, P1063, DOI 10.1016/j.exer.2006.05.011
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   Ruhela D, 2006, BIOCONJUGATE CHEM, V17, P1360, DOI 10.1021/bc0600721
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Thompson RE, 2013, TISSUE ENG PT A, V19, P1564, DOI [10.1089/ten.tea.2012.0084, 10.1089/ten.TEA.2012.0084]
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0
   Vrana NE, 2007, J BIOMAT SCI-POLYM E, V18, P1527
   Wang CM, 2008, ACTA BIOMATER, V4, P1226, DOI 10.1016/j.actbio.2008.03.008
   West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405
   Zhou YL, 2011, TISSUE ENG PT A, V17, P2981, DOI 10.1089/ten.tea.2010.0707
NR 64
TC 13
Z9 14
U1 3
U2 26
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2014
VL 122
BP 277
EP 286
DI 10.1016/j.colsurfb.2014.07.009
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AR5GK
UT WOS:000343612900035
PM 25064477
DA 2018-10-20
ER

PT J
AU Cifuentes, SC
   Frutos, E
   Benavente, R
   Gonzalez-Carrasco, JL
   Lorenzo, V
AF Cifuentes, S. C.
   Frutos, E.
   Benavente, R.
   Gonzalez-Carrasco, J. L.
   Lorenzo, V.
TI Strain rate effect on semi-crystalline PLLA mechanical properties
   measured by instrumented indentation tests
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Polylactic acid; Time-dependent properties; Strain rate; Crystallinity;
   Mechanical properties
ID DEPTH-SENSING INDENTATION; POLY(LACTIC ACID); BIODEGRADABLE POLYMERS;
   POLY(L-LACTIC ACID); VISCOELASTIC SOLIDS; NANOINDENTATION; MODULUS;
   PLASTICIZATION; CRYSTALLINITY; COMPOSITES
AB Poly-L-lactic acid, PLLA, is a widely studied biomaterial, currently approved for use in a range of medical devices. Its mechanical properties can be tailored giving the material different crystallinity degrees. PLLA presents a complex non-linear behaviour that depends not only on structural parameters such as crystallinity degree but also on external parameters such as strain rate and temperature. Failure of polymeric implants is attributed to their intrinsic time-dependent performance under static loading conditions. This work explores the potential of instrumented indentation tests as a suitable technique to measure the complex non-linear time-dependent mechanical properties of PLLA. The applicability of the Oliver-Pharr method, typically used in ceramic and metallic materials, is discussed through the sensitivity of elastic modulus, hardness and material creep response to different strain rates. Likewise, the strain rate influence depending on the crystallinity degree is considered, providing important information about viscoelastic behaviour of PLLA. Whereas possible, results are compared with those obtained from tensile and Dynamic Mechanical Analysis tests extracted from the literature. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Cifuentes, S. C.; Frutos, E.; Gonzalez-Carrasco, J. L.] CENIM CSIC, Ctr Nacl Invest Met, Madrid 28040, Spain.
   [Cifuentes, S. C.; Benavente, R.] ICTP CSIC, Inst Ciencia & Tecnol Polimeros, Madrid 28006, Spain.
   [Frutos, E.] Czech Tech Univ, Fac Elect Engn, Dept Control Engn, CR-16635 Prague 6, Czech Republic.
   [Lorenzo, V.] Univ Politecn Madrid, UA ICTP CSIC, Grp Invest Polimeros Caracterizac & Aplicac, E-28006 Madrid, Spain.
   [Gonzalez-Carrasco, J. L.] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Zaragoza, Spain.
RP Lorenzo, V (reprint author), Univ Politecn Madrid, UA ICTP CSIC, Grp Invest Polimeros Caracterizac & Aplicac, Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.
EM vlorenzo@etsii.upm.es
RI Benavente, Rosario/F-5034-2016
OI Benavente, Rosario/0000-0003-0416-0151; Frutos Torres,
   Emilio/0000-0001-5661-1554; CIFUENTES CUELLAR, SANDRA
   CAROLINA/0000-0001-9779-369X; LORENZO ESTEBAN,
   VICENTE/0000-0002-2883-3990
FU Spanish Projects [MAT2012-37736-C05-01, MAT2010-19883]; Spanish National
   Research Council - CSIC; European Social Fund (Fondo Social Europeo);
   Ministerio de Economia y Competitividad - Instituto de Salud Carlos III
FX The authors wish to express special thanks for the financial support of
   the Spanish Projects MAT2012-37736-C05-01 and MAT2010-19883, Spanish
   National Research Council - CSIC and European Social Fund (Fondo Social
   Europeo) for JAE-I3P Grant. CIBER-BBN is supported by the Ministerio de
   Economia y Competitividad - Instituto de Salud Carlos III
CR Alexander L. E., 1969, XRAY DIFFRACTION MET
   Bigg DM, 1996, SOC PLAST E, V42, P2028
   Briscoe BJ, 1998, J PHYS D APPL PHYS, V31, P2395, DOI 10.1088/0022-3727/31/19/006
   Busam ML, 2006, J AM ACAD ORTHOP SUR, V14, P113, DOI 10.5435/00124635-200602000-00006
   Cheng YT, 2005, J MATER RES, V20, P3061, DOI 10.1557/JMR.2005.0389
   Cheng YT, 2005, J MATER RES, V20, P1046, DOI 10.1557/JMR.2005.0141
   Dobreva T, 2010, J APPL POLYM SCI, V116, P1088, DOI 10.1002/app.31584
   Eglin D, 2008, EUR CELLS MATER, V16, P80, DOI 10.22203/eCM.v016a09
   Feng G, 2002, J MATER RES, V17, P660, DOI 10.1557/JMR.2002.0094
   Fischer-Cripps AC, 2004, MAT SCI ENG A-STRUCT, V385, P74, DOI 10.1016/j.msea.2004.04.070
   FischerCripps AC, 2011, MECH ENG SER, P1, DOI 10.1007/978-1-4419-9872-9
   Ghosh S, 2007, POLYM ENG SCI, V47, P1141, DOI 10.1002/pen.20799
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Giro-Paloma J, 2013, EUR POLYM J, V49, P4047, DOI 10.1016/j.eurpolymj.2013.09.010
   Grau P, 1998, MATER RES SOC SYMP P, V522, P153, DOI 10.1557/PROC-522-153
   Kroeze RJ, 2009, MATERIALS, V2, P833, DOI 10.3390/ma2030833
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   Ngan AHW, 2002, J MATER RES, V17, P2604, DOI 10.1557/JMR.2002.0377
   Oliveira GL, 2014, POLYM TEST, V34, P10, DOI 10.1016/j.polymertesting.2013.12.006
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Perego G, 1996, J APPL POLYM SCI, V59, P37, DOI 10.1002/(SICI)1097-4628(19960103)59:1<37::AID-APP6>3.3.CO;2-7
   Rico A, MECH TIME D IN PRESS
   Smit TH, 2010, J MATER SCI-MATER M, V21, P871, DOI 10.1007/s10856-009-3921-z
   Smit TH, 2008, SPINE, V33, P14, DOI 10.1097/BRS.0b013e31815e39df
   Tang B, 2003, J MATER RES, V18, P1141, DOI 10.1557/JMR.2003.0156
   Tang XG, 2011, J APPL POLYM SCI, V122, P885, DOI 10.1002/app.34032
   Turnbull A, 1996, J MATER SCI, V31, P4189, DOI 10.1007/BF00356438
   VanLandingham MR, 2003, J RES NATL INST STAN, V108, P249, DOI 10.6028/jres.108.024
   Wilberforce SIJ, 2011, ACTA BIOMATER, V7, P2176, DOI 10.1016/j.actbio.2011.02.006
   Zamfirova G, 2003, J APPL POLYM SCI, V88, P1794, DOI 10.1002/app.11788
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
   Zuideveld M, 2006, POLYMER, V47, P3740, DOI 10.1016/j.polymer.2006.03.034
NR 34
TC 6
Z9 6
U1 2
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD OCT
PY 2014
VL 59
BP 239
EP 246
DI 10.1016/j.eurpolymj.2014.07.034
PG 8
WC Polymer Science
SC Polymer Science
GA AR1JI
UT WOS:000343341100027
DA 2018-10-20
ER

PT J
AU Thepsonthi, T
   Ozel, T
AF Thepsonthi, Thanongsak
   Ozel, Tugrul
TI An integrated toolpath and process parameter optimization for
   high-performance micro-milling process of Ti-6Al-4V titanium alloy
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE Micro-end milling; FE simulations; Process optimization; Titanium alloys
ID PARTICLE SWARM OPTIMIZATION; FINITE-ELEMENT SIMULATIONS; SERRATED CHIP
   FORMATION; MODEL-BASED ANALYSIS; SURFACE GENERATION; MULTIOBJECTIVE
   OPTIMIZATION; MICROMILLING STRATEGIES; EXPERIMENTAL VALIDATION;
   PREDICTION; WEAR
AB Titanium alloys such as Ti-6Al-4V offer biocompatibility, corrosion resistance, and superb mechanical properties and are considered the most important metallic biomaterial for medical applications. However, mechanical machining of titanium alloys is still highly difficult and even more challenging for micro-scale machining such as micro-milling. Severe burr formation and rapid tool wear create significant problems such as poor surface roughness. In order to improve the performance of micro-milling Ti-6Al-4Valloy, this study proposes an integrated method in selecting the toolpath and optimum process parameters which can meet micro-machining requirements and constraints. Controlled micro-end-milling experiments for measuring burr formation and surface roughness, finite element simulations for predicting forces and tool wear, and mathematical modeling and optimization techniques have been utilized for determining optimum toolpath strategy and process parameters. Based on the micro-end-milling tests on a circular thin rib feature, process optimization results are validated and indicate a significant improvement in process performances in terms of minimizing burr formation, maximizing tool life, and surface quality.
C1 [Thepsonthi, Thanongsak; Ozel, Tugrul] Rutgers State Univ, Mfg & Automat Res Lab, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA.
RP Ozel, T (reprint author), Rutgers State Univ, Mfg & Automat Res Lab, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA.
EM ozel@rci.rutgers.edu
RI Ozel, Tugrul/C-8979-2009
OI Ozel, Tugrul/0000-0001-8198-490X
CR Afazov SM, 2010, J MATER PROCESS TECH, V210, P2154, DOI 10.1016/j.jmatprotec.2010.07.033
   Alvarez-Benitez JE, 2005, LECT NOTES COMPUT SC, V3410, P459
   Armarego E, 1961, INT J PROD RES, V1, P75
   Attanasio A, 2008, CIRP ANN-MANUF TECHN, V57, P61, DOI 10.1016/j.cirp.2008.03.123
   Aurich JC, 2009, CIRP ANN-MANUF TECHN, V58, P519, DOI 10.1016/j.cirp.2009.09.004
   Bayesteh A., 2013, P NAMRI SME, V41
   Calamaz M, 2008, INT J MACH TOOL MANU, V48, P275, DOI 10.1016/j.ijmachtools.2007.10.014
   Cardoso P, 2010, MATER MANUF PROCESS, V25, P1115, DOI 10.1080/10426914.2010.481002
   Chen MJ, 2012, INT J ADV MANUF TECH, V62, P901, DOI 10.1007/s00170-011-3865-6
   Ciurana J, 2009, MATER MANUF PROCESS, V24, P358, DOI 10.1080/10426910802679568
   Dimov S, 2004, P I MECH ENG B-J ENG, V218, P731, DOI 10.1177/095440540421800706
   Jin XL, 2012, J MATER PROCESS TECH, V212, P542, DOI 10.1016/j.jmatprotec.2011.05.020
   Karpat Y, 2007, INT J ADV MANUF TECH, V35, P234, DOI 10.1007/s00170-006-0719-8
   Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968
   Kuram E, 2013, MEASUREMENT, V46, P1849, DOI 10.1016/j.measurement.2013.02.002
   Liu XY, 2007, J MANUF SCI E-T ASME, V129, P461, DOI 10.1115/1.2716706
   Liu XY, 2007, J MANUF SCI E-T ASME, V129, P453, DOI 10.1115/1.2716705
   Mayor R, 2008, ASME J MANUF SCI ENG, V130
   Navalertporn T, 2011, SWARM EVOL COMPUT, V1, P97, DOI 10.1016/j.swevo.2011.05.003
   Ozel T, 2011, CIRP ANN-MANUF TECHN, V60, P85, DOI 10.1016/j.cirp.2011.03.087
   Ozel T, 2010, CIRP ANN-MANUF TECHN, V59, P77, DOI 10.1016/j.cirp.2010.03.055
   Ozel T, 2009, MATER MANUF PROCESS, V24, P1274, DOI 10.1080/10426910903130008
   Periyanan P. R., 2013, International Journal of Productivity and Quality Management, V12, P410, DOI 10.1504/IJPQM.2013.056735
   Popov K, 2006, P I MECH ENG C-J MEC, V220, P1677, DOI 10.1243/09544062JMES192
   Schueler GM, 2010, BURRS - ANALYSIS, CONTROL AND REMOVAL, P129, DOI 10.1007/978-3-642-00568-8_14
   Shelton JA, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/7/075012
   Sima M, 2010, INT J MACH TOOL MANU, V50, P943, DOI 10.1016/j.ijmachtools.2010.08.004
   Sivakumar K, 2011, COMPUT AIDED DESIGN, V43, P207, DOI 10.1016/j.cad.2010.10.001
   Sreeram S, 2006, INT J ADV MANUF TECH, V30, P1030, DOI 10.1007/s00170-005-0148-0
   Thepsonthi T, 2013, J MATER PROCESS TECH, V213, P532, DOI 10.1016/j.jmatprotec.2012.11.003
   Thepsonthi T, 2012, INT J ADV MANUF TECH, V63, P903, DOI 10.1007/s00170-012-3980-z
   USUI E, 1978, J ENG IND-T ASME, V100, P236, DOI 10.1115/1.3439415
   Vazquez E, 2011, MATER MANUF PROCESS, V26, P403, DOI 10.1080/10426914.2010.520792
   Vogler MP, 2004, J MANUF SCI E-T ASME, V126, P685, DOI 10.1115/1.1813470
   Vogler MP, 2003, J MANUF SCI E-T ASME, V125, P202, DOI 10.1115/1.1556402
NR 35
TC 12
Z9 12
U1 2
U2 52
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-3768
EI 1433-3015
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD OCT
PY 2014
VL 75
IS 1-4
BP 57
EP 75
DI 10.1007/s00170-014-6102-2
PG 19
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA AR6WU
UT WOS:000343722400006
DA 2018-10-20
ER

PT J
AU Chimate, C
   Koc, B
AF Chimate, Chetan
   Koc, Bahattin
TI Pressure assisted multi-syringe single nozzle deposition system for
   manufacturing of heterogeneous tissue scaffolds
SO INTERNATIONAL JOURNAL OF ADVANCED MANUFACTURING TECHNOLOGY
LA English
DT Article
DE Heterogeneous scaffold; Tissue engineering; Multi-syringe single nozzle
   deposition
ID FABRICATION; BONE; HYDROGELS; DESIGN; MATRICES; GROWTH
AB This research focuses on the development of a layered-based novel fabrication methodology for three-dimensional tissue scaffolds with heterogeneous structure of varying concentrations of drug molecules and/or multiple biomaterials. A pressure assisted multi-syringe single nozzle deposition (MSSND) system has been developed for the scaffold fabrication. A custom-designed nozzle has been developed to combine the flows from two or more syringes into a mixing chamber. The presented work also details the fluid model for pressure requirements and material volume flow for a biomaterial. Sodium alginic acid is selected as scaffold biomaterial and cross-linked with calcium chloride solution for gelation. The system designed is able to fabricate three-dimensional (3D) structures from hydrogels with varying concentration of drug microspheres depending on the design requirements. Sample scaffolds are successfully fabricated with different nozzles of diameter 100, 150, and 200 mu m with varying porosities. In this research, 3D heterogeneous scaffolds are developed that are capable of releasing proteins and growth factors spatially and temporally in addition to their function as supporting structures.
C1 [Chimate, Chetan] Penn State Univ, State Coll, PA USA.
   [Koc, Bahattin] Sabanci Univ, TR-34956 Istanbul, Turkey.
RP Koc, B (reprint author), Sabanci Univ, FENS G013, TR-34956 Istanbul, Turkey.
EM bahattinkoc@sabanciuniv.edu
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Choi JW, 2010, INT J ADV MANUF TECH, V49, P543, DOI 10.1007/s00170-009-2434-8
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kale S, 2009, FEATURE BASED BIOMIM
   Khalil S, 2007, MAT SCI ENG C-BIO S, V27, P469, DOI 10.1016/j.msec.2006.05.023
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Koegler WS, 2004, BIOMATERIALS, V25, P2819, DOI 10.1016/j.biomaterials.2003.09.064
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leal L.G, 2007, ADV TRANSPORT PHENOM
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Masood SH, 2005, INT J ADV MANUF TECH, V27, P415, DOI 10.1007/s00170-004-2187-3
   Merriman M, 1916, TREATISE HYDRAULICS
   Nishiyama Y, 2009, J BIOMECH ENG, V131, DOI DOI 10.1115/1.3002759
   Ozbolat IT, 2010, J MED DEVICES, V4, DOI 10.1115/1.4002612
   Park SA, 2011, BIOPROC BIOSYST ENG, V34, P505, DOI 10.1007/s00449-010-0499-2
   PETER XM, 2004, MATER TODAY, V7, P30
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   ROUT PGJ, 1988, BIOCERAMICS CLIN APP, P591
   Salmoria GV, 2013, INT J ADV MANUF TECH, V65, P1529, DOI 10.1007/s00170-012-4277-y
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Vlasea M, 2013, INT J ADV MANUF TECH, V68, P2261, DOI 10.1007/s00170-013-4839-7
   Vossi G, 2003, TISSUE ENG, V8, P1089
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Weiss LE, 2005, COMPUT AIDED DESIGN, V37, P1127, DOI 10.1016/j.cad.2005.02.004
   White F. M., 1991, VISCOUS FLUID FLOW
   Xiong Z, 2001, SCRIPTA MATER, V45, P773, DOI 10.1016/S1359-6462(01)01094-6
NR 32
TC 5
Z9 6
U1 0
U2 8
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-3768
EI 1433-3015
J9 INT J ADV MANUF TECH
JI Int. J. Adv. Manuf. Technol.
PD OCT
PY 2014
VL 75
IS 1-4
BP 317
EP 330
DI 10.1007/s00170-014-6110-2
PG 14
WC Automation & Control Systems; Engineering, Manufacturing
SC Automation & Control Systems; Engineering
GA AR6WU
UT WOS:000343722400026
DA 2018-10-20
ER

PT J
AU Ghosh, A
   Clerens, S
   Deb-Choudhury, S
   Dyer, JM
AF Ghosh, Arun
   Clerens, Stefan
   Deb-Choudhury, Santanu
   Dyer, Jolon M.
TI Thermal effects of ionic liquid dissolution on the structures and
   properties of regenerated wool keratin
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Wool; Keratin; Ionic liquid; Bioresin; Mechanical performance
ID FEATHER KERATIN; FIBER SURFACE; SILK FIBROIN; PROTEINS; FILMS;
   SPECTROSCOPY; DEGRADATION; EXPLOSION; CELLULOSE; POLYMERS
AB Keratins derived from wool and feathers are a source of raw materials for biomaterial use. Such biomaterials are essentially biodegradable polyamides, and offer many favourable features such as biocompatibility in contrast with petro-derived synthetic materials. In the present study, raw wool samples were dissolved in hot ionic liquid (1-butyl-3-methylimidazolium chloride) at temperatures ranging from 120 to 180 degrees C, resulting in regenerated keratins after coagulation with water. The physicochemical characteristics of the regenerated keratins were evaluated with respect to their protein profile, thermal stability, mechanical performance and SEM morphology, and contrasted with those of raw wool. Cysteine content reduced significantly on increasing temperature of ionic liquid and some disordering of protein secondary structures occurred in regenerated keratins. Keratin regenerated from a solution prepared with ionic liquid at 180 degrees C showed improved thermal processing properties, and it revealed dense fibrous network morphology of the film's cross-sectional surface produced under compression moulding. This in-depth study on regenerated keratins demonstrates a potential new route for the conversion of keratinous materials into bio-resin for industrial applications. However, further development is required to create keratinous materials that are melt-processable like classical synthetic polymers. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ghosh, Arun; Clerens, Stefan; Deb-Choudhury, Santanu; Dyer, Jolon M.] AgResearch, Food & Biobased Prod Grp, Christchurch 8140, New Zealand.
RP Ghosh, A (reprint author), AgResearch, Food & Biobased Prod Grp, Cnr Springs Rd & Gerald St, Christchurch 8140, New Zealand.
EM Arun.Ghosh@agresearch.co.nz
RI Clerens, Stefan/L-5755-2013
OI Clerens, Stefan/0000-0003-4703-6353; Dyer, Jolon/0000-0002-7220-6062
FU New Zealand Ministry of Business, Innovation and Employment [C10X0824];
   AgResearch Core Funding [A19117]
FX The funding for this research was supported by the New Zealand Ministry
   of Business, Innovation and Employment (C10X0824) and AgResearch Core
   Funding (A19117). The authors express their sincere gratitude to Guojie
   Wu and Scott Knowles for critically reviewing the manuscript.
CR Aluigi A, 2007, INT J BIOL MACROMOL, V41, P266, DOI 10.1016/j.ijbiomac.2007.03.002
   Barone JR, 2005, J APPL POLYM SCI, V97, P1644, DOI 10.1002/app.21901
   Barone JR, 2007, POLYM DEGRAD STABIL, V92, P859, DOI 10.1016/j.polymdegradstab.2007.01.030
   Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004
   Bertini F, 2013, POLYM DEGRAD STABIL, V98, P980, DOI 10.1016/j.polymdegradstab.2013.02.011
   Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844
   Cao JN, 1997, TEXT RES J, V67, P117, DOI 10.1177/004051759706700207
   Chen P, 2005, MACROMOL BIOSCI, V5, P237, DOI 10.1002/mabi.200400179
   Considine T, 2007, INNOV FOOD SCI EMERG, V8, P1, DOI 10.1016/j.ifset.2006.08.003
   Dyer JM, 2013, HDB FUNCTIONAL NANOM, V4
   Feng L, 2008, J MOL LIQ, V142, P1, DOI 10.1016/j.molliq.2008.06.007
   Ghosh A, 2010, INT J BIOL MACROMOL, V46, P404, DOI 10.1016/j.ijbiomac.2010.02.011
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Huson M, 2008, J STRUCT BIOL, V163, P127, DOI 10.1016/j.jsb.2008.04.011
   Idris A, 2014, GREEN CHEM, V16, P2857, DOI 10.1039/c4gc00213j
   Idris A, 2013, GREEN CHEM, V15, P525, DOI 10.1039/c2gc36556a
   Kubisa P, 2005, J POLYM SCI POL CHEM, V43, P4675, DOI 10.1002/pola.20971
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li QM, 2012, J MATER CHEM, V22, P19964, DOI 10.1039/c2jm34136k
   Li R, 2013, J APPL POLYM SCI, V127, P2648, DOI 10.1002/app.37527
   MACLAREN J, 1981, WOOL SCI CHEM REACTI
   Maclaren JA, 1981, STRUCTURE COMPOSITIO, P1
   Martelli SM, 2012, INT J POLYM MATER, V61, P17, DOI 10.1080/00914037.2011.557809
   McKittrick J, 2012, JOM-US, V64, P449, DOI 10.1007/s11837-012-0302-8
   Meade SJ, 2008, TEXT RES J, V78, P943, DOI 10.1177/0040517507087859
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947
   Ringe D, 2003, BIOPHYS CHEM, V105, P667, DOI 10.1016/S0301-4622(03)00096-6
   Senoz E, 2012, POLYM DEGRAD STABIL, V97, P297, DOI 10.1016/j.polymdegradstab.2011.12.018
   Sun P, 2009, J HAZARD MATER, V170, P786, DOI 10.1016/j.jhazmat.2009.05.034
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Tonin C, 2004, J THERM ANAL CALORIM, V77, P987, DOI 10.1023/B:JTAN.0000041674.04961.b4
   Tonin C, 2006, BIOMACROMOLECULES, V7, P3499, DOI 10.1021/bm060597w
   Ullah A, 2013, MACROMOL MATER ENG, V298, P153, DOI 10.1002/mame.201200010
   Ullah A, 2011, BIOMACROMOLECULES, V12, P3826, DOI 10.1021/bm201112n
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Winterton N, 2006, J MATER CHEM, V16, P4281, DOI 10.1039/b610143g
   Wojciechowska E, 1999, J MOL STRUCT, V511, P307, DOI 10.1016/S0022-2860(99)00173-8
   Wortmann FJ, 1998, J APPL POLYM SCI, V68, P1991
   Xie HB, 2005, GREEN CHEM, V7, P606, DOI 10.1039/b502547h
   Zahn H., 2000, ULLMANNS ENCY IND CH
   Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676
   Zhao W, 2012, GREEN CHEM, V14, P3352, DOI 10.1039/c2gc36243k
   Zoccola M, 2009, J MOL STRUCT, V938, P35, DOI 10.1016/j.molstruc.2009.08.036
NR 44
TC 14
Z9 14
U1 2
U2 88
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD OCT
PY 2014
VL 108
SI SI
BP 108
EP 115
DI 10.1016/j.polymdegradstab.2014.06.007
PG 8
WC Polymer Science
SC Polymer Science
GA AR1YP
UT WOS:000343380800012
DA 2018-10-20
ER

PT J
AU Jeevithan, E
   Wu, WH
   Wang, NP
   Lan, H
   Bao, B
AF Jeevithan, Elango
   Wu, Wenhui
   Wang Nanping
   Lan, He
   Bao, Bin
TI Isolation, purification and characterization of pepsin soluble collagen
   isolated from silvertip shark (Carcharhinus albimarginatus) skeletal and
   head bone
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Shark bone; Pepsin soluble collagen; Denaturation temperature; Amino
   acid composition; Microstructure
ID CHICK STERNAL CARTILAGE; II COLLAGEN; INDUCED ARTHRITIS;
   BIOCHEMICAL-PROPERTIES; FUNCTIONAL-PROPERTIES; THERMAL-STABILITY; SKIN
   COLLAGEN; RED SNAPPER; ACID; GELATIN
AB Type II pepsin soluble collagens (PSC) were isolated from skeletal and head bone of silvertip shark; and examined for their biochemical and structural properties. Among the raw materials, the protein content (8.99%) was high in skeletal bone and the ash content (28%) was high in head bone. After the collagen extraction, the raw materials contained higher amount of ash content ranging from 82 to 88%. The hydroxyproline content of skeletal and skeletal PSC (30 and 113 mg/g) was higher than those head and head PSC. Both collagens were composed of two different alpha-chains (alpha(1)- and alpha(2)-chains) and were characterized as type II collagen. Amino acid analysis of skeletal and head PSC indicated imino acid contents of 156 and 175 amino acid residues per 1000 residues, respectively. Similar, Fourier transform infrared spectra of SCII and HCII were observed, which suggested that the isolation process did not affect the secondary structure and molecular order of collagen, particularly the triple-helical structure. Denaturation temperature of skeletal PSC (31 degrees C) was higher than that of head PSC. SEM microstructure of the collagens depicted a porous, fibrillary and multi-layered structure. These results suggested that the PSC isolated from skeletal and head bone of silvertip shark were found to be suitable biomaterial in commercial applications as alternatives to mammalian collagen. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Jeevithan, Elango; Wu, Wenhui; Bao, Bin] Shanghai Ocean Univ, Dept Marine Pharmacol, Coll Food Sci & Technol, Shanghai 201306, Peoples R China.
   [Wang Nanping; Lan, He] Shanghai Fisheries Res Inst, Shanghai 200433, Peoples R China.
RP Wu, WH (reprint author), Shanghai Ocean Univ, Dept Marine Pharmacol, Coll Food Sci & Technol, Shanghai 201306, Peoples R China.
EM whwu@shou.edu.cn; bbao@shou.edu.cn
OI Wu, Wen Hui/0000-0002-1710-8582; Elango, Jeevithan/0000-0003-4115-9918
FU National High Technology Research and Development Program of China
   [2011AA09070109]; National Natural Science Foundation of China
   [81341082]
FX This work received financial support from the National High Technology
   Research and Development Program of China (No. 2011AA09070109) and the
   National Natural Science Foundation of China (No. 81341082).
CR ABE Y, 1972, BIOPOLYMERS, V11, P1817, DOI 10.1002/bip.1972.360110905
   AOAC, 2000, OFFICIAL METHODS ANA
   Backlund J, 2002, EUR J IMMUNOL, V32, P3776, DOI 10.1002/1521-4141(200212)32:12<3776::AID-IMMU3776>3.0.CO;2-A
   Bae I, 2008, FOOD CHEM, V108, P49, DOI 10.1016/j.foodchem.2007.10.039
   Beck K, 1998, J STRUCT BIOL, V122, P17, DOI 10.1006/jsbi.1998.3965
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Binsi PK, 2009, FOOD HYDROCOLLOID, V23, P132, DOI 10.1016/j.foodhyd.2007.12.004
   Cao H, 2013, EUR REV MED PHARMACO, V17, P1427
   Cao H, 2008, FOOD CHEM, V108, P439, DOI 10.1016/j.foodchem.2007.09.022
   Chen LJ, 2012, PHARMACEUTICALS, V5, P339, DOI 10.3390/ph5040339
   Cho SM, 2004, FOOD HYDROCOLLOID, V18, P573, DOI 10.1016/j.foodhyd.2003.10.001
   Duan R, 2009, FOOD CHEM, V112, P702, DOI 10.1016/j.foodchem.2008.06.020
   Edwards HGM, 1997, J MOL STRUCT, V435, P49, DOI 10.1016/S0022-2860(97)00122-1
   Garcia G, 1999, J AUTOIMMUN, V13, P315, DOI 10.1006/jaut.1999.0320
   HELEN E, 2005, J ORTHOP RES, V23, P142
   Ikoma T, 2003, INT J BIOL MACROMOL, V32, P199, DOI 10.1016/S0141-8130(03)00054-0
   JACKSON M, 1995, BBA-MOL BASIS DIS, V1270, P1, DOI 10.1016/0925-4439(94)00056-V
   Jansson K, 2001, SCAND J PLAST RECONS, V35, P369
   Jonglareonrak A, 2005, FOOD CHEM, V93, P475, DOI 10.1016/j.foodchem.2004.10.026
   Joseph G, 2008, J BIOMED MATER RES A, V87, P1103
   Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042
   Kittiphattanabawon P, 2010, LWT-FOOD SCI TECHNOL, V43, P792, DOI 10.1016/j.lwt.2010.01.006
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Li ZR, 2013, FOOD HYDROCOLLOID, V31, P103, DOI 10.1016/j.foodhyd.2012.10.001
   Liang Q, 2013, PROCESS BIOCH
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Merly L, 2013, INT IMMUNOPHARMACOL, V15, P309, DOI [10.1016/j.intimp2012.12.001, 10.1016/j.intimp.2012.12.001]
   Muyonga JH, 2004, FOOD CHEM, V85, P81, DOI 10.1016/j.foodchem.2003.06.006
   Nagai T, 2008, FOOD CHEM, V111, P296, DOI 10.1016/j.foodchem.2008.03.087
   Ogawa M, 2003, J AGR FOOD CHEM, V51, P8088, DOI 10.1021/jf034350r
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Poole A.R., 2005, ARTHRITIS ALLIED CON, P223
   RAMACHAN.GN, 1973, BIOCHIM BIOPHYS ACTA, V322, P166, DOI 10.1016/0005-2795(73)90187-6
   RIGBY BJ, 1968, NATURE, V219, P166, DOI 10.1038/219166a0
   Rochdi A, 2000, FOOD CHEM, V69, P295, DOI 10.1016/S0308-8146(99)00267-8
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   Safandowska M, 2013, INT J BIOL MACROMOL, V53, P32, DOI 10.1016/j.ijbiomac.2012.10.026
   Sai PK, 2001, COMP BIOCH PHYSL, V128, P81
   Sato K, 2000, J BIOL CHEM, V275, P25870, DOI 10.1074/jbc.M003700200
   Shakila RJ, 2012, LWT-FOOD SCI TECHNOL, V48, P30, DOI 10.1016/j.lwt.2012.03.007
   Singh P, 2011, FOOD CHEM, V124, P97, DOI 10.1016/j.foodchem.2010.05.111
   Usha R, 2005, COLLOID SURFACE B, V41, P21, DOI 10.1016/j.colsurfb.2004.11.001
   Veeruraj A, 2013, PROCESS BIOCHEM, V48, P1592, DOI 10.1016/j.procbio.2013.07.011
   Vercaigne-Marko D, 2000, BIOTECHNOL APPL BIOC, V31, P127, DOI 10.1042/BA19990114
   Wang L, 2007, J FOOD SCI, V72, P450
   Wang L, 2014, FOOD HYDROCOLLOIDS, V38, P4
   Wong D. W. S., 1989, MECH THEORY FOOD CHE
   Woo JW, 2008, FOOD HYDROCOLLOID, V22, P879, DOI 10.1016/j.foodhyd.2007.04.015
   Zhang Y, 2007, FOOD CHEM, V103, P906, DOI 10.1016/j.foodchem.2006.09.053
   Zhao W, 2011, INT IMMUNOPHARMACOL, V11, P12, DOI 10.1016/j.intimp.2010.09.018
   Zhu P, 2007, CLIN IMMUNOL, V122, P75, DOI 10.1016/j.clim.2006.08.004
NR 52
TC 18
Z9 23
U1 0
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD OCT
PY 2014
VL 49
IS 10
BP 1767
EP 1777
DI 10.1016/j.procbio.2014.06.011
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA AR5QW
UT WOS:000343639600025
DA 2018-10-20
ER

PT J
AU Wang, QM
   Liang, GZ
   Zhang, MZ
   Zhao, J
   Patel, K
   Yu, X
   Zhao, C
   Ding, BR
   Zhang, G
   Zhou, FM
   Zheng, J
AF Wang, Qiuming
   Liang, Guizhao
   Zhang, Mingzhen
   Zhao, Jun
   Patel, Kunal
   Yu, Xiang
   Zhao, Chao
   Ding, Binrong
   Zhang, Ge
   Zhou, Feimeng
   Zheng, Jie
TI De Novo Design of Self-Assembled Hexapeptides as beta-Amyloid (A beta)
   Peptide Inhibitors
SO ACS CHEMICAL NEUROSCIENCE
LA English
DT Article
DE Amyloid inhibitor; protein misfolding; self-assembled peptide; amyloid
   cytotoxicity; Alzheimer's disease
ID FIBRIL FORMATION; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PROTECT NEURONS;
   AGGREGATION; POLYPEPTIDE; TAU; TOXICITY; IAPP; FIBRILLOGENESIS
AB The ability of peptides to construct specific secondary structures provides a useful function for biomaterial design that cannot be achieved with traditional organic molecules and polymers. Inhibition of amyloid formation is a promising therapeutic approach for the treatment of neurodegenerative diseases. Existing peptide-based inhibitors are mainly derived from original amyloid sequences, which have very limited sequence diversity and activity. It is highly desirable to explore other peptide-based inhibitors that are not directly derived from amyloid sequences. Here, we develop a hybrid high-throughput computational method to efficiently screen and design hexapeptide inhibitors against amyloid-beta (A beta) aggregation and toxicity from the first principle. Computationally screened/designed inhibitors are then validated for their inhibition activity using biophysical experiments. We propose and demonstrate a proof-of-concept of the "like-interacts-like" design principle that the self-assembling peptides are able to interact strongly with conformationally similar motifs of A beta peptides and to competitively reduce A beta-A beta interactions, thus preventing A beta aggregation and A beta-induced toxicity. Such a de novo design can also be generally applicable to design new peptide inhibitors against other amyloid diseases, beyond traditional peptide inhibitors with homologous sequences to parent amyloid peptides.
C1 [Wang, Qiuming; Zhang, Mingzhen; Zhao, Jun; Yu, Xiang; Zhao, Chao; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Patel, Kunal; Zhang, Ge] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Liang, Guizhao] Chongqing Univ, Minist Educ Coll, Key Lab Biorheol Sci & Technol, Chongqing 400044, Peoples R China.
   [Ding, Binrong; Zhou, Feimeng] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA.
RP Zhou, FM (reprint author), Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA.
EM fzhou@exchange.calstatela.edu; zhengj@uakron.edu
RI Zheng, Jie/B-5057-2013; Zhang, Mingzhen/H-3182-2016; Zhao,
   Jun/G-6883-2011
OI Zheng, Jie/0000-0003-1547-3612; 
FU Natural Science Foundation Project of Chongqing CSTC
   [cstc2012gg-gjhz10003]; NSF [CBET-0952624, CBET-1158447]
FX G.L. is thankful for the support from the Natural Science Foundation
   Project of Chongqing CSTC (cstc2012gg-gjhz10003). J.Z. is thankful for
   the support from NSF grants (CAREER Award CBET-0952624 and
   CBET-1158447).
CR Andreetto E, 2010, ANGEW CHEM INT EDIT, V49, P3081, DOI 10.1002/anie.200904902
   Asai M, 2006, J NEUROCHEM, V96, P533, DOI 10.1111/j.1471-4159.2005.03576.x
   Austen BM, 2008, BIOCHEMISTRY-US, V47, P1984, DOI 10.1021/bi701415b
   Bacskai Brian J., 2001, Nature Medicine, V7, P369, DOI 10.1038/85525
   Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105
   Cairo CW, 2002, BIOCHEMISTRY-US, V41, P8620, DOI 10.1021/bi0156254
   Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006
   Dash PK, 2005, BIOCHEM BIOPH RES CO, V338, P777, DOI 10.1016/j.bbrc.2005.10.006
   Diaz JC, 2009, P NATL ACAD SCI USA, V106, P3348, DOI 10.1073/pnas.0813355106
   Doi T, 2008, ORG LETT, V10, P817, DOI 10.1021/ol702965r
   El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje
   Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105
   Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x
   Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324
   Gilead S, 2004, ANGEW CHEM INT EDIT, V43, P4041, DOI 10.1002/anie.200353565
   Gilead S, 2006, ANGEW CHEM INT EDIT, V45, P6476, DOI 10.1002/anie.200602034
   Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107
   Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103
   Hartman K, 2013, PEERJ, V1, DOI 10.7717/peerj.5
   Hu RD, 2014, LANGMUIR, V30, P5193, DOI 10.1021/la500632d
   Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481
   Jones S, 2003, J MOL BIOL, V325, P249, DOI 10.1016/S0022-2836(02)01227-5
   Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201
   Li HY, 2010, BIOCHEMISTRY-US, V49, P1259, DOI 10.1021/bi902075h
   Liang GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067844
   Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]
   Mazor Y, 2002, J MOL BIOL, V322, P1013, DOI 10.1016/S0022-2836(02)00887-2
   Middleton CT, 2012, NAT CHEM, V4, P355, DOI [10.1038/NCHEM.1293, 10.1038/nchem.1293]
   Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Potter KJ, 2009, BBA-GEN SUBJECTS, V1790, P566, DOI 10.1016/j.bbagen.2009.02.013
   Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289
   Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X
   Seeliger J, 2012, ANGEW CHEM INT EDIT, V51, P679, DOI 10.1002/anie.201105877
   Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q
   Soto P, 2007, BIOPHYS J, V93, P3015, DOI 10.1529/biophysj.107.112086
   Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5
   Takahashi T, 2008, ACCOUNTS CHEM RES, V41, P1309, DOI 10.1021/ar8000475
   Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205
   Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103
   Wang QM, 2013, ACS CHEM NEUROSCI, V4, P1004, DOI 10.1021/cn400051e
   Wang QM, 2011, PHYS CHEM CHEM PHYS, V13, P15200, DOI 10.1039/c1cp21156k
   Westermark P, 1996, FEBS LETT, V379, P203, DOI 10.1016/0014-5793(95)01512-4
   Yamin G, 2009, BIOCHEMISTRY-US, V48, P11329, DOI 10.1021/bi901325g
   Yan LM, 2007, ANGEW CHEM INT EDIT, V46, P1246, DOI 10.1002/anie.200604056
   Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103
   Yu X, 2012, J BIOL CHEM, V287, P14950, DOI 10.1074/jbc.M112.340794
NR 49
TC 21
Z9 21
U1 1
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-7193
J9 ACS CHEM NEUROSCI
JI ACS Chem. Neurosci.
PD OCT
PY 2014
VL 5
IS 10
BP 972
EP 981
DI 10.1021/cn500165s
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences
   & Neurology
GA AR0QO
UT WOS:000343276600013
PM 25133634
DA 2018-10-20
ER

PT J
AU Sigolaeva, LV
   Gladyr, SY
   Gelissen, APH
   Mergel, O
   Pergushov, DV
   Kurochkin, IN
   Plamper, FA
   Richtering, W
AF Sigolaeva, Larisa V.
   Gladyr, Snezhana Yu
   Gelissen, Arjan P. H.
   Mergel, Olga
   Pergushov, Dmitry V.
   Kurochkin, Ilya N.
   Plamper, Felix A.
   Richtering, Walter
TI Dual-Stimuli-Sensitive Microgels as a Tool for Stimulated Spongelike
   Adsorption of Biomaterials for Biosensor Applications
SO BIOMACROMOLECULES
LA English
DT Article
ID POLY N-ISOPROPYLACRYLAMIDE; THIN-FILMS; POLYACRYLAMIDE MICROGELS;
   CHARGED MICROGELS; PHASE-TRANSITION; GLUCOSE-OXIDASE; CHOLINE OXIDASE;
   SIRNA DELIVERY; IONIC-STRENGTH; COMBINED AFM
AB This work examines the fabrication regime and the properties of microgel and microgel/enzyme thin films adsorbed onto conductive substrates (graphite or gold). The films were formed via two sequential steps: the adsorption of a temperature- and pH-sensitive microgel synthesized by precipitation copolymerization of N-isopropylacrylamide (NIPAM) and 3-(N,N-dimethylamino)propylmethacrylamide (DMAPMA) (poly(NIPAM-co-DMAPMA) at the pH-condition corresponding to its noncharged state (first step of adsorption), followed by the enzyme, tyrosinase, adsorption at the pH-condition when the microgel and the enzyme are oppositely charged (second step of adsorption). The stimuli-sensitive properties of poly(NIPAM-co-DMAPMA) microgel were characterized by potentiometric titration and dynamic light scattering (DLS) in solution as well as by atomic force microscopy (AFM) and quartz crystal microbalance with dissipation monitoring (QCM-D) at solid interface. Enhanced deposition of poly(NIPAM-co-DMAPMA) microgel particles was shown at elevated temperatures exceeding the volume phase transition temperature (VPTT). The subsequent electrostatic interaction of the poly(NIPAM-co-DMAPMA) microgel matrix with tyrosinase was examined at different adsorption regimes. A considerable increase in the amount of the adsorbed enzyme was detected when the microgel film is first brought into a collapsed state but then was allowed to interact with the enzyme at T < VPTT. Spongelike approach to enzyme adsorption was applied for modification of screen-printed graphite electrodes by poly(NIPAM-co-DMAPMA)/tyrosinase films and the resultant biosensors for phenol were tested amperometrically. By temperature-induced stimulating both (i) poly(NIPAM-co-DMAPMA) microgel adsorption at T > VPTT and (ii) following spongelike tyrosinase loading at T < VPTT, we can achieve more than 3.5-fold increase in biosensor sensitivity for phenol assay. Thus, a very simple, novel, and fast strategy for physical entrapment of biomolecules by the polymeric matrix was proposed and tested. Being based on this unique stimuli-sensitive behavior of the microgel, this stimulated spongelike adsorption provides polymer films comprising concentrated biomaterial.
C1 [Sigolaeva, Larisa V.; Gladyr, Snezhana Yu; Pergushov, Dmitry V.; Kurochkin, Ilya N.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia.
   [Gelissen, Arjan P. H.; Mergel, Olga; Plamper, Felix A.; Richtering, Walter] Rhein Westfal TH Aachen, Inst Phys Chem 2, D-52056 Aachen, Germany.
RP Sigolaeva, LV (reprint author), Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia.
EM lsigolaeva@genebee.msu.ru
RI Sigolaeva, Larisa/K-3082-2013; Richtering, Walter/E-4130-2012;
   Pergushov, Dmitry/E-8540-2013; Plamper, Felix/E-9747-2012
OI Richtering, Walter/0000-0003-4592-8171; Plamper,
   Felix/0000-0002-0762-6095
FU Deutsche Forschungsgemeinschaft [SFB 985]; Russian Foundation for Basic
   Research [RFBR 14-08-01108]; Lomonosov Moscow State University Program
   of Development; Lomonosov Moscow State University Post-Genomic Program
FX This research was supported by the Deutsche Forschungsgemeinschaft
   within SFB 985 "Funktionelle Mikrogele und Milu-ogelsysteme", the
   Russian Foundation for Basic Research within RFBR 14-08-01108, the
   Lomonosov Moscow State University Program of Development, and the
   Lomonosov Moscow State University Post-Genomic Program. L.V.S. and
   D.V.P. gratefully acknowledge the SFB 985 for financial support of their
   research stays at the RWTH Aachen University.
CR Blackburn WH, 2009, BIOCONJUGATE CHEM, V20, P960, DOI 10.1021/bc800547c
   Buenger D, 2012, PROG POLYM SCI, V37, P1678, DOI 10.1016/j.progpolymsci.2012.09.001
   Burmistrova A, 2010, J MATER CHEM, V20, P3502, DOI 10.1039/b923969c
   Bysell H, 2006, LANGMUIR, V22, P5476, DOI 10.1021/la060452a
   Bysell H, 2011, ADV DRUG DELIVER REV, V63, P1172, DOI 10.1016/j.addr.2011.08.005
   Clarke KC, 2013, LANGMUIR, V29, P12852, DOI 10.1021/la403280s
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Deshmukh PK, 2013, J CONTROL RELEASE, V166, P294, DOI 10.1016/j.jconrel.2012.12.033
   EREMEEV NL, 1992, VESTN MOSK U KHIM+, V33, P511
   EREMEEV NL, 1995, BIOCHEMISTRY-MOSCOW+, V60, P991
   Fernandez E, 2005, POLYMER, V46, P2211, DOI 10.1016/j.polymer.2004.12.039
   Garcia-Salinas MJ, 2010, J COLLOID INTERF SCI, V342, P629, DOI 10.1016/j.jcis.2009.10.064
   Gelissen APH, 2014, POLYMER, V55, P1991, DOI 10.1016/j.polymer.2014.02.062
   Gonzalez-Sanchez MI, 2011, BIOSENS BIOELECTRON, V26, P1883, DOI 10.1016/j.bios.2010.03.024
   Gromova MS, 2011, SOFT MATTER, V7, P7404, DOI 10.1039/c1sm05655g
   Hansson P, 2012, J PHYS CHEM B, V116, P10964, DOI 10.1021/jp306121h
   Perez JPH, 2006, BIOSENS BIOELECTRON, V22, P429, DOI 10.1016/j.bios.2006.05.015
   Hofl S, 2007, POLYMER, V48, P245, DOI 10.1016/j.polymer.2006.10.026
   Horecha M, 2011, COLLOID POLYM SCI, V289, P603, DOI 10.1007/s00396-010-2312-9
   Horecha M, 2010, SOFT MATTER, V6, P5980, DOI 10.1039/c0sm00634c
   Hu L, 2013, ACS APPL MATER INTER, V5, P11977, DOI 10.1021/am403745k
   Huo DX, 2006, COLLOID SURFACE B, V50, P36, DOI 10.1016/j.colsurfb.2006.03.020
   Islam MR, 2013, CHEM COMMUN, V49, P2646, DOI 10.1039/c3cc00211j
   Johansson C, 2010, J COLLOID INTERF SCI, V347, P241, DOI 10.1016/j.jcis.2010.03.072
   Kabanov AV, 2009, ANGEW CHEM INT EDIT, V48, P5418, DOI 10.1002/anie.200900441
   KHOKHLOV AR, 1993, ADV POLYM SCI, V109, P123
   Kleinen J, 2010, LANGMUIR, V26, P11258, DOI 10.1021/la100579b
   Kudaibergenov SE, 2012, SOFT MATTER, V8, P9302, DOI 10.1039/c2sm25766a
   Lehmann S, 2012, J AM CHEM SOC, V134, P15963, DOI 10.1021/ja306808j
   Lu Y, 2011, PROG POLYM SCI, V36, P767, DOI 10.1016/j.progpolymsci.2010.12.003
   Malmsten M, 2010, CURR OPIN COLLOID IN, V15, P435, DOI 10.1016/j.cocis.2010.05.016
   Morisada S, 2011, IND ENG CHEM RES, V50, P12358, DOI 10.1021/ie200779w
   Nolan CM, 2005, MACROMOL SYMP, V227, P285, DOI 10.1002/masy.200550928
   Ogawa K, 2003, LANGMUIR, V19, P3178, DOI 10.1021/la0267185
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   Pich A, 2010, ADV POLYM SCI, V234, P1, DOI 10.1007/12_2010_70
   Pinheiro JP, 2012, LANGMUIR, V28, P5802, DOI 10.1021/la2045477
   Plamper F. A., 2014, ADV POLYM SCI, DOI [10.1007/1012_2014_284, DOI 10.1007/1012_2014_284]
   Retama JR, 2005, BIOSENS BIOELECTRON, V20, P2268, DOI 10.1016/j.bios.2004.10.011
   ROBB DA, 1981, PHYTOCHEMISTRY, V20, P1481, DOI 10.1016/S0031-9422(00)98516-9
   Rubio-Retama J, 2005, TALANTA, V68, P99, DOI 10.1016/j.talanta.2005.04.042
   Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Schmidt S, 2008, LANGMUIR, V24, P12595, DOI 10.1021/la801770n
   Schmidt S, 2008, POLYMER, V49, P749, DOI 10.1016/j.polymer.2007.12.025
   Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730
   Serpe MJ, 2005, BIOMACROMOLECULES, V6, P408, DOI 10.1021/bm049455x
   Sigolaeva L, 2010, CHEM-BIOL INTERACT, V187, P312, DOI 10.1016/j.cbi.2010.01.028
   Sigolaeva LV, 2014, MACROMOL BIOSCI, V14, P1039, DOI 10.1002/mabi.201300580
   Sigolaeva LV, 2013, ANAL METHODS-UK, V5, P3872, DOI 10.1039/c3ay40339d
   Sigolaeva LV, 2013, SOFT MATTER, V9, P2858, DOI 10.1039/c2sm27298a
   SIGOLAEVA LV, 1994, BIOORG KHIM+, V20, P268
   Smith MH, 2012, ACCOUNTS CHEM RES, V45, P985, DOI 10.1021/ar200216f
   Smith MH, 2011, MACROMOLECULES, V44, P8154, DOI 10.1021/ma201365p
   Thavanesan T, 2014, LANGMUIR, V30, P5609, DOI 10.1021/la5007583
   Wellert S, 2014, LANGMUIR, V30, P7168, DOI 10.1021/la500390j
   Welsch N, 2012, SOFT MATTER, V8, P12043, DOI 10.1039/c2sm26798e
   Wong JE, 2009, MACROMOLECULES, V42, P1229, DOI 10.1021/ma802072c
   Wong JE, 2008, CURR OPIN COLLOID IN, V13, P403, DOI 10.1016/j.cocis.2008.04.001
   Wu JY, 2005, J CONTROL RELEASE, V102, P361, DOI 10.1016/j.jconrel.2004.10.008
   Yigit C, 2012, LANGMUIR, V28, P14373, DOI 10.1021/la303292z
   Zhang L, 2014, LANGMUIR, V30, P7628, DOI 10.1021/la500860t
NR 62
TC 43
Z9 44
U1 9
U2 139
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2014
VL 15
IS 10
BP 3735
EP 3745
DI 10.1021/bm5010349
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AQ7VF
UT WOS:000343026600029
PM 25211008
DA 2018-10-20
ER

PT J
AU Fernandez-Colino, A
   Arias, FJ
   Alonso, M
   Rodriguez-Cabello, JC
AF Fernandez-Colino, Alicia
   Javier Arias, F.
   Alonso, Matilde
   Carlos Rodriguez-Cabello, J.
TI Self-Organized ECM-Mimetic Model Based on an Amphiphilic Multiblock
   Silk-Elastin-Like Corecombinamer with a Concomitant Dual Physical
   Gelation Process
SO BIOMACROMOLECULES
LA English
DT Article
ID PROTEIN BLOCK-COPOLYMERS; BOMBYX-MORI; DRUG-DELIVERY; BIOMATERIALS;
   POLYPEPTIDE; POLYMERS; RECOMBINAMERS; SPECTROSCOPY; MICELLES;
   SURFACTANTS
AB Although significant progress has been made in the area of injectable hydrogels for biomedical applications and model cell niches, further improvements are still needed, especially in terms of mechanical performance, stability, and biomimicry of the native fibrillar architecture found in the extracellular matrix (ECM). This work focuses on the design and production of a silk-elastin-based injectable multiblock corecombinamer that spontaneously forms a stable physical nanofibrillar hydrogel under physiological conditions. That differs from previously reported silk-elastin-like polymers on a major content and predominance of the elastin-like part, as well as a more complex structure and behavior of such a part of the molecule, which is aimed to obtain well-defined hydrogels. Rheological and DSC experiments showed that this system displays a coordinated and concomitant dual gelation mechanism. In a first stage, a rapid, thermally driven gelation of the corecombinamer solution takes place once the system reaches body temperature due to the thermal responsiveness of the elastin-like (EL) parts and the amphiphilic multiblock design of the corecombinamer. A bridged micellar structure is the dominant microscopic feature of this stage, as demonstrated by AFM and TEM. Completion of the initial stage triggers the second, which is comprised of a stabilization, reinforcement, and microstructuring of the gel. FTIR analysis shows that these events involve the formation of beta-sheets around the silk motifs. The emergence of such beta-sheet structures leads to the spontaneous self-organization of the gel into the final fibrous structure. Despite the absence of biological cues, here we set the basis of the minimal structure that is able to display such a set of physical properties and undergo microscopic transformation from a solution to a fibrous hydrogel. The results point to the potential of this system as a basis for the development of injectable fibrillar biomaterial platforms toward a fully functional, biomimetic, artificial extracellular matrix, and cell niches.
C1 [Fernandez-Colino, Alicia; Javier Arias, F.; Alonso, Matilde; Carlos Rodriguez-Cabello, J.] Univ Valladolid, GIR Bioforge, CIBER BBN, E-47011 Valladolid, Spain.
RP Rodriguez-Cabello, JC (reprint author), Univ Valladolid, GIR Bioforge, CIBER BBN, Paseo Belen 11, E-47011 Valladolid, Spain.
EM roca@bioforge.uva.es
RI Rodriguez-Cabello, Jose Carlos/G-6555-2017; ALONSO, MATILDE/G-6719-2017;
   Arias, Francisco Javier/A-2640-2012
OI Rodriguez-Cabello, Jose Carlos/0000-0002-3438-858X; ALONSO,
   MATILDE/0000-0002-6853-8427; Arias, Francisco Javier/0000-0001-8584-3768
FU EU through the European regional development fund (ERDF); MINECO
   [MAT2013-41723-R, MAT2013-42473-R, PRI-PIBAR-2011-1403, MAT2012-38043];
   JCyL [VA049A11, VA152A12, VA155A12]; CIBER-BBN; JCyL; Instituto de Salud
   Carlos III under the Network Center of Regenerative Medicine and
   Cellular Therapy of Castilla and Leon
FX We acknowledge financial support from the EU through the European
   regional development fund (ERDF), from the MINECO (MAT2013-41723-R,
   MAT2013-42473-R, PRI-PIBAR-2011-1403, and MAT2012-38043), the JCyL
   (Projects VA049A11, VA152A12, and VA155A12), the CIBER-BBN, the JCyL,
   and the Instituto de Salud Carlos III under the Network Center of
   Regenerative Medicine and Cellular Therapy of Castilla and Leon.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altunbas A., 2011, PEPTIDE BASED MAT, P174
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   Bessa PC, 2010, J CONTROL RELEASE, V142, P312, DOI 10.1016/j.jconrel.2009.11.003
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Betre H, 2002, BIOMACROMOLECULES, V3, P910, DOI 10.1021/bm0255037
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Rodriguez-Cabello JC, 2011, NANOMEDICINE-UK, V6, P111, DOI 10.2217/NNM.10.141
   Rodriguez-Cabello JC, 2009, POLYMER, V50, P5159, DOI 10.1016/j.polymer.2009.08.032
   Chen X, 2012, APPL SPECTROSC, V66, P696, DOI 10.1366/11-06551
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Fandrich M, 2007, CELL MOL LIFE SCI, V64, P2066, DOI 10.1007/s00018-007-7110-2
   Girotti A, 2011, BIOTECHNOL J, V6, P1174, DOI 10.1002/biot.201100116
   Golinska MD, 2013, BIOMACROMOLECULES, V14, P48, DOI 10.1021/bm3011775
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Landau L. D., 1984, THEORY ELASTICITY, P195
   Leach JB, 2005, ACTA BIOMATER, V1, P155, DOI 10.1016/j.actbio.2004.12.001
   Liu WG, 2010, J CONTROL RELEASE, V144, P2, DOI 10.1016/j.jconrel.2010.01.032
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Machado R., 2012, NANOPARTICLES BIOL M, P555
   Machado R, 2013, AMB EXPRESS, V3, P1
   Martin L, 2012, BIOMACROMOLECULES, V13, P293, DOI 10.1021/bm201436y
   Martin L, 2010, SOFT MATTER, V6, P1121, DOI 10.1039/b923684h
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meyer D. E., 2002, PROTEIN INTERACTIONS, P938
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Meyer E., 2002, PROTEIN PROTEIN INTE, P938
   Nagarsekar A, 2003, BIOMACROMOLECULES, V4, P602, DOI 10.1021/bm0201082
   Nagarsekar A, 2002, J BIOMED MATER RES, V62, P195, DOI 10.1002/jbm.10272
   NYSTROM B, 1995, LANGMUIR, V11, P750, DOI 10.1021/la00003a014
   Pham Quynh P., 2006, TISSUE ENG, V12.5, P1197
   Pinedo-Martin G, 2014, LANGMUIR, V30, P3432, DOI 10.1021/la500464v
   Rodriguez-Cabello J. C., 2012, NANOTECHNOLOGY REGEN, P319
   Rodriguez-Cabello J. C., 2010, ADV BIOCHEM ENG BIOT, V125, P145, DOI DOI 10.1007/10_
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   TAMBURRO AM, 1990, BIOPOLYMERS, V29, P855, DOI 10.1002/bip.360290419
   TUNG CYM, 1982, J APPL POLYM SCI, V27, P569, DOI 10.1002/app.1982.070270220
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1992, BIOPOLYMERS, V32, P1243, DOI 10.1002/bip.360320913
   WINTER HH, 1986, J RHEOL, V30, P367, DOI 10.1122/1.549853
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhao Y, 2013, ADV MATER, V25, P5215, DOI 10.1002/adma.201302215
NR 59
TC 25
Z9 25
U1 2
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT
PY 2014
VL 15
IS 10
BP 3781
EP 3793
DI 10.1021/bm501051t
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AQ7VF
UT WOS:000343026600034
PM 25230341
DA 2018-10-20
ER

PT J
AU Doro, FG
   Ramos, AP
   Schneider, JF
   Rodrigues, UP
   Veiga, MAMS
   Yano, CL
   Negreti, A
   Krieger, MH
   Tfouni, E
AF Doro, F. G.
   Ramos, A. P.
   Schneider, J. F.
   Rodrigues-Filho, U. P.
   Veiga, M. A. M. S.
   Yano, C. L.
   Negreti, A.
   Krieger, M. H.
   Tfouni, E.
TI Deposition of organic-inorganic hybrid coatings over 316L surgical
   stainless steel and evaluation on vascular cells
SO CANADIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE ormosil; hybrid coating; biomaterial; sol-gel; stent; vascular cells
ID SOL-GEL COATINGS; DRUG ELUTING STENTS; BIOMEDICAL APPLICATIONS;
   CORROSION-PROTECTION; BIOLOGICAL RESPONSES; EPITHELIAL TISSUE; SURFACE
   SCIENCE; THIN-FILMS; BIOCOMPATIBILITY; POLYMERS
AB Surface coating of metallic materials using the sol-gel technique is a suitable approach to obtain hybrid materials with improved properties for biomedical applications. In this study, an AISI 316L stainless steel surface was coated with ormosils prepared from tetraethylsiloxane and 3-glycidoxypropyltrimethoxysilane or polydimethylsiloxane. The characterization of structural and surface properties was performed by several techniques. Surface microstructure, morphology, and energy are dependent on organosilane type and content. Chemical stability of coatings was investigated by static immersion tests in phosphate buffer solution at 37 degrees C, and silicon leaching after 21 days was found to be in the range of similar to 200-300 mu g L-1. Mechanical adhesion was found to be within 1.0 and 3.7 N cm(-1). The interaction of the samples and materials in the cardiovascular environment was investigated through cellular behavior. Biological assays were performed with slides to avoid any cytotoxic effects on human endothelial cells (HUVEC) and rabbit arterial smooth muscle cells (RASM). No significant alterations were observed after 24 h in the viability of RASM and HUVEC cells exposed to different coatings. No increase of HUVEC or RASM migration was observed after 24 h as evaluated by transwell migration assay. The hybrid materials showed suitable properties for potential application as biomaterials in cardiovascular environment as well as for incorporation of bioactive species with the aim to prepare drug-eluting stents.
C1 [Doro, F. G.; Ramos, A. P.; Veiga, M. A. M. S.; Tfouni, E.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.
   [Doro, F. G.] Univ Fed Bahia, Inst Quim, Dept Quim Geral & Inorgan, BR-40170290 Salvador, BA, Brazil.
   [Schneider, J. F.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil.
   [Rodrigues-Filho, U. P.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil.
   [Yano, C. L.; Negreti, A.; Krieger, M. H.] Univ Estadual Campinas, UNICAMP, Dept Fisiol & Biofis, BR-13081970 Campinas, SP, Brazil.
RP Tfouni, E (reprint author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.
EM eltfouni@usp.br
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; da Veiga,
   Marcia/C-5441-2012; CerTEV, CeRTEV/J-6817-2015; Rodrigues-Filho,
   Ubirajara/G-3216-2012; Schneider, Jose/G-9534-2012; Ramos, Ana
   Paula/N-4426-2013
OI Rodrigues-Filho, Ubirajara/0000-0001-6913-8540; Schneider,
   Jose/0000-0001-5992-2788; Ramos, Ana Paula/0000-0001-6200-8989
FU Sao Paulo Research Foundation (FAPESP); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de
   Aperfeicoamentos do Pessoal do Ensino Superior (CAPES); Fundacao de
   Amparo a Pesquisa do Estado da Bahia (FAPESB); FAPESP [2006/53266-4,
   2003/09578-3, 2011/18271-5, 2010/10674-0, 2011/07376-0]; CNPq
   [308123/2009-3]; FAPESB [PPP0039/2010]; CAPES; CNPq
FX The authors thank grants and fellowships from Sao Paulo Research
   Foundation (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Coordenadoria de Aperfeicoamentos do Pessoal do
   Ensino Superior (CAPES), and Fundacao de Amparo a Pesquisa do Estado da
   Bahia (FAPESB) as follows. E. Tfouni: FAPESP grant 2006/53266-4 and CNPq
   fellowship 308123/2009-3; F.G. Doro: FAPESP fellowship 2003/09578-3 and
   FAPESB grant PPP0039/2010; J.F. Schneider: FAPESP grant 2011/18271-5;
   A.A. Negreti: CAPES fellowship; C.L. Yano: FAPESP fellowship
   2010/10674-0; M. H. Krieger: FAPESP grant 2011/07376-0 and CNPq
   fellowship. The authors also thank M.Sc. Jose Humberto Lopes and the
   laboratory of the 3M Brasil production plant at Ribeirao Preto, SP, for
   adhesion tests of coatings and DEGUSSA for GLYMO samples.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Asefa T, 2012, CAN J CHEM, V90, P1015, DOI 10.1139/V2012-094
   ASTM, 2007, STANDARD TEST METHOD
   Avnir D, 2006, J MATER CHEM, V16, P1013, DOI [10.1039/b512706h, 10.1039/5512706h]
   Bottcher H, 1998, J SOL-GEL SCI TECHN, V13, P277, DOI 10.1023/A:1008603622543
   BRINKER CJ, 1988, J NON-CRYST SOLIDS, V100, P31, DOI 10.1016/0022-3093(88)90005-1
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   BUONASSISI V, 1976, P NATL ACAD SCI USA, V73, P1612, DOI 10.1073/pnas.73.5.1612
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Ceyhan T, 2007, J MATER SCI-MATER M, V18, P1557, DOI 10.1007/s10856-007-3049-y
   Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115
   Chazalviel JN, 2012, THIN SOLID FILMS, V520, P3918, DOI 10.1016/j.tsf.2012.01.046
   Chiriac AP, 2010, MINI-REV MED CHEM, V10, P990
   Ciriminna R, 2013, CHEM REV, V113, P6592, DOI 10.1021/cr300399c
   Coradin T, 2006, CURR MED CHEM, V13, P99, DOI 10.2174/092986706775197999
   Dave BC, 2004, J SOL-GEL SCI TECHN, V32, P143, DOI 10.1007/s10971-004-5779-3
   Engelhardt G., 1987, HIGH RESOLUTION SOLI
   Farhatnia Y, 2013, BIOTECHNOL ADV, V31, P524, DOI 10.1016/j.biotechadv.2012.12.010
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Gad SC, 2013, WOODH PUBL SER BIOM, V64, P285, DOI 10.1533/9780857093684.285
   Gallardo J, 2004, CORROS SCI, V46, P795, DOI 10.1016/S0010-938X(03)000185-9
   Galli C, 2002, COLLOID SURFACE B, V26, P255, DOI 10.1016/S0927-7765(02)00015-2
   Galliano P, 1998, J SOL-GEL SCI TECHN, V13, P723, DOI 10.1023/A:1008653208083
   Galvan JC, 2012, J MATER SCI-MATER M, V23, P657, DOI 10.1007/s10856-012-4549-y
   Guglielmi M, 1997, J SOL-GEL SCI TECHN, V8, P443, DOI 10.1023/A:1018373404815
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Hanawa T, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064102
   HARRIS RK, 1978, NMR PERIODIC TABLE
   Hay JN, 2001, CHEM MATER, V13, P3396, DOI 10.1021/cm011024n
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Innocenzi P, 1999, CHEM MATER, V11, P1672, DOI 10.1021/cm980734z
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Janiszewski M, 2005, J BIOL CHEM, V280, P40813, DOI 10.1074/jbc.M509255200
   Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005
   Joung YK, 2003, J CONTROL RELEASE, V92, P83, DOI 10.1016/S0168-3659(03)00305-5
   Khan W, 2012, J CONTROL RELEASE, V161, P703, DOI 10.1016/j.jconrel.2012.02.010
   Komori Y, 2005, J NON-CRYST SOLIDS, V351, P97, DOI 10.1016/j.jnoncrysol.2004.10.005
   Kraitzer A, 2008, J BIOMED MATER RES B, V85B, P583, DOI 10.1002/jbm.b.30974
   Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Liu X, 2010, BIOMATERIALS, V31, P8198, DOI 10.1016/j.biomaterials.2010.07.069
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Marrey RV, 2006, BIOMATERIALS, V27, P1988, DOI 10.1016/j.biomaterials.2005.10.012
   Meth S, 2003, THIN SOLID FILMS, V425, P49, DOI 10.1016/S0040-6090(02)01296-8
   Metroke TL, 2002, PROG ORG COAT, V44, P295, DOI 10.1016/S0300-9440(02)00063-2
   Metroke TL, 2001, PROG ORG COAT, V41, P233, DOI 10.1016/S0300-9440(01)00134-5
   Morshed MM, 2003, SURF COAT TECH, V163, P541, DOI 10.1016/S0257-8972(02)00619-9
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   PEETERS MPJ, 1995, J NON-CRYST SOLIDS, V189, P77, DOI 10.1016/0022-3093(95)00248-0
   Puranik AS, 2013, INT J PHARMACEUT, V441, P665, DOI 10.1016/j.ijpharm.2012.10.029
   RICHARDS RE, 1949, J CHEM SOC, P124, DOI 10.1039/jr9490000124
   Steele JG, 2000, J BIOMED MATER RES, V50, P475, DOI 10.1002/(SICI)1097-4636(20000615)50:4<475::AID-JBM2>3.0.CO;2-G
   Templin M, 1997, ADV MATER, V9, P814, DOI 10.1002/adma.19970091011
   Tfouni E, 2012, NITRIC OXIDE-BIOL CH, V26, P38, DOI 10.1016/j.niox.2011.11.005
   Tfouni E, 2010, COORDIN CHEM REV, V254, P355, DOI 10.1016/j.ccr.2009.10.011
   Thierry B, 2003, J ENDOVASC THER, V10, P807, DOI 10.1583/1545-1550(2003)010<0807:BABOME>2.0.CO;2
   Thipparaboina R, 2013, INT J PHARMACEUT, V454, P4, DOI 10.1016/j.ijpharm.2013.07.005
   Tsuru K, 2004, J SOL-GEL SCI TECHN, V32, P201, DOI 10.1007/s10971-004-5789-1
   Uilk J, 2000, MACROMOLECULES, V33, P8791, DOI 10.1021/ma000023y
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   Velasco MJ, 2001, BOL SOC ESP CERAM V, V40, P37, DOI 10.3989/cyv.2001.v40.i1.760
   Veranth JM, 2008, NANOSCIENCE NANOTECH, P261
   Wang D, 2009, PROG ORG COAT, V64, P327, DOI 10.1016/j.porgcoat.2008.08.010
   Wen JY, 1996, CHEM MATER, V8, P1667, DOI 10.1021/cm9601143
   Yabuta T, 2004, J SOL-GEL SCI TECHN, V31, P273, DOI 10.1023/B:JSST.0000048002.65187.3a
   Yildirim A, 2010, ACS APPL MATER INTER, V2, P2892, DOI 10.1021/am100568c
   Yim H, 2005, LANGMUIR, V21, P4382, DOI 10.1021/la0474870
   Zhang G, 2003, LANGMUIR, V19, P2434, DOI 10.1021/la025695r
NR 71
TC 4
Z9 4
U1 1
U2 39
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4042
EI 1480-3291
J9 CAN J CHEM
JI Can. J. Chem.
PD OCT
PY 2014
VL 92
IS 10
BP 987
EP 995
DI 10.1139/cjc-2014-0034
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AQ8WO
UT WOS:000343118800013
DA 2018-10-20
ER

PT J
AU Veggiani, G
   Zakeri, B
   Howarth, M
AF Veggiani, Gianluca
   Zakeri, Bijan
   Howarth, Mark
TI Superglue from bacteria: unbreakable bridges for protein nanotechnology
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
DE protein engineering; nanobiotechnology; mechanobiology; synthetic
   biology; supramolecular assembly; biomimetic
ID LIVING CELLS; STREPTOCOCCUS-PYOGENES; STRUCTURAL BASIS; BOND FORMATION;
   QUANTUM DOTS; PEPTIDE TAG; AFFINITY; FORCE; LIGATION; IMMOBILIZATION
AB Biotechnology is often limited by weak interactions. We suggest that an ideal interaction between proteins would be covalent, specific, require addition of only a peptide tag to the protein of interest, and form under a wide range of conditions. Here we summarize peptide tags that are able to form spontaneous amide bonds, based on harnessing reactions of adhesion proteins from the bacterium Streptococcus pyogenes. These include the irreversible peptide-protein interaction of SpyTag with SpyCatcher, as well as irreversible peptide-peptide interactions via SpyLigase. We describe existing applications, including polymerization to enhance cancer cell capture, assembly of living biomaterial, access to diverse protein shapes, and improved enzyme resilience. We also indicate future opportunities for resisting biological force and extending the scope of protein nanotechnology.
C1 [Veggiani, Gianluca; Howarth, Mark] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.
   [Zakeri, Bijan] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA.
RP Howarth, M (reprint author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.
EM mark.howarth@bioch.ox.ac.uk
OI /0000-0002-4639-7248
FU Medical Research Council; Merton College Oxford; Clarendon Fund; Oxford
   University Department of Biochemistry; St. Peter's College, Oxford;
   European Research Council [ERC-2013-CoG 615945-PeptidePadlock]; Medical
   Research Council [1243569]
FX G.V. was funded by the Medical Research Council and Merton College
   Oxford, B.Z. by the Clarendon Fund, Oxford University Department of
   Biochemistry, and St. Peter's College, Oxford, and M.H. by the European
   Research Council (ERC-2013-CoG 615945-PeptidePadlock). The authors thank
   Dr Jacob Orry Fierer and Mr Christopher Schoene for their stimulating
   comments.
CR Abe H, 2013, BIOCONJUGATE CHEM, V24, P242, DOI 10.1021/bc300606b
   Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962
   Amelung S, 2011, CELL MICROBIOL, V13, P1200, DOI 10.1111/j.1462-5822.2011.01610.x
   Beyer MK, 2005, CHEM REV, V105, P2921, DOI 10.1021/cr030697h
   Bornschlogl T, 2011, METHODS MOL BIOL, V783, P233, DOI 10.1007/978-1-61779-282-3_13
   Carvajal-Vallejos P, 2012, J BIOL CHEM, V287, P28686, DOI 10.1074/jbc.M112.372680
   Charville H, 2011, EUR J ORG CHEM, P5981, DOI 10.1002/ejoc.201100714
   Chen AY, 2014, NAT MATER, V13, P515, DOI [10.1038/NMAT3912, 10.1038/nmat3912]
   Chivers CE, 2010, NAT METHODS, V7, P391, DOI [10.1038/NMETH.1450, 10.1038/nmeth.1450]
   DHILLON EKS, 1980, J GEN VIROL, V50, P217, DOI 10.1099/0022-1317-50-1-217
   Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105
   Fierer JO, 2014, P NATL ACAD SCI USA, V111, pE1176, DOI 10.1073/pnas.1315776111
   Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936
   Hagan RM, 2010, ANGEW CHEM INT EDIT, V49, P8421, DOI 10.1002/anie.201004340
   Howarth M, 2008, NAT METHODS, V5, P397, DOI [10.1038/nmeth.1206, 10.1038/NMETH.1206]
   Hu XQ, 2011, J AM CHEM SOC, V133, P478, DOI 10.1021/ja107513t
   Huang J, 2009, J MOL BIOL, V392, P1221, DOI 10.1016/j.jmb.2009.07.067
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654
   Hyre DE, 2006, PROTEIN SCI, V15, P459, DOI 10.1110/ps.051970306
   Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X
   Jain J, 2013, CANCER RES, V73, P2310, DOI 10.1158/0008-5472.CAN-12-2956
   Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806
   Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007
   Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j
   Klock C, 2012, PROTEIN SCI, V21, P1781, DOI 10.1002/pro.2162
   Kufer SK, 2005, EUR BIOPHYS J BIOPHY, V35, P72, DOI 10.1007/s00249-005-0010-1
   Li L, 2014, J MOL BIOL, V426, P309, DOI 10.1016/j.jmb.2013.10.021
   Liu DS, 2012, ACS NANO, V6, P11080, DOI 10.1021/nn304793z
   London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012
   Lu Y, 2014, BIOCONJUGATE CHEM, V25, P989, DOI 10.1021/bc500134w
   Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e
   Matsunaga R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3211
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y
   Popa I, 2013, J AM CHEM SOC, V135, P12762, DOI 10.1021/ja4056382
   Rago F, 2013, J CELL BIOL, V200, P557, DOI 10.1083/jcb.201211113
   Rashidian M, 2013, BIOCONJUGATE CHEM, V24, P1277, DOI 10.1021/bc400102w
   Rossi EA, 2012, TRENDS PHARMACOL SCI, V33, P474, DOI 10.1016/j.tips.2012.06.001
   Schoene C, 2014, ANGEW CHEM INT EDIT, V53, P6101, DOI 10.1002/anie.201402519
   Shah NH, 2014, CHEM SCI, V5, P446, DOI 10.1039/c3sc52951g
   Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014
   Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942
   Stamnaes J, 2008, BBA-PROTEINS PROTEOM, V1784, P1804, DOI 10.1016/j.bbapap.2008.08.011
   Strijbis K, 2012, TRAFFIC, V13, P780, DOI 10.1111/j.1600-0854.2012.01345.x
   Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013
   Swift JL, 2006, BIOPHYS J, V90, P1396, DOI 10.1529/biophysj.105.069526
   Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129
   Wong J, 1999, BIOMOL ENG, V16, P45, DOI 10.1016/S1050-3862(99)00035-2
   Wood DW, 2014, CURR OPIN STRUC BIOL, V26, P54, DOI 10.1016/j.sbi.2014.04.006
   Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021
   Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109
   Zakeri B, 2010, J AM CHEM SOC, V132, P4526, DOI 10.1021/ja910795a
   Zavalova LL, 2000, BBA-PROTEIN STRUCT M, V1478, P69, DOI 10.1016/S0167-4838(00)00006-6
   Zhang WB, 2013, J AM CHEM SOC, V135, P13988, DOI 10.1021/ja4076452
   Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905
NR 56
TC 38
Z9 39
U1 5
U2 94
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD OCT
PY 2014
VL 32
IS 10
BP 506
EP 512
DI 10.1016/j.tibtech.2014.08.001
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AR1LV
UT WOS:000343347600004
PM 25168413
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gao, GF
   Schilling, AF
   Yonezawa, T
   Wang, J
   Dai, GH
   Cui, XF
AF Gao, Guifang
   Schilling, Arndt F.
   Yonezawa, Tomo
   Wang, Jiang
   Dai, Guohao
   Cui, Xiaofeng
TI Bioactive nanoparticles stimulate bone tissue formation in bioprinted
   three-dimensional scaffold and human mesenchymal stem cells
SO BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE Bioprinting; Extracellular matrix; Mesenchymal stem cells; Osteogenesis;
   Photopolymerization
ID CARTILAGE REPAIR; TECHNOLOGY; MARROW; DIFFERENTIATION; BIOMATERIALS;
   CHONDROCYTES; PRINTHEAD; HYDROGELS; DEFECTS
AB Bioprinting based on thermal inkjet printing is a promising but unexplored approach in bone tissue engineering. Appropriate cell types and suitable biomaterial scaffolds are two critical factors to generate successful bioprinted tissue. This study was undertaken in order to evaluate bioactive ceramic nanoparticles in stimulating osteogenesis of printed bone marrow-derived human mesenchymal stem cells (hMSCs) in poly(ethylene glycol) dimethacrylate (PEGDMA) scaffold. hMSCs suspended in PEGDMA were co-printed with nanoparticles of bioactive glass (BG) and hydroxyapatite (HA) under simultaneous polymerization so the printed substrates were delivered with highly accurate placement in three-dimensional (3D) locations. hMSCs interacted with HA showed the highest cell viability (86.62 +/- 6.02%) and increased compressive modulus (358.91 +/- 48.05 kPa) after 21 days in culture among all groups. Biochemical analysis showed the most collagen production and highest alkaline phosphatase activity in PEG-HA group, which is consistent with gene expression determined by quantitative PCR. Masson's trichrome staining also showed the most collagen deposition in PEG-HA scaffold. Therefore, HA is more effective comparing to BG for hMSCs osteogenesis in bioprinted bone constructs. Combining with our previous experience in vasculature, cartilage, and muscle bioprinting, this technology demonstrates the capacity for both soft and hard tissue engineering with biomimetic structures.
C1 [Gao, Guifang; Wang, Jiang; Cui, Xiaofeng] Stemorgan Therapeut, Albany, NY USA.
   [Schilling, Arndt F.] Tech Univ Munich, Klinikum Rechts Isar, Clin Plast Surg & Hand Surg, D-80290 Munich, Germany.
   [Yonezawa, Tomo] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA.
   [Yonezawa, Tomo] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan.
   [Dai, Guohao; Cui, Xiaofeng] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Cui, Xiaofeng] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan 430070, Hubei, Peoples R China.
RP Cui, XF (reprint author), Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, 122 Luoshi Rd, Wuhan 430070, Hubei, Peoples R China.
EM daig@rpi.edu; xfc.cui@gmail.com
RI Cui, Xiaofeng/A-7208-2012
OI Cui, Xiaofeng/0000-0003-2761-3934; Dai, Guohao/0000-0001-7346-2685
FU NSF [1011796]; New York Capital Region Research Alliance Grant; R&D
   Department at Stemorgan Therapeutics
FX The authors would like to acknowledge M. G. Finn, C.-C. Lin, and K.
   Breitenkamp for constructive suggestions and other technical support.
   This work was partially funded by NSF (#1011796), New York Capital
   Region Research Alliance Grant, and R&D Department at Stemorgan
   Therapeutics.
CR Boland T., 2006, J IMAGING SCI TECHN, V2, P86
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   BUSKIRK WA, 1988, HEWLETT-PACKARD J, V39, P55
   Canfield B., 1997, U. S. Patent, Patent No. [5,673,069, 5673069]
   Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Cui X, 2011, OSTEOARTHR CARTILAGE, V19, pS47, DOI 10.1016/S1063-4584(11)60119-2
   Cui XF, 2008, NIP24/DIGITAL FABRICATION 2008: 24TH INTERNATIONAL CONFERENCE ON DIGITAL PRINTING TECHNOLOGIES, TECHNICAL PROGRAM AND PROCEEDINGS, P480
   Cui XF, 2014, JOVE-J VIS EXP, DOI 10.3791/51294
   Cui XF, 2013, BIOTECHNOL LETT, V35, P315, DOI 10.1007/s10529-012-1087-0
   Cui XF, 2012, BIOTECHNOL BIOENG, V109, P2357, DOI 10.1002/bit.24488
   Cui XF, 2012, BIOTECHNOL BIOENG, V109, P2369, DOI 10.1002/bit.24495
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149
   Cui XF, 2010, BIOTECHNOL BIOENG, V106, P963, DOI 10.1002/bit.22762
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Deitch S., 2008, MATER RES SOC S P, V1094, P52
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   HARMON JP, 1988, HEWLETT-PACKARD J, V39, P62
   Hock S. W., 1996, Patent No. [5,521,622, 5521622, US5521622]
   Hoenig E, 2011, TISSUE ENG PT A, V17, P1401, DOI [10.1089/ten.TEA.2010.0395, 10.1089/ten.tea.2010.0395]
   Hunziker EB, 2003, OSTEOARTHR CARTILAGE, V11, P320, DOI 10.1016/S1063-4584(03)00031-1
   Jiang J, 2010, ANN BIOMED ENG, V38, P2183, DOI 10.1007/s10439-010-0038-y
   Jones AC, 2007, BIOMATERIALS, V28, P2491, DOI 10.1016/j.biomaterials.2007.01.046
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011
   LEBOY PS, 1991, J CELL PHYSIOL, V146, P370, DOI 10.1002/jcp.1041460306
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Oreffo ROC, 1999, BONE, V25, p5S, DOI 10.1016/S8756-3282(99)00124-6
   Patel M, 2010, J BIOMED MATER RES A, V94A, P408, DOI 10.1002/jbm.a.32683
   Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Triffitt JT, 2002, J BIOMED MATER RES, V63, P384, DOI 10.1002/jbm.10260
   Vaezi M, 2013, INT J ADV MANUF TECH, V67, P1721, DOI 10.1007/s00170-012-4605-2
NR 44
TC 68
Z9 73
U1 10
U2 183
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1860-6768
EI 1860-7314
J9 BIOTECHNOL J
JI Biotechnol. J.
PD OCT
PY 2014
VL 9
IS 10
BP 1304
EP 1311
DI 10.1002/biot.201400305
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AQ4ZA
UT WOS:000342809300010
PM 25130390
DA 2018-10-20
ER

PT J
AU Calasans-Maia, M
   Resende, R
   Fernandes, G
   Calasans-Maia, J
   Alves, AT
   Granjeiro, JM
AF Calasans-Maia, Monica
   Resende, Rodrigo
   Fernandes, Gustavo
   Calasans-Maia, Jose
   Alves, Adriana Terezinha
   Granjeiro, Jose Mauro
TI A randomized controlled clinical trial to evaluate a new xenograft for
   alveolar socket preservation
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone implant interactions; bone substitutes; clinical research; clinical
   trials
ID EXTRACTION SOCKETS; RIDGE PRESERVATION; TOOTH EXTRACTION;
   CALCIUM-SULFATE; BONE; GRAFT; HUMANS; IMPLANT
AB Objective: The aim of this clinical trial was to compare the effect of Bio-Oss (R) and a new bovine xenograft (Osseus (R)) in alveolar sockets after a 24-week healing period.
   Materials and methods: A total of 20 adult volunteers ages 30-60 were subjected to single tooth extraction. A tooth extraction was performed at the baseline. All sites were randomly allocated to two test groups (TG1: grafted using a new bovine xenograft, Osseus (R), and TG2: grafted using commercially available bovine xenograft-Bio-Oss (R)). Six months later, a sample of the grafted area was obtained and implants were inserted in the same site. Histological sections were examined focusing on the presence of fibrous connective tissue (CT), and newly formed bone in direct contact with the graft. The HE-stained sections were subjected to histomorphometrical evaluation using Image Pro-Plus (R) software (Release 7.0). The definitive crown was placed 3 months later.
   Results: Upon completion of the study, no patients were removed from the study and all inserted implants (10 in each group) were eventually integrated. After 6 months, in the TG1, the mean value of new bone formation was 33.7 (+/- 7.1), for CT was 32.3 (+/- 8.9) and for the remaining biomaterial was 10.7 (+/- 16.2). In the TG2, the mean value of new bone formation was 19.3 (+/- 22.6), of the CT was 49.9 (+/- 14.1) and of the remaining biomaterial was 22.6 (+/- 7.9).
   Conclusions: No statistically significant difference was observed between TG1 and TG2 after 6 months (P > 0.05), and both biomaterials afforded a more favorable implant position.
C1 [Calasans-Maia, Monica; Resende, Rodrigo] Univ Fed Fluminense, Dept Oral Surg, Niteroi, RJ, Brazil.
   [Fernandes, Gustavo] Univ Fed Fluminense, Cell & Mol Biol Dept, Niteroi, RJ, Brazil.
   [Calasans-Maia, Jose] Univ Fed Fluminense, Dept Orthodont, Nova Friburgo, Brazil.
   [Alves, Adriana Terezinha] Univ Gama Filho, Dept Oral Pathol, Rio De Janeiro, Brazil.
   [Granjeiro, Jose Mauro] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Granjeiro, Jose Mauro] Natl Inst Metrol Standardizat & Ind Qual, Bioengn Program, Duque De Caxias, Brazil.
RP Calasans-Maia, M (reprint author), Univ Fed Fluminense, Dept Oral Surg, Rua Mario Santos Braga 30 Ctr, BR-24020140 Rio De Janeiro, Brazil.
EM monicacalasansmaia@gmail.com
RI Calasans-Maia, Monica/G-6203-2013; Calasans-Maia, Jose/G-5270-2013
OI Fernandes, Gustavo/0000-0003-3022-4390; Granjeiro,
   Jose/0000-0002-8027-8293
FU Sistema de Implantes Nacional, Sao Paulo, Brazil (SIN)
FX The authors thank Sistema de Implantes Nacional, Sao Paulo, Brazil (SIN)
   for providing financial support for this study. We also want to express
   our thanks to Dr. Alfredo Schnetzler Neto and Frederico,
   Prosthodontists, Rio de Janeiro, Brazil for his significant
   contributions to developing the prosthodontic rehabilitation.
CR Araujo M. G., 2011, CLIN ORAL IMPLAN RES, V1, P9
   Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Brkovic BMB, 2012, CLIN ORAL INVEST, V16, P581, DOI 10.1007/s00784-011-0531-1
   Calasans-Maia MD, 2009, ACTA ORTOP BRAS, V17, P340, DOI 10.1590/S1413-78522009000600005
   Fernandes PG, 2011, J PERIODONTOL, V82, P72, DOI 10.1902/jop.2010.100241
   Festa V. M., 2011, CLIN IMPLANT DENT R, DOI [10.1111/j.1708-8208.2011.00398.x, DOI 10.1111/J.1708-8208.2011.00398.X.]
   Gonshor A., 2011, INT J ORAL IMPLANTOL, V2, P79
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Hammerle CHF, 2012, CLIN ORAL IMPLAN RES, V23, P80, DOI 10.1111/j.1600-0501.2011.02370.x
   Heberer S, 2011, INT J ORAL MAX IMPL, V26, P385
   Jardelino-Lima C, 2008, KEY ENG MATER, V3, P396
   Kutkut A, 2012, J PERIODONTOL, V83, P401, DOI 10.1902/jop.2011.110237
   Mardas N, 2011, CLIN ORAL IMPLAN RES, V22, P416, DOI 10.1111/j.1600-0501.2010.02154.x
   Morjaria K. R., 2012, CLIN IMPLANT DENT R, DOI [10.1111/j.1708-8208.2012.00450.x, DOI 10.1111/J.1708-8208.2012.00450.X.]
   Munhoz EA, 2006, DENTOMAXILLOFAC RAD, V35, P371, DOI 10.1259/dmfr/64880289
   Pelegrine AA, 2010, CLIN ORAL IMPLAN RES, V21, P535, DOI 10.1111/j.1600-0501.2009.01891.x
   Ruga E, 2011, J CRANIOFAC SURG, V22, P494, DOI 10.1097/SCS.0b013e318208bb21
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421
   Sisti A, 2012, CLIN ORAL IMPLAN RES, V23, P526, DOI 10.1111/j.1600-0501.2011.02386.x
   Spinato S, 2012, IMPLANT DENT, V21, P97, DOI 10.1097/ID.0b013e318248866c
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Ten Heggeler JMAG, 2011, CLIN ORAL IMPLAN RES, V22, P779, DOI 10.1111/j.1600-0501.2010.02064.x
   Van der Weijden F, 2009, J CLIN PERIODONTOL, V36, P1048, DOI 10.1111/j.1600-051X.2009.01482.x
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
   Wood RA, 2012, J PERIODONTOL, V83, P329, DOI 10.1902/jop.2011.110270
   Zambuzzi W. F., 2011, J MATER SCI, V22
   Zambuzzi WF, 2012, CLIN ORAL IMPLAN RES, V23, P367, DOI 10.1111/j.1600-0501.2010.02143.x
NR 29
TC 15
Z9 15
U1 0
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2014
VL 25
IS 10
BP 1125
EP 1130
DI 10.1111/clr.12237
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AQ6FG
UT WOS:000342904800004
PM 23937306
DA 2018-10-20
ER

PT J
AU Wildburger, A
   Payer, M
   Jakse, N
   Strunk, D
   Etchard-Liechtenstein, N
   Sauerbier, S
AF Wildburger, Angelika
   Payer, Michael
   Jakse, Norbert
   Strunk, Dirk
   Etchard-Liechtenstein, Nathalie
   Sauerbier, Sebastian
TI Impact of autogenous concentrated bone marrow aspirate on bone
   regeneration after sinus floor augmentation with a bovine bone
   substitute - a split-mouth pilot study
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE bone regeneration; bone substitutes; clinical research; clinical trials;
   guided tissue regeneration; sinus floor elevation
ID MESENCHYMAL STEM-CELLS; RANDOMIZED CLINICAL-TRIAL; BETA-TRICALCIUM
   PHOSPHATE; PLATELET-RICH PLASMA; HISTOMORPHOMETRIC EVALUATION; DENTAL
   IMPLANTS; GROWTH-FACTORS; IN-VITRO; MAXILLARY; ELEVATION
AB Purpose: Mesenchymal stem cells (MSC) with biomaterials have osteoinductive potential. The aim of this study was to evaluate early bone formation in xenogenic sinus grafts in a direct comparison with and without MSCs after 3 and 6 months. Literature on bone formation in pure xenogenic graft materials after 3 months in a human model is still lacking.
   Materials and methods: In a split-mouth design, seven patients with a bilateral highly atrophic posterior maxilla were included. The test side was grafted with MSCs from concentrated bone marrow aspirate admixed to the bone graft material. On the control side, pure bovine bone material was applied. Biopsies were taken navigated after 3 and 6 months.
   Results: After 3 months, new bone formation in the control group was 11.8% (SD 6.2%) and in the test group 7.4% (SD 4.1%). After 6 months, the control group showed 13.9% (SD 8.5%) of new bone and the test group 13.5% NB (SD 5.4%). The fraction of bovine bone material after 3 months was 42.6% (SD 3.5%) in the test group and 34.9% (SD 11.8%) in the control group. After 6 months, the biomaterial content was comparable at both sides (test 36.2%, SD 7.8%; control 39.5%, SD 9.3%).
   Conclusions: There was no significant difference in new bone formation between the test and control group with n = 7. The results may be dominated by the high mineral content of the biomaterial but could nevertheless be valuable for meta-analysis in the future.
C1 [Wildburger, Angelika; Payer, Michael; Jakse, Norbert] Med Univ Graz, Dept Oral Surg & Radiol, A-8044 Graz, Austria.
   [Strunk, Dirk] Paracelsus Med Univ, Inst Expt & Clin Cell Therapy, Salzburg, Austria.
   [Strunk, Dirk] Paracelsus Med Univ, Spinal Cord Injury Tissue Regenerat Ctr, Salzburg, Austria.
   [Etchard-Liechtenstein, Nathalie] Med Univ Graz, Stem Cell Res Unit, Graz, Austria.
   [Sauerbier, Sebastian] Med Univ Freiburg, Dept Oral & Maxillofacial Surg, Freiburg, Germany.
RP Wildburger, A (reprint author), Med Univ Graz, Dept Oral Surg & Radiol, Auenbruggerpl 12, A-8044 Graz, Austria.
EM angelika.wildburger@medunigraz.at
RI Strunk, Dirk/V-4598-2017
OI Strunk, Dirk/0000-0003-1810-867X
FU GeistlichPharma AG (Wolhusen, Switzerland)
FX The bovine bone material for the sinus augmentation and the preparation
   of the biopsies were funded by GeistlichPharma AG (Wolhusen,
   Switzerland). The BMAC (R) centrifuge for the concentration process of
   the bone marrow aspirate was provided by the Harvest Technologies
   Corporation (Plymouth, MA, USA).
CR Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P445, DOI 10.1111/j.1600-0501.2009.01876.x
   Beaumont C, 2008, J PERIODONTOL, V79, P541, DOI 10.1902/jop.2008.070255 
   Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Chackartchi T, 2011, CLIN ORAL IMPLAN RES, V22, P473, DOI 10.1111/j.1600-0501.2010.02032.x
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Fuerst G, 2004, CLIN ORAL IMPLAN RES, V15, P733, DOI 10.1111/j.1600-0501.2004.01077.x
   Fuerst G, 2009, CLIN ORAL IMPLAN RES, V20, P135, DOI 10.1111/j.1600-0501.2008.01624.x
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P221, DOI 10.1111/j.1600-0501.2009.01827.x
   Gonshor A, 2011, INT J ORAL MAX IMPL, V26, P123
   Gruber R, 2004, CLIN ORAL IMPLAN RES, V15, P575, DOI 10.1111/j.1600-0501.2004.01062.x
   Gutwald R, 2010, BRIT J ORAL MAX SURG, V48, P285, DOI 10.1016/j.bjoms.2009.06.226
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hallman M, 2008, PERIODONTOL 2000, V47, P172, DOI 10.1111/j.1600-0757.2008.00251.x
   Hermann PC, 2007, CELL TRANSPLANT, V16, P1059, DOI 10.3727/000000007783472363
   Herten M, 2009, CLIN ORAL INVEST, V13, P149, DOI 10.1007/s00784-008-0214-8
   Jakse N, 2001, CLIN ORAL IMPLAN RES, V12, P488, DOI 10.1034/j.1600-0501.2001.120509.x
   Jakse N, 2003, CLIN ORAL IMPLAN RES, V14, P578, DOI 10.1034/j.1600-0501.2003.00928.x
   Jakse N, 2007, CLIN ORAL IMPLAN RES, V18, P517, DOI 10.1111/j.1600-0501.2007.01369.x
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Kasten P, 2008, EUR CELLS MATER, V16, P47, DOI 10.22203/eCM.v016a06
   KENT JN, 1989, J ORAL MAXIL SURG, V47, P238, DOI 10.1016/0278-2391(89)90225-5
   Khaled E G, 2011, Open Orthop J, V5 Suppl 2, P289, DOI 10.2174/1874325001105010289
   Kirmeier R, 2008, CLIN ORAL IMPLAN RES, V19, P366, DOI 10.1111/j.1600-0501.2007.01487.x
   Klein M, 2009, CLIN ORAL IMPLAN RES, V20, P67, DOI 10.1111/j.1600-0501.2008.01605.x
   Lundgren S, 2008, PERIODONTOL 2000, V47, P193, DOI 10.1111/j.1600-0757.2008.00264.x
   Pieri F, 2008, J CLIN PERIODONTOL, V35, P539, DOI 10.1111/j.1600-051X.2008.01220.x
   Rickert D, 2011, CLIN ORAL IMPLAN RES, V22, P251, DOI 10.1111/j.1600-0501.2010.01981.x
   Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P215, DOI [10.1089/ten.tec.2009.0269, 10.1089/ten.TEC.2009.0269]
   Sauerbier S, 2011, TISSUE ENG PT A, V17, P2187, DOI [10.1089/ten.tea.2010.0516, 10.1089/ten.TEA.2010.0516]
   Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P1033, DOI 10.1089/ten.TEC.2009.0734
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Seeger FH, 2007, EUR HEART J, V28, P766, DOI 10.1093/eurheartj/ehl509
   Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001
   Szabo G, 2005, INT J ORAL MAX IMPL, V20, P371
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom2007.05.023
   Thorwarth M, 2006, ORAL SURG ORAL MED O, V101, P309, DOI 10.1016/j.tripleo.2005.04.024
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P256, DOI 10.1034/j.1600-0501.2000.011003256.x
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
NR 43
TC 13
Z9 14
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2014
VL 25
IS 10
BP 1175
EP 1181
DI 10.1111/clr.12228
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AQ6FG
UT WOS:000342904800011
PM 23875876
DA 2018-10-20
ER

PT J
AU Barreiros, VCP
   Dias, FJ
   Iyomasa, MM
   Coutinho-Netto, J
   de Sousa, LG
   Fazan, VPS
   Antunes, RD
   Watanabe, IS
   Issa, JPM
AF Pereira Barreiros, Vanessa Cristina
   Dias, Fernando Jose
   Iyomasa, Mamie Mizusaki
   Coutinho-Netto, Joaquim
   de Sousa, Luiz Gustavo
   Sassoli Fazan, Valeria Paula
   Antunes, Ricardo de Souza
   Watanabe, Ii-sei
   Mardegan Issa, Joao Paulo
TI Morphological and morphometric analyses of crushed sciatic nerves after
   application of a purified protein from natural latex and hyaluronic acid
   hydrogel
SO GROWTH FACTORS
LA English
DT Article
DE Hyaluronic acid hydrogel - HAH; peripheral nerve injury; morphology and
   morphometry; natural latex protein-F1
ID SPINAL-CORD-INJURY; PERIPHERAL-NERVES; REGENERATION; MODEL; FIBERS;
   RATS; BIOMEMBRANE; SIZE
AB Hyaluronic acid hydrogels (HAHs) have been used as a carrier of substances and factors in the repair of nervous tissue. Natural latex protein (Hevea brasiliensis, F1) has shown positive effects in treating various types of tissues, including peripheral nerves. This study evaluated the F1 associated with a HAH in a controlled crush injury (axonotmesis) of the sciatic nerve in Wistar rats. The samples were photomicrographed for morphometric and quantitative analyzes using ImageJ 1.47k software (NIH, Bethesda, MD). Morphological, quantitative (myelin area/nerve area ratio and capillary density) and morphometric (minimum nerve fiber diameter, G-Ratio) data revealed an improvement in the recovery of the sciatic nerve with the application of HAH and the combination of HAH and F1 after 4 and 8 weeks of nerve injury. The most efficacious results were observed with the combination of both substances, F1 and HAH, revealing the regenerative capacity of this new biomaterial, which was hardly tested on nerve tissue.
C1 [Pereira Barreiros, Vanessa Cristina; Iyomasa, Mamie Mizusaki; Antunes, Ricardo de Souza; Mardegan Issa, Joao Paulo] Univ Sao Paulo, Sch Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Dias, Fernando Jose; de Sousa, Luiz Gustavo; Watanabe, Ii-sei] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil.
   [Dias, Fernando Jose; Coutinho-Netto, Joaquim; Sassoli Fazan, Valeria Paula] Univ Sao Paulo, Sch Med Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil.
RP Issa, JPM (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Morphol Physiol & Pathol Basic, S-N Cafe Ave, BR-14040904 Ribeirao Preto, SP, Brazil.
EM jpmissa@forp.usp.br
RI Issa, Joao Paulo/A-2505-2011; WATANABE, II-SEI/G-1461-2016
OI Issa, Joao Paulo/0000-0002-1056-0795; Dias, Fernando
   Jose/0000-0001-9945-9185
FU FAPESP [2011/01983-2]
FX The authors are grateful to FAPESP (process no. 2011/01983-2) for the
   financial support of this study.
CR Andrade Luiz Carlos de, 2009, Rev. Col. Bras. Cir., V36, P431, DOI 10.1590/S0100-69912009000500012
   Andrade TAM, 2011, BRAZ J MED BIOL RES, V44, P1036, DOI 10.1590/S0100-879X2011007500116
   Arino H, 2008, SCAND J PLAST RECONS, V42, P281, DOI 10.1080/02844310802393966
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Behmer AO, 1976, MANUAL TECHNIQUES NO, P256
   Mazzer PYCN, 2008, J NEUROSCI METH, V173, P249, DOI 10.1016/j.jneumeth.2008.06.019
   Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754
   Conovaloff A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056003
   Domingos ALA, 2009, INT BRAZ J UROL, V35, P217, DOI 10.1590/S1677-55382009000200012
   Dubovy P, 2011, ANN ANAT, V193, P267, DOI 10.1016/j.aanat.2011.02.011
   Geuna S, 2001, ANAT EMBRYOL, V204, P1, DOI 10.1007/s004290100188
   HOFFMAN PN, 1995, NEUROSCIENTIST, V1, P76, DOI DOI 10.1177/107385849500100204
   HOLM S, 1979, SCAND J STAT, V6, P65
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Li BH, 2012, OR SURG OR MED OR PA, V113, pE26, DOI 10.1016/j.tripleo.2011.07.002
   de Albornoz PM, 2011, BRIT MED BULL, V100, P73, DOI 10.1093/bmb/ldr005
   Mendonca RJ, 2010, PHYTOTHER RES, V24, P64
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   Muratori L, 2012, MICROSURG, V32, P383, DOI 10.1002/micr.21969
   Oliveira EF, 2001, J RECONSTR MICROSURG, V17, P68
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Raimondo S, 2011, ANN ANAT, V193, P334, DOI 10.1016/j.aanat.2011.03.001
   Raimondo S, 2009, INT REV NEUROBIOL, V87, P81, DOI 10.1016/S0074-7742(09)87005-0
   RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655
   Sampaio RB, 2010, CURR EYE RES, V35, P56, DOI 10.3109/02713680903374216
   Santos AP, 2012, LASER MED SCI, V27, P479, DOI 10.1007/s10103-011-0972-4
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008
NR 28
TC 7
Z9 7
U1 0
U2 17
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0897-7194
EI 1029-2292
J9 GROWTH FACTORS
JI Growth Factors
PD OCT
PY 2014
VL 32
IS 5
BP 164
EP 170
DI 10.3109/08977194.2014.952727
PG 7
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA AQ7MK
UT WOS:000343001700004
PM 25257251
DA 2018-10-20
ER

PT J
AU Major, TC
   Handa, H
   Annich, GM
   Bartlett, RH
AF Major, Terry C.
   Handa, Hitesh
   Annich, Gail M.
   Bartlett, Robert H.
TI Development and hemocompatibility testing of nitric oxide releasing
   polymers using a rabbit model of thrombogenicity
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Review
DE Hemocompatibilty; extracorporeal life support; rabbit thrombogenicity
   model; platelets; monocytes; thrombosis; cGMP; P-VASP pathway
ID VASODILATOR-STIMULATED PHOSPHOPROTEIN; CARDIOPULMONARY BYPASS CIRCUITS;
   HEPARIN-COATED CIRCUITS; EXTRACORPOREAL LIFE-SUPPORT; SERINE 239
   PHOSPHORYLATION; PLATELET COUNT DROP; IN-VITRO; WHOLE-BLOOD;
   INFLAMMATORY RESPONSE; SYSTEMIC ANTICOAGULATION
AB Hemocompatibility is the goal for any biomaterial contained in extracorporeal life supporting medical devices. The hallmarks for hemocompatibility include nonthrombogenicity, platelet preservation, and maintained platelet function. Both in vitro and in vivo assays testing for compatibility of the blood/biomaterial interface have been used over the last several decades to ascertain if the biomaterial used in medical tubing and devices will require systemic anticoagulation for viability. Over the last 50 years systemic anticoagulation with heparin has been the gold standard in maintaining effective extracorporeal life supporting. However, the biomaterial that maintains effective ECLS without the use of any systemic anticoagulant has remained elusive. In this review, the in vivo 4-h rabbit thrombogenicity model genesis will be described with emphasis on biomaterials that may require no systemic anticoagulation for extracorporeal life supporting longevity. These novel biomaterials may improve extracorporeal circulation hemocompatibility by preserving near resting physiology of the major blood components, the platelets and monocytes. The rabbit extracorporeal circulation model provides a complete assessment of biomaterial interactions with the intrinsic coagulation players, the circulating platelet and monocytes. This total picture of blood/biomaterial interaction suggests that this rabbit thrombogenicity model could provide a standardization for biomaterial hemocompatibility testing.
C1 [Major, Terry C.; Handa, Hitesh; Bartlett, Robert H.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI 48109 USA.
   [Annich, Gail M.] Univ Michigan Hlth Syst, Dept Pediat, Ann Arbor, MI 48109 USA.
RP Major, TC (reprint author), Univ Michigan Hlth Syst, Dept Gen Surg, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.
EM tcmajor@umich.edu
FU National Institutes of Health [R21EB016236, K25HL111213]
FX The authors declare this work is supported by National Institutes of
   Health grants R21EB016236 and K25HL111213. Authors thank Cindy Cooke for
   editing this manuscript.
CR ADDONIZIO VP, 1982, BIOMATERIALS, V3, P9, DOI 10.1016/0142-9612(82)90054-0
   Adrian K, 2003, ARTIF ORGANS, V27, P570, DOI 10.1046/j.1525-1594.2003.07106.x
   Aktas B, 2003, STROKE, V34, P764, DOI 10.1161/01.STR.0000056527.34434.59
   Ambert-Balay K, 2013, J CLIN VIROL, V56, P194, DOI 10.1016/j.jcv.2012.11.001
   Amoako KA, 2013, J BIOMED MAT RES A
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Annich G, 1999, THROMB HAEMOSTASIS, V82, P1474
   Annich GM, 2000, CRIT CARE MED, V28, P915, DOI 10.1097/00003246-200004000-00001
   ASKEW SC, 1995, BIOORGAN MED CHEM, V3, P1, DOI 10.1016/0968-0896(94)00139-T
   Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37
   Barstad RM, 1998, THROMB HAEMOSTASIS, V79, P302
   Batchelor MM, 2003, J MED CHEM, V46, P5153, DOI 10.1021/jm030286t
   Begonja AJ, 2006, BLOOD CELL MOL DIS, V36, P166, DOI 10.1016/j.bcmd.2005.12.028
   Bhujle R, 1997, ASAIO J, V43, pM739
   Bolton FJ, 2000, J AOAC INT, V83, P299
   Bossavy JP, 1999, ARTERIOSCL THROM VAS, V19, P1348, DOI 10.1161/01.ATV.19.5.1348
   Bossavy JP, 1999, ANN VASC SURG, V13, P393, DOI 10.1007/s100169900274
   Brisbois EJ, 2013, BIOMATERIALS, V34, P6957, DOI 10.1016/j.biomaterials.2013.05.063
   Bruin JP, 2012, J INFECTION, V64, P113, DOI 10.1016/j.jinf.2011.10.001
   BUSSE R, 1995, ANN MED, V27, P331, DOI 10.3109/07853899509002586
   BUTT E, 1994, J BIOL CHEM, V269, P14509
   Byun Y, 1992, ASAIO J, V38, pM649, DOI 10.1097/00002480-199207000-00117
   Cardinal KO, 2006, TISSUE ENG, V12, P3431, DOI 10.1089/ten.2006.12.3431
   Chatterjee K, 2009, J BIOMED MATER RES A, V90A, P27, DOI 10.1002/jbm.a.32076
   Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021
   Chinkhumba J, 2012, AM J TROP MED HYG, V86, P199, DOI 10.4269/ajtmh.2012.11-0350
   Cho CH, 2013, J VIROL METHODS, V187, P51, DOI 10.1016/j.jviromet.2012.09.003
   Colman RW, 2006, J EXP MED, V203, P493, DOI 10.1084/jem.20060217
   COLMAN RW, 1990, ANN THORAC SURG, V49, P32, DOI 10.1016/0003-4975(90)90352-7
   Conn G, 2006, EXPERT REV MED DEVIC, V3, P245, DOI 10.1586/17434440.3.2.245
   Cunningham MT, 2002, ARCH PATHOL LAB MED, V126, P499
   Dalabih Abdallah, 2012, J Extra Corpor Technol, V44, P75
   Dornia C, 2013, ASAIO J, V59, P439, DOI 10.1097/MAT.0b013e3182976eff
   Durand PY, 2000, J RECONSTR MICROSURG, V16, P465, DOI 10.1055/s-2006-947154
   Ebert RF, 1991, INDEX VARIANT HUMAN, P434
   EIGENTHALER M, 1993, J BIOL CHEM, V268, P13526
   Ereth MH, 2001, J CARDIOTHOR VASC AN, V15, P545, DOI 10.1053/jcan.2001.26525
   Eynden FV, 2008, J CARDIAC SURG, V23, P288, DOI 10.1111/j.1540-8191.2008.00682.x
   Falk J, 1998, J VASC SURG, V27, P902, DOI 10.1016/S0741-5214(98)70271-X
   Fiers T, 2012, J CHROMATOGR B, V893, P57, DOI 10.1016/j.jchromb.2012.02.034
   Flom-Halvorsen HI, 2002, PERFUSION-UK, V17, P339, DOI 10.1191/0267659102pf594oa
   FOSSE E, 1994, ANN THORAC SURG, V58, P472, DOI 10.1016/0003-4975(94)92231-4
   Frank RD, 2006, NEPHROL DIAL TRANSPL, V21, P1013, DOI 10.1093/ndt/gfi293
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Fukutomi M, 1996, ARTIF ORGANS, V20, P767, DOI 10.1111/j.1525-1594.1996.tb04538.x
   Gaffney AM, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5317
   Gbadegesin R, 2009, PEDIATR NEPHROL, V24, P589, DOI 10.1007/s00467-008-1047-z
   Geer CB, 2008, BIOMACROMOLECULES, V9, P1876, DOI 10.1021/bm800146j
   Gorog DA, 2013, J AM COLL CARDIOL, V61, P2115, DOI 10.1016/j.jacc.2012.11.080
   Goud C, 1999, GEN PHARMACOL, V32, P51, DOI 10.1016/S0306-3623(98)00059-7
   GRABOWSKI EF, 1977, T AM SOC ART INT ORG, V23, P141
   Hamad OA, 2012, ADV EXP MED BIOL, V946, P185, DOI 10.1007/978-1-4614-0106-3_11
   Handa HB, 2013, J AM CHEM SOC, V65
   Handa H, 2013, J MATER CHEM B, V1, P3578, DOI 10.1039/c3tb20277a
   Harig F, 1999, THORAC CARDIOV SURG, V47, P111, DOI 10.1055/s-2007-1013121
   Harig F, 2001, SHOCK, V16, P33, DOI 10.1097/00024382-200116001-00007
   Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   Heemskerk JWM, 2013, J THROMB HAEMOST, V11, P2, DOI 10.1111/jth.12045
   Hernandez MR, 2004, FUND CLIN PHARMACOL, V18, P423, DOI 10.1111/j.1472-8206.2004.00256.x
   Hogevold HE, 1997, PERFUSION-UK, V12, P9, DOI 10.1177/026765919701200103
   Hong J, 2001, J LAB CLIN MED, V138, P139, DOI 10.1067/mlc.2001.116486
   HUANG SM, 1993, J BIOL CHEM, V268, P8919
   Huang XJ, 2011, MACROMOL BIOSCI, V11, P131, DOI 10.1002/mabi.201000278
   Hussaini BE, 2009, PERFUSION-UK, V24, P317, DOI 10.1177/0267659109353818
   Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312
   Cerda-Cristerna BI, 2011, J CONTROL RELEASE, V153, P269, DOI 10.1016/j.jconrel.2011.04.016
   Janvier G, 1996, ANN THORAC SURG, V62, P1926, DOI 10.1016/S0003-4975(96)00942-3
   Kallmes DF, 1998, NEURORADIOLOGY, V40, P530, DOI 10.1007/s002340050641
   Kanade Swapna, 2012, Indian J Tuberc, V59, P92
   Kawai T, 1999, ASAIO J, V45, P478, DOI 10.1097/00002480-199909000-00021
   Kelly BS, 2002, KIDNEY INT, V62, P2272, DOI 10.1046/j.1523-1755.2002.00684.x
   Kim HS, 2012, J VIROL METHODS, V186, P94, DOI 10.1016/j.jviromet.2012.08.014
   Kjaergaard B, 2009, THROMB RES, V124, P226, DOI 10.1016/j.thromres.2009.01.010
   Klinkhardt U, 2003, CLIN PHARMACOL THER, V73, P232, DOI 10.1067/mcp.2003.13
   Kocakulak M, 2006, J BIOMAT SCI-POLYM E, V17, P449, DOI 10.1163/156856206776374098
   Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55
   Koster A, 2000, ASAIO J, V46, P319, DOI 10.1097/00002480-200005000-00015
   Lamarche Y, 2010, INNOVATIONS, V5, P424, DOI 10.1097/IMI.0b013e3182029a83
   LANE DA, 1994, NEPHROL DIAL TRANSPL, V9, P18
   Lau CL, 1999, PERFUSION-UK, V14, P389, DOI 10.1177/026765919901400511
   Leoncini G, 2005, BIOCHEM PHARMACOL, V69, P289, DOI 10.1016/j.bcp.2004.09.022
   LINDHOUT T, 1994, NEPHROL DIAL TRANSPL, V9, P83
   Lo B, 2004, ANESTH ANALG, V99, P634, DOI 10.1213/ANE.0000130257.64006.5C
   Major TC, 2013, BIOMATERIALS, V34, P8086, DOI 10.1016/j.biomaterials.2013.07.041
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   Major TC, 2010, BIOMATERIALS, V31, P2736, DOI 10.1016/j.biomaterials.2009.12.028
   Martens S, 2001, INT J ARTIF ORGANS, V24, P484
   Maruyama I, 1998, LUPUS, V7, pS41, DOI 10.1177/096120339800700210
   Massaguer A, 2000, TISSUE ANTIGENS, V56, P117, DOI 10.1034/j.1399-0039.2000.560202.x
   McClung W, 2007, J BIOMED MATER RES A, V81A, P644, DOI 10.1002/jbm.a.31018
   Mehran R, 2003, CIRCULATION, V108, P1078, DOI 10.1161/01.CIR.0000086347.31341.F9
   Meinhardt JP, 2003, ASAIO J, V49, P395, DOI 10.1097/01.MAT.0000074113.82547.C8
   Mesana T, 2000, ARTIF ORGANS, V24, P431, DOI 10.1046/j.1525-1594.2000.06594.x
   Moen O, 1996, PERFUSION-UK, V11, P113, DOI 10.1177/026765919601100205
   MOEN O, 1995, ANN THORAC SURG, V60, P1317, DOI 10.1016/0003-4975(95)00777-I
   Moen O, 1996, ANN THORAC SURG, V62, P1134, DOI 10.1016/0003-4975(96)00492-4
   Mueller XM, 2002, ASAIO J, V48, P483, DOI 10.1097/01.MAT.0000026349.66193.66
   Munch K, 2000, J BIOMAT SCI-POLYM E, V11, P1147, DOI 10.1163/156856200744246
   Newland Richard F, 2012, J Extra Corpor Technol, V44, P53
   Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6
   Nsagha DS, 2012, AFR HEALTH SCI, V12, P276, DOI 10.4314/ahs.v12i3.5
   Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999
   Ogouyemi-Hounto A, 2013, Bull Soc Pathol Exot, V106, P27, DOI 10.1007/s13149-012-0264-7
   Ottens Jane, 2010, J Extra Corpor Technol, V42, P153
   Ovrum E, 2001, J THORAC CARDIOV SUR, V121, P324, DOI 10.1067/mtc.2001.111205
   Palanzo DA, 1999, PERFUSION-UK, V14, P195, DOI 10.1177/026765919901400307
   Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403
   Palatianos GM, 2003, ANN THORAC SURG, V76, P129, DOI 10.1016/S0003-4975(03)00338-2
   Palmer K., 1995, Perfusion, V10, P307, DOI 10.1177/026765919501000505
   Pappalardo F, 2009, PERFUSION-UK, V24, P135, DOI 10.1177/0267659109106773
   Park KS, 2012, ANN LAB MED, V32, P79, DOI 10.3343/alm.2012.32.1.79
   Picot J, 2012, HEALTH TECHNOL ASSES, V16, pIX, DOI 10.3310/hta16190
   Preston Thomas J, 2010, J Extra Corpor Technol, V42, P199
   RADOMSKI MW, 1993, ADV EXP MED BIOL, V344, P251
   RADOMSKI MW, 1993, CARDIOVASC RES, V27, P1380, DOI 10.1093/cvr/27.7.1380
   RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1
   Rajagopal SK, 2010, CRIT CARE MED, V38, P382, DOI 10.1097/CCM.0b013e3181bc8293
   Ranucci M, 2002, INT J ARTIF ORGANS, V25, P875
   Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076
   Ratner BD, 2013, BIOMATERIALS SCI, P617
   REDMOND JM, 1993, ANN THORAC SURG, V56, P474, DOI 10.1016/0003-4975(93)90882-I
   Reser D, 2012, PERFUSION-UK, V27, P530, DOI 10.1177/0267659112454558
   Reynolds MM, 2011, ORGANOGENESIS, V7, P42, DOI 10.4161/org.7.1.14029
   Reynolds MM, 2004, FREE RADICAL BIO MED, V37, P926, DOI 10.1016/j.freeradbiomed.2004.06.019
   Riesenfeld J, 1995, Med Device Technol, V6, P24
   Saenz A, 1996, EUR J CARDIO-THORAC, V10, P48, DOI 10.1016/S1010-7940(96)80265-X
   Saito N, 2000, ARTIF ORGANS, V24, P547, DOI 10.1046/j.1525-1594.2000.06520.x
   Sato Y, 2005, J THORAC CARDIOV SUR, V130, P346, DOI 10.1016/j.jtcvs.2004.12.028
   Seeburger J, 2005, CIRCULATION, V112, pI224, DOI 10.1161/CIRCULATIONAHA.104.525378
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   SELLEVOLD OFM, 1994, ACTA ANAESTH SCAND, V38, P372, DOI 10.1111/j.1399-6576.1994.tb03910.x
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121
   Silpasakorn Saowaluk, 2012, J Med Assoc Thai, V95 Suppl 2, pS18
   Sinn S, 2011, J MATER SCI-MATER M, V22, P1521, DOI 10.1007/s10856-011-4335-2
   Skrzypchak AM, 2007, PERFUSION-UK, V22, P193, DOI 10.1177/0267659107080877
   Smolenski A, 1998, N-S ARCH PHARMACOL, V358, P134, DOI 10.1007/PL00005234
   Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029
   Sohn N, 2009, PERFUSION-UK, V24, P231, DOI 10.1177/0267659109351218
   Stammers A H, 1999, J Extra Corpor Technol, V31, P135
   Stasko NA, 2008, BIOMACROMOLECULES, V9, P834, DOI 10.1021/bm7011746
   Sudkamp M, 2002, THORAC CARDIOV SURG, V50, P5, DOI 10.1055/s-2002-20156
   Svenmarker S, 2002, SCAND CARDIOVASC J, V36, P241, DOI 10.1080/14017430260180418
   Svenmarker S, 2001, EUR J CARDIO-THORAC, V19, P47, DOI 10.1016/S1010-7940(00)00625-4
   Tayama E, 2000, ARTIF ORGANS, V24, P618, DOI 10.1046/j.1525-1594.2000.06615.x
   Teligui L, 2014, INTERACT CARDIOV TH, V18, P763, DOI 10.1093/icvts/ivu011
   Tepe G, 2006, BIOMATERIALS, V27, P643, DOI 10.1016/j.biomaterials.2005.06.004
   Tevaearai HT, 1999, INT J ARTIF ORGANS, V22, P629
   Thiara AS, 2010, PERFUSION-UK, V25, P9, DOI 10.1177/0267659110362822
   Toda R, 1996, Kyobu Geka, V49, P389
   Treacher DF, 2001, PERFUSION-UK, V16, P67, DOI 10.1177/026765910101600i110
   Tzoneva R, 2002, J BIOMAT SCI-POLYM E, V13, P1033, DOI 10.1163/156856202760319171
   Urban K, 2007, PERFUSION-UK, V22, P207, DOI 10.1177/0267659107081632
   Vadwai V, 2012, DIAGN MICR INFEC DIS, V74, P282, DOI 10.1016/j.diagmicrobio.2012.06.018
   Van Meurs K, 2005, ECMO EXTRACORPOREAL, p[xxiii, 625]
   van Oeveren W, 2012, INT J BIOMATER, DOI 10.1155/2012/673163
   vanderKamp KWHJ, 1997, INT J ARTIF ORGANS, V20, P43
   Vaughn MW, 1998, AM J PHYSIOL-HEART C, V274, pH2163, DOI 10.1152/ajpheart.1998.274.6.H2163
   Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011
   Vienken Joerg, 2008, Prilozi, V29, P25
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wendel HP, 1999, PERFUSION-UK, V14, P21, DOI 10.1177/026765919901400104
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Yoshizaki T, 2005, INT J ARTIF ORGANS, V28, P834
   Zhang HP, 2003, J AM CHEM SOC, V125, P5015, DOI 10.1021/ja0291538
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhou ZR, 2005, BIOMATERIALS, V26, P6506, DOI 10.1016/j.biomaterials.2005.04.046
   Zimmermann AK, 2004, ASAIO J, V50, P193, DOI 10.1097/01.MAT.0000123638.41808.59
   Zimmermann AK, 2007, J BIOMED MATER RES B, V80B, P433, DOI 10.1002/jbm.b.30614
NR 171
TC 14
Z9 14
U1 3
U2 27
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD OCT
PY 2014
VL 29
IS 4
BP 479
EP 501
DI 10.1177/0885328214538866
PG 23
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ4YK
UT WOS:000342807300001
PM 24934500
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Park, JI
   Yang, C
   Kim, YT
   Kim, MS
   Lee, JS
   Choi, SH
   Jung, UW
AF Park, Jung-Im
   Yang, Cheryl
   Kim, Young-Taek
   Kim, Min-Soo
   Lee, Jung-Seok
   Choi, Seong-Ho
   Jung, Ui-Won
TI Space maintenance using crosslinked collagenated porcine bone grafted
   without a barrier membrane in one-wall intrabony defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE crosslinked collagen; dog; periodontal regeneration; one-wall defect;
   porcine bone
ID PERIODONTAL REPAIR; MORPHOGENETIC PROTEIN-2; STRUCTURAL-PROPERTIES;
   WOUND STABILIZATION; RIDGE AUGMENTATION; DOGS; REGENERATION;
   IMPLANTATION; BIOMATERIAL; LINKING
AB The aim of this study was to determine the efficacy of crosslinked collagenated porcine bone (CPB) for the repair of surgically prepared one-wall intrabony defects in dogs. Buccolingually opened, one-wall, box-type periodontal defects (4 x 5 mm) were prepared bilaterally at the mesial side of the mandibular fourth premolars in beagle dogs (N = 5). Block-type CPB (4 x 5 x 5 mm) was placed on either the left or right side for the CPB site; the opposite site served as a sham-surgery control. Micro-computed tomographic and histological analyses were performed on block specimens obtained from the dogs after a 3-month healing period. There was less mean bone regeneration and cementum regeneration at the experimental sites than at the sham-surgery con-trol sites. Most of the porcine bone particles were located under the floor of the defect and were sequestered from pristine bone. These findings show that CPB can be localized within the defect during the wound-healing period by a process of crosslinking; however, the application of CPB alone without a barrier membrane may not be effective in promoting periodontal regeneration in noncontained-type defects. (C) 2014 Wiley Periodicals, Inc.
C1 [Park, Jung-Im; Yang, Cheryl; Kim, Min-Soo; Lee, Jung-Seok; Choi, Seong-Ho; Jung, Ui-Won] Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
   [Park, Jung-Im; Kim, Young-Taek] Natl Hlth Insurance Serv Ilsan Hosp, Dept Periodont, Goyang, South Korea.
RP Jung, UW (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
EM drjew@yuhs.ac
OI Lee, Jung-Seok/0000-0003-1276-5978; Jung, Ui-Won/0000-0001-6371-4172
FU Korea Health Technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A120822]
FX Contract grant sponsor: Korea Health Technology R&D Project, Ministry of
   Health & Welfare, Republic of Korea; contract grant number: A120822
CR Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Barboza EP, 2000, J PERIODONTOL, V71, P488, DOI 10.1902/jop.2000.71.3.488
   BLUMENTHAL N, 1986, J PERIODONTOL, V57, P84, DOI 10.1902/jop.1986.57.2.84
   Bunyaratavej P, 2001, J PERIODONTOL, V72, P215, DOI 10.1902/jop.2001.72.2.215
   Cortellini P, 1996, J PERIODONTOL, V67, P217, DOI 10.1902/jop.1996.67.3.217
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   HANEY JM, 1993, J PERIODONTOL, V64, P883, DOI 10.1902/jop.1993.64.9.883
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Jung UW, 2011, J PERIODONTAL IMPLAN, V41, P285, DOI 10.5051/jpis.2011.41.6.285
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Kasaj Adrian, 2008, Head Face Med, V4, P22, DOI 10.1186/1746-160X-4-22
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x
   KODAMA T, 1989, J PERIODONTOL, V60, P205, DOI 10.1902/jop.1989.60.4.205
   Lee JS, 2012, J CLIN PERIODONTOL, V39, P466, DOI 10.1111/j.1600-051X.2012.01862.x
   MINABE M, 1989, J PERIODONTOL, V60, P35, DOI 10.1902/jop.1989.60.1.35
   NYSTROM E, 1995, INT J ORAL MAX SURG, V24, P20, DOI 10.1016/S0901-5027(05)80851-3
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Ramirez-Fernandez MP, 2011, CLIN ORAL IMPLAN RES, V22, P767, DOI 10.1111/j.1600-0501.2010.02058.x
   SELVIG KA, 1993, J PERIODONTOL, V64, P730, DOI 10.1902/jop.1993.64.8.730
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P511, DOI 10.1902/jop.1995.66.6.511
   Tal H, 2008, CLIN ORAL IMPLAN RES, V19, P760, DOI 10.1111/j.1600-0501.2008.01546.x
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 1997, J CLIN PERIODONTOL, V24, P366, DOI 10.1111/j.1600-051X.1997.tb00199.x
   Trombelli L, 2002, J CLIN PERIODONTO S3, V29, P160
   Verissimo DM, 2010, ACTA BIOMATER, V6, P4011, DOI 10.1016/j.actbio.2010.04.012
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   Wikesjo U M, 1995, J Calif Dent Assoc, V23, P30
   Wikesjo UME, 2003, J PERIODONTOL, V74, P635, DOI 10.1902/jop.2003.74.5.635
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
   WIKESJO UME, 1990, J PERIODONTOL, V61, P719, DOI 10.1902/jop.1990.61.12.719
   YEH CK, 1984, CALCIFIED TISSUE INT, V36, pS67, DOI 10.1007/BF02406136
NR 35
TC 5
Z9 5
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2014
VL 102
IS 7
BP 1454
EP 1461
DI 10.1002/jbm.b.33124
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ6ZS
UT WOS:000342963000010
PM 24574177
DA 2018-10-20
ER

PT J
AU Anilkumar, TV
   Vineetha, VP
   Revi, D
   Muhamed, J
   Rajan, A
AF Anilkumar, Thapasimuthu V.
   Vineetha, Vadavanath P.
   Revi, Deepa
   Muhamed, Jaseer
   Rajan, Akhila
TI Biomaterial properties of cholecyst-derived scaffold recovered by a
   non-detergent/enzymatic method
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE decellularized scaffold; acellular tissue-derived scaffold;
   cholecyst-derived scaffold; extracellular matrix; wound healing
ID SMALL-INTESTINAL SUBMUCOSA; EXTRACELLULAR-MATRIX; DECELLULARIZATION;
   FORMALDEHYDE; TISSUES; SIS
AB Isolation procedures for the recovery of extracellular matrices (ECMs) from animal organs/tissues that are useful in regenerative medicine involve multiple sequential steps/stages including collection of the source organ at slaughter, their transportation to laboratory, decellularization, decontamination, stabilization, and sterilization. Most of these steps require extensive use of chemicals/reagents/enzymes which may also adversely affect the quality of the scaffold. With an effort to minimize the use of chemicals/reagents/enzymes, while extracting biomaterial-grade ECM from porcine cholecyst (gall bladder), we performed preisolation ex situ incubation of the organ in a stabilizing agent that also caused in situ crosslinking of tissue-components and delaminated the collagen-rich ECM from the tissue-layer beneath the mucosa. The physical, chemical, and biological properties of the isolated scaffolds were similar to that of a commercially available porcine small intestinal submucosa. The cholecyst-derived scaffold not only satisfied preclinical safety-test procedures such as cytotoxicity, local response, and endotoxin load but also showed the potential to promote healing of full-thickness skin wound in a rabbit model. The procedure was also suitable for isolating scaffolds from other hollow organs such as jejunum and urinary bladder. It was concluded that enzyme/detergent treatment may be an avoidable step while isolating biomaterial-grade scaffolds from hollow organs. (C) 2014 Wiley Periodicals, Inc.
C1 [Anilkumar, Thapasimuthu V.; Vineetha, Vadavanath P.; Revi, Deepa; Muhamed, Jaseer; Rajan, Akhila] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Expt Pathol, Trivandrum 695012, Kerala, India.
RP Anilkumar, TV (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Div Expt Pathol, Trivandrum 695012, Kerala, India.
EM tvanilkumar@sctimst.ac.in
OI Muhamed, Jaseer/0000-0001-5046-9438; Rajan, Akhila/0000-0002-9624-4696
FU Department of Biotechnology, Government of India
   [BT/PR15461/MED/32/167/2011]
FX Contract grant sponsor: The Department of Biotechnology, Government of
   India; contract grant number: BT/PR15461/MED/32/167/2011
CR [Anonymous], 2004, USP 23 NF 18, P1696
   [Anonymous], 2007, 109932007 ISO
   [Anonymous], 1099352009 ISO
   Arenas-Herrera JE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014106
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P928, DOI 10.1021/bm061088x
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Deeken CR, 2012, ANN SURG, V255, P595, DOI 10.1097/SLA.0b013e3182445341
   Dhareshwar SS, 2008, J PHARM SCI-US, V97, P4184, DOI 10.1002/jps.21319
   Fitzpatrick JC, 2010, INT J BIOMATER, DOI 10.1155/2010/620503
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Klockenbusch C, 2012, ANAL BIOANAL CHEM, V404, P1057, DOI 10.1007/s00216-012-6065-9
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   Mitkus RJ, 2013, VACCINE, V31, P2738, DOI 10.1016/j.vaccine.2013.03.071
   Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043
   Nakamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054036
   Ning LJ, 2012, J BIOMED MATER RES A, V100A, P1448, DOI 10.1002/jbm.a.34083
   Nonaka PN, 2014, J BIOMED MATER RES A, V102, P413, DOI 10.1002/jbm.a.34708
   Saraydin D, 1998, POLYM BULL, V41, P577, DOI 10.1007/s002890050404
   SHRIVASTAW KP, 1995, BIOLOGICALS, V23, P65, DOI 10.1016/1045-1056(95)90014-4
   Wang XJ, 2014, J BIOMED MATER RES A, V102, P1017, DOI 10.1002/jbm.a.34764
   Youngstrom DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064151
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 27
TC 14
Z9 14
U1 0
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2014
VL 102
IS 7
BP 1506
EP 1516
DI 10.1002/jbm.b.33131
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ6ZS
UT WOS:000342963000015
PM 24596163
DA 2018-10-20
ER

PT J
AU Wei, XJ
   Xi, TF
   Zheng, YF
   Zhang, CQ
   Huang, WH
AF Wei, Xiaojuan
   Xi, Tingfei
   Zheng, Yufeng
   Zhang, Changqing
   Huang, Wenhai
TI In Vitro Comparative Effect of Three Novel Borate Bioglasses on the
   Behaviors of Osteoblastic MC3T3-E1 Cells
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Comparative study; Borate bioglass; Osteoblastic cells; Cell behavior;
   In vitro
ID BIOACTIVE GLASS SCAFFOLDS; RAT CALVARIAL DEFECTS; BONE REGENERATION;
   HYDROXYAPATITE; DIFFERENTIATION; OSTEOMYELITIS; BOROSILICATE;
   TEICOPLANIN; CONVERSION; MODEL
AB Most related investigations focused on the effects of borate glass on cell proliferation/biocompatibility in vitro or bone repair in vivo; however, very few researches were carried out on other cell behaviors. Three novel borate bioglasses were designed as scaffolds for bone regeneration in this wok. Comparative effects of three bioglasses on the behaviors of osteoblastic MC3T3-E1 cells were evaluated. Excellent cytocompatibility of these novel borate bioglasses were approved in this work. Meanwhile, the promotion on cell proliferation, protein secretion and migration with minor cell apoptosis were also discussed in details, which contributed to the potential clinical application as a new biomaterial for orthopedics.
C1 [Wei, Xiaojuan; Xi, Tingfei] Peking Univ, Acad Adv Interdisplinary Studies, Beijing 100871, Peoples R China.
   [Wei, Xiaojuan; Zheng, Yufeng] Peking Univ, Coll Engn, Beijing 100871, Peoples R China.
   [Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed, Shanghai 200233, Peoples R China.
   [Huang, Wenhai] Tongji Univ, Sch Mat Sci & Engn, Inst Bioengn & Informat Technol Mat, Shanghai 200092, Peoples R China.
RP Xi, TF (reprint author), Peking Univ, Acad Adv Interdisplinary Studies, Beijing 100871, Peoples R China.
EM xitingfei@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU National High Technology Research and Development Program of China ("863
   Program") [2012AA020502]
FX The authors gratefully acknowledge the financial support of the project
   from the National High Technology Research and Development Program of
   China ("863 Program", No. 2012AA020502).
CR Bi LX, 2012, J BIOMED MATER RES A, V100A, P3267, DOI 10.1002/jbm.a.34272
   Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679
   Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013
   Fu Q, 2011, TISSUE ENG PT A, V17, P3077, DOI 10.1089/ten.tea.2011.0068
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P172, DOI 10.1002/jbm.a.32823
   Isaac J, 2011, EUR CELLS MATER, V21, P130, DOI 10.22203/eCM.v021a11
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Liu X, 2013, ACTA BIOMATER, V9, P4889, DOI 10.1016/j.actbio.2012.08.029
   Liu X, 2010, J MATER SCI-MATER M, V21, P575, DOI 10.1007/s10856-009-3897-8
   Liu X, 2009, J MATER SCI-MATER M, V20, P1237, DOI 10.1007/s10856-009-3691-7
   Liu X, 2009, J MATER SCI-MATER M, V20, P365, DOI 10.1007/s10856-008-3582-3
   Luo S. H., 2010, J BIOMED MATER RES B, V92, P441
   Margha Fatma H., 2012, PROCESS APPL CERAM, V6, P183
   Marion NW, 2005, MECH ADV MATER STRUC, V12, P239, DOI 10.1080/15376490590928615
   Miguel BS, 2010, J BIOMED MATER RES A, V94A, P1023, DOI 10.1002/jbm.a.32773
   Pan HB, 2010, J R SOC INTERFACE, V7, P1025, DOI 10.1098/rsif.2009.0504
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Xie Z. P., 2009, CONTROL RELEASE, V139, P118
   Yao AH, 2007, J AM CERAM SOC, V90, P303, DOI 10.1111/j.1551-2916.2006.01358.x
   Zhang X, 2010, BIOMATERIALS, V31, P5865, DOI 10.1016/j.biomaterials.2010.04.005
   Zhao D, 2009, ACTA BIOMATER, V5, P1265, DOI 10.1016/j.actbio.2008.11.021
NR 21
TC 4
Z9 4
U1 1
U2 20
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD OCT
PY 2014
VL 30
IS 10
BP 979
EP 983
DI 10.1016/j.jmst.2014.07.007
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AQ4WF
UT WOS:000342800600006
DA 2018-10-20
ER

PT J
AU Toeg, HD
   Abessi, O
   Al-Atassi, T
   de Kerchove, L
   El-Khoury, G
   Labrosse, M
   Boodhwani, M
AF Toeg, Hadi Daood
   Abessi, Ovais
   Al-Atassi, Talal
   de Kerchove, Laurent
   El-Khoury, Gebrine
   Labrosse, Michel
   Boodhwani, Munir
TI Finding the ideal biomaterial for aortic valve repair with ex vivo
   porcine left heart simulator and finite element modeling
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID PERICARDIAL PATCH; REPLACEMENT; CLOSURE; GRAFT; RING
AB Objectives: Aortic valve (AV) repair (AVr) has become an attractive alternative to AV replacement for the correction of aortic insufficiency; however, little clinical evidence exists in determining which biomaterial at AVr would be optimal. Cusp replacement in AVr has been associated with increased long-term AVr failure. We measured the hemodynamic and biomaterial properties using an ex vivo porcine AVr model with clinically relevant biomaterials and generated a finite element model to ascertain which materials would be best suited for valve repair.
   Methods: Porcine aortic roots with intact AVs were placed in a left heart simulator mounted with a high-speed camera for baseline valve assessment. The noncoronary cusp was excised and replaced with autologous porcine pericardium, glutaraldehyde-fixed bovine pericardial patch (Synovis), extracelluar matrix scaffold (CorMatrix), or collagen-impregnated Dacron (Hemashield). The hemodynamic parameters were measured for a range of cardiac outputs (2.5-6.5 L/min) after repair. The biomaterial properties and St Jude Medical pericardial patch were determined using pressurization experiments. Finite element models of the AV and root complex were constructed to determine the hemodynamic characteristics and leaflet stresses.
   Results: The geometric orifice areas after repair were significantly reduced in the Hemashield (P < .05) and CorMatrix (P = .0001) groups. Left ventricular work increased with increasing cardiac output (P = .001) in unrepaired valves, as expected, and was similar among all biomaterial groups. Finite element modeling of the biomaterials displayed differences in the percentage of changes in total Von Mises stress for both replaced (noncoronary cusp) and nonreplaced left and right cusps with the St Jude Medical pericardial patch (+4%, +24%) and autologous porcine pericardium (+5, +26%), with a lower percentage of changes than for the bovine pericardial patch (+12%, +27%), Hemashield (+30%, +9%), and CorMatrix (+13%, +32%).
   Conclusions: The present study has shown that postrepair left ventricular work did not increase despite a decrease in geometric orifice areas in the Hemashield and CorMatrix groups. The autologous porcine pericardium and St Jude Medical pericardial patch had the closest profile to normal AVs; therefore, either biomaterial might be best suited. Finally, the increased stresses found in the bovine pericardial patch, Hemashield, and CorMatrix groups might, after prolonged tensile exposure, be associated with late repair failure.
C1 [Toeg, Hadi Daood; Al-Atassi, Talal; Boodhwani, Munir] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Abessi, Ovais; Labrosse, Michel] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1Y 4W7, Canada.
   [de Kerchove, Laurent; El-Khoury, Gebrine] Clin Univ St Luc, Dept Cardiovasc & Thorac Surg, B-1200 Brussels, Belgium.
RP Boodhwani, M (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM mboodhwani@ottawaheart.ca
FU Natural Sciences and Engineering Research Council of Canada
   [312065-2012]
FX We would like to thank CorMatrix and St Jude Medical for donating their
   respective materials. Dr Labrosse. gratefully acknowledges the Natural
   Sciences and Engineering Research Council of Canada for Discovery (grant
   312065-2012).
CR Aicher D, 2011, CIRCULATION, V123, P178, DOI 10.1161/CIRCULATIONAHA.109.934679
   Al-Halees Z, 1998, ANN THORAC SURG, V65, P601
   Baumer TG, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000081
   Boodhwani M, 2010, J THORAC CARDIOV SUR, V140, P276, DOI 10.1016/j.jtcvs.2009.11.058
   Boodhwani M, 2009, J THORAC CARDIOV SUR, V137, P286, DOI 10.1016/j.jtcvs.2008.08.054
   Chaikof EL, 2007, NEW ENGL J MED, V357, P1368, DOI 10.1056/NEJMp078175
   Cohen O, 2007, HEART SURG FORUM, V10, pE288, DOI 10.1532/HSF98.20071022
   Doss M, 2008, EUR J CARDIO-THORAC, V33, P881, DOI 10.1016/j.ejcts.2008.01.052
   Fattouch K, 2012, INTERACT CARDIOV TH, V15, P644, DOI 10.1093/icvts/ivs195
   Girardi LN, 1997, ANN THORAC SURG, V64, P1032, DOI 10.1016/S0003-4975(97)00491-8
   Gouget CLM, 2012, BIOMECH MODEL MECHAN, V11, P475, DOI 10.1007/s10237-011-0326-y
   HAN HC, 1995, J BIOMECH, V28, P637, DOI 10.1016/0021-9290(94)00091-H
   Hopkins RA, 2004, ANN THORAC SURG, V77, P2144, DOI 10.1016/j.athoracsur.2003.10.105
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Labrosse MR, 2013, J MECH BEHAV BIOMED, V17, P44, DOI 10.1016/j.jmbbm.2012.08.004
   Labrosse MR, 2011, J BIOMECH, V44, P2292, DOI 10.1016/j.jbiomech.2011.05.032
   Labrosse MR, 2010, J BIOMECH, V43, P1916, DOI 10.1016/j.jbiomech.2010.03.020
   Lausberg HF, 2006, EUR J CARDIO-THORAC, V30, P244, DOI 10.1016/j.ejcts.2006.04.031
   Myers PO, 2010, J THORAC CARDIOV SUR, V140, P836, DOI 10.1016/j.jtcvs.2010.06.036
   Nagano N, 2007, J THORAC CARDIOV SUR, V134, P1577, DOI 10.1016/j.jtcvs.2007.08.005
   Quarti A, 2012, INTERACT CARDIOV TH, V13, P569
   Rankin JS, 2012, EUR J CARDIO-THORAC, V42, P149, DOI 10.1093/ejcts/ezr273
   Scharfschwerdt M, 2011, EUR J CARDIO-THORAC, V40, P1127, DOI 10.1016/j.ejcts.2011.02.073
   Stelly M, 2013, ANN THORAC SURG, V96, pE127, DOI 10.1016/j.athoracsur.2013.06.114
   Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048843
   Tao L, 2008, ANN THORAC SURG, V85, P946, DOI 10.1016/j.athoracsur.2007.10.037
   Van Dyck M, 2013, ANN CARDIOTHORAC SUR, V2, P130, DOI 10.3978/j.issn.2225-319X.2012.12.03
   Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014
   Yang C, 2006, ANN THORAC SURG, V81, P57, DOI 10.1016/j.athoracsur.2005.07.013
NR 29
TC 8
Z9 8
U1 0
U2 14
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
EI 1097-685X
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD OCT
PY 2014
VL 148
IS 4
BP 1739
EP +
DI 10.1016/j.jtcvs.2014.05.004
PG 8
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA AQ6CQ
UT WOS:000342896200102
PM 24930607
DA 2018-10-20
ER

PT J
AU Singh, A
   Corvelli, M
   Unterman, SA
   Wepasnick, KA
   McDonnell, P
   Elisseeff, JH
AF Singh, Anirudha
   Corvelli, Michael
   Unterman, Shimon A.
   Wepasnick, Kevin A.
   McDonnell, Peter
   Elisseeff, Jennifer H.
TI Enhanced lubrication on tissue and biomaterial surfaces through
   peptide-mediated binding of hyaluronic acid
SO NATURE MATERIALS
LA English
DT Article
ID ARTICULAR-CARTILAGE; SYNOVIAL-FLUID; KNEE OSTEOARTHRITIS; BOUNDARY
   LUBRICATION; RECOMBINANT LUBRICIN; SODIUM HYALURONATE; RABBIT; JOINTS;
   MODEL; DEGENERATION
AB Lubrication is key for the efficient function of devices and tissues with moving surfaces, such as articulating joints, ocular surfaces and the lungs. Indeed, lubrication dysfunction leads to increased friction and degeneration of these systems. Here, we present a polymer-peptide surface coating platform to non-covalently bind hyaluronic acid ( HA), a natural lubricant in the body. Tissue surfaces treated with the HA-binding system exhibited higher lubricity values, and in vivo were able to retain HA in the articular joint and to bind ocular tissue surfaces. Biomaterials-mediated strategies that locally bind and concentrate HA could provide physical and biological benefits when used to treat tissue-lubricating dysfunction and to coat medical devices.
C1 [Singh, Anirudha; Corvelli, Michael; Unterman, Shimon A.; McDonnell, Peter; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
   [Singh, Anirudha; Corvelli, Michael; Unterman, Shimon A.; McDonnell, Peter; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Wepasnick, Kevin A.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
FU Arthritis Research Foundation [5885]; National Institutes of Health
   (NIH) under the Ruth L. Kirschstein National Research Service Award
   [AG328232]; NIH [R01AR054005]; DoD-PRORP grant; Wallace H. Coulter
   Foundation; Ort Philanthropic Fund; Research to Prevent Blindness
   Foundation
FX We thank F. Guilak (Duke University) for helpful discussions on the
   friction testing. A.S. was supported by the Arthritis Research
   Foundation Award 5885 and S.A.U. was supported in part by the National
   Institutes of Health (NIH) under the Ruth L. Kirschstein National
   Research Service Award AG328232. Funding sources gratefully acknowledged
   are NIH R01AR054005, DoD-PRORP grant, the Wallace H. Coulter Foundation,
   the Ort Philanthropic Fund for supporting the rheometer and the Jules
   Stein Professorship from the Research to Prevent Blindness Foundation.
   We gratefully acknowledge the Johns Hopkins A.B. Mass
   Spectrometry/Proteomic Facility for providing access to the
   matrix-assisted laser-desorption ionization time-of-flight spectrometer,
   the Johns Hopkins Department of Chemistry Instrumentation Facility for
   providing access to the peptide synthesizer, and the Johns Hopkins
   Department of Materials Science and the Fairbrother research group for
   use of the surface analysis laboratory.
CR Amiel D, 2003, OSTEOARTHR CARTILAGE, V11, P636, DOI 10.1016/S1063-4584(03)00119-5
   Brandt KD, 2000, ARTHRITIS RHEUM, V43, P1192, DOI 10.1002/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L
   BROWN TJ, 1991, EXP PHYSIOL, V76, P125, DOI 10.1113/expphysiol.1991.sp003474
   Buckwalter JA, 1997, J BONE JOINT SURG AM, V79A, P612, DOI 10.2106/00004623-199704000-00022
   Caligaris M, 2009, OSTEOARTHR CARTILAGE, V17, P1327, DOI 10.1016/j.joca.2009.03.020
   Chawla K, 2010, ACTA BIOMATER, V6, P3388, DOI 10.1016/j.actbio.2010.03.025
   Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399
   Das SK, 2013, PERVASIVE MOB COMPUT, V9, P1, DOI 10.1016/j.pmcj.2012.12.001
   Desrochers J, 2013, J MECH BEHAV BIOMED, V25, P11, DOI 10.1016/j.jmbbm.2013.03.019
   Dorinson A., 1985, MECH CHEM LUBRICATIO
   Elmorsy S, 2014, OSTEOARTHR CARTILAGE, V22, P121, DOI 10.1016/j.joca.2013.10.005
   Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304
   Fonn D, 2007, OPTOMETRY VISION SCI, V84, P279, DOI 10.1097/OPX.0b013e31804636af
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Greene GW, 2011, P NATL ACAD SCI USA, V108, P5255, DOI 10.1073/pnas.1101002108
   Hargittai I, 2008, STRUCT CHEM, V19, P697, DOI 10.1007/s11224-008-9370-3
   HILLS BA, 1984, ANN RHEUM DIS, V43, P641, DOI 10.1136/ard.43.4.641
   INOUE M, 1993, INVEST OPHTH VIS SCI, V34, P2313
   Jackson DW, 2006, OSTEOARTHR CARTILAGE, V14, P1248, DOI 10.1016/j.joca.2006.05.015
   Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104
   Jones ARC, 2007, J ORTHOP RES, V25, P283, DOI 10.1002/jor.20325
   Julovi SM, 2004, ARTHRITIS RHEUM, V50, P516, DOI 10.1002/art.20004
   Koji K, 2011, TRIBOLOGY ONLINE, V6, P1
   Lee SS, 2013, P I MECH ENG H, V227, P129, DOI 10.1177/0954411912462815
   LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782
   McNary SM, 2012, TISSUE ENG PART B-RE, V18, P88, DOI [10.1089/ten.TEB.2011.0394, 10.1089/ten.teb.2011.0394]
   Messman J. M., MACROMOLECULES, V42
   Moghani T, 2009, J BIOMECH, V42, P1069, DOI 10.1016/j.jbiomech.2009.02.021
   Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623
   Morrell K. C., P NATL ACAD SCI US, V102
   Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769
   Neu CP, 2008, TISSUE ENG PART B-RE, V14, P235, DOI 10.1089/ten.teb.2008.0047
   Pauloin T, 2009, MOL VIS, V15, P577
   PRESTI D, 1994, CELL BIOCHEM FUNCT, V12, P281, DOI 10.1002/cbf.290120409
   Rah MJ, 2011, OPTOMETRY, V82, P38, DOI 10.1016/j.optm.2010.08.003
   Rothenfluh DA, 2008, NAT MATER, V7, P248, DOI 10.1038/nmat2116
   Schmidt TA, 2007, OSTEOARTHR CARTILAGE, V15, P35, DOI 10.1016/j.joca.2006.06.005
   Schmidt T. A., JAMA OPHTHALMOL, V131
   Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838
   Sistiabudi R, 2008, LANGMUIR, V24, P1591, DOI 10.1021/la703561d
   Sivan S, 2010, LANGMUIR, V26, P1107, DOI 10.1021/la9024712
   Smith GN, 2001, J RHEUMATOL, V28, P1341
   Strauss EJ, 2009, AM J SPORT MED, V37, P1636, DOI 10.1177/0363546508326984
   Tolg C, 2012, AM J PATHOL, V181, P1250, DOI 10.1016/j.ajpath.2012.06.036
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Yang B., J BIOL CHEM, V268
   YOSHIMI T, 1994, CLIN ORTHOP RELAT R, P296
   Yu CJ, 2014, J PROTEOMICS, V99, P40, DOI 10.1016/j.jprot.2014.01.016
   Zaleski KJ, 2006, ANTIMICROB AGENTS CH, V50, P3856, DOI 10.1128/AAC.00082-06
   Zhang D, 2007, J ORTHOP RES, V25, P873, DOI 10.1002/jor.20344
   Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013
   Zmolik JM, 2005, J HISTOCHEM CYTOCHEM, V53, P745, DOI 10.1369/jhc.4A6491.2005
NR 54
TC 45
Z9 46
U1 16
U2 137
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD OCT
PY 2014
VL 13
IS 10
BP 988
EP 995
DI 10.1038/NMAT4048
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AQ4DR
UT WOS:000342743100020
PM 25087069
DA 2018-10-20
ER

PT J
AU Shariatzadeh, B
   Moradi, O
AF Shariatzadeh, Behnam
   Moradi, Omid
TI Surface Functionalization of Multiwalled Carbon Nanotubes With Chitosan
   and Magnesium Oxide Nanoparticles by Microwave-Assisted Synthesis
SO POLYMER COMPOSITES
LA English
DT Article
ID CERIA NANOPARTICLES; COMPOSITES; ADSORPTION; BIOSENSOR; WATER; MGO;
   NANOCOMPOSITES; NANOMATERIALS; MECHANISMS; SORPTION
AB Nano-magnesium oxide (nano-MgO) and chitosan (CS) are known for their potent antibacterial activity. In this work, we present the synthesis of magnesium oxide CS-functionalized multiwalled carbon nanotube composites and establish its merits over conventional magnesia and raw CS. We synthesized the composite within 1 h via a one-step microwave method. The presence of nano-MgO and CS on the surface of the nanotubes was confirmed by Fourier transform infrared spectroscopy, scanning electron microscopy, transmission electron microscopy, X-ray probe microanalyzer, and thermal stability analysis. We propose that our novel nanocomposite biomaterial would be useful in the pharmaceutical industry with potential antibacterial applications. (C) 2014 Society of Plastics Engineers
C1 [Shariatzadeh, Behnam; Moradi, Omid] Islamic Azad Univ, Dept Chem, Shahr E Qods Branch, Tehran, Iran.
RP Shariatzadeh, B (reprint author), Islamic Azad Univ, Dept Chem, Shahr E Qods Branch, Tehran, Iran.
EM behnam.shariat@gmail.com
CR Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   Alavi MA, 2010, ULTRASON SONOCHEM, V17, P441, DOI 10.1016/j.ultsonch.2009.08.013
   Ali SR, 2007, ANAL CHEM, V79, P2583, DOI 10.1021/ac062068o
   Almerindo GI, 2011, J POWER SOURCES, V196, P8057, DOI 10.1016/j.jpowsour.2011.05.030
   Ansari AA, 2008, ELECTROCHEM COMMUN, V10, P1246, DOI 10.1016/j.elecom.2008.06.003
   Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300
   Bansi D., 2009, THIN SOLID FILMS, V518, P614
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   Chen SH, 2007, BIOSENS BIOELECTRON, V22, P1268, DOI 10.1016/j.bios.2006.05.022
   Cho HH, 2010, LANGMUIR, V26, P967, DOI 10.1021/la902440u
   Cho JW, 2005, MACROMOL RAPID COMM, V26, P412, DOI 10.1002/marc.200400492
   Chopra N, 2007, ANAL LETT, V40, P2067, DOI 10.1080/00032710701567170
   Di ZC, 2006, CHEMOSPHERE, V62, P861, DOI 10.1016/j.chemosphere.2004.06.044
   Esawi AMK, 2007, MATER DESIGN, V28, P2394, DOI 10.1016/j.matdes.2006.09.022
   Fugetsu B, 2004, ENVIRON SCI TECHNOL, V38, P6890, DOI 10.1021/es049554i
   Gandhi S, 2011, J NON-CRYST SOLIDS, V357, P181, DOI 10.1016/j.jnoncrysol.2010.09.050
   Gianina D., 2012, CHEM ENG J, V203, P130
   Guibal E, 2001, INT J BIOL MACROMOL, V28, P401, DOI 10.1016/S0141-8130(01)00130-1
   Huang L, 2005, J INORG BIOCHEM, V99, P986, DOI 10.1016/j.jinorgbio.2004.12.022
   HUANG L, 2005, CHINESE SCI BULL, V50, P514
   Hyung H, 2008, ENVIRON SCI TECHNOL, V42, P4416, DOI 10.1021/es702916h
   Jason M., 2012, CARBON LETT, V13, P126
   Jin-Gang Y.B., 2009, INT J BIOL MACROMOL, V44, P316
   Jorda-Beneyto M, 2007, CARBON, V45, P293, DOI 10.1016/j.carbon.2006.09.022
   Kaushika A, 2008, BIOSENS BIOELECTRON, V24, P676, DOI 10.1016/j.bios.2008.06.032
   Kumar NA, 2008, EUR POLYM J, V44, P579, DOI 10.1016/j.eurpolymj.2007.12.009
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Li RJ, 2011, MICROCHIM ACTA, V172, P269, DOI 10.1007/s00604-010-0488-9
   Liu A, 2007, BIOSENS BIOELECTRON, V23, P74, DOI 10.1016/j.bios.2007.03.019
   Liu Y, 2008, ADV FUNCT MATER, V18, P1536, DOI 10.1002/adfm.200701433
   Lota G, 2007, ELECTROCHEM COMMUN, V9, P1828, DOI 10.1016/j.elecom.2007.04.015
   Mahmoodian H, 2014, POLYM COMPOSITE, V35, P495, DOI 10.1002/pc.22687
   Mahmoodian H, 2014, INT J BIOL MACROMOL, V63, P92, DOI 10.1016/j.ijbiomac.2013.10.030
   Mamalis AG, 2004, PRECIS ENG, V28, P16, DOI 10.1016/j.precisioneng.2002.11.002
   Moniruzzaman M, 2006, MACROMOLECULES, V39, P5194, DOI 10.1021/ma060733p
   Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n
   Paradise M, 2007, MATER DESIGN, V28, P1477, DOI 10.1016/j.matdes.2006.03.008
   Peigney A, 2001, CARBON, V39, P507, DOI 10.1016/S0008-6223(00)00155-X
   Peng XJ, 2005, MATER LETT, V59, P399, DOI 10.1016/j.matlet.2004.05.090
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Ravi Kumar Majeti N. V., 2000, REACTIVE FUNCTIONAL, V46, P1
   Rivas GA, 2007, TALANTA, V74, P291, DOI 10.1016/j.talanta.2007.10.013
   Shanmugam A., 2011, CARBOHYD POLYM, V83, P1565
   Sinnott SB, 2001, CRIT REV SOLID STATE, V26, P145, DOI 10.1080/20014091104189
   Suresh S, 2011, DIG J NANOMATER BIOS, V6, P1597
   van der Lee MK, 2005, J AM CHEM SOC, V127, P13573, DOI 10.1021/ja053038q
   Wang BH, 2007, DRY TECHNOL, V25, P715, DOI 10.1080/07373930701291108
   Wang JP, 2011, J HAZARD MATER, V186, P1985, DOI 10.1016/j.jhazmat.2010.12.087
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Wang YB, 2005, CARBON, V43, P1015, DOI 10.1016/j.carbon.2004.11.036
   Xu Z, 2006, J AM CHEM SOC, V128, P1052, DOI 10.1021/ja057303j
   Ya-qi C., 2005, J CHROMATOGR A, V1081, P245
   Yamamoto O, 2010, MATER SCI ENG B-ADV, V173, P208, DOI 10.1016/j.mseb.2009.12.007
   Yang YH, 2007, ANAL CHIM ACTA, V584, P268, DOI 10.1016/j.aca.2006.11.055
   Yeong-Tarng S., 2006, EUR POLYM J, V42, P3162
   Yu JG, 2009, INT J BIOL MACROMOL, V44, P316, DOI 10.1016/j.ijbiomac.2008.10.009
   Zang ZP, 2009, J HAZARD MATER, V172, P958, DOI 10.1016/j.jhazmat.2009.07.078
   Zhang MG, 2004, ANAL CHEM, V76, P5045, DOI 10.1021/ac049519u
   Zhou D, 2005, WATER RES, V39, P3755, DOI 10.1016/j.watres.2005.06.033
   Zhu NN, 2005, ANAL CHIM ACTA, V545, P21, DOI 10.1016/j.aca.2005.04.015
NR 60
TC 2
Z9 2
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-8397
EI 1548-0569
J9 POLYM COMPOSITE
JI Polym. Compos.
PD OCT
PY 2014
VL 35
IS 10
BP 2050
EP 2055
DI 10.1002/pc.22866
PG 6
WC Materials Science, Composites; Polymer Science
SC Materials Science; Polymer Science
GA AQ6ZM
UT WOS:000342962400022
DA 2018-10-20
ER

PT J
AU Critchfield, AS
   Mccabe, R
   Klebanov, N
   Richey, L
   Socrate, S
   Norwitz, ER
   Kaplan, DL
   House, M
AF Critchfield, Agatha S.
   Mccabe, Reid
   Klebanov, Nikolai
   Richey, Lauren
   Socrate, Simona
   Norwitz, Errol R.
   Kaplan, David L.
   House, Michael
TI Biocompatibility of a Sonicated Silk Gel for Cervical Injection During
   Pregnancy: In Vivo and In Vitro Study
SO REPRODUCTIVE SCIENCES
LA English
DT Article
DE cerclage; cervix; injectable biomaterial; silk; preterm birth
ID RANDOMIZED CONTROLLED-TRIAL; PRETERM BIRTH; DOUBLE-BLIND; WOMEN;
   PROGESTERONE; CERCLAGE; METAANALYSIS; BIOMATERIAL; PREVENTION; SCAFFOLDS
AB Objective: To evaluate the biocompatibility of silk gel for cervical injection.
   Study Design: Silk gel was injected into the cervix of pregnant rats on day 13 (n = 11) and harvested at day 17. Histology of silk gel was compared with suture controls. Also, human cervical fibroblasts were cultured on silk gel and tissue culture plastic (TCP) in vitro. Cell viability, proliferation, metabolic activity, gene expression (COL1A1, COL3A1, and COX2), and release of proinflammatory mediators (interleukin [IL] 6 and IL-8) were evaluated.
   Results: In vivo, a mild foreign body response was seen surrounding the silk gel and suture controls. In vitro, cervical fibroblasts were viable, metabolically active, and proliferating at 72 hours. Release of IL-6 and IL-8 was similar on silk gel and TCP. Collagen and COX2 gene expression was similar or slightly decreased compared with TCP.
   Conclusions: Silk gel was well tolerated in vivo and in vitro, which supports continuing efforts to develop silk gels as an alternative to cervical cerclage.
C1 [Critchfield, Agatha S.; Norwitz, Errol R.; House, Michael] Tufts Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02111 USA.
   [Mccabe, Reid; Klebanov, Nikolai; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Richey, Lauren] Tufts Univ, Div Lab Anim Med, Boston, MA 02111 USA.
   [Socrate, Simona] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP House, M (reprint author), Tufts Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, 800 Washington St,360, Boston, MA 02111 USA.
EM mhouse@tuftsmedicalcenter.org
OI McCabe, Reid/0000-0003-1046-0740; Klebanov, Nikolai/0000-0001-8310-3029
FU Reproductive Scientist Development Program [2K12HD000849-26]; March of
   Dimes Birth Defects Foundation; Tissue Engineering Resource Center
   (TERC) from the National Institute of Biomedical Imaging and
   Bioengineering [EB002520]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article:
   Reproductive Scientist Development Program (2K12HD000849-26), March of
   Dimes Birth Defects Foundation, Tissue Engineering Resource Center
   (TERC) from the National Institute of Biomedical Imaging and
   Bioengineering (EB002520).
CR Akins ML, 2011, BIOL REPROD, V84, P1053, DOI 10.1095/biolreprod.110.089599
   Berghella V, 2005, OBSTET GYNECOL, V106, P181, DOI 10.1097/01.AOG.0000168435.17200.53
   BERKOWITZ GS, 1993, EPIDEMIOL REV, V15, P414, DOI 10.1093/oxfordjournals.epirev.a036128
   Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896
   BUCKNALL TE, 1983, EUR SURG RES, V15, P59, DOI 10.1159/000128334
   Chang HH, 2013, LANCET, V381, P223, DOI 10.1016/S0140-6736(12)61856-X
   Cotran RS, 1999, PATHOLOGIC BASIS DIS
   Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC
   Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
   Goya M, 2012, LANCET, V379, P1800, DOI 10.1016/S0140-6736(12)60030-0
   Greenough A, 2012, SEMIN FETAL NEONAT M, V17, P73, DOI 10.1016/j.siny.2012.01.009
   Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532
   Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017
   Heard AJ, 2013, REPROD SCI, V20, P929, DOI 10.1177/1933719112468952
   House M, 2010, TISSUE ENG PT A, V16, P2101, DOI [10.1089/ten.tea.2009.0457, 10.1089/ten.TEA.2009.0457]
   House M, 2012, TISSUE ENG PT A, V18, P499, DOI [10.1089/ten.TEA.2011.0309, 10.1089/ten.tea.2011.0309]
   Howson CP, 2012, BORN TOO SOON GLOBAL
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Iams JD, 2010, AM J OBSTET GYNECOL, V203, P89, DOI 10.1016/j.ajog.2010.02.004
   Institute of Medicine, 2006, PRETERM BIRTH CAUSES
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Landy HJ, 2011, OBSTET GYNECOL, V117, P627, DOI 10.1097/AOG.0b013e31820afaf2
   Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1
   LUGO M, 1984, ARCH PATHOL LAB MED, V108, P185
   Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367
   Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1
   Mathews T J, 2011, Natl Vital Stat Rep, V59, P1
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8
   Norwitz Errol R, 2011, Rev Obstet Gynecol, V4, P60
   O'Connor A, 2007, EYE, V21, P1254, DOI 10.1038/sj.eye.6702838
   Owen J, 2009, AM J OBSTET GYNECOL, V201
   Pereira L, 2007, AM J OBSTET GYNECOL, V197, pS48, DOI 10.1016/j.ajog.2007.10.136
   Poellmann MJ, 2013, J MECH BEHAV BIOMED, V17, P66, DOI 10.1016/j.jmbbm.2012.08.002
   Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/RFP-07-0032
   Sennstrom MB, 2000, MOL HUM REPROD, V6, P375, DOI 10.1093/molehr/6.4.375
   Singer LT, 1999, JAMA-J AM MED ASSOC, V281, P799, DOI 10.1001/jama.281.9.799
   To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4
   U. S. Food and Drug Administration/Center for Drug Evaluation and Research, 2012, 22139 NDA US FOOD DR
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
NR 42
TC 6
Z9 8
U1 0
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD OCT
PY 2014
VL 21
IS 10
BP 1266
EP 1273
DI 10.1177/1933719114522551
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA AQ5JK
UT WOS:000342844000008
PM 24520079
OA Green Published
DA 2018-10-20
ER

PT J
AU Turker, NS
   Ozer, AY
   Kutlu, B
   Nohutcu, R
   Sungur, A
   Bilgili, H
   Ekizoglu, M
   Ozalp, M
AF Turker, N. Selcan
   Ozer, A. Yekta
   Kutlu, Burak
   Nohutcu, Rahime
   Sungur, Arzu
   Bilgili, Hasan
   Ekizoglu, Melike
   Ozalp, Meral
TI The Effect of Gamma Radiation Sterilization on Dental Biomaterials
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Gamma radiation sterilization; Ethylene oxide sterilization; Guided
   tissue regeneration; Guided Bone Regeneration; Dental biomaterials
ID ETHYLENE-OXIDE STERILIZATION; BONE TISSUE REGENERATION; IN-VITRO;
   COLLAGEN MEMBRANE; IRRADIATION; DEGRADATION; PERSPECTIVE; CHITOSAN;
   GRAFT; VIVO
AB Biomaterials are used in the field of bone and tissue engineering, orthopaedics and dentistry. Dental biomaterials including commercially available biodegradable materials act as physical barriers to help quicker healing while stimulating the regeneration of periodontal tissues, which is defined as Guided Tissue Regeneration (GTR). Amongst natural and synthetic biomaterials, collagen and aliphatic polyesters, such as polylactic acid (PLA) and poly (lactic-co-glycolic) acid (PLGA) are the most frequently used biomaterials for regenerative therapies due to their excellent biocompatibility and biodegradability. Due to their resorption in the body and interaction with biological systems, the GTR membranes must be sterile and pyrogen free. The sterility and apyrogenicity of the GTR membranes before human use is a regulatory requirement, however the sterilization of biomaterials is challenging due to the physicochemical changes and toxic residues with the commonly used sterilization techniques. The purpose of the present study was to evaluate the effect of gamma radiation and ethylene oxide sterilization on dental biomaterials with analytical, microbiological and histological examinations. PLGA-based GTR dental biomaterial is selected as the most gamma stable membrane according to the FTIR, DSC, TGA, and SEM results. This dental membrane was sterilized with ethylene oxide (EtO) and the effect of sterilization method on PLGA-based membrane was also investigated. Animal experiments were carried out to evaluate the regenerative properties and inflammatory responses of gamma and EtO sterilized PLGA-based GTR membrane after implantation. Histological examinations showed that resorption and bone formation of gamma sterilized PLGA-based GTR membrane was completed in 12 weeks without any inflammatory response; while only 60.095 +/- 2.019% of new bone formation was observed with EtO sterilized one. Gamma sterilized PLGA membrane had significantly faster (P < 0.05) resorption and bone formation in comparison with EtO sterilization. In conclusion, the PLGA-based biomaterials could be sterilized safely and time- and cost-effectively with validated radiation doses for the tissue engineering applications.
C1 [Turker, N. Selcan; Ozer, A. Yekta] Hacettepe Univ, Fac Pharm, Dep Radiopharm, TR-06100 Ankara, Turkey.
   [Turker, N. Selcan] MGH Harvard Med Sch, Dep Radiol, Boston, MA USA.
   [Kutlu, Burak; Nohutcu, Rahime] Hacettepe Univ, Fac Dent, Dept Periodontol, TR-06100 Ankara, Turkey.
   [Sungur, Arzu] Hacettepe Univ, Fac Dent, Dept Pathol, TR-06100 Ankara, Turkey.
   [Bilgili, Hasan] Ankara Univ, Fac Vet Med, Dept Orthopaed & Traumatol, TR-06110 Ankara, Turkey.
   [Ekizoglu, Melike; Ozalp, Meral] Hacettepe Univ, Fac Pharm, Dept Microbiol, TR-06100 Ankara, Turkey.
RP Ozer, AY (reprint author), Hacettepe Univ, Fac Pharm, Dep Radiopharm, TR-06100 Ankara, Turkey.
EM yktzer@yahoo.com
RI Bayram, Cem/D-7403-2013; EKIZOGLU, MELIKE/I-8444-2013
OI Bayram, Cem/0000-0001-8717-4668; 
FU H.U. Research Foundation [07.01.301.008]
FX The authors wish to thank H.U. Research Foundation (Project No:
   07.01.301.008) for the valuable financial support.
CR Azorin E, 2012, APPL RADIAT ISOTOPES, V71, P71, DOI 10.1016/j.apradiso.2012.03.039
   Bitterman N, 2011, EUR J INTERN MED, V22, P39, DOI 10.1016/j.ejim.2010.09.017
   Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022
   Brinston R M, 1993, Med Device Technol, V4, P18
   Bushell JA, 2005, J CONTROL RELEASE, V110, P49, DOI 10.1016/j.jconrel.2005.09.009
   Chen CC, 2003, BIOMATERIALS, V24, P1167, DOI 10.1016/S0142-9612(02)00466-0
   Cignitti M, 1992, Boll Chim Farm, V131, P71
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   de Almeida OM, 2013, ACTA CIR BRAS, V28, P66, DOI 10.1590/S0102-86502013000100011
   Fairand Barry P, 2010, PDA J Pharm Sci Technol, V64, P299
   Franca R, 2013, J BIOMED MATER RES B, V101, P1444, DOI 10.1002/jbm.b.32964
   Friess W, 2006, EUR J PHARM BIOPHARM, V63, P176, DOI 10.1016/j.ejpb.2005.11.007
   Guda T, 2013, TISSUE ENG PT A, V19, P1879, DOI [10.1089/ten.tea.2012.0057, 10.1089/ten.TEA.2012.0057]
   Guo M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245101
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Ji W, 2013, BIOMATERIALS, V34, P735, DOI 10.1016/j.biomaterials.2012.10.016
   Jiang B, 2006, BIOMATERIALS, V27, P15, DOI 10.1016/j.biomaterials.2005.05.091
   Jung RE, 2011, CLIN ORAL IMPLAN RES, V22, P802, DOI 10.1111/j.1600-0501.2010.02068.x
   Kawasaki Y, 2010, J BIOMED MATER RES B, V92B, P161, DOI 10.1002/jbm.b.31502
   Khurshid S. Javaid, 1993, JPMA (Journal of the Pakistan Medical Association), V43, P8
   Kim S, 2010, INT J ORAL MAX IMPL, V25, P309
   Lee JS, 2005, EUR J PHARM BIOPHARM, V59, P169, DOI 10.1016/j.ejpb.2004.06.006
   Li JA, 2013, J BIOMAT SCI-POLYM E, V24, P1519, DOI 10.1080/09205063.2013.777227
   LIU BC, 1989, J BIOMED MATER RES, V23, P833, DOI 10.1002/jbm.820230803
   Lucas Anne D, 2008, Biomed Instrum Technol, V42, P76, DOI 10.2345/0899-8205(2008)42[76:EASOEO]2.0.CO;2
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Mohamed Hamouda Ibrahim, 2012, J Biomed Res, V26, P143, DOI 10.7555/JBR.26.20120027
   NC, 2010, EFF TERM GAMM STER O
   Nguyen H, 2011, J ARTHROPLASTY, V26, P303, DOI 10.1016/j.arth.2010.03.032
   Nieminen T, 2006, INT J ORAL MAX SURG, V35, P727, DOI 10.1016/j.ijom.2006.01.030
   Ozer AY, 2013, INTERV MED APPL SCI, V5, P122, DOI 10.1556/IMAS.5.2013.3.5
   Park SH, 2013, TISSUE ENG REGEN MED, V10, P71, DOI 10.1007/s13770-013-0357-9
   Pekkarinen T, 2005, SCAND J SURG, V94, P67, DOI 10.1177/145749690509400116
   Ramseier A, 2000, ELECTROPHORESIS, V21, P380, DOI 10.1002/(SICI)1522-2683(20000101)21:2<380::AID-ELPS380>3.0.CO;2-L
   Rohm-Rodowald Ewa, 2004, Przegl Epidemiol, V58, P501
   Sahoo NG, 2013, NANOMEDICINE-UK, V8, P639, DOI [10.2217/NNM.13.44, 10.2217/nnm.13.44]
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Shue L, 2012, BIOMATTER, V2, P27
   Singh R, 2013, TISSUE ENG REGEN MED, V10, P110, DOI 10.1007/s13770-013-0004-5
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   Son JS, 2012, BIOTECHNOL LETT, V34, P779, DOI 10.1007/s10529-011-0819-x
   Suljovrujic E, 2007, RADIAT PHYS CHEM, V76, P722, DOI 10.1016/j.radphyschem.2006.02.013
   Thomas RZ, 2007, J DENT, V35, P547, DOI 10.1016/j.jdent.2007.03.002
   Turker NS, 2011, J MED DEVICES, V5
   Turker S, 2013, INTERV MED APPL SCI, V5, P60, DOI 10.1556/IMAS.5.2013.2.2
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Xu C, 2012, J BIOMED MATER RES B, V100B, P1435, DOI 10.1002/jbm.b.32662
NR 47
TC 7
Z9 7
U1 3
U2 47
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD OCT
PY 2014
VL 11
IS 5
BP 341
EP 349
DI 10.1007/s13770-014-0016-9
PG 9
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AQ5NO
UT WOS:000342856100001
DA 2018-10-20
ER

PT J
AU Yang, KJ
   Park, KC
   Choi, H
   Choi, JH
   Park, SR
   Lee, IW
   Lee, HJ
AF Yang, Keum-Jin
   Park, Ki Cheol
   Choi, Hyunsu
   Choi, Jun-Hyuk
   Park, Sang-Ryoul
   Lee, Il-Woo
   Lee, Hyung-Jin
TI Identification and Characterization of Neurotrophic Factors in Porcine
   Small Intestinal Submucosa
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE Neurotrophic factors; Porcine SIS; Decellularized SIS extract;
   Bioactivity of SIS extract
ID NERVE GROWTH-FACTOR; BDNF MESSENGER-RNA; PHEOCHROMOCYTOMA CELLS; NEURITE
   OUTGROWTH; ALZHEIMERS-DISEASE; REGENERATION; RAT; REPAIR; LINE;
   DIFFERENTIATION
AB "Small intestinal submucosa" (SIS) is a natural degradable biomaterial derived from the small intestine of vertebrates. Porcine SIS has been widely used in repairing various tissues and organs, especially in nervous tissues because intrinsic autonomic nerve plexuses are included in submucosal layer. However, little is known about active neurotrophic factors in this material. In this study, we proposed a method to prepare an extract from decellularized SIS and to identify and characterize the major neurotrophic factors in it. Decellularized SIS extract was obtained by sequential procedures: mechanical disassociation, degreasing, enzyme digestion, freeze-drying, freezer-milling, extracting, concentrating, and filtering. Contamination with cellular components in the SIS extract was evaluated by hematoxylin and eosin (H&E) staining and the content of genomic DNA. Major neurotrophic factors in SIS extract was assessed quantitatively by ELISA. The effects of SIS extracts on cells were evaluated by observation of neurite outgrowth from PC12 cells. Decellularized SIS extract was obtained successfully by the proposed method and no cellular component was found within it. Brain-derived neurotrophic factor (BDNF), erythropoietin (EPO), glial cell-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and platelet-derived growth factor (PDGF) were identified and characterized form SIS extract. The bioactivity of SIS extract was assessed in terms of neurite outgrowth from PC12 cells. In summary, we prepared a decellularized extract from porcine SIS and identified major neurotrophic factors present in it. SIS extract also had bioactivity with PC12 cells. From these results, we conclude that SIS may be useful to repair or improve nervous system function.
C1 [Yang, Keum-Jin; Park, Ki Cheol; Choi, Hyunsu] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Clin Res Inst, Taejon 301723, South Korea.
   [Choi, Jun-Hyuk; Park, Sang-Ryoul] Korea Res Inst Stand & Sci, Taejon 305340, South Korea.
   [Lee, Il-Woo; Lee, Hyung-Jin] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Neurosurg, Seoul 137701, South Korea.
RP Lee, HJ (reprint author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Dept Neurosurg, 222 Banpo Daero, Seoul 137701, South Korea.
EM hyungjin@catholic.ac.kr
FU Korea Research Institute of Standards and Science through the Catholic
   University of Korea Industry-Academic Cooperation Foundation
   [KIRSS-2012-12011056]
FX This research was supported by the Korea Research Institute of Standards
   and Science (KIRSS-2012-12011056) through the Catholic University of
   Korea Industry-Academic Cooperation Foundation.
CR Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009
   Chen Wei, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P94
   Choi M, 2014, BIOCHEM BIOPH RES CO, V446, P79, DOI 10.1016/j.bbrc.2014.02.066
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0
   Favalli G, 2012, J PSYCHIATR RES, V46, P1, DOI 10.1016/j.jpsychires.2011.09.022
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   FUJITA K, 1989, ENVIRON HEALTH PERSP, V80, P127, DOI 10.2307/3430738
   Gale Z, 2012, CYTOKINE, V57, P276, DOI 10.1016/j.cyto.2011.10.023
   GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Ho CH, 2013, J FORMOS MED ASSOC, V13, P1
   Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846
   Hong S, 2010, J BIOMED MATER RES B, V94B, P421, DOI 10.1002/jbm.b.31670
   Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483
   Jezierski A, 2014, STEM CELL REV REP, V10, P251, DOI 10.1007/s12015-013-9484-x
   Kang KN, 2011, TISSUE ENG PT A, V17, P2143, DOI [10.1089/ten.tea.2011.0122, 10.1089/ten.TEA.2011.0122]
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   Metzger DW, 1996, 1 SIS S ORL FLOR 11
   Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050
   Negrini S, 2013, BIOL OPEN, V2, P855, DOI 10.1242/bio.20135116
   Nishio T, 1998, NEUROREPORT, V9, P1661, DOI 10.1097/00001756-199805110-00073
   Oh DH, 2012, KOREAN J PHYSIOL PHA, V16, P281, DOI 10.4196/kjpp.2012.16.4.281
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x
   PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Sarina, 2013, BRAIN RES, V1490, P61, DOI 10.1016/j.brainres.2012.10.059
   Schicho R, 1999, BRAIN RES, V815, P60, DOI 10.1016/S0006-8993(98)01094-4
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Serpe CJ, 2005, BRAIN BEHAV IMMUN, V19, P173, DOI 10.1016/j.bbi.2004.07.005
   Su Y, 2007, BRAIN RES, V1145, P41, DOI 10.1016/j.brainres.2007.01.138
   Sun YE, 2006, NEURON, V49, P321, DOI 10.1016/j.neuron.2006.01.014
   Thompson DM, 2004, ANN BIOMED ENG, V32, P1120
   Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x
NR 36
TC 1
Z9 1
U1 0
U2 3
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD OCT
PY 2014
VL 11
IS 5
BP 372
EP 378
DI 10.1007/s13770-014-0043-6
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AQ5NO
UT WOS:000342856100005
DA 2018-10-20
ER

PT J
AU Beckmann, NA
   Bitsch, RG
   Seeger, JB
   Klotz, MCM
   Kretzer, JP
   Jaeger, S
AF Beckmann, Nicholas A.
   Bitsch, Rudi G.
   Seeger, Joern B.
   Klotz, Matthias C. M.
   Kretzer, Jan Philippe
   Jaeger, Sebastian
TI Mechanical properties of a cemented porous implant interface
SO ACTA ORTHOPAEDICA
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; BONE INTERFACE;
   SHEAR-STRENGTH; CANCELLOUS BONE; TRABECULAR BONE; RESURFACING
   ARTHROPLASTY; TANTALUM BIOMATERIAL; INITIAL STABILITY; TENSILE-STRENGTH
AB Background - Revision arthroplasty often requires anchoring of prostheses to poor-quality or deficient bone stock. Recently, newer porous materials have been introduced onto the market as additional, and perhaps better, treatment options for revision arthroplasty. To date, there is no information on how these porous metals interface with bone cement. This is of clinical importance, since these components may require cementing to other prosthesis components and occasionally to bone.
   Methods - We created porous metal and bone cylinders of the same size and geometry and cemented them in a well-established standardized setting. These were then placed under tensile loading and torsional loading until failure was achieved. This permitted comparison of the porous metal/cement interface (group A) with the well-studied bone/cement interface (group B).
   Results - The group A interface was statistically significantly stronger than the group B interface, despite having significantly reduced depth of cement penetration: it showed a larger maximum tensile force (effect size 2.7), superior maximum tensile strength (effect size 2.6), greater maximum torsional force (effect size 2.2), and higher rotational stiffness (effect size 1.5).
   Interpretation - The newer porous implants showed good interface properties when cemented using medium-viscosity bone cement. The axial and rotational mechanical strength of a porous metal/cement interface appeared to be greater than the strength of the standard bone/cement interface. These results indicate that cementing of porous implants can provide great stability in situations where it is needed.
C1 [Beckmann, Nicholas A.; Bitsch, Rudi G.; Klotz, Matthias C. M.; Kretzer, Jan Philippe; Jaeger, Sebastian] Heidelberg Univ, Dept Orthopaed Surg, Lab Biomech & Implant Res, Heidelberg, Germany.
   [Seeger, Joern B.] Univ Hosp Giessen & Marburg UKGM, Dept Orthopaed & Orthopaed Surg, Giessen, Germany.
RP Beckmann, NA (reprint author), Heidelberg Univ, Dept Orthopaed Surg, Lab Biomech & Implant Res, Heidelberg, Germany.
EM nicholas.beckmann@med.uni-heidelberg.de
FU local county; University of Heidelberg; Biomet; Implantcast; Smith
   Nephew; Zimmer; De Puy; Link; Questmed; Ceramtec; Falcon Medical; Corin;
   Aesculap; Hofstetter
FX Funding for this project was provided by a research grant from the local
   county and the University of Heidelberg. None of the authors received
   financial gain directly associated with this work. Some of the authors
   have received grants or financial relationships outside the work
   described: Si has received research and institutional support from
   Biomet, Implantcast, Smith & Nephew, Zimmer, and De Puy. RGB has
   received grants from De Puy and has received research and institutional
   support from Biomet, Implantcast, Smith & Nephew, Zimmer, and De Puy.
   JPK has received grants from De Puy, Link, Biomet, Questmed, Ceramtec,
   Falcon Medical, and Corin; he has also received payment for lectures
   and/or consultancy from Ceramtec, Aesculap, Hofstetter, De Puy, and
   Smith & Nephew, and he is a board member of De Puy, Germany. NAB, MCMK,
   and JBS have not received grants or other financial benefits from
   external companies/corporations.
CR Amirfeyz R, 2009, INT ORTHOP, V33, P843, DOI 10.1007/s00264-008-0558-3
   Aro HT, 2012, ACTA ORTHOP, V83, P107, DOI 10.3109/17453674.2012.678798
   ASKEW M J, 1984, Journal of Orthopaedic Research, V1, P412
   Bannister G C, 1988, Eng Med, V17, P131
   Beckmann NA, 2014, J ARTHROPLASTY, V29, P229, DOI 10.1016/j.arth.2013.04.035
   BENJAMIN JB, 1987, J BONE JOINT SURG BR, V69, P620
   BERGMANN G, 1977, ARCH ORTHOP TRAUM SU, V87, P223, DOI 10.1007/BF00415210
   Bitsch RG, 2007, J ORTHOP RES, V25, P423, DOI 10.1002/jor.20311
   Bitsch RG, 2011, INT ORTHOP, V35, P1759, DOI 10.1007/s00264-011-1212-z
   Bitsch RG, 2010, J ORTHOP RES, V28, P986, DOI 10.1002/jor.21094
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Breusch S., 2005, WELL CEMENTED TOTAL
   Erhart S, 2011, INJURY, V42, P1322, DOI 10.1016/j.injury.2011.04.010
   HALAWA M, 1978, ARCH ORTHOP TRAUM SU, V92, P19, DOI 10.1007/BF00381636
   Jensen CL, 2012, J ARTHROPLASTY, V27, P1820, DOI 10.1016/j.arth.2012.04.036
   KEAVENY TM, 1994, J BIOMECH, V27, P1127, DOI 10.1016/0021-9290(94)90053-1
   KOLBEL R, 1973, ARCH ORTHOP TRAUM SU, V77, P339, DOI 10.1007/BF00418919
   KOLBEL R, 1972, ARCH ORTHOPAD UNFALL, V73, P89, DOI 10.1007/BF00419075
   KRAUSE WR, 1982, CLIN ORTHOP RELAT R, P290
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Levine B, 2008, ADV ENG MATER, V10, P788, DOI 10.1002/adem.200800215
   Levine B, 2006, J AM ACAD ORTHOP SUR, V14, P646, DOI 10.5435/00124635-200611000-00008
   LOOKER AC, 1995, OSTEOPOROSIS INT, V5, P389, DOI 10.1007/BF01622262
   MACDONALD W, 1993, CLIN ORTHOP RELAT R, P283
   Mann KA, 1997, J BIOMECH, V30, P339, DOI 10.1016/S0021-9290(96)00164-9
   Mann KA, 1999, J BIOMECH, V32, P1251, DOI 10.1016/S0021-9290(99)00107-4
   Mann KA, 1997, J BIOMECH ENG-T ASME, V119, P175, DOI 10.1115/1.2796077
   Meneghini RM, 2009, J BONE JOINT SURG AM, V91A, P131, DOI 10.2106/JBJS.H.01061
   Miller MA, 2011, J MECH BEHAV BIOMED, V4, P366, DOI 10.1016/j.jmbbm.2010.11.004
   Morgan EF, 2001, J BIOMECH, V34, P569, DOI 10.1016/S0021-9290(01)00011-2
   Mulroy WF, 1995, J BONE JOINT SURG AM, V77A, P1845, DOI 10.2106/00004623-199512000-00008
   Pulido L, 2011, INT ORTHOP, V35, P289, DOI 10.1007/s00264-010-1198-y
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Ranstam J, 2012, OSTEOARTHR CARTILAGE, V20, P473, DOI 10.1016/j.joca.2012.02.011
   Schlegel UJ, 2011, INT ORTHOP, V35, P1165, DOI 10.1007/s00264-010-1137-y
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Waanders D, 2010, J BIOMECH, V43, P1167, DOI 10.1016/j.jbiomech.2009.11.033
   WALKER PS, 1984, CLIN ORTHOP RELAT R, P155
NR 40
TC 3
Z9 3
U1 0
U2 7
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 1745-3674
EI 1745-3682
J9 ACTA ORTHOP
JI Acta Orthop.
PD OCT
PY 2014
VL 85
IS 5
BP 531
EP 537
DI 10.3109/17453674.2014.919557
PG 7
WC Orthopedics
SC Orthopedics
GA AQ3ZO
UT WOS:000342732200014
PM 24798109
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bohn, GA
   Gass, K
AF Bohn, Gregory A.
   Gass, Kimberly
TI Leg Ulcer Treatment Outcomes with New Ovine Collagen Extracellular
   Matrix Dressing: A Retrospective Case Series
SO ADVANCES IN SKIN & WOUND CARE
LA English
DT Article
DE ovine collagen extracellular matrix; wound care dressing; venous leg
   ulcer
ID CHRONIC VENOUS INSUFFICIENCY; WOUND DRESSINGS; IN-VITRO; FORESTOMACH;
   ANGIOGENESIS; COMPRESSION; BIOMATERIAL; PROTEASES; TISSUE; TRIAL
AB The purpose of this study was to describe the rate of closure observed in venous leg ulcers during treatment with ovine collagen extracellular matrix dressings and compression. Fourteen patients with 23 wounds were retrospectively evaluated with respect to healing rates, time to closure, and weekly facility charge fees.
C1 [Bohn, Gregory A.] West Shore Med Ctr, Ctr Wound & Hyperbar Med, Manistee, MI 49660 USA.
   [Gass, Kimberly] Trinity Wound Ctr Wound & Hyperbar Med, Bettendorf, IA USA.
RP Bohn, GA (reprint author), West Shore Med Ctr, Ctr Wound & Hyperbar Med, Manistee, MI 49660 USA.
FU Hollister Incorporated
FX The authors disclose their work was supported by an unrestricted grant,
   product subsidy, and statistical analysis provided by Hollister
   Incorporated. The grant provided by Hollister Incorporated was for the
   purpose of data collection, analysis, and medical writing of this
   project. Hollister Incorporated also donated product for use during the
   study. The authors thank Karen Beach for her editorial assistance.
   Submitted December 13, 2013; accepted in revised form March 24, 2014.
CR Aetna, CLIN POL B WOUND CAR
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Barwell JR, 2004, LANCET, V363, P1854, DOI 10.1016/S0140-6736(04)16353-8
   Beidler SK, 2008, WOUND REPAIR REGEN, V16, P642, DOI 10.1111/j.1524-475X.2008.00415.x
   CALLAM MJ, 1987, BRIT MED J, V294, P1389, DOI 10.1136/bmj.294.6584.1389
   Collins L, 2010, AM FAM PHYSICIAN, V81, P989
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   Demling RH, 2004, WOUNDS, V16, P18
   Falanga V, 1998, ARCH DERMATOL, V134, P293, DOI 10.1001/archderm.134.3.293
   Floden EW, 2011, J BIOMED MATER RES B, V96B, P67, DOI 10.1002/jbm.b.31740
   Gibson D, 2009, WOUNDS INT, P1
   Hankin Cheryl S, 2012, J Manag Care Pharm, V18, P375
   Hareendran A, 2005, J Wound Care, V14, P53
   Herber OR, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-44
   Herouy Y, 2000, BRIT J DERMATOL, V143, P930, DOI 10.1046/j.1365-2133.2000.03825.x
   Hess CT, 2008, CLIN GUIDE SKIN WOUN
   Independence Blue Cross, 2012, MED POL B
   Irvine SM, 2011, BIOMATERIALS, V32, P6351, DOI 10.1016/j.biomaterials.2011.05.040
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Liden BA, 2013, ADV SKIN WOUND CARE, V26, P164, DOI 10.1097/01.ASW.0000428862.34294.d4
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   Metzmacher I, 2007, WOUND REPAIR REGEN, V15, P549, DOI 10.1111/j.1524-475X.2007.00263.x
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Negron L, 2014, INT WOUND J, V11, P392, DOI 10.1111/j.1742-481X.2012.01106.x
   Nelson EA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001836.pub2
   Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495
   O'Donnell TF, 2006, J VASC SURG, V44, P1118, DOI 10.1016/j.jvs.2006.08.004
   O'Meara S, 2014, COCHRANE DATABASE SY
   O'Meara S., 2013, COCHRANE DATABASE SY
   Olin JW, 1999, VASC MED, V4, P1
   Polignano R, 2004, J Wound Care, V13, P21
   Schultz GS, 1998, WOUNDS, V10, p1F
   Smeets R, 2008, INT WOUND J, V5, P195, DOI 10.1111/j.1742-481X.2007.00367.x
   Valencia IC, 2001, J AM ACAD DERMATOL, V44, P401, DOI 10.1067/mjd.2001.222633
   Vin F, 2002, J Wound Care, V11, P335
   Wollina Uwe, 2005, Int J Low Extrem Wounds, V4, P214, DOI 10.1177/1534734605283001
   Woo Kevin, 2007, Adv Skin Wound Care, V20, P99, DOI 10.1097/00129334-200702000-00009
   Yager DR, 1996, J INVEST DERMATOL, V107, P743, DOI 10.1111/1523-1747.ep12365637
NR 38
TC 7
Z9 7
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1527-7941
EI 1538-8654
J9 ADV SKIN WOUND CARE
JI Adv. Skin Wound Care
PD OCT
PY 2014
VL 27
IS 10
BP 448
EP 454
DI 10.1097/01.ASW.0000453728.12032.6f
PG 7
WC Dermatology; Nursing; Surgery
SC Dermatology; Nursing; Surgery
GA AQ1WE
UT WOS:000342573700004
PM 25198432
DA 2018-10-20
ER

PT J
AU Samsom, ML
   Morrison, S
   Masala, N
   Sullivan, BD
   Sullivan, DA
   Sheardown, H
   Schmidt, TA
AF Samsom, Michael L.
   Morrison, Sheila
   Masala, Nemanja
   Sullivan, Benjamin D.
   Sullivan, David A.
   Sheardown, Heather
   Schmidt, Tannin A.
TI Characterization of full-length recombinant human Proteoglycan 4 as an
   ocular surface boundary lubricant
SO EXPERIMENTAL EYE RESEARCH
LA English
DT Article
DE rhPRG4; lubricin; ocular surface; lubrication
ID CARTILAGE DEGENERATION; ARTICULAR-CARTILAGE; MOLECULAR-WEIGHT;
   SYNOVIAL-FLUID; GROWTH-FACTORS; EXPRESSION; BIOREGULATION; METABOLISM;
   PREVENTION; CYTOKINES
AB Proteoglycan 4 (PRG4, or lubricin) is a lubricating mucin-like glycoprotein recently discovered at the ocular surface, where it functions as a boundary lubricant and appears to play a protective role. Recent technological advances have enabled abundant expression of full-length recombinant human PRG4 (rhPRG4). The objectives of this study were to 1) biochemically characterize the gross structure and glycosylations of full-length rhPRG4, and 2) assess the ocular surface boundary lubricating ability of rhPRG4 at both human cornea-eyelid and human cornea-polydimethylsiloxane (PDMS) biointerfaces. rhPRG4 expressed by a Chinese hamster ovary cell line was characterized and compared to native bovine PRG4 by SDS-PAGE western blotting, and protein identity was assessed by tandem mass spectrometry (MS/MS). Human corneas were articulated against PDMS or human eyelids, at effective sliding velocities of 0.3-30 mm/s under physiological loads of similar to 15 kPa, to assess and compare the ocular lubricating ability of rhPRG4 to PRG4. Samples were tested serially in PRG4, rhPRG4 (both 300 mu g/ml), then saline. Western blotting indicated that rhPRG4 had immunoreactivity at the appropriate apparent molecular weight, and possessed O-linked glycosylation consistent with that of PRG4. rhPRG4 protein identity was confirmed by MS/Ms. Both PRG4 and rhPRG4 significantly, and similarly, reduced friction compared to saline at both human cornea - PDMS and human cornea-eyelid biointerfaces. In conclusion, the rhPRG4 studied here demonstrated appropriate higher order structure, O-linked glycosylations, and ocular surface boundary lubricating. Purified rhPRG4 may have clinical utility as a topical treatment of dry eye disease or contact lens biomaterial coating to promote more comfortable wear. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Samsom, Michael L.; Schmidt, Tannin A.] Univ Calgary, Biomed Engn Grad Program, Calgary, AB T2N 1N4, Canada.
   [Morrison, Sheila; Schmidt, Tannin A.] Univ Calgary, Fac Kinesiol, Calgary, AB T2N 1N4, Canada.
   [Masala, Nemanja; Schmidt, Tannin A.] Univ Calgary, Schulich Sch Engn, Ctr Bioengn Res & Educ, Calgary, AB T2N 1N4, Canada.
   [Sullivan, Benjamin D.] TearLab Res Inc, San Diego, CA USA.
   [Sullivan, David A.] Massachusetts Eye & Ear, Schepens Eye Res Inst, Boston, MA USA.
   [Sullivan, David A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.
   [Sheardown, Heather] McMaster Univ, Hamilton, ON, Canada.
RP Schmidt, TA (reprint author), Univ Calgary, KNB 426,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
EM tschmidt@ucalgary.ca
FU Natural Sciences and Engineering Research Council of Canada; Canadian
   Institutes of Health Research; Faculty of Kinesiology; Schulich School
   of Engineering at the University of Calgary
FX This work was supported by funding from the Natural Sciences and
   Engineering Research Council of Canada, the Canadian Institutes of
   Health Research, as well as the Faculty of Kinesiology and the Schulich
   School of Engineering at the University of Calgary. The authors thank
   Lubris, LLC for providing the rhPRG4 rich media, Dr. M.L Warman,
   Harvard, for providing anti-PRG4 Ab 5C11 and J108N, the Lions Eye Bank
   through the Southern Alberta Organ and Tissue Donation Program for
   providing human corneas; and the University of Calgary Body Donation
   Program for providing human eyelids.
CR [Anonymous], 2012, SELEXIS LUBRIS PARTN
   Asbell PA, 2006, CURR MED RES OPIN, V22, P2149, DOI 10.1185/030079906X132640
   Coles C, 2012, OPTOM VIS SCI, V88
   Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360
   Flannery CR, 2009, ARTHRITIS RHEUM-US, V60, P840, DOI 10.1002/art.24304
   Flannery CR, 1999, BIOCHEM BIOPH RES CO, V254, P535, DOI 10.1006/bbrc.1998.0104
   Girod PA, 2007, NAT METHODS, V4, P747, DOI 10.1038/NMETH1076
   HOLLY FJ, 1994, ADV EXP MED BIOL, V350, P275
   Jay G.D., 2004, CURR OPIN ORTHOP, V15, P355
   Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373
   Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550
   Jones ARC, 2007, EUR CELLS MATER, V13, P40, DOI 10.22203/eCM.v013a04
   Jones ARC, 2007, EUR CELLS MATER, V13, P45
   Jones L, 2013, INVEST OPHTH VIS SCI, V54, P37, DOI 10.1167/iovs.13-13215
   Kern JR, 2013, INVEST OPHTHALMOL VI, V54
   Korb Donald R, 2005, Eye Contact Lens, V31, P2, DOI 10.1097/01.ICL.0000140910.03095.FA
   Kwiecinski JJ, 2011, OSTEOARTHR CARTILAGE, V19, P1356, DOI 10.1016/j.joca.2011.07.019
   Morrison S, 2012, EYE CONTACT LENS, V38, P27, DOI 10.1097/ICL.0b013e31823f7041
   Riley Colleen, 2006, Eye Contact Lens, V32, P281, DOI 10.1097/01.icl.0000224522.04723.7a
   Schmidt TA, 2008, OSTEOARTHR CARTILAGE, V16, P90, DOI 10.1016/j.joca.2007.05.009
   Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446
   Schmidt TA, 2013, JAMA OPHTHALMOL, V131, P766, DOI 10.1001/jamaophthalmol.2013.2385
   Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016
   Steele BL, 2013, OSTEOARTHR CARTILAGE, V21, P498, DOI 10.1016/j.joca.2012.12.002
   SWANN DA, 1977, BIOCHEM J, V161, P473, DOI 10.1042/bj1610473
NR 25
TC 36
Z9 36
U1 2
U2 24
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0014-4835
EI 1096-0007
J9 EXP EYE RES
JI Exp. Eye Res.
PD OCT
PY 2014
VL 127
BP 14
EP 19
DI 10.1016/j.exer.2014.06.015
PG 6
WC Ophthalmology
SC Ophthalmology
GA AQ1KI
UT WOS:000342539900003
PM 24997456
DA 2018-10-20
ER

PT J
AU Kang-Mieler, JJ
   Osswald, CR
   Mieler, WF
AF Kang-Mieler, Jennifer J.
   Osswald, Christian R.
   Mieler, William F.
TI Advances in ocular drug delivery: emphasis on the posterior segment
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE anterior segment delivery; drug delivery; eye; posterior segment
   delivery
ID DIABETIC MACULAR EDEMA; INTRAVITREAL AFLIBERCEPT INJECTION; CHOROIDAL
   NEOVASCULARIZATION; TRANSSCLERAL IONTOPHORESIS; FLUOCINOLONE ACETONIDE;
   PHOTODYNAMIC THERAPY; INTRAOCULAR IMPLANTS; PORCINE MODEL; EYE DISEASE;
   PHASE-I
AB Introduction: Recent advances in pharmacological therapies to treat ocular diseases such as glaucoma, age-related macular degeneration, diabetic macular edema and retinal vascular occlusions have greatly improved the prognosis for these diseases. Due to these advances in pharmacological therapy, there is a great deal of interest in minimally invasive delivery methods, which has generated rapid developments in the field of ocular drug delivery.
   Areas covered: This review will summarize currently available and recent developments for ocular drug delivery to both the anterior and posterior segments. Modes of delivery, including topical, systemic, transcleral/periocular and intravitreal, will be discussed and corresponding examples will be given. This review will highlight the advantages and disadvantages of each mode of delivery and discuss strategies to address these issues.
   Expert opinion: An ideal therapy should maintain effective levels of drug for the intended duration of treatment following a single application, yet a significant number of months of therapy may be required. There are numerous approaches under investigation to improve treatment options. From the use of novel biomaterial implants and depots for sustained release, to prodrug formations, to iontophoresis to improve drug delivery, the main emphasis will continue to be placed on less invasive, longer acting, sustained release formulations in the treatment of numerous ocular disorders.
C1 [Kang-Mieler, Jennifer J.; Osswald, Christian R.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Mieler, William F.] Univ Illinois, Illinois Eye & Ear Infirm, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA.
RP Kang-Mieler, JJ (reprint author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
EM kang-mieler@iit.edu
CR Akula JD, 2010, EXP EYE RES, V91, P153, DOI 10.1016/j.exer.2010.04.008
   Alster Y, 2000, BRIT J OPHTHALMOL, V84, P300, DOI 10.1136/bjo.84.3.300
   [Anonymous], 2014, RET FLUOC AC INTR IM
   [Anonymous], 2014, FOV
   [Anonymous], 2014, IBI 10090
   [Anonymous], 2014, CHRON TECHN
   [Anonymous], 2014, DEX PUNCT PLUG
   [Anonymous], 2012, ECT PIP
   Babizhayev Mark A, 2009, Recent Pat Drug Deliv Formul, V3, P229
   Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200
   Blumenkranz Mark S, 2002, Arch Ophthalmol, V120, P1307
   Bochot A, 1998, J DRUG TARGET, V6, P309, DOI 10.3109/10611869808996838
   Bourges JL, 2006, ADV DRUG DELIVER REV, V58, P1182, DOI 10.1016/j.addr.2006.07.026
   Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017
   Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026
   Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018
   Campochiaro P, 2000, J CELL PHYSL, V184, P201
   Campochiaro PA, 2004, INVEST OPHTH VIS SCI, V45, P922, DOI 10.1167/iovs.03-0955
   Phan CM, 2014, EXPERT OPIN DRUG DEL, V11, P537, DOI 10.1517/17425247.2014.882315
   Ciolino JB, 2009, INVEST OPHTH VIS SCI, V50, P3346, DOI 10.1167/iovs.08-2826
   Cohen AE, 2012, OPHTHALMOLOGY, V119, P66, DOI 10.1016/j.ophtha.2011.07.006
   Davis BM, 2014, SMALL, V10, P1575, DOI 10.1002/smll.201303433
   Department of Ophthalmology and Epidemiology; University of Pennsylvania, 2000, PIP
   Drapala PW, 2014, PHARM RES-DORDR, V31, P742, DOI 10.1007/s11095-013-1195-0
   Drapala PW, 2011, J BIOMAT SCI-POLYM E, V22, P59, DOI 10.1163/092050609X12578498952315
   Driot JY, 2004, J OCUL PHARMACOL TH, V20, P269, DOI 10.1089/1080768041223611
   Duvvuri S, 2003, EXPERT OPIN BIOL TH, V3, P45, DOI 10.1517/14712598.3.1.45
   Ebrahim S, 2005, SURV OPHTHALMOL, V50, P167, DOI 10.1016/j.survophthal.2004.12.006
   Eljarrat-Binstock E, 2005, J CONTROL RELEASE, V106, P386, DOI 10.1016/j.jcornel.2005.05.020
   Emerich DF, 2008, CURR OPIN MOL THER, V10, P506
   Endl MJ, 2014, INTR SURG MED ANN AS
   Fenton C, 2006, DRUG AGING, V23, P421, DOI 10.2165/00002512-200623050-00006
   Fung A. E., 2010, RETIN TODAY, P51
   Fung AE, 2010, ONE YEAR SAFETY EFFI
   Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200
   Guthrie MJ, 2014, MICROVASC RES, V91, P1, DOI 10.1016/j.mvr.2013.11.005
   Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006
   Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3
   Hughes PM, 2005, ADV DRUG DELIVER REV, V57, P2010, DOI 10.1016/j.addr.2005.09.004
   Jaffe GJ, 2005, OPHTHALMOLOGY, V112, P1192, DOI 10.1016/j.ophtha.2005.03.013
   Janoria KG, 2007, EXPERT OPIN DRUG DEL, V4, P371, DOI 10.1517/17425247.4.4.371
   Kane FE, 2008, EXPERT OPIN DRUG DEL, V5, P1039, DOI [10.1517/17425247.5.9.1039 , 10.1517/17425240802358246]
   Kang-Mieler JJ, 2011, DUANES OPHTHALMOLOGY
   Kim SH, 2007, OPHTHAL RES, V39, P244, DOI 10.1159/000108117
   Kokate A, 2006, DESIGN CONTROLLED RE
   Kubota R, 2014, RETINA-J RET VIT DIS, V34, P603, DOI 10.1097/01.iae.0000434565.80060.f8
   Kuppermann BD, 2007, ARCH OPHTHALMOL-CHIC, V125, P309, DOI 10.1001/archopht.125.3.309
   Lee V H, 1986, J Ocul Pharmacol, V2, P67, DOI 10.1089/jop.1986.2.67
   Lewis RA, 2007, J CATARACT REFR SURG, V33, P1217, DOI 10.1016/j.jcrs.2007.03.051
   Lim JI, 1999, AM J OPHTHALMOL, V127, P288, DOI 10.1016/S0002-9394(98)00443-7
   Lockhart AC, 2010, J CLIN ONCOL, V28, P207, DOI 10.1200/JCO.2009.22.9237
   Loftssona T, 1999, ADV DRUG DELIVER REV, V36, P59, DOI 10.1016/S0169-409X(98)00055-6
   Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053
   Myles ME, 2005, ADV DRUG DELIVER REV, V57, P2063, DOI 10.1016/j.addr.2005.08.006d
   Nakano Goto S, 2012, ACTA OPHTHALMOL, V90, P629
   Nakano S, 2010, GRAEF ARCH CLIN EXP, V248, P805, DOI 10.1007/s00417-010-1316-y
   Novack GD, 2008, OCUL SURF, V6, P99, DOI 10.1016/S1542-0124(12)70275-6
   Ocular Therapeutix Inc, 2000, PIP
   Oling F, 2000, J MOL BIOL, V304, P561, DOI 10.1006/jmbi.2000.4183
   Olsen TW, 2006, AM J OPHTHALMOL, V142, P777, DOI 10.1016/j.ajo.2006.05.045
   Olsen TW, 2011, INVEST OPHTH VIS SCI, V52, P4749, DOI 10.1167/iovs.10-6291
   Osswald CR, 2014, MAT BIOM APPL 2 6 AN, VII
   Osswald CR, 2014, PHYS PHARM ARVO ANN
   Pachydaki Sophia, 2007, International Ophthalmology Clinics, V47, P95, DOI 10.1097/IIO.0b013e31802bd7cf
   Patane MA, 2011, CLIN OPHTHALMOL, V5, P633, DOI 10.2147/OPTH.S19349
   Patel SR, 2011, PHARM RES-DORDR, V28, P166, DOI 10.1007/s11095-010-0271-y
   Peyman GA, 2009, RETINA-J RET VIT DIS, V29, P875, DOI 10.1097/IAE.0b013e3181a94f01
   Raghava Swita, 2004, Expert Opin Drug Deliv, V1, P99, DOI 10.1517/17425247.1.1.99
   Ravivarapu H, 2006, DESIGN CONTROLLED RE
   Rizzo S, 2012, RETINA-J RET VIT DIS, V32, P776, DOI 10.1097/IAE.0b013e3182278b0e
   Rodriguez-Aller M, 2012, EUR J PHARM BIOPHARM, V80, P544, DOI 10.1016/j.ejpb.2011.11.017
   Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481
   Saishin Y, 2003, INVEST OPHTH VIS SCI, V44, P4989, DOI 10.1167/iovs.03-0600
   Schmidt-Erfurth U, 2014, OPHTHALMOLOGY, V121, P193, DOI 10.1016/j.ophtha.2013.08.011
   Shirasaki Y, 2008, J PHARM SCI-US, V97, P2462, DOI 10.1002/jps.21200
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Sigurdsson HH, 2007, ACTA OPHTHALMOL SCAN, V85, P598, DOI 10.1111/j.1600-0420.2007.00885.x
   Tajika T, 2011, J OCUL PHARMACOL TH, V27, P43, DOI 10.1089/jop.2010.0093
   Tanito M, 2011, INVEST OPHTH VIS SCI, V52, P7944, DOI 10.1167/iovs.11-8178
   Tao Weng, 2006, Expert Opin Biol Ther, V6, P717, DOI 10.1517/14712598.6.7.717
   Tetz M, 2012, OPHTHALMOLOGICA, V227, P183, DOI 10.1159/000336045
   Turturro SB, 2011, BIOMATERIALS, V32, P3620, DOI 10.1016/j.biomaterials.2011.01.058
   Weiner A. L, 1995, US Patent, Patent No. [5,466,233, 5466233]
   Yang C, 2001, EXPERT OPIN BIOL TH, V1, P159, DOI 10.1517/14712598.1.2.159
   Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003
NR 85
TC 46
Z9 48
U1 2
U2 52
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
EI 1744-7593
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD OCT
PY 2014
VL 11
IS 10
BP 1647
EP 1660
DI 10.1517/17425247.2014.935338
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AP8VZ
UT WOS:000342358700012
PM 24975820
DA 2018-10-20
ER

PT J
AU Gantar, A
   da Silva, LP
   Oliveira, JM
   Marques, AP
   Correlo, VM
   Novak, S
   Reis, RL
AF Gantar, Ana
   da Silva, Lucilia P.
   Oliveira, Joaquim M.
   Marques, Alexandra P.
   Correlo, Vitor M.
   Novak, Sasa
   Reis, Rui L.
TI Nanoparticulate bioactive-glass-reinforced gellan-gum hydrogels for
   bone-tissue engineering
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Scaffold; Gellan-gum; Bioactive-glass; Composite; Bone-tissue
   engineering
ID IN-VITRO; COMPOSITE SCAFFOLDS; IONIC PRODUCTS; STEM-CELLS; PORE-SIZE;
   HYDROXYAPATITE; VIVO; REGENERATION; BIOMATERIAL; DISSOLUTION
AB This work presents bioactive-glass-reinforced gellan-gum spongy-like hydrogels (GG-BAG) as novel hydrophilic materials for use as the scaffolding in bone-tissue engineering. The reinforcement with bioactive-glass particles resulted in an improvement to the microstructure and to the mechanical properties of the material. These mechanical properties were found to be dependent on the composition and improved with the amount of bioactive glass; however, values necessary to accommodate biomechanical loading were not achieved in this study. Nevertheless, by incorporating the bioactive-glass particles, the composite material acquired the ability to form an apatite layer when soaked in simulated body fluid. Furthermore, human-adipose-derived stem cells were able to adhere and spread within the gellan-gum, spongy-like hydrogels reinforced with the bioactive glass, and remain viable, which is an important result when considering their use in bone-tissue engineering. Thus, hydrogels based on gellan-gum and bioactive glass are promising biomaterials for use either alone or with cells, and with the potential for use in osteogenic differentiation. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gantar, Ana; Novak, Sasa] Jozef Stefan Inst, Dept Nanostruct Mat, SI-1000 Ljubljana, Slovenia.
   [Gantar, Ana; Novak, Sasa] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia.
   [da Silva, Lucilia P.; Oliveira, Joaquim M.; Marques, Alexandra P.; Correlo, Vitor M.; Reis, Rui L.] Univ Minho, Dept Polymer Engn, Res Grp 3Bs, P-4719 Braga, Portugal.
   [da Silva, Lucilia P.; Oliveira, Joaquim M.; Marques, Alexandra P.; Correlo, Vitor M.; Reis, Rui L.] PT Govt Associate Lab, ICVS 3Bs, Braga, Guimaraes, Portugal.
RP Novak, S (reprint author), Jozef Stefan Inst, Dept Nanostruct Mat, Jamova C 39, SI-1000 Ljubljana, Slovenia.
EM sasa.novak@ijs.si
RI Oliveira, Joaquim Miguel/H-8636-2012; Group, 3Bs/E-4374-2012; Reis, Rui
   L./A-8938-2008; Marques, Alexandra/B-1238-2012; Correlo,
   Vitor/O-4227-2015
OI Oliveira, Joaquim Miguel/0000-0001-7052-8837; Group,
   3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Marques,
   Alexandra/0000-0002-3222-0310; Correlo, Vitor/0000-0002-5516-7583;
   Pereira da Silva, Lucilia/0000-0002-4889-7799
FU Slovenian Research Agency
FX The Slovenian Research Agency is acknowledged for its financial support
   of the PhD study of the first author, Ms. Ana Gantar. This work was
   partly performed within the short-term scientific mission (STSM
   reference number: ECOST-STSM-MP1005-250912-020779) of Ms. Gantar in the
   3B's group under the COST Action MP1005 "From nano to macro biomaterials
   (design, processing, characterization, modelling) and applications to
   stem cell regenerative orthopaedic and dental medicine - NAMABIO". The
   authors wish to thank Dr Paul McGuiness for proofreading the article.
CR Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Barbani N, 2012, J MATER SCI-MATER M, V23, P51, DOI 10.1007/s10856-011-4505-2
   Barroca N, 2010, ACTA BIOMATER, V6, P3611, DOI 10.1016/j.actbio.2010.03.032
   Bigi A, 2002, J BIOMED MATER RES, V59, P709, DOI 10.1002/jbm.10045
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Cao B, 2008, APPL SURF SCI, V255, P505, DOI 10.1016/j.apsusc.2008.06.066
   Cerqueira MT, 2013, BIOMACROMOLECULES, V14, P3997, DOI 10.1021/bm4011062
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chen QZ, 2006, J BIOMED MATER RES A, V77A, P445, DOI 10.1002/jbm.a.30636
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Doiphode ND, 2011, J MATER SCI-MATER M, V22, P515, DOI 10.1007/s10856-011-4236-4
   Drnovsek N., 2012, DEV COATINGS TI6AL4V, P132
   Drnovsek N, 2012, INT ORTHOP, V36, P1739, DOI 10.1007/s00264-012-1520-y
   Du C, 1999, J BIOMED MATER RES, V44, P407, DOI 10.1002/(SICI)1097-4636(19990315)44:4<407::AID-JBM6>3.0.CO;2-T
   Fabbri P, 2010, COMPOS SCI TECHNOL, V70, P1869, DOI 10.1016/j.compscitech.2010.05.029
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Goonoo N, 2013, POLYM INT, V62, P523, DOI 10.1002/pi.4474
   Hench L. L., 1993, INTRO BIOCERAMICS, V1
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hong Z, 2009, J BIOMED MATER RES A, V88A, P304, DOI 10.1002/jbm.a.31848
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kretlow JD, 2008, AICHE J, V54, P3048, DOI 10.1002/aic.11610
   Liu X, 2011, ACTA BIOMATER, V7, P406, DOI 10.1016/j.actbio.2010.08.025
   Liu X, 2009, J MATER SCI-MATER M, V20, P365, DOI 10.1007/s10856-008-3582-3
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Manda-Guiba MG, 2012, J TISSUE ENG REGEN M, V6, P15
   Mathieu LM, 2006, BIOMATERIALS, V27, P905, DOI 10.1016/j.biomaterials.2005.07.015
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Miyoshi E, 1996, CARBOHYD POLYM, V30, P109, DOI 10.1016/S0144-8617(96)00093-8
   NUNERY WR, 1993, OPHTHALMIC PLAST REC, V9, P96, DOI 10.1097/00002341-199306000-00004
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Pereira DR, 2012, J TISSUE ENG REGEN M, V6, P185
   Pereira DR, 2013, J TISSUE ENG REGEN M, V7, P85, DOI 10.1002/term.500
   Peter M, 2010, CARBOHYD POLYM, V79, P284, DOI 10.1016/j.carbpol.2009.08.001
   Peter M, 2009, CARBOHYD POLYM, V78, P926, DOI 10.1016/j.carbpol.2009.07.016
   SCHEPERS E, 1991, J ORAL REHABIL, V18, P439, DOI 10.1111/j.1365-2842.1991.tb01689.x
   Silva-Correia J, 2012, TISSUE ENG PT A, V18, P1203, DOI [10.1089/ten.tea.2011.0632, 10.1089/ten.TEA.2011.0632]
   Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Varanasi VG, 2011, J BIOMED MATER RES A, V98A, P177, DOI 10.1002/jbm.a.33102
   Wang YJ, 2006, MACROMOL MATER ENG, V291, P254, DOI 10.1002/mame.200500381
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yamada T, 2005, J BIOSCI BIOENG, V99, P521, DOI 10.1263/jbb.99.521
   Yamaoka H, 2006, J BIOMED MATER RES A, V78A, P1, DOI 10.1002/jbm.a.30655
   Zaffe D, 2004, BIOMATERIALS, V25, P3837, DOI 10.1016/j.biomaterials.2003.10.020
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 56
TC 45
Z9 45
U1 2
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 27
EP 36
DI 10.1016/j.msec.2014.06.045
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000004
PM 25175184
DA 2018-10-20
ER

PT J
AU Tallarico, DA
   Gobbi, AL
   Paulin, PI
   da Costa, MEHM
   Nascente, PAP
AF Tallarico, D. A.
   Gobbi, A. L.
   Paulin Filho, P. I.
   Maia da Costa, M. E. H.
   Nascente, P. A. P.
TI Growth and surface characterization of TiNbZr thin films deposited by
   magnetron sputtering for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titanium alloys; Thin films; Biomaterials; XPS; Nanoindentation
ID TITANIUM IMPLANTS; ALLOYS; FATIGUE; TI; OSTEOBLASTS; COATINGS
AB Low modulus of elasticity and the presence of non-toxic elements are important criteria for the development of materials for implant applications. Low modulus Ti alloys can be developed by designing beta-Ti alloys containing non-toxic alloying elements such as Nb and Zr. Actually, most of the metallic implants are produced with stainless steel (SS) because it has adequate bulk properties to be used as biomaterials for orthopedic or dental implants and is less expensive than Ti and its alloys, but it is less biocompatible than them. The coating of this SS implants with Ti alloy thin films may be one alternative to improve the biomaterial properties at a relatively low cost. Sputtering is a physical deposition technique that allows the formation of nanostructured thin films. Nanostructured surfaces are interesting when it comes to the bone/implant interface due to the fact that both the surface and the bone have nanoscale particle sizes and similar mechanical properties. TiNbZr thin films were deposited on both Si(111) and stainless steel (SS) substrates. The TiNbZr/Si(111) film was used as a model system, while the TiNbZr/SS film might improve the biocompatibility and extend the life time of stainless steel implants. The morphology, chemical composition, Young's modulus, and hardness of the films were analyzed by atomic force microscopy (AFM), X-ray photoelectron spectroscopy (XPS), energy-dispersive X-ray spectroscopy (EDS), and nanoindentation. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Tallarico, D. A.] Univ Fed Sao Carlos, Mat Sci & Engn Graduat Program, BR-13565905 Sao Carlos, SP, Brazil.
   [Gobbi, A. L.] Brazilian Nanotechnol Natl Lab, BR-13083100 Campinas, SP, Brazil.
   [Paulin Filho, P. I.; Nascente, P. A. P.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
   [Maia da Costa, M. E. H.] Pontificia Univ Catolica Rio de Janeiro, Dept Phys, BR-22451900 Rio De Janeiro, RJ, Brazil.
RP Nascente, PAP (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Via Washington Luis Km 235, BR-13565905 Sao Carlos, SP, Brazil.
EM nascente@ufscar.br
RI Maia da Costa, Marcelo/O-1017-2018
OI Gobbi, Angelo Luiz/0000-0001-7186-5085
FU Brazilian Synchrotron Light Source (LNLS) [LMF-8912, LMF-10475]; FAPESP
   [2009/17055-7]; CAPES; CNPq [302001/2010-7, 470816/2007-0]
FX This work has been supported by the Brazilian Synchrotron Light Source
   (LNLS) under proposals LMF-8912 and LMF-10475. Grants and scholarships
   from the Brazilian agencies FAPESP (process 2009/17055-7), CAPES, and
   CNPq (processes 302001/2010-7 and 470816/2007-0) are gratefully
   acknowledged.
CR Maya AEA, 2012, MAT SCI ENG C-MATER, V32, P321, DOI 10.1016/j.msec.2011.10.035
   Akahori T, 2005, MAT SCI ENG C-BIO S, V25, P248, DOI 10.1016/j.msec.2004.12.007
   Barrere F, 2004, BIOMATERIALS, V25, P2901, DOI 10.1016/j.biomaterials.2003.09.063
   Boehlert CJ, 2005, MAT SCI ENG C-BIO S, V25, P263, DOI 10.1016/j.msec.2004.12.011
   Caceres D, 2008, ACTA BIOMATER, V4, P1545, DOI 10.1016/j.actbio.2008.04.009
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Dickerson SL, 2000, MAT SCI ENG A-STRUCT, V278, P121
   Dongwoo K., 2008, BIOMATERIALS, V29, P970
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   Kaplan FS, 1994, AM ACAD ORTHOPAEDIC, V1, P127
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   Liu X., 2004, MAT SCI ENG R, V27, P49
   Mandl S, 2002, SURF COAT TECH, V156, P276, DOI 10.1016/S0257-8972(02)00085-3
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Musil J, 2000, SURF COAT TECH, V125, P322, DOI 10.1016/S0257-8972(99)00586-1
   Niinomi M, 2005, MAT SCI ENG C-BIO S, V25, P417, DOI 10.1016/j.msec.2005.01.024
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   NIINOMI M, 2003, ADV MATER, V4, P445
   Olivares-Navarrete R, 2011, COATINGS, V1, P72, DOI 10.3390/coatings1010072
   Oliveira AL, 2003, CURR OPIN SOLID ST M, V7, P309, DOI 10.1016/j.cossms.2003.10.009
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   SCHNEIDER JM, 2000, J APPL D, V33, P173
   Sienz S, 2002, SURF COAT TECH, V156, P185, DOI 10.1016/S0257-8972(02)00081-6
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   Tallarico D.A., 2012, J VAC SCI TECHNOL A, V30-5
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   Wise D. L., 1995, ENCY HDB BIOMATERI B
   You L, 2012, MATER LETT, V80, P165, DOI 10.1016/j.matlet.2012.01.145
NR 32
TC 13
Z9 13
U1 0
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 45
EP 49
DI 10.1016/j.msec.2014.07.013
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000006
PM 25175186
DA 2018-10-20
ER

PT J
AU Tong, W
   Fox, K
   Ganesan, K
   Turnley, AM
   Shimoni, O
   Tran, PA
   Lohrmann, A
   McFarlane, T
   Ahnood, A
   Garrett, DJ
   Meffin, H
   O'Brien-Simpson, NM
   Reynolds, EC
   Prawer, S
AF Tong, Wei
   Fox, Kate
   Ganesan, Kumaravelu
   Turnley, Ann M.
   Shimoni, Olga
   Tran, Phong A.
   Lohrmann, Alexander
   McFarlane, Thomas
   Ahnood, Arman
   Garrett, David J.
   Meffin, Hamish
   O'Brien-Simpson, Neil M.
   Reynolds, Eric C.
   Prawer, Steven
TI Fabrication of planarised conductively patterned diamond for
   bio-applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Diamond; Planar; Neural; Biocompatible; Antibacterial
ID DOPED ULTRANANOCRYSTALLINE DIAMOND; RETINAL PROSTHESIS; MEMS
   APPLICATIONS; THIN-FILMS; SURFACE; CELLS; NANOCRYSTALLINE; PLASMA;
   GROWTH; NANODIAMOND
AB The development of smooth, featureless surfaces for biomedical microelectronics is a challenging feat. Other than the traditional electronic materials like silicon, few microelectronic circuits can be produced with conductive features without compromising the surface topography and/or biocompatibility. Diamond is fast becoming a highly sought after biomaterial for electrical stimulation, however, its inherent surface roughness introduced by the growth process limits its applications in electronic circuitry. In this study, we introduce a fabrication method for developing conductive features in an insulating diamond substrate whilst maintaining a planar topography. Using a combination of microwave plasma enhanced chemical vapour deposition, inductively coupled plasma reactive ion etching, secondary diamond growth and silicon wet-etching, we have produced a patterned substrate in which the surface roughness at the interface between the conducting and insulating diamond is approximately 3 nm. We also show that the patterned smooth topography is capable of neuronal cell adhesion and growth whilst restricting bacterial adhesion. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Tong, Wei; Fox, Kate; Ganesan, Kumaravelu; Shimoni, Olga; Lohrmann, Alexander; McFarlane, Thomas; Ahnood, Arman; Garrett, David J.; Prawer, Steven] Univ Melbourne, Sch Phys, Parkville, Vic 3052, Australia.
   [Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.
   [Tran, Phong A.] Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3052, Australia.
   [Meffin, Hamish] Natl Informat & Commun Technol Australia, Melbourne, Vic 3010, Australia.
   [Meffin, Hamish] Univ Melbourne, Dept Elect & Elect Engn, Melbourne, Vic 3010, Australia.
   [O'Brien-Simpson, Neil M.; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.
RP Fox, K (reprint author), Univ Melbourne, Sch Phys, Parkville, Vic 3052, Australia.
EM kfox@unimelb.edu.au
RI McKenzie, Warren/J-2137-2014; Ganesan, Kumaravelu/D-5274-2009; Ahnood,
   Arman/O-8450-2015
OI Ganesan, Kumaravelu/0000-0001-8976-5218; Ahnood,
   Arman/0000-0002-0253-7579; O'Brien-Simpson, Neil/0000-0001-8462-5603;
   Meffin, Hamish/0000-0003-4307-6841; PRAWER, STEVEN/0000-0002-4959-0828;
   Reynolds, Eric/0000-0002-6618-4856; Shimoni, Olga/0000-0001-8822-1024;
   Garrett, David/0000-0002-4676-8387; Tran, Phong/0000-0003-2820-7399
FU Department of Broadband, Communications and the Digital Economy;
   Australian Research Council through ICT Centre of Excellence Program;
   Australian Research Council (ARC) through its Special Research
   Initiative (SRI) in Bionic Vision Science and Technology grant;
   Melbourne Materials Institute
FX The authors wish to acknowledge the contribution of Dr. Marta Redrado
   Notivoli, Chemistry and Chemical Engineering Department, University of
   Melbourne for collecting AFM data and Ms Rosemary Cicione for her help
   in proofreading the final manuscript. The authors wish to acknowledge
   the Electron Microscopy unit of Bio21 Institute, The University of
   Melbourne for assistance with electron microscopy. Melbourne Centre for
   Nanofabrication is also acknowledged for the use of Oxford PlasmaLab 100
   ICP-RIE General system. NICTA is funded by the Australian Government as
   represented by the Department of Broadband, Communications and the
   Digital Economy and the Australian Research Council through the ICT
   Centre of Excellence Program. This research was supported by the
   Australian Research Council (ARC) through its Special Research
   Initiative (SRI) in Bionic Vision Science and Technology grant to Bionic
   Vision Australia (BVA). The research was also supported by an
   interdisciplinary seed grant from the Melbourne Materials Institute.
CR Achanta S., 2007, NANOTRIBOLOGY MEMS N, P521
   Aharonovich I, 2011, NAT PHOTONICS, V5, P397, DOI [10.1038/NPHOTON.2011.54, 10.1038/nphoton.2011.54]
   Ando Y, 2002, DIAM RELAT MATER, V11, P824, DOI 10.1016/S0925-9635(01)00617-3
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Auciello O, 2010, DIAM RELAT MATER, V19, P699, DOI 10.1016/j.diamond.2010.03.015
   Bajaj P, 2007, BIOMED MICRODEVICES, V9, P787, DOI 10.1007/s10544-007-9090-2
   Ball P., 1999, NATURE NEWS NATURE
   Bhattacharyya S, 2001, APPL PHYS LETT, V79, P1441, DOI 10.1063/1.1400761
   Birrell J, 2003, J APPL PHYS, V93, P5606, DOI 10.1063/1.1564880
   Booth L, 2011, MATERIALS, V4, P857, DOI 10.3390/ma4050857
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058
   Chen YC, 2009, DIAM RELAT MATER, V18, P146, DOI 10.1016/j.diamond.2008.10.004
   Ding GF, 2000, P SOC PHOTO-OPT INS, V4230, P224, DOI 10.1117/12.404907
   EFREMOW NN, 1985, J VAC SCI TECHNOL B, V3, P416, DOI 10.1116/1.583276
   Espinosa HD, 2003, MATER RES SOC SYMP P, V741, P213
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Fox K., 2012, J MATER SCI-MATER M, V24, P849
   Ganesan K, 2014, BIOMATERIALS, V35, P908, DOI 10.1016/j.biomaterials.2013.10.040
   Garrett D.J., 2012, J NEURAL ENG, V9, P10
   Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x
   Gupta S, 2003, J MATER RES, V18, P363, DOI 10.1557/JMR.2003.0047
   Hadjinicolaou AE, 2012, BIOMATERIALS, V33, P5812, DOI 10.1016/j.biomaterials.2012.04.063
   Juvonen H, 2013, ACTA BIOMATER, V9, P6704, DOI 10.1016/j.actbio.2013.01.033
   KATSUMATA S, 1994, DIAM RELAT MATER, V3, P1296, DOI 10.1016/0925-9635(94)90141-4
   Lee S.K., 2010, NANOTECHNOLOGY, P21
   Marciano FR, 2011, VACUUM, V85, P662, DOI 10.1016/j.vacuum.2010.07.017
   Medina O, 2012, DIAM RELAT MATER, V22, P77, DOI 10.1016/j.diamond.2011.12.022
   Moldovan N, 2009, J VAC SCI TECHNOL B, V27, P3125, DOI 10.1116/1.3263174
   Moriarty T.F., 2011, COMPREHENSIVE BIOMAT, V4, P75
   Papo MJ, 2004, J MATER SCI-MATER M, V15, P773, DOI 10.1023/B:JMSM.0000032817.05997.d2
   SANDHU GS, 1989, APPL PHYS LETT, V55, P437, DOI 10.1063/1.101890
   Shiomi H, 1997, JPN J APPL PHYS 1, V36, P7745, DOI 10.1143/JJAP.36.7745
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Sommer AP, 2012, J BIONIC ENG, V9, P353, DOI 10.1016/S1672-6529(11)60125-X
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Vivensang C, 1996, DIAM RELAT MATER, V5, P840, DOI 10.1016/0925-9635(95)00368-1
   Vlasov II, 2006, PHYS STATUS SOLIDI A, V203, P3028, DOI 10.1002/pssa.200671119
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Williams OA, 2008, DIAM RELAT MATER, V17, P1080, DOI 10.1016/j.diamond.2008.01.103
   Windholz R, 1997, J MATER SCI, V32, P4295, DOI 10.1023/A:1018611604403
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Yang N, 2013, MAT SCI ENG C-MATER, V33, P3465, DOI 10.1016/j.msec.2013.04.035
   ZANIN H, 2013, ACS APPL MATER INTER, V6, P990
   Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047
   Zhuang H, 2011, LANGMUIR, V27, P11981, DOI 10.1021/la2024428
   ZIMMERLI W, 1994, J ANTIMICROB CHEMOTH, V33, P959
NR 49
TC 14
Z9 14
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 135
EP 144
DI 10.1016/j.msec.2014.07.016
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000018
PM 25175198
DA 2018-10-20
ER

PT J
AU Krishnamoorthy, G
   Selvakumar, R
   Sastry, TP
   Sadulla, S
   Mandal, AB
   Doble, M
AF Krishnamoorthy, Ganesan
   Selvakumar, Rajendran
   Sastry, Thotapalli Parvathaleswara
   Sadulla, Sayeed
   Mandal, Asit Baran
   Doble, Mukesh
TI Experimental and theoretical studies on Gallic acid assisted EDC/NHS
   initiated crosslinked collagen scaffolds
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Tissue engineering; Collagen scaffold; Gallic add;
   Biocompatibility
ID TISSUE; POLYPHENOLS; LINKING; MATRIX; FIBER; TEA
AB The effect of Gallic acid (GA) in the presence of 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC)/N-hydroxysuccinimide (NHS) on collagen scaffold is investigated. The thermal mechanical analyzer (TMA), differential scanning calorimetric (DSC), and thermogravimetric analysis (TGA) including tensile strength (TS, 180 +/- 3 MPa), denaturation temperature (T-d, 80.03 degrees C), % elongation (%E, 180 +/- 9) and weight loss (31.76%), indicate that the modification improves the structural integrity and stability of the collagen scaffold. The GA-EDC/NHS treatment inhibits the action of collagenase against collagen degradation compared to GA and EDC/NHS. It is concluded from docking studies that GA binds with collagen like peptide (CLP) and collagenase through multiple H-bonds and hydrophobic interactions leading to low binding energy -5.1 and -5.3 Kcal/mol, respectively. The hydrophobic core of the GA molecules, probably incorporates itself into the hydrophobic areas of the collagen groups, whereas -OH and -COOH moieties of GA establish multiple H-bonds with neighboring collagen molecules and carboxamide bond, thereby improving the swelling and water uptake properties, biocompatibility and cell adhesion properties. This results in improving stability of the scaffold, which prevents the free access of the collagenase to reactive sites in the triple helical collagen chains. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Krishnamoorthy, Ganesan; Sastry, Thotapalli Parvathaleswara; Sadulla, Sayeed; Mandal, Asit Baran] CSIR, Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
   [Krishnamoorthy, Ganesan; Selvakumar, Rajendran; Doble, Mukesh] Indian Inst Technol, Dept Biotechnol, Bioengn & Drug Design Lab, Madras 600036, Tamil Nadu, India.
RP Krishnamoorthy, G (reprint author), CSIR, Cent Leather Res Inst, Madras 600020, Tamil Nadu, India.
EM krishnamoorthyganesh@yahoo.com; abmandal@hotmail.com; mukeshd@iitm.ac.in
RI Mandal, Asit Baran/B-9977-2009
OI Doble, Mukeshd/0000-0002-4335-0698
FU Council of Scientific & Industrial Research (CSIR), Government of India,
   New Delhi
FX The first author acknowledges the Council of Scientific & Industrial
   Research (CSIR), Government of India, New Delhi, for his CSIR-SRF
   fellowship.
CR Ahmed S., 2010, ARTHRITIS RES THER, V12, P1
   Avery Nicholas C., 2009, V522, P103, DOI 10.1007/978-1-59745-413-1_6
   Browne S, 2013, TISSUE ENG PT A, V19, P1491, DOI [10.1089/ten.tea.2012.0721, 10.1089/ten.TEA.2012.0721]
   Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318
   Ding CM, 2008, PROCESS BIOCHEM, V43, P287, DOI 10.1016/j.procbio.2007.12.005
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Haroun AA, 2010, J APPL POLYM SCI, V116, P2825, DOI 10.1002/app.31736
   Haslam E, 2007, PHYTOCHEMISTRY, V68, P2713, DOI 10.1016/j.phytochem.2007.09.009
   He Q, 2006, FOOD CHEM, V95, P250, DOI 10.1016/j.foodchem.2004.11.055
   Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034
   Jackson JK, 2010, J MATER SCI-MATER M, V21, P1435, DOI 10.1007/s10856-010-4019-3
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   Khandwekar AP, 2010, J BIOMED MATER RES A, V95A, P413, DOI 10.1002/jbm.a.32852
   Khandwekar AP, 2009, J MATER SCI-MATER M, V20, P1115, DOI 10.1007/s10856-008-3655-3
   Kim H, 2008, WOUND REPAIR REGEN, V16, P714, DOI 10.1111/j.1524-475X.2008.00422.x
   Krishnamoorthy G, 2008, J APPL POLYM SCI, V108, P199, DOI 10.1002/app.27430
   Krishnamoorthy G., 2012, J ENZYM INHIB MED CH, P451
   Krishnamoorthy G, 2011, APPL BIOCHEM BIOTECH, V165, P1075
   Krishnamoorthy G, 2013, J BIOMED MATER RES A, V101, P1173, DOI 10.1002/jbm.a.34411
   Lu ZB, 2006, NEUROCHEM INT, V48, P263, DOI 10.1016/j.neuint.2005.10.010
   Madhan B, 2007, INT J BIOL MACROMOL, V41, P16, DOI 10.1016/j.ijbiomac.2006.11.013
   Punithavathi VR, 2011, J BIOCHEM MOL TOXIC, V25, P68, DOI 10.1002/jbt.20360
   Ratanavaraporn J, 2010, INT J BIOL MACROMOL, V47, P431, DOI 10.1016/j.ijbiomac.2010.06.008
   RYAN JN, 1971, BIOCHEM BIOPH RES CO, V44, P144, DOI 10.1016/S0006-291X(71)80170-5
   Satyam A, 2014, J TISSUE ENG REGEN M, V8, P233, DOI 10.1002/term.1522
   Schloegl W., 2010, EUR J PHARM BIOPHARM, V80, P282
   Shahrzad S, 2001, J NUTR, V131, P1207
   Song N, 2011, PROCESS BIOCHEM, V46, P2187, DOI 10.1016/j.procbio.2011.09.001
   Tang HR, 2003, BIOPOLYMERS, V70, P403, DOI 10.1002/bip.10499
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wu H., 2011, MAT SCI ENG C, V30, P770
   Xiong X, 2009, PROCESS BIOCHEM, V44, P1200, DOI 10.1016/j.procbio.2009.06.010
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Zhang YH, 2008, TALANTA, V76, P246, DOI 10.1016/j.talanta.2008.02.033
NR 35
TC 13
Z9 13
U1 1
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 164
EP 171
DI 10.1016/j.msec.2014.07.003
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000021
PM 25175201
DA 2018-10-20
ER

PT J
AU Chen, HJ
   Wang, CL
   Zhu, XD
   Zhang, K
   Fan, YJ
   Zhang, XD
AF Chen, Hongjie
   Wang, Chunli
   Zhu, Xiangdong
   Zhang, Kai
   Fan, Yujiang
   Zhang, Xingdong
TI Fabrication of porous titanium scaffolds by stack sintering of
   microporous titanium spheres produced with centrifugal granulation
   technology
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porous Ti scaffolds; Stack sintering; Microporous Ti spheres;
   Centrifugal granulation
ID BIOMEDICAL APPLICATIONS; MECHANICAL-PROPERTIES; OSTEOINDUCTIVE
   BIOMATERIALS; BIOACTIVE TITANIUM; PROTEIN ADSORPTION; CALCIUM-PHOSPHATE;
   BONE INGROWTH; IN-VITRO; IMPLANTS; SURFACE
AB Microporosity plays a key role in bioactivity and osteoinductivity of a biomaterial scaffold. A simple new approach to fabricating load-bearing porous titanium (Ti) scaffolds with uniform porous structure, highly controllable pore size and excellent biocompatibility was developed in the present study. This method was based on stack sintering of microporous Ti spheres produced with centrifugal granulation of commercial Ti powders. Macropores (180.0-341.8 mu m) and micropores (6.1-11.8 mu m) of the scaffolds were dependent on the sizes of the Ti spheres and the Ti powders, respectively. The compressive strength of the scaffolds (83.4-108.9 MPa) was high enough for the repair of load-bearing bone defects. Besides, the abundant micropores occurred on the rough and convex surface of the Ti spheres in the scaffolds were more favorable for adsorption of serum proteins, and thus promoted the growth of mesenchymal stem cells (MSCs). (C) 2014 Elsevier B.V. All rights reserved.
C1 [Chen, Hongjie; Wang, Chunli; Zhu, Xiangdong; Zhang, Kai; Fan, Yujiang; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Zhu, XD (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM zxd7303@163.com; zhangxd@scu.edu.cn
FU National Natural Science Foundation of China [81190131]; National Key
   Technology Support Program of China [2012BAI18B04, 2012BAI17B01]
FX This work was financially supported by National Natural Science
   Foundation of China (81190131) and National Key Technology Support
   Program of China (2012BAI18B04 and 2012BAI17B01).
CR Bear J., 1988, DYNAMICS FLUIDS PORO, P43
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Cachinho SCP, 2008, J MATER SCI-MATER M, V19, P451, DOI 10.1007/s10856-006-0052-7
   Cartmell SH, 2003, TISSUE ENG, V9, P1197, DOI 10.1089/10763270360728107
   Chen YJ, 2009, MATER LETT, V63, P2659, DOI 10.1016/j.matlet.2009.09.029
   Dee K.C., 2002, INTRO TISSUE BIOMATE, P37
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Fu QS, 2011, BIOMATERIALS, V32, P7333, DOI 10.1016/j.biomaterials.2011.06.051
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Fujii E, 2006, ACTA BIOMATER, V2, P69, DOI 10.1016/j.actbio.2005.09.002
   Fukuda A, 2011, ACTA BIOMATER, V7, P2327, DOI 10.1016/j.actbio.2011.01.037
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Habibovic P, 2006, J ORTHOP RES, V24, P867, DOI 10.1002/jor.20115
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Huiskes R, 1993, Acta Orthop Belg, V59 Suppl 1, P118
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kim SW, 2013, MAT SCI ENG C-MATER, V33, P2808, DOI 10.1016/j.msec.2013.03.011
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li H, 2006, RARE METAL MAT ENG, V35, P154
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Polak SJ, 2011, ACTA BIOMATER, V7, P1760, DOI 10.1016/j.actbio.2010.12.030
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Wang H, 2013, ACTA BIOMATER, V9, P8413, DOI 10.1016/j.actbio.2013.05.026
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wei DQ, 2013, MAT SCI ENG C-MATER, V33, P4118, DOI 10.1016/j.msec.2013.05.053
   Yang J, 2013, J MATER SCI-MATER M, V24, P2235, DOI 10.1007/s10856-013-4976-4
   Yoshinari M, 2002, BIOMATERIALS, V23, P2879, DOI 10.1016/S0142-9612(01)00415-X
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhao CY, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025006
   Zhao CY, 2010, J BIOMED MATER RES B, V95B, P387, DOI 10.1002/jbm.b.31728
   Zhu XD, 2012, J BIOMED MATER RES B, V100B, P516, DOI 10.1002/jbm.b.31978
NR 47
TC 14
Z9 14
U1 1
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 182
EP 188
DI 10.1016/j.msec.2014.07.026
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000023
PM 25175203
DA 2018-10-20
ER

PT J
AU Jia, L
   Guo, L
   Zhu, JX
   Ma, YL
AF Jia, Lan
   Guo, Li
   Zhu, Jingxin
   Ma, Yanlong
TI Stability and cytocompatibility of silk fibroin-capped gold
   nanoparticles
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fibroin; Gold nanoparticles; Stability; Cytocompatibility
ID COLLOIDAL STABILITY; AQUEOUS-SOLUTIONS; BOMBYX-MORI; PROTEIN; LIGAND;
   WATER; BIOCOMPATIBILITY; CYTOTOXICITY; AGGREGATION; SIZE
AB Surface engineering is crucial in the colloidal stability and biocompatibility of nanoparticles (NPs). Protein silk fibroin (SF), which gained interest in biomaterial and regenerative medicine, was used in this study to stabilize gold (Au) NPs. Characterization results from UV-Vis spectroscopy revealed that SF-capped Au NPs (SF-Au NPs) possessed remarkable colloidal stabilities in the pH range of 2 to 11 and salt concentration range of 50 mM to 1000 mM. In addition, dried particle samples were resuspended after lyophilization without aggregation. The results indicated that the steric hindrance rather than the electrostatic repulsion of SF-Au NPs was essential for colloidal stability. The SF-Au NPs manifested improved cytocompatibility compared with bare Au NPs, which was attributed to the inherent non-cytotoxicity of SF and the good colloidal stability of the NPs. The proposed method was simpler, more efficient, and more cost effective than the conventional modification strategies for Au NPs; thus, SF-Au NPs can be potentially used in biomedical applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Jia, Lan; Guo, Li; Zhu, Jingxin; Ma, Yanlong] Taiyuan Univ Technol, Coll Mat Sci & Engn, Minist Educ, Key Lab Interface Sci & Engn Adv Mat, Taiyuan 030024, Peoples R China.
RP Jia, L (reprint author), Taiyuan Univ Technol, Coll Mat Sci & Engn, Minist Educ, Key Lab Interface Sci & Engn Adv Mat, Taiyuan 030024, Peoples R China.
EM jialan@tyut.edu.cn
FU Nature Science Foundation of China [51303124]; Natural Science
   Foundation of Shanxi [2013021009-2, 2013011012-2]; Qualified Personnel
   Foundation of Taiyuan University of Technology [tyutrc-201155a]
FX We gratefully acknowledge the financial support from the Nature Science
   Foundation of China (Grant No. 51303124), Natural Science Foundation of
   Shanxi (Grant Nos. 2013021009-2 and 2013011012-2), and the Qualified
   Personnel Foundation of Taiyuan University of Technology (Grant No.
   tyutrc-201155a).
CR Aslan K, 2002, LANGMUIR, V18, P6059, DOI 10.1021/la025795x
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Chen P, 2008, MACROMOL RES, V16, P539, DOI 10.1007/BF03218556
   Cui WJ, 2012, NANOMED-NANOTECHNOL, V8, P46, DOI 10.1016/j.nano.2011.05.005
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Gao J, 2012, LANGMUIR, V28, P4464, DOI 10.1021/la204289k
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Jia L, 2011, J NANOPART RES, V13, P4075, DOI 10.1007/s11051-011-0351-x
   Jin Q, 2008, CHEM COMMUN, P3058, DOI 10.1039/b801959b
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595
   Li MZ, 2002, POLYM ADVAN TECHNOL, V13, P605, DOI 10.1002/pat.159
   Liu XS, 2013, NANOSCALE, V5, P3982, DOI 10.1039/c3nr00284e
   Mei BC, 2009, LANGMUIR, V25, P10604, DOI 10.1021/la901423z
   Mucic RC, 1998, J AM CHEM SOC, V120, P12674, DOI 10.1021/ja982721s
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Ojea-Jimenez I, 2009, J AM CHEM SOC, V131, P13320, DOI 10.1021/ja902894s
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Rouhana LL, 2007, LANGMUIR, V23, P12799, DOI 10.1021/la702151q
   Sardar R, 2007, LANGMUIR, V23, P11883, DOI 10.1021/la702359g
   Shi XY, 2008, J PHYS CHEM C, V112, P8251, DOI 10.1021/jp801293a
   Shi XY, 2007, SOFT MATTER, V3, P71, DOI 10.1039/b612972b
   Sperling RA, 2008, CHEM SOC REV, V37, P1896, DOI 10.1039/b712170a
   Vangala K, 2012, J PHYS CHEM C, V116, P3645, DOI 10.1021/jp2107318
   Vasile E, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0918-1
   Wu PY, 2013, ACS APPL MATER INTER, V5, P12638, DOI 10.1021/am403992b
   Yuan JJ, 2006, LANGMUIR, V22, P11022, DOI 10.1021/la0616350
   Zhang F, 2007, J PHYS CHEM A, V111, P12229, DOI 10.1021/jp074293v
   Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m
   Zhou WB, 2010, CHEM COMMUN, V46, P1479, DOI 10.1039/b915125g
   Zhou Y, 2001, CHEM COMMUN, P2518, DOI 10.1039/b108013j
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
NR 34
TC 12
Z9 13
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 231
EP 236
DI 10.1016/j.msec.2014.07.024
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000029
PM 25175209
DA 2018-10-20
ER

PT J
AU Zhang, JJ
   Ma, XX
   Fan, DD
   Zhu, CH
   Deng, JJ
   Hui, JF
   Ma, P
AF Zhang, Jingjing
   Ma, Xiaoxuan
   Fan, Daidi
   Zhu, Chenhui
   Deng, Jianjun
   Hui, Junfeng
   Ma, Pei
TI Synthesis and characterization of hyaluronic acid/human-like collagen
   hydrogels
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Hydrogel; Human-like collagen; Hyaluronic acid; Biocompatibility;
   Biodegradability
ID CROSS-LINKING; BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; BROAD RANGE;
   ACID; BIOMATERIALS; CHITOSAN; CULTURE; FILMS
AB Injectable hydrogel plays an important role in soft tissue filling and repair. We report an injectable hydrogel based on hyaluronic acid (HA) and human-like collagen (HLC), both with favorable biocompatibility and biodegradability. These two types of biomacromolecules were crosslinked with 1,4-butanediol diglycidyl ether to form a three-dimensional network. The redundant crosslinker was removed by dialysis and distillation. An HA-based hydrogel prepared by the same method was used as a control. The cytocompatibility was studied with a Cell Counting Kit-8 (CCK-8) test. Carbazole colorimetry was used to analyze the in vitro degradation rate. The histocompatibility was evaluated by hematoxylin and eosin (H&E) staining analysis and immunohistochemical analysis. The CCK-8 assay demonstrated that the HA/HLC hydrogel was less cytotoxic than the HA-based hydrogel and could promote baby hamster kidney cell (BHK) proliferation. The cell adhesion indicated that BHK could grow well on the surface of the materials and maintain good cell viability. The in vitro degradation test showed that the HA/HLC hydrogel had a longer degradation time and an excellent antienzyme ability. In vivo injection showed that there was little inflammatory response to HA/HLC after 1, 2, and 4 weeks. Therefore, the HA/HLC hydrogel is a promising biomaterial for soft tissue filling and repair. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhang, Jingjing; Ma, Xiaoxuan; Fan, Daidi; Zhu, Chenhui; Deng, Jianjun; Hui, Junfeng; Ma, Pei] NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Dept Chem Engn, Sch Chem Engn, Xian 710069, Shaanxi, Peoples R China.
RP Ma, XX (reprint author), Northwest Univ, Sch Chem Engn, Shaanxi Key Lab Degradable Biomed Mat, Taibai North Rd 229, Xian, Peoples R China.
EM xiaoxuanma@163.com; fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
FU National Natural Science Foundation of China [21276210, 21106112,
   21106111, 21106114, 31000019, 21206135, 21376190]; National High
   Technology Research and Development Program of China (863 Program)
   [2014AA022108]; Shaanxi Provincial Scientific Technology Research and
   Development Program [2007 K06-03, 2011JE003, 2012JQ2019, 2012KJXX-28,
   2013KJXX-28, 2011JQ4026]; Scientific Research Program of Shaanxi
   Provincial Department of Education, China [12JK0449, 13JS106, 13JS105,
   13JS104, 2013JK0696]
FX This study was financially supported by the National Natural Science
   Foundation of China (21276210, 21106112, 21106111, 21106114, 31000019,
   21206135 and 21376190); the National High Technology Research and
   Development Program of China (863 Program, 2014AA022108); the Shaanxi
   Provincial Scientific Technology Research and Development Program (2007
   K06-03, 2011JE003, 2012JQ2019, 2012KJXX-28, 2013KJXX-28, and
   2011JQ4026); and the Scientific Research Program of Shaanxi Provincial
   Department of Education, China (12JK0449, 13JS106, 13JS105, 13JS104, and
   2013JK0696).
CR BROWN TJ, 1991, EXP PHYSIOL, V76, P125, DOI 10.1113/expphysiol.1991.sp003474
   Collins MN, 2007, J APPL POLYM SCI, V104, P3183, DOI 10.1002/app.25993
   Fan D. D., 2006, J CHEM IND ENG, V14, P242
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hua XF, 2006, CHINESE J CHEM ENG, V14, P242, DOI 10.1016/S1004-9541(06)60065-7
   Kenne L, 2013, CARBOHYD POLYM, V91, P410, DOI 10.1016/j.carbpol.2012.08.066
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Li X., 2011, SOFT MATTER, V12, P1
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Malson T, 1987, United States Patent n&DEG;, Patent No. [4 716 154, 4716154, USP4716154]
   Mi FL, 2005, J POLYM SCI POL CHEM, V43, P1985, DOI 10.1002/pla.20669
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ruel-Gariepy E, 2004, EUR J PHARM BIOPHARM, V58, P409, DOI 10.1016/j.ejpb.2004.03.019
   Schante CE, 2012, CARBOHYD POLYM, V87, P2211, DOI 10.1016/j.carbpol.2011.10.050
   Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   Zhu CH, 2009, J BIOACT COMPAT POL, V24, P560, DOI 10.1177/0883911509349689
NR 21
TC 17
Z9 17
U1 6
U2 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD OCT 1
PY 2014
VL 43
BP 547
EP 554
DI 10.1016/j.msec.2014.07.058
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AQ1GD
UT WOS:000342529000069
PM 25175249
DA 2018-10-20
ER

PT J
AU Reddy, B
   Singh, KM
   Patel, AK
   Antony, A
   Panchasara, HJ
   Joshi, CG
AF Reddy, Bhaskar
   Singh, Krishna M.
   Patel, Amrutlal K.
   Antony, Ancy
   Panchasara, Harshad J.
   Joshi, Chaitanya G.
TI Insights into resistome and stress responses genes in Bubalus bubalis
   rumen through metagenomic analysis
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Resistome; Personal genome machine; MG-RAST; Virulence genes; Stress
   gene
ID ANTIBIOTIC-RESISTANCE GENES; CENTRIC METAGENOMICS; MICROBES; VIRUSES;
   ENVIRONMENT
AB Buffalo rumen microbiota experience variety of diets and represents a huge reservoir of mobilome, resistome and stress responses. However, knowledge of metagenomic responses to such conditions is still rudimentary. We analyzed the metagenomes of buffalo rumen in the liquid and solid phase of the rumen biomaterial from river buffalo adapted to varying proportion of concentrate to green or dry roughages, using high-throughput sequencing to know the occurrence of antibiotics resistance genes, genetic exchange between bacterial population and environmental reservoirs. A total of 3914.94 MB data were generated from all three treatments group. The data were analysed with Metagenome rapid annotation system tools. At phyla level, Bacteroidetes were dominant in all the treatments followed by Firmicutes. Genes coding for functional responses to stress (oxidative stress and heat shock proteins) and resistome genes (resistance to antibiotics and toxic compounds, phages, transposable elements and pathogenicity islands) were prevalent in similar proportion in liquid and solid fraction of rumen metagenomes. The fluoroquinolone resistance, MDR efflux pumps and Methicillin resistance genes were broadly distributed across 11, 9, and 14 bacterial classes, respectively. Bacteria responsible for phages replication and prophages and phage packaging and rlt-like streptococcal phage genes were mostly assigned to phyla Bacteroides, Firmicutes and proteaobacteria. Also, more reads matching the sigma B genes were identified in the buffalo rumen. This study underscores the presence of diverse mechanisms of adaptation to different diet, antibiotics and other stresses in buffalo rumen, reflecting the proportional representation of major bacterial groups.
C1 [Reddy, Bhaskar; Singh, Krishna M.; Patel, Amrutlal K.; Antony, Ancy; Joshi, Chaitanya G.] Anand Agr Univ, CVSAH, Dept Anim Biotechnol, Anand 388001, Gujarat, India.
   [Singh, Krishna M.] Xcelris Genom, Xcelris Labs, Ahmadabad, Gujarat, India.
   [Panchasara, Harshad J.] Sardarkrushinagar Dantiwada Agr Univ, Dept Anim Nutr, Sardar Krushinagar, Gujarat, India.
RP Singh, KM (reprint author), Anand Agr Univ, CVSAH, Dept Anim Biotechnol, Anand 388001, Gujarat, India.
EM kmsingh18@gmail.com; cgjoshi@aau.in
RI Joshi, Chaitanya/A-2591-2013
OI Joshi, Chaitanya/0000-0003-4680-2861
FU Niche area of excellence project - Indian Council of Agricultural
   Research, New Delhi, India
FX This research work was supported by Niche area of excellence project
   funded by Indian Council of Agricultural Research, New Delhi, India.
CR Allen HK, 2011, MBIO, V2, DOI 10.1128/mBio.00260-11
   Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312
   Allen HK, 2009, DNA CELL BIOL, V28, P109, DOI 10.1089/dna.2008.0812
   Bockelmann U, 2009, APPL ENVIRON MICROB, V75, P154, DOI 10.1128/AEM.01649-08
   Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105
   Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x
   Cardoso AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048505
   Cavicchioli R, 2006, NAT REV MICROBIOL, V4, P331, DOI 10.1038/nrmicro1390
   Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157
   Diaz-Torres ML, 2003, ANTIMICROB AGENTS CH, V47, P1430, DOI 10.1128/AAC.47.4.1430-1432.2003
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Donato JJ, 2010, APPL ENVIRON MICROB, V76, P4396, DOI 10.1128/AEM.01763-09
   Durso LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048325
   Edwards Robert A, 2006, BMC Genomics, V7, P57
   Graham NAJ, 2011, ECOL LETT, V14, P341, DOI 10.1111/j.1461-0248.2011.01592.x
   Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Hespell RB, 1997, GASTROINTESTINAL MIC, V2
   Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.2810-2826.2005
   Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11
   KLIEVE AV, 1988, APPL ENVIRON MICROB, V54, P1637
   Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111
   Mori T, 2008, APPL ENVIRON MICROB, V74, P6803, DOI 10.1128/AEM.00873-08
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07
   Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x
   Romero-Perez GA, 2011, APPL ENVIRON MICROB, V77, P258, DOI 10.1128/AEM.01289-09
   Singh KM, 2012, GENE, V507, P146, DOI 10.1016/j.gene.2012.07.037
   Singh KM, 2012, MOL BIOL REP, V39, P4841, DOI 10.1007/s11033-011-1278-0
   Soni DK, 2013, INFECT GENET EVOL, V14, P83, DOI 10.1016/j.meegid.2012.09.019
   Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P1947, DOI 10.1021/es902893f
   Swanson KS, 2011, ISME J, V5, P639, DOI 10.1038/ismej.2010.162
NR 33
TC 2
Z9 3
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD OCT
PY 2014
VL 41
IS 10
BP 6405
EP 6417
DI 10.1007/s11033-014-3521-y
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AP9ZE
UT WOS:000342440000011
PM 24985977
DA 2018-10-20
ER

PT J
AU Cherry, JF
   Bennett, NK
   Schachner, M
   Moghe, PV
AF Cherry, Jocie F.
   Bennett, Neal K.
   Schachner, Melitta
   Moghe, Prabhas V.
TI Engineered N-cadherin and L1 biomimetic substrates concertedly promote
   neuronal differentiation, neurite extension and neuroprotection of human
   neural stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE N-cadherin; L1; Human embryonic stem cells; Neural stem cells;
   Electrospun scaffolds; Biomimetic surface
ID SPINAL-CORD-INJURY; ADHESION MOLECULE L1; GROWTH-FACTOR RECEPTOR;
   EXTRACELLULAR-MATRIX PROTEINS; RESTRICTED PRECURSOR CELLS;
   CENTRAL-NERVOUS-SYSTEM; BETA-CATENIN; FGF RECEPTOR; IN-VITRO;
   IMMUNOGLOBULIN SUPERFAMILY
AB We investigated the design of neurotrophic biomaterial constructs for human neural stem cells, guided by neural developmental cues of N-cadherin and L1 adhesion molecules. Polymer substrates fabricated either as two-dimensional (2-D) films or three-dimensional (3-D) microfibrous scaffolds were functionalized with fusion chimeras of N-cadherin-Fc alone and in combination with L1-Fc, and the effects on differentiation, neurite extension and survival of H9 human-embryonic-stem-cell-derived neural stem cells (H9-NSCs) were quantified. Combinations of N-cadherin and L1-Fc co-operatively enhanced neuronal differentiation profiles, indicating the critical nature of the two complementary developmental cues. Notably, substrates presenting low levels of N-cadherin-Fc concentrations, combined with proportionately higher L1-Fc concentration, most enhanced neurite outgrowth and the degree of MAP2+ and neurofilament-M+ H9-NSCs. Low N-cadherin-Fc alone promoted improved cell survival following oxidative stress, compared to higher concentrations of N-cadherin-Fc alone or combinations with L1-Fc. Pharmacological and antibody blockage studies revealed that substrates presenting low levels of N-cadherin are functionally competent so long as they elicit a threshold signal mediated by homophilic N-cadherin and fibroblast growth factor signaling. Overall, these studies highlight the ability of optimal combinations of N-cadherin and L1 to recapitulate a "neurotrophic" microenvironment that enhances human neural stem cell differentiation and neurite outgrowth. Additionally, 3-D fibrous scaffolds presenting low N-cadherin-Fc further enhanced the survival of H9-NSCs compared to equivalent 2-D films. This indicates that similar biofunctionalization approaches based on N-cadherin and L1 can be translated to 3-D "transplantable" scaffolds with enhanced neurotrophic behaviors. Thus, the insights from this study have fundamental and translational impacts for neural-stem-cell-based regenerative medicine. (C) 2014 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Cherry, Jocie F.; Bennett, Neal K.; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA.
   [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ 08854 USA.
   [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou 515041, Peoples R China.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM moghe@rutgers.edu
OI Bennett, Neal/0000-0003-3120-4164
FU NIH [EB001046]; New Jersey Commission on Spinal Cord Research
   Exploratory Grants; National Science Foundation [0801620]
FX The authors are grateful to Professor Joachim Kohn of the New Jersey
   Center for Biomaterials for providing us with the poly(DTE carbonate)
   polymer and use of lab equipment. The authors also would also like to
   appreciatively acknowledge NIH EB001046 (P.V.M.), the New Jersey
   Commission on Spinal Cord Research Exploratory Grants (P.V.M.) and the
   National Science Foundation 0801620 (IGERT on Stem Cell Science and
   Engineering) (J.F.C., N.K.B., P.V.M.).
CR Ando K, 2011, J BIOL CHEM, V286, P7619, DOI 10.1074/jbc.M110.158477
   Brieva TA, 2004, BIOTECHNOL BIOENG, V85, P283, DOI 10.1002/bit.10855
   Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210
   CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Carlson AL, 2012, FASEB J, V26, P3240, DOI 10.1096/fj.11-192732
   Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896
   Cherry JF, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0022-1
   Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469
   Collazos-Castro JE, 2013, BIOMATERIALS, V34, P3603, DOI 10.1016/j.biomaterials.2013.01.097
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Cooke MJ, 2010, J BIOMED MATER RES A, V93A, P824, DOI 10.1002/jbm.a.32585
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Dihne M, 2003, J NEUROSCI, V23, P6638
   Doherty P, 1996, MOL CELL NEUROSCI, V8, P99, DOI 10.1006/mcne.1996.0049
   Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567
   Gago N, 2003, MOL CELL NEUROSCI, V22, P162, DOI 10.1016/S1044-7431(02)00030-1
   Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605
   Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003
   Harrop JS, 2012, J NEUROSURG-SPINE, V17, P230, DOI 10.3171/2012.5.AOSPINE12115
   Hofmann C, 2007, GASTROENTEROLOGY, V132, P587, DOI 10.1053/j.gastro.2006.11.017
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559
   Hwang DH, 2011, CELL TRANSPLANT, V20, P1361, DOI 10.3727/096368910X557155
   Islam R, 2004, MOL BIOL CELL, V15, P2003, DOI 10.1091/mbc.E03-05-0333
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Jain KK, 2009, MOL BIOTECHNOL, V42, P367, DOI 10.1007/s12033-009-9166-8
   Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Keirstead HS, 1999, J NEUROSCI, V19, P7529, DOI 10.1523/JNEUROSCI.19-17-07529.1999
   Kenwrick S, 1998, BIOESSAYS, V20, P668, DOI 10.1002/(SICI)1521-1878(199808)20:8<668::AID-BIES10>3.0.CO;2-X
   Kim BG, 2007, CELL TRANSPLANT, V16, P355, DOI 10.3727/000000007783464885
   Kim H, 2012, TRENDS BIOTECHNOL, V30, P55, DOI 10.1016/j.tibtech.2011.07.002
   Kim SU, 2013, NEUROPATHOLOGY, V33, P491, DOI 10.1111/neup.12020
   Kuhn H. Georg, 2008, V52, P25
   Kulahin N, 2009, J NEUROSCI RES, V87, P1806, DOI 10.1002/jnr.22014
   Kwon YT, 2000, CURR BIOL, V10, P363, DOI 10.1016/S0960-9822(00)00411-5
   Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413
   Lelievre EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033206
   Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009
   LOCHTER A, 1995, J NEUROSCI RES, V42, P145, DOI 10.1002/jnr.490420202
   Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x
   Lukovic D, 2012, STEM CELLS, V30, P1787, DOI 10.1002/stem.1159
   Ma DK, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-16
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827
   McCreedy DA, 2012, NEUROSCI LETT, V519, P115, DOI 10.1016/j.neulet.2012.02.025
   MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2
   Mitsui T, 2005, J NEUROSCI, V25, P9624, DOI 10.1523/JNEUROSCI.2175-05.2005
   Moore RN, 2012, STEM CELLS DEV, V21, P30, DOI 10.1089/scd.2010.0434
   MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291
   Nikoletopoulou V, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200040
   Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127
   Noles SR, 2007, MOL CELL NEUROSCI, V35, P549, DOI 10.1016/j.mcn.2007.04.012
   Numakawa T, 2011, J TOXICOL, DOI 10.1155/2011/405194
   Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218
   Park S, 2004, NEUROSCI LETT, V359, P99, DOI 10.1016/j.neulet.2004.01.073
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   REIFSTECK F, 1987, J MED MICROBIOL, V24, P65, DOI 10.1099/00222615-24-1-65
   Rousso DL, 2012, NEURON, V74, P314, DOI 10.1016/j.neuron.2012.02.024
   Selvaraj V, 2012, FRONT BIOSCI-LANDMRK, V17, P65, DOI 10.2741/3916
   Semler EJ, 2005, TISSUE ENG, V11, P734, DOI 10.1089/ten.2005.11.734
   Shi P, 2007, DEV NEUROBIOL, V67, P1765, DOI 10.1002/dneu.20553
   Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106
   Skaper SD, 2004, MOL CELL NEUROSCI, V26, P17, DOI 10.1016/j.mcn.2003.12.015
   Skaper Stephen D, 2012, Methods Mol Biol, V846, P13, DOI 10.1007/978-1-61779-536-7_2
   Stallcup WB, 2000, J NEUROSCI RES, V61, P33, DOI 10.1002/1097-4547(20000701)61:1<33::AID-JNR4>3.0.CO;2-Y
   Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2
   Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043
   Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002
   Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200
   WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254
   Wang LY, 2009, ARCH BIOCHEM BIOPHYS, V481, P116, DOI 10.1016/j.abb.2008.10.021
   Wang TY, 2012, J BIOMATER APPL, V27, P369, DOI 10.1177/0885328212443297
   WILLIAMS EJ, 1994, NEURON, V13, P583, DOI 10.1016/0896-6273(94)90027-2
   Williams EJ, 2001, J BIOL CHEM, V276, P43879, DOI 10.1074/jbc.M105876200
   Woodhead GJ, 2006, J NEUROSCI, V26, P12620, DOI 10.1523/JNEUROSCI.3180-06.2006
   Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119
   Yoon H, 2012, CANCER LETT, V316, P70, DOI 10.1016/j.canlet.2011.10.024
   Yue XS, 2010, BIOMATERIALS, V31, P5287, DOI 10.1016/j.biomaterials.2010.03.035
   Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025
   Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650
NR 86
TC 12
Z9 12
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2014
VL 10
IS 10
BP 4113
EP 4126
DI 10.1016/j.actbio.2014.06.001
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ1ED
UT WOS:000342523800006
PM 24914828
DA 2018-10-20
ER

PT J
AU Smith, EL
   Kanczler, JM
   Gothard, D
   Roberts, CA
   Wells, JA
   White, LJ
   Qutachi, O
   Sawkins, MJ
   Peto, H
   Rashidi, H
   Rojo, L
   Stevens, MM
   El Haj, AJ
   Rose, FRAJ
   Shakesheff, KM
   Oreffo, ROC
AF Smith, E. L.
   Kanczler, J. M.
   Gothard, D.
   Roberts, C. A.
   Wells, J. A.
   White, L. J.
   Qutachi, O.
   Sawkins, M. J.
   Peto, H.
   Rashidi, H.
   Rojo, L.
   Stevens, M. M.
   El Haj, A. J.
   Rose, F. R. A. J.
   Shakesheff, K. M.
   Oreffo, R. O. C.
TI Evaluation of skeletal tissue repair, Part 2: Enhancement of skeletal
   tissue repair through dual-growth-factor-releasing hydrogels within an
   ex vivo chick femur defect model
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone repair; ECM hydrogel scaffolds; Ex vivo model; Embryonic femur;
   Dual growth factor delivery
ID MESENCHYMAL STEM-CELLS; STIMULATE CHEMOTACTIC MIGRATION; FRACTURE
   REPAIR; REGENERATIVE MEDICINE; GAMMA-IRRADIATION; PROGENITOR CELLS;
   BONE-FORMATION; DELIVERY; MATRIX; MICROPARTICLES
AB There is an unmet need for improved, effective tissue engineering strategies to replace or repair bone damaged through disease or injury. Recent research has focused on developing biomaterial scaffolds capable of spatially and temporally releasing combinations of bioactive growth factors, rather than individual molecules, to recapitulate repair pathways present in vivo. We have developed an ex vivo embryonic chick femur critical size defect model and applied the model in the study of novel extracellular matrix (ECM) hydrogel scaffolds containing spatio-temporal combinatorial growth factor-releasing microparticles and skeletal stem cells for bone regeneration. Alginate/bovine bone ECM (bECM) hydrogels combined with poly(D,L-lactic-co-glycolic acid) (P(DL)LGA)/triblock copolymer (10-30% P(DL)LGA-PEG-PL(DL)GA) microparticles releasing dual combinations of vascular endothelial growth factor (VEGF), chondrogenic transforming growth factor beta 3 (TGF-beta 3) and the bone morphogenetic protein BMP2, with human adult Stro-1 + bone marrow stromal cells (HBMSCs), were placed into 2 mm central segmental defects in embryonic day 11 chick femurs and organotypically cultured. Hydrogels loaded with VEGF combinations induced host cell migration and type I collagen deposition. Combinations of TGF-beta 3/BMP2, particularly with Stro-1 + HBMSCs, induced significant formation of structured bone matrix, evidenced by increased Sirius red-stained matrix together with collagen expression demonstrating birefringent alignment within hydrogels. This study demonstrates the successful use of the chick femur organotypic culture system as a high-throughput test model for scaffold/cell/growth factor therapies in regenerative medicine. Temporal release of dual growth factors, combined with enriched Stro-1 + HBMSCs, improved the formation of a highly structured bone matrix compared to single release modalities. These studies highlight the potential of a unique alginate/bECM hydrogel dual growth factor release platform for bone repair. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Smith, E. L.; Kanczler, J. M.; Gothard, D.; Roberts, C. A.; Wells, J. A.; Oreffo, R. O. C.] Univ Southampton, Inst Dev Sci, Bone & Joint Res Grp, Southampton, Hants, England.
   [White, L. J.; Qutachi, O.; Sawkins, M. J.; Peto, H.; Rashidi, H.; Rose, F. R. A. J.; Shakesheff, K. M.] Univ Nottingham, Sch Pharm, Wolfson Ctr Stem Cells, Tissue Engn & Modelling STEM, Nottingham, England.
   [Rojo, L.; Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
   [Rojo, L.; Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London, England.
   [Stevens, M. M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.
   [Rojo, L.] CSIC, Inst Polymer Sci & Technol, Madrid, Spain.
   [Rojo, L.] CIBER BBN, Madrid, Spain.
   [El Haj, A. J.] Keele Univ, Sch Med, Inst Sci & Technol Med, Newcastle Under Lyme, England.
RP Smith, EL (reprint author), Univ Southampton, Inst Dev Sci, Bone & Joint Res Grp, Southampton, Hants, England.
EM E.L.Smith@soton.ac.uk; kevin.shakesheff@nottingham.ac.uk;
   roco@soton.ac.uk
RI Rashidi, Hassan/D-2572-2009; Rojo, Luis/B-3073-2009; Rashidi,
   Hassan/N-9313-2014; Oreffo, Richard/A-4615-2011; Shakesheff,
   Kevin/O-6371-2018
OI Rashidi, Hassan/0000-0002-9682-8288; Rojo, Luis/0000-0001-6334-6736;
   Rashidi, Hassan/0000-0001-8078-6688; Oreffo,
   Richard/0000-0001-5995-6726; Shakesheff, Kevin/0000-0003-3236-2439;
   Qutachi, Omar/0000-0002-5026-7358; Rose, Felicity/0000-0001-6640-8840;
   Wells, Julia Anne/0000-0001-8272-0236; White, Lisa/0000-0003-0571-999X;
   Wells, Jack/0000-0002-4171-3539
FU strategic longer and larger grant (sLOLA) from the Biotechnology and
   Biological Sciences Research Council, UK [BB/G010579/1]; EU Biodesign
   (EU FP7); Biotechnology and Biological Sciences Research Council
   [BB/G010579/1, BB/G010587/1]
FX This work was supported by the strategic longer and larger grant (sLOLA)
   from the Biotechnology and Biological Sciences Research Council,
   UK-grant number BB/G010579/1, as well as partial funding from EU
   Biodesign (EU FP7). Useful discussions from all in the Bone and Joint
   Research Group are gratefully acknowledged, as well as discussions with
   Professors James Triffitt, Robert Brown and Tim Hardingham.
CR Aarvold A, 2012, J TISSUE ENG REGENER
   Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Ball MD, 2011, CLIN ORTHOP RELAT R, V469, P3085, DOI 10.1007/s11999-011-1895-x
   Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2001.0210
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Cypher T J, 1996, J Foot Ankle Surg, V35, P413
   Drevelle Olivier, 2013, Front Biosci (Schol Ed), V5, P369
   Fiedler J, 2005, BIOCHEM BIOPH RES CO, V334, P561, DOI 10.1016/j.bbrc.2005.06.116
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Franchi A, 2012, CLIN CASES MINER BON, V9, P92
   Freytes DO, 2008, J BIOMED MATER RES B, V84B, P408, DOI 10.1002/jbm.b.30885
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039
   Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gouk SS, 2008, J BIOMED MATER RES B, V84B, P205, DOI 10.1002/jbm.b.30862
   Graves DT, 2011, J EXP CLIN MED, V3, P3, DOI DOI 10.1016/J.JECM.2010.12.006
   Hou QP, 2008, J PHARM SCI-US, V97, P3972, DOI 10.1002/jps.21310
   Huang NF, 2008, REGEN MED, V3, P877, DOI 10.2217/17460751.3.6.877
   Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571
   Kolk A, 2012, J CRANIO MAXILL SURG, V40, P706, DOI 10.1016/j.jcms.2012.01.002
   Lienemann PS, 2012, ADV DRUG DELIVER REV, V64, P1078, DOI 10.1016/j.addr.2012.03.010
   Lin H, 2008, J CELL PHYSIOL, V216, P458, DOI 10.1002/jcp.21414
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Marsh D, 1998, CLIN ORTHOP RELAT R, pS22
   Matassi F, 2011, CLIN CASES MINER BON, V8, P21
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   Nauth A, 2011, INJURY, V42, P574, DOI 10.1016/j.injury.2011.03.034
   PECHAK DG, 1986, BONE, V7, P441, DOI 10.1016/8756-3282(86)90004-9
   PECHAK DG, 1986, BONE, V7, P459, DOI 10.1016/8756-3282(86)90005-0
   Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071
   Reid IR, 2009, BONE, V44, P4, DOI 10.1016/j.bone.2008.09.012
   ROACH HI, 1992, BONE MINER, V19, P1, DOI 10.1016/0169-6009(92)90840-A
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011
   Smith EL, 2012, TISSUE ENG PART C-ME, V18, P984, DOI [10.1089/ten.tec.2012.0132, 10.1089/ten.TEC.2012.0132]
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Stevenson S, 1998, CLIN ORTHOP RELAT R, pS239
   Sun WQ, 2008, ACTA BIOMATER, V4, P817, DOI 10.1016/j.actbio.2008.02.006
   Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200
   White LJ, 2013, MAT SCI ENG C-MATER, V33, P2578, DOI 10.1016/j.msec.2013.02.020
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
NR 50
TC 19
Z9 19
U1 2
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2014
VL 10
IS 10
BP 4197
EP 4205
DI 10.1016/j.actbio.2014.05.025
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ1ED
UT WOS:000342523800014
PM 24907660
DA 2018-10-20
ER

PT J
AU Seelbach, RJ
   Fransen, P
   Peroglio, M
   Pulido, D
   Lopez-Chicon, P
   Duttenhoefer, F
   Sauerbier, S
   Freiman, T
   Niemeyer, P
   Semino, C
   Albericio, F
   Alini, M
   Royo, M
   Mata, A
   Eglin, D
AF Seelbach, Ryan J.
   Fransen, Peter
   Peroglio, Marianna
   Pulido, Daniel
   Lopez-Chicon, Patricia
   Duttenhoefer, Fabian
   Sauerbier, Sebastian
   Freiman, Thomas
   Niemeyer, Philipp
   Semino, Carlos
   Albericio, Fernando
   Alini, Mauro
   Royo, Miriam
   Mata, Alvaro
   Eglin, David
TI Multivalent dendrimers presenting spatially controlled clusters of
   binding epitopes in thermoresponsive hyaluronan hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Multivalent dendrimers; Engineered microenvironments; Injectable
   hydrogels; Hyaluronan; Human mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; ACID-BASED HYDROGELS; OSTEOGENIC
   DIFFERENTIATION; DENDRITIC PLATFORMS; RAFT POLYMERIZATION; CLICK
   CHEMISTRY; IN-VITRO; DELIVERY; MATRIX; CHONDROGENESIS
AB The controlled presentation of biofunctionality is of key importance for hydrogel applications in cell-based regenerative medicine. Here, a versatile approach was demonstrated to present clustered binding epitopes in an injectable, thermoresponsive hydrogel. Well-defined multivalent dendrimers bearing four integrin binding sequences and an azido moiety were covalently grafted to propargylamine-derived hyaluronic acid (Hyal-pa) using copper-catalyzed alkyne-azide cycloaddition (CuAAC), and then combined with pN-modified hyaluronan (Hyal-pN). The dendrimers were prepared by synthesizing a bifunctional diethylenetriamine pentaacetic acid core with azido and NHBoc oligo(ethylene glycol) aminoethyl branches, then further conjugated with solid-phase synthesized RGDS and DGRS peptides. Azido terminated pN was synthesized by reversible addition-fragmentation chain transfer polymerization and reacted to Hyal-pa via CuAAC. Nuclear magnetic resonance (NMR), high performance liquid chromatography, size exclusion chromatography and mass spectroscopy proved that the dendrimers had well-defined size and were disubstituted. NMR and atomic absorption analysis confirmed the hyaluronan was affixed with dendrimers or pN. Rheological measurements demonstrated that dendrimers do not influence the elastic or viscous moduli of thermoresponsive hyaluronan compositions at a relevant biological concentration. Finally, human mesenchymal stromal cells were encapsulated in the biomaterial and cultured for 21 days, demonstrating the faculty of this dendrimer-modified hydrogel as a molecular toolbox for tailoring the biofunctionality of thermoresponsive hyaluronan carriers for biomedical applications. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Seelbach, Ryan J.; Peroglio, Marianna; Alini, Mauro; Eglin, David] AO Res Inst Davos, CH-7270 Davos, Switzerland.
   [Seelbach, Ryan J.] Univ Barcelona, E-08028 Barcelona, Spain.
   [Fransen, Peter; Albericio, Fernando] Inst Biomed Res, Barcelona 08028, Spain.
   [Fransen, Peter; Pulido, Daniel; Albericio, Fernando; Royo, Miriam] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona 08028, Spain.
   [Pulido, Daniel; Royo, Miriam] Combinatorial Chem Unit, Barcelona 08028, Spain.
   [Duttenhoefer, Fabian; Sauerbier, Sebastian; Niemeyer, Philipp] Univ Freiburg Klinikum, D-79106 Freiburg, Germany.
   [Freiman, Thomas] Univ Klinikum Goethe Univ, D-60538 Frankfurt, Germany.
   [Lopez-Chicon, Patricia; Semino, Carlos] Inst Quim Sarria, Barcelona 08017, Spain.
   [Mata, Alvaro] Univ London, London E1 4NS, England.
RP Eglin, D (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM david.eglin@aofoundation.org
RI Mata, Alvaro/D-6028-2015; Royo, Miriam/B-1665-2013; Pulido,
   Daniel/K-7739-2014
OI Mata, Alvaro/0000-0002-6739-9111; Royo, Miriam/0000-0001-5292-0819;
   Pulido, Daniel/0000-0002-2841-194X; Albericio,
   Fernando/0000-0002-8946-0462; Peroglio, Marianna/0000-0002-5458-3446
FU AO Foundation [C10-60S]; AO Exploratory Research Board; Spanish Ministry
   of Economy and Competitiveness [SAF2011-30508-C02-01]; Generalitat de
   Catalunya [2009SGR 1024]; CIBER-BBN; La Caixa social program
FX The authors acknowledge the financial support from the AO Foundation
   (grant number C10-60S) and the consortium grant from AO Exploratory
   Research Board and Spanish Ministry of Economy and Competitiveness
   (SAF2011-30508-C02-01) and the Generalitat de Catalunya (2009SGR 1024).
   CIBER-BBN (DP) and La Caixa social program (PF) are also acknowledged
   for their financial support. The authors are grateful to Mr. Markus
   Glarner (AO Research Institute) and Mr. Matti Kesti (ETH Zurich) for
   their help with the polymer synthesis and rheology, respectively. The
   authors wish to confirm that there are no known conflicts of interest
   associated with this publication and there has been no significant
   financial support for this work that could have influenced its outcome.
CR Bhakta G, 2013, ACTA BIOMATER, V9, P9098, DOI 10.1016/j.actbio.2013.07.008
   Bian LM, 2013, BIOMATERIALS, V34, P413, DOI 10.1016/j.biomaterials.2012.09.052
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Crespo L, 2005, CHEM REV, V105, P1663, DOI 10.1021/cr030449l
   D'Este M, 2012, CARBOHYD POLYM, V90, P1378, DOI 10.1016/j.carbpol.2012.07.007
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gondi SR, 2007, MACROMOLECULES, V40, P474, DOI 10.1021/ma061959v
   Joshi N, 2008, CURR TOP MED CHEM, V8, P1225, DOI 10.2174/156802608785849067
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kim J, 2008, J MATER SCI-MATER M, V19, P3311, DOI 10.1007/s10856-008-3469-3
   Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019
   Lam J, 2013, BIOMATERIALS, V34, P3938, DOI 10.1016/j.biomaterials.2013.01.091
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Li M, 2008, MACROMOL RAPID COMM, V29, P1172, DOI 10.1002/marc.200800073
   Liang Y, 2013, BIOMATERIALS, V34, P5521, DOI 10.1016/j.biomaterials.2013.03.095
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010
   Mazumder MAJ, 2012, J BIOMED MATER RES A, V100A, P1877, DOI 10.1002/jbm.a.34021
   Mortisen D, 2010, BIOMACROMOLECULES, V11, P1261, DOI 10.1021/bm100046n
   Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024
   Oudshoorn MHM, 2007, POLYMER, V48, P1915, DOI 10.1016/j.polymer.2007.01.068
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Peroglio Marianna, 2012, Eur Spine J, V21 Suppl 6, pS839, DOI 10.1007/s00586-011-1976-2
   Pla D, 2009, BIOCONJUGATE CHEM, V20, P1112, DOI 10.1021/bc800504t
   Pulido D, 2014, ORG LETT, V16, P1318, DOI 10.1021/ol500022n
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Santos JL, 2009, J CONTROL RELEASE, V134, P141, DOI 10.1016/j.jconrel.2008.11.007
   Simon-Gracia L, 2013, ORG BIOMOL CHEM, V11, P4109, DOI 10.1039/c3ob40492g
   Tansey W, 2004, J CONTROL RELEASE, V94, P39, DOI 10.1016/j.jconrel.2003.09.005
   Tokatlian T, 2014, BIOMATERIALS, V35, P825, DOI 10.1016/j.biomaterials.2013.10.014
   van der Poll DG, 2010, BIOCONJUGATE CHEM, V21, P764, DOI 10.1021/bc900553n
   Zou LJ, 2008, J ORTHOP RES, V26, P713, DOI 10.1002/jor.20539
NR 37
TC 14
Z9 13
U1 10
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2014
VL 10
IS 10
BP 4340
EP 4350
DI 10.1016/j.actbio.2014.06.028
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ1ED
UT WOS:000342523800028
PM 24993802
DA 2018-10-20
ER

PT J
AU Dewavrin, JY
   Hamzavi, N
   Shim, VPW
   Raghunath, M
AF Dewavrin, Jean-Yves
   Hamzavi, Nader
   Shim, V. P. W.
   Raghunath, Michael
TI Tuning the architecture of three-dimensional collagen hydrogels by
   physiological macromolecular crowding
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Fibrillogenesis; Biomaterial; Excluded-volume effect
ID MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; IN-VITRO; FIBRILLOGENESIS
   INVITRO; MATRIX STIFFNESS; FIBRIL FORMATION; PORE-SIZE; MICROSCOPY;
   SCAFFOLDS; GELS
AB Macromolecular crowding is an optimal physiological feature in intracellular and extracellular spaces, and results from a variety of macromolecules occupying space and contributing to a fractional volume occupancy. Here, we show that soft collagen hydrogels assembled in nature-inspired crowded conditions feature enhanced biophysical properties. We demonstrate that crowding tunes the rate of collagen nucleation and fiber growth, affecting fiber diameter and organization. Adjustments of crowding levels during collagen assembly tune the gel pore size, protein permeability, transparency and resistance to enzymatic degradation. Furthermore, gels assembled in crowded conditions are twice as resistant to mechanical stress as the controls, inducing a 70% boost of proliferation of stem cells cultured on tuned hydrogels. Emulating the crowdedness of interstitial fluids therefore represents a way to optimize the properties of soft collagen gels, with promising applications in soft biomaterials design. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Dewavrin, Jean-Yves; Raghunath, Michael] Natl Univ Singapore, Fac Engn, Dept Biomed Engn, Singapore 117548, Singapore.
   [Dewavrin, Jean-Yves; Raghunath, Michael] Natl Univ Singapore, NUS Tissue Engn Programme, Singapore 117548, Singapore.
   [Dewavrin, Jean-Yves; Raghunath, Michael] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore.
   [Hamzavi, Nader; Shim, V. P. W.] Natl Univ Singapore, Fac Engn, Dept Mech Engn, Impact Mech Lab, Singapore 117548, Singapore.
   [Hamzavi, Nader] A STAR Inst Microelect, Singapore, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.
RP Raghunath, M (reprint author), 9 Engn Dr 1,Block EA 03-12, Singapore 117575, Singapore.
EM bierm@nus.edu.sg
RI Raghunath, Michael/E-6483-2010
OI Raghunath, Michael/0000-0002-2138-6614
FU NUS Graduate School of Integrative Sciences and Engineering (Singapore);
   Singapore International Graduate Award (SINGA, A<INF>*</INF>STAR)
FX The authors wish to thank Dr. Anna Blocki-Beyer (SBIC,
   A<INF>*</INF>STAR) for her technical support and Neo Puay Yong (Tissue
   Repair Lab, NUS) for helpful discussions. The authors also wish to thank
   Prof. Dieter Trau (NUS) for kindly providing AFM instrumentation. J-Y.D.
   is a recipient of a scholarship from the NUS Graduate School of
   Integrative Sciences and Engineering (Singapore) and N.H. is a recipient
   of Singapore International Graduate Award (SINGA, A<INF>*</INF>STAR).
CR Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Akabayov B, 2013, NAT COMMUN, V4
   Chan AW, 2009, BIOMATERIALS, V30, P6119, DOI 10.1016/j.biomaterials.2009.07.034
   Chaudhuri O, 2012, NAT MATER, V11, P568, DOI 10.1038/nmat3366
   Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y
   Cheema U, 2007, ADV FUNCT MATER, V17, P2426, DOI 10.1002/adfm.200700116
   Chen C, 2011, ADV DRUG DELIVER REV, V63, P277, DOI 10.1016/j.addr.2011.03.003
   DOMBI GW, 1985, BIOCHEM J, V228, P551, DOI 10.1042/bj2280551
   Dougherty RP, 2007, MICR MICR M
   FARBER S, 1986, INT J BIOL MACROMOL, V8, P37, DOI 10.1016/0141-8130(86)90069-3
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Grinnell F, 2013, BIOMATERIALS, V34, P965, DOI 10.1016/j.biomaterials.2012.10.036
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200
   HAYASHI T, 1972, J BIOCHEM-TOKYO, V72, P749, DOI 10.1093/oxfordjournals.jbchem.a129953
   Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450
   Jawerth LM, 2010, BIOPHYS J, V98, pL1, DOI 10.1016/j.bpj.2009.09.065
   Johnson KL, 1987, CONTACT MECH
   Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015
   Kadler ME, 1996, BIOCH J 1, V316, P1
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Lanfer B, 2008, BIOMATERIALS, V29, P3888, DOI 10.1016/j.biomaterials.2008.06.016
   Lareu RR, 2007, BIOCHEM BIOPH RES CO, V363, P171, DOI 10.1016/j.bbrc.2007.08.156
   Luo TZ, 2013, EUR POLYM J, V49, P2998, DOI 10.1016/j.eurpolymj.2013.05.013
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   Miller KS, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006340
   Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   PARKINSON J, 1995, J MOL BIOL, V247, P823, DOI 10.1016/S0022-2836(05)80157-3
   Parkinson J, 1997, J BIOMECH, V30, P549, DOI 10.1016/S0021-9290(96)00151-0
   Paul R Gordon, 2003, ScientificWorldJournal, V3, P138
   Raiskup F, 2013, OCUL SURF, V11, P65, DOI 10.1016/j.jtos.2013.01.002
   Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Savina IN, 2011, SOFT MATTER, V7, P4276, DOI 10.1039/c0sm01304h
   SILVER FH, 1983, COLLAGEN REL RES, V3, P393
   Silver PH, 2009, J ENG FIBER FABR, V4, P9
   Stamov DR, 2011, BIOMATERIALS, V32, P7444, DOI 10.1016/j.biomaterials.2011.06.031
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
   Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   Zhang X, 2014, CELL TISSUE BANK, P1
   ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331
NR 49
TC 17
Z9 17
U1 6
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD OCT
PY 2014
VL 10
IS 10
BP 4351
EP 4359
DI 10.1016/j.actbio.2014.06.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ1ED
UT WOS:000342523800029
PM 24932771
DA 2018-10-20
ER

PT J
AU Wu, WM
   Okamoto, O
   Kato, A
   Matsuo, N
   Kumai, J
   Nomizu, M
   Fujiwara, S
AF Wu, Weimin
   Okamoto, Osamu
   Kato, Aiko
   Matsuo, Noritaka
   Kumai, Jun
   Nomizu, Motoyoshi
   Fujiwara, Sakuhei
TI Functional peptide of dermatopontin produces fibrinogen fibrils and
   modifies its biological activity
SO JOURNAL OF DERMATOLOGICAL SCIENCE
LA English
DT Article
DE Dermatopontin; Fibrinogen; Fibrinogen fibril; DP-4 peptide; Wound
   healing
ID MATRIX PROTEIN TRAMP; EXTRACELLULAR-MATRIX; THROMBIN GENERATION;
   CELL-ADHESION; FIBRONECTIN; INTERACTS; SURFACE; GROWTH; ORGANIZATION;
   MIGRATION
AB Background: Dermatopontin (DP), a small extracellular matrix protein, interacts with both fibrinogen and fibrin. DP accelerates fibrin fibril formation and enhances cell adhesion to fibrin fibrils but DP does not influence fibrinogen fibril formation. We have previously demonstrated that DP-4 (PHGQVVVAVRS) is a functional dermatopontin peptide (Wu et al., 2014). Objective: Identification of biological functions of DP-4.
   Methods: Protein-protein interactions were examined by solid-phase assay. The kinetics of fibrinogen/fibrin polymer formation was monitored by turbidity change, SDS-PAGE, and electron microscopy. A cell adhesion assay was performed using human umbilical vein endothelial cells.
   Results: Although DP promoted fibrin formation, the DP-4 peptide promoted fibrinogen polymerization but did not apparently affect fibrin formation. The polymerized fibrinogen formed straight solid fibrils comparable to the normally formed fibrin fibrils. A minimum functional sequence of the DP-4 peptide was determined to be VVVAVRS. An cif domain in fibrinogen was involved in the fibril formation. Fibrinogen fibrils made by DP-4 enhanced endothelial cell adhesion and spreading in a dose-dependent manner. This cell adhesion was inhibited by heparin and by anti-alpha v beta 3 and beta 1 integrin antibodies.
   Conclusion: DP-4 did not reproduce the full functional biological activities of DP with fibrin but DP-4 did promote fibrinogen fibril formation. The fibrinogen fibrils produced by DP-4 are useful as a novel synthetic biomaterial for therapeutic applications. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Wu, Weimin; Kato, Aiko] Oita Univ, Fac Med, Dept Plast Surg, Yufu, Oita 8795593, Japan.
   [Okamoto, Osamu; Fujiwara, Sakuhei] Oita Univ, Fac Med, Dept Dermatol, Yufu, Oita 8795593, Japan.
   [Matsuo, Noritaka] Oita Univ, Fac Med, Dept Biochem, Yufu, Oita 8795593, Japan.
   [Kumai, Jun; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Sch Pharm, Lab Clin Biochem, Hachioji, Tokyo 1920392, Japan.
RP Okamoto, O (reprint author), Oita Univ, Fac Med, Dept Dermatol, 1-1 Idaigaoka,Hasama Machi, Yufu, Oita 8795593, Japan.
EM ookamoto@oita-u.ac.jp
CR Asakura S, 1997, J BIOL CHEM, V272, P8824, DOI 10.1074/jbc.272.13.8824
   Chen GJ, 2010, CHEMPHYSCHEM, V11, P565, DOI 10.1002/cphc.200900916
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Cooper LJ, 2006, INVEST OPHTH VIS SCI, V47, P3303, DOI 10.1167/iovs.05-1426
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   FORBES EG, 1994, FEBS LETT, V351, P433, DOI 10.1016/0014-5793(94)00907-4
   FOWLER WE, 1981, P NATL ACAD SCI-BIOL, V78, P4872, DOI 10.1073/pnas.78.8.4872
   GROVES HM, 1982, LAB INVEST, V46, P605
   Guadiz G, 1997, BLOOD, V90, P2644
   HOLM B, 1985, THROMB RES, V37, P165, DOI 10.1016/0049-3848(85)90043-X
   Kato A, 2011, J BIOL CHEM, V286, P14861, DOI 10.1074/jbc.M110.179762
   Koo J, 2010, J THROMB HAEMOST, V8, P2727, DOI 10.1111/j.1538-7836.2010.04072.x
   Koo J, 2012, BIOMACROMOLECULES, V13, P1259, DOI 10.1021/bm2015976
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lishko VK, 2007, BLOOD, V109, P1541, DOI 10.1182/blood-2006-05-022764
   MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033
   NEAME PJ, 1989, J BIOL CHEM, V264, P5474
   Okamoto O, 1996, J BIOCHEM-TOKYO, V119, P106
   Okamoto O, 1999, BIOCHEM J, V337, P537, DOI 10.1042/0264-6021:3370537
   Okamoto O, 2011, AESTHET DERMATOL, V21, P303
   Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564
   Okamoto O, 2010, BIOCHEMISTRY-US, V49, P147, DOI 10.1021/bi901066f
   Pereira M, 2002, J CELL SCI, V115, P609
   Podolnikova NP, 2010, BIOCHEMISTRY-US, V49, P68, DOI 10.1021/bi9016022
   Rybarczyk BJ, 2003, BLOOD, V102, P4035, DOI 10.1182/blood-2003-03-0822
   Simpson-Haidaris PJ, 1998, INFECT IMMUN, V66, P4431
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   STEWART GJ, 1969, BIOCHIM BIOPHYS ACTA, V194, P462, DOI 10.1016/0005-2795(69)90106-8
   Suehiro K, 1997, J BIOL CHEM, V272, P5360, DOI 10.1074/jbc.272.8.5360
   SUPERTIFURGA A, 1993, GENOMICS, V17, P463, DOI 10.1006/geno.1993.1348
   Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x
   van Ryn J, 2003, THROMB HAEMOSTASIS, V90, P1179, DOI 10.1160/TH03-05-0305
   VANAKEN PJ, 1982, ARTERY, V11, P156
   Wei G, 2008, BIOMACROMOLECULES, V9, P3258, DOI 10.1021/bm800824r
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wu WM, 2014, J INVEST DERMATOL, V134, P256, DOI 10.1038/jid.2013.305
   Yermolenko IS, 2012, J BIOL CHEM, V287, P41979, DOI 10.1074/jbc.M112.410696
NR 40
TC 3
Z9 3
U1 0
U2 11
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0923-1811
EI 1873-569X
J9 J DERMATOL SCI
JI J. Dermatol. Sci.
PD OCT
PY 2014
VL 76
IS 1
BP 34
EP 43
DI 10.1016/j.jdermsci.2014.07.002
PG 10
WC Dermatology
SC Dermatology
GA AP7QD
UT WOS:000342270900005
PM 25082449
DA 2018-10-20
ER

PT J
AU Aina, V
   Malavasi, G
   Magistris, C
   Cerrato, G
   Martra, G
   Viscardi, G
   Menabue, L
   Lusvardi, G
AF Aina, Valentina
   Malavasi, Gianluca
   Magistris, Claudio
   Cerrato, Giuseppina
   Martra, Gianmario
   Viscardi, Guido
   Menabue, Ledi
   Lusvardi, Gigliola
TI Conjugation of amino-bioactive glasses with 5-aminofluorescein as probe
   molecule for the development of pH sensitive stimuli-responsive
   biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID LOCAL-DRUG DELIVERY; CONTROLLED-RELEASE; FUNCTIONALIZATION; DOXORUBICIN;
   BIOCERAMICS; STRATEGIES; DAUNOMYCIN; THERAPY; SYSTEMS
AB Bioceramics, such as silica-based glasses, are widely used in bone and teeth restoration. Nowadays, the association between nanotechnology and pharmacology is one of the most promising research fields in cancer therapy. The advanced processing methods and new chemical strategies allow the incorporation of drugs within them or on their functionalized surfaces. Bioceramics can act as local drug delivery systems to treat bone and teeth diseases. The present paper reports data related to the development of a pH-stimuli responsive bioactive glass. The glass conjugation with 5-aminofluorescein (5-AF), through a pH-sensitive organic spacer, allows to produce a pH-responsive bioactive biomaterial: when it is exposed to specific pH changes, it can favour the release of 5-AF directly at the target site. 5-AF has been chosen as a simple, low cost, non toxic model to simulate doxorubicin, an anticancer drug. As doxorubicin, 5-AF contains an amino group in its structure in order to form an amide bond with the carboxylic functionalities of the glass. Raman spectroscopy and thermal analysis confirm the glass conjugation of 5-AF by means of an amide bond; the amount of 5-AF loaded was very high (a parts per thousand 65 and 44 wt%). The release tests at two different pH (4.2 and 7.4) show that the amount of released 5-AF is higher at acid pH with respect to physiological one. This preliminary datum evidenced that a pH-sensitive drug delivery system has been developed. The low amount of 5-AF released (< 1 wt% of the total 5-AF) is due to the very low solubility of 5-AF in aqueous medium. This disadvantage, may be overcome in a dynamic environment (physiological conditions), where it is possible to obtain a drug release system ensuring an effective therapeutic dose for long times and, at the same time, avoiding the drug toxicity.
C1 [Aina, Valentina; Magistris, Claudio; Cerrato, Giuseppina; Martra, Gianmario; Viscardi, Guido] Univ Turin, INSTM Italian Natl Consortium Mat Sci & Technol, Dept Chem, Interdept NIS, I-10125 Turin, Italy.
   [Malavasi, Gianluca; Menabue, Ledi; Lusvardi, Gigliola] Univ Modena & Reggio Emilia, Dept Chem & Geol Sci, I-41125 Modena, Italy.
RP Aina, V (reprint author), Univ Turin, INSTM Italian Natl Consortium Mat Sci & Technol, Dept Chem, Interdept NIS, Via P Giuria 7, I-10125 Turin, Italy.
EM valentina.aina@unito.it
RI Viscardi, Guido/N-1111-2015; Lusvardi, Gigliola/L-6941-2015; Menabue,
   Ledi/L-7324-2015; Malavasi, Gianluca/H-4658-2013
OI Viscardi, Guido/0000-0002-9387-2849; Lusvardi,
   Gigliola/0000-0002-0772-6037; Menabue, Ledi/0000-0002-7984-3208;
   Malavasi, Gianluca/0000-0002-4557-8135; Martra,
   Gianmario/0000-0002-8012-5342
FU Compagnia di San Paolo [ORTO11RRT5]; Fondazione di Vignola
FX The authors acknowledge Compagnia di San Paolo for the financial support
   (Project: ORTO11RRT5). G. L. acknowledges Fondazione di Vignola for the
   financial support (Progetto "Materiali per la teranostica: progettazione
   di sistemi contenenti nanoparticelle e molecole di interesse
   biologico"). All authors acknowledge Dr. C. Giovannoli of University of
   Torino for acid-basic titration measurements, Prof. E. Diana of
   University of Torino for Raman measurements. The authors thank Ms. F.
   Malafronte and Mr. W. Intelisano for their valuable help.
CR Aina V, 2011, J MATER CHEM, V21, P10970, DOI 10.1039/c1jm10442j
   Alberto G, 2009, J PHYS CHEM C, V113, P21048, DOI 10.1021/jp907415q
   [Anonymous], 1994, CALC US ADV CHEM DEV
   Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039
   Arean CO, 2013, CERAM INT, V39, P7407, DOI 10.1016/j.ceramint.2013.02.084
   Asenath SE, 2008, LANGMUIR, V24, P12405
   Barbero N, 2009, DYES PIGMENTS, V80, P307, DOI 10.1016/j.dyepig.2008.08.006
   Boga C, 2004, ANAL BIOCHEM, V335, P196, DOI 10.1016/j.ab.2004.09.014
   Contessotto L, 2011, CHEM-EUR J, V15, P12043
   Dugas V, 2010, BIOSENSOR, P134
   Gentleman E, 2006, J MATER SCI-MATER M, V17, P1029, DOI 10.1007/s10856-006-0440-z
   Hench LL, 1971, J AM CERAM SOC, V74, P487
   Hu FQ, 2009, BIOMATERIALS, V30, P6955, DOI 10.1016/j.biomaterials.2009.09.008
   Kakinoki A, 2008, BIOL PHARM BULL, V31, P103, DOI 10.1248/bpb.31.103
   Kazarian AA, 2008, J CHROMATOGR A, V1200, P84, DOI 10.1016/j.chroma.2008.04.022
   Lamoureux F, 2007, EXPERT REV ANTICANC, V7, P169, DOI 10.1586/14737140.7.2.169
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lavignac N, 2009, MACROMOL BIOSCI, V9, P480, DOI 10.1002/mabi.200800163
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Lopez-Noriega A, 2010, CHEM-EUR J, V16, P10879, DOI 10.1002/chem.201000137
   Lusvardi G, 2013, MAT SCI ENG C-MATER, V33, P3190, DOI 10.1016/j.msec.2013.03.046
   Manchun S, 2012, LIFE SCI, V90, P381, DOI 10.1016/j.lfs.2012.01.008
   Manzano M, 2012, PROG SOLID STATE CH, V40, P17, DOI 10.1016/j.progsolidstchem.2012.05.001
   McCoy CP, 2010, EXPERT OPIN DRUG DEL, V7, P605, DOI 10.1517/17425241003677731
   Miletto I, 2010, DYES PIGMENTS, V84, P121, DOI 10.1016/j.dyepig.2009.07.004
   Nichele V, 2011, J MOL CATAL B-ENZYM, V139, P189
   Ray-Coquard I, 2012, CANCER TREAT REV, V38, P368, DOI 10.1016/j.ctrv.2011.07.003
   Reddy PY, 1998, SYNTHESIS-STUTTGART, P999
   Remenyi J, 2003, BIOCHEM BIOPH RES CO, V303, P556, DOI 10.1016/S0006-291X(03)00394-2
   Russo L, 2014, INTERFACE FOCUS, V4
   SHEN WC, 1981, BIOCHEM BIOPH RES CO, V102, P1048, DOI 10.1016/0006-291X(81)91644-2
   Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1
   Ulbrich K, 2004, ADV DRUG DELIVER REV, V56, P1023, DOI 10.1016/j.addr.2003.10.040
   Ulbrich K, 2003, J CONTROL RELEASE, V87, P33, DOI 10.1016/S0168-3659(02)00348-6
   Vallet-Regi M, 2006, DALTON T, P5211, DOI 10.1039/b610219k
   Vallet-Regi M, 2012, PHILOS T R SOC A, V370, P1400, DOI 10.1098/rsta.2011.0258
   Verne E, 2009, J BIOMED MATER RES A, V90A, P981, DOI 10.1002/jbm.a.32153
   Yoo SI, 2002, J APPL POLYM SCI, V83, P767, DOI 10.1002/app.2271
   Zhang HT, 2011, EUR J PHARM SCI, V42, P517, DOI 10.1016/j.ejps.2011.02.006
NR 39
TC 4
Z9 4
U1 1
U2 53
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2014
VL 25
IS 10
BP 2243
EP 2253
DI 10.1007/s10856-014-5206-4
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AP9SX
UT WOS:000342421300004
PM 24722810
DA 2018-10-20
ER

PT J
AU Piccinini, F
   Pierini, M
   Lucarelli, E
   Bevilacqua, A
AF Piccinini, Filippo
   Pierini, Michela
   Lucarelli, Enrico
   Bevilacqua, Alessandro
TI Semi-quantitative monitoring of confluence of adherent mesenchymal
   stromal cells on calcium-phosphate granules by using widefield
   microscopy images
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; STEM-CELLS; FLUORESCENCE MICROSCOPE;
   SHADING CORRECTION; BONE-MARROW; ADHESION; EXPRESSION; QUANTIFICATION;
   STRATEGIES; STANDARD
AB The analysis of cell confluence and proliferation is essential to design biomaterials and scaffolds to use as bone substitutes in clinical applications. Accordingly, several approaches have been proposed in the literature to estimate the area of the scaffold covered by cells. Nevertheless, most of the approaches rely on sophisticated equipment not employed for routine analyses, while the rest of them usually do not provide significant statistics about the cell distribution. This research aims at studying confluence and proliferation of mesenchymal stromal cells (MSC) adherent on OSPROLIFEA (R), a commercial biomaterial in the form of granules. In particular, we propose a Computer Vision approach that can routinely be employed to monitor the surface of the single granules covered by cells because only a standard widefield fluorescent microscope is required. In order to acquire significant statistics data, we analyse wide-area images built by using MicroMos v2.0, an updated version of a previously published software specific for stitching brightfield and phase-contrast images manually acquired via a widefield microscope. In particular, MicroMos v2.0 permits to build accurate "mosaics" of fluorescent images, after correcting vignetting and photo-bleaching effects, providing a consistent representation of a sample region containing numerous granules. Then, our method allows to make automatically a statistically significant estimate of the percentage of the area of the single granules covered by cells. Finally, by analysing hundreds of granules at different time intervals we also obtained reliable data regarding cell proliferation, confirming that not only MSC adhere onto the OSPROLIFEA (R) granules, but even proliferate over time.
C1 [Piccinini, Filippo; Bevilacqua, Alessandro] Univ Bologna, Adv Res Ctr Elect Syst Informat & Commun Technol, I-40125 Bologna, Italy.
   [Pierini, Michela; Lucarelli, Enrico] Rizzoli Orthopaed Inst, Osteoarticular Regenerat Lab, Bologna, Italy.
   [Bevilacqua, Alessandro] Univ Bologna, Dept Comp Sci & Engn, I-40125 Bologna, Italy.
RP Bevilacqua, A (reprint author), Univ Bologna, Adv Res Ctr Elect Syst Informat & Commun Technol, Via Toffano 2-2, I-40125 Bologna, Italy.
EM fpiccinini@arces.unibo.it; michela.pierini@ior.it;
   enrico.lucarelli@ior.it; alessandro.bevilacqua@unibo.it
OI Piccinini, Filippo/0000-0002-0371-7782; Lucarelli,
   Enrico/0000-0002-6681-6374; Bevilacqua, Alessandro/0000-0003-2938-5058
CR Ali R, 2012, MACH VISION APPL, V23, P607, DOI 10.1007/s00138-011-0337-9
   Babaloukas G, 2011, J MICROSC-OXFORD, V244, P320, DOI 10.1111/j.1365-2818.2011.03546.x
   Beucher S., 1991, SCANNING MICROSCOPY, P299
   Bevilacqua A, 2011, IEEE ENG MED BIO, P6166, DOI 10.1109/IEMBS.2011.6091523
   Bisht S, 2011, LAB INVEST, V91, P1383, DOI 10.1038/labinvest.2011.86
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Bulj Z, 2013, INT J ONCOL, V42, P118, DOI 10.3892/ijo.2012.1700
   Burga A, 2011, NATURE, V480, P250, DOI 10.1038/nature10665
   Carozza L, 2011, P 8 ANN IEEE S COMP, V1, P55
   Carozza L, 2011, IEEE ENG MED BIO, P6162, DOI 10.1109/IEMBS.2011.6091522
   Cavalcanti PG, 2011, COMPUT MED IMAG GRAP, V35, P481, DOI 10.1016/j.compmedimag.2011.02.007
   Chen CW, 2011, TISSUE ENG PART C-ME, V17, P101, DOI [10.1089/ten.tec.2010.0072, 10.1089/ten.TEC.2010.0072]
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   De Boodt S, 2013, TISSUE ENG PART C-ME, V19, P697, DOI [10.1089/ten.tec.2012.0486, 10.1089/ten.TEC.2012.0486]
   Dehlinger D, 2013, BIOTECHNOL BIOENG, V110, P838, DOI 10.1002/bit.24757
   Dorozhkin S.V., 2011, BIOMATTER, V1, P1, DOI DOI 10.5618/BI0.2011.V1.N1.1
   Drey LL, 2013, BIOTECHNIQUES, V55, P28, DOI 10.2144/000114056
   Friedrichs J, 2010, NAT PROTOC, V5, P1353, DOI 10.1038/nprot.2010.89
   Guarino V, 2010, J MATER SCI-MATER M, V21, P3109, DOI 10.1007/s10856-010-4163-9
   Gudla PR, 2008, CYTOM PART A, V73A, P451, DOI 10.1002/cyto.a.20550
   Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2
   Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006
   Impens S, 2010, TISSUE ENG PART C-ME, V16, P1575, DOI 10.1089/ten.TEC.2010.0069
   JERICEVIC Z, 1989, METHOD CELL BIOL, V30, P47
   Jiang HD, 2010, P NATL ACAD SCI USA, V107, P11234, DOI 10.1073/pnas.1000156107
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Kao ECY, 2011, TOXICOL IN VITRO, V25, P1906, DOI 10.1016/j.tiv.2011.06.005
   Kuglin C. D., 1975, Proceedings of the 1975 International Conference on Cybernetics and Society, P163
   Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817
   Lidke KA, 2012, NAT METHODS, V9, P139, DOI 10.1038/nmeth.1863
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lin JY, 2011, SOFT MATTER, V7, P10010, DOI 10.1039/c1sm05371j
   Michalek J, 2011, MICROSC RES TECHNIQ, V74, P831, DOI 10.1002/jemt.20965
   Model M. A. M., 2006, CURRENT PROTOCOLS CY, V10, P10, DOI DOI 10.1002/0471142956.CYL
   Model MA, 2001, CYTOMETRY, V44, P309, DOI 10.1002/1097-0320(20010801)44:4<309::AID-CYTO1122>3.0.CO;2-3
   Model MA, 2009, CYTOM PART A, V75A, P874, DOI 10.1002/cyto.a.20787
   Moradi I, 2012, MICROSC RES TECHNIQ, V75, P677, DOI 10.1002/jemt.21111
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Neuman U, 2013, BIOCYBERN BIOMED ENG, V33, P63, DOI 10.1016/S0208-5216(13)70056-1
   Nijhuis AG, 2014, J BIOMED MATER RES A, V102, P1102, DOI 10.1002/jbm.a.34776
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189
   Piccinini F, 2013, J MICROSC-OXFORD, V252, P226, DOI 10.1111/jmi.12084
   Piccinini F, 2012, J MICROSC-OXFORD, V248, P6, DOI 10.1111/j.1365-2818.2012.03645.x
   Piccinini F, 2013, I S BIOMED IMAGING, P464
   Piccinini F, 2012, MICROSC RES TECHNIQ, V75, P1582, DOI 10.1002/jemt.22104
   Piccinini M, 2013, IMPLANT DENT, V22, P83, DOI 10.1097/ID.0b013e31827afc19
   Pierini M, 2013, J BONE JOINT SURG AM, V95A, P1101, DOI 10.2106/JBJS.L.00429
   Pierini M, 2012, CYTOTHERAPY, V14, P686, DOI 10.3109/14653249.2012.677821
   Polzer H, 2010, TISSUE ENG PART C-ME, V16, P1277, DOI [10.1089/ten.tec.2009.0745, 10.1089/ten.TEC.2009.0745]
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Rajagopalan S, 2004, P SOC PHOTO-OPT INS, V5370, P1456, DOI 10.1117/12.535927
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Ribeiro CC, 2006, J MATER SCI-MATER M, V17, P455, DOI 10.1007/s10856-006-8473-x
   Rodday B, 2011, J BIOMOL SCREEN, V16, P1119, DOI 10.1177/1087057111419501
   Rosset P, 2014, ORTHOP TRAUMATOL-SUR, V100, pS107, DOI 10.1016/j.otsr.2013.11.010
   Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152
   Schwarzfischer M, 2011, P 5 MICR IM AN APPL, V1, P1
   Simonson LW, 2013, ZEBRAFISH, V10, P147, DOI 10.1089/zeb.2012.0811
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Souchier C, 2004, METHODS CELL SCI, V25, P195
   Sugiuchi H, 2005, J LAB CLIN MED, V146, P36, DOI 10.1016/j.lab.2005.04.004
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Tomazevic D, 2002, J MICROSC-OXFORD, V208, P212, DOI 10.1046/j.1365-2818.2002.01079.x
   Wagner J, 2012, AEROSOL SCI TECH, V46, P862, DOI 10.1080/02786826.2012.674232
   Weigum SE, 2007, LAB CHIP, V7, P995, DOI 10.1039/b703918b
   Yu W, 2004, IEEE T CONSUM ELECTR, V50, P975, DOI 10.1109/TCE.2004.1362487
   ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454
NR 68
TC 6
Z9 6
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2014
VL 25
IS 10
BP 2395
EP 2410
DI 10.1007/s10856-014-5242-0
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AP9SX
UT WOS:000342421300019
PM 24863020
DA 2018-10-20
ER

PT J
AU Kon, E
   Filardo, G
   Perdisa, F
   Di Martino, A
   Busacca, M
   Balboni, F
   Sessa, A
   Marcacci, M
AF Kon, Elizaveta
   Filardo, Giuseppe
   Perdisa, Francesco
   Di Martino, Alessandro
   Busacca, Maurizio
   Balboni, Federica
   Sessa, Andrea
   Marcacci, Maurilio
TI A one-step treatment for chondral and osteochondral knee defects:
   clinical results of a biomimetic scaffold implantation at 2 years of
   follow-up
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE REPAIR;
   COMPOSITE MULTILAYERED BIOMATERIAL; SHEEP MODEL; REGENERATION; COLLAGEN;
   TISSUE; PLUG; METAANALYSIS; LESIONS
AB The increasing interest in the role of subchondral bone with regard to articular surface disease led to the development of new bioengineered strategies. Aim of this study is to evaluate the clinical and MRI outcome after the implantation of a nanostructured biomimetic three-phasic collagen-hydroxyapatite construct for the treatment of chondral and osteochondral defects of the knee in a large cohort of patients. Seventy-nine patients (63 M, 16 W), affected by grade III-IV femoral condyle or trochlea chondral lesions or osteochondritis dissecans (OCD) were consecutively treated. Mean age was 31.0 +/- A 11.3 years, mean lesion size was 3.2 +/- A 2.0 cm(2). Fifty patients underwent previous surgeries, concurrent procedures were necessary in 39 cases. The clinical outcome was evaluated using the IKDC and Tegner scores at 12 and 24 months of follow-up. At follow-up times an MRI was performed and evaluated with the MOCART score. All the scores improved significantly from the baseline. IKDC subjective score showed a further increase between 12 and 24 months of follow-up, and 82.2 % of the patients improved their symptoms at the final evaluation. Patients affected by OCDs had better results than those with degenerative lesions. Some abnormal MRI findings were present, even though no correlation was found with the clinical outcome. This one-step biomimetic approach developed to favor osteochondral tissue regeneration is effective in treating knees affected by damages of the articular surface, leading to a significant clinical improvement. However, abnormal MRI findings were present, even if not correlated with the clinical outcome.
C1 [Kon, Elizaveta; Filardo, Giuseppe; Perdisa, Francesco; Di Martino, Alessandro; Busacca, Maurizio; Balboni, Federica; Sessa, Andrea; Marcacci, Maurilio] Rizzoli Orthopaed Inst, Biomech Lab, Clin 2, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Clin 2, Via Di Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it; g.filardo@biomec.ior.it;
   francescoperdisa@gmail.com; a.dimartino@biomec.ior.it;
   maurizio.busacca@ior.it; balboni.federica@gmail.com;
   a.sessa86@gmail.com; m.marcacci@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
FU CartiHeal Ltd, Israel; Finceramica SpA, Italy; Fidia, Italy
FX All but two authors declare that they have no conflict of interest.
   Elizaveta Kon is paid consultant for CartiHeal (2009) Ltd, Israel and
   has stocks of CartiHeal (2009) Ltd, Israel, and she received fees for
   paid presentation from Finceramica SpA, Italy, and Fidia, Italy.
   Maurilio Marcacci has royalties and received research institutional
   support from Finceramica SpA, Italy.
CR Blackman AJ, 2013, AM J SPORT MED, V41, P1426, DOI 10.1177/0363546513485931
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   de Windt TS, 2013, AM J SPORT MED, V41, P1695, DOI 10.1177/0363546512473258
   Delcogliano M, 2013, KNEE SURG SPORTS TRA
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   Filardo G, 2012, CARTILAGE
   Filardo G., 2013, KNEE SURG SPORTS TRA
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filardo G, 2011, AM J SPORT MED, V39, P2153, DOI 10.1177/0363546511415658
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gotterbarm T, 2013, J BIOMED MAT RES B
   ICRS, 2000, CART INJ EV PACK
   ICRS Cartilage Injury Evaluation Package, 2000, ICRS CART INJ EV PAC
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2013, AM J SPORTS MED
   Kon E, 2013, KNEE SURG SPORTS TRA
   Kon E, 2012, CURR REV MUSCULOSKE, V5, P236, DOI 10.1007/s12178-012-9135-x
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Liu M, 2013, ORTHOPEDICS, V36, P868, DOI 10.3928/01477447-20131021-10
   Marcacci M, 2013, KNEE SURG SPORT TR A, V21, P2509, DOI 10.1007/s00167-013-2388-0
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Marmotti A, 2013, EUR CELLS MATER, V26, P15, DOI 10.22203/eCM.v026a02
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Melton JTK, 2010, EXPERT REV MED DEVIC, V7, P333, DOI 10.1586/ERD.10.15
   Minas T, 2014, CLIN ORTHOP RELAT R, V472, P41, DOI 10.1007/s11999-013-3146-9
   Panni AS, 2011, INT J IMMUNOPATH PH, V24, P149, DOI 10.1177/03946320110241S228
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Pascarella A, 2010, KNEE SURG SPORT TR A, V18, P509, DOI 10.1007/s00167-009-1007-6
   Perdisa F, 2013, EUR REV MED PHARM S3, V17
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43
   Vasiliadis HS, 2010, AM J SPORT MED, V38, P943, DOI 10.1177/0363546509358266
   Zaffagnini S, 2012, KNEE SURG SPORT TR A, V20, P153, DOI 10.1007/s00167-011-1589-7
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.3.CO;2-G
NR 46
TC 22
Z9 22
U1 0
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2014
VL 25
IS 10
BP 2437
EP 2444
DI 10.1007/s10856-014-5188-2
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AP9SX
UT WOS:000342421300022
PM 24599553
DA 2018-10-20
ER

PT J
AU Shimomura, K
   Moriguchi, Y
   Murawski, CD
   Yoshikawa, H
   Nakamura, N
AF Shimomura, Kazunori
   Moriguchi, Yu
   Murawski, Christopher D.
   Yoshikawa, Hideki
   Nakamura, Norimasa
TI Osteochondral Tissue Engineering with Biphasic Scaffold: Current
   Strategies and Techniques
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID ARTICULAR-CARTILAGE REPAIR; MESENCHYMAL STEM-CELLS; COMPOSITE
   MULTILAYERED BIOMATERIAL; AUTOLOGOUS CHONDROCYTE IMPLANTATION; BONE
   MORPHOGENETIC PROTEIN-2; OSTEOARTHRITIS YEAR 2012; SUBCHONDRAL BONE;
   OLDER-ADULTS; OARSI RECOMMENDATIONS; KNEE OSTEOARTHRITIS
AB The management of osteoarthritis (OA) remains challenging and controversial. Although several clinical options exist for the treatment of OA, regeneration of the damaged articular cartilage has proved difficult due to the limited healing capacity. With the advancements in tissue engineering and cell-based technologies over the past decade, new therapeutic options for patients with osteochondral lesions potentially exist. This review will focus on the feasibility of tissue-engineered biphasic scaffolds, which can mimic the native osteochondral complex, for osteochondral repair and highlight the recent development of these techniques toward tissue regeneration. Moreover, basic anatomy, strategy for osteochondral repair, the design and fabrication methods of scaffolds, as well as the choice of cells, growth factor, and materials will be discussed. Specifically, we focus on the latest preclinical animal studies using large animals and clinical trials with high clinical relevance. In turn, this will facilitate an understanding of the latest trends in osteochondral repair and contribute to the future application of such clinical therapies in patients with OA.
C1 [Shimomura, Kazunori; Moriguchi, Yu; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed, Osaka, Japan.
   [Shimomura, Kazunori] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15261 USA.
   [Murawski, Christopher D.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA.
   [Nakamura, Norimasa] Osaka Hlth Sci Univ, Inst Med Sci Sports, Osaka 5300043, Japan.
   [Nakamura, Norimasa] Osaka Univ, Ctr Adv Med Engn & Informat, Osaka, Japan.
RP Nakamura, N (reprint author), Osaka Hlth Sci Univ, Inst Med Sci Sports, Kita Ku, 1-9-27 Tenma, Osaka 5300043, Japan.
EM norimasa.nakamura@ohsu.ac.jp
FU New Energy and Industrial Technology Development Organization, Japan;
   Japan Society, for the promotion of Science, Japan
FX This study was supported by a grant from the New Energy and Industrial
   Technology Development Organization, Japan, and a Grant-in-Aid for
   Scientific Research (B), Japan Society, for the promotion of Science,
   Japan.
CR Ahern BJ, 2009, OSTEOARTHR CARTILAGE, V17, P705, DOI 10.1016/j.joca.2008.11.008
   Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI 10.1089/ten.TEA.2008.0511
   Albrecht C, 2010, INT J MOL MED, V26, P317, DOI 10.3892/ijmm_00000468
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Ando W, 2012, EUR CELLS MATER, V24, P292, DOI 10.22203/eCM.v024a21
   Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015
   Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bal BS, 2010, J BIOMED MATER RES B, V93B, P164, DOI 10.1002/jbm.b.31571
   Barr RJ, 2012, RHEUMATOLOGY, V51, P562, DOI 10.1093/rheumatology/ker382
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bhattarai SR, 2006, J BIOMED MATER RES A, V78A, P247, DOI 10.1002/jbm.a.30695
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Castro NJ, 2012, ANN BIOMED ENG, V40, P1628, DOI 10.1007/s10439-012-0605-5
   Chang KY, 2009, ACTA BIOMATER, V5, P1937, DOI 10.1016/j.actbio.2009.02.002
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chen QZ, 2006, J BIOMED MATER RES A, V77A, P445, DOI 10.1002/jbm.a.30636
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Chubinskaya S, 2008, GROWTH FACTORS, V26, P275, DOI 10.1080/08977190802291733
   CLARK JM, 1990, J BONE JOINT SURG BR, V72, P866
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Deng TZ, 2014, J TISSUE ENG REGEN M, V8, P546, DOI 10.1002/term.1556
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   Duan YH, 2012, RHEUMATOL INT, V32, P985, DOI 10.1007/s00296-010-1731-8
   Dunlop DD, 2001, ARTHRITIS RHEUM, V44, P212, DOI 10.1002/1529-0131(200101)44:1<212::AID-ANR28>3.0.CO;2-Q
   El-Ayoubi R, 2011, J BIOMATER APPL, V25, P429, DOI 10.1177/0885328209355332
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Forsey RW, 2012, BIOTECHNOL APPL BIOC, V59, P142, DOI 10.1002/bab.1009
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Haverkamp DJ, 2011, ARTHRITIS RHEUM-US, V63, P3401, DOI 10.1002/art.30575
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Hsu FY, 2010, ACTA BIOMATER, V6, P2140, DOI 10.1016/j.actbio.2009.12.023
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   Kawanishi M, 2007, TISSUE ENG, V13, P957, DOI 10.1089/ten.2006.0176
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kurz B, 2004, TISSUE ENG, V10, P1277, DOI 10.1089/ten.2004.10.1277
   Levett PA, 2014, J BIOMED MATER RES A, V102, P2544, DOI 10.1002/jbm.a.34924
   Li WJ, 2007, J BIOMECH, V40, P1686, DOI 10.1016/j.jbiomech.2006.09.004
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Lin H, 2013, BIOMATERIALS, V34, P331, DOI 10.1016/j.biomaterials.2012.09.048
   Lynch JA, 2009, OSTEOARTHR CARTILAGE, V17, P1313, DOI 10.1016/j.joca.2009.04.011
   Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z
   Mannoni A, 2003, ANN RHEUM DIS, V62, P576, DOI 10.1136/ard.62.6.576
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   MENTE PL, 1994, J ORTHOPAED RES, V12, P637, DOI 10.1002/jor.1100120506
   Miao XG, 2008, ACTA BIOMATER, V4, P638, DOI 10.1016/j.actbio.2007.10.006
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17
   Mobasheri A, 2012, OSTEOARTHR CARTILAGE, V20, P1451, DOI 10.1016/j.joca.2012.07.009
   Mosher TJ, 2013, OSTEOARTHR CARTILAGE, V21, P1425, DOI 10.1016/j.joca.2013.07.010
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Orth P, 2013, J ORTHOP RES, V31, P1772, DOI 10.1002/jor.22418
   Orth P, 2013, EUR CELLS MATER, V25, P299, DOI 10.22203/eCM.v025a21
   Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1
   Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91
   Pena J, 2006, J BIOMED MATER RES A, V76A, P788, DOI 10.1002/jbm.a.30547
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Ren J, 2008, J MATER SCI-MATER M, V19, P1075, DOI 10.1007/s10856-007-3181-8
   Reyes R., 2013, J TISSUE ENG REGEN M, DOI [10.1002/jbm.a.34769, DOI 10.1002/JBM.A.34769]
   Reyes R, 2014, J BIOMED MATER RES A, V102, P1110, DOI 10.1002/jbma.34769
   Rodrigues MT, 2011, CURR OPIN BIOTECH, V22, P726, DOI 10.1016/j.copbio.2011.04.006
   Roemer FW, 2012, OSTEOARTHR CARTILAGE, V20, P1440, DOI 10.1016/j.joca.2012.07.008
   Rose FRAJ, 2004, J PHARM PHARMACOL, V56, P415, DOI 10.1211/0022357023312
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Sarasam AR, 2006, BIOMACROMOLECULES, V7, P1131, DOI 10.1021/bm050935d
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Schleicher I, 2013, J SURG RES, V183, P184, DOI 10.1016/j.jss.2012.11.036
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shimomura K, 2010, BIOMATERIALS, V31, P8004, DOI 10.1016/j.biomaterials.2010.07.017
   Shintani N, 2007, ARTHRITIS RHEUM, V56, P1869, DOI 10.1002/art.22701
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Takahashi N, 2010, ARTHRITIS RHEUM-US, V62, P1338, DOI 10.1002/art.27410
   Takahashi T, 2007, TISSUE ENG, V13, P1583, DOI 10.1089/ten.2006.0322
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   Tan W, 2010, IEEE T NANOBIOSCI, V9, P111, DOI 10.1109/TNB.2010.2043367
   Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Zhang SF, 2013, ACTA BIOMATER, V9, P7236, DOI 10.1016/j.actbio.2013.04.003
   Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013
   Zhang W, 2007, OSTEOARTHR CARTILAGE, V15, P981, DOI 10.1016/j.joca.2007.06.014
   Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013
   Zhang W, 2013, BIOMATERIALS, V34, P6046, DOI 10.1016/j.biomaterials.2013.04.055
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 111
TC 38
Z9 39
U1 4
U2 69
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT 1
PY 2014
VL 20
IS 5
BP 468
EP 476
DI 10.1089/ten.teb.2013.0543
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AQ1TB
UT WOS:000342562900007
PM 24417741
DA 2018-10-20
ER

PT J
AU Zhang, HB
   Zhou, L
   Zhang, WJ
AF Zhang, Hongbo
   Zhou, Li
   Zhang, Wenjun
TI Control of Scaffold Degradation in Tissue Engineering: A Review
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Review
ID IN-VITRO DEGRADATION; ELECTRON-BEAM RADIATION; EGG-WHITE LYSOZYME;
   DRUG-RELEASE; HYDROLYTIC DEGRADATION; POROUS SCAFFOLDS; ALIPHATIC
   POLYESTERS; VIVO DEGRADATION; DELIVERY SYSTEMS; WATER-UPTAKE
AB Tissue engineering has shown a great promise as a solution to the high demand for tissue and organ transplantations. Biomaterial scaffolds serve to house and direct cells to grow, exposing them to an adequate perfusion of nutrients, oxygen, metabolic products, and appropriate growth factors to enhance their differentiation and function. The degradation of biomaterial scaffolds is a key factor to successful tissue regeneration. In this article, the existing degradation control approaches in the context of scaffold tissue engineering were reviewed and a new paradigm of thinking called active control of scaffold degradation, proposed elsewhere by us, was also revisited and discussed in light of its benefit and requirement of this new technology.
C1 [Zhang, Hongbo; Zhang, Wenjun] E China Univ Sci & Technol, Sch Mech & Power Engn, Complex & Intelligent Res Ctr, Shanghai 200237, Peoples R China.
   [Zhou, Li; Zhang, Wenjun] Univ Saskatchewan, Dept Biomed Engn, Saskatoon, SK S7N 5A9, Canada.
RP Zhang, WJ (reprint author), Univ Saskatchewan, Dept Biomed Engn, 57 Campus Dr, Saskatoon, SK S7N 5A9, Canada.
EM chris.zhang@usask.ca
FU SHRF
FX The corresponding author wants to thank a partial financial support
   received from SHRF through a group phase I project, grant on "BioMEMS."
CR Akkarainen M., 1996, POLYM DEGRAD STABIL, V52, P283
   American Society for the Testing Materials International (ASTM), 2007, ANN BOOK ASTM STAND, P8
   Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b
   Armentano I, 2008, J MATER SCI-MATER M, V19, P2377, DOI 10.1007/s10856-007-3276-2
   Bakry A, 2012, POLYM INT, V61, P1177, DOI 10.1002/pi.4197
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   BOON ME, 1995, BIOMATERIALS, V16, P1089, DOI 10.1016/0142-9612(95)98905-T
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Burkersroda F. V., 1999, MATER RES SOC S P, V550, P17
   Cairns ML, 2012, J BIOMED MATER RES A, V100A, P2223, DOI 10.1002/jbm.a.34156
   Cairns ML, 2011, ACTA BIOMATER, V7, P548, DOI 10.1016/j.actbio.2010.09.012
   Chien KB, 2013, TISSUE ENG PART C-ME, V19, P417, DOI [10.1089/ten.tec.2012.0383, 10.1089/ten.TEC.2012.0383]
   Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   Dado D, 2009, SEMIN CELL DEV BIOL, V20, P656, DOI 10.1016/j.semcdb.2009.02.001
   Dong YX, 2008, TISSUE ENG PT A, V14, P1321, DOI 10.1089/ten.tea.2007.0395
   Felix L. R. P., 2011, ACTA BIOMATER, V7, P3459
   Fu QA, 2010, J BIOMED MATER RES A, V95A, P164, DOI 10.1002/jbm.a.32824
   Galliker P., 2012, NAT COMMUN, V3
   Geethapriya S, 2012, J TISSUE ENG REGEN M, V6, P99
   Gopferich A, 1997, J CONTROL RELEASE, V44, P271, DOI 10.1016/S0168-3659(96)01533-7
   Hakkarainen M, 2008, ADV POLYM SCI, V211, P85, DOI 10.1007/12_2007_128
   Hirenkumar K. M., 2011, POLYMERS, V3, P1377
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   HOPFENBERG HB, 1978, POLYM ENG SCI, V18, P1186, DOI 10.1002/pen.760181511
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Ji W, 2012, BIOMATERIALS, V33, P6604, DOI 10.1016/j.biomaterials.2012.06.018
   Jo SY, 2012, RADIAT PHYS CHEM, V81, P846, DOI 10.1016/j.radphyschem.2012.03.013
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kumar D. Pradip, 2004, J SCI IND RES INDIA, V63, P20
   LANGER R, 1983, J MACROMOL SCI R M C, VC23, P61, DOI 10.1080/07366578308079439
   Lao LL, 2008, EUR J PHARM BIOPHARM, V70, P796, DOI 10.1016/j.ejpb.2008.05.024
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li P, 2010, ACTA BIOMATER, V6, P2991, DOI 10.1016/j.actbio.2010.02.023
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li X, 2011, ACS COMB SCI, V13, P50, DOI 10.1021/co100019d
   Liu H, 2012, J APPL POLYM SCI, V125, pE468, DOI 10.1002/app.36757
   Liu L. Y., 2012, ISRN NANOTECHNOL, V2012, P11
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Lyu SP, 2007, BIOMACROMOLECULES, V8, P2301, DOI 10.1021/bm070313n
   Maeda R, 1997, J FERMENT BIOENG, V84, P478, DOI 10.1016/S0922-338X(97)82012-0
   Makitie AA, 2013, ACTA OTO-LARYNGOL, V133, P412, DOI 10.3109/00016489.2012.761725
   Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021
   Mattioli S., 2012, J APPL POLYM SCI, V125, P239
   Melissinaki V, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045005
   O'Dea RD, 2013, J MATH BIOL, V67, P1199, DOI 10.1007/s00285-012-0587-9
   Petersen LK, 2010, J COMB CHEM, V12, P51, DOI 10.1021/cc900116c
   Phong L, 2010, POLYM DEGRAD STABIL, V95, P771, DOI 10.1016/j.polymdegradstab.2010.02.012
   Ratner B. D., 2003, BIOMATERIALS SCI INT
   Ricci JL, 2012, J CRANIOFAC SURG, V23, P304, DOI 10.1097/SCS.0b013e318241dc6e
   Rivest C., 2007, MECH MAT STRUCT, V2, P756
   Rothstein SN, 2008, J MATER CHEM, V18, P1873, DOI 10.1039/b718277e
   Saito E, 2012, ACTA BIOMATER, V8, P2568, DOI 10.1016/j.actbio.2012.03.028
   SALTON MRJ, 1952, NATURE, V170, P746, DOI 10.1038/170746a0
   Schulz U, 2009, ACCELERATED TESTING
   Seo Y. K., 2011, TISSUE ENG REGEN MED, V8, P28
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P229, DOI 10.1016/S0169-409X(01)00116-8
   Sikorski P, 2005, BIOPOLYMERS, V77, P273, DOI 10.1002/bip.20224
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   Slepicka P, 2012, POLYM DEGRAD STABIL, V97, P1075, DOI 10.1016/j.polymdegradstab.2012.04.013
   Soares JS, 2010, BIOMATERIALS, V31, P3032, DOI 10.1016/j.biomaterials.2010.01.008
   Son J, 2009, J BIOMAT SCI-POLYM E, V20, P2089, DOI 10.1163/156856208X399954
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Suarez N, 1998, BIOMATERIALS, V19, P2347, DOI 10.1016/S0142-9612(98)00151-3
   Tang YW, 1997, BIOMATERIALS, V18, P37, DOI 10.1016/S0142-9612(96)00101-9
   Thombre A. G., 1984, J BIOMATER, V5, P249
   Thombre A. G., 1985, AICHE J, V31, P59
   Thompson PA, 2010, HAEMATOL-HEMATOL J, V95, P1977, DOI 10.3324/haematol.2010.026237
   Tsaih ML, 2003, J APPL POLYM SCI, V90, P3526, DOI 10.1002/app.13027
   Vacanti J. P., 1993, SCIENCE, V12, P347
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Vocadlo DJ, 2001, NATURE, V412, P835, DOI 10.1038/35090602
   Walton M, 2007, J BIOMATER APPL, V21, P395, DOI 10.1177/0885328206065125
   Wang GC, 2012, MAT SCI ENG C-MATER, V32, P1818, DOI 10.1016/j.msec.2012.04.068
   Wang XY, 2012, EXPERT OPIN BIOL TH, V12, P1129, DOI 10.1517/14712598.2012.704016
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   YOSHIMURA K, 1988, BIOCHEM BIOPH RES CO, V150, P794, DOI 10.1016/0006-291X(88)90461-5
   Zhou L., 2011, THESIS U SASKATCHEWA
   Zolnik BS, 2007, J CONTROL RELEASE, V122, P338, DOI 10.1016/j.jconrel.2007.05.034
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zygourakis K, 1996, BIOMATERIALS, V17, P125, DOI 10.1016/0142-9612(96)85757-7
NR 83
TC 32
Z9 32
U1 6
U2 59
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT 1
PY 2014
VL 20
IS 5
BP 492
EP 502
DI 10.1089/ten.teb.2013.0452
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AQ1TB
UT WOS:000342562900009
PM 24547761
DA 2018-10-20
ER

PT J
AU Golob, M
   Moss, RL
   Chesler, NC
AF Golob, Mark
   Moss, Richard L.
   Chesler, Naomi C.
TI Cardiac Tissue Structure, Properties, and Performance: A Materials
   Science Perspective
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE Cardiac myocyte mechanics; Cardiac sarcomere mechanics; Cardiac tissue
   testing; Review
ID LENGTH-DEPENDENT ACTIVATION; RIGHT-VENTRICULAR FUNCTION; FRANK-STARLING
   MECHANISM; MYOSIN HEAVY-CHAIN; SARCOMERE-LENGTH; CALCIUM SENSITIVITY;
   HEART-FAILURE; CROSS-BRIDGE; PULMONARY-HYPERTENSION; TRABECULAE CARNEAE
AB From an engineering perspective, many forms of heart disease can be thought of as a reduction in biomaterial performance, in which the biomaterial is the tissue comprising the ventricular wall. In materials science, the structure and properties of a material are recognized to be interconnected with performance. In addition, for most measurements of structure, properties, and performance, some processing is required. Here, we review the current state of knowledge regarding cardiac tissue structure, properties, and performance as well as the processing steps taken to acquire those measurements. Understanding the impact of these factors and their interactions may enhance our understanding of heart function and heart failure. We also review design considerations for cardiac tissue property and performance measurements because, to date, most data on cardiac tissue has been obtained under non-physiological loading conditions. Novel measurement systems that account for these design considerations may improve future experiments and lead to greater insight into cardiac tissue structure, properties, and ultimately performance.
C1 [Golob, Mark; Chesler, Naomi C.] Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53706 USA.
   [Golob, Mark] Univ Wisconsin, Coll Engn, Mat Sci Program, Madison, WI 53706 USA.
   [Moss, Richard L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.
RP Chesler, NC (reprint author), Univ Wisconsin, Coll Engn, Dept Biomed Engn, 2146 Engn Ctr Bldg,1550 Engn Dr, Madison, WI 53706 USA.
EM chesler@engr.wisc.edu
FU NIH [1R01HL086939, 1R37HL82900]
FX Our work was supported by NIH grants 1R01HL086939 (NCC) and 1R37HL82900
   (RLM). The authors thank Carol Dizack for preparing the illustrations
   and Dr. Jitandrakumar Patel for unpublished force-pCa data.
CR Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275
   BLUHM WF, 1995, J BIOMECH, V28, P1119, DOI 10.1016/0021-9290(94)00018-Y
   Bollensdorff C, 2011, PFLUG ARCH EUR J PHY, V462, P39, DOI 10.1007/s00424-011-0964-z
   BRADY AJ, 1979, NATURE, V282, P728, DOI 10.1038/282728a0
   BRADY AJ, 1991, PHYSIOL REV, V71, P413
   Brixius K, 2003, EUR J APPL PHYSIOL, V89, P249, DOI 10.1007/s00421-002-0782-2
   Bryant SM, 1997, CARDIOVASC RES, V35, P315, DOI 10.1016/S0008-6363(97)00111-9
   Cazorla O, 2001, CIRC RES, V88, P1028, DOI 10.1161/hh1001.090876
   Cazorla O, 2000, J MOL CELL CARDIOL, V32, P735, DOI 10.1006/jmcc.2000.1115
   Chung CS, 2011, J MOL CELL CARDIOL, V50, P731, DOI 10.1016/j.yjmcc.2011.01.005
   Costa KD, 2001, PHILOS T R SOC A, V359, P1233, DOI 10.1098/rsta.2001.0828
   de Tombe PP, 2010, J MOL CELL CARDIOL, V48, P851, DOI 10.1016/j.yjmcc.2009.12.017
   de Tombe PP, 1998, CARDIOVASC RES, V37, P367, DOI 10.1016/S0008-6363(97)00275-7
   deTombe PP, 1996, AM J PHYSIOL-HEART C, V271, pH73
   Diffee G. M., 2003, J APPL PHYSIOL, V95, P1985
   Dobesh DP, 2002, AM J PHYSIOL-HEART C, V282, pH1055, DOI 10.1152/ajpheart.00667.2001
   Edes IF, 2007, AM J PHYSIOL-REG I, V293, pR20, DOI 10.1152/ajpregu.00537.2006
   Farman GP, 2010, BIOPHYS J, V99, P2978, DOI 10.1016/j.bpj.2010.09.003
   Friedberg MK, 2014, CIRCULATION, V129, P1033, DOI 10.1161/CIRCULATIONAHA.113.001375
   GAO WD, 1994, CIRC RES, V74, P408, DOI 10.1161/01.RES.74.3.408
   Garcia-Webb MG, 2007, AM J PHYSIOL-HEART C, V293, pH866, DOI 10.1152/ajpheart.01055.2006
   GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X
   Hamdani N, 2008, CARDIOVASC RES, V77, P649, DOI 10.1093/cvr/cvm079
   Han JC, 2013, J PHYSIOL-LONDON, V591, P701, DOI 10.1113/jphysiol.2012.242719
   Han JC, 2009, J APPL PHYSIOL, V107, P946, DOI 10.1152/japplphysiol.00549.2009
   Hand PE, 2010, B MATH BIOL, V72, P1408, DOI 10.1007/s11538-009-9499-2
   Iribe G, 2007, AM J PHYSIOL-HEART C, V292, pH1487, DOI 10.1152/ajpheart.00909.2006
   Irving TC, 2000, AM J PHYSIOL-HEART C, V279, pH2568
   IWAZUMI T, 1987, AM J PHYSIOL, V252, pC253
   Joho S, 2007, AM J PHYSIOL-HEART C, V292, pH369, DOI 10.1152/ajpheart.00704.2006
   King NMP, 2011, J GEN PHYSIOL, V137, P81, DOI 10.1085/jgp.201010499
   Kondo RP, 2006, J PHYSIOL-LONDON, V571, P131, DOI 10.1113/jphysiol.2005.101428
   Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117
   Korte FS, 2007, J PHYSIOL-LONDON, V581, P725, DOI 10.1113/jphysiol.2007.128199
   Lee EJ, 2010, J MOL CELL CARDIOL, V49, P449, DOI 10.1016/j.yjmcc.2010.05.006
   LeGrice I, 2001, PHILOS T R SOC A, V359, P1217, DOI 10.1098/rsta.2001.0827
   LEGUENNEC JY, 1990, J MOL CELL CARDIOL, V22, P1083, DOI 10.1016/0022-2828(90)90072-A
   Lin G, 2001, IEEE T BIO-MED ENG, V48, P996, DOI 10.1109/10.942589
   Mou YA, 2008, PFLUG ARCH EUR J PHY, V457, P25, DOI 10.1007/s00424-008-0501-x
   Nishimura S, 2004, AM J PHYSIOL-HEART C, V287, pH196, DOI 10.1152/ajpheart.00948.2003
   Nordsletten DA, 2011, PROG BIOPHYS MOL BIO, V104, P77, DOI 10.1016/j.pbiomolbio.2009.11.001
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   Patel JR, 2012, AM J PHYSIOL-HEART C, V302, pH697, DOI 10.1152/ajpheart.00800.2011
   Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732
   PERREAULT CL, 1990, CIRC RES, V67, P707, DOI 10.1161/01.RES.67.3.707
   Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867
   REDINGTON AN, 1988, BRIT HEART J, V59, P23
   Roche SL, 2013, CAN J CARDIOL, V29, P768, DOI 10.1016/j.cjca.2013.04.018
   Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004
   SCHWINGER RHG, 1994, CIRC RES, V74, P959, DOI 10.1161/01.RES.74.5.959
   Shaw J., 2013, PLOS ONE, V8
   Stevens C, 2003, PROG BIOPHYS MOL BIO, V82, P229, DOI 10.1016/S0079-6107(03)00023-3
   Suzuki M, 2005, BIOPHYS J, V89, P321, DOI 10.1529/biophysj.104.054957
   Taberner AJ, 2011, J APPL PHYSIOL, V111, P1798, DOI 10.1152/japplphysiol.00752.2011
   Tabima DM, 2010, AM J PHYSIOL-HEART C, V299, pH2069, DOI 10.1152/ajpheart.00805.2010
   Tasche C, 1999, AM J PHYSIOL-HEART C, V277, pH2400, DOI 10.1152/ajpheart.1999.277.6.H2400
   Trayanova NA, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00043
   Umar S, 2009, AM J PHYSIOL-HEART C, V297, pH1606, DOI 10.1152/ajpheart.00590.2009
   van der Velden J, 2000, CARDIOVASC RES, V46, P487, DOI 10.1016/S0008-6363(00)00050-X
   van der Velden J, 2003, CARDIOVASC RES, V57, P505, DOI 10.1016/S0008-6363(02)00662-4
   van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5
   Walker LA, 2011, AM J PHYSIOL-HEART C, V301, pH832, DOI 10.1152/ajpheart.00249.2011
   Walker LA, 2009, CURR CARDIOL REV, V5, P22, DOI 10.2174/157340309787048077
   Washio T, 2012, CELL MOL BIOENG, V5, P113, DOI 10.1007/s12195-011-0219-2
   Washio T, 2010, SIAM REV, V52, P717, DOI 10.1137/100798429
   Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.2162
   Yasuda S.-I., 2001, AM J PHYSIOL-HEART C, V281, P1442
   Zaffran S, 2004, CIRC RES, V95, P261, DOI 10.1161/01.RES.0000136815.73623.BE
NR 68
TC 4
Z9 4
U1 2
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD OCT
PY 2014
VL 42
IS 10
BP 2003
EP 2013
DI 10.1007/s10439-014-1071-z
PG 11
WC Engineering, Biomedical
SC Engineering
GA AP2NF
UT WOS:000341908500001
PM 25081385
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liu, FH
AF Liu, Fwu-Hsing
TI Fabrication of Bioceramic Bone Scaffolds for Tissue Engineering
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE additive manufacturing; bioceramic; biomaterial; scaffold; sintering;
   tissue engineering
ID PHOSPHATE COMPOSITE SCAFFOLDS; IN-VITRO; MECHANICAL-PROPERTIES;
   HYDROXYAPATITE; PROLIFERATION; DEPOSITION; HYDROGEL; COATINGS; ADHESION;
   DESIGN
AB In this study, microhydroxyapatite and nanosilica sol were used as the raw materials for fabrication of bioceramic bone scaffold using selective laser sintering technology in a self-developed 3D Printing apparatus. When the fluidity of ceramic slurry is matched with suitable laser processing parameters, a controlled pore size of porous bone scaffold can be fabricated under a lower laser energy. Results shown that the fabricated scaffolds have a bending strength of 14.1 MPa, a compressive strength of 24 MPa, a surface roughness of 725 nm, a pore size of 750 mu m, an apparent porosity of 32%, and a optical density of 1.8. Results indicate that the mechanical strength of the scaffold can be improved after heat treatment at 1200 A degrees C for 2 h, while simultaneously increasing surface roughness conducive to osteoprogenitor cell adhesion. MTT method and SEM observations confirmed that bone scaffolds fabricated under the optimal manufacturing process possess suitable biocompatibility and mechanical properties, allowing smooth adhesion and proliferation of osteoblast-like cells. Therefore, they have great potential for development in the field of tissue engineering.
C1 Lunghwa Univ Sci & Technol, Dept Mech Engn, Guishan Township, Taoyuan County, Taiwan.
RP Liu, FH (reprint author), Lunghwa Univ Sci & Technol, Dept Mech Engn, Guishan Township, Taoyuan County, Taiwan.
EM fhliu@mail.lhu.edu.tw
FU National Science Council of Taiwan [NSC 102-2221-E-262-005.]
FX The author would like to thank all students who contributed to this
   study. The author would like to acknowledge Prof. Yung-Kang Shen for his
   help in cell culture. The author also would like to thank the National
   Science Council of Taiwan (Grant No. NSC 102-2221-E-262-005.) for its
   financial supports.
CR [Anonymous], 1996, C1161 ASTM
   Badran Z, 2012, J MATER SCI-MATER M, V23, P797, DOI 10.1007/s10856-011-4534-x
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Duan B, 2011, BIOFABRICATION, V3, P1
   Eosoly S, 2012, MAT SCI ENG C-MATER, V32, P2250, DOI 10.1016/j.msec.2012.06.011
   Eshraghi S, 2012, ACTA BIOMATER, V8, P3138, DOI 10.1016/j.actbio.2012.04.022
   Fielding GA, 2012, DENT MATER, V28, P113, DOI 10.1016/j.dental.2011.09.010
   Hamizah A.S., 2012, J APPL POLYM SCI, V125, P661
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kolan K.C.R., 2011, BIOFABRICATION, V3, P2
   Lee MY, 2011, J MECH MED BIOL, V11, P983, DOI 10.1142/S0219519411004885
   Liu FH, 2014, APPL SURF SCI, V297, P1, DOI 10.1016/j.apsusc.2013.12.130
   Liu FH, 2012, J SOL-GEL SCI TECHN, V64, P704, DOI 10.1007/s10971-012-2905-5
   Liu FH, 2012, INT J PRECIS ENG MAN, V13, P439, DOI 10.1007/s12541-012-0056-9
   Liu FH, 2010, J EUR CERAM SOC, V30, P3283, DOI 10.1016/j.jeurceramsoc.2010.08.001
   Lohfeld S, 2012, ACTA BIOMATER, V8, P3446, DOI 10.1016/j.actbio.2012.05.018
   Ma B., 2006, MANUF MANAG, V207, P710
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Morks ME, 2008, J MECH BEHAV BIOMED, V1, P105, DOI 10.1016/j.jmbbm.2007.04.003
   Muller B, 2012, INT J MATER RES, V103, P242, DOI 10.3139/146.110663
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nebe JB, 2012, MATER SCI FORUM, V706-709, P566, DOI 10.4028/www.scientific.net/MSF.706-709.566
   Rai B, 2010, BIOMATERIALS, V31, P7960, DOI 10.1016/j.biomaterials.2010.07.001
   Ren LM, 2012, APPL SURF SCI, V262, P81, DOI 10.1016/j.apsusc.2012.02.060
   Santos CFL, 2012, MAT SCI ENG C-MATER, V32, P1293, DOI 10.1016/j.msec.2012.04.010
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Shuai C., 2011, NANOTECHNOLOGY, V22, P28
   Silva CC, 2002, J PHYS CHEM SOLIDS, V63, P1745, DOI 10.1016/S0022-3697(01)00262-1
   Tercero JE, 2009, MAT SCI ENG C-MATER, V29, P2195, DOI 10.1016/j.msec.2009.05.001
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Wu J, 2012, RAPID PROTOTYPING J, V18, P318, DOI 10.1108/13552541211231743
   Xiong Z, 2001, SCRIPTA MATER, V45, P773, DOI 10.1016/S1359-6462(01)01094-6
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhao D, 2009, ACTA BIOMATER, V5, P1265, DOI 10.1016/j.actbio.2008.11.021
NR 37
TC 6
Z9 7
U1 2
U2 122
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD OCT
PY 2014
VL 23
IS 10
BP 3762
EP 3769
DI 10.1007/s11665-014-1142-1
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AP6XZ
UT WOS:000342223200041
DA 2018-10-20
ER

PT J
AU Sloff, M
   Simaioforidis, V
   de Vries, R
   Oosterwijk, E
   Feitz, W
AF Sloff, Marije
   Simaioforidis, Vasileios
   de Vries, Rob
   Oosterwijk, Egbert
   Feitz, Wout
TI Tissue Engineering of the Bladder-Reality or Myth? A Systematic Review
SO JOURNAL OF UROLOGY
LA English
DT Review
DE meta-analysis; models; animal; reconstructive surgical procedures;
   tissue engineering; urinary bladder
ID SMALL-INTESTINAL SUBMUCOSA; ACELLULAR MATRIX GRAFT; SMOOTH-MUSCLE
   REGENERATION; URINARY-BLADDER; RABBIT MODEL; AUGMENTATION CYSTOPLASTY;
   BIODEGRADABLE SCAFFOLD; AUTOLOGOUS CELL; SEARCH FILTER; ANIMAL-MODEL
AB Purpose: We systematically reviewed preclinical studies in the literature to evaluate the potential of tissue engineering of the bladder. Study outcomes were compared to the available clinical evidence to assess the feasibility of tissue engineering for future clinical use.
   Materials and Methods: Preclinical studies of tissue engineering for bladder augmentation were identified through a systematic search of PubMed and Embase (TM) from January 1, 1980 to January 1, 2014. Primary studies in English were included if bladder reconstruction after partial cystectomy was performed using a tissue engineered biomaterial in any animal species, with cystometric bladder capacity as an outcome measure. Outcomes were compared to clinical studies available at http://www.clinicaltrials.gov and published clinical studies.
   Results: A total of 28 preclinical studies are included, demonstrating remarkable heterogeneity in study characteristics and design. Studies in which preoperative bladder volumes were compared to postoperative volumes were considered the most clinically relevant (18 studies). Bladder augmentation through tissue engineering resulted in a normal bladder volume in healthy animals, with the influence of a cellular component being negligible. Furthermore, experiments in large animal models (pigs and dogs) approximated the desired bladder volume more accurately than in smaller species. The initial clinical experience was based on seemingly predictive healthy animal models with a promising outcome. Unfortunately these results were not substantiated in all clinical trials, revealing dissimilar outcomes in different clinical/disease backgrounds. Thus, the translational predictability of a model using healthy animals might be questioned.
   Conclusions: Through this systematic approach we present an unbiased overview of all published preclinical studies investigating the effect of bladder tissue engineering on cystometric bladder capacity. Preclinical research in healthy animals appears to show the feasibility of bladder augmentation by tissue engineering. However, in view of the disappointing clinical results based on healthy animal models new approaches should also be evaluated in preclinical models using dysfunctional/diseased bladders. This endeavor may aid in the development of clinically applicable tissue engineered bladder augmentation with satisfactory long-term outcome.
C1 [de Vries, Rob] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Urol, NL-6525 ED Nijmegen, Netherlands.
   [de Vries, Rob] Radboud Univ Nijmegen, Med Ctr, Systemat Review Ctr Lab Anim Experimentat, Cent Anim Facil, NL-6525 ED Nijmegen, Netherlands.
RP Sloff, M (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Urol Expt Urol 267, Geert Grooteplein 26-28,POB 9101, NL-6525 GA Nijmegen, Netherlands.
EM marije.sloff@radboudumc.nl
RI Feitz, W.F.J./H-8028-2014; Vries, R.B.M./L-4732-2015; Oosterwijk,
   Egbert/P-5466-2014
CR Adamowicz J, 2012, TRANSPL P, V44, P1429, DOI 10.1016/j.transproceed.2012.01.144
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Burmeister D, 2010, TISSUE ENG PT A, V16, P2541, DOI [10.1089/ten.tea.2009.0697, 10.1089/ten.TEA.2009.0697]
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen W, 2010, J UROLOGY, V183, P2432, DOI 10.1016/j.juro.2010.02.042
   de Vries RBM, 2012, TISSUE ENG PART B-RE, V18, P427, DOI [10.1089/ten.teb.2012.0059, 10.1089/ten.TEB.2012.0059]
   de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056
   Gilbert SM, 2005, J UROLOGY, V173, P1080, DOI 10.1097/01.ju.0000155248.57049.4e
   Hattori K, 2006, INT J UROL, V13, P529, DOI 10.1111/j.1442-2042.2006.01351.x
   Higgins J, 2011, COCHRANE HDB SYSTEMA
   Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Joseph DB, 2014, J UROLOGY, V191, P1389, DOI 10.1016/j.juro.2013.10.103
   Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   KAMBIC H, 1992, J UROLOGY, V148, P539, DOI 10.1016/S0022-5347(17)36649-1
   KOISO K, 1983, ARTIF ORGANS, V7, P232, DOI 10.1111/j.1525-1594.1983.tb04191.x
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Kwon TG, 2008, J UROLOGY, V179, P2035, DOI 10.1016/j.juro.2008.01.005
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Leenaars M, 2012, LAB ANIM-UK, V46, P24, DOI 10.1258/la.2011.011087
   Lepper Fabio G O, 2002, Int Braz J Urol, V28, P464
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Mauney JR, 2010, BIOMATERIALS, V32, P808
   Mimura Y, 2010, LUTS, V2, P76, DOI 10.1111/j.1757-5672.2010.00067.x
   Nuininga JE, 2004, BIOMATERIALS, V25, P1657, DOI 10.1016/S0142-9612(03)00519-2
   Obara T, 2006, UROLOGY, V68, P892, DOI 10.1016/j.urology.2006.04.030
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Piechota HJ, 1998, BRIT J UROL, V81, P548
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Portis AJ, 2000, J UROLOGY, V164, P1405, DOI 10.1016/S0022-5347(05)67207-2
   Roelofs LAJ, 2013, BJU INT
   Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Sievert KD, 2006, WORLD J UROL, V24, P101, DOI 10.1007/s00345-006-0052-8
   Subramaniam R, 2011, J UROLOGY, V186, P2014, DOI 10.1016/j.juro.2011.07.031
   Wefer J, 2001, J UROLOGY, V165, P1755, DOI 10.1016/S0022-5347(05)66408-7
   Yang SX, 2005, CHINESE MED J-PEKING, V118, P957
   Yu DS, 2007, INT J UROL, V14, P939, DOI 10.1111/j.1442-2042.2007.01871.x
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 50
TC 29
Z9 29
U1 0
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD OCT
PY 2014
VL 192
IS 4
BP 1035
EP 1042
DI 10.1016/j.juro.2014.03.116
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA AP5IW
UT WOS:000342113900009
PM 24769032
DA 2018-10-20
ER

PT J
AU Barton, MJ
   Morley, JW
   Stoodley, MA
   Lauto, A
   Mahns, DA
AF Barton, Matthew J.
   Morley, John W.
   Stoodley, Marcus A.
   Lauto, Antonio.
   Mahns, David A.
TI Nerve repair: toward a sutureless approach
SO NEUROSURGICAL REVIEW
LA English
DT Review
DE Photochemical tissue bonding; Peripheral nerve repair; Nerve conduits;
   Biomaterials; Lasers; Sutures
ID ACTIVATED CHITOSAN ADHESIVE; PROTEIN BAND TECHNIQUE; RAT SCIATIC-NERVE;
   PERIPHERAL-NERVE; FIBRIN GLUE; IN-VIVO; ETHYL-CYANOACRYLATE; ALTERNATIVE
   TECHNIQUE; EPINEURAL SUTURES; TISSUE-REPAIR
AB Peripheral nerve repair for complete section injuries employ reconstructive techniques that invariably require sutures in their application. Sutures are unable to seal the nerve, thus incapable of preventing leakage of important intraneural fluids from the regenerating nerve. Furthermore, sutures are technically demanding to apply for direct repairs and often induce detrimental scarring that impedes healing and functional recovery. To overcome these limitations, biocompatible and biodegradable glues have been used to seal and repair peripheral nerves. Although creating a sufficient seal, they can lack flexibility and present infection risks or cytotoxicity. Other adhesive biomaterials have recently emerged into practice that are usually based on proteins such as albumin and collagen or polysaccharides like chitosan. These adhesives form their union to nerve tissue by either photothermal (tissue welding) or photochemical (tissue bonding) activation with laser light. These biomaterial adhesives offer significant advantages over sutures, such as their capacity to unite and seal the epineurium, ease of application, reduced invasiveness and add the potential for drug delivery in situ to facilitate regeneration. This paper reviews a number of different peripheral nerve repair (or reconstructive) techniques currently used clinically and in experimental procedures for nerve injuries with or without tissue deficit.
C1 [Barton, Matthew J.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4222, Australia.
   [Morley, John W.; Lauto, Antonio.; Mahns, David A.] Univ Western Sydney, Sch Med, Penrith, NSW 2751, Australia.
   [Morley, John W.; Lauto, Antonio.; Mahns, David A.] Univ Western Sydney, MARCS Inst, Bioelect & Neurosci BENS Res Grp, Penrith, NSW 2751, Australia.
   [Stoodley, Marcus A.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia.
RP Barton, MJ (reprint author), Griffith Univ, Griffith Hlth Inst, Gold Coast Campus, Brisbane, Qld 4222, Australia.
EM m.barton@griffith.edu.au
OI Mahns, David/0000-0003-2131-9638; Stoodley, Marcus/0000-0002-4207-8493
CR BARTON AA, 1962, BRAIN, V85, P799, DOI 10.1093/brain/85.4.799
   Barton M, 2013, J BIOPHOTONICS, V6, P938, DOI 10.1002/jbio.201300054
   Barton M, 2012, LASER SURG MED, V44, P762, DOI 10.1002/lsm.22076
   BASS LS, 1992, LASER SURG MED, V12, P500, DOI 10.1002/lsm.1900120508
   Bass LS, 1995, LASER SURG MED, V17, P315, DOI 10.1002/lsm.1900170402
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Bozzali M, 2004, NEUROCHEM RES, V29, P979, DOI 10.1023/B:NERE.0000021242.12455.75
   Brosh T, 2004, LASER SURG MED, V35, P12, DOI 10.1002/lsm.20073
   BRUNELLI GA, 1994, MICROSURG, V15, P176, DOI 10.1002/micr.1920150307
   CAUSEY G, 1959, BRAIN, V82, P594, DOI 10.1093/brain/82.4.594
   Chimutengwende-Gordon Mukai, 2012, Open Orthop J, V6, P103, DOI 10.2174/1874325001206010103
   Choi BH, 2004, INT J ORAL MAX SURG, V33, P777, DOI 10.1016/j.ijom.2004.03.006
   Cooley BC, 1996, MICROSURG, V17, P198, DOI 10.1002/(SICI)1098-2752(1996)17:4<198::AID-MICR6>3.0.CO;2-H
   Dagum B., 1998, J HAND THER, V11, P111
   Deal DN, 2012, J AM ACAD ORTHOP SUR, V20, P63, DOI 10.5435/JAAOS-20-02-063
   Donaldson J, 2002, NEUROSURGERY, V50, P147, DOI 10.1097/00006123-200201000-00023
   EVANS PJ, 1994, PROG NEUROBIOL, V43, P187, DOI 10.1016/0301-0082(94)90001-9
   Felix SP, 2013, MICROSURG, V33, P468, DOI 10.1002/micr.22109
   Flores A J, 2000, Am J Orthop (Belle Mead NJ), V29, P167
   Geuna S, 2009, INT REV NEUROBIOL, V87, P27, DOI 10.1016/S0074-7742(09)87003-7
   HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623
   Jain A, 2011, TISSUE ENG NEUROL NE, V5, P421, DOI DOI 10.1016/B978-0-08-055294-1.00183-5
   JENO CB, 1985, BRAIN RES, V361, P233
   Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012
   Johnson TS, 2007, J SURG RES, V143, P224, DOI 10.1016/j.jss.2007.01.028
   Kemp SWP, 2009, TISSUE ENG PT A, V15, P1975, DOI 10.1089/ten.tea.2008.0338
   KLINE DG, 1990, MUSCLE NERVE, V13, P843, DOI 10.1002/mus.880130911
   KLINE DG, 1963, J NEUROSURG, V20, P647, DOI 10.3171/jns.1963.20.8.0647
   Lanaras TI, 2009, MICROSURG, V29, P87, DOI 10.1002/micr.20583
   Landegren T, 2006, SCAND J PLAST RECONS, V40, P65, DOI 10.1080/02844310500513030
   Landegren T, 2007, SCAND J PLAST RECONS, V41, P217, DOI 10.1080/02844310701552001
   Lauto A, 1998, MICROSURG, V18, P60, DOI 10.1002/(SICI)1098-2752(1998)18:1<60::AID-MICR13>3.0.CO;2-Q
   Lauto A, 2007, LASER SURG MED, V39, P19, DOI 10.1002/lsm.20418
   Lauto A, 1998, MICROSURG, V18, P55, DOI 10.1002/(SICI)1098-2752(1998)18:1<55::AID-MICR12>3.0.CO;2-R
   Lauto A, 2004, LASER SURG MED, V35, P140, DOI 10.1002/lsm.20081
   Lauto A, 1997, LASER SURG MED, V21, P134, DOI 10.1002/(SICI)1096-9101(1997)21:2<134::AID-LSM4>3.0.CO;2-R
   Lauto A, 2001, LASER SURG MED, V28, P44, DOI 10.1002/1096-9101(2001)28:1<44::AID-LSM1015>3.0.CO;2-W
   Lauto A., 2005, FACULTY ENG
   Lauto A, 2008, PHOTOMED LASER SURG, V26, P227, DOI 10.1089/pho.2007.2131
   Lauto A, 2008, J CHEM TECHNOL BIOT, V83, P464, DOI 10.1002/jctb.1771
   Lee SK, 2000, J AM ACAD ORTHOP SUR, V8, P243, DOI DOI 10.5435/00124635-200007000-00005
   Lundborg G, 1997, J HAND SURG-AM, V22A, P99, DOI 10.1016/S0363-5023(05)80188-1
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Madeiro R, 2010, J NEUROTRAUM, V27, P829
   Mafi P, 2012, Open Orthop J, V6, P60, DOI 10.2174/1874325001206010060
   Martins RS, 2005, SURG NEUROL, V64, pS10, DOI 10.1016/j.surneu.2005.04.022
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   Menovsky T, 1996, MICROSURG, V17, P562, DOI 10.1002/(SICI)1098-2752(1996)17:10<562::AID-MICR6>3.0.CO;2-S
   Menovsky T, 1995, NEUROSURG REV, V18, P225, DOI 10.1007/BF00383873
   Menovsky T, 2003, MICROSURG, V23, P109, DOI 10.1002/micr.10100
   Menovsky T, 2001, J NEUROSURG, V95, P694, DOI 10.3171/jns.2001.95.4.0694
   Millesi H, 2006, MICROSURG, V26, P295, DOI 10.1002/micr.20242
   MILLESI H, 1990, WORLD J SURG, V14, P733, DOI 10.1007/BF01670520
   Mostafa BE, 1998, EUR ARCH OTO-RHINO-L, V255, P115, DOI 10.1007/s004050050024
   MOY OJ, 1988, J HAND SURG-AM, V13A, P273, DOI 10.1016/S0363-5023(88)80063-7
   Navarro X, 2003, MED BIOL ENG COMPUT, V41, P220, DOI 10.1007/BF02344893
   Ngeow WC, 2010, ORAL SURG ORAL MED O, V109, P357, DOI 10.1016/j.tripleo.2009.06.030
   O'Neill AC, 2009, J SURG RES, V151, P33, DOI 10.1016/j.jss.2008.01.025
   Ornelas L, 2006, J RECONSTR MICROSURG, V22, P119, DOI 10.1055/s-2006-932506
   Ornelas L, 2006, J RECONSTR MICROSURG, V22, P123, DOI 10.1055/s-2006-932507
   Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010
   Patel M, 2006, TISSUE ENG, V12, P3189, DOI 10.1089/ten.2006.12.3189
   Pereira MJN, 2013, ADV MATER, V25, P1209, DOI 10.1002/adma.201203824
   Pettersson J, 2010, J PLAST RECONSTR AES, V63, P1893, DOI 10.1016/j.bjps.2009.11.024
   Poppas DP, 1996, LASER SURG MED, V18, P335, DOI 10.1002/(SICI)1096-9101(1996)18:4<335::AID-LSM2>3.0.CO;2-T
   Preul MC, 2007, J NEUROSURG, V107, P642, DOI 10.3171/JNS-07/09/0642
   Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031
   Reid AJ, 2013, NEUROSCI LETT, V544, P125, DOI 10.1016/j.neulet.2013.04.001
   Richardson PM, 2009, NEUROSURGERY, V65, pA74, DOI 10.1227/01.NEU.0000352378.26755.C3
   Rickett T, 2009, J BIOMED MATER RES A, V90A, P750, DOI 10.1002/jbm.a.32137
   ROAF R, 1948, LANCET, V254, P242
   Robinson GA, 2003, MUSCLE NERVE, V28, P227, DOI 10.1002/mus.10422
   Robinson Lawrence R, 2004, Suppl Clin Neurophysiol, V57, P173
   Rodriguez FJ, 1999, BIOMATERIALS, V20, P1489, DOI 10.1016/S0142-9612(99)00055-1
   ROWSHAN K, 2004, OPER TECH ORTHOP, V14, P163
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Sameem M, 2011, PLAST RECONSTR SURG, V127, P2381, DOI 10.1097/PRS.0b013e3182131cf5
   Seddon HJ, 1942, BRIT MED J, V1942, P237, DOI 10.1136/bmj.2.4260.237
   Seiler J G 3rd, 1999, J Hand Ther, V12, P135
   Shahbazi J, 2011, LASER SURG MED, V43, P490, DOI 10.1002/lsm.21076
   Shin RH, 2009, J BONE JOINT SURG AM, V91A, P2194, DOI 10.2106/JBJS.H.01301
   Siemionow M, 2004, ANN PLAS SURG, V52, P72, DOI 10.1097/01.sap.0000097258.99511.ad
   Siemionow M, 2002, ANN PLAS SURG, V48, P281, DOI 10.1097/00000637-200203000-00009
   Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6
   Simhon D, 2001, LASER SURG MED, V29, P265, DOI 10.1002/lsm.1118
   Sinis N, 2007, ACTA NEUROCHIR SUPPL, V100, P61
   SNYDER CC, 1968, ANN SURG, V167, P691, DOI 10.1097/00000658-196805000-00007
   Stanec S, 1998, J RECONSTR MICROSURG, V14, P227, DOI 10.1055/s-2007-1000173
   SUNDERLAND S, 1951, BRAIN, V74, P491, DOI 10.1093/brain/74.4.491
   Temple CLF, 2004, J RECONSTR MICROSURG, V20, P645, DOI 10.1055/s-2004-861525
   Terzis JK, 1995, INT ANGIOL, V14, P264
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Whitlock EL, 2010, MICROSURG, V30, P218, DOI 10.1002/micr.20754
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   Wieken K, 2003, J RECONSTR MICROSURG, V19, P17, DOI 10.1055/s-2003-37186
   Wolford Larry M, 2003, Proc (Bayl Univ Med Cent), V16, P152
   Xu J, 2009, PAIN, V144, P329, DOI 10.1016/j.pain.2009.05.019
   Yang LJS, 2012, NEUROSURGERY, V71, P417, DOI 10.1227/NEU.0b013e318257be98
   Zhang PX, 2013, INT J MED SCI, V10, P171, DOI 10.7150/ijms.5312
NR 100
TC 13
Z9 14
U1 0
U2 47
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0344-5607
EI 1437-2320
J9 NEUROSURG REV
JI Neurosurg. Rev.
PD OCT
PY 2014
VL 37
IS 4
BP 585
EP 595
DI 10.1007/s10143-014-0559-1
PG 11
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA AP6MS
UT WOS:000342192500011
PM 25015388
DA 2018-10-20
ER

PT J
AU da Cunha, CB
   Klumpers, DD
   Li, WA
   Koshy, ST
   Weaver, JC
   Chaudhuri, O
   Granja, PL
   Mooney, DJ
AF da Cunha, Cristiana Branco
   Klumpers, Darinka D.
   Li, Weiwei A.
   Koshy, Sandeep T.
   Weaver, James C.
   Chaudhuri, Ovijit
   Granja, Pedro L.
   Mooney, David J.
TI Influence of the stiffness of three-dimensional alginate/collagen-I
   interpenetrating networks on fibroblast biology
SO BIOMATERIALS
LA English
DT Article
DE Wound healing; ECM (extracellular matrix); Mechanical properties;
   Interpenetrating networks (IPNs); Inflammation; Wound dressing
   biomaterial
ID STEM-CELL FATE; EXTRACELLULAR-MATRIX; MECHANICAL-PROPERTIES; COLLAGEN
   MATRICES; ALGINATE HYDROGELS; DELIVERY-SYSTEMS; TISSUE; SKIN;
   REGENERATION; CONTRACTION
AB Wound dressing biomaterials are increasingly being designed to incorporate bioactive molecules to promote healing, but the impact of matrix mechanical properties on the biology of resident cells orchestrating skin repair and regeneration remains to be fully understood. This study investigated whether tuning the stiffness of a model wound dressing biomaterial could control the behavior of dermal fibroblasts. Fully interpenetrating networks (IPNs) of collagen-I and alginate were fabricated to enable gel stiffness to be tuned independently of gel architecture, polymer concentration or adhesion ligand density. Three-dimensional cultures of dermal fibroblasts encapsulated within matrices of different stiffness were shown to promote dramatically different cell morphologies, and enhanced stiffness resulted in upregulation of key-mediators of inflammation such as IL-10 and COX-2. These findings suggest that simply modulating the matrix mechanical properties of a given wound dressing biomaterial deposited at the wound site could regulate the progression of wound healing. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [da Cunha, Cristiana Branco; Klumpers, Darinka D.; Li, Weiwei A.; Koshy, Sandeep T.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [da Cunha, Cristiana Branco; Klumpers, Darinka D.; Li, Weiwei A.; Koshy, Sandeep T.; Weaver, James C.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [da Cunha, Cristiana Branco] Inst Mol Pathol & Immunol Univ Porto IPATIMUP, P-4200465 Oporto, Portugal.
   [da Cunha, Cristiana Branco; Granja, Pedro L.] Inst Engn Biomed Univ Porto INEB, P-4150180 Oporto, Portugal.
   [da Cunha, Cristiana Branco] Fac Med Univ Porto, Hosp S Joao, P-4200319 Oporto, Portugal.
   [Klumpers, Darinka D.] Vrije Univ Amsterdam Med Ctr, Res Inst MOVE, Dept Orthoped Surg, NL-1081 HV Amsterdam, Netherlands.
   [Koshy, Sandeep T.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA.
   [Chaudhuri, Ovijit] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.
   [Granja, Pedro L.] Fac Engn Univ Porto, Dept Met & Mat Engn, P-4200465 Oporto, Portugal.
   [Granja, Pedro L.] Inst Ciencias Biomed Abel Salazar Univ Porto ICBA, P-4050313 Oporto, Portugal.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, 29 Oxford St,319 Pierce Hall, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Granja, Pedro/B-1685-2008
OI Granja, Pedro/0000-0003-2761-4929; Koshy, Sandeep/0000-0003-2836-5813;
   Li, Aileen/0000-0002-1056-5932
FU BASF Advanced Research Initiative at Harvard University; National
   Science Foundation under NSF [ECS-0335765]; Portuguese Fundacao para a
   Ciencia e a Tecnologia (FCT); Calouste Gulbenkian Foundation (FCG);
   Luso-American Development Foundation (FLAD); HHMI ISRF studentship
FX This work was funded by the BASF Advanced Research Initiative at Harvard
   University. This work was performed in part at the Center for Nanoscale
   Systems (CNS), a member of the National Nanotechnology Infrastructure
   Network (NNIN), which is supported by the National Science Foundation
   under NSF award no. ECS-0335765. The authors would like to acknowledge
   Angelo Mao for providing the FITC-labeled alginate, Thomas Ferrante for
   help with confocal microscopy imaging, the Weitz lab for help/use of
   rheometer, Anabela Ribeiro Nunes (from the Office for Science
   Communication at IBMC.INEB) for designing Fig. 1, and Dr. Cathal Kearney
   for insightful review of this article. C.B.C. had research fellowships
   by the Portuguese Fundacao para a Ciencia e a Tecnologia (FCT), Calouste
   Gulbenkian Foundation (FCG) and Luso-American Development Foundation
   (FLAD). SK was supported by an HHMI ISRF studentship.
CR Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Akpalo E, 2011, ACTA BIOMATER, V7, P2418, DOI 10.1016/j.actbio.2011.03.002
   Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   Berg DJ, 2001, J IMMUNOL, V166, P2674, DOI 10.4049/jimmunol.166.4.2674
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Boerckel JD, 2011, P NATL ACAD SCI USA, V108, P674
   Chaudhuri O, 2014, NAT MAT
   Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Crank J., 1979, MATH DIFFUSION
   Dallon JC, 2008, WOUND REPAIR REGEN, V16, P472, DOI 10.1111/j.1524-475X.2008.00392.x
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eastwood M, 1996, J CELL PHYSIOL, V166, P33, DOI 10.1002/(SICI)1097-4652(199601)166:1<33::AID-JCP4>3.0.CO;2-H
   Edwards C, 1995, CLIN DERMATOL, V13, P375, DOI 10.1016/0738-081X(95)00078-T
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102
   Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060
   Grinnell F, 2000, TRENDS CELL BIOL, V10, P362, DOI 10.1016/S0962-8924(00)01802-X
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Jiang HM, 2005, MOL BIOL CELL, V16, P5070, DOI 10.1091/mbc.E05-01-0007
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Maia FR, 2014, ACTA BIOMATER, V10, P3197, DOI 10.1016/j.actbio.2014.02.049
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   McNaught A. D., 1997, COMPENDIUM CHEM TERM
   Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005
   Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Sun J, 2012, SOFT MATTER, V8, P2398, DOI 10.1039/c2sm06869a
   Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004
   Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291
   Tong XM, 2014, BIOMATERIALS, V35, P1807, DOI 10.1016/j.biomaterials.2013.11.064
   Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020
   Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047
   Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev
   WEN C, 2013, MACROMOL MATER ENG, V229, P504
   Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042
   Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574
   Wong VW, 2011, FASEB J, V25, P4498, DOI 10.1096/fj.10-178087
   Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212
   Wu CC, 2005, J BIOMAT SCI-POLYM E, V16, P1261, DOI 10.1163/156856205774269494
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765
NR 62
TC 68
Z9 69
U1 4
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2014
VL 35
IS 32
BP 8927
EP 8936
DI 10.1016/j.biomaterials.2014.06.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO6QL
UT WOS:000341476500003
DA 2018-10-20
ER

PT J
AU Banks, JM
   Mozdzen, LC
   Harley, BAC
   Bailey, RC
AF Banks, Jessica M.
   Mozdzen, Laura C.
   Harley, Brendan A. C.
   Bailey, Ryan C.
TI The combined effects of matrix stiffness and growth factor
   immobilization on the bioactivity and differentiation capabilities of
   adipose-derived stem cells
SO BIOMATERIALS
LA English
DT Article
DE Mechanical properties; Growth factors; Mesenchymal stem cell;
   Osteogenesis; Photolithography; Surface modification
ID COLLAGEN-GAG SCAFFOLDS; BONE MORPHOGENETIC PROTEIN-2;
   EXTRACELLULAR-MATRIX; IN-VITRO; OSTEOGENIC DIFFERENTIATION; TENOGENIC
   DIFFERENTIATION; CROSS-LINKING; GLYCOSAMINOGLYCAN SCAFFOLDS; FACTOR
   SUPPLEMENTATION; TENOCYTE BIOACTIVITY
AB Biomaterial designs are increasingly incorporating multiple instructive signals to induce a desired cell response. However, many approaches do not allow orthogonal manipulation of immobilized growth factor signals and matrix stiffness. Further, few methods support patterning of biomolecular signals across a biomaterial in a spatially-selective manner. Here, we report a sequential approach employing carbodiimide crosslinking and benzophenone photoimmobilization chemistries to orthogonally modify the stiffness and immobilized growth factor content of a model collagen-GAG (CG) biomaterial. We subsequently examined the singular and combined effects of bone morphogenetic protein (BMP-2), platelet derived growth factor (PDGF-BB), and CG membrane stiffness on the bioactivity and osteogenic/ adipogenic lineage-specific gene expression of adipose derived stem cells, an increasingly popular cell source for regenerative medicine studies. We found that the stiffest substrates direct osteogenic lineage commitment of ASCs regardless of the presence or absence of growth factors, while softer substrates require biochemical cues to direct cell fate. We subsequently describe the use of this approach to create overlapping patterns of growth factors across a single substrate. These results highlight the need for versatile approaches to selectively manipulate the biomaterial microenvironment to identify synergies between biochemical and mechanical cues for a range of regenerative medicine applications. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Banks, Jessica M.; Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Mozdzen, Laura C.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Bailey, RC (reprint author), Univ Illinois, Dept Chem, 53 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu; baileyrc@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X; Bailey, Ryan/0000-0003-1021-4267
FU National Science Foundation Division of Material Research [1105300];
   Alfred P. Sloan Foundation; National Institute of Arthritis and
   Musculoskeletal and Skin Diseases of the National Institutes of Health
   [R21 AR063331]; University of Illinois at Urbana-Champaign's Department
   of Chemical and Biomolecular Engineering (BAH), Institute for Genomic
   Biology; Materials Research Laboratory [DE-FG02-07ER46453,
   DE-FG02-07ER46471]; National Science Foundation [0965918]
FX The authors would like to thank Dr. Amy Wagoner Johnson (UIUC) for
   access to the tensile mechanical testing equipment as well as Dr.
   Michael Poellman for assistance with mechanical testing. Porcine adipose
   derived stem cells were a gift from Dr. Mathew Wheeler (UIUC). We would
   also like to thank Aurora Alsop for the synthesizing the
   benzophenone-4-isothiocyanate and Rebecca Hortensius for helpful
   discussions. We gratefully acknowledge the funding provided from the
   National Science Foundation Division of Material Research under award
   1105300 (BAH and RCB) and the Alfred P. Sloan Foundation (RCB). Research
   reported in this publication also was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Numbers R21 AR063331 (BAH).
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. We also appreciate support provided through the University of
   Illinois at Urbana-Champaign's Department of Chemical and Biomolecular
   Engineering (BAH), Institute for Genomic Biology (BAH), and Materials
   Research Laboratory (DE-FG02-07ER46453 and DE-FG02-07ER46471). LM was
   supported through National Science Foundation Grant 0965918 IGERT:
   Training the Next Generation of Researchers in Cellular and Molecular
   Mechanics and BioNanotechnology.
CR ABRAHAMSSON SO, 1991, J ORTHOPAED RES, V9, P495, DOI 10.1002/jor.1100090405
   Ahlen K, 2004, BIOCHEM BIOPH RES CO, V314, P89, DOI 10.1016/j.bbrc.2003.12.057
   Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172
   Banks JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078988
   Becerra-Bayona S, 2012, ACTA BIOMATER, V8, P4397, DOI 10.1016/j.actbio.2012.07.048
   Bhakta G, 2013, ACTA BIOMATER, V9, P9098, DOI 10.1016/j.actbio.2013.07.008
   Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Borselli C, 2010, J BIOMED MATER RES A, V92A, P94, DOI 10.1002/jbm.a.32332
   Buket BF, 2008, BIOMATERIALS, V29, P4195
   Caliari S. R., 2014, TISSUE ENG A
   Caliari SR, 2014, ADV HEALTHC MAT
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2014, J BIOMED MATER RES A, V102, P917, DOI 10.1002/jbm.a.35058
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Chan BP, 2000, ACTA ORTHOP SCAND, V71, P513, DOI 10.1080/000164700317381234
   Chaudhuri O, 2012, NAT MATER, V11, P568, DOI 10.1038/nmat3366
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Cheng XG, 2014, ACTA BIOMATER, V10, P1360, DOI 10.1016/j.actbio.2013.11.017
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Dobaczewski M, 2012, J CARDIOVASC TRANSL, V5, P837, DOI 10.1007/s12265-012-9406-3
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gershlak JR, 2013, BIOCHEM BIOPH RES CO, V439, P161, DOI 10.1016/j.bbrc.2013.08.074
   Hagerty P, 2012, BIOMATERIALS, V33, P6355, DOI 10.1016/j.biomaterials.2012.05.045
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Herman CT, 2011, INTEGR BIOL-UK, V3, P779, DOI 10.1039/c0ib00151a
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hu W-W, 2013, J TISSUE ENG REGEN M
   Hudalla GA, 2010, LANGMUIR, V26, P6449, DOI 10.1021/la1008208
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Kovacevic D, 2011, AM J SPORT MED, V39, P811, DOI 10.1177/0363546511399378
   Lee JS, 2010, ADV MATER, V22, P5494, DOI 10.1002/adma.201002970
   Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049
   Liu HW, 2006, BONE, V39, P825, DOI 10.1016/j.bone.2006.04.027
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martin RM, 2005, CYTOM PART A, V67A, P45, DOI 10.1002/cyto.a.20172
   Martin TA, 2011, ACS APPL MATER INTER, V3, P3762, DOI 10.1021/am2009597
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miller ED, 2011, BIOMATERIALS, V32, P2775, DOI 10.1016/j.biomaterials.2010.12.005
   Monaco E, 2009, OPEN TISSUE ENG REGE, P20, DOI DOI 10.2174/1875043500902010020
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   Odedra D, 2011, ACTA BIOMATER, V7, P3027, DOI 10.1016/j.actbio.2011.05.002
   Oryan A, 2014, J TISSUE ENG REGEN M, V8, P421, DOI 10.1002/term.1534
   Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pountos I, 2010, J ORTHOP TRAUMA, V24, P552, DOI 10.1097/BOT.0b013e3181efa8fe
   Raghavan S, 2013, BIOMATERIALS, V34, P6649, DOI 10.1016/j.biomaterials.2013.05.023
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Schmidt A, 2006, STEM CELLS, V24, P1750, DOI 10.1634/stemcells.2005-0191
   Shah V, 2013, J ORTHOP RES, V31, P413, DOI 10.1002/jor.22222
   SINSHEIMER JE, 1975, J PHARM SCI, V64, P925, DOI 10.1002/jps.2600640605
   Spilker MH, 2001, RESTOR NEUROL NEUROS, V18, P23
   Tan S, 2014, BIOMATERIALS, V35, P5294, DOI 10.1016/j.biomaterials.2014.02.040
   Tan SL, 2012, CELLS TISSUES ORGANS, V196, P325, DOI 10.1159/000335693
   Thomopoulos S, 2012, J ORTHOP RES, V30, P1702, DOI 10.1002/jor.22151
   Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Toh CR, 2009, LANGMUIR, V25, P8894, DOI 10.1021/la9019537
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tseng P, 2014, ADV MATER, V26, P1242, DOI 10.1002/adma.201304607
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   Turgeon AJ, 2014, METHOD CELL BIOL, V121, P231, DOI 10.1016/B978-0-12-800281-0.00015-4
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yoshikawa Y, 2001, ACTA ORTHOP SCAND, V72, P287, DOI 10.1080/00016470152846646
   Zouani OF, 2013, BIOMATERIALS, V34, P2157, DOI 10.1016/j.biomaterials.2012.12.007
NR 82
TC 34
Z9 34
U1 5
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2014
VL 35
IS 32
BP 8951
EP 8959
DI 10.1016/j.biomaterials.2014.07.012
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO6QL
UT WOS:000341476500005
PM 25085859
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Gnanamoorthy, P
   Anandhan, S
   Prabu, VA
AF Gnanamoorthy, P.
   Anandhan, S.
   Prabu, V. Ashok
TI Natural nanoporous silica frustules from marine diatom as a biocarrier
   for drug delivery
SO JOURNAL OF POROUS MATERIALS
LA English
DT Article
DE Biomaterial; Diatom; Nanoporous; Drug delivery; Drug release;
   Biocompatible
ID ORDERED MESOPOROUS MATERIALS; NANOTECHNOLOGY; CARRIERS; RELEASE; MCM-41
AB The possible use of natural silica nanoporous biomaterial from marine diatom for drug delivery applications was explored. Coscinodiscus concinnus have a homogeneous size distribution with radius of 220 +/- A 15 A mu m with surface featuring a mounded topography with about 2 A mu m wide porous domes organized on the surface in pentagonal packing. Streptomycin, used as a hydrophilic drug to demonstrate the in vitro oral drug delivery model based on diatom structure, mainly adsorbed on to the diatom silica surface (foramen), inside pores (cribrum) and into the internal hollow diatom structure (cribellum). The maximum drug loading capacity of streptomycin was 33.33 +/- A 2 %. The release was biphasic, involving initial burst release (first 6 h) mainly from the surface of diatom foramen, and sustained drug release (upto 7 days) from cribrum and cribellum. The study indicated that the live diatoms from marine environment, due to their unique features (easy cultivable, low-cost and biocompatibility), are a potential and alternative natural source of nanoporous siliceous material for in vitro oral drug delivery applications.
C1 [Gnanamoorthy, P.; Anandhan, S.; Prabu, V. Ashok] Annamalai Univ, Ctr Adv Study Marine Biol, Fac Marine Sci, Parangipettai 608502, Tamil Nadu, India.
RP Gnanamoorthy, P (reprint author), Annamalai Univ, Ctr Adv Study Marine Biol, Fac Marine Sci, Parangipettai 608502, Tamil Nadu, India.
EM pg.moorthy87@gmail.com
FU Science and Engineering Research Board (SERB), Department of Science and
   Technology, New Delhi [SERB/F/5582/2012-13]
FX We would like to thank Annamalai University authorities for support, and
   this work was supported by funding under fast track project file no:
   SERB/F/5582/2012-13 from Science and Engineering Research Board (SERB),
   Department of Science and Technology, New Delhi.
CR Angelos S, 2008, CHEM ENG J, V137, P4, DOI 10.1016/j.cej.2007.07.074
   Aw MS, 2011, NANOMEDICINE-UK, V6, P1159, DOI [10.2217/NNM.11.29, 10.2217/nnm.11.29]
   Balas F, 2006, J AM CHEM SOC, V128, P8116, DOI 10.1021/ja062286z
   Bariana M, 2013, INT J PHARMACEUT, V443, P230, DOI 10.1016/j.ijpharm.2012.12.012
   Drum Gordon R.W., 2003, R TRENDS BIOTECHNOL, V21, P325
   Fuhrmann T, 2004, APPL PHYS B-LASERS O, V78, P257, DOI 10.1007/s00340-004-1419-4
   Gnanamoorthy P, 2014, J POROUS MAT, V21, P225, DOI 10.1007/s10934-013-9767-2
   Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003
   Izquierdo-Barba I., 2008, J NANOMATER, V3, P1
   Jeffryes C, 2008, MAT SCI ENG C-BIO S, V28, P107, DOI 10.1016/j.msec.2007.01.002
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109
   Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174
   Losic D, 2007, J POROUS MAT, V14, P61, DOI 10.1007/s10934-006-9009-y
   Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018
   Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9
   Popova MD, 2012, INT J PHARMACEUT, V436, P778, DOI 10.1016/j.ijpharm.2012.07.061
   Ramila A, 2003, J SOL-GEL SCI TECHN, V26, P1199, DOI 10.1023/A:1020764319963
   Sheng GD, 2008, APPL RADIAT ISOTOPES, V66, P1313, DOI 10.1016/j.apradiso.2008.03.005
   Simovic S, 2011, CURR DRUG DISCOV TEC, V8, P250, DOI DOI 10.2174/157016311796799026
   Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943
   Song SW, 2005, LANGMUIR, V21, P9568, DOI 10.1021/la051167e
   Vallet-Regi M, 2005, SOLID STATE SCI, V7, P233, DOI 10.1016/j.solidstatesciences.2004.10.038
   Vallet-Regi M, 2008, PROG SOLID STATE CH, V36, P163, DOI 10.1016/j.progsolidstchem.2007.10.002
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Vallet-Regi M, 2006, CHEM-EUR J, V12, P5934, DOI 10.1002/chem.200600226
   Xu F, 2003, ADV MATER, V15, P1751, DOI 10.1002/adma.200305287
   Yu Y., 2011, CHEMECA 2011, P2187
   Yu Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/1/015008
   Yu Y, 2010, LANGMUIR, V26, P14068, DOI 10.1021/la102083t
NR 31
TC 9
Z9 9
U1 1
U2 43
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-2224
EI 1573-4854
J9 J POROUS MAT
JI J. Porous Mat.
PD OCT
PY 2014
VL 21
IS 5
BP 789
EP 796
DI 10.1007/s10934-014-9827-2
PG 8
WC Chemistry, Applied; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AP1OR
UT WOS:000341840900031
DA 2018-10-20
ER

PT J
AU Xu, HF
AF Xu, Hanfu
TI The advances and perspectives of recombinant protein production in the
   silk gland of silkworm Bombyx mori
SO TRANSGENIC RESEARCH
LA English
DT Review
DE Silkworm; Silk gland; Expression system; Recombinant protein; Silk-based
   biomaterial
ID TRANSGENIC SILKWORMS; EXPRESSION SYSTEM; MECHANICAL-PROPERTIES; SERICIN
   LAYER; H-CHAIN; HIGF-I; FIBROIN; GENE; COCOONS; GENERATION
AB The silk gland of silkworm Bombyx mori, is one of the most important organs that has been fully studied and utilized so far. It contributes finest silk fibers to humankind. The silk gland has excellent ability of synthesizing silk proteins and is a kind tool to produce some useful recombinant proteins, which can be widely used in the biological, biotechnical and pharmaceutical application fields. It's a very active area to express recombinant proteins using the silk gland as a bioreactor, and great progress has been achieved recently. This review recapitulates the progress of producing recombinant proteins and silk-based biomaterials in the silk gland of silkworm in addition to the construction of expression systems. Current challenges and future trends in the production of valuable recombinant proteins using transgenic silkworms are also discussed.
C1 Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China.
RP Xu, HF (reprint author), Southwest Univ, State Key Lab Silkworm Genome Biol, 2 Tiansheng Rd, Chongqing 400715, Peoples R China.
EM xuhf@swu.edu.cn
CR Adachi T, 2006, J BIOTECHNOL, V126, P205, DOI 10.1016/j.jbiotec.2006.04.035
   Adachi T, 2010, BIOTECHNOL BIOENG, V106, P860, DOI 10.1002/bit.22752
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Cannon JG, 2000, NEWS PHYSIOL SCI, V15, P298
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Hastings G E, 1992, Arch Fam Med, V1, P281, DOI 10.1001/archfami.1.2.281
   Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Iizuka M, 2008, J BIOSCI BIOENG, V105, P595, DOI 10.1263/jbb.105.595
   Iizuka M, 2009, FEBS J, V276, P5806, DOI 10.1111/j.1742-4658.2009.07262.x
   Iizuka T, 2013, ADV FUNCT MATER, V23, P5232, DOI 10.1002/adfm.201300365
   Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.jibm.2004.10.002
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Kato T, 2010, APPL MICROBIOL BIOT, V85, P459, DOI 10.1007/s00253-009-2267-2
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kojima K, 2007, BIOSCI BIOTECH BIOCH, V71, P2943, DOI 10.1271/bbb.70353
   Kurihara H, 2007, BIOCHEM BIOPH RES CO, V355, P976, DOI 10.1016/j.bbrc.2007.02.055
   Li YM, 2011, BIOTECHNOL LETT, V33, P489, DOI 10.1007/s10529-010-0462-y
   Ma L, 2011, CELL RES, V21, P934, DOI 10.1038/cr.2011.36
   Ma SY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04489
   Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0
   MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X
   Nagano A, 2011, ACTA BIOMATER, V7, P1192, DOI 10.1016/j.actbio.2010.10.032
   Nakazawa Y, 2011, J BIOMAT SCI-POLYM E, V22, P195, DOI 10.1163/092050609X12586381656530
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   Redwan ERM, 2009, J IMMUNOASS IMMUNOCH, V30, P262, DOI 10.1080/15321810903084400
   Royer C, 2005, TRANSGENIC RES, V14, P463, DOI 10.1007/s11248-005-4351-4
   Sato M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04080
   Sato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034632
   Shin S, 2014, ARCH PHARM RES, V37, P645, DOI 10.1007/s12272-013-0298-9
   Song ZW, 2014, FOOD CHEM TOXICOL, V67, P249, DOI 10.1016/j.fct.2014.02.032
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2
   Tateno M, 2009, J BIOCHEM, V145, P37, DOI 10.1093/jb/mvn147
   Teule F, 2012, P NATL ACAD SCI USA, V109, P923, DOI 10.1073/pnas.1109420109
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x
   Vollrath F, 2009, POLYMER, V50, P5623, DOI 10.1016/j.polymer.2009.09.068
   Wang F, 2013, TRANSGENIC RES, V22, P925, DOI 10.1007/s11248-013-9695-6
   Wang YQ, 2013, CELL RES, V23, P1414, DOI 10.1038/cr.2013.146
   Wu Xiao-feng, 2004, J Zhejiang Univ Sci, V5, P644, DOI 10.1631/jzus.2004.0644
   Wurm FM, 2003, NAT BIOTECHNOL, V21, P34, DOI 10.1038/nbt0103-34
   Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI 10.1016/j.ibmb.2008.11.004
   Xue RY, 2012, TRANSGENIC RES, V21, P101, DOI 10.1007/s11248-011-9513-y
   Yanagisawa S, 2007, BIOMACROMOLECULES, V8, P3487, DOI 10.1021/bm700646f
   Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7
   Zhao Y, 2009, SCI CHINA SER C, V52, P1131, DOI 10.1007/s11427-009-0148-7
   Zhu ZH, 2010, J BIOMAT SCI-POLYM E, V21, P395, DOI 10.1163/156856209X423126
NR 52
TC 10
Z9 11
U1 0
U2 50
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0962-8819
EI 1573-9368
J9 TRANSGENIC RES
JI Transgenic Res.
PD OCT
PY 2014
VL 23
IS 5
BP 697
EP 706
DI 10.1007/s11248-014-9826-8
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AO6BY
UT WOS:000341434600001
PM 25113390
DA 2018-10-20
ER

PT J
AU Hah, Z
   Partin, A
   Parker, KJ
AF Hah, Zaegyoo
   Partin, Alexander
   Parker, Kevin J.
TI Shear Wave Speed and Dispersion Measurements Using Crawling Wave Chirps
SO ULTRASONIC IMAGING
LA English
DT Article
DE shear waves; crawling waves; elastography; biomechanics; dispersion
ID LIVER-DISEASE; ELASTICITY; TISSUE; ELASTOGRAPHY; VISCOSITY
AB This article demonstrates the measurement of shear wave speed and shear speed dispersion of biomaterials using a chirp signal that launches waves over a range of frequencies. A biomaterial is vibrated by two vibration sources that generate shear waves inside the medium, which is scanned by an ultrasound imaging system. Doppler processing of the acquired signal produces an image of the square of vibration amplitude that shows repetitive constructive and destructive interference patterns called "crawling waves." With a chirp vibration signal, successive Doppler frames are generated from different source frequencies. Collected frames generate a distinctive pattern which is used to calculate the shear speed and shear speed dispersion. A special reciprocal chirp is designed such that the equi-phase lines of a motion slice image are straight lines. Detailed analysis is provided to generate a closed-form solution for calculating the shear wave speed and the dispersion. Also several phantoms and an ex vivo human liver sample are scanned and the estimation results are presented.
C1 [Hah, Zaegyoo; Partin, Alexander; Parker, Kevin J.] Univ Rochester, Dept Elect & Comp Engn, Rochester, NY 14627 USA.
RP Parker, KJ (reprint author), Univ Rochester, Dept Elect & Comp Engn, Hopeman Bldg 203,POB 270126, Rochester, NY 14627 USA.
EM kevin.parker@rochester.edu
FU University of Rochester Department of Electrical and Computer
   Engineering
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the University of Rochester Department of Electrical
   and Computer Engineering.
CR An LW, 2011, MED PHYS, V38, P2563, DOI 10.1118/1.3569578
   Barry CT, 2014, ULTRASOUND MED BIOL, V40, P704, DOI 10.1016/j.ultrasmedbio.2013.10.016
   Barry CT, 2012, ULTRASOUND MED BIOL, V38, P175, DOI 10.1016/j.ultrasmedbio.2011.10.019
   Carstensen EL, 2008, ULTRASOUND MED BIOL, V34, P1535, DOI 10.1016/j.ultrasmedbio.2008.03.002
   Carstensen EL, 2014, ULTRASOUND MED BIOL, V40, P655, DOI 10.1016/j.ultrasmedbio.2013.11.001
   Chen SG, 2004, J ACOUST SOC AM, V115, P2781, DOI 10.1121/1.1739480
   Chen SG, 2009, IEEE T ULTRASON FERR, V56, P55, DOI 10.1109/TUFFC.2009.1005
   Doyley MM, 2012, PHYS MED BIOL, V57, pR35, DOI 10.1088/0031-9155/57/3/R35
   Hah Z, 2012, ULTRASOUND MED BIOL, V38, P312, DOI 10.1016/j.ultrasmedbio.2011.10.014
   Hoyt K, 2007, IEEE ULTR S NEW YORK, P28
   Hoyt K, 2008, ULTRASOUND MED BIOL, V34, P276, DOI 10.1016/j.ultrasmedbio.2007.07.011
   Muller M, 2009, ULTRASOUND MED BIOL, V35, P219, DOI 10.1016/j.ultrasmedbio.2008.08.018
   Orescanin M, 2010, IEEE T ULTRASON FERR, V57, P1358, DOI 10.1109/TUFFC.2010.1555
   Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01
   Parker KJ, 2014, ULTRASOUND MED BIOL, V40, P675, DOI 10.1016/j.ultrasmedbio.2013.10.023
   Partin A, 2014, ULTRASOUND MED BIOL, V40, P685, DOI 10.1016/j.ultrasmedbio.2013.05.019
   Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002
NR 17
TC 1
Z9 1
U1 0
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0161-7346
EI 1096-0910
J9 ULTRASONIC IMAGING
JI Ultrason. Imaging
PD OCT
PY 2014
VL 36
IS 4
BP 277
EP 290
DI 10.1177/0161734614527581
PG 14
WC Acoustics; Engineering, Biomedical; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA AO7AE
UT WOS:000341503400003
PM 24658144
DA 2018-10-20
ER

PT J
AU Wu, SQ
   Johansson, J
   Damdimopoulou, P
   Shahsavani, M
   Falk, A
   Hovatta, O
   Rising, A
AF Wu, Siqin
   Johansson, Jan
   Damdimopoulou, Pauliina
   Shahsavani, Mansoureh
   Falk, Anna
   Hovatta, Outi
   Rising, Anna
TI Spider silk for xeno-free long-term self-renewal and differentiation of
   human pluripotent stem cells
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Chemically defined; Human embryonic stem cells; Human
   induced pluripotent stem cells; Functionalized materials; Scaffold
ID CHEMICALLY-DEFINED CONDITIONS; CULTURE; SUBSTRATUM; PROTEINS; MATRICES;
   FIBERS
AB Human pluripotent stem cells (hPSCs) can undergo unlimited self-renewal and have the capacity to differentiate into all somatic cell types, and are therefore an ideal source for the generation of cells and tissues for research and therapy. To realize this potential, defined cell culture systems that allow expansion of hPSCs and subsequent controlled differentiation, ideally in an implantable three-dimensional (3D) matrix, are required. Here we mimic spider silk - Nature's high performance material - for the design of chemically defined 2D and 3D matrices for cell culture. The silk matrices do not only allow xeno-free long-term expansion of hPSCs but also differentiation in both 2D and 3D. These results show that biomimetic spider silk matrices enable hPSC culture in a manner that can be applied for experimental and clinical purposes. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Wu, Siqin; Johansson, Jan; Rising, Anna] Karolinska Inst, Care Sci & Soc NVS, Dept Neurobiol, S-14186 Stockholm, Sweden.
   [Johansson, Jan; Rising, Anna] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Biomed Ctr, S-75123 Uppsala, Sweden.
   [Johansson, Jan] Tallinn Univ, Inst Math & Nat Sci, EE-10120 Tallinn, Estonia.
   [Damdimopoulou, Pauliina; Hovatta, Outi] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, S-14186 Stockholm, Sweden.
   [Damdimopoulou, Pauliina; Hovatta, Outi] Karolinska Univ Hosp, S-14186 Stockholm, Sweden.
   [Shahsavani, Mansoureh; Falk, Anna] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden.
RP Rising, A (reprint author), Karolinska Inst, Care Sci & Soc NVS, Dept Neurobiol, Novum 5th Floor, S-14186 Stockholm, Sweden.
EM anna.rising@ki.se
OI Damdimopoulou, Pauliina/0000-0001-8458-0855; Falk,
   Anna/0000-0003-1634-8610; Rising, Anna/0000-0002-1872-1207
FU Swedish Research Council; Spiber Technologies AB
FX We are grateful to Dr. Thomas Sakmar for valuable input on the
   manuscript. The cyclic RGD peptide was kindly provided by Dr. Staffan
   Johansson at Uppsala University. The work was funded by the Swedish
   Research Council and Spiber Technologies AB. Photos of biomimetic spider
   silk matrices in Fig. 1A were provided by Spiber Technologies AB and Dr.
   Lena Holm.
CR Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Chen KG, 2014, CELL STEM CELL, V14, P13, DOI 10.1016/j.stem.2013.12.005
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fredriksson C, 2009, MATERIALS, V2, P1908, DOI 10.3390/ma2041908
   Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gropp M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045532
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290
   Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lappalainen RS, 2010, REGEN MED, V5, P749, DOI [10.2217/rme.10.58, 10.2217/RME.10.58]
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Lu HF, 2012, BIOMATERIALS, V33, P2419, DOI 10.1016/j.biomaterials.2011.11.077
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821
   Miyazaki T., 2012, NATURE COMMUN, V3, P1236, DOI DOI 10.1038/NC0MMS2231
   Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
NR 33
TC 15
Z9 15
U1 0
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2014
VL 35
IS 30
BP 8496
EP 8502
DI 10.1016/j.biomaterials.2014.06.039
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AN8JE
UT WOS:000340849600004
PM 25043502
DA 2018-10-20
ER

PT J
AU Li, A
   Hokugo, A
   Yalom, A
   Berns, EJ
   Stephanopoulos, N
   McClendon, MT
   Segovia, LA
   Spigelman, I
   Stupp, SI
   Jarrahy, R
AF Li, Andrew
   Hokugo, Akishige
   Yalom, Anisa
   Berns, Eric J.
   Stephanopoulos, Nicholas
   McClendon, Mark T.
   Segovia, Luis A.
   Spigelman, Igor
   Stupp, Samuel I.
   Jarrahy, Reza
TI A bioengineered peripheral nerve construct using aligned peptide
   amphiphile nanofibers
SO BIOMATERIALS
LA English
DT Article
DE Self assembly; Peptide amphiphile; Alignment; Peripheral nerve repair;
   Nerve conduit; Nanofiber
ID FUNCTIONAL ASSESSMENT; NEURITE OUTGROWTH; MONODOMAIN GELS;
   CELL-ADHESION; COMB POLYMERS; RGD PEPTIDES; REGENERATION; RECOVERY;
   DIFFERENTIATION; REPAIR
AB Peripheral nerve injuries can result in lifelong disability. Primary coaptation is the treatment of choice when the gap between transected nerve ends is short. Long nerve gaps seen in more complex injuries often require autologous nerve grafts or nerve conduits implemented into the repair. Nerve grafts, however, cause morbidity and functional loss at donor sites, which are limited in number. Nerve conduits, in turn, lack an internal scaffold to support and guide axonal regeneration, resulting in decreased efficacy over longer nerve gap lengths. By comparison, peptide amphiphiles (PAs) are molecules that can self-assemble into nanofibers, which can be aligned to mimic the native architecture of peripheral nerve. As such, they represent a potential substrate for use in a bioengineered nerve graft substitute. To examine this, we cultured Schwann cells with bioactive PAs (RGDS-PA, IKVAV-PA) to determine their ability to attach to and proliferate within the biomaterial. Next, we devised a PA construct for use in a peripheral nerve critical sized defect model. Rat sciatic nerve defects were created and reconstructed with autologous nerve, PLGA conduits filled with various forms of aligned PAs, or left unrepaired. Motor and sensory recovery were determined and compared among groups. Our results demonstrate that Schwann cells are able to adhere to and proliferate in aligned PA gels, with greater efficacy in bioactive PAs compared to the backbone-PA alone. In vivo testing revealed recovery of motor and sensory function in animals treated with conduit/PA constructs comparable to animals treated with autologous nerve grafts. Functional recovery in conduit/PA and autologous graft groups was significantly faster than in animals treated with empty PLGA conduits. Histological examinations also demonstrated increased axonal and Schwann cell regeneration within the reconstructed nerve gap in animals treated with conduit/PA constructs. These results indicate that PA nanofibers may represent a promising biomaterial for use in bioengineered peripheral nerve repair. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Li, Andrew; Hokugo, Akishige; Yalom, Anisa; Segovia, Luis A.; Jarrahy, Reza] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Plast & Reconstruct Surg, 200 UCLA Med Plaza,Suite 465, Los Angeles, CA 90095 USA.
   [Berns, Eric J.; Stephanopoulos, Nicholas; Stupp, Samuel I.] Northwestern Univ, Inst Bionanotechnol Med, Evanston, IL 60208 USA.
   [Berns, Eric J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [McClendon, Mark T.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Spigelman, Igor] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90095 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Med, Evanston, IL 60208 USA.
RP Jarrahy, R (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Plast & Reconstruct Surg, 200 UCLA Med Plaza,Suite 465, Los Angeles, CA 90095 USA.
EM rjarrahy@mednet.ucla.edu
RI Stupp, Samuel/B-6737-2009
FU Annenberg Fund for Craniofacial Surgery and Research at UCLA; National
   Institutes of Health/National Institute Of Biomedical Imaging And
   Bioengineering [5R01EB003806-09]; National Institute of Dental and
   Craniofacial Research [5R01DE015920-08]; E.I. DuPont de Nemours Co.; Dow
   Chemical Company; Northwestern University; U.S. DOE [DE-AC02-06CH11357]
FX The authors are especially grateful for technical support and assistance
   for behavior tests from Dr. Yatendra Mulpuri, Division of Oral Biology
   and Medicine, UCLA School of Dentistry. This work was generously
   supported by the Annenberg Fund for Craniofacial Surgery and Research at
   UCLA. This project was also supported by National Institutes of
   Health/National Institute Of Biomedical Imaging And Bioengineering Award
   Number 5R01EB003806-09 and the National Institute of Dental and
   Craniofacial Research Award Number 5R01DE015920-08. We acknowledge the
   following Northwestern University facilities: IBNAM Peptide Core, IBNAM
   Equipment Core, and Electron Probe Instrumentation Center (EPIC).
   Portions of this work were performed at the DuPont-Northwestern-Dow
   Collaborative Access Team (DND-CAT) located at Sector 5 of the Advanced
   Photon Source (APS). DND-CAT is supported by E.I. DuPont de Nemours &
   Co., The Dow Chemical Company and Northwestern University. Use of the
   APS, an Office of Science User Facility operated for the U.S. Department
   of Energy (DOE) Office of Science by Argonne National Laboratory, was
   supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.
CR Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Carriel V, 2014, EXPERT REV NEUROTHER, V14, P301, DOI 10.1586/14737175.2014.887444
   Castaneda F, 2002, MUSCLE NERVE, V26, P527, DOI 10.1002/mus.10229
   Craig AD, 2002, J NEUROPHYSIOL, V87, P1902, DOI 10.1152/jn.00578.2001
   Daly W, 2012, J R SOC INTERFACE, V9, P202, DOI 10.1098/rsif.2011.0438
   Ducic I, 2012, ANN PLAS SURG, V68, P180, DOI 10.1097/SAP.0b013e3182361b23
   Evriviades D, 2011, PHILOS T R SOC B, V366, P219, DOI 10.1098/rstb.2010.0237
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Houseman BT, 2001, BIOMATERIALS, V22, P943, DOI 10.1016/S0142-9612(00)00259-3
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Jensen TW, 2004, J AM CHEM SOC, V126, P15223, DOI 10.1021/ja048684o
   Jiang X, 2012, J TISSUE ENG REGEN M
   Jin J, 2012, REGEN MED, V7, P799, DOI [10.2217/RME.12.87, 10.2217/rme.12.87]
   KANAYA F, 1992, PLAST RECONSTR SURG, V89, P924, DOI 10.1097/00006534-199205000-00024
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kim YP, 2012, J TISSUE ENG REGEN M
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASTERS DB, 1993, ANESTHESIOLOGY, V79, P340, DOI 10.1097/00000542-199308000-00020
   Matsuka Y, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-66
   McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040
   Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3
   Millesi H, 1973, Hand, V5, P157, DOI 10.1016/0072-968X(73)90061-2
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Naff NJ, 2001, NEUROSURG CLIN N AM, V12, P197, DOI 10.1016/S1042-3680(18)30078-0
   Neal RA, 2012, J BIOMED MATER RES A, V100A, P406, DOI 10.1002/jbm.a.33204
   Niu YQ, 2014, BIOMATERIALS, V35, P4266, DOI 10.1016/j.biomaterials.2014.02.013
   Oh JH, 2012, BIOMATERIALS, V33, P4089, DOI 10.1016/j.biomaterials.2012.02.028
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833
   Varejao ASP, 2003, MICROSURG, V23, P346, DOI 10.1002/micr.10148
   VISSER PA, 1980, AM J SURG, V140, P596
   WONG BJF, 1991, OTOLARYNG CLIN N AM, V24, P739
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhu YQ, 2011, TISSUE ENG PART C-ME, V17, P705, DOI 10.1089/ten.tec.2010.0565
NR 44
TC 47
Z9 50
U1 5
U2 195
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2014
VL 35
IS 31
BP 8780
EP 8790
DI 10.1016/j.biomaterials.2014.06.049
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO0FN
UT WOS:000340984600003
PM 25064803
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Scaglione, S
   Ceseracciu, L
   Aiello, M
   Coluccino, L
   Ferrazzo, F
   Giannoni, P
   Quarto, R
AF Scaglione, Silvia
   Ceseracciu, Luca
   Aiello, Maurizio
   Coluccino, Luca
   Ferrazzo, Federica
   Giannoni, Paolo
   Quarto, Rodolfo
TI A Novel Scaffold Geometry for Chondral Applications: Theoretical Model
   and in Vivo Validation
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE theroretical model; scaffold porosity; mechanical performance;
   permeability; surface area; cartilage tissue
ID BONE-GRAFT SUBSTITUTES; HUMAN ARTICULAR-CARTILAGE; UNCONFINED
   COMPRESSION; BIOMATERIAL SCAFFOLDS; CELLS; PERMEABILITY; DESIGN; VITRO;
   RESORPTION; POROSITY
AB A theoretical model of the 3D scaffold internal architecture has been implemented with the aim to predict the effects of some geometrical parameters on total porosity, Young modulus, buckling resistance and permeability of the graft. This model has been adopted to produce porous polycaprolacton based grafts for chondral tissue engineering applications, best tuning mechanical and functional features of the scaffolds. Material prototypes were produced with an internal geometry with parallel oriented cylindrical pores of 200 mu m of radius (r) and an interpore distance/pores radius (d/r) ratio of 1. The scaffolds have been then extensively characterized; progenitor cells were then used to test their capability to support cartilaginous matrix deposition in an ectopic model. Scaffold prototypes fulfill both the chemical-physical requirements, in terms of Young's modulus and permeability, and the functional needs, such as surface area per volume and total porosity, for an enhanced cellular colonization and matrix deposition. Moreover, the grafts showed interesting chondrogenic potential in vivo, besides offering adequate mechanical performances in vitro, thus becoming a promising candidate for chondral tissues repair. Finally, a very good agreement was found between the prediction of the theoretical model and the experimental data. Many assumption of this theoretical model, hereby applied to cartilage, may be transposed to other tissue engineering applications, such as bone substitutes. (C) 2014 Wiley Periodicals, Inc.
C1 [Scaglione, Silvia; Aiello, Maurizio] CNR, IEIIT, I-16149 Genoa, Italy.
   [Ceseracciu, Luca; Coluccino, Luca] IIT, Dept Nanophys, Genoa, Italy.
   [Ferrazzo, Federica; Giannoni, Paolo; Quarto, Rodolfo] Univ Genoa, Dept Expt Med, Genoa, Italy.
RP Scaglione, S (reprint author), CNR, IEIIT, Via De Marini 6, I-16149 Genoa, Italy.
EM silvia.scaglione@ieiit.cnr.it
RI Scaglione, Silvia/B-7124-2014; Ceseracciu, Luca/E-9675-2011; Aiello,
   Maurizio/B-7583-2015
OI Scaglione, Silvia/0000-0002-9464-3554; Ceseracciu,
   Luca/0000-0003-3296-8051; Aiello, Maurizio/0000-0001-5008-225X;
   Giannoni, Paolo/0000-0002-7206-376X; Quarto, Rodolfo/0000-0002-1146-894X
FU National funding, MIUR agency, PRIN Innovative chemical methodologies
   for smart biomaterials
FX Contract grant sponsor: National funding, MIUR agency, PRIN Innovative
   chemical methodologies for smart biomaterials
CR Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Almeida HA, 2007, WIT TR BIOMED HEALTH, V12, P157, DOI 10.2495/BIO070161
   Arrigoni E, 2013, J ORTHOP SCI, V18, P331, DOI 10.1007/s00776-012-0349-y
   Aydelotte MB, 1997, JOINT CARTILAGE DEGR
   Babalola OM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128672
   Bashoor-Zadeh M, 2011, BIOMATERIALS, V32, P6362, DOI 10.1016/j.biomaterials.2011.05.030
   Bohner M, 2004, BIOMATERIALS, V25, P3569, DOI 10.1016/j.biomaterials.2003.10.032
   Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008
   Boschetti F, 2004, BIORHEOLOGY, V41, P159
   Byers PD, 2006, OSTEOARTHR CARTILAGE, V14, P3, DOI 10.1016/j.joca.2005.08.008
   Chan O, 2012, ACTA BIOMATER, V8, P2788, DOI 10.1016/j.actbio.2012.03.038
   Choi SW, 2013, ADV HEALTHC MATER, V2, P145, DOI 10.1002/adhm.201200106
   Ciardelli G, 2004, J MATER SCI-MATER M, V15, P305, DOI 10.1023/B:JMSM.0000021092.03087.d4
   CLARKE IC, 1974, J ANAT, V118, P261
   Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019
   Da H, 2013, PLOS ONE, V8, P1
   DiSilvestro MR, 2001, J BIOMECH ENG-T ASME, V123, P198, DOI 10.1115/1.1351887
   Dutoya S, 2000, BIOMATERIALS, V21, P1521, DOI 10.1016/S0142-9612(99)00274-4
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Ford JL, 2004, J ORTHOP RES, V22, P368, DOI 10.1016/j.orthres.2003.08.010
   Galbusera F., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P279, DOI 10.1080/10255840701318404
   Giannoni P., 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1651., DOI 10.1002/TERM.1651, 10.1002/term.1651]
   Gibson L. J, 1999, CELLULAR SOLIDS STRU
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   GOSHIMA J, 1991, BIOMATERIALS, V12, P253, DOI 10.1016/0142-9612(91)90209-S
   Graham R. L., 1968, AM MATH MONTHLY, V75, P192
   Habibovic P, 2010, ACTA BIOMATER, V6, P2219, DOI 10.1016/j.actbio.2009.11.028
   Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hughes L C, 2005, Eur Cell Mater, V9, P68
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kemppainen JM, 2010, BIOMATERIALS, V31, P279, DOI 10.1016/j.biomaterials.2009.09.041
   Kocklenberg R, 1998, J NON-CRYST SOLIDS, V225, P8, DOI 10.1016/S0022-3093(98)00101-X
   Kohles SS, 2002, J BIOMECH ENG-T ASME, V124, P521, DOI 10.1115/1.1503374
   Krupa P, 2007, PHYSIOL RES, V56, pS107
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Low KL, 2010, J BIOMED MATER RES B, V94B, P273, DOI 10.1002/jbm.b.31619
   Lu CY, 2007, J ORTHOP RES, V25, P51, DOI 10.1002/jor.20264
   Marcacci M, 2013, INJURY, V44, pS11, DOI 10.1016/S0020-1383(13)70004-4
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nia HT, 2011, BIOPHYS J, V101, P2304, DOI 10.1016/j.bpj.2011.09.011
   O'Brien EM, 2007, J BIOL CHEM, V282, P4210, DOI 10.1074/jbc.M606300200
   Okamoto M, 2006, J MATER SCI-MATER M, V17, P327, DOI 10.1007/s10856-006-8232-z
   Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Raimondi MT, 2011, IEEE T BIO-MED ENG, V58, P3496, DOI 10.1109/TBME.2011.2163405
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Sacco R, 2011, BIOMECH MODEL MECHAN, V10, P577, DOI 10.1007/s10237-010-0257-z
   Scaglione S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00274
   Scaglione S, 2010, J TISSUE ENG REGEN M, V4, P505, DOI 10.1002/term.265
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   TOFE AJ, 1994, AM SOC TEST MATER, V1196, P163, DOI 10.1520/STP25191S
   Truscello S, 2012, ACTA BIOMATER, V8, P1648, DOI 10.1016/j.actbio.2011.12.021
   Wang YW, 2010, TISSUE ENG PART C-ME, V16, P281, DOI 10.1089/ten.tec.2009.0116
   Wilson CG, 2002, ARCH BIOCHEM BIOPHYS, V408, P246, DOI 10.1016/S0003-9861(02)00562-3
   Zhou L, 2012, J BIOMED MATER RES B, V100B, P1190, DOI 10.1002/jbm.b.32644
NR 64
TC 9
Z9 9
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD OCT
PY 2014
VL 111
IS 10
BP 2107
EP 2119
DI 10.1002/bit.25255
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AO3NA
UT WOS:000341236400019
PM 25073412
DA 2018-10-20
ER

PT J
AU Wang, SF
   Wang, XH
   Draenert, FG
   Albert, O
   Schroder, HC
   Mailander, V
   Mitov, G
   Muller, WEG
AF Wang, Shunfeng
   Wang, Xiaohong
   Draenert, Florian G.
   Albert, Olga
   Schroeder, Heinz C.
   Mailaender, Volker
   Mitov, Gergo
   Mueller, Werner E. G.
TI Bioactive and biodegradable silica biomaterial for bone regeneration
SO BONE
LA English
DT Article
DE Bone metabolism; Biosilica; Silicatein; beta-Tri-calcium phosphate;
   Microspheres; Animal experiments
ID OSTEOBLAST-LIKE CELLS; MARROW STROMAL CELLS; IN-VITRO; TRICALCIUM
   PHOSPHATE; MECHANICAL-PROPERTIES; SODIUM-SILICATE; DIFFERENTIATION;
   NANOINDENTATION; POLYPHOSPHATE; CEMENT
AB Biosilica, a biocompatible, natural inorganic polymer that is formed by an enzymatic, silicatein-mediated reaction in siliceous sponges to build up their inorganic skeleton, has been shown to be morphogenetically active and to induce mineralization of human osteoblast-like cells (SaOS-2) in vitro. In the present study, we prepared beads (microspheres) by encapsulation of beta-tricalciumphosphate [beta-TCP], either alone (control) or supplemented with silica or silicatein, into the biodegradable copolymer poly(D,L-lactide-co-glycolide) [PLGA]. Under the conditions used, approximate to 5% beta-TCP, approximate to 9% silica, and 0.32 mu g/mg of silicatein were entrapped into the PLGA microspheres (diameter approximate to 800 mu m). Determination of the biocompatibility of the beta-TCP microspheres, supplemented with silica or silicatein, revealed no toxicity in the MTT based cell viability assay using SaOS-2 cells. The adherence of SaOS-2 cells to the surface of silica-containing microspheres was higher than for microspheres, containing only beta-TCP. In addition, the silica-containing beta-TCP microspheres and even more pronounced, a 1:1 mixture of microspheres containing beta-TCP and silica, and beta-TCP and silicatein, were found to strongly enhance the mineral deposition by SaOS-2 cells. Using these microspheres, first animal experiments with silica/biosilica were performed in female, adult New Zealand White rabbits to study the effect of the inorganic polymer on bone regeneration in vivo. The microspheres were implanted into 5 mm thick holes, drilled into the femur of the animals, applying a bilateral comparison study design (3 test groups with 4-8 animals each). The control implant on one of the two hind legs contained microspheres with only beta-TCP, while the test implant on the corresponding leg consisted either of microspheres containing beta-TCP and silica, or a 1:1 mixture of microspheres, supplemented with beta-TCP and silica, and beta-TCP and silicatein. The results revealed that tissue/bone sections of silica containing implants and implants, composed of a 1:1 mixture of silica-containing microspheres and silicatein-containing microspheres, show an enhanced regeneration of bone tissue around the microspheres, compared to the control implants containing only beta-TCP. The formation of new bone induced by the microspheres is also evident from measurements of the stiffness/reduced Young's modulus of the regenerated bone tissue. The reduced Young's modulus of the regenerating bone tissue around the implants was markedly higher for the silica-containing microspheres (1.1 MPa), and even more for the 1:1 mixture of the silica- and silicatein-containing microspheres (1.4 MPa), compared to the beta-TCP microsphere controls (0.4 MPa). We propose that based on their morphogenetic activity on bone-forming cells in vitro and the results of the animal experiments presented here, silica/biosilica-based scaffolds are promising materials for bone repair/regeneration. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wang, Shunfeng; Wang, Xiaohong; Albert, Olga; Schroeder, Heinz C.; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, D-55128 Mainz, Germany.
   [Wang, Xiaohong] Chinese Acad Geol Sci, Natl Res Ctr Geoanal, CN-100037 Beijing, Peoples R China.
   [Draenert, Florian G.] Univ Marburg, Clin Oral & Maxillofacial Surg, D-35033 Marburg, Germany.
   [Mailaender, Volker] Max Planck Inst Polymer Res, D-55129 Mainz, Germany.
   [Mailaender, Volker] Johannes Gutenberg Univ Mainz, Med Clin, Univ Med Ctr, D-55131 Mainz, Germany.
   [Mitov, Gergo] Med Univ, Fac Med, Dept Med Microbiol, BG-1431 Sofia, Bulgaria.
RP Wang, XH (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wxh0408@hotmail.com; wmueller@uni-mainz.de
RI Mailander, Volker/H-3589-2012
OI Mailander, Volker/0000-0001-6583-8136
FU ERC [268476 BIOSILICA]; Deutsche Forschungsgemeinschaft [Schr 277/10-3];
   European Commission [604036, 286059, 268476, 311848]; International
   Human Frontier Science Program [RG-333/96-M]; Public Welfare Project of
   Ministry of Land and Resources of the People's Republic of China
   [201011005-06]; BiomaTiCS research initiative of the University Medical
   Center, Mainz [3/14]
FX W.E.G. M. is a holder of an ERC Advanced Investigator Grant (No. 268476
   BIOSILICA). This Work was supported by grants from the Deutsche
   Forschungsgemeinschaft (Schr 277/10-3), the European Commission
   ("Bio-Scaffolds": Customized Rapid Prototyping of Bioactive Scaffolds,
   No. 604036; Industry-Academia Partnerships and Pathways "Core Shell":
   No. 286059; "MarBioTec*EU-CN*": No. 268476; and "BlueGenics": No.
   311848), the International Human Frontier Science Program (Grant No.
   RG-333/96-M), the Public Welfare Project of Ministry of Land and
   Resources of the People's Republic of China (Grant No. 201011005-06),
   and the BiomaTiCS research initiative of the University Medical Center,
   Mainz (Grant No. 3/14).
CR Akhtar R, 2009, J MATER RES, V24, P638, DOI 10.1557/JMR.2009.0130
   Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Boger A, 2008, J BIOMED MATER RES B, V86B, P474, DOI 10.1002/jbm.b.31044
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Bohner M, 2000, INJURY, V31, pS37
   Bohner Marc, 2013, Biomatter, V3, DOI 10.4161/biom.25103
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   Chaudhari A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024186
   Chavan D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4766959
   Chavan D, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3579496
   CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277
   CURL JL, 1983, LAB ANIM, V17, P290, DOI 10.1258/002367783781062361
   Demers C, 2002, BIO-MED MATER ENG, V12, P15
   Draenert FG, 2013, CLIN ORAL IMPLAN RES, V24, P750, DOI 10.1111/j.1600-0501.2012.02481.x
   Draenert GF, 2007, BIOMATERIALS, V28, P1531, DOI 10.1016/j.biomaterials.2006.11.029
   Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007
   Epple M., 2007, BIOMINERALISATION ME, P81
   Fischer-Cripps AC, 2011, MECH ENG SER, P21, DOI 10.1007/978-1-4419-9872-9_2
   FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221
   Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005
   Gabler F, 2007, BIOMOL ENG, V24, P515, DOI 10.1016/j.bioeng.2007.08.013
   Gallego-Perez D, 2011, J BIOMED MATER RES B, V98B, P308, DOI 10.1002/jbm.b.31853
   Gotterbarm T, 2013, J BIOMED MAT RES B
   Silva CCGE, 2008, MATER CHARACT, V59, P1339, DOI 10.1016/j.matchar.2007.11.007
   Hall SJ, 2006, BASIC BIOMECHANICS
   Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j
   Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   KASPERK C, 1988, INT J ORAL MAX SURG, V17, P319
   Kim EJ, 2013, BIOL TRACE ELEM RES, V152, P105, DOI 10.1007/s12011-012-9593-4
   Kim K, 2011, ACTA BIOMATER, V7, P1249, DOI 10.1016/j.actbio.2010.11.007
   Langenbach F, 2011, NAT PROTOC, V6, P1726, DOI 10.1038/nprot.2011.394
   Leyhausen G, 1998, J BONE MINER RES, V13, P803, DOI 10.1359/jbmr.1998.13.5.803
   Ma DJ, 2004, SCI CHINA SER E, V47, P398, DOI 10.1360/03ye0590
   Maxwell AS, 2011, POLYM DEGRAD STABIL, V96, P1015, DOI 10.1016/j.polymdegradstab.2011.01.022
   MERKLEY JW, 1983, POULTRY SCI, V62, P798, DOI 10.3382/ps.0620798
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Middleton CA, 2007, J BIOMED MATER RES A, V83A, P1032, DOI 10.1002/jbm.a.31382
   Miyaji F, 1999, BIOMATERIALS, V20, P913, DOI 10.1016/S0142-9612(98)00235-X
   Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j
   Muller WEG, 2013, CHEM-EUR J, V19, P5790, DOI 10.1002/chem.201204412
   Muller WEG, 2011, ACTA BIOMATER, V7, P2661, DOI 10.1016/j.actbio.2011.03.007
   Muller WEG, 2004, INT REV CYTOL, V235, P53, DOI 10.1016/S0074-7696(04)35002-3
   MULLER WEG, 1977, CANCER, V40, P2787, DOI 10.1002/1097-0142(197712)40:6<2787::AID-CNCR2820400605>3.0.CO;2-G
   Nie NH, 2002, STAT PACKAGE SOCIAL
   Oh KS, 2005, KEY ENG MAT, V284-286, P93, DOI 10.4028/www.scientific.net/KEM.284-286.93
   Olson BJSC, 2007, CURRENT PROTOCOLS PR, V48
   Pautke C, 2010, J ANAT, V217, P76, DOI 10.1111/j.1469-7580.2010.01237.x
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Penk A, 2013, MAGN RESON MED, V70, P925, DOI 10.1002/mrm.24541
   Podaropoulos L, 2009, J ORAL IMPLANTOL, V35, P28, DOI 10.1563/1548-1336-35.1.28
   Rousseeuw PJ, 1999, AM STAT, V53, P382, DOI 10.2307/2686061
   Sachs L, 1984, ANGEW STAT, P242
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Scattarella A, 2010, INT J MED SCI, V7, P267
   Schlossmacher U, 2011, FEBS J, V278, P1145, DOI 10.1111/j.1742-4658.2011.08040.x
   Schroder HC, 2005, J BIOMED MATER RES B, V75B, P387, DOI 10.1002/jbm.b.30322
   Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   Smith PJ, 2004, CURR PROTOC CYTOM
   Somrani S, 2003, J MATER CHEM, V13, P888, DOI 10.1039/b210900j
   Tran RT, 2011, RSC GREEN CHEM SER, P419
   Tukey JW, 1977, EXPLORATORY DATA ANA
   Vazquez B, 2005, BIOMATERIALS, V26, P4309, DOI 10.1016/j.biomaterials.2004.10.042
   Venkatesan J, 2014, MAR DRUGS, V12, P300, DOI 10.3390/md12010300
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang XH, 2014, TRENDS BIOTECHNOL
   Wang XH, 2014, MAR DRUGS, V12, P1131, DOI 10.3390/md12021131
   Wang XH, 2012, SOFT MATTER, V8, P9501, DOI 10.1039/c2sm25889g
   Wang XH, 2012, CURR OPIN BIOTECH, V23, P570, DOI 10.1016/j.copbio.2012.01.018
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Wiens M, 2010, CALCIFIED TISSUE INT, V87, P513, DOI 10.1007/s00223-010-9408-6
   Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002
   Woo YI, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044109
   Xia LU, 2013, MICROPOR MESOPOR MAT, V173, P155, DOI 10.1016/j.micromeso.2013.02.020
   Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029
NR 83
TC 43
Z9 46
U1 4
U2 125
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD OCT
PY 2014
VL 67
BP 292
EP 304
DI 10.1016/j.bone.2014.07.025
PG 13
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AO3KJ
UT WOS:000341227800035
PM 25088401
DA 2018-10-20
ER

PT J
AU Shabna, A
   Saranya, V
   Malathi, J
   Shenbagarathai, R
   Madhavan, HN
AF Shabna, A.
   Saranya, V.
   Malathi, J.
   Shenbagarathai, R.
   Madhavan, H. N.
TI Indigenously produced polyhydroxyalkanoate based co-polymer as cellular
   supportive biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE polyhydroxyalkanoates; SCL-MCL copolymer; Pseudomonas sp; MNNG-S;
   biocompatibility; continuous culture
ID TISSUE ENGINEERING APPLICATIONS; IN-VITRO; PROTEIN ADSORPTION;
   SCAFFOLDS; POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE);
   BIOCOMPATIBILITY; BONE
AB The focus of this study was to evaluate the growth of the cells on a scaffold based on novel polyhydroxyalkanoate (PHA) (Polyhydroxy propionate copoly hydroxy ocatadecanoate copolymer), derived from a mutant strain of Pseudomonas sp. Naive PHA was also blended with several biodegradable polymeric materials (PEG, PLA, and MMT) to improve the scaffold properties. Protein adsorption study was done to evaluate the capability of scaffolds for cellular interaction. PHA: PEG blended scaffold showed better adsorption than others. 3T3 fibroblast cultures on various polymers were equally viable when compared with control culture except for the blend PHA: MMT by CCK 8 kit. MTT assay, performed with the continuous cultures HeLa, HEp-2, Vero, and McCoy on the polymer blends, supported the above finding. Among the blends PHA: PEG showed increased viability and was selected for further studies. Cell proliferation assay with colorimetric BrdU ELISA kit showed increase in cell proliferation over the matrix PHA: PEG than that of control. There were no observable morphological changes of continuous cells grown over matrix PHA: PEG when observed by phase contrast microscopy. HEp-2 cells were enclosed within the matrix when analyzed by SEM. The current study states that the scaffold prepared by using the indigenous PHA in combination with PEG supports cell growth better than the conventional plastic surface. PHA: PEG would be a promising material for tissue engineering. (C) 2013 Wiley Periodicals, Inc.
C1 [Shabna, A.; Malathi, J.; Madhavan, H. N.] Kamal Nayan Bajaj Res Inst, L&T Microbiol Res Ctr, Vision Res Fdn, Madras, Tamil Nadu, India.
   [Saranya, V.; Shenbagarathai, R.] Lady Doak Coll, PG & Res Dept Zool & Biotechnol, Madurai, Tamil Nadu, India.
RP Shenbagarathai, R (reprint author), Lady Doak Coll, PG & Res Dept Zool & Biotechnol, Madurai, Tamil Nadu, India.
EM shenbagarathai@rediffmail.com
FU Department of Biotechnology, India [BT/PR 10211/BCE/08/615/2007,
   BT/PR11256/PID/06/450/2008]; Department of Biotechnology-BIF
   [BT/BI/25/001/2006 (Vol.-II)]
FX Contract grant sponsor: Department of Biotechnology, India; contract
   grant numbers: BT/PR 10211/BCE/08/615/2007, BT/PR11256/PID/06/450/2008;
   Contract grant sponsor: Department of Biotechnology-BIF; contract grant
   number: BT/BI/25/001/2006 (Vol.-II)
CR Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen JY, 2007, CHINESE J CHEM ENG, V15, P391, DOI 10.1016/S1004-9541(07)60097-4
   Hench LL, 2004, J BIOMED MATER RES, V5, P117
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ji CD, 2011, ACTA BIOMATER, V7, P1653, DOI 10.1016/j.actbio.2010.11.043
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Liu Q, 2008, J BIOMAT SCI-POLYM E, V19, P1521, DOI 10.1163/156856208786140391
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Qu XH, 2006, J BIOMAT SCI-POLYM E, V17, P1107, DOI 10.1163/156856206778530704
   ROBERTSON BC, 1990, J COLLOID INTERF SCI, V134, P563, DOI 10.1016/0021-9797(90)90163-I
   Saranya V, 2012, CURR MICROBIOL, V65, P589, DOI 10.1007/s00284-012-0198-0
   Saranya V, 2010, CURR RES J BIOL SCI, V2, P164
   Tseng SCG, 1996, CURR EYE RES, V15, P973, DOI 10.3109/02713689609017643
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 23
TC 6
Z9 6
U1 2
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2014
VL 102
IS 10
BP 3470
EP 3476
DI 10.1002/jbm.a.35029
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO2FD
UT WOS:000341130400015
PM 24222470
DA 2018-10-20
ER

PT J
AU White, JF
   Werkmeister, JA
   Bisucci, T
   Darby, IA
   Ramshaw, JAM
AF White, Jacinta F.
   Werkmeister, Jerome A.
   Bisucci, Teresa
   Darby, Ian A.
   Ramshaw, John A. M.
TI Temporal variation in the deposition of different types of collagen
   within a porous biomaterial implant
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; immunohistochemistry; in situ hybridization; porous material;
   cell; material interaction
ID TISSUE-SPECIFIC EXPRESSION; V COLLAGEN; VASCULAR PROSTHESIS; XII
   COLLAGEN; MONOCLONAL-ANTIBODIES; III COLLAGEN; I COLLAGEN;
   FIBRILLOGENESIS; FIBROSIS; MODEL
AB The deposition of new collagen in association with a medical implant has been studied using expanded polytetrafluoroethylene vascular replacement samples implanted subcutaneously in sheep, for up to 28 days. New type I collagen mRNA synthesis was followed by in situ hybridization, while the accumulation of new collagen types III, V, VI, XII, and XIV was followed by immunohistochemistry. All the collagen detected in the pores of the implant were newly deposited at various times after implantation and were not due to any pre-existing dermal collagen that may have been present around the implant. Collagen deposition was seen initially surrounding the implant and, with time, was seen to infiltrate within its pores. In situ hybridization showed that the majority of infiltrating cells had switched on mRNA that coded for type I collagen production. Histology showed that cellular infiltration increased with time, accompanied by increasing collagen deposition. The deposition of different collagen types happened at different rates. The type V and VI collagens preceded the major interstitial collagens in the newly deposited tissue, although at longer time points, detection of type V collagen appeared to decrease. After disruption of the interstitial collagens with enzyme, the "masked" type V collagen was clearly still visible by immunohistochemistry. Little type XII collagen could be seen within the porous mesh, although it was seen in the surrounding tissues. By contrast, type XIV was seen throughout the porous structure of the implanted mesh, with less being visible outside the material where type XII was more abundant. (C) 2013 Wiley Periodicals, Inc.
C1 [White, Jacinta F.; Werkmeister, Jerome A.; Ramshaw, John A. M.] CSIRO Mat Sci & Engn, Clayton, Vic 3169, Australia.
   [Bisucci, Teresa; Darby, Ian A.] RMIT Univ, Sch Med Sci, Bundoora, Vic 3083, Australia.
RP Ramshaw, JAM (reprint author), CSIRO Mat Sci & Engn, Bayview Ave, Clayton, Vic 3169, Australia.
EM John.Ramshaw@csiro.au
RI White, Jacinta/D-6961-2013; Ramshaw, John/A-9411-2011
OI White, Jacinta/0000-0002-4855-0170; Darby, Ian/0000-0002-0990-1986
CR Ansorge HL, 2009, J BIOL CHEM, V284, P8427, DOI 10.1074/jbc.M805582200
   Berthod F, 1997, J INVEST DERMATOL, V108, P737, DOI 10.1111/1523-1747.ep12292122
   Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3
   BIRK DE, 1990, J CELL SCI, V95, P649
   Bisucci T, 2000, METH MOL B, V123, P291
   Broadbent E, 2012, BRAIN BEHAV IMMUN, V26, P212, DOI 10.1016/j.bbi.2011.06.014
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   CASTAGNOLA P, 1992, EUR J CELL BIOL, V59, P340
   GOODSON WH, 1982, J SURG RES, V33, P394, DOI 10.1016/0022-4804(82)90054-3
   LETHIAS C, 1993, J INVEST DERMATOL, V101, P92, DOI 10.1111/1523-1747.ep12360433
   Marchant JK, 1996, J CELL BIOL, V135, P1415, DOI 10.1083/jcb.135.5.1415
   Massoudi D, 2012, INVEST OPHTH VIS SCI, V53, P7246, DOI 10.1167/iovs.11-8592
   NAKATSUKASA H, 1990, J CLIN INVEST, V85, P1833, DOI 10.1172/JCI114643
   NISHIYAMA T, 1994, J BIOL CHEM, V269, P28193
   OH SP, 1993, DEV DYNAM, V196, P37, DOI 10.1002/aja.1001960105
   Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978
   Saika S, 2001, CURR EYE RES, V23, P463, DOI 10.1076/ceyr.23.6.463.6971
   Shannon C, 1997, J BIOMED MATER RES, V34, P401, DOI 10.1002/(SICI)1097-4636(19970305)34:3<401::AID-JBM15>3.0.CO;2-I
   SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6
   Stamov DR, 2013, J STRUCT BIOL, V183, P394, DOI 10.1016/j.jsb.2013.05.022
   Sun M, 2011, J CELL SCI, V124, P4096, DOI 10.1242/jcs.091363
   Tsuji JM, 2010, WOUND REPAIR REGEN, V18, P335, DOI 10.1111/j.1524-475X.2010.00587.x
   Tzortzaki EG, 2003, ANAT REC PART A, V275A, P1073, DOI 10.1002/ar.a.10120
   VONRECUM AF, 1993, J BIOMED MATER RES, V27, P757, DOI 10.1002/jbm.820270608
   Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200
   Werkmeister J A, 1991, J Long Term Eff Med Implants, V1, P107
   WERKMEISTER JA, 1993, J HISTOCHEM CYTOCHEM, V41, P1701, DOI 10.1177/41.11.8409376
   WERKMEISTER JA, 1991, J HISTOCHEM CYTOCHEM, V39, P1215, DOI 10.1177/39.9.1918939
   WERKMEISTER JA, 1994, MED PROG TECHNOL, V20, P231
   WERKMEISTER JA, 1995, J LONG-TERM EFF MED, V5, P1
   WERKMEISTER JA, 1990, EUR J BIOCHEM, V187, P439, DOI 10.1111/j.1432-1033.1990.tb15323.x
   Werkmeister JA, 2001, CURR OPIN SOLID ST M, V5, P185, DOI 10.1016/S1359-0286(01)00007-9
   WERKMEISTER JA, 1991, BIOCHEM J, V274, P895, DOI 10.1042/bj2740895
   White JF, 2010, J HEART VALVE DIS, V19, P766
   White Jacinta F., 1993, Clinical Materials, V14, P271, DOI 10.1016/0267-6605(93)90013-W
   White JF, 2002, J STRUCT BIOL, V137, P23, DOI 10.1006/jsbi.2002.4460
   Wicke Corinna, 1995, Wound Repair and Regeneration, V3, P284, DOI 10.1046/j.1524-475X.1995.30308.x
   ZHAN Q, 1995, EXP EYE RES, V60, P551, DOI 10.1016/S0014-4835(05)80070-3
NR 38
TC 3
Z9 3
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2014
VL 102
IS 10
BP 3550
EP 3555
DI 10.1002/jbm.a.35027
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO2FD
UT WOS:000341130400023
PM 24243831
DA 2018-10-20
ER

PT J
AU Milkovic, L
   Hoppe, A
   Detsch, R
   Boccaccini, AR
   Zarkovic, N
AF Milkovic, Lidija
   Hoppe, Alexander
   Detsch, Rainer
   Boccaccini, Aldo R.
   Zarkovic, Neven
TI Effects of Cu-doped 45S5 bioactive glass on the lipid
   peroxidation-associated growth of human osteoblast-like cells in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; bioactive glass; copper; lipid peroxidation;
   4-hydroxynonenal
ID TRAUMATIC BRAIN INJURY; OXIDATIVE STRESS; PROLIFERATION; EXPRESSION;
   BIOCHEMISTRY; CHEMISTRY; TOXICITY; PRODUCT
AB Bioactive glass (BG) is a highly attractive material, exhibiting both osteoinductive and osteoconductive properties, which is known to provide a growth enhancing surface for bone cells. Previous studies have shown that lipid peroxidation and in particular generation of 4-hydroxynonenal (HNE) is involved in the growth of human osteoblast-like cells, HOS, on BG. Copper (Cu), which is an essential cofactor of several enzymes as well as a proangiogenic and an antimicrobial agent, is known to induce lipid peroxidation. Therefore, the enrichment of BG with Cu could potentially have beneficial effects on the growth of the bone cells. In this study, we investigated the effects of copper-doped 45S5 BG on the growth of HOS cells and the generation of HNE. Our results confirmed the association of HNE with the growth of HOS cells. The effects of added Cu were dose-dependent. Specifically, low concentrations (i.e., 0.1% w/w) of Cu improved viability and enhanced HOS cell growth, whereas higher Cu concentrations [i.e., 2.5% and 1% (w/w)] were cytotoxic. The observed effects of Cu concentration on cell growth correlated with the level of HNE production. Therefore, Cu containing BG may represent a useful biomaterial for research and development studies of bone regeneration. (C) 2013 Wiley Periodicals, Inc.
C1 [Milkovic, Lidija; Zarkovic, Neven] Rudjer Boskovic Inst, Lab Oxidat Stress, Zagreb 10000, Croatia.
   [Hoppe, Alexander; Detsch, Rainer; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Zarkovic, N (reprint author), Rudjer Boskovic Inst, Lab Oxidat Stress, Bijenicka 54, Zagreb 10000, Croatia.
EM zarkovic@irb.hr
RI Boccaccini, Aldo/C-7905-2013
OI Milkovic, Lidija/0000-0002-4484-039X
FU Croatian Ministry of Science, Education, and Sports; German Academic
   Exchange Service (DAAD)
FX This study was supported by the Croatian Ministry of Science, Education,
   and Sports and the German Academic Exchange Service (DAAD) within
   Bilateral Programme for Cooperative Research Grants. The authors express
   sincere gratitude to Prof. Stjepan Marcelja and Dr. Stewart Craig for
   the valuable advices in preparation of the manuscript.
CR Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033
   Borovic Sunjic S, 2007, CELL GROWTH PROCESSE, P220
   Borovic S, 2007, REDOX REP, V12, P50, DOI 10.1179/135100007X162194
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074
   Cazacu M, 2003, CANCER BIOTHER RADIO, V18, P27, DOI 10.1089/108497803321269304
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8
   Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009
   Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477
   Hayashi T, 2007, FREE RADICAL BIO MED, V43, P1552, DOI 10.1016/j.freeradbiomed.2007.08.013
   Hench LL, 2010, J R SOC INTERFACE, V7, P379, DOI DOI 10.1098/RSIF.2010.0151.FOCUS
   HENCH LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2013, BIOMATER SCI-UK, V1, P254, DOI 10.1039/c2bm00116k
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hum J, 2012, J MATER SCI-MATER M, V23, P2317, DOI 10.1007/s10856-012-4580-z
   Kreuzer T, 1997, CANCER BIOTHER RADIO, V12, P131, DOI 10.1089/cbr.1997.12.131
   Kreuzer T, 1998, FREE RADICAL BIO MED, V25, P42, DOI 10.1016/S0891-5849(98)00029-X
   Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027
   LYNCH SM, 1993, J LIPID RES, V34, P1745
   Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007
   Mrakovcic L, 2010, ACTA BIOCHIM POL, V57, P173
   Parola M, 1999, ANTIOXID REDOX SIGN, V1, P255, DOI 10.1089/ars.1999.1.3-255
   Rudic M, 2012, FREE RADICAL BIOL C, V57C, P22
   Siems Werner, 2003, Molecular Aspects of Medicine, V24, P167, DOI 10.1016/S0098-2997(03)00011-6
   Siow RCM, 2007, REDOX REP, V12, P11, DOI 10.1179/135100007X162167
   Sunjic SB, 2005, BIOFACTORS, V24, P141, DOI 10.1002/biof.5520240117
   Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119
   WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693
   Wildburger R, 2000, WIEN KLIN WOCHENSCHR, V112, P798
   ZARKOVIC N, 1993, CELL BIOCHEM FUNCT, V11, P279, DOI 10.1002/cbf.290110409
   Zarkovic N, 2013, J PROTEOMICS, V92, P239, DOI 10.1016/j.jprot.2013.02.004
NR 35
TC 10
Z9 11
U1 2
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2014
VL 102
IS 10
BP 3556
EP 3561
DI 10.1002/jbm.a.35032
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO2FD
UT WOS:000341130400024
PM 24243858
DA 2018-10-20
ER

PT J
AU McCafferty, MM
   Burke, GA
   Meenan, BJ
AF McCafferty, Mura M.
   Burke, George A.
   Meenan, Brian J.
TI Mesenchymal stem cell response to conformal sputter deposited calcium
   phosphate thin films on nanostructured titanium surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate thin films; titanium nanotopography; sputter
   deposition; mesenchymal stem cells; osteogenic differentiation
ID OSTEOGENIC DIFFERENTIATION; COATINGS; ADHESION; LINEAGE; RUTILE;
   PROLIFERATION; OSTEOBLASTS; FATE
AB e Biomaterial surfaces that can directly induce the osteogenic differentiation of mesenchymal stem cells (MSCs) present an exciting strategy for bone tissue engineering and offers significant benefits for improving the repair or replacement of damaged or lost bone tissue. In this study, titanium nanostructures with distinctive topographical features were produced by radio frequency magnetron sputtering. The response of MSCs to the nanostructured titanium (Ti) surfaces before and after augmentation by a sputter deposited calcium phosphate (CaP) coating has been investigated. The sputtered CaP has the characteristics of a calcium enriched hydroxyapatite surface layer, as determined by X-ray photoelectron spectroscopy and X-ray diffraction studies. The sputter deposited Ti has a polycrystalline surface morphology, as confirmed by atomic force microscopy, and CaP layers deposited thereon (TiCaP) conform to this topography. The effects of these surfaces on MSC focal adhesion formation, actin cytoskeleton organization and Runx2 gene expression were examined. The Ti and TiCaP surfaces were found to promote changes in MSC morphology and adhesion known to be associated with subsequent downstream osteogenic differentiation; however, the equivalent events were not as pronounced on the CaP surface. A significant increase in Runx2 expression was observed for CaP compared to Ti, but no such difference was seen between either Ti and TiCaP, nor CaP and TiCaP. Importantly, the Ti surface engendered the expected contribution of nanoscale features to the MSC response; moreover, the CaP layer when used in combination with this topography has been found to cause no adverse effects in respect of MSC behavior. (c) 2013 Wiley Periodicals, Inc.
C1 [McCafferty, Mura M.; Burke, George A.; Meenan, Brian J.] Univ Ulster, Nanotechnol & Integrated Bioengn Ctr NIBEC, Sch Engn, Newtownabbey BT37 0QB, North Ireland.
RP McCafferty, MM (reprint author), Univ Ulster, Nanotechnol & Integrated Bioengn Ctr NIBEC, Sch Engn, Newtownabbey BT37 0QB, North Ireland.
EM mm.mccafferty@ulster.ac.uk
OI McCafferty, Mura/0000-0002-7457-7529
CR Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   ASTM Guide E. 1523-03, 2003, E152303 ASTM
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2010, P I MECH ENG H, V224, P1441, DOI 10.1243/09544119JEIM775
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   BIGGS MJ, 2008, J BIOMED MAT RES A
   Boyd AR, 2008, J MATER SCI-MATER M, V19, P485, DOI 10.1007/s10856-006-0031-z
   Boyd AR, 2006, SURF COAT TECH, V200, P6002, DOI [10.1016/j.surfcoat.2005.09.032, 10.1016/j.surfcoat.09.032]
   Cairns ML, 2010, COLLOID SURFACE B, V78, P283, DOI 10.1016/j.colsurfb.2010.03.013
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Forch R, 2009, SURFACE DESIGN APPL, P471
   Heo CH, 2005, THIN SOLID FILMS, V475, P183, DOI 10.1016/j.tsf.2004.08.033
   Hu QH, 2007, J MATER CHEM, V17, P4690, DOI 10.1039/b710936a
   Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kumar PM, 2000, THIN SOLID FILMS, V358, P122, DOI 10.1016/S0040-6090(99)00722-1
   Lindahl C, 2010, J MATER SCI-MATER M, V21, P2743, DOI 10.1007/s10856-010-4137-y
   Lindberg F, 2008, BIOMATERIALS, V29, P3317, DOI 10.1016/j.biomaterials.2008.04.034
   Liu XH, 2001, APPL SURF SCI, V174, P35, DOI 10.1016/S0169-4332(01)00007-1
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNamara LE, 2011, BIOMATERIALS, V32, P7403, DOI 10.1016/j.biomaterials.2011.06.063
   Mello A, 2007, BIOMED MATER, V2, P67, DOI 10.1088/1748-6041/2/2/003
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park YR, 2005, THIN SOLID FILMS, V484, P34, DOI 10.1016/j.tsf.2005.01.039
   Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234
   Rossi S, 2007, J BIOMED MATER RES A, V82A, P965, DOI 10.1002/jbm.a.31245
   Shui CX, 2003, J BONE MINER RES, V18, P213, DOI 10.1359/jbmr.2003.18.2.213
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   vanDijk K, 1997, THIN SOLID FILMS, V304, P191, DOI 10.1016/S0040-6090(97)00104-1
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Wolke JGC, 1998, J MATER SCI, V33, P3371, DOI 10.1023/A:1013245632321
   Yim EK, 2009, BIOMATERIALS, V31, P1299
   Yonggang Y, 2005, KEY ENG MATER, V284, P235
NR 44
TC 6
Z9 6
U1 0
U2 32
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2014
VL 102
IS 10
BP 3585
EP 3597
DI 10.1002/jbm.a.35018
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO2FD
UT WOS:000341130400027
PM 24249697
DA 2018-10-20
ER

PT J
AU Liu, T
   Liu, SH
   Zhang, K
   Chen, JY
   Huang, N
AF Liu, Tao
   Liu, Shihui
   Zhang, Kun
   Chen, Junying
   Huang, Nan
TI Endothelialization of implanted cardiovascular biomaterial surfaces: The
   development from in vitro to in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE endothelialization; cardiovascular biomaterial; endothelial cell;
   endothelial progenitor cell; vascular graft
ID CORONARY-ARTERY-DISEASE; DRUG-ELUTING STENTS; ACUTE
   MYOCARDIAL-INFARCTION; ENGINEERED VASCULAR GRAFTS; EMBRYONIC STEM-CELLS;
   ACTIVATED PROTEIN-C; GROWTH-FACTOR GENE; ENDEAVOR IV TRIAL; BARE-METAL
   STENTS; PROGENITOR CELLS
AB Restenosis and thrombosis formation after cardiovascular devices implantation continue to be problematic. Although various platforms and parameters of cardiovascular devices have been designed and optimized over the years, postoperative complications are hard to avoid. The native vascular endothelium always provide a nonthrombogenic surface as well as prevent intimal overproliferation, thereby, the presence of a confluent endothelial cell layer on material surfaces have been widely accepted as an ideal approach to improve the biocompatibility of implanted cardiovascular materials. Endothelialization on biomaterial surfaces is initially developed by in vitro cell seeding. However, numerous no-perfect parts of this method are existed for clinical use. The emergency of endothelial progenitor cells may provide a promising way for setting these limitations. Over the last decades, countless researches about EPCs-based in vivo induced self-endothelialization have been reported and mainly focused on cellular therapy, pharmacological therapy, materials designing, or surface biofunctional modification. This review details the development of endothelialization on cardiovascular material surfaces from in vitro to in vivo. Endothelialization progress on the basis of molecular biological level and bioinformatics theory is expected to be the key point in the coming decades. (c) 2013 Wiley Periodicals, Inc.
C1 [Liu, Tao; Liu, Shihui; Zhang, Kun; Chen, Junying; Huang, Nan] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Chinese Educ Minist, Sch Mat Sci & Engn, Chengdu, Peoples R China.
   [Liu, Shihui] Naton Inst Med Technol, Naton Med Grp, Beijing, Peoples R China.
RP Chen, JY (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Chinese Educ Minist, Sch Mat Sci & Engn, Chengdu, Peoples R China.
EM chenjy@263.net
FU Key Basic Research Project [2011CB606204]; National Nature Science
   Foundation of China [31170916]
FX Contract grant sponsor: Key Basic Research Project; contract grant
   number: 2011CB606204; Contract grant sponsor: National Nature Science
   Foundation of China; contract grant number: 31170916
CR Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF
   Abizaid A, 2004, J AM COLL CARDIOL, V43, P1118, DOI 10.1016/j.jacc.2004.01.023
   Adriaenssens T, 2007, J AM COLL CARDIOL, V49, P1265, DOI 10.1016/j.jacc.2007.02.021
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243
   Avci-Adali M, 2010, BIOTECHNOL ADV, V28, P119, DOI 10.1016/j.biotechadv.2009.10.005
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038
   Boura C, 2005, BIOMATERIALS, V26, P4568, DOI 10.1016/j.biomaterials.2004.11.036
   BUSCH C, 1982, J CLIN INVEST, V69, P726, DOI 10.1172/JCI110502
   Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002
   Butler J. E., 1993, Molecular Immunology, V30, P1165, DOI 10.1016/0161-5890(93)90135-X
   Byrne RA, 2010, J AM COLL CARDIOL, V55, P2536, DOI 10.1016/j.jacc.2010.03.020
   Byrne RA, 2009, EUR HEART J, V30, P923, DOI 10.1093/eurheartj/ehp044
   Bystron M, 2010, CATHETER CARDIO INTE, V76, P627, DOI 10.1002/ccd.22612
   Caves JM, 2006, J VASC SURG, V44, P1363, DOI 10.1016/j.jvs.2006.08.046
   Chen X, 2013, COLLOID SURFACE B, V107, P189, DOI 10.1016/j.colsurfb.2013.02.005
   Cheng Y, 2012, J SURG RES, V176, pE47, DOI 10.1016/j.jss.2012.04.047
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi CK, 2010, TRENDS CELL BIOL, V20, P705, DOI 10.1016/j.tcb.2010.09.007
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Cui B, 2009, CHINESE J MULTIPLE O, V8, P265
   Cui B, 2011, MICROVASC RES, V81, P143, DOI 10.1016/j.mvr.2010.09.009
   DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004
   Dargaville BL, 2013, ACTA BIOMATER, V9, P6885, DOI 10.1016/j.actbio.2013.02.009
   Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357
   Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152
   Du FY, 2012, BIOMATERIALS, V33, P762, DOI 10.1016/j.biomaterials.2011.10.037
   Egashira K, 2007, ARTERIOSCL THROM VAS, V27, P2563, DOI 10.1161/ATVBAHA.107.154609
   Esmon CT, 2000, BBA-PROTEIN STRUCT M, V1477, P349, DOI 10.1016/S0167-4838(99)00266-6
   Everaert BR, 2010, INT J CARDIOL, V144, P350, DOI 10.1016/j.ijcard.2010.04.018
   Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   FUKUDOME K, 1994, J BIOL CHEM, V269, P26486
   Garcia-Tejada J, 2007, REV ESP CARDIOL, V60, P197, DOI 10.1157/13099467
   GARFINKLE AM, 1984, T AM SOC ART INT ORG, V30, P432
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6
   GRIESSER HJ, 1990, APPL POLYM SYMP SER, V46, P361
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059
   He MX, 2007, CHINESE J BASES CLIN, V14, P72
   Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Higashi Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE202, DOI 10.1152/ajpendo.00394.2009
   Hofer T, 2001, FASEB J, V15, P2715, DOI 10.1096/fj.01-0546fje
   Hoffmann J, 2008, J BIOMED MATER RES A, V84A, P614, DOI 10.1002/jbm.a.31309
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Hoshi R.A., 2012, BIOMATERIALS, V34, P30
   HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Iivanainen E, 2003, MICROSC RES TECHNIQ, V60, P13, DOI 10.1002/jemt.10238
   Isenberg BC, 2011, PRINCIPLES OF REGENERATIVE MEDICINE, 2ND EDITION, P853, DOI 10.1016/B978-0-12-381422-7.10047-1
   Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673
   Jiang M, 2008, INT J BIOCHEM CELL B, V40, P2284, DOI 10.1016/j.bioce1.2008.03.012
   Kalinczuk L, 2009, AM J CARDIOL, V104, P531, DOI 10.1016/j.amjcard.2009.03.067
   Kang CK, 2012, COLLOID SURFACE B, V102, P744
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Kastrup J, 2005, J AM COLL CARDIOL, V45, P982, DOI 10.1016/j.jacc.2004.12.068
   Kereiakes DJ, 2010, J AM COLL CARDIOL, V56, P264, DOI 10.1016/j.jacc.2010.04.011
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kipshidze N, 2004, J AM COLL CARDIOL, V44, P733, DOI 10.1016/j.jacc.2004.04.048
   Koens MJW, 2010, ACTA BIOMATER, V6, P4666, DOI 10.1016/j.actbio.2010.06.038
   Krenning G, 2009, TRENDS MOL MED, V15, P180, DOI 10.1016/j.molmed.2009.02.001
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kutryk MJB, 2003, AM J CARDIOL, V92, p94L
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   Lansky AJ, 2004, CIRCULATION, V109, P1948, DOI 10.1161/01.CIR.0000127129.94129.6F
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Leon MB, 2010, J AM COLL CARDIOL, V55, P543, DOI 10.1016/j.jacc.2009.08.067
   Li CS, 2010, MICROVASC RES, V79, P207
   Li S, 2013, J BIOMED MATER RES A, V101, P1244
   [李士勇 LI Shiyong], 2008, [生命科学, Chinese Bulletin of Life Sciences], V20, P463
   Lin QK, 2010, BIOMATERIALS, V31, P4017, DOI 10.1016/j.biomaterials.2010.01.092
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Llevadot J, 2001, J CLIN INVEST, V108, P399, DOI 10.1172/JCI13131
   Lode A, 2007, J BIOMED MATER RES A, V81A, P474, DOI 10.1002/jbm.a.31024
   Lord MS, 2009, BIOMATERIALS, V30, P4898, DOI 10.1016/j.biomaterials.2009.05.063
   Ludwig NS, 2006, J BIOMED MATER RES A, V78A, P615, DOI 10.1002/jbm.a.30776
   MARCUM JA, 1984, BIOCHEMISTRY-US, V23, P1730, DOI 10.1021/bi00303a023
   Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Mehilli J, 2006, CIRCULATION, V113, P273, DOI 10.1161/CIRCULATIONAHA.105.575977
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Meinhart J G, 2001, ANN THORAC SURG, V71, P327
   Mikulikova R, 2005, BIOMATERIALS, V26, P5572, DOI 10.1016/j.biomaterials.2005.02.010
   Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239
   Mrowczynski W, 2014, J VASC SURG, V59, P210, DOI 10.1016/j.jvs.2013.03.004
   Mugnai D, 2012, J THORAC CARDIOVASC, V146, P400
   Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6
   Nagano M, 2007, BLOOD, V110, P151, DOI 10.1182/blood-2006-10-047092
   Nakamura K, 2012, BIOCHEM BIOPH RES CO, V418, P87, DOI 10.1016/j.bbrc.2011.12.139
   Nakano K, 2009, JACC-CARDIOVASC INTE, V2, P277, DOI 10.1016/j.jcin.2008.08.023
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Nur E. K. A., 2006, STEM CELLS, V24, P426, DOI DOI 10.1634/STEMCELLS.2005-0170)
   Ohtani K, 2006, CIRCULATION, V114, P2773, DOI 10.1161/CIRCULATIONAHA.105.582254
   Onuma Y, 2009, J AM COLL CARDIOL, V54, P269, DOI 10.1016/j.jacc.2009.05.016
   Padfield GJ, 2010, J AM COLL CARDIOL, V55, P1553, DOI 10.1016/j.jacc.2009.10.070
   Panteleev MA, 2002, EUR J BIOCHEM, V269, P2016, DOI 10.1046/j.1432-1033.2002.02818.x
   Park DW, 2010, J AM COLL CARDIOL, V56, P1366, DOI 10.1016/j.jacc.2010.03.097
   Park KM, 2012, BIOCONJUGATE CHEM, V23, P2042, DOI 10.1021/bc300110b
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Pompe T, 2007, BIOMATERIALS, V28, P28, DOI 10.1016/j.biomaterials.2006.08.028
   Rabelink TJ, 2004, ARTERIOSCL THROM VAS, V24, P834, DOI 10.1161/01.ATV.0000124891.57581.9f
   RADOMSKI MW, 1987, BRIT J PHARMACOL, V92, P181, DOI 10.1111/j.1476-5381.1987.tb11310.x
   Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226
   Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014
   Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1
   Shao HW, 2008, STEM CELLS, V26, P1376, DOI 10.1634/stemcells.2007-0785
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi ZL, 2005, BIOMATERIALS, V26, P501, DOI 10.1016/j.biomaterials.2004.02.060
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   Simcock JW, 2009, TISSUE ENG PT A, V15, P655, DOI 10.1089/ten.tea.2007.0438
   Spadaccio C, 2010, J CARDIOVASC PHARM, V55, P30, DOI 10.1097/FJC.0b013e3181c37d4d
   Spiel AO, 2008, THROMB RES, V123, P108, DOI 10.1016/j.thromres.2008.03.007
   Stroncek JD, 2012, ACTA BIOMATER, V8, P201, DOI 10.1016/j.actbio.2011.09.002
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Vainionpaa N, 2006, AM J PHYSIOL-CELL PH, V290, pC764, DOI 10.1152/ajpcell.00285.2005
   van Hinsbergh VWM, 2001, EUR J OBSTET GYN R B, V95, P198, DOI 10.1016/S0301-2115(00)00490-5
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152
   Verheye S, 2009, JACC-CARDIOVASC INTE, V2, P205, DOI 10.1016/j.jcin.2008.12.011
   Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Waseda K, 2009, JACC-CARDIOVASC INTE, V2, P779, DOI 10.1016/j.jcin.2009.05.015
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi35
   Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74
   Westerweel PE, 2008, EUR HEART J, V29, P2808, DOI 10.1093/eurheartj/ehn431
   Wilhelm C, 2007, BIOMATERIALS, V28, P3797, DOI 10.1016/j.biomaterials.2007.04.047
   Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1
   Windecker S, 2007, CIRCULATION, V116, P1952, DOI 10.1161/CIRCULATIONAHA.106.683995
   Xiao Y, 1996, BIOPHYS J, V71, P2869, DOI 10.1016/S0006-3495(96)79484-5
   Xu B, 2006, CHINESE MED J-PEKING, V119, P533
   Xu B, 2008, CHINESE MED J-PEKING, V121, P492
   Yi CG, 2006, J SURG RES, V135, P100, DOI 10.1016/j.jss.2006.01.014
   Yin M, 2009, J MATER SCI-MATER M, V20, P1513, DOI 10.1007/s10856-009-3715-3
   Yin YG, 2010, CARDIOVASC PATHOL, V19, P218, DOI 10.1016/j.carpath.2009.04.002
   Zhang L, 2006, J BIOMED MATER RES A, V77A, P277, DOI 10.1002/jbm.a.30614
   Zhang Q, 2006, CHINESE MED J-PEKING, V119, P165
   Zhao XH, 2007, TRANSPL INT, V20, P712, DOI 10.1111/j.1432-2277.2007.00497.x
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 154
TC 33
Z9 33
U1 3
U2 71
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2014
VL 102
IS 10
BP 3754
EP 3772
DI 10.1002/jbm.a.35025
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO2FD
UT WOS:000341130400043
PM 24243819
DA 2018-10-20
ER

PT J
AU Boutopoulos, C
   Chatzipetrou, M
   Papathanasiou, AG
   Zergioti, I
AF Boutopoulos, Christos
   Chatzipetrou, Marianneza
   Papathanasiou, Athanasios G.
   Zergioti, Ioanna
TI Time-resolved imaging and immobilization study of biomaterials on
   hydrophobic and superhydrophobic surfaces by means of laser-induced
   forward transfer
SO LASER PHYSICS LETTERS
LA English
DT Article
DE laser induced forward transfer; laser immobilization of biomaterials;
   time-resolved imaging of LIFT
ID WETTING TRANSITION; PROTEIN ADSORPTION; WATER DROPLETS; NANOSECOND;
   ROUGHNESS; ABLATION
AB In this work, we present the generation of high velocity liquid jets of a photosynthetic biomaterial in buffer solution (i.e. thylakoid membranes) and a test solution, using the laser-induced forward transfer (LIFT) technique. The high impact pressure of the collision of the jets on solid substrates, ranging from 0.045 MPa-35 MPa, resulted in strong physical immobilization of the photosynthetic biomaterial on superhydrophobic (SH) poly(methyl methacrylate) (PMMA) surfaces and hydrophobic gold surfaces. The immobilization efficiency was evaluated by fluorescence microscopy, while time-resolved imaging of the LIFT process was carried out to study the corresponding LIFT dynamics. The results show that this simple, direct and chemical-linkers-free immobilization technique is valuable for several biosensors and microfluidic applications since it can be applied to a variety of hydrophobic and SH substrates, leading to the selective immobilization of the biomaterials, due to the high spatial printing resolution of the LIFT technique.
C1 [Boutopoulos, Christos; Chatzipetrou, Marianneza; Zergioti, Ioanna] Natl Tech Univ Athens, Sch Appl Math & Phys Sci, GR-15780 Athens, Greece.
   [Papathanasiou, Athanasios G.] Natl Tech Univ Athens, Sch Chem Engn, GR-15780 Athens, Greece.
RP Boutopoulos, C (reprint author), Natl Tech Univ Athens, Sch Appl Math & Phys Sci, GR-15780 Athens, Greece.
EM zergioti@central.ntua.gr
RI Papathanasiou, Athanasios/C-3781-2016
OI Papathanasiou, Athanasios/0000-0002-8468-8126; Chatzipetrou,
   Marianneza/0000-0002-5791-4394; Boutopoulos,
   Christos/0000-0002-3892-8483
FU European Research Council under European Community [240710]
FX The authors kindly acknowledge funding from the European Research
   Council under the European Community's Seventh Framework Programme
   (FP7/2007-2013)/ERC Grant Agreement No. [240710] (AGP) The contribution
   of Dimitrios P Papageorgiou is acknowledged. Rough PMMA samples were
   fabricated in NCSR 'Demokritos,' followed by the expert advice of Dr E
   Gogolides and Dr A Tserepi. The authors would also like to acknowledge
   the contribution of E Rigana from B. R. F. A. A. for the fluorescent
   microscopy images and Dr M Massaouti for text editing corrections.
CR Apitz I, 2005, APPL PHYS A-MATER, V81, P329, DOI 10.1007/s00339-005-3213-5
   Barthelmebs L, 2011, METHODS MOL BIOL, V684, P247, DOI 10.1007/978-1-60761-925-3_19
   Boutopoulos C, 2014, MICROFLUID NANOFLUID, V16, P493, DOI 10.1007/s10404-013-1248-z
   Boutopoulos C, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813394
   Boutopoulos C, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3562297
   Boutopoulos C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3025596
   Brown MS, 2012, J FLUID MECH, V709, P341, DOI 10.1017/jfm.2012.337
   Chen Y, 2008, ELECTROPHORESIS, V29, P1801, DOI 10.1002/elps.200700552
   Colina M, 2005, BIOSENS BIOELECTRON, V20, P1638, DOI 10.1016/j.bios.2004.08.047
   Deng B, 2010, ADV MATER, V22, P5473, DOI 10.1002/adma.201002614
   Dinca V, 2008, THIN SOLID FILMS, V516, P6504, DOI 10.1016/j.tsf.2008.02.043
   Duocastella M, 2010, THIN SOLID FILMS, V518, P5321, DOI 10.1016/j.tsf.2010.03.082
   Fardel R, 2010, J PHYS CHEM C, V14, P5617
   Gnanappa AK, 2012, PLASMA PROCESS POLYM, V9, P304, DOI 10.1002/ppap.201100124
   HANCOX NL, 1966, PHILOS TR R SOC S-A, V260, P121, DOI 10.1098/rsta.1966.0036
   Ishino C, 2006, EUROPHYS LETT, V76, P464, DOI 10.1209/epl/i2006-10288-0
   Jung YC, 2008, LANGMUIR, V24, P6262, DOI 10.1021/la8003504
   Jung YC, 2007, SCRIPTA MATER, V57, P1057, DOI 10.1016/j.scriptamat.2007.09.004
   Koc Y, 2008, LAB CHIP, V8, P582, DOI 10.1039/b716509a
   LYNCH DW, 1975, PHYS REV B, V11, P3617, DOI 10.1103/PhysRevB.11.3617
   Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u
   Palla-Papavlu A, 2013, APPL SURF SCI, V278, P180, DOI 10.1016/j.apsusc.2013.03.036
   Papageorgiou DP, 2013, MICROFLUID NANOFLUID, V14, P247, DOI 10.1007/s10404-012-1043-2
   Patankar NA, 2004, LANGMUIR, V20, P8209, DOI 10.1021/la048629t
   Rapp L, 2009, APPL PHYS LETT
   Schiele NR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/032001
   Stewart JS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4717463
   Takada N, 2009, APPL SURF SCI, V255, P9572, DOI 10.1016/j.apsusc.2009.04.087
   Touloupakis E, 2012, ANAL BIOANAL CHEM, V402, P3237, DOI 10.1007/s00216-012-5771-7
   Tsougeni K, 2010, LANGMUIR
   Tsougeni K, 2012, SENSOR ACTUAT B-CHEM, V161, P216, DOI 10.1016/j.snb.2011.10.022
   Unger C, 2011, APPL PHYS A-MATER, V103, P271, DOI 10.1007/s00339-010-6030-4
   Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n
   Vorobyev A, 2012, NANOMATERIALS PROCES, P255
   Wang JW, 2010, ADV MATER, V22, P4462, DOI 10.1002/adma.201001729
   Yan JY, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759344
   Zimmermann J, 2008, ADV FUNCT MATER, V18, P3662, DOI 10.1002/adfm.200800755
NR 37
TC 3
Z9 3
U1 5
U2 49
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1612-2011
EI 1612-202X
J9 LASER PHYS LETT
JI Laser Phys. Lett.
PD OCT
PY 2014
VL 11
IS 10
AR 105603
DI 10.1088/1612-2011/11/10/105603
PG 8
WC Optics; Physics, Applied
SC Optics; Physics
GA AN8EV
UT WOS:000340837000006
DA 2018-10-20
ER

PT J
AU Dwivedi, AD
   Dubey, SP
   Hokkanen, S
   Sillanpaa, M
AF Dwivedi, Amarendra Dhar
   Dubey, Shashi Prabha
   Hokkanen, Sanna
   Sillanpaa, Mika
TI Mechanistic investigation on the green recovery of ionic,
   nanocrystalline, and metallic gold by two anionic nanocelluloses
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Adsorptive-reduction; Anionic cellulose; Gold; Nanocrystallization
ID COLUMN EXPERIMENTS; SEAWEED BIOMASS; CELLULOSE; NANOPARTICLES;
   REDUCTION; GOLD(III); RESIN; BATCH; GEL
AB The modified cellulose (ADAC samples) used as backbone to obtain biodegradable hydrogels, which demonstrated high affinity to concentrate precious gold species. The primary foci of the study were to develop green techniques to recover Au from dilute solutions by providing the mechanistic evidences for the adsorption coupled reduction pathways. The derivatives of anionic nanocellulose were used for recovery of the ionic, nanoparticulate, and metallic forms of Au. The ADAC samples were promising sorbing phase (57 and 60 mg/g capacity) even at low pH for the treatment of the gold-polluted waters. Thermodynamically, ADAC hydrogels were remained active at moderate to higher temperature (295-333 K) in an endothermic way. Reduction of Au occurred at different stages of kinetic curves, facilitating the formation of zerovalent gold (48 and 41 nm particle size). The Au recovery minimally altered by the competing heavy metals (Cd, Co, Cr, Ni, and As), either at equivalent or lower concentrations. A significant amount of Au(III) (83-99%) regenerated by a strong complexing eluent (0,5 M thiourea in 1 M HCl), moreover thermal crystallization yielded metallic gold in an excellent amount (94%). The mechanism of adsorptive-reduction of gold-nanocellulose were investigated and characterized by the spectroscopic studies including X-ray photoelectron spectroscopy. Overall, recovery of gold in desired forms from nanocellulose can be viewed as an effective biomaterial management strategy. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Dwivedi, Amarendra Dhar; Dubey, Shashi Prabha; Hokkanen, Sanna; Sillanpaa, Mika] Lappeenranta Univ Technol, LUT Green Tech, Lab Green Chem, Mikkeli 50130, Finland.
   [Dubey, Shashi Prabha] UNIST, Sch Urban & Environm Engn, Ulsan 698805, South Korea.
RP Dwivedi, AD (reprint author), Lappeenranta Univ Technol, LUT Green Tech, Lab Green Chem, Sammonkatu 12, Mikkeli 50130, Finland.
EM amarendradhar@gmail.com
RI Sillanpaa, Mika/G-1366-2011
OI Sillanpaa, Mika/0000-0003-3247-5337
FU Finnish Funding Agency for Technology and Innovation (Tekes); Laboratory
   of Green Chemistry, Mikkeli, Finland
FX Finnish Funding Agency for Technology and Innovation (Tekes) is thanked
   for the financial support. First author (A.D.D.) would also like to
   acknowledge Lappeenranta University of Technology, for providing
   post-doctoral funding at the Laboratory of Green Chemistry, Mikkeli,
   Finland. The authors are grateful to the fibre and particle engineering
   laboratory, University of Oulu for providing the cellulose materials.
CR Ali I, 2006, NAT PROTOC, V1, P2661, DOI 10.1038/nprot.2006.370
   Arima H, 2003, MATER TRANS, V44, P2099, DOI 10.2320/matertrans.44.2099
   Dubey SP, 2013, SPECTROCHIM ACTA A, V103, P134, DOI 10.1016/j.saa.2012.11.021
   Ho YS, 2002, PROCESS BIOCHEM, V37, P1421, DOI 10.1016/S0032-9592(02)00036-5
   Hokkanen S, 2013, CHEM ENG J, V223, P40, DOI 10.1016/j.cej.2013.02.054
   Hong HL, 2006, GEOCHEM INT+, V44, P1246, DOI 10.1134/S0016702906120093
   Hubbe MA, 2008, BIORESOURCES, V3, P929
   Hyun DC, 2011, ADV MATER, V23, P2946, DOI 10.1002/adma.201100639
   Kim UJ, 2001, J CHROMATOGR A, V919, P29, DOI 10.1016/S0021-9673(01)00800-7
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Laguna A, 2008, MODERN SUPRAMOLECULA
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   Li JS, 2007, HYDROMETALLURGY, V89, P279, DOI 10.1016/j.hydromet.2007.07.015
   Liimatainen H., 2012, WATER RES, V1, P2156
   Liimatainen H, 2013, CELLULOSE, V20, P741, DOI 10.1007/s10570-013-9865-y
   Liimatainen H, 2012, BIOMACROMOLECULES, V13, P1592, DOI 10.1021/bm300319m
   Lodeiro P, 2013, CHEM ENG J, V230, P372, DOI 10.1016/j.cej.2013.06.105
   Lodeiro P, 2013, MAR CHEM, V152, P11, DOI 10.1016/j.marchem.2013.03.003
   Lucas A, 2012, ANAL CHEM, V84, P6994, DOI 10.1021/ac301003g
   Marsden J., 2006, CHEM GOLD EXTRACTION
   Mathew M, 2012, COLLOID SURFACE B, V93, P143, DOI 10.1016/j.colsurfb.2011.12.028
   Mohammadnejad S, 2013, J COLLOID INTERF SCI, V389, P252, DOI 10.1016/j.jcis.2012.08.053
   Oh SY, 2005, CARBOHYD RES, V340, P417, DOI 10.1016/j.carres.2004.11.027
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Rajalaxmi D, 2010, CARBOHYD RES, V345, P284, DOI 10.1016/j.carres.2009.09.037
   Ramesh A, 2008, BIORESOURCE TECHNOL, V99, P3801, DOI 10.1016/j.biortech.2007.07.008
   Sathishkumar M, 2010, IND ENG CHEM RES, V49, P7129, DOI 10.1021/ie100104j
   Sirvio J, 2011, CARBOHYD POLYM, V86, P266, DOI 10.1016/j.carbpol.2011.04.046
   Suopajarvi T, 2013, CHEM ENG J, V231, P59, DOI 10.1016/j.cej.2013.07.010
   Syed S, 2012, HYDROMETALLURGY, V115, P30, DOI 10.1016/j.hydromet.2011.12.012
   Tanaka A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.195415
   Torres E, 2005, LANGMUIR, V21, P7951, DOI 10.1021/la046852k
   Won SW, 2010, BIORESOURCE TECHNOL, V101, P1135, DOI 10.1016/j.biortech.2009.09.056
   Xin JY, 2013, INT J MOL SCI, V14, P21676, DOI 10.3390/ijms141121676
NR 34
TC 17
Z9 18
U1 4
U2 56
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD OCT 1
PY 2014
VL 253
BP 316
EP 324
DI 10.1016/j.cej.2014.05.069
PG 9
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA AM9PN
UT WOS:000340213600038
DA 2018-10-20
ER

PT J
AU Yeo, DC
   Wiraja, C
   Mantalaris, A
   Xu, CJ
AF Yeo, David C.
   Wiraja, Christian
   Mantalaris, Athanasios (Sakis)
   Xu, Chenjie
TI Nanosensors for Regenerative Medicine
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Nanoparticle; Nanosensor; Stem Cell Bioprocessing; Cell Therapy; Tissue
   Engineering; Regenerative Medicine
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; F-18-FLUOROBENZYL
   TRIPHENYL PHOSPHONIUM; FLUORESCENCE LIFETIME MICROSCOPY; MESOPOROUS
   SILICA NANOPARTICLES; MAGNETIC-RESONANCE TRACKING; SEMICONDUCTOR QUANTUM
   DOTS; IRON-OXIDE NANOPARTICLES; IN-VIVO TRACKING; BONE-MARROW
AB Assessing biodistribution, fate, and function of implanted therapeutic cells in preclinical animal experiments is critical to realize safe, effective and efficient treatments for subsequent implementation within the clinic. Currently, tissue histology, the most prevalent analytical technique to meet this need, is limited by end-point analysis, high cost and long preparation time. Moreover, it is disadvantaged by an inability to monitor in real-time, qualitative interpretation and ethical issues arising from animal sacrifice. While genetic engineering techniques allow cells to express molecules with detectable signals (e.g., fluorescence, luminescence, T1 (spin-lattice)/T2 (spin-spin) contrast in magnetic resonance imaging, radionuclide), concerns arise regarding technical complexity, high-cost of genetic manipulation, as well as mutagenic cell dysfunction. Alternatively, cells can be labeled using nanoparticle-sensors-nanosensors that emit signals to identify cell location, status and function in a simple, cost-effective, and non-genetic manner. This review article provides the definition, classification, evolution, and applications of nanosensor technology and focuses on how they can be utilized in regenerative medicine. Several examples of direct applications include: (1) monitoring post-transplantation cell behavior, (2) revealing host response following foreign biomaterial implantation, and (3) optimization of cell bioprocess operating conditions. Incorporating nanosensors is expected to expedite the development of cell-based regenerative medicine therapeutics.
C1 [Yeo, David C.; Wiraja, Christian; Xu, Chenjie] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore.
   [Mantalaris, Athanasios (Sakis)] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2BX, England.
RP Xu, CJ (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 637457, Singapore.
EM cjxu@ntu.edu.sg
RI xu, chenjie/E-4075-2012
OI Xu, Chenjie/0000-0002-8278-3912
FU Academic Research Funds by Singapore Ministry of Education [RG 64/12]
FX This work is supported by the Tier-1 Academic Research Funds by
   Singapore Ministry of Education (RG 64/12 to CX).
CR Ahrens ET, 2013, NAT REV IMMUNOL, V13, P755, DOI 10.1038/nri3531
   Almutairi A, 2009, P NATL ACAD SCI USA, V106, P685, DOI 10.1073/pnas.0811757106
   Alvarez-Barreto JF, 2007, ANN BIOMED ENG, V35, P429, DOI 10.1007/s10439-006-9244-z
   Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426
   Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583
   Anderson J. M., 2008, P SEM IMM
   ANDO J, 1988, IN VITRO CELL DEV B, V24, P871
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Arora P, 2012, J CELL MOL MED, V16, P1991, DOI 10.1111/j.1582-4934.2012.01534.x
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Balasubramanian V, 2010, EXPERT OPIN DRUG DEL, V7, P63, DOI 10.1517/17425240903394520
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Barnett BP, 2007, NAT MED, V13, P986, DOI 10.1038/nm1581
   Barnett EM, 2009, P NATL ACAD SCI USA, V106, P9391, DOI 10.1073/pnas.0812884106
   Behnke T, 2011, J FLUORESC, V21, P937, DOI 10.1007/s10895-010-0632-2
   Benjaminsen RV, 2011, ACS NANO, V5, P5864, DOI 10.1021/nn201643f
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106
   Brasola E, 2003, CHEM COMMUN, P3026, DOI 10.1039/b310582b
   Brasuel M, 2001, ANAL CHEM, V73, P2221, DOI 10.1021/ac0012041
   Bullok K, 2005, J MED CHEM, V48, P5404, DOI 10.1021/jm050008p
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 2002, J CEREBR BLOOD F MET, V22, P899, DOI 10.1097/00004647-200208000-00001
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Cha TG, 2011, ACS NANO, V5, P4236, DOI 10.1021/nn201323h
   Chan KWY, 2013, NAT MATER, V12, P268, DOI [10.1038/NMAT3525, 10.1038/nmat3525]
   Chaudhry MA, 2009, BIOCHEM ENG J, V45, P126, DOI 10.1016/j.bej.2009.03.005
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Chen JL, 2011, CHEM COMMUN, V47, P3135, DOI 10.1039/c0cc03999c
   Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Clark HA, 1998, SENSOR ACTUAT B-CHEM, V51, P12, DOI 10.1016/S0925-4005(98)00212-3
   Contag CH, 2002, ANNU REV BIOMED ENG, V4, P235, DOI 10.1146/annurev.bioeng.4.111901.093336
   CRABTREE JE, 1991, GUT, V32, P1473, DOI 10.1136/gut.32.12.1473
   Csaszar E, 2014, BIOTECHNOL BIOENG, V111, P1258, DOI 10.1002/bit.25163
   Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003
   Cuzzocrea S, 2006, CURR PHARM DESIGN, V12, P3551, DOI 10.2174/138161206778343082
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   Dang TT, 2011, BIOMATERIALS, V32, P4464, DOI 10.1016/j.biomaterials.2011.02.048
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.040437101
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Desai HV, 2013, TISSUE ENG PT A, V19, P40, DOI [10.1089/ten.tea.2012.0127, 10.1089/ten.TEA.2012.0127]
   Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755
   Diepart C, 2010, ANAL BIOCHEM, V396, P250, DOI 10.1016/j.ab.2009.09.029
   Dmitriev RI, 2012, CELL MOL LIFE SCI, V69, P2025, DOI 10.1007/s00018-011-0914-0
   Dogan AK, 2005, J BIOMED MATER RES B, V74B, P504
   Drake TJ, 2004, APPL SPECTROSC, V58, p269A, DOI 10.1366/0003702041959406
   Dunphy I, 2002, ANAL BIOCHEM, V310, P191, DOI 10.1016/S0003-2697(02)00384-6
   Eckert MA, 2013, THERANOSTICS, V3, P583, DOI 10.7150/thno.6584
   Eppler SM, 2002, CLIN PHARMACOL THER, V72, P20, DOI 10.1067/mcp.2002.126179
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   Feinberg AW, 2012, WIRES SYST BIOL MED, V4, P207, DOI 10.1002/wsbm.164
   Fercher A, 2011, ACS NANO, V5, P5499, DOI 10.1021/nn200807g
   Ferreira L, 2009, J CELL BIOCHEM, V108, P746, DOI 10.1002/jcb.22303
   Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007
   Frinking PJA, 2000, ULTRASOUND MED BIOL, V26, P965, DOI 10.1016/S0301-5629(00)00229-5
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gessner R, 2010, MOL IMAGING, V9, P117, DOI 10.2310/7290.2010.00022
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j
   Gu E, 2012, THERANOSTICS, V2, P335, DOI 10.7150/thno.3666
   Gu F, 2008, P NATL ACAD SCI USA, V105, P2586, DOI 10.1073/pnas.0711714105
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Guo JH, 2013, BIOMATERIALS, V34, P9183, DOI 10.1016/j.biomaterials.2013.08.023
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102
   Hsiao JK, 2008, SMALL, V4, P1445, DOI 10.1002/smll.200701316
   Huang CC, 2005, ANAL CHEM, V77, P5735, DOI 10.1021/ac050957q
   Huang CC, 2007, ANAL CHEM, V79, P4798, DOI 10.1021/ac0707075
   Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034
   Hyafil F, 2007, NAT MED, V13, P636, DOI 10.1038/nm1571
   Hyun H, 2013, J CONTROL RELEASE, V170, P352, DOI 10.1016/j.jconrel.2013.06.002
   Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150
   Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041
   Jokerst JV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005228
   Jones SW, 2013, J CLIN INVEST, V123, P3061, DOI 10.1172/JCI66895
   Kale A. A., 2010, LIPOSOMES
   Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1
   Karabutov AA, 2003, LASER PHYS, V13, P711
   Kasili PM, 2004, J AM CHEM SOC, V126, P2799, DOI 10.1021/ja037388t
   Kaur S, 2012, J BIOSCI BIOENG, V113, P1, DOI 10.1016/j.jbiosc.2011.08.024
   Kazakova LI, 2013, ANAL BIOANAL CHEM, V405, P1559, DOI 10.1007/s00216-012-6381-0
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019
   KIM B, 2013, NANOSCALE RES LETT, V8, P1
   Kim GI, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/17/175503
   Kim G, 2010, ANAL CHEM, V82, P2165, DOI 10.1021/ac9024544
   Kim JH, 2009, NAT CHEM, V1, P473, DOI [10.1038/NCHEM.332, 10.1038/nchem.332]
   Kim K, 2006, J AM CHEM SOC, V128, P3490, DOI 10.1021/ja057712f
   Kim YT, 2012, NANO LETT, V12, P3587, DOI 10.1021/nl301253v
   Kingham E, 2013, ACS NANO, V7, P1867, DOI 10.1021/nn3037094
   Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721
   Kneipp J, 2006, NANO LETT, V6, P2225, DOI 10.1021/nl061517x
   Ko JH, 2013, PHYS CHEM CHEM PHYS, V15, P5379, DOI 10.1039/c2cp43155f
   Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.tea.2011.0572, 10.1089/ten.TEA.2011.0572]
   Kumar R, 2004, FOOD BIOPROD PROCESS, V82, P105, DOI 10.1205/0960308041614963
   Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851
   Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004
   Kwon H, 2013, KOREAN J RADIOL, V14, P30, DOI 10.3348/kjr.2013.14.1.30
   Lammers T, 2010, NANO TODAY, V5, P197, DOI 10.1016/j.nantod.2010.05.001
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lassailly F, 2010, BLOOD, V115, P5347, DOI 10.1182/blood-2009-05-224030
   Lavik E, 2011, ACS NANO, V5, P3419, DOI 10.1021/nn201371a
   Lee H, 2009, ADV FUNCT MATER, V19, P1884, DOI 10.1002/adfm.200801838
   Lee H, 2008, BIOMATERIALS, V29, P4709, DOI 10.1016/j.biomaterials.2008.08.038
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee YEK, 2010, ANAL CHEM, V82, P8446, DOI 10.1021/ac1015358
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595
   Li M, 2013, ACS NANO, V7, P4967, DOI 10.1021/nn4018284
   Liu YC, 2012, STEM CELLS, V30, P1911, DOI 10.1002/stem.1164
   Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799
   Madar I, 2009, J NUCL MED, V50, P774, DOI 10.2967/jnumed.108.061283
   Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6
   Marolt D., 2012, P NATL ACAD SCI US
   Martin CH, 2010, APPL ENVIRON MICROB, V76, P417, DOI 10.1128/AEM.01769-09
   Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403
   Maxwell D, 2009, BIOCONJUGATE CHEM, V20, P702, DOI [10.1021/bc800516n, 10.1021/bcB00516n]
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181
   Navarro M., 2012, METHODS MOL BIOL
   Neves AA, 2014, J NUCL MED, V55, P1, DOI 10.2967/jnumed.112.114264
   Nisisako T, 2008, LAB CHIP, V8, P287, DOI 10.1039/b713141k
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Nutiu R., 2005, ANGEW CHEM, V117, P1085
   Okabe K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1714
   Ostendorp M, 2008, CANCER RES, V68, P7676, DOI 10.1158/0008-5472.CAN-08-0689
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Park EJ, 2003, ANAL CHEM, V75, P3784, DOI 10.1021/ac0342323
   Pichler BJ, 2010, J NUCL MED, V51, P333, DOI 10.2967/jnumed.109.061853
   Pimlott SL, 2011, CHEM SOC REV, V40, P149, DOI 10.1039/b922628c
   Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   Quinti L, 2006, NANO LETT, V6, P488, DOI [10.1021/nl0524694, 10.1021/nl052494x]
   Raiche AT, 2004, BIOMATERIALS, V25, P677, DOI 10.1016/S0142-9612(03)00564-7
   Rak-Raszewska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032650
   Ratcliffe E, 2011, BRIT MED BULL, V100, P137, DOI 10.1093/bmb/ldr037
   Reynhout IC, 2007, J AM CHEM SOC, V129, P2327, DOI 10.1021/ja066790f
   Rischpler C, 2011, J NUCL MED, V52, DOI 10.2967/jnumed.110.085993
   Ritman EL, 2011, ANNU REV BIOMED ENG, V13, P531, DOI 10.1146/annurev-bioeng-071910-124717
   Rodriguez-Porcel Martin, 2010, Curr Cardiol Rep, V12, P51, DOI 10.1007/s11886-009-0073-1
   Rosen AB, 2007, STEM CELLS, V25, P2128, DOI 10.1634/stemcells.2006-0722
   Sandros MG, 2006, ANALYST, V131, P229, DOI 10.1039/b511591d
   Saxena A, 2013, MOL IMAGING BIOL, V15, P282, DOI 10.1007/s11307-012-0599-2
   Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/1076327042500391
   Schroeder T, 2011, NAT METHODS, V8, pS30, DOI [10.1038/NMETH.1577, 10.1038/nmeth.1577]
   Schulthess G., 2010, EUR J NUCL MED MOL 1, V37, P980
   Sharma P, 2012, SMALL, V8, P2856, DOI 10.1002/smll.201200258
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shi HB, 2012, J AM CHEM SOC, V134, P17972, DOI 10.1021/ja3064588
   Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354
   Singhal S, 2010, ANNU REV MED, V61, P359, DOI 10.1146/annurev.med.60.052907.094936
   Snippert HJ, 2011, EMBO REP, V12, P113, DOI 10.1038/embor.2010.216
   Solanki A., 2008, NANOTECHNOLOGY REGEN
   Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stich MIJ, 2009, ADV MATER, V21, P2216, DOI 10.1002/adma.200803575
   Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967
   Stringari C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00568
   Stringari C, 2011, P NATL ACAD SCI USA, V108, P13582, DOI 10.1073/pnas.1108161108
   Sumner JP, 2006, SENSOR ACTUAT B-CHEM, V113, P760, DOI 10.1016/j.snb.2005.07.028
   Sumner JP, 2005, ANALYST, V130, P528, DOI 10.1039/b414189j
   Sumner JP, 2002, ANALYST, V127, P11, DOI 10.1039/b108568a
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8
   Tanabe K, 2004, CURR PHARM DESIGN, V10, P357, DOI 10.2174/1381612043453289
   Tang MX, 2011, INTERFACE FOCUS, V1, P520, DOI 10.1098/rsfs.2011.0026
   Tsou CJ, 2013, J MATER CHEM B, V1, P5557, DOI 10.1039/c3tb21009j
   Tsuji T, 2013, ANAL CHEM, V85, P9815, DOI 10.1021/ac402128f
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Vannier MW, 1996, RADIOL CLIN N AM, V34, P545
   Vo-Dinh T., 2010, BIOMEDICAL PHOTONICS
   Voura EB, 2004, NAT MED, V10, P993, DOI 10.1038/nm1096
   Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070
   Wang HB, 2011, ANGEW CHEM INT EDIT, V50, P7065, DOI 10.1002/anie.201101351
   Wang HH, 2009, CHEM-EUR J, V15, P12417, DOI 10.1002/chem.200901548
   Wang H, 2009, STEM CELLS, V27, P1548, DOI 10.1002/stem.81
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang SE, 2013, APPL SPECTROSC, V67, P1270, DOI 10.1366/13-07071
   Wang SH, 2009, J AM CHEM SOC, V131, P11692, DOI 10.1021/ja904824w
   Wang X. D., 2013, ANGEW CHEM, V125, P424
   Wang XP, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/3/035002
   Wang XD, 2011, CHEM SCI, V2, P901, DOI 10.1039/c0sc00610f
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Weissleder R, 2005, NAT BIOTECHNOL, V23, P1418, DOI 10.1038/nbt1159
   Weng MF, 2009, DIAM RELAT MATER, V18, P587, DOI 10.1016/j.diamond.2008.07.012
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson AN, 2013, ADV HEALTHC MATER, V2, P520, DOI 10.1002/adhm.201200332
   Winter PM, 2003, CANCER RES, V63, P5838
   Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95
   Wu TJ, 2013, NAT NANOTECHNOL, V8, P682, DOI [10.1038/nnano.2013.147, 10.1038/NNANO.2013.147]
   Xia ZY, 2011, ACS CHEM BIOL, V6, P1117, DOI 10.1021/cb200135e
   Xu CJ, 2012, NANO LETT, V12, P4131, DOI 10.1021/nl301658q
   Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892
   Yeo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081728
   Yeom J, 2010, TISSUE ENG PART C-ME, V16, P1059, DOI [10.1089/ten.tec.2009.0759, 10.1089/ten.TEC.2009.0759]
   Yoo J.-W., 2010, P NATL ACAD SCI US
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zhang CF, 2007, CANCER RES, V67, P1555, DOI 10.1158/0008-5475.CAN-06-1668
   Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75
   Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
   Zheng D, 2009, NANO LETT, V9, P3258, DOI 10.1021/nl901517b
NR 217
TC 6
Z9 6
U1 6
U2 70
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD OCT
PY 2014
VL 10
IS 10
SI SI
BP 2722
EP 2746
DI 10.1166/jbn.2014.1992
PG 25
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AL9QR
UT WOS:000339476300013
PM 25992416
DA 2018-10-20
ER

PT J
AU Bazaka, K
   Ketheesan, N
   Jacob, MV
AF Bazaka, Kateryna
   Ketheesan, Natkunam
   Jacob, Mohan V.
TI Polymer Encapsulation of Magnesium to Control Biodegradability and
   Biocompatibility
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Magnesium; Implantable Materials; Biocompatibility; Encapsulation
ID SIMULATED BODY-FLUID; CORROSION BEHAVIOR; THIN-FILMS; ALLOYS;
   WETTABILITY; PERFORMANCE; ROUGHNESS; IMPLANTS; SURFACES; COATINGS
AB Clinical utility of biodegradable magnesium implants is undermined by the untimely degradation of these materials in vivo. Their high corrosion rate leads to loss of mechanical integrity, peri-implant alkalization and localised accumulation of hydrogen gas. Biodegradable coatings were produced on pure magnesium using RF plasma polymerisation. A monoterpene alcohol with known anti-inflammatory and antibacterial properties was used as a polymer precursor. The addition of the polymeric layer was found to reduce the degradation rate of magnesium in simulated body fluid. The in vitro studies indicated good cytocompatibility of non-adherent THP-1 cells and mouse macrophage cells with the polymer, and the polymer coated sample. The viability of THP-1 cells was significantly improved when in contact with polymer encapsulated magnesium compared to unmodified samples. Collectively, these results suggest plasma enhanced polymer encapsulation of magnesium as a suitable method to control degradation kinetics of this biomaterial.
C1 [Bazaka, Kateryna; Jacob, Mohan V.] James Cook Univ, Sch Engn & Phys Sci, Elect Mat Res Lab, Townsville, Qld 4811, Australia.
   [Ketheesan, Natkunam] James Cook Univ, Infect Dis & Immunopathogenesis Res Grp, Discipline Microbiol & Immunol, Townsville, Qld 4811, Australia.
RP Jacob, MV (reprint author), James Cook Univ, Sch Engn & Phys Sci, Elect Mat Res Lab, Townsville, Qld 4811, Australia.
RI Jacob, Mohan/B-9097-2009
OI Jacob, Mohan/0000-0002-2598-7193; Bazaka, Kateryna/0000-0003-2032-6377
FU JCU Collaboration Across Boundaries grant
FX This work is supported by the JCU Collaboration Across Boundaries grant.
   The authors thank Natasha Williams for technical assistance with THP-1
   and PEC cultures.
CR Annarelli CC, 1999, J COLLOID INTERF SCI, V213, P386, DOI 10.1006/jcis.1999.6153
   Bazaka K, 2009, MATER LETT, V63, P1594, DOI 10.1016/j.matlet.2009.04.025
   Bazaka K, 2011, J MATER RES, V26, P1018, DOI 10.1557/jmr.2011.23
   Bazaka K, 2011, POLYMERS-BASEL, V3, P388, DOI 10.3390/polym3010388
   Bazaka K, 2010, BIOMACROMOLECULES, V11, P2016, DOI 10.1021/bm100369n
   Easton CD, 2009, CHEM VAPOR DEPOS, V15, P179, DOI 10.1002/cvde.200806719
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Gasparotto A, 2011, J NANOSCI NANOTECHNO, V11, P8206, DOI 10.1166/jnn.2011.5023
   Gonzalo N, 2012, VASC HEALTH RISK MAN, V8, P125, DOI 10.2147/VHRM.S22551
   Hanzi AC, 2009, ACTA BIOMATER, V5, P162, DOI 10.1016/j.actbio.2008.07.034
   Hao L, 2005, APPL SURF SCI, V247, P453, DOI 10.1016/j.apsusc.2005.01.163
   Hu RG, 2012, PROG ORG COAT, V73, P129, DOI 10.1016/j.porgcoat.2011.10.011
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li M, 2012, APPL SURF SCI, V258, P3074, DOI 10.1016/j.apsusc.2011.11.040
   Minagar S, 2012, ACTA BIOMATER, V8, P2875, DOI 10.1016/j.actbio.2012.04.005
   Paosawatyanyong B, 2010, J NANOSCI NANOTECHNO, V10, P7050, DOI 10.1166/jnn.2010.2849
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rude RK, 2009, J AM COLL NUTR, V28, P131, DOI 10.1080/07315724.2009.10719764
   Shimizu Y, 2010, INTERFACE ORAL HEALTH SCIENCE 2009, P318, DOI 10.1007/978-4-431-99644-6_93
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Zhu YY, 2012, SURF COAT TECH, V206, P2961, DOI 10.1016/j.surfcoat.2011.12.029
NR 29
TC 7
Z9 7
U1 0
U2 60
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD OCT
PY 2014
VL 14
IS 10
BP 8087
EP 8093
DI 10.1166/jnn.2014.9409
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AH9VZ
UT WOS:000336494500135
PM 25942929
DA 2018-10-20
ER

PT J
AU Chae, MJ
   Kim, DW
   Kim, YJ
   Kweon, HY
   Cho, YJ
   Choi, SY
   Lee, HR
AF Chae, Min Ju
   Kim, Dae Won
   Kim, Yun Joong
   Kweon, Hae Yong
   Cho, Yong-Jun
   Choi, Soo Young
   Lee, Hae Ran
TI Toxicity assessment of a novel silk fibroin and poly-methyl-methacrylate
   composite material
SO MOLECULAR & CELLULAR TOXICOLOGY
LA English
DT Article
DE Cytotoxicity; Genotoxicity; MTT assay; Ames test; Mouse lymphoma assay;
   Silk fibroin; Poly-methyl-methacrylate; ISO10993
ID MARROW STROMAL CELL; BONE; RESPONSES; BIOMATERIALS; MEMBRANE; FIBERS;
   ASSAY; PMMA
AB Based on its biocompatibility, silk fibroin has been applied in the fabrication of biomaterials in various forms such as gels, powders, fibers, and membranes. Poly-methyl-methacrylate (PMMA), which has been successfully used as a filler material in vertebroplasty, has the disadvantage of excessive inherent stiffness, which may damage adjacent vertebral bodies in elderly patients with osteoporosis. A novel potential filler material, consisting of silk fibroin and PMMA (silk/PMMA), was tested to assess its cytotoxicity, genotoxicity, and intramuscular implantation experiment according to ISO 10993. The MTT assay, Ames test, mouse lymphoma assay, and intramuscular implantation were performed using extracts from solidified silk/PMMA, according to the protocol in ISO10993. Extracts of silk/PMMA did not show cytotoxicity, genotoxicity or toxic reaction in intramuscular implantation. These findings suggest that the silk/PMMA composite materials may potentially be used as a nontoxic biomaterial.
C1 [Chae, Min Ju; Kim, Yun Joong] Hallym Univ, ILSONG Inst Life Sci, Anyang, South Korea.
   [Kim, Dae Won] Gangneung Wonju Natl Univ, Coll Dent, Res Inst Oral Sci, Dept Biochem & Mol Biol, Kangnung 210702, South Korea.
   [Kweon, Hae Yong] Natl Acad Agr Sci, Sericultural & Agicultural Mat Div, RDA, Suwon, South Korea.
   [Cho, Yong-Jun] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Neurosurg, Chunchon, South Korea.
   [Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon, South Korea.
   [Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon, South Korea.
   [Lee, Hae Ran] Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Pediat, Anyang, South Korea.
RP Lee, HR (reprint author), Hallym Univ, Sacred Heart Hosp, Coll Med, Dept Pediat, Anyang, South Korea.
EM drran@hallym.or.kr
FU Next-Generation BioGreen 21 Program [PJ007170012011]; Rural Development
   Administration, Republic of Korea
FX This work was supported by a grant from the Next-Generation BioGreen 21
   Program (No. PJ007170012011), Rural Development Administration, Republic
   of Korea.
CR Boger A, 2007, EUR SPINE J, V16, P2118, DOI 10.1007/s00586-007-0473-0
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Clements J, 2000, MUTAT RES-FUND MOL M, V455, P97, DOI 10.1016/S0027-5107(00)00066-X
   Frazer Robert Q, 2005, J Long Term Eff Med Implants, V15, P629
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   JENSEN JS, 1991, PHARMACOL TOXICOL, V69, P386, DOI 10.1111/j.1600-0773.1991.tb01317.x
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim JY, 2010, BMB REP, V43, P52, DOI 10.5483/BMBRep.2010.43.1.052
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mitchell AD, 1997, MUTAT RES-GEN TOX EN, V394, P177, DOI 10.1016/S1383-5718(97)00115-0
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Nazarian A, 2008, CALCIFIED TISSUE INT, V83, P368, DOI 10.1007/s00223-008-9174-x
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Putthanarat S, 2002, POLYMER, V43, P3405, DOI 10.1016/S0032-3861(02)00161-1
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Song JY, 2011, ORAL SURG ORAL MED O, V112, pE26, DOI 10.1016/j.tripleo.2011.05.002
   Takashima H., 2000, MACROMOL MATER ENG, V283, P126
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Yang F, 2005, SIMUL MODEL PRACT TH, V13, P437, DOI [10.1016/j.simpat.2004.12.004, 10.1016/j,simpat.2004.12.004]
   Yao JM, 2002, MACROMOLECULES, V35, P6, DOI 10.1021/ma011335j
NR 23
TC 1
Z9 1
U1 2
U2 24
PU KOREAN SOCIETY TOXICOGENOMICS & TOXICOPROTEOMICS-KSTT
PI GYEONGGI-DO
PA HANYANG UNIV, SCI & TECHNOL BLDG 1, RM 423, SA-DONG, SANGROK-GU, ANSAN,
   GYEONGGI-DO, 426 791, SOUTH KOREA
SN 1738-642X
EI 2092-8467
J9 MOL CELL TOXICOL
JI Mol. Cell. Toxicol.
PD SEP 30
PY 2014
VL 10
IS 3
BP 277
EP 283
DI 10.1007/s13273-014-0031-x
PG 7
WC Biochemistry & Molecular Biology; Toxicology
SC Biochemistry & Molecular Biology; Toxicology
GA AP9MQ
UT WOS:000342404300007
DA 2018-10-20
ER

PT J
AU Donaghue, IE
   Tam, R
   Sefton, MV
   Shoichet, MS
AF Donaghue, Irja Elliott
   Tam, Roger
   Sefton, Michael V.
   Shoichet, Molly S.
TI Cell and biomolecule delivery for tissue repair and regeneration in the
   central nervous system
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Tissue engineering; Biomaterial drug delivery; Stem cell
   transplantation; Spinal cord injury; Traumatic brain injury
ID SPINAL-CORD-INJURY; BLOOD-BRAIN-BARRIER; PROMOTES FUNCTIONAL RECOVERY;
   HYALURONIC-ACID HYDROGEL; NEURAL STEM-CELLS; LOADED BIODEGRADABLE
   MICROSPHERES; FACTOR-RELEASING MICROSPHERES; NOGO-66 RECEPTOR ANTIBODY;
   FIBROBLAST-GROWTH-FACTOR; RETINAL GANGLION-CELLS
AB Tissue engineering frequently involves cells and scaffolds to replace damaged or diseased tissue. It originated, in part, as a means of effecting the delivery of biomolecules such as insulin or neurotrophic factors, given that cells are constitutive producers of such therapeutic agents. Thus cell delivery is intrinsic to tissue engineering. Controlled release of biomolecules is also an important tool for enabling cell delivery since the biomolecules can enable cell engraftment, modulate inflammatory response or otherwise benefit the behavior of the delivered cells. We describe advances in cell and biomolecule delivery for tissue regeneration, with emphasis on the central nervous system (CNS). In the first section, the focus is on encapsulated cell therapy. In the second section, the focus is on biomolecule delivery in polymeric nano/microspheres and hydrogels for the nerve regeneration and endogenous cell stimulation. In the third section, the focus is on combination strategies of neural stem/progenitor cell or mesenchymal stem cell and biomolecule delivery for tissue regeneration and repair. In each section, the challenges and potential solutions associated with delivery to the CNS are highlighted. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Donaghue, Irja Elliott; Tam, Roger; Sefton, Michael V.; Shoichet, Molly S.] Univ Toronto, Donnelly Ctr, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E1, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Donnelly Ctr, Inst Biomat & Biomed Engn, Dept Chem Engn & Appl Chem, 160 Coll St, Toronto, ON M5S 3E1, Canada.
EM Michael.sefton@utoronto.ca; Molly.shoichet@utoronto.ca
OI Tam, Roger/0000-0002-8441-6681
FU Canadian Institutes of Health Research [MOP-89980]; Natural Sciences and
   Engineering Research Council of Canada [480528]
FX We are grateful to the Canadian Institutes of Health Research
   (MOP-89980) and Natural Sciences and Engineering Research Council of
   Canada (480528) for partial funding of our research.
CR Aebischer P, 1996, HUM GENE THER, V7, P851, DOI 10.1089/hum.1996.7.7-851
   Aebischer P, 1986, ASAIO Trans, V32, P130
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   ALBISSER AM, 1974, DIABETES, V23, P389, DOI 10.2337/diab.23.5.389
   Andrieu-Soler C, 2005, MOL VIS, V11
   Ansorena E, 2013, INT J PHARMACEUT, V455, P148, DOI 10.1016/j.ijpharm.2013.07.045
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Aviles-Olmos I, 2013, J CLIN INVEST, V123, P2730, DOI 10.1172/JCI68295
   Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322
   Bertilsson G, 2008, J NEUROSCI RES, V86, P326, DOI 10.1002/jnr.21483
   Bible E, 2012, BIOMATERIALS, V33, P7435, DOI 10.1016/j.biomaterials.2012.06.085
   Boado RJ, 2008, BIOTECHNOL BIOENG, V100, P387, DOI 10.1002/bit.21764
   BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076
   Bradbury EJ, 1999, EUR J NEUROSCI, V11, P3873, DOI 10.1046/j.1460-9568.1999.00809.x
   Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Burgess A, 2013, ACS CHEM NEUROSCI, V4, P519, DOI 10.1021/cn300191b
   Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002
   Campioni EG, 1998, BIOMATERIALS, V19, P829, DOI 10.1016/S0142-9612(97)00241-X
   Cerqueira SR, 2013, SMALL, V9, P738, DOI 10.1002/smll.201201888
   Checa-Casalengua P, 2011, J CONTROL RELEASE, V156, P92, DOI 10.1016/j.jconrel.2011.06.023
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   CHICK WL, 1975, T AM SOC ART INT ORG, V21, P8
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   CREQUE HM, 1980, DIABETES, V29, P37, DOI 10.2337/diabetes.29.1.37
   Cully M, 2013, NATURE, V503, pS10, DOI 10.1038/503S10a
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Delcroix GJR, 2011, BIOMATERIALS, V32, P1560, DOI 10.1016/j.biomaterials.2010.10.041
   DiNunzio JC, 2008, DRUG DEV IND PHARM, V34, P1141, DOI [10.1080/03639040802020536, 10.1080/03639040802020536 ]
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765
   Follett KA, 2004, ANESTHESIOLOGY, V100, P1582, DOI 10.1097/00000542-200406000-00034
   Fu AL, 2010, BRAIN RES, V1360, P193, DOI 10.1016/j.brainres.2010.09.009
   Gao HL, 2013, PHARM RES-DORDR, V30, P2485, DOI 10.1007/s11095-013-1122-4
   Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Grous LC, 2013, J NEUROSURG-SPINE, V18, P641, DOI 10.3171/2013.3.SPINE12874
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hamann MCJ, 2005, EXP NEUROL, V194, P106, DOI 10.1016/j.expneurol.2005.01.030
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924
   Ji BX, 2005, EUR J NEUROSCI, V22, P587, DOI 10.1111/j.1460-9568.2005.04241.x
   Jiang C, 2007, MOL VIS, V13, P1783
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Jollivet C, 2004, NEUROSCI LETT, V356, P207, DOI 10.1016/j.neulet.2003.11.051
   Jollivet C, 2004, BIOMATERIALS, V25, P933, DOI 10.1016/S0142-9612(03)00601-X
   Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Jordao JF, 2013, EXP NEUROL, V248, P16, DOI 10.1016/j.expneurol.2013.05.008
   Kang CE, 2013, CELLS TISSUES ORGANS, V197, P55, DOI 10.1159/000339589
   Kang CE, 2010, J NEUROTRAUM, V27, P2041, DOI 10.1089/neu.2010.1345
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   Kim H, 2011, PLOS ONE, V6
   Kim YT, 2009, BIOMATERIALS, V30, P2582, DOI 10.1016/j.biomaterials.2008.12.077
   Kinoshita M, 2006, BIOCHEM BIOPH RES CO, V340, P1085, DOI 10.1016/j.bbrc.2005.12.112
   Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1
   Kolb B, 2007, J CEREBR BLOOD F MET, V27, P983, DOI 10.1038/sj.jcbfm.9600402
   KOST J, 1985, J BIOMED MATER RES, V19, P1117, DOI 10.1002/jbm.820190920
   Lampe KJ, 2011, J BIOMED MATER RES A, V96A, P595, DOI 10.1002/jbm.a.33011
   Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Li SX, 2003, J NEUROSCI, V23, P4219
   Li XG, 2009, BIOMATERIALS, V30, P1121, DOI 10.1016/j.biomaterials.2008.10.063
   LIM F, 1981, SCIENCE, V213, P1146, DOI 10.1126/science.213.4512.1146-a
   Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Matsuse D, 2011, TISSUE ENG PT A, V17, P1993, DOI [10.1089/ten.TEA.2010.0585, 10.1089/ten.tea.2010.0585]
   McKerracher L, 2013, J NEUROTRAUM, V30, P1795, DOI 10.1089/neu.2013.2909
   Mehrotra S, 2012, J BIOMAT SCI-POLYM E, V23, P439, DOI 10.1163/092050610X552221
   Mehrotra S, 2010, ADV FUNCT MATER, V20, P247, DOI 10.1002/adfm.200901172
   MENEI P, 1993, BIOMATERIALS, V14, P470, DOI 10.1016/0142-9612(93)90151-Q
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Nance E. A., 2012, SCI TRANSL MED, V4
   Nicholas AP, 2002, NEUROSCI LETT, V323, P85, DOI 10.1016/S0304-3940(01)02534-4
   Nixon J.R., 1976, MICROENCAPSULATION
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   Pakulska M.M., 2012, BIOMED MAT, V7
   Pakulska MM, 2013, J CONTROL RELEASE, V171, P11, DOI 10.1016/j.jconrel.2013.06.029
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Roberts T, 1996, BIOMATERIALS, V17, P267, DOI 10.1016/0142-9612(96)85564-5
   Rogalewski A, 2006, STROKE, V37, P1129, DOI 10.1161/01.STR.0000209330.73175.34
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sawyer Andrew J, 2006, Yale J Biol Med, V79, P141
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   SHAMOON H, 1993, NEW ENGL J MED, V329, P977
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Song BW, 2002, J PHARMACOL EXP THER, V301, P605, DOI 10.1124/jpet.301.2.605
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stanwick JC, 2012, INT J PHARMACEUT, V426, P284, DOI 10.1016/j.ijpharm.2012.01.035
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Sugamori M E, 1989, ASAIO Trans, V35, P791
   Sumbria RK, 2013, BRAIN RES, V1507, P91, DOI 10.1016/j.brainres.2013.02.022
   Taylor SJ, 2006, J CONTROL RELEASE, V116, P204, DOI 10.1016/j.jconrel.2006.07.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003
   THUROW H, 1984, DIABETOLOGIA, V27, P212
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tibbitt MW, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004804
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Tysseling VM, 2010, J NEUROSCI RES, V88, P3161, DOI 10.1002/jnr.22472
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   ULUDAG H, 1994, BIOTECHNOL BIOENG, V44, P1199, DOI 10.1002/bit.260441007
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Vallbacka JJ, 2001, J CONTROL RELEASE, V72, P93, DOI 10.1016/S0168-3659(01)00265-6
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050
   Wang YF, 2013, J CONTROL RELEASE, V172, P1, DOI 10.1016/j.jconrel.2013.07.032
   Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031
   Ward MS, 2007, J PHARM SCI-US, V96, P558, DOI 10.1002/jps.20629
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   Wilson JR, 2013, CAN MED ASSOC J, V185, P485, DOI 10.1503/cmaj.121206
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
   Yao L, 2013, GENE THER, V20, P1149, DOI 10.1038/gt.2013.42
   Zhang Y, 2001, BRAIN RES, V889, P49, DOI 10.1016/S0006-8993(00)03108-5
   Zhang Y, 2001, STROKE, V32, P1378, DOI 10.1161/01.STR.32.6.1378
   Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005
   Zhao RR, 2013, EUR J NEUROSCI, V38, P2946, DOI 10.1111/ejn.12276
   Zhou JP, 2008, BRAIN RES, V1191, P12, DOI 10.1016/j.brainres.2007.10.097
NR 138
TC 37
Z9 37
U1 11
U2 98
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 28
PY 2014
VL 190
SI SI
BP 219
EP 227
DI 10.1016/j.jconrel.2014.05.040
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AU9KH
UT WOS:000345910900010
PM 24878181
DA 2018-10-20
ER

PT J
AU Vellonen, KS
   Malinen, M
   Mannermaa, E
   Subrizi, A
   Toropainen, E
   Lou, YR
   Kidron, H
   Yliperttula, M
   Urtti, A
AF Vellonen, Kati-Sisko
   Malinen, Melina
   Mannermaa, Eliisa
   Subrizi, Astrid
   Toropainen, Elisa
   Lou, Yan-Ru
   Kidron, Heidi
   Yliperttula, Marjo
   Urtti, Arto
TI A critical assessment of in vitro tissue models for ADME and drug
   delivery
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Cell model; RPE; Epidermis; Hepatocyte; Corneal epithelium; In vitro in
   vivo correlation
ID RETINAL-PIGMENT-EPITHELIUM; PLURIPOTENT STEM-CELLS; BLOOD-BRAIN-BARRIER;
   PRIMARY HUMAN HEPATOCYTES; HUMAN CORNEAL EPITHELIUM; CULTURED RAT
   HEPATOCYTES; BETA-BLOCKING-AGENTS; COLLAGEN-SANDWICH CONFIGURATION;
   RESISTANCE-ASSOCIATED PROTEIN-2; EPIDERMAL PERMEABILITY BARRIER
AB Cultured cells are widely used in the evaluation of new drugs and drug delivery systems. Cells can be grown at different levels of complexity ranging from simple reductionist models to complex organotypic models. The models are based on primary, secondary or stem cell derived cell cultures. Generation of tissue mimics with cultured cells is a difficult task, because the tissues have well-defined morphology, complex protein expression patterns and multiple inter-linked functions. Development of organotypic cell culture models requires proper biomaterial matrix and cell culture protocols that are able to guide the cells to the correct phenotype. This review illustrates the critical features of the cell culture models and, then, selected models are discussed in more detail (epidermal, corneal epithelial, retinal pigment epithelium, and hepatocyte models). The cell models are critically evaluated paying attention to the level of characterization and reliability of in vivo translation. Properties of the cell models must be characterized in detail using multiple biological assays and broad sets of model drugs. Robust in vivo predictions can be achieved with well-characterized cell models that are used in combination with computational methods that will bridge the gap between in vitro cell experiments and physiological situation in vivo in the body. (C) 2014 Elsevier B. V. All rights reserved.
C1 [Malinen, Melina; Subrizi, Astrid; Lou, Yan-Ru; Kidron, Heidi; Yliperttula, Marjo; Urtti, Arto] Univ Helsinki, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland.
   [Vellonen, Kati-Sisko; Urtti, Arto] Univ Eastern Finland, Sch Pharm, Kuopio, Finland.
   [Mannermaa, Eliisa; Toropainen, Elisa] Kuopio Univ Hosp, Dept Ophthalmol, SF-70210 Kuopio, Finland.
RP Urtti, A (reprint author), Univ Helsinki, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland.
RI Kidron, Heidi/A-5826-2015; Lou, Yan-Ru/K-4348-2012
OI Kidron, Heidi/0000-0001-6427-8042; Lou, Yan-Ru/0000-0001-7717-6010
FU Academy of Finland
FX This study was supported by grants from the Academy of Finland (A.U.,
   H.K.).
CR ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0
   Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t
   ALM A, 1973, EXP EYE RES, V15, P15, DOI 10.1016/0014-4835(73)90185-1
   Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197
   ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614
   Arndt CF, 2001, INVEST OPHTH VIS SCI, V42, P472
   Aukunuru JV, 2001, PHARM RES-DORDR, V18, P565, DOI 10.1023/A:1011060705599
   Bakri SJ, 2007, OPHTHALMOLOGY, V114, P2179, DOI 10.1016/j.ophtha.2007.09.012
   Balakrishnan A, 2002, INT J PHARM, V247, P115, DOI 10.1016/S0378-5173(02)00405-2
   Ballatori N, 2005, TOXICOL APPL PHARM, V204, P238, DOI 10.1016/j.taap.2004.09.008
   Becker U, 2008, ATLA-ALTERN LAB ANIM, V36, P33
   Becker U, 2007, J OCUL PHARMACOL TH, V23, P172, DOI 10.1089/jop.2006.0095
   Berezovsky DE, 2011, INVEST OPHTH VIS SCI, V52, P7038, DOI 10.1167/iovs.11-7207
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   BRAET F, 2002, COMP HEPATOL, V1, DOI DOI 10.1186/1476-5926-1-1
   Bridges CC, 2002, CURR EYE RES, V24, P129, DOI 10.1076/ceyr.24.2.129.8167
   BROD J, 1991, INT J DERMATOL, V30, P84, DOI 10.1111/j.1365-4362.1991.tb04216.x
   Brouwer KLR, 2013, CLIN PHARMACOL THER, V94, P95, DOI 10.1038/clpt.2013.81
   Brzeszczynska J, 2014, INT J MOL MED, V33, P1597, DOI 10.3892/ijmm.2014.1714
   Cascorbi I, 2006, PHARMACOL THERAPEUT, V112, P457, DOI 10.1016/j.pharmthera.2006.04.009
   Cashman JR, 2008, EXPERT OPIN DRUG MET, V4, P1507, DOI 10.1517/17425250802522188 
   Catros S, 2012, TISSUE ENG PART C-ME, V18, P62, DOI [10.1089/ten.tec.2011.0382, 10.1089/ten.TEC.2011.0382]
   Cerec V, 2007, HEPATOLOGY, V45, P957, DOI 10.1002/hep.21536
   Chandra P, 2004, PHARM RES-DORDR, V21, P719, DOI 10.1023/B:PHAM.0000026420.79421.8f
   Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020
   Chang JE, 2000, PHARMACEUT RES, V17, P670, DOI 10.1023/A:1007569929765
   Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790
   Chu XY, 2013, EXPERT OPIN DRUG MET, V9, P237, DOI 10.1517/17425255.2013.741589
   Chua KN, 2005, BIOMATERIALS, V26, P2537, DOI 10.1016/j.biomaterials.2004.07.040
   Cramer J, 2007, CHEMMEDCHEM, V2, P1783, DOI 10.1002/cmdc.200700160
   Cubitt HE, 2011, XENOBIOTICA, V41, P623, DOI 10.3109/00498254.2011.560294
   Cunha-Vaz JG, 2004, EXP EYE RES, V78, P715, DOI 10.1016/S0014-4835(03)00213-6
   D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645
   Dahlin A, 2013, MOL PHARMACEUT, V10, P650, DOI 10.1021/mp300429e
   Darnell M, 2011, DRUG METAB DISPOS, V39, P1131, DOI 10.1124/dmd.110.037721
   Dash A, 2013, AM J PHYSIOL-CELL PH, V304, pC1053, DOI 10.1152/ajpcell.00331.2012
   DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955
   de Graaf IAM, 2006, DRUG METAB DISPOS, V34, P591, DOI 10.1124/dmd.105.006726
   De S., 2003, INVEST OPHTH VIS SCI, V44, P2909
   Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005
   Deshpande P, 2013, BIOMATERIALS, V34, P5088, DOI 10.1016/j.biomaterials.2013.03.064
   Deuter S., 2007, BR J OPHTHALMOL, V91, P319
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744
   EDELHAUSER HF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1110
   EDELMAN JL, 1991, INVEST OPHTH VIS SCI, V32, P3033
   El Sanharawi M, 2010, PROG RETIN EYE RES, V29, P443, DOI 10.1016/j.preteyeres.2010.04.001
   Elferink MGL, 2011, TOXICOL APPL PHARM, V253, P57, DOI 10.1016/j.taap.2011.03.010
   Elias J.J., 1989, PERCUTANEOUS ABSORPT, P3
   Elias P M, 1998, J Investig Dermatol Symp Proc, V3, P87
   Elias P.M., 1992, PHARM SKIN, P29
   ELIAS PM, 1983, J INVEST DERMATOL, V80, P44, DOI DOI 10.1038/JID.1983.12)
   Elliott NT, 2012, BIOTECHNOL BIOENG, V109, P1326, DOI 10.1002/bit.24397
   Engle SJ, 2013, CELL STEM CELL, V12, P669, DOI 10.1016/j.stem.2013.05.011
   EPSTEIN DL, 1977, ARCH OPHTHALMOL-CHIC, V95, P1378, DOI 10.1001/archopht.1977.04450080088009
   Esser P, 1998, INVEST OPHTH VIS SCI, V39, P164
   Faber KN, 2003, ADV DRUG DELIVER REV, V55, P107, DOI 10.1016/S0169-409X(02)00173-4
   Feingold KR, 2014, BBA-MOL CELL BIOL L, V1841, P280, DOI 10.1016/j.bbalip.2013.11.007
   Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200
   Finneman SC, 2001, J EXP MED, V194, P1289, DOI 10.1084/jem.194.9.1289
   FRAMBACH DA, 1988, INVEST OPHTH VIS SCI, V29, P814
   FRAMBACH DA, 1990, INVEST OPHTH VIS SCI, V31, P1767
   Galetin A, 2005, J PHARMACOL EXP THER, V314, P180, DOI 10.1124/jpet.104.082826
   Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4
   Ghaedi M, 2012, CELL MOL BIOL LETT, V17, P89, DOI 10.2478/s11658-011-0040-x
   Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028
   Gjorevski N, 2014, DEVELOPMENT, V141, P1794, DOI 10.1242/dev.101048
   Grainger CI, 2006, PHARM RES, V23, P1482, DOI 10.1007/s11095-006-0255-0
   Greco D, 2010, MOL VIS, V16, P2109
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   GUGUENGUILLOUZO C, 1983, MOL CELL BIOCHEM, V53-4, P35
   Gulfam M, 2011, BIOTECHNOL PROGR, V27, P466, DOI 10.1002/btpr.515
   GUNDERSEN D, 1991, J CELL BIOL, V112, P863, DOI 10.1083/jcb.112.5.863
   Haghjou N, 2013, PHARM RES-DORDR, V30, P41, DOI 10.1007/s11095-012-0847-9
   Hahne M, 2012, J PHARM SCI-US, V101, P2976, DOI 10.1002/jps.23190
   Hamalainen KM, 1997, J CONTROL RELEASE, V49, P97
   Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153
   Hariharan S, 2009, PHARM RES-DORD, V26, P1270, DOI 10.1007/s11095-008-9741-x
   Hattori K, 2014, METHODS MOL BIOL, V1104, P251, DOI 10.1007/978-1-62703-733-4_17
   Hayeshi R, 2008, EUR J PHARM SCI, V35, P383, DOI 10.1016/j.ejps.2008.08.004
   HIRVONEN J, 1991, PHARMACEUT RES, V8, P933, DOI 10.1023/A:1015824100788
   Hornof M., 2005, EUR J PHARM BIOPHARM, V60, P205
   Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575
   Hu J, 2001, MOL VIS, V7, P14
   HUANG HS, 1983, J PHARM SCI, V72, P1272, DOI 10.1002/jps.2600721109
   HUANG HS, 1983, J PHARM SCI, V72, P1279, DOI 10.1002/jps.2600721110
   Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002
   Ishibashi H, 2009, SEMIN IMMUNOPATHOL, V31, P399, DOI 10.1007/s00281-009-0155-6
   Jain-Vakkalagadda B, 2003, INVEST OPHTH VIS SCI, V44, P2919, DOI 10.1167/iovs.02-0907
   JAMPOL LM, 1984, SURV OPHTHALMOL, V28, P535, DOI 10.1016/0039-6257(84)90237-6
   JARVINEN K, 1995, ADV DRUG DELIVER REV, V16, P3, DOI 10.1016/0169-409X(95)00010-5
   Jia L, 2007, CURR DRUG METAB, V8, P822, DOI 10.2174/138920007782798207
   Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056
   Jindal R, 2009, FASEB J, V23, P2288, DOI 10.1096/fj.08-114934
   Jones HM, 2006, CLIN PHARMACOKINET, V45, P511, DOI 10.2165/00003088-200645050-00006
   Josse R, 2008, DRUG METAB DISPOS, V36, P1111, DOI 10.1124/dmd.107.019901
   Juuti-Uusitalo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030089
   Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P137, DOI 10.1124/dmd.107.017418
   Kansara V, 2006, CURR EYE RES, V31, P415, DOI 10.1080/02713680600646890
   Kanuga N, 2002, INVEST OPHTH VIS SCI, V43, P546
   Karla PK, 2007, INT J PHARM, V336, P12, DOI 10.1016/j.ijpharm.2006.11.031
   Karla PK, 2007, EXP EYE RES, V84, P53, DOI 10.1016/j.exer.2006.08.015
   Karla PK, 2009, J OCUL PHARMACOL TH, V25, P121, DOI 10.1089/jop.2008.0084
   Kawazu K, 2006, BIOL PHARM BULL, V29, P846, DOI 10.1248/bpb.29.846
   Kawazu K, 1999, INVEST OPHTH VIS SCI, V40, P1738
   Kennedy BG, 2002, MOL VIS, V8, P422
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kidron H, 2012, PHARM RES-DORDR, V29, P3302, DOI 10.1007/s11095-012-0822-5
   Kidron H, 2012, EUR J PHARM SCI, V46, P100, DOI 10.1016/j.ejps.2012.02.016
   Kidron H, 2010, PHARM RES-DORDR, V27, P1398, DOI 10.1007/s11095-010-0132-8
   Kim SH, 2007, INVEST OPHTH VIS SCI, V48, P808, DOI 10.1167/iovs.06-0670
   Kim Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015456
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kodawara T, 2002, PHARM RES-DORDR, V19, P738, DOI 10.1023/A:1016184211491
   KOREN G, 1987, CLIN PHARMACOKINET, V13, P334, DOI 10.2165/00003088-198713050-00004
   Korjamo T, 2006, PHARM RES, V23, P1991, DOI 10.1007/s11095-006-9068-4
   Korjamo T, 2009, J PHARM SCI-US, V98, P4469, DOI 10.1002/jps.21762
   LANDMANN L, 1986, J INVEST DERMATOL, V87, P202, DOI 10.1111/1523-1747.ep12695343
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   Le Vee M, 2006, EUR J PHARM SCI, V28, P109, DOI 10.1016/j.ejps.2006.01.004
   Leblanc B, 1998, REGUL TOXICOL PHARM, V28, P124, DOI 10.1006/rtph.1998.1243
   LECLUYSE EL, 1994, AM J PHYSIOL, V266, pC1764
   Lee JB, 2013, BIOTECHNOL J, V8, P1258, DOI 10.1002/biot.201300086
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   LEE VHL, 1979, J PHARM SCI, V68, P673, DOI 10.1002/jps.2600680606
   Lee V, 2014, TISSUE ENG PART C-ME, V20, P473, DOI [10.1089/ten.tec.2013.0335, 10.1089/ten.TEC.2013.0335]
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Lehtinen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041410
   Linnankoski J, 2008, EUR J PHARM SCI, V34, P129, DOI 10.1016/j.ejps.2008.03.001
   Linnankoski J, 2010, J PHARM SCI-US, V99, P2166, DOI 10.1002/jps.21961
   Liu XR, 1999, DRUG METAB DISPOS, V27, P637
   Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149
   Lu Y, 2012, METHODS MOL BIOL, V868, P289, DOI 10.1007/978-1-61779-764-4_17
   Lubberstedt M, 2011, J PHARMACOL TOXICOL, V63, P59, DOI 10.1016/j.vascn.2010.04.013
   Luni C, 2014, CURR OPIN BIOTECH, V25, P45, DOI 10.1016/j.copbio.2013.08.015
   Maeda K, 2008, DRUG METAB PHARMACOK, V23, P223, DOI 10.2133/dmpk.23.223
   Majumdar S, 2003, CURR EYE RES, V26, P175, DOI 10.1076/ceyr.26.3.175.14895
   MAKOID MC, 1976, J PHARM SCI, V65, P150, DOI 10.1002/jps.2600650141
   Malinen MM, 2014, BIOMATERIALS, V35, P5110, DOI 10.1016/j.biomaterials.2014.03.020
   Malinen MM, 2012, TISSUE ENG PT A, V18, P2418, DOI [10.1089/ten.tea.2012.0046, 10.1089/ten.TEA.2012.0046]
   Mandenius CF, 2011, ATLA-ALTERN LAB ANIM, V39, P147
   Mannermaa E, 2006, ADV DRUG DELIVER REV, V58, P1136, DOI 10.1016/j.addr.2006.07.024
   Mannermaa E, 2010, EUR J PHARM SCI, V40, P289, DOI 10.1016/j.ejps.2010.04.001
   Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6
   Markov DA, 2012, LAB CHIP, V12, P4560, DOI 10.1039/c2lc40304h
   Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097
   Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021
   MARSHALL WS, 1983, J MEMBRANE BIOL, V73, P275, DOI 10.1007/BF01870542
   Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200
   Matsushima S, 2005, J PHARMACOL EXP THER, V314, P1059, DOI 10.1124/jpet.105.085589
   Maubon N, 2007, FUND CLIN PHARMACOL, V21, P659, DOI 10.1111/j.1472-8206.2007.00550.x
   McCarey BE, 1997, CURR EYE RES, V16, P44, DOI 10.1076/ceyr.16.1.44.5120
   MILLER SS, 1990, J PHYSIOL-LONDON, V424, P283, DOI 10.1113/jphysiol.1990.sp018067
   Miranda JP, 2009, TISSUE ENG PART C-ME, V15, P157, DOI 10.1089/ten.tec.2008.0352
   Missel PJ, 2012, PHARM RES-DORDR, V29, P3251, DOI 10.1007/s11095-012-0721-9
   Mita S, 2005, AM J PHYSIOL-GASTR L, V288, pG159, DOI 10.1152/ajpgi.00360.2003
   Mitra A. K., 1993, OPHTHALMIC DRUG DELI, P121
   Molokhia SA, 2013, J OCUL PHARMACOL TH, V29, P92, DOI 10.1089/jop.2012.0241
   Mueller D., 2011, J BIOENGN BIOMED SCI, V2, DOI 10.4172/2155-9538.52-002
   Musther H, 2014, EUR J PHARM SCI, V57, P280, DOI 10.1016/j.ejps.2013.08.018
   NABI IR, 1993, J CELL SCI, V104, P37
   Nahmias Y, 2005, BIOTECHNOL BIOENG, V92, P129, DOI 10.1002/bit.20585
   Nahmias Y, 2006, NAT PROTOC, V1, P2288, DOI 10.1038/nprot.2006.386
   Nguyen NT, 2013, ADV DRUG DELIVER REV, V65, P1403, DOI 10.1016/j.addr.2013.05.008
   Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316
   Neve EPA, 2013, MOL PHARMACEUT, V10, P3152, DOI 10.1021/mp400202d
   Ng CP, 2008, BIOTECHNOL BIOENG, V99, P1490, DOI 10.1002/bit.21698
   NIEDERKORN JY, 1990, IN VITRO CELL DEV B, V26, P923
   Nielsen PE, 2004, EUR J PHARM SCI, V22, P33, DOI 10.1016/j.ejps.2004.02.003
   Novik E, 2010, BIOCHEM PHARMACOL, V79, P1036, DOI 10.1016/j.bcp.2009.11.010
   Olinga P, 2001, J PHARMACOL TOXICOL, V45, P55, DOI 10.1016/S1056-8719(01)00127-7
   Oshikata A, 2011, J BIOSCI BIOENG, V111, P590, DOI 10.1016/j.jbiosc.2011.01.006
   Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102
   Pappinen S, 2005, TOXICOL APPL PHARM, V208, P233, DOI 10.1016/j.taap.2005.02.014
   Pappinen S, 2008, BBA-BIOMEMBRANES, V1778, P824, DOI 10.1016/j.bbamem.2007.12.019
   Pappinen S, 2007, EUR J PHARM SCI, V30, P240, DOI 10.1016/j.ejps.2006.11.013
   Pappinen S, 2012, J CONTROL RELEASE, V161, P656, DOI 10.1016/j.jconrel.2012.03.005
   Pasonen-Seppanen S, 2001, J INVEST DERMATOL, V117, P1322, DOI 10.1046/j.0022-202x.2001.01529.x
   Pasonen-Seppanen S, 2001, HISTOCHEM CELL BIOL, V116, P287, DOI 10.1007/s004180100312
   Pelis RM, 2009, J PHARMACOL EXP THER, V329, P479, DOI 10.1124/jpet.108.149625
   Pepic I, 2014, DRUG DISCOV TODAY, V19, P31, DOI 10.1016/j.drudis.2013.08.002
   Petrova A, 2014, STEM CELL REP, V2, P675, DOI 10.1016/j.stemcr.2014.03.009
   Pitkanen L, 2005, INVEST OPHTH VIS SCI, V46, P641, DOI 10.1167/iovs.04-1051
   Pitkanen L, 2007, PHARM RES, V24, P2063, DOI 10.1007/s11095-007-9342-0
   Ponec M, 2003, J INVEST DERMATOL, V120, P581, DOI 10.1046/j.1523-1747.2003.12103.x
   Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024
   Ponec M, 2000, ACTA DERM-VENEREOL, V80, P89
   Poulin P, 2013, J PHARM SCI-US, V102, P3239, DOI 10.1002/jps.23502
   Poulin P, 2013, J PHARM SCI-US, V102, P2085, DOI 10.1002/jps.23562
   Poulin P, 2012, J PHARM SCI-US, V101, P4308, DOI 10.1002/jps.23288
   Poulin P, 2012, J PHARM SCI-US, V101, P838, DOI 10.1002/jps.22792
   Pournaras CJ, 2013, OPHTHALMOLOGICA, V229, P61, DOI 10.1159/000338186
   Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j
   Prestwich GD, 2007, ADV ENZYME REGUL, V47, P196, DOI 10.1016/j.advenzreg.2006.12.012
   QUINN RH, 1992, INVEST OPHTH VIS SCI, V33, P3513
   Rajasekaran SA, 2003, AM J PHYSIOL-CELL PH, V284, pC1497, DOI 10.1152/ajpcell.00355.2002
   Rambhatla L, 2002, INVEST OPHTH VIS SCI, V43, P1622
   Ranta VP, 2003, PHARMACEUT RES, V20, P1409, DOI 10.1023/A:1025754026449
   Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225
   Reichl S, 2003, INT J PHARM, V250, P191, DOI 10.1016/S0378-5173(02)00541-0
   Reichl S, 2008, J PHARM PHARMACOL, V60, P299, DOI 10.1211/jpp.60.3.0004
   Reinisalo M, 2012, MOL VIS, V18, P38
   Rodriguez-Antona C, 2002, XENOBIOTICA, V32, P505, DOI 10.1080/00498250210128675
   ROJANASAKUL Y, 1992, PHARMACEUT RES, V9, P1029, DOI 10.1023/A:1015802427428
   Ryeom SW, 1996, J CELL SCI, V109, P387
   Sakai Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070970
   SALMINEN L, 1984, EXP EYE RES, V38, P203, DOI 10.1016/0014-4835(84)90104-0
   SALMINEN L, 1984, INT J PHARM, V18, P17, DOI 10.1016/0378-5173(84)90103-0
   Santaella RM, 2007, DRUGS, V67, P75, DOI 10.2165/00003495-200767010-00006
   Schaefer O, 2012, DRUG METAB DISPOS, V40, P93, DOI 10.1124/dmd.111.042275
   SCHEUPLEIN RJ, 1971, PHYSIOL REV, V51, P702
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   Schoellhammer CM, 2014, EXPERT OPIN DRUG DEL, V11, P393, DOI 10.1517/17425247.2014.875528
   SCHOENWALD RD, 1983, J PHARM SCI-US, V72, P1266, DOI 10.1002/jps.2600721108
   SCOTT RC, 1990, TOXICOL IN VITRO, V4, P137, DOI 10.1016/0887-2333(90)90035-R
   Seidlits SK, 2008, NANOMEDICINE-UK, V3, P183, DOI 10.2217/17435889.3.2.183
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Serban MA, 2007, BIOMACROMOLECULES, V8, P2821, DOI 10.1021/bm700595S
   Sfikakis PP, 2001, LANCET, V358, P295, DOI 10.1016/S0140-6736(01)05497-6
   Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270
   Shapira A, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/020301
   SHIMADA K, 1976, J PHARM SCI, V65, P1057, DOI 10.1002/jps.2600650725
   Shitara Yoshihisa, 2003, Drug Metab Pharmacokinet, V18, P33, DOI 10.2133/dmpk.18.33
   Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354
   Simon GA, 1998, SKIN PHARMACOL APPL, V11, P80, DOI 10.1159/000029812
   Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d
   Snykers S, 2009, STEM CELLS, V27, P577, DOI 10.1634/stemcells.2008-0963
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   Stringer RA, 2009, DRUG METAB DISPOS, V37, P1025, DOI 10.1124/dmd.108.024810
   Subrizi A, 2012, BIOMATERIALS, V33, P8047, DOI 10.1016/j.biomaterials.2012.07.033
   Suhonen TM, 2003, EUR J PHARM SCI, V20, P107, DOI 10.1016/S0928-0987(03)00176-3
   Suhonen TM, 1999, J CONTROL RELEASE, V59, P149
   Surapaneni SS, 1997, DRUG METAB DISPOS, V25, P1383
   Swift B, 2010, DRUG METAB REV, V42, P446, DOI 10.3109/03602530903491881
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tanaka M, 2004, J PHARM PHARMACOL, V56, P463, DOI 10.1211/0022357023141
   Theodossiadis PG, 2007, RETINA-J RET VIT DIS, V27, P399, DOI 10.1097/MAJ.0b013e3180318fbc
   Thohan Sanjeev, 2002, Methods Mol Biol, V196, P291
   Timmins NE, 2005, CELL TISSUE RES, V320, P207, DOI 10.1007/s00441-004-1064-6
   Toropainen E, 2003, EUR J PHARM SCI, V20, P99, DOI 10.1016/S0928-0987(03)00173-8
   Toropainen E, 2001, INVEST OPHTH VIS SCI, V42, P2942
   Toropainen E, 2007, J GENE MED, V9, P208, DOI 10.1002/jgm.1011
   Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760
   Tsui JH, 2013, ADV DRUG DELIVER REV, V65, P1575, DOI 10.1016/j.addr.2013.07.004
   Turncliff RZ, 2006, BIOCHEM PHARMACOL, V71, P1520, DOI 10.1016/j.bcp.2006.02.004
   Uchida Y, 2011, J NEUROCHEM, V117, P333, DOI 10.1111/j.1471-4159.2011.07208.x
   Ukairo O, 2013, J BIOCHEM MOL TOXIC, V27, P204, DOI 10.1002/jbt.21469
   Underhill GH, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P707, DOI 10.1016/B978-012370615-7/50052-4
   URTTI A, 1990, INT J PHARM, V61, P241, DOI 10.1016/0378-5173(90)90215-P
   URTTI A, 1985, INT J PHARM, V23, P147, DOI 10.1016/0378-5173(85)90005-5
   URTTI A, 1984, INT J PHARM, V19, P53, DOI 10.1016/0378-5173(84)90132-7
   Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027
   Vaajasaari H, 2011, MOL VIS, V17, P558
   Vellonen KS, 2010, EUR J PHARM SCI, V39, P241, DOI 10.1016/j.ejps.2009.12.006
   Vellonen KS, 2010, J PHARM SCI-US, V99, P1087, DOI 10.1002/jps.21878
   Verstraelen J, 2014, MOL PHARMACEUT, V11, P2160, DOI 10.1021/mp400625z
   Verstraelen J, 2013, INT J PHARMACEUT, V441, P765, DOI 10.1016/j.ijpharm.2012.10.007
   Volpe DA, 2008, J PHARM SCI-US, V97, P712, DOI 10.1002/jps.21010
   Wan H, 2010, CURR DRUG METAB, V11, P583, DOI 10.2174/138920010792927334
   Wang Q, 2005, INT J PHARMACEUT, V288, P349, DOI 10.1016/j.ijpharm.2004.10.007
   Wen Y, 2012, ADV EXP MED BIOL, V745, P181, DOI 10.1007/978-1-4614-3055-1_11
   WERTZ PW, 1989, TRANSDERMAL DRUG DEL, P1
   Westerink WMA, 2007, TOXICOL IN VITRO, V21, P1581, DOI 10.1016/j.tiv.2007.05.014
   Xiang CD, 2009, DRUG METAB DISPOS, V37, P992, DOI 10.1124/dmd.108.026286
   Yang Z, 2012, J DIGEST DIS, V13, P168, DOI 10.1111/j.1751-2980.2011.00566.x
   Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141
   Yliperttula M, 2008, EUR J PHARM SCI, V35, P151, DOI 10.1016/j.ejps.2008.04.012
   Yum K, 2014, BIOTECHNOL J, V9, P16, DOI 10.1002/biot.201300187
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang T, 2008, DRUG METAB DISPOS, V36, P1300, DOI 10.1124/dmd.108.021121
   Zhu DH, 2011, INVEST OPHTH VIS SCI, V52, P1573, DOI 10.1167/iovs.10-6413
   Zorn-Kruppa M, 2005, ATLA-ALTERN LAB ANIM, V33, P37
   Zou P, 2012, EXPERT OPIN DRUG MET, V8, P855, DOI 10.1517/17425255.2012.682569
NR 280
TC 15
Z9 16
U1 5
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 28
PY 2014
VL 190
SI SI
BP 94
EP 114
DI 10.1016/j.jconrel.2014.06.044
PG 21
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AS7ZO
UT WOS:000344470600008
PM 24993429
DA 2018-10-20
ER

PT J
AU Perniconi, B
   Coletti, D
   Aulino, P
   Costa, A
   Aprile, P
   Santacroce, L
   Chiaravalloti, E
   Coquelin, L
   Chevallier, N
   Teodori, L
   Adamo, S
   Marrelli, M
   Tatullo, M
AF Perniconi, Barbara
   Coletti, Dario
   Aulino, Paola
   Costa, Alessandra
   Aprile, Paola
   Santacroce, Luigi
   Chiaravalloti, Ernesto
   Coquelin, Laura
   Chevallier, Nathalie
   Teodori, Laura
   Adamo, Sergio
   Marrelli, Massimo
   Tatullo, Marco
TI Muscle acellular scaffold as a biomaterial: effects on C2C12 cell
   differentiation and interaction with the murine host environment
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE extracellular matrix; niche; osteogenic differentiation; myogenic
   differentiation; tissue engineering; regenerative medicine
ID STEM-CELL; SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; IN-VITRO; ASYMMETRIC
   DIVISION; SATELLITE CELLS; MYOGENIC CELLS; TISSUE; NICHE; VIVO
AB The extracellular matrix (ECM) of decellularized organs possesses the characteristics of the ideal tissue-engineering scaffold (i.e., histocompatibility, porosity, degradability, non-toxicity). We previously observed that the muscle acellular scaffold (MAS) is a pro-myogenic environment in vivo. In order to determine whether MAS, which is basically muscle ECM, behaves as a myogenic environment, regardless of its location, we analyzed MAS interaction with both muscle and non-muscle cells and tissues, to assess the effects of MAS on cell differentiation. Bone morphogenetic protein treatment of C2C12 cells cultured within MAS induced osteogenic differentiation in vitro, thus suggesting that MAS does not irreversibly commit cells to myogenesis. In vivo MAS supported formation of nascent muscle fibers when replacing a muscle (orthotopic position). However, heterotopically grafted MAS did not give rise to muscle fibers when transplanted within the renal capsule. Also, no muscle formation was observed when MAS was transplanted under the xiphoid process, in spite of the abundant presence of cells migrating along the laminin-based MAS structure. Taken together, our results suggest that MAS itself is not sufficient to induce myogenic differentiation. It is likely that the pro-myogenic environment of MAS is not strictly related to the intrinsic properties of the muscle scaffold (e.g., specific muscle ECM proteins). Indeed, it is more likely that myogenic stem cells colonizing MAS recognize a muscle environment that ultimately allows terminal myogenic differentiation. In conclusion, MAS may represent a suitable environment for muscle and non-muscle 3D constructs characterized by a highly organized structure whose relative stability promotes integration with the surrounding tissues. Our work highlights the plasticity of MAS, suggesting that it may be possible to consider MAS for a wider range of tissue engineering applications than the mere replacement of volumetric muscle loss.
C1 [Perniconi, Barbara; Coletti, Dario] Univ Paris 06, Sorbonne Univ, INSERM, Dept Biol Adaptat & Aging B2A,CNRS,UMR 8256,ERL U, Paris, France.
   [Perniconi, Barbara; Aulino, Paola; Chiaravalloti, Ernesto; Marrelli, Massimo; Tatullo, Marco] Calabrodent Clin, Maxillofacial Unit, Crotone, Italy.
   [Coletti, Dario; Aulino, Paola; Costa, Alessandra; Adamo, Sergio] Univ Roma La Sapienza, AHFOS Dept, Sect Histol & Med Embryol, I-00185 Rome, Italy.
   [Coletti, Dario; Aulino, Paola; Costa, Alessandra; Adamo, Sergio] IIM, Rome, Italy.
   [Costa, Alessandra; Aprile, Paola; Teodori, Laura] ENEA, UTAPRAD DIM, Frascati, Italy.
   [Aprile, Paola] Univ Roma Tor Vergata, Rome, Italy.
   [Santacroce, Luigi] Univ Bari, Sect Taranto, JSGEM Dept, Taranto, Italy.
   [Coquelin, Laura; Chevallier, Nathalie] Univ Paris Est Creteil, Etab Francais Sang Ile France, Unite Ingn & Therapie Cellulaire, Creteil, France.
   [Marrelli, Massimo; Tatullo, Marco] Tecnol Res Inst, Regenerat Med Sect, Crotone, Italy.
RP Adamo, S (reprint author), AHFOS Dept, Sect Histol & Med Embryol, Via Scarpa 16, I-00161 Rome, Italy.
EM sergio.adamo@uniroma1.it
OI Teodori, Laura/0000-0002-3676-4526; COQUELIN, laura/0000-0003-4591-6939;
   Coletti, Dario/0000-0001-7373-1953; Costa,
   Alessandra/0000-0002-4703-7316; Adamo, Sergio/0000-0002-1409-0452;
   Chevallier, Nathalie/0000-0002-1800-2579
FU MERIT, Fondazione San Raffaele, Ceglie Messapica [RBNE08HM7T]; UPMC
   Emergence [2011-EME1115]; AFM [2012-16117]; ANR [2013-J13R191]; PRIN
   [2009WBFZYM_001]; Sapienza [C26A125ENW]; Calabrodental - Italian MIUR
   [PON01_02834]
FX We gratefully thank Lewis Baker for reviewing the English in the
   manuscript and to Dr. Mathias Mericskay for the assistance with the
   renal capsule grafting technique. Funding of this work was provided by
   MERIT #RBNE08HM7T, Fondazione San Raffaele, Ceglie Messapica to Laura
   Teodori. Additional financial support was provided by UPMC Emergence
   (2011-EME1115), AFM (2012-16117) and ANR (2013-J13R191) to Dario
   Coletti, as well as by PRIN 2009WBFZYM_001 and Sapienza C26A125ENW to
   Sergio Adamo. Part of the research funds and the post-doctoral
   fellowships for Barbara Perniconi and Paola Aulino were provided by
   Calabrodental in the context of a "PROMETEO Project-Progettazione e
   Sviluppo di piattaforme tecnologiche innovative ed ottimizzazione di
   PROcessi per applicazioni in MEdicina rigenerativa in ambito
   oromaxillofaciale, emaTologico, nEurologico e cardiOlogico" PON01_02834
   granted by the Italian MIUR.
CR Adler BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090639
   Badylak S. F., 2013, TERMIS AM C CEL 25 Y
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bhattacharyya S, 2012, ACTA BIOCH BIOPH SIN, V44, P463, DOI 10.1093/abbs/gms027
   Borschel G. H., 2004, PLAST RECONSTR SURG, V113, P603, DOI 10.1097/01.PRS.0000101064.62289.2F
   Borschel GH, 2004, PLAST RECONSTR SURG, V113, P595, DOI 10.1097/01.PRS.0000101064.62289.2F
   Carosio S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01420
   Chang JT, 2008, COLD SH Q B, V73, P73, DOI 10.1101/sqb.2008.73.008
   Coletti D, 2013, REGEN MED RES, V1, DOI 10.1186/2050-490X-1-4
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   Coquelin L, 2012, TISSUE ENG PT A, V18, P1921, DOI [10.1089/ten.tea.2011.0645, 10.1089/ten.TEA.2011.0645]
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahms SE, 1998, BRIT J UROL, V82, P411
   De Arcangelis V, 2005, J CELL PHYSIOL, V202, P787, DOI 10.1002/jcp.20174
   De Arcangelis V, 2003, MOL BIOL CELL, V14, P1392, DOI 10.1091/mbc.E02-03-0156
   Faulk DM, 2014, J CELL PHYSIOL, V229, P984, DOI 10.1002/jcp.24532
   Friedrichs M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-26
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Kirkpatrick CJ, 2014, TISSUE ENG PT A, V20, P1355, DOI 10.1089/ten.tea.2014.0002
   Klumpp D, 2010, J CELL MOL MED, V14, P2622, DOI 10.1111/j.1582-4934.2010.01183.x
   Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leotot J, 2013, ACTA BIOMATER, V9, P6630, DOI 10.1016/j.actbio.2013.02.003
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mericskay M, 2004, DEVELOPMENT, V131, P2061, DOI 10.1242/dev.01090
   Meyer T, 1998, TRANSPLANT P, V30, P354, DOI 10.1016/S0041-1345(97)01302-X
   Minotti S, 1998, CELL GROWTH DIFFER, V9, P155
   Musaro A, 2007, EUR J HISTOCHEM, V51, P35
   Naro F, 2003, AM J PHYSIOL-CELL PH, V284, pC969, DOI 10.1152/ajpcell.00237.2002
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Perniconi B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00255
   Perniconi B, 2011, BIOMATERIALS, V32, P7870, DOI 10.1016/j.biomaterials.2011.07.016
   Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972
   Rochlin K, 2010, DEV BIOL, V341, P66, DOI 10.1016/j.ydbio.2009.10.024
   Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425
   Sivan U., 2014, J TISSUE ENG REGEN M, DOI [10.1002/term.1865, DOI 10.1002/TERM.1865]
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Teodori L, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00218
   Wang SL, 2010, CANCER SCI, V101, P1108, DOI 10.1111/j.1349-7006.2010.01512.x
   Whitney GA, 2012, BIORESEARCH OPEN ACC, V1, P157, DOI 10.1089/biores.2012.0231
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011
   Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004
NR 44
TC 15
Z9 15
U1 1
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD SEP 26
PY 2014
VL 5
AR 354
DI 10.3389/fphys.2014.00354
PG 13
WC Physiology
SC Physiology
GA AX7JY
UT WOS:000347093500001
PM 25309452
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chagas, B
   Farinha, I
   Galinha, CF
   Freitas, F
   Reis, MAM
AF Chagas, Barbara
   Farinha, Ines
   Galinha, Claudia F.
   Freitas, Filomena
   Reis, Maria A. M.
TI Chitin-glucan complex production by Komagataella (Pichia) pastoris:
   impact of cultivation pH and temperature on polymer content and
   composition
SO NEW BIOTECHNOLOGY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; FERMENTATION PROCESS; BATCH FERMENTATION;
   PROTEIN-PRODUCTION; BY-PRODUCT; YEAST; PATHWAY; OPTIMIZATION; GLYCEROL;
   GROWTH
AB Chitin-glucan complex (CGC) is a valuable biomaterial that can be extracted from the cell wall of several yeast and fungi. In this work, the yeast Komagataella (Pichia) pastoris was grown on glycerol as the sole carbon source in batch cultivation experiments to evaluate the effect of pH (3.5-6.5) and temperature (20-40 degrees C) on CGC production and polymer composition. The CGC content in the biomass and the volumetric productivity (r(p)) were not significantly affected within the tested pH and temperature ranges. Nevertheless, both parameters could be maximized (CGC >= 14 wt% and r(p) >= 3.0 gCGC L-1 day(-1)) for temperatures within 27-34 degrees C and pH above 6.0 or below 4.0. In contrast, the effect of pH and temperature on the polymer's chitin:beta-glucan molar ratio was more pronounced. The highest chitin:beta-glucan molar ratio (>14:86) was obtained for the mid-range pH (4.5-5.8) and temperatures (26-33 degrees C), while a drastic reduction of chitin to <= 6% mol was observed outside those ranges. Therefore, a compromise between maximal CGC production and the synthesis of polymers enriched in chitin must be achieved, depending on the final application of this product.
C1 [Chagas, Barbara; Farinha, Ines; Galinha, Claudia F.; Freitas, Filomena; Reis, Maria A. M.] FCT Univ Nova Lisboa, Dept Chem, REQUIMTE CQFB, P-2829516 Caparica, Portugal.
RP Freitas, F (reprint author), FCT Univ Nova Lisboa, Dept Chem, REQUIMTE CQFB, P-2829516 Caparica, Portugal.
EM a4406@fct.unl.pt
RI Reis, Maria/D-8303-2013; Farinha, Ines/M-6951-2014; Galinha,
   Claudia/M-8030-2015; Freitas, Filomena/K-1828-2012
OI Reis, Maria/0000-0003-4000-1836; Farinha, Ines/0000-0002-8157-1731;
   Galinha, Claudia/0000-0003-0045-2528; Freitas,
   Filomena/0000-0002-9430-4640
FU Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)
   [PEst-C/EQB/LA0006/2013]; FCT [SFRH/BPD/72280/2010, SFRH/BD/44465/2008,
   SFRH/BDE/52089/2013]
FX This work was supported by Fundacao para a Ciencia e a Tecnologia (FC&T,
   Portugal) through project PEst-C/EQB/LA0006/2013. Filomena Freitas
   acknowledges FC&T Post-Doctoral fellowship SFRH/BPD/72280/2010. Barbara
   Chagas and Ines Farinha acknowledge FC&T PhD fellowships
   SFRH/BD/44465/2008 and SFRH/BDE/52089/2013, respectively.
CR Aguilar-Uscanga B, 2003, LETT APPL MICROBIOL, V37, P268, DOI 10.1046/j.1472-765X.2003.01394.x
   Artamonova S, 2013, APPL BIOCHEM MICRO+, V49, P426, DOI 10.1134/S0003683813030046
   Calik P, 2010, J CHEM TECHNOL BIOT, V85, P1628, DOI 10.1002/jctb.2474
   Celik E, 2008, IND ENG CHEM RES, V47, P2985, DOI 10.1021/ie071613o
   Chiruvolu V, 1998, APPL BIOCHEM BIOTECH, V75, P163, DOI 10.1007/BF02787771
   Cos O, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-17
   DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157
   Einbu A, 2008, BIOMACROMOLECULES, V9, P1870, DOI 10.1021/bm8001123
   Files D, 2001, ENZYME MICROB TECH, V29, P335, DOI 10.1016/S0141-0229(01)00395-7
   Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200
   Gasser B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-179
   Hsieh JW, 2007, BIOTECHNOL PROGR, V23, P1009, DOI 10.1021/bp070037o
   Inan M, 1999, ENZYME MICROB TECH, V24, P438, DOI 10.1016/S0141-0229(98)00161-6
   KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559
   Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349
   Li ZJ, 2001, PROTEIN EXPRES PURIF, V21, P438, DOI 10.1006/prep.2001.1395
   Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3
   Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511
   Meichik NR, 2012, APPL BIOCHEM MICRO+, V48, P307, DOI 10.1134/S0003683812030088
   Pestov AV, 2009, CHEM SUSTAIN DEV, V17, P281
   Roca C, 2012, PROCESS BIOCHEM, V47, P1670, DOI 10.1016/j.procbio.2012.04.004
   RUSSO P, 1993, MOL GEN GENET, V239, P273
   Shi XZ, 2003, PROTEIN EXPRES PURIF, V28, P321, DOI 10.1016/S1046-5928(02)00706-4
   Smirnou D, 2011, POL J MICROBIOL, V60, P223
   Smits JP, 1998, ENZYME MICROB TECH, V22, P50, DOI 10.1016/S0141-0229(97)00103-8
   Soyaslan ES, 2011, BIOCHEM ENG J, V55, P59, DOI 10.1016/j.bej.2011.03.007
   Tomita M, 1996, J FERMENT BIOENG, V81, P171, DOI 10.1016/0922-338X(96)87598-2
   Wu JM, 2012, INT J MOL SCI, V13, P13212, DOI 10.3390/ijms131013212
   YAMADA Y, 1995, BIOSCI BIOTECH BIOCH, V59, P439, DOI 10.1271/bbb.59.439
NR 29
TC 7
Z9 7
U1 1
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
EI 1876-4347
J9 NEW BIOTECHNOL
JI New Biotech.
PD SEP 25
PY 2014
VL 31
IS 5
BP 468
EP 474
DI 10.1016/j.nbt.2014.06.005
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AO4MV
UT WOS:000341314700010
PM 24998355
DA 2018-10-20
ER

PT J
AU Leszczak, V
   Popat, KC
AF Leszczak, Victoria
   Popat, Ketul C.
TI Improved in Vitro Blood Compatibility of Polycaprolactone Nanowire
   Surfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE polycaprolactone nanowire surfaces; hemocompatibility; platelet
   activation; leukocyte adhesion; hemolysis
ID VASCULAR GRAFTS; ARTIFICIAL SURFACES; PROTEIN ADSORPTION; CELL;
   HEMOCOMPATIBILITY; BIOMATERIALS; COLLAGEN; SCAFFOLDS; POLYMERS;
   COAGULATION
AB There are a multitude of polymeric materials currently utilized to prepare a variety of blood-contacting implantable medical devices. These devices include tissue grafts, coronary artery and vascular stents, and orthopedic implants. The thrombogenic nature of such materials can cause serious complications in patients, and ultimately lead to functional failure. To date, there is no truly hemocompatible biomaterial surface. Nanostructured surfaces improve cellular interactions but there is a limited amount of information regarding their blood compatibility. In this study, the in vitro blood compatibility of four different surfaces (control, PCL; nanowire, NW; collagen immobilized control, cPCL; collagen immobilized nanowire, cNW) were investigated for their use as interfaces for blood-contacting implants. The results presented here indicate enhanced in vitro blood compatibility of nanowire surfaces compared control surfaces. Although there were no significant differences in leukocyte adhesion, there was a decrease in platelet adhesion on NW surfaces. Scanning electron microscopy images showed a decrease in platelet/leukocyte complexes on cNW surfaces and no apparent complexes were formed on NW surfaces compared to PCL and cPCL surfaces. The increase in these complexes likely contributed to a higher expression of specific markers for platelet and leukocyte activation on PCL and cPCL surfaces. No significant differences were found in contact and complement activation on any surface. Further, thrombin antithrombin complexes were significantly reduced on NW surfaces. A significant increase in hemolysis and fibrinogen adsorption was identified on PCL surfaces likely caused by its hydrophobic surface. This work shows the improved blood-compatibility of nanostructured surfaces, identifying this specific nanoarchitecture as a potential interface for promoting the long-term success of blood-contacting biomaterials.
C1 [Leszczak, Victoria; Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
OI Popat, Ketul C./0000-0002-2417-7789
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [5-R21-AR057341-02]
FX Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Number 5-R21-AR057341-02. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868
   ALKHAMIS TM, 1988, T AM SOC ART INT ORG, V34, P868
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Blezer R, 1998, THROMB HAEMOSTASIS, V79, P296
   BOON GD, 1993, TOXICOL PATHOL, V21, P170, DOI 10.1177/019262339302100209
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   CASSIE ABD, 1948, DISCUSS FARADAY SOC, V3, P11, DOI 10.1039/df9480300011
   Cerletti C, 2012, THROMB RES, V129, P263, DOI 10.1016/j.thromres.2011.10.010
   Cheng ZA, 2013, NANO LETT, V13, P3923, DOI 10.1021/nl4020149
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Colman RW, 1997, BLOOD, V90, P3819
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Duling R. R., 2008, J BIOMECH ENG, V130
   Elstad M R, 1995, Curr Opin Hematol, V2, P47
   Feng Y., 2010, FRONT CHEM ENG CHINA, V4, P372, DOI [DOI 10.1007/S11705-010-0005-Z, 10.1007/s11705-010-0005-z]
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   He FP, 2013, COLLOID SURFACE B, V103, P209, DOI 10.1016/j.colsurfb.2012.10.018
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   Huang NF, 2013, BIOMATERIALS, V34, P4038, DOI 10.1016/j.biomaterials.2013.02.036
   Kalaskar DM, 2013, COLLOID SURFACE B, V111, P134, DOI 10.1016/j.colsurfb.2013.05.035
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Leszczak V, 2014, J FUNCT BIOMATER, V5, P58, DOI 10.3390/jfb5020058
   Leszczak V, 2013, J BIOMAT SCI-POLYM E, V24, P1529, DOI 10.1080/09205063.2013.777228
   Li G, 2013, J TEXT I, V104, P1017, DOI 10.1080/00405000.2013.767429
   LINDON JN, 1986, BLOOD, V68, P355
   Liu TY, 2005, BIOMATERIALS, V26, P1437, DOI 10.1016/j.biomaterials.2004.04.039
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Low SW, 2009, SINGAP MED J, V50, P777
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mohan CC, 2013, ACTA BIOMATER, V9, P9568, DOI 10.1016/j.actbio.2013.08.023
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   NYGREN H, 1994, BIOPHYS CHEM, V49, P263, DOI 10.1016/0301-4622(93)E0090-R
   O'Connor SM, 2000, J NEUROSCI METH, V102, P187, DOI 10.1016/S0165-0270(00)00303-4
   Ogedegbe HO, 2002, LAB MED, V33, P948, DOI 10.1092/QWJQLR8ELGL6X32H
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Pruitt L, 2009, JOM-US, V61, P14, DOI 10.1007/s11837-009-0126-3
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1141, DOI 10.1021/bm034513k
   Raffaini G, 2007, MACROMOL BIOSCI, V7, P552, DOI 10.1002/mabi.200600278
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sacks SH, 2003, CURR OPIN IMMUNOL, V15, P487, DOI 10.1016/S0952-7915(03)00100-6
   Santos MI, 2008, BIOMATERIALS, V29, P4306, DOI 10.1016/j.biomaterials.2008.07.033
   Siegismund D, 2013, CELL MOL BIOENG, V6, P210, DOI 10.1007/s12195-012-0266-3
   Sin M.-C., 2013, ACS APPL MATER INTER, V6, P861
   Smith BS, 2010, J BIOMED MATER RES A, V95A, P350, DOI 10.1002/jbm.a.32853
   Solouk A, 2011, BIOTECHNOL APPL BIOC, V58, P311, DOI 10.1002/bab.50
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vijayanand K., 2005, TRENDS BIOMATER ARTI, V18, P73
   Wang XP, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-25
   Wang YM, 2014, ACS APPL MATER INTER, V6, P2958, DOI 10.1021/am405556x
   Wise D. L., 2000, BIOMATERIALS ENG DEV, V1, P1
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Ze Z., 1994, BIOMATERIALS, V15, P483
   Zhu YB, 2009, MAT SCI ENG C-BIO S, V29, P1046, DOI 10.1016/j.msec.2008.09.004
NR 58
TC 15
Z9 15
U1 3
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 24
PY 2014
VL 6
IS 18
BP 15913
EP 15924
DI 10.1021/am503508r
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AP8KQ
UT WOS:000342328300035
PM 25184556
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Podlipec, R
   Gorgieva, S
   Jurasin, D
   Urbancic, I
   Kokol, V
   Strancar, J
AF Podlipec, Rok
   Gorgieva, Selestina
   Jurasin, Darija
   Urbancic, Iztok
   Kokol, Vanja
   Strancar, Janez
TI Molecular Mobility of Scaffolds' Biopolymers Influences Cell Growth
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE scaffold biocompatibility; polymer mobility; morphology;
   viscoelasticity; cell growth
ID IN-VITRO; PORE-SIZE; REGENERATIVE MEDICINE; EXTRACELLULAR-MATRIX;
   STROMAL CELLS; PROLIFERATION; DIFFERENTIATION; STIFFNESS; BEHAVIOR;
   DESIGN
AB Understanding biocompatibility of materials and scaffolds is one of the main challenges in the field of tissue engineering and regeneration. The complex nature of cell biomaterial interaction requires extensive preclinical functionality testing by studying specific cell responses to different biomaterial properties, from morphology and mechanics to surface characteristics at the molecular level. Despite constant improvements, a more general picture of biocompatibility is still lacking and tailormade scaffolds are not yet available. The scope of our study was thus the investigation of the correlation of fibroblast cell growth on different gelatin scaffolds with their morphological, mechanical as well as surface molecular properties. The latter were thoroughly investigated via polymer molecular mobility studied by site-directed spin labeling and electron paramagnetic resonance spectroscopy (EPR) for the first time. Anisotropy of the rotational motion of the gelatin side chain mobility was identified as the most correlated quantity with cell growth in the first days after adhesion, while weaker correlations were found with scaffold viscoelasticity and no correlations with scaffold morphology. Namely, the scaffolds with highly mobile or unrestricted polymers identified with the cell growth being five times less efficient (N-cells = 60 +/- 25 mm(-2)) as compared to cell growth on the scaffolds with considerable part of polymers with the restricted rotational motion (N-cells = 290 +/- 25 mm(-2)). This suggests that molecular mobility of scaffold components could play an important role in cell response to medical devices, reflecting a new aspect of the biocompatibility concept.
C1 [Podlipec, Rok; Kokol, Vanja; Strancar, Janez] Ctr Excellence NAMASTE, SI-1000 Ljubljana, Slovenia.
   [Gorgieva, Selestina; Kokol, Vanja] Univ Maribor, Inst Engn Mat & Design, SI-2000 Maribor, Slovenia.
   [Jurasin, Darija] Rudjer Boskovic Inst, Lab Synth & Proc Self Assembling Organ Mol, HR-10000 Zagreb, Croatia.
   [Urbancic, Iztok; Strancar, Janez] Jozef Stefan Inst, Biophys Lab, SI-1000 Ljubljana, Slovenia.
RP Strancar, J (reprint author), Ctr Excellence NAMASTE, Jamova Cesta 39, SI-1000 Ljubljana, Slovenia.
EM janez.strancar@ijs.si
RI Domazet Jurasin, Darija/P-5134-2016
OI Domazet Jurasin, Darija/0000-0001-5261-5961
FU Centre of Excellence NAMASTE (European Regional Development Fund);
   Slovenian Research Agency (ARRS) [P1-0060, 1000-09-3]; Gaining
   Experience Grant from Unity Through Knowledge Fund
FX This research was financially supported by Centre of Excellence NAMASTE
   (European Regional Development Fund), Slovenian Research Agency (ARRS)
   (program P1-0060 and PhD grant no. 1000-09-3), and Gaining Experience
   Grant from Unity Through Knowledge Fund. We gratefully thank S. Pajk
   (Faculty of Pharmacy, University of Ljubljana) for synthesizing membrane
   targeted fluorescent probes.
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Banks H. T., 2011, PMM-J APPL MATH MEC, V3, P1
   Bhat S, 2011, J R SOC INTERFACE, V8, P540, DOI 10.1098/rsif.2010.0455
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Chen J, 2012, BIOPHYS J, V103, P1188, DOI 10.1016/j.bpj.2012.07.054
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Duron A., 2008, NANOTECHNOLOGY TISSU, P163
   Ivirico JLE, 2009, J BIOMED MATER RES B, V91B, P277, DOI 10.1002/jbm.b.31400
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024
   Gonzalez-Simon A. L., 2012, ENG BIOMATERIALS REG, P143
   Gornall JL, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031908
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   GRIFFITH OH, 1966, P NATL ACAD SCI USA, V55, P8, DOI 10.1073/pnas.55.1.8
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Hacker MC, 2006, TISSUE ENG, V12, P2049, DOI 10.1089/ten.2006.12.2049
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harrison RH, 2014, TISSUE ENG PART B-RE, V20, P1, DOI 10.1089/ten.TEB.2013.0668
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Jithendra P, 2013, ACS APPL MATER INTER, V5, P7291, DOI 10.1021/am401637c
   Karamichos D, 2007, J BIOMED MATER RES A, V83A, P887, DOI 10.1002/jbm.a.31423
   Kavalenka A, 2010, BIOPHYS J, V98, P1055, DOI 10.1016/j.bpj.2009.11.036
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Klare JP, 2009, PHOTOSYNTH RES, V102, P377, DOI 10.1007/s11120-009-9490-7
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Kohane DS, 2010, CHEM SCI, V1, P441, DOI 10.1039/c0sc00203h
   Koo LY, 2002, J CELL SCI, V115, P1423
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee MH, 2010, TISSUE ENG PART B-RE, V16, P41, DOI [10.1089/ten.teb.2009.0449, 10.1089/ten.TEB.2009.0449]
   Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Liu CX, 2012, BIOMATERIALS, V33, P1052, DOI 10.1016/j.biomaterials.2011.10.041
   MCKINNEY RM, 1964, J IMMUNOL, V93, P232
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nesmelov Yuri E, 2010, Biophys Rev, V2, P91, DOI 10.1007/s12551-010-0032-5
   O'Dea R. D., 2012, J MATH BIOL, V67, P1199
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Oh SH, 2010, BIOMACROMOLECULES, V11, P1948, DOI 10.1021/bm100199m
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   PAGE B, 1993, INT J ONCOL, V3, P473
   Patnaik SS, 2014, FRONT NANOBIOMED RES, V2, P77
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Plieva F. M., 2010, ADV BIOMATER, P499
   Radisic M., 2004, AM J PHYSIOL-HEART C, V286, P507
   Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662
   Romano NH, 2011, BBA-GEN SUBJECTS, V1810, P339, DOI 10.1016/j.bbagen.2010.07.005
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sampson SL, 2014, SMALL, V10, P78, DOI 10.1002/smll.201300804
   Santos E, 2012, TRENDS BIOTECHNOL, V30, P331, DOI 10.1016/j.tibtech.2012.03.005
   Sanz-Herrera JA, 2011, INT J MOL SCI, V12, P8217, DOI 10.3390/ijms12118217
   Schlie-Wolter S, 2013, EXP CELL RES, V319, P1553, DOI 10.1016/j.yexcr.2013.03.016
   Schmidt A., 2008, P INT MODEL ANAL C, V3, P1557
   Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Stopar D, 2006, BIOPHYS J, V91, P3341, DOI 10.1529/biophysj.106.090308
   Strancar J, 2007, BIO MAGN RE, V27, P49
   Strancar J, 2010, EUR BIOPHYS J BIOPHY, V39, P499, DOI 10.1007/s00249-009-0510-5
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 67
TC 6
Z9 6
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 24
PY 2014
VL 6
IS 18
BP 15980
EP 15990
DI 10.1021/am5037719
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AP8KQ
UT WOS:000342328300043
PM 25153341
DA 2018-10-20
ER

PT J
AU De Silva, R
   Pasbakhsh, P
   Qureshi, AJ
   Gibson, AG
   Goh, KL
AF De Silva, R.
   Pasbakhsh, P.
   Qureshi, A. J.
   Gibson, A. G.
   Goh, K. L.
TI Stress transfer and fracture in nanostructured particulate-reinforced
   chitosan biopolymer composites: influence of interfacial shear stress
   and particle slenderness
SO COMPOSITE INTERFACES
LA English
DT Article; Proceedings Paper
CT International Symposium on Advanced Polymeric Materials (ISAPM)
CY MAY 14-15, 2014
CL Kuala Lumpur, MALAYSIA
DE polyhedral oligomeric silsesquioxanes; plastic stress transfer; aspect
   ratio; interfacial shear stress; particle pull-out; hydroxyapatite
ID MECHANICAL-PROPERTIES; HYDROXYAPATITE; MORPHOLOGY; NANO; NANOCOMPOSITES;
   FIBERS; SHAPE
AB Analytical models have been evaluated for chitosan nanocomposites reinforced by needle-like hydroxyapatite (HA) and globule-like polyhedral oligomeric silsesquioxane (POSS) particles. The particle elastic stress distribution was investigated for the case of high loads with the matrix deforming plastically and the particle pull-out energy during matrix crack propagation was modelled. Model predictions, over a range of reasonable interfacial shear stress values and particle aspect ratios, show contrasting behaviour between the two types of nanoreinforcement. In HA particles, the axial stress is distributed fairly uniformly, whereas, with POSS it is concentrated towards the centre of the particle. The radial stress at the HA particle surface was found to be uniformly distributed, whereas in POSS it increased non-linearly to a high (theoretically infinite) value with distance from the particle centre to the end. For particles bridging a travelling matrix crack, the model predicts that the pull-out energy density for a POSS particle increases with the interfacial shear stress, the particle aspect ratio and the particle size. The present findings offer a robust methodology for engineering chitosan-based composites for biomaterial implants with mechanical properties tailored to the tissue microenvironment.
C1 [De Silva, R.; Pasbakhsh, P.] Monash Univ Malaysia, Sch Engn, Bandar Sunway 47500, Selangor Darul, Malaysia.
   [Qureshi, A. J.; Gibson, A. G.; Goh, K. L.] Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Qureshi, A. J.; Goh, K. L.] NU Int Singapore Pte Ltd, Singapore 569830, Singapore.
RP Goh, KL (reprint author), Newcastle Univ, Sch Mech & Syst Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM kheng-lim.goh@ncl.ac.uk
RI Goh, Kheng Lim/K-7256-2014; Goh, Khean-Lee/B-6404-2009
OI Goh, Kheng Lim/0000-0002-1813-7641; pasbakhsh,
   pooria/0000-0003-4771-9453
CR Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Bleha M, 2004, DES MONOMERS POLYM, V7, P25, DOI 10.1163/156855504322890025
   Capaldi FM, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2208355
   Chen JH, 2011, CARBOHYD POLYM, V86, P1151, DOI 10.1016/j.carbpol.2011.06.013
   Chew SL, 2011, J MATER SCI-MATER M, V22, P1365, DOI 10.1007/s10856-011-4318-3
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Goh KL, 2008, ADV COMPOS LETT, V17, P131
   Goh KL, 1999, P ROY SOC A-MATH PHY, V455, P3351, DOI 10.1098/rspa.1999.0454
   Jones D. R., 2011, ENG MAT
   KELLY A, 1965, J MECH PHYS SOLIDS, V13, P329, DOI 10.1016/0022-5096(65)90035-9
   Kumar R, 2004, LANGMUIR, V20, P5196, DOI 10.1021/la049304f
   Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002
   Li JJ, 2010, MAT SCI ENG C-MATER, V30, P795, DOI 10.1016/j.msec.2010.03.011
   Liu L, 2007, POLYMER, V48, P3201, DOI 10.1016/j.polymer.2007.03.067
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Ng XW, 2010, J MATER SCI, V45, P1086, DOI 10.1007/s10853-009-4050-2
   Phillips SH, 2004, CURR OPIN SOLID ST M, V8, P21, DOI 10.1016/j.cossms.2004.03.002
   Pu KY, 2006, POLYMER, V47, P1970, DOI 10.1016/j.polymer.2006.01.006
   Rogina A, 2013, MAT SCI ENG C-MATER, V33, P4539, DOI 10.1016/j.msec.2013.07.008
   Strachota A, 2001, J INORG ORGANOMET P, V11, P165, DOI 10.1023/A:1015289611410
   Teraoka K, 1998, J DENT RES, V77, P1560, DOI 10.1177/00220345980770071201
   Xie JZ, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025014
   Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F
   Zamiri A, 2011, J MECH BEHAV BIOMED, V4, P146, DOI 10.1016/j.jmbbm.2010.11.001
NR 24
TC 3
Z9 3
U1 1
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0927-6440
EI 1568-5543
J9 COMPOS INTERFACE
JI Compos. Interfaces
PD SEP 22
PY 2014
VL 21
IS 9
SI SI
BP 807
EP 818
DI 10.1080/15685543.2014.960334
PG 12
WC Materials Science, Composites
SC Materials Science
GA AR5ZO
UT WOS:000343661800005
DA 2018-10-20
ER

PT J
AU Lee, LC
   Wall, ST
   Genet, M
   Hinson, A
   Guccione, JM
AF Lee, Lik Chuan
   Wall, Samuel T.
   Genet, Martin
   Hinson, Andy
   Guccione, Julius M.
TI Bioinjection treatment: Effects of post-injection residual stress on
   left ventricular wall stress
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Congestive heart failure; Biomaterial injection; Left ventricular wall
   stress; Mathematical modeling; Magnetic resonance imaging
ID MYOCARDIAL-INFARCTION; CARDIAC-MUSCLE; GROWTH; LENGTH; HEART; MODEL; RAT
AB Injection of biomaterials into diseased myocardium has been associated with decreased myofiber stress, restored left ventricular (LV) geometry and improved LV function. However, its exact mechanism(s) of action remained unclear. In this work, we present the first patient-specific computational model of biomaterial injection that accounts for the possibility of residual strain and stress introduced by this treatment. We show that the presence of residual stress can create more heterogeneous regional myofiber stress and strain fields. Our simulation results show that the treatment generates low stress and stretch areas between injection sites, and high. stress and stretch areas between the injections and both the endocardium and epicardium. Globally, these local changes are translated into an increase in average myofiber stress and its standard deviation (from 6.9 +/- 4.6 to 11.2 +/- 48.8 kPa and 30 +/- 15 to 35.1 +/- 50.9 kPa at end-diastole and end-systole, respectively). We also show that the myofiber stress field is sensitive to the void-to-size ratio. For a constant void size, the myofiber stress field became less heterogeneous with decreasing injection volume. These results suggest that the residual stress and strain possibly generated by biomaterial injection treatment can have large effects on the regional myocardial stress and strain fields, which may be important in the remodeling process. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Lee, Lik Chuan] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA.
   [Genet, Martin; Guccione, Julius M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.
   [Genet, Martin; Guccione, Julius M.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA.
   [Genet, Martin; Guccione, Julius M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA.
   [Wall, Samuel T.] Simula Res Lab, Oslo, Norway.
   [Hinson, Andy] Lonestar Heart Inc, Oslo, Norway.
RP Lee, LC (reprint author), Michigan State Univ, Dept Mech Engn, 2445 Engn Bldg, E Lansing, MI 48824 USA.
EM lclee@egr.msu.edu
RI Genet, Martin/H-4247-2015
OI Genet, Martin/0000-0003-2204-201X; Lee, Lik Chuan/0000-0002-1123-6428
FU National Heart, Lung, and Blood Institute [R01-HL-077921,
   R01-HL-118627]; Marie-Curie International Outgoing Fellowship within the
   7th European Community Framework Programme
FX This study was supported by National Heart, Lung, and Blood Institute
   Grants R01-HL-077921, R01-HL-118627 (to J. M. Guccione), and by a
   Marie-Curie International Outgoing Fellowship within the 7th European
   Community Framework Programme (M. Genet). We would like to thank Pamela
   Derish in Department of Surgery at UCSF for proofing the manuscript.
CR Carrick R, 2012, ANN THORAC SURG, V93, P1964, DOI 10.1016/j.athoracsur.2012.03.001
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   FRANK JS, 1974, J CELL BIOL, V60, P586, DOI 10.1083/jcb.60.3.586
   GUCCIONE JM, 1991, J BIOMECH ENG-T ASME, V113, P42, DOI 10.1115/1.2894084
   GUCCIONE JM, 1993, J BIOMECH ENG-T ASME, V115, P82, DOI 10.1115/1.2895474
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Kichula E.T., 2013, ANN BIOMED ENG
   Kortsmit J., 2012, COMPUT METHODS BIOME
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee L.C., 2013, J VISUAL EXP, P1
   Lee LC, 2014, MED BIOL ENG COMPUT, V52, P557, DOI 10.1007/s11517-014-1159-5
   Lee LC, 2013, INT J CARDIOL, V168, P2022, DOI 10.1016/j.ijcard.2013.01.003
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016
   STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339
   Sun K, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148464
   TERKEURS HEDJ, 1980, CIRC RES, V46, P703, DOI 10.1161/01.RES.46.5.703
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wenk JF, 2012, ANN THORAC SURG, V93, P1188, DOI 10.1016/j.athoracsur.2011.12.066
   Wenk JF, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000165
NR 21
TC 13
Z9 13
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD SEP 22
PY 2014
VL 47
IS 12
BP 3115
EP 3119
DI 10.1016/j.jbiomech.2014.06.026
PG 5
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AR2CU
UT WOS:000343392000040
PM 25065728
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Shefy-Peleg, A
   Foox, M
   Cohen, B
   Zilberman, M
AF Shefy-Peleg, Adaya
   Foox, Maytal
   Cohen, Benny
   Zilberman, Meital
TI Novel Antibiotic-Eluting Gelatin-Alginate Soft Tissue Adhesives for
   Various Wound Closing Applications
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE bonding strength; gelatin; Alginate; cytotoxicity; ceftazidime hydrate;
   carbodiimide; controlled drug delivery; bioadhesive
ID CROSS-LINKED GELATIN; CONTROLLED-RELEASE; POLY(L-GLUTAMIC ACID);
   MECHANICAL-PROPERTIES; BIOLOGICAL GLUE; SODIUM ALGINATE; IN-VITRO;
   COLLAGEN; BIOMATERIAL; MANAGEMENT
AB Interest in tissue adhesives as alternatives for conventional wound closing applications such as sutures and staples has increased in the last few decades due to numerous possible advantages, including less discomfort and lower cost. In the current study, the authors developed novel tissue adhesives based on gelatin and alginate, crosslinked by carbodiimide. The antibiotic drug ceftazidime was incorporated for prevention of infection. The bonding strength of the bioadhesives, their swelling ration, drug release profile and biocompatibility were studied. The high bonding strength and good biocompatibility turns these new bioadhesives into a promising alternative for use in wound closing applications.
C1 [Shefy-Peleg, Adaya; Foox, Maytal; Cohen, Benny; Zilberman, Meital] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
RP Zilberman, M (reprint author), Tel Aviv Univ, Fac Engn, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.
EM meitalz@post.tau.ac.il
FU Office of the Chief Scientist (OCS) in the Israel Ministry of Industry,
   Trade and Labor
FX The authors are grateful to the Office of the Chief Scientist (OCS) in
   the Israel Ministry of Industry, Trade and Labor, for supporting this
   research.
CR [Anonymous], 1099312 ISO
   Ashley Martin, 2005, Dent Update, V32, P169
   Bae SK, 2002, J ADHES SCI TECHNOL, V16, P361, DOI 10.1163/156856102760067163
   Chaurasia V, 2013, INT J POLYM MATER PO, V62, P119, DOI 10.1080/00914037.2011.610062
   Choi SM, 2013, INT J POLYM MATER PO, V62, P384, DOI 10.1080/00914037.2012.710862
   Cohen B, 2014, J BIOMAT SCI-POLYM E, V25, P224, DOI 10.1080/09205063.2013.849904
   DJABOUROV M, 1983, POLYMER, V24, P537, DOI 10.1016/0032-3861(83)90101-5
   Donkerwolcke M, 1998, BIOMATERIALS, V19, P1461, DOI 10.1016/S0142-9612(98)00059-3
   Draget K. I., 2005, BIOPOLYMERS
   Elsner JJ, 2011, ACTA BIOMATER, V7, P325, DOI 10.1016/j.actbio.2010.07.013
   Elsner JJ, 2009, ACTA BIOMATER, V5, P2872, DOI 10.1016/j.actbio.2009.04.007
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Galdbart JO, 1996, J SURG RES, V66, P174, DOI 10.1006/jsre.1996.0391
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   Kraus R, 2006, EUR J TRAUMA, V32, P141
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Lee JW, 2000, J PHARM SCI-US, V89, P850, DOI 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.3.CO;2-7
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Mallikarjuna B, 2013, DES MONOMERS POLYM, V16, P151, DOI 10.1080/15685551.2012.705503
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   NARAYANI R, 1994, J MICROENCAPSUL, V11, P69, DOI 10.3109/02652049409040439
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   OSMOND MH, 1995, J PEDIATR-US, V126, P892, DOI 10.1016/S0022-3476(95)70203-2
   Osmond MH, 1999, PEDIATR EMERG CARE, V15, P137, DOI 10.1097/00006565-199904000-00015
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Peppas N. A., 2007, HORIZON BIOSCI, P10
   Rachelson A., 2009, ADV ENG MATER, V11
   Rahman MF, 2013, INT J POLYM MATER PO, V62, P695, DOI 10.1080/00914037.2013.769228
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   RICHARDS DM, 1985, DRUGS, V29, P105, DOI 10.2165/00003495-198529020-00002
   Ryou M, 2006, TECH GASTROINTEST EN, V8, P33, DOI 10.1016/j.tgie.2005.12.007
   Sekine T, 2001, J BIOMED MATER RES, V54, P305, DOI 10.1002/1097-4636(200102)54:2<305::AID-JBM18>3.0.CO;2-B
   Sells L, 1999, PEDIAT EMERG MED REP, V4, P1
   SIBERT JR, 1981, ARCH DIS CHILD, V56, P225, DOI 10.1136/adc.56.3.225
   Sierra DH, 2000, J BIOMED MATER RES, V52, P534, DOI 10.1002/1097-4636(20001205)52:3<534::AID-JBM12>3.0.CO;2-7
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Sripriya R, 2004, J BIOMED MATER RES B, V70B, P389, DOI 10.1002/jbm.b.30051
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Yang HX, 2013, INT J POLYM MATER PO, V62, P369, DOI 10.1080/00914037.2012.706839
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 45
TC 5
Z9 5
U1 1
U2 64
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PD SEP 22
PY 2014
VL 63
IS 14
BP 699
EP 707
DI 10.1080/00914037.2013.862535
PG 9
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA AH2JH
UT WOS:000335946800001
DA 2018-10-20
ER

PT J
AU Damanik, FFR
   Rothuizen, TC
   van Blitterswijk, C
   Rotmans, JI
   Moroni, L
AF Damanik, Febriyani F. R.
   Rothuizen, Tonia C.
   van Blitterswijk, Clemens
   Rotmans, Joris I.
   Moroni, Lorenzo
TI Towards an in vitro model mimicking the foreign body response: tailoring
   the surface properties of biomaterials to modulate extracellular matrix
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CELL-PROLIFERATION; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; TISSUE-REPAIR;
   COLLAGEN-I; TGF-BETA; ELASTIN; EXPRESSION; ROUGHNESS; ADHESION
AB Despite various studies to minimize host reaction following a biomaterial implantation, an appealing strategy in regenerative medicine is to actively use such an immune response to trigger and control tissue regeneration. We have developed an in vitro model to modulate the host response by tuning biomaterials' surface properties through surface modifications techniques as a new strategy for tissue regeneration applications. Results showed tunable surface topography, roughness, wettability, and chemistry by varying treatment type and exposure, allowing for the first time to correlate the effect of these surface properties on cell attachment, morphology, strength and proliferation, as well as proinflammatory (IL-1 beta, IL-6) and antiflammatory cytokines (TGF-beta 1, IL-10) secreted in medium, and protein expression of collagen and elastin. Surface microstructuring, derived from chloroform partial etching, increased surface roughness and oxygen content. This resulted in enhanced cell adhesion, strength and proliferation as well as a balance of soluble factors for optimum collagen and elastin synthesis for tissue regeneration. By linking surface parameters to cell activity, we could determine the fate of the regenerated tissue to create successful soft tissue-engineered replacement.
C1 [Damanik, Febriyani F. R.; van Blitterswijk, Clemens; Moroni, Lorenzo] Univ Twente, NL-7522 NB Enschede, Netherlands.
   [Rothuizen, Tonia C.; Rotmans, Joris I.] Leiden Univ, Med Ctr, Dept Nephrol, NL-2333 ZA Leiden, Netherlands.
   [van Blitterswijk, Clemens; Moroni, Lorenzo] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Drienerlolaan 5,Zuidhorst 145, NL-7522 NB Enschede, Netherlands.
EM f.damanik@utwente.nl; l.moroni@maastrichtuniversity.nl
RI Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; van Blitterswijk,
   Clemens/0000-0003-2371-4615
FU DialysisXS of the research program of the BioMedical Materials institute
   - Dutch Ministry of Economic Affairs, Agriculture and Innovation
   [P3.03]; Nierstichting Nederland
FX This research forms part of the Project P3.03 DialysisXS of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affairs, Agriculture and Innovation. The financial
   contribution of the Nierstichting Nederland is gratefully acknowledged.
   Contribution of PCL rods provided from Xeltis, the Netherlands is
   gratefully appreciated.
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   Baranek T, 2007, J IMMUNOL, V179, P6184, DOI 10.4049/jimmunol.179.9.6184
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   da Rocha-Azevedo B, 2013, EXP CELL RES, V319, P2440, DOI 10.1016/j.yexcr.2013.05.003
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930
   Extrand CW, 2004, LANGMUIR, V20, P5013, DOI 10.1021/la036481s
   Extrand CW, 2004, LANGMUIR, V20, P4017, DOI 10.1021/la0354988
   France RM, 1997, J CHEM SOC FARADAY T, V93, P3173, DOI 10.1039/a702311a
   Gao JM, 1998, J BIOMED MATER RES, V42, P417, DOI 10.1002/(SICI)1097-4636(19981205)42:3<417::AID-JBM11>3.3.CO;2-N
   Hamlet S, 2012, CLIN ORAL IMPLAN RES, V23, P584, DOI 10.1111/j.1600-0501.2011.02325.x
   Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098
   He QG, 2003, LANGMUIR, V19, P6982, DOI 10.1021/la020785h
   Hoelzle MK, 2012, MOL BIOL CELL, V23, P310, DOI 10.1091/mbc.E11-08-0719
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Hong HH, 2002, J PERIODONTOL, V73, P145, DOI 10.1902/jop.2002.73.2.145
   Horstmeyer A, 2005, FEBS J, V272, P6297, DOI 10.1111/j.1742-4658.2005.05016.x
   John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772
   Kim KS, 2000, KOREAN J CHEM ENG, V17, P33, DOI 10.1007/BF02789250
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Kolacna L, 2007, PHYSIOL RES, V56, pS51
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   Linker-Israeli M, 1999, CLIN IMMUNOL, V91, P6, DOI 10.1006/clim.1998.4680
   Marie C, 1996, MEDIAT INFLAMM, V5, P334, DOI 10.1155/S0962935196000488
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Moroni L, 2009, J BIOMED MATER RES A, V88A, P644, DOI 10.1002/jbm.a.31915
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   Odelius K, 2011, BIOMACROMOLECULES, V12, P1250, DOI 10.1021/bm1015464
   Pan H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065002
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Petrella BL, 2012, CANCER LETT, V325, P220, DOI 10.1016/j.canlet.2012.07.009
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Shah A, 2011, J TISSUE ENG REGEN M, V5, P301, DOI 10.1002/term.316
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705
   Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415
   van Dijkhuizen-Radersma R, 2002, BIOMATERIALS, V23, P1527, DOI 10.1016/S0142-9612(01)00286-1
   VANBLITTERSWIJK CA, 1993, CELL MATER, V3, P23
   Walter R, 2013, APPL SURF SCI, V279, P343, DOI 10.1016/j.apsusc.2013.04.096
   Wang Y, 2013, J CONTROL RELEASE, V169, P341, DOI 10.1016/j.jconrel.2012.12.028
   Wognum S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000182
   Yamanami M, 2013, J ARTIF ORGANS, V16, P59, DOI 10.1007/s10047-012-0676-y
   Yang DY, 2013, BIOMATERIALS, V34, P5747, DOI 10.1016/j.biomaterials.2013.04.028
   Zeng QO, 2010, BIOMATERIALS, V31, P5772, DOI 10.1016/j.biomaterials.2010.04.022
NR 60
TC 26
Z9 27
U1 3
U2 48
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 19
PY 2014
VL 4
AR 6325
DI 10.1038/srep06325
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AP3PH
UT WOS:000341988700001
PM 25234587
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Xie, MH
   Hu, B
   Wang, Y
   Zeng, XX
AF Xie, Minhao
   Hu, Bing
   Wang, Yan
   Zeng, Xiaoxiong
TI Grafting of Gallic Acid onto Chitosan Enhances Antioxidant Activities
   and Alters Rheological Properties of the Copolymer
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE chitosan; gallic acid; grafting antioxidant; rheological property
ID PHENOLIC-COMPOUNDS; CROSS-LINKING; MULTIFUNCTIONAL FOOD;
   ENZYMATIC-SYNTHESIS; INHIBITORY-ACTIVITY; IN-VITRO; GELATIN;
   DERIVATIVES; CATECHIN; LACCASE
AB A new, simple, and effective method to graft gallic acid (GA) onto chitosan (CS) in aqueous solution in the presence of carbodiimide and hydroxybenzotriazole was developed. The grafting amount of GA reached as much as 209.9 mg/g of copolymer, which appears as the highest one among the reported literature, and the grafting degree of GA to CS was adjustable with modulation of the mass ratio of GA to CS. The covalent insertion of GA onto the polymeric backbones was confirmed by UV-vis and H-1 NMR analyses. Grafting endowed the resulting copolymer GA-grafted-CS (GA-g-CS) with both the advantages of CS and GA. The antioxidant capacity of GA-g-CS was much higher than that of the plain CS examined by assays of DPPH, superoxide, and ABTS radicals scavenging activities, reducing power, chelating power, inhibition of lipid peroxidation, ferric reducing antioxidant potential, and beta-carotene-linoleic acid assays. Particularly, GA-g-CS showed significantly higher antioxidant activity than GA in beta-carotene-linoleic acid assay. Furthermore, the viscosity of GA-g-CS was significantly higher than that of CS. The present study developed a novel approach to synthesize GA-g-CS that could be a potential biomaterial in food industries.
C1 [Xie, Minhao; Hu, Bing; Wang, Yan; Zeng, Xiaoxiong] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
RP Zeng, XX (reprint author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China.
EM zengxx@njau.edu.cn
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD)
FX This work was supported by Project Funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD).
CR Abdille MH, 2005, FOOD CHEM, V90, P891, DOI 10.1016/j.foodchem.2004.09.002
   Adelakun OE, 2012, J MOL CATAL B-ENZYM, V74, P29, DOI 10.1016/j.molcatb.2011.08.010
   Aewsiri T, 2009, FOOD CHEM, V117, P160, DOI 10.1016/j.foodchem.2009.03.092
   Amarowicz R, 2004, FOOD CHEM, V84, P551, DOI 10.1016/S0308-8146(03)00278-4
   Bozic M, 2013, REACT FUNCT POLYM, V73, P1377, DOI 10.1016/j.reactfunctpolym.2013.01.005
   Brzonova I, 2011, EUR J PHARM BIOPHARM, V79, P294, DOI 10.1016/j.ejpb.2011.04.018
   Carvajal-Millan E, 2005, BIOMACROMOLECULES, V6, P309, DOI 10.1021/bm049629a
   Casettari L, 2012, FOOD HYDROCOLLOID, V28, P243, DOI 10.1016/j.foodhyd.2012.01.005
   Charernsriwilaiwat N, 2012, TROP J PHARM RES, V11, P235, DOI 10.4314/tjpr.v11i2.9
   Cho YS, 2011, CARBOHYD POLYM, V83, P1617, DOI 10.1016/j.carbpol.2010.10.019
   Chung JE, 2003, BIOTECHNOL LETT, V25, P1993, DOI 10.1023/B:BILE.0000004391.27564.8e
   Curcio M, 2009, J AGR FOOD CHEM, V57, P5933, DOI 10.1021/jf900778u
   Dai B., 2008, CHIN J MAGN RESON, V4, P453
   Eom TK, 2013, J ENZYM INHIB MED CH, V28, P214, DOI 10.3109/14756366.2011.629197
   Fangkangwanwong J, 2006, BIOPOLYMERS, V82, P580, DOI 10.1002/bip.20511
   Fangkangwanwong J, 2006, MACROMOL RAPID COMM, V27, P1039, DOI 10.1002/marc.200600152
   Frankel EN, 2000, J SCI FOOD AGR, V80, P1925, DOI 10.1002/1097-0010(200010)80:13<1925::AID-JSFA714>3.0.CO;2-4
   Huang DJ, 2005, J AGR FOOD CHEM, V53, P1841, DOI 10.1021/jf030723c
   Ihara N, 2004, BIOMACROMOLECULES, V5, P1633, DOI 10.1021/bm049823x
   Jus S, 2012, BIOCATAL BIOTRANSFOR, V30, P86, DOI 10.3109/10242422.2012.646036
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lee DS, 2013, J AGR FOOD CHEM, V61, P6574, DOI 10.1021/jf401254g
   Liu J, 2013, INT J BIOL MACROMOL, V62, P321, DOI 10.1016/j.ijbiomac.2013.09.032
   Liu J, 2010, CARBOHYD POLYM, V82, P1278, DOI 10.1016/j.carbpol.2010.07.008
   Liu J, 2009, CARBOHYD POLYM, V78, P275, DOI 10.1016/j.carbpol.2009.03.046
   Liu LX, 2009, FOOD CHEM, V112, P35, DOI 10.1016/j.foodchem.2008.05.038
   Liu Y, 2013, ACTA BIOMATER, V9, P6616, DOI 10.1016/j.actbio.2013.01.037
   Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x
   MARCO GJ, 1968, J AM OIL CHEM SOC, V45, P594, DOI 10.1007/BF02668958
   Niki E, 2014, BBA-GEN SUBJECTS, V1840, P809, DOI 10.1016/j.bbagen.2013.03.020
   No HK, 2007, J FOOD SCI, V72, pR87, DOI 10.1111/j.1750-3841.2007.00383.x
   Opanasopit P, 2010, OLIGONUCLEOTIDES, V20, P127, DOI 10.1089/oli.2009.0227
   Pasanphan W, 2008, CARBOHYD POLYM, V72, P169, DOI 10.1016/j.carbpol.2007.08.002
   Pasanphan W, 2010, CARBOHYD RES, V345, P132, DOI 10.1016/j.carres.2009.09.038
   Prabaharan M, 2006, CARBOHYD POLYM, V63, P153, DOI 10.1016/j.carbpol.2005.08.051
   Prodpran T, 2012, INT J BIOL MACROMOL, V51, P774, DOI 10.1016/j.ijbiomac.2012.07.010
   Puoci F, 2012, ANTICANCER RES, V32, P2843
   Ren JM, 2013, INT J BIOL MACROMOL, V53, P77, DOI 10.1016/j.ijbiomac.2012.11.011
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Schreiber SB, 2013, FOOD HYDROCOLLOID, V33, P207, DOI 10.1016/j.foodhyd.2013.03.006
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Shiu JC, 2010, CARBOHYD POLYM, V79, P724, DOI 10.1016/j.carbpol.2009.09.025
   Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003
   Spizzirri UG, 2011, CARBOHYD POLYM, V84, P517, DOI 10.1016/j.carbpol.2010.12.015
   Spizzirri UG, 2010, CARBOHYD POLYM, V79, P333, DOI 10.1016/j.carbpol.2009.08.010
   Spizzirri UG, 2009, BIOMACROMOLECULES, V10, P1923, DOI 10.1021/bm900325t
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Verma S, 2013, ENVIRON TOXICOL PHAR, V35, P473, DOI 10.1016/j.etap.2013.02.011
   Vittorio O, 2012, PHARM RES-DORDR, V29, P2601, DOI 10.1007/s11095-012-0790-9
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Yan MY, 2011, FOOD HYDROCOLLOID, V25, P907, DOI 10.1016/j.foodhyd.2010.08.019
   Yin JY, 2012, J AGR FOOD CHEM, V60, P7981, DOI 10.1021/jf302052t
   Yu SH, 2011, CARBOHYD POLYM, V84, P794, DOI 10.1016/j.carbpol.2010.04.035
   Zhang XQ, 2010, BIOMACROMOLECULES, V11, P1125, DOI 10.1021/bm1001284
NR 54
TC 77
Z9 82
U1 16
U2 117
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD SEP 17
PY 2014
VL 62
IS 37
BP 9128
EP 9136
DI 10.1021/jf503207s
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA AP5KX
UT WOS:000342119200010
PM 25198516
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Lin, C
   Gan, L
   Chen, ZL
   Megharaj, M
   Naidu, R
AF Lin, Chen
   Gan, Li
   Chen, Zuliang
   Megharaj, Mallavarapu
   Naidu, Ravendra
TI Biodegradation of naphthalene using a functional biomaterial based on
   immobilized Bacillus fusiformis (BFN)
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Bacillus fusiformis; Naphthalene; Biodegradation; Immobilization;
   Biomaterial
ID ALCOHOL PVA GEL; POLYVINYL-ALCOHOL; PHANEROCHAETE-CHRYSOSPORIUM;
   PSEUDOMONAS-PUTIDA; SODIUM ALGINATE; DEGRADATION; BEADS; KINETICS;
   REMOVAL; SUPPORT
AB The degradation of naphthalene using immobilized Bacillus fusiformis (BFN) strain on alginate-polyvinyl alcohol (PVA)-clays bead was much higher than that of using a freely suspended BFN strain. This was due to the beads facilitating biodegradation by enhancing concentration of naphthalene using the beads as an adsorbent in the cells' vicinity. This was confirmed by the kinetics of naphthalene on the beads, where its adsorption onto the beads was confirmed by pseudo-second-order kinetics. The biodegradation of naphthalene fitted well to the first-order rate model. More than 99.7% of naphthalene which was removed within 12 h, contained bentonite 2% (w/v), PVA 12% (w/v), alginate 0.3% (w/v) and 10% (v/v) initial biomass loading. Scanning electron microscopy (SEM) of the beads showed that B. fusiformis was evenly distributed within them. Storage stability and reusability results revealed that the ability to degrade naphthalene using beads with immobilized cells remained stable after storage at 4 degrees C for 35 days and being reused 8 times (12 days), respectively. Furthermore the naphthalene degradation rate of immobilized cells was maintained (94.3%) at the eighth cycle. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Lin, Chen; Gan, Li; Chen, Zuliang] Fujian Normal Univ, Sch Environm Sci & Engn, Fuzhou 350007, Fujian Province, Peoples R China.
   [Lin, Chen] Fujian Solid Waste Treatment Co Ltd, Fuzhou 350011, Fujian Province, Peoples R China.
   [Chen, Zuliang; Megharaj, Mallavarapu; Naidu, Ravendra] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
RP Chen, ZL (reprint author), Fujian Normal Univ, Sch Environm Sci & Engn, Fuzhou 350007, Fujian Province, Peoples R China.
EM zuliang.chen@unisa.edu.au
RI Mallavarapu, Megharaj/D-3408-2011
OI Mallavarapu, Megharaj/0000-0002-6230-518X
FU Fujian "Minjiang Fellowship" from Fujian Normal University
FX This research was supported by a Fujian "Minjiang Fellowship" from
   Fujian Normal University.
CR Behera SK, 2008, J HAZARD MATER, V153, P1207, DOI 10.1016/j.jhazmat.2007.09.117
   Blandino A, 1999, J BIOSCI BIOENG, V88, P686, DOI 10.1016/S1389-1723(00)87103-0
   Chen CY, 2010, J HAZARD MATER, V177, P856, DOI 10.1016/j.jhazmat.2009.12.112
   Chen JP, 2007, PROCESS BIOCHEM, V42, P934, DOI 10.1016/j.procbio.2007.03.001
   CHEN S, 1989, J ENVIRON QUAL, V18, P153, DOI 10.2134/jeq1989.00472425001800020004x
   Ei-Naas MH, 2007, CHEM ENG PROCESS, V46, P1391, DOI 10.1016/j.cep.2006.11.003
   El-Naas MH, 2009, J HAZARD MATER, V164, P720, DOI 10.1016/j.jhazmat.2008.08.059
   Gan S, 2009, J HAZARD MATER, V172, P532, DOI 10.1016/j.jhazmat.2009.07.118
   Grivel F, 1999, BIOTECHNOL TECH, V13, P823, DOI 10.1023/A:1008911006199
   Ha J, 2009, BIORESOURCE TECHNOL, V100, P1138, DOI 10.1016/j.biortech.2008.08.022
   Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137
   Idris A, 2006, PROCESS BIOCHEM, V41, P1117, DOI 10.1016/j.procbio.2005.12.002
   Lee J, 2010, KOREAN J CHEM ENG, V27, P193, DOI 10.1007/s11814-009-0330-4
   Lin C, 2010, J HAZARD MATER, V182, P771, DOI 10.1016/j.jhazmat.2010.06.101
   Liu YJ, 2009, BIOCHEM ENG J, V44, P187, DOI 10.1016/j.bej.2008.12.001
   Long Z, 2004, PROCESS BIOCHEM, V39, P2129, DOI 10.1016/j.procbio.2003.11.004
   Manohar S, 2001, APPL MICROBIOL BIOT, V55, P311, DOI 10.1007/s002530000488
   Park C, 2006, ENZYME MICROB TECH, V39, P371, DOI 10.1016/j.enzmictec.2005.11.045
   Park C, 2003, J BIOSCI BIOENG, V95, P567, DOI 10.1016/S1389-1723(03)80163-9
   Pathak H, 2009, J HAZARD MATER, V166, P1466, DOI 10.1016/j.jhazmat.2008.12.074
   Sanjay G, 2005, CATAL COMMUN, V6, P525, DOI 10.1016/j.catcom.2004.04.016
   Szczesna M, 2001, J MOL CATAL B-ENZYM, V11, P671, DOI 10.1016/S1381-1177(00)00151-X
   USEPA, 1985, EV EST POT CARC RISK
   Wu J, 2007, BIORESOURCE TECHNOL, V98, P253, DOI 10.1016/j.biortech.2006.01.018
   Xing XH, 1999, J BIOSCI BIOENG, V87, P372, DOI 10.1016/S1389-1723(99)80048-6
   Yesiloglu Y, 2005, PROCESS BIOCHEM, V40, P2155, DOI 10.1016/j.procbio.2004.08.008
   Zhang K, 2008, BIOCHEM ENG J, V41, P251, DOI 10.1016/j.bej.2008.05.003
   Zhang LS, 2007, J ENVIRON SCI-CHINA, V19, P1293, DOI 10.1016/S1001-0742(07)60211-3
   Zhou LC, 2009, J HAZARD MATER, V167, P1106, DOI 10.1016/j.jhazmat.2009.01.118
NR 29
TC 8
Z9 8
U1 1
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1369-703X
EI 1873-295X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD SEP 15
PY 2014
VL 90
BP 1
EP 7
DI 10.1016/j.bej.2014.05.003
PG 7
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA AO0HN
UT WOS:000340989800001
DA 2018-10-20
ER

PT J
AU Ashfaq, M
   Khan, S
   Verma, N
AF Ashfaq, Mohammad
   Khan, Suphiya
   Verma, Nishith
TI Synthesis of PVA-CAP-based biomaterial in situ dispersed with Cu
   nanoparticles and carbon micro-nanofibers for antibiotic drug delivery
   applications
SO BIOCHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Antibiotics; Biomedical; Biokinetics; Microcarriers; Drug delivery;
   Biomaterial
ID CELLULOSE-ACETATE PHTHALATE; CONTROLLED-RELEASE; POLYVINYL-ALCOHOL;
   MICROSPHERES; TEMPERATURE; POLYMERS; SYSTEMS
AB A novel pH-sensitive and water-soluble polyvinyl alcohol (PVA)-cellulose acetate phthalate (CAP) composite-based biomaterial was prepared, in which the multi-scale web of copper (Cu)-grown carbon micro-nanofibers (Cu-ACF/CNFs) was in situ dispersed during a synthesis stage. PVA-CAP and Cu-nanoparticles (NPs) were used as an encapsulating agent and nano-antibiotics, respectively. The web of Cu-ACF/CNF was prepared by growing CNFs on the activated carbon microfiber (ACF) substrate by chemical vapor deposition using Cu NPs as the catalyst. The novel step of the synthesis included esterification of polyvinyl acetate (PVAc) to produce a PVA gel to which the ball-milled Cu-ACF/CNF was blended at the incipience of the gel formation to produce the PVA-CAP-Cu-ACF/CNF metal-carbon-polymeric composite film. The in vitro dissolution tests revealed that the encapsulating polymeric composite was dispersible in water and its rate of dissolution was high at pH > 6.5. The antibacterial tests performed on the material demonstrated its effectiveness against both gram negative Escherichia coli and gram positive Staphylococcus aureus bacterial strains. The Hixson-Crowell kinetic model described the dissolution profiles of the material. The method of preparation is novel, simple, and environmentally friendly. The prepared biomaterial may be used in several biomedical applications, including wound healing and the controlled release of drugs in the antibiotic delivery system. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ashfaq, Mohammad; Verma, Nishith] Indian Inst Technol, Ctr Environm Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
   [Ashfaq, Mohammad; Khan, Suphiya] Banasthali Univ, Dept Biosci & Biotechnol, Banasthali 304022, India.
   [Verma, Nishith] Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.
RP Verma, N (reprint author), Indian Inst Technol, Dept Chem Engn, Kanpur 208016, Uttar Pradesh, India.
EM nishith@iitk.ac.in
OI ASHFAQ, MOHAMMAD/0000-0003-2644-6783
CR Ashfaq M, 2013, IND ENG CHEM RES, V52, P4672, DOI 10.1021/ie303273s
   Bikshapathi M, 2012, COLLOID SURFACE A, V399, P46, DOI 10.1016/j.colsurfa.2012.02.023
   Bikshapathi M, 2011, IND ENG CHEM RES, V50, P13092, DOI 10.1021/ie101860e
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   Bulmer C, 2012, BIOCHEM ENG J, V68, P61, DOI 10.1016/j.bej.2012.07.007
   Chaturvedi K, 2011, IND ENG CHEM RES, V50, P10414, DOI 10.1021/ie2011005
   Chen XG, 2006, BIOCHEM ENG J, V27, P269, DOI 10.1016/j.bej.2005.08.021
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Das S, 2013, IND ENG CHEM RES, V52, P14192, DOI 10.1021/ie402121f
   Degeratu C.N., 2010, CHEM B, V55, P189
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Fundueanu G, 2008, BIOMATERIALS, V29, P2767, DOI 10.1016/j.biomaterials.2008.03.025
   Gaurav A, 2012, J APPL POLYM SCI, V125, pE16, DOI 10.1002/app.35591
   Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002
   Kadajji VG, 2011, POLYMERS-BASEL, V3, P1972, DOI 10.3390/polym3041972
   Kim EJ, 2001, BIOMATERIALS, V22, P2495, DOI 10.1016/S0142-9612(00)00439-7
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Manson KH, 2000, ANTIMICROB AGENTS CH, V44, P3199, DOI 10.1128/AAC.44.11.3199-3202.2000
   Peresin MS, 2010, BIOMACROMOLECULES, V11, P674, DOI 10.1021/bm901254n
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Sharma AK, 2013, MAT SCI ENG C-MATER, V33, P1702, DOI 10.1016/j.msec.2012.12.083
   Singh S, 2013, NEW BIOTECHNOL, V30, P656, DOI 10.1016/j.nbt.2013.05.002
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vera P, 1997, J APPL POLYM SCI, V65, P2721, DOI 10.1002/(SICI)1097-4628(19970926)65:13<2721::AID-APP13>3.0.CO;2-#
   Weir E, 2008, ANALYST, V133, P835, DOI 10.1039/b715532h
   Zhang J, 2010, ACTA BIOMATER, V6, P445, DOI 10.1016/j.actbio.2009.07.001
   Zhang K, 2004, BIOMATERIALS, V25, P5281, DOI 10.1016/j.biomaterials.2003.12.032
   Zhao K, 2003, BIOCHEM ENG J, V16, P115, DOI 10.1016/S1369-703X(03)00029-9
NR 30
TC 16
Z9 16
U1 3
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1369-703X
EI 1873-295X
J9 BIOCHEM ENG J
JI Biochem. Eng. J.
PD SEP 15
PY 2014
VL 90
BP 79
EP 89
DI 10.1016/j.bej.2014.05.016
PG 11
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA AO0HN
UT WOS:000340989800010
DA 2018-10-20
ER

PT J
AU Kramer, E
   Podurgiel, J
   Wei, M
AF Kramer, Erica
   Podurgiel, Joseph
   Wei, Mei
TI Control of hydroxyapatite nanoparticle morphology using wet synthesis
   techniques: Reactant addition rate effects
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Biomaterials; Ceramics; Bioceramics; Synthesis
ID TEMPERATURE; PH
AB Hydroxyapatite is a widely used biomaterial that, due to its biocompatibility and biodegradability, can be applied to a variety of biomedical problems. The effect of reactant addition rate during wet synthesis on hydroxyapatite particle morphology was studied. It was found that by decreasing reactant addition rate, the size and aspect ratio of hydroxyapatite nanoparticles could be increased. Reactant addition rates tested ranged from 0.80 mL/min to 140 mL/min, with resulting particles ranging from 255 nm long rod-shaped particles to 27 nm diameter spherical particles. X-ray diffraction confirmed that at all reactant addition rates pure hydroxyapatite was generated. Controlling reactant addition rate is therefore a practical and simple approach for preparing hydroxyapatite particles with varied morphologies and particle sizes suitable for different biomedical applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kramer, Erica; Podurgiel, Joseph; Wei, Mei] Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
RP Wei, M (reprint author), Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, 97 North Eagleville Rd, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
FU U.S. Department of Education Graduate Assistance in Areas of National
   Need (GAANN) Fellowship Program [P200A09315]; National Science
   Foundation [BES 0503315, CBET-1133883]
FX The authors would like to thank the U.S. Department of Education
   Graduate Assistance in Areas of National Need (GAANN) Fellowship Program
   (P200A09315) and National Science Foundation (BES 0503315 and
   CBET-1133883) for their support of the research.
CR Billotte WG, 2003, CERAMIC BIOMATERIALS
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Lazic S, 2001, THERMOCHIM ACTA, V374, P13, DOI 10.1016/S0040-6031(01)00453-1
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Martini F, 2006, FUNDAMENTALS ANATOMY
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Peng F, 2012, J NANOSCI NANOTECHNO, V11, P1
   Smiciklas I, 2005, SEP PURIF TECHNOL, V44, P97, DOI 10.1016/j.seppur.2004.12.010
   Pham TTT, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035014
   Torrent-Burgues J, 2001, CRYST RES TECHNOL, V36, P1075, DOI 10.1002/1521-4079(200110)36:8/10<1075::AID-CRAT1075>3.0.CO;2-E
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Zhang HQ, 2011, ACTA BIOMATER, V7, P2960, DOI 10.1016/j.actbio.2011.03.020
NR 14
TC 13
Z9 13
U1 2
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD SEP 15
PY 2014
VL 131
BP 145
EP 147
DI 10.1016/j.matlet.2014.05.105
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AM8QJ
UT WOS:000340141800041
DA 2018-10-20
ER

PT J
AU Elahi, MF
   Guan, GP
   Wang, L
   King, MW
AF Elahi, M. Fazley
   Guan, Guoping
   Wang, Lu
   King, Martin W.
TI Improved Hemocompatibility of Silk Fibroin Fabric Using Layer-by-Layer
   Polyelectrolyte Deposition and Heparin Immobilization
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE hemocompatibility; layer-by-layer deposition; polyelectrolye;
   self-assembly; silk fibroin
ID MESENCHYMAL STEM-CELLS; MOLECULAR-WEIGHT HEPARIN; CONTROLLED-RELEASE;
   BLOOD COMPATIBILITY; 2-METHACRYLOYLOXYETHYL PHOSPHORYLCHOLINE;
   UNFRACTIONATED HEPARIN; CHEMICAL-MODIFICATION; BIOMATERIAL COATINGS;
   SURFACE WETTABILITY; BOMBYX-MORI
AB Silk fibroin has long been used as implantable surgical sutures and it has acceptable mechanical properties and patency rates in animal models and in clinical end-uses. However, fibroin has been shown to be hemolytic and can cause damage to red blood cells. So to be used as an implantable vascular prosthesis its hemocompatibility needs to be improved. This study has taken two sequential steps to address this problem. First, to create a positively charged layer on the fibroin fibers' surface, a 1.5 and 2.5 bilayers polyelectrolyte surface deposition layer-by-layer technique was used with the positive counterion poly(allylamine hydrochloride) and the negative counterion poly(acrylic acid). Second, negatively charged low molecular weight heparin was then immobilized on these positively charged self-assembled surfaces. The presence of the heparin was confirmed with Alcian Blue staining and a toluidine blue assay, and the increased roughness and hydrophilicity of the modified surfaces were characterized by scanning electron microscopy, contact angle measurements, and atomic force microscopy. In addition, a negligible hemolytic effect, reduced protein adsorption, and a higher concentration of free hemoglobin measured by a kinetic clotting time test were found to be enhanced with the use of 2.5 bilayers compared to the 1.5 bilayers self-assembly technique. Given the success of these preliminary results, it is anticipated that this novel approach of surface modification and heparin immobilization will demonstrate long-term patency during future animal trials of small caliber silk fibroin vascular grafts. (C) 2014 Wiley Periodicals, Inc.
C1 [Elahi, M. Fazley; Guan, Guoping; Wang, Lu; King, Martin W.] Donghua Univ, Coll Text, Key Lab Text Sci & Technol, Minist Educ, Shanghai 201620, Peoples R China.
   [King, Martin W.] N Carolina State Univ, Coll Text, Raleigh, NC 27695 USA.
RP Wang, L (reprint author), Donghua Univ, Coll Text, Key Lab Text Sci & Technol, Minist Educ, Shanghai 201620, Peoples R China.
EM wanglu@dhu.edu.cn
FU National Natural Science Foundation of China [51003014, 31100682];
   Fundamental Research Funds for the Central Universities; 111 Project
   "Biomedical Textile Materials Science and Technology" [B07024]
FX This work has been supported by the National Natural Science Foundation
   of China (Grant Nos. 51003014 and 31100682), the Fundamental Research
   Funds for the Central Universities, and the 111 Project "Biomedical
   Textile Materials Science and Technology" (Grant No. B07024).
CR Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Chutipakdeevong J, 2013, J APPL POLYM SCI, V130, P3634, DOI 10.1002/app.39611
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Dey RK, 2003, BIOMATERIALS, V24, P2985, DOI 10.1016/S0142-9612(03)00122-4
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Du YJ, 2007, J BIOMED MATER RES A, V80A, P216, DOI 10.1002/jbm.a.30977
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Furuzono T, 1999, J APPL POLYM SCI, V73, P2541, DOI 10.1002/(SICI)1097-4628(19990919)73:12<2541::AID-APP23>3.0.CO;2-5
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Gajjar C, 2011, THESIS N CAROLINA ST
   He QJ, 2010, BIOMATERIALS, V31, P1085, DOI 10.1016/j.biomaterials.2009.10.046
   Hirsh J, 1998, AM HEART J, V135, pS336, DOI 10.1053/hj.1998.v135.90303
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Johansson E, 2009, LANGMUIR, V25, P2887, DOI 10.1021/la803628w
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Ki CS, 2007, J APPL POLYM SCI, V106, P3922, DOI 10.1002/app.26914
   Ki Dong P., 1992, J BIOMED MATER RES, V26, P739
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Li GC, 2010, COLLOID SURFACE B, V81, P255, DOI 10.1016/j.colsurfb.2010.07.016
   Li J, 2012, MACROMOL CHEM PHYS, V213, P2120, DOI 10.1002/macp.201200251
   Lin YS, 2009, CHEM MATER, V21, P3979, DOI 10.1021/cm901259n
   Liu SS, 2013, ACTA BIOMATER, V9, P8991, DOI 10.1016/j.actbio.2013.06.045
   Liu XY, 2009, MATER LETT, V63, P263, DOI 10.1016/j.matlet.2008.10.006
   Lojou T, 2004, LANGMUIR, V20, P748, DOI 10.1021/la030286w
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Mallwitz F, 2005, ADV MATER, V17, P1296, DOI 10.1002/adma.200401123
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1014, DOI 10.1016/j.msec.2010.05.003
   Nakazawa Y, 2011, J BIOMAT SCI-POLYM E, V22, P195, DOI 10.1163/092050609X12586381656530
   Nogueira GM, 2009, J APPL POLYM SCI, V114, P617, DOI 10.1002/app.30627
   PARK KD, 1991, J POLYM SCI POL CHEM, V29, P1725, DOI 10.1002/pola.1991.080291206
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Podsiadlo P, 2009, LANGMUIR, V25, P14093, DOI 10.1021/la9021323
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Ren ZC, 2013, J APPL POLYM SCI, V127, P308, DOI 10.1002/app.37885
   SCHMITT J, 1993, MACROMOLECULES, V26, P7058, DOI 10.1021/ma00077a052
   Serra A, 1997, THROMB RES, V87, P405, DOI 10.1016/S0049-3848(97)00144-8
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shim D, 1996, CATHETER CARDIO DIAG, V39, P287, DOI 10.1002/(SICI)1097-0304(199611)39:3<287::AID-CCD17>3.0.CO;2-C
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Smith BS, 2010, J BIOMED MATER RES A, V95A, P350, DOI 10.1002/jbm.a.32853
   Szebeni J, 2012, EUR J NANOMED, V33
   Tamada Y, 2003, J APPL POLYM SCI, V87, P2377, DOI 10.1002/app.12022
   Wang S., 2007, EUR CELLS MATER, V14, P94
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Xiao W., 2011, BIOMED MATER, V6
   Yagi T, 2011, J ARTIF ORGANS, V14, P89, DOI 10.1007/s10047-011-0554-z
   Yang XY, 2014, J BIOMATER APPL, V28, P676, DOI 10.1177/0885328212472216
   Young E, 1999, THROMB RES, V96, P373, DOI 10.1016/S0049-3848(99)00125-5
   Zhao YL, 2013, J APPL POLYM SCI, V127, P4825, DOI 10.1002/app.38054
   Zhu ZH, 2008, J APPL POLYM SCI, V109, P2956, DOI 10.1002/app.28460
NR 63
TC 6
Z9 6
U1 5
U2 91
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 15
PY 2014
VL 131
IS 18
AR 40772
DI 10.1002/APP.40772
PG 12
WC Polymer Science
SC Polymer Science
GA AJ4EE
UT WOS:000337623600032
DA 2018-10-20
ER

PT J
AU Homayun, B
   Afshar, A
AF Homayun, Bahman
   Afshar, Abdollah
TI Microstructure, mechanical properties, corrosion behavior and
   cytotoxicity of Mg-Zn-Al-Ca alloys as biodegradable materials
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Mg-Zn-Al-Ca alloys; Biomaterials; Mechanical properties; Corrosion
   behavior; Cytotoxicity
ID SIMULATED BODY-FLUID; IN-VIVO CORROSION; MAGNESIUM ALLOYS; IMPLANT
   MATERIALS; ZR ALLOYS; VITRO; BIOCOMPATIBILITY; BONE; BIOCORROSION;
   DEGRADATION
AB Recently, considerable attentions have been paid to alloy Mg-4Zn-0.2Ca for biomedical applications due to its suitable biocompatibility and acceptable mechanical properties. In this work, the effects of the addition of different amounts of Al on microstructure, mechanical properties, degradation behavior, and biocompatibility of this alloy were investigated. The corrosion behaviors of the alloys were investigated through polarization tests, chronoamperometry analysis, immersion tests, and EIS experiments. The mechanical properties were analyzed by using tensile tests and compression tests. The results showed that the addition of Al up to 3 wt.% considerably modifies the degradation behaviors and the mechanical properties of the alloys due to its positive effects on microstructure refinement. On the other hand, the addition of more quantities of Al leads to the formation of considerable amounts of secondary phases in the grain boundaries of the alloys, leading to noticeably deteriorated properties. Mechanical tests showed that the addition of Al ( up to 3 wt.%) increases the UTS of the alloys from 157 MPa to 198 MPa. Moreover, in vitro corrosion tests in SBF solution revealed that with the addition of Al up to the above mentioned value, the corrosion current densities of the alloys decrease from 134 mu A cm(-2) to 22 mu A cm(-2), and Mg-4Zn-3Al-0.2Ca exhibited the lowest obtained degradation rates in different immersion and electrochemical experiments. Cytotoxicity assessments also indicated the good biocompatibility of this alloy, making it a suitable candidate for further considerations as a degradable metallic biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Homayun, Bahman; Afshar, Abdollah] Sharif Univ Technol, Sch Mat Sci & Engn, Tehran, Iran.
RP Homayun, B (reprint author), Sharif Univ Technol, Sch Mat Sci & Engn, Corros & Surface Coatings Lab, Azadi Ave,POB 11365-9466, Tehran, Iran.
EM Bahmanhomayun@alum.sharif.edu
CR Abdal-Hay A, 2012, APPL SURF SCI, V261, P536, DOI 10.1016/j.apsusc.2012.08.051
   Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   American Society for Testing Materials, 2004, ANN BOOK ASTM STAND
   Aung NN, 2010, CORROS SCI, V52, P589, DOI 10.1016/j.corsci.2009.10.018
   Bakhsheshi-Rad HR, 2014, MATER DESIGN, V53, P283, DOI 10.1016/j.matdes.2013.06.055
   Bakhsheshi-Rad HR, 2012, CORROS SCI, V64, P184, DOI 10.1016/j.corsci.2012.07.015
   Cai SH, 2012, MAT SCI ENG C-MATER, V32, P2570, DOI 10.1016/j.msec.2012.07.042
   Chou DT, 2013, ACTA BIOMATER, V9, P8518, DOI 10.1016/j.actbio.2013.06.025
   Chung SJ, 2011, MATER SCI ENG B-ADV, V176, P1690, DOI 10.1016/j.mseb.2011.08.006
   Datta MK, 2011, MATER SCI ENG B-ADV, V176, P1637, DOI 10.1016/j.mseb.2011.08.008
   Geng L, 2009, MATER LETT, V63, P557, DOI 10.1016/j.matlet.2008.11.044
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1778, DOI 10.1016/j.mseb.2011.05.032
   Gu XN, 2009, ACTA BIOMATER, V5, P2790, DOI 10.1016/j.actbio.2009.01.048
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gu YH, 2012, J ALLOY COMPD, V543, P109, DOI 10.1016/j.jallcom.2012.07.130
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hosseini VA, 2013, MAT SCI ENG A-STRUCT, V565, P165, DOI 10.1016/j.msea.2012.12.034
   Jang Y, 2013, ACTA BIOMATER, V9, P8761, DOI 10.1016/j.actbio.2013.03.026
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Koleini S, 2012, MATER DESIGN, V33, P20, DOI 10.1016/j.matdes.2011.06.063
   Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu C, 2014, MAT SCI ENG C-MATER, V35, P1, DOI 10.1016/j.msec.2013.10.020
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Purnama A, 2010, ACTA BIOMATER, V6, P1800, DOI 10.1016/j.actbio.2010.02.027
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Stulikova I, 2010, MATER CHARACT, V61, P952, DOI 10.1016/j.matchar.2010.06.004
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Wen ZH, 2009, J ALLOY COMPD, V488, P392, DOI 10.1016/j.jallcom.2009.08.147
   Willbold E, 2011, MATER SCI ENG B-ADV, V176, P1835, DOI 10.1016/j.mseb.2011.02.010
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Wu G.S., 2012, SURF COAT TECH, V233, P2
   Wu GS, 2013, SURF COAT TECH, V233, P2, DOI 10.1016/j.surfcoat.2012.10.009
   Wu GS, 2012, APPL SURF SCI, V258, P7651, DOI 10.1016/j.apsusc.2012.04.112
   Xia YH, 2012, MAT SCI ENG C-MATER, V32, P665, DOI 10.1016/j.msec.2012.01.004
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xu ZG, 2011, MATER SCI ENG B-ADV, V176, P1660, DOI 10.1016/j.mseb.2011.06.008
   Yang L, 2013, ACTA BIOMATER, V9, P8499, DOI 10.1016/j.actbio.2013.03.017
   Yang Y., 2011, MAT SCI ENG B, V176, P1827
   Zhang BP, 2011, MAT SCI ENG C-MATER, V31, P1667, DOI 10.1016/j.msec.2011.07.015
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhao YY, 2012, J ALLOY COMPD, V515, P154, DOI 10.1016/j.jallcom.2011.11.125
   Zhou WR, 2013, ACTA BIOMATER, V9, P8488, DOI 10.1016/j.actbio.2013.01.032
NR 54
TC 36
Z9 38
U1 3
U2 100
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD SEP 15
PY 2014
VL 607
BP 1
EP 10
DI 10.1016/j.jallcom.2014.04.059
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA AI0WI
UT WOS:000336570700001
DA 2018-10-20
ER

PT J
AU Lai, WE
   Zhang, HW
   Zhu, YH
   Wen, QY
   Ma, YB
AF Lai, Wei En
   Zhang, Huai Wu
   Zhu, Yao Hua
   Wen, Qi Ye
   Ma, Yan Bing
TI Influence of Window Function on Characterization of Materials in
   Terahertz Spectroscopy
SO SPECTROSCOPY LETTERS
LA English
DT Article
DE fast Fourier transform; terahertz time-domain spectroscopy; window
   function
ID TIME-DOMAIN SPECTROSCOPY; REFLECTION SPECTROSCOPY; LIQUID WATER;
   RADIATION; DYNAMICS; GEOMETRY
AB Terahertz spectroscopy is becoming a potential tool for characterizing various materials including biomaterial specimens, liquids, and semiconductors. Accuracy of the sample information is important for analysis. In this article, the influences of type and position of window functions on accuracy of extracting sample information are studied. Experimental results show that an appropriate type and position of window functions significantly improve the accuracy of the extracted sample information.
C1 [Lai, Wei En; Zhang, Huai Wu; Zhu, Yao Hua; Wen, Qi Ye; Ma, Yan Bing] Univ Elect Sci & Technol China, State Key Lab Elect Films & Integrated Devices, Chengdu 610054, Peoples R China.
RP Lai, WE (reprint author), Univ Elect Sci & Technol China, State Key Lab Elect Films & Integrated Devices, Chengdu 610054, Peoples R China.
EM bluecpu202@163.com
FU National Nature Science Foundation of China [61131005]; Key Grant
   Project of Chinese Ministry of Education [313013]; New Century Excellent
   Talent Foundation [NCET-11-0068]; Sichuan Youth S T Foundation
   [2011JQ0001]; Specialized Research Fund for the Doctoral Program of
   Higher Education [20110185130002]; Fundamental Research Funds for the
   Central Universities [ZYGX2010J034]; CAEP THz Science and Technology
   Foundation [CAEPTHZ201207]
FX Wei-en Lai is supported by the National Nature Science Foundation of
   China (No. 61131005), Key Grant Project of Chinese Ministry of Education
   (No. 313013), the New Century Excellent Talent Foundation (No.
   NCET-11-0068), Sichuan Youth S & T Foundation (No. 2011JQ0001),
   Specialized Research Fund for the Doctoral Program of Higher Education
   (No. 20110185130002), Fundamental Research Funds for the Central
   Universities (No. ZYGX2010J034), and the CAEP THz Science and Technology
   Foundation (No. CAEPTHZ201207).
CR Ashworth PC, 2009, OPT EXPRESS, V17, P12444, DOI 10.1364/OE.17.012444
   Beard MC, 2002, J PHYS CHEM B, V106, P7146, DOI 10.1021/jp020579i
   Berendsen H.J.C, 2011, STUDENTS GUIDE DATA
   Brunner F. D. J., 2001, OPT EXPRESS, V17, P20684
   Cunlin Z., 2010, LASER OPTOELECTRON P, V47
   DEMARCO A, 1976, J MAGN RESON, V24, P201, DOI 10.1016/0022-2364(76)90028-7
   Duvillaret L, 2000, J OPT SOC AM B, V17, P452, DOI 10.1364/JOSAB.17.000452
   Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708
   Ferguson B, 2001, MICROELECTR J, V32, P943, DOI 10.1016/S0026-2692(01)00093-3
   GRISCHKOWSKY D, 1990, J OPT SOC AM B, V7, P2006, DOI 10.1364/JOSAB.7.002006
   Huang SY, 2009, PHYS MED BIOL, V54, P149, DOI 10.1088/0031-9155/54/1/010
   Huang S, 2009, OPT EXPRESS, V17, P3848, DOI 10.1364/OE.17.003848
   Jepsen PU, 2007, OPT EXPRESS, V15, P14717, DOI 10.1364/OE.15.014717
   Jepsen U., 2008, OPT EXPRESS, V16, P9318
   Khazan M, 2001, REV SCI INSTRUM, V72, P3427, DOI 10.1063/1.1384433
   Kitahara H, 2005, J KOREAN PHYS SOC, V46, P82
   Knab JR, 2007, P IEEE, V95, P1605, DOI 10.1109/JPROC.2007.898906
   Lai WE, 2013, APPL SPECTROSC, V67, P36, DOI 10.1366/12-06713
   Nashima S, 2001, APPL PHYS LETT, V79, P3923, DOI 10.1063/1.1413498
   Oppenheim AV, 2009, DISCRETE TIME SIGNAL
   Pashkin A, 2003, REV SCI INSTRUM, V74, P4711, DOI 10.1063/1.1614878
   PASTOL Y, 1989, APPL PHYS LETT, V55, P2277, DOI 10.1063/1.102357
   Pickwell E, 2004, PHYS MED BIOL, V49, P1595, DOI 10.1088/0031-9155/49/9/001
   Ronne C, 2002, J MOL LIQ, V101, P199, DOI 10.1016/S0167-7322(02)00093-4
   Schmit J, 1996, APPL OPTICS, V35, P5642, DOI 10.1364/AO.35.005642
   Stuart B.H., 2004, INFRARED SPECTROSCOP
   THRANE L, 1995, CHEM PHYS LETT, V240, P330, DOI 10.1016/0009-2614(95)00543-D
   Venables DS, 2000, J CHEM PHYS, V113, P3243, DOI 10.1063/1.1287145
   Withayachumnankul W, 2005, P SOC PHOTO-OPT INS, V5840, P221, DOI 10.1117/12.612946
   Withayachumnankul W, 2005, ELECTRON LETT, V41, P800, DOI 10.1049/el:20051467
NR 30
TC 0
Z9 0
U1 1
U2 42
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0038-7010
EI 1532-2289
J9 SPECTROSC LETT
JI Spectr. Lett.
PD SEP 14
PY 2014
VL 47
IS 8
BP 590
EP 596
DI 10.1080/00387010.2013.828759
PG 7
WC Spectroscopy
SC Spectroscopy
GA AG0QD
UT WOS:000335119100002
DA 2018-10-20
ER

PT J
AU Ramadass, SK
   Perumal, S
   Gopinath, A
   Nisal, A
   Subramanian, S
   Madhan, B
AF Ramadass, Satiesh Kumar
   Perumal, Sathiamurthi
   Gopinath, Arun
   Nisal, Anuya
   Subramanian, Saravanan
   Madhan, Balaraman
TI Sol-Gel Assisted Fabrication of Collagen Hydrolysate Composite Scaffold:
   A Novel Therapeutic Alternative to the Traditional Collagen Scaffold
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE collagen; collagen hydrolysate; sol-gel; scaffold; tissue engineering;
   wound Healing
ID IN-VIVO EVALUATION; WOUND DRESSINGS; CONTROLLED-RELEASE; SILICA
   MICROSPHERES; CELL-ADHESION; CROSS-LINKING; TISSUE; VITRO; CHITOSAN;
   ACID
AB Collagen is one of the most widely used biomaterial for various biomedical applications. In this Research Article, we present a novel approach of using collagen hydrolysate, smaller fragments of collagen, as an alternative to traditionally used collagen scaffold. Collagen hydrolysate composite scaffold (CHCS) was fabricated with sol-gel transition procedure using tetraethoxysilane as the silica precursor. CHCS exhibits porous morphology with pore sizes varying between 380 and 780 mu m. Incorporation of silica conferred CHCS with controlled biodegradation and better water uptake capacity. Notably, 3T3 fibroblast proliferation was seen to be significantly better under CHCS treatment when compared to treatment with collagen scaffold. Additionally, CHCS showed excellent antimicrobial activity against the wound pathogens Staphylococcus aureus, Bacillus subtilis, and Escherichia coli due to the inherited antimicrobial activity of collagen hydrolysate. In vivo wound healing experiments with full thickness excision wounds in rat model demonstrated that wounds treated with CHCS showed accelerated healing when compared to wounds treated with collagen scaffold. These findings indicate that the CHCS scaffold from collagen fragments would be an effective and affordable alternative to the traditionally used collagen structural biomaterials.
C1 [Ramadass, Satiesh Kumar; Perumal, Sathiamurthi; Gopinath, Arun; Madhan, Balaraman] Cent Leather Res Inst, CSIR, Madras 600020, Tamil Nadu, India.
   [Perumal, Sathiamurthi; Madhan, Balaraman] Cent Leather Res Inst, Acad CSIR, Madras 600020, Tamil Nadu, India.
   [Nisal, Anuya] Natl Chem Lab, CSIR, Polymer & Adv Mat Lab, Pune 411008, Maharashtra, India.
   [Subramanian, Saravanan] Loyola Coll, Entomol Res Inst, Madras 600034, Tamil Nadu, India.
RP Madhan, B (reprint author), Cent Leather Res Inst, CSIR, Madras 600020, Tamil Nadu, India.
EM bmadhan76@yahoo.co.in
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452
FU CSIR, India [CSC 0134]; CSIR
FX The authors are grateful to CSIR, India, for providing financial
   assistance under the M2D XII plan Project (CSC 0134). Authors are
   thankful to Dr. Ashish Lele of Polymer and Advanced Materials
   Laboratory, CSIR-National Chemical Laboratory, Pune, for his support in
   rheology experiments. Authors S.K.R. and S.P. are grateful to CSIR for
   research fellowship.
CR Boyer D, 2013, ADV SKIN WOUND CARE, V26, P110, DOI 10.1097/01.ASW.0000427923.20121.2d
   Cho Y, 2008, NANOMEDICINE-UK, V3, P507, DOI 10.2217/17435889.3.4.507
   Cho Y, 2010, J NEUROSCI RES, V88, P1433, DOI 10.1002/jnr.22309
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   Desimone MF, 2011, ACS APPL MATER INTER, V3, P3831, DOI 10.1021/am2009844
   Desimone MF, 2010, ACTA BIOMATER, V6, P3998, DOI 10.1016/j.actbio.2010.05.014
   DiCosmo F, 2009, ADV SKIN WOUND CARE, V22, P12
   DOILLON CJ, 1986, J BIOMED MATER RES, V20, P1219, DOI 10.1002/jbm.820200811
   Ehrlich H, 2010, NAT CHEM, V2, P1084, DOI [10.1038/nchem.899, 10.1038/NCHEM.899]
   Ficai A, 2013, J MOL STRUCT, V1037, P154, DOI 10.1016/j.molstruc.2012.12.052
   Gaharwar AK, 2010, ACS APPL MATER INTER, V2, P3119, DOI 10.1021/am100609t
   Giesen-Wiese M., 2011, World Patent, Patent No. [WO 2012065782 A3, 2012065782]
   Gorham S. D., 1991, BIOMATERIALS, P55
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Hans-Ulrich F., 2012, World Patent, Patent No. [WO2013079373 A1, 2013079373]
   Hoyer B, 2014, ACTA BIOMATER, V10, P883, DOI 10.1016/j.actbio.2013.10.022
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Lee S Kwon, 2006, Adv Skin Wound Care, V19, P92, DOI 10.1097/00129334-200603000-00011
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Newton PM, 2004, INFLAMMATION, V28, P207, DOI 10.1023/B:IFLA.0000049045.41784.59
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Paddle-Ledinek JE, 2006, PLAST RECONSTR SURG, V117, p110S, DOI 10.1097/01.prs.0000225439.39352.ce
   Pannone P. J., 2007, TRENDS BIOMATERIALS
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pei Y, 2013, CARBOHYD POLYM, V92, P1752, DOI 10.1016/j.carbpol.2012.11.029
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Petito G. D., 1999, US Patent, Patent No. [US6134361 A, 6134361]
   Podbielska H, 2005, B POL ACAD SCI-TECH, V53, P261
   Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Powell HM, 2006, BIOMATERIALS, V27, P5821, DOI 10.1016/j.biomaterials.2006.07.030
   Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004
   Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E
   Radin S, 2009, BIOMATERIALS, V30, P850, DOI 10.1016/j.biomaterials.2008.09.066
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   Scocchi M, 2011, CELL MOL LIFE SCI, V68, P2317, DOI 10.1007/s00018-011-0721-7
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   TANAKA S, 1988, J BIOL CHEM, V263, P17650
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 47
TC 21
Z9 21
U1 1
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 10
PY 2014
VL 6
IS 17
BP 15015
EP 15025
DI 10.1021/am502948g
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AO7PD
UT WOS:000341544200034
PM 25105509
DA 2018-10-20
ER

PT J
AU Gencoglu, MF
   Spurri, A
   Franko, M
   Chen, JH
   Hensley, DK
   Heldt, CL
   Saha, D
AF Gencoglu, Maria F.
   Spurri, Amanda
   Franko, Mitchell
   Chen, Jihua
   Hensley, Dale K.
   Heldt, Caryn L.
   Saha, Dipendu
TI Biocompatibility of Soft-Templated Mesoporous Carbons
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE mesoporous carbon; biocompatibility; cytotoxicity; cell viability;
   hemolysis; protein adsoprtion
ID DIAMOND-LIKE CARBON; PROTEIN ADSORPTION; DRUG-DELIVERY;
   HEMOLYTIC-ACTIVITY; RESPIRATORY TOXICITY; DLC COATINGS; CANCER-CELLS;
   IN-VITRO; SILICA; CYTOTOXICITY
AB Soft-templated mesoporous carbon is morphologically a non-nano type of carbon. It is a relatively newer variety of biomaterial, which has already demonstrated its successful role in drug delivery applications. To investigate the toxicity and biocompatibility, we introduced three types of mesoporous carbons with varying synthesis conditions and pore textural properties. We compared the Brunauer-Emmett-Teller (BET) surface area and pore width and performed cytotoxicity experiments with HeLa cells, cell viability studies with fibroblast cells and hemocomapatibility studies. Cytotoxicity tests reveal that two of the carbons are not cytotoxic, with cell survival over 90%. The mesoporous carbon with the highest surface area showed slight toxicity (similar to 70% cell survival) at the highest carbon concentration of 500 mu g/mL. Fibroblast cell viability assays suggested high and constant viability of over 98% after 3 days with no apparent relation with materials property and good visible cell-carbon compatibility. No hemolysis (<1%) was confirmed for all the carbon materials. Protein adsorption experiments with bovine serum albumin (BSA) and fibrinogen revealed a lower protein binding capacity of 0.2-0.6 mg/m(2) and 2-4 mg/m(2) for BSA and fibrinogen, respectively, with lower binding associated with an increase in surface area. The results of this study confirm the biocompatibility of soft-templated mesoporous carbons.
C1 [Gencoglu, Maria F.; Heldt, Caryn L.] Michigan Technol Univ, Dept Chem Engn, Houghton, MI 49931 USA.
   [Spurri, Amanda; Franko, Mitchell; Saha, Dipendu] Widener Univ, Dept Chem Engn, Chester, PA 19013 USA.
   [Chen, Jihua; Hensley, Dale K.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA.
RP Heldt, CL (reprint author), Michigan Technol Univ, Dept Chem Engn, 1400 Townsend Dr, Houghton, MI 49931 USA.
EM heldt@mtu.edu; dsaha@mail.widener.edu
RI Hensley, Dale/A-6282-2016; Chen, Jihua/F-1417-2011
OI Hensley, Dale/0000-0001-8763-7765; Chen, Jihua/0000-0001-6879-5936
FU Division of Scientific User Facilities, Office of Basic Energy Sciences,
   U.S. Department of Energy; Department of Chemical Engineering at
   Michigan Technological University; School of Engineering at Widener
   University
FX The authors would like to thank K. Saagar Vijayaragavan and Owen Mills
   for assistance with the FE-SEM images of cells on the mesoporous carbon
   structures, and Adrienne Minerick for providing blood samples. TEM,
   EDXS, and SEM analyses were conducted at the Center for Nanophase
   Materials Sciences, which is sponsored at Oak Ridge National Laboratory
   by the Division of Scientific User Facilities, Office of Basic Energy
   Sciences, U.S. Department of Energy. M.F.G. and C.L.H thank the
   Department of Chemical Engineering at Michigan Technological University
   for funding. D.S. acknowledges the start-up grant and faculty
   development award from the School of Engineering at Widener University.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   ALLISON AC, 1966, J EXP MED, V124, P141, DOI 10.1084/jem.124.2.141
   BURNS CA, 1980, ENVIRON RES, V21, P298, DOI 10.1016/0013-9351(80)90030-4
   Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Chyka P., 1996, J TOXICOL-CLIN TOXIC, V35, P721
   CORBY DG, 1974, PEDIATRICS, V54, P324
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Cui FZ, 2000, SURF COAT TECH, V131, P481, DOI 10.1016/S0257-8972(00)00809-4
   Di Pasqua AJ, 2008, J INORG BIOCHEM, V102, P1416, DOI 10.1016/j.jinorgbio.2007.12.028
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fan HF, 2014, APPL SURF SCI, V288, P193, DOI 10.1016/j.apsusc.2013.10.006
   Fang Y, 2010, ANGEW CHEM INT EDIT, V49, P7987, DOI 10.1002/anie.201002849
   Fujii M, 2006, J APPL PHYS, V100, DOI 10.1063/1.2402343
   GOPINATH C, 1987, ATLAS EXPT TOXICOLOG
   Grill A, 2003, DIAM RELAT MATER, V12, P166, DOI 10.1016/S0925-9635(03)00018-9
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Gu JL, 2011, CHEM COMMUN, V47, P2101, DOI 10.1039/c0cc04598e
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   He QJ, 2010, BIOMATERIALS, V31, P1085, DOI 10.1016/j.biomaterials.2009.10.046
   Heikkila T, 2010, EUR J PHARM BIOPHARM, V74, P483, DOI 10.1016/j.ejpb.2009.12.006
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   HORBETT TA, 1982, ADV CHEM SER, P233
   Hurt RH, 2006, CARBON, V44, P1028, DOI 10.1016/j.carbon.2005.12.023
   Inoue K, 2010, FREE RADICAL BIO MED, V48, P924, DOI 10.1016/j.freeradbiomed.2010.01.013
   Karavasili C, 2013, J MATER CHEM B, V1, P3167, DOI 10.1039/c3tb20304b
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kayat J, 2011, NANOMED-NANOTECHNOL, V7, P40, DOI 10.1016/j.nano.2010.06.008
   Kim TW, 2008, NANO LETT, V8, P3724, DOI 10.1021/nl801976m
   Kortesuo P, 2000, BIOMATERIALS, V21, P193, DOI 10.1016/S0142-9612(99)00148-9
   Labiano A, 2012, MICROPOR MESOPOR MAT, V160, P143, DOI 10.1016/j.micromeso.2012.05.003
   Lin YS, 2010, J AM CHEM SOC, V132, P4834, DOI 10.1021/ja910846q
   Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Muller J, 2006, CARBON, V44, P1048, DOI 10.1016/j.carbon.2005.10.019
   Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008
   Murray AR, 2009, TOXICOLOGY, V257, P161, DOI 10.1016/j.tox.2008.12.023
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   Rammohan A, 2013, RSC ADV, V3, P2008, DOI 10.1039/c2ra22261b
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Saha D, 2014, MICROPOR MESOPOR MAT, V196, P327, DOI 10.1016/j.micromeso.2014.05.024
   Saha D, 2014, CARBON, V71, P47, DOI 10.1016/j.carbon.2014.01.005
   Saha D, 2013, ACS APPL MATER INTER, V5, P5868, DOI 10.1021/am401661f
   Santos HA, 2010, ACTA BIOMATER, V6, P2721, DOI 10.1016/j.actbio.2009.12.043
   Smart SK, 2006, CARBON, V44, P1034, DOI 10.1016/j.carbon.2005.10.011
   Tafur MF, 2013, ANTIVIR RES, V99, P27, DOI 10.1016/j.antiviral.2013.04.019
   Vinu A, 2005, STUD SURF SCI CATAL, V158, P971
   Wang XF, 2011, MICROPOR MESOPOR MAT, V145, P98, DOI 10.1016/j.micromeso.2011.04.033
   Warheit DB, 2008, PHARMACOL THERAPEUT, V120, P35, DOI 10.1016/j.pharmthera.2008.07.001
   Warheit DB, 2006, CARBON, V44, P1064, DOI 10.1016/j.carbon.2005.10.013
   Wick P, 2007, TOXICOL LETT, V168, P121, DOI 10.1016/j.toxlet.2006.08.019
   Yildirim A, 2013, J MATER CHEM B, V1, P1909, DOI 10.1039/c3tb20139b
   Yu T, 2011, ACS NANO, V5, P5717, DOI 10.1021/nn2013904
   Zhao P, 2012, EUR J PHARM BIOPHARM, V80, P535, DOI 10.1016/j.ejpb.2011.12.002
   Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k
   Zhu J, 2012, SMALL, V8, P2715, DOI 10.1002/smll.201200217
   Zhu SQ, 2006, MAR ENVIRON RES, V62, pS5, DOI 10.1016/j.marenvres.2006.04.059
NR 59
TC 16
Z9 16
U1 3
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 10
PY 2014
VL 6
IS 17
BP 15068
EP 15077
DI 10.1021/am503076u
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AO7PD
UT WOS:000341544200040
PM 25144129
DA 2018-10-20
ER

PT J
AU Xu, JF
   Qiu, M
   Ma, BM
   He, CJ
AF Xu, Jianfeng
   Qiu, Ming
   Ma, Bomou
   He, Chunju
TI "Near Perfect" Amphiphilic Conetwork Based on End-Group Cross-Linking of
   Polydimethylsiloxane Triblock Copolymer via Atom Transfer Radical
   Polymerization
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE polydimethylsiloxane; amphiphilic conetwork; atom transfer radical
   polymerization; oxygen permeability; membrane
ID SOLID-STATE NMR; BIOARTIFICIAL PANCREAS; MECHANICAL-PROPERTIES; SWELLING
   BEHAVIOR; MODEL CONETWORKS; MEMBRANES; NETWORKS; POLY(DIMETHYLSILOXANE);
   METHACRYLATE; HYDROGELS
AB Novel amphiphilic conetworks (APCNs) with uniform channel size were synthesized through end-cross-linking of well-defined amphiphilic triblock copolymers via atom transfer radical polymerization (ATRP). A new ditelechelic polydimethylsiloxane macroinitiator was synthesized to initiate the polymerization of N,N-dimethylacrylamide. The resulting triblock copolymers show well-defined molecular weight with narrow polydisperisty, which are telechelic modified by allylamine and fully cross-linked with polyhydrosiloxanes through hydrosilylation. Transmission electron microscopy shows that the APCN has the behavior of micro(p)hase separation with small channel size and uniform phase domain. The resulting APCNs with idealized microstructure exhibit a combination of excellent properties, i.e., superhigh mechanical strength (4 +/- 1 MPa) and elongation ratio (175 +/- 25%), outstanding oxygen permeability (350 +/- 150 barrers), a high water uptake property, and excellent biocompatibility, indicating that in this way, "near perfect" networks are obtained. These results are better than those reported in the literature, suggesting a promising semipermeable barrier for islet encapsulation in relative biomaterial fields.
C1 [Xu, Jianfeng; Qiu, Ming; Ma, Bomou; He, Chunju] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 201620, Peoples R China.
RP He, CJ (reprint author), Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
EM chunjuhe@dhu.edu.cn
FU National Science Foundation [NSF51103019, NSF21174027]; National High
   Technology Research and Development Projects (863) [2012AA03A605];
   Program for New Century Excellent Talents in University [12X10623]
FX This work was financially supported by National Science Foundation
   (NSF51103019, NSF21174027) and National High Technology Research and
   Development Projects (863, 2012AA03A605), Program for New Century
   Excellent Talents in University (12X10623).
CR Achilleos M, 2007, MACROMOLECULES, V40, P5575, DOI 10.1021/ma070614p
   Brown DA, 2001, POLYMER, V42, P4767, DOI 10.1016/S0032-3861(00)00845-4
   Chhabra M, 2008, IND ENG CHEM RES, V47, P3540, DOI 10.1021/ie071071a
   Cordeiro AL, 2009, LANGMUIR, V25, P1509, DOI 10.1021/la803054s
   Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g
   Cui J, 2012, BIOMACROMOLECULES, V13, P584, DOI 10.1021/bm300015s
   Domjan A, 2003, MACROMOLECULES, V36, P9107, DOI 10.1021/ma034891h
   Domjan A, 2012, MACROMOLECULES, V45, P7557, DOI 10.1021/ma301533g
   Erdodi G, 2006, PROG POLYM SCI, V31, P1, DOI 10.1016/j.progpolymsci.2005.11.001
   Erdodi G, 2005, J POLYM SCI POL CHEM, V43, P3491, DOI 10.1002/pola.20791
   Georgiou TK, 2007, MACROMOLECULES, V40, P2335, DOI 10.1021/ma062307+
   Grundfest-Broniatowski SF, 2009, ASAIO J, V55, P400, DOI 10.1097/MAT.0b013e3181a8deba
   Ivan B, 2005, MACROMOL SYMP, V227, P265, DOI 10.1002/masy.200550926
   IVAN B, 1991, ACS SYM SER, V469, P194
   Jewrajka SK, 2008, J BIOMED MATER RES A, V87A, P69, DOI 10.1002/jbm.a.31573
   Kafouris D, 2009, MACROMOLECULES, V42, P2972, DOI 10.1021/ma802859d
   Kali G, 2013, MACROMOLECULES, V46, P5337, DOI 10.1021/ma400535r
   Kang J, 2007, J POLYM SCI POL CHEM, V45, P4276, DOI 10.1002/pola.22170
   Kang J, 2010, MACROMOL BIOSCI, V10, P369, DOI 10.1002/mabi.200900386
   KELLER RN, 1946, INORG SYN, V2, P1, DOI 10.1002/9780470132333.ch1
   Kennedy JP, 2000, DES MONOMERS POLYM, V3, P113, DOI 10.1163/156855500750198762
   Kurian P., 2002, POLYM PREPR AM CHEM, V43, P631
   Limer A, 2006, MACROMOLECULES, V39, P1353, DOI 10.1021/ma051443w
   Lin G, 2009, SILICON-NETH, V1, P173, DOI 10.1007/s12633-009-9011-5
   Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/NCHEM.257, 10.1038/nchem.257]
   Miller PJ, 1999, MACROMOLECULES, V32, P8760, DOI 10.1021/ma991077e
   Pan AZ, 2014, J COLLOID INTERF SCI, V414, P1, DOI 10.1016/j.jcis.2013.09.044
   Panayiotou M, 2005, POLYMER, V46, P615, DOI 10.1016/j.polymer.2004.11.099
   Papaphilippou P, 2012, ACS APPL MATER INTER, V4, P2139, DOI 10.1021/am300144w
   Patrickios CS, 2003, CURR OPIN COLLOID IN, V8, P76, DOI 10.1016/S1359-0294(03)00005-0
   Peng H, 2004, J APPL POLYM SCI, V92, P532, DOI 10.1002/app.20030
   Pyun J, 2004, MACROMOL CHEM PHYSIC, V205, P411, DOI 10.1002/macp.200300070
   Rikkou MD, 2010, J POLYM SCI POL CHEM, V48, P1878, DOI 10.1002/pola.23951
   Scherble J, 2002, MACROMOL CHEM PHYSIC, V203, P1866, DOI 10.1002/1521-3935(200208)203:12<1866::AID-MACP1866>3.0.CO;2-G
   Schoenfeld I, 2013, BIOTECHNOL BIOENG, V110, P2333, DOI 10.1002/bit.24906
   Snijder A, 2002, J POLYM SCI POL CHEM, V40, P2350, DOI 10.1002/pola.10321
   Srividhya A, 2007, J POLYM SCI POL CHEM, V45, P1707, DOI 10.1002/pola.21939
   Sun Y, 2007, BIOMATERIALS, V28, P661, DOI 10.1016/j.biomaterials.2006.09.024
   Suvegh K, 1998, MACROMOLECULES, V31, P7770, DOI 10.1021/ma980466q
   Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005
   Triftaridou AI, 2007, POLYM BULL, V58, P185, DOI 10.1007/s00289-006-0611-6
   Veriter S, 2011, BIOMATERIALS, V32, P5945, DOI 10.1016/j.biomaterials.2011.02.061
   Wang YP, 2011, LANGMUIR, V27, P10365, DOI 10.1021/la202427z
   Whittaker MR, 2006, J AM CHEM SOC, V128, P11360, DOI 10.1021/ja0645990
   Yoshimatsu G, 2013, TRANSPL P, V45, P1875, DOI 10.1016/j.transproceed.2013.01.043
   Zhao WJ, 2010, J POLYM SCI POL CHEM, V48, P4141, DOI 10.1002/pola.24156
   Zhou C, 2014, RSC ADV, V4, P8144, DOI 10.1039/c3ra47939k
NR 47
TC 21
Z9 21
U1 7
U2 66
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP 10
PY 2014
VL 6
IS 17
BP 15283
EP 15290
DI 10.1021/am5037252
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AO7PD
UT WOS:000341544200064
PM 25102277
DA 2018-10-20
ER

PT J
AU Paliwal, R
   Palakurthi, S
AF Paliwal, Rishi
   Palakurthi, Srinath
TI Zein in controlled drug delivery and tissue engineering
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review
DE Zein; Biomaterial; Nanoparticle; Drug delivery; Tissue engineering;
   Diagnostics
ID CONTROLLED-RELEASE; SODIUM CASEINATE; POLYMERIC MICROSPHERES;
   MECHANICAL-PROPERTIES; CORN PROTEIN; NANOPARTICLES; FILMS; FABRICATION;
   SYSTEM; SCAFFOLDS
AB Controlled delivery of a bioactive to specific organ, cellular and sub-cellular level is a desired feature of a drug carrier system. In order to achieve this goal, formulation scientists search for better alternatives of biomaterials to deliver the therapeutics in more precise and controlled manner in vivo. Zein, a plant protein obtained from corn, is a useful biomaterial for several industrial applications including agriculture, cosmetics, packaging and pharmaceuticals. Being a hydrophobic protein, which is biodegradable, biocompatible, economic to use and with generally regarded safe "GRAS" status, it is an attractive biomaterial for human use. Novel biomedical applications of zein such as controlled and targeted delivery of bioactives and tissue engineering are the current research interests of the scientific fraternity. Here we attempt to review the literature on zein as a biopolymer for drug/vaccine/gene delivery and its applicability in tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Paliwal, Rishi; Palakurthi, Srinath] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, Kingsville, TX 78363 USA.
RP Palakurthi, S (reprint author), Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, MSC 131,West Ave B, Kingsville, TX 78363 USA.
EM rishipaliwal@gmail.com; palakurthi@tamhsc.edu
FU National Corn Grower Association, NCGA, USA [23-46082100001]
FX This work was supported in the form of a grant provided by National Corn
   Grower Association, NCGA, USA (23-46082100001) awarded to SP.
CR Arcan I, 2013, FOOD RES INT, V51, P208, DOI 10.1016/j.foodres.2012.12.011
   ARGOS P, 1982, J BIOL CHEM, V257, P9984
   Aswathy R.G., 2012, ADV NAT SCI-NANOSCI, V3
   Beck MI, 1996, INT J PHARM, V141, P137, DOI 10.1016/0378-5173(96)04630-3
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Brahatheeswaran D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045001
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Cagri A, 2004, J FOOD PROTECT, V67, P833, DOI 10.4315/0362-028X-67.4.833
   Cao XY, 2012, CHEM PHARM BULL, V60, P1227, DOI 10.1248/cpb.c12-00270
   Chen HQ, 2014, FOOD HYDROCOLLOID, V35, P358, DOI 10.1016/j.foodhyd.2013.06.012
   Corradini E, 2006, J APPL POLYM SCI, V101, P4133, DOI 10.1002/app.23570
   Dhandayuthapani B., 2012, INT J BIOMATER, V2012
   Dhandayuthapani B, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/2/025008
   Dhandayuthapani B, 2012, INT J BIOMATER, DOI 10.1155/2012/345029
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   DOUGLAS SJ, 1987, CRIT REV THER DRUG, V3, P233
   Ekenseair AK, 2013, ADV DRUG DELIVER REV, V65, P89, DOI 10.1016/j.addr.2012.08.017
   Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011
   Florence AT, 2012, J CONTROL RELEASE, V164, P115, DOI 10.1016/j.jconrel.2012.03.022
   Fu JX, 2009, MAT SCI ENG C-BIO S, V29, P1161, DOI 10.1016/j.msec.2008.09.031
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gao ZB, 2007, INT J PHARM, V328, P57, DOI 10.1016/j.ijpharm.2006.07.048
   Gomez-Estaca J, 2012, FOOD HYDROCOLLOID, V28, P82, DOI 10.1016/j.foodhyd.2011.11.013
   Gong SJ, 2011, J BIOMATER APPL, V26, P195, DOI 10.1177/0885328210363504
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Gonzalez-Alvarez M, 2013, THER DELIV, V4, P157, DOI [10.4155/TDE.12.142, 10.4155/tde.12.142]
   Hawkins MJ, 2008, ADV DRUG DELIVER REV, V60, P876, DOI 10.1016/j.addr.2007.08.044
   Hernandez-Izquierdo VM, 2008, J FOOD SCI, V73, pR30, DOI 10.1111/j.1750-3841.2007.00636.x
   Hoffman KL, 2001, J FOOD PROTECT, V64, P885, DOI 10.4315/0362-028X-64.6.885
   Huang WD, 2013, AAPS PHARMSCITECH, V14, P675, DOI 10.1208/s12249-013-9953-1
   Hurtado-Lopez P, 2006, J MICROENCAPSUL, V23, P303, DOI 10.1080/026520400444149
   Hurtado-Lopez P, 2006, J PHARM PHARMACOL, V58, P769, DOI 10.1211/jpp.58.6.0007
   Hurtado-Lopez P, 2005, J DRUG DELIV SCI TEC, V15, P267, DOI 10.1016/S1773-2247(05)50048-0
   Jahanshahi M., 2008, AFR J BIOTECHNOL, V7
   Jiang HL, 2007, MACROMOL BIOSCI, V7, P517, DOI 10.1002/mabi.200600277
   Jiang QR, 2013, J BIOMED MATER RES A, V101, P1237, DOI 10.1002/jbm.a.34422
   Jiang QR, 2011, J BIOMAT SCI-POLYM E, V22, P1393, DOI 10.1163/092050610X508437
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Kale A, 2007, IND CROP PROD, V26, P44, DOI 10.1016/j.indcrop.2007.01.006
   KAMATH KR, 1993, ADV DRUG DELIVER REV, V11, P59, DOI 10.1016/0169-409X(93)90027-2
   Karthikeyan K, 2012, AAPS PHARMSCITECH, V13, P143, DOI 10.1208/s12249-011-9731-x
   Karthikeyan K., 2014, AAPS PHARMSCITECH
   Kim B.-K., 2013, FASEB J
   Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010
   Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698
   Lai HM, 1997, CEREAL CHEM, V74, P771, DOI 10.1094/CCHEM.1997.74.6.771
   Lai LF, 2011, INT J PHARMACEUT, V404, P317, DOI 10.1016/j.ijpharm.2010.11.025
   Lasic DD, 1996, CURR OPIN SOLID ST M, V1, P392, DOI 10.1016/S1359-0286(96)80031-3
   Lau Esther T L, 2013, Pharmaceutics, V5, P277, DOI 10.3390/pharmaceutics5020277
   Lee S, 2013, INT J PHARMACEUT, V454, P388, DOI 10.1016/j.ijpharm.2013.07.026
   Li KK, 2013, J FOOD ENG, V119, P343, DOI 10.1016/j.jfoodeng.2013.05.038
   Li KK, 2012, J AGR FOOD CHEM, V60, P11592, DOI 10.1021/jf302752v
   Li Y, 2009, J FOOD SCI, V74, pC233, DOI 10.1111/j.1750-3841.2009.01093.x
   Lin JT, 2012, ACS APPL MATER INTER, V4, P1050, DOI 10.1021/am201669z
   Lin T, 2011, AAPS PHARMSCITECH, V12, P172, DOI 10.1208/s12249-010-9565-y
   Liu CJ, 2010, CHEM COMMUN, V46, P7566, DOI 10.1039/c0cc02370a
   Liu LS, 2006, DRUG DELIV, V13, P417, DOI 10.1080/10717540500394935
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Luo YC, 2013, J AGR FOOD CHEM, V61, P7621, DOI 10.1021/jf402198r
   Luo YC, 2013, FOOD CHEM, V139, P224, DOI 10.1016/j.foodchem.2013.01.113
   Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z
   Luo YC, 2010, CARBOHYD POLYM, V82, P942, DOI 10.1016/j.carbpol.2010.06.029
   Mao SR, 2012, EXPERT OPIN DRUG DEL, V9, P1209, DOI 10.1517/17425247.2012.717926
   Mao SR, 2012, EXPERT OPIN DRUG DEL, V9, P1161, DOI 10.1517/17425247.2012.709844
   Matalanis A, 2011, FOOD HYDROCOLLOID, V25, P1865, DOI 10.1016/j.foodhyd.2011.04.014
   MATSUDA Y, 1989, CHEM PHARM BULL, V37, P757
   Matsushima N, 1997, BBA-PROTEIN STRUCT M, V1339, P14, DOI 10.1016/S0167-4838(96)00212-9
   Mehta SK, 2011, COLLOID SURFACE A, V375, P219, DOI 10.1016/j.colsurfa.2010.12.014
   Moros EE, 2002, J AGR FOOD CHEM, V50, P5787, DOI [10.1021/jf020109l, 10.1021/jf0201909l]
   Muller V, 2011, J NANOMATER, DOI 10.1155/2011/928728
   Muthuselvi L, 2006, COLLOID SURFACE B, V51, P39, DOI [10.1016/j.colsurfb.2006.05.012, 10.1016/colsurfb.2006.05.012]
   Neo YP, 2013, FOOD CHEM, V136, P1013, DOI 10.1016/j.foodchem.2012.09.010
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629
   Nonthanum P, 2012, J AGR FOOD CHEM, V60, P1742, DOI 10.1021/jf2035302
   Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001
   Oliviero M, 2011, J AGR FOOD CHEM, V59, P10062, DOI 10.1021/jf201728p
   Pan Y., 2014, FOOD HYDROCOLL
   Park K, 2007, J CONTROL RELEASE, V120, P1, DOI 10.1016/j.jconrel.2007.05.003
   Patel A, 2010, SOFT MATTER, V6, P6192, DOI 10.1039/c0sm00800a
   Peran M, 2012, INT J MOL SCI, V13, P3847, DOI 10.3390/ijms13033847
   Pillay V, 2013, AAPS PHARMSCITECH, V14, P692, DOI 10.1208/s12249-013-9955-z
   Podaralla S, 2012, MOL PHARMACEUT, V9, P2778, DOI 10.1021/mp2006455
   Podaralla S, 2012, AAPS PHARMSCITECH, V13, P919, DOI 10.1208/s12249-012-9816-1
   Podaralla S, 2010, J BIOMED NANOTECHNOL, V6, P312, DOI 10.1166/jbn.2010.1137
   Qu ZH, 2008, ACTA BIOMATER, V4, P1360, DOI 10.1016/j.actbio.2008.03.006
   Reddy N, 2011, TRENDS BIOTECHNOL, V29, P490, DOI 10.1016/j.tibtech.2011.05.003
   Regier MC, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-44
   Rosic R, 2013, ACTA PHARMACEUT, V63, P295, DOI 10.2478/acph-2013-0024
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Son YJ, 2014, ARCH PHARM RES, V37, P69, DOI 10.1007/s12272-013-0284-2
   Sousa FFO, 2013, EUR J PHARM BIOPHARM, V85, P790, DOI 10.1016/j.ejpb.2013.07.008
   Stayton P S, 2005, Orthod Craniofac Res, V8, P219, DOI 10.1111/j.1601-6343.2005.00336.x
   SUZUKI T, 1989, CHEM PHARM BULL, V37, P1051
   Tong R, 2012, WIRES NANOMED NANOBI, V4, P638, DOI 10.1002/wnan.1188
   Torchilin V. P., 2006, NANOPARTICULATES DRU
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang HJ, 2009, COLLOID SURFACE B, V69, P109, DOI 10.1016/j.colsurfb.2008.11.015
   Wang LP, 2013, J BIOMED NANOTECHNOL, V9, P367, DOI 10.1166/jbn.2013.1557
   Wongsasulak S, 2013, J FOOD SCI, V78, pN926, DOI 10.1111/1750-3841.12126
   Wu YP, 2012, LWT-FOOD SCI TECHNOL, V48, P283, DOI 10.1016/j.lwt.2012.03.027
   Xiao D, 2011, J AGR FOOD CHEM, V59, P7393, DOI 10.1021/jf200774v
   Xu HL, 2011, J MATER CHEM, V21, P18227, DOI 10.1039/c1jm11163a
   Xu YZ, 2010, INT J ORAL SCI, V2, P142, DOI 10.4248/IJOS10056
   Yang JM, 2013, COLLOID SURFACE B, V102, P737, DOI 10.1016/j.colsurfb.2012.09.039
   Yao C, 2007, J BIOMAT SCI-POLYM E, V18, P731, DOI 10.1163/156856207781034070
   Yewale C, 2013, EXPERT OPIN DRUG DEL, V10, P1429, DOI 10.1517/17425247.2013.805200
   Yih TC, 2006, J CELL BIOCHEM, V97, P1184, DOI 10.1002/jcb.20796
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zhang B, 2012, J AGR FOOD CHEM, V60, P4162, DOI 10.1021/jf3005417
   Zhang LW, 2008, TOXICOL APPL PHARM, V228, P200, DOI 10.1016/j.taap.2007.12.022
   Zhang YQ, 2014, FOOD CHEM, V142, P269, DOI 10.1016/j.foodchem.2013.07.058
   Zou T, 2013, MOL PHARMACEUT, V10, P2062, DOI 10.1021/mp400086n
NR 115
TC 95
Z9 102
U1 11
U2 181
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 10
PY 2014
VL 189
BP 108
EP 122
DI 10.1016/j.jconrel.2014.06.036
PG 15
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AO5JS
UT WOS:000341381300012
PM 24993426
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Lichawska, ME
   Bodek, KH
   Jezierska, J
   Kufelnicki, A
AF Lichawska, Marta E.
   Bodek, Kazimiera H.
   Jezierska, Julia
   Kufelnicki, Aleksander
TI Coordinative interaction of microcrystalline chitosan with oxovanadium
   (IV) ions in aqueous solution
SO CHEMISTRY CENTRAL JOURNAL
LA English
DT Article
DE Biomaterial; Microcrystalline chitosan; Vanadium (IV); Metal-polymer
   complexes; Equilibria in aqueous solution
ID EQUILIBRIUM-CONSTANTS; BLOOD-SERUM; METAL-IONS; COMPLEXES; DFT;
   DERIVATIVES; HYDROLYSIS; PROGRAMS; VANADIUM
AB Background: Chitosan, a non-toxic, biodegradable and biocompatible polysaccharide has attained great interest in pharmaceutical applications, as versatile drug delivery agent. Chitosan has been already shown to serve as vehicle for sustained drug release by chitosan-vanadium(IV) complex from a chitosan gel matrix. Therefore, chitosan gel proved to retain vanadium and preserve its insulin-mimetic efficacy. Nevertheless, there is a lack of reports concerning complexing equilibria in aqueous solution, in particular when using the more advantageous microcrystalline form of chitosan (MCCh). Microcrystalline chitosan shows a number of valuable features as compared with unmodified chitosan.
   Results: Experimental studies on complexing interaction between a special form of biomaterial - microcrystalline chitosan as ligand, L = MCCh, of two exemplary degrees of deacetylation DD (lower 79.8%; higher 97.7%) with M = oxovanadium (IV) ions have been carried out potentiometrically at four ligand-to-metal concentration ratios (2: 1, 5: 1, 8: 1, 10: 1). Among the five hydrolysis equilibria of VO2+ reported up to now in the literature, under the conditions of the present work i.e. aqueous solutions of ionic strength I = 0.1 (KNO3) and temperature 25.0 +/- 0.1 degrees C, the predominating one was (VO)(2)(OH)(2) (2+) formation: log beta(20-2) = -7.01(2). Analysis of potentiometric results permitted to note that degree of deacetylation does not essentially influence the coordination mode of the complexes formed. In the case of both the two DD values, as well as for all the ligand-to-metal ratios, formation of hydroxyl deprotonated MLH-1 and ML2H-2 moieties has been confirmed potentiometrically (log beta(11-1) = -0.68(2) for DD = 79.8% and -0.68(2) for DD = 97.7%, log beta(12-2) = -7.64(6) for DD = 79.8% and -5.38(7) for DD = 97.7%).
   Conclusion: Microcrystalline chitosan coordinates the vanadyl ions by the hydroxyl groups. Interaction of MCCh with VO2+ ions in aqueous solution occurs within pH 5-7. Amounts of alkali excessive towards NH2 are needed to deprotonate the OH groups. Deprotonation occurring at the chitosan hydroxyl groups permits a "pendant" or "bridge" model of coordination with VO(IV). Lack of complexation via deprotonation of amine groups, typical for simple cations and the molybdenum anion, has been indicated also by FTIR spectroscopy and EPR.
C1 [Lichawska, Marta E.; Kufelnicki, Aleksander] Med Univ Lodz, Fac Pharm, Dept Phys & Biocoordinat Chem, PL-90151 Lodz, Poland.
   [Bodek, Kazimiera H.] Med Univ Lodz, Fac Pharm, Chair Appl Pharm, PL-90151 Lodz, Poland.
   [Jezierska, Julia] Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland.
RP Kufelnicki, A (reprint author), Med Univ Lodz, Fac Pharm, Dept Phys & Biocoordinat Chem, PL-90151 Lodz, Poland.
EM aleksander.kufelnicki@umed.lodz.pl
RI Lichawska, Marta/S-9945-2016; Kufelnicki, Aleksander/B-2614-2010
FU Medical University of Lodz [502-03/3-014-02/502-34-005,
   503/3-021-01/503-01]; Lichawska and Statute Funds [503/3-014-02/503-01]
FX Financial support of this work by the Medical University of Lodz
   (Project 502-03/3-014-02/502-34-005 - M.E. Lichawska and Statute Funds
   No. 503/3-014-02/503-01 - A. Kufelnicki), No. 503/3-021-01/503-01 - K.H.
   Bodek is kindly acknowledged.
CR Baran EJ, 2001, J COORD CHEM, V54, P215, DOI 10.1080/00958970108022636
   Baran EJ, 2008, CARBOHYD POLYM, V74, P704, DOI 10.1016/j.carbpol.2008.04.031
   Baran EJ, 2009, J INORG BIOCHEM, V103, P547, DOI 10.1016/j.jinorgbio.2008.10.008
   Berto S, 2014, INORG CHIM ACTA, V414, P105, DOI 10.1016/j.ica.2014.01.043
   Bodek KH, 2005, J APPL POLYM SCI, V98, P2572, DOI 10.1002/app.22437
   BODEK KH, 1995, J APPL POLYM SCI, V57, P645, DOI 10.1002/app.1995.070570515
   Buck RP, 2002, PURE APPL CHEM, V74, P2169, DOI 10.1351/pac200274112169
   Gans P, 1996, TALANTA, V43, P1739, DOI 10.1016/0039-9140(96)01958-3
   GANS P, 1985, J CHEM SOC DALTON, P1195, DOI 10.1039/dt9850001195
   Hadi AG, 2012, BRIT J SCI, V6, P109
   HENRY RP, 1973, J CHEM SOC DALTON, P1156, DOI 10.1039/dt9730001156
   IRVING HM, 1967, ANAL CHIM ACTA, V38, P475, DOI 10.1016/S0003-2670(01)80616-4
   JanssonCharrier M, 1996, WATER RES, V30, P465, DOI 10.1016/0043-1354(95)00154-9
   Kiss T, 2000, J INORG BIOCHEM, V80, P65, DOI 10.1016/S0162-0134(00)00041-6
   Kofuji K, 2005, J INORG BIOCHEM, V99, P1329, DOI 10.1016/j.jinorgbio.2005.03.007
   KOMURA A, 1977, B CHEM SOC JPN, V50, P2927, DOI 10.1246/bcsj.50.2927
   Kufelnicki A, 2009, J APPL POLYM SCI, V114, P1619, DOI 10.1002/app.30756
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   LICHAWSKA ME, 2010, CLIN EXP MED LETT, V51, P69
   Lodyga-Chruscinska E, 2008, DALTON T, P4903, DOI 10.1039/b803520b
   Lodyga-Chruscinska E, 2013, DALTON T, V42, P13404, DOI 10.1039/c3dt50969a
   Parajon-Costa BS, 2011, SPECTROCHIM ACTA A, V78, P133, DOI 10.1016/j.saa.2010.09.010
   Pisano L, 2009, EUR J INORG CHEM, P2362, DOI 10.1002/ejic.200900045
   Roberts GAF, 1992, CHITIN CHEM, P203
   ROSSOTTI FJC, 1955, ACTA CHEM SCAND, V9, P1177, DOI 10.3891/acta.chem.scand.09-1177
   Rowe RC, 2009, HDB PHARM EXCIPIENTS
   SABATINI A, 1992, COORDIN CHEM REV, V120, P389, DOI 10.1016/0010-8545(92)80060-5
   Sakkinen M, 2006, INT J PHARM, V307, P285, DOI 10.1016/j.ijpharm.2005.10.021
   Sakkinen M, 2004, EUR J PHARM BIOPHARM, V57, P133, DOI 10.1016/S0939-6411(03)00097-3
   Sanna D, 2012, J INORG BIOCHEM, V115, P87, DOI 10.1016/j.jinorgbio.2012.04.020
   Sanna D, 2012, EUR J INORG CHEM, P1079, DOI 10.1002/ejic.201101249
   Schatz C, 2003, BIOMACROMOLECULES, V4, P641, DOI 10.1021/bm025724c
   STRUSZCZYK H, 1987, J APPL POLYM SCI, V33, P177, DOI 10.1002/app.1987.070330115
   Taboada E, 2003, J CHIL CHEM SOC, V48, P7, DOI 10.4067/S0717-97072003000100002
   Tan SC, 1998, TALANTA, V45, P713, DOI 10.1016/S0039-9140(97)00288-9
   Thompson KH, 2009, J INORG BIOCHEM, V103, P554, DOI 10.1016/j.jinorgbio.2008.12.003
   Thompson KH, 2006, J INORG BIOCHEM, V100, P1925, DOI 10.1016/j.jinorgbio.2006.08.016
   Varnagy K, 2007, EUR J INORG CHEM, P4884, DOI 10.1002/ejic.200700502
   ZEKANY L, 1985, COMPUTATIONAL METHOD, P352
NR 39
TC 4
Z9 4
U1 1
U2 27
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-153X
J9 CHEM CENT J
JI Chem. Cent. J.
PD SEP 9
PY 2014
VL 8
AR UNSP 50
DI 10.1186/s13065-014-0050-7
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AP4CF
UT WOS:000342023900001
PM 25342963
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shah, DU
   Vollrath, F
   Porter, D
   Stires, J
   Deheyn, DD
AF Shah, Darshil U.
   Vollrath, Fritz
   Porter, David
   Stires, John
   Deheyn, Dimitri D.
TI Housing tubes from the marine worm Chaetopterus sp.: biomaterials with
   exceptionally broad thermomechanical properties
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE parchment biomaterial; thermomechanical properties; marine polychaete;
   Chaetopterus
ID PLANT FIBER COMPOSITES; VARIOPEDATUS RENIER; POLYCHAETA; CHITIN;
   CHITOSAN; BEHAVIOR; ANNELIDA
AB The housing tube material of the marine worm Chaetopterus sp. exhibits thermal stability up to 250 degrees C, similar to other biological materials such as mulberry silkworm cocoons. Interestingly, however, dynamic mechanical thermal analysis conducted in both air and water elucidated the lack of a glass transition in the organic tube wall material. In fact, the viscoelastic properties of the anhydrous and undried tube were remarkably stable (i.e. constant and reversible) between -75 degrees C and 200 degrees C in air, and 5 degrees C and 75 degrees C in water, respectively. Moreover, it was found that hydration and associated-water plasticization were key to the rubber-like flexible properties of the tube; dehydration transformed the material behaviour to glass-like. The tube is made of bionanocomposite fibrils in highly oriented arrangement, which we argue favours the biomaterial to be highly crystalline or cross-linked, with extensive hydrogen and/or covalent bonds. Mechanical property characterization in the longitudinal and transverse directions ascertained that the tubes were not quasi-isotropic structures. In general, the higher stiffness and strength in the transverse direction implied that there were more nanofibrils orientated at +/- 45 degrees and +/- 65 degrees than at 0 degrees to the tube axis. The order of the mechanical properties of the soft-tough tubes was similar to synthetic rubber-like elastomers and even some viscid silks. The complex structure-property relations observed indicated that the worm has evolved to produce a tubular housing structure which can (i) function stably over a broad range of temperatures, (ii) endure mechanical stresses from specific planes/axes, and (iii) facilitate rapid growth or repair.
C1 [Shah, Darshil U.; Vollrath, Fritz; Porter, David] Univ Oxford, Dept Zool, Oxford Silk Grp, Oxford OX1 3PS, England.
   [Stires, John; Deheyn, Dimitri D.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA.
RP Shah, DU (reprint author), Univ Oxford, Dept Zool, Oxford Silk Grp, S Parks Rd, Oxford OX1 3PS, England.
EM darshil.shah@zoo.ox.ac.uk; ddeheyn@ucsd.edu
OI Shah, Darshil/0000-0002-8078-6802
FU US Air Force Office for Scientific Research (AFOSR grant)
   [F49620-03-1-0111, FA9550-10-1-0112]; European Research Council Advanced
   Grant [SP2-GA-2008-233409]
FX We thank the US Air Force Office for Scientific Research (AFOSR grant
   number F49620-03-1-0111 to F.V. and FA9550-10-1-0112 to D.D.D.) and the
   European Research Council Advanced Grant (SP2-GA-2008-233409) for
   generous funding.
CR Banakar P., 2012, INT J PURE APPL SCI, V9, P61
   BARNES RD, 1965, BIOL BULL, V129, P217, DOI 10.2307/1539840
   Bhaud MR, 1998, SARSIA, V83, P243, DOI 10.1080/00364827.1998.10413685
   Branchini BR, 2014, PHOTOCHEM PHOTOBIOL, V90, P247, DOI 10.1111/php.12169
   BROWN SC, 1971, TISSUE CELL, V3, P65, DOI 10.1016/S0040-8166(71)80031-9
   BROWN SC, 1975, BIOL BULL-US, V149, P136, DOI 10.2307/1540485
   BROWN SC, 1978, ANIM BEHAV, V26, P160, DOI 10.1016/0003-3472(78)90015-5
   Chen F, 2012, THESIS U OXFORD OXFO
   Deheyn DD, 2013, PHYSIOL BIOCHEM ZOOL, V86, P702, DOI 10.1086/673869
   DIXON DR, 1980, J MAR BIOL ASSOC UK, V60, P655, DOI 10.1017/S0025315400040340
   Enders H. E., 1907, P INDIANA ACAD SCI, V17, P128
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Harris B, 1999, ENG COMPOSITE MAT
   Kiel S, 2009, ACTA PALAEONTOL POL, V54, P443, DOI 10.4202/app.2009.0022
   Krenchel H, 1964, AKAD FORLAG, V148, P16
   Lewin M, 2007, HDB FIBER CHEM
   Macginitie GE, 1939, BIOL BULL-US, V77, P115, DOI 10.2307/1537850
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   Omokanwaye T, 2010, IFMBE PROC, V32, P183, DOI 10.1007/978-3-642-14998-6_47
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Shah D, 2013, HIERARCHICALLY CONTR
   Shah DU, 2013, J MATER SCI, V48, P6083, DOI 10.1007/s10853-013-7458-7
   Shah DU, 2012, COMPOS SCI TECHNOL, V72, P1909, DOI 10.1016/j.compscitech.2012.08.005
   Shah DU, 2012, POLYM COMPOSITE, V33, P1494, DOI 10.1002/pc.22279
   Thompson ML, 2001, LIMNOL OCEANOGR, V46, P1899, DOI 10.4319/lo.2001.46.8.1899
   Tzoumaki MV, 2013, CARBOHYD POLYM, V95, P324, DOI 10.1016/j.carbpol.2013.02.066
   Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x
   Voitkovskii K. F., 1960, MECH PROPERTIES ICE
   Zhao HP, 2005, POLYMER, V46, P9192, DOI 10.1016/j.polymer.2005.07.004
NR 29
TC 3
Z9 3
U1 3
U2 33
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD SEP 6
PY 2014
VL 11
IS 98
AR 20140525
DI 10.1098/rsif.2014.0525
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AT0RY
UT WOS:000344643800014
PM 25008085
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Pinheiro, ALB
   Soares, LGP
   Marques, AMC
   Aciole, JMS
   de Souza, RA
   Silveira, L
AF Pinheiro, Antonio Luiz B.
   Soares, Luiz Guilherme P.
   Marques, Aparecida Maria C.
   Aciole, Jouber Mateus S.
   de Souza, Renato Aparecido
   Silveira, Landulfo, Jr.
TI Raman ratios on the repair of grafted surgical bone defects irradiated
   or not with laser (lambda 780 nm) or LED (lambda 850 nm)
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Bone repair; Biomaterial; Beta-tricalcium phosphate; Hydroxyapatite;
   Laser phototherapy; LED phototherapy; Raman spectroscopy
ID EMITTING DIODE IRRADIATION; HUMAN CORTICAL BONE; MORPHOGENETIC PROTEINS;
   RODENT MODEL; IN-VIVO; PHYSICOCHEMICAL PROPERTIES; EARLY MINERALIZATION;
   SYNTHETIC APATITES; CALCIFIED TISSUES; DIABETIC-RATS
AB This work aimed to assess biochemical changes associated to mineralization and remodeling of bone defects filled with Hydroxyapatite + Beta-Beta-tricalcium phosphate irradiated or not with 2 light sources. Ratios of intensities, band position and bandwidth of selected Raman peaks of collagen and apatites were used. Sixty male Wistar rats were divided into 6 groups subdivided into 2 subgroups (15th and 30th days). A standard surgical defect was created on one femur of each animal. In 3 groups the defects were filled with blood clot (Clot, Clot + Laser and Clot + LED groups) and in the remaining 3 groups the defects were filled with biomaterial (Biomaterial, Biomaterial + Laser and Biomaterial + LED groups). When indicated, the defects were irradiated with either Laser (lambda 780 nm, 70 mW, Phi similar to 0.4 cm(2)) or LED (lambda 850 +/- 10 rim, 150 mW, Phi similar to 0.5 cm(2)), 20 J/cm(2) each session, at 48 h intervals/2 weeks (140 J/cm(2) treatment). Following sacrifice, bone fragments were analyzed by Raman spectroscopy. Statistical analysis (ANOVA General Linear Model, p < 0.05) showed that both grafting and time were the variables that presented significance for the ratios of similar to 1660/similar to 1670 cm(-1) (collagen maturation), similar to 1077/similar to 854 cm(-1) (mineralization), similar to 1077/similar to 1070 cm(-1) (carbonate substitution) and the position of the similar to 960 cm(-1) (bone maturation). At 30th day, the ratios indicated an increased deposition of immature collagen for both Clot and Biomaterial groups. Biomaterial group showed increased collagen maturation. Only collagen deposition was significantly dependent upon irradiation independently of the light source, being the amount of collagen I increased in the Clot group at the end of the experimental time. On the other hand, collagen I deposition was reduced in biomaterial irradiated groups. Raman ratios of selected protein matrix and phosphate and carbonate HA indicated that the use of biphasic synthetic micro-granular HA + Beta-TCP graft improved the repair of bone defects, associated or not with Laser or LED light, because of the increasing deposition of HA. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Pinheiro, Antonio Luiz B.; Soares, Luiz Guilherme P.; Marques, Aparecida Maria C.; Aciole, Jouber Mateus S.] Fed Univ Bahia UFBA, Sch Dent, Ctr Biophoton, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio Luiz B.; Marques, Aparecida Maria C.] Univ Sao Paulo, Natl Inst Opt & Photon, Phys Inst Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil.
   [Pinheiro, Antonio Luiz B.; Silveira, Landulfo, Jr.] Univ Camilo Castelo Branco UNICASTELO, Inst Biomed Engn, Sao Jose Dos Campos, SP, Brazil.
   [de Souza, Renato Aparecido] Inst Fed Educ Ciencia & Tecnol Sul Minas Gerais I, Grp Estudos & Pesquisa Ciencias Saude, BR-37890000 Muzambinho, MG, Brazil.
RP Pinheiro, ALB (reprint author), Fed Univ Bahia UFBA, Sch Dent, Ctr Biophoton, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br; luizguilherme_@hotmail.com; cidamarques77@hotmail.com;
   jouber_aciole@hotmail.com; tatosouza2004@yahoo.com.br;
   landulfo.silveira@gmail.com
RI Silveira, Landulfo/I-2474-2012; Pinheiro, Antonio Luiz/A-1962-2008; Sao
   Carlos Institute of Physics, IFSC/USP/M-2664-2016
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321; 
FU CNPq (Brazilian National Counsel of Technological and Scientific
   Development) [309209/2011-0]; FAPESP (Sao Paulo Research Foundation)
   [2009/01788-5]
FX The authors would like to thank the CNPq (Brazilian National Counsel of
   Technological and Scientific Development), Grant No. 309209/2011-0 and
   FAPESP (Sao Paulo Research Foundation), Grant No. 2009/01788-5, for the
   financial support that allowed this research.
CR Ager JW, 2006, J BONE MINER RES, V21, P1879, DOI 10.1359/JBMR.060816
   Ager JW, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1924668
   Akkus O, 2004, BONE, V34, P443, DOI 10.1016/j.bone.2003.11.003
   Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Al-Watban FAH, 2003, J CLIN LASER MED SUR, V21, P249, DOI 10.1089/104454703322564451
   Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0
   Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025
   Boskey A. L., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P532
   Boskey AL, 2007, ELEMENTS, V3, P385, DOI 10.2113/GSELEMENTS.3.6.385
   Boskey Adele L, 2006, Curr Osteoporos Rep, V4, P71, DOI 10.1007/s11914-006-0005-6
   BOSKEY AL, 1992, CALCIFIED TISSUE INT, V51, P443, DOI 10.1007/BF00296678
   Buchwald T, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017007
   Carden A, 2003, CALCIFIED TISSUE INT, V72, P166, DOI 10.1007/s00223-002-1039-0
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho F.B., 2011, P SOC PHOTO-OPT INS, V7887
   Corazza AV, 2007, PHOTOMED LASER SURG, V25, P102, DOI 10.1089/pho.2006.2011
   Donnelly E, 2010, J BIOMED MATER RES A, V92A, P1048, DOI 10.1002/jbm.a.32442
   EMERSON WH, 1962, ARCH ORAL BIOL, V7, P671, DOI 10.1016/0003-9969(62)90116-4
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1271, DOI [10.1359/JBMR.090201, 10.1359/jbmr.090201]
   Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011
   Kelly S., 2012, THESIS U GLASGOW, P237
   Khan AF, 2013, APPL SPECTROSC REV, V48, P329, DOI 10.1080/05704928.2012.721107
   Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Mandair G.S., 2010, P SOC PHOTO-OPT INS, V7548
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   McCreadie BR, 2006, BONE, V39, P1190, DOI 10.1016/j.bone.2006.06.008
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   PINHEIRO ALB, 2001, LASER THER, V13, P73
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Shen J, 2010, OSTEOPOROSIS INT, V21, P81, DOI 10.1007/s00198-009-0949-3
   Silveira L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077003
   Soares LG.P., 2013, LASERS MED SCI
   Stein Rodrigo Steffen, 2009, Rev. bras. ortop., V44, P330, DOI [10.1016/S2255-4971(15)30162-2, 10.1590/S0102-36162009000400008]
   Stewart S, 2002, J RAMAN SPECTROSC, V33, P536, DOI 10.1002/jrs.892
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Tomasz B., 2012, SPECTROSC INT J, V27, P107
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   Verdelis K, 2007, BONE, V40, P1399, DOI 10.1016/j.bone.2006.12.061
   Wallace JM, 2010, ANN BIOMED ENG, V38, P1607, DOI 10.1007/s10439-009-9881-0
   Wallace JM, 2009, J BONE MINER RES, V24, P1002, DOI [10.1359/JBMR.081259, 10.1359/jbmr.081259]
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484
   Whelan HT, 2001, J CLIN LASER MED SUR, V19, P305, DOI 10.1089/104454701753342758
   Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179
   Xiao JW, 2010, CRYST GROWTH DES, V10, P1492, DOI 10.1021/cg9001016
   Yao F, 2009, ACTA BIOMATER, V5, P2169, DOI 10.1016/j.actbio.2009.02.007
   Yerramshetty JS, 2008, BONE, V42, P476, DOI 10.1016/j.bone.2007.12.001
   Zhou WY, 2008, J MATER SCI-MATER M, V19, P103, DOI 10.1007/s10856-007-3156-9
NR 64
TC 9
Z9 9
U1 1
U2 15
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD SEP 5
PY 2014
VL 138
BP 146
EP 154
DI 10.1016/j.jphotobiol.2014.05.022
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AO0GQ
UT WOS:000340987500018
PM 24935415
DA 2018-10-20
ER

PT J
AU Liao, L
   Yang, S
   Miron, RJ
   Wei, JC
   Zhang, YF
   Zhang, M
AF Liao, Lan
   Yang, Shuang
   Miron, Richard J.
   Wei, Junchao
   Zhang, Yufeng
   Zhang, Meng
TI Osteogenic Properties of PBLG-g-HA/PLLA Nanocomposites
SO PLOS ONE
LA English
DT Article
ID MODIFIED HYDROXYAPATITE/POLY(L-LACTIDE) NANOCOMPOSITES; IN-VIVO;
   HYDROXYAPATITE; SCAFFOLDS; CELLS; POLYLACTIDE; REPAIR; DIFFERENTIATION;
   MINERALIZATION; NANOPARTICLES
AB New development of biomaterial scaffolds remains a prominent issue for the regeneration of lost or fractured bone. Of these scaffolds, a number of bioactive polymers have been synthesized and fabricated for diverse biological roles. Although recent evidence has demonstrated that composite scaffolds such as HA/PLLA have improved properties when compared to either HA or PLLA alone, recent investigations have demonstrated that the phase compatibility between HA and PLLA layers is weak preventing optimal enhancement of the mechanical properties and making the composites prone to breakdown. In the present study, poly (gamma-benzyl-L-glutamate) modified hydroxyapatite/(poly (L-lactic acid)) (PBLG-g-HA/PLLA) composite scaffolds were fabricated with improved phase compatibility and tested for their osteogenic properties in 18 Wistar female rats by analyzing new bone formation in 3 mm bilateral femur defects in vivo. At time points, 2, 4 and 8 weeks post surgery, bone formation was evaluated by mu-CT and histological analysis by comparing 4 treatment groups; 1) blank defect, 2) PLLA, 3) HA/PLLA and 4) PBLG-g-HA/PLLA scaffolds. The in vivo analysis demonstrated that new bone formation was much more prominent in HA/PLLA and PBLG-g-HA/PLLA groups as depicted by mu-CT, H&E staining and immunohistochemistry for collagen I. TRAP staining was also utilized to determine the influence of osteoclast cell number and staining intensity to the various scaffolds. No significant differences in either staining intensity or osteoclast numbers between all treatment modalities was observed, however blank defects did contain a higher number of osteoclast-like cells. The results from the present study illustrate the potential of PBLG-g-HA/PLLA scaffolds for bone tissue engineering applications by demonstrating favorable osteogenic properties.
C1 [Liao, Lan; Wei, Junchao; Zhang, Meng] Nanchang Univ, Sch Mat Sci & Engn, Nanchang, Peoples R China.
   [Liao, Lan] Nanchang Univ, Sch Stomatol, Nanchang, Peoples R China.
   [Yang, Shuang; Miron, Richard J.; Zhang, Yufeng] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Sch & Hosp Stomatol, Minist Educ, Wuhan 430072, Peoples R China.
   [Yang, Shuang; Miron, Richard J.; Zhang, Yufeng] Wuhan Univ, Key Lab Oral Biomed, Sch & Hosp Stomatol, Minist Educ, Wuhan 430072, Peoples R China.
   [Zhang, Yufeng] Wuhan Univ, Sch Stomatol, Dept Oral Implantol, Wuhan 430072, Peoples R China.
RP Wei, JC (reprint author), Nanchang Univ, Sch Mat Sci & Engn, Nanchang, Peoples R China.
EM weijunchao@ncu.edu.cn; zyf@whu.edu.cn; zhhmeng@ncu.edu.cn
FU Program for New Century Excellent Talents in University [NCET-11-0414];
   Excellent Youth Foundation of Hubei; National Natural Science Foundation
   of China [81271108, 51203073]; education department of Jiangxi province
   [GJJ13107]
FX This project was supported by Program for New Century Excellent Talents
   in University (NCET-11-0414), Excellent Youth Foundation of Hubei and
   the funds of the National Natural Science Foundation of China (81271108&
   amp; 51203073). The authors are also grateful for the project from
   education department of Jiangxi province (GJJ13107). The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Boccaccini A.R., 2005, BIOACTIVE COMPOSITE
   Cai Q, 2002, BIOMATERIALS, V23, P4483, DOI 10.1016/S0142-9612(02)00168-0
   Charles LF, 2013, J MECH BEHAV BIOMED, V17, P269, DOI 10.1016/j.jmbbm.2012.09.007
   Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y
   Costantino PD, 2000, OTOLARYNG HEAD NECK, V123, P409, DOI 10.1067/mhn.2000.107679
   Dinaryand P, 2011, ACS APPL MATER INTER, V3, P4518, DOI 10.1021/am201212u
   Dugard MN, 2005, CLIN CHIM ACTA, V356, P154, DOI 10.1016/j.cccn.2005.01.020
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Hayashi M, 2013, J CRANIOMAXILLOFAC S
   Komlev VS, 2006, TISSUE ENG, V12, P3449, DOI 10.1089/ten.2006.12.3449
   Li XM, 2007, J CELL BIOCHEM, V100, P527, DOI 10.1002/jcb.21017
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Ludwig SC, 2000, EUR SPINE J
   Matsuo A, 2010, ODONTOLOGY, V98, P85, DOI 10.1007/s10266-009-0111-x
   MCCONNELL D, 1961, SCIENCE, V133, P281, DOI 10.1126/science.133.3448.281
   Mei F, 2007, BIOMACROMOLECULES, V8, P3729, DOI 10.1021/bm7006295
   Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260
   Ngiam M, 2009, TISSUE ENG PT A, V15, P535, DOI 10.1089/ten.tea.2008.0011
   Supova M, 2009, J MAT SCI MAT MED
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   Takayama T, 2009, J MAT SCI
   Wei JC, 2011, CHEM J CHINESE U, V32, P2674
   Wei JC, 2011, SCI CHINA CHEM, V54, P431, DOI 10.1007/s11426-011-4221-2
   Wei JC, 2009, MACROMOL BIOSCI, V9, P631, DOI 10.1002/mabi.200800324
   Wei L., 2013, CLIN IMPLANT DENT RE
   Wildemann B, 2004, J CONTROL RELEASE, V95, P249, DOI 10.1016/j.jconrel.2003.11.014
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
NR 33
TC 8
Z9 9
U1 4
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 3
PY 2014
VL 9
IS 9
AR e105876
DI 10.1371/journal.pone.0105876
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO3TB
UT WOS:000341257700027
PM 25184285
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Yoda, I
   Koseki, H
   Tomita, M
   Shida, T
   Horiuchi, H
   Sakoda, H
   Osaki, M
AF Yoda, Itaru
   Koseki, Hironobu
   Tomita, Masato
   Shida, Takayuki
   Horiuchi, Hidehiko
   Sakoda, Hideyuki
   Osaki, Makoto
TI Effect of surface roughness of biomaterials on Staphylococcus
   epidermidis adhesion
SO BMC MICROBIOLOGY
LA English
DT Article
DE Bacterial adhesion; Biomaterials; Roughness; Staphylococcus epidermidis
ID TOTAL HIP-ARTHROPLASTY; OF-THE-LITERATURE; BACTERIAL ADHESION; BIOFILM
   FORMATION; IN-VIVO; SUBSTRATUM TOPOGRAPHY; SUBGINGIVAL PLAQUE;
   INFECTION; TITANIUM; SUPRAGINGIVAL
AB Background: Implant-related infections are caused by adhesion of bacteria to the surface of biomaterials. In this in vitro research, we evaluated the ability of Staphylococcus epidermidis (ATCC35984) to adhere to the surface of solid biomaterials at different levels of roughness below 30 nm Ra and investigated the minimum level of roughness required to promote bacterial adhesion on five kinds of biomaterials: oxidized zirconium-niobium alloy (Oxinium), cobalt-chromium-molybdenum alloy (Co-Cr-Mo), titanium alloy (Ti-6Al-4 V), commercially pure titanium (Cp-Ti) and stainless steel (SUS316L), samples of which were categorized into a fine group and a coarse group according to surface roughness. The test specimens were physically analyzed and the viable bacterial density of the adhered bacteria was quantitatively determined (n = 20).
   Results: The amount of bacteria that adhered to the biomaterials in the coarse group was higher than those in the fine group. Oxinium, Ti-6Al-4 V and SUS316L in particular demonstrated statistically significant differences between the two groups (P < 0.05). Of the materials, the Co-Cr-Mo specimens exhibited significantly lower amounts of adhered bacteria than the Ti-6Al-4 V, Cp-Ti and SUS316L specimens in the fine group. Similarly, the Co-Cr-Mo specimens in the coarse group exhibited significantly lower values than the other four materials.
   Conclusions: These results suggest that minimum level of roughness affecting initial bacterial adherence activity differs according to the type of biomaterial used, and that even a surface roughness of below 30 nm Ra in Oxinium, Ti-6Al-4 V and SUS316L can promote bacterial adhesion. Relative hydrophobic Co-Cr-Mo surfaces were less susceptible to bacterial adherence.
C1 [Yoda, Itaru; Koseki, Hironobu; Tomita, Masato; Shida, Takayuki; Horiuchi, Hidehiko; Osaki, Makoto] Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, Nagasaki 8528501, Japan.
   [Sakoda, Hideyuki] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
RP Koseki, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Orthoped Surg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.
EM koseki@nagasaki-u.ac.jp
FU JSPS KAKENHI [24592236]
FX This work was partially supported by JSPS KAKENHI Grant Number 24592236.
CR Al-Ahmad A, 2010, J BIOMED MATER RES B, V95B, P101, DOI 10.1002/jbm.b.31688
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0
   Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155
   Busscher H J, 1997, Adv Dent Res, V11, P24
   Chu Vivian H, 2005, Am J Med, V118, P1416
   Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005
   Gottenbos B, 1999, J MATER SCI-MATER M, V10, P853, DOI 10.1023/A:1008989416939
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Henriques M, 2004, COLLOID SURFACE B, V33, P235, DOI 10.1016/j.colsurfb.2003.10.012
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   HUNTER G, 2005, J ASTM INT, V2
   Kajiyama S, 2009, J ORTHOP SCI, V14, P769, DOI 10.1007/s00776-009-1405-0
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Lee BC, 2011, J ADV PROSTHODONT, V3, P81, DOI 10.4047/jap.2011.3.2.81
   Mack D, 2007, ANAL BIOANAL CHEM, V387, P399, DOI 10.1007/s00216-006-0745-2
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   O'Gara JP, 2007, FEMS MICROBIOL LETT, V270, P179, DOI 10.1111/j.1574-6968.2007.00688.x
   Olson ME, 2006, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000229320.45416.0c
   Ozturk O, 2007, J BIOMED MATER RES A, V81A, P663, DOI 10.1002/jbm.a.31037
   Percival SL, 2011, WOUND REPAIR REGEN, V19, P1, DOI 10.1111/j.1524-475X.2010.00651.x
   Phillips CB, 2003, J BONE JOINT SURG AM, V85A, P20, DOI 10.2106/00004623-200301000-00004
   Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008
   Steinberg D, 1998, CLIN ORAL IMPLAN RES, V9, P67, DOI 10.1034/j.1600-0501.1998.090201.x
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   Tang PF, 2011, J NANOMATER, DOI 10.1155/2011/178921
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732
   Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9
NR 43
TC 41
Z9 41
U1 2
U2 46
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD SEP 2
PY 2014
VL 14
AR 234
DI 10.1186/s12866-014-0234-2
PG 7
WC Microbiology
SC Microbiology
GA AO6JY
UT WOS:000341458200001
PM 25179448
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Shah, NJ
   Hyder, MN
   Quadir, MA
   Courchesne, NMD
   Seeherman, HJ
   Nevins, M
   Spector, M
   Hammond, PT
AF Shah, Nisarg J.
   Hyder, Md. Nasim
   Quadir, Mohiuddin A.
   Courchesne, Noemie-Manuelle Dorval
   Seeherman, Howard J.
   Nevins, Myron
   Spector, Myron
   Hammond, Paula T.
TI Adaptive growth factor delivery from a polyelectrolyte coating promotes
   synergistic bone tissue repair and reconstruction
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE regenerative medicine; layer-by-layer; biomaterial; controlled drug
   release; wound healing
ID REGENERATION; DEGRADATION; SCAFFOLDS; MAXILLARY; DNA
AB Traumatic wounds and congenital defects that require large-scale bone tissue repair have few successful clinical therapies, particularly for craniomaxillofacial defects. Although bioactive materials have demonstrated alternative approaches to tissue repair, an optimized materials system for reproducible, safe, and targeted repair remains elusive. We hypothesized that controlled, rapid bone formation in large, critical-size defects could be induced by simultaneously delivering multiple biological growth factors to the site of the wound. Here, we report an approach for bone repair using a polyelectrolye multilayer coating carrying as little as 200 ng of bone morphogenetic protein-2 and platelet-derived growth factor-BB that were eluted over readily adapted time scales to induce rapid bone repair. Based on electrostatic interactions between the polymer multilayers and growth factors alone, we sustained mitogenic and osteogenic signals with these growth factors in an easily tunable and controlled manner to direct endogenous cell function. To prove the role of this adaptive release system, we applied the polyelectrolyte coating on a well-studied biodegradable poly(lactic-co-glycolic acid) support membrane. The released growth factors directed cellular processes to induce bone repair in a critical-size rat calvaria model. The released growth factors promoted local bone formation that bridged a critical-size defect in the calvaria as early as 2 wk after implantation. Mature, mechanically competent bone regenerated the native calvaria form. Such an approach could be clinically useful and has significant benefits as a synthetic, off-the-shelf, cell-free option for bone tissue repair and restoration.
C1 [Shah, Nisarg J.; Hyder, Md. Nasim; Quadir, Mohiuddin A.; Courchesne, Noemie-Manuelle Dorval; Hammond, Paula T.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Shah, Nisarg J.; Hyder, Md. Nasim; Quadir, Mohiuddin A.; Courchesne, Noemie-Manuelle Dorval; Hammond, Paula T.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Seeherman, Howard J.] Restituo LLC, Cambridge, MA 02138 USA.
   [Nevins, Myron] Harvard Univ, Sch Dent Med, Div Periodontol, Dept Oral Med Infect & Immun, Boston, MA 02115 USA.
   [Spector, Myron] Vet Affairs Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA.
   [Spector, Myron] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA.
   [Spector, Myron] Harvard Univ, Sch Med, Boston, MA 02115 USA.
RP Hammond, PT (reprint author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM hammond@mit.edu
OI Spector, Myron/0000-0003-3328-4858
FU National Institutes of Health [R01 AG029601, R01 EB010246, P30
   CA014051]; Natural Sciences and Engineering Research Council of Canada
FX We thank the Koch Institute Swanson Biotechnology Center for assistance
   and Pfizer Inc. for supplying BMP-2. This work was funded by the
   National Institutes of Health through Grants R01 AG029601, R01 EB010246,
   and P30 CA014051. M.N.H. and N.-M.D.C. acknowledge fellowships from the
   Natural Sciences and Engineering Research Council of Canada. P. T. H.
   acknowledges the David H. Koch (1962) Chair Professorship in
   Engineering.
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/nmat3550, 10.1038/NMAT3550]
   Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231
   Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Landes CA, 2006, PLAST RECONSTR SURG, V117, P2347, DOI 10.1097/01.prs.0000218787.49887.73
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2011, SCI TRANSL MED, V3
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Neovius E, 2010, J PLAST RECONSTR AES, V63, P1615, DOI 10.1016/j.bjps.2009.06.003
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Pashuck ET, 2012, SCI TRANSL MED, V4, P160
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Shah NJ, 2013, SCI TRANSL MED, V5
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Will J, 2008, J MATER SCI-MATER M, V19, P2781, DOI 10.1007/s10856-007-3346-5
   Woodruff MA, 2012, MATER TODAY, V15, P430, DOI 10.1016/S1369-7021(12)70194-3
NR 33
TC 55
Z9 56
U1 4
U2 56
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 2
PY 2014
VL 111
IS 35
BP 12847
EP 12852
DI 10.1073/pnas.1408035111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AO3LN
UT WOS:000341230800073
PM 25136093
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Quattrini, A
   Sannino, A
AF Quattrini, Angelo
   Sannino, Alessandro
TI Biomaterial to promote nerve regeneration: Towards clinical trials
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Meeting Abstract
CT European Biotechnology Congress
CY MAY 15-18, 2014
CL Lecce, ITALY
C1 [Quattrini, Angelo] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.
   [Quattrini, Angelo] Ist Sci San Raffaele, INSPE, I-20132 Milan, Italy.
   [Sannino, Alessandro] Univ Lecce, Dept Engn Innovat, I-73100 Lecce, Italy.
EM quattrini.angelo@hsr.it
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD SEP
PY 2014
VL 185
SU S
BP S6
EP S7
DI 10.1016/j.jbiotec.2014.07.026
PG 2
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CC0NH
UT WOS:000350032000008
DA 2018-10-20
ER

PT J
AU Ortega, I
   Sefat, F
   Deshpande, P
   Paterson, T
   Ramachandran, C
   Ryan, AJ
   MacNeil, S
   Claeyssens, F
AF Ortega, Ilida
   Sefat, Farshid
   Deshpande, Pallavi
   Paterson, Thomas
   Ramachandran, Charanya
   Ryan, Anthony J.
   MacNeil, Sheila
   Claeyssens, Frederik
TI Combination of Microstereolithography and Electrospinning to Produce
   Membranes Equipped with Niches for Corneal Regeneration
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 91; electrospinning; microstereolithography; stem
   cell niche; storage; limbal explants
ID LIMBAL STEM-CELLS; AMNIOTIC MEMBRANE; CLINICAL TRANSPLANTATION;
   PROLIFERATION; EPITHELIUM; SCAFFOLDS; REPAIR; FATE
AB Corneal problems affect millions of people worldwide reducing their quality of life significantly. Corneal disease can be caused by illnesses such as Aniridia or Steven Johnson Syndrome as well as by external factors such as chemical burns or radiation. Current treatments are (i) the use of corneal grafts and (ii) the use of stem cell expanded in the laboratory and delivered on carriers (e.g., amniotic membrane); these treatments are relatively successful but unfortunately they can fail after 3-5 years. There is a need to design and manufacture new corneal biomaterial devices able to mimic in detail the physiological environment where stem cells reside in the cornea. Limbal stem cells are located in the limbus (circular area between cornea and sclera) in specific niches known as the Palisades of Vogt. In this work we have developed a new platform technology which combines two cutting-edge manufacturing techniques (microstereolithography and electrospinning) for the fabrication of corneal membranes that mimic to a certain extent the limbus. Our membranes contain artificial micropockets which aim to provide cells with protection as the Palisades of Vogt do in the eye.
C1 [Ortega, Ilida; Sefat, Farshid; Deshpande, Pallavi; Paterson, Thomas; MacNeil, Sheila; Claeyssens, Frederik] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S10 2TN, S Yorkshire, England.
   [Ryan, Anthony J.] Univ Sheffield, Dept Chem, Sheffield S10 2TN, S Yorkshire, England.
   [Ramachandran, Charanya] LV Prasad Eye Inst, Hyderabad, Andhra Pradesh, India.
RP Ortega, I (reprint author), Univ Sheffield, Dept Mat Sci & Engn, Sheffield S10 2TN, S Yorkshire, England.
EM i.ortega@sheffield.ac.uk; f.claeyssens@sheffield.ac.uk
RI Ryan, Anthony/D-9294-2016; Ortega, Ilida/G-1036-2015
OI Ryan, Anthony/0000-0001-7737-0526; Paterson, Thomas/0000-0002-2951-115X;
   Deshpande, Pallavi/0000-0001-9714-9917
FU Wellcome Trust Affordable Healthcare for India; EPSRC
FX We gratefully acknowledge funding from the Wellcome Trust Affordable
   Healthcare for India and an EPSRC Landscape Fellowship for Ilida Ortega
   as well as contributions from The Electrospinning Company Ltd.
CR Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Deshpande P, 2013, BIOMATERIALS, V34, P5088, DOI 10.1016/j.biomaterials.2013.03.064
   Deshpande P, 2010, REGEN MED, V5, P395, DOI [10.2217/rme.10.16, 10.2217/RME.10.16]
   Djalilian AR, 2008, MOL VIS, V14, P1041
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742
   Dua HS, 1999, BRIT J OPHTHALMOL, V83, P748, DOI 10.1136/bjo.83.6.748
   Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0
   Fatima A, 2006, J POSTGRAD MED, V52, P257
   FATT I, 1968, EXP EYE RES, V7, P103, DOI 10.1016/S0014-4835(68)80032-6
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Gicquel JJ, 2009, TISSUE ENG PT A, V15, P1919, DOI 10.1089/ten.tea.2008.0432
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415
   Kinoshita S, 2001, PROG RETIN EYE RES, V20, P639, DOI 10.1016/S1350-9462(01)00007-6
   Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7
   Lehrer MS, 1998, J CELL SCI, V111, P2867
   Moeller HC, 2008, BIOMATERIALS, V29, P752, DOI 10.1016/j.biomaterials.2007.10.030
   Nubile M, 2008, BRIT J OPHTHALMOL, V92, P54, DOI 10.1136/bjo.2007.123026
   Nubile M, 2011, AM J OPHTHALMOL, V151, P809, DOI 10.1016/j.ajo.2010.11.002
   Ortega I., 2013, BIOFABRICATION, V5, P1758
   Ortega I, 2013, ACTA BIOMATER, V9, P5511, DOI 10.1016/j.actbio.2012.10.039
   Raimondi MT, 2013, ACTA BIOMATER, V9, P4579, DOI 10.1016/j.actbio.2012.08.022
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Reinach Peter S., 2008, P17, DOI 10.1007/978-1-59745-375-2_2
   Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580
   Sitalakshmi G., 2008, TISSUE ENG PART A, V15, P407, DOI [10.1089/ten.tea.2008.0041, DOI 10.1089/TEN.TEA.2008.0041]
   THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442
   Truckenmuller R, 2012, BIOMED MICRODEVICES, V14, P95, DOI 10.1007/s10544-011-9588-5
   Wheeldon I, 2010, JALA-J ASSOC LAB AUT, V15, P440, DOI 10.1016/j.jala.2010.05.003
NR 32
TC 2
Z9 2
U1 1
U2 17
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD SEP
PY 2014
IS 91
AR e51826
DI 10.3791/51826
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CB0FM
UT WOS:000349301100043
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Deligianni, DD
AF Deligianni, Despina D.
TI MWCNTs enhance hBMSCs spreading but delay their proliferation in the
   direction of differentiation acceleration
SO CELL ADHESION & MIGRATION
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CARBON NANOTUBES; OSTEOGENIC DIFFERENTIATION;
   IN-VITRO; ADHESION; FUNCTIONALIZATION; ROUGHNESS; RESPONSES; SURFACES;
   GROWTH
AB Investigating the ability of films of pristine multiwalled nanotubes (MWCNTs) to influence human mesenchymal stem cells' proliferation, morphology, and differentiation into osteoblasts, we concluded to the following: A. MWCNTs delay the proliferation of hBMS cells but increase their differentiation. The enhancement of the differentiation markers could be a result of decreased proliferation and maturation of the extracellular matrix B. Cell spread on MWCNTs toward a polygonal shape with many thin filopodia to attach to the surfaces. Spreading may be critical in supporting osteogenic differentiation in pre-osteoblastic progenitors, being related with cytoskeletal tension. C. hBMS cells prefer MWCNTs than tissue plastic to attach and grow, being non-toxic to these cells. MWCNTs can be regarded as osteoinductive biomaterial topographies for bone regenerative engineering.
C1 Univ Patras, Dept Mech Engn & Aeronaut, Rion, Greece.
RP Deligianni, DD (reprint author), Univ Patras, Dept Mech Engn & Aeronaut, Rion, Greece.
EM deligian@mech.upatras.gr
CR Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Boettiger D, 2012, CURR OPIN CELL BIOL, V24, P592, DOI 10.1016/j.ceb.2012.07.002
   Born AK, 2009, EUR CELLS MATER, V18, P49
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Brunette D M, 1988, Int J Oral Maxillofac Implants, V3, P231
   Chang JC, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055002
   Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013
   Firme CP, 2010, NANOMED-NANOTECHNOL, V6, P245, DOI 10.1016/j.nano.2009.07.003
   Gittens RA, 2012, BIOMATERIALS, V33, P8986, DOI 10.1016/j.biomaterials.2012.08.059
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   HUTTENLOCHER A, 1995, CURR OPIN CELL BIOL, V7, P697, DOI 10.1016/0955-0674(95)80112-X
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Khang D, 2008, J BIOMED MATER RES A, V86A, P253, DOI 10.1002/jbm.a.31803
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Knabe C, 2005, CLIN ORAL IMPLAN RES, V16, P119, DOI 10.1111/j.1600-0501.2004.01066.x
   Lian J B, 1995, Iowa Orthop J, V15, P118
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Namgung S, 2011, ACS NANO, V5, P7383, DOI 10.1021/nn2023057
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Reddy ARN, 2010, TOXICOLOGY, V272, P11, DOI 10.1016/j.tox.2010.03.017
   Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234
   Schofer MD, 2011, J MATER SCI-MATER M, V22, P1753, DOI 10.1007/s10856-011-4341-4
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Tsukahara T, 2011, MOL CELL BIOCHEM, V352, P57, DOI 10.1007/s11010-011-0739-z
   Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 30
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1933-6918
EI 1933-6926
J9 CELL ADHES MIGR
JI Celll Adhes. Migr.
PD SEP-OCT
PY 2014
VL 8
IS 5
BP 487
EP 492
DI 10.4161/19336918.2014.969999
PG 6
WC Cell Biology
SC Cell Biology
GA AZ8GD
UT WOS:000348452300008
PM 25482637
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Bhatia, R
AF Bhatia, Rajani
TI CROSS-BORDER SEX SELECTION: ETHICAL CHALLENGES POSED BY A GLOBALIZING
   PRACTICE
SO INTERNATIONAL JOURNAL OF FEMINIST APPROACHES TO BIOETHICS
LA English
DT Article
ID ASSISTED REPRODUCTIVE TECHNOLOGIES; UNITED-STATES; TOURISM; LEGAL
AB In this article, I examine reproductive travel for sex selection with reference to two distinct technologies-MicroSort and preimplantation genetic diagnosis (PGD). Available since the 1990s for sex-linked disease avoidance, I focus here on their imbrication in an emerging global form of nonmedical, lifestyle sex selection that elicits movements of information, biomaterial, patients, providers, and equipment across borders. This web of cross-border, interclinical, and laboratory transactions raises issues highly relevant to a feminist approach to the bioethics of sex selection. International documents, however, have yet to account for their implication in an increasingly stratified system of global sex selection practices.
C1 SUNY Albany, Dept Womens Gender & Sexual Studies, Albany, NY 12222 USA.
RP Bhatia, R (reprint author), SUNY Albany, Dept Womens Gender & Sexual Studies, Albany, NY 12222 USA.
FU University of Maryland Graduate School; Ann G. Wylie Dissertation
   Fellowship
FX In addition to the anonymous reviewers of IJFAB, I thank Dr. Bonnie
   Thornton Dill, Dr. Laura Mamo, Dr. Michelle Rowley, Dr. Carole McCann,
   Dr. Linda Aldoory, and Dr. Susan Dwyer. My research was supported by the
   University of Maryland Graduate School and the Ann G. Wylie Dissertation
   Fellowship.
CR Adamson D, 2005, FAM LAW QUART, V39, P727
   Alexander N.Hecht, 2001, HOUS J HLTH L POLY, P227
   Almond D, 2008, P NATL ACAD SCI USA, V105, P5681, DOI 10.1073/pnas.0800703105
   Baruch S, 2008, FERTIL STERIL, V89, P1053, DOI 10.1016/j.fertnstert.2007.05.048
   Baruch Susannah, 2008, HOUST J HLTH LAW POL, V8, P245
   Belkin Lisa, 1999, NY TIMES MAGAZINE
   Clarke A. E., 2010, BIOMEDICALIZATION TE
   Clarke A. E., 1998, DISCIPLINING REPROD
   Das Madhab, 2013, PRACTICAL GUIDE SETT, P181
   des Jardins Kathy, 2001, PARENT-SCI PRACT, V15, P110
   Dickens BM, 2005, INT J GYNECOL OBSTET, V90, P171, DOI 10.1016/j.ijgo.2005.05.001
   Dondorp W, 2013, HUM REPROD, V28, P1448, DOI 10.1093/humrep/det109
   *ETH COMM AM SOC R, 1999, FERTIL STERIL, V72, P595
   FIGO-International Federation of Gynecology and Obstetrics, 2005, RES SEX SEL NONM PUR
   Foggo D., 2006, SUNDAY TIMES
   Franklin S, 2006, BORN MADE ETHNOGRAPH
   Gender Baby, 2014, TRAV PAT
   Givan Alice Longobardi, 2001, FLOW CYTOMETRY 1 PRI
   Gokhale Ketaki, 2006, INDIA W         0630
   Government of Australia National Health and Medical Research Council, 2004, ETH GUID US ASS REPR
   Government of India, 1994, PREN DIAGN TECHN REG
   Government of the People's Republic of China, 1994, LAW MAT INF HLTH CAR
   Harding Sandra, 2006, SCI SOCIAL INEQUALIT
   HFEA-Human Fertilisation and Embryology Authority, HFEA COD PRACT
   HFEA-Human Fertilisation and Embryology Authority, 1995, HFEA COD PRACT
   Hvistendahl Mara, 2011, UNNATURAL SELECTION
   Ikemoto L.C., 2009, LAW INEQUALITY J THE, V27, P277
   Inhorn M. C., 2002, INFERTILITY GLOBE NE
   Inhorn MC, 2010, ASIA-PAC J PUBLIC HE, V22, p68S, DOI 10.1177/1010539510373007
   Johnson Carla K., 2006, CHICAGO DEFENDER, P38
   Klass Perri, 2001, VOGUE            MAR, P518
   Mamo L., 2010, BIOMEDICALIZATION TE, P173
   McGowan ML, 2013, SCI TECHNOL HUM VAL, V38, P271, DOI 10.1177/0162243912469412
   Medstar LLC, 2010, MICROSORT GEND SEL M
   Napoli Lisa, 2006, MARKETPLACE     0912
   Ouellette A, 2005, AM J LAW MED, V31, P419, DOI 10.1177/009885880503100402
   Oviedo Convention, 1997, EUR CONV HUM RIGHTS
   Pennings G, 2004, HUM REPROD, V19, P2689, DOI 10.1093/humrep/deh486
   Pennings G, 2009, REPROD BIOMED ONLINE, V18, pS15, DOI 10.1016/S1472-6483(10)60443-9
   Purdy L, 2007, REPROD BIOMED ONLINE, V15, P33, DOI 10.1016/S1472-6483(10)60547-0
   Roberts Dorothy E, 1997, KILLING BLACK BODY R
   Robertson JA, 2003, J MED ETHICS, V29, P213, DOI 10.1136/jme.29.4.213
   Robertson John A., 2001, American Journal of Bioethics, V1, P2, DOI 10.1162/152651601300048143
   Ryan MA, 2009, SIGNS, V34, P805, DOI 10.1086/597133
   Schulman J.D., 2010, RG EDWARDS PERSONAL
   Schulman Joseph D., 2007, WHY DO BAD INVESTMEN
   SCHUPPNER NC, 2010, MICH ST UJ MED L, V14, P443
   Seavilleklein V, 2007, CAMB Q HEALTHC ETHIC, V16, P7
   Shekar Preeti, 2007, COLORLINES, P23
   Spar Debora L., 2006, BABY BUSINESS MONEY
   Steinbock B, 2002, HASTINGS CENT REP, V32, P23, DOI 10.2307/3528293
   Theodosiou AA, 2011, REPROD BIOMED ONLINE, V22, P457, DOI 10.1016/j.rbmo.2011.01.008
   Thompson Jennifer Merrill, 2004, CHASING GENDER DREAM
   UN Women, 1996, 4 WORLD C WOM
   UNFPA, 1995, INT C POP DEV
   Van Hoof W, 2012, EUR J HEALTH LAW, V19, P187, DOI 10.1163/157180912X628226
   Van Hoof W, 2011, REPROD BIOMED ONLINE, V23, P546, DOI 10.1016/j.rbmo.2011.07.015
   Wadman Meredith, 2001, FORTUNE
   Westhorp Tanya, 2013, GOLD COAST B    0402
   Wilkinson S, 2013, EUGENICS ETHICS SELE
   World Health Organization, 2011, PREV GEND BIAS SEX S
NR 61
TC 1
Z9 1
U1 0
U2 7
PU UNIV TORONTO PRESS INC
PI TORONTO
PA JOURNALS DIVISION, 5201 DUFFERIN ST, DOWNSVIEW, TORONTO, ON M3H 5T8,
   CANADA
SN 1937-4585
EI 1937-4577
J9 INT J FEM APPROACHES
JI Int. J. Fem. Approaches Bioeth.
PD FAL
PY 2014
VL 7
IS 2
SI SI
BP 185
EP 218
PG 34
WC Ethics; Social Sciences, Biomedical; Women's Studies
SC Social Sciences - Other Topics; Biomedical Social Sciences; Women's
   Studies
GA CA2MQ
UT WOS:000348742900009
DA 2018-10-20
ER

PT J
AU Ohayon, L
AF Ohayon, Laurent
TI Maxillary Sinus Floor Augmentation Using Biphasic Calcium Phosphate: A
   Histologic and Histomorphometric Study
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE beta-tricalcium phosphate; bone substitute; histology; histomorphometry;
   hydroxyapatite; sinus floor augmentation
ID BETA-TRICALCIUM PHOSPHATE; IMPLANT PLACEMENT; BONE DEFECTS; BOVINE BONE;
   BIOMATERIALS; MANDIBLES; CERAMICS; PARTICULATE; RESORPTION; ALLOPLAST
AB Purpose: The aim of this study was to analyze the histologic quality and histomorphometric quantity of newly formed bone and the biologic properties after maxillary sinus floor augmentation with biphasic tricalcium phosphate (BCP) prior to dental implant placement. Materials and Methods: The selected alloplastic bone substitute, a blend of 60% hydroxyapatite and 40% beta-tricalcium phosphate, was placed into the sinus cavity and covered with a bioresorbable membrane. Ten bone samples were harvested from the grafted sinuses of eight patients at 6 months postsurgery for histologic and histomorphometric analysis during implant placement at stage-two surgery. Results: Histologic analysis of the 10 biopsy specimens showed remaining BCP particles in intimate contact with the newly formed bone. Several areas of bone substitute resorption and new bone remodeling were observed. The mean composition of the bone samples harvested from the grafted sinuses was 26.1% +/- 6.3% newly formed bone, 29.3% +/- 9.1% remaining BCP particles, and 44.7% +/- 7.7% connective tissue/bone marrow. Conclusion: BCP biomaterial was osteoconductive and biocompatible. This biomaterial scaffold promoted the formation of new bone, which was in intimate contact with the remaining bone substitute particles. Within the limits of this study, maxillary sinus floor augmentation using BCP bone substitute is a reliable procedure for dental implant placement.
RP Ohayon, L (reprint author), 25 Rue Varenne, F-94100 St Maur Des Fosses, France.
EM ohayonl@wanadoo.fr
CR Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   Bahat O, 2001, INT J PERIODONT REST, V21, P487
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Carcini F, 2005, J ORAL IMPLANTOL, V31, P39
   Chiapasco M, 2006, SINUS BONE GRAFT, P92
   Cordaro L, 2003, CLIN ORAL IMPLAN RES, V14, P201, DOI 10.1034/j.1600-0501.2003.140210.x
   Daculsi G, 1999, BONE, V25, p59S, DOI 10.1016/S8756-3282(99)00135-0
   Daculsi G, 1997, INT REV CYTOL, V172, P129, DOI 10.1016/S0074-7696(08)62360-8
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Detsch R, 2008, ACTA BIOMATER, V4, P139, DOI 10.1016/j.actbio.2007.03.014
   Fleckenstein KB, 2006, J PERIODONTOL, V77, P39, DOI 10.1902/jop.2006.77.1.39
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   HISLOP WS, 1993, BRIT J ORAL MAX SURG, V31, P149, DOI 10.1016/0266-4356(93)90113-B
   Hornez JC, 2007, BIOMOL ENG, V24, P505, DOI 10.1016/j.bioeng.2007.08.015
   Jensen OT, 2004, J ORAL MAXIL SURG, V62, P1423, DOI 10.1016/j.joms.2004.06.037
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Knapp CI, 2003, INT J PERIODONT REST, V23, P129
   Kolerman R, 2012, J ORAL MAXIL SURG, V70, P1835, DOI 10.1016/j.joms.2012.04.034
   Le Lorc'h-Bukiet I, 2005, CLIN ORAL IMPLAN RES, V16, P244, DOI 10.1111/j.1600-0501.2004.01102.x
   Lindgren C, 2012, CLIN IMPLANT DENT R, V14, P41, DOI 10.1111/j.1708-8208.2010.00224.x
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Ohayon L, 2011, INT J PERIODONT REST, V31, P237
   ROHRER MD, 1992, ORAL SURG ORAL MED O, V74, P73, DOI 10.1016/0030-4220(92)90218-F
   Schenk RK, 1984, METHODS CALCIFIED TI, P1
   Schopper Christian, 2003, Clin Oral Implants Res, V14, P743
   Schwartz Z, 1996, J PERIODONTOL, V67, P770
   Shirota T, 1996, J ORAL MAXIL SURG, V54, P15, DOI 10.1016/S0278-2391(96)90294-3
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   von Arx T, 2001, CLIN ORAL IMPLAN RES, V12, P260, DOI 10.1034/j.1600-0501.2001.012003260.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   YAMADA S, 1994, J BIOMED MATER RES, V28, P1357, DOI 10.1002/jbm.820281114
   Yukna Raymond A, 2003, J Oral Implantol, V29, P24, DOI 10.1563/1548-1336(2003)029<0024:UOHSBA>2.3.CO;2
NR 38
TC 10
Z9 10
U1 0
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2014
VL 29
IS 5
BP 1143
EP 1148
DI 10.11607/jomi.3422
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AW2LT
UT WOS:000346120200017
PM 25216141
OA Bronze
DA 2018-10-20
ER

PT J
AU Kim, D
   Choi, T
   Shim, S
   Kim, H
   Lim, S
AF Kim, Daehwan
   Choi, Taeyoung
   Shim, Sungyong
   Kim, Heekyung
   Lim, Sugun
TI Microstructures and Mechanical Properties of Mg-x%HA Composites
   Fabricated by Extrusion
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Biomaterial; Cold Isostatic Pressure; Extrusion; Mg-x%HA Composite
ID MAGNESIUM; ALLOYS
AB In this study, the effects of hydroxyapatite (HA) addition on the extrusion of Mg-x%HA composites were examined. To investigate the microstructures and mechanical properties of the alloy bars that are formed via extrusion, electron probe microanalysis, optical and scanning electron microscopy and a tensile testing were performed. The results demonstrated that increasing the amount of HA in the conposites caused an increase in the extrusion pressure experienced during direct extrusion and a decline in the mechanical properties of the extruded bars.
C1 [Kim, Daehwan; Choi, Taeyoung; Shim, Sungyong; Lim, Sugun] Gyeongsang Natl Univ, ReCAPT, Jinjudaero 501, Jinju, South Korea.
   [Kim, Heekyung] Dongil Met, Ulsan Metropoltan 689872, South Korea.
RP Lim, S (reprint author), Gyeongsang Natl Univ, ReCAPT, Jinjudaero 501, Jinju, South Korea.
EM suglim@gnu.ac.kr
FU Basic Science Research Program through National Research Foundation of
   Korea (NRF) - Ministry of Education, Science, and Technology
   [2012-0001575]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Science, and Technology (2012-0001575).
CR Bazaka K, 2014, J NANOSCI NANOTECHNO, V14, P8087, DOI 10.1166/jnn.2014.9409
   Dieter G. E., 1986, MECH METALLURGY, P629
   German R. M., 1998, POWDER METALLURGY IR, P128
   German R. M., 2010, POWDER METALLURGY PA, V101
   Griffiths H., 2004, BR J CARDIOL, V11, P80
   Gu X., 2009, BIOMATERIALS, V3, P484
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hiromoto S, 2008, CORROS SCI, V50, P2906, DOI 10.1016/j.corsci.2008.08.013
   Jung G. I, 2010, KOREAN IND CHEM NEWS, V13, P18
   Kim Y. S., 2005, J KOREAN HIP SOC, V17, P6
   Lee GJ, 2014, J NANOSCI NANOTECHNO, V14, P221, DOI 10.1166/jnn.2014.9105
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Oh IK, 2014, J NANOSCI NANOTECHNO, V14, P7361, DOI 10.1166/jnn.2014.9546
   SUMNER DR, 1992, CLIN ORTHOP RELAT R, P202
NR 14
TC 2
Z9 2
U1 0
U2 12
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD SEP
PY 2014
VL 6
IS 9
BP 2001
EP 2004
DI 10.1166/sam.2014.2104
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AT6QC
UT WOS:000345062800011
DA 2018-10-20
ER

PT J
AU Zhang, J
   Deng, SJ
   Liu, SY
   Chen, JM
   Han, BQ
   Wang, Y
   Wang, YD
AF Zhang, J.
   Deng, S. J.
   Liu, S. Y.
   Chen, J. M.
   Han, B. Q.
   Wang, Y.
   Wang, Y. D.
TI Preparation and photocatalytic activity of Nd doped ZnO nanoparticles
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Nd doped; ZnO; Nanoparticles; Photocatalysis; Cong red
ID VISIBLE-LIGHT IRRADIATION; FERRITE COMPOSITE NANOPARTICLES; RAY
   PHOTOELECTRON-SPECTROSCOPY; BIOMATERIAL SYSTEM; MAGNETIC CORE;
   ANTIMICROBIAL ACTIVITY; METHYL-ORANGE; AZO-DYE; DEGRADATION;
   DECOLORIZATION
AB As an important II-VI semiconductor, zinc oxide has attracted a great deal of attention as a photocatalytic material. The quick recombination of charge carriers is the main factor influencing the photocatalytic activity of ZnO. In order to improve the photocatalytic activity, different kinds of ions were doped into ZnO by different methods to inhibit the recombination of photoinduced electrons and holes. Nd doped ZnO study is mainly on the optical performances. However, the Nd-ZnO nanoparticles have reported little work on the photodegradation of organic contaminants under visible light irradiation. In this paper, the mainly research is focused on the preparation process and removal properties of organic pollutants Cong red from the wastewater using the Nd doped zinc oxide nanoparticles. The proposed research investigates the Nd doped zinc oxide nanoparticles with varied Nd content that are important in understanding the structure, morphology and the photocatalytic performances. The undoped and Nd doped zinc oxide nanoparticles were prepared by sol-gel technique using zinc acetate dehydrate and dysprosium chloride and neodymium chloride as precursor. X-ray diffraction (XRD) spectra, scanning electron microscopy (SEM), transmission electron microscopy (TEM), and X-ray photoelectron spectroscopy (XPS) were used to examine the morphology and microstructure of the nanoparticles. The analysed results indicate that the nanoparticles have a pure hexagonal wurtzite ZnO structure with the good crystal quality and the Nd ion was in a 3+ charge state in the crystal lattice of ZnO. The performance of Nd doped ZnO powders as efficient photocatalyst was further demonstrated in the degradation of Cong red (CR) under visible light irradiation. The Nd doped ZnO nanoparticles show good photocatalytic activity during the degradation of CR under visible light. It was found that an appropriate amount of Nd dopant can greatly increase photocatalytic activity and the sample with 4% Nd doping exhibits the highest photocatalytic efficiency.
C1 [Zhang, J.; Deng, S. J.; Chen, J. M.; Han, B. Q.; Wang, Y.; Wang, Y. D.] Yunnan Univ, Sch Phys Sci & Technol, Kunming 650091, Peoples R China.
   [Liu, S. Y.] Henan Normal Univ, Xinlian Coll, Dept Mech Engn, Zhengzhou 451464, Peoples R China.
RP Wang, YD (reprint author), Yunnan Univ, Sch Phys Sci & Technol, Kunming 650091, Peoples R China.
EM ydwang@ynu.edu.cn
RI Wang, Yude/G-6188-2012
FU Department of Science and Technology of Yunnan Province via Key Project
   for the Science and Technology [2011FA001]; National Natural Science
   Foundation of China [51262029]; Key Project of the Department of
   Education of Yunnan Province [ZD2013006]; State Key Laboratory of
   Silicon Materials [SKL2012-16]
FX This work was supported by the Department of Science and Technology of
   Yunnan Province via the Key Project for the Science and Technology
   (grant no. 2011FA001), National Natural Science Foundation of China
   (grant no. 51262029),, the Key Project of the Department of Education of
   Yunnan Province (ZD2013006), and the State Key Laboratory of Silicon
   Materials visiting scholar Fund (grant no. SKL2012-16).
CR Armelao L, 2008, J PHYS CHEM C, V112, P4049, DOI 10.1021/jp710207r
   Asuha S, 2010, J HAZARD MATER, V181, P204, DOI 10.1016/j.jhazmat.2010.04.117
   Bai XL, 2008, CHINESE J CHEM PHYS, V21, P81, DOI 10.1088/1674-0068/21/01/81-86
   Cai XY, 2013, J PHYS CHEM SOLIDS, V74, P1196, DOI 10.1016/j.jpcs.2013.03.016
   Cao YQ, 2010, BIOELECTROCHEMISTRY, V79, P71, DOI 10.1016/j.bioelechem.2009.12.001
   CARLIELL CM, 1995, WATER SA, V21, P61
   Chang JS, 2001, WATER RES, V35, P2841, DOI 10.1016/S0043-1354(00)00581-9
   Chen M, 2000, APPL SURF SCI, V158, P134, DOI 10.1016/S0169-4332(99)00601-7
   Chen M, 2011, J PHYS CHEM C, V115, P12763, DOI 10.1021/jp201816d
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Dadd A., 2009, MATER CHEM PHYS, V114, P382
   Dhananjay S.D., 2001, J CHEM TECHNOL BIOT, V77, P102, DOI DOI 10.1002/JCTB.532
   Dindar S., 2001, PHOTOCHEM PHOTOBIO A, V140, P263
   Dixit SG, 1998, COLLOID SURFACE A, V133, P69, DOI 10.1016/S0927-7757(97)00126-X
   Donkova B, 2010, MATER CHEM PHYS, V123, P563, DOI 10.1016/j.matchemphys.2010.05.015
   Fu TH, 2010, CHINESE J CATAL, V31, P797, DOI 10.3724/SP.J.1088.2010.91220
   Hu JS, 2008, ADV MATER, V20, P2977, DOI 10.1002/adma.200800623
   Ince N. H, 1997, J ADV OXID TECHNOL, V2, P442
   Jia Z, 2013, MATER TECHNOL, V28, P221, DOI 10.1179/1753555713Y.0000000061
   Khodja AA, 2001, J PHOTOCH PHOTOBIO A, V141, P231, DOI 10.1016/S1010-6030(01)00423-3
   Kumar S, 2012, J RARE EARTH, V30, P761, DOI 10.1016/S1002-0721(12)60126-4
   Liao DL, 2008, J PHOTOCH PHOTOBIO A, V194, P11, DOI 10.1016/j.jphotochem.2007.07.008
   Lin JC, 2008, THIN SOLID FILMS, V516, P5349, DOI 10.1016/j.tsf.2007.07.096
   Liu H, 2000, J PHYS CHEM A, V104, P7016, DOI 10.1021/jp000171q
   Nadia R., 2011, P 2 INT C ENV SCI TE
   Panda N, 2011, J HAZARD MATER, V185, P359, DOI 10.1016/j.jhazmat.2010.09.042
   Qiu RL, 2008, J HAZARD MATER, V156, P80, DOI 10.1016/j.jhazmat.2007.11.114
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Robinson T, 2001, BIORESOURCE TECHNOL, V77, P247, DOI 10.1016/S0960-8524(00)00080-8
   Rott U, 1999, WATER SCI TECHNOL, V40, P137, DOI 10.1016/S0273-1223(99)00381-9
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Vaishampayan MV, 2011, MATER RES BULL, V46, P771, DOI 10.1016/j.materresbull.2010.11.007
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang JP, 2012, ACS APPL MATER INTER, V4, P4024, DOI 10.1021/am300835p
   Xiao Q, 2009, J ALLOY COMPD, V479, pL4, DOI 10.1016/j.jallcom.2008.12.085
   Yan XL, 2011, PHYSICA B, V406, P3956, DOI 10.1016/j.physb.2011.07.037
   Zhang ZH, 2011, APPL SURF SCI, V257, P7461, DOI 10.1016/j.apsusc.2011.03.015
   Zhao J, 2011, MATER RES BULL, V46, P1207, DOI 10.1016/j.materresbull.2011.04.008
   Zheng JH, 2012, CRYST RES TECHNOL, V47, P713, DOI 10.1002/crat.201200026
   Zhou Y, 2009, ENVIRON PROG SUSTAIN, V28, P226, DOI 10.1002/ep.10318
   Zhu HY, 2009, J HAZARD MATER, V169, P933, DOI 10.1016/j.jhazmat.2009.04.037
   Zollinger H, 1991, COLOR CHEM SYNTHESES
NR 46
TC 11
Z9 11
U1 2
U2 43
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD SEP
PY 2014
VL 29
IS 5
BP 262
EP 268
DI 10.1179/1753555713Y.0000000122
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AT1SP
UT WOS:000344714600002
DA 2018-10-20
ER

PT J
AU Khan, SG
   Herrmann, G
   Al Grafi, M
   Pipe, T
   Melhuish, C
AF Khan, Said G.
   Herrmann, Guido
   Al Grafi, Mubarak
   Pipe, Tony
   Melhuish, Chris
TI Compliance Control and Human-Robot Interaction: Part 1-Survey
SO INTERNATIONAL JOURNAL OF HUMANOID ROBOTICS
LA English
DT Review
DE Compliance; impedance; humanoids; optimal adaptive control; HRI; pHRI
ID MOTION CONTROL; FORCE CONTROL; PASSIVE COMPLIANCE; ACTIVE COMPLIANCE;
   SOFT ROBOTICS; HUMAN ARM; MANIPULATORS; DESIGN; ACTUATION; SYSTEMS
AB Compliance control is highly relevant to human safety in human robot interaction (HRI). This paper presents a review of various compliance control techniques. The paper is aimed to provide a good background knowledge for new researchers and highlight the current hot issues in compliance control research. Active compliance, passive compliance, adaptive and reinforcement learning-based compliance control techniques are discussed. This paper provides a comprehensive literature survey of compliance control keeping in view physical human robot interaction (pHRI) e.g., passing an object, such as a cup, between a human and a robot. Compliance control may eventually provide an immediate and effective layer of safety by avoiding pushing, pulling or clamping in pHRI. Emerging areas such as soft robotics, which exploit the deformability of biomaterial as well as hybrid approaches which combine active and passive compliance are also highlighted.
C1 [Khan, Said G.] Taibah Univ, Coll Engn Yanbu, Dept Mech Engn, Al Madina, Saudi Arabia.
   [Herrmann, Guido] Univ Bristol, Bristol Robot Lab, Bristol B58 1TR, Avon, England.
   [Herrmann, Guido] Univ Bristol, Dept Mech Engn, Bristol B58 1TR, Avon, England.
   [Al Grafi, Mubarak] Taibah Univ, Medina, Saudi Arabia.
   [Pipe, Tony] Univ W England, Bristol Robot Lab, Bristol BS16 1QY, Avon, England.
   [Melhuish, Chris] Univ Bristol, Bristol Robot Lab, Bristol BS16 1QY, Avon, England.
   [Melhuish, Chris] Univ W England, Bristol BS16 1QY, Avon, England.
RP Khan, SG (reprint author), Taibah Univ, Coll Engn Yanbu, Dept Mech Engn, Al Madina, Saudi Arabia.
EM engr_ghani@hotmail.com; g.herrmann@Bristol.ac.uk
OI Herrmann, Guido/0000-0001-5390-4538
FU European Community [215805]; CHRIS project
FX The research leading to these results has received funding from the
   European Community's Information and Communication Technologies Seventh
   Framework Programme [FP7/2007.2013] under grant agreement no. [215805],
   the CHRIS project.
CR Ahmed Muhammad Rehan, 2010, 2010 IEEE International Conference on Mechatronics and Automation (ICMA), P1932, DOI 10.1109/ICMA.2010.5589111
   Al-Jarrah OM, 1998, IEEE T SYST MAN CY B, V28, P116, DOI 10.1109/3477.658590
   Alami R., 2006, P IROS WORKSH PHRI P
   Albu-Schaffer A, 2007, IND ROBOT, V34, P376, DOI 10.1108/01439910710774386
   Albu-Schaffer A, 2008, IEEE ROBOT AUTOM MAG, V15, P20, DOI 10.1109/MRA.2008.927979
   Albu-Schaffer A, 2011, SPRINGER TRAC ADV RO, V70, P185
   Albu-Schaffer A., 2004, P ICRA 04 2004 IEEE, V3
   Albu-Schaffer A., 2003, P IEEE INT C ROB AUT, V3, P3704
   Aslam P., 2008, J MECH SCI TECHNOL, V22, P469
   Astrom K. J., 1996, IEEE CONTROL SYST, V16, P44
   ASTROM KJ, 1983, AUTOMATICA, V19, P471, DOI 10.1016/0005-1098(83)90002-X
   Bauer A, 2008, INT J HUM ROBOT, V5, P47, DOI 10.1142/S0219843608001303
   Berkelman P., 2000, IEEE INT C ROB AUT I, V1, P610
   Beyl P., 2006, NCTAM06 7 NAT C THEO
   BICHI A, 2002, P IARP RAS WORKSH TE, P79
   Braun DJ, 2013, IEEE T ROBOT, V29, P1085, DOI 10.1109/TRO.2013.2271099
   Buchli J., 2010, ROBOTICS SCI SYSTEMS, V30, P820
   Caldwell DG, 2007, INT J HUM ROBOT, V4, P549, DOI 10.1142/S0219843607001151
   Chakarov D., 2004, P 4 BALT BULG C BION, P88
   Chien MC, 2004, ROBOTICA, V22, P395, DOI 10.1017/S0263574704000190
   Choi J, 2011, IEEE T ROBOT, V27, P229, DOI 10.1109/TRO.2010.2100450
   Choi J, 2009, IEEE INT CONF ROBOT, P3392
   Colbaugh R, 1996, IEEE DECIS CONTR P, P394, DOI 10.1109/CDC.1996.574342
   COLBAUGH R, 1995, INT J ROBOT RES, V14, P270, DOI 10.1177/027836499501400305
   Colbaugh R, 1996, INT J ROBOT AUTOM, V11, P1
   Conti F., 2014, SPRINGER TRACTS ADV, V79, P97
   De Schutter J., 1987, IEEE INT C ROB AUT, V4, P1060
   Edsinger A., 2007, 16 IEEE INT C ROB HU, V2, P1167
   Filaretov VF, 2008, IEEE ASME INT C ADV, P96, DOI 10.1109/AIM.2008.4601641
   Filippini R., 2008, IEEE ROBOT AUTOM MAZ, V15
   Formica D, 2006, J DYN SYST-T ASME, V128, P152, DOI 10.1115/1.2173009
   FORMICA D, 2005, P 2005 IEEE 9 INT C, P341
   Garcia E, 2011, ROBOT AUTON SYST, V59, P827, DOI 10.1016/j.robot.2011.06.006
   Goldman RE, 2011, IEEE INT CONF ROBOT, P1126
   Goris K, 2011, INT J HUM ROBOT, V8, P481, DOI 10.1142/S0219843611002563
   Grunwald G., 2003, IEEE T IND ELECTRON, V50, P510
   Haddadin S., 2011, 2011 IEEE Workshop on Advanced Robotics and its Social Impacts (ARSO), P72, DOI 10.1109/ARSO.2011.6301962
   Ham R., 2009, ROBOTICS AUTOMATION, V16, P81, DOI DOI 10.1109/MRA.2009.933629
   Ham W., 1998, P 37 SICE ANN C, P843
   Hirzinger G., 1983, IFAC S REAL TIM DIG, P1060
   Iida F., 2011, EUR TECHN C EXH 2011, P689
   Je HW, 2011, INT J PRECIS ENG MAN, V12, P251, DOI 10.1007/s12541-011-0034-7
   Jiang ZH, 2005, J INTELL ROBOT SYST, V42, P113, DOI 10.1007/s10846-005-0933-x
   Jin ML, 2008, IEEE T IND ELECTRON, V55, P258, DOI 10.1109/TIE.2007.906132
   Jo J., 2011, 2011 8 INT C UB ROB, P446
   Kang SC, 1997, IEEE INT CONF ROBOT, P841, DOI 10.1109/ROBOT.1997.620139
   Khan S. G., 2011, IEEE INT C CIS RAM 2
   KHATIB O, 1987, IEEE T ROBOTIC AUTOM, V3, P43, DOI 10.1109/JRA.1987.1087068
   Khatib O., 1986, P IEEE INT C ROB AUT, V3, P1381
   Kim BH, 2000, KSME INT J, V14, P1081, DOI 10.1007/BF03185062
   Kim B, 2010, IEEE T SYST MAN CY B, V40, P433, DOI 10.1109/TSMCB.2009.2026289
   Koeppe R, 2003, SPRINGER TRAC ADV RO, V6, P207
   Komada S., 1988, P INT C IND EL
   Koonjul G. S., 2011, 2011 IEEE INT C ROB, P489
   Kosaki T., 2011, J INT AUTOM TECHNOL, V5, P493
   Kosuge K, 2004, IEEE ROBIO 2004: PROCEEDINGS OF THE IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, P8
   Kroger T., 2011, ROBOT SYST HANDLING, V67, P293
   Kruger J, 2011, CIRP ANN-MANUF TECHN, V60, P5, DOI 10.1016/j.cirp.2011.03.017
   Kuan CP, 1998, J INTELL ROBOT SYST, V23, P165, DOI 10.1023/A:1008083631190
   Lefebvre T, 2005, ADV ROBOTICS, V19, P479, DOI 10.1163/156855305323383767
   Lewis F. L., 2003, ROBOT MANIPULATOR CO
   Low SC, 2006, INT J HUM ROBOT, V3, P547, DOI 10.1142/S0219843606000904
   Luo R. C., 2011, 2011 8 AS AS CONTR C, P1193
   Ma D., 2011, 2011 IEEE INT C ROB, V2366-2371
   Majidi C, 2014, SOFT ROBOT, V1, P5, DOI 10.1089/soro.2013.0001
   Nakamura T, 2011, INT J HUM ROBOT, V8, P205, DOI 10.1142/S021984361100240X
   NIEMEYER G, 1989, PROCEEDINGS - 1989 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOL 1-3, P566, DOI 10.1109/ROBOT.1989.100045
   Niemeyer G., 1990, Proceedings of the 1990 American Control Conference (IEEE Cat. No.90CH2896-9), P234
   Ott C., 2003, P IEEE INT C ROB AUT
   Ott C., 2004, P IEEE INT C ROB AUT, V3, P2659
   Ott C., 2004, 2004 IEEE INT C ROB, V3, P2659
   Ott C, 2008, IEEE T ROBOT, V24, P416, DOI 10.1109/TRO.2008.915438
   Ott C, 2010, IEEE INT CONF ROBOT, P554, DOI 10.1109/ROBOT.2010.5509861
   Ott C, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3244, DOI 10.1109/IROS.2009.5354136
   Paul P. R., 1976, P 1976 JOINT AUT CON, P694
   Pelletier M., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P78, DOI 10.1109/ROBOT.1990.125949
   PENG ZX, 1993, IEEE T ROBOTIC AUTOM, V9, P831, DOI 10.1109/70.265926
   Petit F, 2011, IEEE INT C INT ROBOT, P4180, DOI 10.1109/IROS.2011.6048341
   Potkonjak Veljko, 2011, 2011 19th Mediterranean Conference on Control & Automation (MED 2011), P1059
   PRATT GA, 1995, IROS '95 - 1995 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS: HUMAN ROBOT INTERACTION AND COOPERATIVE ROBOTS, PROCEEDINGS, VOL 1, P399, DOI 10.1109/IROS.1995.525827
   Rahman MM, 2002, JSME INT J C-MECH SY, V45, P510, DOI 10.1299/jsmec.45.510
   Roy J, 2002, IEEE T ROBOTIC AUTOM, V18, P121, DOI 10.1109/TRA.2002.999642
   Salisbury J., 1980, 19 IEEE C DEC CONTR, V19, P95, DOI 10.1109/CDC.1980.272026
   Sardellitti I., 2007, IEEE RSJ INT C INT R, P1822, DOI DOI 10.1109/IROS.2007.4399073
   Sastry Shankar, 1994, PRENTICE HALL ADV RE
   Schiavi R, 2009, IEEE INT CONF ROBOT, P2471
   SERAJI H, 1994, IEEE INT CONF ROBOT, P2705, DOI 10.1109/ROBOT.1994.350927
   SERAJI H, 1994, ADAPTIVE COMPLIANCE
   SHETTY B, 1996, P IEEE INT C ROB AUT
   Siciliano B, 1996, CONTROL ENG PRACT, V4, P705, DOI 10.1016/0967-0661(96)00054-8
   Siciliano B, 2009, ADV TXB CONTR SIG PR, P1
   Slotine J.-J E, 1991, APPL NONLINEAR CONTR
   Stokes AA, 2014, SOFT ROBOT, V1, P70, DOI 10.1089/soro.2013.0002
   Teti G., 2002, P ICRA 02 IEEE INT C, V2, P1434
   Tsetserukou D, 2009, INT J HUM ROBOT, V6, P699, DOI 10.1142/S0219843609001899
   Tsumugiwa T, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P644, DOI 10.1109/ROBOT.2002.1013431
   Vanderborght B, 2011, AUTON ROBOT, V31, P55, DOI 10.1007/s10514-011-9230-7
   Vasic M., 2013, P 2013 IEEE RAS INT
   VICK A, 2013, P 9 INT WORKSH ROB M, P264
   Villani L., 1999, KLUWER INT SERIES EN
   Villani L., 2013, ROMANSY 19 ROBOT DES, V544, P193
   VISCHER D, 1995, IEEE T ROBOTIC AUTOM, V11, P537, DOI 10.1109/70.406938
   von Albrichsfeld C, 2002, CONTROL ENG PRACT, V10, P165, DOI 10.1016/S0967-0661(01)00112-5
   von Albrichsfeld C., 1995, P 3 EUR CONTR C ECC, V3, P1900
   von Albrichsfeld C., 1996, P WORLD AUT C WAC 96, V3, P765
   Wang W, 1998, IND ROBOT, V25, P48, DOI 10.1108/01439919810196964
   Whitney D.E., 1985, P 1985 IEEE INT C RO, V2, P262, DOI DOI 10.1109/ROBOT.1985.1087266
   Wu C., 1993, P INT S INT CONTR
   Yang CG, 2011, IEEE T ROBOT, V27, P918, DOI 10.1109/TRO.2011.2158251
   YANG JH, 1995, IEEE INT CONF ROBOT, P603, DOI 10.1109/ROBOT.1995.525350
   ZHANG W, 2005, P 2005 IEEE INT C IN
   Zinn M, 2004, IEEE ROBOT AUTOM MAG, V11, P12, DOI 10.1109/MRA.2004.1310938
   Zollo L, 2005, J DYN SYST-T ASME, V127, P321, DOI 10.1115/1.1978911
   Zollo L, 2003, ROBOT AUTON SYST, V44, P101, DOI 10.1016/S0921-8890(03)00042-3
   Zollo L., 2002, IEEE RSJ INT C INT R, V3, P2268
   Zollo L., 2002, P IEEE INT C ROB AUT
   Zollo L., 2001, P IEEE RSJ INT C INT, V4, P2221
NR 117
TC 3
Z9 3
U1 4
U2 88
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0219-8436
EI 1793-6942
J9 INT J HUM ROBOT
JI Int. J. Humanoid Robot.
PD SEP
PY 2014
VL 11
IS 3
AR 1430001
DI 10.1142/S0219843614300013
PG 28
WC Robotics
SC Robotics
GA AS0UH
UT WOS:000343993500001
DA 2018-10-20
ER

PT J
AU McGarvey, JR
   Pettaway, S
   Shuman, JA
   Novack, CP
   Zellars, KN
   Freels, PD
   Echols, RL
   Burdick, JA
   Gorman, JH
   Gorman, RC
   Spinale, FG
AF McGarvey, Jeremy R.
   Pettaway, Sara
   Shuman, James A.
   Novack, Craig P.
   Zellars, Kia N.
   Freels, Parker D.
   Echols, Randall L., Jr.
   Burdick, Jason A.
   Gorman, Joseph H., III
   Gorman, Robert C.
   Spinale, Francis G.
TI Targeted Injection of a Biocomposite Material Alters Macrophage and
   Fibroblast Phenotype and Function following Myocardial Infarction:
   Relation to Left Ventricular Remodeling
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID HEART-FAILURE; CARDIAC MACROPHAGES; INFLAMMATION; HETEROGENEITY;
   ACTIVATION; MECHANISMS; EXPANSION; PATHWAYS; MONOCYTE; MODULATE
AB A treatment target for progressive left ventricular (LV) remodeling prevention following myocardial infarction (MI) is to affect structural changes directly within the MI region. One approach is through targeted injection of biocomposite materials, such as calcium hydroxyapatite microspheres (CHAM), into the MI region. In this study, the effects of CHAM injections upon key cell types responsible for the MI remodeling process, the macrophage and fibroblast, were examined. MI was induced in adult pigs before randomization to CHAM injections (20 targeted 0.1-ml injections within MI region) or saline. At 7 or 21 days post-MI (n = 6/time point per group), cardiac magnetic resonance imaging was performed, followed by macrophage and fibroblast isolation. Isolated macrophage profiles for monocyte chemotactic macrophage inflammatory protein-1 as measured by real-time polymerase chain reaction increased at 7 days post-MI in the CHAM group compared with MI only (16.3 +/- 6.6 versus 1.7 +/- 0.6 cycle times values, P < 0.05), and were similar by 21 days post-MI. Temporal changes in fibroblast function and smooth muscle actin (SMA) expression relative to referent control (n = 5) occurred with MI. CHAM induced increases in fibroblast proliferation, migration, and SMA expression-indicative of fibroblast transformation. By 21 days, CHAM reduced LV dilation (diastolic volume: 75 +/- 2 versus 97 +/- 4 ml) and increased function (ejection fraction: 48 +/- 2% versus 38 +/- 2%) compared with MI only (both P < 0.05). This study identified that effects on macrophage and fibroblast differentiation occurred with injection of biocomposite material within the MI, which translated into reduced adverse LV remodeling. These unique findings demonstrate that biomaterial injections impart biologic effects upon the MI remodeling process over any biophysical effects.
C1 [Pettaway, Sara; Shuman, James A.; Novack, Craig P.; Zellars, Kia N.; Freels, Parker D.; Echols, Randall L., Jr.; Spinale, Francis G.] Univ S Carolina, Sch Med, Cardiovasc Translat Res Ctr, Columbia, SC USA.
   [Pettaway, Sara; Shuman, James A.; Novack, Craig P.; Zellars, Kia N.; Freels, Parker D.; Echols, Randall L., Jr.; Spinale, Francis G.] WJB Dorn Vet Affairs Med Ctr, Columbia, SC USA.
   [Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [McGarvey, Jeremy R.; Gorman, Joseph H., III; Gorman, Robert C.] Univ Penn, Dept Surg, Gorman Cardiovasc Res Grp, Philadelphia, PA 19104 USA.
RP Spinale, FG (reprint author), Univ S Carolina, Sch Med, Cardiovasc Translat Res Ctr, CBA, 6439 Garners Ferry Rd, Columbia, SC 29208 USA.
EM cvctrc@uscmed.sc.edu
FU National Institutes of Health National Heart, Lung, and Blood Institute
   [HL095608, HL111090, HL063954]; Veterans' Affairs Health Administration;
   National Institutes of Health [T32-HL007954]
FX This work was supported by the National Institutes of Health National
   Heart, Lung, and Blood Institute [Grants HL095608, HL111090, and
   HL063954]; and a Merit Award from the Veterans' Affairs Health
   Administration. J.A.B. was supported by a National Institutes of Health
   grant [Grant T32-HL007954].
CR Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126
   Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3003997
   Chapman RE, 2003, J MOL CELL CARDIOL, V35, P539, DOI 10.1016/S0022-2828(03)00077-4
   Cohen HB, 2014, IMMUNITY, V40, P3, DOI 10.1016/j.immuni.2013.12.005
   Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a
   Dixon JA, 2011, CIRCULATION, V124, pS35, DOI 10.1161/CIRCULATIONAHA.111.035774
   Dixon JA, 2010, AM J PHYSIOL-HEART C, V299, pH1947, DOI 10.1152/ajpheart.00314.2010
   Eckhouse SR, 2014, SCI TRANSL MED, V6, P223
   Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019
   Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011
   Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012
   Hohensinner PJ, 2010, THROMB HAEMOSTASIS, V103, P435, DOI 10.1160/TH09-06-0399
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720
   Jacovella PF, 2008, CLIN INTERV AGING, V3, P161, DOI 10.2147/CIA.S2065
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008
   Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lindsey M, 2001, CIRCULATION, V103, P2181
   Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029
   Ma YG, 2013, CIRC RES, V112, P675, DOI 10.1161/CIRCRESAHA.111.300502
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890
   Pilla JJ, 2009, ANN THORAC SURG, V87, P803, DOI 10.1016/j.athoracsur.2008.11.044
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Rodell CB, 2013, BIOMACROMOLECULES, V14, P4125, DOI 10.1021/bm401280z
   Shumaker PR, 2006, LASER SURG MED, V38, P211, DOI 10.1002/lsm.20292
   Shuman JA, 2013, TRENDS CARDIOVAS MED, V23, P301, DOI 10.1016/j.tcm.2013.04.004
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Spinale FG, 2013, CIRC RES, V112, P195, DOI 10.1161/CIRCRESAHA.112.266882
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tous E, 2012, ACTA BIOMATER, V8, P3218, DOI 10.1016/j.actbio.2012.05.027
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331
   Webb CS, 2006, CIRCULATION, V114, P1020, DOI 10.1161/CIRCULATIONAHA.105.600353
   Widgerow AD, 2011, WOUND REPAIR REGEN, V19, P117, DOI 10.1111/j.1524-475X.2010.00662.x
   Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015
NR 43
TC 12
Z9 12
U1 0
U2 7
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD SEP
PY 2014
VL 350
IS 3
BP 701
EP 709
DI 10.1124/jpet.114.215798
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AS8DZ
UT WOS:000344481600008
PM 25022514
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Honsho, CD
   Cardoso, KCD
   Quarterone, C
   Franco, LG
   Brunelli, ATJ
   Dias, FGG
   Magalhaes, GM
AF Honsho, Cristiane dos Santos
   de Freitas Cardoso, Karym Christine
   Quarterone, Carolina
   Franco, Leandro Guimaraes
   Jorge Brunelli, Adriana Torrecilhas
   Goncalves Dias, Fernanda Gosuen
   Magalhaes, Georgia Mode
TI Temporary occlusion of the inferior lacrimal punctum and canaliculi of
   dogs with n-butyl-cyanoacrylate and 2-octyl-cyanoacrylate
SO CIENCIA RURAL
LA English
DT Article
DE biomaterial; keratoconjunctivitis sicca; tear
ID TEAR PRODUCTION; DRY EYE; ADHESIVE
AB The occlusion of the inferior lacrimal punctum limits tear drainage and thus keeps it over the ocular surface, prolongs lubrication and minimizes the need of ocular lubricants. The aim of this study was to evaluate the effectiveness of n-butyl-cyanoacrylate and 2-octyl-cyanoacrylate adhesives in the occlusion of the inferior lacrimal punctum and canaliculi of dogs and their clinical repercussions over 180 days. Eleven dogs, were divided into two groups: occlusion with n-butyl-cyanoacrylate (GB, n=6) and with 2-oczyl-cyanoacrylate (GO, n=5). Tear production, blepharospasm, ocular discharge, epiphora and conjunctival hyperemia were analyzed before the procedure and on days (7) 3,7,15, 30, 45, 60, 90, 120, 150 and 180 after the procedure. Tear production of GB was significantly higher at T90 (P=0.0282) than its control. Variations between days showed that T7 (P=0.0069) and T180 (P=0.0207) varied significantly from TO. In the GO group, when treatment was compared to control, T15 (P<0.001) was significantly different from the rest. Variations between days showed that T15 was significantly different than TO (P=0.0044), T3 (P=0.0234), T60 (P=0.0207) and T90 (P=0.0482). No significant difference was observed between the treatment groups at any given time. It was concluded that both adhesives were effective in occluding lacrimal drainage for long periods and could thus be considered as therapeutic options in treating animals with lacrimal deficiency.
C1 [Honsho, Cristiane dos Santos; de Freitas Cardoso, Karym Christine; Jorge Brunelli, Adriana Torrecilhas; Magalhaes, Georgia Mode] Univ Franca, Programa Posgrad Med Vet Pequenos Anim, BR-14404600 Franca, SP, Brazil.
   [Quarterone, Carolina] Univ Estadual Paulista, Programa Posgrad Anestesiol Vet, Botucatu, SP, Brazil.
   [Franco, Leandro Guimaraes] Univ Estadual Santa Cruz, Programa Posgrad Ciencia Anim, Ilheus, BA, Brazil.
   [Goncalves Dias, Fernanda Gosuen] Univ Franca, Programa Posgrad Ciencias, BR-14404600 Franca, SP, Brazil.
RP Honsho, CD (reprint author), Univ Franca, Programa Posgrad Med Vet Pequenos Anim, R Dr Armando Salles Oliveira,201 Pq Univ, BR-14404600 Franca, SP, Brazil.
EM cristiane.honsho@unifran.edu.br
RI Dias, Fernanda/Q-9838-2017
OI Dias, Fernanda/0000-0001-6072-4789; SANTOS HONSHO,
   CRISTIANE/0000-0002-5307-8552
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
FX The authors would like to thank the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) for their support alongside the
   Programa de Suporte a Pos-Graduacao de Instituicoes de Ensino
   Particulares (PROSUP).
CR *AVRO, STATEMENT FOR THE US
   Berger SL, 1998, J AM ANIM HOSP ASSOC, V34, P79, DOI 10.5326/15473317-34-1-79
   Cardoso KCF, 2013, ARQ BRAS MED VET ZOO, V65, P1729, DOI 10.1590/S0102-09352013000600021
   DIAMOND JP, 1995, EYE, V9, P126, DOI 10.1038/eye.1995.21
   El-Dars LD, 2010, CONTACT DERMATITIS, V62, P315, DOI 10.1111/j.1600-0536.2010.01720.x
   Gagnaire FS, 2003, ANN OCCUP HYG, V47, P297, DOI 10.1093/annhyg/meg038
   Gelatt KN, 2006, VET OPHTHALMOL, V9, P23, DOI 10.1111/j.1463-5224.2005.00430.x
   GELATT KN, 2007, VETERINARY OPHTHALMO
   Hartley C, 2006, VET OPHTHALMOL, V9, P53, DOI 10.1111/j.1463-5224.2005.00437.x
   Herring IP, 2000, J AM ANIM HOSP ASSOC, V36, P427, DOI 10.5326/15473317-36-5-427
   Kaido M, 2004, OPHTHALMOLOGY, V111, P895, DOI 10.1016/j.ophtha.2003.09.034
   *KOHL, 1986, KILN MBL AUGENHEILK, V189, P486, DOI DOI 10.1055/S-2008-1050859
   Liu D, 2002, BRIT J OPHTHALMOL, V86, P1031, DOI 10.1136/bjo.86.9.1031
   Maggs DJ, 2013, SLATTERS FUNDAMENTAL
   Marcovich R, 2001, UROLOGY, V57, P806, DOI 10.1016/S0090-4295(00)01075-X
   Murube J, 1996, SURV OPHTHALMOL, V40, P463, DOI 10.1016/S0039-6257(96)82013-3
   Ohba E, 2011, AM J OPHTHALMOL, V151, P483, DOI 10.1016/j.ajo.2010.08.045
   Ollivier F, 2001, VET OPHTHALMOL, V4, P261, DOI 10.1046/j.1463-5216.2001.00195.x
   PATEL S, 1994, ADV EXP MED BIOL, V350, P605
   Patten J T, 1976, Ophthalmic Surg, V7, P24
   ROSA AS, 2012, REV BRAS MED VET, V34, P353
   Sanchez RF, 2007, J SMALL ANIM PRACT, V48, P211, DOI 10.1111/j.1748-5827.2006.00185.x
   Whitwell J, 1961, Br J Ophthalmol, V45, P439, DOI 10.1136/bjo.45.6.439
   Williams DL, 2005, VET OPHTHALMOL, V8, P325, DOI 10.1111/j.1463-5224.2005.00421.x
   Yen MT, 2001, AM J OPHTHALMOL, V131, P314, DOI 10.1016/S0002-9394(00)00822-9
NR 25
TC 0
Z9 0
U1 0
U2 0
PU UNIV FEDERAL SANTA MARIA
PI SANTA MARIA
PA UNIV FEDERAL SANTA MARIA, SANTA MARIA, RS 97105.9, BRAZIL
SN 0103-8478
EI 1678-4596
J9 CIENC RURAL
JI Cienc. Rural
PD SEP
PY 2014
VL 44
IS 9
BP 1615
EP 1621
DI 10.1590/0103-8478cr20131428
PG 7
WC Agronomy
SC Agriculture
GA AR0QU
UT WOS:000343277200016
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Nguyen, NT
   Liu, JH
AF Ngoc-Thang Nguyen
   Liu, Jui-Hsiang
TI A green method for in situ synthesis of poly(vinyl alcohol)/chitosan
   hydrogel thin films with entrapped silver nanoparticles
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Poly(vinyl alcohol); Chitosan; Silver nanoparticle; Hydrogel thin films;
   Biomedical applications
ID GRAPHENE OXIDE NANOCOMPOSITE; METAL NANOPARTICLES; FABRICATION;
   ANTIBACTERIAL; SURFACE; MICROSPHERES; NANOREACTORS; TEMPERATURE;
   PARTICLES; COMPOSITE
AB Poly(vinyl alcohol)/Chitosan (PVA/CTS) hydrogel thin films of approximately 4 mu m in thickness were synthesized via ultraviolet (UV) irradiation using acrylic acid (AA) monomer as the crosslinker, without the aid of an additional photoinitiator. The prepared hydrogels with a high crosslinking density and a dense inter-porous structure were utilized both as nanoreactors and the immobilizing matrix for the formation of silver nanoparticles (AgNPs). The nanoparticles were formed through in situ reduction of silver nitrate by employing the nontoxic biochemical glucose and the accelerator sodium hydroxide in the environmentally benign medium of water. The composite films were characterized using several analysis tools, including UV-visible spectroscopy (UV/vis), Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), transmission electron microscopy (TEM), scanning electron microscopy (SEM) and mechanical testing. The results confirmed that highly stable and uniformly distributed AgNPs were obtained over the entire hydrogel networks. The tensile test revealed that the effective incorporation of AgNPs within the hydrogel networks rendered the composite films more elastic. Because of its inter-porous structure, well distributed AgNPs, and good mechanical and biocompatible properties, as well as the green synthesis method, the AgNP-loaded PVA/CTS hydrogel thin film could be utilized as a biomaterial in medical applications. (C) 2014 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Ngoc-Thang Nguyen; Liu, Jui-Hsiang] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
RP Liu, JH (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
EM jhliu@mail.ncku.edu.tw
FU National Science Council (NSC) of the Republic of China (Taiwan)
   [101-2221-E-006-074-MY3]; Headquarters of University Advancement at the
   National Cheng Kung University; Ministry of Education, Taiwan, ROC
FX The authors would like to thank the National Science Council (NSC) of
   the Republic of China (Taiwan) for financially supporting this research
   under Contract no. 101-2221-E-006-074-MY3. This research received
   funding from the Headquarters of University Advancement at the National
   Cheng Kung University, which is sponsored by the Ministry of Education,
   Taiwan, ROC.
CR Abdelgawad AM, 2014, CARBOHYD POLYM, V100, P166, DOI 10.1016/j.carbpol.2012.12.043
   Bai WS, 2014, ACS APPL MATER INTER, V6, P5439, DOI 10.1021/am500641d
   Bi L, 2014, J MATER CHEM A, V2, P3715, DOI 10.1039/c3ta15020h
   Cao XL, 2010, J MATER SCI-MATER M, V21, P2861, DOI 10.1007/s10856-010-4133-2
   Chiou JR, 2013, J HAZARD MATER, V248, P394, DOI 10.1016/j.jhazmat.2013.01.030
   Eid M, 2012, J POLYM RES, V19, P1
   El-Mahdy GA, 2014, J TAIWAN INST CHEM E, V45, P1947, DOI 10.1016/j.jtice.2014.02.014
   Fuku K, 2013, ANGEW CHEM INT EDIT, V52, P7446, DOI 10.1002/anie.201301652
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Goia DV, 1998, NEW J CHEM, V22, P1203, DOI 10.1039/a709236i
   Jagur-Grodzinski J, 2010, POLYM ADVAN TECHNOL, V21, P27, DOI 10.1002/pat.1504
   Joshi MK, 2014, COLLOID SURFACE A, V446, P102, DOI 10.1016/j.colsurfa.2014.01.058
   Kao ZK, 2012, J TAIWAN INST CHEM E, V43, P965, DOI 10.1016/j.jtice.2012.05.003
   Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y
   Lee HK, 2005, MATER LETT, V59, P2977, DOI 10.1016/j.matlet.2005.05.005
   Liu JH, 2004, MACROMOL CHEM PHYSIC, V205, P2205, DOI 10.1002/macp.200400197
   Liu JH, 2010, POLYM COMPOSITE, V31, P1352, DOI 10.1002/pc.20920
   Liu JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/3/035301
   Lu YC, 2008, J CHIN INST CHEM ENG, V39, P673, DOI 10.1016/j.jcice.2008.06.005
   Mohan S, 2014, CARBOHYD POLYM, V106, P469, DOI 10.1016/j.carbpol.2014.01.008
   Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045
   Mohan YM, 2010, J COLLOID INTERF SCI, V342, P73, DOI 10.1016/j.jcis.2009.10.008
   MOSTAFAVI M, 1990, CHEM PHYS LETT, V169, P81, DOI 10.1016/0009-2614(90)85169-D
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Nguyen NT, 2013, EUR POLYM J, V49, P4201, DOI 10.1016/j.eurpolymj.2013.09.032
   Niknam JMJ, 2012, J TAIWAN INST CHEM E, V43, P301
   Otari SV, 2013, DALTON T, V42, P9966, DOI 10.1039/c3dt51093j
   Oyen ML, 2014, INT MATER REV, V59, P44, DOI 10.1179/1743280413Y.0000000022
   Prabhu S, 2012, INT NANO LETT, V2, P1, DOI DOI 10.1186/2228-5326-2-32
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Tseng CC, 2011, J TAIWAN INST CHEM E, V42, P989, DOI 10.1016/j.jtice.2011.05.002
   Voronov A, 2007, LANGMUIR, V23, P360, DOI 10.1021/la062737t
   Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093
   Xu W, 2014, CARBOHYD POLYM, V101, P961, DOI 10.1016/j.carbpol.2013.10.032
   You J, 2014, J MATER CHEM A, V2, P8491, DOI 10.1039/c4ta00632a
   Yu HJ, 2007, J APPL POLYM SCI, V103, P125, DOI 10.1002/app.24835
   Zan XJ, 2010, BIOMACROMOLECULES, V11, P1082, DOI 10.1021/bm100048q
   Zhang JG, 2004, J AM CHEM SOC, V126, P7908, DOI 10.1021/ja031523k
NR 38
TC 19
Z9 20
U1 3
U2 108
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD SEP
PY 2014
VL 45
IS 5
BP 2827
EP 2833
DI 10.1016/j.jtice.2014.06.017
PG 7
WC Engineering, Chemical
SC Engineering
GA AR5PC
UT WOS:000343635200096
DA 2018-10-20
ER

PT J
AU Alexander, PG
   Gottardi, R
   Lin, H
   Lozito, TP
   Tuan, RS
AF Alexander, Peter G.
   Gottardi, Riccardo
   Lin, Hang
   Lozito, Thomas P.
   Tuan, Rocky S.
TI Three-dimensional osteogenic and chondrogenic systems to model
   osteochondral physiology and degenerative joint diseases
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Tissue engineering; osteoarthritis; drug screening; biomaterial
   scaffold; bone; cartilage
ID MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERING SCAFFOLDS; CRUCIATE LIGAMENT
   TRANSECTION; DENSITY MICROMASS CULTURES; DOUBLE-CHAMBER BIOREACTOR;
   IN-VITRO CHONDROGENESIS; WALL VESSEL BIOREACTOR; BONE TISSUE;
   ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES
AB Tissue engineered constructs have the potential to function as invitro pre-clinical models of normal tissue function and disease pathogenesis for drug screening and toxicity assessment. Effective high throughput assays demand minimal systems with clearly defined performance parameters. These systems must accurately model the structure and function of the human organs and their physiological response to different stimuli. Musculoskeletal tissues present unique challenges in this respect, as they are load-bearing, matrix-rich tissues whose functionality is intimately connected to the extracellular matrix and its organization. Of particular clinical importance is the osteochondral junction, the target tissue affected in degenerative joint diseases, such as osteoarthritis (OA), which consists of hyaline articular cartilage in close interaction with subchondral bone. In this review, we present an overview of currently available invitro three-dimensional systems for bone and cartilage tissue engineering that mimic native physiology, and the utility and limitations of these systems. Specifically, we address the need to combine bone, cartilage and other tissues to form an interactive microphysiological system (MPS) to fully capture the biological complexity and mechanical functions of the osteochondral junction of the articular joint. The potential applications of three-dimensional MPSs for musculoskeletal biology and medicine are highlighted.
C1 [Alexander, Peter G.; Gottardi, Riccardo; Lin, Hang; Lozito, Thomas P.; Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15219 USA.
   [Alexander, Peter G.; Gottardi, Riccardo; Lin, Hang; Lozito, Thomas P.; Tuan, Rocky S.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Gottardi, Riccardo] Ri MED Fdn, I-90133 Palermo, Italy.
   [Tuan, Rocky S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Tuan, Rocky S.] Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA.
RP Tuan, RS (reprint author), Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Ctr Cellular & Mol Engn, Pittsburgh, PA 15219 USA.
EM rst13@pitt.edu
OI Gottardi, Riccardo/0000-0001-8040-5531; Lin, Hang/0000-0002-0781-6630
FU Commonwealth of Pennsylvania, Department of Health; National Institutes
   of Health [1U18 TR000532]; U.S. Department of Defense [W81XWH-08-2-0032,
   W81XWH-10-1-0850]; Ri.MED Foundation
FX The authors gratefully thank Dr Jian Tan for his help with histology.
   This work was supported by grants from the Commonwealth of Pennsylvania,
   Department of Health, the National Institutes of Health (1U18 TR000532),
   the U.S. Department of Defense (W81XWH-08-2-0032 and W81XWH-10-1-0850),
   and the Ri.MED Foundation.
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5
   Alexander PG, 2012, CARTILAGE, V3, P323, DOI 10.1177/1947603512447301
   Alexander PG, 2012, CARTILAGE, V4, P52
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Anderson DD, 2011, J ORTHOP RES, V29, P802, DOI 10.1002/jor.21359
   Appelman TP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003314
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Augello A, 2010, HUM GENE THER, V21, P1226, DOI 10.1089/hum.2010.173
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]
   Bijlsma JWJ, 2007, BEST PRACT RES CL RH, V21, P59, DOI 10.1016/j.berh.2006.08.013
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Botchwey EA, 2003, BIORHEOLOGY, V40, P299
   Buckland-Wright Christopher, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS10
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Burr David B, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS20
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Cenni E, 2011, ACTA PHARMACOL SIN, V32, P21, DOI 10.1038/aps.2010.143
   Charbord P, 2011, STEM CELL REV REP, V7, P32, DOI 10.1007/s12015-010-9125-6
   Chaudhari AMW, 2008, MED SCI SPORT EXER, V40, P215, DOI 10.1249/mss.0b013e31815cbb0e
   Chen FH, 2006, NAT CLIN PRACT RHEUM, V2, P373, DOI 10.1038/ncprheum0216
   Chen K, 2013, J TISSUE ENG REGEN M, V8, P1902
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376
   Coates EE, 2010, ANN BIOMED ENG, V38, P3371, DOI 10.1007/s10439-010-0096-1
   Coleman CM, 2003, DEV DYNAM, V228, P208, DOI 10.1002/dvdy.10369
   Coleman CM, 2003, MECH DEVELOP, V120, P823, DOI 10.1016/S0925-4773(03)00067-4
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.tea.2011.0543, 10.1089/ten.TEA.2011.0543]
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Darling EM, 2003, ANN BIOMED ENG, V31, P1114, DOI 10.1114/1.1603752
   Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   DeLise AM, 2000, METH MOL B, V137, P359
   DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Dickhut A, 2008, FRONT BIOSCI, V13, P4517, DOI 10.2741/3020
   Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673
   Dormer NH, 2012, J BIOMED MATER RES A, V100A, P162, DOI 10.1002/jbm.a.33225
   Dormer NH, 2010, ANN BIOMED ENG, V38, P2167, DOI 10.1007/s10439-010-0028-0
   Esch MB, 2011, ANNU REV BIOMED ENG, V13, P55, DOI [10.1146/annurev-bioeng-071910-124629, 10.1146/annurev-biocng-071910-124629]
   Falsafi S, 2000, ARCH OTOLARYNGOL, V126, P759, DOI 10.1001/archotol.126.6.759
   Felson DT, 2013, OSTEOARTHR CARTILAGE, V21, P10, DOI 10.1016/j.joca.2012.09.012
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   Frenkel SR, 2005, OSTEOARTHR CARTILAGE, V13, P798, DOI 10.1016/j.joca.2005.04.018
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136
   Fukui N, 2001, Curr Rheumatol Rep, V3, P496, DOI 10.1007/s11926-001-0064-8
   Gardel LS, 2014, TISSUE ENG PART B-RE, V20, P126, DOI [10.1089/ten.teb.2013.0010, 10.1089/ten.TEB.2013.0010]
   Gardel LS, 2013, J BIOMED MATER RES B, V101, P1377, DOI 10.1002/jbm.b.32955
   Gaspar Diana Alves, 2012, Biomatter, V2, P167, DOI 10.4161/biom.22170
   Ge ZG, 2012, J BIOMED MATER RES A, V100A, P2526, DOI 10.1002/jbm.a.34147
   Gerber I, 2005, Eur Cell Mater, V10, P8
   Gibson JS, 2008, PFLUG ARCH EUR J PHY, V455, P563, DOI 10.1007/s00424-007-0310-7
   Giovannini S, 2010, EUR CELLS MATER, V20, P245
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gosain AF, 2002, PLAST RECONSTR SURG, V109, P619, DOI 10.1097/00006534-200202000-00032
   Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9
   Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Grimshaw MJ, 2001, OSTEOARTHR CARTILAGE, V9, P357, DOI 10.1053/joca.2000.0396
   Guevremont M, 2003, J BONE MINER RES, V18, P1073, DOI 10.1359/jbmr.2003.18.6.1073
   Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Haut RC, 1995, J BIOMECH ENG-T ASME, V117, P402, DOI 10.1115/1.2794199
   Hayami T, 2006, BONE, V38, P234, DOI 10.1016/j.bone.2005.08.007
   Hayami T, 2004, ARTHRITIS RHEUM, V50, P1193, DOI 10.1002/art.20124
   Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198
   Henrotin Y, 2012, OSTEOPOROSIS INT, V23, pS847, DOI 10.1007/s00198-012-2162-z
   Hoemann CD, 2012, J KNEE SURG, V25, P85, DOI 10.1055/s-0032-1319782
   Hoenig E, 2013, TISSUE ENG PT A, V19, P1534, DOI [10.1089/ten.tea.2012.0538, 10.1089/ten.TEA.2012.0538]
   Holtorf HL, 2006, ADV EXP MED BIOL, V585, P225
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hunter DJ, 2006, BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639
   Hwang NS, 2007, FEBS LETT, V581, P4172, DOI 10.1016/j.febslet.2007.07.049
   Imhof H, 1997, SKELETAL RADIOL, V26, P398, DOI 10.1007/s002560050254
   Imhof H, 2000, INVEST RADIOL, V35, P581, DOI 10.1097/00004424-200010000-00004
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kerin A, 2002, CELL MOL LIFE SCI, V59, P27, DOI 10.1007/s00018-002-8402-1
   Khan AA, 2009, BIOTECHNOL PROGR, V25, P508, DOI [10.1021/bp.108, 10.1002/btpr.108]
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kim SS, 2006, TISSUE ENG, V12, P2997, DOI 10.1089/ten.2006.12.2997
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kokemuller H, 2014, INT J ORAL MAX SURG, V43, P163, DOI 10.1016/j.ijom.2013.10.013
   KOLLER MR, 1993, BLOOD, V82, P378
   KOSHER RA, 1979, J EMBRYOL EXP MORPH, V50, P75
   Kouri JB, 2006, HISTOL HISTOPATHOL, V21, P793, DOI 10.14670/HH-21.793
   Krasnokutsky S, 2008, OSTEOARTHR CARTILAGE, V16, pS1, DOI 10.1016/j.joca.2008.06.025
   Kraus KH, 2006, VET SURG, V35, P232, DOI 10.1111/j.1532-950X.2006.00142.x
   Kuliwaba JS, 2000, J BONE MINER RES, V15, P332, DOI 10.1359/jbmr.2000.15.2.332
   Laborie LB, 2011, RADIOLOGY, V260, P494, DOI 10.1148/radiol.11102354
   LACOMBEGLEIZE S, 1995, IN VITRO CELL DEV-AN, V31, P649
   Leboy PS, 1997, J CELL BIOCHEM, V66, P394, DOI 10.1002/(SICI)1097-4644(19970901)66:3<394::AID-JCB11>3.0.CO;2-F
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]
   Liu XG, 2013, BIOTECHNOL LETT, V35, P1645, DOI 10.1007/s10529-013-1248-9
   Lories RJ, 2011, NAT REV RHEUMATOL, V7, P43, DOI 10.1038/nrrheum.2010.197
   Lotz M, 2013, ANN RHEUM DIS, V72, P1756, DOI 10.1136/annrheumdis-2013-203726
   Lozito TP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt367
   Lynn SK, 2007, KNEE, V14, P22, DOI 10.1016/j.knee.2006.09.002
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Mello MA, 1999, IN VITRO CELL DEV-AN, V35, P262
   Mello MA, 2006, J ORTHOP RES, V24, P2095, DOI 10.1002/jor.20233
   Mohan N., 2013, BIOTECHNOL BIOENG, V111, P829
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Mueller MB, 2011, PM&R, V3, pS3, DOI 10.1016/j.pmrj.2011.05.009
   Muraoka T, 2007, ARTHRITIS RHEUM, V56, P3366, DOI 10.1002/art.22921
   NEWMAN SA, 1981, DEV BIOL, V84, P440, DOI 10.1016/0012-1606(81)90413-9
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   Noth U, 2002, TISSUE ENG, V8, P131, DOI 10.1089/107632702753503126
   O'Conor Christopher J, 2013, Stem Cell Res Ther, V4, P61, DOI 10.1186/scrt211
   OBERLENDER SA, 1994, DEVELOPMENT, V120, P177
   Pan J, 2009, J ORTHOP RES, V27, P1347, DOI 10.1002/jor.20883
   Park JS, 2009, TISSUE ENG PT A, V15, P2163, DOI 10.1089/ten.tea.2008.0532
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005
   Rauh J, 2011, TISSUE ENG PART B-RE, V17, P263, DOI [10.1089/ten.teb.2010.0612, 10.1089/ten.TEB.2010.0612]
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REPO RU, 1977, J BONE JOINT SURG AM, V59, P1068, DOI 10.2106/00004623-197759080-00012
   Responte DJ, 2012, FASEB J, V26, P3614, DOI 10.1096/fj.12-207241
   Ripamonti U, 1996, BIOMATERIALS, V17, P31, DOI 10.1016/0142-9612(96)80752-6
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Roos EM, 2005, CURR OPIN RHEUMATOL, V17, P195, DOI 10.1097/01.bor.0000151406.64393.00
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   San Antonio J. D., 1986, DEV BIOL, V115, P313
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Schatti O, 2011, EUR CELLS MATER, V22, P214, DOI 10.22203/eCM.v022a17
   Schuurman W, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1638, DOI 10.1002/TERM.1638]
   Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199
   Shahin K, 2012, BIOTECHNOL BIOENG, V109, P1060, DOI 10.1002/bit.24372
   Sharma AR, 2013, INT J MOL SCI, V14, P19805, DOI 10.3390/ijms141019805
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shi XT, 2013, ADV HEALTHC MATER, V2, P846, DOI 10.1002/adhm.201200333
   Shieh AC, 2003, ANN BIOMED ENG, V31, P1, DOI 10.1114/1.1535415
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Silver FH, 2001, CRIT REV BIOMED ENG, V29, P373, DOI 10.1615/CritRevBiomedEng.v29.i4.10
   SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050
   SILYNROBERTS H, 1990, CONNECT TISSUE RES, V24, P143, DOI 10.3109/03008209009152430
   Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1
   SOLURSH M, 1978, IN VITRO CELL DEV B, V14, P51
   SOLURSH M, 1989, AM J MED GENET, V34, P30, DOI 10.1002/ajmg.1320340108
   Song KD, 2008, J BIOMED MATER RES A, V86A, P323, DOI 10.1002/jbm.a.31624
   Spezia Francois, 2013, Methods Mol Biol, V947, P91, DOI 10.1007/978-1-62703-131-8_8
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.teb.2011.0077, 10.1089/ten.TEB.2011.0077]
   Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213
   Steinert AF, 2009, INJURY, V39, pS97
   Steinert AF, 2009, ARTHRITIS RES THER, V11, pR148
   Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036
   Steppacher SD, 2008, CLIN ORTHOP RELAT R, V466, P1633, DOI 10.1007/s11999-008-0242-3
   Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967
   Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09
   Sudarmadji N, 2012, METHODS MOL BIOL, V868, P111, DOI 10.1007/978-1-61779-764-4_7
   Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Temple JP, 2014, J BIOMED MATER RES A, V102, P4317, DOI 10.1002/jbm.a.35107
   Temple JP, 2014, METHODS MOL BIOL, V1202, P57, DOI 10.1007/7651_2013_33
   Thompson ID, 1998, P I MECH ENG H, V212, P127, DOI 10.1243/0954411981533908
   Thompson WR, 2013, ISC 232 APPL REGENER
   Tuan RS, 2013, J AM ACAD ORTHOP SUR, V21, P303, DOI 10.5435/JAAOS-21-05-303
   Tufan AC, 2002, EXP CELL RES, V273, P197, DOI 10.1006/excr.2001.5448
   Tufan AC, 2002, DEV DYNAM, V223, P241, DOI 10.1002/dvdy.10046
   Tufan AC, 2001, FASEB J, V15, P1436, DOI 10.1096/fj.00-0784fje
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   UMANSKY R, 1966, DEV BIOL, V13, P31, DOI 10.1016/0012-1606(66)90048-0
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang WG, 2003, TISSUE CELL, V35, P69, DOI 10.1016/S0040-8166(02)00106-4
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wartella KA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049859
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Winet H, 1998, J BIOMED MATER RES, V40, P567, DOI 10.1002/(SICI)1097-4636(19980615)40:4<567::AID-JBM8>3.0.CO;2-D
   Wong M, 2003, BONE, V33, P1, DOI 10.1016/S8756-3282(03)00083-8
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Woods A, 2007, ENDOCRINOLOGY, V148, P5030, DOI 10.1210/en.2007-0695
   Woodward WA, 1999, DEV GENET, V24, P178, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<178::AID-DVG16>3.0.CO;2-M
   Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646
   Worster AA, 2001, J ORTHOPAED RES, V19, P738, DOI 10.1016/S0736-0266(00)00054-1
   Wu CT, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/032001
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x
   Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
NR 215
TC 26
Z9 26
U1 5
U2 33
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD SEP
PY 2014
VL 239
IS 9
BP 1080
EP 1095
DI 10.1177/1535370214539232
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AQ4MV
UT WOS:000342773100004
PM 24994814
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mohanraj, S
   Murugan, D
   Rengarajan, A
   Rajiv, S
AF Mohanraj, Subashree
   Murugan, Dhanalakshmi
   Rengarajan, Aburva
   Rajiv, Sheeja
TI Anticancer activity of starch/poly[N-(2-hydroxypropyl)methacrylamide]:
   Biomaterial film to treat skin cancer
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Poly[N-(2-hydroxypropyl)methacrylamide] (pHPMA);
   Poly[N-(2hydroxypropyl)methacrylamide]-starch; hybrid (pHPMAS) film;
   Camptothecin (CPT); Biocompatibility; Anticancer activity
ID SYNTHETIC INFUSION SOLUTIONS; POLYMER BLEND FILMS; DRUG-DELIVERY;
   CARBOXYLATE FORMS; CAMPTOTHECIN; STARCH; NANOPARTICLES; HYDROGELS; HPMA;
   BIOCOMPATIBILITY
AB In the present work, films of pHPMA, pHPMAS hybrid, pHPMA-CPT and pHPMAS-CPT hybrid were prepared by solvent casting method and characterized by FT-IR, FT-Raman, XRD and DSC, respectively. The biocompatibility of the prepared pHPMA film and pHPMAS hybrid film were assessed using VERO cell lines and the percentage cell viability was found to be 97.4 and 983% for 7.8 mu g/mL of the film extracts after 72 h of incubation. The cancer cell viability of the pHPMA-CPT film and pHPMAS-CPT film using MCF7 cell lines at pH 5.5 and 7.4 were found to be 4.9 and 8.6% and 7.7 and 12.3%, respectively. In vitro release of camptothecin from pHPMA-CPT and pHPMAS-CPT films in phosphate-buffered saline solution at pH 5.5 and 7.4 were monitored and analyzed using UV-vis spectrophotometer at lambda(max) of 360 nm. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Mohanraj, Subashree; Murugan, Dhanalakshmi; Rengarajan, Aburva; Rajiv, Sheeja] Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
RP Rajiv, S (reprint author), Anna Univ, Dept Chem, Madras 600025, Tamil Nadu, India.
EM sheeja@annauniv.edu
FU University Grants Commission (UGC) [41-346/2012]
FX The authors acknowledge the University Grants Commission (UGC) for
   financial assistance (Project No.: F.No 41-346/2012(SR) dated
   13.07.2012). The instrumentation facility provided under FIST-DST and
   DRS-UGC to the Department of Chemistry, Anna University, Chennai, are
   gratefully acknowledged.
CR Arvanitoyannis I, 1998, CARBOHYD POLYM, V36, P89, DOI 10.1016/S0144-8617(98)00016-2
   Chourpa I, 1997, BBA-GEN SUBJECTS, V1334, P349, DOI 10.1016/S0304-4165(96)00113-4
   Felton LA, 2013, INT J PHARMACEUT, V457, P423, DOI 10.1016/j.ijpharm.2012.12.027
   Guar S., 2012, NANOMED-NANOTECHNOL, V8, P721
   Hopewell JW, 2001, HUM EXP TOXICOL, V20, P461, DOI 10.1191/096032701682693017
   HSIANG YH, 1985, J BIOL CHEM, V260, P4873
   Jager E, 2012, SOFT MATTER, V8, P9563, DOI 10.1039/c2sm26150b
   Khandare J, 2006, PROG POLYM SCI, V31, P359, DOI 10.1016/j.progpolymsci.2005.09.004
   Kim S, 2003, BIOMACROMOLECULES, V4, P1214, DOI 10.1021/bm0340467
   Koo OMY, 2006, J NANOSCI NANOTECHNO, V6, P2996, DOI 10.1166/jnn.2006.460
   KOPECEK J, 1973, J BIOMED MATER RES, V7, P179, DOI 10.1002/jbm.820070206
   Kruszewski S, 2002, OPT APPL, V32, P721
   Larson N, 2012, CHEM MATER, V24, P840, DOI 10.1021/cm2031569
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin Y, 2013, J MEMBRANE SCI, V439, P20, DOI 10.1016/j.memsci.2013.03.033
   Lu L, 2006, PROG POLYM SCI, V31, P576
   Ma HH, 2013, COLLOID SURFACE A, V419, P201, DOI 10.1016/j.colsurfa.2012.11.073
   Martins SM, 2013, EUR J PHARM BIOPHARM, V85, P488, DOI 10.1016/j.ejpb.2013.08.011
   Meneguin AB, 2014, CARBOHYD POLYM, V99, P140, DOI 10.1016/j.carbpol.2013.07.077
   MI ZH, 1994, BIOCHEMISTRY-US, V33, P10325, DOI 10.1021/bi00200a013
   Miro A, 2013, INT J PHARMACEUT, V452, P283, DOI 10.1016/j.ijpharm.2013.05.030
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Namkung S, 2007, J BIOMAT SCI-POLYM E, V18, P901, DOI 10.1163/156856207781367701
   Ozdemir Z, 2013, POLYM BULL, V70, P2857, DOI 10.1007/s00289-013-0993-1
   Pereira AGB, 2011, MAT SCI ENG C-MATER, V31, P443, DOI 10.1016/j.msec.2010.11.004
   Pereira AGB, 2009, MAT SCI ENG C-BIO S, V29, P499, DOI 10.1016/j.msec.2008.09.009
   Pertici V, 2013, ASN NEURO, V5, P149, DOI 10.1042/AN20120082
   Rao SS, 2014, COMPOS PART B-ENG, V60, P43, DOI 10.1016/j.compositesb.2013.12.068
   Rihova B, 2007, COMPOS PART B-ENG, V38, P386, DOI 10.1016/j.compositesb.2006.07.007
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884
   Scott RA, 2013, EUR J PHARM BIOPHARM, V84, P125, DOI 10.1016/j.ejpb.2012.12.002
   Sirikantaramas S, 2013, ADV BOT RES, V68, P139, DOI 10.1016/B978-0-12-408061-4.00005-5
   SPRINCL L, 1976, J BIOMED MATER RES, V10, P953, DOI 10.1002/jbm.820100612
   Tananuwong K, 2004, J AGR FOOD CHEM, V52, P4308, DOI [10.1021/jf049960l, 10.1021/jf0499601]
   Thakral NK, 2012, AAPS PHARMSCITECH, V13, P59, DOI 10.1208/s12249-011-9720-0
   Ulbrich K, 2000, J CONTROL RELEASE, V64, P63, DOI 10.1016/S0168-3659(99)00141-8
   Ur-Rehman T, 2010, INT J PHARMACEUT, V394, P92, DOI 10.1016/j.ijpharm.2010.05.012
   Varela-Rizo H, 2012, J APPL POLYM SCI, V125, P3228, DOI 10.1002/app.36511
   Wang XX, 2006, BIOMATERIALS, V27, P1924, DOI 10.1016/j.biomaterials.2005.09.029
   Witte P., 1996, J MEMBRANE SCI, V117, P1, DOI DOI 10.1016/0376-7388(96)00088-9
   Xue LJ, 2012, PROG POLYM SCI, V37, P564, DOI 10.1016/j.progpolymsci.2011.09.001
   Yang L, 2014, PROG ORG COAT, V77, P305, DOI 10.1016/j.porgcoat.2013.10.004
   Zamani M, 2013, INT J NANOMED, V8, P2997, DOI 10.2147/IJN.S43575
   Zhang Z, 2013, POLYMER, V54, P4446, DOI 10.1016/j.polymer.2013.06.033
   Zheng S., 2011, CARBOHYD POLYM, V86
   Zu YG, 2011, INT J MOL SCI, V12, P4237, DOI 10.3390/ijms12074237
NR 47
TC 4
Z9 4
U1 1
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2014
VL 70
BP 116
EP 123
DI 10.1016/j.ijbiomac.2014.06.041
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AQ0NA
UT WOS:000342478800016
PM 24984026
DA 2018-10-20
ER

PT J
AU Kaur, G
   Singh, D
   Brar, V
AF Kaur, Gurpreet
   Singh, Deepinder
   Brar, Vivekjot
TI Bioadhesive okra polymer based buccal patches as platform for controlled
   drug delivery
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Okra polymer; Mucoadhesion; Drug release studies
ID IN-VITRO; BIOMEDICAL APPLICATIONS; FILMS; GUM; VIVO; PERFORMANCE;
   FORMULATION; HYDROGELS; ALGINATE; TABLETS
AB In the present investigation, polysaccharide from the Okra fruits (Hibiscus esculentus) was extracted, characterized and explored for its mucoadhesive potential. Mucoadhesive films of okra polymer (OP) were prepared by solvent casting method based on 32 factorial design. For these studies, OP (2.0%, 2.5%, 3.0%, w/v) and glycerol (plasticizer) (0.25%, 0.50%, 0.75%, v/v) were taken as independent variables while tensile strength, mucoadhesive strength, contact angle, swelling index and residence time as dependent variables. The developed films were evaluated for their physicochemical, mechanical and electrical properties. The formulated films were found to be smooth, flexible, and displayed adequate mucoadhesive and tensile strength. Their near neutral pH and negative hemolytic studies indicated their non-irritability and biocompatible nature with biological tissues. The formulation comprising of 3% OP and 0.5% glycerol (F8) was found to exhibit optimum mechanical properties. Further, optimized film was loaded with zolmitriptan (model drug) to determine its drug release profiles. In vitro and ex vivo drug release studies demonstrated a controlled release of zolmitriptan over a period of 8 h in simulated salivary fluid (SSF) pH 6.8, with the correlation coefficient values indicating its non-Fickian kinetics. Thus, OP can be used as a promising biomaterial for controlled drug delivery. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kaur, Gurpreet; Singh, Deepinder; Brar, Vivekjot] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Patiala 147002, Punjab, India.
RP Kaur, G (reprint author), Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Patiala 147002, Punjab, India.
EM kaurgpt@gmail.com
CR Aulton M.E., 2002, PHARM SCI DOSAGE FOR, P134
   Avachat AM, 2013, CARBOHYD POLYM, V91, P537, DOI 10.1016/j.carbpol.2012.08.062
   Bajpai SK, 2011, INT FOOD RES J, V18, P417
   Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Cao N, 2007, FOOD HYDROCOLLOID, V21, P1153, DOI 10.1016/j.foodhyd.2006.09.001
   Caridade SG, 2012, J BIOACT COMPAT POL, V27, P429, DOI 10.1177/0883911512448753
   Deveswaran R., 2011, J INNOVATIVE TRENDS, V2, P8
   DHAWAN S, 2009, SCI PHARM, V77, P465, DOI DOI 10.3797/scipharm.0903-10
   Doodipala N., 2011, INT J PHARM SCI NANO, V4, P1463
   Emeje M, 2011, IRAN J PHARM RES, V10, P237
   Evans W., 2009, TREASE EVANS PHARMAC
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Jindal M, 2013, FOOD HYDROCOLLOID, V30, P192, DOI 10.1016/j.foodhyd.2012.05.027
   Koland M, 2011, INT J PHARM INVESTIG, V1, P164, DOI 10.4103/2230-973X.85967
   Kontogiorgos V, 2012, FOOD HYDROCOLLOID, V29, P356, DOI 10.1016/j.foodhyd.2012.04.003
   Korsemeyer RW, 1983, CONTROLLED RELEASE D, P77
   Lorenzo CA, 2013, ADV DRUG DELIV REV, V65, P1148, DOI [10.1016/j.addr.2013.04.016, DOI 10.1016/J.ADDR.2013.04.016]
   Maran JP, 2013, IND CROP PROD, V42, P159, DOI 10.1016/j.indcrop.2012.05.011
   Mirhosseini H, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-1
   Mishra A, 2008, CARBOHYD POLYM, V72, P608, DOI 10.1016/j.carbpol.2007.10.009
   Mohamadnia Z, 2007, J BIOACT COMPAT POL, V22, P342, DOI 10.1177/0883911507078519
   Mohammed FA, 2003, DRUG DEV IND PHARM, V29, P321, DOI 10.1081/DDC-120018206
   MORTAZAVI SA, 1993, J CONTROL RELEASE, V25, P197, DOI 10.1016/0168-3659(93)90078-J
   Nair AB, 2013, J CONTROL RELEASE, V166, P10, DOI 10.1016/j.jconrel.2012.11.019
   OGAJI I, 2010, ASIAN J PHARM, V4, P130
   Palem CR, 2011, ARCH PHARM RES, V34, P1701, DOI 10.1007/s12272-011-1014-2
   Patel Rajesh Singh, 2009, Current Drug Delivery, V6, P140
   Patel V.I., 2012, INT J PHARM RES SCHO, V1, P156
   Pereira R, 2013, INT J BIOL MACROMOL, V52, P221, DOI 10.1016/j.ijbiomac.2012.09.031
   Raghavendra-Rao N.G., 2011, INT J PHARM TECH, V3, P1658
   Rai PR, 2012, CARBOHYD POLYM, V87, P1098, DOI 10.1016/j.carbpol.2011.08.050
   Salamat-Miller N, 2005, ADV DRUG DELIVER REV, V57, P1666, DOI 10.1016/j.addr.2005.07.003
   Sarkar G., 2014, INT J BIOL MACROMOL
   Semalty A, 2010, INDIAN J PHARM SCI, V72, P571, DOI 10.4103/0250-474X.78522
   Singh B, 2008, CARBOHYD POLYM, V74, P489, DOI 10.1016/j.carbpol.2008.04.003
   Thakhiew W, 2010, J FOOD ENG, V99, P216, DOI 10.1016/j.jfoodeng.2010.02.025
   Yehia Soad A., 2009, Current Drug Delivery, V6, P17
NR 37
TC 11
Z9 13
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2014
VL 70
BP 408
EP 419
DI 10.1016/j.ijbiomac.2014.07.015
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AQ0NA
UT WOS:000342478800058
PM 25036601
DA 2018-10-20
ER

PT J
AU Kurland, NE
   Ragland, RB
   Zhang, AL
   Moustafa, ME
   Kundu, SC
   Yadavalli, VK
AF Kurland, Nicholas E.
   Ragland, Robert B.
   Zhang, Aolin
   Moustafa, Mahmoud E.
   Kundu, Subhas C.
   Yadavalli, Vamsi K.
TI pH responsive poly amino-acid hydrogels formed via silk sericin
   templating
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk; Sericin; Polyaspartic Acid; Hydrogel; pH responsive
ID ATOMIC-FORCE MICROSCOPY; POLY(ASPARTIC ACID); SWELLING PROPERTIES;
   PROTEIN SERICIN; VOLUME CHANGE; IN-VITRO; BIOMATERIALS; FIBROBLASTS;
   HYDROLYSIS; RELEASE
AB Poly(amino acid) hydrogels have attracted a great deal of attention as biodegradable biomaterials that can limit products of synthetic polymer degradation. Here we report on a stimuli-responsive, porous, composite biomaterial based on the protein templating of the poly(amino acid) hydrogel from poly(aspartic acid) with the silk protein sericin. This low-cost, biocompatible and biodegradable hydrogel demonstrates a greatly increased porosity and improvement in volumetric swelling over networks formed from pure poly(aspartic acid). The swelling capacity measured over a range of pH values surrounding physiological pH 7.0 demonstrates a linear profile, in which hydrogel volume and mass increase to a maximum, with an increase as a function of higher sericin content. In comparison to pure poly(aspartic acid), this demonstrates a nearly 3-fold increase in retention volume at basic pH. The increase in swelling is also demonstrated by the increase in porosity and internal micro-architecture of the hydrogel networks. The biomaterial is then shown to perform well as a scaffold for cells with high mechanical strength and integrity. This protein- and homo poly(amino acid)-based super-swelling hydrogel has applications in drug delivery and tissue engineering as an economical and environmentally friendly biomaterial, in addition to ensuring the species incorporated maintain their biocompatibility during processing. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kurland, Nicholas E.; Ragland, Robert B.; Zhang, Aolin; Moustafa, Mahmoud E.; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
   [Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu
OI Kundu, Subhas C./0000-0002-7170-2291; Yadavalli,
   Vamsi/0000-0002-8879-1948
FU National Science Foundation [CBET-1144611]
FX This research was partially supported by a grant from the National
   Science Foundation (CBET-1144611). The authors thank Dr. Xuejun Wen and
   Dr. Tuli Dey for help with the cell culture and imaging experiments.
CR Alford Diana D., 1994, Journal of Environmental Polymer Degradation, V2, P225, DOI 10.1007/BF02071970
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Annabi N, 2009, BIOMATERIALS, V30, P4550, DOI 10.1016/j.biomaterials.2009.05.014
   Aramwit P, 2013, NAT PROD COMMUN, V8, P501
   Cai KY, 2002, J BIOMED MATER RES, V62, P283, DOI 10.1002/jbm.10067
   Cao H, 2009, J APPL POLYM SCI, V113, P327, DOI 10.1002/app.29647
   Capar G, 2008, J MEMBRANE SCI, V325, P920, DOI 10.1016/j.memsci.2008.09.020
   Chen G, 2004, J MATER SCI-MATER M, V15, P671, DOI 10.1023/B:JMSM.0000030208.89523.2a
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Drira Z, 2013, J MECH BEHAV BIOMED, V18, P20, DOI 10.1016/j.jmbbm.2012.09.015
   Estroff LA, 2004, CHEM REV, V104, P1201, DOI 10.1021/cr0302049
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Gyenes T, 2008, ACTA BIOMATER, V4, P733, DOI 10.1016/j.actbio.2007.12.004
   Jiang HL, 2006, J APPL POLYM SCI, V99, P2320, DOI 10.1002/app.22737
   Katritzky AR, 1998, HETEROCYCLES, V48, P2677
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khan W, 2011, MACROMOL BIOSCI, V11, P1625, DOI 10.1002/mabi.201100324
   Khripin CY, 2011, ACS NANO, V5, P1401, DOI 10.1021/nn1031774
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253
   Kovalev A, 2004, J MATER RES, V19, P716, DOI 10.1557/jmr.2004.19.3.716
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Kurland NE, 2012, MICRON, V43, P116, DOI 10.1016/j.micron.2011.07.017
   KWON GS, 1993, PHARMACEUT RES, V10, P970, DOI 10.1023/A:1018998203127
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Mosig J, 1997, IND ENG CHEM RES, V36, P2163, DOI 10.1021/ie960678g
   Nakato T, 1998, MACROMOLECULES, V31, P2107, DOI 10.1021/ma971629y
   Nathwani BB, 2009, IEEE T NANOBIOSCI, V8, P72, DOI 10.1109/TNB.2009.2017295
   Nayak S., 2013, PLOS ONE, V8
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PARK TG, 1992, J APPL POLYM SCI, V46, P659, DOI 10.1002/app.1992.070460413
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Strelec JK, 2003, J INTEL MAT SYST STR, V14, P257, DOI 10.1177/104538903034687
   Tachibana Y, 2003, CHEM LETT, V32, P374, DOI 10.1246/cl.2003.374
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Varga Z, 2010, PHYS CHEM CHEM PHYS, V12, P12670, DOI 10.1039/c0cp00527d
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wornyo E, 2007, POLYMER, V48, P3213, DOI 10.1016/j.polymer.2007.03.029
   Xia YN, 2000, ADV MATER, V12, P693, DOI 10.1002/(SICI)1521-4095(200005)12:10<693::AID-ADMA693>3.0.CO;2-J
   Zhang HP, 2011, INT J MOL SCI, V12, P3170, DOI 10.3390/ijms12053170
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhao Y, 2005, POLYMER, V46, P5368, DOI 10.1016/j.polymer.2005.04.015
   Zohuriaan-Mehr MJ, 2009, POLYM ADVAN TECHNOL, V20, P655, DOI 10.1002/pat.1395
   Zrinyi M, 2013, ACTA BIOMATER, V9, P5122, DOI 10.1016/j.actbio.2012.08.046
NR 49
TC 5
Z9 5
U1 4
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD SEP
PY 2014
VL 70
BP 565
EP 571
DI 10.1016/j.ijbiomac.2014.07.036
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AQ0NA
UT WOS:000342478800079
PM 25073107
DA 2018-10-20
ER

PT J
AU Arslan, E
   Garip, IC
   Gulseren, G
   Tekinay, AB
   Guler, MO
AF Arslan, Elif
   Garip, I. Ceren
   Gulseren, Gulcihan
   Tekinay, Ayse B.
   Guler, Mustafa O.
TI Bioactive Supramolecular Peptide Nanofi bers for Regenerative Medicine
SO ADVANCED HEALTHCARE MATERIALS
LA English
   Estonian
DT Review
DE self-assembly; peptide amphiphile; regenerative medicine; bioactivity;
   scaffolds
ID COLLAGEN-MIMETIC PEPTIDE; MARROW STROMAL CELLS; SELF-COMPLEMENTARY
   OLIGOPEPTIDE; MESENCHYMAL STEM-CELLS; SER-ARG-ASN; AMPHIPHILE
   NANOFIBERS; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; NEURITE OUTGROWTH;
   BIOMATERIAL SCAFFOLDS
AB Recent advances in understanding of cell-matrix interactions and the role of the extracellular matrix (ECM) in regulation of cellular behavior have created new perspectives for regenerative medicine. Supramolecular peptide nanofiber systems have been used as synthetic scaffolds in regenerative medicine applications due to their tailorable properties and ability to mimic ECM proteins. Through designed bioactive epitopes, peptide nanofiber systems provide biomolecular recognition sites that can trigger specific interactions with cell surface receptors. The present Review covers structural and biochemical properties of the self-assembled peptide nanofibers for tissue regeneration, and highlights studies that investigate the ability of ECM mimetic peptides to alter cellular behavior including cell adhesion, proliferation, and/or differentiation.
C1 [Arslan, Elif; Garip, I. Ceren; Gulseren, Gulcihan; Tekinay, Ayse B.; Guler, Mustafa O.] Bilkent Univ, Inst Mat Sci & Nanotechnol, Natl Nanotechnol Res Ctr UNAM, TR-06800 Ankara, Turkey.
RP Tekinay, AB (reprint author), Bilkent Univ, Inst Mat Sci & Nanotechnol, Natl Nanotechnol Res Ctr UNAM, TR-06800 Ankara, Turkey.
EM atekinay@unam.bilkent.edu.tr; moguler@unam.bilkent.edu.tr
RI Tekinay, Ayse/A-7212-2015; Guler, Mustafa O./C-9453-2011
OI Tekinay, Ayse/0000-0002-4453-814X; Guler, Mustafa
   O./0000-0003-1168-202X; Yasa, Immihan Ceren/0000-0002-5013-7246
FU TUBITAK-BIDEB 2210 Ph.D. fellowship; Turkish Academy of Sciences
   Distinguished Young Scientist Award (TUBA-GEBIP); TUBITAK [112T042,
   111M410, 111M710]; Loreal Young Women Investigator Award
FX E.A. and I. C. G. contributed equally to this work. I. C. G. and E. A.
   are supported by TUBITAK-BIDEB 2210 Ph.D. fellowship. M.O.G. and A. B.
   T. acknowledge support from the Turkish Academy of Sciences
   Distinguished Young Scientist Award (TUBA-GEBIP) and TUBITAK (112T042,
   111M410, 111M710), A. B. T. acknowledges support form Loreal Young Women
   Investigator Award. Authors thank to A. D. Ozkan, Y. Tumtas, and O. Yasa
   for their fruitful discussions.
CR Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Andersen KB, 2011, NANOSCALE, V3, P994, DOI 10.1039/c0nr00734j
   Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Angeloni NL, 2011, BIOMATERIALS, V32, P1091, DOI 10.1016/j.biomaterials.2010.10.003
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   ATASSI MZ, 1993, P NATL ACAD SCI USA, V90, P8282, DOI 10.1073/pnas.90.17.8282
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N
   Bowerman CJ, 2011, BIOMACROMOLECULES, V12, P2735, DOI 10.1021/bm200510k
   Castillo J, 2008, ELECTROPHORESIS, V29, P5026, DOI 10.1002/elps.200800260
   Castillo-Leon J., 2011, BIOMATER SCI ENG
   Castillo-Leon J, 2011, MICROELECTRON ENG, V88, P1685, DOI 10.1016/j.mee.2010.12.023
   Ceylan H, 2012, SOFT MATTER, V8, P3929, DOI 10.1039/c2sm25127b
   Ceylan H, 2011, BIOMATERIALS, V32, P8797, DOI 10.1016/j.biomaterials.2011.08.018
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Cinar G, 2012, BIOMACROMOLECULES, V13, P3377, DOI 10.1021/bm301141h
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   de Mel A, 2012, MACROMOL BIOSCI, V12, P1010, DOI 10.1002/mabi.201200039
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   Donos N, 2011, CLIN ORAL IMPLAN RES, V22, P365, DOI 10.1111/j.1600-0501.2010.02113.x
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Gorbitz CH, 2001, CHEM-EUR J, V7, P5153, DOI 10.1002/1521-3765(20011203)7:23<5153::AID-CHEM5153>3.0.CO;2-N
   GRINNELL F, 1986, EXP CELL RES, V162, P449, DOI 10.1016/0014-4827(86)90349-6
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   Guler MO, 2005, BIOCONJUGATE CHEM, V16, P501, DOI 10.1021/bc050053b
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hallab NJ, 1995, J LONG-TERM EFF MED, V5, P209
   Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang Z, 2013, BIOMATERIALS, V34, P3303, DOI 10.1016/j.biomaterials.2013.01.054
   Huang Z, 2008, J BONE MINER RES, V23, P1995, DOI 10.1359/JBMR.080705
   Iwamoto Y, 1996, BRIT J CANCER, V73, P589, DOI 10.1038/bjc.1996.102
   Kim TI, 2002, BIOTECHNOL LETT, V24, P2029, DOI 10.1023/A:1021368519336
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kokkoli E, 2006, SOFT MATTER, V2, P1015, DOI 10.1039/b608929a
   Kopecek J, 2007, POLYM INT, V56, P1078, DOI 10.1002/pi.2253
   Kopesky PW, 2010, MATRIX BIOL, V29, P427, DOI 10.1016/j.matbio.2010.02.003
   Kopesky PW, 2011, TISSUE ENG PT A, V17, P83, DOI [10.1089/ten.tea.2010.0198, 10.1089/ten.TEA.2010.0198]
   LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Liu X, 2013, ACTA BIOMATER, V9, P6798, DOI 10.1016/j.actbio.2013.01.027
   Lowik DWPM, 2004, CHEM SOC REV, V33, P234, DOI 10.1039/b212638a
   Luo JN, 2011, ACS NANO, V5, P7739, DOI 10.1021/nn202822f
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Malkar NB, 2003, BIOMACROMOLECULES, V4, P518, DOI 10.1021/bm0256597
   Mammadov B, 2012, ACTA BIOMATER, V8, P2077, DOI 10.1016/j.actbio.2012.02.006
   Mammadov R, 2012, MICRON, V43, P69, DOI 10.1016/j.micron.2011.07.006
   Mammadov R, 2011, BIOMACROMOLECULES, V12, P3508, DOI 10.1021/bm200957s
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Matson JB, 2012, SOFT MATTER, V8, P6689, DOI 10.1039/c2sm25785h
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Meijer GJ, 2007, PLOS MED, V4, P260, DOI 10.1371/journal.pmed.0040009
   Milinkovic I, 2012, MATER TEHNOL, V46, P251
   Nelson M, 2006, INT J NANOMED, V1, P339
   Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/956345
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/NCHEM.1123, 10.1038/nchem.1123]
   Orbach R, 2009, BIOMACROMOLECULES, V10, P2646, DOI 10.1021/bm900584m
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   PYTELA R, 1987, METHOD ENZYMOL, V144, P475
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139
   Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701
   Ryan DM, 2010, SOFT MATTER, V6, P475, DOI 10.1039/b916738b
   Ryan DM, 2010, SOFT MATTER, V6, P3220, DOI 10.1039/c0sm00018c
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Sargeant TD, 2008, BIOMATERIALS, V29, P1085, DOI 10.1016/j.biomaterials.2007.11.002
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3
   Sengupta D, 2010, TISSUE ENG PART B-RE, V16, P285, DOI 10.1089/ten.teb.2009.0591
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shi JF, 2011, BEILSTEIN J ORG CHEM, V7, P167, DOI 10.3762/bjoc.7.23
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Soukasene S, 2011, ACS NANO, V5, P9113, DOI 10.1021/nn203343z
   SQUIER CA, 1981, J PERIODONTAL RES, V16, P434, DOI 10.1111/j.1600-0765.1981.tb00994.x
   Standley SM, 2010, CANCER RES, V70, P3020, DOI 10.1158/0008-5472.CAN-09-3267
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Sulaiman W, 2013, OCHSNER J, V13, P100
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Sutton S, 2009, LANGMUIR, V25, P10285, DOI 10.1021/la9011058
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   TASHIRO K, 1989, J BIOL CHEM, V264, P16174
   Toksoz S, 2010, SOFT MATTER, V6, P5839, DOI 10.1039/c0sm00121j
   Toksoz S, 2009, NANO TODAY, V4, P458, DOI 10.1016/j.nantod.2009.09.002
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ustun S, 2013, BIOMACROMOLECULES, V14, P17, DOI 10.1021/bm301538k
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   Versluis F, 2010, CHEM SOC REV, V39, P3434, DOI 10.1039/b919446k
   Wang J, 2004, BIOMATERIALS, V25, P583, DOI 10.1016/S0142-9612(03)00559-3
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   Webber MJ, 2010, J TISSUE ENG REGEN M, V4, P600, DOI 10.1002/term.273
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Woolfson DN, 2010, CHEM SOC REV, V39, P3464, DOI 10.1039/c0cs00032a
   Yang ZM, 2004, ADV MATER, V16, P1440, DOI 10.1002/adma.200400340
   Yang ZM, 2004, CHEM COMMUN, P208, DOI 10.1039/b310574a
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu SM, 2011, SOFT MATTER, V7, P7927, DOI 10.1039/c1sm05329a
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
   Zou ZW, 2010, J BIOMED MATER RES A, V95A, P1125, DOI 10.1002/jbm.a.32910
   Zustiak SP, 2013, TISSUE ENG PART B-RE, V19, P160, DOI 10.1089/ten.teb.2012.0458
NR 145
TC 40
Z9 40
U1 1
U2 84
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD SEP
PY 2014
VL 3
IS 9
BP 1357
EP 1376
DI 10.1002/adhm.201300491
PG 20
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AP2MY
UT WOS:000341907800001
PM 24574311
OA Green Published
DA 2018-10-20
ER

PT J
AU Quignard, S
   d'Ischia, M
   Chen, Y
   Fattaccioli, J
AF Quignard, Sandrine
   d'Ischia, Marco
   Chen, Yong
   Fattaccioli, Jacques
TI Ultraviolet-Induced Fluorescence of Polydopamine-Coated Emulsion
   Droplets
SO CHEMPLUSCHEM
LA English
DT Article
DE emulsions; fluorescence; interfaces; photoactivation; polydopamine
ID EUMELANIN; EXCITATION; CAPSULES; COATINGS; MELANIN; FUNCTIONALIZATION;
   NANOPARTICLES; DOPAMINE; SURFACES; SHELL
AB Polydopamine (PDA), a multifunctional biomaterial with strong adhesion and coating properties, exhibits melanin-like optoelectronic properties but is virtually devoid of intrinsic fluorescence. Herein we disclose the first PDA-based system that can develop fluorescence without chemical manipulation. The polymerization of dopamine in the presence of oil microdroplets results in the formation of smooth PDA-coated core-shell droplets, which develop a bright and persistent fluorescence upon UVA illumination. The fluorescence induction depends on the excitation wavelength, the nature of the oil, and oxidation and buffer conditions, suggesting photo-oxidation of PDA components within the oil matrix, which shields the developing fluorophores from water quenching. Peroxyl radical scavengers enhance the fluorescence, whereas hydrogen peroxide induces quenching. The new system holds potential interest for imaging and tocopherol sensing applications.
C1 [Quignard, Sandrine] PSL Res Univ, Ecole Normale Super, Dept Chim, F-75005 Paris, France.
   [Chen, Yong] Univ Paris 06, Sorbonne Univ, PASTEUR, F-75005 Paris, France.
   [Fattaccioli, Jacques] CNRS, UMR PASTEUR 8640, F-75005 Paris, France.
   [d'Ischia, Marco] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy.
RP Fattaccioli, J (reprint author), CNRS, UMR PASTEUR 8640, F-75005 Paris, France.
EM jacques.fattaccioli@ens.fr
RI FATTACCIOLI, Jacques/A-4464-2009; d'Ischia, Marco/C-9837-2011; Chen,
   Yong/A-1700-2009
OI FATTACCIOLI, Jacques/0000-0002-0095-2576; d'Ischia,
   Marco/0000-0002-7184-0029; 
CR Chen X, 2014, LANGMUIR, V30, P2921, DOI 10.1021/la4049133
   Corani A, 2012, J PHYS CHEM B, V116, P13151, DOI 10.1021/jp306436f
   Cui JW, 2010, ADV FUNCT MATER, V20, P1625, DOI 10.1002/adfm.201000209
   D'Ischia M, 2005, ADV HETEROCYCL CHEM, V89, P1, DOI 10.1016/S0065-2725(05)89001-4
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Gauden M, 2008, J AM CHEM SOC, V130, P17038, DOI 10.1021/ja806345q
   Kang SM, 2009, J AM CHEM SOC, V131, P13224, DOI 10.1021/ja905183k
   Kerimo J, 2011, PHOTOCHEM PHOTOBIOL, V87, P1042, DOI 10.1111/j.1751-1097.2011.00949.x
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Leal-Calderon F., 2007, EMULSION SCI BASIC P
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Liebscher J, 2013, LANGMUIR, V29, P10539, DOI 10.1021/la4020288
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Lulinski P, 2007, MOLECULES, V12, P2434, DOI 10.3390/12112434
   Lynge ME, 2011, ACS APPL MATER INTER, V3, P2142, DOI 10.1021/am200358p
   Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x
   Nighswander-Rempel SP, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2075147
   Nighswander-Rempel SP, 2005, J PHYS CHEM B, V109, P20629, DOI 10.1021/jp053704+
   Nocera GM, 2014, RSC ADV, V4, P11564, DOI 10.1039/c3ra47063f
   Oshima J, 2006, CHEM PHYS LETT, V423, P306, DOI 10.1016/j.cplett.2006.03.073
   Teuchner K, 2000, J FLUORESC, V10, P275, DOI 10.1023/A:1009453228102
   Tran ML, 2006, BIOPHYS J, V90, P743, DOI 10.1529/biophysj.105.069096
   Wang WC, 2011, J COLLOID INTERF SCI, V358, P567, DOI 10.1016/j.jcis.2011.03.023
   Xu CJ, 2004, J AM CHEM SOC, V126, P9938, DOI 10.1021/ja0464802
   Xu HL, 2011, CHEM MATER, V23, P5105, DOI 10.1021/cm2028417
   YASUNOBU KT, 1957, J BIOL CHEM, V227, P473
   Ye Q, 2011, CHEM SOC REV, V40, P4244, DOI 10.1039/c1cs15026j
   Zhang XY, 2012, NANOSCALE, V4, P5581, DOI 10.1039/c2nr31281f
NR 30
TC 11
Z9 11
U1 3
U2 86
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2192-6506
J9 CHEMPLUSCHEM
JI ChemPlusChem
PD SEP
PY 2014
VL 79
IS 9
BP 1254
EP 1257
DI 10.1002/cplu.201402157
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA AP3PL
UT WOS:000341989100003
DA 2018-10-20
ER

PT J
AU Gu, XN
   Li, SS
   Li, XM
   Fan, YB
AF Gu, Xue-Nan
   Li, Shuang-Shuang
   Li, Xiao-Ming
   Fan, Yu-Bo
TI Magnesium based degradable biomaterials: A review
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE magnesium alloy; degradable biomaterial; coating; degradation; corrosion
ID CALCIUM-PHOSPHATE COATINGS; IN-VITRO DEGRADATION; ZN-ZR ALLOY; MG-CA
   ALLOYS; PLASMA ELECTROLYTIC OXIDATION; BONE IMPLANT APPLICATION;
   BIO-CORROSION PROPERTIES; MECHANICAL-PROPERTIES; VIVO CORROSION;
   RARE-EARTH
AB Magnesium has been suggested as a revolutionary biodegradable metal for biomedical applications. The corrosion of magnesium, however, is too rapid to match the rates of tissue healing and, additionally, exhibits the localized corrosion mechanism. Thus it is necessary to control the corrosion behaviors of magnesium for their practical use. This paper comprehensively reviews the research progress on the development of representative magnesium based alloys, including Mg-Ca, Mg-Sr, Mg-Zn and Mg-REE alloy systems as well as the bulk metallic glass. The influence of alloying element on their microstructures, mechanical properties and corrosion behaviors is summarized. The mechanical and corrosion properties of wrought magnesium alloys are also discussed in comparison with those of cast alloys. Furthermore, this review also covers research carried out in the field of the degradable coatings on magnesium alloys for biomedical applications. Calcium phosphate and biodegradable polymer coatings are discussed based on different preparation techniques used. We also compare the effect of different coatings on the corrosion behaviors of magnesium alloys substrate.
C1 [Gu, Xue-Nan; Li, Shuang-Shuang; Li, Xiao-Ming; Fan, Yu-Bo] Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China.
RP Gu, XN (reprint author), Beihang Univ, Sch Biol Sci & Med Engn, Key Lab Biomech & Mechanobiol, Minist Educ, Beijing 100191, Peoples R China.
EM xngu@buaa.edu.cn
RI Gu, Xuenan/F-5354-2011
FU National Basic Research Program of China (973 Program) [2012CB619102,
   2012CB619100]; Specialized Research Fund for the Doctoral Program of
   Higher Education [20121102120037]; National Natural Science Foundation
   of China [31370959]; Fok Ying Tong Education Foundation [141039];
   Beijing Natural Science Foundation [7142094]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (Grant Nos. 2012CB619102 and 2012CB619100), Specialized
   Research Fund for the Doctoral Program of Higher Education under Grant
   No. 20121102120037, the National Natural Science Foundation of China
   (Grant No. 31370959), Fok Ying Tong Education Foundation (Grant No.
   141039), and Beijing Natural Science Foundation (Grant No. 7142094).
   Xuenan would like to thank Dr. Fuzhai Cui at Tsinghua University for the
   kindly invitation of this review.
CR Alvarez-Lopez M, 2010, ACTA BIOMATER, V6, P1763, DOI 10.1016/j.actbio.2009.04.041
   Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   Avedesian M. M., 1999, ASM SPECIALTY HDB MA
   Bae DH, 2002, ACTA MATER, V50, P2343, DOI 10.1016/S1359-6454(02)00067-8
   Birbilis N, 2009, CORROS SCI, V51, P683, DOI 10.1016/j.corsci.2008.12.012
   Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045
   Bowman B., 2006, PRESENT KNOWLEDGE NU
   Brar HS, 2014, MAT SCI ENG C-MATER, V40, P407, DOI 10.1016/j.msec.2014.03.055
   Brar HS, 2012, J MECH BEHAV BIOMED, V7, P87, DOI 10.1016/j.jmbbm.2011.07.018
   Chang JW, 2007, CORROS SCI, V49, P2612, DOI 10.1016/j.corsci.2006.12.011
   Chang TC, 2006, MATER LETT, V60, P3272, DOI 10.1016/j.matlet.2006.03.052
   Chen XB, 2011, CORROS SCI, V53, P2263, DOI 10.1016/j.corsci.2011.03.008
   Cipriano AF, 2013, J MATER SCI-MATER M, V24, P989, DOI 10.1007/s10856-013-4853-1
   Dahl SG, 2001, BONE, V28, P446, DOI 10.1016/S8756-3282(01)00419-7
   Datta MK, 2011, MATER SCI ENG B-ADV, V176, P1637, DOI 10.1016/j.mseb.2011.08.008
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Erdmann N, 2011, ACTA BIOMATER, V7, P1421, DOI 10.1016/j.actbio.2010.10.031
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   Friedrich H E, 2005, MAGNESIUM TECHNOLOGY
   Gao JH, 2011, MATER LETT, V65, P691, DOI 10.1016/j.matlet.2010.11.015
   Gray-Munro JE, 2009, J BIOMED MATER RES A, V90A, P339, DOI 10.1002/jbm.a.32107
   Gruhl S, 2009, J ANAL ATOM SPECTROM, V24, P181, DOI 10.1039/b813734j
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2011, MATER SCI ENG B-ADV, V176, P1802, DOI 10.1016/j.mseb.2011.04.003
   Gu XN, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044109
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guan RG, 2013, MAT SCI ENG C-MATER, V33, P3661, DOI 10.1016/j.msec.2013.04.054
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hanzi AC, 2009, INT J MATER RES, V100, P1127, DOI 10.3139/146.110157
   Han HS, 2013, J MECH BEHAV BIOMED, V20, P54, DOI 10.1016/j.jmbbm.2012.12.007
   Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6
   Hofstetter J, 2014, JOM-US, V66, P566, DOI 10.1007/s11837-014-0875-5
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Jeong YS, 2014, CORROS SCI, V82, P392, DOI 10.1016/j.corsci.2014.01.041
   Kang F, 2010, ADV ENG MATER, V12, P730, DOI 10.1002/adem.201000014
   Kannan MB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045003
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Lee JY, 2005, MATER LETT, V59, P3801, DOI 10.1016/j.matlet.2005.06.052
   Li JN, 2010, J MATER SCI, V45, P6038, DOI 10.1007/s10853-010-4688-9
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu M, 2010, CORROS SCI, V52, P3687, DOI 10.1016/j.corsci.2010.07.019
   Lorenz C, 2009, ACTA BIOMATER, V5, P2783, DOI 10.1016/j.actbio.2009.04.018
   Ma E, 2009, NAT MATER, V8, P855, DOI 10.1038/nmat2550
   Marie PJ, 2006, BONE, V38, P10, DOI 10.1016/j.bone.2005.07.029
   Nakamura Y, 1997, FUND APPL TOXICOL, V37, P106, DOI 10.1006/faat.1997.2322
   Nielsen SP, 2004, BONE, V35, P583, DOI 10.1016/j.bone.2004.04.026
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   PIERCE FS, 1993, SCIENCE, V261, P737, DOI 10.1126/science.261.5122.737
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Saw B A, 2003, ASM HDB A
   Sealy MP, 2010, J MECH BEHAV BIOMED, V3, P488, DOI 10.1016/j.jmbbm.2010.05.003
   Seiler HG, 1988, HDB TOXICITY INORGAN
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Sigel H., 1986, METAL IONS BIOL SYST
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Srinivasan PB, 2010, APPL SURF SCI, V256, P4017, DOI 10.1016/j.apsusc.2010.01.069
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun HF, 2012, T NONFERR METAL SOC, V22, pS445, DOI 10.1016/S1003-6326(12)61744-0
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Tan LL, 2014, ACTA BIOMATER, V10, P2333, DOI 10.1016/j.actbio.2013.12.020
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Wang HX, 2011, COLLOID SURFACE B, V88, P254, DOI 10.1016/j.colsurfb.2011.06.040
   Wang Q, 2011, MATER SCI ENG B-ADV, V176, P1718, DOI 10.1016/j.mseb.2011.06.005
   Wessels V, 2012, ADV ENG MATER, V14, pB357, DOI 10.1002/adem.201180200
   Willbold E, 2013, ACTA BIOMATER, V9, P8509, DOI 10.1016/j.actbio.2013.02.015
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Wu Q, 2012, J MECH BEHAV BIOMED, V8, P1, DOI 10.1016/j.jmbbm.2011.12.011
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   Yamagishi H, 2010, MATER TRANS, V51, P1255, DOI 10.2320/matertrans.M2009432
   Yang JX, 2009, IEEE T PLASMA SCI, V37, P1161, DOI 10.1109/TPS.2009.2016664
   Yang L, 2013, ACTA BIOMATER, V9, P8499, DOI 10.1016/j.actbio.2013.03.017
   Yang L, 2013, ACTA BIOMATER, V9, P8475, DOI 10.1016/j.actbio.2012.10.001
   Yang L, 2012, J MECH BEHAV BIOMED, V13, P36, DOI 10.1016/j.jmbbm.2012.04.007
   Yang L, 2011, MATER SCI ENG B-ADV, V176, P1827, DOI 10.1016/j.mseb.2011.02.025
   Yao ZP, 2009, APPL SURF SCI, V255, P6724, DOI 10.1016/j.apsusc.2009.02.082
   Yin P, 2013, J MATER SCI-MATER M, V24, P1365, DOI 10.1007/s10856-013-4856-y
   Zarandi F., 2011, MAGNESIUM ALLOYS DES
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zberg B, 2009, ACTA MATER, V57, P3223, DOI 10.1016/j.actamat.2009.03.028
   Zeng RC, 2006, T NONFERR METAL SOC, V16, pS763, DOI 10.1016/S1003-6326(06)60297-5
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zeng RC, 2013, T NONFERR METAL SOC, V23, P3293, DOI 10.1016/S1003-6326(13)62866-6
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang BP, 2011, MAT SCI ENG C-MATER, V31, P1667, DOI 10.1016/j.msec.2011.07.015
   Zhang CY, 2010, T NONFERR METAL SOC, V20, pS655, DOI 10.1016/S1003-6326(10)60556-0
   Zhang CY, 2010, SURF COAT TECH, V204, P3636, DOI 10.1016/j.surfcoat.2010.04.038
   Zhang E, 2008, MAT SCI ENG A-STRUCT, V488, P102, DOI 10.1016/j.msea.2007.10.056
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang WB, 2011, ACTA BIOMATER, V7, P800, DOI 10.1016/j.actbio.2010.08.031
   Zhang XB, 2012, MATER LETT, V74, P128, DOI 10.1016/j.matlet.2012.01.086
   Zhang XB, 2012, J MECH BEHAV BIOMED, V9, P153, DOI 10.1016/j.jmbbm.2012.02.002
   Zhang XB, 2012, J MECH BEHAV BIOMED, V7, P77, DOI 10.1016/j.jmbbm.2011.05.026
   Zhang XB, 2012, MATER LETT, V66, P209, DOI 10.1016/j.matlet.2011.08.079
   Zhang X, 2012, PROG NAT SCI-MATER, V22, P169, DOI 10.1016/j.pnsc.2012.03.014
   Zhang YJ, 2009, J BIOMED MATER RES B, V89B, P408, DOI 10.1002/jbm.b.31228
   Zhao YY, 2012, J ALLOY COMPD, V515, P154, DOI 10.1016/j.jallcom.2011.11.125
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 122
TC 32
Z9 33
U1 5
U2 237
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD SEP
PY 2014
VL 8
IS 3
BP 200
EP 218
DI 10.1007/s11706-014-0253-9
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA AP4PH
UT WOS:000342059600002
DA 2018-10-20
ER

PT J
AU Zeng, RC
   Wang, L
   Zhang, DF
   Cui, HZ
   Han, EH
AF Zeng, Rong-Chang
   Wang, Lei
   Zhang, Ding-Fei
   Cui, Hong-Zhi
   Han, En-Hou
TI In vitro corrosion of Mg-6Zn-1Mn-4Sn-1.5Nd/0.5Y alloys
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE magnesium alloy; yttrium; neodymium; corrosion; biomaterial
ID MAGNESIUM-ZINC ALLOY; MECHANICAL-PROPERTIES; PHOSPHATE COATINGS; PURE
   MAGNESIUM; HANKS SOLUTION; SN ADDITION; CA ALLOY; MICROSTRUCTURE;
   RESISTANCE; APATITE
AB The microstructure evaluation, surface morphology, chemical compositions and phase analysis of the biomedical Mg-6Zn-1Mn-4Sn-1.5Nd/0.5Y (ZMT614-1.5Nd/0.5Y) alloys were investigated by means of optical microscopy, EPMA, X-ray EDS, XRD and FTIR. The corrosion behavior was evaluated using weight-loss measurement, hydrogen evolution, electrochemical and pH measurements. The results demonstrate that the microstructure for both ZMT614-1.5Nd alloy and ZMT614-0.5Y alloy is characterized by alpha-Mg and intermetallic compounds, most of which are distributed along the grain boundaries. These second phases contain Mg2Zn, Mg2Zn11, Mg2Sn and single metal Mn, together with Mg12Nd phase for the ZMT614-1.5Nd alloy, and with Mg24Y5 phase for the ZMT614-0.5Y alloy. Honeycomb-like corrosion product layers form. The corrosion resistance of the ZMT614-0.5Y alloy is higher than that of the ZMT614-1.5Nd alloy, which is ascribed to the addition of the element Y into the alloy delaying the corrosion initiation in comparison to that of Nd element in the alloy.
C1 [Zeng, Rong-Chang; Wang, Lei; Cui, Hong-Zhi] Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
   [Zhang, Ding-Fei] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
   [Han, En-Hou] Chinese Acad Sci, Inst Met Res, Natl Engn Ctr Corros Control, Shenyang 110016, Peoples R China.
RP Zeng, RC (reprint author), Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
EM rczeng@foxmail.com; zhangdingfei@cqu.edu.cn
RI Zeng, Rong-Chang/H-4154-2011
OI Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [51241001]; Natural Science
   Foundation of Shandong Province [ZR2011EMM004]; Open Foundation of State
   Key Laboratory for Corrosion and Protection [SKLCP21012KF03]; SDUST
   Research Fund; Taishan Scholarship Project of Shandong Province
   [TS20110828]
FX This research was financially supported by the National Natural Science
   Foundation of China (Grant No. 51241001), the Natural Science Foundation
   of Shandong Province (Grant No. ZR2011EMM004), the Open Foundation of
   State Key Laboratory for Corrosion and Protection (Grant No.
   SKLCP21012KF03), SDUST Research Fund and Taishan Scholarship Project of
   Shandong Province (Grant No. TS20110828).
CR Chen DY, 2011, INT J MOL MED, V28, P343, DOI 10.3892/ijmm.2011.707
   Chen J, 2008, T NONFERR METAL SOC, V18, P361
   Chen JH, 2008, J ALLOY COMPD, V461, P209, DOI 10.1016/j.jallcom.2007.07.066
   CHUN JS, 1969, J MATER SCI, V4, P861, DOI 10.1007/BF00549777
   CLARK JB, 1965, ACTA METALL MATER, V13, P1281, DOI 10.1016/0001-6160(65)90039-8
   He WW, 2010, MAT SCI ENG C-MATER, V30, P167, DOI 10.1016/j.msec.2009.09.014
   Hu GS, 2014, J RARE EARTH, V32, P52, DOI 10.1016/S1002-0721(14)60033-8
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kouisni L, 2004, SURF COAT TECH, V185, P58, DOI 10.1016/j.surfcoat.2003.10.061
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Li GY, 2006, SURF COAT TECH, V201, P1814, DOI 10.1016/j.surfcoat.2006.03.006
   Li ZC, 2014, ELECTROCHIM ACTA, V115, P56, DOI 10.1016/j.electacta.2013.10.131
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu M, 2010, CORROS SCI, V52, P3687, DOI 10.1016/j.corsci.2010.07.019
   Maeng DY, 2000, SCRIPTA MATER, V43, P385, DOI 10.1016/S1359-6462(00)00428-0
   Nakatsugawa I, 2003, MATER SCI FORUM, V419-4, P845, DOI 10.4028/www.scientific.net/MSF.419-422.845
   Qi FG, 2014, J ALLOY COMPD, V585, P656, DOI 10.1016/j.jallcom.2013.09.156
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song YW, 2009, J ALLOY COMPD, V484, P585, DOI 10.1016/j.jallcom.2009.04.137
   Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P399, DOI 10.1016/S0753-3322(03)00081-7
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yu K, 2002, THESIS CENTRAL S U C
   Zeng 2 R. C., 2006, T NONFERR METAL SOC, V16, P763
   Zeng R C, 2007, T NONFERR METAL SOC, V17, P166
   Zeng RC, 2001, ACTA METALL SIN, V37, P673
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zeng RC, 2011, J ALLOY COMPD, V509, P4462, DOI 10.1016/j.jallcom.2011.01.116
   Zeng RC, 2010, RARE METALS, V29, P193, DOI 10.1007/s12598-010-0033-3
   Zhang DF, 2011, T NONFERR METAL SOC, V21, P15, DOI 10.1016/S1003-6326(11)60672-9
   Zhang DF, 2013, RARE METAL MAT ENG, V42, P931
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang HJ, 2013, MATER LETT, V92, P45, DOI 10.1016/j.matlet.2012.10.051
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhao MC, 2009, CORROS SCI, V51, P1277, DOI 10.1016/j.corsci.2009.03.014
NR 36
TC 8
Z9 8
U1 1
U2 19
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD SEP
PY 2014
VL 8
IS 3
BP 230
EP 243
DI 10.1007/s11706-014-0256-6
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA AP4PH
UT WOS:000342059600004
DA 2018-10-20
ER

PT J
AU Liu, CL
   Zhang, Y
   Zhang, CY
   Wang, W
   Huang, WJ
   Chu, PK
AF Liu, Cheng-Long
   Zhang, Yi
   Zhang, Chun-Yan
   Wang, Wei
   Huang, Wei-Jiu
   Chu, Paul K.
TI Synergistic effect of chloride ion and albumin on the corrosion of pure
   magnesium
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Article
DE magnesium; corrosion; albumin; biomaterial
ID IN-VITRO; ALLOY AZ91D; BEHAVIOR; DEGRADATION; TITANIUM; PROTEINS;
   IMPLANTS; SULFATE; FLUID; SERUM
AB In this work, we report on synergistic effect of chloride ion and albumin on the corrosion of pure magnesium through corrosion tests. We show that the adsorption of albumin mainly affects the anodic polarization behavior of pure magnesium in NaCl solution. Low concentration of albumin enhances the reaction reactivity of pure magnesium and the initial evolvement of hydrogen at the initial immersion time. Addition of 1 g/L albumin provides limited corrosion control for pure magnesium in NaCl solution. In comparison with low concentration albumin, addition of 10 g/L albumin can effectively inhibit the further dissolution of pure magnesium in test solutions with NaCl concentration of 0.2-0.8 wt.%, but this effect lowers gradually with increasing the concentration of chloride ion.
C1 [Liu, Cheng-Long; Zhang, Yi; Zhang, Chun-Yan; Wang, Wei; Huang, Wei-Jiu] Chongqing Univ Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
   [Chu, Paul K.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Huang, WJ (reprint author), Chongqing Univ Technol, Sch Mat Sci & Engn, Chongqing 400050, Peoples R China.
EM huangweijiu@cqut.edu.cn
RI Chu, Paul/B-5923-2013
OI Chu, Paul/0000-0002-5581-4883
FU National Natural Science Foundation of China [31000430, 51201192];
   Science and Technology Development Program of Chongqing Science and
   Technology Commission [cstc2012gg-yyjs0224]
FX The work was financially supported by the National Natural Science
   Foundation of China (Grant Nos. 31000430 and 51201192) and the Science
   and Technology Development Program of Chongqing Science and Technology
   Commission (cstc2012gg-yyjs0224).
CR Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047
   Cohavi O, 2010, J MOL RECOGNIT, V23, P259, DOI 10.1002/jmr.993
   Contu F, 2002, J BIOMED MATER RES, V62, P412, DOI 10.1002/jbm.10329
   Gu XN, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065011
   Hara N, 2007, CORROS SCI, V49, P166, DOI 10.1016/j.corsci.2006.05.033
   Hornberger H, 2011, MATER SCI ENG B-ADV, V176, P1746, DOI 10.1016/j.mseb.2011.07.018
   Klinger A, 1997, J BIOMED MATER RES, V36, P387, DOI 10.1002/(SICI)1097-4636(19970905)36:3<387::AID-JBM13>3.0.CO;2-B
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Ouerd A, 2007, J ELECTROCHEM SOC, V154, pC593, DOI 10.1149/1.2769819
   Padilla N, 2007, J BIOMED MATER RES A, V81A, P531, DOI 10.1002/jbm.a.31046
   Qu Q, 2011, CORROS SCI, V53, P1186, DOI 10.1016/j.corsci.2010.12.014
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song GL, 2004, MAT SCI ENG A-STRUCT, V366, P74, DOI 10.1016/j.msea.2003.08.060
   Song S G, 1998, CORROS SCI, V40, P1769
   Song YW, 2009, MAT SCI ENG C-BIO S, V29, P1039, DOI 10.1016/j.msec.2008.08.026
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Vogt C, 2010, P 8 INT C MAGN ALL T, P1162
   Wang L, 2010, J ALLOY COMPD, V496, P500, DOI 10.1016/j.jallcom.2010.02.088
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Xin YC, 2010, J ELECTROCHEM SOC, V157, pC238, DOI 10.1149/1.3421651
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Zhang YJ, 2005, CORROS SCI, V47, P2816, DOI 10.1016/j.corsci.2005.01.010
NR 30
TC 4
Z9 5
U1 0
U2 15
PU HIGHER EDUCATION PRESS
PI BEIJING
PA NO 4 DEWAI DAJIE, BEIJING 100120, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD SEP
PY 2014
VL 8
IS 3
BP 244
EP 255
DI 10.1007/s11706-014-0251-y
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA AP4PH
UT WOS:000342059600005
DA 2018-10-20
ER

PT J
AU Ungerleider, JL
   Christman, KL
AF Ungerleider, Jessica L.
   Christman, Karen L.
TI Concise Review: Injectable Biomaterials for the Treatment of Myocardial
   Infarction and Peripheral Artery Disease: Translational Challenges and
   Progress
SO STEM CELLS TRANSLATIONAL MEDICINE
LA English
DT Review
DE Myocardial infarction; Peripheral arterial disease; Biocompatible
   materials; Translational medical research
ID EXTRACELLULAR-MATRIX SCAFFOLD; HINDLIMB ISCHEMIC MODEL; CRITICAL LIMB
   ISCHEMIA; SOURCE ANIMAL AGE; THERAPEUTIC ANGIOGENESIS; CARDIAC-FUNCTION;
   STEM-CELLS; PEPTIDE NANOFIBER; DELIVERY-SYSTEM; SKELETAL-MUSCLE
AB Recently, injectable biomaterial-based therapies for cardiovascular disease have been gaining attention, because they have shown therapeutic potential in preclinical models for myocardial infarction (MI) and peripheral artery disease (PAD). Naturally derived (e.g., alginate, hyaluronic acid, collagen, or extracellular matrix-based) or synthetic (e.g., peptide or polymer-based) materials can enhance stem cell survival and retention in vivo, prolong growth factor release from bulk hydrogel or particle constructs, and even stimulate endogenous tissue regeneration as a standalone therapy. Although there are many promising preclinical examples, the therapeutic potential of biomaterial-based products for cardiovascular disease has yet to be proved on a clinical and commercial scale. This review aims to briefly summarize the latest preclinical and clinical studies on injectable biomaterial therapies for MI and PAD. Furthermore, our overall goal is to highlight the major challenges facing translation of these therapies to the clinic (e.g., regulatory, manufacturing, and delivery), with the purpose of increasing awareness of the barriers for translating novel biomaterial therapies for MI and PAD and facilitating more rapid translation of new biomaterial technologies.
C1 [Ungerleider, Jessica L.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, Dept Bioengn, La Jolla, CA 92037 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Sanford Consortium Regenerat Med, Dept Bioengn, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU NIH Heart, Lung, and Blood Institute [5R01HL113468]; American Heart
   Association [12PILT12440002]
FX This work was funded in part by the NIH Heart, Lung, and Blood Institute
   (Grant 5R01HL113468) and by the American Heart Association
   (12PILT12440002).
CR Abbasalizadeh S, 2013, BIOTECHNOL ADV, V31, P1600, DOI 10.1016/j.biotechadv.2013.08.009
   Agudelo CA, 2012, BIOMATERIALS, V33, P2439, DOI 10.1016/j.biomaterials.2011.11.075
   BioLineRx Ltd, NCT00557531 SAF FEAS
   Burdick JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3003997
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   DeQuach JA, 2012, EUR CELLS MATER, V23, P400, DOI 10.22203/eCM.v023a31
   Eckhouse SR, 2014, SCI TRANSL MED, V6
   Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x
   Fujita M, 2013, J BIOMED MATER RES B, V101B, P36, DOI 10.1002/jbm.b.32808
   Giancola Raffaella, 2012, Muscles Ligaments Tendons J, V2, P243
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hu XY, 2007, EUR J CARDIO-THORAC, V31, P438, DOI 10.1016/j.ejcts.2006.11.057
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Ikaria Holdings Inc, NCT01226563 IK 5001
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Johnson T. D., 2014, BIOMATER SCI, V2014
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Kim J, 2011, NANO LETT, V11, P694, DOI 10.1021/nl103812a
   Kim JH, 2013, BIOMATERIALS, V34, P1657, DOI 10.1016/j.biomaterials.2012.11.008
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Koudstaal S, 2014, J CARDIOVASC TRANSL, V7, P232, DOI 10.1007/s12265-013-9518-4
   Kuraitis D, 2011, EUR CELLS MATER, V22, P109, DOI 10.22203/eCM.v022a09
   Ladage D, 2011, GENE THER, V18, P979, DOI 10.1038/gt.2011.52
   Lee J, 2010, PHARM RES-DORDR, V27, P767, DOI 10.1007/s11095-010-0067-0
   Lee RJ, 2013, CELL TRANSPLANT, V22, P529, DOI 10.3727/096368911X637461
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu Y, 2006, EUR J CARDIO-THORAC, V30, P103, DOI 10.1016/j.ejcts.2006.03.043
   LoneStar Heart Inc, NCT00847964 SAF FEAS
   LoneStar Heart Inc, NCT01311791 RAND CON
   Marui A, 2007, CIRC J, V71, P1181, DOI 10.1253/circj.71.1181
   Mayfield AE, 2014, BIOMATERIALS, V35, P133, DOI 10.1016/j.biomaterials.2013.09.085
   Mima Y, 2012, PLOS ONE, V7
   Mukherjee R, 2008, ANN THORAC SURG, V86, P1268, DOI 10.1016/j.athoracsur.2008.04.107
   Nakamura S, 2012, TISSUE ENG PT A, V18, P2239, DOI [10.1089/ten.tea.2011.0741, 10.1089/ten.TEA.2011.0741]
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Ostchega Y, 2007, J AM GERIATR SOC, V55, P583, DOI 10.1111/j.1532-5415.2007.01123.x
   Ouma GO, 2012, VASC MED, V17, P174, DOI 10.1177/1358863X12438270
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Polizzotti BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036788
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2011, J CARDIOVASC TRANSL, V4, P545, DOI 10.1007/s12265-011-9293-z
   Seiler J.P., 2005, GOOD LAB PRACTICE WH
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Tang ZCW, 2011, BIOMATERIALS, V32, P75, DOI 10.1016/j.biomaterials.2010.08.085
   Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   U.S. Food and Drug Administration, 2011, DRAFT GUID IND FDA S
   U.S. Food and Drug Administration, GUID IND PRECL ASS I
   Wang JL, 2012, J BIOMED MATER RES A, V100A, P1438, DOI 10.1002/jbm.a.34081
   Webber MJ, 2011, P NATL ACAD SCI USA, V108, P13438, DOI 10.1073/pnas.1016546108
   White CJ, 2007, CIRCULATION, V116, P2203, DOI 10.1161/CIRCULATIONAHA.106.621391
   Wood L, RES MARKETS MYOCARDI
   Xie JQ, 2013, CARDIOVASC THER, V31, pe12, DOI 10.1111/j.1755-5922.2012.00317.x
   Zhao YL, 2011, J BIOMAT SCI-POLYM E, V22, P665, DOI 10.1163/092050610X489880
NR 62
TC 38
Z9 39
U1 5
U2 75
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 2157-6564
EI 2157-6580
J9 STEM CELL TRANSL MED
JI Stem Cells Transl. Med.
PD SEP
PY 2014
VL 3
IS 9
BP 1090
EP 1099
DI 10.5966/sctm.2014-0049
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA AP6LJ
UT WOS:000342189000025
PM 25015641
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Mendes, AC
   Zelikin, AN
AF Mendes, Ana C.
   Zelikin, Alexander N.
TI Enzyme Prodrug Therapy Engineered into Biomaterials
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALCOHOL) PHYSICAL HYDROGELS;
   NITRIC-OXIDE SYNTHASE; RAW 264.7 CELLS; POLY(VINYL ALCOHOL);
   POLYVINYL-ALCOHOL; MACROMOLECULAR PRODRUGS; CANCER PREVENTION;
   POLYMER-COATINGS; DELIVERY-SYSTEM
AB In this work, enzyme-prodrug therapy (EPT) is engineered into hydrogel biomaterials to achieve localized synthesis of the drugs and their delivery to the adhering cells. The use of EPT in the context of drug delivery mediated by biomaterials significantly empowers the latter in that the same hydrogel is used to successfully synthesize several drugs with dissimilar structures and therapeutic effects. The concentration of the synthesized drugs is conveniently controlled by the concentration of the administered prodrugs. Using prodrugs for two therapeutic agents allows their synthesis and delivery with independent control over the concentration and the time of administration of each of the drugs. Using these tools, sequential delivery of drugs for anti-inflammatory and anti-proliferative activity is accomplished whereby the synthesis of drugs is mediated by the same enzyme-functionalized hydrogel. The use of EPT to perform combination therapy mediated by an implantable biomaterial is also reported. Taken together, these results contribute significantly to the development of flexible and highly powerful tools of substrate-mediated drug delivery with applications in the design of therapeutic implants and tissue engineering.
C1 [Mendes, Ana C.; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.
   [Zelikin, Alexander N.] Aarhus Univ, INano Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark.
RP Mendes, AC (reprint author), Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.
EM zelikin@chem.au.dk
RI Zelikin, Alexander/J-3659-2012; Mendes, Ana/A-8738-2017
OI Zelikin, Alexander/0000-0002-9864-321X; Mendes, Ana/0000-0002-6790-9185
FU Novo Nordisk Foundation
FX This study was supported by a grant from the Novo Nordisk Foundation.
   Authors thank Benjamin M. Wohl (Aarhus University) for expert advice on
   cell culture and quantification of nitric oxide.
CR Acharya G, 2006, ADV DRUG DELIVER REV, V58, P387, DOI 10.1016/j.addr.2006.01.016
   Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Andreasen SO, 2014, NANOSCALE, V6, P4131, DOI 10.1039/c3nr05999e
   Aydin D., 2012, INTELLIGENT SURFACES, P291
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Ben PL, 2011, INT IMMUNOPHARMACOL, V11, P179, DOI 10.1016/j.intimp.2010.11.013
   Carter S, 2009, HPB, V11, P541, DOI 10.1111/j.1477-2574.2009.00071.x
   Chaouat M, 2008, ADV FUNCT MATER, V18, P2855, DOI 10.1002/adfm.200701261
   Chong SF, 2013, SMALL, V9, P942, DOI 10.1002/smll.201201774
   CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X
   Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10
   Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X
   De Clercq E, 2007, NAT REV DRUG DISCOV, V6, P1001, DOI 10.1038/nrd2424
   Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958
   Fejerskov B., 2012, LANGMUIR, V29, P344
   Fejerskov B, 2014, SMALL, V10, P1314, DOI 10.1002/smll.201303101
   Fejerskov B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049619
   Fejerskov B, 2012, ACS APPL MATER INTER, V4, P4981, DOI 10.1021/am3013467
   Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Heath JR, 2008, ANNU REV MED, V59, P251, DOI 10.1146/annurev.med.59.061506.185523
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hosta-Rigau L, 2012, ADV HEALTHC MATER, V1, P791, DOI 10.1002/adhm.201200092
   HUBER BE, 1994, ANN NY ACAD SCI, V716, P104, DOI 10.1111/j.1749-6632.1994.tb21706.x
   Jensen BEB, 2013, NANOSCALE, V5, P6758, DOI 10.1039/c3nr01662e
   Karaman M, 2011, ARCH MED RES, V42, P79, DOI 10.1016/j.arcmed.2011.01.011
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Kryger MBL, 2013, CHEM COMMUN, V49, P2643, DOI 10.1039/c3cc00315a
   Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lehouritis P, 2013, J CONTROL RELEASE, V170, P120, DOI 10.1016/j.jconrel.2013.05.005
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc.1074
   Lu ZR, 1999, NAT BIOTECHNOL, V17, P1101
   Lupattelli T, 2005, EUR J RADIOL, V54, P136, DOI 10.1016/j.ejrad.2004.04.006
   Malmstrom J, 2010, NANO LETT, V10, P686, DOI 10.1021/nl903875r
   Mickova A, 2012, BIOMACROMOLECULES, V13, P952, DOI 10.1021/bm2018118
   Moorcroft MJ, 2001, TALANTA, V54, P785, DOI 10.1016/S0039-9140(01)00323-X
   Mullard A, 2013, NAT REV DRUG DISCOV, V12, P329, DOI 10.1038/nrd4009
   Nawa A, 2008, ANTI-CANCER AGENT ME, V8, P232, DOI 10.2174/187152008783497000
   Niculescu-Duvaz I, 1998, BIOCONJUGATE CHEM, V9, P4, DOI 10.1021/bc970116t
   Oberoi HS, 2011, J CONTROL RELEASE, V153, P64, DOI 10.1016/j.jconrel.2011.03.028
   Pereg D, 2005, J INTERN MED, V258, P115, DOI 10.1111/j.1365-2796.2005.01519.x
   Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977
   Ren GL, 2006, REACT FUNCT POLYM, V66, P1559, DOI 10.1016/j.reactfunctpolym.2006.05.005
   Satchi R, 2001, BRIT J CANCER, V85, P1070, DOI 10.1054/bjoc.2001.2026
   Schellmann N, 2010, MINI-REV MED CHEM, V10, P887, DOI 10.2174/138955710792007196
   Shankarappa SA, 2012, P NATL ACAD SCI USA, V109, P17555, DOI 10.1073/pnas.1214634109
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smith AAA, 2014, ADV HEALTHC MATER, V3, P1404, DOI 10.1002/adhm.201300637
   Solomon B, 1999, J VASC INTERV RADIOL, V10, P793, DOI 10.1016/S1051-0443(99)70117-X
   Springer CJ, 2000, ADV EXP MED BIOL, V465, P403
   SPRINGER CJ, 1997, ADV DRUG DELIV REV, V26, P151
   Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X
   Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Ulrich CM, 2006, NAT REV CANCER, V6, P130, DOI 10.1038/nrc1801
   Walker G, 1997, J BIOL CHEM, V272, P16679, DOI 10.1074/jbc.272.26.16679
   Wang Y, 2008, J MEMBRANE SCI, V309, P73, DOI 10.1016/j.memsci.2007.10.008
   Wohl BM, 2013, BIOMACROMOLECULES, V14, P3916, DOI 10.1021/bm401048s
   Wu LL, 2005, J MEMBRANE SCI, V250, P167, DOI 10.1016/j.memsci.2004.10.024
   Xu G, 2001, CLIN CANCER RES, V7, P3314
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zhao L, 2004, CLIN CANCER RES, V10, P7994, DOI 10.1158/1078-0432.CCR-04-1087
NR 70
TC 14
Z9 15
U1 3
U2 44
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD SEP
PY 2014
VL 24
IS 33
BP 5202
EP 5210
DI 10.1002/adfm.201304312
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AO9TF
UT WOS:000341699200004
DA 2018-10-20
ER

PT J
AU Shrirao, AB
   Kung, FH
   Yip, D
   Cho, CH
   Townes-Anderson, E
AF Shrirao, Anil B.
   Kung, Frank H.
   Yip, Derek
   Cho, Cheul H.
   Townes-Anderson, Ellen
TI Vacuum-assisted fluid flow in microchannels to pattern substrates and
   cells
SO BIOFABRICATION
LA English
DT Article
DE substrate patterning; cell patterning; soft lithography;
   vacuum-assisted; microfluidics
ID MICROFLUIDIC DEVICES; IN-VITRO; BIOSENSOR APPLICATIONS; NEURITE
   OUTGROWTH; CULTURE; SURFACES; GROWTH; COCULTURE; DIFFERENTIATION;
   BIOMOLECULES
AB Substrate and cell patterning are widely used techniques in cell biology to study cell-to-cell and cell-substrate interactions. Conventional patterning techniques work well only with simple shapes, small areas and selected bio-materials. This paper describes a method to distribute cell suspensions as well as substrate solutions into complex, long, closed (dead-end) polydimethylsiloxane (PDMS) microchannels using negative pressure. Our method builds upon a previous vacuum-assisted method used for micromolding (Jeon et al 1999 Adv. Mater 11 946) and successfully patterned collagen-I, fibronectin and Sal-1 substrates on glass and polystyrene surfaces, filling microchannels with lengths up to 120 mm and covering areas up to 13 x 10 mm(2). Vacuum-patterned substrates were subsequently used to culture mammalian PC12 and fibroblast cells and amphibian neurons. Cells were also patterned directly by injecting cell suspensions into microchannels using vacuum. Fibroblast and neuronal cells patterned using vacuum showed normal growth and minimal cell death indicating no adverse effects of vacuum on cells. Our method fills reversibly sealed PDMS microchannels. This enables the user to remove the PDMS microchannel cast and access the patterned biomaterial or cells for further experimental purposes. Overall, this is a straightforward technique that has broad applicability for cell biology.
C1 [Shrirao, Anil B.; Townes-Anderson, Ellen] Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07102 USA.
   [Kung, Frank H.; Townes-Anderson, Ellen] Rutgers State Univ, Grad Sch Biomed Sci, New Jersey Inst Technol, Joint Program Biomed Engn, Newark, NJ USA.
   [Yip, Derek; Cho, Cheul H.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.
RP Shrirao, AB (reprint author), Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07102 USA.
EM anilshrirao@gmail.com; frank.kung@rutgers.edu; derek.s.yip@gmail.com;
   cho@njit.edu; andersel@njms.rutgers.edu
FU NIH [EY 012031, NS 051157]; Wallace H Coulter Foundation; F M Kirby
   Foundation
FX This work was supported by NIH grant EY 012031 (ET-A), NIH Training
   Grant NS 051157 (FHK), an award from the Wallace H Coulter Foundation
   (CHC) and an award from the F M Kirby Foundation (ET-A).
CR Alom R S, 2007, SOFT MATTER, V3, P168, DOI DOI 10.1039/B613349E
   Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z
   Bernard A, 2000, ANAL CHEM, V73, P8
   BHATIA SN, 1994, ANN NY ACAD SCI, V745, P187
   Bogdanowicz DR, 2013, BIOTECHNOL J, V8, P395, DOI 10.1002/biot.201300054
   Cai L, 2012, LANGMUIR, V28, P12557, DOI 10.1021/la302868q
   Carola E, 2007, THESIS MALARDALEN U
   Choi YH, 2005, J MECH SCI TECHNOL, V19, P2133, DOI 10.1007/BF02916509
   CLARK P, 1993, J CELL SCI, V105, P203
   Clarke RJ, 2008, MOL VIS, V14, P706
   Dickinson LE, 2012, LAB CHIP, V12, P4244, DOI 10.1039/c2lc40819h
   Douvas A, 2002, BIOSENS BIOELECTRON, V17, P269, DOI 10.1016/S0956-5663(01)00294-9
   Durst CA, 2011, ACTA BIOMATER, V7, P2467, DOI 10.1016/j.actbio.2011.02.018
   Edahiro J, 2005, BIOMACROMOLECULES, V6, P970, DOI 10.1021/bm0493382
   Feng HY, 2004, CRYOBIOLOGY, V49, P241, DOI 10.1016/j.cryobiol.2004.08.003
   Ferrell N, 2010, ANAL CHEM, V82, P2380, DOI 10.1021/ac902596b
   Folch A, 2000, J BIOMED MATER RES, V52, P346, DOI 10.1002/1097-4636(200011)52:2<346::AID-JBM14>3.0.CO;2-H
   GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747
   Hwang IT, 2011, ACS APPL MATER INTER, V3, P2235, DOI 10.1021/am200630p
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Jeon NL, 1999, ADV MATER, V11, P946, DOI 10.1002/(SICI)1521-4095(199908)11:11<946::AID-ADMA946>3.0.CO;2-9
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   KAPPELI O, 1981, BIOTECHNOL BIOENG, V23, P1897, DOI 10.1002/bit.260230817
   Khademhosseini A, 2006, BIOMATERIALS, V27, P5968, DOI 10.1016/j.biomaterials.2006.06.035
   Kim DS, 2002, J MICROMECH MICROENG, V12, P236, DOI 10.1088/0960-1317/12/3/307
   Kim E, 1996, J AM CHEM SOC, V118, P5722, DOI 10.1021/ja960151v
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Lin Ruei-Zeng, 2006, Biotechnology Journal, V1, P949, DOI 10.1002/biot.200600112
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z
   NachmanClewner M, 1996, J NEUROCYTOL, V25, P597, DOI 10.1007/BF02284827
   Occhetta P, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035002
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Peng CC, 2013, LAB CHIP, V13, P3239, DOI 10.1039/c3lc50388g
   Petrucci R.H., 2007, GEN CHEM PRINCIPLES
   Poudel I, 2013, ACTA BIOMATER, V9, P4592, DOI 10.1016/j.actbio.2012.08.039
   Rhee SW, 2005, LAB CHIP, V5, P102, DOI 10.1039/b403091e
   Shrirao AB, 2012, BIOTECHNIQUES, V53, P315, DOI 10.2144/000113928
   Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851
   Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Veiseh M, 2002, LANGMUIR, V18, P6671, DOI 10.1021/la025529j
   Vendruscolo F., 2012, ISRN CHEM ENG, V2012, DOI DOI 10.5402/2012/601458
   Wang L, 2009, BIOMED MICRODEVICES, V11, P679, DOI 10.1007/s10544-008-9278-0
   Watanabe H, 1989, Nihon Hoigaku Zasshi, V43, P233
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yang IH, 2011, J BIOMED MATER RES A, V97A, P451, DOI 10.1002/jbm.a.33082
   Yeo WS, 2003, J AM CHEM SOC, V125, P14994, DOI 10.1021/ja038265b
   Zhou JW, 2010, ELECTROPHORESIS, V31, P2, DOI 10.1002/elps.200900475
NR 50
TC 6
Z9 6
U1 1
U2 35
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD SEP
PY 2014
VL 6
IS 3
AR 035016
DI 10.1088/1758-5082/6/3/035016
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AP1IX
UT WOS:000341823500016
PM 24989641
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Soffer-Tsur, N
   Shevach, M
   Shapira, A
   Peer, D
   Dvir, T
AF Soffer-Tsur, Neta
   Shevach, Michal
   Shapira, Assaf
   Peer, Dan
   Dvir, Tal
TI Optimizing the biofabrication process of omentum-based scaffolds for
   engineering autologous tissues
SO BIOFABRICATION
LA English
DT Article
DE cardiac tissue engineering; decellularization; omentum; scaffolds
ID EXTRACELLULAR-MATRIX; XENOGENEIC TISSUE; BIOLOGIC SCAFFOLD; CARDIAC
   TISSUES; FIBER DIAMETER; ADIPOSE-TISSUE; DECELLULARIZATION; HEART;
   GLYCOSAMINOGLYCANS; DIFFERENTIATION
AB Omentum-based matrices fabricated by decellularization have the potential to serve as autologous scaffolds for tissue engineering. Transplantation of such scaffolds prepared from the patient's own biomaterial may reduce the immunogenic response after transplantation. Recently we reported on the potential of the decellularized omentum to support the assembly of functional vascularized cardiac patches. Here we compared five distinct protocols for omentum decellularization, utilizing chemical, physical and biological processes. We analyzed the efficiency of cell removal, scaffold macro and micro structure, biochemical composition and the ability of seeded cells to attach and proliferate in the matrix. Moreover, we assessed the ability of the distinct scaffolds to promote the organization of cardiac tissue.
C1 [Soffer-Tsur, Neta; Shevach, Michal; Shapira, Assaf; Dvir, Tal] Tel Aviv Univ, George S Wise Fac Life Sci, Lab Tissue Engn & Regenerat Med, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.
   [Soffer-Tsur, Neta; Peer, Dan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, Lab Nanomed, IL-69978 Tel Aviv, Israel.
   [Shevach, Michal; Peer, Dan; Dvir, Tal] Tel Aviv Univ, Ctr Nanosci & Nanotechnol, IL-69978 Tel Aviv, Israel.
   [Peer, Dan; Dvir, Tal] Tel Aviv Univ, Dept Mat Sci & Engn, IL-69978 Tel Aviv, Israel.
RP Soffer-Tsur, N (reprint author), Tel Aviv Univ, George S Wise Fac Life Sci, Lab Tissue Engn & Regenerat Med, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.
EM tdvir@post.tau.ac.il
OI Peer, Dan/0000-0001-8238-0673
FU European Union FP7 program (Marie Curie, CIG); Alon Fellowship; Israel
   Science Foundation; Nicholas and Elizabeth Slezak Super Center for
   Cardiac Research and Biomedical Engineering at Tel Aviv University
FX T. D acknowledges support from the European Union FP7 program (Marie
   Curie, CIG), Alon Fellowship, Israel Science Foundation and the Nicholas
   and Elizabeth Slezak Super Center for Cardiac Research and Biomedical
   Engineering at Tel Aviv University. The work is part of the doctoral
   thesis of N.S.T. at Tel-Aviv University.
CR [Anonymous], 2012, ORGAN PROCUREMENT TR
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Balguid A, 2009, TISSUE ENG PT A, V15, P437, DOI 10.1089/ten.tea.2007.0294
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Brown BN, 2011, TISSUE ENG PART C-ME, V17, P411, DOI [10.1089/ten.tec.2010.0342, 10.1089/ten.TEC.2010.0342]
   Burk J, 2013, CYTOM PART A, V83A, P103, DOI 10.1002/cyto.a.22216
   Christie W W, 1993, ADV LIPID METHODOLOG, P195
   Cissell DD, 2014, J BIOMECH, V47, P1987, DOI 10.1016/j.jbiomech.2013.10.041
   Collins D, 2009, J GASTROINTEST SURG, V13, P1138, DOI 10.1007/s11605-009-0855-1
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Dvir T, 2007, TISSUE ENG, V13, P2185, DOI 10.1089/ten.2006.0364
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Fleischer S, 2014, BIOTECHNOL BIOENG, V111, P1246, DOI 10.1002/bit.25185
   Fleischer S, 2013, CURR OPIN BIOTECH, V24, P664, DOI 10.1016/j.copbio.2012.10.016
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hayat M A, 2012, STEM CELLS CANC STEM, V9
   Hishida M, 2010, NAGOYA J MED SCI, V72, P91
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   Liebermann-Meffert D, 2000, SURG CLIN N AM, V80, P275, DOI 10.1016/S0039-6109(05)70406-0
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Linhardt RJ, 2004, ACCOUNTS CHEM RES, V37, P431, DOI 10.1021/ar030138x
   Litbarg NO, 2007, CELL TISSUE RES, V328, P487, DOI 10.1007/s00441-006-0356-4
   Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Patel RS, 2009, HEAD NECK-J SCI SPEC, V31, P655, DOI 10.1002/hed.21016
   Platell C, 2000, WORLD J GASTROENTERO, V6, P169
   Porzionato A, 2013, EUR J HISTOCHEM, V57, P24, DOI 10.4081/ejh.2013.e4
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   SCHWINDT R, 1986, J HEALTH POLIT POLIC, V11, P483, DOI 10.1215/03616878-11-3-483
   Shelton EL, 2013, J TISSUE ENG REGEN M, V7, P421, DOI 10.1002/term.528
   Shevach M, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024101
   Shevach M, 2013, J MATER CHEM B, V1, P5210, DOI 10.1039/c3tb20584c
   Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Yang C, 2009, Patent, Patent No. [EP 2229191, 2229191]
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zahler P., 1977, METHODS MEMBRANE BIO, P1
NR 48
TC 3
Z9 3
U1 1
U2 13
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD SEP
PY 2014
VL 6
IS 3
AR 035023
DI 10.1088/1758-5082/6/3/035023
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AP1IX
UT WOS:000341823500023
PM 25162210
DA 2018-10-20
ER

PT J
AU Yan, L
   Zhang, L
   Ma, HY
   Chiu, D
   Bryers, JD
AF Yan, Lin
   Zhang, Lei
   Ma, Hongyan
   Chiu, David
   Bryers, James D.
TI A Single B-Repeat of Staphylococcus epidermidis Accumulation-Associated
   Protein Induces Protective Immune Responses in an Experimental
   Biomaterial-Associated Infection Mouse Model
SO CLINICAL AND VACCINE IMMUNOLOGY
LA English
DT Article
ID DELIVERED POLYCLONAL ANTIBODIES; BIOFILM FORMATION;
   INTERCELLULAR-ADHESION; MICE; EFFICACY; IGG2C; IMMUNOGLOBULIN; ZINC
AB Nosocomial infections are the fourth leading cause of morbidity and mortality in the United States, resulting in 2 million infections and similar to 100,000 deaths each year. More than 60% of these infections are associated with some type of biomedical device. Staphylococcus epidermidis is a commensal bacterium of the human skin and is the most common nosocomial pathogen infecting implanted medical devices, especially those in the cardiovasculature. S. epidermidis antibiotic resistance and biofilm formation on inert surfaces make these infections hard to treat. Accumulation-associated protein (Aap), a cell wall-anchored protein of S. epidermidis, is considered one of the most important proteins involved in the formation of S. epidermidis biofilm. A small recombinant protein vaccine comprising a single B-repeat domain (Brpt1.0) of S. epidermidis RP62A Aap was developed, and the vaccine's efficacy was evaluated in vitro with a biofilm inhibition assay and in vivo in a murine model of biomaterial-associated infection. A high IgG antibody response against S. epidermidis RP62A was detected in the sera of the mice after two subcutaneous immunizations with Brpt1.0 coadministered with Freund's adjuvant. Sera from Brpt1.0-immunized mice inhibited in vitro S. epidermidis RP62A biofilm formation in a dose-dependent pattern. After receiving two immunizations, each mouse was surgically implanted with a porous scaffold disk containing 5 x 10(6) CFU of S. epidermidis RP62A. Weight changes, inflammatory markers, and histological assay results after challenge with S. epidermidis indicated that the mice immunized with Brpt1.0 exhibited significantly higher resistance to S. epidermidis RP62A implant infection than the control mice. Day 8 postchallenge, there was a significantly lower number of bacteria in scaffold sections and surrounding tissues and a lower residual inflammatory response to the infected scaffold disks for the Brpt1.0-immunized mice than for of the ovalbumin (Ova)-immunized mice.
C1 [Yan, Lin; Zhang, Lei; Ma, Hongyan; Chiu, David; Bryers, James D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Ma, Hongyan; Bryers, James D.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Bryers, JD (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM jbryers@uw.edu
RI Zhang, Lei/H-5729-2013; ma, hongyan/H-1707-2012
FU NIH/NIAID [R01AI074661]
FX This work is funded by NIH/NIAID grant R01AI074661.
CR Barekzi NA, 1999, ANTIMICROB AGENTS CH, V43, P1609, DOI 10.1128/AAC.43.7.1609
   Barekzi NA, 2002, PHARMACEUT RES, V19, P1801, DOI 10.1023/A:1021481122011
   Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   Broekhuizen CAN, 2009, BIOMATERIALS, V30, P6444, DOI 10.1016/j.biomaterials.2009.08.018
   Conrady DG, 2013, P NATL ACAD SCI USA, V110, pE202, DOI 10.1073/pnas.1208134110
   Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105
   Cooper A, 2013, CARBOHYD POLYM, V92, P254, DOI 10.1016/j.carbpol.2012.08.114
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Douglas AR, 2009, DIRECT MED COSTS HEA
   GAGNON RF, 1993, INT J ARTIF ORGANS, V16, P789
   Gagnon RF, 1992, ASAIO J, V38, P596
   Gruszka DT, 2012, P NATL ACAD SCI USA, V109, pE1011, DOI 10.1073/pnas.1119456109
   Guo YZ, 2008, ARTHRITIS RHEUM, V58, P764, DOI 10.1002/art.23263
   Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020918
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Lautenbach E., 2001, MAKING HLTH CARE SAF, V43
   Ma HY, 2013, J CONTROL RELEASE, V172, P1035, DOI 10.1016/j.jconrel.2013.10.005
   Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09
   Mack D, 2013, BIOMATERIALS ASS INF
   Mack D, 2009, TOP CURR CHEM, V288, P157, DOI 10.1007/128_2008_19
   Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Petrushina I, 2003, NEUROSCI LETT, V338, P5, DOI 10.1016/S0304-3940(02)01357-5
   Poelstra KA, 2002, J BIOMED MATER RES, V60, P206, DOI 10.1002/jbm.10069
   Poelstra KA, 2000, TISSUE ENG, V6, P401, DOI 10.1089/107632700418100
   Pourmand MR, 2011, J INFECT DEV COUNTR, V5, P34, DOI 10.3855/jidc.984
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Rossi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094699
   Shahrooei M, 2010, THESIS U LEUVEN LEUV
   Shahrooei M, 2012, INFECT IMMUN, V80, P3660, DOI 10.1128/IAI.00104-12
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang ZP, 2012, MOL IMMUNOL, V50, P169, DOI 10.1016/j.molimm.2011.11.006
NR 38
TC 10
Z9 10
U1 3
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1556-6811
EI 1556-679X
J9 CLIN VACCINE IMMUNOL
JI Clin. Vaccine Immunol.
PD SEP
PY 2014
VL 21
IS 9
BP 1206
EP 1214
DI 10.1128/CVI.00306-14
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA AO8SO
UT WOS:000341624800002
PM 24920603
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Klodowski, K
   Kaminski, J
   Nowicka, K
   Tarasiuk, J
   Wronski, S
   Swietek, M
   Blazewicz, M
   Figiel, H
   Turek, K
   Szponder, T
AF Klodowski, K.
   Kaminski, J.
   Nowicka, K.
   Tarasiuk, J.
   Wronski, S.
   Swietek, M.
   Blazewicz, M.
   Figiel, H.
   Turek, K.
   Szponder, T.
TI Micro-imaging of implanted scaffolds using combined MRI and micro-CT
SO COMPUTERIZED MEDICAL IMAGING AND GRAPHICS
LA English
DT Article
DE Magnetic resonance imaging; Micro-computed tomography; Image fusion;
   Medical imaging; Implant; Scaffold; Bone
ID HIGH-RESOLUTION MRI; CANCELLOUS BONE; QUANTIFICATION; MICROARCHITECTURE;
   HISTOMORPHOMETRY; HYDROXYAPATITE; NANOTECHNOLOGY; FEMUR; MODEL; SPINE
AB Rationale and objectives: Thanks to the advanced studies in biomaterial engineering a panoply of polymers can be used to manufacture porous scaffolds for bone tissue regeneration. Suitability of the scaffold for its purpose is determined by factors like size of the pores, its orientation and shape, as well as bio-compatibility of the material. Even though a variety of analysis methods is available for in vitro studies, investigating the process of bone reconstruction on implanted scaffold meets with difficulties.
   Methods and materials: Polylactide porous sponges imbued in hydroxyapatite were implanted into long bones of white New Zealand rabbits for 3 months. The bones obtained from the animals were subjected to MRI and mu CT imaging. The obtained images were subsequently fused together.
   Results and conclusions: Combined MRI and mu CT resulted in high resolution diagnostic images which allow for: implant positioning, inflammation divulgement, rating degree of implant resorption, observation of newly formed trabeculae, texture analysis and other quantitative measurements. (c) 2014 Elsevier Ltd. All rights reserved.
C1 [Klodowski, K.; Kaminski, J.; Tarasiuk, J.; Wronski, S.; Figiel, H.; Turek, K.] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, PL-30059 Krakow, Poland.
   [Nowicka, K.; Swietek, M.; Blazewicz, M.] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, PL-30059 Krakow, Poland.
   [Szponder, T.] Univ Life Sci Lublin, Fac Vet Med, Dept & Clin Anim Surg, PL-20950 Lublin, Poland.
RP Klodowski, K (reprint author), AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Al Mickiewicza 30, PL-30059 Krakow, Poland.
EM klodowski@fis.agh.edu.pl
RI Kaminski, Jakub/A-5265-2017; Klodowski, Krzysztof/M-1266-2018
OI Klodowski, Krzysztof/0000-0002-0880-5175
FU Polish Ministry of Science and Higher Education
FX This work was partially supported by Polish Ministry of Science and
   Higher Education.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Allo Bedilu A, 2012, J Funct Biomater, V3, P432, DOI 10.3390/jfb3020432
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   Batiste DL, 2004, OSTEOARTHR CARTILAGE, V12, P614, DOI 10.1016/j.joca.2004.03.002
   Carbonare LD, 2005, MICRON, V36, P609, DOI 10.1016/j.micron.2005.07.007
   Cattalini JP, 2013, PROCEDIA ENGINEER, V59, P78, DOI 10.1016/j.proeng.2013.05.096
   Chappard D., 2008, Morphologie, V92, P162, DOI 10.1016/j.morpho.2008.10.003
   Chen L, 2011, COMPOS SCI TECHNOL, V71, P1842, DOI 10.1016/j.compscitech.2011.08.015
   Cowin S. C., 2007, TISSUE MECH
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Dougherty R, 2007, MICROSC MICROANAL S2, V13, P1678, DOI DOI 10.1017/S1431927607074430
   Dumas A, 2009, OSTEOPOROSIS INT, V20, P435, DOI 10.1007/s00198-008-0658-3
   Ejbjerg BJ, 2005, ANN RHEUM DIS, V64, P1280, DOI 10.1136/ard.2004.029850
   FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612
   HARRIGAN TP, 1984, J MATER SCI, V19, P761, DOI 10.1007/BF00540446
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Jayabalan M, 2010, ACTA BIOMATER, V6, P763, DOI 10.1016/j.actbio.2009.09.015
   Kotela I, 2009, CERAM INT, V35, P2475, DOI 10.1016/j.ceramint.2009.02.016
   Lespessailles E, 2006, REV RHUM, V73, P435
   Link TM, 1998, J BONE MINER RES, V13, P122, DOI 10.1359/jbmr.1998.13.1.122
   Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   McRobbie DW, 2007, MRI PICTURE PROTON
   Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   Schmid B, 2010, BMC BIOINFORMATICS, V11, P1
   Subia B, 2010, TISSUE ENGINEERING, P141
   Tiainen H, 2012, ACTA BIOMATER, V8, P2384, DOI 10.1016/j.actbio.2012.02.020
   Toriwaki J, 2002, FORMA, V17, P183, DOI DOI 10.1006/CVIU.1999.0791
   van Lenthe GH, 2007, BIOMATERIALS, V28, P2479, DOI 10.1016/j.biomaterials.2007.01.017
   Volume graphics gmbh, 2013, REF MAN VGSTUD MAX R
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 35
TC 7
Z9 7
U1 1
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-6111
EI 1879-0771
J9 COMPUT MED IMAG GRAP
JI Comput. Med. Imaging Graph.
PD SEP
PY 2014
VL 38
IS 6
BP 458
EP 468
DI 10.1016/j.compmedimag.2014.06.014
PG 11
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA AO9KG
UT WOS:000341674000004
PM 25015635
DA 2018-10-20
ER

PT J
AU Oechsle, AM
   Wittmann, X
   Gibis, M
   Kohlus, R
   Weiss, J
AF Oechsle, Anja Maria
   Wittmann, Xandra
   Gibis, Monika
   Kohlus, Reinhard
   Weiss, Jochen
TI Collagen entanglement influenced by the addition of acids
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Collagen type I; Critical overlap concentration; Non-helical
   telopeptides; Hydration forces; pH; Reversed Hofmeister series
ID HOFMEISTER SERIES; I COLLAGEN; STABILITY; PROTEINS; CASINGS; PH;
   CONFORMATION; BIOMATERIAL; CHITOSAN; GELATIN
AB Collagen represents a biopolymer widely used in tissue engineering and the food industry. However, pH and acid effects, and the function of non-helical telopeptides on the collagen fibril microstructure and overall network structure are not completely understood. Thus, native and telopeptide-poor collagen type I were examined at different concentrations in order to characterize the pH and acids effects on the mechanical properties and entanglement characteristics of collagen suspensions. Collagen suspended in phosphoric, sulfuric, hydrochloric, or perchloric acid at pH 1, 2 and 3 were examined by rheological measurements and scanning electron microscopy.
   Collagen entanglement increases with increasing pH values below the isoelectric point. This was confirmed by critical overlap and entanglement concentrations, storage and loss moduli, as well as by scanning electron microscopy. Furthermore, decreased ionic strength, increased Debye screening lengths, increased intrinsic viscosities, and increased radii of gyration accompanied collagen entanglement. Phosphoric acid was the most effective acid in terms of critical overlap and entanglement concentrations. By contrast, oscillation tests assessed the highest storage modulus for perchloric acid, while sulfuric acid reinforced protein-solvent interactions according to the reversed Hofmeister series for pH values below the isoelectric point. Moreover, scanning electron microscopy visualized the acid effects for both, wherein native collagen revealed undefined, but finely meshed amorphous structures and telopeptide-poor collagen indicated crystalline-like and well-ordered structures.
   We demonstrated that collagen entanglement depends strongly on the pH and acid type, thus highlighting the importance of the preparation step of collagen raw materials for subsequent processing that could offer new insights for food manufacturers. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Oechsle, Anja Maria; Wittmann, Xandra; Gibis, Monika; Weiss, Jochen] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Phys & Meat Sci, D-70599 Stuttgart, Germany.
   [Kohlus, Reinhard] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Proc Engn, D-70599 Stuttgart, Germany.
RP Weiss, J (reprint author), Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Phys & Meat Sci, Garbenstr 21-25, D-70599 Stuttgart, Germany.
EM j.weiss@uni-hohenheim.de
OI Gibis, Monika/0000-0003-3386-6719
FU German Industrial-Academic Research Alliance (AiF); German Food &
   Nutrition Research Council (Forschungskreis der Ernaehrungsindustrie -
   FEI) [17478N]
FX This project was financed by a grant awarded by the German
   Industrial-Academic Research Alliance (AiF) and the German Food &
   Nutrition Research Council (Forschungskreis der Ernaehrungsindustrie -
   FEI) under the Grant Award Number 17478N.
CR Allen GM, 1999, AICHE J, V45, P1836
   Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981
   Barbut S, 2010, ITAL J FOOD SCI, V22, P126
   Beckett ST, 1995, ASPECTS FOOD PROCESS
   Bostrom M, 2005, BIOPHYS CHEM, V117, P217, DOI 10.1016/j.bpc.2005.05.010
   Broering JM, 2005, J PHYS CHEM B, V109, P20612, DOI 10.1021/jp053618+
   Buker M, 2009, KOLLAGEN KONZENTRAT
   BVL, 2011, AMTL SAMML UNT NACH
   Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363
   Carreau P. J., 1997, RHEOLOGY POLYM SYSTE
   Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441
   DEGENNES PG, 1976, MACROMOLECULES, V9, P587, DOI 10.1021/ma60052a011
   Desbrieres J, 1996, INT J BIOL MACROMOL, V19, P21, DOI 10.1016/0141-8130(96)01095-1
   Dewick P. M., 2013, ESSENTIALS ORGANIC C
   DOBRYNIN AV, 1995, MACROMOLECULES, V28, P1859, DOI 10.1021/ma00110a021
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   Freudenberg U, 2007, BIOPHYS J, V92, P2108, DOI 10.1529/biophysj.106.094284
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   FUJIWARA S, 1981, J BIOCHEM, V89, P1397, DOI 10.1093/oxfordjournals.jbchem.a133331
   Harper BA, 2012, FOOD RES INT, V49, P494, DOI 10.1016/j.foodres.2012.07.043
   Helgeson ME, 2010, J COLLOID INTERF SCI, V349, P1, DOI 10.1016/j.jcis.2010.05.045
   Highberger J. H., 1939, J AM CHEM SOC, V61, P2302
   Huggins ML, 1942, J AM CHEM SOC, V64, P2716, DOI 10.1021/ja01263a056
   JACKSON DS, 1957, BIOCHIM BIOPHYS ACTA, V26, P638, DOI 10.1016/0006-3002(57)90112-9
   Jiang FZ, 2004, J STRUCT BIOL, V148, P268, DOI 10.1016/j.jsb.2004.07.001
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   Kraemer EO, 1938, IND ENG CHEM, V30, P1200, DOI 10.1021/ie50346a023
   Kwansa AL, 2014, MATRIX BIOL, V34, P161, DOI 10.1016/j.matbio.2013.10.012
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LEIKIN S, 1995, NAT STRUCT BIOL, V2, P205, DOI 10.1038/nsb0395-205
   Liu L, 2007, MEAT SCI, V75, P196, DOI 10.1016/j.meatsci.2006.07.008
   Lovelady HH, 2014, BIOPOLYMERS, V101, P329, DOI 10.1002/bip.22365
   Matmaroh K, 2011, FOOD CHEM, V129, P1179, DOI 10.1016/j.foodchem.2011.05.099
   McClements D. J., 2005, FOOD EMULSIONS PRINC
   NA GC, 1989, BIOCHEMISTRY-US, V28, P7153, DOI 10.1021/bi00444a004
   Nystrom B, 1999, ADV COLLOID INTERFAC, V79, P81, DOI 10.1016/S0001-8686(98)00069-4
   Omta AW, 2003, SCIENCE, V301, P347, DOI 10.1126/science.1084801
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Osburn WN, 2002, PROTEIN-BASED FILMS AND COATINGS, P445
   PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4
   Reger D. L., 2009, CHEM PRINCIPLES PRAC
   REISER K, 1992, FASEB J, V6, P2439
   Shayegan M., 2012, BIOPHYS J, V100, p483a
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Usha R, 2010, INT J BIOL MACROMOL, V47, P402, DOI 10.1016/j.ijbiomac.2010.06.009
   von HIPPEL PETER H., 1963, BIOCHEMISTRY, V2, P1387, DOI 10.1021/bi00906a035
   von HIPPEL PETER H., 1962, BIOCHEMISTRY, V1, P664, DOI 10.1021/bi00910a020
   Yang H, 2007, J FOOD SCI, V72, pC430, DOI 10.1111/j.1750-3841.2007.00480.x
   Zanaboni G, 2000, MATRIX BIOL, V19, P511, DOI 10.1016/S0945-053X(00)00096-2
   Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020
NR 51
TC 15
Z9 16
U1 0
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD SEP
PY 2014
VL 58
BP 144
EP 156
DI 10.1016/j.eurpolymj.2014.06.015
PG 13
WC Polymer Science
SC Polymer Science
GA AO9KU
UT WOS:000341675400015
DA 2018-10-20
ER

PT J
AU Jiang, CP
   Chen, YY
AF Jiang, Cho-Pei
   Chen, Yo-Yu
TI Biofabrication of hybrid bone scaffolds using a dual-nozzle bioplotter
   and in-vitro study of osteoblast cell
SO INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING
LA English
DT Article
DE Biofabrication; Hybrid scaffold; Bioplotter; Osteoblast
ID SOLID FREEFORM FABRICATION; PHYSICAL-CHARACTERIZATION;
   MECHANICAL-PROPERTIES; TISSUE REGENERATION; DEPOSITION SYSTEM; PCL;
   HYDROXYAPATITE; POLYMER; POROSITY
AB Most bone scaffolds made of single biomaterial resulting in limited compressive strength and single property of cell adhesive. In this study, sandwich structures of the bone scaffold with different biomaterials are fabricated to mimic the mechanical properties of human bone. The fabricated scaffolds are also evaluated the cellular efficacy by cell culturing. In this study, biopolymer (mPEG-PCL-mPEG) is synthesized. Biocomposite is made of blending biopolymer with nano-hydroxyapatite (nHA). Both biomaterials are used to form the bone scaffolds with average pore size of 300 mu m using the developed dual-nozzle bioplotter system. Hybrid scaffolds with sandwich structures are proposed and fabricated. All scaffolds are underwent the compressive and microhardness test for comparing the mechanical properties with human bone. Furthermore, a mouse pre-osteoblast MC3T3-E1cell line is seeded onto fabricated scaffolds and cultured for 28 days for validating the biocompatibility and evaluating the cellular efficacy using methylthiazol tetrazolium (MTT) assay. Biocomposite scaffold has the highest ultimate compressive strength and microhardenss among the others. Ultimate compressive strength and microhardness of fabricated scaffold in vertical build plane are higher than those in horizontal build plane. Sandwich architecture of hybrid bone scaffold with biocomposite outer layer and biopolymer inner layer can improve cell adhesive and cellular efficacy.
C1 [Jiang, Cho-Pei] Natl Formosa Univ, Dept Power Mech Engn, Huwei Township 632, Yunlin County, Taiwan.
   [Chen, Yo-Yu] Natl Formosa Univ, Inst Mech & Electromech Engn, Huwei Township 632, Yunlin County, Taiwan.
RP Jiang, CP (reprint author), Natl Formosa Univ, Dept Power Mech Engn, 64 Wunhua Rd, Huwei Township 632, Yunlin County, Taiwan.
EM cpjiang@nfu.edu.tw
FU Ministry of Science and Technology of Taiwan [102-2622-E-150-017-CC1]
FX The authors gratefully acknowledge the financial support from the
   Ministry of Science and Technology of Taiwan under grant no.
   102-2622-E-150-017-CC1.
CR Chern MJ, 2013, INT J PRECIS ENG MAN, V14, P2201, DOI 10.1007/s12541-013-0298-1
   Cushnie EK, 2008, J BIOMED MATER RES A, V84A, P54, DOI 10.1002/jbm.a.31380
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Heo SJ, 2009, J BIOMED MATER RES A, V89A, P108, DOI 10.1002/jbm.a.31726
   Hoque ME, 2009, TISSUE ENG PT A, V15, P3013, DOI [10.1089/ten.tea.2008.0355, 10.1089/ten.TEA.2008.0355]
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jiang CP, 2013, BIOMED MICRODEVICES, V15, P369, DOI 10.1007/s10544-013-9740-5
   Jiang CP, 2011, RAPID PROTOTYPING J, V17, P288, DOI 10.1108/13552541111138414
   Jo S, 2013, MACROMOL BIOSCI, V13, P1389, DOI 10.1002/mabi.201300203
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim J, 2011, INT J PRECIS ENG MAN, V12, P695, DOI 10.1007/s12541-011-0090-z
   Lee EJ, 2010, ACTA BIOMATER, V6, P3557, DOI 10.1016/j.actbio.2010.03.022
   Liao CJ, 1999, BIOMATERIALS, V20, P1807, DOI 10.1016/S0142-9612(99)00076-9
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Sa MW, 2013, INT J PRECIS ENG MAN, V14, P649, DOI 10.1007/s12541-013-0087-x
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Zhao HS, 2012, B KOREAN CHEM SOC, V33, P1638, DOI 10.5012/bkcs.2012.33.5.1638
NR 18
TC 2
Z9 2
U1 1
U2 25
PU KOREAN SOC PRECISION ENG
PI SEOUL
PA RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010,
   SOUTH KOREA
SN 2234-7593
EI 2005-4602
J9 INT J PRECIS ENG MAN
JI Int. J. Precis. Eng. Manuf.
PD SEP
PY 2014
VL 15
IS 9
BP 1947
EP 1953
DI 10.1007/s12541-014-0549-9
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA AP1LD
UT WOS:000341830500021
DA 2018-10-20
ER

PT J
AU Covani, U
   Canullo, L
   Toti, P
   Alfonsi, F
   Barone, A
AF Covani, Ugo
   Canullo, Luigi
   Toti, Paolo
   Alfonsi, Fortunato
   Barone, Antonio
TI Tissue Stability of Implants Placed in Fresh Extraction Sockets: A
   5-Year Prospective Single-Cohort Study
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Alveolar bone grafting; alveolar bone loss; dental implants;
   single-tooth; gingival recession; materials; biocompatible; tooth
   extraction
ID RIDGE PRESERVATION TECHNIQUES; TOOTH IMPLANTS; CASE-SERIES; ANTERIOR
   MAXILLA; FOLLOW-UP; IMMEDIATE PLACEMENT; CLINICAL-TRIAL; AESTHETIC ZONE;
   HARD; SOFT
AB Background: Several materials have been used for ridge preservation after tooth extraction. This 5-year prospective single-cohort study is aimed at evaluating the success rate, marginal bone level (MBL), soft tissue stability, and subjective patient evaluation of implants placed in fresh extraction sockets with the use of a flapless technique and a xenograft to treat the peri-implant bone defect.
   Methods: Patients requiring a single implant in fresh extraction sockets were selected. After flapless extraction and implant insertion, the peri-implant bone defect was grafted with porcine bone. Collagen membrane was used to stabilize the graft. Four months later, a second surgery and prosthetic procedures were performed. Clinical parameters (width of keratinized gingiva [WKG], facial soft tissue level [FST], papilla index, plaque index, and bleeding on probing) were measured, and periapical radiographs were taken at the time of implant placement (baseline) and then at 1, 3, and 5 years thereafter. Image analysis software was applied to measure changes in the marginal bone level (Delta MBL). Additionally, patient satisfaction regarding the implant treatment was evaluated. All analyses were collected and measured by an independent, trained observer. Together with descriptive statistics, for each of the outcome variables, pairwise comparisons were performed using the Wilcoxon signed-rank test for matched samples. The level of statistical significance was set at 0.01 for all analyses.
   Results: Forty-seven consecutive patients were treated, with an implant survival rate at 5 years of 95.7%. Delta MBL showed statistically significant differences: mean values were -0.68 +/- 0.39, -0.94 +/- 0.44, and -1.08 +/- 0.43 mm at the 1, 3, and 5-year follow-up, respectively. Changes in WKG (Delta WKG) and FST (Delta FST) decreased from the 1-year point of the survey (0.80 +/- 0.79 and 0.71 +/- 0.73 mm for Delta WKG and Delta FST, respectively) to the last follow-up check at 5 years (0.67 +/- 0.74 and 0.56 +/- 0.69 mm for Delta WKG and Delta FST, respectively), with no significant differences. The papilla indexes showed significant differences among the baseline and all the other time points. Concerning patient satisfaction, at the last survey time point, 74% +/- 11.8% of patients were satisfied regarding the overall implant treatment, 73.0% +/- 11.1% gave a favorable opinion regarding the appearance of the peri-implant soft tissues, and 80.5% +/- 11.3% judged positively the finished appearance of the implant crown. No significant differences were obtained among the three follow-up times.
   Conclusions: The data of the present study suggest that the placement of a dental implant by means of a flapless technique in a fresh extraction socket filled with slowly resorbable graft biomaterial and with a delayed prosthetic restoration shows positive final esthetic outcomes. At the 5-year point of the survey, the changes in the bone level were minimal. Moreover, both midfacial tissue and the papillae maintained the early increase recorded before the first year of the follow-up.
C1 [Covani, Ugo; Toti, Paolo; Barone, Antonio] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, I-55041 Camaiore, Italy.
   [Covani, Ugo; Canullo, Luigi; Toti, Paolo; Alfonsi, Fortunato; Barone, Antonio] Versilia Gen Hosp, Tuscan Stomatol Inst, Lido Di Camaiore, Italy.
RP Barone, A (reprint author), Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Piazza Diaz 10, I-55041 Camaiore, Italy.
EM barosurg@gmail.com
FU Department of Surgery, Medical, Molecular, and Critical Area Pathology;
   University of Pisa; Pisa, Italy
FX This study was supported by a grant from the Department of Surgery,
   Medical, Molecular, and Critical Area Pathology; University of Pisa;
   Pisa, Italy. The authors report no conflicts of interest related to this
   study.
CR ASHMAN A, 1990, Journal of Oral Implantology, V16, P28
   Barone A, 2006, J PERIODONTOL, V77, P1914, DOI 10.1902/jop.2006.060072
   Barone A, 2015, CLIN IMPLANT DENT R, V17, P1114, DOI 10.1111/cid.12225
   Barone A, 2014, J PERIODONTOL, V85, P14, DOI 10.1902/jop.2013.120711
   Botticelli D, 2008, CLIN ORAL IMPLAN RES, V19, P1226, DOI 10.1111/j.1600-0501.2008.01620.x
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P33, DOI 10.1034/j.1600-0501.1990.010105.x
   Buser D, 2013, J PERIODONTOL, V84, P1517, DOI 10.1902/jop.2013.120635
   Caneva M, 2010, CLIN ORAL IMPLAN RES, V21, P885, DOI 10.1111/j.1600-0501.2010.01931.x
   Chen ST, 2009, J PERIODONTOL, V80, P163, DOI [10.1902/jop.2009.080243, 10.1902/jop.2009.080243 ]
   Cooper LF, 2010, INT J ORAL MAX IMPL, V25, P1222
   Cordaro L, 2009, CLIN ORAL IMPLAN RES, V20, P1307, DOI 10.1111/j.1600-0501.2009.01724.x
   Cosyn J, 2012, J CLIN PERIODONTOL, V39, P582, DOI 10.1111/j.1600-051X.2012.01888.x
   Cosyn J, 2011, J CLIN PERIODONTOL, V38, P746, DOI 10.1111/j.1600-051X.2011.01748.x
   Covani U, 2012, J PERIODONTOL, V83, P1226, DOI 10.1902/jop.2012.110583
   Crespi R, 2008, INT J ORAL MAX IMPL, V23, P753
   Darby I, 2009, INT J ORAL MAX IMPL, V24, P260
   De Rouck T, 2008, J CLIN PERIODONTOL, V35, P649, DOI 10.1111/j.1600-051X.2008.01235.x
   De Rouck T, 2009, CLIN ORAL IMPLAN RES, V20, P566, DOI 10.1111/j.1600-0501.2008.01674.x
   Festa VM, 2013, CLIN IMPLANT DENT R, V15, P707, DOI 10.1111/j.1708-8208.2011.00398.x
   Grundemann LJMM, 2000, J CLIN PERIODONTOL, V27, P9, DOI 10.1034/j.1600-051x.2000.027001009.x
   Grunder U, 2000, INT J PERIODONT REST, V20, P11
   Hammerle CHF, 2004, INT J ORAL MAX IMPL, V19, P26
   Hayacibara RM, 2013, CLIN ORAL IMPLAN RES, V24, P806, DOI 10.1111/j.1600-0501.2012.02461.x
   Iezzi G, 2012, CLIN ORAL IMPLAN RES, V23, P1369, DOI 10.1111/j.1600-0501.2011.02308.x
   Jemt T, 1997, Int J Periodontics Restorative Dent, V17, P326
   Juodzbalys G, 2007, CLIN ORAL IMPLAN RES, V18, P237, DOI 10.1111/j.1600-0501.2006.01312.x
   Kan JYK, 2003, INT J ORAL MAX IMPL, V18, P31
   Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x
   LOE H, 1967, J PERIODONTOL, V38, P610, DOI 10.1902/jop.1967.38.6.610
   Malchiodi L, 2011, INT J ORAL MAX IMPL, V26, P373
   Nordin T, 2007, CLIN ORAL IMPLAN RES, V18, P441, DOI 10.1111/j.1600-0501.2007.01387.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Prosper L, 2010, INT J ORAL MAX IMPL, V25, P607
   Raes F, 2011, J CLIN PERIODONTOL, V38, P385, DOI 10.1111/j.1600-051X.2010.01687.x
   Rasperini G, 2014, J PERIODONTOL, V85, pE152, DOI 10.1902/jop.2013.130415
   Sanz I, 2012, CLIN ORAL IMPLAN RES, V23, P67, DOI 10.1111/j.1600-0501.2011.02339.x
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   Suaid FA, 2014, CLIN ORAL IMPLAN RES, V25, pE10, DOI 10.1111/clr.12036
   Tan WL, 2012, CLIN ORAL IMPLAN RES, V23, P1, DOI 10.1111/j.1600-0501.2011.02375.x
   Testori T, 2004, CLIN ORAL IMPLAN RES, V15, P278, DOI 10.1111/j.1600-0501.2004.01013.x
   Thalmair T, 2013, J CLIN PERIODONTOL, V40, P721, DOI 10.1111/jcpe.12111
   Wagenberg B, 2006, INT J ORAL MAX IMPL, V21, P71
NR 42
TC 15
Z9 15
U1 0
U2 18
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD SEP
PY 2014
VL 85
IS 9
BP E323
EP E332
DI 10.1902/jop.2014.140175
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AO8CQ
UT WOS:000341580700001
PM 24835414
DA 2018-10-20
ER

PT J
AU Jebahi, S
   Oudadesse, H
   Ben Saleh, G
   Saoudi, M
   Mesadhi, S
   Rebai, T
   Keskes, H
   el Feki, A
   el Feki, H
AF Jebahi, Samira
   Oudadesse, Hassane
   Ben Saleh, Gada
   Saoudi, Mongi
   Mesadhi, Sirrar
   Rebai, Tarek
   Keskes, Hassib
   el Feki, Abdelfattah
   el feki, Hafed
TI Chitosan-based bioglass composite for bone tissue healing : Oxidative
   stress status and antiosteoporotic performance in a ovariectomized rat
   model
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Chitosan; Bioactive Glass; Graft Biomaterial; Osteoporosis;
   Antioxidative Profile; Bone Regeneration
AB Tissue engineering has opened up a new therapeutic avenue promising a revolution in regenerative medicine. Considerable attention has been given to chitosan composite materials and their applications in the field of the bone graft substitutes. We evaluated the antioxidative properties of chitosan-doped bioactive glass (BG-CH) with 17 wt% chitosan, and their applications in the guided bone regeneration. BG-CH was produced by a freeze-drying process and implanted in the femoral condyles of ovariectomized rats. Grafted bone tissues were carefully removed to evaluate the oxidative stress analysis, histomorphometric profile and mineral bone distribution by using inductively coupled plasma optical emission spectrometry (ICP-OES). A significant decrease of thiobarbituric acid-reactive substances (TBARs) was observed after BG-CH implantation. Superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) activities significantly increased in ovariectomized group implanted with chitosan-doped bioactive glass (OVXBG-CH) as compared to ovariectomized group implanted with bioactive glass (OVX-BG). The histomorphometric analysis showed that bone/tissue volume (BV/TV), osteoblast number (N.Ob) and osteoblast surface/bone surface (Ob.S/BS) were significantly higher in OVX-BG-CH group than in OVX-BG group. On the other hand, a rise in Ca and P ion concentrations in the implanted microenvironment was shown to lead to the formation/deposition of Ca-P phases. Trace elements such as Sr and Fe were detected in the newly formed bone and involved in bone healing. These results suggested that BG-CH composites could become clinically useful as a therapeutic and implantable material.
C1 [Jebahi, Samira; Oudadesse, Hassane] Univ Rennes 1, CNRS, UMR 6226, F-35042 Rennes, France.
   [Jebahi, Samira; Saoudi, Mongi; el Feki, Abdelfattah] Sfax Fac Sci, Dept Life Sci, Sfax, Tunisia.
   [el feki, Hafed] Sfax Fac Sci, Sci Mat & Environement Lab, Sfax, Tunisia.
   [Mesadhi, Sirrar; Rebai, Tarek; Keskes, Hassib] Sfax Fac Med, Histol Orthopaed & Traumatol Lab, Sfax, Tunisia.
   [Ben Saleh, Gada] Univ Sfax, Fac Med, Lab Human Mol Genet, Sfax, Tunisia.
RP Jebahi, S (reprint author), Univ Rennes 1, CNRS, UMR 6226, Campus Beaulieu,263 Av Gen Leclerc, F-35042 Rennes, France.
EM jbahisamira@yahoo.fr
CR AEBI H, 1984, Methods Enzymology, V105, P126
   Al-Deyab S. S., 2013, KOREAN J CHEM ENG, V30, P428
   Arya N., 2012, J R SOC INTERFACE
   Belalia R., 2008, AGR FOOD CHEM, V56, P8
   Buege J. A., 1984, METHOD ENZYMOL, V105, P310
   Bui X. V., 2012, KOREAN J CHEM ENG, V29, P220
   Chung Y. C., 2005, BIOTECHNOL, V96, P1482
   Dash M., 2011, PROG POLYM SCI, V36, P1014
   Del Maestro R. F., 1981, MICROVASC RES, V22, P70
   Denuziere A., 2000, ANN PHARM, V58, P53
   Doblare Manuel, 2003, Acta Cientifica Venezolana, V54, P58
   Hench L. L., 1973, J BIOMED MATER RES, V7, P42
   Iwata H., 2005, ORAL RADIOL, V21, P22
   Jarudilokkul S., 2011, KOREAN J CHEM ENG, V28, P1251
   Jayakumar R., 2011, BIOTECHNOL ADV, V29, P37
   Jebahi S., 2012, J APPL BIOMED, V10, P209
   Kucukalic-Selimovic E, 2011, BOSNIAN J BASIC MED, V11, P5
   Kurutas E. B., 2009, TURK J BIOL, V33, P282
   Lam K. K., 2009, AM J HYPERTENS, V22, P34
   Lean J. M., 2003, AM SOC CLIN INVEST, V112, P923
   Lee M. J., 2011, KOREAN J CHEM ENG, V28, P1411
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Luz GM, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054104
   Majeti N. V., 2000, REACT FUNCT POLYM, V46, P27
   Marklund S., 1975, EUR J BIOCHEM, V47, P474
   Mate-Sanchez de Val J. E., 2013, J BIOMED MAT RES A
   Mente P. L., 1989, J ORTHOP RES, V7, P461
   Mota J., 2012, ACTA BIOMATER, V8, P80
   Muthusam S., 2005, CLIN CHIM ACTA, V360, P6
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Oudadesse H., 2011, INT J BIOL BIOMED EN, V5, P56
   Pagila D. E., 1967, J LAB CLIN MED, V70, P169
   Rahaman M. N., 2011, ACTA BIOMATER, V7, P2373, DOI DOI 10.1016/J.ACTBI0.2011.03.016
   Rashid T. Ur, 2012, POLYM INT, V61, P1308
   Regnstrom K., 2006, PHARM RES, V23, P482
   Rochet N., 2009, BIOMATERIALS, V30, P7
   Russell T. T., 2001, REV ENDOCR METAB DIS, V2, P127
   Schenk R. K., 1969, ACTA ANAT, V74, P53
   Shahidi F., 1999, TRENDS FOOD SCI TECH, V10, P51
   Song K. E., 2008, CURR THERAP RES, V69, P36
   Tan G., 2012, TURK J BIOL, V36, P621
   Tian F., 2003, J MATER SCI, V38, P4712
   Ul-Islam M., 2011, KOREAN J CHEM ENG, V28, P1743
   Verrona E., 2010, BIOMATERIALS, V31, P84
NR 44
TC 5
Z9 5
U1 0
U2 12
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD SEP
PY 2014
VL 31
IS 9
BP 1616
EP 1623
DI 10.1007/s11814-014-0072-9
PG 8
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA AP0QR
UT WOS:000341768100015
DA 2018-10-20
ER

PT J
AU Shimomura, K
   Moriguchi, Y
   Ando, W
   Nansai, R
   Fujie, H
   Hart, DA
   Gobbi, A
   Kita, K
   Horibe, S
   Shino, K
   Yoshikawa, H
   Nakamura, N
AF Shimomura, Kazunori
   Moriguchi, Yu
   Ando, Wataru
   Nansai, Ryosuke
   Fujie, Hiromichi
   Hart, David A.
   Gobbi, Alberto
   Kita, Keisuke
   Horibe, Shuji
   Shino, Konsei
   Yoshikawa, Hideki
   Nakamura, Norimasa
TI Osteochondral Repair Using a Scaffold-Free Tissue-Engineered Construct
   Derived from Synovial Mesenchymal Stem Cells and a Hydroxyapatite-Based
   Artificial Bone
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   INTERCONNECTED POROUS HYDROXYAPATITE; COMPOSITE MULTILAYERED
   BIOMATERIAL; FULL-THICKNESS DEFECTS; SUBCHONDRAL BONE; IN-VITRO; KNEE
   ARTHROSCOPIES; PERIOSTEAL GRAFTS; CLUSTER FORMATION
AB For an ideal osteochondral repair, it is important to facilitate zonal restoration of the subchondral bone and the cartilage, layer by layer. Specifically, restoration of the osteochondral junction and secure integration with adjacent cartilage could be considered key factors. The purpose of the present study was to investigate the feasibility of a combined material comprising a scaffold-free tissue-engineered construct (TEC) derived from synovial mesenchymal stem cells (MSCs) and a hydroxyapatite (HA) artificial bone using a rabbit osteochondral defect model. Osteochondral defects were created on the femoral groove of skeletally mature rabbits. The TEC and HA artificial bone were hybridized to develop a combined implant just before use, which was then implanted into defects (N = 23). In the control group, HA alone was implanted (N = 18). Histological evaluation and micro-indentation testing was performed for the evaluation of repair tissue. Normal knees were used as an additional control group for biomechanical testing (N = 5). At hybridization, the TEC rapidly attached onto the surface of HA artificial bone block, which was implantable to osteochondral defects. Osteochondral defects treated with the combined implants exhibited more rapid subchondral bone repair coupled with the development of cartilaginous tissue with good tissue integration to the adjacent host cartilage when assessed at 6 months post implantation. Conversely, the control group exhibited delayed subchondral bone repair. In addition, the repair cartilaginous tissue in this group had poor integration to adjacent cartilage and contained clustered chondrocytes, suggesting an early osteoarthritis (OA)-like degenerative change at 6 months post implantation. Biomechanically, the osteochondral repair tissue treated with the combined implants at 6 months restored tissue stiffness, similar to normal osteochondral tissue. The combined implants significantly accelerated and improved osteochondral repair. Specifically, earlier restoration of subchondral bone, as well as good tissue integration of repair cartilage to adjacent host tissue could be clinically relevant in terms of the acceleration of postoperative rehabilitation and longer-term durability of repaired articular surface in patients with osteochondral lesions, including those with OA. In addition, the combined implant could be considered a promising MSC-based bio-implant with regard to safety and cost-effectiveness, considering that the TEC is a scaffold-free implant and HA artificial bone has been widely used in clinical practice.
C1 [Shimomura, Kazunori; Moriguchi, Yu; Kita, Keisuke; Yoshikawa, Hideki; Nakamura, Norimasa] Osaka Univ, Grad Sch Med, Dept Orthopaed, Suita, Osaka, Japan.
   [Ando, Wataru] Kansai Rosai Hosp, Dept Orthopaed, Amagasaki, Hyogo, Japan.
   [Nansai, Ryosuke; Fujie, Hiromichi] Kogakuin Univ, Dept Mech Engn, Biomech Lab, Hachioji, Tokyo, Japan.
   [Fujie, Hiromichi] Tokyo Metropolitan Univ, Fac Syst Design, Div Human Mechatron Syst, Hino, Tokyo, Japan.
   [Hart, David A.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada.
   [Gobbi, Alberto] Orthopaed Arthroscop Surg Int, Milan, Italy.
   [Horibe, Shuji] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Habikino, Osaka, Japan.
   [Shino, Konsei] Osaka Yukioka Coll Hlth Sci, Dept Phys Therapy, Ibaraki, Osaka, Japan.
   [Nakamura, Norimasa] Osaka Hlth Sci Univ, Inst Med Sci Sports, Osaka 5300043, Japan.
   [Nakamura, Norimasa] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan.
RP Nakamura, N (reprint author), Osaka Hlth Sci Univ, Inst Med Sci Sports, Kita Ku, 1-9-27 Tenma, Osaka 5300043, Japan.
EM norimasa.nakamura@ohsu.ac.jp
FU New Energy and Industrial Technology Development Organization, Japan;
   Japan Society for the Promotion of Science, Japan
FX This study was supported by a grant from the New Energy and Industrial
   Technology Development Organization, Japan, and Grant in Aid for
   Scientific Research (B), Japan Society for the Promotion of Science,
   Japan.
CR Ahn JH, 2009, TISSUE ENG PT A, V15, P2595, DOI 10.1089/ten.TEA.2008.0511
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Ando W, 2008, TISSUE ENG PT A, V14, P2041, DOI 10.1089/ten.tea.2008.0015
   Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   Bannuru RR, 2009, ARTHRIT RHEUM-ARTHR, V61, P1704, DOI 10.1002/art.24925
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   Bedi A, 2010, J BONE JOINT SURG AM, V92A, P994, DOI 10.2106/JBJS.I.00895
   Chen HM, 2011, AM J SPORT MED, V39, P1731, DOI 10.1177/0363546511403282
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Crawford DC, 2012, J BONE JOINT SURG AM, V94A, P979, DOI 10.2106/JBJS.K.00533
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Dawson J, 2004, RHEUMATOLOGY, V43, P497, DOI 10.1093/rheumatology/keh086
   Deie M, 2008, KNEE SURG SPORT TR A, V16, P753, DOI 10.1007/s00167-008-0558-2
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Ferruzi A, 2008, J BONE JOINT SURG AM, V90A, P90, DOI 10.2106/JBJS.H.00633
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2012, KNEE SURG SPORT TR A, V20, P2078, DOI 10.1007/s00167-011-1837-x
   Gao Jizong, 2002, Tissue Engineering, V8, P827, DOI 10.1089/10763270260424187
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Griffin MD, 2010, HUM GENE THER, V21, P1641, DOI 10.1089/hum.2010.156
   Harris ED, 2001, ARTHRITIS RHEUM, V44, P1969, DOI 10.1002/1529-0131(200109)44:9<1969::AID-ART342>3.0.CO;2-A
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Hosseini SM, 2013, OSTEOARTHR CARTILAGE, V21, P136, DOI 10.1016/j.joca.2012.09.002
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   Khan IM, 2010, OSTEOARTHR CARTILAGE, V18, P208, DOI 10.1016/j.joca.2009.08.011
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, ARTHROSCOPY, V27, P1490, DOI 10.1016/j.arthro.2011.05.011
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kuriyama K, 2009, MOD RHEUMATOL, V19, P180, DOI 10.1007/s10165-008-0147-8
   Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200
   Marmotti A, 2013, EUR CELLS MATER, V26, P15, DOI 10.22203/eCM.v026a02
   Marquass B, 2010, J ORTHOP RES, V28, P1586, DOI 10.1002/jor.21173
   McCormack T, 1998, J BIOMECH, V31, P55
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Miot S, 2006, J ORTHOP RES, V24, P1078, DOI 10.1002/jor.20098
   Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17
   Mrosek EH, 2010, J ORTHOP RES, V28, P141, DOI 10.1002/jor.20983
   Muldrew K, 2001, OSTEOARTHR CARTILAGE, V9, P432, DOI 10.1053/joca.2000.0409
   Nansai Ryosuke, 2010, Journal of Biomechanical Science and Engineering, V6, P40, DOI 10.1299/jbse.6.40
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Olivos-Meza A, 2010, OSTEOARTHR CARTILAGE, V18, P1183, DOI 10.1016/j.joca.2010.06.003
   Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91
   POOLE CA, 1991, ARTHRITIS RHEUM, V34, P22, DOI 10.1002/art.1780340105
   Quintavalla J, 2005, J CELL PHYSIOL, V204, P560, DOI 10.1002/jcp.20345
   Roemhildt ML, 2013, OSTEOARTHR CARTILAGE, V21, P346, DOI 10.1016/j.joca.2012.10.014
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Salzmanni GM, 2009, OSTEOARTHR CARTILAGE, V17, P1576, DOI 10.1016/j.joca.2009.07.010
   Schleicher I, 2013, J SURG RES, V183, P184, DOI 10.1016/j.jss.2012.11.036
   Shen C, 2009, KNEE SURG SPORT TR A, V17, P1406, DOI 10.1007/s00167-009-0726-z
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shimomura K, 2010, BIOMATERIALS, V31, P8004, DOI 10.1016/j.biomaterials.2010.07.017
   Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   Tamai N, 2010, J ORTHOP SCI, V15, P560, DOI 10.1007/s00776-010-1479-8
   Tateishi K, 2007, OSTEOARTHR CARTILAGE, V15, P709, DOI 10.1016/j.joca.2007.01.006
   Vasara AI, 2004, CALCIFIED TISSUE INT, V74, P107, DOI 10.1007/s00223-002-2153-8
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Yamasaki N, 2009, J BIOMED MATER RES B, V91B, P788, DOI 10.1002/jbm.b.31457
   Zhang SF, 2013, ACTA BIOMATER, V9, P7236, DOI 10.1016/j.actbio.2013.04.003
   Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013
NR 67
TC 27
Z9 27
U1 1
U2 24
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2291
EP 2304
DI 10.1089/ten.tea.2013.0414
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400003
PM 24655056
DA 2018-10-20
ER

PT J
AU Wrobel, S
   Serra, SC
   Ribeiro-Samy, S
   Sousa, N
   Heimann, C
   Barwig, C
   Grothe, C
   Salgado, AJ
   Haastert-Talini, K
AF Wrobel, Sandra
   Serra, Sofia Cristina
   Ribeiro-Samy, Silvina
   Sousa, Nuno
   Heimann, Claudia
   Barwig, Christina
   Grothe, Claudia
   Salgado, Antonio Jose
   Haastert-Talini, Kirsten
TI In Vitro Evaluation of Cell-Seeded Chitosan Films for Peripheral Nerve
   Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; SCHWANN-CELLS; REGENERATION; ACETYLATION;
   SECRETOME; PROLIFERATION; ATTACHMENT; INJURIES; CULTURES; DEFECTS
AB Natural biomaterials have attracted an increasing interest in the field of tissue-engineered nerve grafts, representing a possible alternative to autologous nerve transplantation. With the prospect of developing a novel entubulation strategy for transected nerves with cell-seeded chitosan films, we examined the biocompatibility of such films in vitro. Different types of rat Schwann cells (SCs)-immortalized, neonatal, and adult-as well as rat bone-marrow-derived mesenchymal stromal cells (BMSCs) were analyzed with regard to their cell metabolic activity, proliferation profiles, and cell morphology after different time points of mono-and cocultures on the chitosan films. Overall the results demonstrate a good cytocompatibility of the chitosan substrate. Both cell types were viable on the biomaterial and showed different metabolic activities and proliferation behavior, indicating cell-type-specific cell-biomaterial interaction. Moreover, the cell types also displayed their typical morphology. In cocultures adult SCs used the BMSCs as a feeder layer and no negative interactions between both cell types were detected. Further, the chitosan films allow neurite outgrowth from dissociated sensory neurons, which is additionally supported on film preseeded with SC-BMSC cocultures. The presented chitosan films therefore demonstrate high potential for their use in tissue-engineered nerve grafts.
C1 [Wrobel, Sandra; Grothe, Claudia; Haastert-Talini, Kirsten] Hannover Med Sch, Inst Neuroanat, Hannover, Germany.
   [Wrobel, Sandra; Grothe, Claudia; Haastert-Talini, Kirsten] Ctr Syst Neurosci ZSN, Hannover, Germany.
   [Serra, Sofia Cristina; Ribeiro-Samy, Silvina; Sousa, Nuno; Salgado, Antonio Jose] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal.
   [Serra, Sofia Cristina; Ribeiro-Samy, Silvina; Sousa, Nuno; Salgado, Antonio Jose] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
   [Heimann, Claudia; Barwig, Christina] Medovent GmbH, Mainz, Germany.
RP Salgado, AJ (reprint author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, P-4710057 Braga, Portugal.
EM asalgado@ecsaude.uminho.pt
RI Haastert-Talini, Kirsten/D-2348-2010; Sousa, Nuno/N-9137-2017
OI Haastert-Talini, Kirsten/0000-0003-2502-8969; Sousa,
   Nuno/0000-0002-8755-5126; Salgado, Antonio/0000-0003-3806-9823; Serra,
   Sofia/0000-0003-2034-273X; Samy, Silvina/0000-0002-0908-0874
FU European Community [278612]; Programa Operacional Regional do Norte
   (ON.2-O Novo Norte); ao abrigo do Quadro de Referencia Estrategico
   Nacional (QREN); atraves do Fundo Europeu de Desenvolvimento Regional
   (FEDER)
FX This work was supported by the European Community's Seventh Framework
   Programme (FP7-HEALTH-2011) under grant agreement No. 278612. This work
   was also co-funded by Programa Operacional Regional do Norte (ON.2-O
   Novo Norte), ao abrigo do Quadro de Referencia Estrategico Nacional
   (QREN), and atraves do Fundo Europeu de Desenvolvimento Regional
   (FEDER). The authors gratefully acknowledge the delivery of the chitosan
   raw material by Altakitin S.A., Portugal, and the fabrication of
   chitosan films by Medovent GmbH, Germany.
CR Amaral IF, 2007, J BIOMAT SCI-POLYM E, V18, P469, DOI 10.1163/156856207780425068
   Asplund M, 2009, NEUROEPIDEMIOLOGY, V32, P217, DOI 10.1159/000197900
   Chang H- I, 2011, CELL RESPONSES SURFA
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Freier T., 2005, BIODEGRADABLE POLYM, P1
   Grothe C, 1998, MOL BRAIN RES, V57, P97, DOI 10.1016/S0169-328X(98)00076-X
   Haastert K, 2005, J NEUROSCI METH, V142, P275, DOI 10.1016/j.jneumeth.2004.09.003
   Haastert K, 2007, NAT PROTOC, V2, P99, DOI 10.1038/nprot.2006.486
   Haastert-Talini K, 2013, BIOMATERIALS, V34, P9886, DOI 10.1016/j.biomaterials.2013.08.074
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Keilhoff G, 2006, EUR J CELL BIOL, V85, P11, DOI 10.1016/j.ejcb.2005.09.021
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Ladak A, 2011, EXP NEUROL, V228, P242, DOI 10.1016/j.expneurol.2011.01.013
   Lopez-Perez PM, 2010, J MATER CHEM, V20, P483, DOI 10.1039/b911854c
   Lundborg G, 2004, Handchir Mikrochir Plast Chir, V36, P1
   MACKINNON SE, 1992, PLAST RECONSTR SURG, V90, P695, DOI 10.1097/00006534-199210000-00024
   Martin-Lopez E, 2012, J BIOMATER APPL, V26, P791, DOI 10.1177/0885328210379928
   Meyerrose T, 2010, ADV DRUG DELIVER REV, V62, P1167, DOI 10.1016/j.addr.2010.09.013
   Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P37
   Muir D, 2010, EXP NEUROL, V223, P102, DOI 10.1016/j.expneurol.2009.05.038
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031
   Ribeiro CA, 2011, J TISSUE ENG REGEN M, V5, P668, DOI 10.1002/term.365
   Ribeiro-Samy S, 2013, MACROMOL BIOSCI, V13, P1576, DOI 10.1002/mabi.201300178
   Salgado A.J., 2004, METHODS MOL BIOL CLI, V238, P12
   Shea GKH, 2010, EXP NEUROL, V224, P448, DOI 10.1016/j.expneurol.2010.05.005
   Silva NA, 2013, STEM CELLS DEV, V22, P1232, DOI 10.1089/scd.2012.0524
   Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8
   Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
NR 33
TC 17
Z9 18
U1 6
U2 36
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2339
EP 2349
DI 10.1089/ten.tea.2013.0621
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400007
PM 24606318
OA Green Published
DA 2018-10-20
ER

PT J
AU Petsch, C
   Schlotzer-Schrehardt, U
   Meyer-Blazejewska, E
   Frey, M
   Kruse, FE
   Bachmann, BO
AF Petsch, Corinna
   Schloetzer-Schrehardt, Ursula
   Meyer-Blazejewska, Ewa
   Frey, Markus
   Kruse, Friedrich E.
   Bachmann, Bjoern O.
TI Novel Collagen Membranes for the Reconstruction of the Corneal Surface
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HUMAN AMNIOTIC MEMBRANE; MUCOSAL EPITHELIAL-CELLS; CROSS-LINKED
   COLLAGEN; FOLLICLE STEM-CELLS; STROMA RECONSTRUCTION; ORTHOGONAL
   SCAFFOLD; ULTRAVIOLET-A; TRANSPLANTATION; RIBOFLAVIN; IMPLANTATION
AB No standardized biomaterial exists for the surgical treatment of persistent corneal erosions and ulcerations. We analyzed the suitability and biocompatibility of defined noncross-linked and UV/riboflavin cross-linked equine type I collagen membranes for the reconstruction of the corneal surface. Isolated human oral mucosa epithelial cells, a cell type in clinical use for the treatment of ocular surface diseases, were subcultivated on both types of membranes and examined concerning cell adhesion, proliferation, and differentiation. Biocompatibility was evaluated following superficial and intrastromal corneal transplantation in New Zealand white rabbits. In cell cultures all collagen membranes supported adhesion of oral mucosa epithelial cells leading to the formation of multilayered epithelial cell sheets. After intrastromal corneal implantation clinical signs of degradation were seen in all variants of collagen membranes, which was fastest in noncross-linked variants. The histological and ultrastructural level invasion of keratocytes and production of new collagen fibers inside the collagen membranes could be detected in noncross-linked variants. After superficial corneal implantation covering of the membranes by corneal epithelium over time was visible. Ultrastructural analysis showed a slower rate of degradation and less invading keratocytes in cross-linked variants compared with noncross-linked collagen membranes. Cross-linked and noncross-linked variants of the collagen membrane proofed to be suitable to serve as a carrier for epithelial stem cells in vitro and showed a high biocompatibility in vivo. These results indicate that the tested collagen membranes might be suitable for the reconstruction of the corneal surface in patients with nonhealing ulcerations. Whether membranes with faster or slower degradation properties are preferable for the treatment of persistent corneal ulcerations might depend on the underlying corneal pathology and the degree of concomitant inflammation.
C1 [Petsch, Corinna; Schloetzer-Schrehardt, Ursula; Meyer-Blazejewska, Ewa; Kruse, Friedrich E.; Bachmann, Bjoern O.] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany.
   [Frey, Markus] Resorba Med GmbH, Nurnberg, Germany.
RP Bachmann, BO (reprint author), Univ Erlangen Nurnberg, Dept Ophthalmol, Schwabachanlage 6, D-91054 Erlangen, Germany.
EM bjoern.bachmann@uk-erlangen.de
FU Federal Ministry of Education and Research, Germany (BMBF)
FX The authors thank Prof. Dr. Beckmann (Department of Gynecology,
   University Hospital Erlangen, Germany) for providing amniotic membrane.
   We further thank Dr. Johannes Menzel-Severing, Jasmine Onderka, and
   Carmen Rummelt for expert technical assistance. This work was supported
   by the Federal Ministry of Education and Research, Germany (BMBF).
CR Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   BANGA I, 1965, BIOCHEM Z, V342, P330
   Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721
   Chee KYH, 2006, CLIN EXP OPHTHALMOL, V34, P64, DOI 10.1111/j.1442-9071.2006.1147.x
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Dua HS, 2003, EYE, V17, P877, DOI 10.1038/sj.eye.6700573
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Duncan TJ, 2010, BIOMATERIALS, V31, P8996, DOI 10.1016/j.biomaterials.2010.08.042
   DUNN MW, 1967, SCIENCE, V157, P1329, DOI 10.1126/science.157.3794.1329
   Ehlers N, 2008, ACTA OPHTHALMOL, V86, P549, DOI 10.1111/j.1600-0420.2007.01085.x
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Fagerholm P, 2009, CTS-CLIN TRANSL SCI, V2, P162, DOI 10.1111/j.1752-8062.2008.00083.x
   Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2
   Gomes Jose A P, 2005, Curr Opin Ophthalmol, V16, P233, DOI 10.1097/01.icu.0000172827.31985.3a
   Hu XJ, 2005, TISSUE ENG, V11, P1710, DOI 10.1089/ten.2005.11.1710
   Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015
   KIM JC, 1995, CORNEA, V14, P473
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Kose Osman, 2007, J Oral Sci, V49, P133, DOI 10.2334/josnusd.49.133
   Kruse F E, 2008, Dev Ophthalmol, V41, P159, DOI 10.1159/000131087
   Kruse FE, 1999, OPHTHALMOLOGY, V106, P1504, DOI 10.1016/S0161-6420(99)90444-X
   Kruse FE, 2001, OPHTHALMOLOGE, V98, P801, DOI 10.1007/s003470170055
   Lagali N., 2011, INVEST OPHTHALMOL VI, V52
   Lawrence BD, 2012, JOVE-J VIS EXP, DOI 10.3791/3646
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Levis HJ, 2013, CURR EYE RES, V38, P41, DOI 10.3109/02713683.2012.725799
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Liu WG, 2009, BIOMATERIALS, V30, P1551, DOI 10.1016/j.biomaterials.2008.11.022
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   Lyle S, 1998, J CELL SCI, V111, P3179
   Madhira SL, 2008, MOL VIS, V14, P189
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497
   Powers HJ, 2003, AM J CLIN NUTR, V77, P1352
   Reichl S, 2011, BIOMATERIALS, V32, P3375, DOI 10.1016/j.biomaterials.2011.01.052
   Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001
   SCHIFF W M, 1992, CLAO Journal, V18, P59
   Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016
   Seitz B, 2007, OPHTHALMOLOGE, V104, P1075, DOI 10.1007/s00347-007-1661-3
   Thumann G, 2009, BIOMATERIALS, V30, P287, DOI 10.1016/j.biomaterials.2008.09.039
   Torbet J, 2007, P ANN INT IEEE EMBS, P6400
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   Tseng Scheffer C G, 2004, Ocul Surf, V2, P177
   Whitcher John P., 2002, International Ophthalmology Clinics, V42, P71
   Williams KK, 2007, J OCUL PHARMACOL TH, V23, P517, DOI 10.1089/jop.2007.0008
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3
   Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015
   Yiu SC, 2007, CURR OPIN OPHTHALMOL, V18, P509, DOI 10.1097/ICU.0b013e3282f0ab33
NR 50
TC 11
Z9 11
U1 1
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2378
EP 2389
DI 10.1089/ten.tea.2013.0552
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400010
PM 24621144
DA 2018-10-20
ER

PT J
AU Bullers, SJ
   Baker, SC
   Ingham, E
   Southgate, J
AF Bullers, Samuel J.
   Baker, Simon C.
   Ingham, Eileen
   Southgate, Jennifer
TI The Human Tissue-Biomaterial Interface: A Role for PPAR gamma-Dependent
   Glucocorticoid Receptor Activation in Regulating the CD163(+) M2
   Macrophage Phenotype
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID NUCLEAR RECEPTORS; IN-VITRO; POLARIZATION; SCAFFOLD; MODEL;
   INFLAMMATION; UROTHELIUM; INDUCTION; OUTCOMES; CULTURE
AB In vivo studies of implanted acellular biological scaffolds in experimental animals have shown constructive remodeling mediated by anti-inflammatory macrophages. Little is known about the human macrophage response to such biomaterials, or the nature of the signaling mechanisms that govern the macrophage phenotype in this environment. The cellular events at the interface of a tissue and implanted decellularized biomaterial were examined by establishing a novel ex vivo tissue culture model in which surgically excised human urinary tract tissue was combined with porcine acellular bladder matrix (PABM). Evaluation of the tissue-biomaterial interface showed a time-dependent infiltration of the biomaterial by CD68(+) CD80(-) macrophages. The migration of CD68+ cells from the tissue to the interface was accompanied by maturation to a CD163(hi) phenotype, suggesting that factor(s) associated with the biomaterial or the wound edge was/were responsible for the active recruitment and polarization of local macrophages. Glucocorticoid receptor (GR) and peroxisome proliferator activated receptor gamma (PPAR gamma) signaling was investigated as candidate pathways for integrating inflammatory responses; both showed intense nuclear labeling in interface macrophages. GR and PPAR gamma activation polarized peripheral blood-derived macrophages from a default M1 (CD80(+)) toward an M2 (CD163(+)) phenotype, but PPARg signaling predominated, as its antagonism blocked any GR-mediated effect. Seeding on PABM was effective at polarizing peripheral blood-derived macrophages from a default CD80(+) phenotype on glass to a CD80(-) phenotype, with intense nuclear localization of PPARg. These results endorse in vivo observations that the infiltration of decellularized biological scaffolds, exemplified here by PABM, is pioneered by macrophages. Thus, it appears that natural factors present in PABM are involved in the active recruitment and polarization of macrophages to a CD163(+) phenotype, with activation of PPAR gamma identified as the candidate pathway. The harnessing of these natural matrix-associated factors may be useful in enhancing the integration of synthetic and other natural biomaterials by polarizing macrophage activation toward an M2 regulatory phenotype.
C1 [Bullers, Samuel J.; Baker, Simon C.; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
   [Ingham, Eileen] Univ Leeds, Fac Biol Sci, Inst Med & Biol Engn, Leeds, W Yorkshire, England.
RP Southgate, J (reprint author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
EM jennifer.southgate@york.ac.uk
FU BBSRC CASE [BB \ D527026 \ 1]; York Against Cancer; WELMEC, a Centre of
   Excellence in Medical Engineering - Wellcome Trust; EPSRC [WT
   088908/Z/09/Z]; NIHR; Tissue Regenix Group; Biotechnology and Biological
   Sciences Research Council [BB/E527220/1, E20352]; Engineering and
   Physical Sciences Research Council [EP/G032483/1, EP/J017620/1,
   EP/I019103/1]
FX This work was supported by a BBSRC CASE-funded PhD studentship to S.J.B.
   in partnership with Tissue Regenix Group (grant number BB \ D527026 \
   1). J.S. is funded by York Against Cancer. E. I. receives funding
   through WELMEC, a Centre of Excellence in Medical Engineering funded by
   the Wellcome Trust and EPSRC, under grant number WT 088908/Z/09/Z and
   from the NIHR-funded Leeds Musculoskeletal Biomedical Research Centre
   (LMBRU). The authors acknowledge the York Clinical Research Facility for
   recruiting volunteers, obtaining consent, and taking blood. The authors
   thank Tissue Regenix Group for their support of the project and in
   particular Dr. Helen Berry for helpful discussions in her role as
   industrial supervisor.
CR Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baker SC, 2011, MACROMOL BIOSCI, V11, P618, DOI 10.1002/mabi.201000415
   Beckstead BL, 2009, J BIOMED MATER RES A, V91A, P436, DOI 10.1002/jbm.a.32214
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Eligini S, 2013, J CELL PHYSIOL, V228, P1464, DOI 10.1002/jcp.24301
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Gosset P, 2001, EUR J IMMUNOL, V31, P2857, DOI 10.1002/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X
   Hogger P, 1998, J IMMUNOL, V161, P1883
   HUNT TK, 1984, SURGERY, V96, P48
   Kapetanovic R, 2012, J IMMUNOL, V188, P3382, DOI 10.4049/jimmunol.1102649
   Kapoor M, 2007, PROSTAG LEUKOTR ESS, V76, P103, DOI 10.1016/j.plefa.2006.11.006
   Maniecki MB, 2011, IMMUNOBIOLOGY, V216, P882, DOI 10.1016/j.imbio.2011.02.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nencioni A, 2002, J IMMUNOL, V169, P1228, DOI 10.4049/jimmunol.169.3.1228
   Peramo A, 2009, ANN BIOMED ENG, V37, P401, DOI 10.1007/s10439-008-9614-9
   Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE
   Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9
   Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Turner A, 2011, EUR UROL, V59, P447, DOI 10.1016/j.eururo.2010.12.004
NR 32
TC 10
Z9 10
U1 1
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2390
EP 2401
DI 10.1089/ten.tea.2013.0628
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400011
PM 24548290
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Caliari, SR
   Harley, BAC
AF Caliari, Steven R.
   Harley, Brendan A. C.
TI Collagen-GAG Scaffold Biophysical Properties Bias MSC Lineage Choice in
   the Presence of Mixed Soluble Signals
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TO-BONE INSERTION; MARROW STROMAL CELLS;
   IN-VITRO; CROSS-LINKING; GLYCOSAMINOGLYCAN SCAFFOLDS;
   EXTRACELLULAR-MATRIX; OSTEOGENIC DIFFERENTIATION; SUPRASPINATUS TENDON;
   CHEMICAL-COMPOSITION
AB Biomaterial strategies for regenerating multitissue structures require unique approaches. One strategy is to design scaffolds so that their local biophysical properties can enhance site-specific effects of an otherwise heterogeneous biomolecular environment. This investigation examined the role of biomaterial physical properties (relative density, mineral content) on the human mesenchymal stem cell phenotype in the presence of mixed soluble signals to drive osteogenesis or chondrogenesis. We tested a series of three-dimensional collagen-glycosaminoglycan scaffolds with properties inspired by extracellular matrix characteristics across the osteotendinous interface (tendon, cartilage, and bone). We found that selective scaffold mineralization induced a depressed chondrogenic response compared with nonmineralized groups as demonstrated by gene expression and histological analyses. Interestingly, the greatest chondrogenic response was found in a higher density, nonmineralized scaffold variant despite increased contraction and cellular condensation in lower density nonmineralized scaffolds. In fact, the lower density scaffolds demonstrated a significantly higher expression of osteogenic transcripts as well as ample mineralization after 21 days of culture. This effect may be due to local stiffening of the scaffold microenvironment as the scaffold contracts, leading to increased cell density, accelerated differentiation, and possible endochondral ossification as evidenced by a transition from a glycosaminoglycan (GAG)-rich milieu to higher mineralization at later culture times. These findings will help shape the design rules for graded biomaterials to regenerate distinct fibrillar, fibrocartilagenous, and mineralized regions of orthopedic interfaces.
C1 [Caliari, Steven R.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Roger Adams Lab 110, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Caliari, Steven/0000-0002-7506-3079; Harley, Brendan/0000-0001-5458-154X
FU Chemistry-Biology Interface Training Program NIH [T32GM070421]; NSF
   [1105300]; Chemical and Biomolecular Engineering Dept.; Institute for
   Genomic Biology at the University of Illinois at Urbana-Champaign
FX The authors would like to acknowledge Donna Epps (IGB, UIUC) for
   assistance with histology, Daniel Weisgerber (MSE, UIUC) for preparation
   of mineral scaffolds, and the IGB Core Facilities for assistance with
   real-time PCR. The authors are grateful for the funding for this study
   provided by the Chemistry-Biology Interface Training Program NIH
   T32GM070421 (S.R.C.), NSF 1105300 (B.A.H.), the Chemical and
   Biomolecular Engineering Dept. (B.A.H.), and the Institute for Genomic
   Biology (B.A.H.) at the University of Illinois at Urbana-Champaign.
CR Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Duffy GP, 2011, EUR CELLS MATER, V21, P15, DOI 10.22203/eCM.v021a02
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fox AJS, 2011, J ORTHOP RES, V29, P880, DOI 10.1002/jor.21327
   Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Galatz L, 2007, J ORTHOP RES, V25, P1621, DOI 10.1002/jor.20441
   Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067
   Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043
   Gibson L. J., 2010, CELLULAR MAT NATURE
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Kanungo BP, 2010, ACTA BIOMATER, V6, P344, DOI 10.1016/j.actbio.2009.09.012
   Kanungo BP, 2009, ACTA BIOMATER, V5, P1006, DOI 10.1016/j.actbio.2008.11.029
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Ker EDF, 2011, BIOMATERIALS, V32, P3413, DOI 10.1016/j.biomaterials.2011.01.036
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kuo CK, 2008, DEV DYNAM, V237, P1477, DOI 10.1002/dvdy.21547
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Lynn AK, 2010, J BIOMED MATER RES A, V92A, P1057, DOI 10.1002/jbm.a.32415
   Murphy CM, 2012, J MECH BEHAV BIOMED, V11, P53, DOI 10.1016/j.jmbbm.2011.11.009
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pek YS, 2004, BIOMATERIALS, V25, P473, DOI 10.1016/S0142-9612(03)00541-6
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Spilker MH, 2001, BIOMATERIALS, V22, P1085, DOI 10.1016/S0142-9612(00)00345-8
   Tang SQ, 2007, BIOMED MATER, V2, pS135, DOI 10.1088/1748-6041/2/3/S10
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Wagner DR, 2008, ANN BIOMED ENG, V36, P813, DOI 10.1007/s10439-008-9448-5
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhou JA, 2011, ACTA BIOMATER, V7, P3999, DOI 10.1016/j.actbio.2011.06.040
NR 46
TC 17
Z9 17
U1 0
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2463
EP 2472
DI 10.1089/ten.tea.2013.0400
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400018
PM 24568607
OA Green Published
DA 2018-10-20
ER

PT J
AU Requicha, JF
   Viegas, CA
   Munoz, F
   Azevedo, JM
   Leonor, IB
   Reis, RL
   Causa, H
   Gomes, ME
AF Requicha, Joao F.
   Viegas, Carlos A.
   Munoz, Fernando
   Azevedo, Jorge M.
   Leonor, Isabel B.
   Reis, Rui L.
   Causa, Hon
   Gomes, Manuela E.
TI A Tissue Engineering Approach for Periodontal Regeneration Based on a
   Biodegradable Double-Layer Scaffold and Adipose-Derived Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID STARCH-BASED SCAFFOLDS; MARROW STROMAL CELLS; OSTEOGENIC
   DIFFERENTIATION; IN-VITRO; ALKALINE-PHOSPHATASE; GENE-EXPRESSION; FLOW
   PERFUSION; GROWTH-FACTORS; FIBER MESHES; LIGAMENT
AB Human and canine periodontium are often affected by an inflammatory pathology called periodontitis, which is associated with severe damages across tissues, namely, in the periodontal ligament, cementum, and alveolar bone. However, the therapies used in the routine dental practice, often consisting in a combination of different techniques, do not allow to fully restore the functionality of the periodontium. Tissue Engineering (TE) appears as a valuable alternative approach to regenerate periodontal defects, but for this purpose, it is essential to develop supportive biomaterial and stem cell sourcing/culturing methodologies that address the complexity of the various tissues affected by this condition. The main aim of this work was to study the in vitro functionality of a newly developed double-layer scaffold for periodontal TE. The scaffold design was based on a combination of a three-dimensional (3D) fiber mesh functionalized with silanol groups and a membrane, both made of a blend of starch and poly-epsilon-(caprolactone). Adipose-derived stem cells (canine adipose stem cells [cASCs]) were seeded and cultured onto such scaffolds, and the obtained constructs were evaluated in terms of cellular morphology, metabolic activity, and proliferation. The osteogenic potential of the fiber mesh layer functionalized with silanol groups was further assessed concerning the osteogenic differentiation of the seeded and cultured ASCs. The obtained results showed that the proposed double-layer scaffold supports the proliferation and selectively promotes the osteogenic differentiation of cASCs seeded onto the functionalized mesh. These findings suggest that the 3D structure and asymmetric composition of the scaffold in combination with stem cells may provide the basis for developing alternative therapies to treat periodontal defects more efficiently.
C1 [Requicha, Joao F.; Viegas, Carlos A.; Leonor, Isabel B.; Causa, Hon; Gomes, Manuela E.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4860909 Caldas Das Taipas, Guimaraes, Portugal.
   [Requicha, Joao F.; Viegas, Carlos A.; Leonor, Isabel B.] Univ Tras Os Montes & Alto Douro, Dept Vet Sci, Vila Real, Portugal.
   [Requicha, Joao F.; Viegas, Carlos A.; Leonor, Isabel B.; Causa, Hon; Gomes, Manuela E.] ICVS 3Bs PT Govt Associated Lab, Guimaraes, Portugal.
   [Munoz, Fernando] Univ Santiago de Compostela, Fac Vet, Dept Vet Clin Sci, Lugo, Spain.
   [Azevedo, Jorge M.] Univ Tras Os Montes & Alto Douro, CECAV Ctr Studies Anim & Vet Sci, Dept Anim Sci, Vila Real, Portugal.
RP Gomes, ME (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4860909 Caldas Das Taipas, Guimaraes, Portugal.
EM megomes@dep.uminho.pt
RI Requicha, Joao/E-6506-2012; Leonor, Isabel/B-5260-2011; Munoz,
   Fernando/I-1858-2015; Viegas, Carlos/D-2207-2014; Group,
   3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Gomes, Manuela/B-6282-2009
OI Requicha, Joao/0000-0002-9463-1625; Leonor, Isabel/0000-0002-4319-4883;
   Munoz, Fernando/0000-0002-4130-1526; Viegas, Carlos/0000-0002-8796-5037;
   Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Gomes,
   Manuela/0000-0002-2036-6291; Azevedo, Jorge/0000-0003-2383-5206
FU European Union [REGPOT-CT2012-316331-POLARIS]; Portuguese Foundation for
   Science and Technology (FCT) [SFRH/BD/44143/2008]
FX The research leading to these results has received funding from the
   European Union's Seventh Framework Programme (FP7/2007-2013) under grant
   agreement no REGPOT-CT2012-316331-POLARIS. J.F.R. acknowledges the
   Portuguese Foundation for Science and Technology (FCT) for his PhD
   scholarship (SFRH/BD/44143/2008).
CR Anh DJ, 1998, CALCIFIED TISSUE INT, V62, P332, DOI 10.1007/s002239900441
   Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   Beck GR, 2003, EXP CELL RES, V288, P288, DOI 10.1016/S0014-4827(03)00213-1
   Bosshardt DD, 2009, PERIODONTOL 2000, V51, P208, DOI 10.1111/j.1600-0757.2009.00317.x
   Botelho CM, 2006, J BIOMED MATER RES A, V79A, P723, DOI 10.1002/jbm.a.30806
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Dogan A, 2003, TISSUE ENG, V9, P1189, DOI 10.1089/10763270360728099
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   El-Ghannam A, 2006, J BIOMED MATER RES A, V76A, P386, DOI 10.1002/jbm.a.30517
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Goncalves A, 2011, ACTA BIOMATER, V7, P1644, DOI 10.1016/j.actbio.2010.11.044
   Gupta G, 2007, J BIOMED MATER RES A, V80A, P486, DOI 10.1002/jbm.a.31005
   Haimi S, 2009, TISSUE ENG PT A, V15, P1473, DOI 10.1089/ten.tea.2008.0241
   Iwata T, 2009, BIOMATERIALS, V30, P2716, DOI 10.1016/j.biomaterials.2009.01.032
   Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281
   Kuo LC, 2008, PUBLIC HEALTH, V122, P417, DOI 10.1016/j.puhe.2007.07.004
   LACZKO J, 1975, MIKROSKOPIE, V31, P1
   Leonor IB, 2011, J TISSUE ENG REGEN M, V5, P104, DOI 10.1002/term.294
   Link DP, 2013, J BIOMED MATER RES A, V101, P3059, DOI 10.1002/jbm.a.34614
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Nakahara T, 2004, TISSUE ENG, V10, P537, DOI 10.1089/107632704323061898
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Polimeni G, 2006, PERIODONTOL 2000, V41, P30, DOI 10.1111/j.1600-0757.2006.00157.x
   Puppi D, 2011, J TISSUE ENG REGEN M, V5, P253, DOI 10.1002/term.310
   Requicha JF, 2012, STEM CELL REV REP, V8, P1211, DOI 10.1007/s12015-012-9397-0
   Requicha J. F., 2013, ANAT REC, V297, P6
   Requicha JF, 2016, J TISSUE ENG REGEN M, V10, P392, DOI 10.1002/term.1816
   RODAN G A, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P85
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Rodrigues MT, 2011, J TISSUE ENG REGEN M, V5, P41, DOI 10.1002/term.287
   Santos TC, 2010, ACTA BIOMATER, V6, P4314, DOI 10.1016/j.actbio.2010.06.020
   Sun LY, 2009, MAT SCI ENG C-MATER, V29, P1829, DOI 10.1016/j.msec.2009.02.011
   Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048
   Tuzlakoglu K, 2010, J BIOMED MATER RES A, V92A, P369, DOI 10.1002/jbm.a.32358
   Vieira NM, 2010, CELL TRANSPLANT, V19, P279, DOI 10.3727/096368909X481764
   Wikesjo UME, 2003, J CLIN PERIODONTOL, V30, P655, DOI 10.1034/j.1600-051X.2003.00362.x
NR 39
TC 24
Z9 26
U1 0
U2 30
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2483
EP 2492
DI 10.1089/ten.tea.2013.0360
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400020
PM 24575867
OA Green Published
DA 2018-10-20
ER

PT J
AU Georgi, N
   van Blitterswijk, C
   Karperien, M
AF Georgi, Nicole
   van Blitterswijk, Clemens
   Karperien, Marcel
TI Mesenchymal Stromal/Stem Cell- or Chondrocyte-Seeded Microcarriers as
   Building Blocks for Cartilage Tissue Engineering
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID HUMAN ARTICULAR CHONDROCYTES; STEM-CELLS; IN-VITRO; CHONDROGENIC
   DIFFERENTIATION; CULTURE-SYSTEM; BONE-MARROW; CULTIVATION SYSTEM;
   EXPANSION; REPAIR; MICROSPHERES
AB In this study we have tested the use of mesenchymal stromal/stem cell (MSC)- or chondrocyte (hch)-laden microcarriers as building blocks for engineered cartilage tissue. MSCs and hchs expanded on microcarriers were used in chondrogenic coculture and compared with monoculture of MSCs or hchs. The use of cell-laden microcarriers as building blocks for cartilage tissue engineering led to a compact tissue formation with significant volume increase compared to the biomaterial-free approach. After 28 days of differentiation culture, formation of cartilaginous matrix in cocultures and chondrocyte monoculture approaches was observed. Coculture resulted in beneficial glycosaminoglycan deposition compared with monoculture of MSCs or chondrocytes attached to microcarriers. Further, the microcarrier-adhered coculture displayed increased levels of the differentiation marker ACAN and reduced levels of the dedifferentiation marker COL1A1. To our knowledge, this is the first article that successfully combines an innovative combination of cell expansion on microcarriers and the direct use of MSC-or hch-cell-laden microcarriers as building blocks in cartilage tissue engineering.
C1 [Georgi, Nicole; Karperien, Marcel] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
   [van Blitterswijk, Clemens] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, NL-7500 AE Enschede, Netherlands.
RP Karperien, M (reprint author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.
EM h.b.j.karperien@utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
FU TeRM Smart Mix Program of the Netherlands Ministry of Economic Affairs;
   Netherlands Ministry of Education, Culture and Science
FX The authors gratefully acknowledge the support of the TeRM Smart Mix
   Program of the Netherlands Ministry of Economic Affairs and the
   Netherlands Ministry of Education, Culture and Science.
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Aung A, 2011, ARTHRITIS RHEUM-US, V63, P148, DOI 10.1002/art.30086
   Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]
   Blokhuis TJ, 2000, J BIOMED MATER RES, V51, P369, DOI 10.1002/1097-4636(20000905)51:3<369::AID-JBM10>3.0.CO;2-J
   BOSMAN DK, 1989, J HEPATOL, V9, P49, DOI 10.1016/0168-8278(89)90075-5
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen X, 2006, IMMUNOL CELL BIOL, V84, P413, DOI 10.1111/j.1440-1711.2006.01458.x
   Chun KW, 2004, BIOTECHNOL PROGR, V20, P1797, DOI 10.1021/bp0496981
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   DEMETRIOU AA, 1986, P NATL ACAD SCI USA, V83, P7475, DOI 10.1073/pnas.83.19.7475
   Elder SH, 2009, TISSUE ENG PT A, V15, P3025, DOI [10.1089/ten.tea.2008.0617, 10.1089/ten.TEA.2008.0617]
   Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031
   Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011
   Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94
   Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w
   Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2
   Hendriks JAA, 2013, BIOMATERIALS, V34, P4259, DOI 10.1016/j.biomaterials.2013.02.060
   Hendriks JAA, 2010, SOFT MATTER, V6, P5080, DOI 10.1039/c0sm00266f
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   HUNTER W, 1995, CLIN ORTHOP RELAT R, P3
   Kalyanam S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127250
   Klein TJ, 2009, MACROMOL BIOSCI, V9, P1049, DOI 10.1002/mabi.200900176
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Malda J, 2004, BIOMATERIALS, V25, P5773, DOI 10.1016/j.biomaterials.2004.01.028
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Ng YC, 1996, BIOTECHNOL BIOENG, V50, P627, DOI 10.1002/(SICI)1097-0290(19960620)50:6<627::AID-BIT3>3.0.CO;2-M
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Pettersson S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065001
   Pettersson S, 2009, J TISSUE ENG REGEN M, V3, P450, DOI 10.1002/term.179
   Sart S., 2012, J TISSUE ENG REGEN M
   Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73
   Schrobback K, 2012, CELL TISSUE RES, V347, P649, DOI 10.1007/s00441-011-1193-7
   Schrobback K, 2011, J ORTHOP RES, V29, P539, DOI 10.1002/jor.21264
   Shen H, 2010, ACTA BIOMATER, V6, P455, DOI 10.1016/j.actbio.2009.07.016
   Solorio LD, 2010, J BIOMED MATER RES A, V92A, P1139, DOI 10.1002/jbm.a.32440
   Tajima S, 2012, J TISSUE ENG REGEN M
   Teixeira LSM, 2012, EUR CELLS MATER, V23, P387, DOI 10.22203/eCM.v023a30
   Tuin A, 2010, TISSUE ENG PT A, V16, P1811, DOI 10.1089/ten.TEA.2009.0592
   Wu L, 2011, TISSUE ENG PT A, V17, P1425, DOI [10.1089/ten.tea.2010.0517, 10.1089/ten.TEA.2010.0517]
   Wu L, 2013, STEM CELLS DEV, V22, P2356, DOI 10.1089/scd.2013.0118
NR 42
TC 20
Z9 20
U1 2
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2513
EP 2523
DI 10.1089/ten.tea.2013.0681
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400023
PM 24621188
DA 2018-10-20
ER

PT J
AU Guterl, CC
   Torre, OM
   Purmessur, D
   Dave, K
   Likhitpanichkul, M
   Hecht, AC
   Nicoll, SB
   Iatridis, JC
AF Guterl, Clare C.
   Torre, Olivia M.
   Purmessur, Devina
   Dave, Khyati
   Likhitpanichkul, Morakot
   Hecht, Andrew C.
   Nicoll, Steven B.
   Iatridis, James C.
TI Characterization of Mechanics and Cytocompatibility of Fibrin-Genipin
   Annulus Fibrosus Sealant with the Addition of Cell Adhesion Molecules
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID LOW-BACK-PAIN; INTERVERTEBRAL DISC; REPAIR; MODEL; CHALLENGES;
   DEGENERATION; REPLACEMENT; INTEGRATION; THERAPIES
AB There is an unmet clinical need for a biomaterial sealant capable of repairing small annulus fibrosus (AF) defects. Causes of these defects include painful intervertebral disc herniations, microdiscectomy procedures, morbidity associated with needle puncture injury from discography, and future nucleus replacement procedures. This study describes the enhancements of a fibrin gel through genipin crosslinking (FibGen) and the addition of the cell adhesion molecules (CAMs), fibronectin and collagen. The gel's performance as a potential AF sealant is assessed using a series of in vitro tests. FibGen gels with CAMs had equivalent adhesive strength, gene expression, cytomorphology, and cell proliferation as fibrin alone. However, FibGen gels had enhanced material behaviors that were tunable to higher shear stiffness values and approximated human annulus tissue as compared with fibrin alone, were more dimensionally stable, and had a slower in vitro degradation rate. Cytomorphology of human AF cells cultured on FibGen gels exhibited increased elongation compared with fibrin alone, and the addition of CAMs to FibGen did not significantly affect elongation. This FibGen gel offers the promise of being used as a sealant material to repair small AF defects or to be used in combination with other biomaterials as an adhesive for larger defects.
C1 [Guterl, Clare C.; Torre, Olivia M.; Purmessur, Devina; Dave, Khyati; Likhitpanichkul, Morakot; Hecht, Andrew C.; Iatridis, James C.] Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
   [Guterl, Clare C.; Iatridis, James C.] AO Fdn, Collaborat Res Partner Annulus Fibrosus Rupture P, Davos, Switzerland.
   [Dave, Khyati; Nicoll, Steven B.] CUNY City Coll, Dept Biomed Engn, New York, NY USA.
RP Iatridis, JC (reprint author), Mt Sinai Sch Med, Leni & Peter W May Dept Orthopaed, One Gustave L Levy Pl,Box 1188, New York, NY 10029 USA.
EM james.iatridis@mssm.edu
RI Purmessur (Walter), Devina/J-8821-2015
OI Iatridis, James/0000-0002-2186-0590; Torre, Olivia/0000-0003-3405-6259
FU NIAMS/NIH [R01 AR057397, F32 AR062455]; AO Exploratory Research Board of
   the AO Foundation
FX This work was supported by NIAMS/NIH R01 AR057397, NIAMS/NIH F32
   AR062455, and the AO Exploratory Research Board of the AO Foundation.
   The authors thank Dr. Samuel Cho and Dr. Sheeraz Qureshi for providing
   human surgical specimens used for isolating AF cells as well as Ilana
   Stock.
CR Ahlgren BD, 2000, SPINE, V25, P2165, DOI 10.1097/00007632-200009010-00004
   Andersson GBJ, 1998, ACTA ORTHOP SCAND, V69, P28, DOI 10.1080/17453674.1998.11744790
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   Buser Z, 2014, J TISSUE ENG REGEN M, V8, P77, DOI 10.1002/term.1503
   Buser Z, 2011, SPINE, V36, pE1201, DOI 10.1097/BRS.0b013e31820566b2
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Chang Y, 2001, J THORAC CARDIOV SUR, V122, P1208, DOI 10.1067/mtc.2001.117624
   Chiang YF, 2012, CLIN BIOMECH, V27, P241, DOI 10.1016/j.clinbiomech.2011.09.008
   Costi JJ, 2011, EXPERT REV MED DEVIC, V8, P357, DOI [10.1586/ERD.11.1, 10.1586/erd.11.1]
   Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230
   Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508
   Errington RJ, 1998, J ANAT, V192, P369, DOI 10.1046/j.1469-7580.1998.19230369.x
   GOEL VK, 1995, SPINE, V20, P689, DOI 10.1097/00007632-199503150-00010
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Iatridis JC, 1999, J ORTHOPAED RES, V17, P732, DOI 10.1002/jor.1100170517
   Jiao Y, 2012, SOFT MATTER, V8, P1499, DOI 10.1039/c1sm05786c
   Lewis G, 2012, J BIOMED MATER RES B, V100B, P1702, DOI 10.1002/jbm.b.32712
   Maher SA, 2010, J TISSUE ENG REGEN M, V4, P25, DOI 10.1002/term.205
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   SPILKER RL, 1986, J BIOMECH ENG-T ASME, V108, P1, DOI 10.1115/1.3138575
   Taruilli AW, 2007, NEUROL CLIN, V25, P387, DOI 10.1016/j.ncl.2007.01.008
   Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005
   Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8
NR 29
TC 11
Z9 11
U1 2
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2014
VL 20
IS 17-18
BP 2536
EP 2545
DI 10.1089/ten.tea.2012.0714
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AP1LC
UT WOS:000341830400025
PM 24684314
OA Green Published
DA 2018-10-20
ER

PT J
AU Tan, XW
   Goh, TW
   Saraswathi, P
   Nyein, CL
   Setiawan, M
   Riau, A
   Lakshminarayanan, R
   Liu, SP
   Tan, D
   Beuerman, RW
   Mehta, JS
AF Tan, Xiao Wei
   Goh, Tze Wei
   Saraswathi, P.
   Nyein, Chan Lwin
   Setiawan, Melina
   Riau, Andri
   Lakshminarayanan, R.
   Liu, Shouping
   Tan, Donald
   Beuerman, Roger W.
   Mehta, Jodhbir S.
TI Effectiveness of Antimicrobial Peptide Immobilization for Preventing
   Perioperative Cornea Implant-Associated Bacterial Infection
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; ORTHOPEDIC-SURGERY;
   SURGICAL IMPLANTS; RANDOMIZED-TRIAL; KERATOPROSTHESIS; TITANIUM;
   ENDOPHTHALMITIS; KERATITIS; INFLAMMATION
AB Titanium (Ti) is a promising candidate biomaterial for an artificial corneal skirt. Antimicrobial peptide (AMP) immobilization may improve the bactericidal effect of the Ti substrate. In this study, we tested the bactericidal efficacy of a functionalized Ti surface in a rabbit keratitis model. A corneal stromal pocket was created by a femtosecond laser. The Ti films were then inserted into the pocket, and Staphylococcus aureus or Pseudomonas aeruginosa was inoculated into the pocket above the implant films. The corneas with Ti-AMP implants were compared with the corneas implanted with unprotected Ti by slit lamp observation and anterior segment optical coherence tomography (AS-OCT). Inflammatory responses were evaluated by bacterium counting, hematoxylin-eosin staining, and immunostaining. There was a lower incidence and a lesser extent of infection on rabbit corneas with Ti-AMP implants than on those with unprotected Ti implants. The bactericidal effect of AMP against S. aureus was comparable to that of postoperative prophylactic antibiotic treatment; hence, SESB2V AMP bound to the Ti implant provided functional activity in vivo, but its efficacy was greater against S. aureus than against P. aeruginosa. This work suggests that SESB2V AMP can be successfully functionalized in a rabbit keratitis model to prevent perioperative corneal infection.
C1 [Tan, Xiao Wei; Goh, Tze Wei; Nyein, Chan Lwin; Setiawan, Melina; Riau, Andri; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.
   [Saraswathi, P.; Lakshminarayanan, R.; Liu, Shouping; Beuerman, Roger W.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Antimicrobials Grp, Singapore, Singapore.
   [Tan, Donald; Beuerman, Roger W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore.
   [Tan, Donald; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore.
   [Lakshminarayanan, R.; Liu, Shouping; Tan, Donald; Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Singapore, Singapore.
   [Beuerman, Roger W.] Duke NUS SRP Neurosci & Behav Disorders, Singapore, Singapore.
RP Mehta, JS (reprint author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.
EM jodmehta@gmail.com
FU Singhealth Research Foundation [SHF/FG488S/2010]
FX This work was supported by Singhealth Research Foundation (grant
   SHF/FG488S/2010).
CR Actis Dato A, 1992, MINERVA CARDIOANGIOL, V40, P225
   APT L, 1984, ARCH OPHTHALMOL-CHIC, V102, P728, DOI 10.1001/archopht.1984.01040030584025
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Baker AS, 1989, INFECT ASS INDWELLIN, P75
   Behlau I, 2008, ARCH OPHTHALMOL-CHIC, V126, P1572, DOI 10.1001/archopht.126.11.1572
   Behlau I, 2011, BIOMATERIALS, V32, P8783, DOI 10.1016/j.biomaterials.2011.08.010
   Bourcier T, 2003, J CATARACT REFR SURG, V29, P407, DOI 10.1016/S0886-3350(02)01484-0
   Boxma H, 1996, LANCET, V347, P1133, DOI 10.1016/S0140-6736(96)90606-6
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chan CC, 2012, CORNEA, V31, P1128, DOI 10.1097/ICO.0b013e318245c02a
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Cho WM, 2007, BIOORG MED CHEM LETT, V17, P5772, DOI 10.1016/j.bmcl.2007.08.056
   Clinical and Laboratory Standards Institute, 2009, M07A8 CLIN LAB STAND
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Dajcs JJ, 2002, DNA CELL BIOL, V21, P375, DOI 10.1089/10445490260099656
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hughes EH, 2008, RETINA-J RET VIT DIS, V28, P1138, DOI 10.1097/IAE.0b013e318174e10e
   Jenssen H, 2010, METHODS MOL BIOL, V618, P329, DOI 10.1007/978-1-60761-594-1_20
   JOHNSON MK, 1990, CURR EYE RES, V9, P1107, DOI 10.3109/02713689008997584
   Karthikeyan RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064867
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Lakshminarayanan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087730
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Musella M, 2001, EUR J SURG, V167, P130
   Nouri M, 2001, ARCH OPHTHALMOL-CHIC, V119, P484
   Park SC, 2011, INT J MOL SCI, V12, P5971, DOI 10.3390/ijms12095971
   Pullamsetti SS, 2011, CLIN MICROBIOL INFEC, V17, P7, DOI 10.1111/j.1469-0691.2010.03285.x
   PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x
   Robert MC, 2012, BRIT J OPHTHALMOL, V96, P776, DOI 10.1136/bjophthalmol-2011-301263
   Schaff H, 1999, J HEART VALVE DIS, V8, P131
   Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276
   Shehadeh-Masha'our R, 2004, J CATARACT REFR SURG, V30, P1802, DOI 10.1016/j.jcrs.2004.01.034
   Tan AN, 2012, OCUL SURF, V10, P15, DOI 10.1016/j.jtos.2012.01.003
   Tan XW, 2012, J BIOMED MATER RES B, V100B, P2090, DOI 10.1002/jbm.b.32774
   Tan XW, 2011, INVEST OPHTH VIS SCI, V52, P21, DOI 10.1167/iovs.10-6186
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   VINE AK, 1995, ARCH OPHTHALMOL-CHIC, V113, P1479
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
   Xie JW, 2012, J BIOMED MATER RES A, V100A, P929, DOI 10.1002/jbm.a.34030
NR 47
TC 18
Z9 18
U1 0
U2 19
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD SEP
PY 2014
VL 58
IS 9
BP 5229
EP 5238
DI 10.1128/AAC.02859-14
PG 10
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA AO3UV
UT WOS:000341262700026
PM 24957820
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Cleophas, RTC
   Sjollema, J
   Busscher, HJ
   Kruijtzer, JAW
   Liskamp, RMJ
AF Cleophas, Rik T. C.
   Sjollema, Jelmer
   Busscher, Henk J.
   Kruijtzer, John A. W.
   Liskamp, Rob M. J.
TI Characterization and Activity of an Immobilized Antimicrobial Peptide
   Containing Bactericidal PEG-Hydrogel
SO BIOMACROMOLECULES
LA English
DT Article
ID CATIONIC-PEPTIDE; BROAD-SPECTRUM; INFECTIONS; PREVENTION; ANTIBIOTICS;
   CHEMISTRY; IMPLANTS; SURFACES; COATINGS; TITANIUM
AB A single step immobilization-polymerization strategy of a highly active antimicrobial peptide into a soft hydrogel network on a poly(ethylene terephthalate) surface using thiol-ene chemistry is described. The bactericidal hydrogel was molecularly characterized via Coomassie and Lowry assay protein staining agents as well as by X-ray photoelectron spectroscopy. The bactericidal activity was established against Staphylococcus aureus and Staphylococcus epidermidis, two bacterial strains commonly associated with biomaterial infections. To gain further insight into the biological stability, the hydrogels were incubated with human serum prior to activity testing without loss of activity. These studies revealed a promising bactericidal hydrogel with good stability under physiological conditions.
C1 [Cleophas, Rik T. C.; Kruijtzer, John A. W.; Liskamp, Rob M. J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CG Utrecht, Netherlands.
   [Sjollema, Jelmer; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Liskamp, RMJ (reprint author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Univ Weg 99, NL-3584 CG Utrecht, Netherlands.
EM r.m.j.liskamp@uu.nl
RI Liskamp, Rob/I-5889-2012
FU BioMedical Materials institute [P4.01 NANTICO]; Dutch Ministry of
   Economic Affairs, Agriculture and Innovation
FX This research forms part of the Project P4.01 NANTICO of the research
   program of the BioMedical Materials institute, cofunded by the Dutch
   Ministry of Economic Affairs, Agriculture and Innovation. Joop de Vries
   is kindly acknowledged for the XPS measurements at UMCG. We thank
   Heidrun Keul for her help with the hydrogel formation at DSM Biomedical,
   Geleen and Steffen van der Wal at UU for many fruitful discussions.
CR Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Bennett-Guerrero E, 2010, NEW ENGL J MED, V363, P1038, DOI 10.1056/NEJMoa1000837
   Browning MB, 2012, BIOMACROMOLECULES, V13, P779, DOI 10.1021/bm201707z
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j
   Cleophas RTC, 2014, ACS MACRO LETT, V3, P477, DOI 10.1021/mz5001465
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Daghighi S, 2012, ACTA BIOMATER, V8, P3991, DOI 10.1016/j.actbio.2012.07.017
   De Giglio E, 2011, ACTA BIOMATER, V7, P882, DOI 10.1016/j.actbio.2010.07.030
   DeForest CA, 2012, ANNU REV CHEM BIOMOL, V3, P421, DOI 10.1146/annurev-chembioeng-062011-080945
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Gupta N, 2010, NAT CHEM, V2, P138, DOI [10.1038/NCHEM.478, 10.1038/nchem.478]
   Hamamoto K, 2002, MICROBIOL IMMUNOL, V46, P741, DOI 10.1111/j.1348-0421.2002.tb02759.x
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Hui A, 2012, MATERIALS, V5, P85, DOI 10.3390/ma5010085
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Laverty G, 2012, J BIOMED MATER RES A, V100A, P1803, DOI 10.1002/jbm.a.34132
   Li Y, 2012, LANGMUIR, V28, P12134, DOI 10.1021/la302732w
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Mohorcic M, 2010, J MATER SCI-MATER M, V21, P2775, DOI 10.1007/s10856-010-4136-z
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257
   Peetsch A, 2012, COLLOIDS SURF B C, V102C, P724
   Pickard R., 2012, LANCET, V6736, P1
   Sinclair KD, 2012, J BIOMED MATER RES A, V100A, P2732, DOI 10.1002/jbm.a.34209
   Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 37
TC 19
Z9 19
U1 3
U2 114
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2014
VL 15
IS 9
BP 3390
EP 3395
DI 10.1021/bm500899r
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AO5UC
UT WOS:000341409800020
PM 25109707
DA 2018-10-20
ER

PT J
AU Laverty, G
   McCloskey, AP
   Gilmore, BF
   Jones, DS
   Zhou, J
   Xu, B
AF Laverty, Garry
   McCloskey, Alice P.
   Gilmore, Brendan F.
   Jones, David S.
   Zhou, Jie
   Xu, Bing
TI Ultrashort Cationic Naphthalene-Derived Self-Assembled Peptides as
   Antimicrobial Nanomaterials
SO BIOMACROMOLECULES
LA English
DT Article
ID DEVICE-RELATED INFECTIONS; DESIGNED PEPTIDE; BETA-SHEETS; HYDROGELS;
   BIOMATERIALS; AMPHIPHILES; PREVENTION; SCAFFOLDS; NANOFIBERS; NANOTUBES
AB Self-assembling dipeptides conjugated to naphthalene show considerable promise as nanomaterial structures, biomaterials, and drug delivery devices. Biomaterial infections are responsible for high rates of patient mortality and morbidity. The presence of biofilrn bacteria, which thrive on implant surfaces, are a huge burden on healthcare budgets, as they are highly resistant to current therapeutic strategies. Ultrashort cationic self-assembled peptides represent a highly innovative and cost-effective strategy to form antibacterial nanomaterials. Lysine conjugated variants display the greatest potency with 2% w/v NapFFKK hydrogels significantly reducing the viable Staphylococcus epidermidis biofilm by 94%. Reducing the size of the R-group methylene chain on cationic moieties resulted in reduction of antibiofilm activity. The primary amine of the protruding R-group tail may not be as readily available to interact with negatively charged bacterial membranes. Cryo-SEM, FTIR, CD spectroscopy, and oscillatory rheology provided evidence of supramolecular hydrogel formation at physiological pH (pH 7.4). Cytotoxicity assays against murine fibroblast (NCTC 929) cell lines confirmed the gels possessed reduced cytotoxicity relative to bacterial cells, with limited hemolysis upon exposure to equine erythrocytes. The results presented in this paper highlight the significant potential of ultrashort cationic naphthalene peptides as future biomaterials.
C1 [Laverty, Garry; McCloskey, Alice P.; Gilmore, Brendan F.; Jones, David S.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland.
   [Zhou, Jie; Xu, Bing] Brandeis Univ, Dept Chem, Waltham, MA 02453 USA.
RP Laverty, G (reprint author), Queens Univ Belfast, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.
EM garry.laverty@qub.ac.uk
OI Laverty, Garry/0000-0002-1435-2942; McCloskey, Alice/0000-0003-3014-1624
FU Queen's University Research Support Package for New Academic Staff; DEL
   studentship grant
FX The authors acknowledge funding provided by the Queen's University
   Research Support Package for New Academic Staff to G.L. and a DEL
   studentship grant to A.P.M. We acknowledge the help from Daniel Corbett,
   Tao Yu, and Dr. Marie Migaud (all QUB) with their guidance with regard
   to cryo-SEM, rheological, and NMR methodology, respectively.
CR Adams DJ, 2010, SOFT MATTER, V6, P4144, DOI 10.1039/c0sm00409j
   Adams DJ, 2009, SOFT MATTER, V5, P1856, DOI 10.1039/b901556f
   Altunbas A, 2011, BIOMATERIALS, V32, P5906, DOI 10.1016/j.biomaterials.2011.04.069
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bowerman CJ, 2009, MOL BIOSYST, V5, P1058, DOI 10.1039/b904439f
   Castelletto V, 2009, BIOPHYS CHEM, V141, P169, DOI 10.1016/j.bpc.2009.01.008
   Cheng G, 2010, LANGMUIR, V26, P4990, DOI 10.1021/la903678e
   Danese PN, 2002, CHEM BIOL, V9, P873, DOI 10.1016/S1074-5521(02)00192-8
   Dasgupta A, 2013, RSC ADV, V3, P9117, DOI 10.1039/c3ra40234g
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Debnath S, 2010, J PHYS CHEM B, V114, P4407, DOI 10.1021/jp909520w
   Di Stefano A, 2009, MICROB BIOTECHNOL, V2, P634, DOI 10.1111/j.1751-7915.2009.00120.x
   Elbert DL, 2011, CURR OPIN BIOTECH, V22, P674, DOI 10.1016/j.copbio.2011.04.001
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   George M, 2006, ACCOUNTS CHEM RES, V39, P489, DOI 10.1021/ar0500923
   Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200
   Guler MO, 2006, BIOMACROMOLECULES, V7, P1855, DOI 10.1021/bm060161g
   Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k
   Haines LA, 2005, J AM CHEM SOC, V127, P17025, DOI 10.1021/ja054719o
   Hughes M, 2013, BIOMATER SCI-UK, V1, P1138, DOI 10.1039/c3bm60135h
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Karp JM, 2007, CURR OPIN BIOTECH, V18, P454, DOI 10.1016/j.copbio.2007.09.008
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Laverty G, 2012, J BIOMED MATER RES A, V100A, P1803, DOI 10.1002/jbm.a.34132
   Laverty G, 2011, INT J MOL SCI, V12, P6566, DOI 10.3390/ijms12106566
   Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x
   Li JY, 2013, J AM CHEM SOC, V135, P9907, DOI 10.1021/ja404215g
   Mart RJ, 2006, SOFT MATTER, V2, P822, DOI 10.1039/b607706d
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Paladini F, 2013, J MATER SCI-MATER M, V24, P2461, DOI 10.1007/s10856-013-4986-2
   Paquette DW, 1997, J CLIN PERIODONTOL, V24, P216, DOI 10.1111/j.1600-051X.1997.tb01834.x
   Pettit RK, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-28
   Piluso S, 2013, SOFT MATTER, V9, P6752, DOI 10.1039/c3sm00131h
   Pogorelov AG, 2010, B EXP BIOL MED+, V150, P153, DOI 10.1007/s10517-010-1091-0
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Roelfsema F, 2008, BIOL-TARGETS THER, V2, P463
   Rotondi KS, 2006, BIOPOLYMERS, V84, P13, DOI 10.1002/bip.20390
   Ryan DM, 2012, POLYM CHEM-UK, V3, P18, DOI 10.1039/c1py00335f
   Ryan DM, 2010, SOFT MATTER, V6, P3220, DOI 10.1039/c0sm00018c
   Salick DA, 2007, J AM CHEM SOC, V129, P14793, DOI 10.1021/ja076300z
   Salick DA, 2009, ADV MATER, V21, P4120, DOI 10.1002/adma.200900189
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Shu JY, 2013, ANNU REV PHYS CHEM, V64, P631, DOI 10.1146/annurev-physchem-040412-110108
   Siddique B, 2011, LANGMUIR, V27, P6639, DOI 10.1021/la200676s
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Sreerama N., 2000, CIRCULAR DICHROISM P, P601
   Stickler DJ, 2006, J MED MICROBIOL, V55, P489, DOI 10.1099/jmm.0.46404-0
   Stone Patricia W, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P417, DOI 10.1586/erp.09.53
   Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039
   Turner APF, 2013, CHEM SOC REV, V42, P3184, DOI 10.1039/c3cs35528d
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Valery C, 2003, P NATL ACAD SCI USA, V100, P10258, DOI 10.1073/pnas.1730609100
   Veiga AS, 2013, BIOPOLYMERS, V100, P637, DOI 10.1002/bip.22412
   Veiga AS, 2012, BIOMATERIALS, V33, P8907, DOI 10.1016/j.biomaterials.2012.08.046
   Wang HM, 2012, MATER TODAY, V15, P500, DOI 10.1016/S1369-7021(12)70219-5
   Yang ZM, 2007, J MATER CHEM, V17, P850, DOI 10.1039/b611255b
   Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y
   Yao S, 2004, J AM CHEM SOC, V126, P8336, DOI 10.1021/ja0496367
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang Y, 2011, LANGMUIR, V27, P529, DOI 10.1021/la1020324
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 63
TC 25
Z9 25
U1 5
U2 129
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2014
VL 15
IS 9
BP 3429
EP 3439
DI 10.1021/bm500981y
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AO5UC
UT WOS:000341409800025
PM 25068387
OA Green Published
DA 2018-10-20
ER

PT J
AU Hwang, KJ
   Hwang, CH
   Lee, IH
   Kim, T
   Jin, S
   Park, JY
AF Hwang, Kyung-Jun
   Hwang, Cheol-Ho
   Lee, In-Hwa
   Kim, Taewoo
   Jin, Sungho
   Park, Ju-Young
TI Synthesis and characterization of hollow metal oxide micro-tubes using a
   biomaterial template
SO BIOMASS & BIOENERGY
LA English
DT Article
DE Biomaterial template; Hollow metal oxide micro-tube; SnO2; ZrO2; ZnO;
   NiO
ID ZINC-OXIDE; ZNO; NANOPARTICLES; ELECTRODES; TITANIUM; POWDERS; FIBERS;
   KAPOK; GAS
AB Various hollow metal oxide micro-tubes (SnO2, ZrO2, ZnO, and NiO) were prepared by a simple impregnation method using Ceiba pentandra (L.) Gaertn. (kapok) as a biomaterial template. Calcination heat treatment was successfully used for the removal of the kapok template. Field emission scanning electron microscopy (FE-SEM) was used to study the uniform morphology of the hollow metal oxide micro-tubes, which had an average diameter of 15-20 mu m. The hollow metal oxide micro-tubes were further characterized by thermal gravity analysis (TGA), X-ray diffraction (XRD), and X-ray photo-electron spectroscopy (XPS). This synthesis method provides a new facile route for the fabrication of hollow metal oxide micro-tubes. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hwang, Kyung-Jun; Kim, Taewoo; Jin, Sungho] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Hwang, Cheol-Ho; Lee, In-Hwa; Park, Ju-Young] Chosun Univ, Dept Environm Engn, Kwangju 501759, South Korea.
RP Park, JY (reprint author), Chosun Univ, Dept Environm Engn, Kwangju 501759, South Korea.
EM kyhwang@ucsd.edu; barnabas1@nate.com; ihlee@chosun.ac.kr;
   c15251@naver.com; jin@ucsd.edu; gom8812@hanmail.net
FU Korea Institute of Energy Technology Evaluation and Planning (KETEP) -
   Korean Government Ministry of Trade, Industry, and Energy
   [20134010200560]
FX This work was supported by the Human Resources Development Program (No.
   20134010200560) of the Korea Institute of Energy Technology Evaluation
   and Planning (KETEP) grant funded by the Korean Government Ministry of
   Trade, Industry, and Energy.
CR AOKI A, 1970, JPN J APPL PHYS, V9, P582, DOI 10.1143/JJAP.9.582
   Bahadur J, 2008, J SOLID STATE CHEM, V181, P1227, DOI 10.1016/j.jssc.2008.01.050
   Bao N, 2010, J HAZARD MATER, V174, P129, DOI 10.1016/j.jhazmat.2009.09.026
   Boury B, 2012, NEW J CHEM, V36, P2196, DOI 10.1039/c2nj40576h
   CHOPRA KL, 1983, THIN SOLID FILMS, V102, P1, DOI 10.1016/0040-6090(83)90256-0
   Chung JT, 2013, MATER LETT, V93, P401, DOI 10.1016/j.matlet.2012.09.016
   Cullity B.D., 2011, ELEMENTS XRAY DIFFRA
   Duan CT, 2013, CELLULOSE, V20, P849, DOI 10.1007/s10570-013-9875-9
   Golego N, 2000, J ELECTROCHEM SOC, V147, P1592, DOI 10.1149/1.1393400
   Greenwood N.N, 1984, CHEM ELEMENTS
   Hori K, 2000, J WOOD SCI, V46, P401
   Kasuga T, 1998, LANGMUIR, V14, P3160, DOI 10.1021/la9713816
   Kung H. H., 1989, TRANSITION METAL OXI
   Lascelles K, 2005, ULLMANNS ENCY IND CH
   LI J, 2007, ENERG FUEL, V22, P16
   Li J, 2008, J AM CERAM SOC, V91, P1350, DOI 10.1111/j.1551-2916.2008.02276.x
   Liang S, 2001, J CRYST GROWTH, V225, P110, DOI 10.1016/S0022-0248(01)00830-2
   Lin YH, 1999, ADV MATER OPT ELECTR, V9, P205, DOI 10.1002/1099-0712(199909/10)9:5<205::AID-AMO383>3.0.CO;2-8
   Nogueram C, 1996, PHYS CHEM OXIDE SURF
   Paraguay-Delgado F, 2005, NANOTECHNOLOGY, V16, P688, DOI 10.1088/0957-4484/16/6/011
   Peng ZY, 2000, CHEM COMMUN, P2125, DOI 10.1039/b007687m
   Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u
   Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X
   Song P, 2010, SENSOR ACTUAT B-CHEM, V147, P248, DOI 10.1016/j.snb.2010.03.006
   Stevens R, 1986, MAGNESIUM ELEKT PUBL
   Vaezi MR, 2007, MATER DESIGN, V28, P515, DOI 10.1016/j.matdes.2005.08.016
   Ying Z, 2004, NANOTECHNOLOGY, V15, P1682, DOI 10.1088/0957-4484/15/11/053
   Zhao Y, 2006, NANOTECHNOLOGY, V17, P2090, DOI 10.1088/0957-4484/17/9/003
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 29
TC 10
Z9 11
U1 4
U2 48
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0961-9534
EI 1873-2909
J9 BIOMASS BIOENERG
JI Biomass Bioenerg.
PD SEP
PY 2014
VL 68
BP 62
EP 66
DI 10.1016/j.biombioe.2014.06.004
PG 5
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA AO4YO
UT WOS:000341347500007
DA 2018-10-20
ER

PT J
AU Omer, M
   Khan, M
   Kim, YK
   Lee, JH
   Kang, IK
   Park, SY
AF Omer, Muhammad
   Khan, Mashooq
   Kim, Young Kyoo
   Lee, Joon Hyung
   Kang, Inn-Kyu
   Park, Soo-Young
TI Biosensor utilizing a liquid crystal/water interface functionalized with
   poly(4-cyanobiphenyl-4 '-oxyundecylacrylate-b-((2-dimethyl amino) ethyl
   methacrylate))
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Weak cationic polyelectrolyte; Poly(4-cyanobiphenyl-4
   '-oxyundecylacrylate-b-((2-dimethyl amino) ethyl methacrylate));
   Protein; Langmuir Blodgett films; DNA; Biosensor
ID IONIC-STRENGTH; BIOMOLECULAR INTERACTIONS; SERUM-ALBUMIN; SENSOR;
   POLYELECTROLYTES; POLYMERS; FILMS; ADSORPTION; RECEPTOR; MICELLES
AB The interface between the nematic liquid crystal, 4-cyano-4'-pentylbiphenyl (5CB) and water within a transmission electron microscopy (TEM) grid cell coated with the pH-dependent weak cationic amphiphilic block copolymer poly((4-cyanobiphenyl-4'-oxyundecylacrylate)-b-((2-dimethyl amino) ethyl methacrylate)) (LCP-b-PDMAEMA) (which was successfully synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization) was subsequently evaluated for protein and deoxyribonucleic acid (DNA) detection. The LCP-b-PDMAEMA monolayer was fabricated using a Langmuir Blodgett trough, transferred to the 5CB-filled TEM grid, and placed on the octadecyltrichlorosilane-coated glass (TEMPDMAEMA) in such a way that the LCP chains were immersed in the 5CB while the PDMAEMA chains were pointed away from the 5CB surface and immersed in water. Several model proteins such as bovine serum albumin (BSA), hemoglobin (Hb), and chymotrypsinogen (ChTg) were tested at pH values ranging from 2 to 12 to determine the role of the charge state of the protein on protein detection by a weak polyelectrolyte such as PDMAEMA. PDMAEMA contains cationic and neutral states below and above the pKa value, respectively, and is thus able to absorb proteins below its pKa threshold through electrostatic interactions. BSA exhibited a homeotropic to planar (H-P) change in orientation within the TEMPDMAEMA grid cell at concentrations greater than 0.02 wt% within the pH range between the isoelectric point (pI) of BSA and the pKa of PDMAEMA, where the charge states of BSA and PDMAEMA were negative and positive, respectively. However, this change in orientation did not occur with other proteins that exhibited a pI higher than the pKa of PDMAEMA due to the electrostatic repulsions resulting from their same cationic charges. This result indicates that the electrostatic interactions between proteins and PDMAEMA are a major contributing factor for protein detection by the H-P transformation within the TEMPDMAEMA grid cell. DNA, a pH-independent strong anionic polyelectrolyte, was also tested with the TEMPDMAEMA grid cell, and it exhibited an H-P transformation at the charged state of PDMAEMA below its pKa threshold at concentrations higher than 0.01 wt%. Thus, we demonstrated that the TEMPDMAEMA grid cell effectively facilitated the detection of negatively charged biomaterials (i.e.; protein and DNA) through the H-P transformation using the polarized optical microscope. This simple and inexpensive experimental set-up for non-specific biomaterial detection lays the basic groundwork for developing effective biosensors using polyelectrolytes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Omer, Muhammad; Khan, Mashooq; Kim, Young Kyoo; Kang, Inn-Kyu; Park, Soo-Young] Kyungpook Natl Univ, Sch Appl Chem Engn, Taegu 702701, South Korea.
   [Lee, Joon Hyung] Kyungpook Natl Univ, Sch Adv Mat Engn, Taegu 702701, South Korea.
RP Park, SY (reprint author), Kyungpook Natl Univ, Sch Appl Chem Engn, Taegu 702701, South Korea.
EM psy@knu.ac.kr
RI Khan, Mashooq/F-2600-2018; park, soo-young/N-3170-2017
OI Khan, Mashooq/0000-0003-1387-0008; park, soo-young/0000-0001-6796-4929;
   Lee, Joon-Hyung/0000-0001-5597-4521
FU National Research Foundationof Korea [NRF-2011-0020264]
FX This work was supported by the National Research Foundationof Korea
   (NRF-2011-0020264).
CR Ali N, 2009, MACROMOL RES, V17, P553, DOI 10.1007/BF03218907
   Bai YQ, 2012, J AM CHEM SOC, V134, P548, DOI 10.1021/ja2089475
   Bi XY, 2008, SENSOR ACTUAT B-CHEM, V134, P432, DOI 10.1016/j.snb.2008.05.030
   Bi XY, 2007, SENSOR ACTUAT B-CHEM, V127, P406, DOI 10.1016/j.snb.2007.04.040
   Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749
   Brake JM, 2003, LANGMUIR, V19, P6436, DOI 10.1021/la034132s
   DUBOIS JC, 1986, MOL CRYST LIQ CRYST, V137, P349, DOI 10.1080/00268948608070932
   Espina V, 2004, J IMMUNOL METHODS, V290, P121, DOI 10.1016/j.jim.2004.04.013
   Greenwood R, 2000, POWDER TECHNOL, V113, P148, DOI 10.1016/S0032-5910(00)00225-4
   Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077
   Khan M., 2013, ANAL CHEM, V86, P1493
   Khan W, 2011, SOFT MATTER, V7, P780, DOI 10.1039/c0sm00758g
   Kim J, 2013, ACS APPL MATER INTER, V5, P13135, DOI 10.1021/am404174n
   Kinsinger MI, 2010, J COLLOID INTERF SCI, V341, P124, DOI 10.1016/j.jcis.2009.09.026
   Kinsinger ML, 2007, ADV MATER, V19, P4208, DOI 10.1002/adma.200700718
   Lee DY, 2010, SOFT MATTER, V6, P1964, DOI 10.1039/b926461b
   Li PY, 2004, SENSOR ACTUAT B-CHEM, V99, P6, DOI 10.1016/S0925-4005(03)00604-X
   Li YN, 2013, SENSOR ACTUAT B-CHEM, V188, P772, DOI 10.1016/j.snb.2013.07.093
   Liu Y, 2007, SENSOR ACTUAT B-CHEM, V123, P148, DOI 10.1016/j.snb.2006.08.006
   Lockwood NA, 2005, CURR OPIN COLLOID IN, V10, P111, DOI 10.1016/j.cocis.2005.06.002
   Ma C, 2012, ANAL CHIM ACTA, V734, P69, DOI 10.1016/j.aca.2012.05.020
   Ozmen M, 2013, ELECTROCHIM ACTA, V111, P535, DOI 10.1016/j.electacta.2013.08.130
   Peng P, 2012, COLLOID SURFACE A, V408, P32, DOI 10.1016/j.colsurfa.2012.05.002
   Perrier S, 2004, MACROMOLECULES, V37, P2709, DOI 10.1021/ma035468b
   Pourjavadi A, 2005, MACROMOL RES, V13, P45, DOI 10.1007/BF03219014
   Read ES, 2007, CHEM COMMUN, P3021, DOI 10.1039/b701217a
   Seo JM, 2012, SOFT MATTER, V8, P198, DOI 10.1039/c1sm06616a
   Shi Yunwei M.Y., 2006, CHINESE J ANAL CHEM, V34, P503
   Su L, 2013, BIOSENS BIOELECTRON, V44, P16, DOI 10.1016/j.bios.2013.01.005
   Vermohlen K, 2000, COLLOID SURFACE A, V163, P45, DOI 10.1016/S0927-7757(99)00429-X
   Wang HF, 2009, J SEP SCI, V32, P1981, DOI 10.1002/jssc.200800562
   Wang Z, 2013, SENSOR ACTUAT B-CHEM, V176, P211, DOI 10.1016/j.snb.2012.10.002
   Winterbottom DA, 2003, SENSOR ACTUAT B-CHEM, V90, P52, DOI 10.1016/S0925-4005(03)00021-2
   Wittemann A, 2004, ANAL CHEM, V76, P2813, DOI 10.1021/ac0354692
   Zahn R, 2010, CURR OPIN COLLOID IN, V15, P427, DOI 10.1016/j.cocis.2010.07.006
   Zhao M, 2013, POLYMER, V54, P297, DOI 10.1016/j.polymer.2012.11.029
NR 36
TC 16
Z9 16
U1 3
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD SEP 1
PY 2014
VL 121
BP 400
EP 408
DI 10.1016/j.colsurfb.2014.06.028
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AO4UB
UT WOS:000341335800049
PM 25009103
DA 2018-10-20
ER

PT J
AU Persson, M
   Lorite, GS
   Kokkonen, HE
   Cho, SW
   Lehenkari, PP
   Skrifvars, M
   Tuukkanen, J
AF Persson, Maria
   Lorite, Gabriela S.
   Kokkonen, Hanna E.
   Cho, Sung-Woo
   Lehenkari, Petri P.
   Skrifvars, Mikael
   Tuukkanen, Juha
TI Effect of bioactive extruded PLA/HA composite films on focal adhesion
   formation of preosteoblastic cells
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Cell attachment; Focal adhesion; Hydroxyapatite composite; Surface
   roughness; Poly(lactic acid)
ID CYTOSKELETAL ORGANIZATION; MECHANICAL-PROPERTIES; SURFACE MODIFICATION;
   TISSUE REGENERATION; PROTEIN ADSORPTION; BONE; HYDROXYAPATITE;
   OSTEOBLASTS; SCAFFOLDS; ACID)
AB The quality of the initial cell attachment to a biomaterial will influence any further cell function, including spreading, proliferation, differentiation and viability. Cell attachment is influenced by the material's ability to adsorb proteins, which is related to the surface chemistry and topography of the material. In this study, we incorporated hydroxyapatite (HA) particles into a poly(lactic acid) (PLA) composite and evaluated the surface structure and the effects of HA density on the initial cell attachment in vitro of murine calvarial preosteoblasts (MC3T3-EI). Scanning electron microscopy (SEM), atomic force microscopy (AFM) and infrared spectroscopy (FTIR) showed that the HA particles were successfully incorporated into the PLA matrix and located at the surface which is of importance in order to maintain the bioactive effect of the HA particles. SEM and AFM investigation revealed that the HA density (particles/area) as well as surface roughness increased with HA loading concentration (i.e. 5, 10, 15 and 20 wt%), which promoted protein adsorption. Furthermore, the presence of HA on the surface enhanced cell spreading, increased the formation of actin stress fibers and significantly improved the expression of vinculin in MC3T3-E1 cells which is a key player in the regulation of cell adhesion. These results suggest the potential utility of PLA/HA composites as biomaterials for use as a bone substitute material and in tissue engineering applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Persson, Maria; Lorite, Gabriela S.; Kokkonen, Hanna E.; Lehenkari, Petri P.; Tuukkanen, Juha] Univ Oulu, Dept Anat & Cell Biol, FI-90014 Oulu, Finland.
   [Persson, Maria; Lehenkari, Petri P.; Tuukkanen, Juha] Med Res Ctr Oulu, FI-90014 Oulu, Finland.
   [Cho, Sung-Woo; Skrifvars, Mikael] Univ Boras, Sch Engn, SE-50190 Boras, Sweden.
RP Persson, M (reprint author), Univ Oulu, Dept Anat & Cell Biol, FI-90014 Oulu, Finland.
EM Maria.Persson@oulu.fi
RI Tuukkanen, Juha/R-3728-2018; Lehenkari, Petri/O-3009-2016; Lorite,
   Gabriela/M-9095-2016
OI Tuukkanen, Juha/0000-0002-1723-6461; Lehenkari,
   Petri/0000-0002-0055-5183; Lorite, Gabriela/0000-0002-6530-5281;
   Skrifvars, Mikael O V/0000-0002-6596-8069
FU TEKES; MIUR; Svenska Kulturfonden, Finland
FX This work has been performed in the project Scaffolds for Tissue
   Engineering, which belongs to the MATERA Era-Net program and is financed
   by the national agencies TEKES and MIUR. In addition, a personal grant
   for the author (M Persson) was received from the Svenska Kulturfonden,
   Finland.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Arnett T, 2003, P NUTR SOC, V62, P511, DOI 10.1079/PNS2003268
   Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021
   Aydin E, 2011, J MATER SCI-MATER M, V22, P2413, DOI 10.1007/s10856-011-4435-z
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Charles LF, 2010, J MATER SCI-MATER M, V21, P1845, DOI 10.1007/s10856-010-4051-3
   Charras GT, 2001, ULTRAMICROSCOPY, V86, P85, DOI 10.1016/S0304-3991(00)00076-0
   Chuenjitkuntaworn B, 2010, POLYM INT, V59, P227, DOI 10.1002/pi.2712
   Chung S, 2011, BIOTECHNOL APPL BIOC, V58, P423, DOI 10.1002/bab.60
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   DAMERVAL C, 1987, ELECTROPHORESIS, V8, P158, DOI 10.1002/elps.1150080308
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Goldmann WH, 2002, BIOCHEM BIOPH RES CO, V290, P749, DOI 10.1006/bbrc.2001.6243
   Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Ko KS, 2001, BIOCHEM BIOPH RES CO, V285, P1077, DOI 10.1006/bbrc.2001.5177
   Kokkonen H, 2008, BIOMACROMOLECULES, V9, P2369, DOI 10.1021/bm800356b
   Kokkonen H, 2012, J BIOMED MATER RES A, V100A, P111, DOI 10.1002/jbm.a.33240
   Kokkonen HE, 2007, BIOMACROMOLECULES, V8, P509, DOI 10.1021/bm060614h
   Lackman JJ, 2014, J BIOL CHEM, V289, P17830, DOI 10.1074/jbc.M114.566273
   Li H, 2012, ACS APPL MATER INTER, V4, P687, DOI 10.1021/am201795g
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Naveena N, 2012, J MATER CHEM, V22, P5239, DOI 10.1039/c1jm14401d
   Peng F., 2013, J BIOMATER APPL, V27, P64
   Persson M, 2013, ACS APPL MATER INTER, V5, P6864, DOI 10.1021/am401895f
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Teti Anna, 2011, Curr Osteoporos Rep, V9, P264, DOI 10.1007/s11914-011-0078-8
   VANWACHEM PB, 1987, J BIOMED MATER RES, V21, P701, DOI 10.1002/jbm.820210603
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Yanagida H, 2009, J BIOSCI BIOENG, V108, P235, DOI 10.1016/j.jbiosc.2009.04.003
   Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004
NR 44
TC 22
Z9 23
U1 3
U2 57
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD SEP 1
PY 2014
VL 121
BP 409
EP 416
DI 10.1016/j.colsurfb.2014.06.029
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AO4UB
UT WOS:000341335800050
PM 24986753
DA 2018-10-20
ER

PT J
AU Acil, Y
   Zhang, XC
   Nitsche, T
   Moller, B
   Gassling, V
   Wiltfang, J
   Gierloff, M
AF Acil, Yahya
   Zhang, Xiacong
   Nitsche, Tobias
   Moeller, Bjoern
   Gassling, Volker
   Wiltfang, Joerg
   Gierloff, Matthias
TI Effects of different scaffolds on rat adipose tissue derived stroma
   cells
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Adipose tissue derived stroma cells (ASC's); Collagen membranes;
   Hyaluronic acid gel; Tissue engineering; Multilineage potential;
   Scaffold; Biocompatibility
ID MESENCHYMAL STEM-CELLS; IN-VITRO; BONE-MARROW; CHONDROGENIC
   DIFFERENTIATION; ASSISTED LIPOTRANSFER; CLINICAL-APPLICATION; MEMBRANES;
   REGENERATION; BIOCOMPATIBILITY; PROLIFERATION
AB Background: Adipose tissue derived stroma cells (ASC's) offer for many advantages for tissue engineering strategies over mesenchymal stroma cells from other sources and ideal carrier materials have to be identified for them. The aim of this study was to demonstrate and to compare the effects of three clinically established biomaterials on proliferation and metabolic activity of rat ASC's in vitro.
   Materials and methods: Rat adipose tissue derived stroma cells (ASC's) were isolated and differentiated into distinct lineages proved by lineage specific staining and gene expression analysis (RT-PCR). The biomaterials Bio-Gide (R), Tutodent (R) Membrane and Belotero (R) Soft were tested with rat ASC's for their biocompatibility using scanning electron microscopy (SEM), cell vitality staining, cytotoxicity and proliferation tests (LDH, MU, BrdU, WST-1).
   Results: The collagen membrane Bio-Gide (R) resulted in a significantly higher viability and proliferation (WST-1, BrdU) compared to Tutodent (R) Membrane. No significant difference was determined in the LDH and MIT test. The hyaluronic acid gel Belotero (R) Soft showed no cytotoxicity (LDH, FDA/PI) and had no negative effects on metabolic activity (WST-1, MIT) or cell proliferation (BrdU) of ASC's.
   Conclusion: Our results indicate Bio-Gide (R) and Belotero (R) Soft as preferable carrier materials for ASC's. For the further establishment of ASC's-based treatment strategies, in vivo investigations on the tissue regeneration potential of these cell-biomaterial scaffolds should follow. (C) 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Acil, Yahya; Zhang, Xiacong; Nitsche, Tobias; Moeller, Bjoern; Gassling, Volker; Wiltfang, Joerg; Gierloff, Matthias] Univ Kiel, Dept Oral & Maxillofacial Surg, D-24105 Kiel, Germany.
RP Gierloff, M (reprint author), Univ Kiel, Dept Oral & Maxillofacial Surg, Arnold Heller Str 16, D-24105 Kiel, Germany.
EM gierloff@mkg.uni-kiel.de
RI Gassling, Volker/E-4671-2016
OI Gassling, Volker/0000-0002-0096-6142
FU Faculty of Medicine of the Christians-Albrechts University of Kiel
FX The authors thank the Faculty of Medicine of the Christians-Albrechts
   University of Kiel for their financial support of this study. They also
   thank Mrs. Refrath and Mrs. Nessenius for their kind support and
   technical assistance in the laboratory.
CR Aimaiti A, 2011, CHIN J TRAUMATOL, V14, P215, DOI 10.3760/cma.j.issn.1008-1275.2011.04.004
   Angele P, 2004, BIOMATERIALS, V25, P2831, DOI 10.1016/j.biomaterials.2003.09.066
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Ben-David D, 2011, J CRANIO MAXILL SURG, V39, P364, DOI 10.1016/j.jcms.2010.09.001
   Brayfield C, 2010, HANDCHIR MIKROCHIR P, V42, P124, DOI 10.1055/s-0030-1248269
   CLAR C, 2005, HEALTH TECHNOL ASSES, V9, P1
   Fini M, 2007, J ORTHOP RES, V25, P98, DOI 10.1002/jor.20295
   Gassling V, 2013, CLIN ORAL IMPLAN RES, V24, P320, DOI 10.1111/j.1600-0501.2011.02333.x
   Gassling V, 2013, J CRANIO MAXILL SURG, V41, P76, DOI 10.1016/j.jcms.2012.10.015
   Gassling V, 2010, CLIN ORAL IMPLAN RES, V21, P543, DOI 10.1111/j.1600-0501.2009.01900.x
   Hong L, 2007, TISSUE ENG, V13, P1197, DOI 10.1089/ten.2006.0317
   Kim BS, 2010, CELL PROLIFERAT, V43, P249, DOI 10.1111/j.1365-2184.2010.00680.x
   Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766
   Lee JH, 2008, BIOCHEM BIOPH RES CO, V370, P456, DOI 10.1016/j.bbrc.2008.03.123
   Liu Q, 2011, CLIN ORAL IMPLAN RES, V22, P1259, DOI 10.1111/j.1600-0501.2010.02100.x
   Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Pak J, 2011, PAK J MED CASE REPOR, V5, P296, DOI DOI 10.1186/1752-1947-5-296
   Pavicic T, 2011, J DRUGS DERMATOL, V10, P134
   Prager W, 2010, EUR J DERMATOL, V20, P748, DOI 10.1684/ejd.2010.1085
   Prasad BR, 2010, COLLOID SURFACE B, V78, P237, DOI 10.1016/j.colsurfb.2010.03.006
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Sauerbier S, 2006, CLIN ORAL IMPLAN RES, V17, P625, DOI 10.1111/j.1600-0501.2006.01229.x
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Stockmann P, 2012, J CRANIO MAXILL SURG, V40, P310, DOI 10.1016/j.jcms.2011.05.004
   Warnke PH, 2009, CLIN ORAL IMPLAN RES, V20, P761, DOI 10.1111/j.1600-0501.2009.01709.x
   Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
   Young DA, 2011, ACTA BIOMATER, V7, P1040, DOI 10.1016/j.actbio.2010.09.035
   Zhao YN, 2009, TISSUE ENG PT A, V15, P13, DOI 10.1089/ten.tea.2008.0039
   Zimmermann CE, 2011, TISSUE ENG PT A, V17, P1147, DOI [10.1089/ten.tea.2009.0577, 10.1089/ten.TEA.2009.0577]
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 33
TC 8
Z9 9
U1 0
U2 17
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD SEP
PY 2014
VL 42
IS 6
BP 825
EP 834
DI 10.1016/j.jcms.2013.11.020
PG 10
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA AO6LG
UT WOS:000341463000020
PM 24411468
DA 2018-10-20
ER

PT J
AU Soares, LGP
   Marques, AMC
   Barbosa, AFS
   Santos, NR
   Aciole, JMS
   Souza, CMC
   Pinheiro, ALB
   Silveira, L
AF Soares, Luiz Guilherme P.
   Marques, Aparecida Maria C.
   Barbosa, Artur Felipe S.
   Santos, Nicole R.
   Aciole, Jouber Mateus S.
   Souza, Caroline Mathias C.
   Pinheiro, Antonio Luiz B.
   Silveira, Landulfo, Jr.
TI Raman study of the repair of surgical bone defects grafted with biphasic
   synthetic microgranular HA plus beta-calcium triphosphate and irradiated
   or not with lambda 780 nm laser
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Bone repair; Hydroxyapatite; Laser phototherapy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; DENTAL IMPLANTS; REGENERATION; SPECTROSCOPY; LIGHT; THERAPY;
   PHOTOBIOMODULATION
AB The treatment of bone loss due to different etiologic factors is difficult, and many techniques aim to improve repair, including a wide range of biomaterials and, recently, photobioengineering. This work aimed to assess, through Raman spectroscopy, the level of bone mineralization using the intensities of the Raman peaks of both inorganic (similar to 960, similar to 1,070, and similar to 1,077 cm(-1)) and organic (similar to 1,454 and similar to 1,666 cm(-1)) contents of bone tissue. Forty rats were divided into four groups each subdivided into two subgroups according to the time of killing (15 and 30 days). Surgical bone defects were made on femur of each animal with a trephine drill. On animals of group Clot, the defect was filled only by blood clot; on group Laser, the defect filled with the clot was further irradiated. On animals of groups Biomaterial and Laser + Biomaterial, the defect was filled by biomaterial and the last one was further irradiated (lambda 780 nm, 70 mW, I broken vertical bar similar to aEuro parts per thousand 0.4 cm(2), 20 J/cm(2) session, 140 J/cm(2) treatment) in four points around the defect at 48-h intervals and repeated for 2 weeks. At both 15th and 30th day following killing, samples were taken and analyzed by Raman spectroscopy. At the end of the experimental time, the intensities of both inorganic and organic contents were higher on group Laser + Biomaterial. It is concluded that the use of laser phototherapy associated to biomaterial was effective in improving bone healing on bone defects as a result of the increasing deposition of calcium hydroxyapatite measured by Raman spectroscopy.
C1 [Soares, Luiz Guilherme P.; Marques, Aparecida Maria C.; Barbosa, Artur Felipe S.; Santos, Nicole R.; Aciole, Jouber Mateus S.; Souza, Caroline Mathias C.; Pinheiro, Antonio Luiz B.] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Marques, Aparecida Maria C.; Pinheiro, Antonio Luiz B.] Univ Sao Paulo, Phys Inst Sao Carlos, Natl Inst Opt & Photon, BR-13560970 Sao Carlos, SP, Brazil.
   [Pinheiro, Antonio Luiz B.; Silveira, Landulfo, Jr.] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose dos Campos, BR-12247004 Eugenio De Melo, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, Ave Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM luizguilherme_@hotmail.com; cidamarques77@hotmail.com;
   arturfelipes@gmail.com; ribeironicole@hotmail.com;
   jouber.aciole@hotmail.com; Caroline.mathias@hotmail.com; albp@ufba.br;
   landulfo.silveira@gmail.com
RI Silveira, Landulfo/I-2474-2012; Pinheiro, Antonio Luiz/A-1962-2008; Sao
   Carlos Institute of Physics, IFSC/USP/M-2664-2016
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321; 
CR Awonusi A, 2007, CALCIFIED TISSUE INT, V81, P46, DOI 10.1007/s00223-007-9034-0
   Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815
   Cameron MH, 1999, REHABILITATION RES P, P303
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho F.B., 2011, P SOC PHOTO-OPT INS, V7887
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Kalfas IH, 2001, NEUROSURG FOCUS, V10, P7
   Karu T. I., 1988, Lasers in the Life Sciences, V2, P53
   Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1
   Kavukcuoglu NB, 2009, J MECH BEHAV BIOMED, V2, P254
   Lin SY, 2007, SPECTROSC-INT J, V21, P1
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Motomura K, 1984, NIPPON REZA IGAKKAI, V4, P195
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Okagbare PI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090502
   PASSARELLA S, 1985, BIOCHEM BIOPH RES CO, V130, P546, DOI 10.1016/0006-291X(85)90451-6
   Penel G, 2005, BONE, V36, P893, DOI 10.1016/j.bone.2005.02.012
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 2003, DENT MED PROBL, V40, P37
   Pinheiro AL, 2010, PHOTOMED LASER SURG, V28, P89
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   PINHEIRO ALB, 2001, LASER THER, V13, P73
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   PROLO DJ, 1990, CLIN NEUR, V36, P135
   Recker RR, 1992, DISORDERS BONE MINER, P219
   Silveira L, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.077003
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Yamada K, 1991, J JPN ORTHOP ASSOC, V65, P101
   YOUNG S, 1989, LASER SURG MED, V9, P497, DOI 10.1002/lsm.1900090513
NR 44
TC 11
Z9 12
U1 0
U2 12
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD SEP
PY 2014
VL 29
IS 5
BP 1539
EP 1550
DI 10.1007/s10103-013-1297-2
PG 12
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA AO7AF
UT WOS:000341503500002
PM 23525868
DA 2018-10-20
ER

PT J
AU Higuchi, A
   Ling, QD
   Kumar, SS
   Chang, Y
   Kao, TC
   Munusamy, MA
   Alarfaj, AA
   Hsu, ST
   Umezawa, A
AF Higuchi, Akon
   Ling, Qing-Dong
   Kumar, S. Suresh
   Chang, Yung
   Kao, Ta-Chun
   Munusamy, Murugan A.
   Alarfaj, Abdullah A.
   Hsu, Shih-Tien
   Umezawa, Akihiro
TI External stimulus-responsive biomaterials designed for the culture and
   differentiation of ES, iPS, and adult stem cells
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Biomaterial; Stem cell; Thixotropic; Photoresponsive; Thermoresponsive;
   Microcarrier
ID SELF-ASSEMBLED MONOLAYERS; PHOTORESPONSIVE SMART TEMPLATE; PHOTOCAGED
   RGDS PEPTIDES; MYOCARDIAL-INFARCTION; DRUG-DELIVERY; SHEET RECOVERY;
   IN-VITRO; CARDIOMYOCYTE DIFFERENTIATION; SPATIOTEMPORAL CONTROL;
   REDUCING TEMPERATURE
AB The physical and chemical characteristics of biomaterial surface and hydrogels can be altered by external stimuli, such as light irradiation, temperature changes, pH shifts, shear stress forces, electrical forces, and the addition of small chemical molecules. Such external stimulus-responsive biomaterials represent promising candidates that have been developed for the culture and differentiation of embryonic stem (ES) cells, induced pluripotent stem (iPS) cells, and adult stem cells. Biomaterials that are designed to respond in a reversible manner to specific external signals can be formed on micropatterned or non-micropatterned surface, in hydrogels, or on microcarriers. Stem cells and the cells differentiated from them into specific tissue lineages can be cultured and/or differentiated on dishes with immobilized external stimulus-responsive polymers. Cells can be detached from these dishes without using an enzymatic digestion method or a mechanical method when the appropriate external stimulus is generated on the surface. This review discusses the polymers and polymeric designs employed to produce surface and hydrogels for stem cell culture, differentiation, and/or cell detachment using various external stimuli. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Higuchi, Akon; Kao, Ta-Chun] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
   [Higuchi, Akon; Umezawa, Akihiro] Natl Res Inst Child Hlth & Dev, Dept Reprod, Tokyo 1578535, Japan.
   [Higuchi, Akon; Ling, Qing-Dong] Cathay Gen Hosp, Cathay Med Res Inst, Taipei 221, Taiwan.
   [Ling, Qing-Dong] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Taoyuan 32001, Taiwan.
   [Kumar, S. Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Slangor, Malaysia.
   [Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Munusamy, Murugan A.; Alarfaj, Abdullah A.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Hsu, Shih-Tien] Taiwan Landseed Hosp, Dept Internal Med, Taoyuan 32405, Taiwan.
RP Higuchi, A (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
EM higuchi@ncu.edu.tw
OI Kumar S, Suresh/0000-0002-0505-7554; Higuchi, Akon/0000-0003-2970-8531
FU National Science Council of Taiwan [101-2120-M-008-003,
   102-2120-M-008-002, 102-2221-E-008-112-MY2]; LandSeed Hospital project
   [NCU-LSH-101-A-001, NCU-LSH-102-A-003]; National Defense Medical Center
   Project [102NCU-NDMC-01]; Cathay General Hospital Project
   [101CGH-NCU-A2, 102NCU-CGH-02, CGH-MR-10025, CGH-MR-10103, CGH-MR-10115,
   CGH-MR-A10204]; Ministry of Education, Culture, Sports, Science, and
   Technology of Japan [24560968]; International High Cited Research Group
   (IHCRG) [14-104]; Deanship of Scientific Research, King Saud University,
   Riyadh, Kingdom of Saudi Arabia
FX This research was partially supported by the National Science Council of
   Taiwan under Grant numbers 101-2120-M-008-003, 102-2120-M-008-002, and
   102-2221-E-008-112-MY2. This work was also supported by the LandSeed
   Hospital project (NCU-LSH-101-A-001 and NCU-LSH-102-A-003), the National
   Defense Medical Center Project (102NCU-NDMC-01), and the Cathay General
   Hospital Project (101CGH-NCU-A2, 102NCU-CGH-02, CGH-MR-10025,
   CGH-MR-10103, CGH-MR-10115, and CGH-MR-A10204). A Grant-in-Aid for
   Scientific Research (number 24560968) from the Ministry of Education,
   Culture, Sports, Science, and Technology of Japan is also acknowledged.
   We acknowledge the International High Cited Research Group (IHCRG #
   14-104), Deanship of Scientific Research, King Saud University, Riyadh,
   Kingdom of Saudi Arabia. Akon Higuchi thanks King Saud University,
   Riyadh, Kingdom of Saudi Arabia, for the Visiting Professorship.
CR Andreopoulos FM, 2006, BIOMATERIALS, V27, P2468, DOI 10.1016/j.biomaterials.2005.11.019
   Arvidson SA, 2013, MACROMOLECULES, V46, P300, DOI 10.1021/ma3019359
   Auernheimer J, 2005, J AM CHEM SOC, V127, P16107, DOI 10.1021/ja053648q
   Banerjee IA, 2003, J AM CHEM SOC, V125, P9542, DOI 10.1021/ja0344011
   Barbucci R, 2010, SOFT MATTER, V6, P3524, DOI 10.1039/c001949f
   Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291
   Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200
   Brun-Graeppi AKAS, 2010, PROG POLYM SCI, V35, P1311, DOI 10.1016/j.progpolymsci.2010.07.007
   Brun-Graeppi AKAS, 2010, POLYM DEGRAD STABIL, V95, P254, DOI 10.1016/j.polymdegradstab.2009.11.001
   Bunker BC, 2003, NANO LETT, V3, P1723, DOI 10.1021/nl034759v
   Chan EWL, 2008, MOL BIOSYST, V4, P746, DOI 10.1039/b801394b
   Choi I, 2013, CHEMPHYSCHEM, V14, P55, DOI 10.1002/cphc.201200293
   Cui JX, 2013, MACROMOL RAPID COMM, V34, P310, DOI 10.1002/marc.201200634
   Dai S, 2008, SOFT MATTER, V4, P435, DOI 10.1039/b714741d
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Delaittre G, 2012, SOFT MATTER, V8, P7323, DOI 10.1039/c2sm07407a
   Dillmore WS, 2004, LANGMUIR, V20, P7223, DOI 10.1021/la049826v
   Ebara M, 2004, TISSUE ENG, V10, P1125, DOI 10.1089/ten.2004.10.1125
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Edagawa Y, 2012, COLLOID SURFACE B, V99, P20, DOI 10.1016/j.colsurfb.2011.09.027
   Edahiro J, 2005, BIOMACROMOLECULES, V6, P970, DOI 10.1021/bm0493382
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Foo CTSWP, 2009, P NATL ACAD SCI USA, V106, P22067, DOI 10.1073/pnas.0904851106
   Gong YH, 2013, J MATER CHEM B, V1, P2013, DOI 10.1039/c3tb20073f
   Gong YH, 2011, MACROMOLECULES, V44, P7499, DOI 10.1021/ma201676w
   Gong ZG, 2012, SOFT MATTER, V8, P2875, DOI 10.1039/c2sm06984a
   Goubko CA, 2013, J BIOMED MATER RES A, V101, P787, DOI 10.1002/jbm.a.34381
   Goubko CA, 2010, BIOMED MICRODEVICES, V12, P555, DOI 10.1007/s10544-010-9412-7
   Goulet-Hanssens A, 2012, BIOMACROMOLECULES, V13, P2958, DOI 10.1021/bm301037k
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hamilton TD, 2011, J AM CHEM SOC, V133, P3365, DOI 10.1021/ja106095w
   Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003
   Haque A, 2011, BIOMATERIALS, V32, P2032, DOI 10.1016/j.biomaterials.2010.11.045
   Hasegawa M, 2005, TISSUE ENG, V11, P469, DOI 10.1089/ten.2005.11.469
   He XM, 2012, NATURE, V487, P214, DOI 10.1038/nature11223
   Higuchi A, 2005, BIOMACROMOLECULES, V6, P691, DOI 10.1021/bm0494850
   Higuchi A, 2004, BIOMACROMOLECULES, V5, P1770, DOI 10.1021/bm049737x
   Higuchi A, 2008, BIOMACROMOLECULES, V9, P634, DOI 10.1021/bm701107w
   Higuchi A, 2006, J BIOMED MATER RES A, V79A, P380, DOI 10.1002/jbm.a.30773
   Higuchi A, 2014, PROG POLYM SCI, V39, P1348, DOI 10.1016/j.progpolymsci.2014.01.002
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612
   Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102
   Huang CC, 2010, BIOMATERIALS, V31, P6218, DOI 10.1016/j.biomaterials.2010.04.067
   Huang Y, 2013, BIOMACROMOLECULES, V14, P2023, DOI 10.1021/bm400358z
   Huh KM, 2012, MACROMOL RES, V20, P224, DOI 10.1007/s13233-012-0059-5
   Imanishi Y, 2011, CIRCULATION, V124, pS10, DOI 10.1161/CIRCULATIONAHA.110.009993
   Ito S, 2012, BIOMATERIALS, V33, P5278, DOI 10.1016/j.biomaterials.2012.03.073
   Iwata T, 2010, J CLIN PERIODONTOL, V37, P1088, DOI 10.1111/j.1600-051X.2010.01597.x
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Kaneko S, 2011, PHYS CHEM CHEM PHYS, V13, P4051, DOI 10.1039/c0cp02013c
   Kanzaki M, 2007, BIOMATERIALS, V28, P4294, DOI 10.1016/j.biomaterials.2007.06.009
   Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343
   Kikuchi K, 2009, BIOTECHNOL BIOENG, V103, P552, DOI 10.1002/bit.22253
   Kikuchi Y, 2008, LANGMUIR, V24, P13084, DOI 10.1021/la8024414
   Kim SJ, 2013, TISSUE ENG REGEN MED, V10, P139, DOI 10.1007/s13770-013-0401-9
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Kloxin AM, 2010, ADV MATER, V22, P61, DOI 10.1002/adma.200900917
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kolhar P, 2010, J BIOTECHNOL, V146, P143, DOI 10.1016/j.jbiotec.2010.01.016
   Kubota A, 2006, BIOMATERIALS, V27, P3639, DOI 10.1016/j.biomaterials.2006.02.018
   KUBOTA K, 1990, J PHYS CHEM-US, V94, P5154, DOI 10.1021/j100375a070
   Kuroki H, 2012, ANNU REV MATER RES, V42, P343, DOI 10.1146/annurev-matsci-070511-155044
   Kushida A, 2000, J BIOMED MATER RES, V51, P216, DOI 10.1002/(SICI)1097-4636(200008)51:2<216::AID-JBM10>3.0.CO;2-K
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Kwon OH, 2003, BIOMATERIALS, V24, P1223, DOI 10.1016/S0142-9612(02)00469-6
   Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025
   Liu DB, 2009, ANGEW CHEM INT EDIT, V48, P4406, DOI 10.1002/anie.200901130
   Liu HJ, 2011, SOFT MATTER, V7, P5430, DOI 10.1039/c1sm05198a
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Masumoto H, 2012, STEM CELLS, V30, P1196, DOI 10.1002/stem.1089
   Matsuura K, 2013, J CONTROL RELEASE, V169, P336, DOI 10.1016/j.jconrel.2013.03.003
   Matsuura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052176
   Matsuura K, 2012, BIOCHEM BIOPH RES CO, V425, P321, DOI 10.1016/j.bbrc.2012.07.089
   Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Mendes PM, 2008, CHEM SOC REV, V37, P2512, DOI 10.1039/b714635n
   Meng QY, 2012, BIOMATERIALS, V33, P1414, DOI 10.1016/j.biomaterials.2011.11.007
   Mie M, 2008, J BIOMED MATER RES B, V86B, P283, DOI 10.1002/jbm.b.31019
   Minato A, 2012, BIOMATERIALS, V33, P515, DOI 10.1016/j.biomaterials.2011.09.070
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015
   Nagaoka M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-60
   Nakajima K, 2001, BIOMATERIALS, V22, P1213, DOI 10.1016/S0142-9612(00)00270-2
   Nakanishi J, 2008, ANAL SCI, V24, P67, DOI 10.2116/analsci.24.67
   Nakanishi J, 2007, J AM CHEM SOC, V129, P6694, DOI 10.1021/ja070294p
   Nakanishi J, 2006, ANAL CHIM ACTA, V578, P100, DOI 10.1016/j.aca.2006.04.059
   Nakanishi J, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/4/044608
   Nakanishi J, 2010, J PHOTOPOLYM SCI TEC, V23, P171, DOI 10.2494/photopolymer.23.171
   Nanda J, 2013, SOFT MATTER, V9, P4198, DOI 10.1039/c3sm27050e
   Nandivada H, 2007, ADV MATER, V19, P2197, DOI 10.1002/adma.200602739
   Nandivada H, 2010, PROG POLYM SCI, V35, P141, DOI 10.1016/j.progpolymsci.2009.11.001
   Nayak A, 2006, ANGEW CHEM INT EDIT, V45, P4094, DOI 10.1002/anie.200600581
   Nisbet DR, 2006, BIOPHYS CHEM, V121, P14, DOI 10.1016/j.bpc.2005.12.005
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   Nunes SP, 2011, ACS NANO, V5, P3516, DOI 10.1021/nn200484v
   Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576
   Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050
   Ohmuro-Matsuyama Y, 2008, ANGEW CHEM INT EDIT, V47, P7527, DOI 10.1002/anie.200802731
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Olsen BD, 2010, MACROMOLECULES, V43, P9094, DOI 10.1021/ma101434a
   Park S, 2008, LANGMUIR, V24, P6201, DOI 10.1021/la8005663
   Patois E, 2009, J BIOMED MATER RES A, V91A, P324, DOI 10.1002/jbm.a.32211
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Pek YS, 2008, NAT NANOTECHNOL, V3, P671, DOI 10.1038/nnano.2008.270
   Petersen S, 2008, ANGEW CHEM INT EDIT, V47, P3192, DOI 10.1002/anie.200704857
   Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Robertus J, 2010, CHEM SOC REV, V39, P354, DOI 10.1039/b906608j
   Sakaguchi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01316
   Sawa Y, 2012, SURG TODAY, V42, P181, DOI 10.1007/s00595-011-0106-4
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Shimizu H, 2009, BIOMATERIALS, V30, P5943, DOI 10.1016/j.biomaterials.2009.07.042
   Shimizu T, 2006, FASEB J, V20, P708, DOI 10.1096/fj.05-4715fje
   Shiroyanagi Y, 2003, TISSUE ENG, V9, P1005, DOI 10.1089/107632703322495646
   Skardal A, 2010, BIOMATERIALS, V31, P8426, DOI 10.1016/j.biomaterials.2010.07.047
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tada Y, 2006, J APPL POLYM SCI, V100, P495, DOI 10.1002/app.23197
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tibbitt MW, 2010, SOFT MATTER, V6, P5100, DOI 10.1039/c0sm00174k
   Tomatsu I, 2011, ADV DRUG DELIVER REV, V63, P1257, DOI 10.1016/j.addr.2011.06.009
   Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091
   van Dongen SFM, 2013, ADV MATER, V25, P1687, DOI 10.1002/adma.201204474
   Vlassiouk I, 2006, NANO LETT, V6, P1013, DOI 10.1021/nl060313d
   Wang E, 2013, NANO LETT, V13, P2826, DOI 10.1021/nl401088b
   Wang GJ, 2012, J PHOTOCH PHOTOBIO C, V13, P299, DOI 10.1016/j.jphotochemrev.2012.06.002
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Watanabe K, 2007, BIOMATERIALS, V28, P745, DOI 10.1016/j.biomaterials.2006.09.043
   Weber C, 2012, PROG POLYM SCI, V37, P686, DOI 10.1016/j.progpolymsci.2011.10.002
   Wei H, 2009, PROG POLYM SCI, V34, P893, DOI 10.1016/j.progpolymsci.2009.05.002
   Weis S, 2013, ACTA BIOMATER, V9, P8059, DOI 10.1016/j.actbio.2013.06.019
   Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.TEA.2011.0172, 10.1089/ten.tea.2011.0172]
   Wirkner M, 2011, ADV MATER, V23, P3907, DOI 10.1002/adma.201100925
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093
   Zhang JX, 2012, PROG POLYM SCI, V37, P1130, DOI 10.1016/j.progpolymsci.2011.11.005
   Zhang JX, 2010, NANO TODAY, V5, P337, DOI 10.1016/j.nantod.2010.06.011
   Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341
   Zhu LP, 2013, J POLYM SCI POL PHYS, V51, P1062, DOI 10.1002/polb.23302
NR 145
TC 26
Z9 26
U1 4
U2 149
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD SEP
PY 2014
VL 39
IS 9
SI SI
BP 1585
EP 1613
DI 10.1016/j.progpolymsci.2014.05.001
PG 29
WC Polymer Science
SC Polymer Science
GA AO6RU
UT WOS:000341480000001
DA 2018-10-20
ER

PT J
AU Spanoudes, K
   Gaspar, D
   Pandit, A
   Zeugolis, DI
AF Spanoudes, Kyriakos
   Gaspar, Diana
   Pandit, Abhay
   Zeugolis, Dimitrios I.
TI The biophysical, biochemical, and biological toolbox for tenogenic
   phenotype maintenance in vitro
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
DE Tendon cell based therapies; tenogenic phenotype maintenance; tenogenic
   differentiation; in vitro tools
ID MESENCHYMAL STEM-CELLS; COLLAGEN SPONGE CONSTRUCTS; ENDOTHELIAL
   GROWTH-FACTOR; PATELLAR TENDON REPAIR; PLATELET-RICH PLASMA;
   ACHILLES-TENDON; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION;
   CHONDROGENIC DIFFERENTIATION; MECHANICAL STIMULATION
AB Tendon injuries constitute an unmet clinical need, with 3 to 5 million new incidents occurring annually worldwide. Tissue grafting and biomaterial-based approaches fail to provide environments that are conducive to regeneration; instead they lead to nonspecific cell adhesion and scar tissue formation, which collectively impair functionality. Cell based therapies may potentially recover native tendon function, if tenocyte trans-differentiation can be evaded and stem cell differentiation towards tenogenic lineage is attained. To this end, recreating an artificial in vivo tendon niche by engineering functional in vitro microenvironments is a research priority. Clinically relevant cell based therapies for tendon repair and regeneration could be created using tools that harness biophysical beacons (surface topography, mechanical loading), biochemical cues (oxygen tension), and biological signals (growth factors).
C1 [Spanoudes, Kyriakos; Gaspar, Diana; Pandit, Abhay; Zeugolis, Dimitrios I.] NUI Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
RP Zeugolis, DI (reprint author), NUI Galway, Network Excellence Funct Biomat NFB, Biosci Bldg, Galway, Ireland.
EM dimitrios.zeugolis@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Gaspar, Diana/0000-0003-0422-1954;
   SPANOUDES, KYRIAKOS/0000-0001-9484-7920; zeugolis,
   dimitrios/0000-0002-7599-5191
FU EU; Marie Curie; Industry-Academia Partnerships and Pathways award;
   Tendon Regeneration Project [251385]; Science Foundation Ireland
   [SFI_09-RFP-ENM2483]; Health Research Board, Health Research Awards
   Programme [HRA_POR/2011/84]; Enterprise Ireland, Collaborative Centre
   for Applied Nanotechriology under the Irish Government's National
   Development Plan [CCIRP-2007-CCAN-0509]; College of Engineering and
   Informatics; Embark Initiative, Irish Research Council
FX We thank Mr Maciek Doczyk (http://doczykdesign.com) for his support in
   the preparation of Figures 1 and 2 of this manuscript. This work is
   supported by: EU FP7/2007-2013, Marie Curie, Industry-Academia
   Partnerships and Pathways award, part of the People programme, Tendon
   Regeneration Project (Grant Agreement Number: 251385) to D.Z.; Science
   Foundation Ireland (Project Number: SFI_09-RFP-ENM2483) to D.Z.; Health
   Research Board, Health Research Awards Programme, under the grant
   agreement number HRA_POR/2011/84 to D.Z.; Enterprise Ireland,
   Collaborative Centre for Applied Nanotechriology (Project No:
   CCIRP-2007-CCAN-0509), under the Irish Government's National Development
   Plan 2007-2013 to D.Z.; College of Engineering and Informatics,
   Postgraduate Scholarship Scheme to K.S. and D.Z.; and Embark Initiative,
   Irish Research Council to D.G. and D.Z. We thank N.W. Tex Net for
   hosting K.S. and Vornia Biomaterials for hosting D.Z.
CR Abate M, 2012, INT J IMMUNOPATH PH, V25, P325, DOI 10.1177/039463201202500202
   Abbah S.A., 2014, STEM CELL RES THER, V5, P1
   Alberton P, 2012, STEM CELLS DEV, V21, P846, DOI 10.1089/scd.2011.0150
   Aspenberg P, 2000, SCAND J MED SCI SPOR, V10, P372, DOI 10.1034/j.1600-0838.2000.010006372.x
   BATES CJ, 1972, BIOCHIM BIOPHYS ACTA, V278, P372, DOI 10.1016/0005-2795(72)90241-3
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Chen B, 2012, BIOMATERIALS, V33, P6086, DOI 10.1016/j.biomaterials.2012.05.022
   Chen X., 2013, TISSUE ENG PART A, V20, P1583
   Chen X, 2012, SCI REP-UK, V2, DOI 10.1038/srep00977
   Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61
   Cheung EV, 2010, STEM CELLS CLONING, V3, P135, DOI 10.2147/SCCAA.S7359
   Cigognini D, 2013, DRUG DISCOV TODAY, V18, P1099, DOI 10.1016/j.drudis.2013.06.007
   Creaney L, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.040071
   Donnelly E, 2010, J ORTHOP RES, V28, P77, DOI 10.1002/jor.20946
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   Durgam S.S., 2011, AM J VET RES, V73, P162
   Edalat F, 2012, ANN BIOMED ENG, V40, P1301, DOI 10.1007/s10439-011-0452-9
   Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908
   Erisken C, 2013, TISSUE ENG PT A, V19, P519, DOI 10.1089/ten.tea.2012.0072
   Ersen A., 2013, ARCH ORTHOP TRAUMA S, V134, P405
   FALANGA V, 1993, J CELL PHYSIOL, V157, P408, DOI 10.1002/jcp.1041570225
   Farng E, 2008, CLIN ORTHOP RELAT R, V466, P1930, DOI 10.1007/s11999-008-0300-x
   Hansen M, 2013, SCAND J MED SCI SPOR, V23, P614, DOI 10.1111/j.1600-0838.2011.01431.x
   Holladay C, 2014, J TISSUE ENG REGEN M
   Hoppe S, 2013, J SHOULDER ELB SURG, V22, P340, DOI 10.1016/j.jse.2012.01.016
   Huang TF, 2013, AM J SPORT MED, V41, P1117, DOI 10.1177/0363546513480786
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P2291, DOI 10.1089/ten.2006.12.2291
   Kashiwagi K, 2004, SCAND J PLAST RECONS, V38, P193, DOI 10.1080/02844310410029110
   Kawamura K, 2005, EXP HEMATOL, V33, P865, DOI 10.1016/j.exphem.2005.05.010
   Kimelman-Bleich N, 2011, J TISSUE ENG REGEN M, V5, P384, DOI 10.1002/term.324
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   Kraus A., 2013, PLAST RECONSTR SURG, V132, P754
   Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415
   Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531
   Lee WYW, 2012, TISSUE ENG PT A, V18, P484, DOI [10.1089/ten.tea.2011.0130, 10.1089/ten.TEA.2011.0130]
   LEVINTOW L, 1957, SCIENCE, V126, P611, DOI 10.1126/science.126.3274.611
   Li WL, 2013, CELL RES, V23, P81, DOI 10.1038/cr.2012.182
   Liang M, 2012, ADV ORTHOP, DOI 10.1155/2012/984950
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229
   Mishra A, 2009, TISSUE ENG PART C-ME, V15, P431, DOI 10.1089/ten.tec.2008.0534
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Moraes VY, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD010071.PUB2
   Morita Y, 2013, ACTA BIOENG BIOMECH, V15, P71, DOI 10.5277/abb130309
   Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823
   Oryan A, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1534, DOI 10.1002/TERM.1534]
   PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0
   Pelled G, 2012, J ORTHOP RES, V30, P1932, DOI 10.1002/jor.22167
   Petersen W, 2004, J ORTHOPAED RES, V22, P847, DOI 10.1016/j.orthres.2003.11.009
   Petersen W, 2003, ARCH ORTHOP TRAUM SU, V123, P485, DOI 10.1007/s00402-003-0493-0
   Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008
   Rui YF, 2011, J ORTHOP RES, V29, P390, DOI 10.1002/jor21218
   Satyam A, 2014, ADV MATER, V26, P3024, DOI 10.1002/adma.201304428
   Schnabel LV, 2009, J ORTHOP RES, V27, P1392, DOI 10.1002/jor.20887
   Scott A, 2005, J ORTHOP RES, V23, P1219, DOI 10.1016/j.orthres.2004.12.011
   Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687
   Shah V, 2013, J ORTHOP RES, V31, P413, DOI 10.1002/jor.22222
   Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504
   Smith Jay, 2014, Clin J Sport Med, V24, P88, DOI 10.1097/JSM.0000000000000063
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Takahashi Y, 2000, J BIOL CHEM, V275, P14139, DOI 10.1074/jbc.275.19.14139
   Tan SL, 2012, CELLS TISSUES ORGANS, V196, P325, DOI 10.1159/000335693
   Tohidnezhad M, 2011, HISTOCHEM CELL BIOL, V135, P453, DOI 10.1007/s00418-011-0808-0
   Tong WY, 2012, BIOMATERIALS, V33, P7686, DOI 10.1016/j.biomaterials.2012.07.002
   Waggett AD, 2006, EUR J CELL BIOL, V85, P1145, DOI 10.1016/j.ejcb.2006.06.002
   Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909
   Wang T, 2013, TISSUE ENG PART B-RE, V19, P133, DOI [10.1089/ten.teb.2012.0295, 10.1089/ten.TEB.2012.0295]
   Wang XT, 2005, J HAND SURG-AM, V30A, P1255, DOI 10.1016/j.jhsa.2005.06.001
   Wang XT, 2004, J HAND SURG-AM, V29A, P884, DOI 10.1016/j.jhsa.2004.05.016
   Wright WE, 2006, NAT PROTOC, V1, P2088, DOI 10.1038/nprot.2006.374
   Xu W, 2013, TISSUE ENG PT A, V19, P2439, DOI [10.1089/ten.tea.2012.0453, 10.1089/ten.TEA.2012.0453]
   Yang GG, 2005, GENE, V363, P166, DOI 10.1016/j.gene.2005.08.006
   Yang G, 2013, BIOMATERIALS, V34, P9295, DOI 10.1016/j.biomaterials.2013.08.054
   Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Zeugolis DI, 2011, TISSUE ENGINEERING: FROM LAB TO CLINIC, P537, DOI 10.1007/978-3-642-02824-3_25
   Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061424
   Zhang YJ, 2010, BIOTECHNOL LETT, V32, P181, DOI 10.1007/s10529-009-0137-8
   Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058
NR 82
TC 24
Z9 24
U1 1
U2 30
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD SEP
PY 2014
VL 32
IS 9
SI SI
BP 474
EP 482
DI 10.1016/j.tibtech.2014.06.009
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AO6QW
UT WOS:000341477600008
PM 25043371
DA 2018-10-20
ER

PT J
AU Balaz, M
AF Balaz, Matej
TI Eggshell membrane biomaterial as a platform for applications in
   materials science
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Eggshell membrane; Application; Review; Biomaterial
ID SOLID-PHASE EXTRACTION; PEPTIDE LIGAND LIBRARIES; EGG-WHITE PROTEOME;
   CHICKEN EGGSHELL; AVIAN EGGSHELL; MATRIX PROTEINS; SHELL MEMBRANE;
   WASTE-WATER; FUNCTIONAL-CHARACTERIZATION; IMMOBILIZATION PLATFORM
AB Eggshell membrane (ESM) is a unique biomaterial, which is generally considered as waste. However, it has extraordinary properties which can be utilized in various fields and its potential applications are therefore now being widely studied. The first part of this review focuses on the chemical composition and morphology of ESM. The main areas of ESM application are discussed in the second part. These applications include its utilization as a biotemplate for the synthesis of nanoparticles; as a sorbent of heavy metals, organics, dyes, sulfonates and fluorides; as the main component of biosensors; in medicine; and various other applications. For each area of interest, a detailed literature survey is given. (C) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Slovak Acad Sci, Inst Geotech, Kosice 04001, Slovakia.
RP Balaz, M (reprint author), Slovak Acad Sci, Inst Geotech, Watsonova 45, Kosice 04001, Slovakia.
EM balazm@saske.sk
FU Agency for Science and Development [APVV-0189-10]; Slovak Grant Agency
   [VEGA 2/0027/13]; Slovak Academy of Sciences (SAS Centre of Excellence:
   CFNT-MVEP); European Regional Fund [ITMS 26220120019, ITMS 26220120035]
FX This work was supported by projects of the Agency for Science and
   Development (APVV-0189-10), the Slovak Grant Agency (VEGA 2/0027/13) and
   the Slovak Academy of Sciences (SAS Centre of Excellence: CFNT-MVEP).
   The support of the European Regional Fund (projects nanoCEXmat I- ITMS
   26220120019 and nanoCEXmat II- ITMS 26220120035 is also gratefully
   acknowledged.
CR Arami M, 2006, CHEMOSPHERE, V65, P1999, DOI 10.1016/j.chemosphere.2006.06.074
   Arias JL, 1997, CONNECT TISSUE RES, V36, P21, DOI 10.3109/03008209709160211
   ARIAS JL, 1991, CONNECT TISSUE RES, V26, P37, DOI 10.3109/03008209109152162
   ARIAS JL, 1993, INT REV CYTOL, V145, P217, DOI 10.1016/S0074-7696(08)60428-3
   Arias JL, 1997, BRIT POULTRY SCI, V38, P351
   Armitage OE, 2012, J MATER RES, V27, P3157, DOI 10.1557/jmr.2012.379
   Ashraf S, 2013, J CHEM SOC PAKISTAN, V35, P730
   Balaz M, 2013, MAT SCI SEMICON PROC, V16, P1899, DOI 10.1016/j.mssp.2013.06.024
   Balaz P., 2008, MECHANOCHEMISTRY NAN
   Balaz P, 2013, CHEM SOC REV, V42, P7571, DOI 10.1039/c3cs35468g
   BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B
   BELLAIRS R, 1969, Z ZELLFORSCH MIK ANA, V96, P237, DOI 10.1007/BF00338771
   Benson KF, 2012, J MED FOOD, V15, P360, DOI 10.1089/jmf.2011.0197
   Camaratta R, 2013, MATER RES BULL, V48, P1569, DOI 10.1016/j.materresbull.2012.12.047
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Chai Z, 2013, J AGR FOOD CHEM, V61, P589, DOI 10.1021/jf3040572
   Chen H, 2012, ADV MAT RES, V573-754, P63
   Chen WW, 2009, BIOSENS BIOELECTRON, V24, P2534, DOI 10.1016/j.bios.2009.01.010
   Cheng X, 2011, 5 INT C BIOINF BIOM
   Cheng X. Z., 2011, 2011 INT C EL TECHN, P1356
   Cheng XZ, 2011, ATOM SPECTROSC, V32, P175
   Cheng XZ, 2010, ADV MATER RES-SWITZ, V113-116, P22, DOI 10.4028/www.scientific.net/AMR.113-116.22
   Cheng XZ, 2011, MATER SCI FORUM, V675-677, P279, DOI 10.4028/www.scientific.net/MSF.675-677.279
   Chien YC, 2008, J STRUCT BIOL, V163, P84, DOI 10.1016/j.jsb.2008.04.008
   CHOWDHURY SD, 1990, WORLD POULTRY SCI J, V46, P153, DOI 10.1079/WPS19900018
   Chung SH, 2013, ADV MAT IN PRESS
   Cordeiro CMM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084112
   D'Ambrosio C, 2008, J PROTEOME RES, V7, P3461, DOI 10.1021/pr800193y
   D'Souza SF, 2013, MAT SCI ENG C-MATER, V33, P850, DOI 10.1016/j.msec.2012.11.010
   Daraei H, 2013, DESALIN WAT IN PRESS
   Deng WT, 2012, RSC ADV, V2, P1743, DOI 10.1039/c2ra00885h
   Devi PS, 2012, RSC ADV, V2, P11578, DOI 10.1039/c2ra21053c
   Dong DH, 2011, J MATER CHEM, V21, P1028, DOI 10.1039/c0jm03061a
   Dong Q, 2008, CHEM ENG J, V137, P428, DOI 10.1016/j.cej.2007.05.045
   Dong Q, 2007, LANGMUIR, V23, P8108, DOI 10.1021/1a062653k
   Dong Q, 2007, J AM CERAM SOC, V90, P376, DOI 10.1111/j.1551-2916.2006.01392.x
   Farinazzo A, 2009, J CHROMATOGR A, V1216, P1241, DOI 10.1016/j.chroma.2008.11.051
   Farjah GH, 2013, IRAN J BASIC MED SCI, V16, P901
   Fernandez MS, 1997, MATRIX BIOL, V16, P13, DOI 10.1016/S0945-053X(97)90112-8
   Fernandez MS, 2004, J STRUCT BIOL, V148, P1, DOI 10.1016/j.jsb.2004.05.003
   Gautron J, 2001, CONNECT TISSUE RES, V42, P255, DOI 10.3109/03008200109016840
   Gautron J, 2007, J BIOL CHEM, V282, P5273, DOI 10.1074/jbc.M610294200
   Gautron Joel, 2007, P103, DOI 10.1007/978-3-540-37885-3_16
   Gunasekaran S, 2008, INDIAN J PURE AP PHY, V46, P315
   Guo XX, 2011, CHEM ENG J, V166, P81, DOI 10.1016/j.cej.2010.10.010
   Guru PS, 2014, ADV COLLOID INTERFAC, V209, P49, DOI 10.1016/j.cis.2013.12.013
   HARRIS ED, 1980, SCIENCE, V208, P55, DOI 10.1126/science.6102412
   Hincke MT, 2012, FRONT BIOSCI-LANDMRK, V17, P1266, DOI 10.2741/3985
   Hincke MT, 2010, J POULT SCI, V47, P208, DOI 10.2141/jpsa.009122
   Hincke MT, 1995, CONNECT TISSUE RES, V31, P227, DOI 10.3109/03008209509010814
   Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0
   Hirata A, 2013, GRAEF ARCH CLIN EXP, V251, P1621, DOI 10.1007/s00417-012-2247-6
   Hsieh S, 2013, FOOD CHEM, V141, P2117, DOI 10.1016/j.foodchem.2013.04.115
   Huang X, 2010, J AGR FOOD CHEM, V58, P12137, DOI 10.1021/jf101728d
   Ishikawa S, 2002, BIORESOURCE TECHNOL, V81, P201, DOI 10.1016/S0960-8524(01)00134-1
   Jia J, 2012, J NANOMATER, DOI 10.1155/2012/282736
   Joshi P, 2010, MICROCHIM ACTA, V169, P383, DOI 10.1007/s00604-010-0346-9
   KAIDEN K, 1987, APPL SPECTROSC, V41, P180, DOI 10.1366/000370287774986714
   Kang J, 2010, J APPL POLYM SCI, V117, P2042, DOI 10.1002/app.32035
   Kaweewong K, 2013, PROTEIN J, V32, P297, DOI 10.1007/s10930-013-9487-0
   Kim GH, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/1/016006
   King'ori AM, 2011, INT J POULT SCI, V10, P908, DOI DOI 10.3923/IJPS.2011.908.912
   Kodali VK, 2011, PLOS ONE, P6
   Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x
   Kumari TSD, 2010, IONICS, V16, P61, DOI 10.1007/s11581-009-0342-4
   LEACH RM, 1982, POULTRY SCI, V61, P2040, DOI 10.3382/ps.0612040
   Lee SM, 2009, PHYS CHEM CHEM PHYS, V11, P3608, DOI 10.1039/b820436e
   Lee T, 2010, THIN SOLID FILMS, V518, P5488, DOI 10.1016/j.tsf.2010.04.019
   Li BX, 2008, ANAL BIOCHEM, V374, P64, DOI 10.1016/j.ab.2007.10.036
   Li N, 2011, BIOMATERIALS, V32, P8743, DOI 10.1016/j.biomaterials.2011.08.007
   Li Z, 2012, ADV ENERGY MATER, V2, P431, DOI 10.1002/aenm.201100548
   Liang M, 2014, J MATER SCI, V49, P1639, DOI 10.1007/s10853-013-7847-y
   Liong JWW, 1997, J FOOD PROTECT, V60, P1022
   Liu D, 2008, J MOL STRUCT, V883, P228, DOI 10.1016/j.molstruc.2008.02.025
   Liu J, 2012, ADV MATER RES-SWITZ, V599, P391, DOI 10.4028/www.scientific.net/AMR.599.391
   Liu N, 2013, MECH MATER, V299, P207
   Liu S, 2013, ANAL METHODS, V5, P5154
   Liu T, 2011, ADV MATER RES-SWITZ, V183-185, P2120, DOI 10.4028/www.scientific.net/AMR.183-185.2120
   Liu WJ, 2013, ANAL METHODS-UK, V5, P5154, DOI 10.1039/c3ay40327k
   Lu JW, 2009, J BIOMED MATER RES A, V91A, P701, DOI 10.1002/jbm.a.32304
   Lunge S, 2012, J HAZARD MATER, V237, P161, DOI 10.1016/j.jhazmat.2012.08.023
   Maeda K, 1981, BURNS, V8, P313
   Mallampati R, 2012, J NANOSCI NANOTECHNO, V12, P618, DOI 10.1166/jnn.2012.5365
   Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032
   Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790
   Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397
   Mann K, 2007, PROTEOMICS, V7, P106, DOI 10.1002/pmic.200600635
   Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x
   Mogosanu GD, 2014, INT J PHARMACEUT, V463, P127, DOI 10.1016/j.ijpharm.2013.12.015
   Nakano T, 2003, POULTRY SCI, V82, P510, DOI 10.1093/ps/82.3.510
   Neelakandeswari N, 2011, SYNTH REACT INORG M, V41, P513, DOI 10.1080/15533174.2011.568434
   Ning L, 2011, ADV MATER RES-SWITZ, V183-185, P963, DOI 10.4028/www.scientific.net/AMR.183-185.963
   Nys Y, 2004, CR PALEVOL, V3, P549, DOI 10.1016/j.crpv.2004.08.002
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   Oda J, 1998, JSME INT J A-SOLID M, V41, P121, DOI 10.1299/jsmea.41.121
   OSUOJI CI, 1971, BIOCHIM BIOPHYS ACTA, V244, P481, DOI 10.1016/0304-4165(71)90253-4
   PICARD J, 1973, BIOCHIM BIOPHYS ACTA, V320, P427, DOI 10.1016/0304-4165(73)90324-3
   Poland AL, 2001, J FOOD PROTECT, V64, P486, DOI 10.4315/0362-028X-64.4.486
   Ponkham W., 2011, Thai Journal of Agricultural Science, V44, P354
   Pourmortazavi SM, 2014, MATER LETT, V121, P5, DOI 10.1016/j.matlet.2014.01.142
   Qi QL, 2009, CHINESE J POLYM SCI, V27, P387, DOI 10.1142/S0256767909004047
   Rath MK, 2014, CERAM INT, V40, P3295, DOI 10.1016/j.ceramint.2013.09.105
   ROBINSON DS, 1963, NATURE, V199, P497, DOI 10.1038/199497a0
   Ruff KJ, 2009, CLIN INTERV AGING, V4, P235
   Ruff KJ, 2009, CLIN RHEUMATOL, V28, P907, DOI 10.1007/s10067-009-1173-4
   Sah MK, 2014, J APPL POLYM SCI, V131
   Shao CY, 2011, J MATER CHEM, V21, P2863, DOI 10.1039/c0jm04071a
   Shimada Y, 2010, KAGAKU KOGAKU RONBUN, V36, P255, DOI 10.1252/kakoronbunshu.36.255
   Song NN, 2012, MICRO NANO LETT, V7, P943, DOI 10.1049/mnl.2012.0631
   STARCHER BC, 1980, CONNECT TISSUE RES, V8, P53, DOI 10.3109/03008208009152122
   Su HL, 2006, J MEMBRANE SCI, V283, P7, DOI 10.1016/j.memsci.2006.07.010
   Su HL, 2012, APPL PHYS A-MATER, V106, P93, DOI 10.1007/s00339-011-6561-3
   Su HL, 2011, APPL PHYS A-MATER, V104, P269, DOI 10.1007/s00339-010-6122-1
   Su HL, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/1/015045
   Takahashi K, 1996, BIOSCI BIOTECH BIOCH, V60, P1299, DOI 10.1271/bbb.60.1299
   Tang JL, 2011, J FLUORESC, V21, P339, DOI 10.1007/s10895-010-0721-2
   Tang QW, 2011, RSC ADV, V1, P1453, DOI 10.1039/c1ra00712b
   Tang QW, 2011, J MATER CHEM, V21, P13354, DOI 10.1039/c1jm11857a
   Tao YY, 2009, INT J PHARMACEUT, V378, P30, DOI 10.1016/j.ijpharm.2009.05.025
   Tembe S, 2008, ANAL CHIM ACTA, V612, P212, DOI 10.1016/j.aca.2008.02.031
   Torres FG, 2013, J THERM ANAL CALORIM, V111, P1921, DOI 10.1007/s10973-012-2915-0
   Torres FG, 2010, ACTA BIOMATER, V6, P3687, DOI 10.1016/j.actbio.2010.03.014
   Trimbos KB, 2009, J ORNITHOL, V150, P915, DOI 10.1007/s10336-009-0422-2
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Flores-Cano JV, 2013, APPL SURF SCI, V276, P682, DOI 10.1016/j.apsusc.2013.03.153
   Wang F, 2010, J HAZARD MATER, V173, P510, DOI 10.1016/j.jhazmat.2009.08.114
   Wang Q, 2012, ANALYST, V137, P5392, DOI 10.1039/c2an36059d
   Wang S, 2013, J AGR FOOD CHEM, V61, P4988, DOI 10.1021/jf4003939
   Wang WD, 2010, J CHROMATOGR A, V1217, P5659, DOI 10.1016/j.chroma.2010.07.017
   Wang X, 2002, POULTRY SCI, V81, P805, DOI 10.1093/ps/81.6.805
   Wang XJ, 2012, ORG BIOMOL CHEM, V10, P8082, DOI 10.1039/c2ob26279g
   Wang Z, 2014, CATAL TODAY IN PRESS
   Wang ZT, 2013, CATAL TODAY, V216, P44, DOI 10.1016/j.cattod.2013.05.023
   Wen GM, 2013, J FOOD ENG, V118, P56, DOI 10.1016/j.jfoodeng.2013.01.006
   Weymuth T, 2010, J PHYS CHEM B, V114, P10649, DOI 10.1021/jp104542w
   Whitehead KA, 2011, BIOFOULING, V27, P907, DOI 10.1080/08927014.2011.611879
   WONG M, 1984, DEV BIOL, V104, P28, DOI 10.1016/0012-1606(84)90033-2
   WU TM, 1995, MATRIX BIOL, V14, P507, DOI 10.1016/0945-053X(95)90008-X
   Xiong X, 2012, J BIOMAT SCI-POLYM E, V23, P1217, DOI 10.1163/092050611X576981
   Xu Z, 2010, MAT SCI ENG C-MATER, V30, P822, DOI 10.1016/j.msec.2010.03.014
   Yamauchi K, 2013, CONNECT TISSUE RES, V54, P416, DOI 10.3109/03008207.2013.834895
   Yang T, 2011, ANALYST, V136, P83, DOI 10.1039/c0an00480d
   Yeni F, 2008, ANAL LETT, V41, P2743, DOI 10.1080/00032710802363594
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
   Yi F, 2003, MACROMOL BIOSCI, V3, P234, DOI 10.1002/mabi.200390030
   Yi F, 2007, J WUHAN UNIV TECHNOL, V22, P117, DOI 10.1007/s11595-005-1117-z
   Yoo S, 2009, BIORESOURCE TECHNOL, V100, P6416, DOI 10.1016/j.biortech.2009.06.112
   Yu HJ, 2012, J POWER SOURCES, V206, P463, DOI 10.1016/j.jpowsour.2012.01.116
   Zhang RH, 2012, ADV MATER RES-SWITZ, V457-458, P536, DOI 10.4028/www.scientific.net/AMR.457-458.536
   Zhang Y, 2011, BIOTECHNOL J, V6, P492, DOI 10.1002/biot.201000395
   Zhang YJ, 2010, TALANTA, V80, P1907, DOI 10.1016/j.talanta.2009.10.042
   Zhao Y.-H, 2009, BIOTECHNOLOGY, V8, P254
   Zheng BZ, 2011, SENSOR ACTUAT B-CHEM, V152, P49, DOI 10.1016/j.snb.2010.09.051
   Zhou J, 2010, NANO RES, V4, P171
   Zou X, 2013, ANAL METHODS-UK, V5, P6486, DOI 10.1039/c3ay41015c
NR 155
TC 64
Z9 66
U1 9
U2 152
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2014
VL 10
IS 9
SI SI
BP 3827
EP 3843
DI 10.1016/j.actbio.2014.03.020
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AN8KO
UT WOS:000340853300003
PM 24681370
DA 2018-10-20
ER

PT J
AU Omer, M
   Park, SY
AF Omer, Muhammad
   Park, Soo-Young
TI Preparation of QP4VP-b-LCP liquid crystal block copolymer and its
   application as a biosensor
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Article
DE Strong cationic polyelectrolyte; QP4VP-b-LCP; Protein; DNA; RAFT
   polymerization; Biosensor
ID POLY(4-VINYL PYRIDINE); RAFT POLYMERIZATION; SURFACES; QUATERNIZATION;
   PROTEINS
AB The interface between nematic liquid crystal, 4-cyano-4'-pentylbiphenyl (5CB), and water in a transmission electron microscopy (TEM) grid cell coated with QP4VP-b-LCP (quaternized poly(4-vinylpyridine) (QP4VP) and poly(4-cyanobiphenyl-4'-oxyundecylacrylate) (LCP)) was examined for protein and DNA detection. QP4VP-b-LCP was synthesized by reversible addition-fragmentation chain transfer (RAFT) polymerization. Quaternization of P4VP with iodomethane (CH3I) made it a strong cationic polyelectrolyte and allowed QP4VP-b-LCP to form complexes with oppositely charged biological species. Several proteins, such as bovine serum albumin (BSA), hemoglobin (Hb), alpha chymotrypsinogen-A (ChTg), and lysozyme (LYZ), were tested for nonspecific protein detection. By injecting the protein solutions into the TEM grid cell, the initial homeotropic orientation of the TEM grid cell changed to a planar orientation above their isoelectric points (PIs) due to electrostatic interactions between QP4VP (+charge) and proteins (-charge), which did not occur below the PIs of the tested proteins. Their minimum concentrations at which the homeotropic to planar configurational change (H-P change) occurred were 0.01, 0.02, 0.03, and 0.04 wt.% for BSA, ChTg, Hb, and LYZ, respectively. One of the strong anionic polyelectrolytes, deoxyribonucleic acid (DNA) (due to the phosphate deoxyribose backbone) was also tested. A H-P change was observed with as little as 0.0013 wt.% salmon sperm DNA regardless of the pH of the cell. A H-P change occurred in 5CB and was observed by polarized optical microscopy. This simple and inexpensive setup for nonspecific biomaterial detection provides the basic idea for developing effective selective biosensors by introducing specific binding groups, such as the aptamer and antibody.
C1 [Omer, Muhammad; Park, Soo-Young] Kyungpook Natl Univ, Dept Polymer Sci, Taegu 702701, South Korea.
RP Park, SY (reprint author), Kyungpook Natl Univ, Dept Polymer Sci, 1370 Sangyuk Dong, Taegu 702701, South Korea.
EM psy@knu.ac.kr
RI park, soo-young/N-3170-2017
OI park, soo-young/0000-0001-6796-4929
FU National Research Foundation of Korea [NRF-2011-0020264]
FX This work was supported by the National Research Foundation of Korea
   (NRF-2011-0020264).
CR Bicak N, 2003, J MACROMOL SCI PURE, VA40, P585, DOI 10.1081/MA-120020865
   Bozovic-Vukic J, 2007, MACROMOLECULES, V40, P7132, DOI 10.1021/ma070789z
   Brake JM, 2003, SCIENCE, V302, P2094, DOI 10.1126/science.1091749
   DUBOIS JC, 1986, MOL CRYST LIQ CRYST, V137, P349, DOI 10.1080/00268948608070932
   Hamley IW, 2004, PROG POLYM SCI, V29, P909, DOI 10.1016/j.progpolymsci.2004.06.001
   JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002
   Khan W, 2012, LAB CHIP, V12, P4553, DOI 10.1039/c2lc40710h
   Khan W, 2011, SOFT MATTER, V7, P11549
   Kyung WK, 2006, MACROMOL RES, V14, P483
   Lee DY, 2010, SOFT MATTER, V6, P1964, DOI 10.1039/b926461b
   Lee E, 2012, MACROMOL RES, V20, P1219, DOI 10.1007/s13233-013-1010-0
   Perrier S, 2004, MACROMOLECULES, V37, P2709, DOI 10.1021/ma035468b
   Sehoon J, 2009, MACROMOL RES, V17, P192
   Seo JM, 2012, SOFT MATTER, V8, P198, DOI 10.1039/c1sm06616a
   Seong HC, 2005, MACROMOL RES, V13, P39
   Skaife JJ, 2001, LANGMUIR, V17, P5595, DOI 10.1021/la010132l
   Skaife JJ, 2001, LANGMUIR, V17, P5448, DOI 10.1021/la0017678
   Sonmez HB, 2002, REACT FUNCT POLYM, V51, P55, DOI 10.1016/S1381-5148(02)00033-0
   Yang J. Y., 1994, MICROCHEMISTRY SPECT
   Yeh SW, 2005, MACROMOLECULES, V38, P6559, DOI 10.1021/ma047653a
   York AW, 2008, ADV DRUG DELIVER REV, V60, P1018, DOI 10.1016/j.addr.2008.02.006
NR 21
TC 11
Z9 11
U1 2
U2 50
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD SEP
PY 2014
VL 406
IS 22
BP 5369
EP 5378
DI 10.1007/s00216-014-7900-y
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA AN8TK
UT WOS:000340877200015
PM 24980600
DA 2018-10-20
ER

PT J
AU Avila, HM
   Schwarz, S
   Feldmann, EM
   Mantas, A
   von Bomhard, A
   Gatenholm, P
   Rotter, N
AF Avila, Hector Martinez
   Schwarz, Silke
   Feldmann, Eva-Maria
   Mantas, Athanasios
   von Bomhard, Achim
   Gatenholm, Paul
   Rotter, Nicole
TI Biocompatibility evaluation of densified bacterial nanocellulose
   hydrogel as an implant material for auricular cartilage regeneration
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Bacterial cellulose; Depyrogenation; Endotoxin analysis;
   Biocompatibility; Auricular cartilage tissue engineering
ID CELLULOSE SCAFFOLDS; ACETOBACTER-XYLINUM; POTENTIAL SCAFFOLD;
   CHONDROCYTES; INFLAMMATION; RESPONSES; BEHAVIOR; SYSTEMS; PLA
AB Bacterial nanocellulose (BNC), synthesized by the bacterium Gluconacetobacter xylinus, is composed of highly hydrated fibrils (99 % water) with high mechanical strength. These exceptional material properties make BNC a novel biomaterial for many potential medical and tissue engineering applications. Recently, BNC with cellulose content of 15 % has been proposed as an implant material for auricular cartilage replacement, since it matches the mechanical requirements of human auricular cartilage. This study investigates the biocompatibility of BNC with increased cellulose content (17 %) to evaluate its response in vitro and in vivo. Cylindrical BNC structures (48 Au 20 mm) were produced, purified in a built-in house perfusion system, and compressed to increase the cellulose content in BNC hydrogels. The reduction of endotoxicity of the material was quantified by bacterial endotoxin analysis throughout the purification process. Afterward, the biocompatibility of the purified BNC hydrogels with cellulose content of 17 % was assessed in vitro and in vivo, according to standards set forth in ISO 10993. The endotoxin content in non-purified BNC (2,390 endotoxin units (EU)/ml) was reduced to 0.10 EU/ml after the purification process, level well below the endotoxin threshold set for medical devices. Furthermore, the biocompatibility tests demonstrated that densified BNC hydrogels are non-cytotoxic and cause a minimal foreign body response. In support with our previous findings, this study concludes that BNC with increased cellulose content of 17 % is a promising non-resorbable biomaterial for auricular cartilage tissue engineering, due to its similarity with auricular cartilage in terms of mechanical strength and host tissue response.
C1 [Avila, Hector Martinez; Mantas, Athanasios; Gatenholm, Paul] Chalmers, Dept Chem & Biol Engn, S-41346 Gothenburg, Sweden.
   [Schwarz, Silke; Feldmann, Eva-Maria; von Bomhard, Achim; Rotter, Nicole] Univ Ulm, Med Ctr, Dept Otorhinolaryngol, D-89075 Ulm, Germany.
RP Gatenholm, P (reprint author), Chalmers, Dept Chem & Biol Engn, Kemivagen 4, S-41346 Gothenburg, Sweden.
EM hectorm@chalmers.se; Silke.Schwarz@uniklinik-ulm.de;
   eva-maria.feldmann@uniklinik-ulm.de; mantatha@gmail.com;
   achimvonbomhard@gmail.com; paul.gatenholm@chalmers.se;
   nicole.rotter@uniklinik-ulm.de
FU ERANET/EuroNanoMed [EAREG-406340-131009/1]
FX The authors acknowledge ERANET/EuroNanoMed (EAREG-406340-131009/1) for
   funding this work; Veronika Fuss and Anette Jork at Cell Med AG,
   Alzenau, Germany, for the support with histopathological evaluation and
   cytotoxicity testing; Alexander Elsaesser at Ulm University Medical
   Center, Ulm, Germany, for helping with the animal study; and Johan
   Sundberg, Anne Wendel, and Professor Vratislav Langer at Chalmers
   University of Technology, Gothenburg, Sweden, for the SEM analysis,
   ESCA, and XRD measurements, respectively.
CR Ahrem H, 2014, ACTA BIOMATER, V10, P1341, DOI 10.1016/j.actbio.2013.12.004
   Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 1999, J CONTROL RELEASE, V57, P107, DOI 10.1016/S0168-3659(98)00178-3
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Andrade FK, 2013, J BIOACT COMPAT POL, V28, P97, DOI 10.1177/0883911512467643
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Bermueller C, 2013, TISSUE ENG PT A, V19, P2201, DOI [10.1089/ten.tea.2012.0650, 10.1089/ten.TEA.2012.0650]
   Bodin A, 2010, BIOMATERIALS, V31, P8889, DOI 10.1016/j.biomaterials.2010.07.108
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   DEINEMA MH, 1971, ARCH MIKROBIOL, V78, P42, DOI 10.1007/BF00409087
   Feldmann EM, 2013, J BIOMATER APPL, V28, P626, DOI 10.1177/0885328212472547
   Fink HP, 1997, MACROMOL SYMP, V120, P207, DOI 10.1002/masy.19971200121
   Gatenholm P, 2012, BACTERIAL NANOCELLUL, P197
   Gea S, 2011, BIORESOURCE TECHNOL, V102, P9105, DOI 10.1016/j.biortech.2011.04.077
   Grobelski B, 2014, INT J POLYM MATER PO, V63, P518, DOI 10.1080/00914037.2013.854223
   Heine H, 2001, MOL BIOTECHNOL, V19, P279, DOI 10.1385/MB:19:3:279
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hold GL, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P371, DOI 10.1007/978-3-7091-0733-1_12
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Klechkovskaya VV, 2003, CRYSTALLOGR REP+, V48, P755, DOI 10.1134/1.1612596
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D, 2012, BACTERIAL NANOCELLUL, P175
   Kondo T, 2002, P NATL ACAD SCI USA, V99, P14008, DOI 10.1073/pnas.212238399
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kowalska-Ludwicka K, 2013, ARCH MED SCI, V9, P527, DOI 10.5114/aoms.2013.33433
   Mansikkamaki P, 2005, CELLULOSE, V12, P233, DOI 10.1007/s10570-004-3132-1
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   Martinez-Sanz M, 2011, CELLULOSE, V18, P335, DOI 10.1007/s10570-010-9471-1
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   Moharram MA, 2007, J APPL POLYM SCI, V105, P2978, DOI 10.1002/app.26580
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Rosen CL, 2011, NEUROSURGERY, V69, P1093, DOI 10.1227/NEU.0b013e3182284aca
   Sano MB, 2010, ANN BIOMED ENG, V38, P2475, DOI 10.1007/s10439-010-9999-0
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Silipo A, 2011, BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, P1, DOI 10.1007/978-3-7091-0733-1_1
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tim S., 2011, J GXP COMPLIANCE, V15, P90
   USDoHH Services, 2012, GUID IND PYR END TES, P11
   White DG, 1989, CELLULOSE WOOD CHEM, P573
   Williams K., 2007, ENDOTOXINS PYROGENS, P301
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 48
TC 24
Z9 24
U1 4
U2 97
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD SEP
PY 2014
VL 98
IS 17
BP 7423
EP 7435
DI 10.1007/s00253-014-5819-z
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AN8FB
UT WOS:000340837600012
PM 24866945
DA 2018-10-20
ER

PT J
AU Ball, V
AF Ball, Vincent
TI Physicochemical perspective on "polydopamine" and "poly(catecholamine)"
   films for their applications in biomaterial coatings
SO BIOINTERPHASES
LA English
DT Review
ID POLYMERIZED POLYANILINE FILMS; MUSSEL ADHESIVE PROTEIN; CROSS-LINKING;
   MULTIFUNCTIONAL COATINGS; DOPAMINE POLYMERIZATION;
   MECHANICAL-PROPERTIES; SURFACE MODIFICATION; INSPIRED COATINGS; MELANIN
   FILMS; THIN-FILMS
AB Bioinspired poly(catecholamine) based coatings, mostly "polydopamine," were conceived based on the chemistry used by mussels to adhere strongly to the surface of stones and wood in water and to remain attached to their substrates even under conditions of strong shear stresses. These kinds of films can in turn be easily modified with a plethora of molecules and inorganic (nano)materials. This review shows that poly(catecholamine) based coatings are an ideal film forming method for applications in the field of biomaterials. It is written from a physicochemical and a materials science perspective and discusses optical, chemical, electrochemical, and mechanical properties of polydopamine films. It further demonstrates that a better understanding of the polydopamine film deposition mechanism is warranted to improve the properties of these coatings even further. (C) 2014 American Vacuum Society.
C1 [Ball, Vincent] Univ Strasbourg, Fac Chirurg Dent, F-67000 Strasbourg, France.
   [Ball, Vincent] Inst Natl Sante & Rech Med, UMR 1121, F-67085 Strasbourg, France.
RP Ball, V (reprint author), Univ Strasbourg, Fac Chirurg Dent, 8 Rue St Elisabeth, F-67000 Strasbourg, France.
EM vball@unistra.fr
RI BALL, Vincent/E-8500-2016
CR Arzillo M, 2012, BIOMACROMOLECULES, V13, P2379, DOI 10.1021/bm3006159
   Ball V, 2010, COLLOID SURFACE A, V363, P92, DOI 10.1016/j.colsurfa.2010.04.020
   Ball V, 2013, LANGMUIR, V29, P12754, DOI 10.1021/la4029782
   Ball V, 2012, BIONANOSCIENCE, V2, P16, DOI 10.1007/s12668-011-0032-3
   Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030
   Ball V, 2011, J COLLOID INTERF SCI, V364, P359, DOI 10.1016/j.jcis.2011.08.038
   Bernsmann F, 2008, SOFT MATTER, V4, P1621, DOI 10.1039/b806649c
   Bernsmann F, 2011, LANGMUIR, V27, P2819, DOI 10.1021/la104981s
   Bernsmann F, 2011, ELECTROCHIM ACTA, V56, P3914, DOI 10.1016/j.electacta.2011.02.028
   Bernsmann F, 2010, J COLLOID INTERF SCI, V344, P54, DOI 10.1016/j.jcis.2009.12.052
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Bernsrnann F, 2010, CHEMPHYSCHEM, V11, P3299, DOI 10.1002/cphc.201000384
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Bothma JP, 2008, ADV MATER, V20, P3539, DOI 10.1002/adma.200703141
   Brubaker CE, 2011, BIOMACROMOLECULES, V12, P4326, DOI 10.1021/bm201261d
   Chassepot A, 2014, J COLLOID INTERF SCI, V414, P97, DOI 10.1016/j.jcis.2013.10.002
   Chen CT, 2013, ACS NANO, V7, P1524, DOI 10.1021/nn305305d
   d'Ischia M, 2011, EUR J ORG CHEM, P5501, DOI 10.1002/ejoc.201100796
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Del Frari D, 2012, POLYM DEGRAD STABIL, V97, P1844, DOI 10.1016/j.polymdegradstab.2012.05.002
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Dreyer DR, 2013, CHEM SCI, V4, P3796, DOI 10.1039/c3sc51501j
   Farnad N, 2012, WATER AIR SOIL POLL, V223, P3535, DOI 10.1007/s11270-012-1131-7
   Gao HC, 2013, ACS APPL MATER INTER, V5, P425, DOI 10.1021/am302500v
   Gidanian S, 2002, J INORG BIOCHEM, V89, P54, DOI 10.1016/S0162-0134(01)00405-6
   Guo SL, 2008, PHOTOCHEM PHOTOBIOL, V84, P671, DOI 10.1111/j.1751-1097.2008.00331.x
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   Heinz P, 2008, LANGMUIR, V24, P6166, DOI 10.1021/la800575f
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Hong L, 2007, J PHYS CHEM B, V111, P7938, DOI 10.1021/jp071439h
   Hong S., ADV MAT INT IN PRESS
   Hong S, 2013, ANGEW CHEM INT EDIT, V52, P9187, DOI 10.1002/anie.201301646
   Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jaber M, 2010, J PHYS CHEM LETT, V1, P85, DOI 10.1021/jz900020m
   Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kang SM, 2011, ADV FUNCT MATER, V21, P108, DOI 10.1002/adfm.201001692
   Kang SM, 2009, J AM CHEM SOC, V131, P13224, DOI 10.1021/ja905183k
   Kim S, 2010, LANGMUIR, V26, P14730, DOI 10.1021/la1027509
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Langer R, 2013, J BIOMED MATER RES A, V101, P2449, DOI 10.1002/jbm.a.34811
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee C, 2013, BIOMACROMOLECULES, V14, P2004, DOI 10.1021/bm400352d
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Li B, 2009, LANGMUIR, V25, P7368, DOI 10.1021/la900262p
   Li RJ, 2013, ANGEW CHEM INT EDIT, V52, P5535, DOI 10.1002/anie.201300312
   Li YL, 2006, THIN SOLID FILMS, V497, P270, DOI 10.1016/j.tsf.2005.10.048
   Lin SC, 2014, SOFT MATTER, V10, P457, DOI 10.1039/c3sm51810h
   Liu QZ, 2011, MACROMOL BIOSCI, V11, P1227, DOI 10.1002/mabi.201100061
   Liu Y., CHEM REV IN PRESS
   Loizou E, 2006, MACROMOL BIOSCI, V6, P711, DOI 10.1002/mabi.200600097
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c
   Matyjaszewski K, 2007, LANGMUIR, V23, P4528, DOI 10.1021/la063402e
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x
   Mihai I, 2013, COLLOID SURFACE A, V434, P118, DOI 10.1016/j.colsurfa.2013.05.028
   Moses DN, 2006, ACTA BIOMATER, V2, P521, DOI 10.1016/j.actbio.2006.05.002
   Mostert AB, 2013, J PHYS CHEM B, V117, P4965, DOI 10.1021/jp401615e
   Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109
   Muller M, 2011, LANGMUIR, V27, P12499, DOI 10.1021/la202908b
   Nam HJ, 2014, CHEM COMMUN, V50, P1458, DOI 10.1039/c3cc48309f
   Ogaki R, 2012, LANGMUIR, V28, P8594, DOI 10.1021/la301441t
   Ou JF, 2009, J PHYS CHEM C, V113, P20429, DOI 10.1021/jp9073416
   Ponzio F, 2014, COLLOID SURFACE A, V443, P540, DOI 10.1016/j.colsurfa.2013.12.027
   Postma A, 2009, CHEM MATER, V21, P3042, DOI 10.1021/cm901293e
   Raper HS, 1927, BIOCHEM J, V21, P89, DOI 10.1042/bj0210089
   Riede A, 2000, LANGMUIR, V16, P6240, DOI 10.1021/la991414c
   Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347
   Sapurina I, 2001, SYNTHETIC MET, V123, P503, DOI 10.1016/S0379-6779(01)00349-6
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   SWALEN JD, 1987, LANGMUIR, V3, P932, DOI 10.1021/la00078a011
   Wang AJ, 2012, ELECTROCHIM ACTA, V61, P31, DOI 10.1016/j.electacta.2011.11.063
   Wang JT, 2009, J POWER SOURCES, V192, P336, DOI 10.1016/j.jpowsour.2009.03.014
   Watt AAR, 2009, SOFT MATTER, V5, P3754, DOI 10.1039/b902507c
   Wei HL, 2013, COLLOID SURFACE B, V110, P22, DOI 10.1016/j.colsurfb.2013.04.008
   Wei Q, 2011, J BIOMED MATER RES A, V96A, P38, DOI 10.1002/jbm.a.32956
   Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a
   Wen Q, 2013, EXP CELL RES, V319, P2481, DOI 10.1016/j.yexcr.2013.05.017
   Xu HL, 2012, LANGMUIR, V28, P13060, DOI 10.1021/la302394e
   Xu H, 2011, APPL SURF SCI, V257, P6799, DOI 10.1016/j.apsusc.2011.02.129
   Yang HC, 2013, CHEM COMMUN, V49, P10522, DOI 10.1039/c3cc46127k
   Yang SH, 2011, J AM CHEM SOC, V133, P2795, DOI 10.1021/ja1100189
   Yu B, 2010, CHEM COMMUN, V46, P5900, DOI 10.1039/c0cc00596g
   Yu B, 2009, CHEM COMMUN, P6789, DOI 10.1039/b910679k
   Zangmeister RA, 2013, LANGMUIR, V29, P8619, DOI 10.1021/la400587j
   Zhang Y, 2013, LANGMUIR, V29, P10213, DOI 10.1021/la402118u
   Zhang Y, 2012, LANGMUIR, V28, P17585, DOI 10.1021/la304080c
   Zhu BC, 2011, POLYMER, V52, P2141, DOI 10.1016/j.polymer.2011.03.027
NR 94
TC 11
Z9 11
U1 18
U2 232
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD SEP
PY 2014
VL 9
IS 3
AR 030801
DI 10.1116/1.4875115
PG 10
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA AN8YY
UT WOS:000340893400001
PM 25280841
DA 2018-10-20
ER

PT J
AU Carey, LE
   Dearth, CL
   Johnson, SA
   Londono, R
   Medberry, CJ
   Daly, KA
   Badylak, SE
AF Carey, Lisa E.
   Dearth, Christopher L.
   Johnson, Scott A.
   Londono, Ricardo
   Medberry, Christopher J.
   Daly, Kerry A.
   Badylak, Stephen E.
TI In vivo degradation of 14C-labeled porcine dermis biologic scaffold
SO BIOMATERIALS
LA English
DT Article
DE Extracellular matrix; Dermis; Biomaterial degradation; C-14
   quantification
ID SMALL-INTESTINAL SUBMUCOSA; XENOGENEIC EXTRACELLULAR-MATRIX; MACROPHAGE
   PHENOTYPE; COLLAGEN-FIBERS; WALL REPAIR; SKIN; REGENERATION;
   ARRANGEMENT; MODEL; IMPLANTATION
AB Biologic scaffold materials are used for repair and reconstruction of injured or missing tissues. Such materials are often composed of allogeneic or xenogeneic extracellular matrix (ECM) manufactured by decellularization of source tissue, such as dermis. Dermal ECM (D-ECM) has been observed to degrade and remodel in vivo more slowly than other biologic scaffold materials, such as small intestinal submucosa (SIS-ECM). Histologic examination is a common method for evaluating material degradation, but it lacks sensitivity and is subject to observer bias. Utilization of C-14-proline labeled ECM is a quantitative alternative for measuring degradation of ECM scaffolds. Using both methods, the amount of degradation of D-ECM and SIS-ECM was determined at 2, 4, and 24 weeks post-implantation in a rodent model. Results utilizing C-14 liquid scintillation counting (LSC) analysis showed distinct differences in degradation at the three time points. D-ECM material in situ stayed the same at 76% remaining from 2 to 4 weeks post-implantation, and then decreased to 44% remaining at 24 weeks. In the same time period, implanted SIS-ECM material decreased from 72% to 13% to 0%. Visual examination of device degradation by histology overestimated degradation at 2 weeks and underestimated device degradation at 24 weeks, compared to the C-14 method. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Carey, Lisa E.; Dearth, Christopher L.; Medberry, Christopher J.; Daly, Kerry A.; Badylak, Stephen E.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Carey, Lisa E.; Johnson, Scott A.; Londono, Ricardo; Medberry, Christopher J.; Badylak, Stephen E.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Dearth, Christopher L.; Daly, Kerry A.; Badylak, Stephen E.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
   [Londono, Ricardo] Univ Pittsburgh, Med Scientist Training Program, Pittsburgh, PA 15261 USA.
   [Daly, Kerry A.] Dept Agr, Canberra, ACT 2601, Australia.
RP Badylak, SE (reprint author), Univ Pittsburgh, Dept Bioengn, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM careyle@upmc.edu; dearthcl2@upmc.edu; johnsonsa4@upmc.edu;
   londonor@upmc.edu; medberrycj@upmc.edu; dalyka@upmc.edu;
   badylaks@upmc.edu
OI Londono, Ricardo/0000-0001-5785-0645; Badylak,
   Stephen/0000-0003-3555-0689
FU NIH-NHLBI "Cardiovascular Bioengineering Training Program" through the
   University of Pittsburgh, Department of Bioengineering [T32-HL76124-6]
FX Funding for this research was provided, in part, by C. R. Bard. Lisa
   Carey was partially supported by the NIH-NHLBI training grant
   (T32-HL76124-6) entitled "Cardiovascular Bioengineering Training
   Program" through the University of Pittsburgh, Department of
   Bioengineering. The authors would like to thank Deanna Rhoads and Lori
   Perez at the McGowan Histology Center for histologic section
   preparation. The authors would also like to thank Tim Keane, Denver
   Faulk, Peter Slivka, and Eve Simpson for their assistance with animal
   care and manuscript preparation.
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Deeken CR, 2010, J AM COLL SURGEONS, V212, P880
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]
   Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002
   GABELLA G, 1987, CELL TISSUE RES, V248, P491, DOI 10.1007/BF00216474
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gilbert TW, 2007, BIOMATERIALS, V28, P147, DOI 10.1016/j.biomaterials.2006.08.022
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Harding K, 2010, ACELLULAR MATRICES T
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Jenkins ED, 2011, SURG ENDOSC, V25, P604, DOI 10.1007/s00464-010-1230-8
   Katerinaki E, 2010, J PLAST RECONSTR AES, V63, pE840, DOI 10.1016/j.bjps.2010.06.033
   Kelly DJ, 2009, TISSUE ENG PT A, V15, P2189, DOI 10.1089/ten.tea.2008.0430
   KOMURO T, 1988, CELL TISSUE RES, V251, P117, DOI 10.1007/BF00215455
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   MEIGEL WN, 1977, ARCH DERMATOL RES, V259, P1, DOI 10.1007/BF00562732
   MEYER W, 1982, J ANAT, V134, P139
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Nieponice A, 2009, GASTROINTEST ENDOSC, V69, P289, DOI 10.1016/j.gie.2008.04.022
   Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rickey F, 2000, NUCL INSTRUM METH B, V172, P1097
   Salzberg CA, 2013, J PLAST RECONSTR AES, V66, P323, DOI 10.1016/j.bjps.2012.10.015
   Sicari B, 2013, METHODS MOL BIOL, V1037, P3, DOI 10.1007/978-1-62703-505-7_1
   Silver FH, 2001, SKIN RES TECHNOL, V7, P18, DOI 10.1034/j.1600-0846.2001.007001018.x
   Tanaka R, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061231
   Turner NJ, 2010, TISSUE ENG PT A, V16, P3309, DOI [10.1089/ten.tea.2010.0169, 10.1089/ten.TEA.2010.0169]
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2010, BIOMATERIALS, V31, P7475, DOI 10.1016/j.biomaterials.2010.06.039
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Yasui T, 2004, J BIOMED OPT, V9, P259, DOI 10.1117/1.16441161
NR 49
TC 16
Z9 16
U1 2
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2014
VL 35
IS 29
BP 8297
EP 8304
DI 10.1016/j.biomaterials.2014.06.015
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AN8KP
UT WOS:000340853400002
PM 24997479
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Yildirimer, L
   Seifalian, AM
AF Yildirimer, Lara
   Seifalian, Alexander M.
TI Three-dimensional biomaterial degradation - Material choice, design and
   extrinsic factor considerations
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Organs; Biomaterial scaffolds; Regenerative medicine; Tissue
   engineering; Degradation; Synthetic; Natural; Growth factors; Stem
   cells; Delivery
ID GROWTH-FACTOR-DELIVERY; POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; IN-VITRO
   DEGRADATION; MACROPHAGE-MEDIATED BIODEGRADATION; PERIODONTAL TISSUE
   REGENERATION; BONE MORPHOGENETIC PROTEINS; PERIPHERAL-NERVE REPAIR;
   TRAUMATIC BRAIN-INJURY; DRUG-DELIVERY; CROSS-LINKING
AB The apparent difficulty to precisely control fine-tuning of biomaterial degradation has initiated the recent paradigm shift from conventional top-down fabrication methods to more nature-inspired bottom-up assemblies. Sophistication of material fabrication techniques allows today's scientists to reach beyond conventional natural materials in order to synthesise tomorrow's 'designer material'. Material degradation into smaller components and subsequent release of encapsulated cells or cell-signalling agents have opened medically exploitable avenues, transforming the area of regenerative medicine into a dynamic and self-propagating branch of modem medicine. The aim to synthesise ever more refined scaffolding structures in order to create micro- and nanoenvironments resembling those found in natural tissues now represents an ever growing niche in the materials sciences. Recently, we have developed and conducted the world's first in-human tracheal transplantation using a non-degradable completely synthetic biomaterial. Fuelled by such clinical potential, we are currently developing a biodegradable version suitable for skin tissue engineering and paediatric applications. However, despite enormous efforts, current, as yet insurmountable challenges include precise biomaterial degradation within pre-determined spatial and temporal confines in an effort to release bio-signalling agents in such orchestrated fashion as to fully regenerate functioning tissues. In this review, the authors, almost anti-climactically, ask the readers to step out of the artificially over-constructed spiral of ever more convoluted scaffold fabrication techniques and consider the benefits of controllable bottom-up scaffold fabrication methods. It will further be investigated how scaffold designs and fabrication methods may influence degradation and subsequent release of incorporated elements. A focus will be placed on the delivery of growth factors, stem cells and therapeutic agents alone or in parallel. The difficulties of designing a delivery vehicle capable of delivering multiple factors whilst maintaining distinct release kinetics will be highlighted. Finally, this review will be rounded off with an insight into current literature addressing the recurring issues of degradation product toxicities and suggests means of overcoming those. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yildirimer, Lara; Seifalian, Alexander M.] UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
   [Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, London NW3 2QG, England.
RP Seifalian, AM (reprint author), UCL, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England.
EM a.seifalian@ucl.ac.uk
CR Agarwal A, 2012, BIOMATERIALS, V33, P6783, DOI 10.1016/j.biomaterials.2012.05.068
   Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Andreadis ST, 2006, TRENDS BIOTECHNOL, V24, P331, DOI 10.1016/j.tibtech.2006.05.001
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   Berski S, 2008, BIOMACROMOLECULES, V9, P2353, DOI 10.1021/bm800327s
   BERTHOD F, 1993, BIOMATERIALS, V14, P749, DOI 10.1016/0142-9612(93)90039-5
   Biondi M, 2008, ADV DRUG DELIVER REV, V60, P229, DOI 10.1016/j.addr.2007.08.038
   Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655
   BOSTMAN O, 1989, CLIN ORTHOP RELAT R, P195
   BOSTMAN OM, 1991, J BONE JOINT SURG BR, V73, P679
   BREM H, 1989, SELECT CANCER THER, V5, P55, DOI 10.1089/sct.1989.5.55
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Cao L, 2012, INT J NANOMED, V7, P5881, DOI 10.2147/IJN.S38127
   Chapanian R, 2010, J CONTROL RELEASE, V143, P53, DOI 10.1016/j.jconrel.2009.11.025
   Chen C, 2011, EXPERT OPIN DRUG DEL, V8, P1221, DOI 10.1517/17425247.2011.602399
   Chen FM, 2007, J CONTROL RELEASE, V121, P81, DOI 10.1016/j.jconrel.2007.05.023
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   Chen FM, 2006, J CONTROL RELEASE, V114, P209, DOI 10.1016/hj.jconrel.2006.05.014
   Chen FM, 2010, TISSUE ENG PART B-RE, V16, P219, DOI [10.1089/ten.teb.2009.0562, 10.1089/ten.TEB.2009.0562]
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen FM, 2009, BIOMATERIALS, V30, P5215, DOI 10.1016/j.biomaterials.2009.06.009
   Chen FM, 2009, MED RES REV, V29, P472, DOI 10.1002/med.20144
   Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071265
   Chen YH, 2011, ACTA BIOMATER, V7, P1140, DOI 10.1016/j.actbio.2010.09.038
   Cheng DX, 2009, TISSUE ENG PT A, V15, P1929, DOI 10.1089/ten.tea.2008.0470
   Chlapanidas T, 2013, INT J IMMUNOPATH PH, V26, P43, DOI 10.1177/03946320130260S106
   Cho EJ, 2003, J BIOMED MATER RES A, V66A, P417, DOI 10.1002/jbm.a.10598
   Courtman DW, 2001, J BIOMED MATER RES, V55, P576, DOI 10.1002/1097-4636(20010615)55:4<576::AID-JBM1051>3.0.CO;2-9
   Cui HT, 2012, BIOMACROMOLECULES, V13, P2881, DOI 10.1021/bm300897j
   CUTRIGHT DE, 1971, ORAL SURG ORAL MED O, V32, P165, DOI 10.1016/0030-4220(71)90265-9
   DAHM M, 1990, J THORAC CARDIOV SUR, V99, P1082
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   ESTEBAN MJ, 1990, ANTIMICROB AGENTS CH, V34, P1268, DOI 10.1128/AAC.34.6.1268
   Felice V Di, 2013, J TISSUE ENG REGEN M
   Fu Y, 2009, PHARM RES-DORD, V26, P2115, DOI 10.1007/s11095-009-9923-1
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   Giunchedi P, 1998, J CONTROL RELEASE, V56, P53, DOI 10.1016/S0168-3659(98)00068-6
   Go DP, 2011, BIOMACROMOLECULES, V12, P1494, DOI 10.1021/bm1014574
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Gorczyca G, 2014, CARBOHYD POLYM, V102, P901, DOI 10.1016/j.carbpol.2013.10.060
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Gu F, 2007, J CONTROL RELEASE, V117, P80, DOI 10.1016/j.jconrel.2006.09.077
   Guaccio A, 2008, BIOMATERIALS, V29, P1484, DOI 10.1016/j.biomaterials.2007.12.020
   Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047
   Guldberg RE, 2009, J BONE MINER RES, V24, P1507, DOI [10.1359/JBMR.090801, 10.1359/jbmr.090801]
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037
   He CL, 2009, J BIOMED MATER RES A, V89A, P80, DOI 10.1002/jbm.a.32004
   He XZ, 2007, BIOMACROMOLECULES, V8, P780, DOI 10.1021/bm060671a
   Imparato G, 2013, BIOMATERIALS, V34, P7851, DOI 10.1016/j.biomaterials.2013.06.062
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Kanczler JM, 2010, BIOMATERIALS, V31, P1242, DOI 10.1016/j.biomaterials.2009.10.059
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137
   Keeney M, 2013, BIOMACROMOLECULES, V14, P794, DOI 10.1021/bm3018559
   Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kim HW, 2005, J MATER SCI-MATER M, V16, P189, DOI 10.1007/s10856-005-6679-y
   Kim J, 2008, J MATER SCI-MATER M, V19, P3311, DOI 10.1007/s10856-008-3469-3
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Kobsa S, 2008, PEDIATR RES, V63, P513, DOI 10.1203/PDR.0b013e318165f14d
   Labow RS, 2005, J BIOMAT SCI-POLYM E, V16, P1167, DOI 10.1163/1568562054798563
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Lee BK, 2012, INT J PHARMACEUT, V427, P305, DOI 10.1016/j.ijpharm.2012.02.011
   Lee KH, 2000, J BIOMED MATER RES, V49, P25, DOI 10.1002/(SICI)1097-4636(200001)49:1<25::AID-JBM4>3.0.CO;2-I
   Lewandrowski KU, 2000, J BIOMAT SCI-POLYM E, V11, P401, DOI 10.1163/156856200743788
   Li SM, 1999, J BIOMED MATER RES, V48, P342, DOI 10.1002/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7
   Li SM, 2003, BIOMACROMOLECULES, V4, P372, DOI 10.1021/bm025748j
   Li SM, 1999, BIOMATERIALS, V20, P35, DOI 10.1016/S0142-9612(97)00226-3
   Liebschner MAK, 2012, METHODS MOL BIOL, V868, P71, DOI 10.1007/978-1-61779-764-4_5
   Losi P, 2013, ACTA BIOMATER, V9, P7814, DOI 10.1016/j.actbio.2013.04.019
   Lotz AS, 2009, TOXICOL LETT, V190, P128, DOI 10.1016/j.toxlet.2009.06.880
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Ma L, 2007, J BIOMED MATER RES B, V83B, P285, DOI 10.1002/jbm.b.30794
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Macdonald M, 2008, J CONTROL RELEASE, V131, P228, DOI 10.1016/j.jconrel.2008.07.032
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   MARANTO AR, 1988, CIRC RES, V63, P844, DOI 10.1161/01.RES.63.4.844
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   MATSUMOTO T, 1993, BIORHEOLOGY, V30, P435
   Mayer Michael H., 1995, P173
   McClure MJ, 2012, J MECH BEHAV BIOMED, V10, P48, DOI 10.1016/j.jmbbm.2012.02.026
   MCGILL DB, 1974, NEW ENGL J MED, V291, P278, DOI 10.1056/NEJM197408082910604
   Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016
   Mekala Naveen Kumar, 2013, J Biomed Res, V27, P318, DOI 10.7555/JBR.27.20130001
   Moroni L, 2008, J BIOMAT SCI-POLYM E, V19, P543, DOI 10.1163/156856208784089571
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Mourino V, 2013, EXPERT OPIN DRUG DEL, V10, P1353, DOI 10.1517/17425247.2013.808183
   Nair NR, 2012, BIOTECHNOL LETT, V34, P2031, DOI 10.1007/s10529-012-1005-5
   Ng KW, 2005, J BIOMED MATER RES A, V75A, P425, DOI 10.1002/jbm.a.30454
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Numata K, 2012, BIOMACROMOLECULES, V13, P1383, DOI 10.1021/bm300089a
   Numata K, 2011, BIOMACROMOLECULES, V12, P2137, DOI 10.1021/bm200221u
   Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m
   Oh SH, 2006, J MATER SCI-MATER M, V17, P131, DOI 10.1007/s10856-006-6816-2
   Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001
   Park JS, 2012, BIOMATERIALS, V33, P7151, DOI 10.1016/j.biomaterials.2012.06.023
   Park SU, 2014, INT WOUND J, V11, P35, DOI 10.1111/j.1742-481X.2012.01035.x
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Parlato M, 2013, ACTA BIOMATER, V9, P9270, DOI 10.1016/j.actbio.2013.08.011
   Peng LH, 2013, CELL TISSUE RES, V352, P573, DOI 10.1007/s00441-013-1609-7
   Pereira MJN, 2013, ADV MATER, V25, P1209, DOI 10.1002/adma.201203824
   Piskin E, 2009, J BIOMED MATER RES A, V90A, P1137, DOI 10.1002/jbm.a.32157
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   PRYDE CA, 1982, POLYM ENG SCI, V22, P370, DOI 10.1002/pen.760220608
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Raghunath J, 2009, J BIOMED MATER RES A, V91A, P834, DOI 10.1002/jbm.a.32335
   Razaq S, 2003, EUR SPINE J, V12, P341, DOI 10.1007/s00586-003-0582-3
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rujivipat S, 2010, INT J PHARMACEUT, V402, P72, DOI 10.1016/j.ijpharm.2010.09.021
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Saurer EM, 2011, BIOMATERIALS, V32, P610, DOI 10.1016/j.biomaterials.2010.09.009
   SCHMITT EA, 1994, MACROMOLECULES, V27, P743, DOI 10.1021/ma00081a019
   Sedaghati T, 2011, BIOTECHNOL APPL BIOC, V58, P288, DOI 10.1002/bab.51
   Seras-Franzoso J, 2013, J CONTROL RELEASE, V171, P63, DOI 10.1016/j.jconrel.2013.06.034
   Serban MA, 2013, BIOTECHN APPL BIOCH
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Shmueli RB, 2013, BIOMATERIALS, V34, P7544, DOI 10.1016/j.biomaterials.2013.06.044
   Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Skop NB, 2013, ACTA BIOMATER, V9, P6834, DOI 10.1016/j.actbio.2013.02.043
   Sollazzo V, 2011, INT J IMMUNOPATH PH, V24, P59, DOI 10.1177/03946320110240S211
   Son JS, 2011, J CONTROL RELEASE, V153, P133, DOI 10.1016/j.jconrel.2011.03.010
   Song SH, 2012, J BIOMED MATER RES B, V100B, P1289, DOI 10.1002/jbm.b.32695
   Spark JI, 2008, BRIT J SURG, V95, P582, DOI 10.1002/bjs.6052
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   SPIVAK JM, 1990, J BIOMED MATER RES, V24, P1121, DOI 10.1002/jbm.820240902
   Su Y, 2009, COLLOID SURFACE B, V73, P376, DOI 10.1016/j.colsurfb.2009.06.009
   Subramanian A, 2013, BIOMED RES INT, DOI 10.1155/2013/390518
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Sun Z, 2013, PLOS ONE, V8
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Sung HW, 1996, BIOMATERIALS, V17, P1405, DOI 10.1016/0142-9612(96)87282-6
   Sykova E, 2006, CELL MOL NEUROBIOL, V26, P1113, DOI 10.1007/s10571-006-9007-2
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tan A, 2012, J CONTROL RELEASE, V163, P342, DOI 10.1016/j.jconrel.2012.08.009
   Tang YW, 2003, BIOMATERIALS, V24, P2805, DOI 10.1016/S0142-9612(03)00081-4
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Thakral S, 2013, EXPERT OPIN DRUG DEL, V10, P131, DOI 10.1517/17425247.2013.736962
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Tiruvannamalai-Annamalai R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084287
   Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722
   Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Ueng SWN, 2011, J TRAUMA, V70, P1503, DOI 10.1097/TA.0b013e3181edb873
   Valmikinathan CM, 2008, J NEURAL ENG, V5, P422, DOI 10.1088/1741-2560/5/4/007
   van der Veen VC, 2011, WOUND REPAIR REGEN, V19, pS59, DOI 10.1111/j.1524-475X.2011.00713.x
   Varkey Mathew, 2004, Expert Opin Drug Deliv, V1, P19, DOI 10.1517/17425247.1.1.19
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   Wang HA, 2012, BIOMATERIALS, V33, P8695, DOI 10.1016/j.biomaterials.2012.08.024
   Wang HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056330
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wang Y, 2013, BIOMACROMOLECULES, V14, P3034, DOI 10.1021/bm401131w
   Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442
   Whu SW, 2013, MAT SCI ENG C-MATER, V33, P2855, DOI 10.1016/j.msec.2013.03.003
   WIEBE D, 1988, SURGERY, V104, P26
   Williams DF, 2006, TRENDS BIOTECHNOL, V24, P4, DOI 10.1016/j.tibtech.2005.10.006
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Wischke C, 2010, PHARM RES-DORDR, V27, P2063, DOI 10.1007/s11095-010-0202-y
   Wu MH, 2007, BIOTECHNOL PROGR, V23, P430, DOI 10.1021/bp060024v
   Xie XY, 2010, J BIOMAT SCI-POLYM E, V21, P1239, DOI 10.1163/092050609X12481751806295
   Xu QX, 2013, BIOMATERIALS, V34, P3902, DOI 10.1016/j.biomaterials.2013.02.015
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yap KK, 2013, BIOMATERIALS, V34, P3992, DOI 10.1016/j.biomaterials.2013.02.011
   Yellowley CE, 1997, AM J PHYSIOL-CELL PH, V273, pC30
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
   Yildirimer L, 2011, NANO TODAY, V6, P585, DOI 10.1016/j.nantod.2011.10.001
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yu WW, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-68
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang JT, 2006, LANGMUIR, V22, P239, DOI 10.1021/052360b
   Zhang X, 2014, CELL TISSUE BANK
NR 188
TC 23
Z9 25
U1 4
U2 105
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD SEP-OCT
PY 2014
VL 32
IS 5
BP 984
EP 999
DI 10.1016/j.biotechadv.2014.04.014
PG 16
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AN6HZ
UT WOS:000340696900007
PM 24858478
DA 2018-10-20
ER

PT J
AU Hendrikson, WJ
   van Blitterswijk, CA
   Verdonschot, N
   Moroni, L
   Rouwkema, J
AF Hendrikson, W. J.
   van Blitterswijk, C. A.
   Verdonschot, N.
   Moroni, L.
   Rouwkema, J.
TI Modeling Mechanical Signals on the Surface of mu CT and CAD Based Rapid
   Prototype Scaffold Models to Predict (Early Stage) Tissue Development
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE finite element analysis; modelling; scaffold; computational fluid
   dynamics; mechanobiology; tissue engineering
ID FINITE-ELEMENT; ENGINEERING SCAFFOLDS; CELL-DIFFERENTIATION; BIOPHYSICAL
   STIMULI; SIMULATION; STRESS; ARCHITECTURE
AB In the field of tissue engineering, mechano-regulation theories have been applied to help predict tissue development in tissue engineering scaffolds in the past. For this, finite element models (FEMs) were used to predict the distribution of strains within a scaffold. However, the strains reported in these studies are volumetric strains of the material or strains developed in the extracellular matrix occupying the pore space. The initial phase of cell attachment and growth on the biomaterial surface has thus far been neglected. In this study, we present a model that determines the magnitude of biomechanical signals on the biomaterial surface, enabling us to predict cell differentiation stimulus values at this initial stage. Results showed that magnitudes of the 2D strain-termed surface strain-were lower when compared to the 3D volumetric strain or the conventional octahedral shear strain as used in current mechano-regulation theories. Results of both mu CT and CAD derived FEMs from the same scaffold were compared. Strain and fluid shear stress distributions, and subsequently the cell differentiation stimulus, were highly dependent on the pore shape. CAD models were not able to capture the distributions seen in the mu CT FEM. The calculated mechanical stimuli could be combined with current mechanobiological models resulting in a tool to predict cell differentiation in the initial phase of tissue engineering. Although experimental data is still necessary to properly link mechanical signals to cell behavior in this specific setting, this model is an important step towards optimizing scaffold architecture and/or stimulation regimes. (c) 2014 Wiley Periodicals, Inc.
C1 [Hendrikson, W. J.; van Blitterswijk, C. A.; Moroni, L.] Univ Twente, Dept Tissue Regenerat, NL-7500 AE Enschede, Overijssel, Netherlands.
   [Verdonschot, N.; Rouwkema, J.] Univ Twente, Dept Biomech Engn, NL-7500 AE Enschede, Overijssel, Netherlands.
   [Verdonschot, N.] Radboud Nijmegen Med Ctr, Orthopead Res Lab, NL-6500 HB Nijmegen, Netherlands.
RP Rouwkema, J (reprint author), Univ Twente, Dept Biomech Engn, Drienerlolaan 5, NL-7500 AE Enschede, Overijssel, Netherlands.
EM j.rouwkema@utwente.nl
RI Verdonschot, N.J.J./H-8104-2014; Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; Rouwkema,
   Jeroen/0000-0001-9666-9064; van Blitterswijk,
   Clemens/0000-0003-2371-4615
FU Netherlands Institute of Regenerative Medicine [FES0908]; VENI
   fellowship from the Dutch Technology Foundation STW; Netherlands
   Organisation For Scientific Research (NWO)
FX Contract grant sponsor: Netherlands Institute of Regenerative Medicine;
   Contract grant number: FES0908; Contract grant sponsor: VENI fellowship
   from the Dutch Technology Foundation STW; Contract grant sponsor:
   Netherlands Organisation For Scientific Research (NWO)
CR Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517
   Carter DR, 1998, CLIN ORTHOP RELAT R, pS41
   Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044
   Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5
   Cordonnier T, 2011, ADV ENG MATER, V13, pB135, DOI 10.1002/adem.201080098
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   De Boodt S, 2010, TISSUE ENG PART C-ME, V16, P1553, DOI 10.1089/ten.tec.2010.0107
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037
   Isaksson H, 2006, J ORTHOP RES, V24, P898, DOI 10.1002/jor.20118
   Khayyeri H, 2009, J ORTHOP RES, V27, P1659, DOI 10.1002/jor.20926
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068
   Milan JL, 2010, BIOMECH MODEL MECHAN, V9, P583, DOI 10.1007/s10237-010-0199-5
   Milan JL, 2009, BIOMATERIALS, V30, P4219, DOI 10.1016/j.biomaterials.2009.04.026
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Olivares AL, 2009, BIOMATERIALS, V30, P6142, DOI 10.1016/j.biomaterials.2009.07.041
   Pauwels F, 1960, ANAT EMBRYOL, V121, P478, DOI [DOI 10.1007/BF00523401, 10.1007/BF00523401]
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Sakkers RJB, 1998, J MATER SCI-MATER M, V9, P375, DOI 10.1023/A:1013227428530
   Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011
   Sandino C, 2011, BIOMECH MODEL MECHAN, V10, P565, DOI 10.1007/s10237-010-0256-0
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Truscello S, 2012, ACTA BIOMATER, V8, P1648, DOI 10.1016/j.actbio.2011.12.021
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 29
TC 11
Z9 13
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD SEP
PY 2014
VL 111
IS 9
BP 1864
EP 1875
DI 10.1002/bit.25231
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AO3MX
UT WOS:000341236100017
PM 24824318
DA 2018-10-20
ER

PT J
AU Gemini-Piperni, S
   Milani, R
   Bertazzo, S
   Peppelenbosch, M
   Takamori, ER
   Granjeiro, JM
   Ferreira, CV
   Teti, A
   Zambuzzi, W
AF Gemini-Piperni, Sara
   Milani, Renato
   Bertazzo, Sergio
   Peppelenbosch, Maikel
   Takamori, Esther R.
   Granjeiro, Jose Mauro
   Ferreira, Carmen V.
   Teti, Anna
   Zambuzzi, Willian
TI Kinome Profiling of Osteoblasts on Hydroxyapatite Opens New Avenues on
   Biomaterial Cell Signaling
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE bioengineering; hydroxyapatite; osteoblast; signal transduction; kinome
   profile; peptide array; biotechnology
ID DIFFERENTIATION; ADHESION; BONE; ADDUCIN; PHOSPHORYLATION;
   PHOSPHOPROTEOME; SURFACES; PATHWAY; KINASE; ACTIN
AB In degenerative diseases or lesions, bone tissue replacement and regeneration are important clinical goals. The most used bone substitutes today are hydroxyapatite (HA) scaffolds. These scaffolds, developed over the last few decades, present high porosity and good osteointegration, but haven't completely solved issues related to bone defects. Moreover, the exact intracellular mechanisms involved in the response to HA have yet to be addressed. This prompted us to investigate the protein networks responsible for signal transduction during early osteoblast adhesion on synthetic HA scaffolds. By performing a global kinase activity assay, we showed that there is a specific molecular machinery responding to HA contact, immediately triggering pathways leading to cytoskeleton rearrangement due to activation of Adducin 1 (ADD1), protein kinase A (PKA), protein kinase C (PKC), and vascular endothelial growth factor (VEGF). Moreover, we found a significantly increased phosphorylation of the activating site Ser-421 in histone deacetylase 1 (HDAC1), a substrate of Cyclin-Dependent Kinase 5 (CDK5). These phosphorylation events are hallmarks of osteoblast differentiation, pointing to HA surfaces ability to promote differentiation. We also found that AKT was kept active, suggesting the maintenance of survival pathways. Interestingly, though, the substrate sequence of CDK5 also presented higher phosphorylation levels when compared to control conditions. To our knowledge, this kinase has never before been related to osteoblast biology, opening a new avenue of investigation for novel pathways involved in this matter. These results suggest that HA triggers a specific intracellular signal transduction cascade during early osteoblast adhesion, activating proteins involved with cytoskeleton rearrangement, and induction of osteoblast differentiation. (c) 2014 Wiley Periodicals, Inc.
C1 [Gemini-Piperni, Sara; Teti, Anna] Univ Aquila, Dept Biotechnol & Appl Clin Sci, I-67100 Laquila, Italy.
   [Milani, Renato; Ferreira, Carmen V.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Bioquim, Campinas, SP, Brazil.
   [Bertazzo, Sergio] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London, England.
   [Peppelenbosch, Maikel] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands.
   [Takamori, Esther R.] Univ Estadual Paulista, Dept Chem & Biochem, Biosci Inst, Lab Bioensaios & Dinam Celular, Sao Paulo, Brazil.
   [Granjeiro, Jose Mauro] Diretoria Programas DIPRO Bioengn, Inst Nacl Metrol Normalizacao & Qualidade Ind INM, Xerem, RJ, Brazil.
RP Zambuzzi, W (reprint author), Univ Estadual Paulista, Dept Chem & Biochem, Biosci Inst, Lab Bioensaios & Dinam Celular, Campus Botucatu, Sao Paulo, Brazil.
EM wzambuzzi@ibb.unesp.br
RI Bertazzo, Sergio/J-7357-2016; Gemini Piperni, Sara/A-9858-2015;
   Zambuzzi, Willian/F-9519-2012
OI Bertazzo, Sergio/0000-0003-4889-8190; Gemini Piperni,
   Sara/0000-0002-7724-9491; Zambuzzi, Willian/0000-0002-4149-5965;
   Peppelenbosch, Maikel/0000-0001-9112-6028; Granjeiro,
   Jose/0000-0002-8027-8293; Teti, Anna Maria/0000-0002-5887-4419
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Fundacao de Pesquisa do Estado do Rio de Janeiro (Faperj); Marie Curie
   International Research Staff Exchange Scheme Fellowship
   [PIRSES-GA-2011-295181]; Rosetrees Trust and the Junior Research
   Fellowship scheme at Imperial College London
FX Contract grant sponsor: Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq); Contract grant sponsor: Fundacao de Pesquisa do
   Estado do Rio de Janeiro (Faperj); Contract grant sponsor: Marie Curie
   International Research Staff Exchange Scheme Fellowship
   (PIRSES-GA-2011-295181); Contract grant sponsor: Rosetrees Trust and the
   Junior Research Fellowship scheme at Imperial College London
CR Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122
   Bertazzo S, 2009, CLIN ORAL IMPLAN RES, V20, P288, DOI 10.1111/j.1600-0501.2008.01642.x
   Bertazzo S, 2008, J INORG BIOCHEM, V102, P137, DOI 10.1016/j.jinorgbio.2007.07.031
   Bertazzo S, 2010, CLIN ORAL IMPLAN RES, V21, P1411, DOI 10.1111/j.1600-0501.2010.01968.x
   Bertazzo S, 2010, COLLOID SURFACE B, V78, P177, DOI 10.1016/j.colsurfb.2010.02.027
   Bose S, 2012, ACTA BIOMATER, V8, P1401, DOI 10.1016/j.actbio.2011.11.017
   Caplan MR, 2009, CELL BIOCHEM BIOPHYS, V54, P1, DOI 10.1007/s12013-009-9048-5
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200
   Donahue HJ, 2000, AM J PHYSIOL-CELL PH, V278, pC315
   Dorozhkin Sergey V, 2012, Biomatter, V2, P53, DOI 10.4161/biom.21340
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105
   Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986
   Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061
   Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209
   Lopez-Macipe A, 1998, J MATER SYNTH PROCES, V6, P21, DOI 10.1023/A:1022603024806
   Matassi F, 2011, CLIN CASES MINER BON, V8, P21
   Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731
   Milani R, 2010, J CELL BIOCHEM, V109, P957, DOI 10.1002/jcb.22479
   Paglini G, 2001, EUR J BIOCHEM, V268, P1528, DOI 10.1046/j.1432-1033.2001.02023.x
   Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200
   Rigbolt KTG, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001570
   Ruggiu A, 2013, BIOMATERIALS, V34, P9318, DOI 10.1016/j.biomaterials.2013.08.018
   Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7
   Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JC131581
   Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200
   Zambuzzi Willian F., 2012, Braz. Dent. J., V23, P315, DOI 10.1590/S0103-64402012000400002
   Zambuzzi WF, 2011, BIOTECHNOL BIOENG, V108, P1246, DOI 10.1002/bit.23117
   Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002
   Zambuzzi WF, 2009, J CELL BIOCHEM, V108, P134, DOI 10.1002/jcb.22236
NR 33
TC 13
Z9 14
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD SEP
PY 2014
VL 111
IS 9
BP 1900
EP 1905
DI 10.1002/bit.25246
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AO3MX
UT WOS:000341236100021
PM 24668294
DA 2018-10-20
ER

PT J
AU Albadarin, AB
   Glocheux, Y
   Ahmad, MNM
   Walker, GM
   Mangwandi, C
AF Albadarin, Ahmad B.
   Glocheux, Yoann
   Ahmad, M. N. M.
   Walker, Gavin M.
   Mangwandi, Chirangano
TI Novel comparison of kinetic models for the adsorption-coupled reduction
   of Cr(VI) using untreated date pit biomaterial
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Hexavalent chromium; Bioreduction; Adsorption coupled reduction; Kinetic
   experiments
ID HEXAVALENT CHROMIUM; WASTE; BIOSORPTION; INDUSTRIAL; SORPTION; BIOMASS;
   STONES; VI
AB Biosorption of Cr(VI) onto date pit biomass has been investigated via kinetic studies as functions of initial Cr(VI) concentration, solution temperature and date pit particle size. Kinetic experiments indicated that chromate ions accumulate onto the date pits and then reduce to less toxic Cr(III) compounds. The Lopez-Garcia, Escudero and Park Cr(VI) biosorption kinetic models, which take into consideration the direct reduction, the passivation process and the follow-on decrease of the active surface area of reaction, were applied to the kinetic data. The models represented the experimental data accurately at low Cr(VI) concentration (0.480mM) and small particle size (0.11-0.22 mm) at which the Cr(VI) was completely removed from the aqueous solution and completely reduced to Cr(III) after 420 mm. Date pit biomass thus offers a green chemical process for the remediation of chromium from wastewater. This investigation will help researchers employ the adsorption-coupled reduction of Cr(VI) models and simplify their application to kinetic experimental data. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Albadarin, Ahmad B.; Glocheux, Yoann; Ahmad, M. N. M.; Walker, Gavin M.; Mangwandi, Chirangano] Univ Limerick, Mat Surface Sci Inst, Dept Chem & Environm Sci, Limerick, Ireland.
   [Albadarin, Ahmad B.; Walker, Gavin M.] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT9 5AG, Antrim, North Ireland.
   [Ahmad, M. N. M.] Amer Univ Beirut, Fac Engn & Architecture, Lebanon, NH USA.
RP Albadarin, AB (reprint author), Queens Univ Belfast, Sch Chem & Chem Engn, Belfast BT9 5AG, Antrim, North Ireland.
EM aalbadarin01@qub.ac.uk
RI Walker, Gavin/I-8097-2015; Mangwandi, Chirangano/H-2595-2014
OI Ahmad, Mohammad/0000-0002-0237-9494; Albadarin,
   Ahmad/0000-0002-5686-564X; Walker, Gavin/0000-0003-4102-0019
CR Ahmed MJ, 2012, POWDER TECHNOL, V229, P237, DOI 10.1016/j.powtec.2012.06.043
   Albadarin AB, 2013, J ENVIRON MANAGE, V114, P190, DOI 10.1016/j.jenvman.2012.09.017
   Albadarin AB, 2012, CHEM ENG J, V179, P193, DOI 10.1016/j.cej.2011.10.080
   Albadarin AB, 2011, CHEM ENG J, V169, P20, DOI 10.1016/j.cej.2011.02.044
   Anandkumar J, 2011, J HAZARD MATER, V186, P1088, DOI 10.1016/j.jhazmat.2010.11.104
   Barrera-Diaz CE, 2012, J HAZARD MATER, V223, P1, DOI 10.1016/j.jhazmat.2012.04.054
   Cabatingan LK, 2001, IND ENG CHEM RES, V40, P2302, DOI 10.1021/ie0008575
   Dayan AD, 2001, HUM EXP TOXICOL, V20, P439, DOI 10.1191/096032701682693062
   Deng BL, 1996, ENVIRON SCI TECHNOL, V30, P2484, DOI 10.1021/es950780p
   Dupont L., 2003, ENVIRON SCI TECHNOL, V94, P49
   Escudero C, 2009, J HAZARD MATER, V170, P286, DOI 10.1016/j.jhazmat.2009.04.100
   Hawley E.L., 2004, TREATMENT TECHNOLOGI
   Hodaifa G, 2013, IND CROP PROD, V49, P526, DOI 10.1016/j.indcrop.2013.05.039
   Huang C.P., 1979, ACTIVATED CARBON PRO
   Irem S, 2013, ECOL ENG, V58, P399, DOI 10.1016/j.ecoleng.2013.07.005
   Kiran B, 2012, ECOL ENG, V38, P93, DOI 10.1016/j.ecoleng.2011.11.001
   Li L, 2010, J ENVIRON SCI-CHINA, V22, P1273, DOI 10.1016/S1001-0742(09)60250-3
   Lopez-Garcia M, 2013, BIORESOURCE TECHNOL, V139, P181, DOI 10.1016/j.biortech.2013.04.044
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2008, BIORESOURCE TECHNOL, V99, P8810, DOI 10.1016/j.biortech.2008.04.042
   Poch J, 2010, J HAZARD MATER, V175, P770, DOI 10.1016/j.jhazmat.2009.10.075
   Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005
   Sahinkaya E, 2012, J HAZARD MATER, V219, P253, DOI 10.1016/j.jhazmat.2012.04.002
   Silva B., 2009, INT J CHEM BIOL ENG, V2, P100
   Tazrouti N, 2009, BIORESOURCES, V4, P740
   Ullah I, 2013, ECOL ENG, V60, P99, DOI 10.1016/j.ecoleng.2013.07.028
NR 26
TC 6
Z9 7
U1 1
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
EI 1872-6992
J9 ECOL ENG
JI Ecol. Eng.
PD SEP
PY 2014
VL 70
BP 200
EP 205
DI 10.1016/j.ecoleng.2014.05.002
PG 6
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA AN5SR
UT WOS:000340652100024
DA 2018-10-20
ER

PT J
AU Trouche, G
   Bastianelli, D
   Hamadou, TVC
   Chantereau, J
   Rami, JF
   Pot, D
AF Trouche, G.
   Bastianelli, D.
   Hamadou, T. V. Cao
   Chantereau, J.
   Rami, J. -F.
   Pot, D.
TI Exploring the variability of a photoperiod-insensitive sorghum genetic
   panel for stem composition and related traits in temperate environments
SO FIELD CROPS RESEARCH
LA English
DT Article
DE Sorghum; Phenotypic variation; Stem biochemical composition; Biomass
   yield
ID BICOLOR L. MOENCH; CELL-WALL DIGESTIBILITY; BROWN-MIDRIB MUTANTS;
   SUGAR-RELATED TRAITS; GRAIN-SORGHUM; MAIZE; FIBER; QTL; FEEDSTOCK;
   GENOTYPES
AB Over the last decade, the merits of sorghum as a dedicated feedstock have been highlighted. The relevance of sorghum biomass as an energy or biomaterial source relies on the possibility that its composition meets the requirement of the different production processes. In order to better assess the phenotypic variation existing in sorghum for stem composition, 103 accessions representing a broad genetic panel of insensitive and moderate photoperiod-sensitive landraces were evaluated during two consecutive years at Montpellier, South of France. Our data confirmed the existence of a great range of variation for several key parameters of stem composition, in particular for crude protein, lignin content and in vitro organic matter degradation and at a less extent for fibre digestibility. Sugar content in stems estimated by Brix was positively correlated with cycle duration and dry stem yield. Lignin content and fibre digestibility, two key traits linked to the potential utilization of sorghum biomass for fodder and 2nd-generation energy source, were strongly (positive and negative, respectively) correlated with plant height but not linked with dry stem yield. These results indicated that both biomass yield and quality can be improved simultaneously. Variability of stem composition was highly structured according to the genetic origins of the accessions. Durra and kafir groups emerged as good sources of high fibre digestibility. The same two groups and the photoperiod-insensitive caudatum from Africa comprised the best accessions for high sugar content in stems. Several Chinese caudatum and bicolor-caudatum accessions included in this panel stand out for high lignin content. This information will be mobilized to broaden the genetic diversity relevant for on-going breeding programs of sweet and biomass sorghum for temperate areas. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Trouche, G.; Hamadou, T. V. Cao; Rami, J. -F.; Pot, D.] CIRAD, UMR AGAP, F-34398 Montpellier, France.
   [Bastianelli, D.] CIRAD, UMR SELMET, F-34398 Montpellier, France.
   [Chantereau, J.] Previously CIRAD, UMR AGAP, F-34398 Montpellier, France.
RP Trouche, G (reprint author), CIRAD, UMR AGAP, F-34398 Montpellier, France.
EM gilles.trouche@cirad.fr
RI Bastianelli, Denis/A-5572-2011
OI Bastianelli, Denis/0000-0002-6394-5920
FU Grassbiofuel project - French Research Agency (ANR) [ANR-07-GPLA-018];
   Genoplante consortium
FX This research was supported by the Grassbiofuel project
   (ANR-07-GPLA-018) funded by the French Research Agency (ANR) and the
   Genoplante consortium. The authors are grateful to Yves Barriere,
   coordinator of this project and Main Vidal for his efficient support in
   the management of field experiments. We also thank the CIRAD unit of
   genetic resources (LSRG) which provided the seed for accessions
   belonging to the core Collection.
CR Aufrere J, 2007, PROD ANIM, V20, P129
   Barbanti L, 2006, EUR J AGRON, V25, P30, DOI 10.1016/j.eja.2006.03.001
   Berenji J, 2004, J AGRON CROP SCI, V190, P332, DOI 10.1111/j.1439-037X.2004.00102.x
   Blummel M, 2003, FIELD CROP RES, V84, P143, DOI 10.1016/S0378-4290(03)00146-1
   Brenner EA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-27
   Brown TR, 2011, BIOFUEL BIOPROD BIOR, V5, P54, DOI 10.1002/bbb.254
   Carpita NC, 2008, TRENDS PLANT SCI, V13, P415, DOI 10.1016/j.tplants.2008.06.002
   Deu M, 2006, GENOME, V49, P168, DOI 10.1139/G05-092
   Dien BS, 2009, BIOENERG RES, V2, P153, DOI 10.1007/s12155-009-9041-2
   Dje Y, 2000, THEOR APPL GENET, V100, P918, DOI 10.1007/s001220051371
   Garofalo P., 2011, ITAL J AGRON, V1, P133
   Gorshkova T, 2012, CRIT REV PLANT SCI, V31, P201, DOI 10.1080/07352689.2011.616096
   Guan YA, 2011, EUPHYTICA, V182, P431, DOI 10.1007/s10681-011-0528-5
   Jung HG, 2006, CROP SCI, V46, P1793, DOI 10.2135/cropsci2005.02-0085
   Kenney KL, 2013, BIOFUELS-UK, V4, P111, DOI [10.4155/BFS.12.83, 10.4155/bfs.12.83]
   Murray SC, 2008, CROP SCI, V48, P2165, DOI 10.2135/cropsci2008.01.0016
   Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068
   Oliver AL, 2005, CROP SCI, V45, P2240, DOI 10.2135/cropsci2004.0660
   Petrini C., 1993, European Journal of Agronomy, V2, P185
   Pichon M, 2006, MOL BREEDING, V18, P253, DOI 10.1007/s11032-006-9033-2
   Pot D., 2011, 22 EUC MAIZ SORGH C, P19
   Qingshan Lu, 2001, Economic Botany, V55, P401, DOI 10.1007/BF02866563
   Reddy N, 2007, J AGR FOOD CHEM, V55, P5569, DOI 10.1021/jf0707379
   Ritter KB, 2008, MOL BREEDING, V22, P367, DOI 10.1007/s11032-008-9182-6
   Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15
   Saballos A, 2008, BIOENERG RES, V1, P193, DOI 10.1007/s12155-008-9025-7
   Sabatier D, 2012, J NEAR INFRARED SPEC, V20, P371, DOI 10.1255/jnirs.999
   Serapiglia MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00057
   Shiringani AL, 2010, THEOR APPL GENET, V121, P323, DOI 10.1007/s00122-010-1312-y
   Vandenbrink JP, 2010, IND CROP PROD, V31, P444, DOI 10.1016/j.indcrop.2010.01.001
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   Vermerris W., 2007, CROP SCI, V47, P142, DOI DOI 10.2135/CROPSCI2007.04.0013IPBS
   Vermerris W, 2010, J EXP BOT, V61, P2479, DOI 10.1093/jxb/erq093
   Vietor DM, 2010, FIELD CROP RES, V118, P243, DOI 10.1016/j.fcr.2010.06.001
   WILSON JR, 1993, J SCI FOOD AGR, V63, P407, DOI 10.1002/jsfa.2740630406
   Zhang TY, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-56
   Zhao YL, 2009, FIELD CROP RES, V111, P55, DOI 10.1016/j.fcr.2008.10.006
   Zhong J, 2010, J APPL POLYM SCI, V117, P1385, DOI 10.1002/app.31925
NR 38
TC 6
Z9 6
U1 0
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4290
EI 1872-6852
J9 FIELD CROP RES
JI Field Crop. Res.
PD SEP
PY 2014
VL 166
BP 72
EP 81
DI 10.1016/j.fcr.2014.06.008
PG 10
WC Agronomy
SC Agriculture
GA AN6IP
UT WOS:000340698500009
DA 2018-10-20
ER

PT J
AU Hameed, A
   Hastings, C
   Roche, E
   O'Brien, F
   Walsh, C
   Mooney, D
   Duffy, G
AF Hameed, A.
   Hastings, C.
   Roche, E.
   O'Brien, F.
   Walsh, C.
   Mooney, D.
   Duffy, G.
TI Advanced Materials For Cardiac Regeneration (AMCARE): Improving Stem
   Cell Delivery to the Infarcted Heart Using Biomaterial Approaches
SO IRISH JOURNAL OF MEDICAL SCIENCE
LA English
DT Meeting Abstract
C1 [Hameed, A.; Hastings, C.; O'Brien, F.; Duffy, G.] RCSI, Dept Anat, Dublin 2, Ireland.
   [Roche, E.; Walsh, C.; Mooney, D.] Harvard Univ, Dept Engn & Appl Sci, Wyss Inst, Cambridge, MA 02138 USA.
RI O'Brien, Fergal/F-9485-2011; Hameed, Aamir/C-2144-2017
OI O'Brien, Fergal/0000-0003-2030-8005; Hameed, Aamir/0000-0002-9242-6185
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0021-1265
EI 1863-4362
J9 IRISH J MED SCI
JI Irish J. Med. Sci.
PD SEP
PY 2014
VL 183
SU 5
MA 73
BP S246
EP S246
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA AO1PX
UT WOS:000341086600074
DA 2018-10-20
ER

PT J
AU Wang, KB
   Guo, LH
   Xiong, W
   Sun, LL
   Zheng, Y
AF Wang, Kebing
   Guo, Longhua
   Xiong, Wei
   Sun, Leilei
   Zheng, Yi
TI Nanoparticles of star-like copolymer mannitol-functionalized
   poly(lactide)-vitamin E TPGS for delivery of paclitaxel to prostate
   cancer cells
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Star-like copolymer; paclitaxel; prostate cancer; nanoparticles; drug
   delivery
ID DOCETAXEL-LOADED NANOPARTICLES; VITAMIN-E TPGS; CERVICAL-CANCER;
   CO-DELIVERY; MOLECULAR BIOMATERIAL; MULTIDRUG-RESISTANCE; PLGA
   NANOPARTICLES; DRUG-DELIVERY; BREAST-CANCER; SUCCINATE
AB The purpose of this research was to develop novel nanoparticles (NPs) of star-like copolymer mannitol-functionalized poly(lactide)-vitamin E TPGS (M-PLA-TPGS) for paclitaxel delivery for prostate cancer treatment, and evaluate their therapeutic effects in prostate cancer cell line and animal model in comparison with the linear PLGA NPs and poly(lactide)-vitamin E TPGS (PLA-TPGS) NPs. The paclitaxel-loaded M-PLA-TPGS NPs, prepared by a modified nano-precipitation method, were observed by FESEM to be near-spherical shape with narrow size distribution. The drug-loaded NPs were further characterized in terms of size, surface charge, drug content, encapsulation efficiency and in vitro drug release. The results showed that the M-PLA-TPGS NPs were found to be stable, showing almost no change in particle size and surface charge during the three-month storage period. In vitro drug release exhibited biphasic pattern with initial burst release followed by slow and continuous release. The cellular uptake level of M-PLA-TPGS NPs was demonstrated higher than linear PLGA NPs and PLA-TPGS NPs in PC-3 cells. The data also showed that the paclitaxel-loaded M-PLA-TPGS nanoparticles have higher antitumor efficacy than that of linear PLA-TPGS nanoparticles and PLGA nanoparticles in vitro and in vivo. In summary, the star-like copolymer M-PLA-TPGS could be used as a potential and promising molecular biomaterial in developing novel nanoformulation for prostate cancer treatment.
C1 [Wang, Kebing; Xiong, Wei] Guangdong Med Coll, Nanshan Affiliated Hosp, Dept Urol, Shenzhen, Guangdong, Peoples R China.
   [Guo, Longhua] Peoples Hosp New Dist Longhua, Dept Clin Lab, Shenzhen, Guangdong, Peoples R China.
   [Sun, Leilei; Zheng, Yi] Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Ctr Biotech & BioMed,Shenzhen Key Lab Gene & Anti, Shenzhen, Guangdong, Peoples R China.
   [Sun, Leilei] Northeastern Univ, Boston, MA 02115 USA.
   [Zheng, Yi] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
RP Sun, LL (reprint author), Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Ctr Biotech & BioMed,Shenzhen Key Lab Gene & Anti, Shenzhen, Guangdong, Peoples R China.
EM alice_sunll@163.com; zhengy@sz.tsinghua.edu.cn
FU State Key Laboratory of Virology of China [2013006]
FX The authors are grateful for the financial support from Open Research
   Fund Program of the State Key Laboratory of Virology of China (No.
   2013006).
CR Baimark Y, 2012, J APPL POLYM SCI, V124, P3871, DOI 10.1002/app.35473
   Fang C, 2009, SMALL, V5, P1637, DOI 10.1002/smll.200801647
   Feng SS, 2009, BIOMATERIALS, V30, P3297, DOI 10.1016/j.biomaterials.2009.02.045
   Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f
   Guo JW, 2011, BIOMATERIALS, V32, P8010, DOI 10.1016/j.biomaterials.2011.07.004
   Lapienis G, 2009, PROG POLYM SCI, V34, P852, DOI 10.1016/j.progpolymsci.2009.04.006
   Lapienis G, 2009, POLYMER, V50, P77, DOI 10.1016/j.polymer.2008.10.034
   Lee SJ, 2006, J POLYM SCI POL CHEM, V44, P888, DOI 10.1002/pola.21193
   Li ZB, 2004, SCIENCE, V306, P98, DOI 10.1126/science.1103350
   Ma YD, 2011, INT J NANOMED, V6, P2679, DOI 10.2147/IJN.S25251
   Ma YD, 2010, POLYMER, V51, P5952, DOI 10.1016/j.polymer.2010.10.029
   Ma YD, 2010, NANOSCALE RES LETT, V5, P1161, DOI 10.1007/s11671-010-9620-3
   Mei L, 2014, NANOMEDICINE-UK, V9, P9, DOI 10.2217/nnm.13.180
   Mi Y, 2012, BIOMATERIALS, V33, P7519, DOI 10.1016/j.biomaterials.2012.06.100
   Muthu MS, 2012, BIOMATERIALS, V33, P3494, DOI 10.1016/j.biomaterials.2012.01.036
   Cuong NV, 2012, J MATER CHEM, V22, P1006, DOI 10.1039/c1jm13588k
   Ouyang CP, 2012, POLYM BULL, V68, P27, DOI 10.1007/s00289-011-0516-x
   Park W, 2012, BIOMATERIALS, V33, P8848, DOI 10.1016/j.biomaterials.2012.08.042
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Qiu B, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-666
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Sanna V, 2012, NANOMED-NANOTECHNOL, V8, pS31, DOI 10.1016/j.nano.2012.05.009
   Schubert S, 2011, SOFT MATTER, V7, P1581, DOI 10.1039/c0sm00862a
   Song SH, 2009, APPL MICROBIOL BIOT, V84, P55, DOI 10.1007/s00253-009-2086-5
   Tao W, 2013, ACTA BIOMATER, V9, P8910, DOI 10.1016/j.actbio.2013.06.034
   Thamake SI, 2012, BIOMATERIALS, V33, P7164, DOI 10.1016/j.biomaterials.2012.06.026
   Tomasina J, 2013, BIOMATERIALS, V34, P1073, DOI 10.1016/j.biomaterials.2012.10.055
   Wang JL, 2012, BIOMATERIALS, V33, P6877, DOI 10.1016/j.biomaterials.2012.06.019
   Yan F, 2010, NANOMED-NANOTECHNOL, V6, P170, DOI 10.1016/j.nano.2009.05.004
   Yang CM, 2013, J BIOMED NANOTECHNOL, V9, P1617, DOI 10.1166/jbn.2013.1646
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang XJ, 2010, MACROMOLECULES, V43, P6671, DOI 10.1021/ma100653u
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zhang ZP, 2012, NANOMEDICINE-UK, V7, P1645, DOI [10.2217/NNM.12.117, 10.2217/nnm.12.117]
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
   Zheng Y, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-161
   Zhu ZS, 2010, J CONTROL RELEASE, V142, P438, DOI 10.1016/j.jconrel.2009.11.002
NR 37
TC 4
Z9 4
U1 2
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD SEP
PY 2014
VL 29
IS 3
BP 329
EP 340
DI 10.1177/0885328214527486
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AN8CG
UT WOS:000340828800002
PM 24621530
DA 2018-10-20
ER

PT J
AU Rinkevich-Shop, S
   Landa-Rouben, N
   Epstein, FH
   Holbova, R
   Feinberg, MS
   Goitein, O
   Kushnir, T
   Konen, E
   Leor, J
AF Rinkevich-Shop, Shunit
   Landa-Rouben, Natalie
   Epstein, Frederick H.
   Holbova, Radka
   Feinberg, Micha S.
   Goitein, Orly
   Kushnir, Tammar
   Konen, Eli
   Leor, Jonathan
TI Injectable Collagen Implant Improves Survival, Cardiac Remodeling, and
   Function in the Early Period After Myocarditis in Rats
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
LA English
DT Article
DE animal model; cardiac remodeling; collagen implant; injectable
   biomaterials/scaffold; myocarditis
ID DILATED CARDIOMYOPATHY; INFARCT EXPANSION; INJECTION; HEART; FAILURE;
   BIOMATERIAL; MANAGEMENT; THERAPY; MATRIX; REPAIR
AB Aim: Despite clear evidence of immune system involvement in the pathogenesis of myocarditis, the treatment of myocarditis remains nonspecific and supportive. We sought to test the hypothesis that injection of a collagen-based implant into the inflamed myocardium would stabilize the left ventricular (LV) wall and prevent adverse remodeling and dysfunction. Methods and Results: Autoimmune myocarditis was induced in 42 male Lewis rats. Development of myocarditis was evaluated and confirmed by serial echocardiography and cardiac magnetic resonance scans, LV wall thickening, global and regional LV wall motion abnormalities, and in some cases pericardial effusion. Sick animals were randomized to either injectable collagen implantation or saline injection into the anterior inflamed myocardium 14 days after immunization. Significantly, injectable collagen implantation improved 31-day survival compared with controls (85.7% vs 50%; P = .03). Furthermore, although injectable collagen significantly attenuated LV systolic and diastolic dilatation and preserved LV geometry and function, control animals developed significant LV dilatation and dysfunction. These favorable effects on LV remodeling were confirmed by postmortem morphometry. Significantly, the injectable collagen implant attenuated cardiomyocyte hypertrophy and infiltration of macrophages and lymphocytes into the myocardium. Conclusions: The present study shows, for the first time, that injectable collagen biomaterial improves survival and attenuates cardiac inflammation, cardiomyocyte hypertrophy, LV remodeling, and dysfunction in the early period after myocarditis in rats. Our findings suggest a new biomaterial-based strategy to ameliorate the devastating effects of myocarditis.
C1 [Rinkevich-Shop, Shunit; Landa-Rouben, Natalie; Holbova, Radka; Feinberg, Micha S.; Leor, Jonathan] Chaim Sheba Med Ctr, Tamman Cardiovasc Res Inst, Leviev Heart Ctr, IL-52621 Tel Hashomer, Israel.
   [Rinkevich-Shop, Shunit; Landa-Rouben, Natalie; Holbova, Radka; Feinberg, Micha S.; Leor, Jonathan] Chaim Sheba Med Ctr, Regenerat Med Stem Cells & Tissue Engn Ctr, IL-52621 Tel Hashomer, Israel.
   [Rinkevich-Shop, Shunit; Landa-Rouben, Natalie; Holbova, Radka; Feinberg, Micha S.; Leor, Jonathan] Tel Aviv Univ, Sackler Fac Med, Neufeld Cardiac Res Inst, IL-69978 Tel Aviv, Israel.
   [Epstein, Frederick H.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA.
   [Epstein, Frederick H.] Univ Virginia, Dept Radiol, Charlottesville, VA USA.
   [Goitein, Orly; Kushnir, Tammar; Konen, Eli] Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel.
RP Leor, J (reprint author), Chaim Sheba Med Ctr, Neufeld Cardiac Res Inst, IL-52621 Tel Hashomer, Israel.
EM leorj@post.tau.ac.il
RI Leor, Jonathan/O-2930-2017
FU US-Israel Binational Science Foundation [2007290]; Schlezak Foundation;
   Tel Aviv University, Israel
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article: This work
   was supported by the US-Israel Binational Science Foundation (FHE and
   JL) grant number 2007290 and the Schlezak Foundation (JL), Tel Aviv
   University, Israel.
CR Caforio ALP, 2013, EUR HEART J, V34, P2636, DOI 10.1093/eurheartj/eht210
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   DOUGLAS PS, 1989, J AM COLL CARDIOL, V13, P311, DOI 10.1016/0735-1097(89)90504-4
   Frustaci A, 2013, EUR J HEART FAIL, V15, P284, DOI 10.1093/eurjhf/hfs169
   Harrison DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00128
   Heymans S, 2013, CIRCULATION, V128, P1420, DOI 10.1161/CIRCULATIONAHA.112.001357
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Laude D, 2000, J BIOMECH ENG-T ASME, V122, P231, DOI 10.1115/1.429653
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Mavrogeni S, 2011, EUR J HEART FAIL, V13, P830, DOI 10.1093/eurjhf/hfr052
   Mendes LA, 1999, AM HEART J, V138, P303, DOI 10.1016/S0002-8703(99)70116-X
   Mina Y, 2013, J CARDIOVASC PHARM T, V18, P152, DOI 10.1177/1074248412458975
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Papageorgiou AP, 2012, IMMUNOBIOLOGY, V217, P503, DOI 10.1016/j.imbio.2011.07.011
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ravichandran R, 2012, INT J NANOMED, V7, P5969, DOI 10.2147/IJN.S37575
   Rinkevich-Shop S, 2013, EUR HEART J-CARD IMG, V14, P1069, DOI 10.1093/ehjci/jet044
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Schultheiss HP, 2011, EUR HEART J, V32, P2616, DOI 10.1093/eurheartj/ehr165
   Shoshani D, 2007, DERMATOL SURG, V33, pS152, DOI 10.1111/j.1524-4725.2007.33355.x
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Ye KY, 2011, J CARDIOVASC TRANSL, V4, P575, DOI 10.1007/s12265-011-9303-1
   Zouein Fouad A, 2012, Congest Heart Fail, V18, P284, DOI 10.1111/j.1751-7133.2012.00298.x
NR 29
TC 3
Z9 3
U1 0
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1074-2484
EI 1940-4034
J9 J CARDIOVASC PHARM T
JI J. Cardiovasc. Pharmacol. Ther.
PD SEP
PY 2014
VL 19
IS 5
BP 470
EP 480
DI 10.1177/1074248414522347
PG 11
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA AO1HY
UT WOS:000341064400008
PM 24572032
DA 2018-10-20
ER

PT J
AU Hempel, U
   Matthaus, C
   Preissler, C
   Moller, S
   Hintze, V
   Dieter, P
AF Hempel, Ute
   Matthaeus, Claudia
   Preissler, Carolin
   Moeller, Stephanie
   Hintze, Vera
   Dieter, Peter
TI Artificial Matrices With High-Sulfated Glycosaminoglycans and Collagen
   Are Anti-Inflammatory and Pro-Osteogenic for Human Mesenchymal Stromal
   Cells
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; INFLAMMATION; MESENCHYMAL
   STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; PROSTAGLANDINS
ID NF-KAPPA-B; ALKALINE-PHOSPHATASE ACTIVITY; ADULT BONE-MARROW;
   STEM-CELLS; CHONDROITIN SULFATE; GROWTH-FACTOR; IN-VITRO; ENDOCHONDRAL
   OSSIFICATION; SIGNALING PATHWAYS; HYALURONIC ACIDS
AB Bone healing has been described to be most efficient if the early inflammatory phase is resolved timely. When the inflammation elevates or is permanently established, bone healing becomes impaired and, moreover, bone destruction often takes place. Systemic disorders such as diabetes and bone diseases like arthritis and osteoporosis are associated with sustained inflammation and delayed bone healing. One goal of biomaterial research is the development of materials/surface modifications which support the healing process by inhibiting the inflammatory bone erosion and suppressing pro-inflammatory mediators and by that promoting the bone repair process. In the present study, the influence of artificial extracellular matrices (aECM) on the interleukin (IL)-1 beta-induced pro-inflammatory response of human mesenchymal stromal cells (hMSC) was studied. hMSC cultured on aECM composed of collagen I and high-sulfated glycosaminoglycan (GAG) derivatives did not secrete IL-6, IL-8, monocyte chemoattractant protein-1, and prostaglandin E-2 in response to IL-1 beta. The activation and nuclear translocation of nuclear factor kappa Bp65 induced by IL-1 beta, tumor necrosis factor-alpha or lipopolysaccharide was abrogated. Furthermore, these aECM promoted the osteogenic differentiation of hMSC as determined by an increased activity of tissue non-specific alkaline phosphatase (TNAP); however, the aECM had no effect on the IL-1 beta-induced TNAP activity. These data suggest that aECM with high-sulfated GAG derivatives suppress the formation of pro-inflammatory mediators and simultaneously promote the osteogenic differentiation of hMSC. Therefore, these aECM might offer an interesting approach as material/surface modification supporting the bone healing process. (C) 2014 Wiley Periodicals, Inc.
C1 [Hempel, Ute; Matthaeus, Claudia; Preissler, Carolin; Dieter, Peter] Tech Univ Dresden, Carl Gustav Carus Fac Med, Inst Physiol Chem, D-01307 Dresden, Germany.
   [Moeller, Stephanie] INNOVENT eV, Biomat Dept, D-07745 Jena, Germany.
   [Hintze, Vera] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
RP Hempel, U (reprint author), Tech Univ Dresden, Carl Gustav Carus Fac Med, Inst Physiol Chem, Fiedlerstr 42, D-01307 Dresden, Germany.
EM ute.hempel@tu-dresden.de
FU Deutsche Forschungsgemeinschaft [SFB/TR67]
FX The authors are very grateful to Professor Bornhauser and colleagues
   from the stem cell lab of the University Hospital in Dresden for
   providing the human mesenchymal stromal cells. This work was supported
   by grant of Deutsche Forschungsgemeinschaft (SFB/TR67 projects B1, A2,
   and A3).
CR Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446
   Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060
   Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004
   Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036
   Buttner M, 2013, J CELL PHYSIOL, V228, P330, DOI 10.1002/jcp.24135
   Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200
   Campo GM, 2008, OSTEOARTHR CARTILAGE, V16, P1474, DOI 10.1016/j.joca.2008.04.002
   Campo GM, 2009, ARCH BIOCHEM BIOPHYS, V491, P7, DOI 10.1016/j.abb.2009.09.017
   Canas N, 2010, NEUROSCIENCE, V167, P872, DOI 10.1016/j.neuroscience.2010.02.069
   Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954
   CHANG NS, 1994, J LEUKOCYTE BIOL, V55, P778
   Chen GP, 1997, BIOCONJUGATE CHEM, V8, P730, DOI 10.1021/bc9700493
   Chen X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.14
   Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1
   Dieter P, 1999, MEDIAT INFLAMM, V8, P295, DOI 10.1080/09629359990306
   Ding J, 2009, LIFE SCI, V84, P499, DOI 10.1016/j.lfs.2009.01.013
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   GALLAGHER JT, 1992, GLYCOBIOLOGY, V2, P523, DOI 10.1093/glycob/2.6.523
   Hempel U, 2012, ACTA BIOMATER, V8, P4064, DOI 10.1016/j.actbio.2012.06.039
   Hempel U, 2012, ACTA BIOMATER, V8, P659, DOI 10.1016/j.actbio.2011.10.026
   Hirata M, 2009, BIOCHEM BIOPH RES CO, V381, P139, DOI 10.1016/j.bbrc.2009.01.146
   Hochberg M, 2013, CURR MED RES OPIN, V29, P259, DOI 10.1185/03007995.2012.753430
   Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196
   Kim SE, 2011, BIOMATERIALS, V32, P366, DOI 10.1016/j.biomaterials.2010.09.008
   Kliemt S, 2013, J PROTEOME RES, V12, P378, DOI 10.1021/pr300640h
   Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133
   Kunze R, 2010, PROSTAG OTH LIPID M, V92, P8, DOI 10.1016/j.prostaglandins.2010.01.001
   Lin FH, 2010, J ORTHOP RES, V28, P958, DOI 10.1002/jor.21099
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Magnani A, 1996, THROMB RES, V81, P383, DOI 10.1016/0049-3848(96)00009-6
   Magnani A, 1998, POLYM INT, V46, P225, DOI 10.1002/(SICI)1097-0126(199807)46:3<225::AID-PI45>3.0.CO;2-I
   Martel-Pelletier J, 2010, OSTEOARTHR CARTILAGE, V18, pS7, DOI 10.1016/j.joca.2010.01.015
   Mumme M, 2012, EUR CELLS MATER, V24, P224, DOI 10.22203/eCM.v024a16
   Nagahata M, 2004, BIOCHEM BIOPH RES CO, V315, P603, DOI 10.1016/j.bbrc.2004.01.098
   Nakao S, 2002, MOL CELL BIOCHEM, V238, P11, DOI 10.1023/A:1019927616000
   Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159
   Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Pecchi E, 2012, OSTEOARTHR CARTILAGE, V20, P1727
   Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937
   Pietrogrande L, 2011, AGING CLIN EXP RES, V23, P65
   Pittenger Mark F., 2008, V449, P27, DOI 10.1007/978-1-60327-169-1_2
   Redlich K, 2012, NAT REV DRUG DISCOV, V11, P234, DOI 10.1038/nrd3669
   Salbach J, 2012, BIOMATERIALS, V33, P8418, DOI 10.1016/j.biomaterials.2012.08.028
   Salbach J, 2012, J MOL MED, V90, P625, DOI 10.1007/s00109-011-0843-2
   Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110
   Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967
   Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563
   Volpi Nicola, 2011, Inflammopharmacology, V19, P299, DOI 10.1007/s10787-011-0098-0
   Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022
NR 50
TC 6
Z9 6
U1 1
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD SEP
PY 2014
VL 115
IS 9
BP 1561
EP 1571
DI 10.1002/jcb.24814
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AN5XB
UT WOS:000340664300011
PM 24706396
DA 2018-10-20
ER

PT J
AU Almeida, LM
   Floriano, JF
   Ribeiro, TP
   Magno, LN
   da Mota, LSLS
   Peixoto, N
   Mrue, F
   Melo-Reis, P
   Lino, RD
   Graeff, CFD
   Goncalves, PJ
AF Almeida, Luciane Madureira
   Floriano, Juliana Ferreira
   Ribeiro, Thuanne Pires
   Magno, Lais Nogueira
   Lima Silveira da Mota, Ligia Souza
   Peixoto, Nei
   Mrue, Fatima
   Melo-Reis, Paulo
   Lino Junior, Ruy de Souza
   de Oliveira Graeff, Carlos Frederico
   Goncalves, Pablo Jose
TI Hancornia speciosa latex for biomedical applications: physical and
   chemical properties, biocompatibility assessment and angiogenic activity
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GUIDED BONE REGENERATION; HEVEA-BRASILIENSIS; NATURAL-RUBBER;
   GROWTH-FACTORS; MEMBRANE; ALLERGY; GOMES; CIS-1,4-POLYISOPRENE; MODEL;
   FTIR
AB The latex obtained from Hancornia speciosa is used in folk medicine for treatment of several diseases, such as acne, warts, diabetes, gastritis and inflammation. In this work, we describe the biocompatibility assessment and angiogenic properties of H. speciosa latex and its potential application in medicine. The physical-chemical characterization was carried out following different methodologies (CHN elemental analyses; thermogravimetric analyses and Fourier transform infrared spectroscopy). The biocompatibility was evaluated through cytotoxicity and genotoxicity tests in fibroblast mouse cells and the angiogenic properties were evaluated using the chick chorioallantoic membrane (CAM) assay model. The physical-chemical results showed that the structure of Hancornia speciosa latex biomembrane is very similar to that of Hevea brasiliensis (commercially available product). Moreover, the cytotoxicity and genotoxicity assays showed that H. speciosa latex is biocompatible with life systems and can be a good biomaterial for medical applications. The CAM test showed the efficient ability of H. speciosa latex in neovascularization of tissues. The histological analysis was in accordance with the results obtained in the CAM assay. Our data indicate that the latex obtained from H. speciosa and eluted in water showed significant angiogenic activity without any cytotoxic or genotoxic effects on life systems. The same did not occur with H. speciosa latex stabilized with ammonia. Addition of ammonia does not have significant effects on the structure of biomembranes, but showed a smaller cell survival and a significant genotoxicity effect. This study contributes to the understanding of the potentialities of H. speciosa latex as a source of new phytomedicines.
C1 [Almeida, Luciane Madureira; Ribeiro, Thuanne Pires; Peixoto, Nei] Univ Estadual Goias, BR-75780000 Ipameri, Brazil.
   [Floriano, Juliana Ferreira; de Oliveira Graeff, Carlos Frederico] Univ Estadual Paulista, Fac Ciencia Bauru, Bauru, SP, Brazil.
   [Magno, Lais Nogueira; Goncalves, Pablo Jose] Univ Fed Goias UFG, Inst Fis, Goiania, Go, Brazil.
   [Lima Silveira da Mota, Ligia Souza] Univ Estadual Paulista, Dept Genet, Botucatu, SP, Brazil.
   [Mrue, Fatima] Pontificia Univ Catolica Goias, Dept Med, PUCGo, Goiania, Go, Brazil.
   [Melo-Reis, Paulo] Pontificia Univ Catolica Goias, Dept Biomed, Lab Estudos Expt & Biotecnol, PUCGo, Goiania, Go, Brazil.
   [Lino Junior, Ruy de Souza] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil.
RP Almeida, LM (reprint author), Univ Estadual Goias, Rodovia GO 330,Km 241 Anel Viario S-N, BR-75780000 Ipameri, Brazil.
EM almeidalm@hotmail.com
RI Goncalves, Pablo/O-2469-2018; Mota, Ligia/C-4583-2013; Graeff,
   Carlos/C-6703-2012
OI Mota, Ligia/0000-0003-4513-753X; Graeff, Carlos/0000-0003-0162-8273
FU MCT/CNPq; FNDCT; CAPES; FINEP; FAPEG; FAPESP; FUNAPEP
FX The authors acknowledge the Brazilian funding agencies MCT/CNPq, FNDCT,
   CAPES, FINEP, FAPEG, FAPESP and FUNAPEP. Revision of the English
   language text was carried out by Universidade Estadual de Goias (UEG).
CR AKASAWA A, 1995, J ALLERGY CLIN IMMUN, V95, P1196, DOI 10.1016/S0091-6749(95)70076-5
   Alam TM, 2001, RADIAT PHYS CHEM, V60, P121, DOI 10.1016/S0969-806X(00)00314-5
   Araujo MM, 2012, ACTA CIR BRAS, V27, P566, DOI 10.1590/S0102-86502012000800009
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Bannerman R. H., 1982, World Health Forum, V3, P8
   Berthelot K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048065
   BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3
   Carvalho PCL, 2001, REV BRAS FRUTIC, V23, P730
   CIAPETTI G, 1994, J MATER SCI-MATER M, V5, P647, DOI 10.1007/BF00120348
   Cibulkova Z, 2006, J THERM ANAL CALORIM, V84, P709, DOI 10.1007/s10973-005-7547-1
   de Carvalho BR, 2008, REV BRAS GINECOL OBS, V30, P31
   Dulngali S, 1980, PRESERVATIVE SYSTEM
   Ebo DG, 2002, ACTA CLIN BELG, V57, P58, DOI 10.1179/acb.2002.015
   Ereno C, 2010, J BIOMED MATER RES A, V95A, P932, DOI 10.1002/jbm.a.32919
   Ferreira HC, 2007, PHYTOMEDICINE, V14, P473, DOI 10.1016/j.phymed.2006.11.008
   Ferreira HC, 2007, J ETHNOPHARMACOL, V109, P161, DOI 10.1016/j.jep.2006.06.009
   Floriano JF, 2014, J MATER SCI-MATER M, V25, P461, DOI 10.1007/s10856-013-5089-9
   Fokman J., 1992, INFLAMMATION BASIC P, P821
   Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465
   Frade Marco Andrey Cipriani, 2012, An. Bras. Dermatol., V87, P45, DOI 10.1590/S0365-05962012000100005
   Goyal M, 2012, J ETHNOPHARMACOL, V144, P786, DOI 10.1016/j.jep.2012.10.006
   Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008
   Herculano RD, 2009, MATER RES-IBERO-AM J, V12, P253, DOI 10.1590/S1516-14392009000200023
   INTERNATIONAL ORGANIZATION FOR STANDARDIZATION-ISO, 1992, 109933 ISO
   International Standardization Organization, 1992, 109935 ISO
   Jackson JR, 1997, FASEB J, V11, P457
   Kekwick R, 1996, CLIN EXP IMMUNOL, V104, P337, DOI 10.1046/j.1365-2249.1996.24731.x
   Konno K, 2004, PLANT J, V37, P370, DOI [10.1046/j.1365-313X.2003.01968.x, 10.1111/j.1365-313X.2004.01968.x]
   La Grutta S, 2003, ALLERGY, V58, P814, DOI 10.1034/j.1398-9995.2003.00196.x
   Lambert J., 1997, 355 WORLD BANK
   Parente LML, 2011, ACTA CIR BRAS, V26, P19, DOI 10.1590/S0102-86502011000100005
   Macedo M., 2004, Rev. bras. farmacogn., V14, P40, DOI 10.1590/S0102-695X2004000300016
   Malmonge JA, 2009, J APPL POLYM SCI, V111, P2986, DOI 10.1002/app.29316
   Marinho DG, 2011, J ETHNOPHARMACOL, V135, P530, DOI 10.1016/j.jep.2011.03.059
   Martins R, 2010, FULL DENSITRY SCI, V1, P224
   May AE, 2008, ARTERIOSCLER THROMB, V28, P5
   Mello VJ, 2008, PHYTOMEDICINE, V15, P237, DOI 10.1016/j.phymed.2007.06.004
   Melo-Reis PR, 2010, BRAZ J BIOL, V70, P189, DOI 10.1590/S1519-69842010000100026
   Moraes TDM, 2008, J ETHNOPHARMACOL, V120, P161, DOI 10.1016/j.jep.2008.08.001
   Polovkova J, 2006, CHEM PAP, V60, P327, DOI 10.2478/s11696-006-0060-6
   REMMERS EF, 1991, SEMIN ARTHRITIS RHEU, V21, P191, DOI 10.1016/0049-0172(91)90009-O
   Ritter M.R., 2002, Rev. bras. farmacogn., V12, P51, DOI 10.1590/S0102-695X2002000200001
   Sampaio RB, 2010, CURR EYE RES, V35, P56, DOI 10.3109/02713680903374216
   Sampaio TS, 2006, FOOD CHEM, V95, P606, DOI 10.1016/j.foodchem.2005.01.038
   Schultz GS, 2003, WOUND REPAIR REGEN, V11, pS1, DOI 10.1046/j.1524-475X.11.s2.1.x
   Shen JT, 2003, J CUTAN MED SURG, V7, P217, DOI 10.1007/s10227-002-0106-5
   SILVA C. G., 2011, J ETHNOPHARMACOL, V137, P709
   SINGH NP, 1994, INT J RADIAT BIOL, V66, P23, DOI 10.1080/09553009414550911
   Smith-Hall C, 2012, J ETHNOBIOL ETHNOMED, V8, DOI 10.1186/1746-4269-8-43
   Wagner B, 1999, J ALLERGY CLIN IMMUN, V104, P1084, DOI 10.1016/S0091-6749(99)70093-X
   Wiegand C, 2008, KRANKENAUSHYGIENE IN, V3, P1863
   Yagami T, 2004, INT ARCH ALLERGY IMM, V135, P3, DOI 10.1159/000080036
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001
NR 54
TC 13
Z9 14
U1 2
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2014
VL 25
IS 9
BP 2153
EP 2162
DI 10.1007/s10856-014-5255-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AN5EF
UT WOS:000340612100010
PM 24973907
DA 2018-10-20
ER

PT J
AU Wang, CW
   Chiang, TY
   Chang, HC
   Ding, SJ
AF Wang, Chien-Wen
   Chiang, Ting-Yi
   Chang, Hsien-Chang
   Ding, Shinn-Jyh
TI Physicochemical properties and osteogenic activity of radiopaque calcium
   silicate-gelatin cements
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO; DICALCIUM SILICATE; BONE-GRAFTS;
   PROROOT MTA; STEM-CELLS; DIFFERENTIATION; PH; COLLAGEN
AB The purpose of this study is to evaluate the physicochemical properties and in vitro osteogenic activity of radiopaque calcium silicate-gelatin cements. The radiopacity, setting time, working time, flow, diametral tensile strength, pH value, washout resistance and morphology of the cements with gelatin (0, 5 and 10 % by weight) were measured, which compared to a popular endodontic material, ProRoot white-colored mineral trioxide aggregate (WMTA). The cell morphology, cell attachment and proliferation, alkaline phosphatase and osteocalcin levels on the cements were measured by culturing the specimens with dental pulp cells. The results indicated that the presence of gelatin significantly (P < 0.05) reduced radiopacity and diametral tensile strength and prolonged setting time. Nevertheless, the 5 wt% gelatin cement had a radiopacity (5.1 mm of Al thickness) higher than ISO 6876:2001 standards (3 mm of Al thickness). The setting time (33 min), working time (9 min) and flow value (17.4 mm) of the 5 wt% gelatin cement were significantly (P < 0.05) better than those of WMTA (corresponding 165, 6 min and 14.2 mm). The fresh WMTA completely degraded after soaking in a physiological solution for 1 h, while the gelatin cements resisted washout, showing no noticeable breakdown even after 1 day of soaking. The gelatin cement enhanced the higher expression of cell attachment, proliferation and differentiation as compared to WMTA. It was concluded that the 5 wt% gelatin-calcium silicate hybrid cement appears to be promising as a radiopaque biomaterial for medical applications such as endodontics and vertebroplasty.
C1 [Wang, Chien-Wen; Chang, Hsien-Chang] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Chiang, Ting-Yi] Cent Taiwan Univ Sci & Technol, Dept Dent Lab Technol, Taichung 406, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Dent, Taichung 402, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
RP Chang, HC (reprint author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
EM hcchang@mail.ncku.edu.tw; sjding@csmu.edu.tw
CR Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Ber BS, 2007, J ENDODONT, V33, P1231, DOI 10.1016/j.joen.2007.06.012
   Chen CC, 2011, INT ENDOD J, V44, P836, DOI 10.1111/j.1365-2591.2011.01890.x
   Chen CC, 2014, J ALLOY COMPD, V585, P25, DOI 10.1016/j.jallcom.2013.09.138
   Chen CC, 2010, J MATER SCI-MATER M, V21, P1057, DOI 10.1007/s10856-009-3948-1
   Chen CC, 2009, J ENDODONT, V35, P1288, DOI 10.1016/j.joen.2009.05.036
   Chiang TY, 2013, INT ENDOD J, V46, P234, DOI 10.1111/j.1365-2591.2012.02112.x
   Chiang TY, 2014, J MED BIOL ENG, V34, P30, DOI 10.5405/jmbe.1386
   Chiang TY, 2010, J ENDODONT, V36, P1683, DOI 10.1016/j.joen.2010.07.003
   Candeiro GTD, 2012, J ENDODONT, V38, P842, DOI 10.1016/j.joen.2012.02.029
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   Ding SJ, 2011, J MATER CHEM, V21, P12793, DOI 10.1039/c1jm11171j
   Ding SJ, 2011, ADV ENG MATER, V13, pB246, DOI 10.1002/adem.201080132
   Duarte MAH, 2012, INT ENDOD J, V45, P565, DOI 10.1111/j.1365-2591.2012.02012.x
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Gandolfi MG, 2010, INT ENDOD J, V43, P917, DOI 10.1111/j.1365-2591.2010.01768.x
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Huang TH, 2008, J ENDODONT, V34, P590, DOI 10.1016/j.joen.2008.02.002
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   Leblebicioglu B, 1996, J PERIODONTOL, V67, P472, DOI 10.1902/jop.1996.67.5.472
   Lewis G, 2006, J BIOMED MATER RES B, V76B, P456, DOI 10.1002/jbm.b.30398
   McMichen FRS, 2003, INT ENDOD J, V36, P629, DOI 10.1046/j.1365-2591.2003.00701.x
   Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Porter ML, 2010, J ENDODONT, V36, P524, DOI 10.1016/j.joen.2009.11.012
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sugawara A, 2013, J MATER CHEM B, V1, P1081, DOI 10.1039/c2tb00061j
   Takechi M, 1996, J MATER SCI-MATER M, V7, P317, DOI 10.1007/BF00154542
NR 30
TC 8
Z9 8
U1 4
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2014
VL 25
IS 9
BP 2193
EP 2203
DI 10.1007/s10856-014-5258-5
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AN5EF
UT WOS:000340612100014
PM 24970350
DA 2018-10-20
ER

PT J
AU Hsu, HA
   Wu, CY
   Chu, JS
   Lin, LH
   Lu, CA
   Ou, KL
AF Hsu, Hsiu-An
   Wu, Chia-Yu
   Chu, Jan-Show
   Lin, Li-Hsiang
   Lu, Chen-An
   Ou, Keng-Liang
TI Effect of Recombinant Human Bone Morphogenetic Protein-2 and Ling Zhi-8
   on Osteogenesis: A Comparative Study Using a Rabbit Sinus Model
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID IMMUNOMODULATORY PROTEIN; GANODERMA-LUCIDIUM; AUGMENTATION; FRACTURE;
   REGENERATION; SURVIVAL; RHBMP-2; FLOOR; RATES; LZ-8
AB Purpose: This study evaluated the osteogenetic capability of Ling Zhi-8 (LZ-8; a protein purified from traditional Chinese medicine [lingzhi]) compared with recombinant human bone morphogenic protein-2 (rhBMP-2) in a standardized bony defect using a rabbit sinus model.
   Materials and Methods: Twelve male New Zealand white rabbits (18 to 24 weeks old, 3.3 to 3.8 kg) were included in the study. Implants of normal saline 0.1 mg, rhBMP-2 0.1 mg, and LZ-8 0.1 mg were each mixed with a uniform biodegradable polyurethane-based material (Nasopore). The implants were inserted in a standardized bony defect of the nasal bone created by a 2.5-mm trephine bur. The rabbits were sacrificed at 1, 2, 4, and 8 weeks postoperatively. Volume computerized tomographic and histomorphometric examinations were used to evaluate the quantity and quality of regenerated bone.
   Results: At postoperative week 4, radiography showed that the new bone volume was significantly larger in the rhBMP-2 group compared with the LZ-8 group (P = .041) and the control group (P = .015). Histomorphometrically, better wound healing of the rhBMP-2 group was found during the healing phase compared with the other 2 groups.
   Conclusion: The biomaterial implants using rhBMP-2 and LZ-8 had good biocompatibility and osteogenetic capabilities in the rabbit sinus model. Bone healing in rhBMP-2-treated defects was excellent and showed a significant difference compared with LZ-8. However, LZ-8-treated defects also exhibited bone regeneration, and this traditional Chinese medicine may possess osteogenic potential. Further investigations of the mechanism and application of this protein in osteogenesis are needed. (C) 2014 American Association of Oral and Maxillofacial Surgeons
C1 [Hsu, Hsiu-An] Chang Gung Mem Hospitial, Linkou, Taiwan.
   [Hsu, Hsiu-An] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei 110, Taiwan.
   [Hsu, Hsiu-An; Chu, Jan-Show; Lin, Li-Hsiang] Taipei Med Univ, Res Ctr Biomed Devices & Prototyping Prod, Taipei 110, Taiwan.
   [Wu, Chia-Yu] Taipei Med Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Taipei, Taiwan.
   [Wu, Chia-Yu; Lin, Li-Hsiang] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan.
   [Chu, Jan-Show] Taipei Med Univ, Grad Inst Clin Med, Taipei 110, Taiwan.
   [Chu, Jan-Show] Taipei Med Univ, Dept Pathol, Coll Med, Taipei 110, Taiwan.
   [Lu, Chen-An] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Nutr & Hlth Sci, Taipei 110, Taiwan.
   [Ou, Keng-Liang] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Oral Med, Res Ctr Biomed Devices & Prototyping Prod, Taipei 110, Taiwan.
   [Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei 110, Taiwan.
   [Ou, Keng-Liang] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, Taipei 110, Taiwan.
RP Ou, KL (reprint author), Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei 110, Taiwan.
EM klou@tmu.edu.tw
FU Department of Health, Executive Yuan, Taiwan [MOHW103-TDU-N-211-133001];
   Implant Dentistry Research and Education Foundation (IDREF) of
   International Congress of Oral Implantologists [A-101-057]
FX This work was supported by the Department of Health, Executive Yuan,
   Taiwan (contract number MOHW103-TDU-N-211-133001) and the Implant
   Dentistry Research and Education Foundation (IDREF) of International
   Congress of Oral Implantologists (contract number A-101-057).
CR ALTMAN RD, 1995, J ORTHOP TRAUMA, V9, P392, DOI 10.1097/00005131-199505000-00006
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Boyne PJ, 1997, INT J PERIODONT REST, V17, P10
   Branemark P I, 1971, Tandlakartidningen, V63, P486
   Branemark P I, 1972, Lakartidningen, V69, P4813
   Branemark P I, 1972, Tandlakartidningen, V844, P662
   Branemark P I, 1971, Lakartidningen, V68, P3105
   Carter DR, 1998, CLIN ORTHOP RELAT R, pS41
   Choi Y, 2012, CLIN ORAL IMPLAN RES, V23, P682, DOI 10.1111/j.1600-0501.2011.02222.x
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Deatherage J, 2010, ORAL MAXIL SURG CLIN, V22, P347, DOI 10.1016/j.coms.2010.06.003
   DEKEL S, 1981, J BONE JOINT SURG BR, V63, P185
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   Gan KH, 1998, J NAT PROD, V61, P485, DOI 10.1021/np9704664
   Gerstenfeld LC, 2007, J BONE JOINT SURG AM, V89A, P114, DOI 10.2106/JBJS.F.00495
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P604
   Hsu HY, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/513542
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x
   KINO K, 1989, J BIOL CHEM, V264, P472
   Lu YT, 2011, J ANAT, V219, P132, DOI 10.1111/j.1469-7580.2011.01380.x
   MASOUD I, 1986, J ORTHOP RES, V4, P221, DOI 10.1002/jor.1100040211
   Masoud I M, 1985, Prog Clin Biol Res, V187, P233
   Misch CE, 2008, IMPLANT DENT, V17, P5, DOI 10.1097/ID.0b013e3181676059
   Miyamoto I, 2009, EUR J PHARMACOL, V602, P1, DOI 10.1016/j.ejphar.2008.11.005
   Moura SAL, 2011, J PHARM SCI-US, V100, P2886, DOI 10.1002/jps.22497
   Neyt J G, 1998, Iowa Orthop J, V18, P118
   Riachi F, 2012, INT J DENT, DOI 10.1155/2012/737262
   RO J, 1976, ACTA ORTHOP SCAND, V47, P588, DOI 10.3109/17453677608988744
   Saad B, 2000, ARTIF ORGANS, V24, P939, DOI 10.1046/j.1525-1594.2000.06664.x
   Sbordone C, 2013, J CRANIO MAXILL SURG, V41, P235, DOI 10.1016/j.jcms.2012.09.007
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Sokolsky-Papkov M, 2007, ADV DRUG DELIVER REV, V59, P187, DOI 10.1016/j.addr.2007.04.001
   Spagnoli Daniel B, 2011, Dent Clin North Am, V55, P883, DOI 10.1016/j.cden.2011.07.014
   TANAKA S, 1989, J BIOL CHEM, V264, P16372
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110
   Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6<699::AID-IJC12>3.0.CO;2-5
   Woo I, 2004, Implant Dent, V13, P28, DOI 10.1097/01.ID.0000116369.66716.12
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   Yoon Sang Yeon, 1994, Archives of Pharmacal Research (Seoul), V17, P438, DOI 10.1007/BF02979122
NR 43
TC 0
Z9 0
U1 0
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD SEP
PY 2014
VL 72
IS 9
DI 10.1016/j.joms.2014.02.037
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AO5DC
UT WOS:000341361400014
PM 24836420
DA 2018-10-20
ER

PT J
AU Fehr, F
   Peng, Y
   Werkmeister, JA
   Ramshaw, JAM
AF Fehr, F.
   Peng, Y.
   Werkmeister, J. A.
   Ramshaw, J. A. M.
TI EXPRESSED PROTEIN LIGATION AS A MODIFICATION TOOL FOR A NOVEL NON-ANIMAL
   COLLAGEN-LIKE PROTEIN
SO JOURNAL OF PEPTIDE SCIENCE
LA English
DT Meeting Abstract
DE expressed protein ligation; collagen; cell-biomaterial interaction;
   tissue engineering
C1 [Fehr, F.; Peng, Y.; Werkmeister, J. A.; Ramshaw, J. A. M.] CSIRO, Future Mfg Flagship, Melbourne, Vic 3168, Australia.
RI Fehr, Friederike/H-3388-2011
OI Fehr, Friederike/0000-0002-6466-7475
CR Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   Peng Y., 2012, MICROB CELL FACT, V1, P14
   Peng YY, 2014, APPL MICROBIOL BIOT, V98, P1807, DOI 10.1007/s00253-013-5475-8
   Werkmeister A., 2012, BIOMED MATER, V7
NR 4
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1075-2617
EI 1099-1387
J9 J PEPT SCI
JI J. Pept. Sci.
PD SEP
PY 2014
VL 20
SU 1
MA P162
BP S211
EP S211
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA AN8TD
UT WOS:000340876400307
DA 2018-10-20
ER

PT J
AU Vora, HD
   Rajamure, RS
   Dahotre, SN
   Ho, YH
   Banerjee, R
   Dahotre, NB
AF Vora, Hitesh D.
   Rajamure, Ravi Shanker
   Dahotre, Sanket N.
   Ho, Yee-Hsien
   Banerjee, Rajarshi
   Dahotre, Narendra B.
TI Integrated experimental and theoretical approach for corrosion and wear
   evaluation of laser surface nitrided, Ti-6Al-4V biomaterial in
   physiological solution
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Laser surface nitriding; Laser gas alloying; First-principles
   calculations; DFT; Corrosion; Wear
ID TOTAL-ENERGY CALCULATIONS; INITIO MOLECULAR-DYNAMICS; WAVE BASIS-SET;
   TI-MO ALLOYS; ELECTROCHEMICAL-BEHAVIOR; MECHANICAL-PROPERTIES;
   ELECTRONIC-PROPERTIES; TITANIUM NITRIDE; RESISTANCE; STABILITY
AB A laser based surface nitriding process was adopted to further enhance the osseo-integration, corrosion resistance, and tribological properties of the commonly used bioimplant alloy, Ti-6Al-4V. Earlier preliminary osteoblast, electrochemical, and corrosive wear studies of laser nitrided titanium in simulated body fluid clearly revealed improvement of cell adhesion as well as enhancement in corrosion and wear resistance but mostly lacked the in-depth fundamental understanding behind these improvements. Therefore, a novel integrated experimental and theoretical approach were implemented to understand the physical phenomena behind the improvements and establish the property-structure-processing correlation of nitrided surface. The first principle and thermodynamic calculations were employed to understand the thermodynamic, electronic, and elastic properties of TiN for enthalpy of formation, Gibbs free energy, density of states, and elastic properties of TiN were investigated. Additionally, open circuit potential and cyclic potentio-dynamic polarization tests were carried out in simulated body fluid to evaluate the corrosion resistance that in turn linked with the experimentally measured and computationally predicted surface energies of TiN. From these results, it is concluded that the enhancement in the corrosion resistance after laser nitriding is mainly attributed to the presence of covalent bonding via hybridization among Ti (p) and N (d) orbitals. Furthermore, mechanical properties, such as, Poisson's ratio, stiffness, Pugh's ductility criteria, and Vickers hardness, predicted from first principle calculations were also correlated to the increase in wear resistance of TiN. All the above factors together seem to have contributed to significant improvement in both wear and corrosion performance of nitride surface compared to the bare Ti-6Al-417 in physiological environment indicating its suitability for bioimplant applications. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Vora, Hitesh D.; Rajamure, Ravi Shanker; Dahotre, Sanket N.; Ho, Yee-Hsien; Banerjee, Rajarshi; Dahotre, Narendra B.] CART, Lab Laser Mat Proc & Synth, Denton, TX USA.
   [Vora, Hitesh D.; Rajamure, Ravi Shanker; Ho, Yee-Hsien; Banerjee, Rajarshi; Dahotre, Narendra B.] Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA.
   [Dahotre, Sanket N.] Univ N Texas, TAMS, Denton, TX 76203 USA.
RP Dahotre, NB (reprint author), Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA.
EM Narendra.Dahotre@unt.edu
OI Vora, Hitesh/0000-0001-8504-0455
CR Ahuja R, 1996, PHYS REV B, V53, P3072, DOI 10.1103/PhysRevB.53.3072
   Andrievski RA, 1997, NANOSTRUCT MATER, V9, P607, DOI 10.1016/S0965-9773(97)00136-0
   [Anonymous], 2013, THERM WIND US GUID V
   [Anonymous], SURF EN MOL
   Ansara I., 1999, SGTE SUBSTANCE DATAB
   Balla VK, 2012, J MECH BEHAV BIOMED, V6, P9, DOI 10.1016/j.jmbbm.2011.09.007
   Basu B, 2009, ADV BIOMATERIALS FUN
   Biswas A., 2006, LASER ENG, V17, P59
   Black J, 2006, BIOL PERFORMANCE MAT
   Born M, 1940, P CAMB PHILOS SOC, V36, P160
   Chen XQ, 2011, INTERMETALLICS, V19, P1275, DOI 10.1016/j.intermet.2011.03.026
   Chung KH, 2004, SURF COAT TECH, V188, P745, DOI 10.1016/j.surfcoat.2004.07.050
   COLL BF, 1988, SURF COAT TECH, V36, P867, DOI 10.1016/0257-8972(88)90027-8
   Dahotre S.N., 2013, ANN BIOMED ENG, V42, P50
   Dahotre SN, 2013, APPL SURF SCI, V271, P141, DOI 10.1016/j.apsusc.2013.01.151
   Dinsdale A. T., 2001, SGTE DATA PURE ELEME
   DINSDALE AT, 1991, CALPHAD, V15, P317, DOI 10.1016/0364-5916(91)90030-N
   Dridi Z, 2002, J PHYS-CONDENS MAT, V14, P10237, DOI 10.1088/0953-8984/14/43/320
   Frantsevich I.N., 1983, ELASTIC CONSTANTS EL, P60
   Heakal FE, 2012, CORROS SCI, V56, P86, DOI 10.1016/j.corsci.2011.11.019
   Hoche D, 2011, HEAT MASS TRANSFER, V47, P519, DOI 10.1007/s00231-010-0742-z
   IGNATIEV M, 1993, WEAR, V166, P233, DOI 10.1016/0043-1648(93)90266-O
   JIANG X, 1991, J APPL PHYS, V69, P3053, DOI 10.1063/1.348963
   Jonsson S, 1996, Z METALLKD, V87, P691
   Kartsonakis IA, 2012, CORROS SCI, V65, P481, DOI 10.1016/j.corsci.2012.08.052
   KLOOSTERMAN AB, 1998, SURFACE MODIFICATION
   KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558
   Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0
   KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015
   Latella BA, 2006, SURF COAT TECH, V200, P3605, DOI 10.1016/j.surfcoat.2004.09.008
   Li QL, 2009, J BIOACT COMPAT POL, V24, P129, DOI 10.1177/0883911508101553
   Liu LL, 2014, ACTA BIOMATER, V10, P1005, DOI 10.1016/j.actbio.2013.09.021
   Mario M., 2000, PHYS REV B, V62, P2899
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Moreno JMC, 2013, CORROS SCI, V77, P52, DOI 10.1016/j.corsci.2013.07.026
   Ni YX, 2009, J MATER SCI, V44, P4031, DOI 10.1007/s10853-009-3562-0
   Nizhenko VI, 2004, POWDER METALL MET C+, V43, P273, DOI 10.1023/B:PMMC.0000042462.03736.18
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oshida Y., 2007, BIOSCIENCE BIOENGINE
   Paital SR, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025001
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   PETTIFOR DG, 1992, MATER SCI TECH SER, V8, P345, DOI 10.1179/mst.1992.8.4.345
   Singh R, 2006, J BIOMATER APPL, V21, P49, DOI 10.1177/0885328206055998
   Singh R, 2008, J MATER SCI-MATER M, V19, P1363, DOI 10.1007/s10856-007-3263-7
   Sovak G, 2000, J BONE JOINT SURG BR, V82B, P290, DOI 10.1302/0301-620X.82B2 .9819
   TRITA-MAC, 1993, 505 TRITAMAC
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vasilescu C, 2012, CORROS SCI, V65, P431, DOI 10.1016/j.corsci.2012.08.042
   Vitos L, 1998, SURF SCI, V411, P186, DOI 10.1016/S0039-6028(98)00363-X
   Wang S., 2007, APPL PHYS LETT, V91
   WHITE JA, 1994, PHYS REV B, V50, P4954, DOI 10.1103/PhysRevB.50.4954
   Xu CG, 2011, CORROS SCI, V53, P2066, DOI 10.1016/j.corsci.2011.02.019
   Yilbas BS, 2011, IND LUBR TRIBOL, V63, P293, DOI 10.1108/00368791111140503
   Zaveri N. A., 2007, BIOCORROSION STUDIES
   Zhecheva A, 2005, SURF COAT TECH, V200, P2192, DOI 10.1016/j.surfcoat.2004.07.115
   Zhu JJ, 2013, APPL SURF SCI, V268, P87, DOI 10.1016/j.apsusc.2012.11.171
NR 59
TC 10
Z9 10
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD SEP
PY 2014
VL 37
BP 153
EP 164
DI 10.1016/j.jmbbm.2014.05.017
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AO0GM
UT WOS:000340987100016
PM 24922620
DA 2018-10-20
ER

PT J
AU Zhang, X
   Li, XW
   Li, JG
   Sun, XD
AF Zhang, Xue
   Li, Xiao-Wu
   Li, Ji-Guang
   Sun, Xu-Dong
TI Preparation and mechanical property of a novel 3D porous magnesium
   scaffold for bone tissue engineering
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porous magnesium; Microstructure; Mechanical properties; Fiber
   deposition hot pressing; Porosity
ID PORE-SIZE; BIOMEDICAL MAGNESIUM; POLYMERIC SCAFFOLDS; HYDROXYAPATITE;
   POROSITY; OSTEOCONDUCTION; OSTEOGENESIS; BIOMATERIAL; BEHAVIOR; MG
AB Porous magnesium has been recently recognized as a biodegradable metal for bone substitute applications. A novel porous Mg scaffold with three-dimensional (3D) interconnected pores and with a porosity of 33-54% was produced by the fiber deposition hot pressing (FDHP) technology. The microstructure and morphologies of the porous Mg scaffold were characterized by scanning electron microscopy (SEM), and the effects of porosities on the microstructure and mechanical properties of the porous Mg were investigated. Experimental results indicate that the measured Young's modulus and compressive strength of the Mg scaffold are ranged in 0.10-037 GPa, and 11.1-303 MPa, respectively, which are fairly comparable to those of cancellous bone. Such a porous Mg scaffold having a 3D interconnected network structure has the potential to be used in bone tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zhang, Xue; Li, Xiao-Wu] Northeastern Univ, Coll Sci, Inst Mat Phys & Chem, Shenyang 110819, Peoples R China.
   [Zhang, Xue; Li, Xiao-Wu; Li, Ji-Guang; Sun, Xu-Dong] Northeastern Univ, Key Lab Anisotropy & Texture Engn Mat, Minist Educ, Shenyang 110819, Peoples R China.
RP Li, XW (reprint author), Northeastern Univ, Coll Sci, Inst Mat Phys & Chem, Shenyang 110819, Peoples R China.
EM xwli@mail.neu.edu.cn
RI Li, Xiao-Wu/F-8109-2013
OI Sun, Xudong/0000-0003-4770-0840
FU Fundamental Research Funds for the Central University of China
   [N110105001, N120505001, N110605003]; National Natural Science
   Foundation of China (NSFC) [51271054, 51231002]
FX This work was financially supported by the Fundamental Research Funds
   for the Central University of China under Grant nos. N110105001,
   N120505001 and N110605003, and partially by the National Natural Science
   Foundation of China (NSFC) under Grant nos. 51271054 and 51231002. Prof.
   X.W. Li is grateful for the support.
CR Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Geng F., 2008, THESIS CHINESE ACAD
   Geng F, 2009, J MATER SCI TECHNOL, V25, P123
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kirkland NT, 2011, MATER SCI ENG B-ADV, V176, P1666, DOI 10.1016/j.mseb.2011.04.006
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu DM, 1998, CERAM INT, V24, P441, DOI 10.1016/S0272-8842(97)00033-3
   Liu DM, 1997, CERAM INT, V23, P135, DOI 10.1016/S0272-8842(96)00009-0
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Narayanan R, 2007, CORROS SCI, V49, P542, DOI 10.1016/j.corsci.2006.06.021
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Shen Jian, 2006, METALLIC FUNCTIONAL, V13, P9
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   Tan G.Q., 2006, BIOCERAMIC MAT
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   Wen CE, 2004, MATER LETT, V58, P357, DOI 10.1016/S0167-577X(03)004500-7
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Wiesmann HP, 1997, J BONE MINER RES, V12, P380, DOI 10.1359/jbmr.1997.12.3.380
   Zhang X, 2013, KEY ENG MATER, V544, P276, DOI 10.4028/www.scientific.net/KEM.544.276
   Zhang X, 2013, PROG NAT SCI-MATER, V23, P183, DOI 10.1016/j.pnsc.2013.03.006
NR 28
TC 24
Z9 26
U1 1
U2 63
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2014
VL 42
BP 362
EP 367
DI 10.1016/j.msec.2014.05.044
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AN6EJ
UT WOS:000340687400046
PM 25063129
DA 2018-10-20
ER

PT J
AU Malaise, S
   Rami, L
   Montembault, A
   Alcouffe, P
   Burdin, B
   Bordenave, L
   Delmond, S
   David, L
AF Malaise, Sebastien
   Rami, Lila
   Montembault, Alexandra
   Alcouffe, Pierre
   Burdin, Beatrice
   Bordenave, Laurence
   Delmond, Samantha
   David, Laurent
TI Bioresorption mechanisms of chitosan physical hydrogels: A scanning
   electron microscopy study
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterial; Bioresorption; Cell colonization; Capillary; Tuneable;
   Hydrogel
ID HYALURONIC-ACID HYDROGELS; HYDROALCOHOLIC MEDIUM; ACETYLATION;
   DERIVATIVES
AB Tissue-engineered biodegradable medical devices are widely studied and systems must present suitable balance between versatility and elaboration simplicity. In this work, we aim at illustrating that such equilibrium can be found by processing chitosan physical hydrogels without external cross-linker. Chitosan concentration, degree of acetylation, solvent composition, and neutralization route were modulated in order to obtain hydrogels exhibiting different physico-chemical properties. The resulting in vivo biological response was investigated by scanning electron microscopy. "Soft" hydrogels were obtained from chitosan of high degree of acetylation (35%) and by the neutralization with gaseous ammonia of a chitosan acetate aqueous solutions presenting low polymer concentration (Cp = 1.6% w/w). "Harder" hydrogels were obtained from chitosan with lower degree of acetylation (5%) and after neutralization in sodium hydroxide bath (1 M) of hydro-alcoholic chitosan solutions (50/50 w/w water/1,2-propanediol) with a polymer concentration of 2.5% w/w. Soft and hard hydrogels exhibited bioresorption times from below 10 days to higher than 60 days, respectively. We also evidenced that cell colonization and neo-vascularization mechanisms depend on the hydrogel-aggregated structure that is controlled by elaboration conditions and possibly in relation with mechanical properties. Specific processing conditions induced micron-range capillary formation, which can be assimilated to colonization channels, also acting on the resorption scenario. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Malaise, Sebastien; Montembault, Alexandra; Alcouffe, Pierre; David, Laurent] Univ Lyon 1, Univ Lyon, CNRS, IMPUMR 5223, F-69622 Villeurbanne, France.
   [Rami, Lila; Bordenave, Laurence] Univ Bordeaux, F-33000 Bordeaux, France.
   [Rami, Lila; Bordenave, Laurence] INSERM, U1026, F-33000 Bordeaux, France.
   [Burdin, Beatrice] Univ Lyon 1, Univ Lyon, Ctr Technol Microstruct, F-69622 Villeurbanne, France.
   [Bordenave, Laurence; Delmond, Samantha] CHU Bordeaux, CIC IT Biomat, F-33000 Bordeaux, France.
RP Malaise, S (reprint author), Univ Lyon 1, Univ Lyon, CNRS, IMPUMR 5223, 15 Blvd Latarjet, F-69622 Villeurbanne, France.
EM sebastien.malaise@gmail.com
FU ANR [ANR2010-TECS017]
FX The authors thank ANR for funding the TECSAN collaborative research
   program ChitoArt (ANR2010-TECS017).
CR Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   Boucard N, 2007, BIOMACROMOLECULES, V8, P1209, DOI 10.1021/bm060911m
   Boucard N, 2005, BIOMACROMOLECULES, V6, P3227, DOI 10.1021/bm050653d
   Butler MF, 2006, BIOMACROMOLECULES, V7, P2961, DOI 10.1021/bm060133y
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   Desorme M, 2013, CARBOHYD POLYM, V98, P50, DOI 10.1016/j.carbpol.2013.04.070
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dupasquier F., Solution aqueuse homogene de chitosane injectable, Patent No. [WO 2013079646 A1, 2013079646]
   Hassan R., 2013, ADV BIOSENS BIOELECT, V2, P47
   Hirai A., 1991, SPECTROSCOPY, V94, P87
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kristiansen KA, 2009, CARBOHYD POLYM, V77, P725, DOI 10.1016/j.carbpol.2009.02.018
   Ladet SG, 2011, BIOMATERIALS, V32, P5354, DOI 10.1016/j.biomaterials.2011.04.012
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   Lamarque G, 2005, BIOMACROMOLECULES, V6, P131, DOI 10.1021/bm0496357
   Ma D, 2010, BIOMACROMOLECULES, V11, P2204, DOI 10.1021/bm100676a
   Mellegard H, 2011, INT J FOOD MICROBIOL, V148, P48, DOI 10.1016/j.ijfoodmicro.2011.04.023
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Montembault A, 2006, BIOCHIMIE, V88, P551, DOI 10.1016/j.biochi.2006.03.002
   Montembault A, 2005, BIOMATERIALS, V26, P933, DOI 10.1016/j.biomaterials.2004.03.033
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Pochat-Bohatier C., 2013, J APPL POLYM SCI, V128, P2945
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   Rami L., 2013, J BIOMED MAT RES A, V00A
   Rivas-Araiza R, 2010, LANGMUIR, V26, P17495, DOI 10.1021/la102907u
   Rodriguez-Nunez JR, 2012, INT J FOOD SCI TECH, V47, P2127, DOI 10.1111/j.1365-2621.2012.03079.x
   Schmitt F, 2010, J CONTROL RELEASE, V144, P242, DOI 10.1016/j.jconrel.2010.02.008
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Serrero A., THESIS UCB LYON, P12009
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Sorlier P, 2003, BIOMACROMOLECULES, V4, P1034, DOI 10.1021/bm03405n
NR 32
TC 11
Z9 11
U1 3
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2014
VL 42
BP 374
EP 384
DI 10.1016/j.msec.2014.04.060
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AN6EJ
UT WOS:000340687400048
PM 25063131
DA 2018-10-20
ER

PT J
AU Li, XM
   Li, HZ
   Wang, SP
   Huang, HM
   Huang, HH
   Ai, HJ
   Xu, J
AF Li, Xiu-Mei
   Li, Hui-Zhe
   Wang, Shao-Ping
   Huang, Hsun-Miao
   Huang, Her-Hsiung
   Ai, Hong-Jun
   Xu, Jian
TI MRI-compatible Nb-60Ta-2Zr alloy used for vascular stents:
   Haemocompatibility and its correlation with protein adsorption
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Haemocompatibility; Platelet adhesion; Protein adsorption; Niobium;
   Stent
ID STAINLESS-STEEL; IN-VITRO; SURFACE WETTABILITY; BIOMATERIAL SURFACES;
   BLOOD-COMPATIBILITY; PLATELET-ADHESION; NANOMETER-SCALE; SERUM-ALBUMIN;
   WHOLE-BLOOD; NITI ALLOYS
AB Nb-60Ta-2Zr is a newly developed MRI-compatible alloy used for vascular stents. In this work, its haemocompatibility was investigated, including platelet adhesion (lactate dehydrogenase activity), platelet activation (P-selectin expression), coagulation and haemolysis. For comparison, parallel assessments for these factors were performed for the niobium, tantalum, 316L stainless steel (316L SS) and L605 Co-Cr alloy (L605). In addition, albumin and fibrinogen were selected to examine the correlation of protein adsorption with platelet adhesion and metal surface properties. The propensity for platelet adhesion and activation on the Nb-60Ta-2Zr alloy was at nearly the same level as that for Nb and Ta but was slightly less than those of 316L SS and L605. The mitigated platelet adhesion and activation of the Nb-60Ta-2Zr alloy is associated with its decreased adsorption of fibrinogen. The Nb-60Ta-2Zr alloy has a longer clotting time and exhibits significantly superior thromboresistance than 316L SS and L605. Moreover, the haemolysis rate of the Nb-60Ta-2Zr alloy satisfies the bin-safety requirement of the ISO 10993-4 standard. The favourable haemocompatiblity of the Nb-60Ta-2Zr alloy provides evidence of its good biocompatibility and of its suitability as a candidate stent material. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Li, Xiu-Mei; Ai, Hong-Jun] China Med Univ, Sch Stomatol, Shenyang 110002, Peoples R China.
   [Li, Hui-Zhe; Wang, Shao-Ping; Xu, Jian] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China.
   [Huang, Hsun-Miao; Huang, Her-Hsiung] Natl Yang Ming Univ, Dept Dent, Biomat & Elect Lab, Taipei 112, Taiwan.
RP Ai, HJ (reprint author), China Med Univ, Sch Stomatol, 117 Nanjing North St, Shenyang 110002, Peoples R China.
EM aih0620@yahoo.com.cn; jianxu@imr.ac.cn
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   [Anonymous], 2000, STAND PRACT ASS HEM
   Armitage DA, 2003, J BIOMED MATER RES A, V66A, P129, DOI 10.1002/jbm.a.10549
   Bayram C, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/055007
   Byrne TM, 2009, SURF SCI, V603, P992, DOI 10.1016/j.susc.2009.02.014
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Chen JL, 2009, APPL SURF SCI, V255, P6894, DOI 10.1016/j.apsusc.2009.03.011
   Chuang TW, 2008, J BIOMED MATER RES A, V86A, P648, DOI 10.1002/jbm.a.31662
   Constantine G, 2004, LANCET, V363, P2162, DOI 10.1016/S0140-6736(04)16509-4
   De Muth JE, 2006, BASIC STAT PHARM STA, P229
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   Fritsche A, 2010, MATERIALWISS WERKST, V41, P83, DOI 10.1002/mawe.200900547
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   Goodman SL, 1999, J BIOMED MATER RES, V45, P240, DOI 10.1002/(SICI)1097-4636(19990605)45:3<240::AID-JBM12>3.3.CO;2-3
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hanawa T, 2009, J ARTIF ORGANS, V12, P73, DOI 10.1007/s10047-008-0456-x
   Hansi C, 2009, CATHETER CARDIO INTE, V73, P488, DOI 10.1002/ccd.21834
   Holton A, 2002, J CARDIOV MAGN RESON, V4, P423, DOI 10.1081/JCMR-120016381
   Hong J, 2005, BIOMATERIALS, V26, P1397, DOI 10.1016/j.biomaterials.2004.05.036
   ISO, 2002, 109934 ISO
   Israelachvili J, 1996, NATURE, V379, P219, DOI 10.1038/379219a0
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kempe DS, 2005, AM J PHYSIOL-CELL PH, V288, pC396, DOI 10.1152/ajpcell.00115.2004
   Khan F, 1998, J THROMB THROMBOLYS, V5, P83
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Li HZ, 2014, J MECH BEHAV BIOMED, V32, P166, DOI 10.1016/j.jmbbm.2013.12.015
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Niemoeller OM, 2006, TOXICOL APPL PHARM, V217, P168, DOI 10.1016/j.taap.2006.09.001
   Noh H, 2006, BIOMATERIALS, V27, P5801, DOI 10.1016/j.biomaterials.2006.08.005
   O'Brien B, 2008, J MECH BEHAV BIOMED, V1, P303, DOI 10.1016/j.jmbbm.2007.11.003
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   O'Brien BJ, 2008, BIOMATERIALS, V29, P4540, DOI 10.1016/j.biomaterials.2008.08.013
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pradier CM, 2002, SURF INTERFACE ANAL, V34, P50, DOI 10.1002/sia.1250
   Rao GHR, 1999, B MATER SCI, V22, P633, DOI 10.1007/BF02749979
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shabalovskaya SA, 2013, MAT SCI ENG C-MATER, V33, P127, DOI 10.1016/j.msec.2012.08.018
   SHIRLEY DA, 1972, PHYS REV B, V5, P4709, DOI 10.1103/PhysRevB.5.4709
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silva-Bermudez P, 2013, APPL SURF SCI, V282, P351, DOI 10.1016/j.apsusc.2013.05.133
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Sprague EA, 2005, J ENDOVASC THER, V12, P594, DOI 10.1583/05-1555.1
   Sui JH, 2006, DIAM RELAT MATER, V15, P1720, DOI 10.1016/j.diamond.2006.03.004
   TAMADA Y, 1995, BIOMATERIALS, V16, P259, DOI 10.1016/0142-9612(95)92126-Q
   Vasilescu C, 2012, CORROS SCI, V65, P431, DOI 10.1016/j.corsci.2012.08.042
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang W, 2012, CORROS SCI, V57, P11, DOI 10.1016/j.corsci.2011.12.039
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yoshioka T, 2003, BIOMATERIALS, V24, P2889, DOI 10.1016/S0142-9612(03)00127-3
   Zhao TT, 2011, J MATER SCI-MATER M, V22, P2311, DOI 10.1007/s10856-011-4406-4
   Zhu SF, 2009, SURF COAT TECH, V203, P1523, DOI 10.1016/j.surfcoat.2008.11.033
NR 62
TC 6
Z9 7
U1 3
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2014
VL 42
BP 385
EP 395
DI 10.1016/j.msec.2014.05.051
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AN6EJ
UT WOS:000340687400049
PM 25063132
DA 2018-10-20
ER

PT J
AU Guo, P
   Yuan, YS
   Chi, FL
AF Guo, Peng
   Yuan, Yasheng
   Chi, Fanglu
TI Biomimetic alginate/polyacrylamide porous scaffold supports human
   mesenchymal stem cell proliferation and chondrogenesis
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Polyacrylamide; Alginate; Hydrogel; Mesenchymal stem cell;
   Proliferation; Chondrogenesis
ID POLYMER NETWORK HYDROGELS; ARTICULAR-CARTILAGE REPAIR; ALGINATE GEL
   SYSTEM; SODIUM ALGINATE; ALKALINE-PHOSPHATASE; TISSUE; BONE;
   DIFFERENTIATION; CHONDROCYTES; UTILITY
AB We describe the development of alginate/polyacrylamide (ALG/PAAm) porous hydrogels based on interpenetrating polymer network structure for human mesenchymal stem cell proliferation and chondrogenesis. Three ALG/PAAm hydrogels at molar ratios of 10/90,20/80, and 30/70 were prepared and characterized with enhanced elastic and rubbery mechanical properties, which are similar to native human cartilage tissues. Their elasticity and swelling properties were also studied under different physiological pH conditions. Finally, in vitro tests demonstrated that human mesenchymal stem cells could proliferate on the as-synthesized hydrogels with improved alkaline phosphatase activities. These results suggest that ALG/PAAm hydrogels may be a promising biomaterial for cartilage tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Guo, Peng; Yuan, Yasheng; Chi, Fanglu] EENT Hosp, Dept ENT Head & Neck Surg, Shanghai 200031, Peoples R China.
   [Guo, Peng; Yuan, Yasheng; Chi, Fanglu] Fudan Univ, Shanghai Med Sch, Shanghai 210029, Peoples R China.
   [Yuan, Yasheng] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Eaton Peabody Lab, Boston, MA 02114 USA.
RP Yuan, YS (reprint author), EENT Hosp, Dept ENT Head & Neck Surg, Shanghai 200031, Peoples R China.
EM yuanyasheng@163.com
OI Guo, Peng/0000-0003-1689-5622
FU National Institute on Deafness and other Communicative Disorders (from
   the NSFC grant) [81028003/H1305, 30973303]; National Institute on
   Deafness and other Communicative Disorders (from the Key Basic Research
   Project of Shanghai Committee of Science and Technology) [10JC1402500];
   National Institute on Deafness and other Communicative Disorders (from
   the Ministry of Education grant) [20090071120072]; National Institute on
   Deafness and other Communicative Disorders (from the Innovation Program
   of Shanghai Committee of Science and Technology) [11411952300]
FX This work was supported by grants from the National Institute on
   Deafness and other Communicative Disorders (Award Number 81028003/H1305
   from the NSFC grant; 30973303 from the NSFC grant; 10JC1402500 from the
   Key Basic Research Project of Shanghai Committee of Science and
   Technology; 20090071120072 from the Ministry of Education grant, and
   11411952300 from the Innovation Program of Shanghai Committee of Science
   and Technology).
CR BARNETT SE, 1987, ANN ROY COLL SURG, V69, P153
   BELLOWS CG, 1991, BONE MINER, V14, P27, DOI 10.1016/0169-6009(91)90100-E
   BOYDE TRC, 1976, J CHROMATOGR, V124, P219, DOI 10.1016/S0021-9673(00)89737-X
   Christensen LH, 2003, PLAST RECONSTR SURG, V111, P1883, DOI 10.1097/01.PRS.0000056873.87165.5A
   Chung CW, 2011, COLLOID SURFACE B, V88, P711, DOI 10.1016/j.colsurfb.2011.08.005
   Clair Benjamin L, 2009, Foot Ankle Spec, V2, P179, DOI 10.1177/1938640009342272
   COOK W, 1986, J BIOMED MATER RES, V20, P1, DOI 10.1002/jbm.820200103
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   Ghahramanpoor MK, 2011, J MATER SCI-MATER M, V22, P2365, DOI 10.1007/s10856-011-4396-2
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Keeney M, 2011, CURR OPIN BIOTECH, V22, P734, DOI 10.1016/j.copbio.2011.04.003
   Lee DA, 2003, ACTA ORTHOP SCAND, V74, P6, DOI 10.1080/00016470310013581
   Lee F, 2013, ACTA BIOMATER, V9, P5143, DOI 10.1016/j.actbio.2012.08.036
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Liu L, 2005, BIOMATERIALS, V26, P233, DOI 10.1016/j.biomaterials.2004.02.025
   Main Symposia And Workshops, 2013, FEBS J, V280, P3
   Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Rehm B. H. A, 2009, ALGINATES BIOL APPL
   Rogalsky AD, 2011, J BIOMED MATER RES A, V99A, P367, DOI 10.1002/jbm.a.33192
   Song YL, 2011, FOOD CONTROL, V22, P608, DOI 10.1016/j.foodcont.2010.10.012
   Soppirnath KS, 2002, EUR J PHARM BIOPHARM, V53, P87, DOI 10.1016/S0939-6411(01)00205-3
   Stevens MM, 2004, BIOMATERIALS, V25, P887, DOI 10.1016/j.biomaterials.2003.07.002
   Sturm S, 2010, J BIOMECH, V43, P1738, DOI 10.1016/j.jbiomech.2010.02.020
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Sun J, 2012, SOFT MATTER, V8, P2398, DOI 10.1039/c2sm06869a
   TAYLOR DE, 1986, BIOMATERIALS, V7, P277, DOI 10.1016/0142-9612(86)90050-5
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   VANSTRAALEN JP, 1991, CLIN CHIM ACTA, V201, P27, DOI 10.1016/0009-8981(91)90021-4
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Waters DJ, 2011, MACROMOLECULES, V44, P5776, DOI 10.1021/ma200693e
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   You ML, 2011, BIOMATERIALS, V32, P2305, DOI 10.1016/j.biomaterials.2010.12.009
   Zhang Lijie, 2009, Critical Reviews in Biomedical Engineering, V37, P1
NR 41
TC 18
Z9 19
U1 3
U2 61
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2014
VL 42
BP 622
EP 628
DI 10.1016/j.msec.2014.06.013
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AN6EJ
UT WOS:000340687400079
PM 25063162
DA 2018-10-20
ER

PT J
AU Gonzalez, M
   Pena, J
   Gil, FJ
   Manero, JM
AF Gonzalez, M.
   Pena, J.
   Gil, F. J.
   Manero, J. M.
TI Low modulus Ti-Nb-Hf alloy for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Corrosion; Biocompatibility; Cytotoxicity; Low elastic modulus; Stress
   shielding effect; TiNbHf alloys
ID CORROSION BEHAVIOR; TITANIUM; HAFNIUM
AB beta-Type titanium alloys with a low elastic modulus are a potential strategy to reduce stress shielding effect and to enhance bone remodeling in implants used to substitute failed hard tissue. For biomaterial application, investigation on the mechanical behavior, the corrosion resistance and the cell response is required. The new Ti25Nb16Hf alloy was studied before and after 95% cold rolling (95% C.R.). The mechanical properties were determined by tensile testing and its corrosion behavior was analyzed by potentiostatic equipment in Hank's solution at 37 degrees C. The cell response was studied by means of cytotoxicity evaluation, cell adhesion and proliferation measurements. The stress-strain curves showed the lowest elastic modulus (42 GPa) in the cold worked alloy and high tensile strength, similar to that of Ti6Al4V. The new alloy exhibited better corrosion resistance in terms of open circuit potential (E-OCP), but was similar in terms of corrosion current density (i(CORR)) compared to Ti grade II. Cytotoxicity studies revealed that the chemical composition of the alloy does not induce cytotoxic activity. Cell studies in the new alloy showed a lower adhesion and a higher proliferation compared toll grade II presenting, therefore, mechanical features similar to those of human cortical bone and, simultaneously, a good cell response. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Gonzalez, M.; Pena, J.; Gil, F. J.; Manero, J. M.] Univ Politecn Cataluna, Dept Mat Sci & Met, E-08028 Barcelona, Spain.
   [Gonzalez, M.; Pena, J.] Escola Super Disseny Engn Barcelona, Barcelona 08002, Spain.
   [Gil, F. J.; Manero, J. M.] Ciber BBN, Zaragoza, Spain.
RP Gonzalez, M (reprint author), Univ Politecn Cataluna, Dept Mat Sci & Met, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM Marta.Gonzalez.Colominas@upc.edu
RI Manero, Jose Maria/B-4169-2015
OI Manero, Jose Maria/0000-0002-1673-4389
CR American Society for Testing, 1978, ANN BOOK ASTM STAND, P817
   Arciniegas M, 2013, J BIOMED MATER RES B, V101B, P709, DOI 10.1002/jbm.b.32873
   Arciniegas M, 2008, PHILOS MAG, V88, P2529, DOI 10.1080/14786430802375667
   ASTM, 2004, ANN BOOK ASTM STAND
   Balakrishnan A., 2008, TRENDS BIOMATER ARTI, V2, P58
   Duering TW, 1990, ENG ASPECTS SHAPE ME
   Gonzalez M, 2011, J MATER ENG PERFORM, V20, P653, DOI 10.1007/s11665-011-9917-0
   Gonzalez M, 2009, J MATER ENG PERFORM, V18, P506, DOI 10.1007/s11665-009-9393-y
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Hao Y.L., 2007, Titanium alloy with extra-low modulus and superelasticity and its producing method and processing thereof, Patent No. [US 2007/0137742 al, 20070137742]
   Hao Y.L., 2005, APPL PHYS LETT, V87, P1
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mishra R, 2004, CORROS SCI, V46, P3019, DOI 10.1016/j.corsci.2004.04.007
   MOFFAT DL, 1988, METALL TRANS A, V19, P1687, DOI 10.1007/BF02645136
   Mohammadi S, 2001, J MATER SCI-MATER M, V12, P603, DOI 10.1023/A:1011237610299
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   NIINOMI M., 1998, MAT SCI ENG A-STRUCT, V243, P243
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Ridzwan M. I. Z, 2007, J MED SCI, V7, P460
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   Wang BL, 2009, MATER CORROS, V60, P788, DOI 10.1002/maco.200805173
   Wang B.L., 2010, BIOMED MATER, V5, P1
   Zander D, 2004, MAT SCI ENG A-STRUCT, V375, P53, DOI 10.1016/j.msea.2003.10.230
NR 27
TC 13
Z9 13
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2014
VL 42
BP 691
EP 695
DI 10.1016/j.msec.2014.06.010
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA AN6EJ
UT WOS:000340687400087
PM 25063170
DA 2018-10-20
ER

PT J
AU Ramadan, Y
   Gonzalez-Sanchez, MI
   Hawkins, K
   Rubio-Retama, J
   Valero, E
   Perni, S
   Prokopovich, P
   Lopez-Cabarcos, E
AF Ramadan, Yousof
   Isabel Gonzalez-Sanchez, M.
   Hawkins, Karl
   Rubio-Retama, Jorge
   Valero, Edelmira
   Perni, Stefano
   Prokopovich, Polina
   Lopez-Cabarcos, Enrique
TI Obtaining new composite biomaterials by means of mineralization of
   methacrylate hydrogels using the reaction-diffusion method
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Composite materials; Reaction diffusion; Brushite particles; Hydrogels;
   Bone regeneration material
ID SPATIALLY CONFINED PRECIPITATION; PERIODIC PATTERN-FORMATION; GLUCOSE
   SENSORS; GENE-TRANSFER; BIOMINERALIZATION; AUGMENTATION; POLYPLEXES;
   MICROGELS; DELIVERY; OXIDASE
AB The present paper describes the synthesis and characterization of a new polymeric biomaterial mineralized with calcium phosphate using the reaction-diffusion method. The scaffold of this biomaterial was a hydrogel constituted by biocompatible polyethylene glycol methyl ether methacrylate (PEGMEM) and 2-(dimethylamino)ethyl methacrylate (DMAEM), which were cross-linked with N-N'-methylenebisacrylamide (BIS). The cross-linking content of the hydrogels was varied from 0.25% to 15% (w/w). The gels were used as matrix where two reactants (Na2HPO4 and CaCl2) diffused from both ends of the gel and upon encountering produced calcium phosphate crystals that precipitated within the polymer matrix forming bands. The shape of the crystals was tuned by modifying the matrix porosity in such a way that when the polymer matrix was slightly reticulated the diffusion reaction produced round calcium phosphate microcrystals, whilst when the polymer matrix was highly reticulated the reaction yielded flat calcium phosphate crystals. Selected area electron diffraction performed on the nanocrystals that constitute the microcrystals showed that they were formed by Brushite (CaHPO4 center dot 2H(2)O). This new composite material could be useful in medical and dentistry applications such as bone regeneration, bone repair or tissue engineering. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ramadan, Yousof; Rubio-Retama, Jorge; Lopez-Cabarcos, Enrique] Univ Complutense Madrid, Fac Pharm, Dept Phys Chem 2, E-28040 Madrid, Spain.
   [Isabel Gonzalez-Sanchez, M.; Valero, Edelmira] Castilla La Mancha Univ, Sch Ind Engn, Dept Phys Chem, Albacete 02071, Spain.
   [Hawkins, Karl] Swansea Univ, Ctr Nanohlth, Inst Life Sci, Coll Med, Swansea SA2 8PP, W Glam, Wales.
   [Perni, Stefano; Prokopovich, Polina] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff CF10 3NB, S Glam, Wales.
   [Prokopovich, Polina] Cardiff Univ, Inst Med Engn & Med Phys, Cardiff CF10 3AX, S Glam, Wales.
   [Perni, Stefano; Prokopovich, Polina] MA Inst Technol, Dept Biol Engn, Cambridge, MA USA.
RP Lopez-Cabarcos, E (reprint author), Univ Complutense Madrid, Fac Pharm, Dept Phys Chem 2, E-28040 Madrid, Spain.
EM cabarcos@farm.ucm.es
RI Perni, Stefano/B-8158-2009; Farrag, Yousof/M-7660-2018; Lopez Cabarcos,
   Enrique/L-5802-2014; GONZALEZ SANCHEZ, MARIA ISABEL/M-4223-2015;
   Rubio-Retama, Jorge/L-4262-2014
OI Perni, Stefano/0000-0002-3101-0098; Farrag, Yousof/0000-0003-1715-8157;
   Lopez Cabarcos, Enrique/0000-0003-2939-4130; GONZALEZ SANCHEZ, MARIA
   ISABEL/0000-0002-7390-5420; Rubio-Retama, Jorge/0000-0002-1785-5844;
   Hawkins, Karl/0000-0003-0174-4151; Prokopovich,
   Polina/0000-0002-5700-9570
FU Spanish Science and Innovation Ministry [MAT2010-15349]; Arthritis
   Research UK [ARUK:18461]; Regional Ministry of Science and Technology
   (Consejeria de Ciencia y Tecnologia) [POII-10-0235-8597]; Regional
   Ministry of Science and Technology (JCCM, Spain) [POII-10-0235-8597]; 
   [COST Action CM1101]
FX The authors acknowledge financial support from the Spanish Science and
   Innovation Ministry (Grant MAT2010-15349), from the Regional Ministry of
   Science and Technology (Consejeria de Ciencia y Tecnologia; JCCM, Spain)
   (POII-10-0235-8597) and from COST Action CM1101. PP also thanks
   Arthritis Research UK (ARUK:18461) for the financial support.
CR Bos GW, 2000, INT J PHARM, V211, P79, DOI 10.1016/S0378-5173(00)00593-7
   Cabarcos EL, 1996, PHYS REV LETT, V77, P2834
   CHOPARD B, 1994, PHYS REV LETT, V72, P1384, DOI 10.1103/PhysRevLett.72.1384
   Cursaru B., 2010, UPB SCI B B, V72
   da Silva MS, 2011, INT J PHARMACEUT, V416, P61, DOI 10.1016/j.ijpharm.2011.06.004
   Fernandez E, 2005, POLYMER, V46, P2211, DOI 10.1016/j.polymer.2004.12.039
   Henisch H.K., 1988, CRYSTALS GELS LIESEG
   Henry V. K., 1994, CRC HDB THERMOPHYSIC
   Huang JJ, 2012, CHEM MATER, V24, P1331, DOI 10.1021/cm203764f
   KAI S, 1982, J CHEM PHYS, V76, P1392, DOI 10.1063/1.443131
   Kaner D, 2011, J CLIN PERIODONTOL, V38, P95, DOI 10.1111/j.1600-051X.2010.01630.x
   KARPATISMIDROCZKI E, 1995, COLLOID POLYM SCI, V273, P857, DOI 10.1007/BF00657635
   Kuo CS, 1997, PHYSICA A, V239, P390, DOI 10.1016/S0378-4371(96)00494-3
   Leeuwenburgh Sander C.G., 2010, BIOMACROMOLECULES, V11, P2653
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Li HY, 2007, J AM CHEM SOC, V129, P5480, DOI 10.1021/ja067901d
   Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583
   Mann S, 2001, BIOMINERALIZATION PR
   Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8
   Murayama E, 2002, EUR J BIOCHEM, V269, P688, DOI 10.1046/j.0014-2956.2001.02701.x
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Retama JR, 2003, BIOMATERIALS, V24, P2965, DOI 10.1016/S0142-9612(03)00095-4
   Retama JR, 2008, MACROMOLECULES, V41, P4739, DOI 10.1021/ma800668t
   Serrano-Ruiz D, 2010, J POLYM SCI POL PHYS, V48, P1668, DOI 10.1002/polb.22049
   Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y
   Sohier J, 2010, ACTA BIOMATER, V6, P2932, DOI 10.1016/j.actbio.2010.02.013
   Suetoh Y, 2000, POLYMER, V41, P505, DOI 10.1016/S0032-3861(99)00175-5
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tamimi FM, 2006, J CLIN PERIODONTOL, V33, P922, DOI 10.1111/j.1600-051X.2006.01004.x
   Teng SH, 2006, COLLOID SURFACE B, V49, P87, DOI 10.1016/j.colsurfb.2006.03.005
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Verbaan F, 2003, EUR J PHARM SCI, V20, P419, DOI 10.1016/j.ejps.2003.09.005
   Verbaan FJ, 2005, INT J PHARM, V304, P185, DOI 10.1016/j.ijpharm.2005.07.018
   Wang K, 2010, INT J PHARMACEUT, V389, P130, DOI 10.1016/j.ijpharm.2010.01.026
   Watanabe J, 2007, BIOMACROMOLECULES, V8, P2288, DOI 10.1021/bm0702915
   Yokoi T, 2010, MAT SCI ENG C-MATER, V30, P154, DOI 10.1016/j.msec.2009.09.012
   Yoshida H., 1993, J THERM ANAL, V40, P489
NR 38
TC 3
Z9 3
U1 4
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD SEP 1
PY 2014
VL 42
BP 696
EP 704
DI 10.1016/j.msec.2014.06.017
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AN6EJ
UT WOS:000340687400088
PM 25063171
DA 2018-10-20
ER

PT J
AU Conconi, MT
   Borgio, L
   Di Liddo, R
   Sartore, L
   Dalzoppo, D
   Amista, P
   Lora, S
   Parnigotto, PP
   Grandi, C
AF Conconi, Maria Teresa
   Borgio, Luca
   Di Liddo, Rosa
   Sartore, Leonardo
   Dalzoppo, Daniele
   Amista, Pietro
   Lora, Silvan
   Parnigotto, Pier Paolo
   Grandi, Claudio
TI Evaluation of vascular grafts based on polyvinyl alcohol cryogels
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article
DE polyvinyl alcohol; vascular tissue engineering; scaffold; decellularized
   matrix; vascular graft
ID BLOOD-VESSELS; HYDROGELS; MODEL; FLOW
AB The present study designed and developed blood vessel substirutes (BVSs) composed of polyvinyl alcohol (PVA) cryogels. The in vitro results demonstrated that the coating of the polymer with lyophilized decellularized vascular matrix (DVM) greatly enhanced the adhesion of human umbilical vein endothelial cells (HUVECs). However, when PVA/DVM BVSs were implanted into the abdominal aorta of Sprague-Dawley rats, DV M was identified as a highly thrombogenic surface resulting in the mortality of all animals 3-4 days after surgery. By contrast, all rats implanted with PVA survived and were sacrificed after 12 months. The luminal surface of the explanted grafts was completely covered by endothelial cells and the inner diameter was similar to that of the original vessel. In conclusion, the present study indicated that PVA may be considered as a promising biomaterial for the fabrication of artificial vessels.
C1 [Conconi, Maria Teresa; Borgio, Luca; Di Liddo, Rosa; Dalzoppo, Daniele; Grandi, Claudio] Univ Padua, Dept Pharmaceut & Pharmacol Sci, I-35131 Padua, Italy.
   [Borgio, Luca; Lora, Silvan; Parnigotto, Pier Paolo] TES Tissue Engn & Signaling ONLUS, Fdn Biol & Regenerat Med, I-35131 Padua, Italy.
   [Amista, Pietro] Hosp Rovigo, Dept Neuroradiol, I-45100 Rovigo, Italy.
   [Sartore, Leonardo] Univ Padua, Dept Plast & Reconstruct Surg, I-35131 Padua, Italy.
RP Grandi, C (reprint author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy.
EM claudio.grandi@unipd.it
CR Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Cascone MG, 2001, J BIOMAT SCI-POLYM E, V12, P267, DOI 10.1163/156856201750180807
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   Conconi MT, 2009, J BIOMED MATER RES A, V89A, P304, DOI 10.1002/jbm.a.31982
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Grandi C, 2011, INT J MOL MED, V28, P947, DOI 10.3892/ijmm.2011.776
   Grandi C, 2011, INT J MOL MED, V28, P315, DOI 10.3892/ijmm.2011.720
   Hung HS, 2011, CELL TRANSPLANT, V20, P63, DOI 10.3727/096368910X532864
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   King DM, 2011, ULTRASOUND MED BIOL, V37, P813, DOI 10.1016/j.ultrasmedbio.2011.02.012
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   Mathews DT, 2008, J BIOMED MATER RES B, V84B, P531, DOI 10.1002/jbm.b.30901
   MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8
   MIYAKE H, 1984, Microsurgery, V5, P144, DOI 10.1002/micr.1920050310
   Nemeno-Guanzon JG, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/956345
   O'Flynn PM, 2005, ASAIO J, V51, P426, DOI 10.1097/01.mat.0000170629.92765.bb
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Stephan S, 2006, J ANAT, V209, P495, DOI 10.1111/j.1469-7580.2006.00633.x
   TAMURA K, 1985, BIOMATER ARTIF CELL, V13, P133, DOI 10.3109/10731198509118847
   Thomas LV, 2013, INT J CARDIOL, V167, P1091, DOI 10.1016/j.ijcard.2012.09.069
   Thomas LV, 2009, J MATER SCI-MATER M, V20, P259, DOI 10.1007/s10856-008-3599-7
   Udelsman BV, 2013, HEART, V99, P454, DOI 10.1136/heartjnl-2012-302984
   Vrana NE, 2010, J BIOMED MATER RES A, V94A, P1080, DOI 10.1002/jbm.a.32790
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
NR 24
TC 3
Z9 3
U1 0
U2 12
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD SEP
PY 2014
VL 10
IS 3
BP 1329
EP 1334
DI 10.3892/mmr.2014.2348
PG 6
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA AN8LA
UT WOS:000340854500021
PM 24969541
DA 2018-10-20
ER

PT J
AU Mohammadi, S
   Postnikoff, C
   Wright, AM
   Gorbet, M
AF Mohammadi, Saman
   Postnikoff, Cameron
   Wright, Ann M.
   Gorbet, Maud
TI Design and Development of an In Vitro Tear Replenishment System
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Tear replenishment; Artificial tear solution; In vitro cornea model;
   Micro-fluidic system; Ophthalmic biomaterial
ID CORNEAL EPITHELIAL-CELLS; CONTACT-LENS MATERIALS; MULTIPURPOSE
   SOLUTIONS; SILICONE HYDROGEL; CULTURE MODELS; EYE IRRITATION;
   BIOCOMPATIBILITY; VIABILITY; RELEASE
AB Understanding the cellular and molecular mechanisms of the corneal tissue and translating them into effective therapies requires organotypic culture systems that can better model the physiological conditions of the front of the eye. Human corneal in vitro models currently exist, however, the lack of tear replenishment limits corneal in vitro models' ability to accurately simulate the physiological environment of the human cornea. The tear replenishment system (TRS), a micro-fluidic device, was developed to mimic the in vivo tear replenishment in the human eye in an in vitro corneal model. The TRS is capable of generating adjustable intermittent flow from 0.1 A mu L in every cycle. The TRS is a sterilizable device that is designed to fit standard 6-well cell culture plates. Experiments with the corneal models demonstrated that exposure to the TRS did not damage the integrity of the stratified cell culture. Contact lenses "worn" by the in vitro corneal model also remained moist at all times and the cytotoxicity of BAK could also be verified using this model. These in vitro results confirmed that the TRS presents novel avenues to assess lens-solution biocompatibility and drug delivery systems in a physiologically relevant milieu.
C1 [Mohammadi, Saman; Postnikoff, Cameron; Gorbet, Maud] Univ Waterloo, Waterloo, ON N2L 3G1, Canada.
   [Wright, Ann M.] Alcon CIBAVis, Duluth, GA USA.
   [Gorbet, Maud] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON N2L 3G1, Canada.
RP Gorbet, M (reprint author), Univ Waterloo, 200 Univ Ave, Waterloo, ON N2L 3G1, Canada.
EM mgorbet@uwaterloo.ca
FU Natural Sciences and Engineering Research Council of Canada; Alcon
FX The funding for this project was provided by the Natural Sciences and
   Engineering Research Council of Canada and CibaVision (now Alcon).
   Authors also would like to thank Jason Benninger for his technical
   assistance in the manufacturing of the microfluidics parts and
   Christopher Amos from CIBA Vision for fruitful discussion related to the
   development of this in vitro model.
CR Baca JT, 2007, OCUL SURF, V5, P280, DOI 10.1016/S1542-0124(12)70094-0
   Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001
   Castro-Munozledo F, 2008, EXP EYE RES, V86, P459, DOI 10.1016/j.exer.2007.11.017
   Cavet ME, 2012, CONTACT LENS ANTERIO, V35, P163, DOI 10.1016/j.clae.2012.02.003
   Cavet ME, 2010, CONTACT LENS ANTERIO, V33, pS18, DOI 10.1016/j.clae.2010.06.012
   Chalmers RL, 2012, OPTOMETRY VISION SCI, V89, P316, DOI 10.1097/OPX.0b013e318240c7ff
   Chalmers RL, 2011, INVEST OPHTH VIS SCI, V52, P6690, DOI 10.1167/iovs.10-7018
   Chu MX, 2011, BIOMED MICRODEVICES, V13, P603, DOI 10.1007/s10544-011-9530-x
   Debbasch C, 2005, FOOD CHEM TOXICOL, V43, P155, DOI 10.1016/j.fct.2004.09.004
   Geerling G, 2001, INVEST OPHTH VIS SCI, V42, P948
   Gorbet MB, 2011, MOL VIS, V17, P3458
   Gorbet MB, 2010, MOL VIS, V16, P272
   Griffith M., 2003, USA patent, Patent No. 6645715
   Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009
   Hui A, 2008, EYE CONTACT LENS, V34, P266, DOI 10.1097/ICL.0b013e3181812ba2
   Jacob J., 2013, BIOMATERIALS SCI INT, P909
   Keay L., 2007, EYE CONTACT LENS, V33, P62
   Keay Lisa, 2007, Eye Contact Lens, V33, P346, DOI 10.1097/ICL.0b013e318157c49d
   KLYCE SD, 1972, J PHYSIOL-LONDON, V226, P407, DOI 10.1113/jphysiol.1972.sp009991
   Lefebvre A. H., 1989, ATOMIZATION SPRAYS
   Lehmann DM, 2010, TOXICOL IN VITRO, V24, P1306, DOI 10.1016/j.tiv.2010.02.018
   Lim MJ, 2009, EYE CONTACT LENS, V35, P287, DOI 10.1097/ICL.0b013e3181b9e92c
   Lorentz H, 2012, OPTOMETRY VISION SCI, V89, P856, DOI 10.1097/OPX.0b013e318255ddc8
   Mansouri K, 2012, ARCH OPHTHALMOL-CHIC, V130, P1534, DOI [10.1001/archophthalmol.2012.2280, 10.1001/jamaophthalmol.2013.1350]
   MISHIMA S., 1966, INVEST OPHTHALMOL, V5, P264
   MITRA AK, 2003, OPHTHALMIC DRUG DELI
   Mohammadi S., 2013, INVESTIG OPHTHALMOL, V53
   Morgan PB, 2010, CONTACT LENS ANTERIO, V33, P196, DOI 10.1016/j.clae.2009.12.011
   Mowrey-McKee Mary, 2002, CLAO Journal, V28, P160
   Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992
   Postnikoff CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096448
   Powell CH, 2010, CONTACT LENS ANTERIO, V33, P9, DOI 10.1016/j.clae.2009.10.006
   Reichl S, 2004, BRIT J OPHTHALMOL, V88, P560, DOI 10.1136/bjo.2003.028225
   Reichl S, 2011, EXPERT OPIN DRUG MET, V7, P559, DOI 10.1517/17425255.2011.562195
   Sanchez I, 2011, INVEST OPHTH VIS SCI, V52, P8310, DOI 10.1167/iovs.10-7064
   Sjoquist B, 2002, SURV OPHTHALMOL, V47, pS6, DOI 10.1016/S0039-6257(02)00302-8
   Soluri A, 2012, OPTOMETRY VISION SCI, V89, P1140, DOI 10.1097/OPX.0b013e3182639dc8
   TIFFANY JM, 1989, CURR EYE RES, V8, P507, DOI 10.3109/02713688909000031
   TIFFANY JM, 1991, INT OPHTHALMOL, V15, P371, DOI 10.1007/BF00137947
   Whitson JT, 2012, ADV THER, V29, P874, DOI 10.1007/s12325-012-0057-1
   Xiang CD, 2009, DRUG METAB DISPOS, V37, P992, DOI 10.1124/dmd.108.026286
   Yao HF, 2011, BIOSENS BIOELECTRON, V26, P3290, DOI 10.1016/j.bios.2010.12.042
   York M, 1998, J APPL TOXICOL, V18, P233, DOI 10.1002/(SICI)1099-1263(199807/08)18:4<233::AID-JAT496>3.0.CO;2-Y
NR 43
TC 6
Z9 6
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD SEP
PY 2014
VL 42
IS 9
BP 1923
EP 1931
DI 10.1007/s10439-014-1045-1
PG 9
WC Engineering, Biomedical
SC Engineering
GA AN2DN
UT WOS:000340394100012
PM 24923378
DA 2018-10-20
ER

PT J
AU Asadi-Eydivand, M
   Solati-Hashjin, M
   Farzadi, A
   Abu Osman, NA
AF Asadi-Eydivand, Mitra
   Solati-Hashjin, Mehran
   Farzadi, Arghavan
   Abu Osman, Noor Azuan
TI Artificial neural network approach to estimate the composition of
   chemically synthesized biphasic calcium phosphate powders
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biphasic calcium phosphate; Chemical processing; Calcium to phosphate
   ratio; Artificial neural network
ID MICROWAVE-ASSISTED SYNTHESIS; LEVENBERG-MARQUARDT; BEHAVIOR;
   HYDROXYAPATITE; ALGORITHM; ALLOY; BONE; ORTHOPHOSPHATES; BIOCERAMICS;
   PERFORMANCE
AB Calcium phosphates ceramics are widely used as implants and scaffolds in different orthopedic and dental applications. Major chemical and physical properties of these bioceramics; such as solubility, biodegradation, and mechanical behavior; are dependent on their structures, which in turn are mostly determined by the calcium to phosphate (Ca/P) ratio in their empirical formula In this study, the Ca/P ratio of wet chemically synthesized calcium phosphate powders was estimated using a three-layered back-propagation neural network (BPNN). Biphasic calcium phosphate (BCP) samples were synthesized via wet chemical method to prepare the training and testing data sets. The pH and Ca/P ratio of the reactants were considered as inputs and the Ca/P ratio of the products was considered as the output parameter. BPNN was then optimized by changing the number of samples for each stage and the number of hidden layer neurons. The accuracy of the optimized network was tested using additional empirical samples that had not been used in the training stage. The synthesized powders were characterized by X-ray diffraction and Fourier transform infrared spectroscopy techniques. Comparing the results of the predicted values and the experimental data indicate that the developed model has an acceptable accuracy in estimating the Ca/P ratio of the BCP powders, and that a proper correlation between the actual and calculated values exists. By predicting the Ca/P, synthesis condition can be tailored to obtain desired properties according to the biomaterial application requirements. (C) 2014 The Authors. Published by Elsevier Ltd.
C1 [Asadi-Eydivand, Mitra; Solati-Hashjin, Mehran; Farzadi, Arghavan; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
RP Asadi-Eydivand, M (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
EM mitra@um.edu.my
RI ABU OSMAN, NOOR AZUAN/B-9265-2010
OI ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Solati-Hashjin,
   Mehran/0000-0002-1187-1237
FU University of Malaya [UM.C/HIR/MOHE/ENG/10 D000010-16001]
FX This study was supported by High Impact Research Grant
   UM.C/HIR/MOHE/ENG/10 D000010-16001 from the University of Malaya.
CR Abbassi F., 2012, MAT DES
   Aguir H, 2011, MATER DESIGN, V32, P48, DOI 10.1016/j.matdes.2010.06.039
   Alosarczyk A., 1996, J AM CERAM SOC, V79, P2539
   Aminian A, 2011, CERAM INT, V37, P1219, DOI 10.1016/j.ceramint.2010.11.044
   Asadi-Eydivand M., 2012, BIOM ENG SCI IECBES, P90
   Choi DW, 2004, MATER RES BULL, V39, P417, DOI 10.1016/j.materresbull.2003.10.013
   Costa MA, 2007, NEUROCOMPUTING, V70, P1342, DOI 10.1016/j.neucom.2006.09.003
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Dua V, 2011, COMPUT CHEM ENG, V35, P545, DOI 10.1016/j.compchemeng.2010.06.005
   El-Mallawany R, 2014, CERAM INT, V40, P7389, DOI 10.1016/j.ceramint.2013.12.084
   Eslami H., 2008, IRAN J PHARM SCI, V4, P127
   Eslami H, 2008, J CERAM PROCESS RES, V9, P224
   Eslami M., 2010, MAT SCI POL, V28
   Evis Z, 2011, CERAM INT, V37, P1147, DOI 10.1016/j.ceramint.2010.10.037
   Farzadi A, 2010, CERAM TRANS, V218, P59
   Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021
   Fernandez E, 1999, J MATER SCI-MATER M, V10, P169, DOI 10.1023/A:1008937507714
   Gueddar T, 2011, COMPUT CHEM ENG, V35, P1838, DOI 10.1016/j.compchemeng.2011.04.016
   Haghdadi N, 2013, MATER DESIGN, V49, P386, DOI 10.1016/j.matdes.2012.12.082
   Hao Z, 2004, FUEL PROCESS TECHNOL, V85, P113, DOI 10.1016/S0378-3820(03)00155-3
   Haykin S., 2004, NEURAL NETWORKS, V2, P1
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hsu CK, 2003, MATER CHEM PHYS, V80, P409, DOI 10.1016/S0254-0584(02)00166-9
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Karthikeyan S, 2014, CERAM INT, V40, P3171, DOI 10.1016/j.ceramint.2013.09.125
   Kasperkiewicz J, 2000, J MATER PROCESS TECH, V106, P74, DOI 10.1016/S0924-0136(00)00641-5
   KhalaJ G, 2014, CERAM INT, V40, P5515, DOI 10.1016/j.ceramint.2013.10.141
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Li Q, 2006, MAT SCI ENG A-STRUCT, V419, P214, DOI 10.1016/j.msea.2005.12.027
   Liu Y, 2012, DESALINATION, V289, P66, DOI 10.1016/j.desal.2012.01.011
   Lukic M, 2011, J EUR CERAM SOC, V31, P19, DOI 10.1016/j.jeurceramsoc.2010.09.006
   Manjubala I, 2001, MATER CHEM PHYS, V71, P272, DOI 10.1016/S0254-0584(01)00293-0
   MOORE DC, 1987, J ORTHOP RES, V5, P356, DOI 10.1002/jor.1100050307
   Mukherjee I, 2012, EXPERT SYST APPL, V39, P2397, DOI 10.1016/j.eswa.2011.08.087
   Nazari A, 2013, CERAM INT, V39, P2247, DOI 10.1016/j.ceramint.2012.08.070
   Paliwal M, 2009, EXPERT SYST APPL, V36, P2, DOI 10.1016/j.eswa.2007.10.005
   Parhi P, 2004, MATER LETT, V58, P3610, DOI 10.1016/j.matlet.2004.06.056
   Pasand EG, 2012, INT J MIN MET MATER, V19, P441, DOI 10.1007/s12613-012-0576-4
   Pouraliakbar H., 2014, CERAM INT
   PourAsiabi H, 2012, MATER DESIGN, V35, P782, DOI 10.1016/j.matdes.2011.09.052
   RADIN SR, 1993, J BIOMED MATER RES, V27, P35, DOI 10.1002/jbm.820270106
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   S. Samarasinghe Neural Networks for Applied Sciences and Engineering, 2006, NEURAL NETWORKS APPL
   Santos Maria Helena, 2004, Mat. Res., V7, P625, DOI 10.1590/S1516-14392004000400017
   Shojaeefard M.H., 2012, MATER DESIGN, V44, P190
   Sinha A, 2013, MATER DESIGN, V46, P227
   Sun Y, 2011, MATER DESIGN, V32, P1537, DOI 10.1016/j.matdes.2010.10.004
   Tavangarian F, 2010, INT J MOD PHYS B, V24, P3365, DOI 10.1142/S0217979210055329
   Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574
   Willumeit R, 2013, ACTA BIOMATER, V9, P8722, DOI 10.1016/j.actbio.2013.02.042
   Xu YJ, 2014, CERAM INT, V40, P5425, DOI 10.1016/j.ceramint.2013.10.125
   YEGNANARAYANA B, 1994, SADHANA-ACAD P ENG S, V19, P189, DOI 10.1007/BF02811896
   Yilmaz I, 2011, EXPERT SYST APPL, V38, P5958, DOI 10.1016/j.eswa.2010.11.027
   Yin F, 2011, MATER DESIGN, V32, P3457, DOI 10.1016/j.matdes.2011.01.058
   Zou L.-H, 2012, J THEOR APPL INF TEC, V44
NR 56
TC 7
Z9 8
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD SEP
PY 2014
VL 40
IS 8
BP 12439
EP 12448
DI 10.1016/j.ceramint.2014.04.095
PN A
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA AN1FR
UT WOS:000340328600117
OA Other Gold
DA 2018-10-20
ER

PT J
AU Kramer, E
   Itzkowitz, E
   Wei, M
AF Kramer, Erica
   Itzkowitz, Emily
   Wei, Mei
TI Synthesis and characterization of cobalt-substituted hydroxyapatite
   powders
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Hydroxyapatite; Nanoparticles; Ion-exchange; Paramagnetic; Biomaterial
ID PH-CYCLING METHOD; MAGNETIC NANOPARTICLES; EXCHANGED HYDROXYAPATITE;
   CALCIUM HYDROXYAPATITE; CRYSTAL-STRUCTURE; IONS
AB The crystal structure of hydroxyapatite lends itself to a wide variety of substitutions and ion doping, which allows for tailoring of material properties. Magnetic properties are one area of interest in which substitutions can be used to tailor hydroxyapatite properties. Pure HA is. diamagnetic, but metal ion doping may lead to a magnetic apatite. In this study, cobalt doped hydroxyapatite Was synthesized via two methods: a simple ion-exchange procedure and wet synthesis. The resulting materials were characterized thoroughly for crystal structure and phase purity using X-ray diffraction, energy-dispersive X-ray spectroscopy, and Fourier transform infrared spectroscopy. Magnetic properties were studied using vibrating sample magnetometer and superconducting quantum interference device analysis. The degradation behavior and cobalt release of pure HA and CoHA in simulated body fluid was also examined. The results showed that after both cobalt substitution methods the powder retained characteristic apatite crystal structure and functional groups. Cobalt substituted samples displayed paramagnetic properties, as opposed to the diamagnetism of pure HA. Degradation studies showed that CoHA did not display markedly different degradation behavior from pure HA and the amount of cobalt released over the course of a month was extremely low, alleviating toxicity concerns. Cobalt substituted hydroxyapatite nanoparticles, a biomaterial with magnetic properties, could be a promising material to be used in a variety of biomedical applications, including magnetic imaging, drug delivery, or hyperthermia based cancer treatments. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Kramer, Erica; Wei, Mei] Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Itzkowitz, Emily] Univ Connecticut, Sch Engn, Storrs, CT 06269 USA.
RP Wei, M (reprint author), Univ Connecticut, Inst Mat Sci, Dept Mat Sci & Engn, 97 North Eagleville Rd, Storrs, CT 06269 USA.
EM mei.wei@uconn.edu
FU U.S. Department of Education [P200A09315]; National Science Foundation
   [BES 0503315, CBET-1133883]
FX The authors would like to thank the U.S. Department of Education
   Graduate Assistance in Areas of National Need (GAANN) Fellowship Program
   (P200A09315) and National Science Foundation (BES 0503315 and
   CBET-1133883) for their support of the research. They would also like to
   thank Dr. William Hines for his assistance with the SQUID equipment and
   Michael Zilm for his assistance with XPS.
CR Biji A., 2007, INORG CHIM ACTA, V360, P1009
   Billotte WG, 2003, BIOMATERIALS PRINCIP, P21
   BORODKO YG, 1976, CHEM PHYS LETT, V42, P264, DOI 10.1016/0009-2614(76)80360-0
   Browning E, 1969, TOXICITY IND METALS
   Carson B. L, 1986, TOXICOLOGY BIOL MONI
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Cheng ZH, 1998, LANGMUIR, V14, P6681, DOI 10.1021/la980339n
   Dorozhkin S.V., 2004, J MATER CHEM, V14, P2148
   Duguet E, 2006, NANOMEDICINE-UK, V1, P157, DOI 10.2217/17435889.1.2.157
   Elkabouss K, 2004, J CATAL, V226, P16, DOI 10.1016/j.jcat.2004.05.007
   Gross K.A., 2002, EUR CELLS MATER, V3, P114
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Ignjatovic N, 2013, J MATER SCI-MATER M, V24, P343, DOI 10.1007/s10856-012-4793-1
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jia M., 2013, MAT SCI ENG C, V33, P2388
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Kramer ER, 2013, J MATER SCI, V48, P665, DOI 10.1007/s10853-012-6779-2
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Markides H, 2012, J NANOMATER, V2012, P13, DOI [10.1155/2012/614094, DOI 10.1155/2012/614094]
   Martini F, 2006, FUNDAMENTALS ANATOMY
   Morrissey R, 2005, J MATER SCI-MATER M, V16, P387, DOI 10.1007/s10856-005-6976-5
   Moseke C, 2013, MAT SCI ENG C-MATER, V33, P1654, DOI 10.1016/j.msec.2012.12.075
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Patel N., 2005, Journal of the Australasian Ceramic Society, V41, P1
   Prakash K. H., 2006, Molecular & Cellular Biomechanics, V3, P177
   Qu H, 2005, J MATER SCI-MATER M, V16, P447, DOI 10.1007/s10856-005-6985-4
   Qu H, 2005, J MATER SCI-MATER M, V16, P129, DOI 10.1007/s10856-005-5943-5
   Stojanovic Z, 2009, MATER MANUF PROCESS, V24, P1096, DOI 10.1080/10426910903032113
   Tank KP, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1644-z
   Tkaczyk Cathy, 2010, Open Orthop J, V4, P221, DOI 10.2174/1874325001004010221
   Veselinovic L, 2010, J APPL CRYSTALLOGR, V43, P320, DOI 10.1107/S0021889809051395
   Wang H.A., 2007, NANOTECHNOLOGY, V18
   Wang J, 2008, J MATER SCI-MATER M, V19, P2663, DOI 10.1007/s10856-007-3365-2
   Wei M, 2002, BIOMATERIALS, V23, P167, DOI 10.1016/S0142-9612(01)00092-8
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
NR 37
TC 10
Z9 10
U1 6
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD SEP
PY 2014
VL 40
IS 8
BP 13471
EP 13480
DI 10.1016/j.ceramint.2014.05.072
PN B
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA AN1CW
UT WOS:000340321300109
DA 2018-10-20
ER

PT J
AU Guo, TL
   Shi, F
   Zhang, BJ
   Li, JY
   Wang, DW
   Xiao, DQ
   Duan, RQ
   Zhi, W
   Zheng, YY
   Weng, J
AF Guo, Tailin
   Shi, Feng
   Zhang, Bingjun
   Li, Jinyu
   Wang, Dongwei
   Xiao, Dongqin
   Duan, Rongquan
   Zhi, Wei
   Zheng, Yuanyuan
   Weng, Jie
TI Modulating cellular behaviors on completely dense hydroxyapatite through
   biomimic pits
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomimic pit; Dense hydroxyapatite; Dense HA; Osteoinduction; Micro/Nano
   topography
ID CALCIUM-PHOSPHATE CERAMICS; MESENCHYMAL STEM-CELLS; BONE;
   DIFFERENTIATION; BIOMATERIALS; SHAPE
AB Since biomaterial surfaces and their micro and nano structures significantly influence cellular behavior, manipulating the surface characteristics of hydroxyapatite (HA) might potentiallyrepresent a strategy to control cell function. In this study, pure hydroxyapatite with varying microporosity, e.g.,1 +/- 0.3% translucent HA(T-HA), 7 +/- 0.8% dense HA(D-HA), and 26 +/- 1% porous HA(P-HA), were prepared, and biomimic pits were then produced by polishing T-HA and D-HA. The effect of surface pits on cellular behavior was further investigated by analyzing cell adhesion, in addition to cell proliferation and differentiation by co-culturing the materials with MC3T3-E1 cells. We found that the completely dense HA with micropits had the same capacity for cell adhesion, spreading and proliferation, and had a greater capacity for cellular differentiation in vitro than porous HA. Therefore, we believe that polished high-strength, completely dense HA has marked potential in the biomedical applications of tissue engineering due in part to its mechanical and osteoinducible properties. (C) 2014 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Guo, Tailin; Shi, Feng; Zhang, Bingjun; Li, Jinyu; Wang, Dongwei; Xiao, Dongqin; Duan, Rongquan; Zhi, Wei; Weng, Jie] Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
   [Guo, Tailin; Zheng, Yuanyuan] Southwest Jiaotong Univ, Sch Life Sci & Engn, Chengdu 610031, Peoples R China.
RP Weng, J (reprint author), Southwest Jiaotong Univ, Key Lab Adv Technol Mat, Minist Educ, Sch Mat Sci & Engn, Chengdu 610031, Peoples R China.
EM jweng@swjtu.cn
RI Weng, Jie/B-3005-2010
FU National Basic Research Program of China [2012CB933602]; National
   Natural Science Foundation of China [51172188]; Science and Technology
   Pillar Project of Sichuan [2010FZ0048]; Fundamental Research Funds for
   the Central Universities [2682013CX034]
FX This work is supported by the National Basic Research Program of China
   (2012CB933602); the National Natural Science Foundation of
   China(51172188); the Science and Technology Pillar Project of Sichuan
   (2010FZ0048); and the Fundamental Research Funds for the Central
   Universities (2682013CX034).
CR Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Boyan BD, 2011, NAT REV RHEUMATOL, V7, P8, DOI 10.1038/nrrheum.2010.210
   Caria PHF, 2007, J ORAL MAXIL SURG, V65, P847, DOI 10.1016/j.joms.2006.05.059
   Chaudhry AA, 2011, ACTA BIOMATER, V7, P791, DOI 10.1016/j.actbio.2010.09.029
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 2000, CURR ORTHOPAED, V14, P7, DOI 10.1054/cuor.1999.0074
   Hui-Tao L., 2013, J INORG MATER, V28, P5
   Keenan MJ, 1997, J BONE MINER RES, V12, P1903, DOI 10.1359/jbmr.1997.12.11.1903
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lee J.T.Y., 2011, J BIOMATER NANOBIOTE, V02, P41
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Mata A, 2009, SOFT MATTER, V5, P1228, DOI 10.1039/b819002j
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Urist MR, 2002, CLIN ORTHOP RELAT R, P5
   Wang M, 2001, J MATER SCI-MATER M, V12, P855, DOI 10.1023/A:1012899318688
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Yuan H.P., 2011, NAT REV RHEUMATOL, V7
   Yuan HP, 2001, BIOMATERIALS, V22, P2617, DOI 10.1016/S0142-9612(00)00450-6
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhu XD, 2007, J MATER SCI-MATER M, V18, P2243, DOI 10.1007/s10856-006-0057-2
NR 28
TC 3
Z9 3
U1 2
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD SEP
PY 2014
VL 40
IS 8
BP 13591
EP 13597
DI 10.1016/j.ceramint.2014.05.079
PN B
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AN1CW
UT WOS:000340321300124
DA 2018-10-20
ER

PT J
AU Shukla, A
   Almeida, B
AF Shukla, Anita
   Almeida, Bethany
TI Advances in cellular and tissue engineering using layer-by-layer
   assembly
SO WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY
LA English
DT Review
ID POLYELECTROLYTE MULTILAYER FILMS; MESENCHYMAL STEM-CELLS; THIN-FILMS;
   BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; PROTEIN ADSORPTION; PLASMID DNA;
   LBL FILMS; RELEASE; SURFACES
AB Layer-by-layer (LbL) assembly is a self-assembly technique used to develop multilayer films based on complementary interactions between film components. These multilayer films have had a significant impact on the fields of cellular and tissue engineering. The aim of cellular engineering is to understand and control cell behavior, which not only impacts applications in regenerative medicine but also other biomedical therapies that rely on cell interactions with biomaterials, including treatments for autoimmune disorders and cancer. Tissue engineering approaches to tissue repair and regeneration utilize three-dimensional biomaterial scaffolds that interact favorably with cells. Cellular engineering studies can better inform the design of these scaffolds. The ease of tuning the chemical and mechanical properties of LbL films, the ability to coat a variety of medically relevant substrates (including cell culture surfaces and scaffolds), and the wide range of species that can be incorporated into these films (ranging from proteins to small molecules) have led to the successful use of LbL assembly for a variety of cellular and tissue engineering applications. The films used in these biomedical applications can be divided into those that release therapeutics, often with controlled stimuli-responsive release behavior, and those that act without releasing these agents. (C) 2014 Wiley Periodicals, Inc.
C1 [Shukla, Anita; Almeida, Bethany] Brown Univ, Sch Engn, Inst Mol & Nanoscale Innovat, Ctr Biomed Engn, Providence, RI 02912 USA.
RP Shukla, A (reprint author), Brown Univ, Sch Engn, Inst Mol & Nanoscale Innovat, Ctr Biomed Engn, Providence, RI 02912 USA.
EM anita_shukla@brown.edu
CR Agarwal A, 1863, ADV FUNCT MATER, V2011, P21
   Bieker P, 2010, MACROMOLECULES, V43, P5052, DOI 10.1021/ma1007489
   Boudou T, 2012, J CONTROL RELEASE, V159, P403, DOI 10.1016/j.jconrel.2012.01.022
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Brunot C, 2008, DENT MATER, V24, P1025, DOI 10.1016/j.dental.2007.11.022
   Chen XY, 2012, ACTA BIOMATER, V8, P4380, DOI 10.1016/j.actbio.2012.08.014
   Cho J, 2001, ADV MATER, V13, P1076, DOI 10.1002/1521-4095(200107)13:14<1076::AID-ADMA1076>3.0.CO;2-M
   Choi J, 2005, MACROMOLECULES, V38, P116, DOI 10.1021/ma048596o
   Costa RR, 2013, WOODH PUBL SER BIOM, V56, P88, DOI 10.1533/9780857097231.1.88
   De Cock LJ, 2010, ANGEW CHEM INT EDIT, V49, P6954, DOI 10.1002/anie.200906266
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Delcea M, 2011, ADV DRUG DELIVER REV, V63, P730, DOI 10.1016/j.addr.2011.03.010
   DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/nmat3550, 10.1038/NMAT3550]
   Deng HB, 2010, CARBOHYD POLYM, V80, P474, DOI 10.1016/j.carbpol.2009.12.004
   Deshmukh PK, 2013, J CONTROL RELEASE, V166, P294, DOI 10.1016/j.jconrel.2012.12.033
   Ding ZB, 2009, POLYMER, V50, P4205, DOI 10.1016/j.polymer.2009.07.001
   Dubas ST, 1999, MACROMOLECULES, V32, P8153, DOI 10.1021/ma981927a
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Grant GGS, 2001, BIOMED MICRODEVICES, V3, P301, DOI 10.1023/A:1012456714628
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Gu X, 2013, COLLOID SURFACE B, V108, P205, DOI 10.1016/j.colsurfb.2013.03.007
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   He XY, 2012, APPL SURF SCI, V258, P9918, DOI 10.1016/j.apsusc.2012.06.051
   Hoogeveen NG, 1996, LANGMUIR, V12, P3675, DOI 10.1021/la951574y
   Hu Y, 2009, BIOMATERIALS, V30, P3626, DOI 10.1016/j.biomaterials.2009.03.037
   Jewell CM, 2006, BIOMACROMOLECULES, V7, P2483, DOI 10.1021/bm0604808
   Jewell CM, 2008, CURR OPIN COLLOID IN, V13, P395, DOI 10.1016/j.cocis.2008.03.005
   Johnston APR, 2005, NANO LETT, V5, P953, DOI 10.1021/nl050608b
   Jourdainne L, 2007, MACROMOLECULES, V40, P316, DOI 10.1021/ma062201e
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   Kharlampieva E, 2009, ADV MATER, V21, P3053, DOI 10.1002/adma.200803653
   Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029
   Kotov NA, 1999, NANOSTRUCT MATER, V12, P789, DOI 10.1016/S0965-9773(99)00237-8
   Krogman KC, 2007, LANGMUIR, V23, P3137, DOI 10.1021/la063085b
   Krogman KC, 2009, NAT MATER, V8, P512, DOI [10.1038/NMAT2430, 10.1038/nmat2430]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Larkin AL, 2013, TISSUE ENG PART C-ME, V19, P875, DOI [10.1089/ten.TEC.2012.0700, 10.1089/ten.tec.2012.0700]
   Lei L, 2010, J CONTROL RELEASE, V146, P45, DOI 10.1016/j.jconrel.2010.05.017
   Luo J, 2012, BIOMATERIALS, V33, P8733, DOI 10.1016/j.biomaterials.2012.08.041
   Lynn DM, 2007, ADV MATER, V19, P4118, DOI 10.1002/adma.200701748
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Marchenko I, 2012, J CONTROL RELEASE, V162, P599, DOI 10.1016/j.jconrel.2012.08.006
   Nathaniel H, 2010, NAT MATER, V9, P518
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Nurajes N, 2010, LANGMUIR, V27, P782
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park S, 2012, BIOMATERIALS, V33, P5468, DOI 10.1016/j.biomaterials.2012.04.005
   Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Plewa A, 2011, EUR POLYM J, V47, P1503, DOI 10.1016/j.eurpolymj.2011.06.002
   Poon Z, 2011, ACS NANO, V5, P4284, DOI 10.1021/nn200876f
   Samuel RE, 2011, BIOMATERIALS, V32, P7491, DOI 10.1016/j.biomaterials.2011.06.032
   Saurer EM, 2009, ACTA BIOMATER, V5, P913, DOI 10.1016/j.actbio.2008.08.022
   Schlenoff JB, 2000, LANGMUIR, V16, P9968, DOI 10.1021/la001312i
   Schmidt DJ, 2010, CHEM MATER, V22, P6416, DOI 10.1021/cm102578j
   Shah N. J., 2013, SCI TRANSL MED, V5
   Shah NJ, 2011, BIOMATERIALS, V32, P6183, DOI 10.1016/j.biomaterials.2011.04.036
   Shchukina EM, 2011, ADV DRUG DELIVER REV, V63, P837, DOI 10.1016/j.addr.2011.03.009
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Shukla A, 2011, J BIOMAT SCI-POLYM E, V23, P23
   Shukla A, 2012, J CONTROL RELEASE, V157, P64, DOI 10.1016/j.jconrel.2011.09.062
   Shukla A, 2012, ADV MATER, V24, P492, DOI 10.1002/adma.201103794
   Shukla A, 2011, J CONTROL RELEASE, V155, P159, DOI 10.1016/j.jconrel.2011.06.011
   Shukla A, 2010, SMALL, V6, P2392, DOI 10.1002/smll.201001150
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Such GK, 2006, J AM CHEM SOC, V128, P9318, DOI 10.1021/ja063043+
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Tsai WB, 2009, ACTA BIOMATER, V5, P3467, DOI 10.1016/j.actbio.2009.05.034
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Veerabadran NG, 2007, MACROMOL BIOSCI, V7, P877, DOI 10.1002/mabi.200700061
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wong SY, 2012, BIOMACROMOLECULES, V13, P719, DOI 10.1021/bm201637e
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Zacharia NS, 2007, MACROMOLECULES, V40, P9523, DOI 10.1021/ma071828+
NR 86
TC 18
Z9 18
U1 5
U2 89
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-5116
EI 1939-0041
J9 WIRES NANOMED NANOBI
JI Wiley Interdiscip. Rev.-Nanomed. Nanobiotechnol.
PD SEP-OCT
PY 2014
VL 6
IS 5
BP 411
EP 421
DI 10.1002/wnan.1269
PG 11
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA AN2CI
UT WOS:000340390600001
PM 24723385
DA 2018-10-20
ER

PT J
AU Li, M
   Yao, ZTT
   Chen, T
   Lou, ZHH
   Xia, MS
AF Li, Mei
   Yao, Zhitong T.
   Chen, Tao
   Lou, Zhanghua H.
   Xia, Meisheng
TI The antibacterial activity and mechanism of mussel shell waste derived
   material
SO POWDER TECHNOLOGY
LA English
DT Article
DE Shell waste; Antibacterial material; Biomaterial; Silver; Antibacterial
   activity
ID SILVER-LOADED ZEOLITE; ESCHERICHIA-COLI; ACTIVATED CARBON; POWDER;
   NANOPARTICLES; COPPER; ANTIMICROBIALS; BACTERIA; PH
AB The preparation, characterization and antibacterial activity of mussel shell waste doped with silver are reported. The characterizations were performed by X-ray diffraction (XRD), scanning electron microscopy equipped with an energy dispersive spectrometer (SEM-EDS), X-ray photoelectronic spectroscopy (XPS), and Fourier transformed infrared spectroscopy (FT-IR). The antibacterial activity was evaluated against typical Gram-negative bacteria Escherichia coli and Gram-positive bacteria Staphylococcus aureus. XPS measurement and EDS analysis confirmed the incorporation of silver in the mussel shell. The antibacterial test demonstrated that the prepared material had good antibacterial property, which was mainly attributed to the silver present and slightly higher pH value. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Li, Mei; Chen, Tao; Lou, Zhanghua H.; Xia, Meisheng] Zhejiang Univ, Ocean Coll, Hangzhou 310058, Zhejiang, Peoples R China.
   [Yao, Zhitong T.] Hangzhou Dianzi Univ, Coll Mat Sci & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China.
RP Yao, ZTT (reprint author), Hangzhou Dianzi Univ, Coll Mat Sci & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China.
EM sxyzt@126.com; iwr@zju.edu.cn
FU Zhejiang Provincial Natural Science Foundation of China [LQ13B070005];
   Key Laboratory for Solid Waste Management and Environment Safety Open
   Fund [SWMES 2011-07]; Scientific Research Foundation of Hangzhou Dianzi
   University [KYS205612029]
FX This study was financially supported by the Zhejiang Provincial Natural
   Science Foundation of China (Grant no. LQ13B070005), the Key Laboratory
   for Solid Waste Management and Environment Safety Open Fund (Grant no.
   SWMES 2011-07) and the Scientific Research Foundation of Hangzhou Dianzi
   University (Grant no. KYS205612029). The authors are thankful to Ms.
   Xiayun Zhang for her help in testing antibacterial activity. We also
   would like to thank the anonymous referees for their helpful comments on
   this article.
CR Bae DH, 2006, ARCH PHARM RES, V29, P298, DOI 10.1007/BF02968574
   Briggs D., 1996, AUGER XRAY PHOTOELEC, V1
   Chae HH, 2011, SYNTHETIC MET, V161, P2124, DOI 10.1016/j.synthmet.2011.08.013
   CHERRINGTON CA, 1991, ADV MICROB PHYSIOL, V32, P87, DOI 10.1016/S0065-2911(08)60006-5
   Choi YM, 2006, FOOD CONTROL, V17, P695, DOI 10.1016/j.foodcont.2005.04.005
   Dizman B, 2007, APPL CLAY SCI, V38, P57, DOI 10.1016/j.clay.2007.01.002
   Duncan TV, 2011, J COLLOID INTERF SCI, V363, P1, DOI 10.1016/j.jcis.2011.07.017
   Fang M, 2006, INT J ANTIMICROB AG, V27, P513, DOI 10.1016/j.ijantimicag.2006.01.008
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ferreira L, 2012, MICROPOR MESOPOR MAT, V160, P126, DOI 10.1016/j.micromeso.2012.05.006
   Glasson JH, 2008, J CLIN MICROBIOL, V46, P1281, DOI 10.1128/JCM.01687-07
   Hilonga A, 2012, POWDER TECHNOL, V215-16, P219, DOI 10.1016/j.powtec.2011.09.051
   Hindler J.F., 2004, CLIN MICROBIOLOGY PR, V2
   Hrenovic J., 2003, MICROPOR MESOPOR MAT, V169, P148
   Hu CH, 2006, APPL CLAY SCI, V31, P180, DOI 10.1016/j.clay.2005.10.010
   HUFNER S, 1975, SOLID STATE COMMUN, V17, P417, DOI 10.1016/0038-1098(75)90468-8
   Inoue Y., 2012, J BIOMATER NANOBIOTE, V3, P114
   Inoue Y, 2008, CHEM PHARM BULL, V56, P692, DOI 10.1248/cpb.56.692
   Jazie A.A., 2013, INT J SUSTAIN DEV GR, V2, P27
   Jia HS, 2008, DENT MATER, V24, P244, DOI 10.1016/j.dental.2007.04.015
   Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X
   Kwakye-Awuah B, 2008, J APPL MICROBIOL, V104, P1516, DOI 10.1111/j.1365-2672.2007.03673.x
   Lin L, 2013, J MATER CHEM B, V1, P2719, DOI 10.1039/c3tb20223b
   Lin L, 2013, COLLOID SURFACE B, V101, P97, DOI 10.1016/j.colsurfb.2012.06.001
   Losito I, 2005, THIN SOLID FILMS, V473, P104, DOI 10.1016/j.tsf.2004.07.059
   Magana SM, 2008, J MOL CATAL A-CHEM, V281, P192, DOI 10.1016/j.molcata.2007.10.024
   MENDONCA AF, 1994, APPL ENVIRON MICROB, V60, P4009
   Naemchan K, 2008, ADV MATER RES-SWITZ, V55-57, P333, DOI 10.4028/www.scientific.net/AMR.55-57.333
   Ohniwa RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019172
   Oikawa K, 2000, J HEALTH SCI, V46, P98
   Ortiz-Ibarra H, 2007, J COLLOID INTERF SCI, V314, P562, DOI 10.1016/j.jcis.2007.05.062
   Percival SL, 2005, J HOSP INFECT, V60, P1, DOI 10.1016/j.jhin.2004.11.014
   Prakash C.R., 2011, J SAUDI CHEM SOC
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Sawai J, 1997, J CHEM ENG JPN, V30, P1034, DOI 10.1252/jcej.30.1034
   Schwartzberg AM, 2008, J PHYS CHEM C, V112, P10323, DOI 10.1021/jp801770w
   Sharma J, 2004, J COLLOID INTERF SCI, V272, P145, DOI 10.1016/j.jcis.2003.09.016
   Slonczewski, 1992, ASM NEWS, V58, P140
   Song J, 2012, ADV ENG MATER, V14, pB240, DOI 10.1002/adem.201180085
   Tang XF, 2006, CHEM ENG J, V118, P119, DOI 10.1016/j.cej.2006.02.002
   Top A, 2004, APPL CLAY SCI, V27, P13, DOI 10.1016/j.clay.2003.12.002
   Tuan TQ, 2011, J HAZARD MATER, V192, P1321, DOI 10.1016/j.jhazmat.2011.06.044
   Wang JC, 2011, MICROPOR MESOPOR MAT, V146, P216, DOI 10.1016/j.micromeso.2011.04.005
   Zhang Y, 2010, AGR SCI CHINA, V9, P911, DOI 10.1016/S1671-2927(09)60171-1
   Zhao DF, 2006, APPL CLAY SCI, V33, P161, DOI 10.1016/j.clay.2006.04.003
   Zhao Y., 2012, APPL CLAY SCI
   Zhu JH, 2009, CRYSTENGCOMM, V11, P539, DOI 10.1039/b817535g
NR 47
TC 5
Z9 5
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD SEP
PY 2014
VL 264
BP 577
EP 582
DI 10.1016/j.powtec.2014.05.067
PG 6
WC Engineering, Chemical
SC Engineering
GA AM9PR
UT WOS:000340214000065
DA 2018-10-20
ER

PT J
AU Soares, LGP
   Marques, AMC
   Aciole, JMS
   da Guarda, MG
   Cangussu, MCT
   Silveira, L
   Pinheiro, ALB
AF Pinheiro Soares, Luiz Guilherme
   Cordeiro Marques, Aparecida Maria
   Santos Aciole, Jouber Mateus
   da Guarda, Milena Goes
   Teixeira Cangussu, Maria Cristina
   Silveira, Landulfo, Jr.
   Barbosa Pinheiro, Antonio Luiz
TI Do laser/LED phototherapies influence the outcome of the repair of
   surgical bone defects grafted with biphasic synthetic microgranular HA
   plus beta-tricalcium phosphate? A Raman spectroscopy study
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Biomaterial; Bone repair; Hydroxyapatite; Laser and LED phototherapies
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; LIGHT; PHOTOBIOMODULATION; THERAPY; ASSOCIATION;
   RABBITS
AB The treatment of bone loss is difficult. Many techniques are proposed to improve repair, including biomaterials and, recently, phototherapies. This work studied bone mineralization by Raman spectroscopy assessing intensities of Raman peaks of both inorganic (similar to 960, similar to 1,070 cm(-1)) and organic (similar to 1,454 cm(-1)) contents in animal model. Six groups were studied: clot, laser, light-emitting diode (LED), biomaterial (HA + beta-tricalcium phosphate), laser + biomaterial, and LED + biomaterial. Defects at right tibia were performed with a drill. When indicated, defects were further irradiated at a 48-h interval during 2 weeks. At the 15th and 30th days, the tibias were withdrawn and analyzed. The similar to 960-cm(-1) peak was significantly affected by phototherapy on both clot- and biomaterial-filled defects. The similar to 1,070-cm(-1) peak was affected by both time and the use of the LED light on clot-filled defects. On biomaterial-filled defects, only the use of the laser light significantly influenced the outcome. No significant influence of either the time or the use of the light was detected on clot-filled defects as regards the similar to 1,454-cm(-1) peak. Raman intensities of both mineral and matrix components indicated that the use of laser and LED phototherapies improved the repair of bone defects grafted or not with biphasic synthetic microgranular HA + beta-tricalcium phosphate.
C1 [Pinheiro Soares, Luiz Guilherme; Cordeiro Marques, Aparecida Maria; Santos Aciole, Jouber Mateus; da Guarda, Milena Goes; Teixeira Cangussu, Maria Cristina; Barbosa Pinheiro, Antonio Luiz] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Cordeiro Marques, Aparecida Maria; Barbosa Pinheiro, Antonio Luiz] Univ Sao Paulo, Phys Inst Sao Carlos, Natl Inst Opt & Photon, BR-13560970 Sao Carlos, SP, Brazil.
   [Silveira, Landulfo, Jr.; Barbosa Pinheiro, Antonio Luiz] Univ Camilo Castelo Branco, Inst Biomed Engn, BR-12247016 Sao Jose Dos Campos, SP, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, Ave Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Silveira, Landulfo/I-2474-2012; Sao Carlos Institute of Physics,
   IFSC/USP/M-2664-2016; Pinheiro, Antonio Luiz/A-1962-2008
OI Silveira, Landulfo/0000-0002-6616-3334; Pinheiro, Antonio
   Luiz/0000-0002-5805-0321
FU CNPq (National Counsel of Technological and Scientific Development);
   FAPESP (Sao Paulo Research Foundation)
FX The authors acknowledge CNPq (National Counsel of Technological and
   Scientific Development) and FAPESP (Sao Paulo Research Foundation) for
   the financial support.
CR Akkus O, 2003, J BONE MINER RES, V18, P1012, DOI 10.1359/jbmr.2003.18.6.1012
   Al-Watban FAH, 2006, PHOTOMED LASER SURG, V24, P10, DOI 10.1089/pho.2006.24.10
   Boivin G, 2003, OSTEOPOROSIS INT, V14, pS19, DOI 10.1007/s00198-002-1347-2
   Carden A, 2000, J BIOMED OPT, V5, P259, DOI 10.1117/1.429994
   Carvalho FB, 2011, P SOC PHOTO-OPT INS, V7887, DOI DOI 10.1117/12.874288
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Hanlon EB, 2000, PHYS MED BIOL, V45, pR1, DOI 10.1088/0031-9155/45/2/201
   Kalfas IH, 2001, NEUROSURG FOCUS, V10, P1, DOI DOI 10.3171/FOC.2001.10.4.2
   Karu TI, 2004, PHOTOCHEM PHOTOBIOL, V80, P366, DOI 10.1562/2004-03-25-RA-123.1
   Krafft C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040801
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2010, J BIOMED MATER RES A, V94A, P1257, DOI 10.1002/jbm.a.32800
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Maher JR, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.7.077001
   Martinez MEM, 2008, LASER MED SCI, V23, P313, DOI 10.1007/s10103-007-0488-0
   McCreadie BR, 2006, BONE, V39, P1190, DOI 10.1016/j.bone.2006.06.008
   Morris MD, 2011, CLIN ORTHOP RELAT R, V469, P2160, DOI 10.1007/s11999-010-1692-y
   Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530
   Okagbare PI, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.090502
   Penel G, 2005, BONE, V36, P893, DOI 10.1016/j.bone.2005.02.012
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Penel G, 2003, DENT MED PROBL, V40, P37
   Pinheiro A.L.B., 2001, LASER THER, V13, P73, DOI DOI 10.5978/ISLSM.13.73
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   PROLO DJ, 1990, CLIN NEUR, V36, P135
   Recker RR, 1992, DISORDERS BONE MINER, P219
   Silveira L, 2002, LASER SURG MED, V30, P290, DOI 10.1002/lsm.10053
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   TANG XM, 1986, LASER SURG MED, V6, P346, DOI 10.1002/lsm.1900060309
   Timlin JA, 1999, APPL SPECTROSC, V53, P1429, DOI 10.1366/0003702991945786
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   TRELLES MA, 1987, LASER SURG MED, V7, P36, DOI 10.1002/lsm.1900070107
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Weiss RA, 2005, DERMATOL SURG, V31, P1199
   Yamada K, 1991, J JPN ORTHOP ASSOC, V65, P101
NR 44
TC 6
Z9 6
U1 0
U2 0
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD SEP
PY 2014
VL 29
IS 5
BP 1575
EP 1584
DI 10.1007/s10103-014-1563-y
PG 10
WC Engineering, Biomedical; Surgery
SC Engineering; Surgery
GA AO7AF
UT WOS:000341503500007
PM 24627284
DA 2018-10-20
ER

PT J
AU Chu, XH
   Xu, Q
   Feng, ZQ
   Xiao, JQ
   Li, Q
   Sun, XT
   Cao, Y
   Ding, YT
AF Chu, Xue-Hui
   Xu, Qian
   Feng, Zhang-Qi
   Xiao, Jiang-Qiang
   Li, Qiang
   Sun, Xi-Tai
   Cao, Yang
   Ding, Yi-Tao
TI In vitro biocompatibility of polypyrrole/PLGA conductive nanofiber
   scaffold with cultured rat hepatocytes
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE polypyrrole; hepatocyte; nanofiber scaffold; biocompatibility
AB To intruduce conductive biomaterial into liver tissue engineering, a conductive nanofiber scaffold, polypyrrole/poly(lactic-co-glycolic) acid(PLGA), was designed and prepared via electro-spinning and oxidative polymerization. Effects of the scaffold on hepatocyte adhesion, viability and function were then investigated. SEM revealed pseudopodium formation and abundant extracellular matrix on the surface of PLGA membrane and polypyrrole/PLGA membrane. The adhesion rate, cellular activity, urea synthesis and albumin secretion of the hepatocytes cultured on polypyrrole/PLGA group were similar to those on the PLGA group, but were significantly higher than those on the control group. There were no significant differences in concentrations of LDH and TNF-alpha among three groups. These results suggested the potential application of this conductive nanofiber scaffold as a suitable substratum for hepatocyte culturing in liver tissue engineering.
C1 [Chu, Xue-Hui; Xiao, Jiang-Qiang; Li, Qiang; Sun, Xi-Tai; Ding, Yi-Tao] Nanjing Univ, Dept Hepatobiliary Surg, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.
   [Xu, Qian; Cao, Yang] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Feng, Zhang-Qi] Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Nanjing 210094, Jiangsu, Peoples R China.
RP Chu, XH (reprint author), Nanjing Univ, Dept Hepatobiliary Surg, Affiliated Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.
EM yitaoding@hotmail.com
FU National Natural Science Foundation of China [81101161, 51103181,
   11204033]; Natural Science Foundation of Guangdong province, China
   [S2013040016083]; Fundamental Research Funds for the Central
   Universities; Open Research Fund of State Key Laboratory of
   Bioelectronics, Southeast University
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 81101161, 51103181 and 11204033), the Natural Science
   Foundation of Guangdong province, China (Grant No. S2013040016083), the
   Fundamental Research Funds for the Central Universities, the Open
   Research Fund of State Key Laboratory of Bioelectronics, Southeast
   University.
CR Aznar-Cervantes S, 2012, BIOELECTROCHEMISTRY, V85, P36, DOI 10.1016/j.bioelechem.2011.11.008
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Chu XH, 2009, BIOTECHNOL LETT, V31, P347, DOI 10.1007/s10529-008-9892-1
   Griffin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072978
   Lee JS, 2014, BIOMACROMOLECULES, V15, P206, DOI 10.1021/bm4015039
   Ohashi K, 2012, CELL TRANSPLANT, V21, P429, DOI 10.3727/096368911X605330
   Palakkan AA, 2013, LIVER INT, V33, P666, DOI 10.1111/liv.12134
   Pelto J, 2013, TISSUE ENG PT A, V19, P882, DOI [10.1089/ten.tea.2012.0111, 10.1089/ten.TEA.2012.0111]
   Pietronave S, 2014, STEM CELLS DEV, V23, P888, DOI 10.1089/scd.2013.0375
   Saigal R, 2013, IEEE ENG MED BIO, P1627, DOI 10.1109/EMBC.2013.6609828
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Uygun BE, 2013, CURR OPIN BIOTECH, V24, P893, DOI 10.1016/j.copbio.2013.05.008
NR 12
TC 3
Z9 5
U1 1
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD SEP
PY 2014
VL 1
IS 3
AR 035402
DI 10.1088/2053-1591/1/3/035402
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA V43ER
UT WOS:000209665200060
DA 2018-10-20
ER

PT J
AU Wiegmann, B
   Figueiredo, C
   Gras, C
   Pflaum, M
   Schmeckebier, S
   Korossis, S
   Haverich, A
   Blasczyk, R
AF Wiegmann, Bettina
   Figueiredo, Constanca
   Gras, Christiane
   Pflaum, Michael
   Schmeckebier, Sabrina
   Korossis, Sotirios
   Haverich, Axel
   Blasczyk, Rainer
TI Prevention of rejection of allogeneic endothelial cells in a biohybrid
   lung by silencing HLA-class I expression
SO BIOMATERIALS
LA English
DT Article
DE Biohybrid lung; HLA; Biomaterial; Endothelial cells
ID KIDNEY-TRANSPLANTATION; ALLOGRAFT-REJECTION; ANTIBODIES; HETEROGENEITY;
   INDUCTION; SECRETION; PLATELETS; APOPTOSIS; SURVIVAL; ADHESION
AB Variability in Human Leukocyte Antigens (HLA) remains a hurdle to the application of allogeneic cellular products. Due to insufficient autologous endothelial cell harvesting for the biohybrid lung, allogeneic human cord blood derived endothelial cells (HCBEC) were used for the endothelialization of poly-4-methyl-1-pentene (PMP) gas exchange membranes. Therefore, HLA class I expression was silenced stably in HCBECs to prevent rejection. The capacity of HLA class I-silenced HCBEC to abrogate allogeneic immune responses, their functional properties and suitability for endothelialization of PMP membranes were investigated. Delivery of beta 2-microglobulin (beta 2m)-specific shRNAs reduced beta 2m mRNA levels by up to 90% and caused a knockdown of HLA class I expression by up to 85%. HLA-silenced HCBEC abrogated T-cell responses and escaped antibody-mediated complement-dependent cytotoxicity. The EC phenotype and cytokine secretion profiles between HLA-expressing or -silenced HCBEC remained unaltered. EC specific activation (e.g. ICAM) and thrombogenic markers (e.g. thrombomodulin) remained unaffected by HLA-silencing, but their expression was upregulated by TNF alpha-stimulation. Furthermore, HLA-silenced HCBECs showed high proliferation rates and built an EC monolayer onto PMP membranes. This study represents a new therapeutic concept in the field of cell and organ transplantation and may bring the bioartificial lung as an alternative to lung transplantation closer to reality. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Wiegmann, Bettina; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany.
   [Wiegmann, Bettina; Pflaum, Michael; Schmeckebier, Sabrina; Korossis, Sotirios; Haverich, Axel] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Leibniz Res Labs Biotechnol & Artificial Organs, D-30625 Hannover, Germany.
   [Wiegmann, Bettina; Korossis, Sotirios; Haverich, Axel] Lower Saxony Ctr Biomed Engn Implant Res & Dev, D-30625 Hannover, Germany.
   [Wiegmann, Bettina; Haverich, Axel] German Ctr Lung Res, D-30625 Hannover, Germany.
   [Figueiredo, Constanca; Gras, Christiane; Blasczyk, Rainer] Hannover Med Sch, Inst Transfus Med, D-30625 Hannover, Germany.
RP Figueiredo, C (reprint author), Inst Transfus Med, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Figueiredo.Constanca@mh-hannover.de
RI Korossis, Sotirios/S-4427-2016
OI Korossis, Sotirios/0000-0002-9893-6338; Pflaum,
   Michael/0000-0002-4539-386X
FU Cluster of Excellence REBIRTH [EXC 62/1]; German Center for Lung
   Research (DZL) [DZL: 82DZL00201]; Lower Saxony Center for Biomedical
   Technology (NIFE); German Research Foundation [WI 4088/1-1]
FX We are grateful to Stefanie Vahlsing and Julia Janke for the excellent
   technical support. In addition, we are thankful to Nina McGuinness for
   proofreading the manuscript. This work was partly supported by funding
   by the Cluster of Excellence REBIRTH (From Regenerative Biology to
   Reconstructive Therapy EXC 62/1) (Unit 4.1 and 6.3), as well as by the
   German Center for Lung Research (DZL) (DZL: 82DZL00201), Lower Saxony
   Center for Biomedical Technology (NIFE) and German Research Foundation
   (WI 4088/1-1).
CR Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Al-Lamki RS, 2008, TRANSPLANTATION, V86, P1340, DOI 10.1097/TP.0b013e3181891d8b
   [Anonymous], 2014, TRANSPL REG
   Becker LE, 2013, CURR OPIN ORGAN TRAN, V18, P445, DOI 10.1097/MOT.0b013e3283636c20
   Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5
   Bhorade SM, 2000, J HEART LUNG TRANSPL, V19, P1199, DOI 10.1016/S1053-2498(00)00215-1
   Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432
   De Serres SA, 2012, CLIN J AM SOC NEPHRO, V7, P1018, DOI 10.2215/CJN.11051011
   DeNicola MM, 2013, J HEART LUNG TRANSPL, V32, P326, DOI 10.1016/j.healun.2012.11.018
   Dervillez X, 2013, J IMMUNOL, V191, P5124, DOI 10.4049/jimmunol.1301415
   Figueiredo C, 2006, J MOL MED-JMM, V84, P425, DOI 10.1007/s00109-005-0024-2
   Figueiredo C, 2013, BIOMED RES INT, DOI 10.1155/2013/796046
   Figueiredo C, 2010, TRANSFUSION, V50, P1690, DOI 10.1111/j.1537-2995.2010.02644.x
   Fischer S, 2000, ANN SURG, V231, P424, DOI 10.1097/00000658-200003000-00016
   Florea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073146
   Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gras C, 2013, HUM GENE THER, V24, P1018, DOI 10.1089/hum.2013.074
   Hess C, 2010, TISSUE ENG PT A, V16, P3043, DOI [10.1089/ten.tea.2010.0131, 10.1089/ten.TEA.2010.0131]
   Hinrichs J, 2009, MOL IMMUNOL, V46, P1451, DOI 10.1016/j.molimm.2008.12.011
   Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2
   Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104
   Jaimes Y, 2011, TISSUE ANTIGENS, V77, P36, DOI 10.1111/j.1399-0039.2010.01576.x
   Klein K, 2013, ATHEROSCLEROSIS SUPP, V14, P199, DOI 10.1016/j.atherosclerosissup.2012.10.030
   Kruger S, 2001, EXP NEPHROL, V9, P223
   Lee JH, 2013, TISSUE ENG A, V20
   Luo W, 2013, ONCOTARGET, V4, P1472, DOI 10.18632/oncotarget.1269
   Manchanda PK, 2006, TRANSPL IMMUNOL, V15, P289, DOI 10.1016/j.trim.2006.01.004
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Mesri M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078885
   Michell DL, 2011, J VIS EXP, V23
   Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174
   Naemi FMA, 2013, TRANSPLANTATION, V96, P258, DOI 10.1097/TP.0b013e3182985504
   Opelz G, 2010, TRANSPLANTATION, V90, P912, DOI 10.1097/TP.0b013e3181f2c981
   Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X
   Sabry M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00408
   Sis B, 2008, AM J KIDNEY DIS, V51, P127, DOI 10.1053/j.ajkd.2007.08.023
   Suesal C, 2009, TRANSPLANTATION, V87, P1367, DOI 10.1097/TP.0b013e3181a24073
   Sumen C, 2004, J CELL BIOL, V166, P579, DOI 10.1083/jcb.200404059
   Sun QQ, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/859761
   Tian BX, 2013, CANCER BIOTHER RADIO, V28, P466, DOI 10.1089/cbr.2012.1426
   Viel S, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26011
   Wang CY, 1998, CIRC RES, V82, P762, DOI 10.1161/01.RES.82.7.762
   World Health Organization, 2014, WORLD HLTH STAT
NR 44
TC 7
Z9 7
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2014
VL 35
IS 28
BP 8123
EP 8133
DI 10.1016/j.biomaterials.2014.06.007
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM3TC
UT WOS:000339774700007
PM 24961166
DA 2018-10-20
ER

PT J
AU Long, TJ
   Sprenger, CC
   Plymate, SR
   Ratner, BD
AF Long, Thomas J.
   Sprenger, Cynthia C.
   Plymate, Stephen R.
   Ratner, Buddy D.
TI Prostate cancer xenografts engineered from 3D precision-porous
   poly(2-hydroxyethyl methacrylate) hydrogels as models for tumorigenesis
   and dormancy escape
SO BIOMATERIALS
LA English
DT Article
DE PolyHEMA; Scaffold; Xenograft; Prostate cancer; Dormancy; Tumor
   microenvironment
ID PROTEIN-RELATED PROTEIN-1; MAMMARY EPITHELIAL-CELLS; IN-VITRO
   EVALUATION; TUMOR DORMANCY; GROWTH; PROGRESSION; CULTURE; EXPRESSION;
   METASTASIS; BIOLOGY
AB Synthetic biomaterial scaffolds show promise for in vitro and in vivo 3D cancer models. Tumors engineered in biomaterial scaffolds have shown evidence of being more physiologically relevant than some traditional preclinical model systems, and synthetic biomaterials provide the added benefit of defined and consistent microenvironmental control. Here, we examine sphere-templated poly(2-hydroxyethyl methacrylate) (pHEMA) scaffolds as the basis for engineering xenografts from multiple human prostate cancer cell lines. pHEMA scaffolds seeded and pre-cultured with tumorigenic M12 cells prior to implantation generated tumors in athymic nude mice, demonstrating the ability of the scaffolds to be used as a synthetic vehicle for xenograft generation. pHEMA scaffolds seeded with LNCaP C4-2 cells, which require Matrigel or stromal cell support for tumor formation, were poorly tumorigenic up to 12 weeks after implantation even when Matrigel was infused into the scaffold, demonstrating a lack of necessary pro-tumorigenic signaling within the scaffolds. Finally, M12mac25 cells, which are ordinarily rendered non-tumorigenic through the expression of the tumor suppressor insulin-like growth factor binding protein 7 (IGFBP7), displayed a tumorigenic response when implanted within porous pHEMA scaffolds. These M12mac25 tumors showed significant macrophage infiltration within the scaffolds driven by the foreign body response to the materials. These findings show the potential for this biomaterials-based model system to be used in the study of prostate cancer tumorigenesis and dormancy escape. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Long, Thomas J.; Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Sprenger, Cynthia C.; Plymate, Stephen R.] Univ Washington, Dept Med, Seattle, WA 98195 USA.
   [Plymate, Stephen R.] Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA USA.
RP Ratner, BD (reprint author), Univ Washington, Dept Bioengn, Box 355061,3720 15th Ave NE, Seattle, WA 98195 USA.
EM ratner@uweb.engr.washington.edu
FU Nanotechnology and Physical Science in Cancer Research Training Program
   NIH [T32CA138312]; TMEN [U54-CAl26540, P01 CA085859]; Veterans Affairs
   Research Service
FX The authors would like to thank Shihua Sun, Colleen Irvin, Kathryn
   Soriano, and Gerry Hammer for technical assistance. This work was
   supported by the Nanotechnology and Physical Science in Cancer Research
   Training Program NIH T32CA138312 (TJL and BDR), TMEN U54-CAl26540 (SRP),
   P01 CA085859 (SRP), and the Veterans Affairs Research Service (SRP).
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256
   [Anonymous], 2012, DET GUID PROST CANC
   Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   BOXBERGER HJ, 1994, BIOL CELL, V82, P109, DOI 10.1016/S0248-4900(94)80013-8
   Burdett E, 2010, TISSUE ENG PART B-RE, V16, P351, DOI [10.1089/ten.teb.2009.0676, 10.1089/ten.TEB.2009.0676]
   Burger AM, 1998, ONCOGENE, V16, P2459, DOI 10.1038/sj.onc.1201772
   Chung LWK, 2005, J UROLOGY, V173, P10, DOI 10.1097/01.ju.0000141582.15218.10
   Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004
   Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695
   Dhiman HK, 2004, BIOMATERIALS, V25, P5147, DOI 10.1016/j.biomaterials.2003.12.025
   Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI [10.1089/ten.tea.2010.0135, 10.1089/ten.TEA.2010.0135]
   Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Hutmacher DW, 2009, J CELL MOL MED, V13, P1417, DOI 10.1111/j.1582-4934.2009.00853.x
   Hwa V, 1998, J CLIN ENDOCR METAB, V83, P4355, DOI 10.1210/jc.83.12.4355
   Kievit FM, 2010, BIOMATERIALS, V31, P5903, DOI 10.1016/j.biomaterials.2010.03.062
   Kim JB, 2005, SEMIN CANCER BIOL, V15, P365, DOI 10.1016/j.semcancer.2005.05.002
   Klein CA, 2011, CURR OPIN GENET DEV, V21, P42, DOI 10.1016/j.gde.2010.10.011
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Komatsu S, 2000, BIOCHEM BIOPH RES CO, V267, P109, DOI 10.1006/bbrc.1999.1937
   Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4
   Lee J, 2012, P NATL ACAD SCI USA, V109, P19638, DOI 10.1073/pnas.1208384109
   Leung M, 2010, PHARM RES-DORDR, V27, P1939, DOI 10.1007/s11095-010-0198-3
   Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027
   Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297
   Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064
   Long TJ, 2013, TISSUE ENG PART C-ME, V19, P738, DOI [10.1089/ten.tec.2012.0388, 10.1089/ten.TEC.2012.0388]
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Morgan TM, 2009, CLIN CANCER RES, V15, P677, DOI 10.1158/1078-0432.CCR-08-1754
   Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632
   Sato Y, 2007, CANCER SCI, V98, P1055, DOI 10.1111/j.1349-7006.2007.00502.x
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217
   Sprenger CC, 1999, CANCER RES, V59, P2370
   Sprenger CC, 2002, ONCOGENE, V21, P140, DOI 10.1038/sj.onc.1205021
   Sprenger CCT, 2008, NEOPLASIA, V10, P1350, DOI 10.1593/neo.08746
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   SWISSHELM K, 1995, P NATL ACAD SCI USA, V92, P4472, DOI 10.1073/pnas.92.10.4472
   Szot CS, 2011, BIOMATERIALS, V32, P7905, DOI 10.1016/j.biomaterials.2011.07.001
   Tan PHS, 2011, BIOMATERIALS, V32, P6131, DOI 10.1016/j.biomaterials.2011.04.084
   THALMANN GN, 1994, CANCER RES, V54, P2577
   Thalmann GN, 2000, PROSTATE, V44, P91
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Weiss MS, 2012, BIOMATERIALS, V33, P3548, DOI 10.1016/j.biomaterials.2012.01.055
   Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x
   Zhang XL, 2005, BIOTECHNOL PROGR, V21, P1289, DOI 10.1021/bp050003l
NR 56
TC 12
Z9 12
U1 0
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2014
VL 35
IS 28
BP 8164
EP 8174
DI 10.1016/j.biomaterials.2014.04.090
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM3TC
UT WOS:000339774700011
PM 24942815
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Takabatake, K
   Yamachika, E
   Tsujigiwa, H
   Takeda, Y
   Kimura, M
   Takagi, S
   Nagatsuka, H
   Iida, S
AF Takabatake, Kiyofumi
   Yamachika, Eiki
   Tsujigiwa, Hidetsugu
   Takeda, Yasushi
   Kimura, Mariko
   Takagi, Shin
   Nagatsuka, Hitoshi
   Iida, Seiji
TI Effect of geometry and microstructure of honeycomb TCP scaffolds on bone
   regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE honeycomb TCP; bone; sintering temperature; scaffold; geometric
   structure
ID BETA-TRICALCIUM-PHOSPHATE; MORPHOGENETIC PROTEIN; POROUS HYDROXYAPATITE;
   CELL-SUBSTRATUM; CARRIERS; DIFFERENTIATION; OSTEOINDUCTION;
   PROLIFERATION; OSTEOGENESIS; ROUGHNESS
AB In recent years, artificial biological materials have been commonly used for the treatment of bone tissue defects caused by trauma, tumors, or surgical stress. Although tricalcium phosphate (TCP) is a promising absorbent bone tissue reconstruction biomaterial, it has been reported that its biocompatibility and osteoconductivity depend on its preparation method and sintering temperature. In addition, although it is thought that the microenvironment produced by the extracellular matrix plays an important role in cell growth and differentiation, there have been few studies on how the geometric structure of artificial biological materials affects cells. In the present study, a new honeycomb TCP scaffold containing through-holes with diameters of 300 mm has been developed. The influence of the sintering temperature on the crystal structure and material properties of the honeycomb TCP scaffold was investigated using scanning electron microscopy and X-ray diffraction. Its biocompatibility and osteoconductivity were also evaluated by implantation into experimental animals. It was found that a beta-TCP scaffold sintered at 1200 degrees C exhibited high biocompatibility and osteoconductivity, and when it was loaded with BMP-2, it exhibited both osteoconductivity and osteoinductivity, promoting rapid bone formation in both ectopic and orthotopic areas. It is thus a highly promising bone reconstruction material that is expected to find clinical applications. (C) 2013 Wiley Periodicals, Inc.
C1 [Takabatake, Kiyofumi; Yamachika, Eiki; Takagi, Shin; Iida, Seiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008530, Japan.
   [Tsujigiwa, Hidetsugu; Nagatsuka, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Okayama 7008530, Japan.
   [Takeda, Yasushi] Sumitomo Besshi Hosp, Dept Otolaryngol, Niihama, Ehime, Japan.
   [Kimura, Mariko] PILOT Corp, Shonan Dev Ctr, Kawasaki, Kanagawa, Japan.
RP Yamachika, E (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Reconstruct Surg, Okayama 7008530, Japan.
EM eikiyama@md.okayama-u.ac.jp; tsuji@md.okayama-u.ac.jp
FU Japan Society for the Promotion of Science [24593054]
FX Contract grant sponsor: Japan Society for the Promotion of Science;
   contract grant number: 24593054
CR Abarrategi A, 2008, TISSUE ENG PT A, V14, P1305, DOI 10.1089/ten.tea.2007.0229
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Brown O, 2010, J MATER SCI-MATER M, V21, P2271, DOI 10.1007/s10856-010-4032-6
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   ENLOW DH, 1962, AM J ANAT, V110, P269, DOI 10.1002/aja.1001100305
   Ghanaati S., 2012, BIOMED MATER, V7, P1
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Huipin Y, 2001, J MATER SCI-MATER M, V12, P7
   Huipin Y, 2000, BIOMATERIALS, V21, P1283
   Huipin Y, 1999, BIOMATERIALS, V20, P1799
   Huipin Y, 2001, BIOMATERIALS, V22, P2617
   Jin QM, 2000, J BIOMED MATER RES, V51, P491, DOI 10.1002/1097-4636(20000905)51:3<491::AID-JBM25>3.0.CO;2-1
   Kawakubo A, 2011, MICROSC RES TECHNIQ, V74, P1161, DOI 10.1002/jemt.21009
   Kiba H, 2012, J HARD TISSUE BIOL, V21, P307, DOI 10.2485/jhtb.21.307
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kuboki Y, 1995, CONNECT TISSUE RES, V32, P219, DOI 10.3109/03008209509013726
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee D D, 1999, Clin Orthop Relat Res, pS396, DOI 10.1097/00003086-199910001-00038
   Mickiewicz RA, 2002, J BIOMED MATER RES, V61, P581, DOI 10.1002/jbm.10222
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   NAGASE M, 1989, J ORAL MAXIL SURG, V47, P582, DOI 10.1016/S0278-2391(89)80073-4
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Reddi AH, 2001, J BONE JOINT SURG AM, V83, P1
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Sohier J, 2009, J BIOMED MATER RES A, V92, P1105
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Vivanco J, 2011, J MECH BEHAV BIOMED, V4, P2150, DOI 10.1016/j.jmbbm.2011.07.015
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Winn SR, 1998, ADV DRUG DELIVER REV, V31, P303, DOI 10.1016/S0169-409X(97)00126-9
   Wiria FE, 2008, J MATER SCI-MATER M, V19, P989, DOI 10.1007/s10856-007-3176-5
   Yagami K, 2011, BIO-MED MATER ENG, V21, P291, DOI 10.3233/BME-2012-0677
   Yamada M, 2007, J BIOMED MATER RES B, V82B, P139, DOI 10.1002/jbm.b.30715
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yang HY, 2008, J MATER SCI-MATER M, V19, P3345, DOI 10.1007/s10856-008-3473-7
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
NR 41
TC 3
Z9 3
U1 1
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 2952
EP 2960
DI 10.1002/jbm.a.34966
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200006
PM 24115688
DA 2018-10-20
ER

PT J
AU Dailey, MMC
   Silvia, AW
   McIntire, PJ
   Wilson, GO
   Moore, JS
   White, SR
AF Dailey, Mary M. Caruso
   Silvia, Alexander W.
   McIntire, Patrick J.
   Wilson, Gerald O.
   Moore, Jeffrey S.
   White, Scott R.
TI A self-healing biomaterial based on free-radical polymerization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE self-healing; radical polymerization; microencapsulation; simulated body
   fluid; epoxy vinyl ester
ID ACRYLIC BONE-CEMENT; POLYMERS; MICROENCAPSULATION; COMPOSITES; SYSTEM
AB Self-healing chemistry used for damage repair have not previously been demonstrated for free-radical polymerization pathways. However, this chemistry is important for addition polymers such as poly(methyl methacrylate) used in bone cement and epoxy vinyl ester used in dental resins. Self-healing biomaterials offer the potential for safer and longer lasting implants and restoratives by slowing or arresting crack damage. In the free-radical self-healing system reported here, the three components required for polymerization (free-radical peroxide initiator, tertiary amine activator, and vinyl acrylate monomers) are compartmentalized into two separate microcapsules-one containing the peroxide initiator, and the other containing both monomer and activator. Crack damage ruptures the capsules so that the three components mix and react to form a new polymer that effectively rebonds the crack and restores approximately 75% of the original fracture toughness. Optimal healing is obtained by a systematic evaluation of the effect of monomer, initiator, and activator concentration on healing performance. (C) 2013 Wiley Periodicals, Inc.
C1 [Dailey, Mary M. Caruso; Silvia, Alexander W.; McIntire, Patrick J.; Moore, Jeffrey S.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Wilson, Gerald O.] Auton Mat Inc, Champaign, IL 61822 USA.
   [Moore, Jeffrey S.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA.
   [Moore, Jeffrey S.; White, Scott R.] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
   [White, Scott R.] Univ Illinois, Dept Aerosp Engn, Urbana, IL 61801 USA.
RP White, SR (reprint author), Univ Illinois, Beckman Inst, 405 N Mathews Ave, Urbana, IL 61801 USA.
EM swhite@illinois.edu
OI White, Scott/0000-0002-0831-9097
FU Air Force Office of Scientific Research [FA9550-05-1-0346]; Department
   of Defense (National Defense Science and Engineering Graduate
   Fellowship)
FX Contract grant sponsor: Air Force Office of Scientific Research;
   contract grant number: MURI grant no. FA9550-05-1-0346; Contract grant
   sponsor: Department of Defense (National Defense Science and Engineering
   Graduate Fellowship)
CR Biggs Patrick, 2009, International Journal of Nano and Biomaterials, V2, P494, DOI 10.1504/IJNBM.2009.028339
   Blaiszik BJ, 2010, ANNU REV MATER RES, V40, P179, DOI 10.1146/annurev-matsci-070909-104532
   Blaiszik BJ, 2009, POLYMER, V50, P990, DOI 10.1016/j.polymer.2008.12.040
   Brochu ABW, 2012, J BIOMED MATER RES B, V100B, P1764, DOI 10.1002/jbm.b.32743
   Brochu ABW, 2011, J BIOMED MATER RES A, V96A, P492, DOI 10.1002/jbm.a.32987
   Brown EN, 2004, J MATER SCI, V39, P1703, DOI 10.1023/B:JMSC.0000016173.73733.dc
   Brown EN, 2003, J MICROENCAPSUL, V20, P719, DOI 10.1080/0265204031000154160
   Brown EN, 2002, EXP MECH, V42, P372, DOI 10.1177/001448502321548193
   Caruso MM, 2008, ADV FUNCT MATER, V18, P1898, DOI 10.1002/adfm.200800300
   Caruso MM, 2009, CHEM REV, V109, P5755, DOI 10.1021/cr9001353
   CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28
   Cho SH, 2006, ADV MATER, V18, P997, DOI 10.1002/adma.200501814
   JUD K, 1979, POLYM BULL, V1, P697
   Kim SI, 2004, ELECTROCHIM ACTA, V50, P317, DOI 10.1016/j.electacta.2003.12.068
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Li CD, 2004, J MATER SCI-MATER M, V15, P85, DOI 10.1023/B:JMSM.0000010101.45352.d1
   McFarland B, 2004, MACROMOLECULES, V37, P6670, DOI 10.1021/ma0492216
   McFarland B, 2006, MACROMOLECULES, V39, P53
   Niu LF, 2010, LANGMUIR, V26, P4069, DOI 10.1021/la9034722
   Park J., 2007, BIOMATERIALS INTRO
   PAUL DR, 1973, J APPL POLYM SCI, V17, P2771, DOI 10.1002/app.1973.070170914
   Rule JD, 2007, POLYMER, V48, P3520, DOI 10.1016/j.polymer.2007.04.008
   Sideridou ID, 2008, J APPL POLYM SCI, V109, P515, DOI 10.1002/app.28093
   Stevens M. P., 1999, POLYM CHEM INTRO
   Wang HP, 2010, MACROMOLECULES, V43, P595, DOI 10.1021/ma902021v
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   White SR, 2008, MRS BULL, V33, P766, DOI 10.1557/mrs2008.163
   White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232
   Wilson GO, 2008, ADV FUNCT MATER, V18, P44, DOI 10.1002/adfm.200700419
   Wilson GO, 2010, J POLYM SCI POL CHEM, V48, P2698, DOI 10.1002/pola.24053
   Wilson GO, 2007, THESIS U ILLINOIS UR
NR 32
TC 8
Z9 9
U1 5
U2 142
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 3024
EP 3032
DI 10.1002/jbm.a.34975
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200013
PM 24124084
DA 2018-10-20
ER

PT J
AU Widjaja, LK
   Bora, M
   Chan, PNPH
   Lipik, V
   Wong, TTL
   Venkatraman, SS
AF Widjaja, Leonardus Kresna
   Bora, Meghali
   Chan, Paul Ng Poh Huat
   Lipik, Vitali
   Wong, Tina T. L.
   Venkatraman, Subbu S.
TI Hyaluronic acid-based nanocomposite hydrogels for ocular drug delivery
   applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyaluronic acid; hydrogel; liposome; nanocomposite; ocular drug delivery
ID BIOMEDICAL APPLICATIONS; SUSTAINED DELIVERY; BROAD RANGE; IN-VITRO;
   LIPOSOMES; RELEASE; GEL; CIPROFLOXACIN; FORMULATION; STABILITY
AB Hyaluronic acid (HA) is a widely investigated biomaterial for many therapeutic applications owing to its unique properties of biocompatibility, biodegradation, and viscoelasticity. HA being a natural component of eye tissue with significant role in wound healing is a natural choice as a carrier for ocular drug delivery, provided the incorporated drugs are released in a sustained manner. However, localized sustained release of drugs inside eye has been difficult to achieve because of the inability to retain carriers for long periods in the eye. Using noncrosslinked (soluble) HA offers limited control over site retention of drugs. In order to obtain prolonged sustained delivery, two HA-based composite hydrogels incorporating nanocarriers, have been synthesized and characterized for swelling, rheology, degradation, and in vitro release of latanoprost, a drug used to reduce intraocular pressure. The HA is first chemically modified, mixed with drug-loaded liposomes, and then crosslinked to obtain nanocomposite hydrogels. In vitro release study shows longer sustained release of latanoprost from composite hydrogels as compared to liposomes or hydrogels alone indicating additional resistance to drug diffusion because of the incorporation of liposomes inside the hydrogels. It is believed that these nanocomposite hydrogels, with controlled degradation properties and sustained release, could serve as potential drug delivery systems for many ocular diseases. (C) 2013 Wiley Periodicals, Inc.
C1 [Widjaja, Leonardus Kresna; Bora, Meghali; Chan, Paul Ng Poh Huat; Lipik, Vitali; Wong, Tina T. L.; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
RP Venkatraman, SS (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM ASSubbu@ntu.edu.sg
RI Venkatraman, Subramanian/A-2228-2011
OI Venkatraman, Subramanian/0000-0002-8693-1070; Bora,
   Meghali/0000-0002-8676-6810
FU Agency for Science, Technology and Research (A*STAR), Singapore
FX Authors would like to acknowledge the financial support provided by
   Agency for Science, Technology and Research (A*STAR), Singapore and Dr
   Seow Yiqi from Molecular Engineering Laboratory Science and Engineering
   Institutes, A*STAR for providing the NanoSight facility for size
   measurement of liposomes.
CR Balazs EA, 2004, CHEMISTRY AND BIOLOGY OF HYALURONAN, P415
   Bochot A, 1998, PHARMACEUT RES, V15, P1364, DOI 10.1023/A:1011989202488
   Borzacchiello A, 2004, TISSUE ENG NOVEL DEL, P330
   Budai L, 2007, INT J PHARM, V343, P34, DOI 10.1016/j.ijpharm.2007.04.013
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   DAVIDSON J M, 1991, Clinical Materials, V8, P171, DOI 10.1016/0267-6605(91)90027-D
   DiTizio V, 2000, J BIOMED MATER RES, V51, P96, DOI 10.1002/(SICI)1097-4636(200007)51:1<96::AID-JBM13>3.0.CO;2-S
   Falcone SJ, 2006, ACS SYM SER, V934, P155
   Fraser JRE, 1998, WENN GR INT, V72, P85
   Hosny KM, 2010, AAPS PHARMSCITECH, V11, P241, DOI 10.1208/s12249-009-9373-4
   Jin Yu-Jin, 2010, Journal of Pharmaceutical Investigation, V40, P33, DOI 10.4333/KPS.2010.40.S.033
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Lajavardi L, 2009, J CONTROL RELEASE, V139, P22, DOI 10.1016/j.jconrel.2009.05.033
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   LAURENT TC, 1992, FASEB J, V6, P2397
   LAURENT TC, 1995, ANN RHEUM DIS, V54, P429, DOI 10.1136/ard.54.5.429
   Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32
   Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Liu Y, 2012, SOFT MATTER, V8, P4517, DOI 10.1039/c2sm25092f
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Machluf Marcel, 1996, Journal of Controlled Release, V43, P35
   MacKinnon N, 2009, LANGMUIR, V25, P9413, DOI 10.1021/la900163r
   Mourtas S, 2007, COLLOID SURFACE B, V55, P212, DOI 10.1016/j.colsurfb.2006.12.005
   Mufamadi M.S., 2011, J DRUG DELIV, V3, DOI DOI 10.1155/2011/939851
   Mulik R, 2009, DRUG DEV IND PHARM, V35, P49, DOI 10.1080/03639040802178144 
   Narayanaswamy AK, 2012, OPHTHALMOLOGY, V119, P314, DOI 10.1016/j.ophtha.2011.07.053
   Natarajan Jayaganesh V, 2012, Int J Nanomedicine, V7, P123, DOI 10.2147/IJN.S25468
   Natarajan JV, 2011, PLOS ONE, V6, P1
   Nickerson CS, 2008, J BIOMECH, V41, P1840, DOI 10.1016/j.jbiomech.2008.04.015
   Nie SF, 2011, INT J NANOMED, V6, P151, DOI 10.2147/IJN.S15057
   Pjanovic R, 2010, J CHEM TECHNOL BIOT, V85, P693, DOI 10.1002/jctb.2357
   Sakai Y, 2005, INT J PHARM, V305, P176, DOI 10.1016/j.ijpharm.2005.08.017
   Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   SHAH CB, 1992, J APPL POLYM SCI, V45, P293, DOI 10.1002/app.1992.070450211
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Stenekes RJH, 2000, PHARM RES-DORDR, V17, P690
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9
   Wang SS, 2008, DRUG DELIV, V15, P149, DOI [10.1080/10717540801952456, 10.1080/10717540801952456 ]
   WEINER AL, 1985, J PHARM SCI, V74, P922, DOI 10.1002/jps.2600740903
   Xu X, 2012, SOFT MATTER, V8, P3280, DOI 10.1039/c2sm06463d
   Yeom J, 2010, BIOCONJUGATE CHEM, V21, P240, DOI 10.1021/bc9002647
   Zawko SA, 2008, J BIOMED MATER RES A, V87A, P1044, DOI 10.1002/jbm.a.31845
NR 46
TC 34
Z9 36
U1 1
U2 71
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 3056
EP 3065
DI 10.1002/jbm.a.34976
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200016
PM 24124098
DA 2018-10-20
ER

PT J
AU Luong, PT
   Browning, MB
   Bixler, RS
   Cosgriff-Hernandez, E
AF Luong, P. T.
   Browning, M. B.
   Bixler, R. S.
   Cosgriff-Hernandez, E.
TI Drying and storage effects on poly(ethylene glycol) hydrogel mechanical
   properties and bioactivity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(ethylene glycol) hydrogels; processing; storage; drying; mechanical
   properties; bioactivity retention
ID GROUP-A STREPTOCOCCUS; PEG HYDROGELS; OXIDE) HYDROGELS; VASCULAR GRAFTS;
   DRUG-DELIVERY; CELL ADHESIVE; TISSUE; COLLAGEN; GROWTH; MEDICINE
AB Hydrogels based on poly(ethylene glycol) (PEG) are increasingly used in biomedical applications because of their ability to control cell-material interactions by tuning hydrogel physical and biological properties. Evaluation of stability after drying and storage are critical in creating an off-the-shelf biomaterial that functions in vivo according to original specifications. However, there has not been a study that systematically investigates the effects of different drying conditions on hydrogel compositional variables. In the first part of this study, PEG-diacrylate hydrogels underwent common processing procedures (vacuum-drying, lyophilizing, hydrating then vacuum-drying), and the effect of this processing on the mechanical properties and swelling ratios was measured. Significant changes in compressive modulus, tensile modulus, and swelling ratio only occurred for select processed hydrogels. No consistent trends were observed after processing for any of the formulations tested. The effect of storage conditions on cell adhesion and spreading on collagen- and streptococcal collagen- like protein (Scl2-2)-PEG-diacrylamide hydrogels was then evaluated to characterize bioactivity retention after storage. Dry storage conditions preserved bioactivity after 6 weeks of storage; whereas, storage in PBS significantly reduced bioactivity. This loss of bioactivity was attributed to ester hydrolysis of the protein linker, acrylate-PEG-N-hydroxysuccinimide. These studies demonstrate that these processing methods and dry storage conditions may be used to prepare bioactive PEG hydrogel scaffolds with recoverable functionality after storage. (C) 2013 Wiley Periodicals, Inc.
C1 [Luong, P. T.; Browning, M. B.; Bixler, R. S.; Cosgriff-Hernandez, E.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP Cosgriff-Hernandez, E (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
EM cosgriff.hernandez@tamu.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU NIH/NIBIB [R01 EB013297]
FX Contract grant sponsor: NIH/NIBIB; R01 EB013297
CR Akagi Y, 2009, MACROMOLECULES, V43, P488
   Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Appelman TP, 2009, BIOMATERIALS, V30, P518, DOI 10.1016/j.biomaterials.2008.09.063
   Arcaute K, 2011, TISSUE ENG PART C-ME, V17, P27, DOI [10.1089/ten.tec.2010.0011, 10.1089/ten.TEC.2010.0011]
   Bozec L, 2011, BIOPHYS J, V101, P228, DOI 10.1016/j.bpj.2011.04.033
   Brinker C.J., 1990, SOL GEL SCI PHYS CHE, P357
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Browning MB, 2011, J BIOMED MATER RES A, V98A, P268, DOI 10.1002/jbm.a.33109
   Browning MB, 2012, BIOMACROMOLECULES, V13, P779, DOI 10.1021/bm201707z
   Browning MB, 2013, BIOMACROMOLECULES
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Caswell CC, 2008, MOL MICROBIOL, V67, P584, DOI 10.1111/j.1365-2958.2007.06067.x
   Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x
   Caswell CC, 2008, J BIOL CHEM, V283, P36168, DOI 10.1074/jbc.M806865200
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durst CA, 2011, ACTA BIOMATER, V7, P2467, DOI 10.1016/j.actbio.2011.02.018
   Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Hahn MS, 2007, ANN BIOMED ENG, V35, P190, DOI 10.1007/s10439-006-9099-3
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Han RL, 2006, MOL MICROBIOL, V61, P351, DOI 10.1111/j.1365-2958.2006.05237.x
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   Hui JH, 2013, CLIN ORTHOP RELAT R, V471, P1174, DOI 10.1007/s11999-012-2487-0
   Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200
   Kanjickal D, 2008, J BIOMED MATER RES A, V87A, P608, DOI 10.1002/jbm.a.31811
   Karajanagi SS, 2011, BIOTECHNOL BIOENG, V108, P1716, DOI 10.1002/bit.23105
   Kim J, 2009, TISSUE ENG PT A, V15, P2299, DOI 10.1089/ten.tea.2008.0326
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Lynn AD, 2009, J BIOMED MATER RES A, V93A, P941
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Moeinzadeh S, 2011, POLYMER, V52, P3887, DOI 10.1016/j.polymer.2011.07.007
   Omidian H, 2010, BIOMEDICAL APPLICATIONS OF HYDROGELS HANDBOOK, P351, DOI 10.1007/978-1-4419-5919-5_19
   Patel VR, 1996, PHARMACEUT RES, V13, P588, DOI 10.1023/A:1016054306763
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Peters R, 2007, J CHROMATOGR A, V1156, P111, DOI 10.1016/j.chroma.2006.10.071
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Pierce Biotechnology I, 2005, PROT STAB STOR
   Qiu YQ, 2012, INT J PHARMACEUT, V437, P51, DOI 10.1016/j.ijpharm.2012.07.035
   SCRANTON AB, 1990, POLYMER, V31, P1288, DOI 10.1016/0032-3861(90)90221-J
   Sebra RP, 2005, LANGMUIR, V21, P10907, DOI 10.1021/la052101m
   Sen M, 2005, J BIOMED MATER RES A, V74A, P187, DOI 10.1002/jbm.a.30308
   SHALABY WSW, 1991, J CONTROL RELEASE, V16, P355, DOI 10.1016/0168-3659(91)90013-4
   Sigma-Aldrich, 2013, COLL SOL TYP 1 RAT T
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Stringer JL, 1996, J CONTROL RELEASE, V42, P195, DOI 10.1016/0168-3659(96)01457-5
   Tan HP, 2010, J BIOMED MATER RES A, V92A, P979, DOI 10.1002/jbm.a.32438
   Temenoff JS, 2003, J BIOMAT SCI-POLYM E, V14, P989, DOI 10.1163/156856203322381465
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
NR 63
TC 6
Z9 6
U1 2
U2 41
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 3066
EP 3076
DI 10.1002/jbm.a.34977
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200017
PM 24123725
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Frick, CP
   DiRienzo, AL
   Hoyt, AJ
   Safranski, DL
   Saed, M
   Losty, EJ
   Yakacki, CM
AF Frick, Carl P.
   DiRienzo, Amy L.
   Hoyt, Anthony J.
   Safranski, David L.
   Saed, Mohand
   Losty, Eric J.
   Yakacki, Christopher M.
TI High-strength poly(para-phenylene) as an orthopedic biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(para-phenylene); mechanical properties; water absorption; fatigue;
   cytotoxicity
ID FATIGUE CRACK-PROPAGATION; RIGID-ROD POLYMER; MECHANICAL-PROPERTIES;
   P-POLYPHENYL; SUBSTITUTED POLY(P-PHENYLENES); SOLUBLE
   POLY(PARA-PHENYLENE)S; METHACRYLATE COPOLYMERS; HYDROXYALKYL ACRYLATE;
   SYNTHETIC HYDROGELS; WEAR PROPERTIES
AB Poly(para-phenylene) (PPP) exhibits exceptional mechanical strength, stiffness, toughness, and chemical inertness, although it is not currently used in any biomedical applications. The purpose of this study is to serve as a preliminary investigation into the potential of PPP as a biomaterial in orthopedic load-bearing applications. Nuclear magnetic resonance (NMR) analysis confirmed a polymer structure composed of an aromatic backbone and side groups. Tensile PPP specimens along with samples from several other polymers often used for orthopedic applications were elongated to failure after being soaked in phosphate buffered saline (PBS) for 1 h, 1 day, 1 week, 2 weeks, 1 month, and more than 1 year. Results showed that PBS absorption of the PPP plateaued at 1 week at values of similar to 0.7 wt % and remained within one standard deviation when soaked for over 1 year. PBS absorption did not affect elastic modulus (5.0 GPa), yield strength (141 MPa), fracture strength (120 MPa) and strain-to-failure (17%) more than one standard deviation. Zero-to-tension fatigue testing established an endurance limit of approximately 35 MPa, which was relatively insensitive to frequency (1-10 Hz). Eagle's minimum essential medium (MEM) elution assay with fibroblasts confirmed that the PPP was noncytotoxic. Relative to other polymers used for load-bearing biomedical applications, PPP displays promising mechanical properties that remain stable in aqueous solution. Lastly, prototype PPP and polyetheretherketone (PEEK) bone plates were manufactured and tested, with the PPP plate showing a 38% higher maximum tensile load before failure. (C) 2013 Wiley Periodicals, Inc.
C1 [Frick, Carl P.; DiRienzo, Amy L.; Hoyt, Anthony J.] Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
   [Safranski, David L.] MedShape Inc, Res & Dev, Atlanta, GA 30318 USA.
   [Saed, Mohand; Losty, Eric J.; Yakacki, Christopher M.] Univ Colorado, Dept Mech Engn, Denver, CO 80217 USA.
RP Frick, CP (reprint author), Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
EM cfrick@uwyo.edu
OI Frick, Carl/0000-0002-8202-924X
FU Solvay Specialty Polymers, LLC
FX CPF and CMY gratefully thank Solvay Specialty Polymers, LLC for their
   support of this work.
CR Arnold RT, 1939, J AM CHEM SOC, V61, P1407, DOI 10.1021/ja01875a024
   BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   BASQUIN O.H., 1910, P AM SOC TEST MATER, V10, P625
   Boinard E, 2000, POLYMER, V41, P1063, DOI 10.1016/S0032-3861(99)00259-1
   Burstone CJ, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.05.030
   CHATURVEDI V, 1993, MACROMOLECULES, V26, P2607, DOI 10.1021/ma00062a032
   Chen JK, 2005, POLYMER, V46, P2354, DOI 10.1016/j.polymer.2005.01.046
   CHIVERS RA, 1994, POLYMER, V35, P110, DOI 10.1016/0032-3861(94)90057-4
   Chlopek J, 2005, J MATER SCI-MATER M, V16, P1051, DOI 10.1007/s10856-005-4759-7
   Cianga I, 2002, MACROMOL SYMP, V183, P145, DOI 10.1002/1521-3900(200207)183:1<145::AID-MASY145>3.0.CO;2-R
   CONNOLLY M, 1995, MACROMOLECULES, V28, P1872, DOI 10.1021/ma00110a022
   CORKHILL PH, 1987, POLYMER, V28, P1758, DOI 10.1016/0032-3861(87)90021-8
   de Campos A, 2013, J POLYM ENVIRON, V21, P1, DOI 10.1007/s10924-012-0512-8
   Dean D, 1998, J POLYM SCI POL PHYS, V36, P2971, DOI 10.1002/(SICI)1099-0488(19981130)36:16<2971::AID-POLB12>3.3.CO;2-I
   Drummond JL, 2008, J DENT RES, V87, P710, DOI 10.1177/154405910808700802
   Friedrich K, 2011, TRIBOL INT, V44, P1032, DOI 10.1016/j.triboint.2011.04.008
   Friedrich K, 2011, J MATER SCI, V46, P1714, DOI 10.1007/s10853-010-4989-z
   Friedrich K, 2010, INT J POLYM MATER, V59, P680, DOI 10.1080/00914037.2010.483211
   GIN DL, 1994, J AM CHEM SOC, V116, P10507, DOI 10.1021/ja00102a018
   GREM G, 1992, ADV MATER, V4, P36, DOI 10.1002/adma.19920040107
   Harre K, 2006, POLYMER, V47, P7312, DOI 10.1016/j.polymer.2006.05.067
   HARTWIG G, 1991, CRYOGENICS, V31, P231, DOI 10.1016/0011-2275(91)90081-7
   Jang ES, 2011, PROG ORG COAT, V71, P36, DOI 10.1016/j.porgcoat.2010.12.007
   KOVACIC P, 1963, J AM CHEM SOC, V85, P454, DOI 10.1021/ja00887a019
   KOVACIC P, 1963, J ORG CHEM, V28, P968, DOI 10.1021/jo01039a022
   KOVACIC P, 1963, J ORG CHEM, V28, P1864, DOI 10.1021/jo01042a031
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lakhera N, 2013, J APPL POLYM SCI, V128, P1913, DOI 10.1002/app.38371
   Lupshak N, 2001, SYNTHETIC MET, V119, P95, DOI 10.1016/S0379-6779(00)00885-7
   Martin AC, 2013, COMPOS SCI TECHNOL, DOI [10.1016/j.compscitech.2013.09.012, DOI 10.1016/J.C0MPSCITECH.2013.09.012]
   Mitschke U, 2000, J MATER CHEM, V10, P1471, DOI 10.1039/a908713c
   Morgan SE, 2006, POLYMER, V47, P2865, DOI 10.1016/j.polymer.2006.02.025
   Nieminen T, 2008, J BIOMED MATER RES A, V84A, P377, DOI 10.1002/jbm.a.31310
   Nunes JP, 2009, PLAST RUBBER COMPOS, V38, P167, DOI 10.1179/174328909X387946
   Pei XQ, 2012, WEAR, V274, P452, DOI 10.1016/j.wear.2011.09.009
   Percec V, 1999, MACROMOLECULES, V32, P2597, DOI 10.1021/ma9900129
   RAMIREZ A, 1982, POLYM ENG SCI, V22, P975, DOI 10.1002/pen.760221512
   REHAHN M, 1989, POLYMER, V30, P1054, DOI 10.1016/0032-3861(89)90078-5
   REHAHN M, 1989, POLYMER, V30, P1060, DOI 10.1016/0032-3861(89)90079-7
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   RUNT J, 1991, J MATER SCI, V26, P792, DOI 10.1007/BF00588317
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Simon GP, 1998, J POLYM SCI POL PHYS, V36, P1465, DOI 10.1002/(SICI)1099-0488(19980715)36:9<1465::AID-POLB5>3.0.CO;2-J
   Smith KE, 2009, POLYMER, V50, P5112, DOI 10.1016/j.polymer.2009.08.040
   TALBOTT MF, 1987, J COMPOS MATER, V21, P1056, DOI 10.1177/002199838702101104
   Taylor DK, 2000, MACROMOLECULES, V33, P2355, DOI 10.1021/ma9911896
   Trimmer MS, 1997, INT SAMPE TECH CONF, V42, P1315
   TROTIGNON JP, 1993, J MATER SCI, V28, P2207, DOI 10.1007/BF00367585
   Vaia RA, 1998, POLYMER, V39, P6021, DOI 10.1016/S0032-3861(98)00113-X
   Vuorinen AM, 2011, COMPOS INTERFACE, V18, P387, DOI 10.1163/156855411X595807
   Vuorinen AM, 2011, J ADHES DENT, V13, P333, DOI 10.3290/j.jad.a19653
   Vuotinen AM, 2008, DENT MATER, V24, P708, DOI 10.1016/j.dental.2007.07.003
   WITTELER H, 1993, MAKROMOL CHEM-RAPID, V14, P471
   Xiong DS, 2001, WEAR, V250, P242, DOI 10.1016/S0043-1648(01)00647-0
   Yakacki CM, 2008, ADV ENG MATER, V10, P112, DOI 10.1002/adem.200700184
   Yang B, 2004, SMART MATER STRUCT, V13, P191, DOI 10.1088/0964-1726/13/1/022
   YEH JT, 1991, J POLYM SCI POL PHYS, V29, P371, DOI 10.1002/polb.1991.090290313
   Zhang HW, 2013, ACTA POLYM SIN, P63, DOI 10.3724/SP.J.1105.2013.12139
NR 58
TC 8
Z9 8
U1 3
U2 48
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 3122
EP 3129
DI 10.1002/jbm.a.34982
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200023
PM 24123879
DA 2018-10-20
ER

PT J
AU Ponta, O
   Ciceo-Lucacel, R
   Vulpoi, A
   Radu, T
   Simon, S
AF Ponta, Oana
   Ciceo-Lucacel, Raluca
   Vulpoi, Adriana
   Radu, Teodora
   Simon, Simion
TI Molybdenum effect on the structure of SiO2-CaO-P2O5 bioactive xerogels
   and on their interface processes with simulated biofluids
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE molybdenum ions; powelite nanocrystallites; SBF immersion; BSA
   functionalization
ID CALCIUM-PHOSPHATE GLASSES; PROTEIN ADSORPTION; TITANOSILICATE
   MICROSPHERES; SERUM-ALBUMIN; SYSTEM; MOO3; XPS; CRYSTALLIZATION;
   NANOPARTICLES; SPECTROSCOPY
AB The study is focused on synthesis, investigation of the structural and morphological changes induced by MoO3 addition, and thermal treatment, as well as in vitro characterization of a new sol-gel derived SiO2-CaO-P2O5 bioactive materials. The obtained systems are composite materials consisting of nanocrystalline apatite, bioactive glass and CaMoO4 nanoparticles, which are of interest for both regenerative medicine and specific medical applications of the releasable molybdenum ions. The changes induced by the thermal treatments and MoO3 addition with respect to the structure and morphology were completed using differential thermal analysis\thermogravimetric analysis, X-ray diffraction (XRD), scanning electron microscopy (SEM), energy dispersive X-ray (EDX), X-ray photoelectron spectroscopy (XPS), Fourier transform infrared (FTIR) spectroscopy, electron paramagnetic resonance, and Brunauer-Emmett-Teller. The biological performance of these materials was evaluated in vitro by performing bioactivity and biocompatibility tests. The bioactive properties in terms of hydroxyapatite layer formation on the biomaterial surface after simulated body fluid immersion were studied by XRD and SEM. To establish their biocompatibility, the biomaterials surface was functionalized with protein and the resulted sample was investigated using SEM, FTIR, and XPS. The obtained results suggest that the addition of molybdenum oxide in proper concentration improves the biocompatibility in terms of enhancement of protein adherence on Si-Ca-P surface due to CaMoO4 crystalline phase development and does not inhibit bioactivity. (C) 2013 Wiley Periodicals, Inc.
C1 [Ponta, Oana] Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
   Univ Babes Bolyai, Inst Interdisciplinary Res Bionanosci, Cluj Napoca 400084, Romania.
RP Ponta, O (reprint author), Univ Babes Bolyai, Fac Phys, Cluj Napoca 400084, Romania.
EM oana.ponta@phys.ubbcluj.ro
RI Lucacel Ciceo, Raluca/F-2154-2013; Radu, Maria Teodora/C-2554-2012;
   Vulpoi, Adriana/D-3890-2012
OI Radu, Maria Teodora/0000-0002-7925-0795; Vulpoi,
   Adriana/0000-0001-5334-4980
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-RU-TE-2011-3-0032]
FX Contract grant sponsor: Romanian National Authority for Scientific
   Research, CNCS-UEFISCDI; contract grant number: PN-II-RU-TE-2011-3-0032
CR Akkouch A, 2010, J BIOMED MATER RES A, V92A, P221, DOI 10.1002/jbm.a.32357
   Areva S, 2002, CHEM MATER, V14, P1614, DOI 10.1021/cm0107272
   Bih L, 2008, J MOL STRUCT, V872, P1, DOI 10.1016/j.molstruc.2007.02.005
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Brash JL, 1987, ACS S SERIES, V343
   Buchanan LA, 2010, J BIOMED MATER RES A, V93A, P537, DOI 10.1002/jbm.a.32561
   Caurant D, 2007, J AM CERAM SOC, V90, P774, DOI 10.1111/j.1551-2916.2006.01467.x
   Cho WS, 1997, J AM CERAM SOC, V80, P765, DOI 10.1111/j.1151-2916.1997.tb02895.x
   Chrissanthopoulos A, 2008, VIB SPECTROSC, V48, P118, DOI 10.1016/j.vibspec.2007.11.008
   COHEN HJ, 1971, J BIOL CHEM, V246, P374
   Costa D, 2013, J BIOMED MATER RES A, V101, P1210, DOI 10.1002/jbm.a.34416
   Cozar O, 2008, J NON-CRYST SOLIDS, V354, P1032, DOI 10.1016/j.jnoncrysol.2007.08.002
   COZAR O, 1993, SOLID STATE COMMUN, V85, P461, DOI 10.1016/0038-1098(93)90700-W
   DOMINE F, 1983, J NON-CRYST SOLIDS, V55, P125, DOI 10.1016/0022-3093(83)90012-1
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Farges F, 2006, CAN MINERAL, V44, P731, DOI 10.2113/gscanmin.44.3.731
   Flower GL, 2007, PHYSICA B, V393, P61, DOI 10.1016/j.physb.2006.12.070
   Fraqueza G, 2012, J INORG BIOCHEM, V107, P82, DOI 10.1016/j.jinorgbio.2011.10.010
   Fujii E, 2006, ACTA BIOMATER, V2, P69, DOI 10.1016/j.actbio.2005.09.002
   Garbout A, 2009, J ALLOY COMPD, V469, P229, DOI 10.1016/j.jallcom.2008.01.086
   Gruian C, 2012, BBA-PROTEINS PROTEOM, V1824, P873, DOI 10.1016/j.bbapap.2012.04.008
   Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034
   JAMNICKY M, 1995, J NON-CRYST SOLIDS, V185, P151, DOI 10.1016/0022-3093(94)00642-3
   Jones R, 2010, P I MECH ENG H, V224, P1373
   Khyzhun OY, 2004, J ALLOY COMPD, V366, P54, DOI 10.1016/S0925-8388(03)00736-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kumar AVR, 2012, J MOL STRUCT, V1016, P39, DOI 10.1016/j.molstruc.2012.02.039
   LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Mendel RR, 2005, DALTON T, P3404, DOI 10.1039/b505527j
   MOOTZ D, 1990, J INCLUS PHENOM MOL, V8, P139, DOI 10.1007/BF01131293
   Mozafari M, 2010, J NON-CRYST SOLIDS, V356, P1470, DOI 10.1016/j.jnoncrysol.2010.04.040
   NICHOLAS DJD, 1954, J BIOL CHEM, V207, P341
   Ponta O, 2013, J MOL STRUCT, V1044, P2, DOI 10.1016/j.molstruc.2013.01.026
   Ponta O, 2012, MATER CHEM PHYS, V135, P863, DOI 10.1016/j.matchemphys.2012.05.071
   Ponta O, 2011, J SOL-GEL SCI TECHN, V58, P530, DOI 10.1007/s10971-011-2423-x
   Pryce RS, 2004, J MATER CHEM, V14, P2303, DOI 10.1039/b400922c
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Short RJ, 2005, J NUCL MATER, V340, P179, DOI 10.1016/j.jnucmat.2004.11.008
   Simon S, 2012, J MATER SCI-MATER M, V23, P1193, DOI 10.1007/s10856-012-4590-x
   SIMON S, 1983, J NON-CRYST SOLIDS, V57, P23, DOI 10.1016/0022-3093(83)90405-2
   Stankova M.J., 2007, J TRACE ELEM MED BIO, V21, P8
   Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439
   Tamasan M, 2010, APPL CLAY SCI, V50, P418, DOI 10.1016/j.clay.2010.08.022
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Toloman D, 2013, J ALLOY COMPD, V556, P67, DOI 10.1016/j.jallcom.2012.12.112
   Vanea E, 2011, APPL SURF SCI, V257, P2346, DOI 10.1016/j.apsusc.2010.09.101
   Vedeanu NS, 2012, J ALLOY COMPD, V534, P93, DOI 10.1016/j.jallcom.2012.04.079
   Vulpoi A, 2012, J BIOMED MATER RES A, V100A, P1179, DOI 10.1002/jbm.a.34060
   Vulpoi A, 2012, MAT SCI ENG C-MATER, V32, P178, DOI 10.1016/j.msec.2011.10.015
   Wang ZL, 2002, HDB NANOPHASE NANOST, VI
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Wienold J, 2003, EUR J INORG CHEM, P1058
   Yurong C., 2005, MATER CHEM PHYS, V94, P283
NR 54
TC 5
Z9 5
U1 2
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 3177
EP 3185
DI 10.1002/jbm.a.34989
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200028
PM 24142573
DA 2018-10-20
ER

PT J
AU Oberwallner, B
   Brodarac, A
   Choi, YH
   Saric, T
   Anic, P
   Morawietz, L
   Stamm, C
AF Oberwallner, Barbara
   Brodarac, Andreja
   Choi, Yeong-Hoon
   Saric, Tomo
   Anic, Petra
   Morawietz, Lars
   Stamm, Christof
TI Preparation of cardiac extracellular matrix scaffolds by
   decellularization of human myocardium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE heart; decellularization; scaffold; stem cell; regeneration
ID MESENCHYMAL STEM-CELLS; SOURCE ANIMAL AGE; MECHANICAL FUNCTION; BIOLOGIC
   SCAFFOLD; IMMUNE-RESPONSE; HEART-DISEASE; BONE-MARROW; TISSUE; PATCH;
   REPAIR
AB Extracellular matrix (ECM) derived by tissue decellularization has applications as a tissue engineering scaffold and for support of cellular regeneration. Myocardial ECM from animals has been produced by whole-organ perfusion or immersion processes, but methods for preparation of human myocardial ECM for therapy and research have not been compared in detail, yet. We analyzed the impact of decellularization processes on human myocardial ECM, and tested its ability to serve as a scaffold for cell seeding. Sodium dodecyl sulfate (SDS)-based decellularization, but not treatments based on Triton X-100, deoxycholate or hypo/hypertonic incubations, removed cells satisfactorily, and incubation with fetal bovine serum (FBS) eliminated residual DNA. ECM architecture was best preserved by a protocol consisting of 2 h lysis, 6 h SDS, and 3 h FBS, but age and pathology of the donor tissue are highly important for producing reproducible, high-quality scaffolds. We also studied ECM repopulation with mesenchymal stem cells (CB-MSC), cardiomyocytes derived from induced pluripotent stem cells (iPS-CM), and naive neonatal mouse cardiomyocytes. Cells attached to the matrix and proliferated and displayed higher viability than in standard culture. We conclude that human cardiac ECM sheets may be suitable scaffold for cell-matrix interaction studies and as a biomaterial for tissue regeneration and engineering. (C) 2013 Wiley Periodicals, Inc.
C1 [Oberwallner, Barbara; Brodarac, Andreja; Stamm, Christof] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.
   [Brodarac, Andreja; Anic, Petra; Morawietz, Lars; Stamm, Christof] Deutsch Herzzentrum Berlin DHZB, Berlin, Germany.
   [Choi, Yeong-Hoon; Saric, Tomo] Univ Cologne, D-50931 Cologne, Germany.
RP Stamm, C (reprint author), Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.
EM stamm@dhzb.de
RI Saric, Tomo/B-3415-2015
OI Saric, Tomo/0000-0001-8344-1095
FU Charite Universitatsmedizin [FKZ 1315848A]; Helmholtz-Zentrum Geesthacht
   [FKZ 1315848B]
FX Contract grant sponsor: Charite Universitatsmedizin; contract grant
   number: FKZ 1315848A; Contract grant sponsor: Helmholtz-Zentrum
   Geesthacht; contract grant number: FKZ 1315848B
CR Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Badylak SF, 2006, CELL TRANSPLANT, V15, pS29, DOI 10.3727/000000006783982368
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bayrak A, BIOMATERIALS, V31, P3793
   Bayrak A, 2013, TISSUE ENG PT A, V19, P1592, DOI [10.1089/ten.tea.2012.0394, 10.1089/ten.TEA.2012.0394]
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Gersh BJ, 2009, MAYO CLIN PROC, V84, P876, DOI 10.1016/S0025-6196(11)60505-3
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Gui LQ, 2010, TISSUE ENG PART C-ME, V16, P173, DOI 10.1089/ten.TEC.2009.0120
   Halbach M, 2013, CARDIOVASC RES, V100, P432, DOI 10.1093/cvr/cvt213
   Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004
   Hata H, 2010, EUR J CARDIO-THORAC, V38, P450, DOI 10.1016/j.ejcts.2010.02.009
   Herrmann JL, 2009, ANN THORAC SURG, V88, P1714, DOI 10.1016/j.athoracsur.2009.05.079
   Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124
   Jung T, 2007, ANN NY ACAD SCI, V1119, P97, DOI 10.1196/annals.1404.008
   Kelly DJ, 2009, TISSUE ENG PT A, V15, P2189, DOI 10.1089/ten.tea.2008.0430
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   McCormick RJ, 1998, BASIC APPL MYOL, V8, P143
   Ota T, 2007, J THORAC CARDIOV SUR, V133, P979, DOI 10.1016/j.jtcvs.2006.11.035
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozeki M, 2006, J BIOMED MATER RES A, V79A, P771, DOI 10.1002/jbm.a.30885
   Potapova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2257, DOI 10.1152/ajpheart.00219.2008
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437
   Sicari BM, 2012, BIOMATERIALS, V33, P5524, DOI 10.1016/j.biomaterials.2012.04.017
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Stamm C, 2009, HEART LUNG CIRC, V18, P245, DOI 10.1016/j.hlc.2008.10.014
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Tottey S, 2011, BIOMATERIALS, V32, P128, DOI 10.1016/j.biomaterials.2010.09.006
   Tudorache I, 2009, EUR J CARDIO-THORAC, V36, P306, DOI 10.1016/j.ejcts.2009.02.038
   Turner WS, J BIOMED MAT RES B, V100, P2060
   Wainwright JM, 2009, TISSUE ENG PART C-ME, V16, P525
   Wainwright JM, 2012, CELLS TISSUES ORGANS, V195, P159, DOI 10.1159/000331400
   Wang B, 2010, J BIOMED MATER RES A, V94A, P1100, DOI 10.1002/jbm.a.32781
   Weymann A, 2011, CIRC J, V75, P852, DOI 10.1253/circj-CJ-10-0717
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
NR 46
TC 37
Z9 37
U1 2
U2 54
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2014
VL 102
IS 9
BP 3263
EP 3272
DI 10.1002/jbm.a.35000
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AM6HP
UT WOS:000339965200037
PM 24142588
DA 2018-10-20
ER

PT J
AU Thambi, T
   Park, JH
AF Thambi, Thavasyappan
   Park, Jae Hyung
TI Recent Advances in Shell-Sheddable Nanoparticles for Cancer Therapy
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Review
DE Polymeric Nanoparticles; Micelle; pH; Reducing Agents; Triggered Release
ID INTRACELLULAR DRUG-DELIVERY; BLOCK-COPOLYMER NANOCARRIERS;
   SELF-ASSEMBLED NANOPARTICLES; LONG-CIRCULATING NANOPARTICLES; DEXTRAN
   SULFATE NANOPARTICLES; HYALURONIC-ACID NANOPARTICLES; GLYCOL CHITOSAN
   NANOPARTICLES; CONTROLLED-RELEASE SYSTEM; CROSS-LINKED MICELLES;
   POLYMERIC MICELLES
AB Cancer remains one of the most incurable diseases associated with high mortality and morbidity. Although extensive studies have been carried out for cancer therapy, there are still no gold standards available for treatment. Spurred by advances in biomaterial sciences, recent efforts have focused on the development of polymeric nanoparticles for site-specific delivery of anticancer drugs. Such nanoparticles have distinct characteristics, including high thermodynamic stability, good biocompatibility, and prolonged circulation in the bloodstream. Owing to these unique features, systemically administered nanoparticles can passively accumulate at tumor tissue with leaky vasculature and poor lymphatic drainage system, which is called the enhanced permeation and retention (EPR) effect. However, the site-specific accumulation of nanoparticles does not guarantee high antitumor efficacy because the conventional nanoparticles release the drugs in a sustained manner via the passive diffusion mechanism, which may not endow tumor tissue with cytotoxic local concentrations of the drugs. To surmount this limitation, nanoparticles that can rapidly release the drug at the tumor site need to be developed. In recent years, it has been demonstrated that shell-sheddable nanoparticles have an ability to rapidly release the drug by recognizing the specific environments of the tumor tissue. After systemic administration, shell-sheddable nanoparticles reach tumor sites via the EPR effect, followed by exposure to tumor microenvironment-specific stimuli which cause a burst release of the drug. Representative stimuli, used to design shell-sheddable nanparticles, include pH, redox, enzymes, temperature, ultraviolet, and ultrasound. In this review, we discuss the recent advances in tumor-specific, shell-sheddable nanoparticles for drug delivery.
C1 [Thambi, Thavasyappan; Park, Jae Hyung] Sungkyunkwan Univ, Sch Chem Engn, Suwon 440746, South Korea.
   [Park, Jae Hyung] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Suwon 440746, South Korea.
RP Park, JH (reprint author), Sungkyunkwan Univ, Sch Chem Engn, Suwon 440746, South Korea.
EM jhpark1@skku.edu
RI Park, Jae Hyung/B-5967-2018; Thavasyappan, Thambi/F-2391-2016
FU Global Research Laboratory Program [NRF-2013K1A1A2A02076442]; Basic
   Science Research Programs of NRF [20100027955, 2012012827]
FX This work was financially supported by the Global Research Laboratory
   Program (NRF-2013K1A1A2A02076442) and the Basic Science Research
   Programs (20100027955 and 2012012827) of NRF.
CR Aleksanian S, 2012, POLYM CHEM-UK, V3, P2138, DOI 10.1039/c2py20154b
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Amoozgar Z, 2012, WIRES NANOMED NANOBI, V4, P219, DOI 10.1002/wnan.1157
   Anitha A, 2013, J BIOMED NANOTECHNOL, V9, P335, DOI 10.1166/jbn.2013.1558
   Bae Y, 2005, MOL BIOSYST, V1, P242, DOI 10.1039/b500266d
   Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653
   Batist G, 2001, J CLIN ONCOL, V19, P1444, DOI 10.1200/JCO.2001.19.5.1444
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bernkop-Schnurch A, 2012, EUR J PHARM BIOPHARM, V81, P463, DOI 10.1016/j.ejpb.2012.04.007
   Bhatnagar I, 2014, J BIOMED NANOTECHNOL, V10, P120, DOI 10.1166/jbn.2014.1677
   Bildstein L, 2011, ADV DRUG DELIVER REV, V63, P3, DOI 10.1016/j.addr.2010.12.005
   Binauld S, 2013, CHEM COMMUN, V49, P2082, DOI 10.1039/c2cc36589h
   Broaders KE, 2010, J AM CHEM SOC, V133, P756
   Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]
   Cerritelli S, 2007, BIOMACROMOLECULES, V8, P1966, DOI 10.1021/bm070085x
   Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529
   Chabot GG, 1997, CLIN PHARMACOKINET, V33, P245, DOI 10.2165/00003088-199733040-00001
   Chadha R., 2013, J NANOPHARM DRUG DEL, V1, P173
   Chan N, 2014, POLYM CHEM-UK, V5, P1637, DOI 10.1039/c3py00852e
   Chan N, 2013, CHEM COMMUN, V49, P7534, DOI 10.1039/c3cc44200d
   Chen B, 2014, J BIOMED NANOTECHNOL, V10, P4, DOI 10.1166/jbn.2014.1781
   Chen HY, 2012, BIOCONJUGATE CHEM, V23, P1915, DOI 10.1021/bc3003088
   Chen J, 2011, BIOMACROMOLECULES, V12, P3601, DOI 10.1021/bm200804j
   Chen W, 2013, J CONTROL RELEASE, V169, P171, DOI 10.1016/j.jconrel.2013.01.001
   Chen W, 2009, BIOMACROMOLECULES, V10, P1727, DOI 10.1021/bm900074d
   Cheng QY, 2013, J NANOSCI NANOTECHNO, V13, P755, DOI 10.1166/jnn.2013.6058
   Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030
   Cho Y, 2013, CHEM COMMUN, V49, P1202, DOI 10.1039/c2cc36297j
   Choi KY, 2011, ACS NANO, V5, P8591, DOI 10.1021/nn202070n
   Choi KY, 2011, BIOMATERIALS, V32, P1880, DOI 10.1016/j.biomaterials.2010.11.010
   Choi KY, 2009, J MATER CHEM, V19, P4102, DOI 10.1039/b900456d
   Coradini D, 1999, INT J CANCER, V81, P411, DOI 10.1002/(SICI)1097-0215(19990505)81:3<411::AID-IJC15>3.0.CO;2-F
   Coradini D, 2004, CLIN CANCER RES, V10, P4822, DOI 10.1158/1078-0432.CCR-04-0349
   Davis ME, 2009, ADV DRUG DELIVER REV, V61, P1189, DOI 10.1016/j.addr.2009.05.005
   de la Rica R, 2012, ADV DRUG DELIVER REV, V64, P967, DOI 10.1016/j.addr.2012.01.002
   Deng C, 2012, NANO TODAY, V7, P467, DOI 10.1016/j.nantod.2012.08.005
   Deng L, 2012, RSC ADV, V2, P12909, DOI 10.1039/c2ra21888g
   Ding CX, 2009, BIOCONJUGATE CHEM, V20, P1163, DOI 10.1021/bc800563g
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Du JZ, 2011, J AM CHEM SOC, V133, P17560, DOI 10.1021/ja207150n
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958
   Felber AE, 2012, ADV DRUG DELIVER REV, V64, P979, DOI 10.1016/j.addr.2011.09.006
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fleige E, 2012, ADV DRUG DELIVER REV, V64, P866, DOI 10.1016/j.addr.2012.01.020
   Gao C, 2004, PROG POLYM SCI, V29, P183, DOI 10.1016/j.progpolymsci.2003.12.002
   Gao GH, 2011, J CONTROL RELEASE, V155, P11, DOI 10.1016/j.jconrel.2010.09.012
   Gao WW, 2010, ANGEW CHEM INT EDIT, V49, P6567, DOI 10.1002/anie.201001868
   Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478
   Geng J, 2012, ADV HEALTHC MATER, V1, P332, DOI 10.1002/adhm.201200067
   Go YM, 2008, BIOCHIM BIOPHYS ACTA, V1780, P1273, DOI DOI 10.1016/J.BBAGEN.2008.01.011
   Goodarzi N, 2013, CARBOHYD POLYM, V92, P1280, DOI 10.1016/j.carbpol.2012.10.036
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Guo Q, 2012, COLLOID SURFACE B, V100, P138, DOI 10.1016/j.colsurfb.2012.04.041
   HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9
   Hamaguchi T, 2010, CLIN CANCER RES, V16, P5058, DOI 10.1158/1078-0432.CCR-10-0387
   Hamilton A., 2001, EUR J CANCER, V37, P15
   Han P, 2010, LANGMUIR, V26, P14414, DOI 10.1021/la102837a
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Hashida M., 2008, BIOCONJUGATE CHEM, V20, P60
   Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607
   Homma A, 2010, BIOORGAN MED CHEM, V18, P1062, DOI 10.1016/j.bmc.2009.12.053
   Hong H, 2012, ACS NANO, V6, P2361, DOI 10.1021/nn204625e
   Hornig S, 2009, J COLLOID INTERF SCI, V338, P56, DOI 10.1016/j.jcis.2009.05.025
   Hu FQ, 2012, MOL PHARMACEUT, V9, P2469, DOI 10.1021/mp300002v
   Huo M, 2014, POLYM CHEM-UK, V5, P1519, DOI 10.1039/c3py01192e
   Ishii H, 2003, JPN J CLIN ONCOL, V33, P570, DOI 10.1093/jjco/hyg106
   Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977
   Jaracz S, 2005, BIOORGAN MED CHEM, V13, P5043, DOI 10.1016/j.bmc.2005.04.084
   Jayakumar R., 2013, J NANOPHARM DRUG DEL, V1, P18
   Jee JP, 2012, CURR OPIN SOLID ST M, V16, P333, DOI 10.1016/j.cossms.2013.01.002
   Jiang K., 2013, REV NANOSCI NANOTECH, V2, P171
   Jin Y, 2011, BIOMACROMOLECULES, V12, P3460, DOI 10.1021/bm200956u
   Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8
   Kang M., 2008, MACROMOLECULES, V42, P455
   Kato K, 2012, INVEST NEW DRUG, V30, P1621, DOI 10.1007/s10637-011-9709-2
   Kato Y, 2004, BIOMATERIALS, V25, P907, DOI 10.1016/S0142-9612(03)00598-2
   Katz JS, 2010, J AM CHEM SOC, V132, P3654, DOI 10.1021/ja910606y
   Khandare J, 2006, PROG POLYM SCI, V31, P359, DOI 10.1016/j.progpolymsci.2005.09.004
   Khang G., 2013, SCI REP, V3, P2233
   Khorsand B, 2013, BIOMACROMOLECULES, V14, P2103, DOI 10.1021/bm4004805
   Kim H, 2013, J MATER CHEM B, V1, P429, DOI 10.1039/c2tb00287f
   Kim H, 2013, ACS NANO, V7, P6735, DOI 10.1021/nn403096s
   Kim SH, 2013, CHEM COMMUN, V49, P10349, DOI 10.1039/c3cc44260h
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   Koo AN, 2012, BIOMATERIALS, V33, P1489, DOI 10.1016/j.biomaterials.2011.11.013
   Koo AN, 2008, CHEM COMMUN, P6570, DOI 10.1039/b815918a
   Koo H, 2013, J CONTROL RELEASE, V172, P823, DOI 10.1016/j.jconrel.2013.08.297
   Kopecek J, 2013, ADV DRUG DELIVER REV, V65, P49, DOI 10.1016/j.addr.2012.10.014
   Kwag DS, 2013, CHEM COMMUN, V49, P282, DOI 10.1039/c2cc36596k
   Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lee E, 2008, J MED CHEM, V51, P6442, DOI 10.1021/jm800767c
   Lee H, 2013, J BIOMED NANOTECHNOL, V9, P299, DOI 10.1166/jbn.2013.1498
   Lee H, 2008, BIOCONJUGATE CHEM, V19, P1319, DOI 10.1021/bc8000485
   Lee SJ, 2011, BIOMATERIALS, V32, P4021, DOI 10.1016/j.biomaterials.2011.02.009
   Li J, 2012, BIOMATERIALS, V33, P2310, DOI 10.1016/j.biomaterials.2011.11.022
   Li XQ, 2011, CHEM COMMUN, V47, P8647, DOI 10.1039/c1cc12495a
   Li Y, 2013, ADV HEALTHC MATER, V2, P388, DOI 10.1002/adhm.201200313
   Li Y, 2011, POLYMER, V52, P3304, DOI 10.1016/j.polymer.2011.05.049
   Li YW, 2010, CHEM COMMUN, V46, P7739, DOI 10.1039/c0cc02628j
   Li YL, 2009, ANGEW CHEM INT EDIT, V48, P9914, DOI 10.1002/anie.200904260
   Li YP, 2011, BIOMATERIALS, V32, P6633, DOI 10.1016/j.biomaterials.2011.05.050
   Liu G, 2013, POLYM CHEM-UK, V4, P3431, DOI 10.1039/c3py21121e
   Liu J., 2007, BIOMACROMOLECULES, V9, P255
   Liu JN, 2012, MACROMOL RAPID COMM, V33, P760, DOI 10.1002/marc.201200029
   Liu JY, 2011, ANGEW CHEM INT EDIT, V50, P9162, DOI 10.1002/anie.201102280
   Liu TY, 2009, ADV FUNCT MATER, V19, P616, DOI 10.1002/adfm.200801304
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lovell JF, 2010, CHEM REV, V110, P2839, DOI 10.1021/cr900236h
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u
   Ma N, 2011, LANGMUIR, V27, P5874, DOI 10.1021/la2009682
   Ma NN, 2013, J NANOSCI NANOTECHNO, V13, P6485, DOI 10.1166/jnn.2013.7525
   Machida Y, 2000, J CONTROL RELEASE, V66, P159, DOI 10.1016/S0168-3659(99)00267-9
   Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3
   Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5
   Maeda H., 1986, CANCER RES, V46, P6387
   Manju S, 2011, J COLLOID INTERF SCI, V359, P318, DOI 10.1016/j.jcis.2011.03.071
   Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204
   Mazzarino L, 2014, J BIOMED NANOTECHNOL, V10, P787, DOI 10.1166/jbn.2014.1768
   Meng FH, 2012, MATER TODAY, V15, P436, DOI 10.1016/S1369-7021(12)70195-5
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Min KH, 2012, BIOMATERIALS, V33, P5788, DOI 10.1016/j.biomaterials.2012.04.057
   Min KH, 2010, J CONTROL RELEASE, V144, P259, DOI 10.1016/j.jconrel.2010.02.024
   Misra R., 2013, DRUG DELIV, V1, P103
   Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x
   Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X
   Mohammed N, 2013, J BIOMED NANOTECHNOL, V9, P1521, DOI 10.1166/jbn.2013.1647
   Moughton AO, 2008, J AM CHEM SOC, V130, P8714, DOI 10.1021/ja800230k
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Musumeci T, 2006, INT J PHARM, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023
   Muthiah M, 2013, J NANOSCI NANOTECHNO, V13, P1626, DOI 10.1166/jnn.2013.6979
   Nelson-Mendez A, 2011, SOFT MATTER, V7, P7441, DOI 10.1039/c1sm05781b
   Neri D, 2011, NAT REV DRUG DISCOV, V10, P767, DOI 10.1038/nrd3554
   Nevozhay D, 2006, ANTICANCER RES, V26, P1135
   Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445
   Oh IH, 2013, BIOMATERIALS, V34, P6454, DOI 10.1016/j.biomaterials.2013.05.017
   Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus
   Park I, 2009, MACROMOLECULES, V42, P1805, DOI 10.1021/ma8026996
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Park JH, 2006, BIOMATERIALS, V27, P119, DOI 10.1016/j.biomaterials.2005.05.028
   Park K, 2006, J CONTROL RELEASE, V114, P300, DOI 10.1016/j.jconrel.2006.05.017
   Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010
   Egusquiaguirre SP, 2012, CLIN TRANSL ONCOL, V14, P83, DOI 10.1007/s12094-012-0766-6
   Pavillard V, 2001, BRIT J CANCER, V85, P1077, DOI 10.1054/bjoc.2001.2027
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Platt VM, 2008, MOL PHARMACEUT, V5, P474, DOI 10.1021/mp800024g
   Plummer R, 2011, BRIT J CANCER, V104, P593, DOI 10.1038/bjc.2011.6
   Qiu YY, 2013, J NANOSCI NANOTECHNO, V13, P5935, DOI 10.1166/jnn.2013.7537
   Rajkurnar M, 2013, J CHITIN CHITOSAN SC, V1, P65, DOI 10.1166/jcc.2013.1011
   Ren TB, 2011, POLYMER, V52, P3580, DOI 10.1016/j.polymer.2011.06.013
   Ren TB, 2011, SOFT MATTER, V7, P2329, DOI 10.1039/c1sm05020f
   Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7
   Rosler A, 2001, ADV DRUG DELIVER REV, V53, P95, DOI 10.1016/S0169-409X(01)00222-8
   Ryu JH, 2012, BIOMACROMOLECULES, V13, P1515, DOI 10.1021/bm300201x
   Sampathkumar K, 2014, J BIOMED NANOTECHNOL, V10, P367, DOI 10.1166/jbn.2014.1778
   Sanchis J, 2010, NANOMEDICINE-UK, V5, P915, DOI [10.2217/nnm.10.71, 10.2217/NNM.10.71]
   Schumers JM, 2010, POLYM CHEM-UK, V1, P161, DOI 10.1039/b9py00218a
   Shen YQ, 2010, J AM CHEM SOC, V132, P4259, DOI 10.1021/ja909475m
   Shuai XT, 2004, J CONTROL RELEASE, V98, P415, DOI 10.1016/j.jconrel.2004.06.003
   Singh J., 2013, NANOSCI NANOTECHNOL, V2, P275
   Sivasubramanian M, 2013, J NANOSCI NANOTECHNO, V13, P7306, DOI 10.1166/jnn.2013.8090
   Sivasubramanian M, 2013, J NANOSCI NANOTECHNO, V13, P7271, DOI 10.1166/jnn.2013.8091
   Sivasubramanian M, 2013, CARBOHYD POLYM, V97, P643, DOI 10.1016/j.carbpol.2013.05.018
   SKINNER HA, 1945, T FARADAY SOC, V41, P645, DOI 10.1039/tf9454100645
   Smitha KT, 2013, COLLOID SURFACE B, V104, P245, DOI 10.1016/j.colsurfb.2012.11.031
   Son YJ, 2003, J CONTROL RELEASE, V91, P135, DOI 10.1016/S0168-3659(03)00231-1
   Song N, 2011, COLLOID SURFACE B, V87, P454, DOI 10.1016/j.colsurfb.2011.06.009
   Sourkohi BK, 2011, BIOMACROMOLECULES, V12, P3819, DOI 10.1021/bm2011032
   STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A
   Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394
   Sun HL, 2013, EXPERT OPIN DRUG DEL, V10, P1109, DOI 10.1517/17425247.2013.783009
   Sun HL, 2010, BIOMACROMOLECULES, V11, P848, DOI 10.1021/bm1001069
   Sun HL, 2009, BIOMATERIALS, V30, P6358, DOI 10.1016/j.biomaterials.2009.07.051
   Sun TB, 2013, POLYM CHEM-UK, V4, P4017, DOI 10.1039/c3py00406f
   Sun Y, 2010, BIOMATERIALS, V31, P7124, DOI 10.1016/j.biomaterials.2010.06.011
   Swierczewska M, 2012, NANO LETT, V12, P3613, DOI 10.1021/nl301309g
   Tang LY, 2009, BIOCONJUGATE CHEM, V20, P1095, DOI 10.1021/bc900144m
   TANNOCK IF, 1989, CANCER RES, V49, P4373
   Thambi T, 2014, BIOMATERIALS, V35, P1735, DOI 10.1016/j.biomaterials.2013.11.022
   Thambi T, 2013, MACROMOL RES, V21, P100, DOI 10.1007/s13233-013-1014-9
   Thambi T, 2012, J MATER CHEM, V22, P22028, DOI 10.1039/c2jm34546c
   Thambi T, 2011, BIOCONJUGATE CHEM, V22, P1924, DOI [10.1021/bc2000963, 10.1021/bc2000969]
   Thambi T, 2011, POLYMER, V52, P4753, DOI 10.1016/j.polymer.2011.08.024
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   Tu CL, 2013, POLYMER, V54, P2020, DOI 10.1016/j.polymer.2012.12.029
   Upadhyay KK, 2009, BIOMACROMOLECULES, V10, P2802, DOI 10.1021/bm9006419
   Upadhyay KK, 2012, NANOMED-NANOTECHNOL, V8, P71, DOI 10.1016/j.nano.2011.05.008
   van der Vlies AJ, 2014, J BIOMATER TISS ENG, V4, P28, DOI 10.1166/jbt.2014.1135
   Varshosaz J, 2012, EXPERT OPIN DRUG DEL, V9, P509, DOI 10.1517/17425247.2012.673580
   Viger ML, 2013, J AM CHEM SOC, V135, P7847, DOI 10.1021/ja403167p
   Waku T, 2010, CHEM COMMUN, V46, P7025, DOI 10.1039/c0cc01051k
   Wang JR, 2013, ADV MATER, V25, P3670, DOI 10.1002/adma.201300929
   Wang W, 2012, SOFT MATTER, V8, P3949, DOI 10.1039/c2sm07461c
   Wang YS, 2011, CARBOHYD POLYM, V86, P1665, DOI 10.1016/j.carbpol.2011.06.080
   Wang YC, 2011, BIOCONJUGATE CHEM, V22, P1939, DOI 10.1021/bc200139n
   Watanabe M, 2006, INT J PHARM, V308, P183, DOI 10.1016/j.ijpharm.2005.10.030
   Wei H, 2013, PROG POLYM SCI, V38, P503, DOI 10.1016/j.progpolymsci.2012.07.002
   Wen HY, 2011, CHEM COMMUN, V47, P3550, DOI 10.1039/c0cc04983b
   Wen HY, 2012, SMALL, V8, P760, DOI 10.1002/smll.201101613
   Wu GY, 2004, J NUTR, V134, P489
   Xie J, 2010, ADV DRUG DELIVER REV, V62, P1064, DOI 10.1016/j.addr.2010.07.009
   Xu H, 2009, J AM CHEM SOC, V132, P442
   Yan Q, 2010, J AM CHEM SOC, V132, P9268, DOI 10.1021/ja1027502
   Yang Q, 2014, J BIOMED NANOTECHNOL, V10, P580, DOI 10.1166/jbn.2014.1746
   YOKOYAMA M, 1992, BIOCONJUGATE CHEM, V3, P295, DOI 10.1021/bc00016a007
   Yoon HY, 2013, BIOMATERIALS, V34, P5273, DOI 10.1016/j.biomaterials.2013.03.050
   Yoon HY, 2012, BIOMATERIALS, V33, P3980, DOI 10.1016/j.biomaterials.2012.02.016
   Yuan YY, 2012, ADV MATER, V24, P5476, DOI 10.1002/adma.201202296
   Zhan FX, 2011, BIOMACROMOLECULES, V12, P3612, DOI 10.1021/bm200876x
   Zhang J.C., 2011, LANGMUIR, V28, P2056
   Zhang Q, 2013, POLYM CHEM-UK, V4, P351, DOI 10.1039/c2py20582c
   Zhang Q, 2012, CHEM COMMUN, V48, P7542, DOI 10.1039/c2cc32408c
   Zhong YN, 2013, BIOMACROMOLECULES, V14, P3723, DOI 10.1021/bm401098w
   Zhou L, 2011, BIOMACROMOLECULES, V12, P1460, DOI 10.1021/bm101340u
   Zitzmann S, 2002, CANCER RES, V62, P5139
NR 221
TC 25
Z9 25
U1 3
U2 148
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD SEP
PY 2014
VL 10
IS 9
SI SI
BP 1841
EP 1862
DI 10.1166/jbn.2014.1977
PG 22
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA AL9AC
UT WOS:000339430600009
PM 25992443
DA 2018-10-20
ER

PT J
AU Lertvachirapaiboon, C
   Jirapisitkul, T
   Pienpinijtham, P
   Wongravee, K
   Thammacharoen, C
   Ekgasit, S
AF Lertvachirapaiboon, Chutiparn
   Jirapisitkul, Thiluksakorn
   Pienpinijtham, Prompong
   Wongravee, Kanet
   Thammacharoen, Chuchaat
   Ekgasit, Sanong
TI Air-gap-enhanced pearlescent effect in periodic stratified bilayers of
   Perna viridis shell
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID MECHANICAL-PROPERTIES; ORGANIC MATRIX; NACRE; ABALONE; WASTE;
   IRIDESCENCE; ARAGONITE; PEARL; DIFFRACTION; BIODIESEL
AB Pearlescent effect is a unique optical phenomenon originated by an interference of visible light with biomaterial having periodic structure such as pearls, mother-of-pearls, mollusk shells, beetle wings, and butterfly wings. The pearlescent effect exhibits series of vivid colors at a particular spot as an angle of observation is changed. In this paper, the pearlescent effect in Asian green mussel (Perna viridis) shell was investigated. The nacreous layer of the shells is an assembly of stratified bilayers of alternate aragonite calcium carbonate and organic matrix. A consecutive chemical/thermal treatment was employed to remove the organic layer. The enhanced pearlescent effect, indicated by more vivid and brighter colors, was due to a greater refractive index difference within the treated structure as the organic layers were replaced by air gaps of the same thickness. The modified transfer matrix method developed for the stratified bilayers system was employed to verify enhanced pearlescent effect. The results from theoretical simulation corroborated the visual observation as a 4-time full-width-at-half-maximum increment of the reflectance peak, and a broader spectral coverage was achieved after the replacement of organic layers by air gaps.
C1 [Lertvachirapaiboon, Chutiparn; Jirapisitkul, Thiluksakorn; Pienpinijtham, Prompong; Wongravee, Kanet; Thammacharoen, Chuchaat; Ekgasit, Sanong] Chulalongkorn Univ, Dept Chem, Sensor Res Unit, Fac Sci, Bangkok 10330, Thailand.
RP Ekgasit, S (reprint author), Chulalongkorn Univ, Dept Chem, Sensor Res Unit, Fac Sci, 254 Phayathai Rd, Bangkok 10330, Thailand.
EM sanong.e@chula.ac.th
FU National Research University Project of Thailand, Office of the Higher
   Education Commission [WCU-020-FM-57]; National Research Council of
   Thailand (NRCT)
FX The authors gratefully acknowledge financial supports from the National
   Research University Project of Thailand, Office of the Higher Education
   Commission (WCU-020-FM-57) and the National Research Council of Thailand
   (NRCT).
CR Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010
   Ballester P, 2007, CEMENT CONCRETE RES, V37, P559, DOI 10.1016/j.cemconres.2007.01.004
   Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P
   BEVELANDER G, 1969, CALC TISS RES, V3, P84, DOI 10.1007/BF02058648
   Chaya W, 2007, J CLEAN PROD, V15, P1463, DOI 10.1016/j.jclepro.2006.03.008
   Ekgasit S, 2004, ANAL CHEM, V76, P561, DOI 10.1021/ac035042v
   Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001
   Hasen WN, 1968, J OPT SOC AM, V58, P380
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Kinoshita S, 2005, CHEMPHYSCHEM, V6, P1442, DOI 10.1002/cphc.200500007
   Lertwattanaruk P, 2012, J ENVIRON MANAGE, V111, P133, DOI 10.1016/j.jenvman.2012.06.032
   Leung HM, 2009, TRIBOL INT, V42, P40, DOI 10.1016/j.triboint.2008.05.015
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   Lin A, 2005, MAT SCI ENG A-STRUCT, V390, P27, DOI 10.1016/j.msea.2004.06.072
   Liu Y, 1999, OPT EXPRESS, V4, P177, DOI 10.1364/OE.4.000177
   Lopez MI, 2014, ACTA BIOMATER, V10, P2056, DOI 10.1016/j.actbio.2013.12.016
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Mosher S, 2010, ENVIRON TOXICOL, V27, P268, DOI DOI 10.1002/T0X.20639
   Nair P, 2012, J CLEAN PROD, V29-30, P82, DOI 10.1016/j.jclepro.2012.01.039
   Parker JE, 2010, CRYSTENGCOMM, V12, P1590, DOI 10.1039/b921487a
   Perdikouri C, 2011, GEOCHIM COSMOCHIM AC, V75, P6211, DOI 10.1016/j.gca.2011.07.045
   Rezaei R, 2013, FUEL, V109, P534, DOI 10.1016/j.fuel.2013.03.004
   Rousseau M, 2005, BIOMATERIALS, V26, P6254, DOI 10.1016/j.biomaterials.2005.03.028
   Snow MR, 2004, AM MINERAL, V89, P1353
   Sun JY, 2013, RSC ADV, V3, P14862, DOI 10.1039/c3ra41096j
   Sun JY, 2012, RSC ADV, V2, P7617, DOI 10.1039/c2ra20218b
   Tan TL, 2004, OPT EXPRESS, V12, P4847, DOI 10.1364/OPEX.12.004847
   Verma D, 2006, SPECTROCHIM ACTA A, V64, P1051, DOI 10.1016/j.saa.2005.09.014
   Weiss IM, 2002, CHEM MATER, V14, P3252, DOI 10.1021/cm001217v
   Yan ZG, 2007, BIOMACROMOLECULES, V8, P3597, DOI 10.1021/bm0701494
   Zhang GS, 2013, J STRUCT BIOL, V182, P36, DOI 10.1016/j.jsb.2013.01.010
NR 31
TC 2
Z9 2
U1 1
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD SEP
PY 2014
VL 49
IS 18
BP 6282
EP 6289
DI 10.1007/s10853-014-8353-6
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AK3TQ
UT WOS:000338348000013
DA 2018-10-20
ER

PT J
AU Sjollema, J
   Dijkstra, RJB
   Abeln, C
   van der Mei, HC
   van Asseldonk, D
   Busscher, HJ
AF Sjollema, Jelmer
   Dijkstra, Rene J. B.
   Abeln, Caroline
   van der Mei, Henny C.
   van Asseldonk, Dirk
   Busscher, Henk J.
TI On-demand antimicrobial release from a temperature-sensitive polymer -
   Comparison with ad libitum release from central venous catheters
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Central venous catheters; Chlorhexidine; Silver; Biofilms; Infection
ID DRUG-DELIVERY; MEDICAL DEVICES; INFECTIONS; BLOOD; METAANALYSIS; CARE
AB Antimicrobial releasing biomaterial coatings have found application for instance in the fixation of orthopedic joint prostheses and central venous catheters. Most frequently, the release kinetics is such that antimicrobially-effective concentrations are only reached within the first days to weeks after implantation, leaving no local antimicrobial release available when a biomaterial-associated infection occurs later. Here we compare the ad libitum release of chlorhexidine and silver-sulfadiazine from a central venous catheter with their release from a new, on-demand release coating consisting of a temperature-sensitive copolymer of styrene and n-butyl (meth)acrylate. The copolymer can be loaded with an antimicrobial, which is released when the temperature is raised above its glass transition temperature. Ad libitum release of chlorhexidine and silver-sulfadiazine from a commercially-purchased catheter and associated antimicrobial efficacy against Staphylococcus aureus was limited to 16 days. Consecutive temperature-triggers of our on-demand coating yielded little or no antimicrobial efficacy of silver-acetate release, but antimicrobially-effective chlorhexidine concentrations were observed over a time period of 60-80 days. This attests to the clear advantage of on-demand coatings above ad libitum releasing coatings, that may have released their antimicrobial content before it is actually needed. Importantly, glass transition temperature of chlorhexidine loaded copolymers was lower (48 degrees C) than of silver loaded ones (61 degrees C), facilitating their clinical use. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Sjollema, Jelmer; Dijkstra, Rene J. B.; van der Mei, Henny C.; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   [Abeln, Caroline; van Asseldonk, Dirk] Dolphys Med BV, NL-5612 AR Eindhoven, Netherlands.
RP Sjollema, J (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM j.sjollema@umcg.nl
FU Dutch Ministry of Economic Affairs [P4.01]
FX This research forms part of the Project P4.01 NANTICO of the research
   program of the BioMedical Materials institute, co-funded by the Dutch
   Ministry of Economic Affairs (P4.01 NANTIC). JS, RJBD, HCvdM and HJB are
   employed by UMCG, Groningen, The Netherlands. CA and DvA are employed by
   Dolphys Medical B.V. (De Lismortel 31, 5612 AR Eindhoven, The
   Netherlands), while HJB is also a director of a consulting company, SASA
   BV (GN Schutterlaan 4, 9797 PC Thesinge, The Netherlands). The authors
   declare no potential conflicts of interest with respect to authorship
   and/or publication of this article. Opinions and assertions contained
   herein are those of the authors and are not construed as necessarily
   representing views of the funding organization or their respective
   employers.
CR Casey AL, 2008, LANCET INFECT DIS, V8, P763, DOI 10.1016/S1473-3099(08)70280-9
   Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007
   Halton K, 2007, EMERG INFECT DIS, V13, P815, DOI 10.3201/eid1306.070048
   Herron DM, 1997, J TRAUMA, V43, P219, DOI 10.1097/00005373-199708000-00003
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Hoare T, 2009, NANO LETT, V9, P3651, DOI 10.1021/nl9018935
   Keurentjes JTF, 2009, ANGEW CHEM INT EDIT, V48, P9867, DOI 10.1002/anie.200904172
   Klekamp J, 1999, J ARTHROPLASTY, V14, P339, DOI 10.1016/S0883-5403(99)90061-X
   McCoy CP, 2010, EXPERT OPIN DRUG DEL, V7, P605, DOI 10.1517/17425241003677731
   McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883
   Mermel LA, 2011, CLIN INFECT DIS, V52, P211, DOI 10.1093/cid/ciq108
   Meyer DE, 2001, J CONTROL RELEASE, V74, P213, DOI 10.1016/S0168-3659(01)00319-4
   Monzillo V, 2012, NEW MICROBIOL, V35, P175
   Mura S, 2013, NAT MATER, V12, P991, DOI [10.1038/nmat3776, 10.1038/NMAT3776]
   Otten MPT, 2012, CLIN ORAL INVEST, V16, P1435, DOI 10.1007/s00784-011-0648-2
   Safdar N, 2004, INTENS CARE MED, V30, P62, DOI 10.1007/s00134-003-2045-z
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Simanovskii DM, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011915
   Tambe SM, 2001, J ANTIMICROB CHEMOTH, V47, P589, DOI 10.1093/jac/47.5.589
NR 19
TC 8
Z9 8
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD AUG 28
PY 2014
VL 188
BP 61
EP 66
DI 10.1016/j.jconrel.2014.06.013
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA AN6IX
UT WOS:000340699300007
PM 24950430
DA 2018-10-20
ER

PT J
AU Yang, MY
   Shuai, YJ
   Zhou, GS
   Mandal, N
   Zhu, LJ
   Mao, CB
AF Yang, Mingying
   Shuai, Yajun
   Zhou, Guanshan
   Mandal, Namita
   Zhu, Liangjun
   Mao, Chuanbin
TI Tuning Molecular Weights of Bombyx mori (B. mori) Silk Sericin to Modify
   Its Assembly Structures and Materials Formation
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Bombyx mori (B. mori) silk sericin; electrospinning; nanofibers;
   microparticles
ID MESENCHYMAL STEM-CELLS; OSTEOBLASTIC DIFFERENTIATION; PROTEIN SERICIN;
   FIBROIN; FABRICATION; HYDROXYAPATITE; BIOMATERIALS; NANOFIBERS;
   NUCLEATION; SCAFFOLDS
AB Bombyx mori (B. mori) silk sericin is a protein with features desirable as a biomaterial, such as increased hydrophilicity and biodegradation, as well as resistance to oxidation, bacteria, and ultraviolet light. In contrast to other widely studied B. mori silk proteins such as fibroin, sericin is still unexplored as a building block for fabricating biomaterial, and thus a facile technique of processing it into a material is needed. Here, electrospinning technology was used to fabricate it into biomaterials from two forms of B. mori silk sericin with different molecular weights, one is a low (12.0 kDa) molecular sericin (LS) form and another is a high (66.0 kDa) molecular weight sericin (HS) form. Circular dichroism (CD) spectra showed that LS in hexafluoroacetone (HFA) solvent adopted a predominantly random coil conformation, whereas HS tended to form a beta-sheet structure along with a large content of random coils. In addition, LS and HS in HFA solvent were found to form cylinder-like smaller nanoparticles and larger irregular aggregates before electrospinning, respectively. As a result, biomaterials based on microparticles and nanofibers were successfully fabricated by electrospinning of LS and HS dissolved in HFA, respectively. The cell viability and differentiation assay indicated that nanofibers and microparticles improved cell adhesion, growth, and differentiation, proving that the scaffolds electrospun from sericin are biocompatible regardless of its molecular weight. The microparticles, not common in electrospinning of silk proteins reported previously, were found to promote the osteogenic differentiation of mesenchymal stem cells in comparison to the nanofibers. This study suggested that molecular weight of sericin mediates its secondary structure and assembly structure, which in turn leads to a control of final morphology of the electrospun materials. The microparticles and nanofibers of sericin can be potentially used as building blocks for fabricating the scaffolds for tissue engineering.
C1 [Yang, Mingying; Shuai, Yajun; Zhou, Guanshan; Mandal, Namita; Zhu, Liangjun] Zhejiang Univ, Inst Appl Bioresource Res, Coll Anim Sci, Hangzhou 310058, Zhejiang, Peoples R China.
   [Mao, Chuanbin] Univ Oklahoma, Stephenson Life Sci Res Ctr, Dept Chem & Biochem, Norman, OK 73019 USA.
RP Yang, MY (reprint author), Zhejiang Univ, Inst Appl Bioresource Res, Coll Anim Sci, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM yangm@zju.edu.cn; cbmao@ou.edu
OI Mao, Chuanbin/0000-0002-8142-3659
FU National High Technology Research and Development Program
   [2013AA102507]; Silkworm Industry Science and Technology Innovation Team
   [2011R50028]; Zhejiang Provincial Natural Science Foundation of China
   [LZ12C17001]; National Natural Science Foundation of China [21172194,
   20804037]; National Institutes of Health [EB015190, HL092526]; National
   Science Foundation [CBET-0854465, CMMI-1234957, CBET-0854414,
   DMR-0847758]; Department of Defense Peer Reviewed Medical Research
   Program [W81XWH-12-1-0384]; Oklahoma Center for Adult Stem Cell Research
   [434003]; Oklahoma Center for the Advancement of Science and Technology
   [HR11-006]
FX M.Y. acknowledges the support of National High Technology Research and
   Development Program 863 (2013AA102507), Silkworm Industry Science and
   Technology Innovation Team (2011R50028), Zhejiang Provincial Natural
   Science Foundation of China (LZ12C17001), and National Natural Science
   Foundation of China (21172194 and 20804037). C.B.M. would like to thank
   the financial support from National Institutes of Health (EB015190 and
   HL092526), National Science Foundation (CBET-0854465, CMMI-1234957,
   CBET-0854414, and DMR-0847758), Department of Defense Peer Reviewed
   Medical Research Program (W81XWH-12-1-0384), Oklahoma Center for Adult
   Stem Cell Research (434003), and Oklahoma Center for the Advancement of
   Science and Technology (HR11-006).
CR Abdel-Fattah WI, 2007, ACTA BIOMATER, V3, P503, DOI 10.1016/j.actbio.2006.12.004
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Brown RA, 2013, TISSUE ENG PT A, V19, P1495, DOI [10.1089/ten.tea.2013.0133, 10.1089/ten.TEA.2013.0133]
   Cao B, 2007, LANGMUIR, V23, P10701, DOI 10.1021/1a7014435
   Cao H, 2013, J MATER SCI, V48, P150, DOI 10.1007/s10853-012-6722-6
   Cho KY, 2003, INT J BIOL MACROMOL, V32, P36, DOI 10.1016/S0141-8130(03)00023-0
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Ha SW, 2006, BIOMACROMOLECULES, V7, P18, DOI 10.1021/1bm050783rn
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Iafisco M, 2013, J NANOSCI NANOTECHNO, V13, P4720, DOI 10.1166/jnn.2013.7195
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Khan MMR, 2013, J MATER SCI, V48, P3731, DOI 10.1007/s10853-013-7171-6
   Lee K, 2003, INT J BIOL MACROMOL, V33, P75, DOI 10.1016/S0141-8130(03)00069-2
   Lee S. S., 2012, BIOMATERIALS, V34, P452
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Marelli B, 2012, MACROMOL BIOSCI, V12, P1566, DOI 10.1002/mabi.201200195
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Sasaki M, 2000, NUTR RES, V20, P1505, DOI 10.1016/S0271-5317(00)80031-7
   Sasaki M, 2000, ONCOL REP, V7, P1049
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Yang M, 2008, J BIOMED MATER RES A, V84A, P353, DOI 10.1002/jbm.a.31348
   Yang MY, 2013, J POLYM SCI POL PHYS, V51, P742, DOI 10.1002/polb.23249
   Yang MY, 2009, POLYMER, V50, P117, DOI 10.1016/j.polymer.2008.10.008
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Zhang XH, 2012, INT J BIOL MACROMOL, V50, P337, DOI 10.1016/j.ijbiomac.2011.12.006
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhaorigetu S, 2007, J NUTR SCI VITAMINOL, V53, P297, DOI 10.3177/jnsv.53.297
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
NR 35
TC 20
Z9 23
U1 4
U2 93
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 27
PY 2014
VL 6
IS 16
BP 13782
EP 13789
DI 10.1021/am503214g
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AO2CB
UT WOS:000341122000058
PM 25050697
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Pinney, JR
   Melkus, G
   Cerchiari, A
   Hawkins, J
   Desai, TA
AF Pinney, James R.
   Melkus, Gerd
   Cerchiari, Alec
   Hawkins, James
   Desai, Tejal A.
TI Novel Functionalization of Discrete Polymeric Biomaterial
   Microstructures for Applications in Imaging and Three-Dimensional
   Manipulation
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE tissue engineering; 3D alignment; SPION; F-19 MRI; biomaterial;
   microrods; polymer functionalization
ID IRON-OXIDE NANOPARTICLES; DRUG-DELIVERY; PERFLUOROCARBON NANOEMULSIONS;
   BIOMEDICAL APPLICATIONS; MAGNETIC NANOPARTICLES; BIODEGRADABLE POLYMERS;
   PROTEIN ADSORPTION; MEDICAL DEVICES; HYDROGELS; MATRIX
AB Adapting ways to functionalize polymer materials is becoming increasingly important to their implementation in translational biomedical sciences. By tuning the mechanical, chemical, and biological qualities of these materials, their applications can be broadened, opening the door for more advanced integration into modem medical techniques. Here, we report on a method to integrate chemical functionalizations into discrete, microscale polymer structures, which are used for tissue engineering applications, for in vivo localization, and three-dimensional manipulation. Iron oxide nanoparticles were incorporated into the polymer matrix using common photolithographic techniques to create stably functional microstructures with magnetic potential. Using magnetic resonance imaging (MRI), we can promote visualization of microstructures contained in small collections, as well as facilitate the manipulation and alignment of microtopographical cues in a realistic tissue environment. Using similar polymer functionalization techniques, fluorine-containing compounds were also embedded in the polymer matrix of photolithographically fabricated microstructures. The incorporation of fluorine-containing compounds enabled highly sensitive and specific detection of microstructures in physiologic settings using fluorine MRI techniques (F-19 MM). These functionalization strategies will facilitate more reliable noninvasive tracking and characterization of microstructured polymer implants as well as have implications for remote microstructural scaffolding alignment for three-dimensional tissue engineering applications.
C1 [Pinney, James R.; Cerchiari, Alec; Desai, Tejal A.] Univ Calif San Francisco, San Francisco, CA 94158 USA.
   [Melkus, Gerd; Hawkins, James] Univ Calif San Francisco, UCSF Imaging Ctr China Basin, Dept Radiol, San Francisco, CA 94107 USA.
   [Melkus, Gerd] Ottawa Hosp, Dept Med Imaging, Ottawa, ON K1Y 4E9, Canada.
   [Pinney, James R.; Cerchiari, Alec] UC Berkeley UCSF Grad Program Bioengn, San Francisco, CA 94158 USA.
RP Desai, TA (reprint author), Univ Calif San Francisco, 1700 Fourth St,Byers Hall Room 203, San Francisco, CA 94158 USA.
EM tejal.desai@ucsf.edu
FU UCSF; NIH [R01 HL090523]; NSF-MRI [0821619]; NSF-EAR [0949176]; DoD
   through NDSEG; California Institute for Regenerative Medicine
   [TG2-01153]
FX We would like to thank the UCSF Biomedical Micro- and Nanofabrication
   Facility for use of photolithography equipment as well as the UCSF
   Preclinical 7T MRI Core Facility at China Basin for use of the system.
   We gratefully acknowledge use of the Carl Zeiss Ultra 55 FE-SEM and
   supporting equipment at San Francisco State University. We would also
   like to thank Jean Kim for her assistance with the SEM. This research
   was made possible by a grant from the California Institute for
   Regenerative Medicine (Grant no. TG2-01153). The contents of this
   publication are solely the responsibility of the authors and do not
   necessarily represent the official views of CIRM or any other agency of
   the State of California. This work was also supported by the UCSF
   Research Allocation Program and in part by the NIH (R01 HL090523). The
   FE-SEM and supporting facilities were obtained under NSF-MRI award
   #0821619 and NSF-EAR award #0949176, respectively. A.C. was supported by
   the DoD through the NDSEG Fellowship Program.
CR Amsalem Y., 2007, CIRCULATION, V116, P138
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Bae PK, 2013, MOL IMAGING BIOL, V15, P401, DOI 10.1007/s11307-013-0622-2
   Bardajee GR, 2014, CARBOHYD POLYM, V101, P741, DOI 10.1016/j.carbpol.2013.10.028
   BASZKIN A, 1980, J BIOMED MATER RES, V14, P393, DOI 10.1002/jbm.820140406
   Boateng SY, 2003, AM J PHYSIOL-CELL PH, V285, pC171, DOI 10.1152/ajpcell.00013.2003
   Bulte JWM, 2005, NAT BIOTECHNOL, V23, P945, DOI 10.1038/nbt0805-945
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Coffins J. M., 2010, SMALL, V<IT>6</IT>, P355
   Cong HL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/7/075307
   Curtis MW, 2010, BIOMED MICRODEVICES, V12, P1073, DOI 10.1007/s10544-010-9461-y
   Diaz-Lopez R, 2010, PHARM RES-DORDR, V27, P1, DOI 10.1007/s11095-009-0001-5
   Doraiswamy A, 2006, ACTA BIOMATER, V2, P267, DOI 10.1016/j.actbio.2006.01.004
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Giraudeau C, 2013, ANGIOGENESIS, V16, P171, DOI 10.1007/s10456-012-9310-0
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Janjic JM, 2014, BIOMATERIALS, V35, P4958, DOI 10.1016/j.biomaterials.2014.03.006
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Kim P, 2005, NANOTECHNOLOGY, V16, P2420, DOI 10.1088/0957-4484/16/10/072
   Kim YS, 2001, APPL PHYS LETT, V79, P2285, DOI 10.1063/1.1407859
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Krishnan KM, 2010, IEEE T MAGN, V46, P2523, DOI 10.1109/TMAG.2010.2046907
   Lee H, 2006, J AM CHEM SOC, V128, P7383, DOI 10.1021/ja061529k
   Lee HY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/16/165101
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   LUTZ J, 1995, ARTIF CELL BLOOD SUB, V23, P407, DOI 10.3109/10731199509117956
   Mahmoudi M, 2009, J COLLOID INTERF SCI, V336, P510, DOI 10.1016/j.jcis.2009.04.046
   Martino R, 2005, J PHARMACEUT BIOMED, V38, P871, DOI 10.1016/j.jpba.2005.01.047
   Meenach SA, 2013, J BIOMAT SCI-POLYM E, V24, P1112, DOI 10.1080/09205063.2012.741321
   Meenach SA, 2010, J POLYM SCI POL CHEM, V48, P3229, DOI 10.1002/pola.24087
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Motlagh D, 2003, J BIOMED MATER RES A, V67A, P148, DOI 10.1002/jbm.a.10083
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Peng H, 2009, BIOMACROMOLECULES, V10, P374, DOI 10.1021/bm801136m
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570
   Seif-Naraghi SB, 2010, TISSUE ENG PT A, V16, P2017, DOI 10.1089/ten.TEA.2009.0768
   Srinivas M, 2010, BIOMATERIALS, V31, P7070, DOI 10.1016/j.biomaterials.2010.05.069
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Sun C, 2008, ADV DRUG DELIVER REV, V60, P1252, DOI 10.1016/j.addr.2008.03.018
   Tao SL, 2003, ADV DRUG DELIVER REV, V55, P315, DOI 10.1016/S0169-409X(02)00227-2
   Tee R, 2010, ANZ J SURG, V80, P683, DOI 10.1111/j.1445-2197.2010.05435.x
   Tromsdorf UI, 2009, NANO LETT, V9, P4434, DOI 10.1021/nl902715v
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Zhang Y., 2014, MACROMOL BIOSCI
   Zhu SL, 2010, J ELECTROCHEM SOC, V157, pA1158, DOI 10.1149/1.3478667
NR 54
TC 3
Z9 3
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 27
PY 2014
VL 6
IS 16
BP 14477
EP 14485
DI 10.1021/am503778t
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AO2CB
UT WOS:000341122000140
PM 25068888
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Custodio, CA
   Miguel-Arranz, VS
   Gropeanu, RA
   Gropeanu, M
   Wirkner, M
   Reis, RL
   Mano, JF
   del Campo, A
AF Custodio, C. A.
   Miguel-Arranz, V. San
   Gropeanu, R. A.
   Gropeanu, M.
   Wirkner, M.
   Reis, R. L.
   Mano, J. F.
   del Campo, A.
TI Photopatterned Antibodies for Selective Cell Attachment
SO LANGMUIR
LA English
DT Article
ID PHOTOREMOVABLE PROTECTING GROUPS; ORTHO-NITROBENZYL ESTERS;
   REACTION-MECHANISMS; CAGED-BIOTIN; PROTEIN; SURFACES; IMMOBILIZATION;
   ADHESION; LIGHT; CHEMISTRY
AB We present a phototriggerable system that allows for the spatiotemporal controlled attachment of selected cell types to a biomaterial using immobilized antibodies that specifically target individual cell phenotypes. o-Nitrobenzyl caged biotin was used to functionalize chitosan membranes and mediate site-specific coupling of streptavidin and biotinylated antibodies after light activation. The ability of this system to capture and immobilize specific cells on a surface was tested using endothelial-specific biotinylated antibodies and nonspecific ones as controls. Homogeneous patterned monolayers of human umbilical vein endothelial cells were obtained on CD31-functionalized surfaces. This is a simple and generic approach that is applicable to other ligands, materials, and cell types and shows the flexibility of caged ligands to trigger and control the interaction between cells and biomaterials.
C1 [Custodio, C. A.; Miguel-Arranz, V. San; Gropeanu, R. A.; Gropeanu, M.; Wirkner, M.; del Campo, A.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Custodio, C. A.; Reis, R. L.; Mano, J. F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Caldas Dal Taipas Guimar, Portugal.
   [Custodio, C. A.; Reis, R. L.; Mano, J. F.] 3 ICVS 3Bs, PT Govt Associated Lab, Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Caldas Dal Taipas Guimar, Portugal.
EM jmano@dep.uminho.pt; delcampo@mpip-mainz.mpg.de
RI Reis, Rui L./A-8938-2008; Mano, Joao/A-4418-2009; Custodio,
   Catarina/N-3290-2016; Group, 3Bs/E-4374-2012; San Miguel,
   Veronica/C-5451-2008; San Miguel, Veronica/L-7731-2014
OI Reis, Rui L./0000-0002-4295-6129; Mano, Joao/0000-0002-2342-3765;
   Custodio, Catarina/0000-0003-2967-700X; Group, 3Bs/0000-0002-5195-3456;
   San Miguel, Veronica/0000-0001-8014-2452; del Campo,
   Aranzazu/0000-0001-5725-2135
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/61390/2009]; International Max-Planck Research School in Mainz;
   European Union [REGPOT-CT2012-316331-POLARIS]
FX We thank Martina Knecht (MPIP) for help with the synthesis of caged
   biotin and Dr. Ron Unger and Prof. C. J. Kirkpatrick (University Clinic
   Mainz, RepairLab) for providing HUVECs. C.A.C. acknowledges funding
   support from the Portuguese Foundation for Science and Technology (FCT)
   (fellowship SFRH/BD/61390/2009) and from the International Max-Planck
   Research School in Mainz. The research leading to these results has
   received funding from the European Union's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no. REGPOT-CT2012-316331-POLARIS.
CR ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059
   Alonso JM, 2008, LANGMUIR, V24, P448, DOI 10.1021/la702696b
   Alvarez M, 2011, LANGMUIR, V27, P2789, DOI 10.1021/la104511x
   Bhagawati M, 2010, J AM CHEM SOC, V132, P5932, DOI 10.1021/ja1000714
   Blawas AS, 1998, LANGMUIR, V14, P4243, DOI 10.1021/la971231v
   Choi HJ, 2005, ANAL BIOCHEM, V347, P60, DOI 10.1016/j.ab.2005.08.015
   Cui JX, 2013, BIOMACROMOLECULES, V14, P1251, DOI 10.1021/bm400022h
   Custodio C. A., 2012, BIOINTERPHASES, V7
   Dillmore WS, 2004, LANGMUIR, V20, P7223, DOI 10.1021/la049826v
   Efremov AN, 2013, BIOMATERIALS, V34, P1757, DOI 10.1016/j.biomaterials.2012.11.034
   Ellis-Davies GCR, 2007, NAT METHODS, V4, P619, DOI 10.1038/NMETH1072
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182
   Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b
   Gatterdam V, 2014, ANGEW CHEM INT EDIT, V53, P5680, DOI 10.1002/anie.201309930
   Gatterdam V, 2012, ANGEW CHEM INT EDIT, V51, P3960, DOI 10.1002/anie.201108073
   Goulet-Hanssens A, 2012, BIOMACROMOLECULES, V13, P2958, DOI 10.1021/bm301037k
   Grunwald C, 2010, P NATL ACAD SCI USA, V107, P6146, DOI 10.1073/pnas.0912617107
   Hengsakul M, 1996, BIOCONJUGATE CHEM, V7, P249, DOI 10.1021/bc960007z
   Il'ichev YV, 2004, J AM CHEM SOC, V126, P4581, DOI 10.1021/ja039071z
   Kaigala GV, 2012, ANGEW CHEM INT EDIT, V51, P11224, DOI 10.1002/anie.201201798
   Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164
   Kikuchi Y, 2008, LANGMUIR, V24, P13084, DOI 10.1021/la8024414
   Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3
   Klan P, 2013, CHEM REV, V113, P119, DOI 10.1021/cr300177k
   Ku SH, 2010, LANGMUIR, V26, P15104, DOI 10.1021/la102825p
   Laboria N, 2013, ANGEW CHEM INT EDIT, V52, P848, DOI 10.1002/anie.201206698
   Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z
   Lee JY, 2008, LANGMUIR, V24, P2232, DOI 10.1021/la702883d
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453
   Oliveira MB, 2013, SMALL, V9, P768, DOI 10.1002/smll.201201436
   Pelliccioli AP, 2002, PHOTOCH PHOTOBIO SCI, V1, P441, DOI 10.1039/b200777k
   Pirrung MC, 1996, BIOCONJUGATE CHEM, V7, P317, DOI 10.1021/bc960013v
   Salierno MJ, 2013, ADV FUNCT MATER, V23, P5974, DOI 10.1002/adfm.201300902
   Sandberg S. A., 1995, J AM CHEM SOC, V117, P12050
   Sasaki D, 2009, BIOMATERIALS, V30, P4384, DOI 10.1016/j.biomaterials.2009.05.003
   SCHUPP H, 1987, J PHOTOCHEM, V36, P85, DOI 10.1016/0047-2670(87)87064-8
   Terai T, 2011, CHEM BIOL, V18, P1261, DOI 10.1016/j.chembiol.2011.09.007
   Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109
   Vermette P, 2003, J COLLOID INTERF SCI, V259, P13, DOI 10.1016/S0021-9797(02)00185-6
   Wirkner M., 2011, CHEMBIOCHEM, V12, P2623
   Wylie RG, 2011, BIOMACROMOLECULES, V12, P3789, DOI 10.1021/bm201037j
   You C, 2009, ANAL BIOANAL CHEM, V393, P1563, DOI 10.1007/s00216-008-2595-6
   Yu HM, 2005, LAB CHIP, V5, P1089, DOI 10.1039/b504403k
   ZHU QQ, 1987, J PHOTOCHEM, V39, P317, DOI 10.1016/0047-2670(87)80041-2
NR 46
TC 18
Z9 18
U1 1
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 26
PY 2014
VL 30
IS 33
BP 10066
EP 10071
DI 10.1021/la502688h
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AO0IV
UT WOS:000340993200024
PM 25076392
OA Green Published
DA 2018-10-20
ER

PT J
AU Jones, CH
   Ravikrishnan, A
   Chen, MF
   Reddinger, R
   Ahmadi, MK
   Rane, S
   Hakansson, AP
   Pfeifer, BA
AF Jones, Charles H.
   Ravikrishnan, Anitha
   Chen, Mingfu
   Reddinger, Ryan
   Ahmadi, Mahmoud Kamal
   Rane, Snehal
   Hakansson, Anders P.
   Pfeifer, Blaine A.
TI Hybrid biosynthetic gene therapy vector development and dual engineering
   capacity
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE nonviral vectors; cationic polymers; bactofection; vaccination;
   immunization
ID ESCHERICHIA-COLI; POLY(BETA-AMINO ESTERS); E. COLI; DELIVERY; CELLS;
   RECOMBINANT; MACROPHAGES; VACCINES; LIBRARY; DNA
AB Genetic vaccines offer a treatment opportunity based upon successful gene delivery to specific immune cell modulators. Driving the process is the vector chosen for gene cargo packaging and subsequent delivery to antigen-presenting cells (APCs) capable of triggering an immune cascade. As such, the delivery process must successfully navigate a series of requirements and obstacles associated with the chosen vector and target cell. In this work, we present the development and assessment of a hybrid gene delivery vector containing biological and biomaterial components. Each component was chosen to design and engineer gene delivery separately in a complimentary and fundamentally distinct fashion. A bacterial (Escherichia coli) inner core and a biomaterial [poly (beta-amino ester)]-coated outer surface allowed the simultaneous application of molecular biology and polymer chemistry to address barriers associated with APC gene delivery, which include cellular uptake and internalization, phagosomal escape, and intracellular cargo concentration. The approach combined and synergized normally disparate vector properties and tools, resulting in increased in vitro gene delivery beyond individual vector components or commercially available transfection agents. Furthermore, the hybrid device demonstrated a strong, efficient, and safe in vivo humoral immune response compared with traditional forms of antigen delivery. In summary, the flexibility, diversity, and potential of the hybrid design were developed and featured in this work as a platform for multivariate engineering at the vector and cellular scales for new applications in gene delivery immunotherapy.
C1 [Jones, Charles H.; Ravikrishnan, Anitha; Chen, Mingfu; Ahmadi, Mahmoud Kamal; Rane, Snehal; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Reddinger, Ryan; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol Immunol, Buffalo, NY 14260 USA.
   [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
RI Hakansson, Anders/H-8190-2014
OI Hakansson, Anders/0000-0002-2834-6009; Chen, Mingfu/0000-0002-0169-613X
FU National Institutes of Health [AI088485, DC013554]; State University of
   New York at Buffalo Schomburg Fellowship
FX We thank Randall Smith, C. K. Chen, and Chong Cheng (University at
   Buffalo) for assistance with flow cytometry and polymer synthesis and
   characterization. We recognize support from National Institutes of
   Health Awards AI088485 (to B.A.P.) and DC013554 (to A.P.H.) and a State
   University of New York at Buffalo Schomburg Fellowship (to C.H.J.).
CR Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2
   Castagliuolo I, 2005, GENE THER, V12, P1070, DOI 10.1038/sj.gt.3302493
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chart H, 2000, J APPL MICROBIOL, V89, P1048, DOI 10.1046/j.1365-2672.2000.01211.x
   Cheung W, 2012, BIOENGINEERED, V3, P86, DOI 10.4161/bbug.18621
   Critchley R, 2004, GENE THER, V11, P1224, DOI 10.1038/sj.gt.3302281
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237
   Doshi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010051
   Eko FO, 1999, VACCINE, V17, P1643, DOI 10.1016/S0264-410X(98)00423-X
   Eltoukhy AA, 2012, BIOMATERIALS, V33, P3594, DOI 10.1016/j.biomaterials.2012.01.046
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Green Jordan J., 2009, V480, P53, DOI 10.1007/978-1-59745-429-2_4
   Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x
   He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259
   He LZ, 2004, CLIN CANCER RES, V10, P1920, DOI 10.1158/1078-0432.CCR-03-0264
   Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Keler T, 2005, CURR OPIN MOL THER, V7, P157
   Laner A, 2005, GENE THER, V12, P1559, DOI 10.1038/sj.gt.3302576
   Larsen MDB, 2008, GENE THER, V15, P434, DOI 10.1038/sj.gt.3303090
   Leboulch P, 2013, NATURE, V500, P280, DOI 10.1038/500280a
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Parsa S, 2008, PHARM RES, V25, P1202, DOI 10.1007/s11095-008-9563-x
   Parsa S, 2007, MOL PHARMACEUT, V4, P4, DOI 10.1021/mp0600889
   Radford KJ, 2002, GENE THER, V9, P1455, DOI 10.1038/sj.gt.3301812
   Schmidt C, 2013, NAT BIOTECHNOL, V31, P957, DOI 10.1038/nbt.2733
   STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037543
   Sunshine JC, 2011, BIOMACROMOLECULES, V12, P3592, DOI 10.1021/bm200807s
   Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137
   WITTE A, 1992, ARCH MICROBIOL, V157, P381, DOI 10.1007/BF00248685
   Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt.1211
   Zugates GT, 2007, BIOCONJUGATE CHEM, V18, P1887, DOI 10.1021/bc7002082
   Zugates GT, 2007, MOL THER, V15, P1306, DOI 10.1038/sj.mt.6300132
NR 41
TC 15
Z9 15
U1 0
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 26
PY 2014
VL 111
IS 34
BP 12360
EP 12365
DI 10.1073/pnas.1411355111
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AN7LA
UT WOS:000340780300031
PM 25114239
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Yavari, SA
   van der Stok, J
   Ahmadi, SM
   Wauthle, R
   Schrooten, J
   Weinans, H
   Zadpoor, AA
AF Yavari, S. Amin
   van der Stok, J.
   Ahmadi, S. M.
   Wauthle, R.
   Schrooten, J.
   Weinans, H.
   Zadpoor, A. A.
TI Mechanical analysis of a rodent segmental bone defect model: The effects
   of internal fixation and implant stiffness on load transfer
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Segmental bone defect model; Animal models; Implant stiffness; Load
   transfer; Variability
ID GRAFT SUBSTITUTES; POROUS TITANIUM; ANIMAL-MODELS; IN-VIVO; TRABECULAR
   BONE; BIOMATERIALS; SCAFFOLDS; REGENERATION; REPAIR; AUTOGRAFT
AB Segmental bone defect animal models are often used for evaluating the bone regeneration performance of bone substituting biomaterials. Since bone regeneration is dependent on mechanical loading, it is important to determine mechanical load transfer after stabilization of the defect and to study the effects of biomaterial stiffness on the transmitted load. In this study, we assess the mechanical load transmitted over a 6 mm femur defect that is stabilized with an internal PEEK fixation plate. Subsequently, three types of selective laser melted porous titanium implants with different stiffness values were used to graft the defect (five specimens per group). In one additional group, the defect was left empty. Micro strain gauges were used to measure strain values at four different locations of the fixation plate during external loading on the femoral head. The load sharing between the fixation plate and titanium implant was highly variable with standard deviations of measured strain values between 31 and 93% of the mean values. As a consequence, no significant differences were measured between the forces transmitted through the titanium implants with different elastic moduli. Only some non-significant trends were observed in the mean strain values that, consistent with the results of a previous finite element study, implied the force transmitted through the implant increases with the implant stiffness. The applied internal fixation method does not standardize mechanical loading over the defect to enable detecting small differences in bone regeneration performances of bone substituting biomaterials. In conclusion, the fixation method requires further optimization to reduce the effects of the operative procedure and make the mechanical loading more consistent and improve the overall sensitivity of this rat femur defect model. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Yavari, S. Amin; Ahmadi, S. M.; Weinans, H.; Zadpoor, A. A.] Delft Univ Technol, Fac Mech Maritime & Mat Engn, TU Delft, NL-2628 CD Delft, Netherlands.
   [van der Stok, J.] Erasmus Univ, Rotterdam Med Ctr, Dept Orthopaed, Orthopaed Res Lab, Rotterdam, Netherlands.
   [Wauthle, R.] Katholieke Univ Leuven, Dept Mech Engn, Sect Prod Engn Machine Design & Automat PMA, B-3001 Leuven, Belgium.
   [Wauthle, R.] LayerWise NV, B-3001 Leuven, Belgium.
   [Schrooten, J.] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   [Weinans, H.] UMC Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Weinans, H.] UMC Utrecht, Dept Rheumatol, NL-3584 CX Utrecht, Netherlands.
RP Yavari, SA (reprint author), Delft Univ Technol, Fac Mech Maritime & Mat Engn, TU Delft, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM s.aminyavari@tudelft.nl
RI Zadpoor, Amir A/A-8510-2008; Amin Yavari, Saber/G-9486-2013; Amin
   Yavari, Saber/E-5360-2017
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
CR Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bendele A. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P363
   Betz RR, 2002, ORTHOPEDICS, V25, pS561
   Blemker SS, 2007, J MAGN RESON IMAGING, V25, P441, DOI 10.1002/jmri.20805
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Campoli G, 2012, J MECH BEHAV BIOMED, V10, P108, DOI 10.1016/j.jmbbm.2012.02.011
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Carson JS, 2007, INJURY, V38, pS33, DOI 10.1016/j.injury.2007.02.008
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Garcia P, 2013, EUR CELLS MATER, V26, P1
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Hill NM, 1999, AUST NZ J SURG, V69, P726, DOI 10.1046/j.1440-1622.1999.01674.x
   Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007
   Knothe UR, 2010, J BIOMECH, V43, P2728, DOI 10.1016/j.jbiomech.2010.06.026
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Lindfors NC, 2009, J BIOMED MATER RES B, V90B, P131, DOI 10.1002/jbm.b.31263
   Liu L, 2007, J BIOMECH, V40, P3516, DOI 10.1016/j.jbiomech.2007.04.019
   Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1
   Nikooyan AA, 2012, IEEE T BIO-MED ENG, V59, P797, DOI 10.1109/TBME.2011.2179803
   Nikooyan AA, 2011, J BIOMECH, V44, P984, DOI 10.1016/j.jbiomech.2010.11.032
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Poelert S.L., 2012, J BIOMECH S1, V45, pS334
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Ramsay JW, 2009, J BIOMECH, V42, P463, DOI 10.1016/j.jbiomech.2008.11.035
   Reinbolt JA, 2005, J BIOMECH, V38, P621, DOI 10.1016/j.jbiomech.2004.03.031
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Shi ZL, 2009, TISSUE ENG PT A, V15, P417, DOI 10.1089/ten.tea.2007.0415
   Tate MLK, 2011, J MECH BEHAV BIOMED, V4, P829, DOI 10.1016/j.jmbbm.2011.03.009
   Tomford William W., 2000, Cell and Tissue Banking, V1, P105, DOI 10.1023/A:1010158731885
   TOMFORD WW, 1995, J BONE JOINT SURG AM, V77A, P1742, DOI 10.2106/00004623-199511000-00017
   Traore Alidou, 2013, J Clin Orthop Trauma, V4, P119, DOI 10.1016/j.jcot.2013.07.001
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Venugopal J, 2010, PHILOS T R SOC A, V368, P2065, DOI 10.1098/rsta.2010.0012
   Verhulp E, 2004, J BIOMECH, V37, P1313, DOI 10.1016/j.jbiomech.2003.12.036
   Vitale-Brovarone C, 2007, ACTA BIOMATER, V3, P199, DOI 10.1016/j.actbio.2006.07.012
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   Yavari SA, 2014, APPL SURF SCI, V290, P287, DOI 10.1016/j.apsusc.2013.11.069
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Yavari SA, 2013, J BIOMECH, V46, P1282, DOI 10.1016/j.jbiomech.2013.02.007
   Zadpoor AA, 2006, J BIOMECH, V39, P388, DOI 10.1016/j.jbiomech.2005.08.015
   Zadpoor AA, 2013, APPL MATH MODEL, V37, P5260, DOI 10.1016/j.apm.2012.10.049
   Zadpoor AA, 2010, METALL MATER TRANS A, V41A, P3365, DOI 10.1007/s11661-010-0403-3
   Zadpoor AA, 2010, MATER DESIGN, V31, P4611, DOI 10.1016/j.matdes.2010.05.041
NR 51
TC 13
Z9 13
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD AUG 22
PY 2014
VL 47
IS 11
BP 2700
EP 2708
DI 10.1016/j.jbiomech.2014.05.006
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AO6LF
UT WOS:000341462900025
PM 24882739
DA 2018-10-20
ER

PT J
AU Sanchez-Palencia, DM
   D'Amore, A
   Gonzalez-Mancera, A
   Wagner, WR
   Briceno, JC
AF Sanchez-Palencia, Diana M.
   D'Amore, Antonio
   Gonzalez-Mancera, Andres
   Wagner, William R.
   Briceno, Juan C.
TI Effects of fabrication on the mechanics, microstructure and
   micromechanical environment of small intestinal submucosa scaffolds for
   vascular tissue engineering
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE SIS (small intestine submucosa); Mechanical properties; Microstructure;
   Constitutive modeling; Scaffold
ID EXTRACELLULAR-MATRIX; MACROPHAGE PHENOTYPE; FIBER ARCHITECTURE; LAYERED
   COLLAGEN; FOCAL ADHESIONS; FLUID SHEAR; CELL; MECHANOTRANSDUCTION;
   BIOMATERIAL; ELASTICITY
AB In small intestinal submucosa scaffolds for functional tissue engineering, the impact of scaffold fabrication parameters on success rate may be related to the mechanotransductory properties of the final microstructural organization of collagen fibers. We hypothesized that two fabrication parameters, 1) preservation (P) or removal (R) of a dense collagen layer present in SIS and 2) SIS in a final dehydrated (D) or hydrated (H) state, have an effect on scaffold void area, microstructural anisotropy (fiber alignment) and mechanical anisotropy (global mechanical compliance). We further integrated our experimental measurements in a constitutive model to explore final effects on the micromechanical environment inside the scaffold volume. Our results indicated that PH scaffolds might exhibit recurrent and large force fluctuations between layers (up to 195 pN), while fluctuations in RH scaffolds might be larger (up to 256 pN) but not as recurrent. In contrast, both PD and RD groups were estimated to produce scarcer and smaller fluctuations (not larger than 50 pN). We concluded that the hydration parameter strongly affects the micromechanics of SIS and that an adequate choice of fabrication parameters, assisted by the herein developed method, might leverage the use of SIS for functional tissue engineering applications, where forces at the cellular level are of concern in the guidance of new tissue formation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Sanchez-Palencia, Diana M.; Briceno, Juan C.] Univ Los Andes, Dept Biomed Engn, Bogota 111711, Colombia.
   [Sanchez-Palencia, Diana M.; Briceno, Juan C.] CEIBA Complex Syst Res Ctr, Bogota 111711, Colombia.
   [D'Amore, Antonio; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [D'Amore, Antonio; Wagner, William R.] McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [D'Amore, Antonio] RiMED Fdn, I-90133 Palermo, Italy.
   [D'Amore, Antonio] Univ Palermo, DICGIM, I-90128 Palermo, Italy.
   [Gonzalez-Mancera, Andres] Univ Los Andes, Dept Mech Engn, Bogota 111711, Colombia.
   [Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15213 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.
RP Sanchez-Palencia, DM (reprint author), Carrera 1Este 19A-40 ML-304, Bogota, Colombia.
EM dm.sanchez310@uniandes.edu.co
RI Briceno Triana, Juan Carlos/O-1931-2017; D'Amore, Antonio/E-7111-2012
OI D'Amore, Antonio/0000-0002-3151-3170
FU CEIBA-COLCIENCIAS [286-2006]; Colciencias [2778-569-34609]; RiMED
   Foundation
FX This project was funded by CEIBA-COLCIENCIAS Grant No. 286-2006 (DS),
   Colciencias Grant No. 2778-569-34609 and a RiMED Foundation Fellowship
   (AD). Funding sponsors had no involvement in the study.
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Badylak S, 1999, BIOMATERIALS, V20, P2257, DOI 10.1016/S0142-9612(99)00156-8
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak S, 2008, ACAD PR SER BIOM ENG, P121, DOI 10.1016/B978-0-12-370869-4.00005-7
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   British Standards Institution, 2004, PHYS TEST RUBB 5, P903
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Canham PB, 1996, J MICROSC-OXFORD, V183, P170, DOI 10.1046/j.1365-2818.1996.840642.x
   CANHAM PB, 1991, ANAT RECORD, V231, P579, DOI 10.1002/ar.1092310420
   Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8
   D'Amore A, 2010, BIOMATERIALS, V31, P5345, DOI 10.1016/j.biomaterials.2010.03.052
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Du J, 2011, P NATL ACAD SCI USA, V108, P9466, DOI 10.1073/pnas.1106467108
   DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Freytes DO, 2008, J BIOMED MATER RES A, V87A, P862, DOI 10.1002/jbm.a.31821
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghosh K, 2013, BIOMATERIALS SCI INT, P1165
   Gilbert TW, 2006, J BIOMECH ENG-T ASME, V128, P890, DOI 10.1115/1.2354200
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   KIERNAN J. A., 2000, MICROSC TODAY, V8, P8
   Kim BS, 2011, PROG POLYM SCI, V36, P238, DOI 10.1016/j.progpolymsci.2010.10.001
   Koch RG, 2014, J BIOMECH, V47, P935, DOI 10.1016/j.jbiomech.2014.01.027
   Lantz G C, 1990, J Invest Surg, V3, P217, DOI 10.3109/08941939009140351
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Martins PALS, 2006, STRAIN, V42, P135, DOI 10.1111/j.1475-1305.2006.00257.x
   Sacks MS, 1999, J BIOMED MATER RES, V46, P1, DOI 10.1002/(SICI)1097-4636(199907)46:1<1::AID-JBM1>3.0.CO;2-7
   SACKS MS, 1992, J BIOMECH ENG-T ASME, V114, P183, DOI 10.1115/1.2891370
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Tan AR, 2008, J BIOMED MATER RES A, V87A, P1034, DOI 10.1002/jbm.a.31853
   Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345
   Wei HJ, 2005, BIOMATERIALS, V26, P1905, DOI 10.1016/j.biomaterials.2004.06.014
   YEOH OH, 1990, RUBBER CHEM TECHNOL, V63, P792, DOI 10.5254/1.3538289
   Yu JD, 2004, COMPUT BIOL MED, V34, P539, DOI 10.1016/j.compbiomed.2003.06.001
NR 44
TC 11
Z9 12
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD AUG 22
PY 2014
VL 47
IS 11
BP 2766
EP 2773
DI 10.1016/j.jbiomech.2014.04.048
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AO6LF
UT WOS:000341462900034
PM 24877881
DA 2018-10-20
ER

PT J
AU Chan, DD
   Gossett, PC
   Butz, KD
   Nauman, EA
   Neu, CP
AF Chan, Deva D.
   Gossett, Paull C.
   Butz, Kent D.
   Nauman, Eric A.
   Neu, Corey P.
TI Comparison of intervertebral disc displacements measured under applied
   loading with MRI at 3.0 T and 9.4 T
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Displacement-encoded imaging; High-field MRI; Clinical MRI;
   Biomechanics; Elastography
ID CARTILAGE DEFORMATION; ARTICULAR-CARTILAGE
AB The purpose of this study was to compare displacement behavior of cyclically loaded cadaveric human intervertebral discs as measured noninvasively on a clinical 3.0 T and a research 9.4 T MRI system. Intervertebral discs were cyclically compressed at physiologically relevant levels with the same MRI-compatible loading device in the clinical and research systems. Displacement-encoded imaging was synchronized to cyclic loading to measure displacements under applied loading with MRI (dualMRI). Displacements from the two systems were compared individually using linear regression and, across all specimens, using Bland-Altman analysis. In-plane displacement patterns measured at 3.0 T and 9.4 T were qualitatively comparable and well correlated. Bland-Altman analyses showed that over 90% of displacement values within the intervertebral disc regions of interest lay within the limits of agreement. Measurement of displacement using dualMRI using a 3.0 T clinical system is comparable to that of a 9.4 T research system. Additional refinements of software, technique implementation, and image processing have potential to improve agreement between different MRI systems. Despite differences in MRI systems in this initial implementation, this work demonstrates that dualMRI can be reliably implemented at multiple magnetic field strengths, permitting translation of dualMRI for a variety of applications in the study of tissue and biomaterial biomechanics. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Chan, Deva D.; Gossett, Paull C.; Nauman, Eric A.; Neu, Corey P.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   [Butz, Kent D.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.
RP Neu, CP (reprint author), 206 South Martin Jischke Dr, W Lafayette, IN 47907 USA.
EM cpneu@purdue.edu
OI Chan, Deva/0000-0003-1508-1045
FU NSF [CMMI 1100554]; NIH [R25 EB013029-02, S10 RR019920-01, R01 AR063712,
   R21 AR064178]; Indiana CTSI Core Pilot Funding
FX Funding for this study was provided by NSF CMMI 1100554, NIH R25
   EB013029-02, NIH S10 RR019920-01, NIH R01 AR063712, NIH R21 AR064178,
   and Indiana CTSI Core Pilot Funding. Study sponsors were not involved in
   the design of the study, the collection, analysis and interpretation of
   data, the writing of the manuscript, nor the decision to publish. The
   authors thank Aaditya Chandramouli for assistance with specimen
   preparation and also Limin Li, Gregory Tamer, and Thomas Talavage for
   their technical expertise on MRI systems.
CR Antoniou J., 2013, J MAGN RESON IMAGING
   BLAND JM, 1986, LANCET, V1, P307
   Chan DD, 2009, OSTEOARTHR CARTILAGE, V17, P1461, DOI 10.1016/j.joca.2009.04.021
   Chan D.D., 2012, COMPUT METHODS BIOME
   Chan DD, 2013, MAGN RESON MED
   Chan DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033463
   Chan DD, 2011, SPINE, V36, P1438, DOI 10.1097/BRS.0b013e3181f8be52
   Cortes D.H., 2013, MAGN RESON MED
   Gilchrist CL, 2004, IEEE T MED IMAGING, V23, P546, DOI 10.1109/TMI.2004.825616
   Glaser KJ, 2006, MAGNET RESON MED, V55, P59, DOI 10.1002/mrm.20748
   Hardy PA, 2005, MAGNET RESON MED, V53, P1065, DOI 10.1002/mrm.20439
   Herberhold C, 1999, J BIOMECH, V32, P1287, DOI 10.1016/S0021-9290(99)00130-X
   Neu CP, 2008, MAGN RESON MED, V59, P149, DOI 10.1002/mrm.21464
   Neu CP, 2005, MAGNET RESON MED, V54, P1290, DOI 10.1002/mrm.20669
   O'Connell GD, 2007, SPINE, V32, P2860, DOI 10.1097/BRS.0b013e31815b75fb
   Subburaj K, 2012, J ORTHOP RES, V30, P919, DOI 10.1002/jor.22031
   Willett TL, 2005, P I MECH ENG H, V219, P23, DOI 10.1243/095441105X9200
   Zhong XD, 2010, MAGN RESON MED, V64, P1089, DOI 10.1002/mrm.22503
NR 18
TC 2
Z9 2
U1 1
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD AUG 22
PY 2014
VL 47
IS 11
BP 2801
EP 2806
DI 10.1016/j.jbiomech.2014.05.026
PG 6
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AO6LF
UT WOS:000341462900040
PM 24968943
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Formentin, P
   Alba, M
   Catalan, U
   Fernandez-Castillejo, S
   Pallares, J
   Sola, R
   Marsal, LF
AF Formentin, Pilar
   Alba, Maria
   Catalan, Ursula
   Fernandez-Castillejo, Sara
   Pallares, Josep
   Sola, Rosa
   Marsal, Lluis F.
TI Effects of macro- versus nanoporous silicon substrates on human aortic
   endothelial cell behavior
SO NANOSCALE RESEARCH LETTERS
LA English
DT Article
DE Porous silicon; HAEC; Cell adhesion; Cell morphology
ID POROUS SILICON; STRUCTURE FABRICATION; ADHESION; PROLIFERATION;
   NANOSCALE
AB Human aortic endothelial cells play a key role in the pathogenesis of atherosclerosis, which is a common, progressive, and multifactorial disease that is the clinical endpoint of an inflammatory process and endothelial dysfunction. Study and development of new therapies against cardiovascular disease must be tested in vitro cell models, prior to be evaluated in vivo. To this aim, new cell culture platforms are developed that allow cells to grow and respond to their environment in a realistic manner. In this work, the cell adhesion and morphology of endothelial cells are investigated on functionalized porous silicon substrates with two different pore size configurations: macroporous and nanoporous silicon. Herein, we modified the surfaces of porous silicon substrates by aminopropyl triethoxysilane, and we studied how different pore geometries induced different cellular response in the cell morphology and adhesion. The cell growth over the surface of porous silicon becomes an attractive field, especially for medical applications. Surface properties of the biomaterial are associated with cell adhesion and as well as, with proliferation, migration and differentiation.
C1 [Formentin, Pilar; Alba, Maria; Pallares, Josep; Marsal, Lluis F.] Univ Rovira & Virgili, Dept Engn Elect Elect & Automat, E-43007 Tarragona, Spain.
   [Catalan, Ursula; Fernandez-Castillejo, Sara; Sola, Rosa] Univ Rovira & Virgili, Fac Med & Ciencies Salut, Unit Lipids & Atherosclerosis Res, Tarragona 43201, Spain.
RP Marsal, LF (reprint author), Univ Rovira & Virgili, Dept Engn Elect Elect & Automat, Paisos Catalans 26, E-43007 Tarragona, Spain.
EM lluis.marsal@urv.cat
RI SOLA, Rosa/N-5919-2014; Catalan, Ursula/N-5712-2014; Alba,
   Maria/F-6604-2016; Marsal, Lluis/G-8852-2011
OI Catalan, Ursula/0000-0001-8884-9823; Alba, Maria/0000-0003-2119-9082;
   Marsal, Lluis/0000-0002-5976-1408; Fernandez-Castillejo,
   Sara/0000-0002-8109-9713; SOLA, Rosa/0000-0002-8359-235X
FU Spanish Ministerio de Economia y Competividad (MINECO) [TEC2012-34397];
   Generalitat de Catalunya [2014-SGR-1344]; Spanish Ministerio de
   Educacion y Ciencia [AGL2012-40144-C03-02]; Centre Tecnologic de
   Nutricio i Salut (CTNS)
FX This work was supported by the Spanish Ministerio de Economia y
   Competividad (MINECO) under grant number TEC2012-34397, Generalitat de
   Catalunya under grant number 2014-SGR-1344, Spanish Ministerio de
   Educacion y Ciencia AGL2012-40144-C03-02, and the support of Centre
   Tecnologic de Nutricio i Salut (CTNS).
CR Alba M, 2014, RSC ADV, V4, P11409, DOI 10.1039/c3ra48062c
   Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Bhattacharyya D, 2010, J BIOMED MATER RES A, V94A, P640, DOI 10.1002/jbm.a.32713
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   Canham L, 1997, PROPERTIES POROUS SI, P416
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Collart-Dutilleul PY, 2014, ACS APPL MATER INTER, V6, P1719, DOI 10.1021/am4046316
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Gentile F, 2012, ACS APPL MATER INTER, V4, P2903, DOI 10.1021/am300519a
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   Hajdu K, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-400
   Janshoff A, 1998, J AM CHEM SOC, V120, P12108, DOI 10.1021/ja9826237
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Lakard S, 2004, BIOELECTROCHEMISTRY, V62, P19, DOI 10.1016/j.bioelechem.2003.03.009
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Punzon-Quijorna E, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-396
   Stewart MP, 2000, ADV MATER, V12, P859, DOI 10.1002/1521-4095(200006)12:12<859::AID-ADMA859>3.0.CO;2-0
   Sun W, 2007, ADV MATER, V19, P921, DOI 10.1002/adma.200600319
   Sweetman MJ, 2012, ADV FUNCT MATER, V22, P1158, DOI 10.1002/adfm.201102000
   Trifonov T, 2008, SENSOR ACTUAT A-PHYS, V141, P662, DOI 10.1016/j.sna.2007.09.001
   Trifonov T, 2005, PHYS STATUS SOLIDI C, V2, P3104, DOI 10.1002/pssc.200460743
   Xifre-Perez E, 2009, APPL PHYS B-LASERS O, V95, P169, DOI 10.1007/s00340-009-3416-0
NR 26
TC 7
Z9 7
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD AUG 21
PY 2014
VL 9
AR 421
DI 10.1186/1556-276X-9-421
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AP6VR
UT WOS:000342216700001
PM 25246859
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ying, J
AF Ying, Jackie
TI Interview with Jackie Ying
SO CHEMICAL COMMUNICATIONS
LA English
DT Editorial Material
AB Jackie Y. Ying was born in Taipei, and raised in Singapore and New York, and graduated with BE summa cum laude in Chemical Engineering from The cooper Union in 1987. As an AT&T Bell Laboratories PhD. Scholar at Princeton University, she began research in materials chemistry, linking the importance of materials processing and microstructure with the tailoring of materials surface chemistry and energetics. Prof. Ying has been on the Chemical Engineering faculty at Massachusetts Institute of Technology (MIT) since 1992, and-was promoted to Associate Professor in 1996, and-to Professor in 2001. She is currently the Executive Director of the Institute of Bioengineering and Nanotechnology (IBN), Singapore. IBN is a multidisciplinary national research institute founded by Prof. Ying in March 2003 to advance the frontiers of engineering, science and medicine; it has grown to 170 research staff and students under Prof. Ying's leadership: Prof. Ying's research is interdisciplinary in nature, with a theme in the synthesis of advanced, nanostructured materials for catalytic and biomaterial applications. Her laboratory has been responsible for several novel wet-chemical and physical vapor Synthesis approaches that create nanocomposites, nanoporous materials and nanodevices with Unique size-dependent characteristics. Prof. Ying serves on the Advisory Boards of several high profile journals and she is the Editor-in-Chief of Nano Today.
C1 [Ying, Jackie] Princeton Univ, Princeton, NJ 08544 USA.
NR 0
TC 0
Z9 0
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1359-7345
EI 1364-548X
J9 CHEM COMMUN
JI Chem. Commun.
PD AUG 21
PY 2014
VL 50
IS 65
BP 9032
EP 9033
DI 10.1039/c4cc90235a
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA AM5VZ
UT WOS:000339930400001
PM 25007854
DA 2018-10-20
ER

PT J
AU Hadjesfandiari, N
   Yu, K
   Mei, Y
   Kizhakkedathu, JN
AF Hadjesfandiari, Narges
   Yu, Kai
   Mei, Yan
   Kizhakkedathu, Jayachandran N.
TI Polymer brush-based approaches for the development of
   infection-resistant surfaces
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; CATIONIC ANTIMICROBIAL PEPTIDES;
   POLY(ETHYLENE OXIDE) BRUSHES; ANTIBACTERIAL SURFACES; MICROBIAL
   ADHESION; BACTERIAL ADHESION; SILICONE-RUBBER; BIOFILM FORMATION;
   COATINGS; IMMOBILIZATION
AB In this highlight, we discuss the current strategies for developing infection-resistant biomaterials by making them non-fouling, bactericidal or both. ye focus on approaches that have used polymer brush systems by providing examples of hydrophilic non-fouling polymer brushes, those that incorporated bactericidal agents (antibiotics, antimicrobial peptides and proteins) and synthetic polyelectrolyte polymer brushes. We discuss the most important research reported in recent years and deliberate their merits, future potential and further developments required. Initially we give a brief account on the use of anti-adhesive hydrophilic polymer brushes as bacteria-resistant surfaces and their potential utility in short term applications. The importance of the chemistry and physical properties of the brushes is highlighted along with the need for the development of bactericidal coatings. Further, recent developments involving bactericide-releasing and contact killing coatings are discussed. Approaches based on antimicrobial peptide conjugated polymer brushes, those incorporating enzymes (e.g. lysozyme), viruses and chemical functionalities (polyelectrolytes) that can kill bacteria are highlighted. As an important criterion for the in vivo application of infection-resistant coatings, the biocompatibility of the modified surfaces is briefly discussed in each section. The covalent attachment, availability of multitude of functionalities for further modification, ability to alter the physical structure of the coating, biocompatibility, potential application to various biomedical surfaces and the robust mechanical properties of polymer brush systems make them ideal for further development as a novel surface coating to address biomaterial-associated infections.
C1 [Hadjesfandiari, Narges; Yu, Kai; Mei, Yan; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T IZ3, Canada.
   [Hadjesfandiari, Narges; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Chem, Vancouver, BC V6T IZ3, Canada.
   [Yu, Kai; Mei, Yan; Kizhakkedathu, Jayachandran N.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T IZ3, Canada.
RP Kizhakkedathu, JN (reprint author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T IZ3, Canada.
EM jay@pathology.ubc.ca
FU Canadian Institutes of Health Research (CIHR); Natural Sciences and
   Engineering Research Council of Canada (NSERC); Health Canada/Canadian
   Blood Services graduate fellowship; China Scholarship Council; NSERC
   CREATE NCPRM; Michael Smith Foundation for Health Research (MSFHR)
   Career Investigator Scholar Award
FX Authors acknowledge the funding from Canadian Institutes of Health
   Research (CIHR) and Natural Sciences and Engineering Research Council of
   Canada (NSERC). N.H. is a recipient of Health Canada/Canadian Blood
   Services graduate fellowship. Y.M. is a recipient of a fellowship from
   the China Scholarship Council. Y.M. also acknowledges funding from NSERC
   CREATE NCPRM. J.N.K. is a recipient of a Michael Smith Foundation for
   Health Research (MSFHR) Career Investigator Scholar Award.
CR Appendini P., 1997, Packaging Technology & Science, V10, P271, DOI 10.1002/(SICI)1099-1522(199709/10)10:5<271::AID-PTS412>3.3.CO;2-I
   Asadinezhad A, 2010, PLASMA PROCESS POLYM, V7, P504, DOI 10.1002/ppap.200900132
   Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Basu A, 2013, J MATER CHEM B, V1, P4746, DOI 10.1039/c3tb20805b
   Bertal K, 2009, J MATER SCI, V44, P6233, DOI 10.1007/s10853-009-3843-7
   Blin T, 2011, BIOMACROMOLECULES, V12, P1259, DOI 10.1021/bm101547d
   Branch DW, 2001, BIOMATERIALS, V22, P1035, DOI 10.1016/S0142-9612(00)00343-4
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Cademartiri R, 2010, BIOMATERIALS, V31, P1904, DOI 10.1016/j.biomaterials.2009.11.029
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Charnley M, 2011, REACT FUNCT POLYM, V71, P329, DOI 10.1016/j.reactfunctpolym.2010.10.013
   Cheng G, 2008, ANGEW CHEM INT EDIT, V47, P8831, DOI 10.1002/anie.200803570
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Fundeanu I, 2008, COLLOID SURFACE B, V64, P297, DOI 10.1016/j.colsurfb.2008.02.005
   Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010
   Fundeanu I, 2010, J BIOMED MATER RES A, V94A, P997, DOI 10.1002/jbm.a.32789
   Gao G, 2012, CHEM BIOL, V19, P199, DOI 10.1016/j.chembiol.2011.12.015
   Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Hancock R E, 2001, Lancet Infect Dis, V1, P156, DOI 10.1016/S1473-3099(01)00092-5
   Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Hirota K, 2005, FEMS MICROBIOL LETT, V248, P37, DOI 10.1016/j.femsle.2005.05.019
   Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978, DOI 10.1002/anie.200901607
   Hosseinidoust Z, 2011, LANGMUIR, V27, P5472, DOI 10.1021/la200102z
   Hu R, 2013, LANGMUIR, V29, P3773, DOI 10.1021/la304708b
   Huang JY, 2007, BIOMACROMOLECULES, V8, P1396, DOI 10.1021/bm061236j
   Jiang H, 2011, LANGMUIR, V27, P11575, DOI 10.1021/la202101q
   Kawai F, 2002, APPL MICROBIOL BIOT, V58, P30, DOI 10.1007/s00253-001-0850-2
   Kim JC, 2012, MACROMOL RES, V20, P746, DOI 10.1007/s13233-012-0099-x
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   Kugel A, 2011, PROG ORG COAT, V72, P222, DOI 10.1016/j.porgcoat.2011.07.004
   Laloyaux X, 2010, ADV MATER, V22, P5024, DOI 10.1002/adma.201002538
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Lee HS, 2011, LANGMUIR, V27, P12458, DOI 10.1021/la202616u
   Li X, 2014, ACTA BIOMATER, V10, P258, DOI 10.1016/j.actbio.2013.09.009
   Li Y, 2011, CHEM-EUR J, V17, P2656, DOI 10.1002/chem.201001533
   Lim K, 2013, ACS APPL MATER INTER, V5, P6412, DOI 10.1021/am401629p
   Liu QS, 2012, BIOMACROMOLECULES, V13, P1086, DOI 10.1021/bm201814p
   Mishra B, 2014, J MATER CHEM B, V2, P1706, DOI 10.1039/c3tb21300e
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nejadnik MR, 2008, J ANTIMICROB CHEMOTH, V62, P1323, DOI 10.1093/jac/dkn395
   Nejadnik MR, 2008, BIOMATERIALS, V29, P4117, DOI 10.1016/j.biomaterials.2008.07.014
   Page K, 2009, J MATER CHEM, V19, P3819, DOI 10.1039/b818698g
   Pidhatika B, 2010, BIOMATERIALS, V31, P9462, DOI 10.1016/j.biomaterials.2010.08.033
   Ramstedt M, 2007, LANGMUIR, V23, P3314, DOI 10.1021/la062670+
   Rapsch K, 2014, BIOCONJUGATE CHEM, V25, P308, DOI 10.1021/bc4004469
   Roosjen A, 2004, LANGMUIR, V20, P10949, DOI 10.1021/la0484691
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Rossegger E, 2013, POLYMERS-BASEL, V5, P956, DOI 10.3390/polym5030956
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Smith RS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004120
   Takahashi N, 2014, J PROSTHET DENT, V112, P194, DOI 10.1016/j.prosdent.2013.08.020
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Wang CH, 2005, BIOMATERIALS, V26, P2803, DOI 10.1016/j.biomaterials.2004.07.064
   Yang WJ, 2013, BIOMACROMOLECULES, V14, P2041, DOI 10.1021/bm400382e
   Yang WJ, 2011, LANGMUIR, V27, P7065, DOI 10.1021/la200620s
   Yao F, 2008, J MEMBRANE SCI, V319, P149, DOI 10.1016/j.memsci.2008.03.049
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Zhang SF, 1998, BIOMATERIALS, V19, P691, DOI 10.1016/S0142-9612(97)00174-9
NR 77
TC 48
Z9 48
U1 4
U2 153
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD AUG 21
PY 2014
VL 2
IS 31
BP 4968
EP 4978
DI 10.1039/c4tb00550c
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AM4YB
UT WOS:000339861000001
DA 2018-10-20
ER

PT J
AU Fang, GH
   Tang, B
   Liu, ZT
   Gou, JX
   Zhang, Y
   Xu, H
   Tang, X
AF Fang, Guihua
   Tang, Bo
   Liu, Zitong
   Gou, Jingxin
   Zhang, Yu
   Xu, Hui
   Tang, Xing
TI Novel hydrophobin-coated docetaxel nanoparticles for intravenous
   delivery: In vitro characteristics and in vivo performance
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Hydrophobin; Docetaxel; Nanoparticles; Drug delivery
ID DRUG-DELIVERY; POLYMERIC MICELLES; PROTEIN; ADSORPTION; STABILITY;
   EMULSIONS; BEHAVIOR; CARRIERS; SYSTEMS; SURFACE
AB Novel hydrophobin (H star Protein (R) B, HPB)-coated docetaxel (DTX) nanoparticles were designed for intravenous delivery. DTX-HPB nanoparticles (DTX-HPB-NPs) were prepared using a nanoprecipitation-ultrasonication technique. The physicochemical properties in terms of particle size, size distribution, zeta potential, morphology, crystalline state of the drug, in vitro release and plasma stability were evaluated. To investigate the drug-hydrophobin interaction, FTIR analysis was carried out. The pharmacokinetics of DTX-HPB-NPs and Taxotere were compared after i.v. administration to rats. The optimized formulations have a high drug loading (>25%) and nanoparticle yield (>93%), small particle size with a narrow distribution, and exhibit delayed release. X-ray diffraction (XRD) demonstrated that the drug is present in a crystalline state. FTIR analysis suggested that the interaction of DTX and HPB involved hydrogen bonding. In vitro hemolysis study confirmed the safety of these nanoparticles. In plasma, DTX-HPB nanoparticles exhibited a significantly enhanced C-max (1300.618 +/- 405.045 ng/mL vs 453.174 +/- 164.437 ng/mL, p <0.05), and AUC(0-t) (409.602 +/- 70.267 vs 314.924 +/- 57.426 mu g/L h, p < 0.05), and a significantly reduced volume of distribution (36.635 +/- 15.189 vs 95.199 +/- 40.972 L/kg, p < 0.05) compared with the Taxotere. These results demonstrated that hydrophobin has the potential to be used as a novel biocompatible biomaterial for drug delivery. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Fang, Guihua; Tang, Bo; Liu, Zitong; Gou, Jingxin; Zhang, Yu; Xu, Hui; Tang, Xing] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China.
RP Tang, X (reprint author), Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China.
EM tanglab@126.com
FU National Science & Technology Major Project 'Key New Drug Creation and
   Manufacturing Program' [2013ZX09301305]; National High-tech R&D Program
   of China 863 Program [2012AA020305]; Doctoral Start-up Fund Program of
   Liaoning Province, China [20111141]
FX This work is supported by the National Science & Technology Major
   Project 'Key New Drug Creation and Manufacturing Program'
   (2013ZX09301305), National High-tech R&D Program of China 863 Program
   (2012AA020305) and the Doctoral Start-up Fund Program of Liaoning
   Province, China (20111141).
CR Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264
   Akanbi MHJ, 2010, COLLOID SURFACE B, V75, P526, DOI 10.1016/j.colsurfb.2009.09.030
   [Anonymous], 2001, ANNU REV MICROBIOL, V55, P625
   Askolin S, 2006, BIOMACROMOLECULES, V7, P1295, DOI 10.1021/bm050676s
   Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002
   De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Emsting M.J., 2012, BIOMATERIALS, V33, P1445
   Gu PF, 2012, INT J NANOMED, V7, P109, DOI 10.2147/IJN.S27475
   Han YS, 2010, ACS NANO, V4, P2838, DOI 10.1021/nn100307j
   He W, 2013, INT J PHARMACEUT, V441, P269, DOI 10.1016/j.ijpharm.2012.11.033
   Hektor HJ, 2005, CURR OPIN BIOTECH, V16, P434, DOI 10.1016/j.copbio.2005.05.004
   Jones MC, 1999, EUR J PHARM BIOPHARM, V48, P101, DOI 10.1016/S0939-6411(99)00039-9
   Kendrick BS, 1996, J PHARM SCI, V85, P155, DOI 10.1021/js950332f
   Li YH, 2012, ADV DRUG DELIVER REV, V64, P29, DOI 10.1016/j.addr.2011.04.006
   Linder MB, 2005, FEMS MICROBIOL REV, V29, P877, DOI 10.1016/j.femsre.2005.01.004
   Liu DH, 2011, COLLOID SURFACE B, V85, P262, DOI 10.1016/j.colsurfb.2011.02.038
   Liu YZ, 2012, J PHYS CHEM B, V116, P12227, DOI 10.1021/jp304796p
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Lowery A, 2011, J CONTROL RELEASE, V150, P117, DOI 10.1016/j.jconrel.2010.11.006
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   Mulligan CN, 2005, ENVIRON POLLUT, V133, P183, DOI 10.1016/j.envpol.2004.06.009
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Paslay LC, 2013, BIOMACROMOLECULES, V14, P2283, DOI 10.1021/bm400407c
   Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197
   Rabinow BE, 2004, NAT REV DRUG DISCOV, V3, P785, DOI 10.1038/nrd1494
   Reger M, 2012, J COLLOID INTERF SCI, V368, P378, DOI 10.1016/j.jcis.2011.10.050
   Reger M, 2011, SOFT MATTER, V7, P11021, DOI 10.1039/c1sm06525d
   Reger M, 2011, SOFT MATTER, V7, P8248, DOI 10.1039/c1sm06155k
   Rowinsky EK, 1997, ANNU REV MED, V48, P353
   Sarparanta M, 2012, MOL PHARMACEUT, V9, P654, DOI 10.1021/mp200611d
   Sebak S, 2010, INT J NANOMED, V5, P525
   SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6
   Shalel S, 2002, J COLLOID INTERF SCI, V252, P66, DOI 10.1006/jcis.2002.8474
   Sunde M, 2008, MICRON, V39, P773, DOI 10.1016/j.micron.2007.08.003
   Valo H, 2011, J CONTROL RELEASE, V156, P390, DOI 10.1016/j.jconrel.2011.07.016
   Wang X, 2002, PROTEIN SCI, V11, P1172, DOI 10.1110/ps.4530102
   Yallapu MM, 2011, BIOMATERIALS, V32, P1890, DOI 10.1016/j.biomaterials.2010.11.028
NR 38
TC 16
Z9 16
U1 1
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD AUG 18
PY 2014
VL 60
BP 1
EP 9
DI 10.1016/j.ejps.2014.04.016
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AJ8ZF
UT WOS:000337995900001
PM 24815943
DA 2018-10-20
ER

PT J
AU Kumar, CG
   Sujitha, P
AF Kumar, C. Ganesh
   Sujitha, Pombala
TI Green synthesis of Kocuran-functionalized silver glyconanoparticles for
   use as antibiofilm coatings on silicone urethral catheters
SO NANOTECHNOLOGY
LA English
DT Article
DE glyconanoparticles; antibiofilm coatings; urethral catheters; Kocuran;
   exopolysaccharide
ID PSEUDOMONAS-AERUGINOSA BS-161R; ESCHERICHIA-COLI; METAL NANOPARTICLES;
   GOLD GLYCONANOPARTICLES; ANTIMICROBIAL ACTIVITY; MEDIATED SYNTHESIS;
   SURFACE-CHARGE; BACTERIA; BIOFILM; IRON
AB Microbial infections due to biofilm formation on medical implants are serious complications arising after surgery which can be prevented by using antimicrobial coatings on biomaterial surfaces. We developed a simple, rapid and green chemistry approach for synthesis of silver glyconanoparticles (AgNPs) using Kocuran, an exopolysaccharide produced by Kocuria rosea strain BS-1. Kocuran-capped AgNPs exhibited a characteristic surface plasmon resonance (SPR) peak around 435 nm. They were mono-dispersed, spherical with an average particle size of 12 nm. XRD and SAED studies suggested that AgNPs were crystalline in nature. AgNPs had a zeta potential of -33.9 mV and were anionic charged. They showed colloidal stability at different pH (6 to 10), temperatures (30 degrees C to 100 degrees C), in NaCl, NaNO3 and BSA solutions. Kocuran-capped AgNPs exhibited effective antimicrobial activity against Staphylococcus aureus and Escherichia coli and cell death was mainly due to hydroxyl radical induction and depletion of NADH. They also inhibited the biofilm development by S. aureus and E. coli and confocal scanning laser microscopic images revealed the damage of intact cell architecture. In vitro evaluation of Kocuran-capped silver glyconanoparticles on human gingival fibroblasts demonstrated good cell proliferation as compared to commercial AgNPs suggesting that they are biocompatible and non-toxic in nature. This is a first report on Kocuran-functionalized AgNPs exhibiting potential antibacterial and antiadhesive properties for use as antimicrobial coatings against bacterial adhesion and biofilm formation on silicone urethral catheters.
C1 [Kumar, C. Ganesh; Sujitha, Pombala] CSIR, Indian Inst Chem Technol, Acad Sci & Innovat Res, Hyderabad 500007, Andhra Pradesh, India.
   [Kumar, C. Ganesh; Sujitha, Pombala] CSIR, Indian Inst Chem Technol, Med Chem & Pharmacol Div, Hyderabad 500007, Andhra Pradesh, India.
RP Kumar, CG (reprint author), CSIR, Indian Inst Chem Technol, Acad Sci & Innovat Res, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.
EM cgkumar@iict.res.in; cgkumar5@gmail.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India
FX The authors acknowledge the financial assistance provided to Pombala
   Sujitha in the form of Senior Research Fellowship by Council of
   Scientific and Industrial Research (CSIR), New Delhi, India.
CR Barrientos AG, 2003, CHEM-EUR J, V9, P1909, DOI 10.1002/chem.200204544
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Brady MJ, 2003, AM J INFECT CONTROL, V31, P208, DOI 10.1067/mic.2003.23
   Chaplin M. F., 1986, CARBOHYDRATE ANAL PR, P129
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Chung YC, 2008, BIOMATERIALS, V29, P1807, DOI 10.1016/j.biomaterials.2007.12.032
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   de la Fuente JDM, 2005, TETRAHEDRON-ASYMMETR, V16, P387, DOI 10.1016/j.tetasy.2004.12.002
   de la Fuente JM, 2001, ANGEW CHEM INT EDIT, V40, P2258, DOI 10.1002/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S
   De la Fuente JM, 2006, BBA-GEN SUBJECTS, V1760, P636, DOI 10.1016/j.bbagen.2005.12.001
   de Paz JL, 2005, TETRAHEDRON-ASYMMETR, V16, P149, DOI 10.1016/j.tetasy.2004.11.066
   El Badawy AM, 2010, ENVIRON SCI TECHNOL, V44, P1260, DOI 10.1021/es902240k
   FARR SB, 1991, MICROBIOL REV, V55, P561
   Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3
   Hoang VT, 2010, COLLOID SURFACE A, V360, P32, DOI 10.1016/j.colsurfa.2010.02.007
   Hollinger MA, 1996, CRIT REV TOXICOL, V26, P255, DOI 10.3109/10408449609012524
   Hunter R.J., 1981, ZETA POTENTIAL COLLO, P17
   Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI [10.1111/j.1365-2958.2006.05028.x, 10.1111/j.1365-2958.2005.05028.x]
   Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002
   Jiang JK, 2009, J NANOPART RES, V11, P77, DOI 10.1007/s11051-008-9446-4
   Kanmani P, 2013, PROCESS BIOCHEM, V48, P1099, DOI 10.1016/j.procbio.2013.05.011
   Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635
   Kora Aruna Jyothi, 2012, Org Med Chem Lett, V2, P17, DOI 10.1186/2191-2858-2-17
   Kumar CG, 2012, PROCESS BIOCHEM, V47, P1488, DOI 10.1016/j.procbio.2012.05.023
   Kumar CG, 2011, COLLOID SURFACE B, V84, P462, DOI 10.1016/j.colsurfb.2011.01.042
   Kumar CG, 2010, J MICROBIOL BIOTECHN, V20, P1061, DOI 10.4014/jmb.1001.01018
   Kumar CG, 2012, BIOTECHNOL PROGR, V28, P1507, DOI 10.1002/btpr.1634
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023
   Lemarchand C, 2004, EUR J PHARM BIOPHARM, V58, P327, DOI 10.1016/j.ejpb.2004.02.016
   Leonardo MR, 1996, J BACTERIOL, V178, P6013, DOI 10.1128/jb.178.20.6013-6018.1996
   Leung TCY, 2010, MATER CHEM PHYS, V121, P402, DOI 10.1016/j.matchemphys.2010.02.026
   Liu JC, 2006, CHEM-EUR J, V12, P2132, DOI 10.1002/chem.200500925
   Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001
   Mandal D, 2006, APPL MICROBIOL BIOT, V69, P485, DOI 10.1007/s00253-005-0179-3
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Medina-Ramirez I, 2009, COLLOID SURFACE B, V73, P185, DOI 10.1016/j.colsurfb.2009.05.015
   Mock JJ, 2002, J CHEM PHYS, V116, P6755, DOI 10.1063/1.1462610
   Mohan YM, 2007, J APPL POLYM SCI, V106, P3375, DOI 10.1002/app.26979
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukherjee P, 2001, NANO LETT, V1, P515, DOI 10.1021/nl0155274
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Omoike A, 2004, BIOMACROMOLECULES, V5, P1219, DOI 10.1021/bm034461z
   Paniagua-Contreras G, 2012, ADV MICROBIOL, V2, P476, DOI 10.4236/aim.2012.24061
   Philip D, 2010, SPECTROCHIM ACTA A, V75, P1078, DOI 10.1016/j.saa.2009.12.058
   Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001
   Rai M, 2008, CRIT REV BIOTECHNOL, V28, P277, DOI [10.1080/07388550802368903, 10.1080/07388550802368903 ]
   Raveendran P, 2006, GREEN CHEM, V8, P34, DOI 10.1039/b512540e
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Rzhepishevska O, 2013, BIOMATER SCI-UK, V1, P589, DOI 10.1039/c3bm00197k
   Selvakumar R, 2014, J EXP NANOSCI, V9, P1075, DOI 10.1080/17458080.2013.778425
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Tiwari Pramil, 2013, Value Health Reg Issues, V2, P87, DOI 10.1016/j.vhri.2013.03.002
   Venkatpurwar V, 2011, MATER LETT, V65, P999, DOI 10.1016/j.matlet.2010.12.057
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042
   VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639
   WHO, 2002, PREV HOSP ACQ INF PR
   Zhang L, 2006, J PHYS CHEM B, V110, P6615, DOI 10.1021/jp0570216
   Zuo S, 2011, J NANOMATER, DOI [10.1155/2011/382068, 10.1155/2011/270974]
NR 64
TC 15
Z9 16
U1 1
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD AUG 15
PY 2014
VL 25
IS 32
AR 325101
DI 10.1088/0957-4484/25/32/325101
PG 16
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AM1NO
UT WOS:000339613400003
PM 25060660
DA 2018-10-20
ER

PT J
AU Braceras, I
   Pacha-Olivenza, MA
   Calzado-Martin, A
   Multigner, M
   Vera, C
   Labajos-Broncano, L
   Gallardo-Moreno, AM
   Gonzalez-Carrasco, JL
   Vilaboa, N
   Gonzalez-Martin, ML
AF Braceras, Inigo
   Pacha-Olivenza, Miguel A.
   Calzado-Martin, Alicia
   Multigner, Marta
   Vera, Carolina
   Labajos-Broncano, Luis
   Gallardo-Moreno, Amparo M.
   Luis Gonzalez-Carrasco, Jose
   Vilaboa, Nuria
   Luisa Gonzalez-Martin, M.
TI Decrease of Staphylococcal adhesion on surgical stainless steel after Si
   ion implantation
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT 18th International Conference on Surface Modification of Materials by
   Ion Beams (SMMIB)
CY SEP 15-20, 2013
CL Kusadasi, TURKEY
DE Ion implantation; Silicon; Stainless steel; Bacteria; Biocompatibility;
   XPS
ID BACTERIAL ADHESION; MECHANICAL-PROPERTIES; INFECTION; SURFACES;
   ANTIBACTERIAL; COPPER; MICROSTRUCTURE; REDUCTION; TITANIUM; SILVER
AB 316LVM austenitic stainless steel is often the material of choice on temporal musculoskeletal implants and surgical tools as it combines good mechanical properties and acceptable corrosion resistance to the physiologic media, being additionally relatively inexpensive.
   This study has aimed at improving the resistance to bacterial colonization of this surgical stainless steel, without compromising its biocompatibility and resistance. To achieve this aim, the effect of Si ion implantation on 316LVM has been studied. First, the effect of the ion implantation parameters (50 keV; fluence: 2.5-5 x 10(16) ions/cm(2); angle of incidence: 45-90 degrees) has been assessed in terms of depth profiling of chemical composition by XPS and nano-topography evaluation by AFM. The in vitro biocompatibility of the alloy has been evaluated with human mesenchymal stem cells. Finally, bacterial adhesion of Staphylococcus epidermidis and Staphylococcus aureus on these surfaces has been assessed.
   Reduction of bacterial adhesion on Si implanted 316LVM is dependent on the implantation conditions as well as the features of the bacterial strains, offering a promising implantable biomaterial in terms of biocompatibility, mechanical properties and resistance to bacterial colonization. The effects of surface composition and nano-topography on bacterial adhesion, directly related to ion implantation conditions, are also discussed. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Braceras, Inigo; Vera, Carolina] Tecnalia, Donostia San Sebastian 20009, Spain.
   [Braceras, Inigo; Pacha-Olivenza, Miguel A.; Calzado-Martin, Alicia; Multigner, Marta; Vera, Carolina; Labajos-Broncano, Luis; Gallardo-Moreno, Amparo M.; Luis Gonzalez-Carrasco, Jose; Vilaboa, Nuria; Luisa Gonzalez-Martin, M.] CIBER BBN, Zaragoza, Spain.
   [Pacha-Olivenza, Miguel A.; Labajos-Broncano, Luis; Gallardo-Moreno, Amparo M.; Luisa Gonzalez-Martin, M.] Univ Extremadura, Dept Fis Aplicada, Fac Ciencias, Badajoz 06006, Spain.
   [Calzado-Martin, Alicia; Vilaboa, Nuria] Hosp Univ La Paz IdiPAZ, Madrid 28046, Spain.
   [Multigner, Marta; Luis Gonzalez-Carrasco, Jose] CENIM CSIC, Ctr Nacl Invest Met, Madrid 28040, Spain.
RP Braceras, I (reprint author), Tecnalia, Mikeletegi Pasealekua 2, Donostia San Sebastian 20009, Spain.
EM inigo.braceras@tecnalia.com
RI Calzado-Martin, Alicia/M-1878-2014; Pacha Olivenza, Miguel/M-8285-2014;
   Multigner, Marta/H-5210-2015; Vilaboa, Nuria/L-1727-2014; Gonzalez
   Martin, Maria Luisa/L-3476-2014; Braceras, Inigo/I-1871-2015
OI Calzado-Martin, Alicia/0000-0001-6305-8267; Pacha Olivenza,
   Miguel/0000-0003-3505-9320; Multigner, Marta/0000-0002-1584-0163;
   Gonzalez Martin, Maria Luisa/0000-0002-9207-444X; Braceras,
   Inigo/0000-0001-9095-7663; Gonzalez-Carrasco, Jose
   Luis/0000-0003-2004-4505
CR Arens S, 1996, J BONE JOINT SURG BR, V78B, P647
   Asenjo A, 1999, J MAGN MAGN MATER, V196, P23, DOI 10.1016/S0304-8853(98)00646-5
   Braceras I, 2007, SURF COAT TECH, V201, P8511, DOI 10.1016/j.surfcoat.2006.02.082
   Brunski J. B., 2004, BIOMATERIALS SCI INT, P137
   Calzado-Martin A, 2010, ACTA BIOMATER, V6, P3325, DOI 10.1016/j.actbio.2010.02.048
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chen RS, 2013, VACUUM, V89, P249, DOI 10.1016/j.vacuum.2012.05.025
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   De las Heras Evangelina, 2009, Functional Properties of Bio-Inspired Surfaces Characterization and Technological Applications, P343, DOI 10.1142/9789812837028_0012
   Gallardo-Moreno AM, 2011, MAT SCI ENG C-MATER, V31, P1567, DOI 10.1016/j.msec.2011.07.008
   Gallardo-Moreno AM, 2004, COLLOID SURFACE A, V249, P99, DOI 10.1016/j.colsurfa.2004.08.058
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   Jaafar M, 2008, IEEE T NANOTECHNOL, V7, P245, DOI 10.1109/TNANO.2008.917785
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Multigner M, 2010, SURF COAT TECH, V205, P1830, DOI 10.1016/j.surfcoat.2010.07.126
   Multigner M, 2009, MAT SCI ENG C-BIO S, V29, P1357, DOI 10.1016/j.msec.2008.11.002
   Saldana L, 2009, ACTA BIOMATER, V5, P1294, DOI 10.1016/j.actbio.2008.11.022
   STRACHAN CJL, 1995, J HOSP INFECT, V30, P54, DOI 10.1016/0195-6701(95)90006-3
   Talha M, 2013, MAT SCI ENG C-MATER, V33, P3563, DOI 10.1016/j.msec.2013.06.002
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Xiong J, 2009, INT J MIN MET MATER, V16, P293, DOI 10.1016/S1674-4799(09)60052-2
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zhang W, 2007, APPL SURF SCI, V253, P8981, DOI 10.1016/j.apsusc.2007.05.019
   Zhao Q, 2008, MED ENG PHYS, V30, P341, DOI 10.1016/j.medengphy.2007.04.004
   Zhao Q, 2007, APPL SURF SCI, V253, P8674, DOI 10.1016/j.apsusc.2007.04.044
NR 29
TC 3
Z9 3
U1 4
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 15
PY 2014
VL 310
SI SI
BP 36
EP 41
DI 10.1016/j.apsusc.2014.03.167
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA AL0GQ
UT WOS:000338805800007
DA 2018-10-20
ER

PT J
AU Hegewald, AA
   Cluzel, J
   Kruger, JP
   Endres, M
   Kaps, C
   Thome, C
AF Hegewald, Aldemar Andres
   Cluzel, Jessie
   Krueger, Jan Philipp
   Endres, Michaela
   Kaps, Christian
   Thome, Claudius
TI Effects of initial boost with TGF-beta 1 and grade of intervertebral
   disc degeneration on 3D culture of human annulus fibrosus cells
SO JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH
LA English
DT Article
DE Tissue engineering; Regenerative medicine; Spine; Intervertebral disc;
   Annulus fibrosus; Biomaterial; Growth factors
ID MESENCHYMAL STEM-CELLS; ANULUS FIBROSUS; NUCLEUS PULPOSUS;
   GENE-EXPRESSION; HYALURONIC-ACID; ASPARTIC-ACID; MATRIX; LOCALIZATION;
   REPAIR; PROTEOGLYCANS
AB Background: Three-dimensional (3D) culture in porous biomaterials as well as stimulation with growth factors are known to be supportive for intervertebral disc cell differentiation and tissue formation. Unless sophisticated releasing systems are used, however, effective concentrations of growth factors are maintained only for a very limited amount of time in in vivo applications. Therefore, we investigated, if an initial boost with transforming growth factor-beta 1 (TGF-beta 1) is capable to induce a lasting effect of superior cartilaginous differentiation in slightly and severely degenerated human annulus fibrosus (AF) cells.
   Methods: Human AF tissue was harvested during surgical treatment of six adult patients with lumbar spinal diseases. Grading of disc degeneration was performed with magnet resonance imaging. AF cells were isolated and expanded in monolayer culture and rearranged three-dimensionally in a porous biomaterial consisting of stepwise absorbable poly-glycolic acid and poly-(lactic-co-glycolic) acid and a supportive fine net of non-absorbable polyvinylidene fluoride. An initial boost of TGF-beta 1 or TGF-beta 1 and hyaluronan was applied and compared with controls. Matrix formation was assessed at days 7 and 21 by (1) histological staining of the typical extracellular matrix molecules proteoglycan and type I and type II collagens and by (2) real-time gene expression analysis of aggrecan, decorin, biglycan, type I, II, III, and X collagens as well as of catabolic matrix metalloproteinases MMP-2 and MMP-13.
   Results: An initial boost with TGF-beta 1 or TGF-beta 1 and hyaluronan did not enhance the expression of characteristic AF matrix molecules in our 3D culture system. AF cells showed high viability in the progressively degrading biomaterial. Stratification by grade of intervertebral disc degeneration showed that AF cells from both, slightly degenerated, or severely degenerated tissue are capable of significant up-regulations of characteristic matrix molecules in 3D culture. AF cells from severely degenerated tissue, however, displayed significantly lower up-regulations in some matrix molecules such as aggrecan.
   Conclusions: We failed to show a supportive effect of an initial boost with TGF-beta 1 in our 3D culture system. This underlines the need for further investigations on growth factor releasing systems.
C1 [Hegewald, Aldemar Andres] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, D-68167 Mannheim, Germany.
   [Cluzel, Jessie; Krueger, Jan Philipp; Endres, Michaela] TransTissue Technol GmbH, D-10117 Berlin, Germany.
   [Endres, Michaela; Kaps, Christian] Charite, Dept Rheumatol, Tissue Engn Lab, D-10117 Berlin, Germany.
   [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, A-6020 Innsbruck, Austria.
RP Hegewald, AA (reprint author), Heidelberg Univ, Univ Med Ctr Mannheim, Dept Neurosurg, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.
EM aldemar.hegewald@medma.uni-heidelberg.de
OI Hegewald, Aldemar Andres/0000-0002-2022-2060
FU Federal Ministry of Education and Research [13N9827, 13N9831]
FX This study was supported by the Federal Ministry of Education and
   Research (BioInside: 13N9827 + 13N9831). The authors would like to thank
   Samuel Vetterlein for the excellent technical assistance. PGA-PLGA-PVDF
   scaffolds were kindly provided by 3T GmbH, Aachen, Germany.
CR Bailey A, 2013, SPINE, V38, P1161, DOI 10.1097/BRS.0b013e31828b2e2f
   Bhang SH, 2011, BIOTECHNOL APPL BIOC, V58, P271, DOI 10.1002/bab.39
   Cabraja M, 2012, J NEUROSURG-SPINE, V17, P177, DOI 10.3171/2012.4.SPINE111095
   Cho H, 2013, ARTIF ORGANS, V37, pE131, DOI 10.1111/aor.12066
   CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
   CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P536
   Cs-Szabo G, 2002, SPINE, V27, P2212, DOI 10.1097/01.BRS.0000029249.02864.5B
   Gotz W, 1997, CELL TISSUE RES, V289, P185, DOI 10.1007/s004410050864
   Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0
   Gruber HE, 2011, EXP MOL PATHOL, V91, P534, DOI 10.1016/j.yexmp.2011.06.001
   Gruber HE, 2010, SPINE, V35, P1033, DOI 10.1097/BRS.0b013e3181bc3e04
   Guterl CC, 2013, EUR CELLS MATER, V25, P1
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   Hegewald AA, 2010, EUR SPINE J S3, V19, P254
   Hegewald AA, 2012, TISSUE CELL, V45, P68
   Hegewald AA, 2012, SPINE, V37, P101, DOI 10.1097/BRS.0b013e318210ed55
   Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652
   Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608
   Melrose J, 2007, EUR SPINE J, V16, P2193, DOI 10.1007/s00586-007-0497-5
   Neidlinger-Wilke C, 2005, J NEUROSURG-SPINE, V2, P457, DOI 10.3171/spi.2005.2.4.0457
   OBRIEN MC, 1995, CYTOMETRY, V19, P243, DOI 10.1002/cyto.990190308
   Reza AT, 2008, ANN BIOMED ENG, V36, P204, DOI 10.1007/s10439-007-9407-6
   Schmid T M, 1991, In Vivo, V5, P533
   Singh K, 2009, SPINE, V34, P10, DOI 10.1097/BRS.0b013e31818e5ddd
   Sivan SS, 2008, J BIOL CHEM, V283, P8796, DOI 10.1074/jbc.M709885200
   Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200
   Sohier J, 2008, EXPERT OPIN DRUG DEL, V5, P543, DOI [10.1517/17425247.5.5.543 , 10.1517/17425240802088033]
   Vadala G, 2012, EUR SPINE J, V21, pS20, DOI 10.1007/s00586-012-2235-x
   Wallach Corey J, 2006, Spine J, V6, P107, DOI 10.1016/j.spinee.2005.05.002
   Weiler C, 2002, EUR SPINE J, V11, P308, DOI 10.1007/s00586-002-0472-0
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
   Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085
NR 32
TC 6
Z9 6
U1 2
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-799X
J9 J ORTHOP SURG RES
JI J. Orthop. Surg. Res.
PD AUG 14
PY 2014
VL 9
AR 73
DI 10.1186/s13018-014-0073-8
PG 8
WC Orthopedics
SC Orthopedics
GA AO8RQ
UT WOS:000341622300001
PM 25116605
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bhaumik, A
   Shearin, AM
   Delong, R
   Wanekaya, A
   Ghosh, K
AF Bhaumik, A.
   Shearin, A. M.
   Delong, R.
   Wanekaya, A.
   Ghosh, K.
TI Probing the Interaction at the Nano-Bio Interface Using Raman
   Spectroscopy: ZnO Nanoparticles and Adenosine Triphosphate Biomolecules
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID AQUEOUS SOLUTION; ZINC-OXIDE; METAL-IONS; ADENINE; SCATTERING; SPECTRA;
   ATP; COMPLEXES; RESONANCE; BINDING
AB With the advent of nanobiotechnology, there will be an increase in the interaction between engineered nanomaterials and biomolecules. Nanoconjugates with cells, organelles, and intracellular structures containing DNA, RNA, and proteins establish sequences of nano-bio boundaries that depend on several intricate complex biophysicochemical reactions. Given the complexity of these interactions, and their import in governing life at the molecular level, it is extremely important to begin to understand such nanoparticle biomaterial association. Here we report a unique method of probing the kinematics between an energy biomolecule, adenosine triphosphate (ATP), and hydrothermally synthesized ZnO nanostructures using micro Raman spectroscopy, X-ray diffraction, and electron microscopy experiments. For the first time we have shown by Raman spectroscopy analysis that the ZnO nanostructures interact strongly with the nitrogen (N-7) atom in the adenine ring of the ATP biomolecule. Raman spectroscopy also confirms the importance of nucleotide base NH2 group hydrogen bonding with water molecules and phosphate group ionization and their pH dependence. Calculation of molecular bond force constants from Raman spectroscopy reinforces our experimental data. These data present convincing evidence of pH-dependent interactions between ATP and zinc oxide nanomaterials. Significantly, Raman spectroscopy is able to probe such difficult to study and subtle nano-bio interactions and may be applied to elegantly elucidate the nano-bio interface more generally.
C1 [Bhaumik, A.; Shearin, A. M.; Ghosh, K.] Missouri State Univ, Dept Phys Astron & Mat Sci, Springfield, MO 65897 USA.
   [Delong, R.] Missouri State Univ, Dept Biomed Sci, Springfield, MO 65897 USA.
   [Wanekaya, A.] Missouri State Univ, Dept Chem, Springfield, MO 65897 USA.
RP Ghosh, K (reprint author), Missouri State Univ, Dept Phys Astron & Mat Sci, Springfield, MO 65897 USA.
EM kartikghosh@missouristate.edu
FU National Cancer Institute [1R15 CA139390-01]
FX This research was supported by the National Cancer Institute (Grant 1R15
   CA139390-01).
CR ALBERTY RA, 1968, J BIOL CHEM, V243, P1337
   Alim KA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1944222
   Amin G, 2011, J NANOMATER, DOI 10.1155/2011/269692
   ARGUELLO CA, 1969, PHYS REV, V181, P1351, DOI 10.1103/PhysRev.181.1351
   Baruah S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/013001
   CALLEJA JM, 1977, PHYS REV B, V16, P3753, DOI 10.1103/PhysRevB.16.3753
   CHEARY RW, 1992, J APPL CRYSTALLOGR, V25, P109, DOI 10.1107/S0021889891010804
   CHINSKY L, 1978, NUCLEIC ACIDS RES, V5, P2969, DOI 10.1093/nar/5.8.2969
   DAMEN TC, 1966, PHYS REV, V142, P570, DOI 10.1103/PhysRev.142.570
   FORREST G, 1977, J RAMAN SPECTROSC, V6, P32, DOI 10.1002/jrs.1250060108
   Gilbert B, 2004, SCIENCE, V305, P651, DOI 10.1126/science.1098454
   GLASSMAN TA, 1971, BIOCHEMISTRY-US, V10, P843
   Gong MG, 2014, J MATER CHEM A, V2, P6180, DOI 10.1039/c3ta14102k
   Hamada YZ, 2010, J COORD CHEM, V63, P284, DOI 10.1080/00958970903377279
   HEYDE ME, 1971, BIOCHEMISTRY-US, V10, P1121
   Hu XG, 2007, J PHYS CHEM C, V111, P6962, DOI 10.1021/jp0712194
   HUANG K, 1963, Z PHYS, V171, P213, DOI 10.1007/BF01379349
   Huang ZB, 2008, LANGMUIR, V24, P4140, DOI 10.1021/la7035949
   ITO M, 1991, BIOMATERIALS, V12, P41, DOI 10.1016/0142-9612(91)90130-3
   Zhou J, 2006, ADV MATER, V18, P2432, DOI 10.1002/adma.200600200
   KHALIL FL, 1964, J AM CHEM SOC, V86, P5113, DOI 10.1021/ja01077a014
   KUNTZ GPP, 1972, BIOCHEMISTRY-US, V11, P538, DOI 10.1021/bi00754a009
   LANIR A, 1979, J BIOL CHEM, V254, P5882
   LEWIS A, 1975, BIOCHEMISTRY-US, V14, P1532, DOI 10.1021/bi00678a029
   MAJOUBE M, 1985, BIOPOLYMERS, V24, P2357, DOI 10.1002/bip.360241213
   McCusker LB, 1999, J APPL CRYSTALLOGR, V32, P36, DOI 10.1107/S0021889898009856
   Min YJ, 2008, NAT MATER, V7, P527, DOI 10.1038/nmat2206
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Oberdorster Gunter, 2005, Part Fibre Toxicol, V2, P8, DOI 10.1186/1743-8977-2-8
   ORSTAVIK D, 1985, BIOMATERIALS, V6, P129, DOI 10.1016/0142-9612(85)90076-6
   Rajalakshmi M, 2000, J APPL PHYS, V87, P2445, DOI 10.1063/1.372199
   RICHTER H, 1981, SOLID STATE COMMUN, V39, P625, DOI 10.1016/0038-1098(81)90337-9
   RIMAI L, 1969, BIOPHYS J, V9, P320, DOI 10.1016/S0006-3495(69)86389-7
   RIMAI L, 1970, BIOCHEM BIOPH RES CO, V41, P313, DOI 10.1016/0006-291X(70)90505-X
   RIMAI L, 1970, BIOCHEM BIOPH RES CO, V38, P231, DOI 10.1016/0006-291X(70)90701-1
   Rumyantseva A, 2013, ACS NANO, V7, P3420, DOI 10.1021/nn400307a
   So MK, 2006, NAT BIOTECHNOL, V24, P339, DOI 10.1038/nbt1188
   Sundaresan A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.161306
   TAJMIRRIAHI HA, 1988, BIOCHIM BIOPHYS ACTA, V956, P211, DOI 10.1016/0167-4838(88)90137-9
   TAKEUCHI H, 1988, J AM CHEM SOC, V110, P392, DOI 10.1021/ja00210a013
   Uetsuki K, 2010, J PHYS CHEM C, V114, P7515, DOI 10.1021/jp9114805
   Uskokovic-Markovic S, 2013, J MED BIOCHEM, V32, P96, DOI 10.2478/jomb-2013-0004
   Velegol D, 2007, J NANOPHOTONICS, V1, DOI 10.1117/1.2759184
   Vertegel AA, 2004, LANGMUIR, V20, P6800, DOI 10.1021/la0497200
   WHATLEY FR, 1960, PLANT PHYSIOL, V35, P188, DOI 10.1104/pp.35.2.188
   Xu JF, 1999, J RAMAN SPECTROSC, V30, P413, DOI 10.1002/(SICI)1097-4555(199905)30:5<413::AID-JRS387>3.0.CO;2-N
   YU NT, 1977, CRC CR REV BIOCH MOL, V4, P229, DOI 10.3109/10409237709102559
   ZHELYASKOV V, 1992, BIOCHEM J, V287, P561, DOI 10.1042/bj2870561
NR 49
TC 8
Z9 9
U1 4
U2 62
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD AUG 14
PY 2014
VL 118
IS 32
BP 18631
EP 18639
DI 10.1021/jp506200a
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AN2VQ
UT WOS:000340444500042
PM 25152799
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Nurunnabi, M
   Khatun, Z
   Reeck, GR
   Lee, DY
   Lee, YK
AF Nurunnabi, Md
   Khatun, Zehedina
   Reeck, Gerald R.
   Lee, Dong Yun
   Lee, Yong-kyu
TI Photoluminescent Graphene Nanoparticles for Cancer Phototherapy and
   Imaging
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE graphene nanodots; noninvasive imaging; phototherapy; biomaterial; in
   vivo
ID SEMICONDUCTOR QUANTUM DOTS; PHOTODYNAMIC THERAPY; DELIVERY; PLATFORM;
   DISEASE; AGENTS
AB Graphene-based nanomaterials are of great interest in a wide range of applications in electronics, the environment, and energy as well as in biomedical and bioengineering. Their unique properties make them generally applicable as prognostic, diagnostic, and therapeutic agents in cancer. In this work, we focused on photodynamic and photothermal therapeutic properties of our previously synthesized carboxylated photoluminescent graphene nanodots (cGdots). The cGdots are similar to 5 nm in diameter and excited at 655 nm. Our findings reveal that, upon laser irradiation by near-infrared (wavelength 670 rim) sensitizer, electrons of the cGdots starts to vibrate and form electron clouds, thereby generating sufficient heat (>50 degrees C) to kill the cancer cells by thermal ablation. The generation of singlet oxygen also occurs due to irradiation, thus acting similarly to pheophorbide-A, a well-known photodynamic therapeutic agent. The cGdots kills MDA-MB231 cancer cells (more than 70%) through both photodynamic and photothermal effects. The cGdots were equally effective in the in vivo model of MDA-MB231 xenografted tumor-bearing mice also as observed for 21 days. The cGdot was intravenously injected, and the tumor was irradiated by laser, resulting in final volume of tumor was similar to 70% smaller than that of saline-treated tumor. It indicates that the growth rate of cGdot-treated tumor was slower compared to saline-treated tumor. The synthesized cGdots could enable visualization of tumor tissue in mice, thereby illustrating their use as optical imaging agents for detecting cancer noninvasively in deep tissue/organ. Collectively, our findings reveal that multimodal cGdots can be used for phototherapy, through photothermal or photodynamic effects, and for noninvasive optical imaging of deep tissues and tumors simultaneously.
C1 [Nurunnabi, Md] Korea Natl Univ Transportat, Dept Polymer Sci & Engn, Chungju 380702, South Korea.
   [Khatun, Zehedina; Lee, Yong-kyu] Korea Natl Univ Transportat, Dept Green Bioengn, Chungju 380702, South Korea.
   [Lee, Yong-kyu] Korea Natl Univ Transportat, Dept Chem & Biol Engn, Chungju 380702, South Korea.
   [Reeck, Gerald R.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.
   [Lee, Dong Yun] Hanyang Univ, PLUS Future Biopharmaceut Human Resources Trainin, Inst Bioengn & Biopharmaceut Res, Dept Bioengn,Coll Engn, Seoul 133791, South Korea.
RP Lee, DY (reprint author), Hanyang Univ, PLUS Future Biopharmaceut Human Resources Trainin, Inst Bioengn & Biopharmaceut Res, Dept Bioengn,Coll Engn, Seoul 133791, South Korea.
EM dongyunlee@hanyang.ac.kr; leeyk@ut.ac.kr
OI Nurunnabi, Md/0000-0003-4457-3401
FU National Research Foundation of Korea (NRF) - Ministry of Education,
   Science and Technology [NRF-2010-0021427, NRF-2012R1A2A1A01012042]
FX This research was supported by a Grant (NRF-2010-0021427,
   NRF-2012R1A2A1A01012042) through the National Research Foundation of
   Korea (NRF) funded by the Ministry of Education, Science and Technology.
   We thank Prof. A. Khademhosseini (Harvard-MIT Division of Health
   Sciences and Technology, Wyss Institute for Biologically Inspired
   Engineering) for his thoughtful comments and helpful corrections.
CR Bluhm H, 2011, NAT PHYS, V7, P109, DOI 10.1038/NPHYS1856
   Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/nphoton.2010.186, 10.1038/NPHOTON.2010.186]
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Charlotte A.E.H., 2010, NATURE, V468, P516
   Chen X, 2013, ACS NANO, V7, P531, DOI 10.1021/nn304673a
   Cheng HH, 2012, ACS NANO, V6, P2237, DOI 10.1021/nn204289t
   Datta SN, 1997, BRIT J CANCER, V76, P312, DOI 10.1038/bjc.1997.384
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Khatun Z, 2014, J CONTROL RELEASE, V177, P64, DOI 10.1016/j.jconrel.2013.12.034
   Knipe JM, 2013, NANO TODAY, V8, P21, DOI 10.1016/j.nantod.2012.12.004
   Li JM, 2011, BIOMATERIALS, V32, P7978, DOI 10.1016/j.biomaterials.2011.07.011
   Li L, 2014, J MATER CHEM B, V2, P2929, DOI 10.1039/c4tb00181h
   Li L, 2013, J CONTROL RELEASE, V171, P241, DOI 10.1016/j.jconrel.2013.07.002
   Li M, 2012, ADV MATER, V24, P1722, DOI 10.1002/adma.201104864
   Liu Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225505
   Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707
   Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102
   Nurunnabi M, 2013, ACS APPL MATER INTER, V5, P8246, DOI 10.1021/am4023863
   Nurunnabi M, 2013, ACS NANO, V7, P6858, DOI 10.1021/nn402043c
   Nurunnabi M, 2013, CHEM COMMUN, V49, P5079, DOI 10.1039/c3cc42334d
   Nurunnabi M, 2010, BIOMATERIALS, V31, P5436, DOI 10.1016/j.biomaterials.2010.03.057
   Obaid G, 2012, ANGEW CHEM INT EDIT, V51, P6158, DOI 10.1002/anie.201201468
   Peng J, 2012, NANO LETT, V12, P844, DOI 10.1021/nl2038979
   Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955
   Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803
   Seo WS, 2006, NAT MATER, V5, P971, DOI 10.1038/nmat1775
   Son DI, 2012, NAT NANOTECHNOL, V7, P465, DOI [10.1038/NNANO.2012.71, 10.1038/nnano.2012.71]
   Wang YC, 2011, NAT MATER, V10, P482, DOI 10.1038/nmat3060
   Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917
   Yan X, 2010, J AM CHEM SOC, V132, P5944, DOI 10.1021/ja1009376
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Ye L, 2012, NAT NANOTECHNOL, V7, P453, DOI [10.1038/nnano.2012.74, 10.1038/NNANO.2012.74]
   You J.-O., 2013, ANGEW CHEM INT EDIT, V52, P1
   Zhang Y, 2008, P NATL ACAD SCI USA, V105, P1798, DOI 10.1073/pnas.0709501105
NR 35
TC 42
Z9 42
U1 3
U2 97
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG 13
PY 2014
VL 6
IS 15
BP 12413
EP 12421
DI 10.1021/am504071z
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AN2WI
UT WOS:000340446300072
PM 25054687
DA 2018-10-20
ER

PT J
AU McLoughlin, SY
   Kastantin, M
   Schwartz, DK
   Kaar, JL
AF McLoughlin, Sean Yu
   Kastantin, Mark
   Schwartz, Daniel K.
   Kaar, Joel L.
TI Single-molecule resolution of protein structure and interfacial dynamics
   on biomaterial surfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 248th National Meeting of the American-Chemical-Society (ACS)
CY AUG 10-14, 2014
CL San Francisco, CA
SP Amer Chem Soc
C1 [McLoughlin, Sean Yu; Kastantin, Mark; Schwartz, Daniel K.; Kaar, Joel L.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
EM joel.kaar@colorado.edu
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 10
PY 2014
VL 248
MA 548-COLL
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA CA8JN
UT WOS:000349165104083
DA 2018-10-20
ER

PT J
AU Zhang, H
   Dicker, KT
   Liu, S
   Deng, F
   Xu, X
   Jia, XQ
   Fox, JM
AF Zhang, Han
   Dicker, Kevin T.
   Liu, Shuang
   Deng, Fei
   Xu, Xian
   Jia, Xinqiao
   Fox, Joseph M.
TI Tetrazine ligation: Developing fast bioorthogonal chemistry and
   applications in biomaterial-related research
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 248th National Meeting of the American-Chemical-Society (ACS)
CY AUG 10-14, 2014
CL San Francisco, CA
SP Amer Chem Soc
C1 [Zhang, Han; Fox, Joseph M.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19713 USA.
   [Dicker, Kevin T.; Liu, Shuang; Deng, Fei; Xu, Xian; Jia, Xinqiao] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19713 USA.
EM han@udel.edu
NR 0
TC 0
Z9 0
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 10
PY 2014
VL 248
MA 353-ORGN
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA CA8KC
UT WOS:000349167402816
DA 2018-10-20
ER

PT J
AU Chelariu, R
   Bolat, G
   Izquierdo, J
   Mareci, D
   Gordin, DM
   Gloriant, T
   Souto, RM
AF Chelariu, R.
   Bolat, G.
   Izquierdo, J.
   Mareci, D.
   Gordin, D. M.
   Gloriant, T.
   Souto, R. M.
TI Metastable beta Ti-Nb-Mo alloys with improved corrosion resistance in
   saline solution
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Ti-Nb-Mo alloys; Corrosion resistance; Ti based surface oxides; Saline
   solution; Biomaterial application
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; SIMULATED BODY-FLUID; RESOLUTION
   ELECTRON-MICROSCOPY; SHAPE-MEMORY PROPERTIES; BIOMEDICAL APPLICATIONS;
   TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; PHYSIOLOGICAL SOLUTIONS;
   TI-12MO-5TA ALLOY; SURGICAL IMPLANTS
AB The present study explores the microstructural characteristics and electrochemical responses of four metastable beta Ti-Nb-Mo alloys for biomedical implantation. They were synthesized by the cold crucible levitation melting technique, and compositions were selected to keep the molybdenum equivalency close to 12 wt% Mo-eq. For the sake of comparison, Ti12Mo was also investigated. Microstructural characterization reveals that all the alloys are beta (body-centred cubic structure), and the surface is composed by beta equiaxial grains with dimensions in the range of tens to hundreds mu m. The corrosion resistance (potentiodynamic polarization and electrochemical impedance spectroscopy) of the alloys was determined in 0.9 wt%NaCl saline solution at 25 degrees C. The materials spontaneously form a passivating oxide film on their surface, and they are stable for polarizations up to +1.0 V-SCE. No evidence of localized breakdown of the oxide layers is found for polarizations more positive than those encountered in the human body. The passive layers show dielectric characteristics, and the wide frequency ranges displaying capacitive characteristics occur for both higher niobium contents in the alloy and longer exposures to the saline solution. The insulating characteristics of the oxide-covered surfaces were investigated by scanning electrochemical microscopy operated in the feedback mode, using ferrocene-methanol as redox mediator. Both z-approach curves and amperometric images were taken over the surface of the samples both at their open circuit potential and polarized. It has been found that Ti8Nb10Mo and Ti16Nb8Mo exhibit the lowest activity towards electron transfer. The new Ti-Nb-Mo ternary alloys are regarded to be potential candidates for biomedical application on the basis of both their microstructural characteristics and their corrosion resistance in saline solution with chloride content equivalent to body fluids. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Chelariu, R.] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, Iasi 700050, Romania.
   [Bolat, G.; Mareci, D.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Izquierdo, J.; Souto, R. M.] Univ La Laguna, Dept Chem, E-38205 Tenerife, Canary Islands, Spain.
   [Gordin, D. M.; Gloriant, T.] CNRS, INSA Rennes, Inst Sci Chim Rennes Chim Met, UMR 6226, F-35043 Rennes, France.
   [Souto, R. M.] Univ La Laguna, Inst Univ Mat & Nanotecnol, Tenerife 38200, Canary Islands, Spain.
RP Souto, RM (reprint author), Univ La Laguna, Dept Chem, E-38205 Tenerife, Canary Islands, Spain.
EM rsouto@ull.es
OI Izquierdo Perez, Javier/0000-0003-3287-9403; Mareci,
   Daniel/0000-0002-5859-1996; Gordin, Doina Margareta/0000-0003-2200-9930;
   Souto, Ricardo M./0000-0001-9429-5513
FU Romanian National Authority for Scientific Research, CNCS-UEFISCDI
   [PN-II-ID-PCE-2011-3-0218]; Spanish Ministry of Economy and
   Competitiveness; European Regional Development Fund [CTQ2012-36787];
   Spanish Ministry of Education
FX This work was supported by a grant of the Romanian National Authority
   for Scientific Research, CNCS-UEFISCDI, project number
   PN-II-ID-PCE-2011-3-0218, and by the Spanish Ministry of Economy and
   Competitiveness, and the European Regional Development Fund (Project No.
   CTQ2012-36787). A Grant awarded to J.I. by the Spanish Ministry of
   Education (Programa de Formacion de Personal Investigador) is gratefully
   acknowledged.
CR Addison O, 2012, J R SOC INTERFACE, V9, P3161, DOI 10.1098/rsif.2012.0438
   Airoldi G, 1997, AM J ORTHOD DENTOFAC, V112, P58, DOI 10.1016/S0889-5406(97)70274-9
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Alkhateeb E, 2005, J BIOMED MATER RES A, V75A, P934, DOI 10.1002/jbm.a.30508
   Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Assis SL, 2008, MATER CORROS, V59, P739, DOI 10.1002/maco.200804148
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Atapour M, 2011, MAT SCI ENG C-MATER, V31, P885, DOI 10.1016/j.msec.2011.02.005
   Bai YJ, 2011, MAT SCI ENG C-MATER, V31, P702, DOI 10.1016/j.msec.2010.12.010
   Balamurugan A, 2008, MATER CORROS, V59, P855, DOI 10.1002/maco.200804173
   Balazic Matej, 2007, International Journal of Nano and Biomaterials, V1, P3, DOI 10.1504/IJNBM.2007.016517
   Blackburn M.J., 1968, METALL SOC AM I MINI, V242, P2461
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Bolat G, 2013, ELECTROCHIM ACTA, V88, P447, DOI 10.1016/j.electacta.2012.10.026
   Bundy KJ, 2005, ASTM INT MAN SER, P500
   CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701
   Chan CW, 2012, CORROS SCI, V56, P158, DOI 10.1016/j.corsci.2011.11.020
   Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047
   Ciurescu G, 2012, INT J ELECTROCHEM SC, V7, P7404
   COLLINGS E.W., 1994, MAT PROPERTIES HDB T, P10
   de Almeida L.H., 2014, J ALLOYS COMPOUNDS
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Elias LM, 2006, MAT SCI ENG A-STRUCT, V432, P108, DOI 10.1016/j.msea.2006.06.013
   Gabriel S.B., MAT SCI ENG C, V33
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gloriant T, 2006, ADV ENG MATER, V8, P961, DOI 10.1002/adem.200600106
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim SE, 2007, MET MATER-INT, V13, P151, DOI 10.1007/BF03027566
   Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lavos-Valereto IC, 2004, J MATER SCI-MATER M, V15, P55, DOI 10.1023/B:JMSM.0000010097.86245.74
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Lu JW, 2013, MATER CHARACT, V84, P105, DOI 10.1016/j.matchar.2013.07.014
   Mansfeld F., 1993, 26 SOL SCHLUMB
   Mantovani D, 2000, JOM-J MIN MET MAT S, V52, P36, DOI 10.1007/s11837-000-0082-4
   Mareci D, 2013, EUR J SCI THEOL, V9, P189
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Milosev I., 2000, J BONE JOINT SURG BR, V82, P352
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1087, DOI 10.1016/j.msec.2011.11.007
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 1998, BIOMATERIALS, V19, P1197, DOI 10.1016/S0142-9612(97)00235-4
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Oliveira NTC, 2006, ELECTROCHIM ACTA, V51, P3506, DOI 10.1016/j.electacta.2005.10.007
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Polmear I. J., 2006, LIGHT ALLOYS TRADITI, P301
   Prima F, 2006, SCRIPTA MATER, V54, P645, DOI 10.1016/j.scriptamat.2005.10.024
   Qazi JI, 2005, ADV ENG MATER, V7, P993, DOI 10.1002/adem.200500060
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   Shukla AK, 2005, J ALLOY COMPD, V389, P144, DOI 10.1016/j.jallcom.2004.08.005
   Souza MEP, 2009, J MATER SCI-MATER M, V20, P549, DOI 10.1007/s10856-008-3623-y
   SUKEDAI E, 1991, PHILOS MAG A, V64, P1201, DOI 10.1080/01418619108225343
   Tait W.S., 1994, INTRO ELECTROCHEMICA, P37
   Tamilselvi S, 2007, MATER CORROS, V58, P285, DOI 10.1002/maco.200604001
   Tamilselvi S, 2007, MATER CORROS, V58, P113, DOI 10.1002/maco.200603979
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tamilselvi S., 2006, TRENDS BIOMATER ARTI, V20, P49
   Tobe H, 2013, J ALLOY COMPD, V577, pS435, DOI 10.1016/j.jallcom.2012.02.023
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Vidal CV, 2008, CORROS SCI, V50, P1954, DOI 10.1016/j.corsci.2008.04.002
   Wallinder D, 1999, CORROS SCI, V41, P275
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Wang YB, 2008, MATER LETT, V62, P269, DOI 10.1016/j.matlet.2007.05.038
   Wang YB, 2009, MATER LETT, V63, P1293, DOI 10.1016/j.matlet.2009.02.062
   Xu LJ, 2013, T NONFERR METAL SOC, V23, P692, DOI 10.1016/S1003-6326(13)62518-2
   Zheng YF, 2006, MAT SCI ENG A-STRUCT, V438, P891, DOI 10.1016/j.msea.2006.01.131
   Zhou YL, 2011, MATER CHARACT, V62, P931, DOI 10.1016/j.matchar.2011.07.010
NR 81
TC 36
Z9 37
U1 8
U2 66
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD AUG 10
PY 2014
VL 137
BP 280
EP 289
DI 10.1016/j.electacta.2014.06.021
PG 10
WC Electrochemistry
SC Electrochemistry
GA AO6LB
UT WOS:000341462500036
DA 2018-10-20
ER

PT J
AU Ahtinen, H
   Kulkova, J
   Lindholm, L
   Eerola, E
   Hakanen, AJ
   Moritz, N
   Soderstrom, M
   Saanijoki, T
   Jalkanen, S
   Roivainen, A
   Aro, HT
AF Ahtinen, Helena
   Kulkova, Julia
   Lindholm, Laura
   Eerola, Erkki
   Hakanen, Antti J.
   Moritz, Niko
   Soderstrom, Mirva
   Saanijoki, Tiina
   Jalkanen, Sirpa
   Roivainen, Anne
   Aro, Hannu T.
TI Ga-68-DOTA-Siglec-9 PET/CT imaging of peri-implant tissue responses and
   staphylococcal infections
SO EJNMMI RESEARCH
LA English
DT Article
DE Ga-68-DOTA-Siglec-9; Implant infection; Osteomyelitis; PET; S. aureus;
   S. epidermidis; VAP-1
ID VASCULAR ADHESION PROTEIN-1; PROSTHETIC-JOINT INFECTIONS; EXPERIMENTAL
   OSTEOMYELITIS; ANIMAL-MODELS; AUREUS; BONE; INFLAMMATION; EPIDERMIDIS;
   LEUKOCYTE; DIAGNOSIS
AB Background: Staphylococcus epidermidis (S. epidermidis) has emerged as one of the leading pathogens of biomaterial-related infections. Vascular adhesion protein-1 (VAP-1) is an inflammation-inducible endothelial molecule controlling extravasation of leukocytes. Sialic acid-binding immunoglobulin-like lectin 9 (Siglec-9) is a leukocyte ligand of VAP-1. We hypothesized that Ga-68-labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated Siglec-9 motif containing peptide (Ga-68-DOTA-Siglec-9) could detect inflammatory response due to S. epidermidis peri-implant infection by positron emission tomography (PET).
   Methods: Thirty Sprague-Dawley rats were randomized into three groups. A sterile catheter was implanted into the medullary canal of the left tibia. In groups 1 and 2, the implantation was followed by peri-implant injection of S. epidermidis or Staphylococcus aureus (S. aureus) with adjunct injections of aqueous sodium morrhuate. In group 3, sterile saline was injected instead of bacteria and no aqueous sodium morrhuate was used. At 2 weeks after operation, Ga-68-DOTA-Siglec-9 PET coupled with computed tomography (CT) was performed with the measurement of the standardized uptake value (SUV). The presence of the implant-related infection was verified by microbiological analysis, imaging with fluorescence microscope, and histology. The in vivo PET results were verified by ex vivo measurements by gamma counter.
   Results: In group 3, the tibias with implanted sterile catheters showed an increased local uptake of Ga-68-DOTA-Siglec-9 compared with the intact contralateral bones (SUVratio + 29.5%). Ga-68-DOTA-Siglec-9 PET detected inflammation induced by S. epidermidis and S. aureus catheter-related bone infections (SUVratio + 58.1% and + 41.7%, respectively). The tracer uptake was significantly higher in the S. epidermidis group than in group 3 without bacterial inoculation, but the difference between S. epidermidis and S. aureus groups was not statistically significant. The difference between the S. aureus group and group 3 was neither statistically significant.
   Conclusion: PET/CT imaging with novel Ga-68-DOTA-Siglec-9 tracer was able to detect inflammatory tissue response induced by catheter implantation and staphylococcal infections.
C1 [Ahtinen, Helena; Saanijoki, Tiina; Roivainen, Anne] Univ Turku, Turku Univ Hosp, Turku PET Ctr, FI-20521 Turku, Finland.
   [Kulkova, Julia; Aro, Hannu T.] Univ Turku, Turku Univ Hosp, Dept Orthopaed Surg & Traumatol, Orthopaed Res Unit, FI-20521 Turku, Finland.
   [Lindholm, Laura; Eerola, Erkki; Jalkanen, Sirpa] Univ Turku, Dept Med Microbiol & Immunol, FI-20521 Turku, Finland.
   [Hakanen, Antti J.] Natl Inst Hlth & Welf, Antimicrobial Resistance Unit, FI-20521 Turku, Finland.
   [Moritz, Niko] Univ Turku, Turku Clin Biomat Ctr, Inst Dent, FI-20521 Turku, Finland.
   [Soderstrom, Mirva] Univ Turku, Dept Pathol, Turku Univ Hosp, FI-20521 Turku, Finland.
   [Jalkanen, Sirpa] Univ Turku, MediCity Res Lab, FI-20521 Turku, Finland.
   [Roivainen, Anne] Univ Turku, Turku Ctr Dis Modeling, FI-20521 Turku, Finland.
RP Aro, HT (reprint author), Univ Turku, Turku Univ Hosp, Dept Orthopaed Surg & Traumatol, Orthopaed Res Unit, FI-20521 Turku, Finland.
EM hannu.aro@utu.fi
OI Roivainen, Anne/0000-0002-4006-7977; Aro, Hannu/0000-0003-3118-9144
FU Sigrid Juselius Foundation; Turku University Hospital (EVO grant)
   [13856]; Academy of Finland [119048, 258814]; FinPharma Doctoral
   Programme Drug Discovery Section; National Doctoral Program of
   Musculoskeletal Disorders and Biomaterials
FX This research was financially supported by the Sigrid Juselius
   Foundation. The development and construction of the Siglec-9 tracer has
   been supported by grants from the Turku University Hospital (EVO grant
   #13856) and from the Academy of Finland (#119048 and #258814). Helena
   Ahtinen is a PhD student supported by the FinPharma Doctoral Programme
   Drug Discovery Section, and Julia Kulkova is a PhD student supported by
   the National Doctoral Program of Musculoskeletal Disorders and
   Biomaterials.
CR Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076
   Alt V, 2011, BONE, V48, P1146, DOI 10.1016/j.bone.2011.01.018
   An YH, 2006, INT J ARTIF ORGANS, V29, P407
   An YHH, 1998, J INVEST SURG, V11, P139, DOI 10.3109/08941939809032193
   Autio A, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-10
   Autio A, 2010, EUR J NUCL MED MOL I, V37, P1918, DOI 10.1007/s00259-010-1497-y
   Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001
   Cremieux AC, 1997, CLIN INFECT DIS, V25, P1295, DOI 10.1086/516135
   Crocker PR, 2012, ANN NY ACAD SCI, V1253, P102, DOI 10.1111/j.1749-6632.2011.06449.x
   Del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P4064, DOI 10.1128/AAC.00432-09
   Della Valle C, 2011, J BONE JOINT SURG AM, V93A, P1355, DOI 10.2106/JBJS.9314ebo
   Gemmel F, 2012, EUR J NUCL MED MOL I, V39, P892, DOI 10.1007/s00259-012-2062-7
   Glaudemans AWJM, 2013, EUR J NUCL MED MOL I, V40, P1760, DOI 10.1007/s00259-013-2481-0
   Glaudemans AWJM, 2013, EUR CELLS MATER, V25, P61, DOI 10.22203/eCM.v025a05
   Gratz S, 2001, J NUCL MED, V42, P1257
   HIENZ SA, 1995, J INFECT DIS, V171, P1230, DOI 10.1093/infdis/171.5.1230
   Jaakkola K, 2000, AM J PATHOL, V157, P463, DOI 10.1016/S0002-9440(10)64558-0
   Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005
   Koort JK, 2004, J NUCL MED, V45, P1406
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   LAMBE DW, 1991, CLIN ORTHOP RELAT R, P285
   Lankinen P, 2008, EUR J NUCL MED MOL I, V35, P352, DOI 10.1007/s00259-007-0637-5
   Lankinen P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-41
   Lazzeri E, 2014, EUR J NUCL MED MOL I, V41, P1811, DOI 10.1007/s00259-014-2777-8
   Love C, 2009, SEMIN NUCL MED, V39, P66, DOI 10.1053/j.semnuclmed.2008.08.007
   Makinen TJ, 2005, BONE, V36, P292, DOI 10.1016/j.bone.2004.11.009
   Makinen TJ, 2005, EUR J NUCL MED MOL I, V32, P1259, DOI 10.1007/s00259-005-1841-9
   MAYBERRYCARSON KJ, 1984, INFECT IMMUN, V43, P825
   Merritt J.H., 2005, CURR PROTOC MICROB B, V1B, P1, DOI DOI 10.1002/9780471729259.MC01B01S00
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   PETTY W, 1985, J BONE JOINT SURG AM, V67A, P1236, DOI 10.2106/00004623-198567080-00015
   Queck Shu Yeong, 2008, P227
   Rantakokko-Jalava K, 2000, J CLIN MICROBIOL, V38, P32
   Sadykov MR, 2011, MICROBIOL-SGM, V157, P3458, DOI 10.1099/mic.0.051243-0
   Sakaeda H, 1988, Nihon Seikeigeka Gakkai Zasshi, V62, P791
   Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1
   SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341
   Signore A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-8
   Stumpe KDM, 2004, RADIOLOGY, V231, P333, DOI 10.1148/radiol.2312021596
   Teterycz D, 2010, INT J INFECT DIS, V14, pE913, DOI 10.1016/j.ijid.2010.05.014
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Ujula T, 2009, NUCL MED BIOL, V36, P631, DOI 10.1016/j.nucmedbio.2009.04.008
   VOLK A, 1994, MAGN RESON IMAGING, V12, P1039, DOI 10.1016/0730-725X(94)91235-O
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 45
TC 14
Z9 14
U1 1
U2 12
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2191-219X
J9 EJNMMI RES
JI EJNMMI Res.
PD AUG 8
PY 2014
VL 4
AR 45
DI 10.1186/s13550-014-0045-3
PG 11
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA CM9SU
UT WOS:000358050100001
PM 25520903
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Cai, L
   Foster, CJ
   Liu, XF
   Wang, SF
AF Cai, Lei
   Foster, Camera J.
   Liu, Xifeng
   Wang, Shanfeng
TI Enhanced bone cell functions on poly(epsilon-caprolactone) triacrylate
   networks grafted with polyhedral oligomeric silsesquioxane nanocages
SO POLYMER
LA English
DT Article
DE Poly(epsilon-caprolactone) triacrylate; Polyhedral oligomeric
   silsesquioxane; Cell-material interactions
ID PHOTO-CROSS-LINKING; POLY(PROPYLENE FUMARATE); PHYSICAL-PROPERTIES;
   MECHANICAL-PROPERTIES; NANOHYBRID POLYMERS; FOCAL ADHESIONS; POSS
   POLYMERS; BEHAVIOR; NANOCOMPOSITES; COPOLYMERS
AB Poly(epsilon-caprolactone) triacrylate (PCLTA) developed in our laboratory is a photo-crosslinkable, injectable, and biodegradable polymeric biomaterial for diverse tissue engineering applications. To engineer its physical properties for bone regeneration, we incorporated PCLTA networks with a photo-reactive methacryl isobutyl polyhedral oligomeric silsesquioxane (POSS), which is a silicon-based monomer with a nano-sized cage. Homogeneous nanohybrid networks were prepared by photo-crosslinking POSS with two PCLTAs having molecular weights of similar to 7000 and similar to 20,000 g/mol at the POSS weight compositions (phi(POSS)) of 0-20%. The lower-molecular-weight PCLTA resulted in amorphous networks while the higher one resulted in semi-crystalline networks. POSS nanocages tethered in the PCLTA networks greatly enhanced the mechanical and rheological properties, but did not significantly alter the surface wettability and the capability of adsorbing serum proteins from cell culture media. Better mouse preosteoblastic MC3T3-E1 cell attachment, spreading, and proliferation were found on the stiffer PCLTA20k networks than on the PCLTA7k ones, and on the networks with phi(POSS) of 10-20% than the networks containing no POSS. Mineralization of MC3T3-E1 cell cultured for two weeks showed a significantly higher alkaline phosphatase activity and more mineralized nodules on the PCLTA20k networks with phi(POSS) of 10-20%, in correlation with their enhanced mechanical properties. The present results indicated that this series of nanohybrid PCLTA/POSS networks with improved mechanical properties and osteoconductivity has great potential as scaffolding materials for bone repair and regeneration. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Cai, Lei; Foster, Camera J.; Liu, Xifeng; Wang, Shanfeng] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
RP Wang, SF (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM swang16@utk.edu
RI Liu, Xifeng/F-8195-2017
OI Liu, Xifeng/0000-0002-2684-6309
FU National Science Foundation [DMR-11-06142]; Center for Materials
   Processing
FX This work was supported by National Science Foundation (DMR-11-06142).
   CJF received partial support from the Center for Materials Processing
   for her to work as a summer undergraduate student on this project.
CR Brandrup J., 1989, POLYM HDB
   Cai L, 2012, ADV FUNCT MATER, V22, P3181, DOI 10.1002/adfm.201200457
   Cai L, 2012, LANGMUIR, V28, P12557, DOI 10.1021/la302868q
   Cai L, 2011, ACTA BIOMATER, V7, P2185, DOI 10.1016/j.actbio.2011.01.034
   Cai L, 2010, BIOMATERIALS, V31, P7423, DOI 10.1016/j.biomaterials.2010.06.028
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   Cai L, 2010, POLYMER, V51, P164, DOI 10.1016/j.polymer.2009.11.042
   Cai L, 2010, BIOMACROMOLECULES, V11, P304, DOI 10.1021/bm901237t
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gu XZ, 2011, BIOMACROMOLECULES, V12, P3066, DOI 10.1021/bm2006938
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Khatiwala CB, 2007, J CELL PHYSIOL, V211, P661, DOI 10.1002/jcp.20974
   Kim SK, 2007, J ORAL REHABIL, V34, P389, DOI 10.1111/j.1365-2842.2006.01671.x
   Kuo SW, 2011, PROG POLYM SCI, V36, P1649, DOI 10.1016/j.progpolymsci.2011.05.002
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Li GZ, 2001, J INORG ORGANOMET P, V11, P123, DOI 10.1023/A:1015287910502
   Li GZ, 2005, J POLYM SCI POL CHEM, V43, P355, DOI 10.1002/pola.20503
   Liu YR, 2008, J APPL POLYM SCI, V110, P2989, DOI 10.1002/app.28425
   Mantz RA, 1996, CHEM MATER, V8, P1250, DOI 10.1021/cm950536x
   Misra R, 2007, J POLYM SCI POL PHYS, V45, P2441, DOI 10.1002/polb.21261
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Pielichowski K, 2006, ADV POLYM SCI, V201, P225, DOI 10.1007/12_077
   Wang K, 2012, ADV HEALTHC MATER, V1, P292, DOI 10.1002/adhm.201200030
   Wang K, 2011, POLYMER, V52, P2827, DOI 10.1016/j.polymer.2011.04.048
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang SF, 2005, MACROMOLECULES, V38, P7358, DOI 10.1021/ma050884c
   Wang SF, 2008, BIOMACROMOLECULES, V9, P1229, DOI 10.1021/bm7012313
   Wang SF, 2009, ACTA BIOMATER, V5, P1531, DOI 10.1016/j.actbio.2008.12.015
   Wang SF, 2008, POLYMER, V49, P5692, DOI 10.1016/j.polymer.2008.10.021
   Wang SF, 2009, BIOMATERIALS, V30, P3359, DOI 10.1016/j.biomaterials.2009.03.015
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu J, 2007, MACROMOLECULES, V40, P544, DOI 10.1021/ma061886f
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Wu XH, 2014, POLYMER, V55, P1756, DOI 10.1016/j.polymer.2014.02.029
   Xu HY, 2002, MACROMOLECULES, V35, P8788, DOI 10.1021/ma0202843
NR 39
TC 14
Z9 14
U1 3
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD AUG 5
PY 2014
VL 55
IS 16
SI SI
BP 3836
EP 3845
DI 10.1016/j.polymer.2014.06.057
PG 10
WC Polymer Science
SC Polymer Science
GA AN7WS
UT WOS:000340812300064
DA 2018-10-20
ER

PT J
AU Gomes, AP
   Mano, JF
   Queiroz, JA
   Gouveia, IC
AF Gomes, Ana P.
   Mano, Joao F.
   Queiroz, Joao A.
   Gouveia, Isabel C.
TI New Biomaterial Based on Cotton with Incorporated Biomolecules
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; biomedical applications; functionalization of polymers;
   self-assembly; textiles
ID TEMPO-MEDIATED OXIDATION; COATED ALGINATE MICROSPHERES; IR ATR
   SPECTROSCOPY; BY-LAYER DEPOSITION; ANTIBACTERIAL ACTIVITY; L-CYSTEINE;
   CELLULOSE NANOCRYSTALS; CHITOSAN NANOPARTICLES; ANTIMICROBIAL ACTIVITY;
   CONTROLLED-RELEASE
AB The aim of this study was to investigate a method of embedding l-cysteine (l-cys), an antimicrobial agent, between layers of chitosan (CH) and sodium alginate (ALG) onto cotton samples obtained via a layer-by-layer electrostatic deposition technique via several embedding methods. The results show that the best way to incorporate l-cys into the layers was the one that used the property of gelling ALG. To monitor the l-cys embedding into the CH/ALG multilayer film, different methods were used: energy-dispersive X-ray spectrometry analysis to assess the presence of sulfur on the sample, Ellman's reagent method to analyze l-cys release from the sample, and attenuated total reflectance (ATR) Fourier transform infrared spectroscopy (FTIR) to compare the ATR-FTIR spectra of the pure l-cys and l-cys embedded in the CH/ALG multilayer film to study the interaction between the l-cys and the CH/ALG multilayer films. Functionalized CH/ALG cotton samples were also investigated for their antibacterial properties toward Staphylococcus aureus and Klebsiella pneumonia with the Japanese Industrial Standard method JIS L 1902:2002, and the results show an enhancement of the antibacterial effect due to the presence of l-cys. (c) 2014 Wiley Periodicals, Inc.
C1 [Gomes, Ana P.] Univ Beira Interior, Opt Ctr, P-6201001 Covilha, Portugal.
   [Mano, Joao F.] Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Res Grp Biomat Biodegradables & Biomimet 3Bs, P-4806909 Taipas, Guimaraes, Portugal.
   [Mano, Joao F.] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
   [Queiroz, Joao A.] Univ Beira Interior, Hlth Sci Res Ctr, P-6201001 Covilha, Portugal.
   [Gouveia, Isabel C.] Univ Beira Interior, R&D Unit Text & Paper Mat, Fac Engn, P-6201001 Covilha, Portugal.
RP Gomes, AP (reprint author), Univ Beira Interior, Opt Ctr, P-6201001 Covilha, Portugal.
EM anapaula@ubi.pt
RI Queiroz, Joao/L-3104-2014; Mano, Joao/A-4418-2009; Gouveia, Isabel
   Cristina/K-1651-2014; Group, 3Bs/E-4374-2012
OI Queiroz, Joao/0000-0002-3096-8325; Mano, Joao/0000-0002-2342-3765;
   Gouveia, Isabel Cristina/0000-0003-3290-9529; Group,
   3Bs/0000-0002-5195-3456; Gomes, Ana Paula/0000-0002-3332-834X
FU Fundacao para a Ciencia e Tecnologia [PTDC/EBB-BIO/113671/2009
   (FCOMP-01-0124-FEDER-014752)]
FX The authors thank Fundacao para a Ciencia e Tecnologia for the funding
   granted concerning the project PTDC/EBB-BIO/113671/2009
   (FCOMP-01-0124-FEDER-014752). Also, they thank Fundo Europeu de
   Desenvolvimento Regional through COMPETE-Programa Operacional Factores
   de Competitividade for cofunding.
CR ALEXAKIS T, 1995, APPL BIOCHEM BIOTECH, V50, P93, DOI 10.1007/BF02788043
   Alves NM, 2009, MACROMOL BIOSCI, V9, P776, DOI 10.1002/mabi.200800336
   [Anonymous], 2002, L19022002 JIS
   BODMEIER R, 1989, DRUG DEV IND PHARM, V15, P1475, DOI 10.3109/03639048909062758
   Caldeira E, 2013, J BIOTECHNOL, V168, P426, DOI 10.1016/j.jbiotec.2013.10.021
   Campos MGN, 2009, J MATER SCI-MATER M, V20, P537, DOI 10.1007/s10856-008-3611-2
   Chung C, 2004, CARBOHYD POLYM, V58, P417, DOI 10.1016/j.carbpol.2004.08.005
   Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044
   Dai L, 2011, BIORESOURCES, V6, P2619
   Dang Z, 2007, CARBOHYD POLYM, V70, P310, DOI 10.1016/j.carbpol.2007.04.014
   Davidovich-Pinhas M, 2009, J CONTROL RELEASE, V136, P38, DOI 10.1016/j.jconrel.2009.01.029
   de Moraes MA, 2013, J APPL POLYM SCI, V130, P3451, DOI 10.1002/app.39598
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Deng HB, 2010, CARBOHYD POLYM, V80, P474, DOI 10.1016/j.carbpol.2009.12.004
   Diez I, 2011, MACROMOL BIOSCI, V11, P1185, DOI 10.1002/mabi.201100099
   Dong H, 2009, ACS APPL MATER INTER, V1, P797, DOI 10.1021/am800225j
   Dong Y, 2010, CHINESE CHEM LETT, V21, P1011, DOI 10.1016/j.cclet.2010.04.010
   Elsner JJ, 2011, ACTA BIOMATER, V7, P325, DOI 10.1016/j.actbio.2010.07.013
   Feliciano-Ramos I, 2010, J ELECTROANAL CHEM, V650, P98, DOI 10.1016/j.jelechem.2010.09.001
   Fernandes JC, 2010, J MICROBIOL BIOTECHN, V20, P311, DOI 10.4014/jmb.0904.04038
   Gomes AP, 2013, POLYM ADVAN TECHNOL, V24, P1005, DOI 10.1002/pat.3176
   Gomes AP, 2012, J POLYM ENVIRON, V20, P1084, DOI 10.1007/s10924-012-0507-5
   Gouveia IC, 2012, J APPL POLYM SCI, V124, P1352, DOI 10.1002/app.34587
   Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y
   Hsieh SH, 2007, J APPL POLYM SCI, V103, P4080, DOI 10.1002/app.25508
   Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026
   Kafshgari MH, 2011, IRAN POLYM J, V20, P445
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Leguen E, 2007, BIOMOL ENG, V24, P33, DOI 10.1016/j.bioeng.2006.05.023
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Martins GV, 2010, MACROMOL BIOSCI, V10, P1444, DOI 10.1002/mabi.201000193
   Maurstad G, 2008, CARBOHYD POLYM, V71, P672, DOI 10.1016/j.carbpol.2007.07.019
   Montanari S, 2005, MACROMOLECULES, V38, P1665, DOI 10.1021/ma048396c
   Nabok A., 2005, ORGANIC INORGANIC NA
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972
   Park SJ, 2010, FIBER POLYM, V11, P357, DOI 10.1007/s12221-010-0357-5
   Pedrosa VA, 2007, J ELECTROANAL CHEM, V602, P149, DOI 10.1016/j.jelechem.2006.12.011
   Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007
   Qin ZY, 2011, BIORESOURCES, V6, P1136
   Ribeiro AJ, 1999, INT J PHARMACEUT, V187, P115, DOI 10.1016/S0378-5173(99)00173-8
   Rudra JS, 2006, J BIOMAT SCI-POLYM E, V17, P1301, DOI 10.1163/156856206778667433
   Rujitanaroj PO, 2008, POLYMER, V49, P4723, DOI 10.1016/j.polymer.2008.08.021
   Saito T, 2006, CARBOHYD POLYM, V65, P435, DOI 10.1016/j.carbpol.2006.01.034
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Sanders W, 2009, J COLLOID INTERF SCI, V331, P318, DOI 10.1016/j.jcis.2008.12.010
   Sevgi F, 2008, PHARM DEV TECHNOL, V13, P5, DOI [10.1080/10837450701702339, 10.1080/10837450701702339 ]
   Shao J, 2003, J APPL POLYM SCI, V88, P2575, DOI 10.1002/app.12098
   Shilpa A, 2003, J MACROMOL SCI-POL R, VC43, P187, DOI 10.1081/MC-120020160
   Silva CM, 2006, EUR J PHARM SCI, V29, P148, DOI 10.1016/j.ejps.2006.06.008
   Silva CM, 2005, AAPS J, V7, pE903, DOI 10.1208/aapsj070488
   Smrdel P, 2006, DRUG DEV IND PHARM, V32, P623, DOI 10.1080/03639040600599863
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Takeoka S, 2008, PURE APPL CHEM, V80, P2259, DOI 10.1351/pac200880112259
   Tan WH, 2007, ADV MATER, V19, P2696, DOI 10.1002/adma.200700433
   Varghese MV, 2009, SYNTH REACT INORG M, V39, P554, DOI 10.1080/15533170903327869
   Wang P, 2008, J ENVIRON SCI-CHINA, V20, P1519, DOI 10.1016/S1001-0742(08)62559-0
   Wang Q, 2006, CARBOHYD RES, V341, P2170, DOI 10.1016/k.carres.2006.04.048
   Wang XH, 2005, POLYM BULL, V55, P105, DOI 10.1007/s00289-005-0414-1
   Wang YC, 2003, BIOMATERIALS, V24, P1047, DOI 10.1016/S0142-9612(02)00434-9
   Wolpert M, 2006, SPECTROCHIM ACTA A, V64, P987, DOI 10.1016/j.saa.2005.08.025
   Yan HJ, 2009, CELLULOSE, V16, P1099, DOI 10.1007/s10570-009-9349-2
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 64
TC 5
Z9 5
U1 2
U2 64
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD AUG 5
PY 2014
VL 131
IS 15
AR 40519
DI 10.1002/app.40519
PG 9
WC Polymer Science
SC Polymer Science
GA AH9IX
UT WOS:000336456400020
DA 2018-10-20
ER

PT J
AU He, B
   Yuan, X
   Zhou, AG
   Zhang, H
   Jiang, DM
AF He, Bin
   Yuan, Xiao
   Zhou, Aiguo
   Zhang, Hua
   Jiang, Dianming
TI Designer functionalised self-assembling peptide nanofibre scaffolds for
   cartilage tissue engineering
SO EXPERT REVIEWS IN MOLECULAR MEDICINE
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; EXTRACELLULAR-MATRIX
   PRODUCTION; BONE MORPHOGENETIC PROTEIN-2; CHONDROCYTES IN-VITRO;
   SPINAL-CORD-INJURY; ARG-GLY-ASP; ARTICULAR-CARTILAGE; AMPHIPHILE
   NANOFIBERS; CONTROLLED-RELEASE
AB Owing to the limited regenerative capacity of cartilage tissue, cartilage repair remains a challenge in clinical treatment. Tissue engineering has emerged as a promising and important approach to repair cartilage defects. It is well known that material scaffolds are regarded as a fundamental element of tissue engineering. Novel biomaterial scaffolds formed by self-assembling peptides consist of nanofibre networks highly resembling natural extracellular matrices, and their fabrication is based on the principle of molecular self-assembly. Indeed, peptide nanofibre scaffolds have obtained much progress in repairing various damaged tissues (e.g. cartilage, bone, nerve, heart and blood vessel). This review outlines the rational design of peptide nanofibre scaffolds and their potential in cartilage tissue engineering.
C1 [He, Bin; Zhou, Aiguo; Zhang, Hua; Jiang, Dianming] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing 400016, Peoples R China.
   [Yuan, Xiao] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing 400016, Peoples R China.
RP Jiang, DM (reprint author), 1 Yi Xue Yuan Rd, Chongqing 400016, Peoples R China.
EM jdm571026@vip.163.com
FU China National "973 Project''; Natural Science Foundation Project of CQ
   CSTC [2009AB5080]; National Natural Science Foundation of China (NSFC)
   [81171685/H0604]
FX D.M. Jiang was supported in part by China National "973 Project'' and by
   the grant from the Natural Science Foundation Project of CQ CSTC
   (2009AB5080), and National Natural Science Foundation of China (NSFC,
   81171685/H0604). We apologize to all the scientists whose work we could
   not cite due to space restrictions.
CR Ahmed TAE, 2011, TISSUE ENG PT A, V17, P323, DOI [10.1089/ten.tea.2009.0773, 10.1089/ten.TEA.2009.0773]
   Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]
   Ateshian GA, 2007, NAT MATER, V6, P89, DOI 10.1038/nmat1830
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Baumann K, 2012, NAT REV MOL CELL BIO, V13, DOI 10.1038/nrm3342
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Block JA, 2014, NAT REV RHEUMATOL, V10, P324, DOI 10.1038/nrrheum.2014.61
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Bougault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036964
   Bovee JVMG, 2010, NAT REV CANCER, V10, P481, DOI 10.1038/nrc2869
   Branco MC, 2009, BIOMATERIALS, V30, P1339, DOI 10.1016/j.biomaterials.2008.11.019
   Bugbee W, 2012, J KNEE SURG, V25, P109, DOI 10.1055/s-0032-1313743
   Bussmann BM, 2016, J TISSUE ENG REGEN M, V10, pE54, DOI 10.1002/term.1766
   Callahan LAS, 2013, ACTA BIOMATER, V9, P7420, DOI 10.1016/j.actbio.2013.04.005
   Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Chen CH, 2013, MOL THER, V21, P670, DOI 10.1038/mt.2012.268
   Chen J.L., 2014, STEM CELLS, V8, P14
   Chen P, 2005, COLLOID SURFACE A, V261, P3, DOI 10.1016/j.colsurfa.2004.12.048
   Chen WC, 2011, CYTOTECHNOLOGY, V63, P13, DOI 10.1007/s10616-010-9314-9
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Clair Benjamin L, 2009, Foot Ankle Spec, V2, P179, DOI 10.1177/1938640009342272
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cully Megan, 2013, Nat Rev Rheumatol, V9, P135, DOI 10.1038/nrrheum.2013.9
   Dhinsa BS, 2012, CURR STEM CELL RES T, V7, P143
   Dolgin E, 2011, NAT MED, V17, P1032, DOI 10.1038/nm0911-1032
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Drewa T, 2012, NAT REV UROL, V9, P561, DOI 10.1038/nrurol.2012.158
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Ebihara G, 2012, BIOMATERIALS, V33, P3846, DOI 10.1016/j.biomaterials.2012.01.056
   Endres M, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-37
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369
   Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661
   Florine EM, 2013, CARTILAGE, V4, P63, DOI 10.1177/1947603512455196
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Guo HD, 2010, BIOCHEM BIOPH RES CO, V399, P42, DOI 10.1016/j.bbrc.2010.07.031
   Handorf AM, 2014, J CELL PHYSIOL, V229, P162, DOI 10.1002/jcp.24428
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hartgerink JD, 2001, CURR OPIN SOLID ST M, V5, P355, DOI 10.1016/S1359-0286(01)00019-5
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   He B, 2014, RSC ADV, V4, P23610, DOI 10.1039/c4ra01826e
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hosseinkhani H., 2006, PEPT SCI, V2005, P63
   Hosseinkhani H, 2006, PEPT SCI, V2005, P341
   Hosseinkhani H, 2006, YAKHTEH, V8, P204
   Hosseinkhani H, 2006, BIOMED MATER, V1, P8, DOI 10.1088/1748-6041/1/1/002
   Hosseinkhani H, 2007, J CONTROL RELEASE, V117, P380, DOI 10.1016/j.jconrel.2006.11.018
   Hosseinkhani H, 2007, TISSUE ENG, V13, P11, DOI 10.1089/ten.2006.0120
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5089, DOI 10.1016/j.biomaterials.2006.05.050
   Hosseinkhani H, 2013, CHEM REV, V113, P4837, DOI 10.1021/cr300131h
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jackson RW, 2003, ARTHROSCOPY, V19, P13, DOI 10.1053/jars.2003.50022
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Jeong CG, 2012, J BIOMED MATER RES A, V100A, P2088, DOI 10.1002/jbm.a.33249
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005
   Kisiday JD, 2008, J ORTHOP RES, V26, P322, DOI 10.1002/jor.20508
   Kokemueller H, 2010, INT J ORAL MAX SURG, V39, P379, DOI 10.1016/j.ijom.2010.01.010
   Kon E, 2012, J KNEE SURG, V25, P17, DOI 10.1055/s-0031-1299651
   Kopesky PW, 2010, MATRIX BIOL, V29, P427, DOI 10.1016/j.matbio.2010.02.003
   Kopesky PW, 2014, J BIOMED MATER RES A, V102, P1275, DOI 10.1002/jbm.a.34789
   Kopesky PW, 2010, TISSUE ENG PT A, V16, P465, DOI [10.1089/ten.tea.2009.0158, 10.1089/ten.TEA.2009.0158]
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Kropp BP, 2006, NAT CLIN PRACT UROL, V3, P588, DOI 10.1038/ncpuro0628
   Kyle S, 2010, BIOMATERIALS, V31, P9395, DOI 10.1016/j.biomaterials.2010.08.051
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Liu JP, 2010, MACROMOL BIOSCI, V10, P1164, DOI 10.1002/mabi.200900450
   Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004
   Luo ZL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002364
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maher SA, 2010, J TISSUE ENG REGEN M, V4, P25, DOI 10.1002/term.205
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Miller RE, 2010, OSTEOARTHR CARTILAGE, V18, P1608, DOI 10.1016/j.joca.2010.09.004
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mujeeb A, 2013, ACTA BIOMATER, V9, P4609, DOI 10.1016/j.actbio.2012.08.044
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425
   Oshima Y, 2009, TISSUE ENG PART C-ME, V15, P595, DOI [10.1089/ten.tec.2008.0487, 10.1089/ten.TEC.2008.0487]
   Ouzzine M, 2012, METHODS MOL BIOL, V836, P339, DOI 10.1007/978-1-61779-498-8_22
   Panseri S, 2012, KNEE SURG SPORT TR A, V20, P1182, DOI 10.1007/s00167-011-1655-1
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   Raub CB, 2013, OSTEOARTHR CARTILAGE, V21, P860, DOI 10.1016/j.joca.2013.03.014
   Reddi AH, 2011, TISSUE ENG PART B-RE, V17, P301, DOI [10.1089/ten.TEB.2011.0141, 10.1089/ten.teb.2011.0141]
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Schmidt JJ, 2011, TISSUE ENG PT A, V17, P2687, DOI 10.1089/ten.tea.2010.0685
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shannon FJ, 2001, INT ORTHOP, V25, P242, DOI 10.1007/s002640000212
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   Steadman J Richard, 2002, J Knee Surg, V15, P170
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Swieszkowski W, 2007, BIOMOL ENG, V24, P489, DOI 10.1016/j.bioeng.2007.07.014
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Ustun S, 2013, BIOMACROMOLECULES, V14, P17, DOI 10.1021/bm301538k
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yoshimi R, 2009, J CRANIOFAC SURG, V20, P1523, DOI 10.1097/SCS.0b013e3181b09b7e
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 145
TC 16
Z9 17
U1 4
U2 57
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1462-3994
J9 EXPERT REV MOL MED
JI Expert Rev. Mol. Med.
PD AUG 4
PY 2014
VL 16
AR e12
DI 10.1017/erm.2014.13
PG 19
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Research & Experimental Medicine
GA AN6PU
UT WOS:000340718700001
PM 25089851
DA 2018-10-20
ER

PT J
AU Bond, JE
   Garrison, NL
   Hamilton, CA
   Godwin, RL
   Hedin, M
   Agnarsson, I
AF Bond, Jason E.
   Garrison, Nicole L.
   Hamilton, Chris A.
   Godwin, Rebecca L.
   Hedin, Marshal
   Agnarsson, Ingi
TI Phylogenomics Resolves a Spider Backbone Phylogeny and Rejects a
   Prevailing Paradigm for Orb Web Evolution
SO CURRENT BIOLOGY
LA English
DT Article
ID ESTIMATING SPECIES TREES; INFRAORDER MYGALOMORPHAE; DIVERGENCE TIMES;
   GENE FAMILY; SYSTEMATICS; SELECTION; ARANEAE; ALIGNMENTS; LIKELIHOOD;
   SEQUENCES
AB Spiders represent an ancient predatory lineage known for their extraordinary biomaterials, including venoms and silks. These adaptations make spiders key arthropod predators in most terrestrial ecosystems. Despite ecological, biomedical, and biomaterial importance, relationships among major spider lineages remain unresolved or poorly supported [1]. Current working hypotheses for a spider "backbone" phylogeny are largely based on morphological evidence, as most molecular markers currently employed are generally inadequate for resolving deeper-level relationships. We present here a phylogenomic analysis of spiders including taxa representing all major spider lineages. Our robust phylogenetic hypothesis recovers some fundamental and uncontroversial spider clades, but rejects the prevailing paradigm of a monophyletic Orbiculariae, the most diverse linage, containing orb-weaving spiders. Based on our results, the orb web either evolved much earlier than previously hypothesized and is ancestral for a majority of spiders or else it has multiple independent origins, as hypothesized by precladistic authors. Cribellate deinopoid orb weavers that use mechanically adhesive silk are more closely related to a diverse clade of mostly webless spiders than to the araneoid orb-weaving spiders that use adhesive droplet silks. The fundamental shift in our understanding of spider phylogeny proposed here has broad implications for interpreting the evolution of spiders, their remarkable biomaterials, and a key extended phenotype-the spider web.
C1 [Bond, Jason E.; Garrison, Nicole L.; Hamilton, Chris A.; Godwin, Rebecca L.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.
   [Bond, Jason E.; Garrison, Nicole L.; Hamilton, Chris A.; Godwin, Rebecca L.] Auburn Univ, Museum Nat Hist, Auburn, AL 36849 USA.
   [Hedin, Marshal] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.
   [Agnarsson, Ingi] Univ Vermont, Dept Biol, Burlington, VT 05405 USA.
RP Bond, JE (reprint author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.
EM jbond@auburn.edu
RI Bond, Jason/P-1501-2017
OI Bond, Jason/0000-0001-6373-3875
FU Auburn University; US NSF [DEB-1153218, DBI-1349205]; US FWS
   [F13PX00770]; SDSU UGP
FX We thank Scotty Santos for assistance with ExaBayes analyses; Jon
   Coddington and three anonymous reviewers provided helpful comments on
   the manuscript. Michael Brewer provided early assistance in protocol and
   analysis pipeline development. Jim Starrett conducted some of the RNA
   extractions. This work was primarily supported by funding from Auburn
   University and the US NSF (DEB-1153218 to J.E.B. and DBI-1349205 to
   I.A.). M.H. was supported by the US FWS (contract no. F13PX00770) and an
   SDSU UGP grant. This is contribution no. 700 of the Auburn University
   Museum of Natural History.
CR Agnarsson I., 2013, SPIDER RES 21 CENTUR, P58
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Bond JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038753
   Bond JE, 1998, EVOLUTION, V52, P403, DOI 10.1111/j.1558-5646.1998.tb01641.x
   Brewer MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079935
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Coddington J. A., 2005, SPIDERS N AM IDENTIF, P18
   Dimitrov D, 2012, P ROY SOC B-BIOL SCI, V279, P1341, DOI 10.1098/rspb.2011.2011
   Ebersberger I, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-157
   Fernandez R.M., 2014, CURR BIOL
   Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Griswold Charles E., 2005, Proceedings of the California Academy of Sciences, V56, P1
   Gui JH, 2014, CURR BIOL, V24, P473, DOI 10.1016/j.cub.2014.01.013
   Hausdorf B, 1999, J EVOLUTION BIOL, V12, P980, DOI 10.1046/j.1420-9101.1999.00104.x
   Hayashi CY, 2004, MOL BIOL EVOL, V21, P1950, DOI 10.1093/molbev/msh204
   Hormiga G, 2014, ANNU REV ENTOMOL, V59, P487, DOI 10.1146/annurev-ento-011613-162046
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650
   Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382
   Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024
   Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10
   Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017
   Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027
   Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302
   Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031
   Platnick N. I., 2014, WORLD SPIDER CATALOG
   RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1
   Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2
   Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208
   Selden PA, 2013, NATURWISSENSCHAFTEN, V100, P1171, DOI 10.1007/s00114-013-1121-7
   Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Starrett J, 2013, GENE, V524, P175, DOI 10.1016/j.gene.2013.04.037
   Tamura K, 2012, P NATL ACAD SCI USA, V109, P19333, DOI 10.1073/pnas.1213199109
NR 37
TC 84
Z9 84
U1 4
U2 86
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD AUG 4
PY 2014
VL 24
IS 15
BP 1765
EP 1771
DI 10.1016/j.cub.2014.06.034
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA AM7UL
UT WOS:000340074100025
PM 25042592
DA 2018-10-20
ER

PT J
AU Zakrzewski, JL
   van den Brink, MRM
   Hubbell, JA
AF Zakrzewski, Johannes L.
   van den Brink, Marcel R. M.
   Hubbell, Jeffrey A.
TI Overcoming immunological barriers in regenerative medicine
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID VERSUS-HOST-DISEASE; MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS;
   EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MAJOR HISTOCOMPATIBILITY
   COMPLEX; ANTIGEN-SPECIFIC TOLERANCE; REFRACTORY ACUTE GVHD; ALLOGRAFT
   SURVIVAL; INTRATHYMIC INJECTION; DENDRITIC CELLS
AB Regenerative therapies that use allogeneic cells are likely to encounter immunological barriers similar to those that occur with transplantation of solid organs and allogeneic hematopoietic stem cells (HSCs). Decades of experience in clinical transplantation hold valuable lessons for regenerative medicine, offering approaches for developing tolerance-induction treatments relevant to cell therapies. Outside the field of solid-organ and allogeneic HSC transplantation, new strategies are emerging for controlling the immune response, such as methods based on biomaterials or mimicry of antigen-specific peripheral tolerance. Novel biomaterials can alter the behavior of cells in tissue-engineered constructs and can blunt host immune responses to cells and biomaterial scaffolds. Approaches to suppress autoreactive immune cells may also be useful in regenerative medicine. The most innovative solutions will be developed through closer collaboration among stem cell biologists, transplantation immunologists and materials scientists.
C1 [Zakrzewski, Johannes L.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA.
   [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA.
   [van den Brink, Marcel R. M.] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10021 USA.
   [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, Lausanne, Switzerland.
   [Hubbell, Jeffrey A.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA.
RP Zakrzewski, JL (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.
EM zakrzewj@mskcc.org
FU NCI NIH HHS [P30 CA072720, P30 CA008748, K08 CA160659]; NHLBI NIH HHS
   [R01 HL069929]
CR Adkins D, 2009, TRANSPLANTATION, V88, P198, DOI 10.1097/TP.0b013e3181abfbf7
   Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0
   Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807
   Asberg A, 2006, TRANSPLANTATION, V82, P62, DOI 10.1097/01.tp.0000225803.04995.2b
   Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136
   Beyersdorf N, 2008, BLOOD, V112, P4328, DOI 10.1182/blood-2008-03-146662
   Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212
   Bour-Jordan H, 2011, IMMUNOL REV, V241, P180, DOI 10.1111/j.1600-065X.2011.01011.x
   Brady AC, 2013, TISSUE ENG PT A, V19, P2544, DOI [10.1089/ten.tea.2012.0686, 10.1089/ten.TEA.2012.0686]
   BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110
   CALNE RY, 1978, LANCET, V2, P1323
   Chen WJ, 1998, J IMMUNOL, V160, P1504
   Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253
   Christopeit M, 2009, BLOOD, V113, P3130, DOI 10.1182/blood-2009-01-200527
   Chung B, 2007, BLOOD, V110, P2803, DOI 10.1182/blood-2006-11-055673
   Cicciarelli J.C., 2012, IMMUNOLOGICAL BARRIE, P147
   Clark RA, 2005, J CLIN INVEST, V115, P3239, DOI 10.1172/JCI24731
   Cober SR, 1999, J SURG RES, V85, P204, DOI 10.1006/jsre.1999.5688
   Crop MJ, 2009, TRANSPLANTATION, V87, P896, DOI 10.1097/TP.0b013e31819b3d72
   Cui H, 2009, TRANSPLANTATION, V88, P160, DOI 10.1097/TP.0b013e3181abbfc1
   Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726
   Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009
   Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894
   Djamali A, 2004, TRANSPLANT INT, V17, P301, DOI 10.1007/s00147-004-0717-4
   Drobyski WR, 2011, BIOL BLOOD MARROW TR, V17, P1862, DOI 10.1016/j.bbmt.2011.07.001
   Eggenhofer E, 2011, TRANSPL IMMUNOL, V24, P157, DOI 10.1016/j.trim.2010.12.002
   Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205
   Ezzelarab MB, 2013, AM J TRANSPLANT, V13, P1989, DOI 10.1111/ajt.12310
   Fan HM, 2011, SEMIN IMMUNOL, V23, P453, DOI 10.1016/j.smim.2011.08.012
   Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577
   Fuchimoto Y, 2000, J CLIN INVEST, V105, P1779, DOI 10.1172/JCI8721
   Garcia-Cadenas I, 2013, BIOL BLOOD MARROW TR, V19, P435, DOI 10.1016/j.bbmt.2012.11.012
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Ghobadi A., 2013, 55 AM SOC HEM ANN M
   Gill RG, 2010, CURR OPIN IMMUNOL, V22, P649, DOI 10.1016/j.coi.2010.09.005
   Glowacki AJ, 2013, P NATL ACAD SCI USA, V110, P18525, DOI 10.1073/pnas.1302829110
   Gordon JR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00007
   Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839
   Hippen KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001809
   Hirosue S, 2014, J IMMUNOL, V192, P5002, DOI 10.4049/jimmunol.1302492
   Hoda D, 2010, BONE MARROW TRANSPL, V45, P1347, DOI 10.1038/bmt.2009.343
   Jacobson P, 1998, BONE MARROW TRANSPL, V22, P217, DOI 10.1038/sj.bmt.1701331
   Jang MS, 2008, TRANSPLANTATION, V85, P1051, DOI 10.1097/TP.0b013e31816846f6
   Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2003-10-0005
   Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623
   Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074
   Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009
   Kim N, 2013, ANN HEMATOL, V92, P1295, DOI 10.1007/s00277-013-1796-z
   Komori J, 2012, NAT BIOTECHNOL, V30, P976, DOI 10.1038/nbt.2379
   Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110
   Koreth J, 2011, NEW ENGL J MED, V365, P2055, DOI 10.1056/NEJMoa1108188
   Koreth J, 2009, BLOOD, V114, P3956, DOI 10.1182/blood-2009-07-231092
   Lakkis FG, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014993
   Larsen CP, 1996, NATURE, V381, P434, DOI 10.1038/381434a0
   Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Leveson-Gower DB, 2011, BLOOD, V117, P3220, DOI 10.1182/blood-2010-08-303008
   Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987
   Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399
   Li J, 2011, BIOL BLOOD MARROW TR, V17, P962, DOI 10.1016/j.bbmt.2011.01.018
   Li N, 2010, CELL MOL IMMUNOL, V7, P133, DOI 10.1038/cmi.2009.120
   Li S, 2006, J SURG RES, V136, P238, DOI 10.1016/j.jss.2006.05.032
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Liu K, 2002, J EXP MED, V196, P1091, DOI 10.1084/jem.20021215
   Logan AC, 2012, CURR OPIN IMMUNOL, V24, P640, DOI 10.1016/j.coi.2012.08.002
   Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005
   Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105
   Lutterotti A, 2013, SCI TRANSL MED, V5
   Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123
   Magro L, 2009, BLOOD, V114, P719, DOI 10.1182/blood-2009-02-204750
   Mai HL, 2014, J CLIN INVEST, V124, P1723, DOI 10.1172/JCI66287
   Maltzman JS, 2012, AM J TRANSPLANT, V12, P2269, DOI 10.1111/j.1600-6143.2012.04185.x
   Mapara MY, 2001, BIOL BLOOD MARROW TR, V7, P646, DOI 10.1053/bbmt.2001.v7.pm11787527
   Marodon G, 2006, BLOOD, V108, P2972, DOI 10.1182/blood-2006-03-010900
   Martin AJ, 2010, J IMMUNOL, V185, P3326, DOI 10.4049/jimmunol.1000802
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   Mukherjee G, 2013, INT IMMUNOL, V25, P651, DOI 10.1093/intimm/dxt031
   Muraoka N, 2014, ANNU REV PHYSIOL, V76, P21, DOI 10.1146/annurev-physiol-021113-170301
   Neufeld T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070150
   Page A, 2012, AM J TRANSPLANT, V12, P115, DOI 10.1111/j.1600-6143.2011.03737.x
   Penack O, 2010, J NATL CANCER I, V102, P894, DOI 10.1093/jnci/djq172
   Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y
   Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610
   Petersdorf EW, 2013, BLOOD, V122, P1863, DOI 10.1182/blood-2013-05-355982
   Pillai AB, 2007, J IMMUNOL, V178, P6242, DOI 10.4049/jimmunol.178.10.6242
   Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729
   Pruett TL, 2009, TRANSPL P, V41, P3655, DOI 10.1016/j.transproceed.2009.06.226
   Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712
   Rossi Robert J, 2012, Methods Mol Biol, V900, P471, DOI 10.1007/978-1-60761-720-4_23
   Sachs DH, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015529
   Sagoo P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00184
   Schlitt HJ, 2001, LANCET, V357, P587, DOI 10.1016/S0140-6736(00)04055-1
   Schneidawind D, 2013, BLOOD, V122, P3116, DOI 10.1182/blood-2013-08-453126
   Schub N, 2011, BONE MARROW TRANSPL, V46, P143, DOI 10.1038/bmt.2010.68
   Seach N, 2010, TISSUE ENG PART C-ME, V16, P543, DOI [10.1089/ten.tec.2009.0135, 10.1089/ten.TEC.2009.0135]
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837
   Shimabukuro-Vornhagen A, 2008, BLOOD, V112, P1544, DOI 10.1182/blood-2008-04-149609
   Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684
   Shono Y, 2014, CANCER DISCOV, V4, P578, DOI 10.1158/2159-8290.CD-13-0585
   Shtrichman R, 2013, CURR MOL MED, V13, P792, DOI 10.2174/1566524011313050010
   Stenger EO, 2012, BLOOD, V119, P5088, DOI 10.1182/blood-2011-11-364091
   Stern JNH, 2010, P NATL ACAD SCI USA, V107, P17280, DOI 10.1073/pnas.1010263107
   Strioga MM, 2013, CRIT REV IMMUNOL, V33, P489
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang Chad, 2013, Methods Mol Biol, V1029, P17, DOI 10.1007/978-1-62703-478-4_2
   Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552
   Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652
   Taylor PA, 2005, BLOOD, V105, P3372, DOI 10.1182/blood-2004-10-3869
   Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459
   Trzonkowski P, 2009, CLIN IMMUNOL, V133, P22, DOI 10.1016/j.clim.2009.06.001
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Tuckett AZ, 2014, BLOOD, V123, P2797, DOI 10.1182/blood-2013-10-535401
   Vijayakrishnan L, 2011, TRENDS PHARMACOL SCI, V32, P25, DOI 10.1016/j.tips.2010.10.004
   Vodanovic-Jankovic S, 2006, BLOOD, V107, P827, DOI 10.1182/blood-2005-05-1820
   Wabbijn Marike, 2004, Exp Clin Transplant, V2, P201
   WALLACE PM, 1994, TRANSPLANTATION, V58, P602, DOI 10.1097/00007890-199409150-00013
   Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227
   Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497
   Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012
   Yap WT, 2013, TISSUE ENG PT A, V19, P2361, DOI [10.1089/ten.tea.2013.0033, 10.1089/ten.TEA.2013.0033]
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
NR 123
TC 52
Z9 53
U1 2
U2 46
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD AUG
PY 2014
VL 32
IS 8
BP 786
EP 794
DI 10.1038/nbt.2960
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AW7PF
UT WOS:000346455900019
PM 25093888
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wu, WZ
   Geng, P
   Zhao, J
   Zhang, Y
   Rosen, DW
   Zhang, HB
AF Wu, W. Z.
   Geng, P.
   Zhao, J.
   Zhang, Y.
   Rosen, D. W.
   Zhang, H. B.
TI Manufacture and thermal deformation analysis of semicrystalline polymer
   polyether ether ketone by 3D printing
SO MATERIALS RESEARCH INNOVATIONS
LA English
DT Article
DE Crystalline polymer; PEEK; 3D printing; Thermal deformation analysis;
   Biomaterial
ID PEEK
AB This study developed a polyether ether ketone ( PEEK) three-dimensional (3D) printing system. Three-dimensional printing chamber is designed for researching and solving the thermal deformation problem of the fabricating high melting point biomaterial PEEK process through 3D printing. A multi-parameter single factor experiments were carried out to analyse the effect of chamber temperature T-1, nozzle temperature T-2 on deformation of PEEK 3D printing samples. The results prove that the warping deformation is minimal with the chamber temperature at 130 degrees C, the nozzle temperature at 350 degrees C. The PEEK parts were printed successfully through the optimal parameters determined by the experiment. The results of this study demonstrate the feasibility of manufacturing personalised small batch PEEK function parts in industrial and medical fields.
C1 [Wu, W. Z.; Geng, P.; Zhao, J.; Zhang, Y.] Jilin Univ, Sch Mech Sci & Engn, Changchun 130025, Peoples R China.
   [Rosen, D. W.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Zhang, H. B.] Jilin Univ, Alan G MacDiarmid Inst, Coll Chem, Changchun 130012, Peoples R China.
RP Zhang, HB (reprint author), Jilin Univ, Alan G MacDiarmid Inst, Coll Chem, Qianjin St 10, Changchun 130012, Peoples R China.
EM zhanghaib@jlu.edu.cn
FU National Natural Science Foundation of China [51205163]; 'SRFDP' [2012
   0061120030]; Young Research Fund of Jilin Province Science and
   Technology Development Plan [20 140520124JH]
FX This research is supported by National Natural Science Foundation of
   China (No. 51205163), 'SRFDP' (No. 2012 0061120030), Young Research Fund
   of Jilin Province Science and Technology Development Plan (No. 20
   140520124JH).
CR HOSEMANN R, 1963, J APPL PHYS, V34, P25, DOI 10.1063/1.1729085
   Pawlyn M, 2013, NATURE, V494, P174, DOI 10.1038/494174a
   Schmidt M, 2007, CIRP ANN-MANUF TECHN, V56, P205, DOI 10.1016/j.cirp.2007.05.097
   Wang C, 1997, J COMPOS MATER, V31, P1480, DOI 10.1177/002199839703101502
NR 4
TC 7
Z9 7
U1 10
U2 111
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1432-8917
EI 1433-075X
J9 MATER RES INNOV
JI Mater. Res. Innov.
PD AUG
PY 2014
VL 18
SU 5
BP 12
EP 16
DI 10.1179/1432891714Z.000000000898
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA AW3DA
UT WOS:000346164500005
DA 2018-10-20
ER

PT J
AU Huri, PY
   Ozilgen, BA
   Hutton, DL
   Grayson, WL
AF Huri, Pinar Yilgor
   Ozilgen, B. Arda
   Hutton, Daphne L.
   Grayson, Warren L.
TI Scaffold pore size modulates in vitro osteogenesis of human
   adipose-derived stem/stromal cells
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE adipose-derived stem/stromal cell; PCL scaffold; pore size;
   osteogenesis; paraffin particles
ID MESENCHYMAL STEM-CELLS; BMP-INDUCED OSTEOGENESIS; BONE REGENERATION;
   TISSUE; DIFFERENTIATION; HYDROXYAPATITE; THERAPIES; POLYCAPROLACTONE;
   CHONDROGENESIS; TRANSLATION
AB Trabecular bone has an interconnected porous structure, which influences cellular responses, biochemical transport and mechanical strength. Appropriately mimicking this structural organization in biomaterial scaffolds can facilitate more robust bone tissue regeneration and integration by providing a native microenvironment to the cells. This study examined the effect of pore size on human adipose-derived stem/stromal cell (ASC) osteogenesis within poly(epsilon-caprolactone) (PCL) scaffolds. Scaffold pore size was controlled by porogen leaching of custom-made paraffin particles with three different size ranges: P200 (< 500 mu m), P500 (500-1000 mu m), and P1000 (1000-1500 mu m). Scaffolds produced by leaching these particles exhibited highly interconnected pores and rough surface structures that were favorable for cell attachment and ingrowth. The osteogenic response of ASCs was evaluated following 3 weeks of in vitro culture using biochemical (ALP, Ca2+/DNA content), mechanical (compression test) and histological (H&E and von Kossa staining) analyses. It was observed that while the total number of cells was similar for all scaffolds, the cell distributions and osteogenic properties were affected by the scaffold pore size. ASCs were able to bridge smaller pores and grow uniformly within these scaffolds (P200) while they grew as a layer along the periphery of the largest pores (P1000). The cell-biomaterial interactions specific to the latter case led to enhanced osteogenic responses. The ALP activity and Ca2+ deposition were doubled in P1000 scaffolds as compared to P200 scaffolds. A significant difference was observed between the compressive strength of unseeded and seeded P1000 scaffolds. Therefore, we demonstrated that the use of scaffolds with pores that are in the range of 1 mm enhances in vitro ASC osteogenesis, which may improve their performance in engineered bone substitutes.
C1 [Huri, Pinar Yilgor; Ozilgen, B. Arda; Hutton, Daphne L.; Grayson, Warren L.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
RP Huri, PY (reprint author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
EM wgrayson@jhmi.edu
FU Maryland Stem Cell Research Fund [2010-MSCRFE-0150-00, 2012-MSCRFF-165];
   US Department of Defense [DM090323]
FX We gratefully acknowledge the support of the Maryland Stem Cell Research
   Fund (2010-MSCRFE-0150-00 & 2012-MSCRFF-165) and the US Department of
   Defense (DM090323). Use of the Zeiss LSM 510 confocal microscope was
   made possible thanks to the Microscopy and Imaging Core Module of the
   Wilmer Core Grant.
CR Abdollahi S, 2013, LANGMUIR, V29, P1466, DOI 10.1021/la304647r
   Baksh D, 1998, J MATER SCI-MATER M, V9, P743, DOI 10.1023/A:1008959103864
   Brydone AS, 2010, P I MECH ENG H, V224, P1329, DOI 10.1243/09544119JEIM770
   Carvalho PP, 2014, J BIOMED MATER RES A, V102, P3102, DOI 10.1002/jbm.a.34983
   Chen BQ, 2005, POLYM TEST, V24, P978, DOI 10.1016/j.polymertesting.2005.07.013
   Choi JW, 2014, ANN PLAS SURG, V72, P225, DOI 10.1097/SAP.0b013e31825f70f5
   Choi K, 2013, J BIOMED MATER RES B, V101B, P919, DOI 10.1002/jbm.b.32897
   Correia C, 2014, J TISSUE ENG REGEN M, V8, P629, DOI 10.1002/term.1564
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Eosoly S, 2012, MAT SCI ENG C-MATER, V32, P2250, DOI 10.1016/j.msec.2012.06.011
   Fisher MB, 2013, TISSUE ENG PART B-RE, V19, P1, DOI [10.1089/ten.teb.2012.0723, 10.1089/ten.TEB.2012.0723]
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI [10.1089/ten.tea.2009.0164, 10.1089/ten.TEA.2009.0164]
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Huri PY, 2013, BIOCHEM BIOPH RES CO, V438, P180, DOI 10.1016/j.bbrc.2013.07.049
   Hutton DL, 2012, TISSUE ENG PT A, V18, P1729, DOI [10.1089/ten.tea.2011.0599, 10.1089/ten.TEA.2011.0599]
   Im GI, 2012, CELL TRANSPLANT, V21, P2397, DOI 10.3727/096368912X638865
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim BS, 2014, J BIOMED MATER RES B, V102, P943, DOI 10.1002/jbm.b.33075
   Kim TH, 2013, MACROMOL RES, V21, P878, DOI 10.1007/s13233-013-1099-1
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kuboki Y, 1998, J BIOMED MATER RES, V39, P190, DOI 10.1002/(SICI)1097-4636(199802)39:2<190::AID-JBM4>3.0.CO;2-K
   Liu GP, 2013, BIOMATERIALS, V34, P2655, DOI 10.1016/j.biomaterials.2013.01.004
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]
   Olah L, 2008, ACTA BIOENG BIOMECH, V10, P61
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Pilia M, 2013, BIOMED RES INT, DOI 10.1155/2013/458253
   Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720
   Salerno A, 2010, TISSUE ENG PT A, V16, P2661, DOI 10.1089/ten.tea.2009.0494
   Salgado AJ, 2013, INT REV NEUROBIOL, V108, P1, DOI 10.1016/B978-0-12-410499-0.00001-0
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Schuckert KH, 2010, TISSUE ENG PART C-ME, V16, P1335, DOI [10.1089/ten.tec.2010.0020, 10.1089/ten.TEC.2010.0020]
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Wu XH, 2013, TISSUE ENG PT A, V19, P2486, DOI [10.1089/ten.tea.2013.0124, 10.1089/ten.TEA.2013.0124]
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 46
TC 22
Z9 23
U1 1
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD AUG
PY 2014
VL 9
IS 4
AR 045003
DI 10.1088/1748-6041/9/4/045003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AU4YS
UT WOS:000345614900003
PM 24945873
DA 2018-10-20
ER

PT J
AU Thompson, R
   Johnston, L
   Taruscio, D
   Monaco, L
   Beroud, C
   Gut, IG
   Hansson, MG
   't Hoen, PBA
   Patrinos, GP
   Dawkins, H
   Ensini, M
   Zatloukal, K
   Koubi, D
   Heslop, E
   Paschall, JE
   Posada, M
   Robinson, PN
   Bushby, K
   Lochmuller, H
AF Thompson, Rachel
   Johnston, Louise
   Taruscio, Domenica
   Monaco, Lucia
   Beroud, Christophe
   Gut, Ivo G.
   Hansson, Mats G.
   't Hoen, Peter-Bram A.
   Patrinos, George P.
   Dawkins, Hugh
   Ensini, Monica
   Zatloukal, Kurt
   Koubi, David
   Heslop, Emma
   Paschall, Justin E.
   Posada, Manuel
   Robinson, Peter N.
   Bushby, Kate
   Lochmueller, Hanns
TI RD-Connect: An Integrated Platform Connecting Databases, Registries,
   Biobanks and Clinical Bioinformatics for Rare Disease Research
SO JOURNAL OF GENERAL INTERNAL MEDICINE
LA English
DT Review
DE genetics; medical informatics; databases; clinical trials; Electronic
   health records
ID MICROATTRIBUTION; PHENOTYPE; NETWORK
AB Research into rare diseases is typically fragmented by data type and disease. Individual efforts often have poor interoperability and do not systematically connect data across clinical phenotype, genomic data, biomaterial availability, and research/trial data sets. Such data must be linked at both an individual-patient and whole-cohort level to enable researchers to gain a complete view of their disease and patient population of interest. Data access and authorization procedures are required to allow researchers in multiple institutions to securely compare results and gain new insights. Funded by the European Union's Seventh Framework Programme under the International Rare Diseases Research Consortium (IRDiRC), RD-Connect is a global infrastructure project initiated in November 2012 that links genomic data with registries, biobanks, and clinical bioinformatics tools to produce a central research resource for rare diseases.
C1 [Thompson, Rachel; Johnston, Louise; Ensini, Monica; Heslop, Emma; Bushby, Kate; Lochmueller, Hanns] Newcastle Univ, Ctr Neuromuscular Dis, MRC, Inst Med Genet, London, England.
   [Taruscio, Domenica] Ist Super Sanita, I-00161 Rome, Italy.
   [Monaco, Lucia] Fdn Telethon, Milan, Italy.
   [Beroud, Christophe] Aix Marseille Univ, INSERM, Marseille, France.
   [Gut, Ivo G.] Ctr Nacl Anal Genom, Barcelona, Spain.
   [Hansson, Mats G.] Uppsala Univ, Uppsala, Sweden.
   ['t Hoen, Peter-Bram A.] Leiden Univ, Med Ctr, Leiden, Netherlands.
   [Patrinos, George P.] Univ Patras, Patras, Greece.
   [Dawkins, Hugh] Dept Hlth Western Australia, Off Populat Hlth Genom, Perth, WA, Australia.
   [Zatloukal, Kurt] Med Univ Graz, Graz, Austria.
   [Koubi, David] Finovatis, Lyon, France.
   [Paschall, Justin E.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England.
   [Posada, Manuel] Inst Salud Carlos III, Inst Invest Enfermedades Raras, CIBERER, Madrid, Spain.
   [Robinson, Peter N.] Charite, Inst Med Genet & Human Genet, D-13353 Berlin, Germany.
RP Bushby, K (reprint author), Newcastle Univ, Ctr Neuromuscular Dis, MRC, Inst Med Genet, London, England.
EM kate.bushby@newcastle.ac.uk
RI BEROUD, Christophe/A-8381-2008; TARUSCIO, DOMENICA/A-6646-2015; Posada,
   Manuel/C-3832-2008
OI BEROUD, Christophe/0000-0003-2986-8738; TARUSCIO,
   DOMENICA/0000-0001-5403-233X; Posada, Manuel/0000-0002-8372-4180;
   Thompson, Rachel/0000-0002-6889-0121; Lochmuller,
   Hanns/0000-0003-2324-8001
FU Medical Research Council [MR/K000608/1]; National Institute for Health
   Research [NF-SI-0512-10036]
CR [Anonymous], 2013, ORPHANET REPORT SERI
   Ayme S, 2013, REPORT STATE ART RAR
   Bellgard M, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-21
   Brudno M, FIGSHARE
   Bushby K, 2009, Acta Myol, V28, P12
   Bushby K, 2009, LANCET, V374, P1849, DOI 10.1016/S0140-6736(09)61834-1
   Church DM, 2010, NAT GENET, V42, P813, DOI 10.1038/ng1010-813
   Commission E, 2013, RAR DIS EUR IS M CHA
   Crosswell LC, 2012, TRENDS BIOTECHNOL, V30, P241, DOI 10.1016/j.tibtech.2012.02.002
   Editorial, 2013, NAT BIOTECHNOL, V31, P661
   Filocamo M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-129
   Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010
   Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438
   Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970
   Giardine B, 2011, NAT GENET, V43, P295, DOI 10.1038/ng.785
   Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347
   Global Rare Diseases Patient Registry and Data Repository, CDE OV
   Groth Paul, 2010, Information Services & Use, V30, P51, DOI 10.3233/ISU-2010-0613
   Gut IG, 2013, CLIN TRANSL ONCOL, V15, P879, DOI 10.1007/s12094-013-1073-6
   Hall D, 2012, NEUROINFORMATICS, V10, P331, DOI 10.1007/s12021-012-9151-4
   Hansson MG, 2013, LANCET ONCOL, V14, P451, DOI 10.1016/S1470-2045(13)70129-3
   Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987
   Hunter AA, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-1
   Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026
   Lochmuller Hanns, 2009, Biopreserv Biobank, V7, P155, DOI 10.1089/bio.2010.7302
   Lochmuller H, 2010, ADV EXP MED BIOL, V686, P105, DOI 10.1007/978-90-481-9485-8_7
   Lopes P, 2013, J BIOMED INFORM, P21
   Lopes P, 2012, J BIOMED SEMANT, V3, DOI 10.1186/2041-1480-3-11
   McCormick J, 2010, LANCET, V375, P1007, DOI 10.1016/S0140-6736(09)62161-9
   Orth M, 2010, PLOS CURRENTS H 0928
   Patrinos GP, 2012, HUM MUTAT, V33, P1503, DOI 10.1002/humu.22144
   Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078
   Robinson P, 2013, GENOME RES
   Roos M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S10-S9
   't Hoen P.A.C., 2013, NAT BIOTECHNOL, V31, P1015, DOI DOI 10.1038/NBT.2702
   Tabrizi SJ, 2013, LANCET NEUROL, V12, P637, DOI 10.1016/S1474-4422(13)70088-7
   Tremblay JP, 2013, MOL THER, V21, P266, DOI 10.1038/mt.2013.4
   Tuffery-Giraud S, 2009, HUM MUTAT, V30, P934, DOI 10.1002/humu.20976
   Wichmann HE, 2011, NAT BIOTECHNOL, V29, P795, DOI 10.1038/nbt.1958
   Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050
NR 40
TC 60
Z9 60
U1 2
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0884-8734
EI 1525-1497
J9 J GEN INTERN MED
JI J. Gen. Intern. Med.
PD AUG
PY 2014
VL 29
SU 3
BP S780
EP S787
DI 10.1007/s11606-014-2908-8
PG 8
WC Health Care Sciences & Services; Medicine, General & Internal
SC Health Care Sciences & Services; General & Internal Medicine
GA AU1XU
UT WOS:000345411700011
PM 25029978
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Qiao, LY
   Wang, Y
   Wang, WL
   Mohedano, M
   Gong, CH
   Gao, JC
AF Qiao, Liying
   Wang, Yong
   Wang, Weilang
   Mohedano, Marta
   Gong, Caihua
   Gao, Jiacheng
TI The Preparation and Corrosion Performance of Self-Assembled Mono layers
   of Stearic Acid and MgO Layer on Pure Magnesium
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE self-assembled monolayers; magnesium and its alloys; stearic acid;
   corrosion resistance; biomaterials
ID CALCIUM-PHOSPHATE COATINGS; PASSIVE FILM BREAKDOWN; SIMULATED
   BODY-FLUID; HANKS SOLUTION; BIOMATERIAL APPLICATIONS; ALLOY AZ31;
   MONOLAYERS; SURFACE; IRON; NUCLEATION
AB Self-assembled monolayers (SAMs) of stearic acid (SA) film were developed on pure magnesium with heat-pretreatment in order to improve both the corrosion resistance and the bioactivity of pure magnesium. A new method using a high concentration of SA solution (10 i mol/L) is proposed to reduce the process time of the conventional SAMs methods. The effect of ultrasonic cleaning treatment on SAMs was investigated. Contact angle measurements were employed to evaluate the hydrophobic properties of the SAMs. The corrosion resistance and the bioactivity of the specimens were evaluated under biological conditions (simulated body fluid, 37 C) using potentiodynamic polarization method and long term immersion test. Surface morphology, composition and structure analysis of samples were characterized by the scanning electron microscope (SEM), energy dispersive X-ray spectroscopy (EDS) and attenuated total reflectance fourier transform infrared spectroscopy (ATR-FTIR) after immersion test..The results showed the corrosion resistance of pure Mg was improved by stearic acid-SAMs and the MgO layer made by heat-pretreatment, the SA_Ms made in high concentration (10-1mol/L) of stearic acid solution just for 1.5 h showed better properties than conventional SAMs. Furthermore, ultrasonic cleaning treatment led to the formation of more dense and orderly SAMs and improved the anticorrosion property of SAMs prepared in high concentration of SA solution. Moreover, SAMs-Mg had better bioactivity than untreated magnesium.
C1 [Qiao, Liying; Wang, Yong; Wang, Weilang; Gong, Caihua; Gao, Jiacheng] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400045, Peoples R China.
   [Qiao, Liying; Wang, Yong] Chongqing Univ, Natl Engn Ctr Magnesium Alloy, Chongqing 400044, Peoples R China.
   [Qiao, Liying; Mohedano, Marta] Helmholtz Zentrum Geesthacht, Inst Mat Res, D-21502 Geesthacht, Germany.
RP Qiao, LY (reprint author), Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400045, Peoples R China.
EM qiaoly@cqu.edu.cn
RI Mohedano, Marta/J-9907-2015
OI Mohedano, Marta/0000-0002-9318-3031
FU National Natural Science Foundation of China [51101174]; National Key
   Technologies RD Program [2011BAE22B04]; Natural Science Foundation of
   Chongqing Science & Technology Commission [cstc2011jjA50012]
FX This work has been supported by National Natural Science Foundation of
   China (51101174), National Key Technologies R&D Program (2011BAE22B04)
   and the Natural Science Foundation of Chongqing Science & Technology
   Commission (cstc2011jjA50012).
CR Abbona F, 1996, J CRYST GROWTH, V165, P98, DOI 10.1016/0022-0248(96)00156-X
   Al-Abdullat Y, 2001, MATER TRANS, V42, P1777, DOI 10.2320/matertrans.42.1777
   Aramaki K, 2005, CORROS SCI, V47, P1582, DOI 10.1016/j.corsci.2004.07.046
   Aramaki K, 2004, CORROS SCI, V46, P313, DOI 10.1016/S0010-938X(03)00156-2
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Barrere F, 1999, BONE, V25, p107S, DOI 10.1016/S8756-3282(99)00145-3
   Bleek K, 2013, ACTA BIOMATER, V9, P6283, DOI 10.1016/j.actbio.2012.12.027
   Chang LM, 2013, CORROS SCI, V72, P118, DOI 10.1016/j.corsci.2013.03.017
   Grubac Z, 2013, MAT SCI ENG C-MATER, V33, P2152, DOI 10.1016/j.msec.2013.01.028
   Ishizaki T, 2011, LANGMUIR, V27, P6009, DOI 10.1021/la200122x
   KIBALCZYC W, 1990, J CRYST GROWTH, V106, P355, DOI 10.1016/0022-0248(90)90080-5
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   Liu Q, 2002, BIOMATERIALS, V23, P3103, DOI 10.1016/S0142-9612(02)00050-9
   Liu XY, 2006, APPL SURF SCI, V253, P814, DOI 10.1016/j.apsusc.2006.01.038
   Ma CL, 1997, J CRYST GROWTH, V173, P141, DOI 10.1016/S0022-0248(96)00775-0
   Ng WF, 2010, SURF COAT TECH, V204, P1823, DOI 10.1016/j.surfcoat.2009.11.024
   Oosterbeek RN, 2013, SURF COAT TECH, V236, P420, DOI 10.1016/j.surfcoat.2013.10.029
   [乔丽英 Qiao Liying], 2013, [重庆大学学报. 自然科学版, Journal of Chongqing University. Natural Science Edition], V36, P74
   Qiao LY, 2012, ADV MATER RES-SWITZ, V415-417, P1279, DOI 10.4028/www.scientific.net/AMR.415-417.1279
   Salman SA, 2012, J PHYS CHEM SOLIDS, V73, P863, DOI 10.1016/j.jpcs.2012.02.018
   Shadanbaz S, 2012, ACTA BIOMATER, V8, P20, DOI 10.1016/j.actbio.2011.10.016
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sung MM, 2000, J PHYS CHEM B, V104, P1556, DOI 10.1021/jp993288r
   Szillies S, 2013, APPL SURF SCI, V283, P339, DOI 10.1016/j.apsusc.2013.06.113
   Tan X. W., 2006, SCI TECHNOLOGY REV, V24, P67
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Tao YT, 1996, J AM CHEM SOC, V118, P6724, DOI 10.1021/ja960672i
   TenHuisen KS, 1997, J BIOMED MATER RES, V36, P306, DOI 10.1002/(SICI)1097-4636(19970905)36:3<306::AID-JBM5>3.0.CO;2-I
   Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017
   Vracar LM, 2002, CORROS SCI, V44, P1669, DOI 10.1016/S0010-938X(01)00166-4
   Wang YM, 2013, SURF COAT TECH, V219, P8, DOI 10.1016/j.surfcoat.2012.12.040
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Wu DJ, 2013, SURF COAT TECH, V228, pS24, DOI 10.1016/j.surfcoat.2012.09.048
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Yue TM, 2011, MATER TRANS, V52, P810, DOI 10.2320/matertrans.M2010274
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 37
TC 5
Z9 6
U1 2
U2 39
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2014
VL 55
IS 8
BP 1337
EP 1343
DI 10.2320/matertrans.M2014117
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA AR1GK
UT WOS:000343333500042
OA Bronze
DA 2018-10-20
ER

PT J
AU Yu, YD
   Lu, XY
   Ding, F
AF Yu, Yadong
   Lu, Xiaoying
   Ding, Fei
TI The Role of Integrins in Poly(L-Lactic Acid) Aligned Nanofiber-PC12 Cell
   Interaction Revealed by mRNA-MicroRNA Profile Integrative Analysis
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Integrins; Aligned Nanofiber; PC12 Cell; mRNA-MicroRNA Expression
   Profile Integrative Analysis
ID EXPRESSION; SCAFFOLDS; TARGETS; SYSTEM
AB Understanding the roles of integrins in aligned nanofibers and neural cell interaction will facilitate the biomaterial biocompatibility research and the application of aligned nanofibers in nerve tissue engineering. In this study, we utilized pentapeptide GRGDS to hamper the functions of integrins between the interaction of poly(L-lactic acid) (PLLA) aligned nanofibers and PC12 cells, and then investigated the corresponding changes in cell morphology, mRNA and microRNA (miRNA) expression profiles. The results indicated that when treated with pentapeptide Gly-Arg-Gly-Asp-Ser (GRGDS), the morphologies and neurites outgrowth of PC12 cells on PLLA aligned nanofibers were significantly affected. Moreover, by integrating mRNA and miRNA expression profiles, we found that miRNAs such as miR-93 and miR-23a were induced to regulate target genes (e.g., E2f1 and Rras2) and thereby affect many pathways, including regulation of actin cytoskeleton pathway and MAPK pathway. These findings showed the important roles of integrins in aligned nanofiber-neural cell interaction and the close relationships between integrins and miRNAs.
C1 [Yu, Yadong; Lu, Xiaoying] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Ding, Fei] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China.
RP Lu, XY (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, 2 Sipailou, Nanjing 210096, Jiangsu, Peoples R China.
EM luxy@seu.edu.cn
FU 973 Project [2009CB930000]; National Natural Science Foundation of China
   [31170910, 31271012, 30770583]; Specialized Research Fund for the
   Doctoral Program of Higher Education of China [20100092110027]; Opening
   Fund of Jiangsu Key Laboratory of Neuroregeneration [SK2011-2]
FX This study was supported by the 973 Project (No. 2009CB930000), National
   Natural Science Foundation of China (Nos. 31170910, 31271012, 30770583),
   Specialized Research Fund for the Doctoral Program of Higher Education
   of China (No. 20100092110027) and Opening Fund of Jiangsu Key Laboratory
   of Neuroregeneration (SK2011-2). SOLiD sequencing and cDNA microarray
   experiments were carried out by KangChen Bio-tech Company (Shanghai,
   China) and Agene Bioinformative Technologies Company (Wuxi, China),
   respectively.
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Baji A, 2014, J NANOSCI NANOTECHNO, V14, P4781, DOI 10.1166/jnn.2014.8841
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Chauhan R., 2013, J BIONANOSCI, V7, P348
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098
   Jun TS, 2013, J NANOSCI NANOTECHNO, V13, P6249, DOI 10.1166/jnn.2013.7693
   Kim HW, 2008, J BIOMED MATER RES A, V87A, P25, DOI 10.1002/jbm.a.31677
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li SC, 2011, BIOMATERIALS, V32, P9021, DOI 10.1016/j.biomaterials.2011.08.033
   Lu XY, 2013, J INORG MATER, V28, P21, DOI 10.3724/SP.J.1077.2013.12269
   Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501
   Muller DW, 2008, ONCOGENE, V27, P6698, DOI 10.1038/onc.2008.282
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Nam S, 2009, NUCLEIC ACIDS RES, V37, P356
   Paitya N., 2013, J BIONANOSCI, V7, P145
   Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373
   Ramalingam M, 2013, J NANOSCI NANOTECHNO, V13, P4645, DOI 10.1166/jnn.2013.7185
   Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543
   Seo MK, 2013, J NANOSCI NANOTECHNO, V13, P7920, DOI 10.1166/jnn.2013.8126
   Shabafrooz V, 2014, J NANOSCI NANOTECHNO, V14, P522, DOI 10.1166/jnn.2014.9195
   Varma M. M., 2013, J BIONANOSCI, V7, P360
   Varma M. M., 2013, J BIONANOSCI, V7, P560
   Wu XM, 2011, ACTA PHARMACOL SIN, V32, P259, DOI 10.1038/aps.2010.204
   Xiao F, 2009, NUCL RES, V37, P105, DOI DOI 10.1093/NAR/GKN851
   Yahya A., 2013, J BIONANOSCI, V7, P210
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yu Y. D., 2014, J BIOMED NA IN PRESS, DOI [10.1166/jbn.2014.1973, DOI 10.1166/JBN.2014.1973]
   Zha RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087665
   Zhou YY, 2013, J NANOSCI NANOTECHNO, V13, P6581, DOI 10.1166/jnn.2013.7738
NR 32
TC 3
Z9 3
U1 5
U2 20
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD AUG
PY 2014
VL 6
IS 8
BP 1919
EP 1926
DI 10.1166/sam.2014.1939
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AQ0NS
UT WOS:000342480600032
DA 2018-10-20
ER

PT J
AU Sugiura, Y
   Onuma, K
   Nagao, M
   Momma, K
   Kimura, Y
   Yamazaki, A
AF Sugiura, Yuki
   Onuma, Kazuo
   Nagao, Masahiro
   Momma, Koichi
   Kimura, Yuki
   Yamazaki, Atsushi
TI Dissolution behavior of vaterite spherulite in solutions containing
   phosphate ions
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE Vaterite; Calcium carbonate; Phosphate; Spherulite; Biomaterial; Drug
   delivery systems
ID AMORPHOUS CALCIUM-CARBONATE; CLUSTERS; TRANSFORMATION; ARAGONITE; MODEL
AB Vaterite is a crystalline polymorph of calcium carbonate that exhibits low stability in comparison with the other crystalline polymorphs of calcium carbonate. It often assumes a spherical shape. The physical properties of vaterite are utilized in advanced biomaterials such as drug delivery systems (DDSs). The potential application of vaterite in DDSs demands a comprehensive understanding of its dissolution rate as a function of PO4 concentration. Using in situ optical studies, we analyzed the dissolution behavior of vaterite in a simulated PO4-containing biogenic environment. The varying physicality (i. e., the pseudo-physiological conditions) of vaterite were investigated using high-resolution cryogenic transmission electron microscopy and small-angle X-ray scattering. In addition, we measured the PO4/Ca ratio in each part of vaterite spherulites using field-emission scanning electron microscopy in conjunction with energy-dispersive X-ray spectroscopy and inductively coupled plasma atomic emission spectrometry.
   We categorized the vaterite spherulites into three parts - the shell, mantle, and core parts - on the basis of their dissolution behavior and PO4 response. The PO4 response to the dissolution dynamics increases toward the outer part, although the adsorption rate decreases in the presence of PO4 and PO4 fluorescence materials. The composition of the shell part was nearly identical to that of ideal vaterite, whereas the inner part exhibited a high C/Ca ratio and a poorly crystalline phase referred to as vaterite-like material. The dissolution rate of each part was 0.23-1.58nm/s (shell), 0.63-3.19nm/s (mantle), and 1.38-5.71 nm/s (core). The vaterite and vaterite-like materials were further identified according to their composition and particle size distribution. (C) 2014 The Ceramic Society of Japan. All rights reserved.
C1 [Sugiura, Yuki; Nagao, Masahiro; Yamazaki, Atsushi] Waseda Univ, Sch Creat Sci & Technol, Dept Environm & Resources Engn, Shinjuku Ku, Tokyo 1698555, Japan.
   [Onuma, Kazuo] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan.
   [Momma, Koichi] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050055, Japan.
   [Kimura, Yuki] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan.
RP Sugiura, Y (reprint author), Waseda Univ, Sch Creat Sci & Technol, Dept Environm & Resources Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.
EM arch.quartz@gmail.com; k.onuma@aist.go.jp
RI Sugiura, Yuki/L-6895-2018; Momma, Koichi/F-1090-2016; Kimura,
   Yuki/J-9635-2014
OI Sugiura, Yuki/0000-0003-1472-5435; Kimura, Yuki/0000-0002-9218-7663
FU Japan Society for Promotion of Science (JSPS) [25.2283]; Material
   Characterization Central Laboratory; Waseda University; Nano Processing
   Facility of the National Institute of the Advanced Industrial Science
   and Technology (AIST); Nano Technology Platform, Ministry of Education,
   Culture, Sports, Science and Technology (MEXT), Japan
FX We would like to thank Dr. Y. Sogo, Dr. M. Sorai, and Dr. A. Ito for
   assistance with the in situ optical studies. We also thank Dr. A. Oyane,
   Dr. T. Hara, and Ms. Y. Hara for assistance with the FE-SEM/EDX
   measurements and Dr. T. Nagai, Dr. T. Sakai, Ms. F. Hayashi, and Mr. T.
   Goto for TEM observations using the microtome equipment. We thank Dr. K.
   Nakamura for helpful discussions. This work was performed with a
   grant-in-aid by the Japan Society for Promotion of Science (JSPS)
   Research Fellowships for Doctoral Course Student, grant number 25.2283
   and was supported in part by the Material Characterization Central
   Laboratory, Waseda University, Nano Processing Facility of the National
   Institute of the Advanced Industrial Science and Technology (AIST), and
   by the Nano Technology Platform, Ministry of Education, Culture, Sports,
   Science and Technology (MEXT), Japan.
CR Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381
   Akiva-Tal A., 2011, P NATL ACAD SCI USA, V36, P14763
   BRECEVIC L, 1989, J CRYST GROWTH, V98, P504, DOI 10.1016/0022-0248(89)90168-1
   Demichelis R, 2013, CRYST GROWTH DES, V13, P2247, DOI 10.1021/cg4002972
   Demichelis R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1604
   Falini G, 2005, EUR J INORG CHEM, P162, DOI 10.1002/ejic.200400419
   Gebauer D, 2010, ANGEW CHEM INT EDIT, V49, P8889, DOI 10.1002/anie.201003220
   Gebauer D, 2008, SCIENCE, V322, P1819, DOI 10.1126/science.1164271
   Kabalah-Amitai L, 2013, SCIENCE, V340, P454, DOI 10.1126/science.1232139
   Kanzaki N, 2001, BIOMATERIALS, V22, P2921, DOI 10.1016/S0142-9612(01)00039-4
   Katsifaras A, 1999, J CRYST GROWTH, V204, P183, DOI 10.1016/S0022-0248(99)00174-8
   Kim S, 2013, ADV FUNCT MATER, V23, P10, DOI 10.1002/adfm.201201994
   Le Bail A, 2011, POWDER DIFFR, V26, P16, DOI 10.1154/1.3552994
   Mann S, 2001, BIOMINERALIZATION PR
   Nishikane Y, 2011, MAR MICROPALEONTOL, V78, P84, DOI 10.1016/j.marmicro.2010.10.002
   PLUMMER LN, 1982, GEOCHIM COSMOCHIM AC, V46, P1011, DOI 10.1016/0016-7037(82)90056-4
   Rodriguez-Blanco J.D., 2010, NANOSCALE, V3, P265
   Sato A, 2011, NAT CHEM BIOL, V7, P197, DOI 10.1038/NCHEMBIO.532
   Sudheesh-Kumar P. T., 2013, COLLOID SURFACE B, V106, P109
   Sugiura Y, 2013, AM MINERAL, V98, P262, DOI 10.2138/am.2013.4212
   Sunagawa I., 2005, CRYSTALS GROWTH MORP
   SUTOR DJ, 1968, SCIENCE, V159, P1113, DOI 10.1126/science.159.3819.1113
   Suzuki M, 2006, CRYST GROWTH DES, V6, P2004, DOI 10.1021/cg0602921
   WEINER S, 2003, BIOMINERALISATION, V54, P1, DOI DOI 10.2113/0540001
   Wenk H. R., 2004, MINERALS THEIR CONST
   Zhong C, 2010, CRYST GROWTH DES, V10, P5043, DOI 10.1021/cg1002644
NR 26
TC 3
Z9 3
U1 0
U2 12
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD AUG
PY 2014
VL 122
IS 1428
BP 679
EP 687
DI 10.2109/jcersj2.122.679
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA AP4RL
UT WOS:000342065900019
OA Bronze
DA 2018-10-20
ER

PT J
AU Jebahi, S
   Ben Saleh, G
   Saoudi, M
   Besaleh, S
   Oudadesse, H
   Mhadbi, M
   Rebai, T
   Keskes, H
   El Feki, A
AF Jebahi, Samira
   Ben Saleh, Ghada
   Saoudi, Mongi
   Besaleh, Salma
   Oudadesse, Hassane
   Mhadbi, Moufida
   Rebai, Tarek
   Keskes, Hassib
   El Feki, Abdelfattah
TI Genotoxicity effect, antioxidant and biomechanical correlation:
   Experimental study of agarose-chitosan bone graft substitute in New
   Zealand white rabbit model
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE Agarose-chitosan; graft biomaterial; antioxidative profile; bone
   regeneration; genotoxicity; mechanical hardness test
ID IN-VIVO; OXIDATIVE STRESS; OVARIECTOMIZED RATS; HYDROGEN-PEROXIDE;
   VITRO; MICRONUCLEUS; ASSAYS; DERIVATIVES; COMPOSITE; SYSTEM
AB Bone loss associated with skeletal trauma or metabolic diseases often requires bone grafting. In such situations, a biomaterial is necessary for migrated cells to produce new tissue. In this study, agarose-chitosan was implanted in the femoral condyle of New Zealand White rabbits that were divided into three groups: Group I was used as control; Groups II and III were used as implanted tissue with agarose-chitosan and presenting empty defects, respectively. This study evaluated the agarose-chitosan biocompatibility by determining the in vivo genotoxicity, oxidative stress balance that correlated with the hardness mechanical property. Moreover, the histopathological and quantitative elements analyzed by using inductively coupled plasma optical emission spectrometry were determined. After 30 days of implantation, the in vivo analysis of genotoxicity showed that agarose-chitosan did not induce chromosome aberration or micronucleus damage. A significant decrease in thiobarbituric and acid-reactive substance was observed after agarose-chitosan implantation in the bone tissue. Superoxide dismutase, catalase and glutathione peroxidase were significantly enhanced in agarose-chitosan-treated group compared with that of control group. A negative correlation coefficient of the mechanical property with malonyldialdehyde level was detected (R=-0.998). The histological study exhibited a significantly increased angiogenesis and newly formed tissue. No presence of inflammatory process, necrotic or fibrous tissue was detected. Major and trace elements such as Ca, P, Zn, Mg and Fe were increased significantly in the newly formed bone. These findings show that agarose-chitosan biomaterial implantation might be effective for treating trauma and bone regeneration.
C1 [Jebahi, Samira; Oudadesse, Hassane] Univ Rennes 1, UMR CNRS 6226, F-35042 Rennes, France.
   [Jebahi, Samira; Besaleh, Salma; Mhadbi, Moufida; Rebai, Tarek; Keskes, Hassib] Univ Sfax, Fac Med Sfax, Histol Orthopaed & Traumatol Lab, Sfax, Tunisia.
   [Jebahi, Samira; Saoudi, Mongi; El Feki, Abdelfattah] Univ Sfax, Fac Sci Sfax, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Ben Saleh, Ghada] Univ Sfax, Fac Med Sfax, Lab Human Mol Genet, Sfax, Tunisia.
RP Jebahi, S (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu,263 Av Gen Leclerc, F-35042 Rennes, France.
EM jbahisamira@yahoo.fr
CR Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Baek KH, 2010, CALCIFIED TISSUE INT, V87, P226, DOI 10.1007/s00223-010-9393-9
   Bhamra MS, 2006, P I MECH ENG H, V220, P379, DOI 10.1243/095441105X68971
   Boujbiha MA, 2012, BIOL TRACE ELEM RES, V148, P76, DOI 10.1007/s12011-012-9342-8
   Buege J. A., 1984, METHOD ENZYMOL, V105, P302
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Cao Z, 2009, BIOMACROMOLECULES, V10, P2954, DOI 10.1021/bm900670n
   Cervellati C, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/569563
   Chen S, 2013, CELL DEATH DIS, V11, P722
   Cvijetic S, 2011, CROAT MED J, V52, P164, DOI 10.3325/cmj.2011.52.164
   D'Souza Urban J A, 2002, Indian J Physiol Pharmacol, V46, P468
   Estai MA, 2012, AFR J PHARM PHARMACO, V6, P148, DOI 10.5897/AJPP11.416
   Graves DT, 2011, J EXP CLIN MED, V3, P3, DOI DOI 10.1016/J.JECM.2010.12.006
   HALLIWELL B, 1995, CRIT REV FOOD SCI, V35, P7, DOI 10.1080/10408399509527682
   Hassan A, 2011, SAINS MALAYS, V40, P163
   HAYASHI M, 1994, MUTAT RES, V312, P293, DOI 10.1016/0165-1161(94)90039-6
   Heddle JA, 2011, MUTAGENESIS, V26, P3, DOI 10.1093/mutage/geq085
   Jebahi S, 2014, KOREAN J CHEM ENG, V31, P1616, DOI 10.1007/s11814-014-0072-9
   Jebahi S, 2012, J APPL BIOMED, V10, P195, DOI 10.2478/v10136-012-0009-8
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Kumar Banothu Anil, 2013, J Nat Sci Biol Med, V4, P414, DOI 10.4103/0976-9668.117021
   Lian Q, 2008, P I MECH ENG H, V222, P347, DOI 10.1243/09544119JEIM340
   Ling Q, 2006, CLIN BIOMECH, V21, P387
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Morikawa D, 2013, J BONE MINER RES, V28, P2368, DOI 10.1002/jbmr.1981
   Noushad M, 2009, TOXICOL IN VITRO, V23, P1145, DOI 10.1016/j.tiv.2009.05.025
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   SHARMA P., 2012, J BOT, V2012, P26, DOI DOI 10.1155/2012/217037
   Sheweita SA, 2007, CURR DRUG METAB, V8, P519
   Shuang F, 2014, EUR REV MED PHARMACO, V18, P740
   Tanner KE, 2010, P I MECH ENG H, V224, P1359, DOI 10.1243/09544119JEIM823
   Tian F, 2003, J MATER SCI, V38, P4709, DOI 10.1023/A:1027466716950
   TOPPING RE, 1994, CLIN ORTHOP RELAT R, P220
   Valette H, 2002, NUCL MED BIOL, V29, P849, DOI 10.1016/S0969-8051(02)00331-1
   Wang GG, 2013, CROAT MED J, V54, P171, DOI 10.3325/cmj.2013.54.171
   Xie WM, 2001, BIOORG MED CHEM LETT, V11, P1699, DOI 10.1016/S0960-894X(01)00285-2
   Yan JK, 2013, MOLECULES, V18, P167, DOI 10.3390/molecules18010167
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang HW, 2003, BIOMATERIALS, V24, P2909, DOI 10.1016/S0142-9612(03)00132-7
NR 42
TC 2
Z9 2
U1 0
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD AUG
PY 2014
VL 228
IS 8
BP 800
EP 809
DI 10.1177/0954411914547247
PG 10
WC Engineering, Biomedical
SC Engineering
GA AP4PA
UT WOS:000342058800006
PM 25205747
DA 2018-10-20
ER

PT J
AU Gallo, J
   Holinka, M
   Moucha, CS
AF Gallo, Jiri
   Holinka, Martin
   Moucha, Calin S.
TI Antibacterial Surface Treatment for Orthopaedic Implants
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE orthopaedic; biomaterial-associated infection; prosthetic joint
   infection; anti-adhesive; antibacterial; surface treatment; silver;
   antibacterial proteins; smart surfaces
ID PROSTHETIC JOINT INFECTION; TOTAL HIP-ARTHROPLASTY; SURGICAL SITE
   INFECTION; STAPHYLOCOCCUS-AUREUS ADHESION; DEVICE-ASSOCIATED INFECTIONS;
   LAMINAR AIR-FLOW; ANTIMICROBIAL ACTIVITY; SILVER NANOPARTICLES;
   BACTERIAL ADHESION; IN-VITRO
AB It is expected that the projected increased usage of implantable devices in medicine will result in a natural rise in the number of infections related to these cases. Some patients are unable to autonomously prevent formation of biofilm on implant surfaces. Suppression of the local peri-implant immune response is an important contributory factor. Substantial avascular scar tissue encountered during revision joint replacement surgery places these cases at an especially high risk of periprosthetic joint infection. A critical pathogenic event in the process of biofilm formation is bacterial adhesion. Prevention of biomaterial-associated infections should be concurrently focused on at least two targets: inhibition of biofilm formation and minimizing local immune response suppression. Current knowledge of antimicrobial surface treatments suitable for prevention of prosthetic joint infection is reviewed. Several surface treatment modalities have been proposed. Minimizing bacterial adhesion, biofilm formation inhibition, and bactericidal approaches are discussed. The ultimate anti-infective surface should be "smart" and responsive to even the lowest bacterial load. While research in this field is promising, there appears to be a great discrepancy between proposed and clinically implemented strategies, and there is urgent need for translational science focusing on this topic.
C1 [Gallo, Jiri; Holinka, Martin] Palacky Univ, Univ Hosp, Fac Med & Dent, Dept Orthopaed, Olomouc 77520, Czech Republic.
   [Moucha, Calin S.] Icahn Sch Med Mt Sinai, Mt Sinai Joint Replacement Ctr, Dept Orthopaed Surg, New York, NY 10029 USA.
RP Gallo, J (reprint author), Palacky Univ, Univ Hosp, Fac Med & Dent, Dept Orthopaed, IP Pavlova 6, Olomouc 77520, Czech Republic.
EM jiri.gallo@volny.cz; MHolinka@seznam.cz; calin.moucha@mountsinai.org
OI Gallo, Jiri/0000-0002-7424-8653; Holinka, Martin/0000-0001-9180-4458
FU Czech Ministry of Health [IGA MZ CR NT/14267]
FX Funding was obtained from the Czech Ministry of Health (IGA MZ CR
   NT/14267). The authors thank to Karel Lemr and Robert Prucek from the
   Faculty of Natural Sciences Palacky University Olomouc, Regional Centre
   of Advanced Technologies and Materials Olomouc, Czech Republic for
   reading of the manuscript.
CR Aggarwal VK, 2014, J KNEE SURG, V27, P399, DOI 10.1055/s-0033-1364102
   Aggarwal VK, 2013, J ARTHROPLASTY, V28, P193, DOI [10.1016/j.arth.2013.09.028, 10.1016/j.arth.2012.06.023]
   Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a
   Alt V, 2006, BIOMATERIALS, V27, P4627, DOI 10.1016/j.biomaterials.2006.04.035
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1997, J BONE JOINT SURG BR, V79B, P816, DOI 10.1302/0301-620X.79B5.7228
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson AE, 2012, AM J INFECT CONTROL, V40, P750, DOI 10.1016/j.ajic.2011.09.015
   Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Arenas MA, 2013, COLLOID SURFACE B, V105, P106, DOI 10.1016/j.colsurfb.2012.12.051
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Banerjee M, 2010, LANGMUIR, V26, P5901, DOI 10.1021/la9038528
   Barros J, 2013, INT MICROBIOL, V16, P191, DOI 10.2436/20.1501.01.193
   Berbari EF, 2012, INFECT CONT HOSP EP, V33, P774, DOI 10.1086/666641
   Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580
   Bieser AM, 2011, MACROMOL BIOSCI, V11, P526, DOI 10.1002/mabi.201000398
   Bottcher T, 2013, J AM CHEM SOC, V135, P2927, DOI 10.1021/ja3120955
   Bondarenko O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064060
   Borovicka J, 2013, J AM CHEM SOC, V135, P5282, DOI 10.1021/ja400781f
   Bouchet AM, 2014, COLLOID SURFACE B, V114, P363, DOI 10.1016/j.colsurfb.2013.10.025
   Bozic KJ, 2014, J ARTHROPLASTY, V29, P154, DOI 10.1016/j.arth.2013.04.015
   Braem A, 2014, J BIOMED MATER RES A, V102, P215, DOI 10.1002/jbm.a.34688
   Breier AC, 2011, INFECT CONT HOSP EP, V32, P1097, DOI 10.1086/662182
   Brooks JL, 2012, ADV APPL MICROBIOL, V81, P63, DOI 10.1016/B978-0-12-394382-8.00002-2
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Campoccia D, 2006, INT J ARTIF ORGANS, V29, P622
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2012, INT J ARTIF ORGANS, V35, P800, DOI 10.5301/ijao.5000140
   Carson L, 2010, FEMS IMMUNOL MED MIC, V59, P447, DOI 10.1111/j.1574-695X.2010.00696.x
   Cataldo MA, 2010, J INFECTION, V61, P443, DOI 10.1016/j.jinf.2010.09.033
   Cats-Baril W, 2013, CLIN ORTHOP RELAT R, V471, P4065, DOI 10.1007/s11999-013-3329-4
   Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303
   Chen F, 2013, INT J MOL SCI, V14, P17477, DOI 10.3390/ijms140917477
   Chen GZ, 2011, MOL CELL, V42, P199, DOI 10.1016/j.molcel.2011.04.003
   Chen XN, 2012, EUR CELLS MATER, V24, P237, DOI 10.22203/eCM.v024a17
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Cheng H, 2014, J BIOMED MATER RES A, V102, P3488, DOI 10.1002/jbm.a.35019
   Chennell P, 2013, INT J PHARMACEUT, V455, P298, DOI 10.1016/j.ijpharm.2013.07.014
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Clyburn Terry A, 2011, Instr Course Lect, V60, P565
   Cohen HC, 2013, AM J PATHOL, V182, P2180, DOI 10.1016/j.ajpath.2013.02.022
   Corvec S, 2012, INT J ARTIF ORGANS, V35, P923, DOI 10.5301/ijao.5000168
   Costa F, 2014, ACTA BIOMATER, V10, P3513, DOI 10.1016/j.actbio.2014.02.028
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI20365
   Cristina ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052809
   Daghighi S, 2013, BIOMATERIALS, V34, P8013, DOI 10.1016/j.biomaterials.2013.07.044
   Dale H, 2009, ACTA ORTHOP, V80, P639, DOI 10.3109/17453670903506658
   Dale H, 2012, ACTA ORTHOP, V83, P449, DOI 10.3109/17453674.2012.733918
   Dale H, 2011, ACTA ORTHOP, V82, P646, DOI 10.3109/17453674.2011.636671
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Della Valle C, 2012, INT J ARTIF ORGANS, V35, P864, DOI 10.5301/ijao.5000161
   Dobson AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076521
   Dong W, 2013, J NANOSCI NANOTECHNO, V13, P6782, DOI 10.1166/jnn.2013.7757
   Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Elguindi J, 2009, J APPL MICROBIOL, V106, P1448, DOI 10.1111/j.1365-2672.2009.04148.x
   Elizabeth E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/11/115101
   Engelsman AF, 2010, BIOFOULING, V26, P761, DOI 10.1080/08927014.2010.515027
   Engesaeter LB, 2006, ACTA ORTHOP, V77, P351, DOI 10.1080/17453670610046253
   Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135
   Everhart JS, 2013, CLIN ORTHOP RELAT R, V471, P3112, DOI 10.1007/s11999-013-2923-9
   Fei J, 2011, J MATER SCI-MATER M, V22, P989, DOI 10.1007/s10856-011-4277-8
   Fielding GA, 2012, ACTA BIOMATER, V8, P3144, DOI 10.1016/j.actbio.2012.04.004
   Finke B, 2012, ADV ENG MATER, V14, pB224, DOI 10.1002/adem.201180054
   Foka A, 2012, EUR CELLS MATER, V24, P386, DOI 10.22203/eCM.v024a28
   Follmann HDM, 2012, BIOMACROMOLECULES, V13, P3711, DOI 10.1021/bm3011962
   Forbes S, 2013, BIOMATERIALS, V34, P5453, DOI 10.1016/j.biomaterials.2013.03.087
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Friedman A, 2009, EXPERT OPIN DRUG DEL, V6, P1113, DOI 10.1517/17425240903196743
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138
   Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Gastmeier P, 2012, J HOSP INFECT, V81, P73, DOI 10.1016/j.jhin.2012.04.008
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gomes J, 2013, CHIMIA, V67, P275, DOI 10.2533/chimia.2013.275
   Gomes J, 2013, CHEM COMMUN, V49, P155, DOI 10.1039/c2cc37287h
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   Grass G, 2011, APPL ENVIRON MICROB, V77, P1541, DOI 10.1128/AEM.02766-10
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Gu YX, 2014, COLLOID SURFACE B, V117, P42, DOI 10.1016/j.colsurfb.2014.01.051
   Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353
   Haenle M, 2011, J MATER SCI-MATER M, V22, P381, DOI 10.1007/s10856-010-4204-4
   Haney EF, 2013, BIOPOLYMERS, V100, P572, DOI 10.1002/bip.22250
   Hans M, 2013, LANGMUIR, V29, P16160, DOI 10.1021/la404091z
   Hardes J, 2010, J SURG ONCOL, V101, P389, DOI 10.1002/jso.21498
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/ERD.12.82, 10.1586/erd.12.82]
   Hauslich LB, 2013, CLIN ORAL IMPLAN RES, V24, P49, DOI 10.1111/j.1600-0501.2011.02364.x
   Hawn MT, 2013, JAMA SURG, V148, P649, DOI 10.1001/jamasurg.2013.134
   He T, 2010, J BIOMED MATER RES A, V95A, P454, DOI 10.1002/jbm.a.32872
   Hensler D, 2013, J BONE JOINT SURG AM, V95A, P2029, DOI 10.2106/JBJS.L.01315
   Hester R A, 1992, J Arthroplasty, V7, P267, DOI 10.1016/0883-5403(92)90047-T
   HEY JD, 1983, J HEALTH ECON, V2, P119, DOI 10.1016/0167-6296(83)90002-4
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Ho KKK, 2014, BIOMATERIALS, V35, P2336, DOI 10.1016/j.biomaterials.2013.11.072
   Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406
   Hoene A, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035009
   Holinka J, 2013, BONE JOINT J, V95B, P678, DOI 10.1302/0301-620X.95B5.31216
   Holmberg KV, 2013, ACTA BIOMATER, V9, P8224, DOI 10.1016/j.actbio.2013.06.017
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Humphreys H, 2012, J HOSP INFECT, V81, P71, DOI 10.1016/j.jhin.2012.03.007
   Hussmann B, 2013, BIOMED RES INT, DOI 10.1155/2013/763096
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jamsen Esa, 2012, J Bone Joint Surg Am, V94, pe101, DOI 10.2106/JBJS.J.01935
   Jan T, 2013, INT J NANOMED, V8, P3679, DOI 10.2147/IJN.S45439
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jennison T, 2014, ACTA BIOMATER, V10, P595, DOI 10.1016/j.actbio.2013.09.019
   Kakinuma H, 2015, J BIOMED MATER RES A, V103, P57, DOI 10.1002/jbm.a.35157
   Kause Antti, 2012, Frontiers in Genetics, V3, P262, DOI 10.3389/fgene.2012.00262
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V31, P9519, DOI 10.1016/j.biomaterials.2010.08.035
   Kiran MD, 2008, INT J ARTIF ORGANS, V31, P761
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Kose N, 2013, CLIN ORTHOP RELAT R, V471, P2532, DOI 10.1007/s11999-013-2894-x
   Koseki H, 2013, INT J NANOMED, V8, P593, DOI 10.2147/IJN.S39201
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Lan MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075364
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI [10.2217/FMB.13.7, 10.2217/fmb.13.7]
   Lee FP, 2013, BIOFOULING, V29, P295, DOI 10.1080/08927014.2013.769967
   Leisner M, 2009, BIOPHYS J, V96, P1178, DOI 10.1016/j.bpj.2008.10.034
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Li BY, 2011, CLIN ORTHOP RELAT R, V469, P3262, DOI 10.1007/s11999-010-1690-0
   Li BY, 2009, BIOMATERIALS, V30, P2552, DOI 10.1016/j.biomaterials.2009.01.042
   Lischer S, 2011, J R SOC INTERFACE, V8, P1019, DOI 10.1098/rsif.2010.0596
   Liu Y, 2012, BIOMATERIALS, V33, P8745, DOI 10.1016/j.biomaterials.2012.08.010
   Lopez-Leban F, 2010, INT J ARTIF ORGANS, V33, P582
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Ludecke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084837
   Lui LT, 2013, NAT CHEM, V5, P1058, DOI [10.1038/NCHEM.1793, 10.1038/nchem.1793]
   MacCallum JL, 2011, TRENDS BIOCHEM SCI, V36, P653, DOI 10.1016/j.tibs.2011.08.003
   Malik MHA, 2007, J ARTHROPLASTY, V22, P265, DOI 10.1016/j.arth.2006.02.163
   Markova Z, 2012, GREEN CHEM, V14, P2550, DOI 10.1039/c2gc35545k
   Martinez-Gutierrez F, 2013, BIOFOULING, V29, P651, DOI 10.1080/08927014.2013.794225
   Martynkova GS, 2014, J NANOSCI NANOTECHNO, V14, P673, DOI 10.1166/jnn.2014.8903
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Mastronardi E, 2014, SENSORS-BASEL, V14, P3156, DOI 10.3390/s140203156
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005
   Merollini KMD, 2013, AM J INFECT CONTROL, V41, P221, DOI 10.1016/j.ajic.2012.03.027
   Mijnendonckx K, 2013, BIOMETALS, V26, P609, DOI 10.1007/s10534-013-9645-z
   Min J, 2014, BIOMATERIALS, V35, P2507, DOI 10.1016/j.biomaterials.2013.12.009
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244
   Montanaro L, 2008, INT J ARTIF ORGANS, V31, P771
   Moseke C, 2011, J MATER SCI-MATER M, V22, P2711, DOI 10.1007/s10856-011-4457-6
   Muszanska AK, 2014, BIOMACROMOLECULES, V15, P2019, DOI 10.1021/bm500168s
   Nair LS, 2008, J BONE JOINT SURG AM, V90A, P128, DOI 10.2106/JBJS.G.01520
   Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211
   Navratilova Z, 2012, TISSUE ANTIGENS, V80, P444, DOI 10.1111/tan.12001
   Neoh KG, 2011, ACS APPL MATER INTER, V3, P2808, DOI 10.1021/am200646t
   Neut D, 2012, J BIOMED MATER RES A, V100A, P3220, DOI 10.1002/jbm.a.34258
   Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009
   Noda I, 2009, J BIOMED MATER RES B, V89B, P456, DOI 10.1002/jbm.b.31235
   Norman TM, 2013, NATURE, V503, P481, DOI 10.1038/nature12804
   Norowski PA, 2011, IMPLANT DENT, V20, P56, DOI 10.1097/ID.0b013e3182087ac4
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Panacek A, 2013, COLLOID SURFACE B, V110, P191, DOI 10.1016/j.colsurfb.2013.04.031
   Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065
   Pandit V, 2013, TISSUE ENG PT A, V19, P2452, DOI [10.1089/ten.tea.2012.0644, 10.1089/ten.TEA.2012.0644]
   Parvizi J, 2007, EXPERT REV MED DEVIC, V4, P55, DOI 10.1586/17434440.4.1.55
   Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011
   Peng ZX, 2011, ANTIMICROB AGENTS CH, V55, P860, DOI 10.1128/AAC.01005-10
   Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Pishbin F, 2014, ACS APPL MATER INTER, V6, P8796, DOI 10.1021/am5014166
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020
   Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039
   Pruzansky JS, 2014, J ARTHROPLASTY, V29, P272, DOI 10.1016/j.arth.2013.06.019
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Rapsch K, 2014, BIOCONJUGATE CHEM, V25, P308, DOI 10.1021/bc4004469
   Rasouli MR, 2013, CLIN ORTHOP RELAT R, V471, P3102, DOI 10.1007/s11999-013-2949-z
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P259
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P588
   Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367
   Ribeiro Marta, 2012, Biomatter, V2, P176, DOI 10.4161/biom.22905
   Rizzello L, 2014, CHEM SOC REV, V43, P1501, DOI 10.1039/c3cs60218d
   Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodriguez-Valencia C, 2013, J BIOMED MATER RES A, V101, P853, DOI 10.1002/jbm.a.34387
   Rojo L, 2008, BIOMACROMOLECULES, V9, P2530, DOI 10.1021/bm800570u
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Schneider GF, 2008, NANO LETT, V8, P3598, DOI 10.1021/nl801511w
   Seil JT, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/49/495101
   Shchukin D, 2013, SCIENCE, V341, P1458, DOI 10.1126/science.1242895
   Shchukin DG, 2007, SMALL, V3, P926, DOI 10.1002/smll.200700064
   Shi XW, 2013, J BIOMED MATER RES A, V101, P1373, DOI 10.1002/jbm.a.34432
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Shida T, 2013, INT J NANOMED, V8, P3955, DOI 10.2147/IJN.S51994
   Shirwaiker RA, 2013, WIRES NANOMED NANOBI, V5, P191, DOI 10.1002/wnan.1201
   Shtansky DV, 2006, BIOMATERIALS, V27, P3519, DOI 10.1016/j.biomaterials.2006.02.012
   Siddiq DM, 2012, NAT REV UROL, V9, P305, DOI 10.1038/nrurol.2012.68
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Song C, 2014, J COLLOID INTERF SCI, V427, P2, DOI 10.1016/j.jcis.2013.10.067
   Song J, 2014, ADV COLLOID INTERFAC, V203, P37, DOI 10.1016/j.cis.2013.11.007
   Stahelova A, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-25
   Stallard CP, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0031-0
   Stoodley P., 2013, BIOMATERIALS SCI INT, P565
   Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tan HL, 2012, BIOMATERIALS, V33, P365, DOI 10.1016/j.biomaterials.2011.09.084
   Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021
   Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Tran PA, 2010, J BIOMED MATER RES A, V93A, P1417, DOI 10.1002/jbm.a.32631
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Tsaras G, 2012, INFECT CONT HOSP EP, V33, P1207, DOI 10.1086/668421
   Uhm SH, 2014, J BIOMED MATER RES B, V102, P592, DOI 10.1002/jbm.b.33038
   Vadillo-Rodriguez V, 2013, J BIOMED MATER RES A, V101, P1397, DOI 10.1002/jbm.a.34447
   van de Vosse E, 2009, LANCET INFECT DIS, V9, P688, DOI 10.1016/S1473-3099(09)70255-5
   Vargas-Reus MA, 2012, INT J ANTIMICROB AG, V40, P135, DOI 10.1016/j.ijantimicag.2012.04.012
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Vishwakarma V, 2009, BIOFOULING, V25, P705, DOI 10.1080/08927010903132183
   Wagner C, 2011, INT J ARTIF ORGANS, V34, P811, DOI 10.5301/ijao.5000061
   Walter MS, 2014, DENT MATER, V30, P200, DOI 10.1016/j.dental.2013.11.006
   Wang HR, 2013, ACS APPL MATER INTER, V5, P11014, DOI 10.1021/am403250t
   Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082745
   Wang JP, 2011, ACS APPL MATER INTER, V3, P67, DOI 10.1021/am100862h
   Wang Q, 2012, J BIOMED MATER RES A, V100A, P3205, DOI 10.1002/jbm.a.34262
   Wang Y, 2012, BIOFOULING, V28, P1011, DOI 10.1080/08927014.2012.725471
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xia W, 2012, J BIOMED MATER RES B, V100B, P82, DOI 10.1002/jbm.b.31925
   Yang CC, 2013, MAT SCI ENG C-MATER, V33, P2203, DOI 10.1016/j.msec.2013.01.038
   Yeo IS, 2012, INT J ARTIF ORGANS, V35, P762, DOI 10.5301/ijao.5000154
   Yilmaz C, 2013, J BONE JOINT SURG AM, V95A, P117, DOI 10.2106/JBJS.K.01135
   Yount NY, 2012, ANNU REV PHARMACOL, V52, P337, DOI 10.1146/annurev-pharmtox-010611-134535
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Yue CX, 2014, BIOMATERIALS, V35, P2580, DOI 10.1016/j.biomaterials.2013.12.036
   Zaborowska M, 2015, J BIOMED MATER RES B, V103, P179, DOI 10.1002/jbm.b.33179
   Zan XJ, 2010, BIOMACROMOLECULES, V11, P1082, DOI 10.1021/bm100048q
   Zhang SY, 2013, CURR OPIN IMMUNOL, V25, P19, DOI 10.1016/j.coi.2012.11.001
   Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010
   Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhao XL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02238
   Zheng D, 2013, J COLLOID INTERF SCI, V406, P238, DOI 10.1016/j.jcis.2013.05.060
   Zhou B, 2014, COLLOID SURFACE B, V116, P432, DOI 10.1016/j.colsurfb.2014.01.016
   Zhu H, 2014, CHEM COMMUN, V50, P3900, DOI 10.1039/c3cc47818a
   Zhuang JM, 2013, CHEM SOC REV, V42, P7421, DOI 10.1039/c3cs60094g
   Ziakas PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081047
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
   Zmistowski B, 2013, J BONE JOINT SURG AM, V95A, P2177, DOI 10.2106/JBJS.L.00789
NR 261
TC 95
Z9 96
U1 6
U2 128
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD AUG
PY 2014
VL 15
IS 8
BP 13849
EP 13880
DI 10.3390/ijms150813849
PG 32
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA AO7GD
UT WOS:000341519600045
PM 25116685
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Omer, M
   Islam, MT
   Khan, M
   Kim, YK
   Lee, JH
   Kang, IK
   Park, SY
AF Omer, Muhammad
   Islam, Mohammad Tariqul
   Khan, Mashooq
   Kim, Young Kyoo
   Lee, Joon Hyung
   Kang, Inn-Kyu
   Park, Soo-Young
TI Liquid crystal-based biosensors using a strong
   polyelectrolyte-containing block copolymer,
   poly(4-cyanobiphenyl-4'-oxyundecylacrylate)-b-poly(sodium styrene
   sulfonate)
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE strong anionic polyelectrolyte; poly(4-cyanobiphenyl-4
   '-oxyundecylacrylate)-b-poly(sodium styrene sulfonate); monolayer;
   protein; reversible addition-fragmentation polymerization; biosensor
ID PH-SENSITIVE MEMBRANES; PROTEIN ADSORPTION; INTERFACES; POLYMER;
   MULTILAYERS
AB The interface between a nematic liquid crystal phase, 4-cyano-4'-pentylbiphenyl (5CB) and water was examined for protein detection by monitoring the formation of a complex between sodium polystyrene sulfonate (PSSNa) and a positively charged biological species on the 5CB in a transmission electron microscopy (TEM) grid cell coated with a strong anionic polyelectrolyte-containing block copolymer, LCP-b-PSSNa (LCP:poly(4-cyanobiphenyl-4'-oxyundecylacrylate)). This block copolymer was successfully synthesized by reversible addition-fragmentation chain transfer polymerization. A monolayer of LCP-b-PSSNa in a Langmuir Blodgett trough (in which PSSNa and LCP were located in and above water, respectively, in the TEM grid cell) was transferred to the 5CB/water interface in the 5CB-filled TEM grid that was already placed on octadecyltrichlorosilane-coated glass. Model proteins such as bovine serum albumin (BSA), hemoglobin (Hb), alpha chymotrypsinogen-A (ChTg), and lysozyme (LYZ) having different isoelectric points (pIs) were tested for non-specific protein detection. When the protein solutions were injected into the TEM grid cell, the initial homeotropic orientation of 5CB in the TEM grid cell changed to a planar one below the pIs of the proteins due to electrostatic interactions between PSSNa (- charge) and the proteins (+ charge); this did not occur above the pIs of the tested proteins. The minimum concentrations at which the homeotropic to planar configurational changes (H-P changes) occurred were 0.02, 0.04, 0.04, and 0.08 wt% for BSA, Hb, ChTg, and LYZ, respectively. Therefore, the positively charged biomaterials were visually detected at the PSSNa-coated LC/water interface during an H-P change by using polarized optical microscopy under crossed polarizers. This simple set-up for non-specific biomaterial detection paves a way for the development of efficient and excellent quality biosensors.
C1 [Omer, Muhammad; Islam, Mohammad Tariqul; Khan, Mashooq; Kim, Young Kyoo; Kang, Inn-Kyu; Park, Soo-Young] Kyungpook Natl Univ, Sch Appl Chem Engn, Taegu 702701, South Korea.
   [Lee, Joon Hyung] Kyungpook Natl Univ, Sch Adv Mat Engn, Taegu 702701, South Korea.
RP Park, SY (reprint author), Kyungpook Natl Univ, Sch Appl Chem Engn, Taegu 702701, South Korea.
EM psy@knu.ac.kr
RI Khan, Mashooq/F-2600-2018; park, soo-young/N-3170-2017
OI Khan, Mashooq/0000-0003-1387-0008; park, soo-young/0000-0001-6796-4929;
   Lee, Joon-Hyung/0000-0001-5597-4521
FU National Research Foundation of Korea [NRF-2011-0020264]
FX This work was supported by the National Research Foundation of Korea
   (NRF-2011-0020264).
CR [Anonymous], 2008, ADV MATER, V195, P20, DOI DOI 10.1002/ADMA.200890067
   BELANGER DR, 1992, ANN EMERG MED, V21, P1312, DOI 10.1016/S0196-0644(05)81893-1
   Bi XY, 2008, SENSOR ACTUAT B-CHEM, V134, P432, DOI 10.1016/j.snb.2008.05.030
   Bi XY, 2007, SENSOR ACTUAT B-CHEM, V127, P406, DOI 10.1016/j.snb.2007.04.040
   Cho EC, 2004, POLYMER, V45, P3195, DOI 10.1016/j.polymer.2004.02.052
   DUBOIS JC, 1986, MOL CRYST LIQ CRYST, V137, P349, DOI 10.1080/00268948608070932
   GUDEMAN LF, 1995, J MEMBRANE SCI, V107, P239, DOI 10.1016/0376-7388(95)00120-7
   Hester JF, 2002, J MEMBRANE SCI, V208, P375, DOI 10.1016/S0376-7388(02)00317-4
   Huang R, 2009, J MEMBRANE SCI, V336, P42, DOI 10.1016/j.memsci.2009.03.002
   Khan W, 2012, LAB CHIP, V12, P4553, DOI 10.1039/c2lc40710h
   Khan W, 2011, SOFT MATTER, V7, P780, DOI 10.1039/c0sm00758g
   Kinsinger MI, 2010, J COLLOID INTERF SCI, V341, P124, DOI 10.1016/j.jcis.2009.09.026
   Lee DY, 2010, SOFT MATTER, V6, P1964, DOI 10.1039/b926461b
   Lockwood NA, 2005, CURR OPIN COLLOID IN, V10, P111, DOI 10.1016/j.cocis.2005.06.002
   Orlov M, 2007, MACROMOLECULES, V40, P2086, DOI 10.1021/ma062821f
   Perrier S, 2004, MACROMOLECULES, V37, P2709, DOI 10.1021/ma035468b
   Salloum DS, 2004, BIOMACROMOLECULES, V5, P1089, DOI 10.1021/bm034522t
   Seo JM, 2012, SOFT MATTER, V8, P198, DOI 10.1039/c1sm06616a
   Shi Q, 2008, J MEMBRANE SCI, V319, P271, DOI 10.1016/j.memsci.2008.03.047
   Tsuboi A, 1996, LANGMUIR, V12, P6295, DOI 10.1021/la960653m
   Wandera D, 2010, J MEMBRANE SCI, V357, P6, DOI 10.1016/j.memsci.2010.03.046
   Wei Q, 2009, J MEMBRANE SCI, V337, P266, DOI 10.1016/j.memsci.2009.03.055
   Winterbottom DA, 2003, SENSOR ACTUAT B-CHEM, V90, P52, DOI 10.1016/S0925-4005(03)00021-2
   Wong SY, 2012, BIOMACROMOLECULES, V13, P719, DOI 10.1021/bm201637e
   Yang J. Y., 1994, MICROCHEMISTRY SPECT
   Ying L, 2002, MACROMOLECULES, V35, P673, DOI 10.1021/ma0112568
NR 26
TC 10
Z9 10
U1 1
U2 30
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD AUG
PY 2014
VL 22
IS 8
BP 888
EP 894
DI 10.1007/s13233-014-2112-z
PG 7
WC Polymer Science
SC Polymer Science
GA AO6VB
UT WOS:000341488800015
DA 2018-10-20
ER

PT J
AU Barbosa, AA
   Ferraz, AD
   Dantas, AC
   Olivier, NC
AF Barbosa, Amanda Alves
   Ferraz, Andrea de Vasconcelos
   Dantas, Alan Christie
   Olivier, Nelson Cardenas
TI The Production of Hydroxyapatite Prototypes from Solid Bodies of
   Gypsum/Polyvinyl Alcohol Composites
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE hydroxyapatite; gypsum; PVA; prototypes
AB Prototypes of porous hydroxyapatite (HAp) were produced from Gypsum/PVA composite, using a mass proportion of 15% polymer. The material was obtained by means of chemical conversion in (NH4)(2)HPO4 0.5 mol.L-1 solution and NH4OH 6.0 mol.L-1 alkaline medium for pH control, maintained between 6.0 and 9.0. The reaction occurred at a temperature of 100 degrees C at different test times. The obtained HAp was characterized by several techniques, such as FTIR, which identified the SO42- groups characteristic for the Gypsum block, and the PO43- groups that are attributed to the biomaterial HAp, besides XRD and SEM, which made it possible to confirm a successful conversion of the material. Tests for mechanical resistance to compression (sigma(c)) were carried out for both materials as well.
C1 [Barbosa, Amanda Alves; Ferraz, Andrea de Vasconcelos; Dantas, Alan Christie; Olivier, Nelson Cardenas] Univ Fed Vale Sao Francisco UNIVASF, BR-48902300 Juazeiro, BA, Brazil.
RP Barbosa, AA (reprint author), Univ Fed Vale Sao Francisco UNIVASF, Av Antonio Carlos Magalhaes 510, BR-48902300 Juazeiro, BA, Brazil.
EM andrea.ferraz@univasf.edu.br
FU Gesso Mineral Industry; FACEPE; CAPES
FX The authors gratefully acknowledge the Gesso Mineral Industry, FACEPE
   and CAPES.
CR Akiyoshi MM, 2001, CERAMICA, V47, P301
   Aldrich Chemistry, 2009, MANUAL PRODUTOS QUIM
   Andrade MC, 1999, J BIOMED MATER RES, V46, P441
   Aranha I., 2001, POLIMEROS, V11, P174, DOI DOI 10.1590/S0104-14282001000400007
   Canut MMC., 2006, THESIS U FEDERAL MIN
   Fernandes DM, 2005, THESIS U ESTADUAL MA
   Fernandes F., 2010, AGROMINERAIS BRASIL
   Harada E, 2009, AN 14 ENC IN CIENT P
   Hench LL, 1999, INTRO BIOCERAMICS AD
   Iglesia A. L., 2009, ESTUDOS GEOLOGICOS, V65, P109, DOI DOI 10.3989/EGE0L.39849.060
   Kanno WM, 2009, THESIS U SAO PAULO S
   Maia M, 2010, REV BRASILEIRA CIRUR, V25, P566
   Ravaglioli A., 1992, BIOCERAMICS MAT PROP
   Resende CX, 2007, THESIS U FEDERAL RIO
   Rigo E. C. S., 2007, REV DENT PRESS PERIO, V1, P39
   Santos RD, 2008, THESIS U FEDERAL RIO
   Trommer RM, 2006, AN 17 C BRAS ENG CIE
NR 17
TC 1
Z9 1
U1 0
U2 4
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD AUG
PY 2014
VL 17
SU 1
BP 39
EP 44
DI 10.1590/S1516-14392014005000062
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA AO7XK
UT WOS:000341565800008
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Pavlukhina, S
   Zhuk, I
   Mentbayeva, A
   Rautenberg, E
   Chang, W
   Yu, XJ
   van de Belt-Gritter, B
   Busscher, HJ
   van der Mei, HC
   Sukhishvili, SA
AF Pavlukhina, Svetlana
   Zhuk, Iryna
   Mentbayeva, Almagul
   Rautenberg, Emily
   Chang, Wei
   Yu, Xiaojun
   van de Belt-Gritter, Betsy
   Busscher, Henk J.
   van der Mei, Henny C.
   Sukhishvili, Svetlana A.
TI Small-molecule-hosting nanocomposite films with multiple
   bacteria-triggered responses
SO NPG ASIA MATERIALS
LA English
DT Article
ID BY-LAYER FILMS; CONTROLLED-RELEASE; POLYELECTROLYTE MULTILAYERS; POLYMER
   NANOCOMPOSITES; CELL-ADHESION; CLAY; COATINGS; MONTMORILLONITE;
   INFECTION; SURFACES
AB We report pH/bacteria-responsive nanocomposite coatings with multiple mechanisms of antibacterial protection that include the permanent retention of antimicrobials, bacteria-triggered release of antibiotics and bacteria-induced film swelling. A novel small-molecule-hosting film was constructed using layer-by-layer deposition of montmorillonite (MMT) clay nanoplatelets and polyacrylic acid (PAA) components, both of which carry a negative charge at neutral pH. The films were highly swollen in water, and they exhibited major changes in swelling as a function of pH. Under physiologic conditions (pH 7.5, 0.2 M NaCl), hydrogel-like MMT/PAA films took up and sequestered similar to 45% of the dry film matrix mass of the antibiotic gentamicin, causing dramatic film deswelling. Gentamicin remained sequestrated within the films for months under physiologic conditions and therefore did not contribute to the development of antibiotic resistance. When challenged with bacteria (Staphylococcus aureus, Staphylococcus epidermidis or Escherichia coli), the coatings released PAA-bound gentamicin because of bacteria-induced acidification of the immediate environment, whereas gentamicin adsorbed to MMT nanoplatelets remained bound within the coating, affording sustained antibacterial protection. Moreover, an increase in film swelling after gentamicin release further hindered bacterial adhesion. These multiple bacteria-triggered responses, together with nontoxicity to tissue cells, make these coatings promising candidates for protecting biomaterial implants and devices against bacterial colonization.
C1 [Pavlukhina, Svetlana; Zhuk, Iryna; Chang, Wei; Yu, Xiaojun; Sukhishvili, Svetlana A.] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.
   [Mentbayeva, Almagul] Nazarbayev Univ, Sch Engn, Astana, Kazakhstan.
   [Rautenberg, Emily] Stevens Inst Technol, Dept Comp Sci, Hoboken, NJ 07030 USA.
   [Rautenberg, Emily] Stevens Inst Technol, Dept Visual Arts & Technol, Hoboken, NJ 07030 USA.
   [van de Belt-Gritter, Betsy; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Groningen, Netherlands.
   [van de Belt-Gritter, Betsy; Busscher, Henk J.; van der Mei, Henny C.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP Sukhishvili, SA (reprint author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, 507 River St, Hoboken, NJ 07030 USA.
EM ssukhish@stevens.edu
CR ANDERSEN KB, 1980, J BACTERIOL, V144, P114
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Busscher HJ, 2006, CLIN MICROBIOL REV, V19, P127, DOI 10.1128/CMR.19.1.127-141.2006
   Cado G, 2013, ADV FUNCT MATER, V23, P4801, DOI 10.1002/adfm.201300416
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chaturbedy P, 2010, ACS NANO, V4, P5921, DOI 10.1021/nn100700b
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Essington ME, 2010, SOIL SCI SOC AM J, V74, P1577, DOI 10.2136/sssaj2009.0283
   Glinel K, 2002, J PHYS CHEM B, V106, P11246, DOI 10.1021/jp026327z
   Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   Hendricks SK, 2000, J BIOMED MATER RES, V50, P160, DOI 10.1002/(SICI)1097-4636(200005)50:2<160::AID-JBM10>3.0.CO;2-M
   Jain A, 2007, CRIT REV THER DRUG, V24, P393, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i5.10
   Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P386, DOI 10.1017/CBO9780511790461.012
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Li YC, 2010, ACS NANO, V4, P3325, DOI 10.1021/nn100467e
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lutkenhaus JL, 2007, LANGMUIR, V23, P8515, DOI 10.1021/la700432p
   Lvov Y, 1996, LANGMUIR, V12, P3038, DOI 10.1021/la951002d
   Meng N, 2009, INT J PHARMACEUT, V382, P45, DOI 10.1016/j.ijpharm.2009.08.004
   Moskowitz JS, 2010, BIOMATERIALS, V31, P6019, DOI 10.1016/j.biomaterials.2010.04.011
   Nepal D, 2008, NANO LETT, V8, P1896, DOI 10.1021/nl080522t
   Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Podsiadlo P, 2009, ANGEW CHEM INT EDIT, V48, P7073, DOI 10.1002/anie.200901720
   Podsiadlo P, 2007, SCIENCE, V318, P80, DOI 10.1126/science.1143176
   Priolo MA, 2010, NANO LETT, V10, P4970, DOI 10.1021/nl103047k
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Schaer TP, 2012, BIOMATERIALS, V33, P1245, DOI 10.1016/j.biomaterials.2011.10.038
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   SMITH SM, 1991, ANTIMICROB AGENTS CH, V35, P237, DOI 10.1128/AAC.35.2.237
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Tran NH, 2005, J COLLOID INTERF SCI, V290, P392, DOI 10.1016/j.jcis.2005.05.069
   Vaia RA, 2001, MRS BULL, V26, P394, DOI 10.1557/mrs2001.93
   Wang Y, 2012, BIOFILMS BIOENGINEER
   Wong SY, 2010, J AM CHEM SOC, V132, P17840, DOI 10.1021/ja106288c
   Zhuk A, 2011, ACS NANO, V5, P8790, DOI 10.1021/nn202812a
   Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q
NR 40
TC 16
Z9 16
U1 2
U2 57
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1884-4049
EI 1884-4057
J9 NPG ASIA MATER
JI NPG Asia Mater.
PD AUG
PY 2014
VL 6
AR e121
DI 10.1038/am.2014.63
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA AO8SE
UT WOS:000341623700005
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Saxena, S
   Hansen, CE
   Lyon, LA
AF Saxena, Shalini
   Hansen, Caroline E.
   Lyon, L. Andrew
TI Microgel Mechanics in Biomaterial Design
SO ACCOUNTS OF CHEMICAL RESEARCH
LA English
DT Review
ID CORE-SHELL MICROGELS; DRUG-DELIVERY; CELL-CULTURE; TEMPERATURE;
   PARTICLES; TISSUE; BIOCOMPATIBILITY; TRANSLOCATION; HYDROGELS; ADHESION
AB CONSPECTUS: The field of polymeric biomaterials has received much attention in recent years due to its potential for enhancing the biocompatibility of systems and devices applied to drug delivery and tissue engineering. Such applications continually push the definition of biocompatibility from relatively straightforward issues such as cytotoxicity to significantly more complex processes such as reducing foreign body responses or even promoting/recapitulating natural body functions. Hydrogels and their colloidal analogues, microgels, have been and continue to be heavily investigated as viable materials for biological applications because they offer numerous, facile avenues in tailoring chemical and physical properties to approach biologically harmonious integration. Mechanical properties in particular are recently coming into focus as an important manner in which biological responses can be altered.
   In this Account, we trace how mechanical properties of microgels have moved into the spotlight of research efforts with the realization of their potential impact in biologically integrative systems. We discuss early experiments in our lab and in others focused on synthetic modulation of particle structure at a rudimentary level for fundamental drug delivery studies. These experiments elucidated that microgel mechanics are a consequence of polymer network distribution, which can be controlled by chemical composition or particle architecture. The degree of deformability designed into the microgel allows for a defined response to an imposed external force. We have studied deformation in packed colloidal phases and in translocation events through confined pores; in all circumstances, microgels exhibit impressive deformability in response to their environmental constraints.
   Microgels further translate their mechanical properties when assembled in films to the properties of the bulk material. In particular, microgel films have been a large focus in our lab as building blocks for self-healing materials. We have shown that their ability to heal after damage arises from polymer mobility during hydration. Furthermore, we have shown film mobility dictates cell adhesion and spreading in a manner that is fundamentally different from previous work on mechanotransduction. In total, we hope that this Account presents a broad introduction to microgel research that intersects polymer chemistry, physics, and regenerative medicine. We expect that research intersection will continue to expand as we fill the knowledge gaps associated with soft materials in biological milieu.
C1 [Saxena, Shalini] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA.
   [Saxena, Shalini; Hansen, Caroline E.; Lyon, L. Andrew] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Hansen, Caroline E.; Lyon, L. Andrew] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Lyon, LA (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM lyon@gatech.edu
RI Lyon, Andrew/A-4082-2009
OI Lyon, Andrew/0000-0001-7828-7345
FU NSF [0965945]; NIH [R01GM088291]; Georgia Tech and the GT/Emory/CHOA
   Center for Pediatric Nanomedicine
FX Funding for S.S. was provided by the NSF Integrative Graduate Education
   and Research Traineeship program in Stem Cell Biomanufacturing (0965945)
   and the NIH (R01GM088291). Additional funding from Georgia Tech and the
   GT/Emory/CHOA Center for Pediatric Nanomedicine is gratefully
   acknowledged.
CR Bae KH, 2013, J MATER CHEM B, V1, P5371, DOI 10.1039/c3tb20940g
   Banquy X, 2009, SOFT MATTER, V5, P3984, DOI 10.1039/b821583a
   Berndt I, 2003, MACROMOLECULES, V36, P8780, DOI 10.1021/ma034771+
   Berndt I, 2006, ANGEW CHEM INT EDIT, V45, P1081, DOI 10.1002/anie.200502893
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Champion JA, 2007, J CONTROL RELEASE, V121, P3, DOI 10.1016/j.jconrel.2007.03.022
   Dai ZJ, 2013, J POLYM SCI POL CHEM, V51, P2995, DOI 10.1002/pola.26698
   Deen WM, 2001, AM J PHYSIOL-RENAL, V281, pF579
   Deshayes S, 2013, J POLYM SCI POL CHEM, V51, P3531, DOI 10.1002/pola.26765
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Drummond DC, 1999, PHARMACOL REV, V51, P691
   Galperin A, 2010, BIOMACROMOLECULES, V11, P2583, DOI 10.1021/bm100521x
   Gao J, 2003, LANGMUIR, V19, P5212, DOI 10.1021/la0269762
   Gaulding JC, 2013, POLYM CHEM-UK, V4, P4890, DOI 10.1039/c3py00173c
   Gaulding JC, 2013, COLLOID POLYM SCI, V291, P99, DOI 10.1007/s00396-012-2692-0
   Hendrickson GR, 2010, ADV FUNCT MATER, V20, P1697, DOI 10.1002/adfm.200902429
   Hendrickson GR, 2010, ANGEW CHEM INT EDIT, V49, P2193, DOI 10.1002/anie.200906606
   Holden DA, 2011, SOFT MATTER, V7, P8035, DOI 10.1039/c1sm05680h
   Iyer AS, 2009, ANGEW CHEM INT EDIT, V48, P4562, DOI 10.1002/anie.200901670
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Jones CD, 2000, MACROMOLECULES, V33, P8301, DOI 10.1021/ma001398m
   Jones CD, 2003, MACROMOLECULES, V36, P1988, DOI 10.1021/ma021079q
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Lau C, 2009, AM J PHYSIOL-REG I, V296, pR1761, DOI 10.1152/ajpregu.90731.2008
   Merkel TJ, 2011, P NATL ACAD SCI USA, V108, P586, DOI 10.1073/pnas.1010013108
   Milani AH, 2012, BIOMACROMOLECULES, V13, P2793, DOI 10.1021/bm3007727
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Saunders BR, 2004, LANGMUIR, V20, P3925, DOI 10.1021/la036390v
   Saunders BR, 2009, ADV COLLOID INTERFAC, V147-48, P251, DOI 10.1016/j.cis.2008.08.008
   Saunders JM, 2007, SOFT MATTER, V3, P486, DOI 10.1039/b613943d
   Saxena S, 2014, SOFT MATTER, V10, P1356, DOI 10.1039/c3sm52518j
   Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730
   Smith MH, 2011, MACROMOLECULES, V44, P8154, DOI 10.1021/ma201365p
   Smith MH, 2011, J PHYS CHEM B, V115, P3761, DOI 10.1021/jp111634k
   South AB, 2010, CHEM MATER, V22, P3300, DOI 10.1021/cm100702p
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
NR 40
TC 24
Z9 24
U1 5
U2 185
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0001-4842
EI 1520-4898
J9 ACCOUNTS CHEM RES
JI Accounts Chem. Res.
PD AUG
PY 2014
VL 47
IS 8
BP 2426
EP 2434
DI 10.1021/ar500131v
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AN6JY
UT WOS:000340702000020
PM 24873478
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Yang, K
   Jung, H
   Lee, HR
   Lee, JS
   Kim, SR
   Song, KY
   Cheong, E
   Bang, J
   Im, SG
   Cho, SW
AF Yang, Kisuk
   Jung, Hyunjung
   Lee, Hak-Rae
   Lee, Jong Seung
   Kim, Su Ran
   Song, Ki Yeong
   Cheong, Eunji
   Bang, Joona
   Im, Sung Gap
   Cho, Seung-Woo
TI Multiscale, Hierarchically Patterned Topography for Directing Human
   Neural Stem Cells into Functional Neurons
SO ACS NANO
LA English
DT Article
DE hierarchically patterned substrate; topographical stimulation; human
   neural stem cell; focal adhesion; cytoskeleton alignment;
   differentiation
ID BLOCK-COPOLYMER LITHOGRAPHY; OSTEOGENIC DIFFERENTIATION; PROGENITOR
   CELLS; FOCAL ADHESION; ENDOTHELIAL-CELLS; FATE; MATRIX;
   MECHANOTRANSDUCTION; INDUCTION; LINEAGE
AB Various biophysical and biochemical factors are important for determining the fate of neural stem cells (NSCs). Among biophysical signals, topographical stimulation by micro/nanopatterns has been applied to control NSC differentiation. In this study, we developed a hierarchically patterned substrate (HPS) platform that can synergistically enhance the differentiation of human NSCs (hNSCs) by simultaneously providing microscale and nanoscale spatial controls to facilitate the alignment of the cytoskeleton and the formation of focal adhesions. The multiscale HPS was fabricated by combining microgroove patterns (groove size: 15 mu m), prepared by a conventional photolithographic process, and nanopore patterns (pore diameter: 10 nm), prepared from cylinder-forming block copolymer thin films. The hNSCs grown on the HPS exhibited not only a highly aligned, elongated morphology, but also a greatly enhanced differentiation into neuronal and astrocyte lineages, compared to hNSCs on a flat substrate (FS) or single-type patterned substrates [microgroove patterned substrate (MPS) and nanopore patterned substrate (NPS)]. Interestingly, the application of the HPS directed hNSC differentiation toward neurons rather than astrocytes. The expression of focal adhesion proteins in hNSCs was also significantly increased on the HPS compared to the FS, MPS, and NPS, likely a result of the presence of more focal contact points provided by nanopore structures. Inhibition of both beta 1 integrin-mediated binding and the intracellular Rho-associated protein kinase pathway of hNSCs eliminated the beneficial effects of the HPS on focal adhesion formation and actin filament alignment, which subsequently reduced hNSC differentiation. More importantly, hNSCs on the HPS differentiated into functional neurons exhibiting sodium currents and action potentials. The multiscale, hierarchically patterned topography would be useful for the design of functional biomaterial scaffolds to potentiate NSC therapeutic efficacy.
C1 [Yang, Kisuk; Lee, Jong Seung; Kim, Su Ran; Song, Ki Yeong; Cheong, Eunji; Cho, Seung-Woo] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
   [Jung, Hyunjung; Bang, Joona] Korea Univ, Dept Chem & Biol Engn, Seoul 136713, South Korea.
   [Lee, Hak-Rae; Im, Sung Gap] Korea Adv Inst Sci & Technol, Dept Chem & Biomol Engn, Taejon 305701, South Korea.
   [Lee, Hak-Rae; Im, Sung Gap] Korea Adv Inst Sci & Technol, KI Nanocentury, Taejon 305701, South Korea.
RP Bang, J (reprint author), Korea Univ, Dept Chem & Biol Engn, Seoul 136713, South Korea.
EM joona@korea.ac.kr; sgim@kaist.ac.kr; seungwoocho@yonsei.ac.kr
RI Im, Sung Gap/C-1823-2011; Bang, Joona/F-6589-2013
OI Im, Sung Gap/0000-0002-2802-6398; Bang, Joona/0000-0002-2301-6190
FU National Research Foundation of Korea (NRF) [NRF-2010-0020409,
   NRF-2013R1A1A2A10061422, NRF-2012R1A2-A2A01014473, NRF-2012M3A7B4049863,
   NRF-2013022350]; Translational Research Center for Protein Function
   Control (TRCP) - Ministry of Science, ICT, and Future Planning (MSIP),
   Republic of Korea [2009-0083522]; Advanced Biomass R&D Center (ABC) for
   the Global Frontier Project - MSIP [ABC-2011-0031356]
FX This work was supported by grants (NRF-2010-0020409,
   NRF-2013R1A1A2A10061422, NRF-2012R1A2-A2A01014473, NRF-2012M3A7B4049863,
   and NRF-2013022350) from the National Research Foundation of Korea (NRF)
   and a grant (2009-0083522) from the Translational Research Center for
   Protein Function Control (TRCP) funded by the Ministry of Science, ICT,
   and Future Planning (MSIP), Republic of Korea. This work was also
   supported by the Advanced Biomass R&D Center (ABC) for the Global
   Frontier Project (ABC-2011-0031356) funded by the MSIP.
CR Ahn EH, 2014, BIOMATERIALS, V35, P2401, DOI 10.1016/j.biomaterials.2013.11.037
   Aizawa Y, 2012, BIOMATERIALS, V33, P5198, DOI 10.1016/j.biomaterials.2012.03.062
   Ankam S, 2013, ACTA BIOMATER, V9, P4535, DOI 10.1016/j.actbio.2012.08.018
   Bang J, 2007, ADV MATER, V19, P4552, DOI 10.1002/adma.200701866
   Bang J, 2009, ADV MATER, V21, P4769, DOI 10.1002/adma.200803302
   Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Cho SW, 2009, ADV FUNCT MATER, V19, P3112, DOI 10.1002/adfm.200900519
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Guerrero J, 2013, ACTA BIOMATER, V9, P8200, DOI 10.1016/j.actbio.2013.05.025
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Hawker CJ, 2005, MRS BULL, V30, P952, DOI 10.1557/mrs2005.249
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jung H., 2012, ADV FUNCT MATER, V23, P1597
   Jung H, 2011, ACS NANO, V5, P6164, DOI 10.1021/nn2006943
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Leibfarth FA, 2010, NAT CHEM, V2, P207, DOI [10.1038/NCHEM.538, 10.1038/nchem.538]
   Moe AAK, 2012, SMALL, V8, P3050, DOI 10.1002/smll.201200490
   Morgan PJ, 2012, STEM CELLS DEV, V21, P1501, DOI 10.1089/scd.2011.0335
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Savic R, 2006, LANGMUIR, V22, P3570, DOI 10.1021/la0531998
   Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7
   Seo CH, 2014, BIOMATERIALS, V35, P2245, DOI 10.1016/j.biomaterials.2013.11.089
   Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Stoykovich MP, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71619-4
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Teo BKK, 2013, ACS NANO, V7, P4785, DOI 10.1021/nn304966z
   Teo BKK, 2010, METHOD CELL BIOL, V98, P241, DOI 10.1016/S0091-679X(10)98011-4
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Vukicevic V, 2012, CELL TRANSPLANT, V21, P2471, DOI 10.3727/096368912X638874
   Wang XL, 2013, J BIOMED MATER RES A, V101, P3388, DOI 10.1002/jbm.a.34645
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   Yamamoto K, 2003, J APPL PHYSIOL, V95, P2081, DOI 10.1152/japplphysiol.00232.2003
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
   Yang K, 2013, BIOMATERIALS, V34, P6607, DOI 10.1016/j.biomaterials.2013.05.067
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029
NR 51
TC 52
Z9 52
U1 6
U2 99
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD AUG
PY 2014
VL 8
IS 8
BP 7809
EP 7822
DI 10.1021/nn501182f
PG 14
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AO0IM
UT WOS:000340992300026
PM 25050736
DA 2018-10-20
ER

PT J
AU Hovlid, ML
   Lau, JL
   Breitenkamp, K
   Higginson, CJ
   Laufer, B
   Manchester, M
   Finn, MG
AF Hovlid, Marisa L.
   Lau, Jolene L.
   Breitenkamp, Kurt
   Higginson, Cody J.
   Laufer, Burkhardt
   Manchester, Marianne
   Finn, M. G.
TI Encapsidated Atom-Transfer Radical Polymerization in Q beta Virus-like
   Nanoparticles
SO ACS NANO
LA English
DT Article
DE virus-like particle; ATRP; polymerization; encapsulation; unnatural
   amino acid
ID BACTERIOPHAGE-Q BETA; THIAZOLE ORANGE; COAT PROTEIN; RNA; PARTICLES;
   DELIVERY; PEGYLATION; POLYMERS; INTERIOR; COEFFICIENT
AB Virus-like particles (VLPs) are unique macromolecular structures that hold great promise in biomedical and biomaterial applications. The interior of the 30 nm-diameter Q beta VLP was functionalized by a three-step process: (1) hydrolytic removal of endogenously packaged RNA, (2) covalent attachment of initiator molecules to unnatural amino acid residues located on the interior capsid surface, and (3) atom transfer radical polymerization of tertiary amine-bearing methacrylate monomers. The resulting polymer-containing particles were moderately expanded in size; however, biotin-derivatized polymer strands were only very weakly accessible to avidin, suggesting that most of the polymer was confined within the protein shell. The polymer-containing particles were also found to exhibit physical and chemical properties characteristic of positively charged nanostructures, including the ability to easily enter mammalian cells and deliver functional small interfering RNA.
C1 [Hovlid, Marisa L.; Lau, Jolene L.; Breitenkamp, Kurt; Higginson, Cody J.; Laufer, Burkhardt; Finn, M. G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.
   [Hovlid, Marisa L.; Lau, Jolene L.; Breitenkamp, Kurt; Higginson, Cody J.; Laufer, Burkhardt; Finn, M. G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
   [Manchester, Marianne] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
   [Finn, M. G.] Georgia Inst Technol, Sch Biol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Finn, MG (reprint author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.
EM mgfinn@gatech.edu
OI Higginson, Cody/0000-0003-0257-4852
FU NIH [R01 RR021886, GM101421]; National Science Foundation; Skaggs
   Institute for Chemical Biology
FX This work was supported by the NIH (R01 RR021886 and GM101421), the
   National Science Foundation (predoctoral research fellowships to M.L.H.
   and C.J.H.), and the Skaggs Institute for Chemical Biology. We thank M.
   Behlke of Integrated DNA Technologies for a kind gift of siRNA samples,
   J. Fiedler for TEM images, K. Kacanowska for synthesizing biotin-alkyne
   derivatives, F. Manzenrieder for a cyclic RGD derivative, M. Baksh for
   zeta potential measurements, J. Pokorski for general advice, and I.
   Rupniewski for helpful graphic design tips.
CR Abe S, 2009, J AM CHEM SOC, V131, P6958, DOI 10.1021/ja901234j
   Abedin MJ, 2009, J AM CHEM SOC, V131, P4346, DOI 10.1021/ja8079862
   Agarwal S, 2012, MATER TODAY, V15, P388, DOI 10.1016/S1369-7021(12)70165-7
   Aljabali AAA, 2010, SMALL, V6, P818, DOI 10.1002/smll.200902135
   [Anonymous], 1987, Natl Inst Health Consens Dev Conf Consens Statement, V6, P1
   Ashley C. E., 2011, ACS NANO
   Assessment of Nucleic Acid Purity, 2011, T042 TECHN B NAN SPE, P1
   Averick S., 2011, ACS MACRO LETT, P6
   Bhattacharjee S, 2011, J POLYM ENVIRON, V19, P203, DOI 10.1007/s10924-010-0264-2
   Bontempo D, 2005, J AM CHEM SOC, V127, P6508, DOI 10.1021/ja042230+
   Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088
   Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9
   Fiedler JD, 2010, ANGEW CHEM INT EDIT, V49, P9648, DOI 10.1002/anie.201005243
   Galaway FA, 2013, MOL PHARMACEUT, V10, P59, DOI 10.1021/mp3003368
   Gauthier MA, 2010, POLYM CHEM-UK, V1, P1352, DOI 10.1039/c0py90001j
   Golmohammadi R, 1996, STRUCTURE, V4, P543, DOI 10.1016/S0969-2126(96)00060-3
   Goodman SL, 2002, J MED CHEM, V45, P1045, DOI 10.1021/jm0102598
   Hansson S, 2013, BIOMACROMOLECULES, V14, P64, DOI 10.1021/bm3013132
   Heredia KL, 2007, ORG BIOMOL CHEM, V5, P45, DOI 10.1039/b612355d
   Herrington-Symes A. P., 2013, ADV BIOSCI BIOTECHNO, V4, P689, DOI DOI 10.4236/ABB.2013.45090
   Hoffman AS, 2007, PROG POLYM SCI, V32, P922, DOI 10.1016/j.progpolymsci.2007.05.005
   Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087
   Hooker JM, 2004, J AM CHEM SOC, V126, P3718, DOI 10.1021/ja031790q
   Hovlid ML, 2012, NANOSCALE, V4, P3698, DOI 10.1039/c2nr30571b
   Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129
   Jevsevar S, 2010, BIOTECHNOL J, V5, P113, DOI 10.1002/biot.200900218
   Jones RA, 2004, J CONTROL RELEASE, V96, P379, DOI 10.1016/j.jconrel.2004.01.011
   Jung B, 2013, ADV POLYM SCI, V253, P37, DOI 10.1007/12_2012_169
   KATRE NV, 1993, ADV DRUG DELIVER REV, V10, P91, DOI 10.1016/0169-409X(93)90005-O
   Komiyama M, 1999, CHEM COMMUN, P1443, DOI 10.1039/a901621j
   Koudelka KJ, 2013, BIOMACROMOLECULES, V14, P4169, DOI 10.1021/bm401577f
   Lau JL, 2011, ACS NANO, V5, P7722, DOI 10.1021/nn2006927
   LEE LG, 1986, CYTOMETRY, V7, P508, DOI 10.1002/cyto.990070603
   Li HM, 2011, POLYM CHEM-UK, V2, P1531, DOI 10.1039/c1py00031d
   Lim F, 1996, J BIOL CHEM, V271, P31839, DOI 10.1074/jbc.271.50.31839
   Lin J, 2012, J VIROL, V86, P5959, DOI 10.1128/JVI.05990-11
   Lucon J, 2013, EUR POLYM J, V49, P2976, DOI 10.1016/j.eurpolymj.2013.06.010
   Lucon J, 2012, NAT CHEM, V4, P781, DOI [10.1038/NCHEM.1442, 10.1038/nchem.1442]
   Manzenrieder F, 2011, ANGEW CHEM INT EDIT, V50, P2601, DOI 10.1002/anie.201006134
   Marek SR, 2010, POLYMER, V51, P1237, DOI 10.1016/j.polymer.2010.01.060
   Matsumura K, 1997, J BIOCHEM-TOKYO, V122, P387
   Nicolas J, 2007, MACROMOL RAPID COMM, V28, P1083, DOI 10.1002/marc.200700112
   Nygren J, 1998, BIOPOLYMERS, V46, P39, DOI 10.1002/(SICI)1097-0282(199807)46:1<39::AID-BIP4>3.3.CO;2-M
   Oba M, 2007, BIOCONJUGATE CHEM, V18, P1415, DOI 10.1021/bc0700133
   Orakdogen N, 2011, POLYM BULL, V67, P1347, DOI 10.1007/s00289-011-0559-z
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   Pan T., 2000, CURRENT PROTOCOLS NU, P631
   Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037
   Peeler JC, 2010, J AM CHEM SOC, V132, P13575, DOI 10.1021/ja104493d
   Pfister D., 2010, J CONTROL RELEASE, V180, P1
   Pokorski JK, 2011, J AM CHEM SOC, V133, P9242, DOI 10.1021/ja203286n
   Porterfield JZ, 2010, VIROLOGY, V407, P281, DOI 10.1016/j.virol.2010.08.015
   Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773
   Rhee JK, 2011, BIOMACROMOLECULES, V12, P3977, DOI 10.1021/bm200983k
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneemann A, 2006, ANNU REV MICROBIOL, V60, P51, DOI 10.1146/annurev.micro.60.080805.142304
   Smith MT, 2013, CURR OPIN BIOTECH, V24, P620, DOI 10.1016/j.copbio.2013.01.011
   Strable E, 2008, BIOCONJUGATE CHEM, V19, P866, DOI 10.1021/bc700390r
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   van den Worm SHE, 2006, J MOL BIOL, V363, P558, DOI 10.1016/j.jmb.2006.08.053
   VANDALEN JP, 1974, J IMMUNOL METHODS, V5, P103, DOI 10.1016/0022-1759(74)90052-0
   Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004
   Wallat JD, 2014, POLYM CHEM-UK, V5, P1545, DOI 10.1039/c3py01193c
   Wang H, 2014, MACROMOL BIOSCI, V14, P166, DOI 10.1002/mabi.201300333
   Werner J, 2012, INNATE IMMUN-LONDON, V18, P55, DOI 10.1177/1753425910392934
   Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404
   WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498
   Yildiz I, 2013, J CONTROL RELEASE, V172, P568, DOI 10.1016/j.jconrel.2013.04.023
   Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4
   ZHAO XX, 1995, VIROLOGY, V207, P486, DOI 10.1006/viro.1995.1108
NR 70
TC 35
Z9 36
U1 3
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD AUG
PY 2014
VL 8
IS 8
BP 8003
EP 8014
DI 10.1021/nn502043d
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AO0IM
UT WOS:000340992300046
PM 25073013
OA Green Published, Bronze
DA 2018-10-20
ER

EF